<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC5764404\results\search\disease\results.xml">
   <result pre="Population Biology : Population Genetics: Phylogeography Continental synchronicity of human" exact="influenza" post="virus epidemics despite climactic variation Synchronicity of human influenza"/>
   <result pre="human influenza virus epidemics despite climactic variation Synchronicity of human" exact="influenza" post="virus http://orcid.org/0000-0003-0970-0153GeogheganJemma L.ConceptualizationFormal analysisInvestigationMethodologyProject administrationResourcesSoftwareValidationVisualizationWriting – original draftWriting –"/>
   <result pre="factors that determine the pattern and rate of spread of" exact="influenza" post="virus at a continental-scale are uncertain. Although recent work"/>
   <result pre="at a continental-scale are uncertain. Although recent work suggests that" exact="influenza" post="epidemics in the United States exhibit a strong geographical"/>
   <result pre="States exhibit a strong geographical correlation, the spatiotemporal dynamics of" exact="influenza" post="in Australia, a country and continent of approximately similar"/>
   <result pre="are not known. Using a unique combination of large-scale laboratory-confirmed" exact="influenza" post="surveillance comprising &amp;gt;450,000 entries and genomic sequence data we"/>
   <result pre="this important human pathogen nationwide in Australia. We used laboratory-confirmed" exact="influenza" post="data to characterize the spread of influenza virus across"/>
   <result pre="We used laboratory-confirmed influenza data to characterize the spread of" exact="influenza" post="virus across Australia during 2007–2016. The onset of established"/>
   <result pre="global phylogeographic patterns we show that the synchronized dissemination of" exact="influenza" post="across Australian cities involved multiple introductions from the global"/>
   <result pre="influenza across Australian cities involved multiple introductions from the global" exact="influenza" post="population, coupled with strong domestic connectivity, rather than through"/>
   <result pre="United States. In addition, by comparing the spatial structure of" exact="influenza" post="A and B, we found that these viruses tended"/>
   <result pre="immunity or viral interference effects. The highly synchronized outbreaks of" exact="influenza" post="virus at a continental-scale revealed here highlight the importance"/>
   <result pre="Author summary We use a unique combination of large-scale laboratory-confirmed" exact="influenza" post="surveillance and genomic sequence data to determine the pattern"/>
   <result pre="genomic sequence data to determine the pattern and determinants of" exact="influenza" post="spread through time and space at a continental scale,"/>
   <result pre="of the manuscript. fig-count: table-count: page-count: Data Availability The laboratory-confirmed" exact="influenza" post="data were obtained through a research agreement between the"/>
   <result pre="the Bureau of Infrastructure, Transport and Regional Economics (https://bitre.gov.au/statistics/aviation/). Global" exact="influenza" post="sequence data are available from the GISAID EpiFlu database"/>
   <result pre="from the GISAID EpiFlu database (platform.gisaid.org). Introduction Seasonal and pandemic" exact="influenza" post="remains one of the most important infectious diseases of"/>
   <result pre="the continual accumulation of small changes in surface antigens of" exact="influenza" post="virus that escape host immunity and hence allow reinfection"/>
   <result pre="hence allow reinfection [2]. At present, four different forms of" exact="influenza" post="virus co-circulate in human populations: the H3N2 and H1N1"/>
   <result pre="co-circulate in human populations: the H3N2 and H1N1 subtypes of" exact="influenza" post="A virus and the Victoria and Yamagata lineages of"/>
   <result pre="influenza A virus and the Victoria and Yamagata lineages of" exact="influenza" post="B virus. Influenza-related mortality is highest in years when"/>
   <result pre="the year [5]. Defining the seasonal and climatic drivers of" exact="influenza" post="virus in both temperate and tropical regions has proven"/>
   <result pre="[6, 7]. However, a detailed characterization of the spread of" exact="influenza" post="virus through time and space at the scale of"/>
   <result pre="lack of spatially refined incidence data. Indeed, our understanding of" exact="influenza" post="transmission has relied heavily on observations of influenza-like illness"/>
   <result pre="influenza-like illness (ILI). Unfortunately, the accuracy of clinical diagnosis of" exact="influenza" post="based on ILI alone is limited due to the"/>
   <result pre="overlap of symptoms caused by other respiratory pathogens [8], with" exact="influenza" post="virus reported to cause as few as 29% of"/>
   <result pre="United States has shown that the nationwide spatial transmission of" exact="influenza" post="virus is principally driven by workflow commuting [10]. In"/>
   <result pre="air travel has been suggested as an important driver of" exact="influenza" post="introduction and subsequent spread [11]. Much of this work"/>
   <result pre="Much of this work suggests a high geographical correlation of" exact="influenza" post="epidemics both at a local level in the United"/>
   <result pre="continent of Australia offers a unique and opposing exploration of" exact="influenza" post="dissemination. Australia’s human population is geographically concentrated in urban"/>
   <result pre="in temperate regions of Australia generally experience seasonal outbreaks of" exact="influenza" post="infection between May and October [13]. Nevertheless, inter-seasonal influenza"/>
   <result pre="of influenza infection between May and October [13]. Nevertheless, inter-seasonal" exact="influenza" post="has been shown to persist locally with sustained transmission,"/>
   <result pre="necessary to consider Australia’s climate complexity to inform its national" exact="influenza" post="vaccination strategy [14]. The national and international spread of"/>
   <result pre="influenza vaccination strategy [14]. The national and international spread of" exact="influenza" post="virus is clearly complex, with the onset, duration and"/>
   <result pre="uncertainty associated with ILI data. Quantifying the spatiotemporal spread of" exact="influenza" post="virus is particularly important for identifying the factors that"/>
   <result pre="precise targeting of control interventions. Here, we utilize large-scale laboratory-confirmed" exact="influenza" post="incidence data collected by the National Notifiable Disease Surveillance"/>
   <result pre="collected on a global scale, to determine the correlation of" exact="influenza" post="spread through time and space within Australia during the"/>
   <result pre="country, and what this means for understanding the determinants of" exact="influenza" post="spread. Results Australian laboratory-confirmed influenza The data provided by"/>
   <result pre="for understanding the determinants of influenza spread. Results Australian laboratory-confirmed" exact="influenza" post="The data provided by the Australian NNDSS are characterized"/>
   <result pre="test and, in the vast majority (98%) of cases, the" exact="influenza" post="virus type detected. Although the overall aim for this"/>
   <result pre="Nevertheless, this is one of the most well defined laboratory-confirmed" exact="influenza" post="data sets at a nationwide level currently available globally."/>
   <result pre="currently available globally. The data set included the number of" exact="influenza" post="cases per day between 2006 and 2016, by age"/>
   <result pre="virus type/subtype (S1 Fig). The majority (75%) of viruses were" exact="influenza" post="A virus; however, in 70% of these cases the"/>
   <result pre="of these cases the subtype was unspecified, with the remaining" exact="influenza" post="A cases defined as H3N2 (8%) and H1N1 (22%)."/>
   <result pre="as H3N2 (8%) and H1N1 (22%). The number of un-subtyped" exact="influenza" post="A virus cases varied among years. For this reason,"/>
   <result pre="varied among years. For this reason, we necessarily considered all" exact="influenza" post="A cases in the main analysis as a single"/>
   <result pre="main analysis as a single group rather than considering individual" exact="influenza" post="A virus subtypes. Other viruses isolated included: A and"/>
   <result pre="and prior were excluded from further analysis. Time series of" exact="influenza" post="viruses We examined the number of cases of influenza"/>
   <result pre="of influenza viruses We examined the number of cases of" exact="influenza" post="A and B, the most common influenza viruses in"/>
   <result pre="of cases of influenza A and B, the most common" exact="influenza" post="viruses in the data set, over the ten-year sampling"/>
   <result pre="the fact that few laboratories in Australia currently test for" exact="influenza" post="C. Maps show that the proportion of influenza A"/>
   <result pre="test for influenza C. Maps show that the proportion of" exact="influenza" post="A compared to influenza B varied each year between"/>
   <result pre="Maps show that the proportion of influenza A compared to" exact="influenza" post="B varied each year between 2007–2016. As expected, very"/>
   <result pre="B varied each year between 2007–2016. As expected, very few" exact="influenza" post="B cases were reported during the 2009 H1N1 pandemic,"/>
   <result pre="while in other years more locations reported higher proportions of" exact="influenza" post="B cases. Influenza B dominated in 2015 with 60%"/>
   <result pre="Influenza B dominated in 2015 with 60% of the total" exact="influenza" post="cases, while only 39% were influenza A and the"/>
   <result pre="60% of the total influenza cases, while only 39% were" exact="influenza" post="A and the remaining cases were mixed infections of"/>
   <result pre="mixed infections of A and B. In all other years," exact="influenza" post="A was the dominant virus. During 2012, influenza A"/>
   <result pre="other years, influenza A was the dominant virus. During 2012," exact="influenza" post="A cases were concentrated in the southeast of Australia,"/>
   <result pre="A cases were concentrated in the southeast of Australia, while" exact="influenza" post="B cases were largely concentrated in northern and western"/>
   <result pre="regions. While the majority of seasons displayed a co-circulation of" exact="influenza" post="A and B, these two virus types often occupied"/>
   <result pre="1 (A) Maps show the proportion of laboratory-confirmed cases of" exact="influenza" post="A compared to influenza B between 2007–2016 for each"/>
   <result pre="the proportion of laboratory-confirmed cases of influenza A compared to" exact="influenza" post="B between 2007–2016 for each Australian postal area corresponding"/>
   <result pre="postal area corresponding to the adjacent color scale (i.e. blue:" exact="influenza" post="B and yellow: influenza A). A colored box indicates"/>
   <result pre="the adjacent color scale (i.e. blue: influenza B and yellow:" exact="influenza" post="A). A colored box indicates the year, where the"/>
   <result pre="for that year. Any deviation from this proportion suggests that" exact="influenza" post="A and B were occupying different spatial regions. (B)"/>
   <result pre="occupying different spatial regions. (B) (i) proportional time series of" exact="influenza" post="A and influenza B cases; (ii) the number of"/>
   <result pre="regions. (B) (i) proportional time series of influenza A and" exact="influenza" post="B cases; (ii) the number of laboratory-confirmed cases per"/>
   <result pre="(ii) the number of laboratory-confirmed cases per week (left axis:" exact="influenza" post="B; right axis: influenza A); and (iii) de-seasonalized number"/>
   <result pre="laboratory-confirmed cases per week (left axis: influenza B; right axis:" exact="influenza" post="A); and (iii) de-seasonalized number of laboratory confirmed cases,"/>
   <result pre="showing only long-term trends and the noise components (left axis:" exact="influenza" post="B; right axis: influenza A). For seasonal smoothing, data"/>
   <result pre="and the noise components (left axis: influenza B; right axis:" exact="influenza" post="A). For seasonal smoothing, data were de-trended and a"/>
   <result pre="series data. We next analyzed the time series of each" exact="influenza" post="virus. These displayed a strong seasonal signature and an"/>
   <result pre="average annual peak at week ~34 (i.e. mid-August) for both" exact="influenza" post="A and B, but was delayed in 2010 until"/>
   <result pre="2009. We also investigated the possibility of cross-protective immunity among" exact="influenza" post="A and B by analyzing the time series in"/>
   <result pre="residual immunity from previous seasons infection or vaccination. Establishment of" exact="influenza" post="epidemics through time and space We next estimated the"/>
   <result pre="space We next estimated the timing of epidemic onset of" exact="influenza" post="in Australia. To this end we first compared epidemic"/>
   <result pre="which corresponds to the breakpoint in the piecewise regression, of" exact="influenza" post="A across ten years from 2007–2016 (Fig 2). This"/>
   <result pre="week 30.9 in 2010. Fig 2 The number of laboratory-confirmed" exact="influenza" post="A (all strains) cases per week for each influenza"/>
   <result pre="laboratory-confirmed influenza A (all strains) cases per week for each" exact="influenza" post="season from 2007 to 2016 (red line, left axes)"/>
   <result pre="each year is shown. To determine whether the timing of" exact="influenza" post="outbreaks varied across Australia, we also estimated the epidemic"/>
   <result pre="baseline and is hence reliant on the strength of the" exact="influenza" post="signal in each location. The total number of locations"/>
   <result pre="was therefore only a fraction of those locations with reported" exact="influenza" post="cases, and ranged from 53 locations in 2008 to"/>
   <result pre="to 679 locations in 2016 (Table 1). The time for" exact="influenza" post="to reach all locations ranged from 28 weeks in"/>
   <result pre="Fig 3 (A) Epidemic onset timing per location of laboratory-confirmed" exact="influenza" post="A cases 2007–2016. Each circle on the map represents"/>
   <result pre="sustained outbreak for each year. (B) The mean week of" exact="influenza" post="A epidemic onset timing (as well as 25% and"/>
   <result pre="1 Summary statistics describing the epidemic onset timing of laboratory-confirmed" exact="influenza" post="A cases between 2007–2016 for each location sampled (i.e."/>
   <result pre="location sampled (i.e. Fig 3). Year Number of laboratory confirmed" exact="influenza" post="A cases Number of locations with reported influenza cases"/>
   <result pre="laboratory confirmed influenza A cases Number of locations with reported" exact="influenza" post="cases Number of locations with established epidemics Mean week"/>
   <result pre="particularly during 2009 (Fig 3B). This result suggests dissemination of" exact="influenza" post="through long-distance domestic air travel, likely coupled with multiple"/>
   <result pre="long-distance domestic air travel, likely coupled with multiple entries of" exact="influenza" post="into Australia within a short period of time. We"/>
   <result pre="period of time. We also found that onset timing of" exact="influenza" post="A and B epidemics occurred around the same time"/>
   <result pre="pandemic season. In 2009, the mean epidemic onset timing of" exact="influenza" post="B was week ~7 due to a few sporadic,"/>
   <result pre="Fig). Although the important caveats regarding the sampling inconsistencies of" exact="influenza" post="A subtypes (noted in the Materials and methods) prevented"/>
   <result pre="in 2009 (S2B Fig). To help reveal the determinants of" exact="influenza" post="spread, we next investigated the role of population density"/>
   <result pre="determine the role of distance on the spatial spread of" exact="influenza" post="in Australia, we investigated the difference in onset timing"/>
   <result pre="points tended to display synchrony in onset timing suggesting that" exact="influenza" post="reached both coastal extremes of Australia at approximately the"/>
   <result pre="order shown in S1 Table. Global circulation and introduction of" exact="influenza" post="virus into Australia To determine the relationship of those"/>
   <result pre="influenza virus into Australia To determine the relationship of those" exact="influenza" post="viruses present in Australia and those circulating globally, we"/>
   <result pre="inferred phylogenetic trees for three subtypes over key years: (i)" exact="influenza" post="A H1N1 during 2009; (ii) influenza A H3N2 during"/>
   <result pre="over key years: (i) influenza A H1N1 during 2009; (ii)" exact="influenza" post="A H3N2 during 2014; and (iii) influenza B during"/>
   <result pre="during 2009; (ii) influenza A H3N2 during 2014; and (iii)" exact="influenza" post="B during 2015 (Fig 6). Because of their relatively"/>
   <result pre="the positions of the Australian sequences. For each of these" exact="influenza" post="seasons there was little clustering of Australian sequences. Indeed,"/>
   <result pre="the 224 Australian sequences available from the outbreak of H1N1" exact="influenza" post="A virus in 2009 fell into 41 phylogenetically distinct"/>
   <result pre="2014 = 23 (of 196 (12%) Australian samples); and (iii)" exact="influenza" post="B, 2015 = 30 (of 164 (18%) Australian samples)."/>
   <result pre="are shown). Fig 6 Maximum likelihood phylogenetic trees of global" exact="influenza" post="virus. All available HA genetic sequences were downloaded from"/>
   <result pre="Fig. Discussion We examined the spatial and temporal spread of" exact="influenza" post="viruses in Australia over ten years between 2007–2016 using"/>
   <result pre="2007–2016 using a unique data set of spatially refined laboratory-confirmed" exact="influenza" post="cases that comprises &amp;gt;450,000 entries. While many studies of"/>
   <result pre="&amp;gt;450,000 entries. While many studies of the spatial spread of" exact="influenza" post="are based on ILI data, in which accuracy is"/>
   <result pre="our data set offers a rare opportunity to study laboratory-confirmed" exact="influenza" post="(based mostly on real-time PCR testing). We focused on"/>
   <result pre="our study was that despite its huge climatic variation sustained" exact="influenza" post="epidemics in Australia were often highly synchronized, especially during"/>
   <result pre="A/H3N2 variant). However, due to the low level of exact" exact="influenza" post="A subtype data we could not assess whether the"/>
   <result pre="synchronicity has been enhanced by the multiple introductions of global" exact="influenza" post="viruses into Australia, a process that was clearly apparent"/>
   <result pre="pattern is indeed genuine and reflects the intrinsic dynamics of" exact="influenza" post="in Australia. This synchronicity occurs despite the diverse array"/>
   <result pre="considerable climatic variation. The onset of epidemics during the 2009" exact="influenza" post="season exhibited the greatest synchrony. Famously, 2009 was dominated"/>
   <result pre="Famously, 2009 was dominated by the emergence of a novel" exact="influenza" post="A/H1N1 virus that resulted in a global pandemic and"/>
   <result pre="up to 65% of ILI clinical isolates tested positive for" exact="influenza" post="A and by early July 2009, A/H1N1 accounted for"/>
   <result pre="and by early July 2009, A/H1N1 accounted for 90% of" exact="influenza" post="A isolates [17]. Indeed, following its initial detection in"/>
   <result pre="clade), A/Switzerland/9715293/2013-like viruses (3C.3a) and A/Newcastle/22/2014-like viruses (3C.3b). Following both" exact="influenza" post="seasons, there was a change in the H3 vaccine"/>
   <result pre="viruses that had circulated in 2015, 2015 was dominated by" exact="influenza" post="B such that relatively few A/H3N2 cases were detected"/>
   <result pre="work flow may have played a relatively minor role in" exact="influenza" post="epidemic spread. Rather, these synchronized epidemics across Australian cities"/>
   <result pre="by multiple global introductions. Indeed, our phylogeographic analysis of global" exact="influenza" post="gene sequence data from key years shows that there"/>
   <result pre="key years shows that there have been multiple introductions of" exact="influenza" post="into Australia annually, which were then able to establish"/>
   <result pre="isolates. Overall, this pattern again highlights the fluidity with which" exact="influenza" post="viruses spread both nationally and globally [21], and which"/>
   <result pre="difference reflects underlying differences in the data collected (i.e. laboratory-confirmed" exact="influenza" post="versus ILI), the degree of synchronicity that we have"/>
   <result pre="degree of synchronicity that we have observed during novel antigenic" exact="influenza" post="seasons supports continued highly coordinated public health responses across"/>
   <result pre="other highly urbanized localities. Materials and methods Data collection Laboratory-confirmed" exact="influenza" post="notifications data were requested from CDNA. These data can"/>
   <result pre="granted by The University of Sydney, project number 2015/625. Laboratory-confirmed" exact="influenza" post="is a notifiable disease in Australia, with notifications made"/>
   <result pre="a five-year age group) and, in 98% of cases, the" exact="influenza" post="virus type (i.e. A, B or C) detected. The"/>
   <result pre="Time series analysis We first analyzed the number of laboratory-confirmed" exact="influenza" post="cases of influenza viruses A and B to determine"/>
   <result pre="We first analyzed the number of laboratory-confirmed influenza cases of" exact="influenza" post="viruses A and B to determine the dominant viruses"/>
   <result pre="viruses present in Australia between 2007–2016. All cases specified as" exact="influenza" post="A and B were included in this analysis. Only"/>
   <result pre="and B were included in this analysis. Only 33% of" exact="influenza" post="A notifications included the subtype (i.e. A/H1N1 or A/H3N2),"/>
   <result pre="onset timing’, defined as the timing of the break-point in" exact="influenza" post="incidence [10], across the ten-year period for which sufficient"/>
   <result pre="therefore fitted piecewise linear models to determine the break-point in" exact="influenza" post="incidence using the Segmented package in R [22]. Importantly,"/>
   <result pre="influenza, whereas an introduction simply represents the first case of" exact="influenza" post="each year regardless of whether that first introduction triggered"/>
   <result pre="an outbreak. To this end, the onset timing of all" exact="influenza" post="A (regardless of subtype) epidemics for each year was"/>
   <result pre="aimed to better understand the spatial and temporal spread of" exact="influenza" post="in Australia. To this end we estimated the epidemic"/>
   <result pre="onset timing in each postcode area for all cases of" exact="influenza" post="A between 2007–2016. We investigated the synchrony of epidemic"/>
   <result pre="Brisbane, Adelaide, Townsville, Darwin, Hobart and Perth), and between laboratory-confirmed" exact="influenza" post="A and B viruses. Next, we performed additional quantitative"/>
   <result pre="kilometers) from each postcode to its nearest airport. Phylogeography of" exact="influenza" post="virus To further investigate the introduction and subsequent spatial"/>
   <result pre="To further investigate the introduction and subsequent spatial spread of" exact="influenza" post="virus in Australia, particularly the number of introductions in"/>
   <result pre="in Australia, particularly the number of introductions in any one" exact="influenza" post="season and the presence of Australia-specific clades, we estimated"/>
   <result pre="presence of Australia-specific clades, we estimated the phylogenetic relationships of" exact="influenza" post="virus A and B on a global scale. For"/>
   <result pre="[23, 24] (note that these data are unlinked to the" exact="influenza" post="incidence data analyzed here). All available HA genetic sequences,"/>
   <result pre="of 500 nucleotides, were downloaded for years in which global" exact="influenza" post="data were abundant: (i) 2009 H1N1 (n = 10,016);"/>
   <result pre="10,016); (ii) 2014 H3N2 (n = 5,584); and (iii) 2015" exact="influenza" post="B virus (n = 3,882). Each sequence data set"/>
   <result pre="Fig Summary of the data set. The number of laboratory-confirmed" exact="influenza" post="cases in Australia, per day, from 1st January 2006"/>
   <result pre="(and 95% confidence intervals) week of epidemic onset timing for" exact="influenza" post="A (both subtypes and unsubtyped data) and B in"/>
   <result pre="(and 95% confidence intervals) week of epidemic onset timing for" exact="influenza" post="A/H1N1, A/H3N2 and B. (TIF) LINK Click here for"/>
   <result pre="additional data file. S3 Fig Maximum likelihood phylogenetic trees of" exact="influenza" post="virus, showing the two largest clades isolated from Australia"/>
   <result pre="the main text (A-B: A/H1N1 2009; C-D: A/H3N2 2014; E-F:" exact="influenza" post="B 2015). HA genetic sequences were downloaded from the"/>
   <result pre="doi: 10.1126/science.112523716574822 3FergusonNM, GalvaniAP, BushRM. Ecological and immunological determinants of" exact="influenza" post="evolution. Nature. 2003;422(6930):428–33. doi: 10.1038/nature0150912660783 4SmithDJ, LapedesAS, de JongJC,"/>
   <result pre="RimmelzwaanGF, OsterhausADME, et al.Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science. 2004;305(5682):371–6. doi: 10.1126/science.109721115218094 5SimonsenL. The global impact"/>
   <result pre="virus. Science. 2004;305(5682):371–6. doi: 10.1126/science.109721115218094 5SimonsenL. The global impact of" exact="influenza" post="on morbidity and mortality. Vaccine. 1999;17:S3–S10. doi: 10.1016/S0264-410X(99)00099-710471173 6Patterson"/>
   <result pre="10.1016/S0264-410X(99)00099-710471173 6Patterson RossZ, KomadinaN, DengY-M, SpirasonN, KellyHA, SullivanSG, et al.Inter-seasonal" exact="influenza" post="is characterized by extended virus transmission and persistence. PLoS"/>
   <result pre="HeM, LamTT-Y, LuX, ViboudC, et al.Epidemiological dynamics and phylogeography of" exact="influenza" post="virus in southern China. J Infect Dis. 2013;207(1):106–14. doi:"/>
   <result pre="8PeltolaV, ReunanenT, ZieglerT, SilvennoinenH, HeikkinenT. Accuracy of clinical diagnosis of" exact="influenza" post="in outpatient children. Clin Infect Dis. 2005;41(8):1198–200. doi: 10.1086/44450816163640"/>
   <result pre="Dis. 2005;41(8):1198–200. doi: 10.1086/44450816163640 9ZambonMC, StocktonJD, ClewleyJP, FlemingDM. Contribution of" exact="influenza" post="and respiratory syncytial virus to community cases of influenza-like"/>
   <result pre="KisslerS, SimonsenL, et al.Human mobility and the spatial transmission of" exact="influenza" post="in the United States. PLoS Comp Bio. 2017;13(2):e1005382doi: 10.1371/journal.pcbi.100538228187123"/>
   <result pre="Empirical evidence for the effect of airline travel on inter-regional" exact="influenza" post="spread in the United States. PLoS Medicine. 2006;3(10):e401doi: 10.1371/journal.pmed.003040116968115"/>
   <result pre="Exploring a proposed WHO method to determine thresholds for seasonal" exact="influenza" post="surveillance. PLoS ONE. 2013;8(10):e77244doi: 10.1371/journal.pone.007724424146973 14SullivanSG, TayEL, KellyH. Variable"/>
   <result pre="ONE. 2013;8(10):e77244doi: 10.1371/journal.pone.007724424146973 14SullivanSG, TayEL, KellyH. Variable definitions of the" exact="influenza" post="season and their impact on vaccine effectiveness estimates. Vaccine."/>
   <result pre="et al.Stochastic processes are key determinants of short-term evolution in" exact="influenza" post="a virus. PLoS Pathog. 2006;2(12):e125doi: 10.1371/journal.ppat.002012517140286 16Health Do. Australia"/>
   <result pre="2014. 17BishopJF, MurnaneMP, OwenR. Australia's winter with the 2009 pandemic" exact="influenza" post="A (H1N1) Virus. N Engl J Med. 2009;361(27):2591–4. doi:"/>
   <result pre="WentworthD, FanJ, BeckE, St. GeorgeK, et al.The early diversification of" exact="influenza" post="A/H1N1pdm. PLoS Currents. 2009;1:RRN1126doi: 10.1371/currents.RRN112620029664 19WHO. [accessed November 2017]."/>
   <result pre="BoyneAR, BeraJ, HalpinR, et al.Molecular epidemiology of A/H3N2 and A/H1N1" exact="influenza" post="virus during a single epidemic season in the United"/>
   <result pre="News. 2008;8(1):20–5. 23ShuY, McCauleyJ. GISAID: Global initiative on sharing all" exact="influenza" post="data–from vision to reality. Eurosurveill. 2017;22(13):30494doi: 10.2807/1560-7917.ES.2017.22.13.3049428382917 24ElbeS, Buckland-MerrettG."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6002110\results\search\disease\results.xml">
   <result pre="(YFV) (family Flaviviridae, genus Flavivirus) is the etiologic agent of" exact="yellow fever" post="(YF). In Brazil, the urban cycle has not occured"/>
   <result pre="the urban cycle has not occured since 1942, but sylvatic" exact="yellow fever" post="(SYF) occurs in the Amazon Basin (S1A Fig) in"/>
   <result pre="and adjacent regions. Supporting information S1 Fig Historical data of" exact="yellow fever" post="in Brazil. (A) Geopolitical map of Brazil and the"/>
   <result pre="Brazil and the Amazon Basin. The Amazon Basin, where sylvatic" exact="yellow fever" post="is endemic, is highlighted. Brazilian geopolitical regions are colored"/>
   <result pre="and Ministério do Meio Ambiente [35]. (B) Number of sylvatic" exact="yellow fever" post="human cases, from 2001 to February 2018, according to"/>
   <result pre="The Brazilian regions and the bars representing the numbers of" exact="yellow fever" post="human cases are colored accordingly. *data from May 2016"/>
   <result pre="2017 to February 2018 [36]. Data regarding the number of" exact="yellow fever" post="cases were obtained from Sistema de Informação de Agravos"/>
   <result pre="South American Genotypes are shown in green, and the Brazilian" exact="yellow fever" post="virus from outbreaks 2016–2018 are collapsed in a triangle."/>
   <result pre="circles drawn in scale in the nodes. Clades containing Brazilian" exact="yellow fever" post="virus from outbreaks 2000–01, 2008–09 and the current (2016–2018)"/>
   <result pre="de, SantosMP, RibeiroIP, et al.Genomic and structural features of the" exact="yellow fever" post="virus from the 2016–2017 Brazilian outbreak. J Gen Virol."/>
   <result pre="dos SantosCN. Isolation and characterization of a Brazilian strain of" exact="yellow fever" post="virus from an epizootic outbreak in 2009. Acta Trop."/>
   <result pre="BradyOJ, KraemerMUG, et al.Existing and potential infection risk zones of" exact="yellow fever" post="worldwide: a modelling analysis. Lancet Glob Heal. 2018;6: e270–e278."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6002135\results\search\disease\results.xml">
   <result pre="started in the French West Indies, about two years after" exact="chikungunya" post="epidemics, spread by the same mosquito, hit the same"/>
   <result pre="the Middle East [1–3], Ebola virus in West Africa [4–10]," exact="chikungunya" post="virus (CHIKV) [11] and Zika virus (ZIKV) [12–14] in"/>
   <result pre="1) [28]. Cases of ZIKV infection were defined as &quot;a" exact="rash" post="with or without fever and at least two signs"/>
   <result pre="(B-C) Weekly incidence (per 1,000 population) during the epidemics of" exact="chikungunya" post="virus (CHIKV) in the French West Indies in 2013–2015"/>
   <result pre="years, had the same kind of clinical signs (i.e., fever," exact="rash" post="and arthralgia) and were reported by the same surveillance"/>
   <result pre="9, 46], and forecasting challenges have been set up for" exact="influenza" post="[47], for Ebola [45] and for chikungunya [48]. Comparing"/>
   <result pre="set up for influenza [47], for Ebola [45] and for" exact="chikungunya" post="[48]. Comparing and systematically evaluating models’ forecasting performances is"/>
   <result pre="multiple epidemics, for instance with the joint analysis of six" exact="smallpox" post="epidemics [49], for transmissibility and duration of carriage in"/>
   <result pre="analysis of multistrain pneumococcus carriage [50], or for forecasting seasonal" exact="influenza" post="[51]. Other modelling papers specifically attempted to take advantage"/>
   <result pre="different Aedes-transmitted diseases, e.g., by estimating the risk of acquiring" exact="chikungunya" post="from the prevalence of dengue [52] or by assesssing"/>
   <result pre="Dataset D 2 . Weekly number of reported cases of" exact="chikungunya" post="virus infection in the French West Indies (2013–2015). (CSV)"/>
   <result pre=". Weekly number of reported cases of Zika virus and" exact="chikungunya" post="virus infection in French Polynesia (2013–2015). (CSV) LINK Click"/>
   <result pre="QuenelP, De ValkH, ColizzaV, et al.Local and regional spread of" exact="chikungunya" post="fever in the Americas. Eurosurveillance. 2014;19(28):20854doi: 10.2807/1560-7917.ES2014.19.28.2085425060573 12PerkinsAT, SirajAS,"/>
   <result pre="Zika virus infection during Colombia epidemic, 2015–2016. Travel medicine and" exact="infectious disease." post="2016;14(3):274–276. doi: 10.1016/j.tmaid.2016.03.01627060613 15HeesterbeekH, AndersonRM, AndreasenV, BansalS, De AngelisD,"/>
   <result pre="10.1016/j.tmaid.2016.03.01627060613 15HeesterbeekH, AndersonRM, AndreasenV, BansalS, De AngelisD, DyeC, et al.Modeling" exact="infectious disease" post="dynamics in the complex landscape of global health. Science."/>
   <result pre="HensN, BeutelsP. Lessons from a decade of individual-based models for" exact="infectious disease" post="transmission: a systematic review (2006–2015). BMC Infectious Diseases. 2017;17:612doi:"/>
   <result pre="et al.Multinational patterns of seasonal asymmetry in human movement influence" exact="infectious disease" post="dynamics. Nature Communications. 2017;8(1):2069doi: 10.1038/s41467-017-02064-429234011 24CharuV, ZegerS, GogJ, BjørnstadON,"/>
   <result pre="KisslerS, SimonsenL, et al.Human mobility and the spatial transmission of" exact="influenza" post="in the United States. PLOS Computational Biology. 2017;13(2):e1005382doi: 10.1371/journal.pcbi.100538228187123"/>
   <result pre="Population-level differences in disease transmission: A Bayesian analysis of multiple" exact="smallpox" post="epidemics. Epidemics. 2013;5(3):146–156. doi: 10.1016/j.epidem.2013.07.00124021521 50CauchemezS, TemimeL, GuillemotD, VaronE,"/>
   <result pre="2017;. 52MassadE, MaS, BurattiniMN, TunY, CoutinhoFAB, AngLW. The risk of" exact="chikungunya" post="fever in a dengue-endemic area. Journal of travel medicine."/>
   <result pre="Dzul-ManzanillaF, Gomez-DantésH, Pavia-RuzN, HladishTJ, LenhartA, et al.Spatio-temporal coherence of dengue," exact="chikungunya" post="and Zika outbreaks in Merida, Mexico. PLoS neglected tropical"/>
   <result pre="MeurisseS, CarratF, BoëllePY. Transmissibility and geographic spread of the 1889" exact="influenza" post="pandemic. Proceedings of the National Academy of Sciences. 2010;107(19):8778–8781."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6050668\results\search\disease\results.xml">
   <result pre="to the data of NHPs vaccinated with a recombinant vesicular" exact="stomatitis" post="virus vaccine (rVSV-EBOV) [44]. This vaccine had shown a"/>
   <result pre="R0 Basic reproduction number Re Effective reproduction number VSV Vesicular" exact="stomatitis" post="virus WHO World health organization Electronic supplementary material The"/>
   <result pre="Sci USA20141115118095610.1073/pnas.142155111125502594 4WillemLVerelstFBilckeJHensNBeutelsPLessons from a decade of individual-based models for" exact="infectious disease" post="transmission: a systematic review (2006-2015)BMC Infect Dis201717161210.1186/s12879-017-2699-828893198 5AndersonRMMayRMInfectious Diseases"/>
   <result pre="5AndersonRMMayRMInfectious Diseases of Humans: Dynamics and Control1992OxfordOUP Oxford 6HeesterbeekHAndersonRMAndreasenVBansalSDe AngelisDDyeCEamesKTDEdmundsWJFrostSDWFunkSHollingsworthTDHouseTIshamVKlepacPLesslerJLloyd-SmithJOMetcalfCJEMollisonDPellisLPulliamJRCRobertsMGViboudCModeling" exact="infectious disease" post="dynamics in the complex landscape of global healthScience201534762274339910.1126/science.aaa4339 7BrittonTStochastic"/>
   <result pre="Ring VaccinationPLoS Negl Trop Dis20161011000509310.1371/journal.pntd.0005093 11LukensSDePasseJRosenfeldRGhedinEMochanEBrownSTGrefenstetteJBurkeDSSwigonDClermontGA large-scale immuno-epidemiological simulation of" exact="influenza" post="A epidemicsBMC Public Health201414101910.1186/1471-2458-14-101925266818 12World Health Organization. Outbreak communication:"/>
   <result pre="Technical report. 13Nguyen VK, Parra-Rojas C, Hernandez-Vargas EA. The 2017" exact="plague" post="outbreak in Madagascar: data descriptions and epidemic modelling. Epidemics."/>
   <result pre="kinetics and exhaled droplet size affect indoor transmission dynamics of" exact="influenza" post="infectionIndoor Air20091954011310.1111/j.1600-0668.2009.00603.x19659895 19FarberDLYudaninNARestifoNPHuman memory T cells: generation, compartmentalization and"/>
   <result pre="generation, compartmentalization and homeostasisNat Rev Immunol2014141243510.1038/nri356724336101 20Hernandez-VargasEAWilkECaniniLToapantaFRBinderSCUvarovskiiARossTMGuzmanCAPerelsonASMeyer-HermannMEffects of aging on" exact="influenza" post="virus infection dynamicsJ. Virol.201488841233110.1128/JVI.03644-1324478442 21RozhnovaGMetcalfCJEGrenfellBTCharacterizing the dynamics of rubella"/>
   <result pre="on influenza virus infection dynamicsJ. Virol.201488841233110.1128/JVI.03644-1324478442 21RozhnovaGMetcalfCJEGrenfellBTCharacterizing the dynamics of" exact="rubella" post="relative to measles: the role of stochasticityJ R Soc"/>
   <result pre="Interface20131088201306432013064310.1098/rsif.2013.064324026472 22CaudronQMahmudASMetcalfCJEGottfrethssonMViboudCCliffADGrenfellBTPredictability in a highly stochastic system: final size of" exact="measles" post="epidemics in small populationsJ R Soc Interface2014121022014112510.1098/rsif.2014.1125 23FinkenstadtBFA stochastic"/>
   <result pre="for extinction and recurrence of epidemics: estimation and inference for" exact="measles" post="outbreaksBiostatistics20023449351010.1093/biostatistics/3.4.49312933594 24MurilloLNMurilloMSPerelsonASTowards multiscale modeling of influenza infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630"/>
   <result pre="estimation and inference for measles outbreaksBiostatistics20023449351010.1093/biostatistics/3.4.49312933594 24MurilloLNMurilloMSPerelsonASTowards multiscale modeling of" exact="influenza" post="infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630 25DayTAlizonSMideoNBridging scales in the evolution of"/>
   <result pre="influenza infectionJ Theor Biol20133322679010.1016/j.jtbi.2013.03.02423608630 25DayTAlizonSMideoNBridging scales in the evolution of" exact="infectious disease" post="life histories: theoryEvolution2011651234486110.1111/j.1558-5646.2011.01394.x22133217 26LonginiIMNizamAXuSUngchusakKHanshaoworakulWCummingsDAHalloranMEContaining pandemic influenza at the sourceScience200530957371083710.1126/science.111571716079251"/>
   <result pre="the evolution of infectious disease life histories: theoryEvolution2011651234486110.1111/j.1558-5646.2011.01394.x22133217 26LonginiIMNizamAXuSUngchusakKHanshaoworakulWCummingsDAHalloranMEContaining pandemic" exact="influenza" post="at the sourceScience200530957371083710.1126/science.111571716079251 27CenXFengZZhaoYEmerging disease dynamics in a model"/>
   <result pre="networksPhys Rev Let2001863200310.1103/PhysRevLett.86.320011290142 32BrownSTTaiJHBaileyRRCooleyPCWheatonWDPotterMAVoorheesRELeJeuneMGrefenstetteJJBurkeDSMcGloneSMLeeBYWould school closure for the 2009 H1N1" exact="influenza" post="epidemic have been worth the cost?: a computational simulation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6083217\results\search\disease\results.xml">
   <result pre="similarities to other flaviviruses, such as West Nile virus, Japanese" exact="encephalitis" post="virus (JEV) and dengue virus. ZIKV has an approximately"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6091172\results\search\disease\results.xml">
   <result pre="D. Hepatitis A immunisation in persons not previously exposed to" exact="hepatitis" post="A. Cochrane Database Syst Rev. 2012;(Issue 7):Art No.:CD009051. 16.FrancisDPHadlerSCThompsonSEMaynardJEOrstrowDGet"/>
   <result pre="Database Syst Rev. 2012;(Issue 7):Art No.:CD009051. 16.FrancisDPHadlerSCThompsonSEMaynardJEOrstrowDGet al.The prevention of" exact="hepatitis" post="B with vaccineAnn Intern Med19829736236610.7326/0003-4819-97-3-3626810736 17.GuptaRWarrenTWaldAGenital HerpesLancet20073702127213710.1016/S0140-6736(07)61908-418156035 18.Moreno R,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6109282\results\search\disease\results.xml">
   <result pre="effective vector control and immunization programs for nearly a century," exact="yellow fever" post="epidemics reemerged in many Latin American countries, particularly Brazil."/>
   <result pre="to constrain yellow fever: vector control and immunization. In contrast," exact="yellow fever" post="is absent from Asia and the Pacific despite the"/>
   <result pre="virus. Based on a review of the global history of" exact="yellow fever" post="and its epidemiology, the authors deliver some recommendations for"/>
   <result pre="Brazil Latin America Africa Background Brazil has experienced an exceptional" exact="yellow fever" post="(YF) outbreak since December 2016 (Table 1). After the"/>
   <result pre="2016 to 8 May 2018, in 2050 confirmed cases of" exact="yellow fever" post="including 681 deaths, indicating a case fatality rate of"/>
   <result pre="of the virus at this stage [2]. Table 1 Confirmed" exact="yellow fever" post="cases and deaths in Brazil from December, 2016 to"/>
   <result pre="Federal 1 1 Total 2050 681 Fig. 1 Confirmed human" exact="yellow fever" post="cases in Brazil between 1980 and 2017 (from Sinan;"/>
   <result pre="2017 (from Sinan; GT-Arbo/UVTV/CGDT/DEVIT/SVS/MS [2]) Fig. 2 Number of confirmed" exact="yellow fever" post="cases by epidemiological week (EW) based on date of"/>
   <result pre="in major Brazilian cities and improve preventive measures. History of" exact="yellow fever" post="and origin of the virus YF probably impacted the"/>
   <result pre="virus: &quot;It is more than likely that the germs of" exact="yellow fever," post="as well as those of small pox, measles, hydrophobia,"/>
   <result pre="discontinued because of its adverse effects [53, 54]. Epidemiology of" exact="yellow fever" post="in Africa YF has been known in Africa since"/>
   <result pre="by its stability and administration by scarification associated with the" exact="smallpox" post="vaccine, mass immunization led to remarkably effective control of"/>
   <result pre="introducing routine YF vaccination in 9-month-old children together with the" exact="measles" post="immunization supported by GAVI (Global Alliance for Vaccines and"/>
   <result pre="by GAVI (Global Alliance for Vaccines and Immunization). Epidemiology of" exact="yellow fever" post="in the Americas In South America, YF was mentioned"/>
   <result pre="century when it was revealed as an urban vector of" exact="dengue fever" post="[114]. Phylogenetic data suggest that the Asian strain originates"/>
   <result pre="Oceania. In addition, the abundant circulation of other arboviruses, dengue," exact="chikungunya" post="and Zika, the latter two coming from Africa like"/>
   <result pre="expense of YF and d) cross-reactivity with other Flavoviridae, including" exact="dengue fever," post="in humans and other animals [121, 122]. Recent modeling"/>
   <result pre="the probability of YF expansion in Asia (&quot;Asian hypothesis�?) and" exact="dengue fever" post="in Africa (&quot;African hypothesis�?) [123]. The first was based"/>
   <result pre="have not yet been elucidated. Rooting out and controlling of" exact="yellow fever" post="in Brazil Since its introduction in the seventeenth century,"/>
   <result pre="of vector development is high. The recent epidemics of dengue," exact="chikungunya" post="and Zika in Brazil demonstrated the limits of this"/>
   <result pre="incidence of serious adverse events (SAE). In addition to vaccine" exact="hypersensitivity" post="and anaphylactic shock, SAEs were categorized into two groups:"/>
   <result pre="6.BryantJEHolmesECBarrettADTOut of Africa: a molecular perspective on the introduction of" exact="yellow fever" post="virus into the AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 7.MutebiJPRijnbrandRCWangHRymanKDWangEFulopLDet al.Genetic relationships and"/>
   <result pre="AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 7.MutebiJPRijnbrandRCWangHRymanKDWangEFulopLDet al.Genetic relationships and evolution of genotypes of" exact="yellow fever" post="virus and other members of the yellow fever virus"/>
   <result pre="genotypes of yellow fever virus and other members of the" exact="yellow fever" post="virus group within the Flavivirus genus based on the"/>
   <result pre="based on the 3′ noncoding regionJ Virol200478189652966510.1128/JVI.78.18.9652-9665.200415331698 8.LiYYangZAdaptive diversification between" exact="yellow fever" post="virus west African and south American lineages: a genome-wide"/>
   <result pre="York: Oxford University Press; 2009. pp. 102–4. 11.MarrJSCatheyJTThe 1802 saint-Domingue" exact="yellow fever" post="epidemic and the Louisiana purchaseJ Public Health Manag Pract2013191778210.1097/PHH.0b013e318252eea823169407"/>
   <result pre="Louisiana purchaseJ Public Health Manag Pract2013191778210.1097/PHH.0b013e318252eea823169407 12.Augustin G. History of" exact="yellow fever." post="Searcy &amp;amp; Pfaff ltd, New Orleans, USA; 1909. 13.EltonNWYellow"/>
   <result pre="20.BeauperthuyLDRecherches sur la cause du choléra asiatique, sur celle du" exact="typhus" post="ictérode et de fièvres de marécagesC R Acad Sci18561413692693"/>
   <result pre="Habana188118147169 23.ReedWRecent researches concerning the etiology, propagation, and prevention of" exact="yellow fever," post="by the United States Army CommissionJ Hyg (Lond)19022210111910.1017/S002217240000185620474139 24.ReedWCarrolJAgramonteAThe"/>
   <result pre="the United States Army CommissionJ Hyg (Lond)19022210111910.1017/S002217240000185620474139 24.ReedWCarrolJAgramonteAThe etiology of" exact="yellow fever" post="- an additional noteJAMA19013643144010.1001/jama.1901.52470070017001f 25.ReedWCarrollJAgramonteALazearJWThe etiology of yellow fever-a"/>
   <result pre="théorique et clinique de la fièvre jaune1891ParisDoin 28.DeubelVDigoutteJPMonathTPGirardMGenetic heterogeneity of" exact="yellow fever" post="virus strains from Africa and the AmericasJ Gen Virol.198667Pt"/>
   <result pre="the AmericasJ Gen Virol.198667Pt 120921310.1099/0022-1317-67-1-2093944583 29.LepiniecLDalgarnoLHuongVTMonathTPDigoutteJPDeubelVGeographic distribution and evolution of" exact="yellow fever" post="viruses based on direct sequencing of genomic cDNA fragmentsJ"/>
   <result pre="cDNA fragmentsJ Gen Virol199475Pt 241742310.1099/0022-1317-75-2-4178113765 30.MutebiJPWangHLiLBryantJEBarrettADPhylogenetic and evolutionary relationships among" exact="yellow fever" post="virus isolates in AfricaJ Virol200175156999700810.1128/JVI.75.15.6999-7008.200111435580 31.von LindernJJAronerSBarrettNDWickerJADavisCTBarrettADGenome analysis and"/>
   <result pre="phylogenetic relationships between east, central and west African isolates of" exact="yellow fever" post="virusJ Gen Virol.200687Pt 489590710.1099/vir.0.81236-016528039 32.Beaty BJ, Aitken THG. In"/>
   <result pre="Virol.200687Pt 489590710.1099/vir.0.81236-016528039 32.Beaty BJ, Aitken THG. In vitro transmission of" exact="yellow fever" post="virus by geographic strains of Aedes aegypti. Mosq News."/>
   <result pre="strains of Aedes aegypti. Mosq News. 1979;39(2):232–8. 33.EllisBRBarrettADThe enigma of" exact="yellow fever" post="in East AfricaRev Med Virol200818533134610.1002/rmv.58418615782 34.MonathTCetronMSTeuwenDEPlotkinSAOrensteinWAOffitPAYellow fever vaccineVaccines20085PhiladelphiaSaunders Elsevier9591055"/>
   <result pre="caseRev Inst Med Trop Sao Paulo199537433734110.1590/S0036-466519950004000098599063 38.ChristophersSRAedes aegypti (L.) the" exact="yellow fever" post="mosquitoIts life history, bionomics and structure1960Cambridge, Great BritainCambridge University"/>
   <result pre="mémoireAnn Inst Pasteur1906251640 41.FontenilleDDialloMMondoMNdiayeMThonnonJFirst evidence of natural vertical transmission of" exact="yellow fever" post="virus in Aedes aegypti, its epidemic vectorTrans R Soc"/>
   <result pre="Yellow Fever. Med News. 1898;73:326–331 and 360–9. 48.StokesABauerJHHudsonNPExperimental transmission of" exact="yellow fever" post="to laboratory animalsAm J Trop Med1928810316410.4269/ajtmh.1928.s1-8.103 49.TheilerMSmithHHThe use of"/>
   <result pre="fever to laboratory animalsAm J Trop Med1928810316410.4269/ajtmh.1928.s1-8.103 49.TheilerMSmithHHThe use of" exact="yellow fever" post="modified by in vitro cultivation for human immunizationJ Exp"/>
   <result pre="Histoires », Paris2004201205 71.TaylorRMFonseca da CunhaJAn epidemiological study of jungle" exact="yellow fever" post="in an endemic area in Brazil; epidemiology of human"/>
   <result pre="Trop Med Hyg.1946266 Suppl 26920279501 72.LaemmertHWJrFerreiraLCTaylorRMAn epidemiological study of jungle" exact="yellow fever" post="in an endemic area in Brazil. Investigation of vertebrate"/>
   <result pre="al. Evidence for multiple sylvatic transmission cycles during the 2016-2017" exact="yellow fever" post="virus outbreak, Brazil. Clin Microbiol Infect. 2018; 74.KummHWLaemmertHWJrThe geographical"/>
   <result pre="Clin Microbiol Infect. 2018; 74.KummHWLaemmertHWJrThe geographical distribution of immunity to" exact="yellow fever" post="among the primates of BrazilAm J Trop Med Hyg.195030573374810.4269/ajtmh.1950.s1-30.73314771397"/>
   <result pre="to Brazilian monkeys preliminary observationsJ Exp Med1929501818510.1084/jem.50.1.8119869607 76.FernandesNCCACunhaMSGuerraJMRéssioRACirqueiraCDSIgleziasSDet al.Outbreak of" exact="yellow fever" post="among nonhuman primates, Espirito Santo, Brazil, 2017Emerg Infect Dis201723122038204110.3201/eid2312.17068529148378"/>
   <result pre="Pathol Exot19918443863971687266 79.MondetBVasconcelosPFTravassos da RosaAPTravassos da RosaESRodriguesSGTravassos RosaJFet al.Isolation of" exact="yellow fever" post="virus from nulliparous Haemagogus (Haemagogus) janthinomys in eastern AmazoniaVector"/>
   <result pre="serratus mosquitoes, southern Brazil, 2008Emerg Infect Dis201016121918192410.3201/eid1612.10060821122222 81.AlencarJMelloCFBarbosaLSGil-SantanaHRMaiaDAMarcondesCBet al.Diversity of" exact="yellow fever" post="mosquito vectors in the Atlantic Forest of Rio de"/>
   <result pre="mosquitoes (Diptera: Culicidae) in an area of sylvatic transmission of" exact="yellow fever" post="in the state of São Paulo, BrazilJ Venom Anim"/>
   <result pre="83.MucciLFMedeiros-SousaARCeretti-JúniorWFernandesACamargoAAEvangelistaEet al.Haemagogus leucocelaenus and other mosquitoes potentially associated with sylvatic" exact="yellow fever" post="in Cantareira State Park in the São Paulo metropolitan"/>
   <result pre="Assoc201632432933210.2987/16-6587.128206862 84.Couto-LimaDMadecYBersotMICamposSSMottaMASantosFBDet al.Potential risk of re-emergence of urban transmission of" exact="yellow fever" post="virus in Brazil facilitated by competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779"/>
   <result pre="competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779 85.VasconcelosPFCBryantJEda RosaAPATTeshRBRodriguesSGBarrettADTGenetic divergence and dispersal of" exact="yellow fever" post="virus, BrazilEmerg Infect Dis20041091578158410.3201/eid1009.04019715498159 86.NunesMRPalaciosGCardosoJFMartinsLCSousaECJrde LimaCPet al.Genomic and phylogenetic"/>
   <result pre="Infect Dis20041091578158410.3201/eid1009.04019715498159 86.NunesMRPalaciosGCardosoJFMartinsLCSousaECJrde LimaCPet al.Genomic and phylogenetic characterization of Brazilian" exact="yellow fever" post="virus strainsJ Virol20128624132631327110.1128/JVI.00565-1223015713 87.CarringtonCVAugusteAJEvolutionary and ecological factors underlying the"/>
   <result pre="87.CarringtonCVAugusteAJEvolutionary and ecological factors underlying the tempo and distribution of" exact="yellow fever" post="virus activityInfect Genet Evol20131319821010.1016/j.meegid.2012.08.01522981999 88.de SouzaRPFosterPGSallumMACoimbraTLMaedaAYSilveiraVRet al.Detection of a"/>
   <result pre="virus activityInfect Genet Evol20131319821010.1016/j.meegid.2012.08.01522981999 88.de SouzaRPFosterPGSallumMACoimbraTLMaedaAYSilveiraVRet al.Detection of a new" exact="yellow fever" post="virus lineage within the south American genotype I in"/>
   <result pre="south American genotype I in BrazilJ Med Virol201082117518510.1002/jmv.2160619950229 89.MirDDelatorreEBonaldoMLourenço-de-OliveiraRVicenteACBelloGPhylodynamics of" exact="yellow fever" post="virus in the Americas: new insights into the origin"/>
   <result pre="Brazilian outbreakSci Rep201771738510.1038/s41598-017-07873-728785067 90.VasconcelosPFRodriguesSGDegallierNMoraesMAda RosaJFda RosaESet al.An epidemic of sylvatic" exact="yellow fever" post="in the southeast region of Maranhao state, Brazil, 1993-1994:"/>
   <result pre="Aedes aegypti to Brazil, the major vector of the dengue," exact="chikungunya" post="and Zika virusesPLoS Negl Trop Dis2017117e000565310.1371/journal.pntd.000565328742801 93.ReiterPAedes albopictus and"/>
   <result pre="to come?J Am Mosq Control Assoc199814183949599329 94.DialloMThonnonJFontenilleDVertical transmission of the" exact="yellow fever" post="virus by Aedes aegypti (Diptera, Culicidae): dynamics of infection"/>
   <result pre="Negl Trop Dis201374e217510.1371/journal.pntd.000217523638196 105.TabachnickWJWallisGPAitkenTHMillerBRAmatoGDLorenzLet al.Oral infection of Aedes aegypti with" exact="yellow fever" post="virus: geographic variation and genetic considerationsAm J Trop Med"/>
   <result pre="historical and recent evolution in Aedes aegypti, the dengue and" exact="yellow fever" post="mosquitoEvolution201468251452510.1111/evo.1228124111703 111.PowellJRTabachnickWJHistory of domestication and spread of Aedes aegypti"/>
   <result pre="populations of this major disease vectorBMC Biol20171511610.1186/s12915-017-0351-028241828 113.MutebiJPBarrettADThe epidemiology of" exact="yellow fever" post="in AfricaMicrobes Infect20024141459146810.1016/S1286-4579(02)00028-X12475636 114.SmithCEThe history of dengue in tropical"/>
   <result pre="115.WallisGPTabachnickWJPowellJRMacrogeographic genetic variation in a human commensal: Aedes aegypti, the" exact="yellow fever" post="mosquitoGenet Res198341324125810.1017/S00166723000213156884770 116.ScarpassaVMCardozaTBCardoso JuniorRPPopulation genetics and phylogeography of Aedes"/>
   <result pre="al.Flavivirus susceptibility in Aedes aegyptiArch Med Res200233437938810.1016/S0188-4409(02)00373-912234528 119.CuiSPanYLyuYLiangZLiJSunYet al.Detection of" exact="yellow fever" post="virus genomes from four imported cases in ChinaInt J"/>
   <result pre="J Infect Dis2016489810310.1016/j.ijid.2016.04.02527156836 121.TheilerMAndersonCRThe relative resistance of dengue-immune monkeys to" exact="yellow fever" post="virusAm J Trop Med Hyg.197524111511710.4269/ajtmh.1975.24.1151111351 122.XiaoSYGuzmanHda RosaAPZhuHBTeshRBAlteration of clinical"/>
   <result pre="Med Hyg.197524111511710.4269/ajtmh.1975.24.1151111351 122.XiaoSYGuzmanHda RosaAPZhuHBTeshRBAlteration of clinical outcome and histopathology of" exact="yellow fever" post="virus infection in a hamster model by previous infection"/>
   <result pre="with heterologous flavivirusesAm J Trop Med Hyg.200368669570312887029 123.AmakuMCoutinhoFAMassadEWhy dengue and" exact="yellow fever" post="coexist in some areas of the world and not"/>
   <result pre="R Soc Trop Med Hyg2014108525225710.1093/trstmh/tru04324743951 125.TuboiSHCostaZGVasconcelosPFHatchDClinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: analysis of reported cases 1998-2002Trans R Soc"/>
   <result pre="used in Aedes aegypti control in the successful campaign for" exact="yellow fever" post="prophylaxis in Rio de Janeiro, Brazil, in 1928 and"/>
   <result pre="2008-2009PLoS Negl Trop Dis201483e274010.1371/journal.pntd.000274024625634 130.Camargo-NevesVLFPolettoDWRodasLACPachioliMLCardosoRPScandarSASet al.Entomological investigation of a sylvatic" exact="yellow fever" post="area in São Paulo state, BrazilCad Saude Publica.20052141278128610.1590/S0102-311X200500040003116021266 131.CavalcanteKRLJTauilPLEpidemiological"/>
   <result pre="in São Paulo state, BrazilCad Saude Publica.20052141278128610.1590/S0102-311X200500040003116021266 131.CavalcanteKRLJTauilPLEpidemiological characteristics of" exact="yellow fever" post="in Brazil, 2000-2012Epidemiol Serv Saude2016251112027861674 132.FortalezaCMCBRochaRAragãoVDNAlmeidaRAMB&quot;Syndromic surveillance�? and the"/>
   <result pre="Brazil, 2000-2012Epidemiol Serv Saude2016251112027861674 132.FortalezaCMCBRochaRAragãoVDNAlmeidaRAMB&quot;Syndromic surveillance�? and the reemergence of" exact="yellow fever" post="in São Paulo state, Brazil, 2009J Venom Anim Toxins"/>
   <result pre="age of a dengue vaccinePLoS Negl Trop Dis2017118e000578510.1371/journal.pntd.000578528806786 136.ShearerFMMoyesCLPigottDMBradyOJMarinhoFDeshpandeAet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="analysisLancet Infect Dis201717111209121710.1016/S1473-3099(17)30419-X28822780 137.Martins RdeMPavãoALde OliveiraPMdos SantosPRCarvalhoSMMohrdieckRet al.Adverse events following" exact="yellow fever" post="immunization: report and analysis of 67 neurological cases in"/>
   <result pre="BrazilVaccine201432496676668210.1016/j.vaccine.2014.05.00324837504 138.MonathTPWoodallJPGublerDJYuillTMMackenzieJSMartinsRMet al.Yellow fever vaccine supply: a possible solutionLancet2016387100281599160010.1016/S0140-6736(16)30195-727116054 139.BarrettADMonathTPBarbanVNiedrigMTeuwenDE17D" exact="yellow fever" post="vaccines: new insights. A report of a workshop held"/>
   <result pre="tropics, Marseille, France, Monday 12 September 2005Vaccine200725152758276510.1016/j.vaccine.2006.12.01517368349 140.MartinsRMMaia MdeLFariasRHCamachoLAFreireMSGallerRet al.17DD" exact="yellow fever" post="vaccine: a double blind, randomized clinical trial of immunogenicity"/>
   <result pre="safety on a dose-response studyHum Vaccin Immunother20139487988810.4161/hv.2298223364472 141.WuJTPeakCMLeungGMLipsitchMFractional dosing of" exact="yellow fever" post="vaccine to extend supply: a modelling studyLancet2016388100622904291110.1016/S0140-6736(16)31838-427837923 142.VisserLGRoukensAHModelling a"/>
   <result pre="142.VisserLGRoukensAHModelling a way out of yellow feverLancet2016388100622847284810.1016/S0140-6736(16)31330-727837922 143.ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTThe safety of" exact="yellow fever" post="vaccine 17D or 17DD in children, pregnant women, HIV+"/>
   <result pre="systematic reviewAm J Trop Med Hyg.201286235937210.4269/ajtmh.2012.11-052522302874 144.SeligmanSJCohenJEItanYCasanovaJLPezzulloJCDefining risk groups to" exact="yellow fever" post="vaccine-associated viscerotropic disease in the absence of denominator dataAm"/>
   <result pre="dataAm J Trop Med Hyg.201490226727110.4269/ajtmh.13-054224394480 145.ThomasRELorenzettiDLSpraginsWJacksonDWilliamsonTActive and passive surveillance of" exact="yellow fever" post="vaccine 17D or 17DD-associated serious adverse events: systematic reviewVaccine201129284544455510.1016/j.vaccine.2011.04.05521549787"/>
   <result pre="vaccine-associated adverse events following extensive immunization in ArgentinaVaccine201432111266127210.1016/j.vaccine.2014.01.01524456625 147.collab: WHOEliminate" exact="yellow fever" post="epidemics (EYE): a global strategy, 2017-2026Wkly Epidemiol Rec2017921619320428429585 148.ReiterPGlobal"/>
   <result pre="http://www.who.int/csr/don/09-march-2018-yellow-fever-brazil/en/ (accessed 17 Apr 2018). 150.AlmeidaMABCardosoJCdos SantosEda FonsecaDFCruzLLFaracoFJCet al.Surveillance for" exact="yellow fever" post="virus in non-human primates in southern Brazil, 2001-2011: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6133644\results\search\disease\results.xml">
   <result pre="Article: Observational Study Analysis of seasonal tendencies in pediatric Henoch–Schönlein" exact="purpura" post="and comparison with outbreak of infectious diseases HwangHyun HoMDaLimIn"/>
   <result pre="commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0medi-97-e12217.pdf Abstract Abstract Henoch–Schönlein" exact="purpura" post="(HSP) is one of the most common vasculitis in"/>
   <result pre="Abstract Henoch–Schönlein purpura (HSP) is one of the most common" exact="vasculitis" post="in children. This study was aimed at identifying seasonal"/>
   <result pre="variations. Depending on the age group, the epidemic patterns of" exact="influenza" post="and rotaviruses were temporally and statistically similar to that"/>
   <result pre="may play an important role in pathophysiology. Keywords child Henoch–Schönlein" exact="purpura" post="infection vasculitis 1 Introduction Henoch–Schönlein purpura (HSP) occurs across"/>
   <result pre="an important role in pathophysiology. Keywords child Henoch–Schönlein purpura infection" exact="vasculitis" post="1 Introduction Henoch–Schönlein purpura (HSP) occurs across all races"/>
   <result pre="pathophysiology. Keywords child Henoch–Schönlein purpura infection vasculitis 1 Introduction Henoch–Schönlein" exact="purpura" post="(HSP) occurs across all races worldwide and is one"/>
   <result pre="worldwide and is one of the most common forms of" exact="vasculitis" post="in children with 10 to 30 cases reported per"/>
   <result pre="and kidneys. In acute cases, severe abdominal pain, arthralgia, or" exact="proteinuria" post="may develop.[3–5] Complications such as intussusception, perforation, and renal"/>
   <result pre="8 respiratory viruses (adenovirus, parainfluenza virus, respiratory syncytial virus [RSV]," exact="influenza" post="virus, coronavirus, rhinovirus, bocavirus, and metapneumovirus) and 4 enteric"/>
   <result pre="after a preceding infection. Usually, a virus that causes an" exact="infectious disease" post="is detected a few days after the disease has"/>
   <result pre="Over 4 years, 15 patients (0.09%) underwent surgical treatments for" exact="intussusception" post="or perforation. Table 1 Epidemiology of pediatric Henoch–Schönlein purpura"/>
   <result pre="for intussusception or perforation. Table 1 Epidemiology of pediatric Henoch–Schönlein" exact="purpura" post="patients. 3.2 Trends and time series of pediatric HSP"/>
   <result pre="incidences. Figure 1 Trends and time series of pediatric Henoch–Schönlein" exact="purpura" post="patients. In the analysis based on age groups, the"/>
   <result pre="of monthly, seasonal, and yearly incidences of newly diagnosed Henoch–Schönlein" exact="purpura" post="according to age groups. 3.3 Comparison of epidemics of"/>
   <result pre="showed a definite tendency from November to January, while the" exact="influenza" post="virus was prevalent in winter from January to April."/>
   <result pre="monthly comparisons. Among the 12 viruses, the epidemic patterns of" exact="influenza" post="virus and rotavirus were statistically similar to those of"/>
   <result pre="to those of HSP. Table 3 Correlation analysis between Henoch–Schönlein" exact="purpura" post="occurrence and prevalence of viral infections. Table 4 compares"/>
   <result pre="HSP was found to be associated with epidemics of RSV," exact="influenza" post="virus, and norovirus. In the middle childhood group, influenza"/>
   <result pre="RSV, influenza virus, and norovirus. In the middle childhood group," exact="influenza" post="virus and norovirus epidemics were associated with the seasonality"/>
   <result pre="HSP among the adolescents. Table 4 Correlation analysis between Henoch–Schönlein" exact="purpura" post="occurrence and prevalence of viral infections according to age"/>
   <result pre="of HSP have limitations. HSP was reported in the 2009" exact="influenza" post="virus pandemic, and there have been reports that HSP"/>
   <result pre="pandemic, and there have been reports that HSP incidences followed" exact="influenza" post="vaccinations.[22–24] However, most of these studies are case studies"/>
   <result pre="occur evenly throughout the year. Several studies have described the" exact="influenza" post="virus to be a predisposing cause of HSP with"/>
   <result pre="incidence. On the contrary, if there was, for example, an" exact="influenza" post="virus epidemic which caused severe symptoms, and relatively more"/>
   <result pre="References References [1]TizardEHamilton-AyresMHenoch–Schönlein purpura. Arch Dis Child Educ Pract2008;93:1–8. [2]TrnkaPHenoch–Schonlein" exact="purpura" post="in children. J Paediatr Child Health2013;49:995–1003.24134307 [3]OzenSRupertoNDillonMJet al.EULAR/PReS endorsed"/>
   <result pre="prospective study. Arch Dis Child2010;95:871–6.20371584 [5]JauholaORonkainenJKoskimiesOet al.Renal manifestations of Henoch–Schonlein" exact="purpura" post="in a 6-month prospective study of 223 children. Arch"/>
   <result pre="prospective study of 223 children. Arch Dis Child2010;95:877–82.20852275 [6]PeruHSoylemezogluOBakkalogluSAet al.Henoch–Schonlein" exact="purpura" post="in childhood: clinical analysis of 254 cases over a"/>
   <result pre="and Henoch–Schonlein purpura?Autoimmun Rev2013;12:1016–21.23684700 [10]Lopez-MejiasRGenreFPerezBSet al.Association of HLA-B∗41:02 with Henoch–Schonlein" exact="purpura" post="(IgA vasculitis) in Spanish individuals irrespective of the HLA-DRB1"/>
   <result pre="Ther2015;17:102.25889603 [11]López-MejíasRGenreFPérezBSet al.HLA-DRB1 association with Henoch–Schonlein purpura. Arthritis Rheumatol2015;67:823–7.25470797 [12]SaulsburyFTHenoch–Schonlein" exact="purpura" post="in children. Report of 100 patients and review of"/>
   <result pre="patients and review of the literature. Medicine (Baltimore)1999;78:395–409.10575422 [13]TrapaniSMicheliAGrisoliaFet al.Henoch–Schonlein" exact="purpura" post="in childhood: epidemiological and clinical analysis of 150 cases"/>
   <result pre="period and review of literature. Semin Arthritis Rheum2005;35:143–53.16325655 [14]LeeYHKimYBKooJWet al.Henoch–Schonlein" exact="purpura" post="in children hospitalized at a tertiary hospital during 2004–2015"/>
   <result pre="pylori and skin autoimmune diseases. World J Gastroenterol2014;20:1510–6.24587626 [19]ApostolopoulosPVafiadis-ZouboulisEDelladetsimaIet al.Henoch–Schonlein" exact="purpura" post="associated with Campylobacter enterocolitis. J Clin Gastroenterol1999;29:346–7.10599641 [20]CalviñoMCLlorcaJGarcía-PorrúaCHenoch–Schönlein purpura"/>
   <result pre="al.Henoch–Schonlein purpura associated with Campylobacter enterocolitis. J Clin Gastroenterol1999;29:346–7.10599641 [20]CalviñoMCLlorcaJGarcía-PorrúaCHenoch–Schönlein" exact="purpura" post="in children from northwestern Spain: a 20-year epidemiologic and"/>
   <result pre="skin lesions: a case report. J Med Case Rep2011;5:132.21457559 [23]WatanabeTHenoch–Schonlein" exact="purpura" post="following influenza vaccinations during the pandemic of influenza A"/>
   <result pre="a case report. J Med Case Rep2011;5:132.21457559 [23]WatanabeTHenoch–Schonlein purpura following" exact="influenza" post="vaccinations during the pandemic of influenza A (H1N1). Pediatr"/>
   <result pre="Rep2011;5:132.21457559 [23]WatanabeTHenoch–Schonlein purpura following influenza vaccinations during the pandemic of" exact="influenza" post="A (H1N1). Pediatr Nephrol2011;26:795–8.21120537 [24]ParkCWLimISYunSWet al.Henoch–Schonlein purpura without typical"/>
   <result pre="the pandemic of influenza A (H1N1). Pediatr Nephrol2011;26:795–8.21120537 [24]ParkCWLimISYunSWet al.Henoch–Schonlein" exact="purpura" post="without typical lesions, presenting with gastrointestinal manifestations and kidney"/>
   <result pre="Int J Dermatol2009;48:1157–65.20064166 [26]GedaliaAHenoch–Schönlein purpura. Curr Rheumatol Rep2004;6:195–202.15134598 [27]FarhadianJACastillaCShvartsbeynMet al.IgA" exact="vasculitis" post="(Henoch–Schönlein purpura). Dermatol Online J2015;21. [28]LauKKSuzukiHNovakJet al.Pathogenesis of Henoch–Schonlein"/>
   <result pre="vasculitis (Henoch–Schönlein purpura). Dermatol Online J2015;21. [28]LauKKSuzukiHNovakJet al.Pathogenesis of Henoch–Schonlein" exact="purpura" post="nephritis. Pediatr Nephrol2010;25:19–26.19526254"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6134710\results\search\disease\results.xml">
   <result pre="Aedes aegypti populations in Madeira Island to transmit dengue and" exact="chikungunya" post="viruses SeixasGonçalogseixas@ihmt.unl.pt1JupilleHenrihenri.jupille@outlook.com2YenPei-Shipei-shi.yen@pasteur.fr2ViveirosBelabela.viveiros@gmail.com3FaillouxAnna-Bellaanna-bella.failloux@pasteur.fr2http://orcid.org/0000-0002-2386-7577SousaCarla Alexandracasousa@ihmt.unl.pt1[1], 0000000121511713grid.10772.33Global Health and Tropical Medicine, Instituto"/>
   <result pre="spp. mosquitoes mainly transmit the arboviruses dengue virus (DENV) and" exact="chikungunya" post="virus (CHIKV) in urban areas, causing a severe public"/>
   <result pre="Flavivirus, family Flaviviridae), Ae. aegypti is also experimentally competent for" exact="chikungunya" post="virus (CHIKV; genus Alphavirus, family Togaviridae) [7, 8]. Dengue"/>
   <result pre="virus (CHIKV; genus Alphavirus, family Togaviridae) [7, 8]. Dengue and" exact="chikungunya" post="are serious public health issues in tropical regions, and"/>
   <result pre="dissemination and transmission [12]. The recent emergence of dengue and" exact="chikungunya" post="in Europe, such as the 2012 outbreaks of dengue"/>
   <result pre="such as the 2012 outbreaks of dengue in Madeira and" exact="chikungunya" post="in France [13, 14] and Italy [15], have raised"/>
   <result pre="a different pattern of susceptibility to dengue infection compared to" exact="chikungunya" post="infection. While both populations presented similar IR [Chi-square test"/>
   <result pre="25], and Africa [26]. In the case of a possible" exact="chikungunya" post="outbreak on the island, the onset of cases would"/>
   <result pre="another species, Ae. albopictus, has been implicated in the last" exact="chikungunya" post="and dengue outbreaks [13–15]. Coordination of vector control strategies"/>
   <result pre="historical and recent evolution in Aedes aegypti, the dengue and" exact="yellow fever" post="mosquitoEvolution.20146851452510.1111/evo.1228124111703 3.AlmeidaAPGGonçalvesYMNovoMTSousaCAMelimMGracioAJVector monitoring of Aedes aegypti in the Autonomous"/>
   <result pre="Jacobs F, Stroo A. The first detected airline introductions of" exact="yellow fever" post="mosquitoes (Aedes aegypti) to Europe, at Schiphol International Airport,"/>
   <result pre="presentation and laboratory findings for the first autochthonous cases of" exact="dengue fever" post="in Madeira Island, Portugal, October 2012. Euro Surveill. 2013;18:20398."/>
   <result pre="et al. High efficiency of temperate Aedes albopictus to transmit" exact="chikungunya" post="and dengue viruses in the southeast of France. PLoS"/>
   <result pre="American countries as a crucial factor in the spread of" exact="chikungunya" post="virusJ Virol.2014886294630610.1128/JVI.00370-1424672026 9.GuzmanMGHalsteadSBArtsobHBuchyPFarrarJGublerDJet al.Dengue: a continuing global threatNat Rev"/>
   <result pre="Senegal and Cape Verde Archipelago for West African lineages of" exact="chikungunya" post="virus. Am J Trop Med Hyg. 2014;91:635–41. 12.SchwartzOAlbertMLBiology and"/>
   <result pre="Am J Trop Med Hyg. 2014;91:635–41. 12.SchwartzOAlbertMLBiology and pathogenesis of" exact="chikungunya" post="virusNat Rev Microbiol.2010849150010.1038/nrmicro236820551973 13.GouldEAGallianPDe LamballerieXCharrelRNFirst cases of autochthonous dengue"/>
   <result pre="of chikungunya virusNat Rev Microbiol.2010849150010.1038/nrmicro236820551973 13.GouldEAGallianPDe LamballerieXCharrelRNFirst cases of autochthonous" exact="dengue fever" post="and chikungunya fever in France: from bad dream to"/>
   <result pre="Rev Microbiol.2010849150010.1038/nrmicro236820551973 13.GouldEAGallianPDe LamballerieXCharrelRNFirst cases of autochthonous dengue fever and" exact="chikungunya" post="fever in France: from bad dream to reality!Clin Microbiol"/>
   <result pre="M, Grard G, et al. Preliminary report of an autochthonous" exact="chikungunya" post="outbreak in France, July to September 2017. Euro Surveill."/>
   <result pre="M, Riccardo F, Severini F, et al. Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
   <result pre="albopictus populations in the Central African Republic to transmit enzootic" exact="chikungunya" post="virus strainsParasit Vectors.20171016410.1186/s13071-017-2101-028347325 27.MouraAde MeloSMOliveiraCGuedesDde Carvalho-LeandroDda Cruz BritoMet al.Vector"/>
   <result pre="Paniz-Mondolfi AE. Venezuela: far from the path to dengue and" exact="chikungunya" post="control. J Clin Virol. 2015;66:60–1. 35.TorresJOrdunaTPiña-PozasMVázquez-VegaDSartiEEpidemiological characteristics of dengue"/>
   <result pre="al.Three-way interactions between mosquito population, viral strain and temperature underlying" exact="chikungunya" post="virus transmission potentialProc Biol Sci.20142812014107810.1098/rspb.2014.107825122228"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6137132\results\search\disease\results.xml">
   <result pre="to cause yearly seasonal epidemics worldwide and periodically pandemics. Although" exact="influenza" post="virus infection and its epidemiology have been extensively studied,"/>
   <result pre="studied, a new pandemic is likely. One of the reasons" exact="influenza" post="virus causes epidemics is its ability to constantly antigenically"/>
   <result pre="In this mini-review, we describe the evolutionary procedures related with" exact="influenza" post="viruses and their hosts, under the prism of a"/>
   <result pre="under the prism of a predator-prey relationship. adaptation antagonistic evolution" exact="influenza" post="virus bottleneck immune system antigen genetics mutation fig-count: table-count:"/>
   <result pre="table-count: equation-count: ref-count: page-count: word-count: Introduction Health disasters caused by" exact="influenza" post="viruses are abundant in human history (1–3). The Spanish"/>
   <result pre="and 2 million deaths each. In 2009, a novel H1N1" exact="influenza" post="virus spread rapidly from Mexico to the rest of"/>
   <result pre="mutagenesis or due to transmission in other species. Pandemics of" exact="influenza" post="are due to these random and sudden viral mutations"/>
   <result pre="transmissions. Under this perspective, in this paper, we discuss about" exact="influenza" post="viruses and the coevolution with the human genomes. Influenza"/>
   <result pre="antigenically distinct HA subtypes and 11 distinct NA subtypes of" exact="influenza" post="A virus strains infecting humans and animals have so"/>
   <result pre="of such receptors, making zoonotic transmission difficult. For example, human" exact="influenza" post="strains have a predilection for SA α-2,6 galactose receptors,"/>
   <result pre="respiratory epithelium of the upper airways in humans, while animal" exact="influenza" post="A viruses bind to SA α-2,3 galactose, which is"/>
   <result pre="of 1–2 days. Systemic symptoms are characteristic and help differentiate" exact="influenza" post="from other upper respiratory tract viral illnesses. These include"/>
   <result pre="throat, hoarseness, nasal congestion, and discharge (18). Different subtypes of" exact="influenza" post="have different ability to infect airway epithelial cells of"/>
   <result pre="result in severe lung injury (21–23). Host immune response to" exact="influenza" post="virus infection Cells of the innate immune response are"/>
   <result pre="innate immune response are the first and fast responders upon" exact="influenza" post="virus infection, recruited by chemokines released by airway epithelial"/>
   <result pre="pyrin domain containing 3 (NALP3) inflammasome is also activated upon" exact="influenza" post="virus infection promoting IL-1β and IL-18 secretion, and pulmonary"/>
   <result pre="activity. NK cells have cytotoxic activity on cells infected with" exact="influenza" post="virus, macrophages phagocytose infected cells and regulate adaptive immune"/>
   <result pre="B cells are essential in the adaptive immune response to" exact="influenza" post="virus infection. Naive CD8+ T cells, upon activation by"/>
   <result pre="to cytotoxic T lymphocytes (CTLs). CTLs are able to kill" exact="influenza" post="virus-infected cells and also restrict viral replication via production"/>
   <result pre="cell specific responses (32). Comprising an essential defense mechanism against" exact="influenza" post="virus infection, B cells generate neutralizing (hemagglutinin-inhibiting antibodies) as"/>
   <result pre="cell-mediated cytotoxicity, play an important role in cross-protection against different" exact="influenza" post="subtypes (31, 33). There is increased interest in the"/>
   <result pre="could elicit &quot;universal�? immunity against different or novel strains of" exact="influenza" post="viruses. Viral evolution Predator and prey. antagonistic evolution Predator-prey"/>
   <result pre="this being a highly effective immunological shield. Genetic diversification of" exact="influenza" post="viruses Influenza viruses exhibit vast genetic variability sourced from"/>
   <result pre="of different viral strains. The eight RNA fragments of the" exact="influenza" post="virus can re-assort between different strains, producing new subtypes."/>
   <result pre="people live in proximity with animals (38). Antigenic shifts caused" exact="influenza" post="pandemics in the past. On the other hand, mutations,"/>
   <result pre="proteins, this being the cause of the appearance of new" exact="influenza" post="strains each year (39). Antigenic drifts are very important"/>
   <result pre="production. The major cause of the high evolutionary rate of" exact="influenza" post="viruses is the lack of proofreading (correction) function of"/>
   <result pre="innate immune recognition, something that is not so vital for" exact="influenza" post="B evolution (42, 43). Additionally, it has been shown"/>
   <result pre="has been shown that antigenic drifts are more frequent to" exact="influenza" post="A viruses than influenza B viruses (44). Even though"/>
   <result pre="antigenic drifts are more frequent to influenza A viruses than" exact="influenza" post="B viruses (44). Even though antigenic drifts are usually"/>
   <result pre="be excluded. One of the most interesting recent findings regarding" exact="influenza" post="virus' genetic variability and evolution is that when people"/>
   <result pre="Further understanding of the mutational and evolutionary procedures related to" exact="influenza" post="viruses can help us develop prediction models. Prediction models"/>
   <result pre="surface protein hemagglutinin (49). Hemagglutinin DNA sequences for thousands of" exact="influenza" post="A strains, isolated over the last 40 years, are"/>
   <result pre="reviews (51) and (52). A predator—prey relationship between human and" exact="influenza" post="virus The relationship between viruses and eukaryotic cells has"/>
   <result pre="this long lasting ancient interaction (53, 54). Antibody-mediated immunity to" exact="influenza" post="viruses is well-understood. Vaccines success is based on this"/>
   <result pre="T8 cells epitopes may have shaped the long-term evolution of" exact="influenza" post="A virus (55, 56). On the other hand, influenza"/>
   <result pre="of influenza A virus (55, 56). On the other hand," exact="influenza" post="viruses seem to respond to this evolutionary pressure by"/>
   <result pre="membrane lipid layers. IFITM3 seems to be more specific for" exact="influenza" post="viruses (61). Gene polymorphisms in IFITM3 gene can increase"/>
   <result pre="polymorphisms in IFITM3 gene can increase or reduce susceptibility to" exact="influenza" post="infections, underlining the evolutionary significance of these proteins (62,"/>
   <result pre="(67). Experimental studies in ferret and guinea pig showed that" exact="influenza" post="infections coming from limited dose of aerosol exposure had"/>
   <result pre="the past and will continue to co-evolve. Our understanding of" exact="influenza" post="virus pathogenesis and evolution has increased, however, we are"/>
   <result pre="1.RamiroDGarciaSCasadoYCilekLChowellG. Age-specific excess mortality patterns and transmissibility during the 1889-1890" exact="influenza" post="pandemic in Madrid, Spain. Ann Epidemiol. (2018) 28:267–72. 10.1016/j.annepidem.2017.12.00929336941"/>
   <result pre="10.1016/j.bbi.2008.05.01019618626 4.ChowellGSullivanPRothenbergR. Introduction to symposium: a century after the 1918" exact="influenza" post="pandemic. Ann Epidemiol. (2018) 28:265–6. 10.1016/j.annepidem.2018.03.01029622467 5.JohnsonNPASMuellerJ. Updating the"/>
   <result pre="5.JohnsonNPASMuellerJ. Updating the accounts: global mortality of the 1918-1920 &quot;Spanish�?" exact="influenza" post="pandemic. Bull Hist Med. (2002) 76:105–15. 10.1353/bhm.2002.002211875246 6.CockburnWCDelonPJFerreiraW. Origin"/>
   <result pre="10.1353/bhm.2002.002211875246 6.CockburnWCDelonPJFerreiraW. Origin and progress of the 1968-69 Hong Kong" exact="influenza" post="epidemic. Bull World Health Organ. (1969) 41:345–8. 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;25309437 7.SimonsenLSpreeuwenbergPLustigRTaylorRJFlemingDMKronemanMet"/>
   <result pre="41:345–8. 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;25309437 7.SimonsenLSpreeuwenbergPLustigRTaylorRJFlemingDMKronemanMet al.. Global mortality estimates for the 2009" exact="influenza" post="pandemic from the GLaMOR project: a modeling study. PLoS"/>
   <result pre="Dis. (2017) 23:1392–6. 10.3201/eid2308.17005928726609 11.MatsuzakiYAbikoCMizutaKSugawaraKTakashitaEMurakiYet al.. A nationwide epidemic of" exact="influenza" post="C virus infection in Japan in 2004. J Clin"/>
   <result pre="PLoS Pathog. (2015) 11:e1004819. 10.1371/journal.ppat.100481926042416 14.LinYPGregoryVBennettMHayA. Recent changes among human" exact="influenza" post="viruses. Virus Res. (2004) 103:47–52. 10.1016/j.virusres.2004.02.01115163487 15.ShawMWXuXLiYNormandSUekiRTKunimotoGYet al.. Reappearance"/>
   <result pre="10.1016/j.virusres.2004.02.01115163487 15.ShawMWXuXLiYNormandSUekiRTKunimotoGYet al.. Reappearance and global spread of variants of" exact="influenza" post="B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons."/>
   <result pre="and 2001-2002 seasons. Virology (2002) 303:1–8. 10.1006/viro.2002.171912482653 16.IkonenNPyhäläRAxelinTKleemolaMKorpelaH. Reappearance of" exact="influenza" post="B/Victoria/2/87-lineage viruses: Epidemic activity, genetic diversity and vaccination efficacy"/>
   <result pre="Defence Forces. Epidemiol Infect. (2005) 133:263–71. 10.1017/S095026880400346215816151 17.SunXWhittakerGR. Entry of" exact="influenza" post="virus. Adv Exp Med Biol. (2013) 790:72–82. 10.1007/978-1-4614-7651-1_423884586 18.MandellGBennettJDolinRMandell,"/>
   <result pre="Sciences (2015). 19.de GraafMFouchierRAM. Role of receptor binding specificity in" exact="influenza" post="A virus transmission and pathogenesis. EMBO J. (2014) 33:823–41."/>
   <result pre="33:823–41. 10.1002/embj.20138744224668228 20.Byrd-LeotisLCummingsRDSteinhauerDA. The interplay between the host receptor and" exact="influenza" post="virus hemagglutinin and neuraminidase. Int J Mol Sci. (2017)"/>
   <result pre="Sci. (2017) 18:e18071541. 10.3390/ijms1807154128714909 21.Van RielDMunsterVJDe WitERimmelzwaanGFFouchierRAMOsterhausADMEet al.. Human and" exact="avian influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="(2017) 18:e18071541. 10.3390/ijms1807154128714909 21.Van RielDMunsterVJDe WitERimmelzwaanGFFouchierRAMOsterhausADMEet al.. Human and avian" exact="influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="mammals. Am J Pathol. (2007) 171:1215–23. 10.2353/ajpath.2007.07024817717141 22.KuikenTRiteauBFouchierRAMRimmelzwaanGF. Pathogenesis of" exact="influenza" post="virus infections: The good, the bad and the ugly."/>
   <result pre="Curr Opin Virol. (2012) 2:276–86. 10.1016/j.coviro.2012.02.01322709515 23.NichollsJMChanMCWChanWYWongHKCheungCYKwongDLWet al.. Tropism of" exact="avian influenza" post="A (H5N1) in the upper and lower respiratory tract."/>
   <result pre="Opin Virol. (2012) 2:276–86. 10.1016/j.coviro.2012.02.01322709515 23.NichollsJMChanMCWChanWYWongHKCheungCYKwongDLWet al.. Tropism of avian" exact="influenza" post="A (H5N1) in the upper and lower respiratory tract."/>
   <result pre="Nat Med. (2007) 13:147–9. 10.1038/nm152917206149 24.Le GofficRPothlichetJVitourDFujitaTMeursEChignardMet al.. Cutting edge:" exact="influenza" post="A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses"/>
   <result pre="59-diphosphates. Nature (2014) 514:372–5. 10.1038/nature1359025119032 26.ChenXLiuSGorayaMUMaaroufMHuangSChenJ-L. Host immune response to" exact="influenza" post="A virus infection. Front Immunol. (2018) 9:1–13. 10.3389/fimmu.2018.0032029403488 27.OngJDHMansellATateMD."/>
   <result pre="9:1–13. 10.3389/fimmu.2018.0032029403488 27.OngJDHMansellATateMD. Hero turned villain: NLRP3 inflammasome-induced inflammation during" exact="influenza" post="A virus infection. J Leukoc Biol. (2017) 101:863–74. 10.1189/jlb.4MR0616-288R27707881"/>
   <result pre="it hurts. Rev Med Virol. (2011) 21:301–14. 10.1002/rmv.69721714121 29.GrantEJQuiñones-ParraSMClemensEBKedzierskaK. Human" exact="influenza" post="viruses and CD8 + T cell responses. Curr Opin"/>
   <result pre="Curr Opin Virol. (2016) 16:132–42. 10.1016/j.coviro.2016.01.01626974887 30.LiangSMozdzanowskaKPalladinoGGerhardW. Heterosubtypic immunity to" exact="influenza" post="type A virus in mice. effector mechanisms and their"/>
   <result pre="J Immunol. (1994) 152:1653–61. 10.4049/jimmunol.178.2.10308120375 31.SridharS. Heterosubtypic T-cell immunity to" exact="influenza" post="in humans: Challenges for universal T-cell influenza vaccines. Front"/>
   <result pre="T-cell immunity to influenza in humans: Challenges for universal T-cell" exact="influenza" post="vaccines. Front Immunol. (2016) 7:e00195. 10.3389/fimmu.2016.0019527242800 32.La GrutaNLTurnerSJ. T"/>
   <result pre="DunandCJWilsonPC. Heads, stalks and everything else: how can antibodies eradicate" exact="influenza" post="as a human disease?Curr Opin Immunol. (2016) 42:48–55. 10.1016/j.coi.2016.05.01227268395"/>
   <result pre="Soc B Biol Sci. (1998) 265:1177–83. 10.1098/rspb.1998.04169699311 37.ShaoWLiXGorayaMUWangSChenJL. Evolution of" exact="influenza" post="a virus by mutation and re-assortment. Int J Mol"/>
   <result pre="(2017) 18:e18081650. 10.3390/ijms1808165028783091 38.MaWKahnRERichtJAThe pig as a mixing vessel for" exact="influenza" post="viruses: human and veterinary implications. J Mol Genet Med."/>
   <result pre="03:158–66. 10.4172/1747-0862.1000028 39.JohnsonKEESongTGreenbaumBGhedinE. Getting the flu: 5 key facts about" exact="influenza" post="virus evolution. PLoS Pathog. (2017) 13:1–6. 10.1371/journal.ppat.100645028837690 40.AhlquistP. RNA-dependent"/>
   <result pre="viruses, and RNA silencing. Science (2002) 296:1270–3. 10.1126/science.106913212016304 41.ChenRHolmesEC. Avian" exact="influenza" post="virus exhibits rapid evolutionary dynamics. Mol Biol Evol. (2006)"/>
   <result pre="42.Jimenez-BarandaSGreenbaumBManchesOHandlerJRabadanRLevineAet al.. Oligonucleotide motifs that disappear during the evolution of" exact="influenza" post="virus in humans increase alpha interferon secretion by plasmacytoid"/>
   <result pre="Proc Natl Acad Sci USA. (2014) 111:5054–9. 10.1073/pnas.140228511124639520 44.BedfordTSuchardMALemeyPDudasGGregoryVHayAJet al.Integrating" exact="influenza" post="antigenic dynamics with molecular evolution. Elife (2014) 2014:e0191410.7554/eLife.01914 45.PoonLLMSongTRosenfeldRLinXRogersMBZhouBet"/>
   <result pre="dynamics with molecular evolution. Elife (2014) 2014:e0191410.7554/eLife.01914 45.PoonLLMSongTRosenfeldRLinXRogersMBZhouBet al.. Quantifying" exact="influenza" post="virus diversity and transmission in humans. Nat Genet. (2016)"/>
   <result pre="al.Deep sequencing reveals potential antigenic variants at low frequencies in" exact="influenza" post="A virus-infected humans. J Virol. (2016) 90:3355–65. 10.1128/JVI.03248-1526739054 47.�?ukszaMLässigM."/>
   <result pre="The effects of a deleterious mutation load on patterns of" exact="influenza" post="A/H3N2's antigenic evolution in humans. Elife (2015) 4: e07361."/>
   <result pre="Elife (2015) 4: e07361. 10.7554/eLife.0736126371556 49.MorrisDHGosticKMPompeiSBedfordT�?ukszaMNeherRAet al.. Predictive modeling of" exact="influenza" post="shows the promise of applied evolutionary biology. Trends Microbiol."/>
   <result pre="(2017) 26:102–18. 10.1016/j.tim.2017.09.00429097090 50.ShuYMcCauleyJ. GISAID: Global initiative on sharing all" exact="influenza" post="data – from vision to reality. Eurosurveillance (2017) 22:30494."/>
   <result pre="(2017) 22:30494. 10.2807/1560-7917.ES.2017.22.13.3049428382917 51.AgorJKÖzaltinOY. Models for predicting the evolution of" exact="influenza" post="to inform vaccine strain selection. Hum Vaccin Immunother. (2018)"/>
   <result pre="14:678–83. 10.1080/21645515.2017.142315229337643 52.KlingenTRReimeringSGuzmánCAMcHardyAC. In silico vaccine strain prediction for human" exact="influenza" post="viruses. Trends Microbiol. (2017) 26:119–31. 10.1016/j.tim.2017.09.00129032900 53.LanderESLintonLMBirrenBNusbaumCZodyMCBaldwinJet al.. Initial"/>
   <result pre="6:1001191. 10.1371/journal.pgen.100119121124940 55.WoolthuisRGVan DorpCHKeşmirCDe BoerRJVan BovenM. Long-term adaptation of the" exact="influenza" post="A virus by escaping cytotoxic T-cell recognition. Sci Rep."/>
   <result pre="10.1038/srep3333427629812 56.FanKJiaYWangSLiHWuDWangGet al.Role of Itk signaling in the interaction between" exact="influenza" post="A virus and T cells. J Gen Virol. (2012)"/>
   <result pre="A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human" exact="influenza" post="A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol."/>
   <result pre="78:5216–22. 10.1128/JVI.78.10.5216-5222.200415113903 58.BerkhoffEGMGeelhoed-MierasMMFouchierRAMOsterhausADMERimmelzwaanGF. Assessment of the extent of variation in" exact="influenza" post="A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+"/>
   <result pre="Sequence variation in a newly identified HLA-B35-restricted epitope in the" exact="influenza" post="A virus nucleoprotein associated with escape from cytotoxic T"/>
   <result pre="Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe" exact="influenza" post="in Chinese individuals. Nat Commun. (2013) 4:1418. 10.1038/ncomms243323361009 64.ZwartMPElenaSF."/>
   <result pre="Virol. (2012) 2:546–55. 10.1016/j.coviro.2012.08.00122921636 66.StackJCMurciaPRGrenfellBTWoodJLNHolmesEC. Inferring the inter-host transmission of" exact="influenza" post="A virus using patterns of intra-host genetic variation. Proc"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6142641\results\search\disease\results.xml">
   <result pre="virus, SARS, MERS, Dengue, Chicken Guinea, West Nile and Japanese" exact="encephalitis" post="have created panic owing to their severe life-threatening consequences,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6160391\results\search\disease\results.xml">
   <result pre=": Commentary IFN-λ: A new spotlight in innate immunity against" exact="influenza" post="virus infection SunYepingJiangJingwenTienPoLiuWenjunliuwj@im.ac.cnLiJinglj418@163.com[], 0000000119573309grid.9227.eCAS Key Laboratory of Pathogenic Microbiology"/>
   <result pre="health. Seasonal flu epidemics, which are caused by the co-circulating" exact="influenza" post="A viruses (IAVs) and influenza B viruses (IBVs), occur"/>
   <result pre="are caused by the co-circulating influenza A viruses (IAVs) and" exact="influenza" post="B viruses (IBVs), occur annually and lead to tens"/>
   <result pre="devastating. The 2009 swine-originated H1N1 virus, which caused the latest" exact="influenza" post="pandemic, spread from Mexico and U.S. to virtually all"/>
   <result pre="among children, young adults, and pregnant women than typical seasonal" exact="influenza" post="viruses (Fineberg, 2014). The zoonotic avian influenza viruses, including"/>
   <result pre="women than typical seasonal influenza viruses (Fineberg, 2014). The zoonotic" exact="avian influenza" post="viruses, including H5N1, H5N6, H7N9 and H10N8, cause alarmingly"/>
   <result pre="than typical seasonal influenza viruses (Fineberg, 2014). The zoonotic avian" exact="influenza" post="viruses, including H5N1, H5N6, H7N9 and H10N8, cause alarmingly"/>
   <result pre="rate in human cases, raising a public concern of pandemic" exact="influenza" post="outbreak of avian origin (Poovorawan et al., 2013; Barr,"/>
   <result pre="Innate immune system is an important barrier of defending against" exact="influenza" post="virus infection. According to the traditional paradigm, after IAV"/>
   <result pre="viral clearance (Iwasaki and Pillai, 2014). However, effective protection from" exact="influenza" post="virus infection is provided by finely tuned antiviral immunity,"/>
   <result pre="immunity, while excessive innate immunity causes detrimental inflammation. Infection with" exact="influenza" post="viruses is usually self-limited, though the severe cases, especially"/>
   <result pre="and H7N9) are characterized by severe pulmonary disease and lethal" exact="acute respiratory distress syndrome" post="(ARDS) (Bauer et al., 2006; Ramsey and Kumar, 2011;"/>
   <result pre="components of the innate immune response. The cytokines produced in" exact="influenza" post="virus infected epithelial and endothelial cells, and cytokines and"/>
   <result pre="the high mortality in human cases infected with highly pathogenic" exact="influenza" post="virus strains such as 1918 pandemic H1N1 virus and"/>
   <result pre="with IAV can have fatal consequences. Therefore, benign outcomes of" exact="influenza" post="virus infection results from inducing sufficient IFN-mediated antiviral immunity"/>
   <result pre="harmful inflammatory response. Most current knowledge about innate immunity in" exact="influenza" post="virus infection has come from IAV. Although IBV contributes"/>
   <result pre="importance of type III IFNs has been suggested by life-threatening" exact="influenza" post="developed in genetically deficiency that leads to impaired production"/>
   <result pre="are more advantageous than type I IFNs in defending against" exact="influenza" post="virus for several reasons: (1) IFN-λs are produced earlier"/>
   <result pre="(1) IFN-λs are produced earlier and in larger amount during" exact="influenza" post="virus infection; (2) unlike type I IFNs, IFN-λs are"/>
   <result pre="innate interferon gamma participate in the host defense against respiratory" exact="vaccinia virus" post="infectionJ Virol20159012914110.1128/JVI.01894-1526468539 BarrIGAssessing the potential pandemic risk of recent"/>
   <result pre="virus infectionJ Virol20159012914110.1128/JVI.01894-1526468539 BarrIGAssessing the potential pandemic risk of recent" exact="avian influenza" post="virusesEur Respir J201749160251710.1183/13993003.02517-201628275178 BauerTTEwigSRodloffACMullerEEAcute respiratory distress syndrome and pneumonia:"/>
   <result pre="infectionJ Virol20159012914110.1128/JVI.01894-1526468539 BarrIGAssessing the potential pandemic risk of recent avian" exact="influenza" post="virusesEur Respir J201749160251710.1183/13993003.02517-201628275178 BauerTTEwigSRodloffACMullerEEAcute respiratory distress syndrome and pneumonia:"/>
   <result pre="systems analysis identifies a feedforward inflammatory circuit leading to lethal" exact="influenza" post="infectionCell201315419721210.1016/j.cell.2013.06.01323827683 BroggiATanYGranucciFZanoniIIFN-lambda suppresses intestinal inflammation by non-translational regulation of"/>
   <result pre="functionNat Immunol2017181084109310.1038/ni.382128846084 BuiCMChughtaiAAAdamDCMacIntyreCRAn overview of the epidemiology and emergence of" exact="influenza" post="A infection in humans over timeArch Public Health2017751510.1186/s13690-017-0182-z28352464 ChaiNSwemLRParkSNakamuraGChiangNEstevezAFongRKamenLKhoEReicheltMet"/>
   <result pre="timeArch Public Health2017751510.1186/s13690-017-0182-z28352464 ChaiNSwemLRParkSNakamuraGChiangNEstevezAFongRKamenLKhoEReicheltMet al.A broadly protective therapeutic antibody against" exact="influenza" post="B virus with two mechanisms of actionNat Commun201781423410.1038/ncomms1423428102191 ChowKTGaleMJrSnapShot:"/>
   <result pre="of actionNat Commun201781423410.1038/ncomms1423428102191 ChowKTGaleMJrSnapShot: interferon signalingCell20151631808–1808e1801 CiancanelliMJHuangSXLuthraPGarnerHItanYVolpiSLafailleFGTrouilletCSchmolkeMAlbrechtRAet al.Infectious disease. Life-threatening" exact="influenza" post="and impaired interferon amplification in human IRF7 deficiencyScience201534844845310.1126/science.aaa157825814066 CiancanelliMJAbelLZhangSYCasanovaJLHost"/>
   <result pre="Opin Immunol20163810912010.1016/j.coi.2015.12.00226761402 DienzORudJGEatonSMLanthierPABurgEDrewABunnJSurattBTHaynesLRinconMEssential role of IL-6 in protection against H1N1" exact="influenza" post="virus by promoting neutrophil survival in the lungMucosal Immunol2012525826610.1038/mi.2012.222294047"/>
   <result pre="the lungMucosal Immunol2012525826610.1038/mi.2012.222294047 FinebergHVPandemic preparedness and response—lessons from the H1N1" exact="influenza" post="of 2009N Engl J Med20143701335134210.1056/NEJMra120880224693893 GalaniIETriantafylliaVEleminiadouEEKoltsidaOStavropoulosAManioudakiMThanosDDoyleSEKotenkoSVThanopoulouKet al.Interferon-lambda mediates non-redundant"/>
   <result pre="J Med20143701335134210.1056/NEJMra120880224693893 GalaniIETriantafylliaVEleminiadouEEKoltsidaOStavropoulosAManioudakiMThanosDDoyleSEKotenkoSVThanopoulouKet al.Interferon-lambda mediates non-redundant front-line antiviral protection against" exact="influenza" post="virus infection without compromising host fitnessImmunity201746875–890e876 GalmozziEViganoMLamperticoPSystematic review with"/>
   <result pre="interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in" exact="hepatitis" post="B infection?Aliment Pharmacol Ther20143956957810.1111/apt.1263124461198 GinsbergJMohebbiMHPatelRSBrammerLSmolinskiMSBrilliantLDetecting influenza epidemics using search"/>
   <result pre="outcome of interferon-therapy in hepatitis B infection?Aliment Pharmacol Ther20143956957810.1111/apt.1263124461198 GinsbergJMohebbiMHPatelRSBrammerLSmolinskiMSBrilliantLDetecting" exact="influenza" post="epidemics using search engine query dataNature2009457U1012U101410.1038/nature07634 IvashkivLBDonlinLTRegulation of type"/>
   <result pre="of type I interferon responsesNat Rev Immunol201414364910.1038/nri358124362405 IwasakiAPillaiPSInnate immunity to" exact="influenza" post="virus infectionNat Rev Immunol20141431532810.1038/nri366524762827 JiangJWLiJFanWHZhengWNYuMChenCSunLBiYHDingCGaoGFet al.Robust Lys63-linked ubiquitination of"/>
   <result pre="al.Robust Lys63-linked ubiquitination of RIG-I promotes cytokine eruption in early" exact="influenza" post="B virus infectionJ Virol2016906263627510.1128/JVI.00549-1627122586 LazearHMNiceTJDiamondMSInterferon-lambda: immune functions at barrier"/>
   <result pre="in the absence of adaptive immunityScience201534726927310.1126/science.125810025431489 PeirisJSCheungCYLeungCYNichollsJMInnate immune responses to" exact="influenza" post="A H5N1: friend or foe?Trends Immunol20093057458410.1016/j.it.2009.09.00419864182 PhillipsSMistrySRivaACooksleyHHadzhiolova-LebeauTPlavovaSKatzarovKSimonovaMZeuzemSWoffendinCet al.Peg-interferon lambda"/>
   <result pre="lambda treatment induces robust innate and adaptive immunity in chronic" exact="hepatitis" post="B patientsFront Immunol2017862110.3389/fimmu.2017.0062128611778 PoovorawanYPyungpornSPrachayangprechaSMakkochJGlobal alert to avian influenza virus"/>
   <result pre="immunity in chronic hepatitis B patientsFront Immunol2017862110.3389/fimmu.2017.0062128611778 PoovorawanYPyungpornSPrachayangprechaSMakkochJGlobal alert to" exact="avian influenza" post="virus infection: from H5N1 to H7N9Pathog Glob Health201310721722310.1179/2047773213Y.000000010323916331 RamseyCKumarAH1N1:"/>
   <result pre="in chronic hepatitis B patientsFront Immunol2017862110.3389/fimmu.2017.0062128611778 PoovorawanYPyungpornSPrachayangprechaSMakkochJGlobal alert to avian" exact="influenza" post="virus infection: from H5N1 to H7N9Pathog Glob Health201310721722310.1179/2047773213Y.000000010323916331 RamseyCKumarAH1N1:"/>
   <result pre="influenza virus infection: from H5N1 to H7N9Pathog Glob Health201310721722310.1179/2047773213Y.000000010323916331 RamseyCKumarAH1N1:" exact="viral pneumonia" post="as a cause of acute respiratory distress syndromeCurr Opin"/>
   <result pre="virus infection: from H5N1 to H7N9Pathog Glob Health201310721722310.1179/2047773213Y.000000010323916331 RamseyCKumarAH1N1: viral" exact="pneumonia" post="as a cause of acute respiratory distress syndromeCurr Opin"/>
   <result pre="ameliorate lung injury and the development of severe disease during" exact="influenza" post="infectionJ Immunol20091837441745010.4049/jimmunol.090249719917678 TeijaroJRThe role of cytokine responses during influenza"/>
   <result pre="during influenza infectionJ Immunol20091837441745010.4049/jimmunol.090249719917678 TeijaroJRThe role of cytokine responses during" exact="influenza" post="virus pathogenesis and potential therapeutic optionsCurr Top Microbiol Immunol201538632225267464"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6196792\results\search\disease\results.xml">
   <result pre="work is properly cited. Abstract The rapid worldwide spread of" exact="chikungunya" post="(CHIKV), dengue (DENV), and Zika (ZIKV) viruses have raised"/>
   <result pre="Tecnológico300700/2016-4 Medical Research CouncilMC_UU_12014MR/N017552/1 1. Introduction Mosquito-borne viruses such as" exact="chikungunya" post="(CHIKV), dengue (DENV), and Zika (ZIKV) viruses have rapidly"/>
   <result pre="the Flaviviridae family, which also includes other species such as" exact="yellow fever" post="virus (YFV), Japanese encephalitis virus (JEV), Spondweni virus (SPOV),"/>
   <result pre="includes other species such as yellow fever virus (YFV), Japanese" exact="encephalitis" post="virus (JEV), Spondweni virus (SPOV), and West Nile virus"/>
   <result pre="on this neglected virus because of the dramatic increase of" exact="microcephaly" post="in newborns [17, 18]. There is by now compelling"/>
   <result pre="Ae. albopictuseLife2015410.7554/eLife.08347 6Beltrán-SilvaS. L.Chacón-HernándezS. S.Moreno-PalaciosE.Pereyra-MolinaJ. �?.Clinical and differential diagnosis: dengue," exact="chikungunya" post="and ZikaRevista Médica del Hospital General de México201881314615310.1016/j.hgmx.2016.09.011 7CareyD."/>
   <result pre="T.FariaN. R.de VasconcelosJ. M.et al.Emergence and potential for spread of" exact="chikungunya" post="virus in BrazilBMC Medicine2015131p. 10210.1186/s12916-015-0348-x25976325 10BhattS.GethingP. W.BradyO. J.et al.The"/>
   <result pre="using a graphic matroid approachBMC Bioinformatics2009101p. 15210.1186/1471-2105-10-15219450271 48GuzmanM. G.KouriG.Dengue and" exact="dengue hemorrhagic fever" post="in the Americas: lessons and challengesJournal of Clinical Virology200327111310.1016/S1386-6532(03)00010-612727523"/>
   <result pre="indicated by solid colors. The sequences in bold indicate ZIKV-associated" exact="microcephaly" post="and those in italics indicate that ZIKV was imported"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6197989\results\search\disease\results.xml">
   <result pre="pmcid: 6197989S2319-4170(18)30297-X doi: 10.1016/j.bj.2018.08.002 : Special Edition Centennial review of" exact="influenza" post="in Taiwan GongYu-Nonga1KuoRei-Linabc1ChenGuang-Wugwchen@mail.cgu.edu.twade∗∗ShihShin-Rusrshih@mail.cgu.edu.twabef∗[a], [b], [c], [d], [e], [f], ∗Corresponding"/>
   <result pre="under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract The history of" exact="influenza" post="in Taiwan can be traced up to the 1918"/>
   <result pre="1968 H3N2, and the 2009 new H1N1. A couple of" exact="avian influenza" post="viruses of H5N1 and H7N9 also posed threats to"/>
   <result pre="H3N2, and the 2009 new H1N1. A couple of avian" exact="influenza" post="viruses of H5N1 and H7N9 also posed threats to"/>
   <result pre="in Taiwan in the two recent decades. Nevertheless, two seasonal" exact="influenza" post="A viruses and two lineages of influenza B viruses"/>
   <result pre="Nevertheless, two seasonal influenza A viruses and two lineages of" exact="influenza" post="B viruses continue causing annual endemics one after the"/>
   <result pre="Keywords Influenza Pandemic Genome evolution Surveillance Brief history of global" exact="influenza" post="virus outbreaks There are four types of influenza viruses:"/>
   <result pre="of global influenza virus outbreaks There are four types of" exact="influenza" post="viruses: types A, B, C, and D. Influenza A,"/>
   <result pre="on human health globally. Influenza B causes seasonal epidemics while" exact="influenza" post="C causes mild human infections with minimal public health"/>
   <result pre="pandemic known as the &quot;Asian flu�? caused by an H2N2" exact="influenza" post="A virus resulted in another million deaths. In 1968"/>
   <result pre="virus acquired a novel haemagglutinin and PB2 gene segment from" exact="avian influenza" post="virus origin to cause another pandemic that was first"/>
   <result pre="acquired a novel haemagglutinin and PB2 gene segment from avian" exact="influenza" post="virus origin to cause another pandemic that was first"/>
   <result pre="and led to epidemics worldwide. Since that time, the two" exact="influenza" post="A viruses, H1N1 and H3N2, have circulated worldwide as"/>
   <result pre="H1N1 and H3N2, have circulated worldwide as the major human" exact="influenza" post="A seasonal flu viruses resulting in annual epidemics or"/>
   <result pre="history. This new H1N1 virus was initially called a &quot;swine-origin�?" exact="influenza" post="virus because its gene segments are derived from swine"/>
   <result pre="influenza virus because its gene segments are derived from swine" exact="influenza" post="viruses. The 2009 pandemic virus replaced the previous seasonal"/>
   <result pre="to 2008 and since then has co-circulated in humans with" exact="influenza" post="A H3N2 and influenza B viruses. Pandemics and epidemics"/>
   <result pre="then has co-circulated in humans with influenza A H3N2 and" exact="influenza" post="B viruses. Pandemics and epidemics in Taiwan 1918 H1N1"/>
   <result pre="the western Pacific Ocean, is relatively isolated from other countries," exact="influenza" post="pandemics have still affected its inhabitants. During the 1918"/>
   <result pre="pandemics have still affected its inhabitants. During the 1918 H1N1" exact="influenza" post="pandemic, Taiwan was governed by Japan. Previous studies have"/>
   <result pre="[1], [2]. Similar to the transmission route of the 1918" exact="influenza" post="virus in the United States, this H1N1 virus may"/>
   <result pre="Megumi in 1918–19 [Fig. 1], the earliest cases of the" exact="influenza" post="infection may have originated in Keelung Harbor in northern"/>
   <result pre="population during 1918–20 in Taiwan and concluded that the 1918" exact="influenza" post="pandemic caused significant mortality in Taiwan [4]. Wilson Smith"/>
   <result pre="[4]. Wilson Smith (1933) isolated the causative agent of human" exact="influenza" post="in 1933. Fig. 1 Part of the original manuscript"/>
   <result pre="Part of the original manuscript (in Japanese) describing the 1918" exact="influenza" post="pandemic in Taiwan reported by a Japanese medical officer,"/>
   <result pre="caused the 1957 Asian flu pandemic was recognized as an" exact="influenza" post="A virus [5] of different A subtype designated as"/>
   <result pre="haemagglutinin (HA), neuraminidase (NA) and PB1 gene segments from an" exact="avian influenza" post="virus [7]. Several strains of the influenza A virus"/>
   <result pre="(HA), neuraminidase (NA) and PB1 gene segments from an avian" exact="influenza" post="virus [7]. Several strains of the influenza A virus"/>
   <result pre="from an avian influenza virus [7]. Several strains of the" exact="influenza" post="A virus related to the pandemic were isolated in"/>
   <result pre="1968, a new worldwide pandemic was caused by an H3N2" exact="influenza" post="A virus. Because the virus was first isolated in"/>
   <result pre="H2N2 virus acquiring HA and PB1 gene segments from an" exact="avian influenza" post="A virus [13], [14]. During 1968–71, the number of"/>
   <result pre="virus acquiring HA and PB1 gene segments from an avian" exact="influenza" post="A virus [13], [14]. During 1968–71, the number of"/>
   <result pre="[13], [14]. During 1968–71, the number of deaths related to" exact="influenza" post="infection in Taiwan increased, which may indicate the burden"/>
   <result pre="the first indication of reverse zoonosis, with pigs acquiring human" exact="influenza" post="viruses [15]. Several influenza A viruses closely related to"/>
   <result pre="reverse zoonosis, with pigs acquiring human influenza viruses [15]. Several" exact="influenza" post="A viruses closely related to human A/Hong Kong/68 (H3N2)"/>
   <result pre="H3N2 virus has continuously circulated among humans as a seasonal" exact="influenza" post="virus. Antigenic drift of this H3N2 has occurred. Reappearance"/>
   <result pre="strain of H3N2 adapted to humans and became a seasonal" exact="influenza" post="virus, an H1N1 virus reappeared and caused epidemics in"/>
   <result pre="its emergence in 1977, the H1N1 virus became a seasonal" exact="influenza" post="virus that co-circulated with H3N2 viruses worldwide, including in"/>
   <result pre="California were identified to be infected with a novel H1N1" exact="influenza" post="A virus that was genetically similar to the swine-origin"/>
   <result pre="North American avian, human H3N2, classic swine, and Eurasian swine" exact="influenza" post="A viruses [22], [23], [24]. In Taiwan, the first"/>
   <result pre="with less number of viruses being isolated. Interestingly, the severe" exact="influenza" post="and pneumonia/influenza related death from this virus seemed to"/>
   <result pre="the A (H1N1)pdm09 virus now being recognized as a seasonal" exact="influenza" post="virus. At the time of writing this review, the"/>
   <result pre="1977 up to 2009 in Taiwan [30]. Threats related to" exact="avian influenza" post="viruses H5N1 and H7N9 In 1997, cases of human"/>
   <result pre="up to 2009 in Taiwan [30]. Threats related to avian" exact="influenza" post="viruses H5N1 and H7N9 In 1997, cases of human"/>
   <result pre="In 1997, cases of human infection with a highly pathogenic" exact="avian influenza" post="A virus (H5N1) were reported in Hong Kong [31]."/>
   <result pre="1997, cases of human infection with a highly pathogenic avian" exact="influenza" post="A virus (H5N1) were reported in Hong Kong [31]."/>
   <result pre="in Taiwan at the time of writing this review, this" exact="avian influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="Taiwan at the time of writing this review, this avian" exact="influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="to public health. Several imported cases of infection with another" exact="avian influenza" post="A virus (H7N9) in humans have been reported in"/>
   <result pre="public health. Several imported cases of infection with another avian" exact="influenza" post="A virus (H7N9) in humans have been reported in"/>
   <result pre="established surveillance systems and early diagnostic technology to monitor the" exact="avian influenza" post="viruses throughout Taiwan. Epidemics of seasonal influenza viruses in"/>
   <result pre="surveillance systems and early diagnostic technology to monitor the avian" exact="influenza" post="viruses throughout Taiwan. Epidemics of seasonal influenza viruses in"/>
   <result pre="monitor the avian influenza viruses throughout Taiwan. Epidemics of seasonal" exact="influenza" post="viruses in Taiwan Seasonal influenza A and B viruses"/>
   <result pre="throughout Taiwan. Epidemics of seasonal influenza viruses in Taiwan Seasonal" exact="influenza" post="A and B viruses circulate worldwide, infecting 5–10% of"/>
   <result pre="and this network has substantially contributed to the control of" exact="influenza" post="virus infections [37]. Influenza epidemic waves from 2000 to"/>
   <result pre="the time of writing this review, the major lineages of" exact="influenza" post="viruses responsible for influenza epidemics in Taiwan are the"/>
   <result pre="this review, the major lineages of influenza viruses responsible for" exact="influenza" post="epidemics in Taiwan are the H3N2 and H1N1 subtypes"/>
   <result pre="epidemics in Taiwan are the H3N2 and H1N1 subtypes of" exact="influenza" post="A viruses and the Victoria and Yamagata lineages of"/>
   <result pre="influenza A viruses and the Victoria and Yamagata lineages of" exact="influenza" post="B viruses. The peak circulation of these viruses is"/>
   <result pre="dominant lineages in the 2000–01 and 2001–02 seasons were the" exact="influenza" post="B and H1N1 viruses, respectively, those in 2002–03 and"/>
   <result pre="2003–04 were H3N2 [37], and in 2004–05 H3N2 co-circulated with" exact="influenza" post="B viruses [38], [39]. In the subsequent period from"/>
   <result pre="H1N1 subtype prevailed (except for the co-circulation of H3N2 and" exact="influenza" post="B viruses in 2006–07) [38], [39]. The 2009 pandemic"/>
   <result pre="A (H1N1)pdm09 virus, which was generated by reassortment of several" exact="influenza" post="viruses. This new H1N1 virus continued to be the"/>
   <result pre="viruses. This new H1N1 virus continued to be the dominant" exact="influenza" post="virus in the two subsequent winters [40] and replaced"/>
   <result pre="H1N1 virus to become the new seasonal H1N1 virus. Although" exact="influenza" post="B viruses circulated in 2011–12, a summer epidemic of"/>
   <result pre="epidemics in 2005, 2007, and 2012 followed the circulation of" exact="influenza" post="B viruses during the winters of 2004–05, 2006–07, and"/>
   <result pre="prediction of their global migrations In addition to Taiwan, summer" exact="influenza" post="outbreaks have been reported in Okinawa (Japan), Hong Kong,"/>
   <result pre="computational analytics may improve understanding of the global spread of" exact="influenza" post="viruses. 2015–16 H1N1 epidemic In Taiwan, a most recent"/>
   <result pre="in 2015–16, causing 163 deaths and 1663 severe infections (including" exact="influenza" post="infection cases with pulmonary complications, neurologic complications, myocarditis, invasive"/>
   <result pre="with pulmonary complications, neurologic complications, myocarditis, invasive bacterial infections, or" exact="pericarditis" post="that required intensive care or resulting in death) from"/>
   <result pre="federal districts of Russia, the rate of morbidity due to" exact="influenza" post="and acute respiratory infection rapidly increased in the 2015–16"/>
   <result pre="(A/Michigan/45/2015) in the following 2017 southern and 2017–18 northern hemisphere" exact="influenza" post="seasons [54], [55]. This suggests that selection of strains"/>
   <result pre="This suggests that selection of strains for vaccines against seasonal" exact="influenza" post="viruses must be improved. Establishing a real-time monitoring system"/>
   <result pre="enable more effective selection of vaccine strains. Circulating H3N2 and" exact="influenza" post="B viruses from 2016 to 2018 The H3N2 virus"/>
   <result pre="climatic changes were possible contributors [58]. After this summer epidemic," exact="influenza" post="B viruses were the dominant viruses in the 2017–18"/>
   <result pre="October 2017 to March 2018 [59]. Notably, an unusually early" exact="influenza" post="epidemic caused by the H3N2 virus co-circulating with the"/>
   <result pre="by the H3N2 virus co-circulating with the Yamagata lineage of" exact="influenza" post="B viruses occurred during this period in Canada [60]."/>
   <result pre="still prevailed, and thus further research is necessary to improve" exact="influenza" post="vaccines. In conclusion, although the timing of influenza epidemics"/>
   <result pre="to improve influenza vaccines. In conclusion, although the timing of" exact="influenza" post="epidemics and the evolutionary pattern of influenza viruses remain"/>
   <result pre="the timing of influenza epidemics and the evolutionary pattern of" exact="influenza" post="viruses remain unpredictable, recent computational techniques and sequencing platforms"/>
   <result pre="and highly effective method for analyzing the rapid evolution of" exact="influenza" post="viruses. Improving our understanding of and capacity to predict"/>
   <result pre="our understanding of and capacity to predict the evolution of" exact="influenza" post="viruses could lead to the development of superior techniques"/>
   <result pre="superior techniques for public health surveillance and effective recommendations for" exact="influenza" post="vaccine strains in future seasons. Discussion and future perspectives"/>
   <result pre="the establishment of an island-wide laboratory-based surveillance network has facilitated" exact="influenza" post="epidemiology monitoring in Taiwan since 2000. The seamless collaboration"/>
   <result pre="H5N1 disease in humans had been reported in Taiwan, this" exact="avian influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="disease in humans had been reported in Taiwan, this avian" exact="influenza" post="virus is a constant threat to public health. Several"/>
   <result pre="public health. Several imported cases of human infection with an" exact="avian influenza" post="A virus (H7N9) have been reported in Taiwan since"/>
   <result pre="health. Several imported cases of human infection with an avian" exact="influenza" post="A virus (H7N9) have been reported in Taiwan since"/>
   <result pre="and early diagnostic technology to monitor both human seasonal and" exact="avian influenza" post="virus throughout Taiwan. In particular, advances in cell culture,"/>
   <result pre="early diagnostic technology to monitor both human seasonal and avian" exact="influenza" post="virus throughout Taiwan. In particular, advances in cell culture,"/>
   <result pre="modeling should all contribute to help in our understanding of" exact="influenza" post="epidemics. Conflicts of interest The authors declare no conflicts"/>
   <result pre="declare no conflicts of interest. References References 1ChanC.H.Gene analysis of" exact="influenza" post="A and B Isolates1999Institute of Microbiology and Immunology. Ph.D.:"/>
   <result pre="Immunology. Ph.D.: National Yang-Ming University 2NHRISpecial report for the 1918" exact="influenza" post="pandemic in Taiwan. H5N1 influenza2008The National Health Research InstituteTaiwan"/>
   <result pre="influenza2008The National Health Research InstituteTaiwan 3HsiehY.H.ChanC.H.Excess healthcare burden during 1918-1920" exact="influenza" post="pandemic in Taiwan: implications for post-pandemic preparednessBMC Publ Health11201141"/>
   <result pre="post-pandemic preparednessBMC Publ Health11201141 4HsiehY.H.Excess deaths and immunoprotection during 1918-1920" exact="influenza" post="pandemic, TaiwanEmerg Infect Dis1520091617161919861055 5KilbourneE.D.Studies on influenza in the"/>
   <result pre="immunoprotection during 1918-1920 influenza pandemic, TaiwanEmerg Infect Dis1520091617161919861055 5KilbourneE.D.Studies on" exact="influenza" post="in the pandemic of 1957-1958. III. Isolation of influenza"/>
   <result pre="on influenza in the pandemic of 1957-1958. III. Isolation of" exact="influenza" post="A (Asian strain) viruses from influenza patients with pulmonary"/>
   <result pre="1957-1958. III. Isolation of influenza A (Asian strain) viruses from" exact="influenza" post="patients with pulmonary complications; details of virus isolation and"/>
   <result pre="isolates, with quantitative comparison of isolation methodsJ Clin Invest38195926627413620785 6DunnF.L.Pandemic" exact="influenza" post="in 1957; review of international spread of new Asian"/>
   <result pre="strainJ Am Med Assoc16619581140114813513331 7SchaferJ.R.KawaokaY.BeanW.J.SussJ.SenneD.WebsterR.G.Origin of the pandemic 1957 H2" exact="influenza" post="A virus and the persistence of its possible progenitors"/>
   <result pre="8WangS.P.LinT.Y.Laboratory studies on some biological properties of the far east" exact="influenza" post="virusJ Infect Dis103195817818213588070 9GreenI.J.RasmussenA.F.HsuS.H.HsiehW.C.HungS.C.Antigenic characteristics of Asian influenza viruses"/>
   <result pre="far east influenza virusJ Infect Dis103195817818213588070 9GreenI.J.RasmussenA.F.HsuS.H.HsiehW.C.HungS.C.Antigenic characteristics of Asian" exact="influenza" post="viruses isolated on Taiwan in 1961Taiwan Yi Xue Hui"/>
   <result pre="Xue Hui Za Zhi61196210510913901411 10ChangS.S.ChenC.Y.Studies on complement fixation antigens of" exact="influenza" post="virus. I. Type-specific and strainspecific complement fixation tests as"/>
   <result pre="as compared with hemagglutination-inhibition testJ Formos Med Assoc60196110101025 11PaleseP.WangT.T.Why do" exact="influenza" post="virus subtypes die out? A hypothesisMBio22011pii=e00150-11 12JonesJ.C.BaranovichT.MaratheB.M.DannerA.F.SeilerJ.P.FranksJ.Risk assessment of"/>
   <result pre="virus subtypes die out? A hypothesisMBio22011pii=e00150-11 12JonesJ.C.BaranovichT.MaratheB.M.DannerA.F.SeilerJ.P.FranksJ.Risk assessment of H2N2" exact="influenza" post="viruses from the avian reservoirJ Virol8820141175118824227848 13KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of"/>
   <result pre="avian reservoirJ Virol8820141175118824227848 13KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of the PB1 gene of" exact="influenza" post="A viruses in the 1957 and 1968 pandemicsJ Virol631989460346082795713"/>
   <result pre="1968 pandemicsJ Virol631989460346082795713 14ScholtissekC.RohdeW.Von HoyningenV.RottR.On the origin of the human" exact="influenza" post="virus subtypes H2N2 and H3N2Virology8719781320664248 15KundinW.D.Hong Kong A-2 influenza"/>
   <result pre="human influenza virus subtypes H2N2 and H3N2Virology8719781320664248 15KundinW.D.Hong Kong A-2" exact="influenza" post="virus infection among swine during a human epidemic in"/>
   <result pre="of influenzavirus A subtype H1N1Bull World Health Organ561978919922310733 18NakajimaK.DesselbergerU.PaleseP.Recent human" exact="influenza" post="A (H1N1) viruses are closely related genetically to strains"/>
   <result pre="related genetically to strains isolated in 1950Nature2741978334339672956 19KendalA.P.NobleG.R.SkehelJ.J.DowdleW.R.Antigenic similarity of" exact="influenza" post="A (H1N1) viruses from epidemics in 1977-1978 to &quot;Scandinavian&quot;"/>
   <result pre="strain and the gain-of-function debatemBio62015e01013e0101526286690 21Centers for Disease C, PreventionSwine" exact="influenza" post="A (H1N1) infection in two children--Southern California, March-April 2009MMWR"/>
   <result pre="2009MMWR Morb Mortal Wkly Rep58200940040219390508 22DawoodF.S.JainS.FinelliL.ShawM.W.LindstromS.GartenR.J.Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humansN Engl J Med36020092605261519423869 23GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.Antigenic"/>
   <result pre="J Med36020092605261519423869 23GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humansScience325200919720119465683 24SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.Origins and evolutionary genomics of"/>
   <result pre="humansScience325200919720119465683 24SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemicNature45920091122112519516283 25HoT.S.WangS.M.LiuC.C.Historical review of pandemic influenza A in"/>
   <result pre="2009 swine-origin H1N1 influenza A epidemicNature45920091122112519516283 25HoT.S.WangS.M.LiuC.C.Historical review of pandemic" exact="influenza" post="A in Taiwan, 2009Pediatr Neonatol512010838820417458 26YenM.Y.ChiuA.W.SchwartzJ.KingC.C.LinY.E.ChangS.C.From SARS in 2003"/>
   <result pre="green I and modified probe real-time reverse transcription-PCR assays identify" exact="influenza" post="H1N1 viruses and distinguish between pandemic and seasonal strainsJ"/>
   <result pre="29WuU.I.WangJ.T.ChangS.C.ChuangY.C.LinW.R.LuM.C.Impacts of a mass vaccination campaign against pandemic H1N1 2009" exact="influenza" post="in Taiwan: a time-series regression analysisInt J Infect Dis232014828924721165"/>
   <result pre="a time-series regression analysisInt J Infect Dis232014828924721165 30ChuangJ.H.HuangA.S.HuangW.T.LiuM.T.ChouJ.H.ChangF.Y.Nationwide surveillance of" exact="influenza" post="during the pandemic (2009-10) and post-pandemic (2010-11) periods in"/>
   <result pre="and post-pandemic (2010-11) periods in TaiwanPLoS One72012e3612022545158 31ClaasE.C.OsterhausA.D.van BeekR.De JongJ.C.RimmelzwaanG.F.SenneD.A.Human" exact="influenza" post="A H5N1 virus related to a highly pathogenic avian"/>
   <result pre="JongJ.C.RimmelzwaanG.F.SenneD.A.Human influenza A H5N1 virus related to a highly pathogenic" exact="avian influenza" post="virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621"/>
   <result pre="influenza A H5N1 virus related to a highly pathogenic avian" exact="influenza" post="virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621"/>
   <result pre="highly pathogenic avian influenza virusLancet35119984724779482438 32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9" exact="influenza" post="in TaiwanLancet38120131621 33YangJ.R.KuoC.Y.HuangH.Y.WuF.T.HuangY.L.ChengC.Y.Characterization of influenza A (H7N9) viruses isolated"/>
   <result pre="32ChangS.Y.LinP.H.TsaiJ.C.HungC.C.ChangS.C.The first case of H7N9 influenza in TaiwanLancet38120131621 33YangJ.R.KuoC.Y.HuangH.Y.WuF.T.HuangY.L.ChengC.Y.Characterization of" exact="influenza" post="A (H7N9) viruses isolated from human cases imported into"/>
   <result pre="imported into TaiwanPLoS One102015e011979225748033 34GaoR.CaoB.HuY.FengZ.WangD.HuW.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human"/>
   <result pre="(H7N9) virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in ChinaN Engl J Med370201452053223614499 36World Health"/>
   <result pre="virusN Engl J Med36820131888189723577628 35LiQ.ZhouL.ZhouM.ChenZ.LiF.WuH.Epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in ChinaN Engl J Med370201452053223614499 36World Health"/>
   <result pre="36World Health OrganizationSeasonal influenza2018http://www.who.int/ith/diseases/influenza_seasonal/en/ 37ShihS.R.ChenG.W.YangC.C.YangW.Z.LiuD.P.LinJ.H.Laboratory-based surveillance and molecular epidemiology of" exact="influenza" post="virus in TaiwanJ Clin Microbiol4320051651166115814980 38LinJ.H.ChiuS.C.ChengJ.C.ChangH.W.HsiaoK.L.LinY.C.Molecular epidemiology and antigenic"/>
   <result pre="in TaiwanJ Clin Microbiol4320051651166115814980 38LinJ.H.ChiuS.C.ChengJ.C.ChangH.W.HsiaoK.L.LinY.C.Molecular epidemiology and antigenic analyses of" exact="influenza" post="A viruses H3N2 in TaiwanClin Microbiol Infect17201121422220370800 39LinJ.H.ChiuS.C.LinY.C.ChengJ.C.WuH.S.SalemiM.Exploring the"/>
   <result pre="Microbiol Infect17201121422220370800 39LinJ.H.ChiuS.C.LinY.C.ChengJ.C.WuH.S.SalemiM.Exploring the molecular epidemiology and evolutionary dynamics of" exact="influenza" post="A virus in TaiwanPLoS One82013e6195723613982 40ChenG.W.TsaoK.C.HuangC.G.GongY.N.ChangS.C.LiuY.C.Amino acids transitioning of"/>
   <result pre="2011PLoS One72012e4594623029335 41YangJ.R.TengH.J.LiuM.T.LiS.Y.Taiwan's public health national laboratory system: success in" exact="influenza" post="diagnosis and surveillanceHealth Secur15201715416428418742 42SunagawaS.IhaY.TairaK.OkanoS.KinjoT.HigaF.An epidemiological analysis of summer"/>
   <result pre="influenza diagnosis and surveillanceHealth Secur15201715416428418742 42SunagawaS.IhaY.TairaK.OkanoS.KinjoT.HigaF.An epidemiological analysis of summer" exact="influenza" post="epidemics in OkinawaIntern Med5520163579358427980256 43BaeleG.SuchardM.A.RambautA.LemeyP.Emerging concepts of data integration"/>
   <result pre="Biol52009e100050519855824 46BedfordT.CobeyS.BeerliP.PascualM.Global migration dynamics underlie evolution and persistence of human" exact="influenza" post="A (H3N2)PLoS Pathog62010e100091820523898 47BahlJ.NelsonM.I.ChanK.H.ChenR.VijaykrishnaD.HalpinR.A.Temporally structured metapopulation dynamics and persistence"/>
   <result pre="A (H3N2)PLoS Pathog62010e100091820523898 47BahlJ.NelsonM.I.ChanK.H.ChenR.VijaykrishnaD.HalpinR.A.Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humansProc Natl Acad Sci U"/>
   <result pre="S A1082011193591936422084096 48LemeyP.SuchardM.RambautA.Reconstructing the initial global spread of a human" exact="influenza" post="pandemic: a Bayesian spatial-temporal model for the global spread"/>
   <result pre="global spread of H1N1pdmPLoS Curr12009RRN103120029613 49GongY.N.TsaoK.C.ChenG.W.Inferring the global phylodynamics of" exact="influenza" post="A/H3N2 viruses in TaiwanJ Formos Med Assoc2018[Epub ahead of"/>
   <result pre="their molecular determinantsPLoS Pathog62010e100088420463813 51Taiwan Centers for Disease Control. Taiwan" exact="influenza" post="express (2016/03/06-2016/03/12), https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=204B424A955D572F&amp;amp;tid=C363651DDC5981F3; [accessed 6 July 2018]. 52CousinsS.Death toll"/>
   <result pre="from swine flu in India exceeds 2500BMJ3512015h496626384378 53KomissarovA.FadeevA.SergeevaM.PetrovS.SintsovaK.EgorovaA.Rapid spread of" exact="influenza" post="A(H1N1)pdm09 viruses with a new set of specific mutations"/>
   <result pre="(Russian Federation)Influenza Other Respir Viruses10201624725326992820 54World Health OrganizationRecommended composition of" exact="influenza" post="virus vaccines for use in the 2017 southern hemisphere"/>
   <result pre="influenza virus vaccines for use in the 2017 southern hemisphere" exact="influenza" post="season2016http://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1 55World Health OrganizationRecommended composition of influenza virus vaccines"/>
   <result pre="2017 southern hemisphere influenza season2016http://www.who.int/influenza/vaccines/virus/recommendations/201609_recommendation.pdf?ua=1 55World Health OrganizationRecommended composition of" exact="influenza" post="virus vaccines for use in the 2017-2018 northern hemisphere"/>
   <result pre="influenza virus vaccines for use in the 2017-2018 northern hemisphere" exact="influenza" post="season2017http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 56NeherR.A.BedfordT.nextflu: real-time tracking of seasonal influenza virus evolution"/>
   <result pre="2017-2018 northern hemisphere influenza season2017http://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 56NeherR.A.BedfordT.nextflu: real-time tracking of seasonal" exact="influenza" post="virus evolution in humansBioinformatics3120153546354826115986 57TsouT.P.SuC.P.HuangW.T.YangJ.R.LiuM.T.Influenza A(H3N2) virus variants and"/>
   <result pre="57TsouT.P.SuC.P.HuangW.T.YangJ.R.LiuM.T.Influenza A(H3N2) virus variants and patient characteristics during a summer" exact="influenza" post="epidemic in Taiwan, 2017Euro Surveill222017pii=17-00767 58YangJ.R.HsuS.Z.KuoC.Y.HuangH.Y.HuangT.Y.WangH.C.An epidemic surge of"/>
   <result pre="influenza epidemic in Taiwan, 2017Euro Surveill222017pii=17-00767 58YangJ.R.HsuS.Z.KuoC.Y.HuangH.Y.HuangT.Y.WangH.C.An epidemic surge of" exact="influenza" post="A(H3N2) virus at the end of the 2016-2017 season"/>
   <result pre="genetic heterogeneityJ Clin Virol99–10020181521 59Taiwan Centers for Disease Control. Taiwan" exact="influenza" post="express (2018/03/04-2018/03/10), https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=CB122F160E7AC2B9&amp;amp;tid=3D8AA6E7A9B58EDA; [accessed 6 July 2018]. 60SkowronskiD.M.ChambersC.De SerresG.DickinsonJ.A.WinterA.L.HickmanR.Early"/>
   <result pre="https://www.cdc.gov.tw/info.aspx?treeid=1F07E8862BA550CF&amp;amp;nowtreeid=CB122F160E7AC2B9&amp;amp;tid=3D8AA6E7A9B58EDA; [accessed 6 July 2018]. 60SkowronskiD.M.ChambersC.De SerresG.DickinsonJ.A.WinterA.L.HickmanR.Early season co-circulation of" exact="influenza" post="A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness,"/>
   <result pre="of 2017/18 vaccine effectiveness, Canada, January 2018Euro Surveill23201818-00035 61SullivanS.G.ChilverM.B.CarvilleK.S.DengY.M.GrantK.A.HigginsG.Low interim" exact="influenza" post="vaccine effectiveness, Australia, 1 May to 24 September 2017Euro"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6197992\results\search\disease\results.xml">
   <result pre="pmcid: 6197992S2319-4170(18)30382-2 doi: 10.1016/j.bj.2018.08.006 : Special Edition Legacy of the" exact="influenza" post="pandemic 1918: Introduction GordonSiamonsiamon.gordon@mail.cgu.edu.tw∗[], [], ∗Corresponding author. Graduate Institute"/>
   <result pre="and secretory responses to a range of pathogens, including flaviviruses," exact="influenza" post="and HIV.He is interested in the history of immunology,"/>
   <result pre="first group of reviews to mark the centennial of the" exact="influenza" post="pandemic which swept the world in 1918, continuing into"/>
   <result pre="social and economic disruption, reminiscent of previous epidemics of smallpox," exact="plague" post="and cholera. It coincided with the termination of the"/>
   <result pre="of infection, yet its role in the onset of the" exact="influenza" post="pandemic is not entirely clear. The pandemic initiated a"/>
   <result pre="respiratory epithelium which underlie the pathobiology of infection by the" exact="influenza" post="virus; Yu-Nong Gong, Rei-Lin Kuo, Guang-Wu Chen, and Shin-Ru"/>
   <result pre="Shih trace the viral evolution associated with the epidemiology of" exact="influenza" post="outbreaks in Taiwan, and Andrew McMichael outlines milestones in"/>
   <result pre="the initial response to infection and vaccines. Our understanding of" exact="influenza" post="virus–host interactions has catalyzed research into other emerging virus"/>
   <result pre="HIV and Ebola, as well as vaccination strategies for polio," exact="measles" post="and flaviviruses such as yellow fever and dengue. Yet,"/>
   <result pre="as vaccination strategies for polio, measles and flaviviruses such as" exact="yellow fever" post="and dengue. Yet, the development of effective antiviral treatment"/>
   <result pre="by the three corresponding authors. Ling-Pei Ho: Respiratory epithelium during" exact="influenza" post="virus infection The specific role of respiratory epithelium in"/>
   <result pre="specific role of respiratory epithelium in the host defence against" exact="influenza" post="has been less studied compared to the immune system"/>
   <result pre="as the first point in the innate immune machinery against" exact="influenza" post="virus infection. Prof Ho and her team were originally"/>
   <result pre="T cell (NKT) regulated lung immune responses [1]. They used" exact="influenza" post="as a model to understand lung immune responses [2],"/>
   <result pre="found that myeloid cells are key to immunepathology during murine" exact="influenza" post="virus infections [5], [6]. During the recent pandemic, Prof"/>
   <result pre="that again implicated the monocyte-macrophage pathway in lung immunepathology during" exact="influenza" post="infection [7]. Her team also contributed to studies which"/>
   <result pre="3ZhaoY.H.ZhangL.DenneyL.YoungD.PowellT.PengY.C.High levels of virus-specific CD4+ T cells predict severe pandemic" exact="influenza" post="a virus infectionAm J Respir Crit Care Med18620121292129723087026 4HoL.P.DenneyL.LuhnK.TeohD.ClellandC.McMichaelA.J.Activation"/>
   <result pre="the innate immune response and improves the disease course in" exact="influenza" post="A virus infectionEur J Immunol3820081913192218521958 5KokW.L.DenneyL.BenamK.ClellandC.McMichaelA.J.HoL.P.Invariant NKT cells decrease"/>
   <result pre="infectionEur J Immunol3820081913192218521958 5KokW.L.DenneyL.BenamK.ClellandC.McMichaelA.J.HoL.P.Invariant NKT cells decrease immunepathology in lethal" exact="influenza" post="A virus infection by reducing accumulation of inflammatory monocytes"/>
   <result pre="9ZhangY.H.ZhaoY.LiN.PengY.C.GiannoulatouE.JinR.H.IFITM3 rs12252-C is associated with disease severity in acute, pandemic" exact="influenza" post="A H1N1/09 infected Chinese individualsNat Commun42013141823361009 Shin-Ru Shih: Centennial"/>
   <result pre="H1N1/09 infected Chinese individualsNat Commun42013141823361009 Shin-Ru Shih: Centennial review of" exact="influenza" post="in Taiwan Shin-Ru Shih obtained her bachelor degree in"/>
   <result pre="Gung University in 2009 as centre director. Dr. Shih began" exact="influenza" post="virus research from her Ph.D. study under the supervision"/>
   <result pre="of Professor Robert M. Krug [1], [2]. Her papers regarding" exact="influenza" post="virus surveillance have been widely discussed in influenza control"/>
   <result pre="papers regarding influenza virus surveillance have been widely discussed in" exact="influenza" post="control and surveillance [3], [4]. Her team identified several"/>
   <result pre="References References 1ShihS.R.NemeroffM.E.KrugR.M.The choice of alternative 5 splice sites in" exact="influenza" post="virus M1 mRNA is regulated by the viral polymerase"/>
   <result pre="Acad Sci USA921995632463287541537 2ShihS.R.KrugR.M.Novel exploitation of a nuclear function by" exact="influenza" post="virus : the cellular SF2/ASF splicing factor controls the"/>
   <result pre="protein in infected cellsEMBO J151996541554278895585 3ChenG.W.ChangS.C.MokC.K.LoY.L.WangJ.Y.ChiangC.Genomic signatures of human versus" exact="avian influenza" post="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1)"/>
   <result pre="in infected cellsEMBO J151996541554278895585 3ChenG.W.ChangS.C.MokC.K.LoY.L.WangJ.Y.ChiangC.Genomic signatures of human versus avian" exact="influenza" post="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1)"/>
   <result pre="a virusesEmerg Infect Dis1220061353136017073083 4ChenG.W.ShihS.R.Genomic signatures of pandemic (H1N1) 2009" exact="influenza" post="virusEmerg Infect Dis1520091897190319998748 5ChenM.F.WengK.F.HuangS.Y.LiuY.C.TsengS.N.DavidM.Pretreatment with a heat-killed probiotic modulates"/>
   <result pre="probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of" exact="influenza" post="and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of avian influenza"/>
   <result pre="pathogenicity of influenza and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of" exact="avian influenza" post="A virus replication in human cells by host restriction"/>
   <result pre="of influenza and enterovirus 71 infectionsMucosal Immunol10201721522727072606 6KuoS.M.ChenC.J.ChangS.C.LiuT.J.ChenY.S.HuangS.Y.Inhibition of avian" exact="influenza" post="A virus replication in human cells by host restriction"/>
   <result pre="is correlated with autophagyMBio82017e00481-1728611246 Andrew J McMichael: Legacy of the" exact="influenza" post="pandemic 1918: The host T cell response The wealth"/>
   <result pre="T cell response The wealth of knowledge gained on the" exact="influenza" post="virus, stimulated by the 1918 pandemic and subsequent discovery"/>
   <result pre="revealed twelve years later when Townsend et al. showed that" exact="influenza" post="specific T cells recognized peptides bound to class I"/>
   <result pre="References References 1ZinkernagelR.M.DohertyP.C.Restriction of in vitro T cell-mediated cytotoxicity in" exact="lymphocytic choriomeningitis" post="within a syngeneic or semiallogeneic systemNature24819747017024133807 2TownsendA.R.RothbardJ.GotchF.M.BahadurG.WraithD.McMichaelA.J.The epitopes of"/>
   <result pre="choriomeningitis within a syngeneic or semiallogeneic systemNature24819747017024133807 2TownsendA.R.RothbardJ.GotchF.M.BahadurG.WraithD.McMichaelA.J.The epitopes of" exact="influenza" post="nucleoprotein recognized by cytotoxic T lymphocytes can be defined"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6199244\results\search\disease\results.xml">
   <result pre="a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Seasonal H3N2" exact="influenza" post="viruses are recognized as major epidemic viruses, exhibiting complex"/>
   <result pre="we performed a genome-wide analysis of samples collected from 62" exact="influenza" post="A/H3N2-infected patients in Shanghai during 2016–2017. Phylogenetic analysis of"/>
   <result pre="during 2016–2017. Phylogenetic analysis of all eight segments of the" exact="influenza" post="A virus revealed that there were two epidemic influenza"/>
   <result pre="the influenza A virus revealed that there were two epidemic" exact="influenza" post="virus strains circulating in the 2016–2017 winter season (2016–2017win)"/>
   <result pre="in viral adaptation and persistence in subsequent seasons. Introduction Seasonal" exact="influenza" post="is responsible for an average of approximately 1 billion"/>
   <result pre="to 500,000 deaths annually. Increasing evidence has suggested that seasonal" exact="influenza" post="patterns are highly diverse in different zones, especially in"/>
   <result pre="into the following three regions according to the seasonality of" exact="influenza" post="viruses: the northern provinces experience epidemics during winter, the"/>
   <result pre="belongs to the category of provinces at intermediate latitudes, and" exact="influenza" post="A epidemics, particularly seasonal A/H3N2 and A/H1N1 viruses, usually"/>
   <result pre="A/H1N1 viruses, usually appear between autumn and spring, with the" exact="influenza" post="activity peaking after October2,3. Between 2014 and 2016, only"/>
   <result pre="activity peaking after October2,3. Between 2014 and 2016, only sporadic" exact="influenza" post="infections were reported during summer in Shanghai. However, in"/>
   <result pre="September among inpatients at Ruijin Hospital. To further examine the" exact="influenza" post="epidemics during the summer of 2017 in Shanghai, we"/>
   <result pre="of the mutations in the internal gene segments of the" exact="influenza" post="A virus during 2017. The influenza A virus contains"/>
   <result pre="gene segments of the influenza A virus during 2017. The" exact="influenza" post="A virus contains eight gene segments, namely, basic polymerase"/>
   <result pre="was to compare the complete genome sequences of two sequential" exact="influenza" post="epidemic viruses and to investigate whether the genetic differences"/>
   <result pre="confer temperature sensitivity and attenuate the polymerase activity of the" exact="influenza" post="virus, changing the seasonality and adaptation of the virus."/>
   <result pre="virus. Results Clinical characterization of patients infected with the H3N2" exact="influenza" post="virus during 2016–2017 Sixty-two patients were diagnosed with a"/>
   <result pre="virus during 2016–2017 Sixty-two patients were diagnosed with a H3N2" exact="influenza" post="virus infection from Nov. 2016 to Sep. 2017: 28"/>
   <result pre="were observed in all patients who were subsequently diagnosed with" exact="influenza" post="A by real-time RT-PCR. No significant differences were observed"/>
   <result pre="1 Demographic characteristics and clinical features of 62 inpatients with" exact="influenza" post="infection from 2016–2017 Characteristics Inpatients during Nov. 2016– Mar."/>
   <result pre="mutations in several segments The gene sequences of all eight" exact="influenza" post="virus gene segments were analyzed. Genetic analysis of the"/>
   <result pre="subunit. Compared with the WHO-recommended vaccine strains for the 2016–2018" exact="influenza" post="seasons (A/Hong Kong/4801/ 2014), the 2017sum and 2016–2017win virus"/>
   <result pre="using a minireplicon assay. The pPolI-NP-luciferase plasmid produces a modified" exact="influenza" post="virus NP viral RNA in which the NP-coding sequences"/>
   <result pre="lead to reduced polymerase activity at high temperatures. Discussion Seasonal" exact="influenza" post="epidemics are known to result in substantial morbidity and"/>
   <result pre="in regions with temperate climates, and the mechanism of seasonal" exact="influenza" post="activity and transmission has not been elucidated. Influenza seasons"/>
   <result pre="been elucidated. Influenza seasons are determined by climate regions. Worldwide," exact="influenza" post="epidemics always follow low seasonal temperatures, suggesting that low"/>
   <result pre="host susceptibility14,15. Moreover, humidity may be a critical driver of" exact="influenza" post="outbreaks. Absolute humidity has a regulatory effect on airborne"/>
   <result pre="influenza outbreaks. Absolute humidity has a regulatory effect on airborne" exact="influenza" post="transmission, and this effect can be modulated by temperature16."/>
   <result pre="Generally, the northern and southern regions in China experience different" exact="influenza" post="seasonality and evolutionary dynamics. Usually, the northern region experiences"/>
   <result pre="seasonality and evolutionary dynamics. Usually, the northern region experiences an" exact="influenza" post="season during the winter months (with a median peak"/>
   <result pre="ranging from Dec. to Jan.), while the southern region experiences" exact="influenza" post="during the summer months (with a median peak from"/>
   <result pre="subtropical climate but is located in the intermediate-latitude region, the" exact="influenza" post="seasonality in Shanghai is atypical3,17. Between 2006 and 2016,"/>
   <result pre="and 2016, the annual seasonality in Shanghai was irregular. Two" exact="influenza" post="peaks were observed in 2008 and 2010, and only"/>
   <result pre="during the other years. However, in 2017, the following two" exact="influenza" post="epidemics occurred in Shanghai: one epidemic between Nov. 2016"/>
   <result pre="2017 and Sep. 2017. These epidemics were consistent with the" exact="influenza" post="epidemics observed in Hong Kong and Guangdong in 2017."/>
   <result pre="epidemics observed in Hong Kong and Guangdong in 2017. Although" exact="influenza" post="epidemics occur frequently during summer in the southern region,"/>
   <result pre="during summer in the southern region, the mechanism underlying summer" exact="influenza" post="epidemics has not been elucidated18. In this study, we"/>
   <result pre="2017 in an attempt to investigate the evolution of the" exact="influenza" post="virus during 2017 in Shanghai and the effects of"/>
   <result pre="segments of the 2017sum virus strains were already present in" exact="influenza" post="viruses circulating in 2016. This tendency was consistent with"/>
   <result pre="was consistent with the phylogenetic analysis of other segments. The" exact="influenza" post="virus polymerase consists of three subunits, encoded by the"/>
   <result pre="To further investigate the effects of these mutations on the" exact="influenza" post="polymerase in the 2016–2017win and 2017sum virus strains, we"/>
   <result pre="the polymerase complex in determining the temperature range over which" exact="influenza" post="viruses can replicate5. Bradel Tretheway et al.21 showed that"/>
   <result pre="the 2016–2017win viruses was conferred by a mutation in the" exact="influenza" post="polymerase PA subunit. Introducing a single substitution at residue"/>
   <result pre="the PKR-binding site of the NS1 protein (position 123–127)26. The" exact="influenza" post="virus NS1 protein plays a key role in blocking"/>
   <result pre="a key role in blocking the activation of PKR during" exact="influenza" post="infection and interacts with the viral polymerase to mediate"/>
   <result pre="result in the deregulation of vRNA synthesis, resulting in attenuated" exact="influenza" post="virus replication27. There has been no report regarding mutations"/>
   <result pre="of vRNA at the early infection stage. In summary, the" exact="influenza" post="A (H3N2) virus strains circulating in the 2016–2017 winter"/>
   <result pre="may be the result of the natural evolution of the" exact="influenza" post="virus and could explain the second epidemic that occurred"/>
   <result pre="Shanghai. These data further enhance our understanding of the summer" exact="influenza" post="epidemic in Shanghai and subtropical Asia and thus provide"/>
   <result pre="insights for the prediction of the next epidemic strain of" exact="influenza" post="A (H3N2). Our research provides information on the temperature-sensitive"/>
   <result pre="temperature-sensitive signature and further insight into the function of the" exact="influenza" post="A polymerase. Future studies investigating the functional properties of"/>
   <result pre="should be performed to fully understand the evolution of the" exact="influenza" post="virus and pave the way for the prevention of"/>
   <result pre="and pave the way for the prevention of new severe" exact="influenza" post="pandemics. Materials and methods Ethics statement The Research Laboratory"/>
   <result pre="Hospital. Nasopharyngeal specimens from the 2016–2017 winter and 2017 summer" exact="influenza" post="outbreaks were collected from influenza-infected inpatients before the administration"/>
   <result pre="Research Database under GenBank accession numbers MG984093 to MG984541. The" exact="influenza" post="A viruses were isolated from MDCK cells as previously"/>
   <result pre="than 99.9% identity in all eight segments. We used an" exact="influenza" post="A (H3N2) viral strain isolated in 2014 as our"/>
   <result pre="Contaminant DNA was eliminated using DNase. Amplification of all eight" exact="influenza" post="genome segments (PB2, PB1, PA, HA, NP, NA, M,"/>
   <result pre="The amino acids in epitopes A to E of the" exact="influenza" post="A (H3N2) HA protein referenced in this study have"/>
   <result pre="of an additional 18 to 20 nucleotides unrelated to the" exact="influenza" post="virus were added to distinguish the three types of"/>
   <result pre="influenza virus were added to distinguish the three types of" exact="influenza" post="RNAs (vRNA, cRNA, and mRNA). The resulting cDNA was"/>
   <result pre="of interest. References References 1.BedfordTet al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 2.SahaSChadhaMShuYDivergent seasonal patterns of"/>
   <result pre="influenza viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 2.SahaSChadhaMShuYDivergent seasonal patterns of" exact="influenza" post="types A and B across latitude gradient in Tropical"/>
   <result pre="in Tropical AsiaInfluenza Other Respir. Virus.20161017618410.1111/irv.12372 3.YuHet al.Characterization of regional" exact="influenza" post="seasonality patterns in China and implications for vaccination strategies:"/>
   <result pre="5.JinHet al.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
   <result pre="from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793 6.ChanWZhouHKembleGJinHThe cold adapted and temperature sensitive" exact="influenza" post="A/Ann Arbor/6/60 virus, the master donor virus for live"/>
   <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
   <result pre="7.JinHZhouHLuBKembleGImparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34" exact="influenza" post="virus by transferring the genetic signature for temperature sensitivity"/>
   <result pre="sensitivity from cold-adapted A/Ann Arbor/6/60J. Virol.20047899599810.1128/JVI.78.2.995-998.200414694130 8.NotonSLet al.Studies of an" exact="influenza" post="A virus temperature-sensitive mutant identify a late role for"/>
   <result pre="NP in the formation of infectious virionsJ. Virol.20098356257110.1128/JVI.01424-0818987140 9.FengLet al.Seasonal" exact="influenza" post="vaccine supply and target vaccinated population in China, 2004-2009Vaccine2010286778678210.1016/j.vaccine.2010.07.06420688038"/>
   <result pre="supply and target vaccinated population in China, 2004-2009Vaccine2010286778678210.1016/j.vaccine.2010.07.06420688038 10.ZhouLet al.Seasonal" exact="influenza" post="vaccination coverage rate of target groups in selected cities"/>
   <result pre="in China by season (2009/10 to 2011/12)PLoS ONE20138e7372410.1371/journal.pone.007372424040041 11.CarrSet al.Oseltamivir-resistant" exact="influenza" post="A and B viruses pre- and postantiviral therapy in"/>
   <result pre="young adults with cancerPediatr. Infect. Dis. J.20113028428810.1097/INF.0b013e3181ff863b21048522 12.MoncorgeOet al.Investigation of" exact="influenza" post="virus polymerase activity in pig cellsJ. Virol.20138738439410.1128/JVI.01633-1223077313 13.ReganJFLiangYParslowTGDefective assembly"/>
   <result pre="virus polymerase activity in pig cellsJ. Virol.20138738439410.1128/JVI.01633-1223077313 13.ReganJFLiangYParslowTGDefective assembly of" exact="influenza" post="A virus due to a mutation in the polymerase"/>
   <result pre="PAJ. Virol.20068025226110.1128/JVI.80.1.252-261.200616352550 14.Azziz BaumgartnerEet al.Seasonality, timing, and climate drivers of" exact="influenza" post="activity worldwideJ. Infect. Dis.201220683884610.1093/infdis/jis46722829641 15.YaariRKatrielGHuppertAAxelsenJBStoneLModelling seasonal influenza: the role"/>
   <result pre="AsiaBull. World Health Organ20149231833010.2471/BLT.13.12441224839321 18.ParkAWGlassKDynamic patterns of avian and human" exact="influenza" post="in east and southeast AsiaLancet Infect. Dis.2007754354810.1016/S1473-3099(07)70186-X17646027 19.HayashiTWillsSBusseyKATakimotoTIdentification of"/>
   <result pre="influenza in east and southeast AsiaLancet Infect. Dis.2007754354810.1016/S1473-3099(07)70186-X17646027 19.HayashiTWillsSBusseyKATakimotoTIdentification of" exact="influenza" post="A virus PB2 residues involved in enhanced polymerase activity"/>
   <result pre="low temperaturesJ. Virol.2015898042804910.1128/JVI.00901-1526018156 20.WangLet al.FunctionalJ. Virol.2015902938294710.1128/JVI.02400-1526719244 21.Bradel-TrethewayBGet al.The human H5N1" exact="influenza" post="A virus polymerase complex is active in vitro over"/>
   <result pre="coat protein of phage P22Genetics19941364274388150274 23.KawaguchiANagataKDe novo replication of the" exact="influenza" post="virus RNA genome is regulated by DNA replicative helicase,"/>
   <result pre="24.ObayashiEet al.The structural basis for an essential subunit interaction in" exact="influenza" post="virus RNA polymeraseNature20084541127113110.1038/nature0722518660801 25.GhanemAet al.Peptide-mediated interference with influenza A"/>
   <result pre="interaction in influenza virus RNA polymeraseNature20084541127113110.1038/nature0722518660801 25.GhanemAet al.Peptide-mediated interference with" exact="influenza" post="A virus polymeraseJ. Virol.2007817801780410.1128/JVI.00724-0717494067 26.minJYLiSSenGCKrugRMA site on the influenza"/>
   <result pre="with influenza A virus polymeraseJ. Virol.2007817801780410.1128/JVI.00724-0717494067 26.minJYLiSSenGCKrugRMA site on the" exact="influenza" post="A virus NS1 protein mediates both inhibition of PKR"/>
   <result pre="RNA synthesisVirology200736323624310.1016/j.virol.2007.01.03817320139 27.LiFet al.Robust expression of vault RNAs induced by" exact="influenza" post="A virus plays a critical role in suppression of"/>
   <result pre="induced by influenza A virus plays a critical role in" exact="suppression" post="of PKR-mediated innate immunityNucleic Acids Res.201543103211033726490959 28.BalishALKatzJMKlimovAIInfluenza: propagation, quantification,"/>
   <result pre="of Gymnophthalmid lizardsSyst. Biol.20045344846910.1080/1063515049044579715503673 31.Da CostaBet al.Temperature-sensitive mutants in the" exact="influenza" post="A virus RNA polymerase: alterations in the PA linker"/>
   <result pre="protein expressionJ. Virol. Methods200512819219710.1016/j.jviromet.2005.05.00515955576 33.KawakamiEet al.Strand-specific real-time RT-PCR for distinguishing" exact="influenza" post="vRNA, cRNA, and mRNAJ. Virol. Methods20111731610.1016/j.jviromet.2010.12.01421185869 34.WangSet al.Transport of"/>
   <result pre="influenza vRNA, cRNA, and mRNAJ. Virol. Methods20111731610.1016/j.jviromet.2010.12.01421185869 34.WangSet al.Transport of" exact="influenza" post="virus neuraminidase (NA) to host cell surface is regulated"/>
   <result pre="proteinsJ. Biol. Chem.20122879804981610.1074/jbc.M111.31295922318733 35.AlymovaIVet al.Immunopathogenic and antibacterial effects of H3N2" exact="influenza" post="A virus PB1-F2 map to amino acid residues 62,"/>
   <result pre="79, and 82J. Virol.201185123241233310.1128/JVI.05872-1121937639 36.GambaryanASet al.Receptor-binding profiles of H7 subtype" exact="influenza" post="viruses in different host speciesJ. Virol.2012864370437910.1128/JVI.06959-1122345462"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6200010\results\search\disease\results.xml">
   <result pre="2014 (4), and the reported dissemination of dengue (9) and" exact="chikungunya" post="(10) viruses from French Caribbean territories into French Polynesia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6205565\results\search\disease\results.xml">
   <result pre="and Tropheryma whipplei; others are known, historical diseases such as" exact="plague" post="and cholera. In addition are diseases related to previously"/>
   <result pre="as a priority. Keywords Africa cholera emerging infectious diseases fever" exact="plague" post="At the beginning of the 21st century, infectious diseases"/>
   <result pre="It was also considered as a rare cause of rickettsial" exact="spotted fever" post="transmitted by fleas. Only about 70 described human cases"/>
   <result pre="R. felis DNA in blood samples of febrile individuals without" exact="malaria" post="(Table 1) [8], [9]. A more consistent study, involving"/>
   <result pre="of R. felis in blood samples of febrile individuals without" exact="malaria" post="in Senegal (9/204) and Kenya (6/163) •2013: Confirmation of"/>
   <result pre="about 6.4% (13/204) in blood samples of febrile individuals without" exact="malaria" post="in Senegal; (b) Main detected cause of fever in"/>
   <result pre="of R. felis and T. whipplei support the notion that" exact="malaria" post="in people with undifferentiated fever has long been overdiagnosed."/>
   <result pre="epidemics (Table 1) [27]. Among recent examples, an epidemic of" exact="bubonic plague" post="emerged in Oran (Algeria) in June 2003 [28]. The"/>
   <result pre="(Table 1) [27]. Among recent examples, an epidemic of bubonic" exact="plague" post="emerged in Oran (Algeria) in June 2003 [28]. The"/>
   <result pre="(Algeria) in June 2003 [28]. The last human cases of" exact="plague" post="had occurred in this city in 1946 and in"/>
   <result pre="have died [29]. Overall, the fact that there was a" exact="plague" post="outbreak in Madagascar is not astonishing. Indeed, there is"/>
   <result pre="capital [29]. It is not just bad luck that this" exact="plague" post="outbreak emerged in a country with an extremely fragile"/>
   <result pre="deaths from 2008 to 2009 [32], [33]. Although mortality from" exact="measles" post="has declined in sub-Saharan Africa, it remains a major"/>
   <result pre="is another factor that can explain the failure to eradicate" exact="yellow fever" post="in Africa (Fig. 1) [37]. Since 2000, numerous outbreaks"/>
   <result pre="in Africa (Fig. 1) [37]. Since 2000, numerous outbreaks of" exact="yellow fever" post="have been observed in West Africa, the Horn of"/>
   <result pre="a real increase in disease [36]. A large epidemic of" exact="yellow fever" post="was reported in Angola and the DRC from 2015"/>
   <result pre="suspected cases and 42 laboratory-confirmed cases, with death of confirmed" exact="monkeypox" post="patient with history of immunosuppression Reduce risk of wildlife-to-human"/>
   <result pre="caused by Orthopoxvirus, a virus very close to that causing" exact="smallpox" post="in humans. This virus is endemic to central and"/>
   <result pre="several cases of human-to-human transmission occurred [40]. Since 2000, human" exact="monkeypox" post="cases have been reported in the Central African Republic,"/>
   <result pre="outbreak around 40 years after the last confirmed cases of" exact="monkeypox" post="[43]. Ebola fever due to Ebola virus (Filoviridae) has"/>
   <result pre="mosquitoes [50], [51]. The virus is associated with fever with" exact="rash" post="and arthralgias [52]. Severe joint pains can persist for"/>
   <result pre="2011, an epidemic hit the DRC [50]. The circulation of" exact="chikungunya" post="was also reported in Senegal in the area of"/>
   <result pre="circulating enterovirus strains. These strains derived from oral vaccination rendering" exact="poliomyelitis" post="eradication strategies more complex [53]. Tick-borne relapsing fever, although"/>
   <result pre="oral vaccination rendering poliomyelitis eradication strategies more complex [53]. Tick-borne" exact="relapsing fever," post="although it always existed in Western and Eastern Africa,"/>
   <result pre="the growing availability of diagnostic methods in rural Africa. Indeed," exact="relapsing fever" post="may be the second leading cause, after malaria, of"/>
   <result pre="countries such as Senegal [54]. In conclusion, increasing efforts targeting" exact="infectious disease" post="studies in Africa have identified new infectious agents. It"/>
   <result pre="It is evident that Africa is characterized by the greatest" exact="infectious disease" post="burden as well as by the weakest public health"/>
   <result pre="of epidemic fever, Senegal, 2010–2012Emerg Infect Dis2220161229133427314980 27GracioA.J.D.S.GracioM.A.A.Plague: a millenary" exact="infectious disease" post="reemerging in the 21st centuryBiomed Res Int201720175696542 28BitamI.BazizB.RolainJ.M.BelkaidM.RaoultD.Zoonotic focus"/>
   <result pre="Infect Dis1220061975197717326957 29BondsM.H.OuenzarM.A.GarchitorenaA.CordierL.F.McCartyM.G.RichM.L.Madagascar can build stronger health systems to fight" exact="plague" post="and prevent the next epidemicPLoS Negl Trop Dis122018e0006131 30LesslerJ.MooreS.M.LuqueroF.J.McKayH.S.GraisR.HenkensM.Mapping"/>
   <result pre="34MauriceJ.Measles outbreak in DR Congo an ‘epidemic emergency’Lancet386201594326369457 35AshbaughH.R.HoffN.A.DoshiR.H.AlfonsoV.H.GadothA.MukadiP.Predictors of" exact="measles" post="vaccination coverage among children 6–59 months of age in"/>
   <result pre="37MarkoffL.Yellow fever outbreak in SudanN Engl J Med368201368969123387798 38KraemerM.U.G.FariaN.R.ReinerR.C.Jr.GoldingN.NikolayB.StasseS.Spread of" exact="yellow fever" post="virus outbreak in Angola and the Democratic Republic of"/>
   <result pre="poxvirus: emergence of monkeypoxMed Sante Trop272017293928406414 40LearnedL.A.ReynoldsM.G.WassaD.W.LiY.OlsonV.A.KaremK.Extended interhuman transmission of" exact="monkeypox" post="in a hospital community in the Republic of the"/>
   <result pre="central Africa, 1970–2017MMWR Morb Mortal Wkly Rep67201830631029543790 42KalthanE.Dondo-FongbiaJ.P.YambeleS.Dieu-CreerL.R.ZepioR.PamatikaC.M.Twelve cases of" exact="monkeypox" post="virus outbreak in Bangassou District (Central African Republic) in"/>
   <result pre="Republic) in December 2015Bull Soc Pathol Exot109201635836327783372 43Yinka-OgunleyeA.ArunaO.OgoinaD.AworabhiN.EtengW.BadaruS.Reemergence of human" exact="monkeypox" post="in Nigeria, 2017Emerg Infect Dis2420181149115129619921 44RouquetP.FromentJ.M.BermejoM.KilbournA.KareshW.ReedP.Wild animal mortality monitoring"/>
   <result pre="in pandemic Zika virusMem Inst Oswaldo Cruz1132018e170385 50WahidB.AliA.RafiqueS.IdreesM.Global expansion of" exact="chikungunya" post="virus: mapping the 64-year historyInt J Infect Dis582017697628288924 51ZellerH.VanB.W.SudreB.Chikungunya:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6213772\results\search\disease\results.xml">
   <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Live attenuated" exact="influenza" post="vaccines (LAIV) have prevented morbidity and mortality associated with"/>
   <result pre="influenza vaccines (LAIV) have prevented morbidity and mortality associated with" exact="influenza" post="viral infections for many years and represent the best"/>
   <result pre="years and represent the best therapeutic option to protect against" exact="influenza" post="viral infections in humans. However, the development of LAIV"/>
   <result pre="to be a highly appropriate option for the treatment of" exact="influenza" post="viral infections. For that, the viral RNA synthesis machinery"/>
   <result pre="In this review, we discuss the potential to manipulate the" exact="influenza" post="viral RNA-dependent RNA polymerase (RdRp) complex to generate attenuated"/>
   <result pre="that can be used as LAIV for the treatment of" exact="influenza" post="viral infections, one of the current and most effective"/>
   <result pre="current and most effective prophylactic options for the control of" exact="influenza" post="in humans. influenza virus influenza vaccine live-attenuated influenza virus"/>
   <result pre="effective prophylactic options for the control of influenza in humans." exact="influenza" post="virus influenza vaccine live-attenuated influenza virus recombinant influenza virus"/>
   <result pre="options for the control of influenza in humans. influenza virus" exact="influenza" post="vaccine live-attenuated influenza virus recombinant influenza virus viral polymerase"/>
   <result pre="control of influenza in humans. influenza virus influenza vaccine live-attenuated" exact="influenza" post="virus recombinant influenza virus viral polymerase complex nucleoprotein temperature-sensitive"/>
   <result pre="in humans. influenza virus influenza vaccine live-attenuated influenza virus recombinant" exact="influenza" post="virus viral polymerase complex nucleoprotein temperature-sensitive cold-adapted attenuated 1."/>
   <result pre="are the causative agents of influenza. There are four recognized" exact="influenza" post="types denoted as A, B, C, and the recently"/>
   <result pre="in the absence of pre-existing immunity in humans. In contrast," exact="influenza" post="B viruses (IBV) are mainly restricted and adapted to"/>
   <result pre="thought to cause epidemics or pandemics [12,13]. The newly identified" exact="influenza" post="D viruses (IDV) primarily affect cattle and pigs and,"/>
   <result pre="infections represent a serious public health problem that cause contagious" exact="respiratory disease" post="and substantial morbidity and mortality in humans, resulting in"/>
   <result pre="introduced into the human population [23]. For instance, the first" exact="influenza" post="pandemic of the 21st century was declared in 2009"/>
   <result pre="These two lineages diverged in the 1980s from the ancestral" exact="influenza" post="B/Lee/40. Although perceived as less dangerous than IAV, IBV"/>
   <result pre="IAV to modify their genome and their rapid transmission, seasonal" exact="influenza" post="vaccines need to be reformulated annually to ensure that"/>
   <result pre="important human virus are highly desirable [34,35]. Despite countermeasures against" exact="influenza" post="that prevent (vaccines) or treat (antivirals) viral infections, this"/>
   <result pre="data from the World Health Organization (WHO) estimate that seasonal" exact="influenza" post="virus infections are responsible of about 3–5 million cases"/>
   <result pre="deaths worldwide yearly [36] (http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)). Current available options to counter" exact="influenza" post="infections include both vaccines and antivirals. Vaccines are the"/>
   <result pre="immunity, and they are the primary prophylactic means to prevent" exact="influenza" post="viral infections [35,37,38]. The first vaccine option is the"/>
   <result pre="infections [35,37,38]. The first vaccine option is the chemically inactivated" exact="influenza" post="vaccine (IIV), which requires a large quantity of virus"/>
   <result pre="does not match the predicted circulating strains. Most recently, an" exact="influenza" post="vaccine made of purified recombinant HA antigens (https://www.cdc.gov/flu/protect/vaccine/qa_flublok-vaccine.htm) has"/>
   <result pre="to IIV. The remaining prophylactic option is the live attenuated" exact="influenza" post="vaccine (LAIV), which is associated with broader responses and"/>
   <result pre="responses. In addition, its administration mimics the usual route of" exact="influenza" post="virus infection that has been shown to provide more"/>
   <result pre="shown to provide more efficient cross-reactive cellular-mediated protection against heterologous" exact="influenza" post="viruses, important in cases where the vaccine and circulating"/>
   <result pre="in healthy children and non-pregnant adults. Independent of type, seasonal" exact="influenza" post="vaccines typically contain antigens from the two IAV subtypes"/>
   <result pre="circulating in humans [43,44]. Worryingly, over the past decade, seasonal" exact="influenza" post="vaccines have shown a low protection efficacy rate [34,38,45]."/>
   <result pre="[34,38,45]. In order to improve the effectiveness of current seasonal" exact="influenza" post="vaccines, a quadrivalent influenza vaccine formulation, including both IBV"/>
   <result pre="improve the effectiveness of current seasonal influenza vaccines, a quadrivalent" exact="influenza" post="vaccine formulation, including both IBV lineage components (Victoria- and"/>
   <result pre="2017–18 in the US [48,49]. However, for the current 2018–19" exact="influenza" post="season, LAIV will be included again among the eligible"/>
   <result pre="be included again among the eligible prophylactic options to prevent" exact="influenza" post="infections (https://www.aafp.org/news/health-of-the-public/20180226acipmtg-laiv.html). The variability in influenza vaccine efficiency is"/>
   <result pre="prophylactic options to prevent influenza infections (https://www.aafp.org/news/health-of-the-public/20180226acipmtg-laiv.html). The variability in" exact="influenza" post="vaccine efficiency is leading to an increasing concern on"/>
   <result pre="is leading to an increasing concern on how to combat" exact="influenza" post="virus infection and protect population from seasonal infections. Consequently,"/>
   <result pre="are necessary to prevent the morbidity and mortality associated with" exact="influenza" post="virus infections, as are studies aimed to better understand"/>
   <result pre="associated with the current LAIV. Public health concerns associated with" exact="influenza" post="viral infections in humans are intensified by the limited"/>
   <result pre="options to combat viral infections and prevent the rapid-spreading of" exact="influenza" post="viruses [50]. Up to now, only a few therapeutic"/>
   <result pre="Up to now, only a few therapeutic choices to control" exact="influenza" post="infections are licensed and they are limited to two"/>
   <result pre="2. IAV Genome Organization, Virion Structure, and Life Cycle Although" exact="influenza" post="viruses shar similar structural characteristics and comparable replication and"/>
   <result pre="complex at one end that pseudo-circularizes the vRNA [62,63,64]. Although" exact="influenza" post="vRNAs are single-stranded, the last nucleotides at their 5′"/>
   <result pre="could be implemented as potential LAIV for the treatment of" exact="influenza" post="viral infections. Likewise, information obtained from the viral polymerase"/>
   <result pre="targeting specific polymerase functions and/or components for the treatment of" exact="influenza" post="viral infections [78,83,84]. The replicase complex core of IAV"/>
   <result pre="in two phases (Figure 1C). In a first phase, the" exact="influenza" post="viral polymerase complex catalyzes the transcription of vRNA into"/>
   <result pre="viral polymerase will be decisive to understand the machinery of" exact="influenza" post="RNA synthesis. The three subunits of the polymerase complex"/>
   <result pre="their cellular localization and protein–protein interactions. 3.1. PB1 Subunit The" exact="influenza" post="PB1 component contains the RdRp catalytic site and is"/>
   <result pre="for the generation and identification of novel antivirals to treat" exact="influenza" post="infections [62,91]. 3.2. PB2 Subunit The main role of"/>
   <result pre="which is the site of the most significant sequelae of" exact="influenza" post="infection [28,36]. Current seasonal LAIV can be generated either"/>
   <result pre="or canine (A/canine/NY/dog23/09 H3N8) [118,127] and equine (A/equine/Ohio/03 H3N8) [140]" exact="influenza" post="viruses, a similar ts and att phenotype was observed"/>
   <result pre="and/or development. However, it is important emphasize that high resolution" exact="influenza" post="polymerase structure will have significant implications to understand the"/>
   <result pre="[151]. Similarly, Noton et al. described the characterization of an" exact="avian influenza" post="virus (A/chicken/Rostock/34 H7N1) ts NP mutant (M239L) (Table 1)"/>
   <result pre="Similarly, Noton et al. described the characterization of an avian" exact="influenza" post="virus (A/chicken/Rostock/34 H7N1) ts NP mutant (M239L) (Table 1)"/>
   <result pre="variants, distinct from the selected vaccine strain, during a given" exact="influenza" post="season can result in significant loss of vaccine effectiveness."/>
   <result pre="Centers of Excellence for Influenza Research and Surveillance CIV Canine" exact="influenza" post="virus(es) CKTC Chicken kidney tissue culture cRNA Complementary RNA"/>
   <result pre="cRNA Complementary RNA eIF4E Eukaryotic initiation factor 4E EIV Equine" exact="influenza" post="virus(es) FDA Food and Drug Administration HA Hemagglutinin HPAIV"/>
   <result pre="FDA Food and Drug Administration HA Hemagglutinin HPAIV Highly pathogenic" exact="avian influenza" post="virus(es) IAV Influenza A virus(es) IBV Influenza B virus(es)"/>
   <result pre="Food and Drug Administration HA Hemagglutinin HPAIV Highly pathogenic avian" exact="influenza" post="virus(es) IAV Influenza A virus(es) IBV Influenza B virus(es)"/>
   <result pre="C virus(es) IDV Influenza D virus(es) IFN Interferon IIV Inactivated" exact="influenza" post="vaccine(s) kDa Kilodalton LAIV Live attenuated influenza vaccine(s) LAV"/>
   <result pre="Interferon IIV Inactivated influenza vaccine(s) kDa Kilodalton LAIV Live attenuated" exact="influenza" post="vaccine(s) LAV Live attenuated vaccine(s) Len/17 A/Leningrad/134/17/57 H2N2 LAIV"/>
   <result pre="protein 2 PFU Plaque forming units pH1N1 Pandemic A/California/04/09 H1N1" exact="influenza" post="virus PR8 A/Puerto Rico/8/34 H1N1 influenza virus RBD Receptor"/>
   <result pre="pH1N1 Pandemic A/California/04/09 H1N1 influenza virus PR8 A/Puerto Rico/8/34 H1N1" exact="influenza" post="virus RBD Receptor binding domain RdRp Viral RNA-dependent RNA"/>
   <result pre="Soviet Socialist Republics WHO World Health Organization WSN A/WSN/33 H1N1" exact="influenza" post="virus WT Wild-type X31 Reassortant influenza virus containing the"/>
   <result pre="Organization WSN A/WSN/33 H1N1 influenza virus WT Wild-type X31 Reassortant" exact="influenza" post="virus containing the HA and NA genes of A/Hong"/>
   <result pre="NA genes of A/Hong Kong/1/68 H3N2 in the background of" exact="influenza" post="PR8 virus References References 1.ChiapponiC.FacciniS.De MattiaA.BaioniL.BarbieriI.RosignoliC.NigrelliA.FoniE.Detection of influenza D"/>
   <result pre="background of influenza PR8 virus References References 1.ChiapponiC.FacciniS.De MattiaA.BaioniL.BarbieriI.RosignoliC.NigrelliA.FoniE.Detection of" exact="influenza" post="D virus among swine and cattle, ItalyEmerg. Infect. Dis.20162235235410.3201/eid2202.15143926812282"/>
   <result pre="understanding of an emerging viral infection in swineSci. Rep.201771166010.1038/s41598-017-12012-328916759 3.SuS.FuX.LiG.KerlinF.VeitM.Novel" exact="influenza" post="D virus: Epidemiology, pathology, evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 4.BakerS.F.NogalesA.FinchC.TuffyK.M.DommW.PerezD.R.TophamD.J.Martinez-SobridoL.Influenza"/>
   <result pre="reservoirs and intermediate hosts: Dogs, horses, and new possibilities for" exact="influenza" post="virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 7.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern of the"/>
   <result pre="formationCell Host Microbe2010744045110.1016/j.chom.2010.05.00920542248 11.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 12.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of" exact="influenza" post="c virus but not influenza D virus in scottish"/>
   <result pre="virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 12.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of influenza c virus but not" exact="influenza" post="D virus in scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 13.HengrungN.El"/>
   <result pre="OmariK.SeRNA MartinI.VreedeF.T.CusackS.RamboR.P.VonrheinC.BricogneG.StuartD.I.GrimesJ.M.et al.Crystal structure of the RNA-dependent RNA polymerase from" exact="influenza" post="c virusNature201552711411710.1038/nature1552526503046 14.SalemE.CookE.A.J.LbachaH.A.OlivaJ.AwoumeF.AploganG.L.HymannE.C.MuloiD.DeemS.L.AlaliS.et al.Serologic evidence for influenza c and"/>
   <result pre="RNA polymerase from influenza c virusNature201552711411710.1038/nature1552526503046 14.SalemE.CookE.A.J.LbachaH.A.OlivaJ.AwoumeF.AploganG.L.HymannE.C.MuloiD.DeemS.L.AlaliS.et al.Serologic evidence for" exact="influenza" post="c and d virus among ruminants and camelids, Africa,"/>
   <result pre="camelids, Africa, 1991–2015Emerg. Infect. Dis.2017231556155910.3201/eid2309.17034228820371 15.MolinariN.A.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the us: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 16.BarrI.G.McCauleyJ.CoxN.DanielsR.EngelhardtO.G.FukudaK.GrohmannG.HayA.KelsoA.KlimovA.et"/>
   <result pre="and genetic characteristics of seasonal Influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: Basis for the who recommendation on the composition"/>
   <result pre="viruses: Basis for the who recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 northern hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635"/>
   <result pre="the 2009–2010 northern hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635 17.GrohskopfL.A.SokolowL.Z.BroderK.R.OlsenS.J.KarronR.A.JerniganD.B.BreseeJ.S.Prevention and control of seasonal" exact="influenza" post="with vaccinesMMWR Recomm. Rep.20166515410.15585/mmwr.rr6505a127560619 18.PaleseP.S.Orthomyxoviridae: The viruses and their"/>
   <result pre="and WilkinsLondon, UK200716471689 19.Byrd-LeotisL.CummingsR.D.SteinhauerD.A.The interplay between the host receptor and" exact="influenza" post="virus hemagglutinin and neuraminidaseInt. J. Mol. Sci.201718154110.3390/ijms180728714909 20.GaymardA.Le BriandN.FrobertE.LinaB.EscuretV.Functional"/>
   <result pre="Mol. Sci.201718154110.3390/ijms180728714909 20.GaymardA.Le BriandN.FrobertE.LinaB.EscuretV.Functional balance between neuraminidase and haemagglutinin in" exact="influenza" post="virusesClin. Microbiol. Infect.20162297598310.1016/j.cmi.2016.07.00727424943 21.ChenR.HolmesE.C.The evolutionary dynamics of human Influenza"/>
   <result pre="Evol.20086665566310.1007/s00239-008-9119-z18504518 22.GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.SessionsW.M.XuX.SkepnerE.DeydeV.et al.Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humansScience200932519720110.1126/science.117622519465683 23.SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.MaS.K.CheungC.L.RaghwaniJ.BhattS.et al.Origins and evolutionary genomics"/>
   <result pre="virus circulated between 1979 and 2003J. Virol.200478128171282810.1128/JVI.78.23.12817-12828.200415542634 26.HiteL.K.GlezenW.P.DemmlerG.J.MunozF.M.Medically attended pediatric" exact="influenza" post="during the resurgence of the victoria lineage of Influenza"/>
   <result pre="interference between Influenza A and B virusesArch. Virol.19827328729410.1007/BF013180827149996 30.MontoA.S.OhmitS.E.MarguliesJ.R.TalsmaA.Medical practice-based" exact="influenza" post="surveillance: Viral prevalence and assessment of morbidityAm. J. Epidemiol.199514150250610.1093/oxfordjournals.aje.a1174647900716"/>
   <result pre="treatment of Influenza A (H5N1) infectionN. Engl. J. Med.20053532667267210.1056/NEJMoa05451216371632 32.HurtA.C.HolienJ.K.ParkerM.KelsoA.BarrI.G.Zanamivir-resistant" exact="influenza" post="viruses with a novel neuraminidase mutationJ. Virol.200983103661037310.1128/JVI.01200-0919641000 33.MontoA.S.McKimm-BreschkinJ.L.MackenC.HampsonA.W.HayA.KlimovA.TashiroM.WebsterR.G.AymardM.HaydenF.G.et al.Detection"/>
   <result pre="viruses with a novel neuraminidase mutationJ. Virol.200983103661037310.1128/JVI.01200-0919641000 33.MontoA.S.McKimm-BreschkinJ.L.MackenC.HampsonA.W.HayA.KlimovA.TashiroM.WebsterR.G.AymardM.HaydenF.G.et al.Detection of" exact="influenza" post="viruses resistant to neuraminidase inhibitors in global surveillance during"/>
   <result pre="years of their useAntimicrob. Agents Chemother.2006502395240210.1128/AAC.01339-0516801417 34.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 35.FinchC.LiW.PerezD.R.Design"/>
   <result pre="review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 35.FinchC.LiW.PerezD.R.Design of alteRNAtive live attenuated" exact="influenza" post="virus vaccinesCurr. Top. Microbiol. Immunol.201538620523525005928 36.GirardM.P.CherianT.PervikovY.KienyM.P.A review of vaccine"/>
   <result pre="research and development: Human acute respiratory infectionsVaccine2005235708572410.1016/j.vaccine.2005.07.04616154667 37.KrammerF.PaleseP.SteelJ.Advances in universal" exact="influenza" post="virus vaccine design and antibody mediated therapies based on"/>
   <result pre="Top. Microbiol. Immunol.201538630132125007847 38.NogalesA.Martinez-SobridoL.Reverse genetics approaches for the development of" exact="influenza" post="vaccinesInt. J. Mol. Sci.2016182010.3390/ijms1801002028025504 39.DiazGranadosC.A.DunningA.J.KimmelM.KirbyD.TreanorJ.CollinsA.PollakR.ChristoffJ.EarlJ.LandolfiV.et al.Efficacy of high-dose versus"/>
   <result pre="vaccinesInt. J. Mol. Sci.2016182010.3390/ijms1801002028025504 39.DiazGranadosC.A.DunningA.J.KimmelM.KirbyD.TreanorJ.CollinsA.PollakR.ChristoffJ.EarlJ.LandolfiV.et al.Efficacy of high-dose versus standard-dose" exact="influenza" post="vaccine in older adultsN. Engl. J. Med.201437163564510.1056/NEJMoa131572725119609 40.TsangP.GorseG.J.StroutC.B.SperlingM.GreenbergD.P.Ozol-GodfreyA.DiazGranadosC.LandolfiV.Immunogenicity and"/>
   <result pre="Med.201437163564510.1056/NEJMoa131572725119609 40.TsangP.GorseG.J.StroutC.B.SperlingM.GreenbergD.P.Ozol-GodfreyA.DiazGranadosC.LandolfiV.Immunogenicity and safety of fluzone ® intradermal and high-dose" exact="influenza" post="vaccines in older adults &amp;gt;/=65 years of age: A"/>
   <result pre="age: A randomized, controlled, phase II trialVaccine2014322507251710.1016/j.vaccine.2013.09.07424120672 41.PicaN.PaleseP.Toward a universal" exact="influenza" post="virus vaccine: Prospects and challengesAnnu. Rev. Med.20136418920210.1146/annurev-med-120611-14511523327522 42.GorseG.J.BelsheR.B.MunnN.J.Superiority of"/>
   <result pre="vaccines in older, chronically ill adultsChest199110097798410.1378/chest.100.4.9771914615 43.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation" exact="influenza" post="vaccines: Recipes for success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 44.SunW.Approval Letter-Fluarix Quadrivalent (bl 125127/513)U.S."/>
   <result pre="(FDA)Washington, DC, USA2012 45.PyoH.M.ZhouY.Protective efficacy of intranasally administered bivalent live" exact="influenza" post="vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 46.CaspardH.MalloryR.M.YuJ.AmbroseC.S.Live-attenuated influenza"/>
   <result pre="live influenza vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 46.CaspardH.MalloryR.M.YuJ.AmbroseC.S.Live-attenuated" exact="influenza" post="vaccine effectiveness in children from 2009 to 2015–2016: A"/>
   <result pre="comparison of immunogenicity and safety of quadrivalent recombinant versus inactivated" exact="influenza" post="vaccine in healthy adults 18–49 years of ageJ. Infect."/>
   <result pre="years of ageJ. Infect. Dis.20172161219122610.1093/infdis/jix47828968871 48.GrohskopfL.A.SokolowL.Z.BroderK.R.WalterE.B.BreseeJ.S.FryA.M.JerniganD.B.Prevention and control of seasonal" exact="influenza" post="with vaccines: Recommendations of the advisory committee on immunization"/>
   <result pre="Recommendations of the advisory committee on immunization practices-united states, 2017–18" exact="influenza" post="seasonAm. J. Transplant.2017172970298210.1111/ajt.1451129083555 49.MurrayJ.S.Prevention and control of influenza in"/>
   <result pre="states, 2017–18 influenza seasonAm. J. Transplant.2017172970298210.1111/ajt.1451129083555 49.MurrayJ.S.Prevention and control of" exact="influenza" post="in children during the 2016–2017 seasonal epidemicJ. Spec. Pediatr."/>
   <result pre="africaEmerg. Infect. Dis.2008141809181010.3201/eid1411.08095818976580 57.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistanceScience20103281272127510.1126/science.118781620522774 58.BakerS.F.NogalesA.Martinez-SobridoL.Downregulating viral gene expression: Codon usage bias"/>
   <result pre="61.EisfeldA.J.NeumannG.KawaokaY.At the centre: Influenza A virus ribonucleoproteinsNat. Rev. Microbiol.201513284110.1038/nrmicro336725417656 62.Resa-InfanteP.JorbaN.ColomaR.OrtinJ.The" exact="influenza" post="virus RNA synthesis machine: Advances in its structure and"/>
   <result pre="bound to the viral RNA promoterNature201451635536010.1038/nature1400825409142 64.ArranzR.ColomaR.ChichonF.J.ConesaJ.J.CarrascosaJ.L.ValpuestaJ.M.OrtinJ.Martin-BenitoJ.The structure of native" exact="influenza" post="virion ribonucleoproteinsScience20123381634163710.1126/science.122817223180776 65.RobertsonJ.S.5′ and 3′ terminal nucleotide sequences of"/>
   <result pre="3′ terminal nucleotide sequences of the RNA genome segments of" exact="influenza" post="virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 66.HuangT.S.PaleseP.KrystalM.Determination of influenza virus proteins required"/>
   <result pre="RNA genome segments of influenza virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 66.HuangT.S.PaleseP.KrystalM.Determination of" exact="influenza" post="virus proteins required for genome replicationJ. Virol.199064566956732214032 67.HeldtF.S.FrensingT.ReichlU.Modeling the"/>
   <result pre="required for genome replicationJ. Virol.199064566956732214032 67.HeldtF.S.FrensingT.ReichlU.Modeling the intracellular dynamics of" exact="influenza" post="virus replication to understand the control of viral RNA"/>
   <result pre="viral RNA synthesisJ. Virol.2012867806781710.1128/JVI.00080-1222593159 68.LambR.A.ChoppinP.W.The gene structure and replication of" exact="influenza" post="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 69.PlotchS.J.BouloyM.UlmanenI.KrugR.M.A unique cap(m7gpppxm)-dependent influenza virion endonuclease"/>
   <result pre="and replication of influenza virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 69.PlotchS.J.BouloyM.UlmanenI.KrugR.M.A unique cap(m7gpppxm)-dependent" exact="influenza" post="virion endonuclease cleaves capped RNAs to generate the primers"/>
   <result pre="primers that initiate viral RNA transcriptionCell19812384785810.1016/0092-8674(81)90449-96261960 70.NayakD.P.HuiE.K.BarmanS.Assembly and budding of" exact="influenza" post="virusVirus Res.200410614716510.1016/j.virusres.2004.08.01215567494 71.RossmanJ.S.LambR.A.Influenza virus assembly and buddingVirology201141122923610.1016/j.virol.2010.12.00321237476 72.SchmittA.P.LambR.A.Influenza virus"/>
   <result pre="contributes to pathogenicity in a mouse modelJ. Virol.200983123251233510.1128/JVI.01373-0919793828 76.SteelJ.LowenA.C.MubarekaS.PaleseP.Transmission of" exact="influenza" post="virus in a mammalian host is increased by PB2"/>
   <result pre="in PA, NP, and HA of a pandemic (H1N1) 2009" exact="influenza" post="virus contribute to its adaptation to miceVirus Res.201115812412910.1016/j.virusres.2011.03.02221458512 78.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural"/>
   <result pre="to miceVirus Res.201115812412910.1016/j.virusres.2011.03.02221458512 78.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural insights into RNA synthesis by the" exact="influenza" post="virus transcription-replication machineVirus Res.201723410311710.1016/j.virusres.2017.01.01328115197 79.Crescenzo-ChaigneB.NaffakhN.van der WerfS.Comparative analysis of"/>
   <result pre="WerfS.Comparative analysis of the ability of the polymerase complexes of" exact="influenza" post="viruses type A, B and C to assemble into"/>
   <result pre="in vivoVirology199926534235310.1006/viro.1999.005910600605 80.EngelhardtO.G.FodorE.Functional association between viral and cellular transcription during" exact="influenza" post="virus infectionRev. Med. Virol.20061632934510.1002/rmv.51216933365 81.ReichS.GuilligayD.PflugA.MaletH.BergerI.CrepinT.HartD.LunardiT.NanaoM.RuigrokR.W.et al.Structural insight into cap-snatching"/>
   <result pre="Virol.20061632934510.1002/rmv.51216933365 81.ReichS.GuilligayD.PflugA.MaletH.BergerI.CrepinT.HartD.LunardiT.NanaoM.RuigrokR.W.et al.Structural insight into cap-snatching and RNA synthesis by" exact="influenza" post="polymeraseNature201451636136610.1038/nature1400925409151 82.ThierryE.GuilligayD.KosinskiJ.BockT.GaudonS.RoundA.PflugA.HengrungN.El OmariK.BaudinF.et al.Influenza polymerase can adopt an alternative"/>
   <result pre="synthesisNat. Rev. Microbiol.20161447949310.1038/nrmicro.2016.8727396566 84.LukarskaM.FournierG.PflugA.Resa-InfanteP.ReichS.NaffakhN.CusackS.Structural basis of an essential interaction between" exact="influenza" post="polymerase and pol II CTDNature201754111712110.1038/nature2059428002402 85.de FariasS.T.Dos Santos JuniorA.P.RegoT.G.JoseM.V.Origin"/>
   <result pre="Santos JuniorA.P.RegoT.G.JoseM.V.Origin and evolution of RNA-dependent RNA polymeraseFront. Genet.2017812510.3389/fgene.2017.0012528979293 86.NogalesA.Marquez-JuradoS.GalanC.EnjuanesL.AlmazanF.Transmissible" exact="gastroenteritis" post="coronavirus RNA-dependent RNA polymerase and nonstructural proteins 2, 3,"/>
   <result pre="particlesJ. Virol.2012861261126610.1128/JVI.06428-1122090122 87.GuilligayD.TarendeauF.Resa-InfanteP.ColomaR.CrepinT.SehrP.LewisJ.RuigrokR.W.OrtinJ.HartD.J.et al.The structural basis for cap binding by" exact="influenza" post="virus polymerase subunit PB2Nat. Struct. Mol. Biol.20081550050610.1038/nsmb.142118454157 88.DengT.VreedeF.T.BrownleeG.G.Different de"/>
   <result pre="Mol. Biol.20081550050610.1038/nsmb.142118454157 88.DengT.VreedeF.T.BrownleeG.G.Different de novo initiation strategies are used by" exact="influenza" post="virus RNA polymerase on its cRNA and viral RNA"/>
   <result pre="during viral RNA replicationJ. Virol.2006802337234810.1128/JVI.80.5.2337-2348.200616474140 89.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an" exact="avian influenza" post="polymerase PAN reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 90.StubbsT.M.Te VelthuisA.J.The"/>
   <result pre="viral RNA replicationJ. Virol.2006802337234810.1128/JVI.80.5.2337-2348.200616474140 89.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an avian" exact="influenza" post="polymerase PAN reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 90.StubbsT.M.Te VelthuisA.J.The"/>
   <result pre="Influenza A virusFuture Virol.2014986387610.2217/fvl.14.6625431616 91.SuC.Y.ChengT.J.LinM.I.WangS.Y.HuangW.I.Lin-ChuS.Y.ChenY.H.WuC.Y.LaiM.M.ChengW.C.et al.High-throughput identification of compounds targeting" exact="influenza" post="RNA-dependent RNA polymerase activityProc. Natl. Acad. Sci. USA2010107191511915610.1073/pnas.101359210720974907 92.CarrS.M.CarneroE.Garcia-SastreA.BrownleeG.G.FodorE.Characterization"/>
   <result pre="92.CarrS.M.CarneroE.Garcia-SastreA.BrownleeG.G.FodorE.Characterization of a mitochondrial-targeting signal in the PB2 protein of" exact="influenza" post="virusesVirology200634449250810.1016/j.virol.2005.08.04116242167 93.WoodfinB.M.KazimA.L.Interaction of the amino-terminus of an influenza virus"/>
   <result pre="protein of influenza virusesVirology200634449250810.1016/j.virol.2005.08.04116242167 93.WoodfinB.M.KazimA.L.Interaction of the amino-terminus of an" exact="influenza" post="virus protein with mitochondriaArch. Biochem. Biophys.199330642743010.1006/abbi.1993.15338215446 94.NilssonB.E.Te VelthuisA.J.FodorE.Role of"/>
   <result pre="lies on the surface of a discrete, folded domain of" exact="influenza" post="virus polymerase PB2 subunitPLoS Pathog.20084e100013610.1371/journal.ppat.100013618769709 96.PooleE.EltonD.MedcalfL.DigardP.Functional domains of the"/>
   <result pre="Influenza A virus polymerase host restrictionNature201652910110410.1038/nature1647426738596 100.DiasA.BouvierD.CrepinT.McCarthyA.A.HartD.J.BaudinF.CusackS.RuigrokR.W.The cap-snatching endonuclease of" exact="influenza" post="virus polymerase resides in the PA subunitNature200945891491810.1038/nature0774519194459 101.KowalinskiE.ZubietaC.WolkerstorferA.SzolarO.H.RuigrokR.W.CusackS.Structural analysis"/>
   <result pre="specific metal chelating inhibitor binding to the endonuclease domain of" exact="influenza" post="pH1N1 (2009) polymerasePLoS Pathog.20128e100283110.1371/journal.ppat.100283122876177 102.CrepinT.DiasA.PalenciaA.SwaleC.CusackS.RuigrokR.W.Mutational and metal binding analysis"/>
   <result pre="and metal binding analysis of the endonuclease domain of the" exact="influenza" post="virus polymerase PA subunitJ. Virol.2010849096910410.1128/JVI.00995-1020592097 103.NogalesA.RodriguezL.DeDiegoM.L.TophamD.J.Martinez-SobridoL.Interplay of PA-X and"/>
   <result pre="for expression of a model RNA templateVirology199723520921710.1006/viro.1997.86829281500 108.HondaA.UedaK.NagataK.IshihamaA.RNA polymerase of" exact="influenza" post="virus: Role of np in RNA chain elongationJ. Biochem.19881041021102610.1093/oxfordjournals.jbchem.a1225693243763"/>
   <result pre="components required for the initiation of unprimed RNA synthesis by" exact="influenza" post="virus RNA polymeraseNucleic Acids Res.20023042943810.1093/nar/30.2.42911788704 110.NewcombL.L.KuoR.L.YeQ.JiangY.TaoY.J.KrugR.M.Interaction of the Influenza"/>
   <result pre="viral RNA replicationJ. Virol.200983293610.1128/JVI.02293-0718945782 111.ZhangS.WengL.GengL.WangJ.ZhouJ.DeubelV.BuchyP.ToyodaT.Biochemical and kinetic analysis of the" exact="influenza" post="virus RNA polymerase purified from insect cellsBiochem. Biophys. Res."/>
   <result pre="A virus ribonucleoprotein complexesNat. Commun.20134159110.1038/ncomms258923481399 113.BiswasS.K.BoutzP.L.NayakD.P.Influenza virus nucleoprotein interacts with" exact="influenza" post="virus polymerase proteinsJ. Virol.199872549355019621005 114.OzawaM.FujiiK.MuramotoY.YamadaS.YamayoshiS.TakadaA.GotoH.HorimotoT.KawaokaY.Contributions of two nuclear localization"/>
   <result pre="A virus nucleoprotein to viral replicationJ. Virol.200781304110.1128/JVI.01434-0617050598 115.BouloS.AkarsuH.RuigrokR.W.BaudinF.Nuclear traffic of" exact="influenza" post="virus proteins and ribonucleoprotein complexesVirus Res.2007124122110.1016/j.virusres.2006.09.01317081640 116.O’NeillR.E.TalonJ.PaleseP.The influenza virus"/>
   <result pre="traffic of influenza virus proteins and ribonucleoprotein complexesVirus Res.2007124122110.1016/j.virusres.2006.09.01317081640 116.O’NeillR.E.TalonJ.PaleseP.The" exact="influenza" post="virus nep (ns2 protein) mediates the nuclear export of"/>
   <result pre="nuclear export of viral ribonucleoproteinsEMBO J.19981728829610.1093/emboj/17.1.2889427762 117.NishiyamaS.IkegamiT.Temperature-sensitive mutations for live-attenuated" exact="rift valley fever" post="vaccines: Implications from other RNA virusesFront. Microbiol.2015678710.3389/fmicb.2015.0078726322023 118.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.Temperature-sensitive live-attenuated"/>
   <result pre="vaccines: Implications from other RNA virusesFront. Microbiol.2015678710.3389/fmicb.2015.0078726322023 118.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.Temperature-sensitive live-attenuated canine" exact="influenza" post="virus H3N8 vaccineJ. Virol.20179110.1128/JVI.02211-1627928017 119.TobitaK.TanakaT.GotoH.FengS.Y.Temperature-sensitive Influenza A virus clones"/>
   <result pre="Virol.198375172710.1007/BF013141246830443 120.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 121.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.-T.C.E.S.Live attenuated versus inactivated"/>
   <result pre="influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 121.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.-T.C.E.S.Live attenuated versus inactivated" exact="influenza" post="vaccine in infants and young childrenN. Engl. J. Med.200735668569610.1056/NEJMoa06536817301299"/>
   <result pre="infants and young childrenN. Engl. J. Med.200735668569610.1056/NEJMoa06536817301299 122.MaassabH.F.Plaque formation of" exact="influenza" post="virus at 25 °CNature196821964564610.1038/219645a05665725 123.SnyderM.H.BettsR.F.DeBordeD.TierneyE.L.ClementsM.L.HerringtonD.SearsS.D.DolinR.MaassabH.F.MurphyB.R.Four viral genes independently contribute"/>
   <result pre="reassortant virus vaccinesJ. Virol.1988624884953336068 124.MaassabH.F.BryantM.L.The development of live attenuated cold-adapted" exact="influenza" post="virus vaccine for humansRev. Med. Virol.1999923724410.1002/(SICI)1099-1654(199910/12)9:4&amp;lt;237::AID-RMV252&amp;gt;3.0.CO;2-G10578119 125.WongS.S.WebbyR.J.Traditional and new"/>
   <result pre="influenza virus vaccine for humansRev. Med. Virol.1999923724410.1002/(SICI)1099-1654(199910/12)9:4&amp;lt;237::AID-RMV252&amp;gt;3.0.CO;2-G10578119 125.WongS.S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 126.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated"/>
   <result pre="influenza vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 126.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated" exact="influenza" post="virus that permits in vivo analysis of enhancements to"/>
   <result pre="vivo analysis of enhancements to the safety of live attenuated" exact="influenza" post="virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for"/>
   <result pre="of live attenuated influenza virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 128.GhendonY.Z.Molecular characteristics and"/>
   <result pre="vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 128.GhendonY.Z.Molecular characteristics and biological properties (genetic markers) of"/>
   <result pre="properties (genetic markers) of candidate strains for preparation of live" exact="influenza" post="virus vaccinesBull. World Health Organ.1984624934996331910 129.GhendonY.Z.PolezhaevF.I.LisovskayaK.V.MedvedevaT.E.AlexandrovaG.I.KlimovA.I.Recombinant cold-adapted attenuated Influenza"/>
   <result pre="phenotype of a master donor virus used in live attenuated" exact="influenza" post="vaccines: A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 132.Isakova-SivakI.RudenkoL.Safety, immunogenicity and infectivity of new"/>
   <result pre="A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 132.Isakova-SivakI.RudenkoL.Safety, immunogenicity and infectivity of new live attenuated" exact="influenza" post="vaccinesExpert Rev. Vaccines2015141313132910.1586/14760584.2015.107588326289975 133.TsfasmanT.M.MarkushinS.G.AkopovaI.I.GhendonY.Z.Molecular mechanisms of reversion to the"/>
   <result pre="Influenza A/Leningrad/134/57 (H2N2) virusVirology199218679579710.1016/0042-6822(92)90050-Y1733114 135.KlimovA.I.EgorovA.Y.GushchinaM.I.MedvedevaT.E.GambleW.C.RudenkoL.G.AlexandrovaG.I.CoxN.J.Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2)" exact="influenza" post="virus: Sequence analysis of live cold-adapted reassortant vaccine strains"/>
   <result pre="and after replication in childrenJ. Gen. Virol.1995761521152510.1099/0022-1317-76-6-15217782782 136.KendalA.P.Cold-adapted live attenuated" exact="influenza" post="vaccines developed in Russia: Can they contribute to meeting"/>
   <result pre="in Russia: Can they contribute to meeting the needs for" exact="influenza" post="control in other countries?Eur. J. Epidemiol.19971359160910.1023/A:10073275058629258574 137.ChanW.ZhouH.KembleG.JinH.The cold adapted"/>
   <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
   <result pre="in replication at the restrictive temperatureVirology200838030431110.1016/j.virol.2008.07.02718768193 138.HeW.WangW.HanH.WangL.ZhangG.GaoB.Molecular basis of live-attenuated" exact="influenza" post="virusPLoS ONE20138e6041310.1371/journal.pone.006041323555969 139.ZhouB.LiY.SpeerS.D.SubbaA.LinX.WentworthD.E.Engineering temperature sensitive live attenuated influenza vaccines"/>
   <result pre="of live-attenuated influenza virusPLoS ONE20138e6041310.1371/journal.pone.006041323555969 139.ZhouB.LiY.SpeerS.D.SubbaA.LinX.WentworthD.E.Engineering temperature sensitive live attenuated" exact="influenza" post="vaccines from emerging virusesVaccine2012303691370210.1016/j.vaccine.2012.03.02522449422 140.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine"/>
   <result pre="influenza vaccines from emerging virusesVaccine2012303691370210.1016/j.vaccine.2012.03.02522449422 140.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine" exact="influenza" post="virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 141.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in"/>
   <result pre="141.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in ferrets to a/puerto rico/8/34" exact="influenza" post="virus by transferring the genetic signature for temperature sensitivity"/>
   <result pre="Arbor/6/60J. Virol.20047899599810.1128/JVI.78.2.995-998.200414694130 142.YoungnerJ.S.Whitaker-DowlingP.ChambersT.M.RushlowK.E.SebringR.Derivation and characterization of a live attenuated equine" exact="influenza" post="vaccine virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 143.ChambersT.M.HollandR.E.TudorL.R.TownsendH.G.CookA.BogdanJ.LunnD.P.HusseyS.Whitaker-DowlingP.YoungnerJ.S.et al.A new modified"/>
   <result pre="virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 143.ChambersT.M.HollandR.E.TudorL.R.TownsendH.G.CookA.BogdanJ.LunnD.P.HusseyS.Whitaker-DowlingP.YoungnerJ.S.et al.A new modified live equine" exact="influenza" post="virus vaccine: Phenotypic stability, restricted spread and efficacy against"/>
   <result pre="Respi. viruses2010433934410.1111/j.1750-2659.2010.00176.x20958927 145.PaillotR.A systematic review of recent advances in equine" exact="influenza" post="vaccinationVaccines2014279783110.3390/vaccines204079726344892 146.ParkA.W.DalyJ.M.LewisN.S.SmithD.J.WoodJ.L.GrenfellB.T.Quantifying the impact of immune escape on transmission"/>
   <result pre="immune escape on transmission dynamics of influenzaScience200932672672810.1126/science.117598019900931 147.LeeK.H.SeoS.U.SongJ.M.LeeC.M.KimH.A.SeongB.L.Characterization of live" exact="influenza" post="vaccine donor strain derived from cold-adaptation of X-31 virusVaccine2006241966197410.1016/j.vaccine.2005.10.05116343703"/>
   <result pre="X-31 virusVaccine2006241966197410.1016/j.vaccine.2005.10.05116343703 148.JangY.H.JungE.J.LeeK.H.ByunY.H.YangS.W.SeongB.L.Genetic analysis of attenuation markers of cold-adapted X-31" exact="influenza" post="live vaccine donor strainVaccine2016341343134910.1016/j.vaccine.2016.01.05326851733 149.ZhangW.TuJ.ZhaoZ.ChenH.JinM.The new temperature-sensitive mutation pa-f35s"/>
   <result pre="temperature-sensitive mutation pa-f35s for developing recombinant avian live attenuated H5N1" exact="influenza" post="vaccineVirol. J.201299710.1186/1743-422X-9-9722621130 150.Da CostaB.SaussetA.MunierS.GhounarisA.NaffakhN.Le GofficR.DelmasB.Temperature-sensitive mutants in the Influenza"/>
   <result pre="and result in viral attenuationJ. Virol.2015896376639010.1128/JVI.00589-1525855727 151.TsybalovaL.M.GorevN.E.PotapchukM.V.RepkoI.A.KorotkovA.V.SergeevaM.V.KomissarovA.B.PisarevaM.M.KuznetsovV.V.GrudininM.P.et al.characterization of cold-adapted" exact="influenza" post="strain A/Hongkong/1/68/162/35 as a potential donor of attenuation and"/>
   <result pre="A/Wsn/33 virus by altering the basic amino acid domain of" exact="influenza" post="virus matrix proteinJ. Virol.2004789585959110.1128/JVI.78.18.9585-9591.200415331690 154.GaraigortaU.FalconA.M.OrtinJ.Genetic analysis of influenza virus"/>
   <result pre="domain of influenza virus matrix proteinJ. Virol.2004789585959110.1128/JVI.78.18.9585-9591.200415331690 154.GaraigortaU.FalconA.M.OrtinJ.Genetic analysis of" exact="influenza" post="virus ns1 gene: A temperature-sensitive mutant shows defective formation"/>
   <result pre="human Influenza A virusesJ. Virol.20179110.1128/JVI.01930-1628003482 156.ZhouB.MeliopoulosV.A.WangW.LinX.StuckerK.M.HalpinR.A.StockwellT.B.Schultz-CherryS.WentworthD.E.Reversion of cold-adapted live attenuated" exact="influenza" post="vaccine into a pathogenic virusJ. Virol.2016908454846310.1128/JVI.00163-1627440882 157.ChenZ.AspelundA.KembleG.JinH.Genetic mapping of"/>
   <result pre="of B/Ann Arbor/1/66, the master donor virus for live attenuated" exact="influenza" post="vaccines (flumist)Virology200634541642310.1016/j.virol.2005.10.00516289204 158.DonabedianA.M.DeBordeD.C.CookS.SmitkaC.W.MaassabH.F.A mutation in the pa protein gene"/>
   <result pre="mutation in the pa protein gene of cold-adapted B/Ann Arbor/1/66" exact="influenza" post="virus associated with reversion of temperature sensitivity and attenuated"/>
   <result pre="temperature sensitivity and attenuated virulenceVirology198816344445110.1016/0042-6822(88)90285-13354203 159.DonabedianA.M.DeBordeD.C.MaassabH.F.Genetics of cold-adapted B/Ann Arbor/1/66" exact="influenza" post="virus reassortants: The acidic polymerase (PA) protein gene confers"/>
   <result pre="control the expression of the temperature-sensitive phenotype of cold-adapted B/Ussr/60/69" exact="influenza" post="master donor virusJ. Gen. Virol.20109193193710.1099/vir.0.017996-020007357 162.PerezD.R.Garcia-SastreA.H5N1, a wealth of"/>
   <result pre="of importin-alpha isoforms governs cell tropism and host adaptation of" exact="influenza" post="virusNat. Commun.2011215610.1038/ncomms115821245837 164.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity"/>
   <result pre="Commun.2011215610.1038/ncomms115821245837 164.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (flumist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
   <result pre="intracellular localization of M1J. Virol.2012861522153010.1128/JVI.06230-1122090133 167.AliA.AvalosR.T.PonimaskinE.NayakD.P.Influenza virus assembly: Effect of" exact="influenza" post="virus glycoproteins on the membrane association of M1 proteinJ."/>
   <result pre="glycoproteins on the membrane association of M1 proteinJ. Virol.2000748709871910.1128/JVI.74.18.8709-8719.200010954572 168.ChenB.J.LeserG.P.JacksonD.LambR.A.The" exact="influenza" post="virus M2 protein cytoplasmic tail interacts with the M1"/>
   <result pre="assembly at the site of virus buddingJ. Virol.200882100591007010.1128/JVI.01184-0818701586 169.NogalesA.DeDiegoM.L.TophamD.J.Martinez-SobridoL.Rearrangement of" exact="influenza" post="virus spliced segments for the development of live-attenuated vaccinesJ."/>
   <result pre="for the development of live-attenuated vaccinesJ. Virol.2016906291630210.1128/JVI.00410-1627122587 170.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 171.HaleB.G.RandallR.E.OrtinJ.JacksonD.The multifunctional NS1 protein of"/>
   <result pre="Virol.2008892359237610.1099/vir.0.2008/004606-018796704 172.FalconA.M.MarionR.M.ZurcherT.GomezP.PortelaA.NietoA.OrtinJ.Defective RNA replication and late gene expression in temperature-sensitive" exact="influenza" post="viruses expressing deleted forms of the NS1 proteinJ. Virol.2004783880388810.1128/JVI.78.8.3880-3888.200415047804"/>
   <result pre="the NS1 protein grow efficiently in vero cellsJ. Virol.199872643764419658085 174.NogalesA.HuangK.ChaucheC.DeDiegoM.L.MurciaP.R.ParrishC.R.Martinez-SobridoL.Canine" exact="influenza" post="viruses with modified NS1 proteins for the development of"/>
   <result pre="H3N2 human Influenza A virusesJ. Virol.2016909693971110.1128/JVI.01039-1627535054 176.BelsheR.B.NewmanF.K.WilkinsK.GrahamI.L.BabusisE.EwellM.FreyS.E.Comparative immunogenicity of trivalent" exact="influenza" post="vaccine administered by intradermal or intramuscular route in healthy"/>
   <result pre="intramuscular route in healthy adultsVaccine2007256755676310.1016/j.vaccine.2007.06.06617692438 177.HuZ.JiaoX.LiuX.Antibody immunity induced by H7N9" exact="avian influenza" post="vaccines: Evaluation criteria, affecting factors, and implications for rational"/>
   <result pre="route in healthy adultsVaccine2007256755676310.1016/j.vaccine.2007.06.06617692438 177.HuZ.JiaoX.LiuX.Antibody immunity induced by H7N9 avian" exact="influenza" post="vaccines: Evaluation criteria, affecting factors, and implications for rational"/>
   <result pre="al.Preexisting influenza-specific CD4+ T cells correlate with disease protection against" exact="influenza" post="challenge in humansNat. Med.20121827428010.1038/nm.261222286307 179.ChengB.Y.Ortiz-RianoE.NogalesA.de la TorreJ.C.Martinez-SobridoL.Development of live-attenuated"/>
   <result pre="generating reassortant virus is based on the co-infection with two" exact="influenza" post="viruses in eggs. Both the WHO candidate IAV (left)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6223252\results\search\disease\results.xml">
   <result pre="6223252 pmid: 3042740500402 doi: 10.1590/S1678-9946201860070 : Review Hand, foot and" exact="mouth disease" post="and herpangina caused by enterovirus A71 infections: a review"/>
   <result pre="doi: 10.1590/S1678-9946201860070 : Review Hand, foot and mouth disease and" exact="herpangina" post="caused by enterovirus A71 infections: a review of enterovirus"/>
   <result pre="(EV-A71) infections are one of the main etiological agents of" exact="hand, foot and mouth disease" post="(HFMD) and herpangina worldwide. EV-A71 infection is a life-threatening"/>
   <result pre="one of the main etiological agents of hand, foot and" exact="mouth disease" post="(HFMD) and herpangina worldwide. EV-A71 infection is a life-threatening"/>
   <result pre="etiological agents of hand, foot and mouth disease (HFMD) and" exact="herpangina" post="worldwide. EV-A71 infection is a life-threatening communicable disease and"/>
   <result pre="for the development of an EV-A71 vaccine. Hand, foot and" exact="mouth disease" post="Herpangina Enterovirus A71 Vaccine fig-count: table-count: equation-count: ref-count: INTRODUCTION"/>
   <result pre="ref-count: INTRODUCTION Enterovirus A71 (EV-A71) is an important cause of" exact="hand, foot and mouth disease" post="(HFMD) and herpangina 1 . EV-A71 infects infants and"/>
   <result pre="A71 (EV-A71) is an important cause of hand, foot and" exact="mouth disease" post="(HFMD) and herpangina 1 . EV-A71 infects infants and"/>
   <result pre="important cause of hand, foot and mouth disease (HFMD) and" exact="herpangina" post="1 . EV-A71 infects infants and young children and"/>
   <result pre="is characterized by a febrile illness accompanied by a maculopapular" exact="rash" post="or blisters on the hands, soles of feet and"/>
   <result pre="In 1969, EV-A71 was first isolated from a child with" exact="encephalitis" post="in the USA 14 . Subsequently, several EV-A71 epidemics"/>
   <result pre="38 , a total of 46 children with EV-A71-related brainstem" exact="encephalitis" post="(EBE) were enrolled and subsequently underwent 1.5 Tesla magnetic"/>
   <result pre="infection can lead to severe or fatal disease due to" exact="pulmonary edema." post="The mechanism of pulmonary edema among patients with severe"/>
   <result pre="or fatal disease due to pulmonary edema. The mechanism of" exact="pulmonary edema" post="among patients with severe EV-A71 infection is currently unclear."/>
   <result pre="EV-A71 infection may be an important etiological mechanism of neurogenic" exact="pulmonary edema." post="Virus-host interactions significantly influence viral replication, virulence and pathogenicity"/>
   <result pre="vaccines can prevent more than 90% of EV-A71-associated HFMD or" exact="herpangina" post="and 80% of other EV-A71-associated disease symptoms. It has"/>
   <result pre="vaccinesClin Exp Vaccine Res2017641428168168 2ChenKTChangHLWangSTChengYTYangJYEpidemiologic features of hand-foot-mouth disease and" exact="herpangina" post="caused by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic hand,"/>
   <result pre="and herpangina caused by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic" exact="hand, foot and mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis20039788512533285 4BessaudMRazafindratsimandresyRNougairèdeAJoffretMLDeshpandeJMDubot-PérèsAet"/>
   <result pre="by enterovirus 71 in Taiwan, 1998-2005Pediatrics2007120e244e25217671037 3ChanKPGohKTChongCYTeoESLauGLingAEEpidemic hand, foot and" exact="mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis20039788512533285 4BessaudMRazafindratsimandresyRNougairèdeAJoffretMLDeshpandeJMDubot-PérèsAet"/>
   <result pre="diversityPLoS One20149e9062424598878 5ChanLGParasharUDLyeMSOngFGZakiSRAlexanderJPet al.Deaths of children during an outbreak of" exact="hand, foot, and mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="al.Deaths of children during an outbreak of hand, foot, and" exact="mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="of enterovirus 71 infection in children during an outbreak of" exact="hand, foot, and mouth disease" post="in Western AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and"/>
   <result pre="infection in children during an outbreak of hand, foot, and" exact="mouth disease" post="in Western AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and"/>
   <result pre="AustraliaClin Infect Dis20013223624211170913 7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and virologic investigation of" exact="hand, foot, and mouth disease," post="southern Vietnam, 2005Emerg Infect Dis2007131733174118217559 8KomatsuHShimizuYTakeuchiYIshikoHTakadaHOutbreak of severe neurologic"/>
   <result pre="7Van TuPThaoNTPereraDTruongKHTienNTKThuongTCet al.Epidemiologic and virologic investigation of hand, foot, and" exact="mouth disease," post="southern Vietnam, 2005Emerg Infect Dis2007131733174118217559 8KomatsuHShimizuYTakeuchiYIshikoHTakadaHOutbreak of severe neurologic"/>
   <result pre="enterovirus 71 infections and meteorological parameters in TaiwanPLoS One20127e4684523071650 11MaELamTWongCChuangSKIs" exact="hand, foot and mouth disease" post="associated with meteorological parameters?Epidemiol Infect20101381779178820875200 12DowellSFSeasonal variation in host"/>
   <result pre="and meteorological parameters in TaiwanPLoS One20127e4684523071650 11MaELamTWongCChuangSKIs hand, foot and" exact="mouth disease" post="associated with meteorological parameters?Epidemiol Infect20101381779178820875200 12DowellSFSeasonal variation in host"/>
   <result pre="Infect Dis19741293043094361245 15HosoyaMKawasakiYSatoMHonzumiKKatoAHiroshimaTet al.Genetic diversity of enterovirus 71 associated with" exact="hand, foot and mouth disease" post="epidemics in Japan from 1983 to 2003Pediatr Infect Dis"/>
   <result pre="al.Genetic diversity of enterovirus 71 associated with hand, foot and" exact="mouth disease" post="epidemics in Japan from 1983 to 2003Pediatr Infect Dis"/>
   <result pre="Plain of ChinaPLoS One20116e2789522125635 20GeogheganJLTan leVKühnertDHalpinRALinXSimenauerAet al.Phylodynamics of enterovirus A71-associated" exact="hand, foot, and mouth disease" post="in Viet NamJ Virol2015898871887926085170 21ChumakovMVoroshilovaMShindarovLLavrovaIGrachevaLKorolevaGet al.Enterovirus 71 isolated from"/>
   <result pre="One20116e2789522125635 20GeogheganJLTan leVKühnertDHalpinRALinXSimenauerAet al.Phylodynamics of enterovirus A71-associated hand, foot, and" exact="mouth disease" post="in Viet NamJ Virol2015898871887926085170 21ChumakovMVoroshilovaMShindarovLLavrovaIGrachevaLKorolevaGet al.Enterovirus 71 isolated from"/>
   <result pre="53OngKCDeviSCardosaMJWongKTFormaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71" exact="encephalomyelitis" post="against diseaseJ Virol20108466166519864378 54LiuLZhangYWangJZhaoHJiangLCheYet al.Study of the integrated immune"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6247931\results\search\disease\results.xml">
   <result pre="grave concern. For instance, China has experienced seasonal epidemics of" exact="influenza" post="A/H7N9 over the past five years. Despite no known"/>
   <result pre="Nextstrain presents a single, continuously updated overview of both endemic" exact="viral disease" post="(seasonal influenza, dengue) as well as emergent viral outbreaks"/>
   <result pre="23, 62–67.25461574 de VriesR.P.et al. (2017) Three mutations switch H7N9" exact="influenza" post="to human-type receptor specificity. PLoS Pathog., 13, e1006390–e1006316.28617868 FariaN.R.et"/>
   <result pre="546, 406–410.28538727 LiQ.et al. (2014) Epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in China. N. Engl. J. Med., 370,"/>
   <result pre="406–410.28538727 LiQ.et al. (2014) Epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in China. N. Engl. J. Med., 370,"/>
   <result pre="370, 520–532.23614499 NeherR.A., BedfordT. (2015) nextflu: real-time tracking of seasonal" exact="influenza" post="virus evolution in humans. Bioinformatics, 31, 3546–3548.26115986 PybusO.et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6249340\results\search\disease\results.xml">
   <result pre="IAV can result in severe or fatal clinical complications including" exact="pneumonia" post="and respiratory distress syndrome. Treatment of IAV infections is"/>
   <result pre="ANXs as a suitable target for IAV therapy. annexins ANXA1" exact="influenza" post="virus FPR2 immunomodulatory Funding National Medical Research Council10.13039/501100001349NMRC/CBRG/0056/2014 fig-count:"/>
   <result pre="2018). An estimate of 3–5 million individuals suffer from severe" exact="influenza" post="infection annually (WHO, 2018), with 290,000–650,000 resulting in deaths"/>
   <result pre="et al., 2011; WHO, 2018). Among the four types of" exact="influenza" post="viruses (types A, B, C, and D), Influenza A"/>
   <result pre="IAV-related complications such as bronchitis, sinus infections, ear infections, and" exact="pneumonia" post="may arise, which can result in organ failure and"/>
   <result pre="failure and death (CDC, 2018). The recurrence of such seasonal" exact="influenza" post="epidemics is primarily due to the constant mutation of"/>
   <result pre="a large host-range, there is a continuous emergence of new" exact="influenza" post="viruses that results in periodic pandemics (Taubenberger and Morens,"/>
   <result pre="At present, there are two fundamental approaches to managing the" exact="influenza" post="epidemic: vaccination and, treatment using antivirals. Several influenza vaccines"/>
   <result pre="managing the influenza epidemic: vaccination and, treatment using antivirals. Several" exact="influenza" post="vaccines are available with several modes of administration such"/>
   <result pre="2011). Increasing numbers of antivirals have been approved to facilitate" exact="influenza" post="treatment. Amantadine and rimantadine target the IAV M2 proteins,"/>
   <result pre="been shown in the literature to possess various functions during" exact="influenza" post="virus infection. ANXA1, ANXA2, ANXA5, and ANXA6 amongst others"/>
   <result pre="during IAV infection is essential to develop therapeutics targeting the" exact="viral disease." post="One of the earliest reports to implicate FPR2 in"/>
   <result pre="reported that the binding of ANXA2 to highly pathogenic H5N1" exact="influenza" post="virus non-structural protein 1 (NS1) enhances viral replication (Ma"/>
   <result pre="a 33 kDa protein that binds 3 different strains of" exact="influenza" post="A and one strain of influenza B via a"/>
   <result pre="3 different strains of influenza A and one strain of" exact="influenza" post="B via a sialic acid-independent mechanism (Otto et al.,"/>
   <result pre="(Otto et al., 1994). It was further shown that ANXA5" exact="aids" post="the entry of influenza viruses into cells, by acting"/>
   <result pre="It was further shown that ANXA5 aids the entry of" exact="influenza" post="viruses into cells, by acting as an alternative receptor"/>
   <result pre="The first evidence on the possible role of ANXA6 in" exact="influenza" post="virus infection was its ability to interact with the"/>
   <result pre="AriasC. F.Escalera-ZamudioM.Soto-Del Rio MdeL. A.Cobian-GuemesG.IsaP.LopezS. (2009). Molecular anatomy of 2009" exact="influenza" post="virus A (H1N1).Arch. Med. Res.40643–654. 10.1016/j.arcmed.2009.10.00720304251 AroraS.LimW.BistP.PerumalsamyR.LukmanH. M.LiF.et al."/>
   <result pre="Chem.28724690–24697. 10.1074/jbc.M112.37710122610094 BerriF.HaffarG.LeV. B.SadewasserA.PakiK.LinaB.et al. (2014). Annexin V incorporated into" exact="influenza" post="virus particles inhibits gamma interferon signaling and promotes viral"/>
   <result pre="RIP1 to constitutively activate IKK complex and NF-kappaB: implication in" exact="breast cancer" post="metastasis.Oncogene303174–3185. 10.1038/onc.2011.2821383699 BistP.ShuS.LeeH.AroraS.NairS.LimJ. Y.et al. (2013). Annexin-A1 regulates TLR-mediated"/>
   <result pre="to constitutively activate IKK complex and NF-kappaB: implication in breast" exact="cancer" post="metastasis.Oncogene303174–3185. 10.1038/onc.2011.2821383699 BistP.ShuS.LeeH.AroraS.NairS.LimJ. Y.et al. (2013). Annexin-A1 regulates TLR-mediated"/>
   <result pre="J. Pharmacol.1027–9. 10.1111/j.1476-5381.1991.tb12122.x1828384 De ClercqE. (2006). Antiviral agents active against" exact="influenza" post="A viruses.Nat. Rev. Drug Discov.51015–1025. 10.1038/nrd217517139286 de GraauwM.van MiltenburgM."/>
   <result pre="A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like" exact="breast cancer" post="cells.Proc. Natl. Acad. Sci. U.S.A.1076340–6345. 10.1073/pnas.091336010720308542 DuftonN.HannonR.BrancaleoneV.DalliJ.PatelH. B.GrayM.et al."/>
   <result pre="regulates TGF-beta signaling and promotes metastasis formation of basal-like breast" exact="cancer" post="cells.Proc. Natl. Acad. Sci. U.S.A.1076340–6345. 10.1073/pnas.091336010720308542 DuftonN.HannonR.BrancaleoneV.DalliJ.PatelH. B.GrayM.et al."/>
   <result pre="Natl. Acad. Sci. U.S.A.11018033–18034. 10.1073/pnas.131779811024154723 FukuyamaS.KawaokaY. (2011). The pathogenesis of" exact="influenza" post="virus infections: the contributions of virus and host factors.Curr."/>
   <result pre="T.LichtenbergB.RickO. (1996). Involvement of annexin V in the entry of" exact="influenza" post="viruses and role of phospholipids in infection.FEBS Lett.39259–62. 10.1016/0014-5793(96)00783-18769315"/>
   <result pre="accumulation is a host cell-protective mechanism inhibiting endosomal escape of" exact="influenza" post="a virus.mBio9:e1345-18. 10.1128/mBio.01345-1830042202 LeBouderF.MorelloE.RimmelzwaanG. F.BosseF.PechouxC.DelmasB. (2008). Annexin II incorporated"/>
   <result pre="a virus.mBio9:e1345-18. 10.1128/mBio.01345-1830042202 LeBouderF.MorelloE.RimmelzwaanG. F.BosseF.PechouxC.DelmasB. (2008). Annexin II incorporated into" exact="influenza" post="virus particles supports virus replication by converting plasminogen into"/>
   <result pre="Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in" exact="influenza" post="virions.Nat. Commun.5:5645. 10.1038/ncomms664525487526 LimL. H.PervaizS. (2007). Annexin 1: the"/>
   <result pre="10.1073/pnas.95.24.145359826735 MaH.KienF.ManiereM.ZhangY.LagardeN.TseK. S.et al. (2012). Human annexin A6 interacts with" exact="influenza" post="a virus protein M2 and negatively modulates infection.J. Virol.861789–1801."/>
   <result pre="protein 1 and promotes the replication of highly pathogenic H5N1" exact="avian influenza" post="virus.BMC Microbiol.17:191. 10.1186/s12866-017-1097-028893180 MadernaP.CottellD. C.ToivonenT.DuftonN.DalliJ.PerrettiM. (2010). FPR2/ALX receptor expression"/>
   <result pre="1 and promotes the replication of highly pathogenic H5N1 avian" exact="influenza" post="virus.BMC Microbiol.17:191. 10.1186/s12866-017-1097-028893180 MadernaP.CottellD. C.ToivonenT.DuftonN.DalliJ.PerrettiM. (2010). FPR2/ALX receptor expression"/>
   <result pre="10.1186/s12967-016-0843-727071553 MoraesL. A.KarS.FooS. L.GuT.TohY. Q.AmpomahP. B.et al. (2017). Annexin-A1 enhances" exact="breast cancer" post="growth and migration by promoting alternative macrophage polarization in"/>
   <result pre="MoraesL. A.KarS.FooS. L.GuT.TohY. Q.AmpomahP. B.et al. (2017). Annexin-A1 enhances breast" exact="cancer" post="growth and migration by promoting alternative macrophage polarization in"/>
   <result pre="MüllerK. H.KakkolaL.NagarajA. S.CheltsovA. V.AnastasinaM.KainovD. E. (2012). Emerging cellular targets for" exact="influenza" post="antiviral agents.Trends Pharmacol. Sci.3389–99. 10.1016/j.tips.2011.10.00422196854 MuramotoY.NodaT.KawakamiE.AkkinaR.KawaokaY. (2013). Identification of"/>
   <result pre="antiviral agents.Trends Pharmacol. Sci.3389–99. 10.1016/j.tips.2011.10.00422196854 MuramotoY.NodaT.KawakamiE.AkkinaR.KawaokaY. (2013). Identification of novel" exact="influenza" post="A virus proteins translated from PA mRNA.J. Virol.872455–2462. 10.1128/JVI.02656-1223236060"/>
   <result pre="Virol.872455–2462. 10.1128/JVI.02656-1223236060 MusiolA.GranS.EhrhardtC.LudwigS.GrewalT.GerkeV. (2013). Annexin A6-balanced late endosomal cholesterol controls" exact="influenza" post="A replication and propagation.mBio4:e00608-13. 10.1128/mBio.00608-1324194536 NicholsonK. G.WoodJ. M.ZambonM. (2003)."/>
   <result pre="33 kDa in cultured cells as a binding protein of" exact="influenza" post="viruses.FEBS Lett.356125–129. 10.1016/0014-5793(94)01241-57988705 PepinskyR. B.SinclairL. K. (1986). Epidermal growth"/>
   <result pre="Pharmacol.501037–1042. 10.1016/0006-2952(95)00238-U7575659 PetrovaV. N.RussellC. A. (2018). The evolution of seasonal" exact="influenza" post="viruses.Nat. Rev. Microbiol.1647–60. 10.1038/nrmicro.2017.14629081496 PleschkaS.WolffT.EhrhardtC.HobomG.PlanzO.RappU. R. (2001). Influenza virus"/>
   <result pre="The Annexin A1 receptor FPR2 regulates the endosomal export of" exact="influenza" post="virus.Int. J. Mol. Sci.19:E1400. 10.3390/ijms1905140029738458 RescherU.GerkeV. (2004). Annexins–unique membrane"/>
   <result pre="10.1038/nature1347924899309 ShawM. L.StoneK. L.ColangeloC. M.GulcicekE. E.PaleseP. (2008). Cellular proteins in" exact="influenza" post="virus particles.PLoS Pathog.4:e1000085. 10.1371/journal.ppat.100008518535660 ShenZ.LouK.WangW. (2015). New small-molecule drug"/>
   <result pre="ShenZ.LouK.WangW. (2015). New small-molecule drug design strategies for fighting resistant" exact="influenza" post="A.Acta Pharm. Sin. B5419–430. 10.1016/j.apsb.2015.07.00626579472 ShiY.WuY.ZhangW.QiJ.GaoG. F. (2014). Enabling"/>
   <result pre="Enabling the ‘host jump’: structural determinants of receptor-binding specificity in" exact="influenza" post="A viruses.Nat. Rev. Microbiol.12822–831. 10.1038/nrmicro336225383601 SolitoE.ChristianH. C.FestaM.MullaA.TierneyT.FlowerR. J.et al."/>
   <result pre="Immunol. Res.20168239258. 10.1155/2016/823925826885535 TaubenbergerJ. K.MorensD. M. (2008). The pathology of" exact="influenza" post="virus infections.Annu. Rev. Pathol.3499–522. 10.1146/annurev.pathmechdis.3.121806.15431618039138 TcherniukS.CenacN.ComteM.FrouardJ.Errazuriz-cerdaE.GalabovA.et al. (2016). Formyl"/>
   <result pre="Rep.6:27028. 10.1038/srep2702827426034 ZhirnovO. P.KlenkH. D. (2007). Control of apoptosis in" exact="influenza" post="virus-infected cells by up-regulation of Akt and p53 signaling.Apoptosis121419–1432."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6251852\results\search\disease\results.xml">
   <result pre="Abstract Chikungunya (CHIK) is an arboviral infection caused by the" exact="chikungunya" post="virus. An unusual feature of CHIK is its long"/>
   <result pre="range from a mild self-limiting febrile illness with arthralgia and" exact="rash" post="to crippling acute and lingering debilitating arthritis. In about"/>
   <result pre="of CHIK across the globe. Keywords Arboviral infection Chikungunya Inflammatory" exact="arthritis" post="Introduction Chikungunya (CHIK) is an arboviral infection caused by"/>
   <result pre="Introduction Chikungunya (CHIK) is an arboviral infection caused by the" exact="chikungunya" post="virus (CHIKV), belonging to the family Togaviridae and genus"/>
   <result pre="Manifestations of CHIK range from a mild self-limiting fever with" exact="rash" post="and arthralgia to severe crippling acute debilitating arthritis. Musculoskeletal"/>
   <result pre="before apparently disappearing for several years to decades. Also, unlike" exact="dengue fever," post="with CHIK the dearth of asymptomatic infections leads to"/>
   <result pre="switching and has been speculated to be associated with persistent" exact="arthritis" post="in CHIKV [26]. Clinical Features Clinical manifestations of CHIK"/>
   <result pre="the large joints, such as the knee and shoulder. CHIK" exact="arthritis" post="has also a predilection to affect both early and"/>
   <result pre="are extremely tender to touch in many patients [30]. The" exact="arthritis" post="persists for varying periods of time. In the pervious"/>
   <result pre="time. In the pervious study conducted by the authors, the" exact="arthritis" post="resolved within 1 week in 25% of patients and"/>
   <result pre="with or without tenderness is a common feature of CHIK" exact="arthritis" post="and close to 90% patients in the authors’ study"/>
   <result pre="authors’ previous study, the most common joints affected with chronic" exact="arthritis" post="were the ankle (63%), followed by the knee (55%)"/>
   <result pre="arthritis. Apart from chronic arthritis, CHIK can evolve or precipitate" exact="rheumatoid arthritis," post="as was noted by the authors in 5% of"/>
   <result pre="manifestations are a prominent feature of CHIK fever. Transient maculopapular" exact="rash" post="may be seen in approximately 50% patients [27]. Nasal"/>
   <result pre="centrofacial hyperpigmentation, lichenoid eruptions, hyperpigmentation in photodistributed areas and exfoliative" exact="dermatitis" post="are other dermatological manifestations observed [27]. In the authors’"/>
   <result pre="other dermatological manifestations observed [27]. In the authors’ previous study," exact="rash" post="was present in 68% patients, which was erythematous (45%),"/>
   <result pre="(42%) and papular in pattern (20%) [28]. An unusual centrofacial" exact="rash" post="was observed in 21% patients, which began as an"/>
   <result pre="was observed in 21% patients, which began as an erythematous" exact="rash" post="at the tip of the nose and malar eminences"/>
   <result pre="and malar eminences and later became hyperpigmented, resembling the malar" exact="rash" post="of systemic lupus erythematosus. Desquamation of ear lobules, palms"/>
   <result pre="eminences and later became hyperpigmented, resembling the malar rash of" exact="systemic lupus erythematosus." post="Desquamation of ear lobules, palms and soles was observed"/>
   <result pre="and later became hyperpigmented, resembling the malar rash of systemic" exact="lupus erythematosus." post="Desquamation of ear lobules, palms and soles was observed"/>
   <result pre="observed in 26% of patients, and pruritus with or without" exact="rash" post="was seen in 29% [28]. Mucosal lesions in the"/>
   <result pre="lesions in the form of aphthous ulcers, lip ulcers and" exact="glossitis" post="were also observed [28]. Other systemic manifestations of CHIK"/>
   <result pre="systemic manifestations of CHIK include headache, asthenia, myalgia, vomiting and" exact="lymphadenopathy" post="[28, 31]. Although alphaviruses are notorious in causing neurological"/>
   <result pre="usually mild in these cases, with fever, irritability and bullous" exact="dermatitis" post="[7, 27]. Diagnosis Laboratory Diagnosis As there is considerable"/>
   <result pre="common Retro-orbital pain Less common More common Characteristic pattern of" exact="rash" post="Centrofacial hyperpigmentation Erythematous maculo-papular &quot;White Islands in Red Sea�?"/>
   <result pre="reveal lymphopenia consistent with that of a viral fever. However," exact="thrombocytopenia" post="is not a prominent finding and its presence would"/>
   <result pre="finding and its presence would help to differentiate CHIK from" exact="dengue fever" post="[27]. Also, the erythrocyte sedimentation rate and acute phase"/>
   <result pre="onset of fever and severe arthralgia/arthritis with or without skin" exact="rash" post="and residence in an epidemic area or having been"/>
   <result pre="Chloroquine phosphate (CQ) has been used effectively to manage CHIKV" exact="arthritis" post="[36]. In a previous study, the authors used hydroxychloroquine"/>
   <result pre="compared to sulfasalazine alone in patients with chronic persistent CHIK" exact="arthritis" post="not responding to NSAIDs and HCQ for 3 months"/>
   <result pre="initial therapy [40]. The role of DMARDs in acute CHIK" exact="arthritis" post="is uncertain. HCQ takes weeks to produce its effect,"/>
   <result pre="takes weeks to produce its effect, by which time the" exact="arthritis" post="has resolved in the majority of patients. Also, the"/>
   <result pre="effects if used early in the disease course before the" exact="arthritis" post="self-remits [7]. In one study, ribavarin 200 mg twice"/>
   <result pre="the viral persistence and progression of the disease into disabling" exact="arthritis" post="is a realistic goal. Newer research avenues with the"/>
   <result pre="Health Organization; 2013. http://www.who.int/mediacentre/factsheets/fs32. 4.SudeepABParasharDChikungunya: an overviewJ Biosci20083344344910.1007/s12038-008-0063-219208970 5.LahariyaCPradhanSKEmergence of" exact="chikungunya" post="infection in India after 32 years: a reviewJ Vect"/>
   <result pre="of dengue and chikungunyaIndian J Med Res200612447548017213513 19.McIntoshBMJuppPGAttempts to transmit" exact="chikungunya" post="virus with six species of mosquitoJ Med Ent1970761561810.1093/jmedent/7.5.615 20.PradeepKJosephRKamarajTJambulingamPA226V"/>
   <result pre="of mosquitoJ Med Ent1970761561810.1093/jmedent/7.5.615 20.PradeepKJosephRKamarajTJambulingamPA226V mutation in virus during 2007" exact="chikungunya" post="outbreak in Kerala, IndiaJ Gen Virol2008891945194810.1099/vir.0.83628-018632966 21.GérardinPBarauGMichaultAet al.Multidisciplinary prospective"/>
   <result pre="Kerala, IndiaJ Gen Virol2008891945194810.1099/vir.0.83628-018632966 21.GérardinPBarauGMichaultAet al.Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the island of La RéunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797"/>
   <result pre="virus infectionAm J Trop Med200879113313910.4269/ajtmh.2008.79.133 24.SchilteCCoudercTChretienFet al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ Exp Med2010207242944210.1084/jem.2009085120123960"/>
   <result pre="reunion: epidemiology and surveillanceEuro Surveill200611210.2807/esm.11.12.00665-en 31.CeciliaDCurrent status of dengue and" exact="chikungunya" post="in IndiaWHO South-East Asia J Public Health.2014312210.4103/2224-3151.20687928607250 32.SebastianMLodhaRKabraSChikungunya infection"/>
   <result pre="cytokine response in patients with early persistent musculoskeletal pain and" exact="arthritis" post="following chikungunya virus infectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 38.RavindranVinodAliasGeorgeEfficacy of combination DMARD"/>
   <result pre="in patients with early persistent musculoskeletal pain and arthritis following" exact="chikungunya" post="virus infectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 38.RavindranVinodAliasGeorgeEfficacy of combination DMARD therapy vs."/>
   <result pre="of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent" exact="chikungunya" post="arthritis: a 24-week randomized controlled open label studyClinical Rheumatology20163661335134010.1007/s10067-016-3429-027699657"/>
   <result pre="upJ Assoc Phys India2011598386 40.SimonFJavelleECabieAet al.French guidelines for management of" exact="chikungunya" post="(acute and persistent presentations), November 2014Med Mal Infect.20154524326310.1016/j.medmal.2015.05.00726119684 41.RavichandranRManianMRibavirin"/>
   <result pre="41.RavichandranRManianMRibavirin therapy for Chikungunya arthritisJ Infect Dev Ctries.2008214014210.3855/T2.2.14019738340 42.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamSProtection from" exact="arthritis" post="and myositis in a mouse model of acute chikungunya"/>
   <result pre="for Chikungunya arthritisJ Infect Dev Ctries.2008214014210.3855/T2.2.14019738340 42.RulliNERolphMSSrikiatkhachornAAnantapreechaSGuglielmottiAMahalingamSProtection from arthritis and" exact="myositis" post="in a mouse model of acute chikungunya virus disease"/>
   <result pre="from arthritis and myositis in a mouse model of acute" exact="chikungunya" post="virus disease by bindarit, an inhibitor of monocyte chemotactic"/>
   <result pre="autophagy-inducing peptideNature201349420120610.1038/nature1186623364696 45.WangYLuJLinCet al.Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya" post="virus entry and transmissionAntiviral Res2016135819010.1016/j.antiviral.2016.10.00327742486 46.HoYWangYLuJet al.Suramin inhibits chikungunya"/>
   <result pre="against chikungunya virus entry and transmissionAntiviral Res2016135819010.1016/j.antiviral.2016.10.00327742486 46.HoYWangYLuJet al.Suramin inhibits" exact="chikungunya" post="virus entry and transmissionPLoS One2015107e013351110.1371/journal.pone.013351126208101 47.LounibosLPKramerLDInvasiveness of Aedes aegypti"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6254586\results\search\disease\results.xml">
   <result pre="doi: 10.2147/IDR.S179517idr-11-2411 : Original Research Epidemiological and molecular analysis of" exact="avian influenza" post="A(H7N9) virus in Shanghai, China, 2013–2017 WangSeong Jin123LiuXue Wei1ShenXiaojuan12HuaXiu"/>
   <result pre="10.2147/IDR.S179517idr-11-2411 : Original Research Epidemiological and molecular analysis of avian" exact="influenza" post="A(H7N9) virus in Shanghai, China, 2013–2017 WangSeong Jin123LiuXue Wei1ShenXiaojuan12HuaXiu"/>
   <result pre="is properly attributed. Abstract Background Human infections with a novel" exact="avian influenza" post="A virus (H7N9) were reported in Shanghai municipality, China,"/>
   <result pre="properly attributed. Abstract Background Human infections with a novel avian" exact="influenza" post="A virus (H7N9) were reported in Shanghai municipality, China,"/>
   <result pre="in Shanghai municipality, China, at the beginning of 2013. High-pathogenic" exact="avian influenza" post="(HPAI) H7N9 virus emerged in late February 2017 along"/>
   <result pre="Shanghai municipality, China, at the beginning of 2013. High-pathogenic avian" exact="influenza" post="(HPAI) H7N9 virus emerged in late February 2017 along"/>
   <result pre="virus emerged in late February 2017 along with existing low-pathogenic" exact="avian influenza" post="(LPAI) H7N9 virus, and this has the potential to"/>
   <result pre="emerged in late February 2017 along with existing low-pathogenic avian" exact="influenza" post="(LPAI) H7N9 virus, and this has the potential to"/>
   <result pre="to human-type receptors, with the characteristics of high-virulence and low-pathogenic" exact="influenza" post="viruses. Furthermore, our findings suggest that the Shanghai chicken"/>
   <result pre="of the outbreak of human infection caused by a novel" exact="avian influenza" post="A H7N9 virus [A(H7N9) virus] in Shanghai, China, in"/>
   <result pre="the outbreak of human infection caused by a novel avian" exact="influenza" post="A H7N9 virus [A(H7N9) virus] in Shanghai, China, in"/>
   <result pre="circulating among poultry in China had been categorized as low-pathogenic" exact="avian influenza" post="(LPAI), and the infected poultry showed no symptoms.3 Since"/>
   <result pre="among poultry in China had been categorized as low-pathogenic avian" exact="influenza" post="(LPAI), and the infected poultry showed no symptoms.3 Since"/>
   <result pre="2017, in the fifth epidemic, the appearance of a high-pathogenic" exact="avian influenza" post="(HPAI) A(H7N9) virus infection in humans was first reported"/>
   <result pre="in the fifth epidemic, the appearance of a high-pathogenic avian" exact="influenza" post="(HPAI) A(H7N9) virus infection in humans was first reported"/>
   <result pre="A(H7N9) viruses because migratory shorebirds are a natural reservoir for" exact="avian influenza" post="virus.11–13 Several coastal wetland areas, which are significant congregation"/>
   <result pre="viruses because migratory shorebirds are a natural reservoir for avian" exact="influenza" post="virus.11–13 Several coastal wetland areas, which are significant congregation"/>
   <result pre="in Shanghai, increasing the risk of the emergence of novel" exact="influenza" post="viruses.14 It should be noted that the first case"/>
   <result pre="(SHMCHFP) from 1 January 2013 to 31 December 2017. Avian" exact="influenza" post="reports published by the Department of Health, Government of"/>
   <result pre="PA, are regarded as essential for mammalian adaptation of the" exact="avian influenza" post="virus.19–21 E627K mutations in the PB2 protein occurred in"/>
   <result pre="are regarded as essential for mammalian adaptation of the avian" exact="influenza" post="virus.19–21 E627K mutations in the PB2 protein occurred in"/>
   <result pre="surface receptor, which is believed to play important roles in" exact="influenza" post="infection. It is noteworthy that a single amino acid"/>
   <result pre="prevention could be more effective than nationwide policies in controlling" exact="infectious disease." post="WHO and Chinese experts assessed that quarantine measures conducted"/>
   <result pre="A(H7N9) viruses circulating within Shanghai belong to high-virulence and low-pathogenic" exact="influenza" post="viruses, considering their NA deletion (positions 69–73) and the"/>
   <result pre="H7N9 Avian Viruses in Mainland ChinaJ Virol20179123 3WangXJiangHWuPet al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Avian Viruses in Mainland ChinaJ Virol20179123 3WangXJiangHWuPet al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Dis201717882283228583578 4PeirisJSCowlingBJWuJTet al.Interventions to reduce zoonotic and pandemic risks from" exact="avian influenza" post="in AsiaLancet Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging"/>
   <result pre="4PeirisJSCowlingBJWuJTet al.Interventions to reduce zoonotic and pandemic risks from avian" exact="influenza" post="in AsiaLancet Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging"/>
   <result pre="Infect Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging highly pathogenic H7N9" exact="avian influenza" post="virus in ChinaJ Infect2017751717528390707 6QuanCShiWYangYet al.New Threats from H7N9"/>
   <result pre="Dis201616225225826654122 5ZhangFBiYWangJet al.Human infections with recently-emerging highly pathogenic H7N9 avian" exact="influenza" post="virus in ChinaJ Infect2017751717528390707 6QuanCShiWYangYet al.New Threats from H7N9"/>
   <result pre="Epidemic - China, October 2016-February 2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel" exact="avian influenza" post="A H7N9 and influenza A H3N2 viruses in Jiangsu"/>
   <result pre="- China, October 2016-February 2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel avian" exact="influenza" post="A H7N9 and influenza A H3N2 viruses in Jiangsu"/>
   <result pre="2017MMWR201766925425528278147 9ZhuYQiXCuiLZhouMWangHHuman co-infection with novel avian influenza A H7N9 and" exact="influenza" post="A H3N2 viruses in Jiangsu province, ChinaLancet20133819883213423769236 10KileJCRenRLiuLet al.Update:"/>
   <result pre="2016–August 7, 2017MMWR2017663592893228880856 11GaoRCaoBHuYet al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med2013368201888189723577628 12CapuaIAlexanderDJAvian influenza: recent"/>
   <result pre="influenza: recent developmentsAvian Pathol200433439340415370036 13AlvarezPMattielloRRivaillerPet al.First isolation of an H1N1" exact="avian influenza" post="virus from wild terrestrial non-migratory birds in ArgentinaVirology20103961768419896684 14BaiQChenJChenZZengQIdentification"/>
   <result pre="recent developmentsAvian Pathol200433439340415370036 13AlvarezPMattielloRRivaillerPet al.First isolation of an H1N1 avian" exact="influenza" post="virus from wild terrestrial non-migratory birds in ArgentinaVirology20103961768419896684 14BaiQChenJChenZZengQIdentification"/>
   <result pre="Bigger DatasetsMol Biol Evol20163371870187427004904 17XiongXMartinSRHaireLFet al.Receptor binding by an H7N9" exact="influenza" post="virus from humansNature2013499745949649923787694 18MunierSLarcherTCormier-AlineFet al.A genetically engineered waterfowl influenza"/>
   <result pre="H7N9 influenza virus from humansNature2013499745949649923787694 18MunierSLarcherTCormier-AlineFet al.A genetically engineered waterfowl" exact="influenza" post="virus with a deletion in the stalk of the"/>
   <result pre="Respiratory TractScience2006312577239916556800 20LiZChenHJiaoPet al.Molecular basis of replication of duck H5N1" exact="influenza" post="viruses in a mammalian mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection"/>
   <result pre="mammalian mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection with possible precursor of" exact="avian influenza" post="A(H7N9) virus in a child, China, 2013Emerg Infect Dis20142081362136525061975"/>
   <result pre="mouse modelJ Virol20057918120581206416140781 21RenLYuXZhaoBet al.Infection with possible precursor of avian" exact="influenza" post="A(H7N9) virus in a child, China, 2013Emerg Infect Dis20142081362136525061975"/>
   <result pre="child, China, 2013Emerg Infect Dis20142081362136525061975 22RogersGNPaulsonJCDanielsRSSkehelJJWilsonIAWileyDCSingle amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificityNature1983304592176786191220 23ImaiMWatanabeTHattaMet al.Experimental adaptation of"/>
   <result pre="haemagglutinin change receptor binding specificityNature1983304592176786191220 23ImaiMWatanabeTHattaMet al.Experimental adaptation of an" exact="influenza" post="H5 haemagglutinin (HA) confers respiratory droplet transmission to a"/>
   <result pre="HA/H1N1 virus in ferretsNature2012486740342042822722205 24WangDYangLGaoRet al.Genetic tuning of the novel" exact="avian influenza" post="A(H7N9) virus during interspecies transmission, China, 2013Euro Surveill20141925 25LamTTHonCCTangJWUse"/>
   <result pre="virus in ferretsNature2012486740342042822722205 24WangDYangLGaoRet al.Genetic tuning of the novel avian" exact="influenza" post="A(H7N9) virus during interspecies transmission, China, 2013Euro Surveill20141925 25LamTTHonCCTangJWUse"/>
   <result pre="viral infectionsCrit Rev Clin Lab Sci201047154920367503 26WebsterRGBeanWJGormanOTChambersTMKawaokaYEvolution and ecology of" exact="influenza" post="A virusesMicrobiol Rev19925611521791579108 27SchrauwenEJHerfstSLeijtenLMet al.The multibasic cleavage site in"/>
   <result pre="in ferretsJ Virol20128673975398422278228 28ShinyaKMakinoAHattaMet al.Subclinical brain injury caused by H5N1" exact="influenza" post="virus infectionJ Virol201185105202520721389133 29ShinyaKMakinoATanakaHet al.Systemic dissemination of H5N1 influenza"/>
   <result pre="H5N1 influenza virus infectionJ Virol201185105202520721389133 29ShinyaKMakinoATanakaHet al.Systemic dissemination of H5N1" exact="influenza" post="A viruses in ferrets and hamsters after direct intragastric"/>
   <result pre="for a correlation of hemagglutinin cleavability and virulence of an" exact="avian influenza" post="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities"/>
   <result pre="a correlation of hemagglutinin cleavability and virulence of an avian" exact="influenza" post="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities"/>
   <result pre="A virusJ Virol1994685312031288151777 31McKimm-BreschkinJTrivediTHampsonAet al.Neuraminidase sequence analysis and susceptibilities of" exact="influenza" post="virus clinical isolates to zanamivir and oseltamivirAntimicrob Agents Chemother20034772264227212821478"/>
   <result pre="and virology of mild, severe and fatal human infections with" exact="avian influenza" post="A (H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human"/>
   <result pre="virology of mild, severe and fatal human infections with avian" exact="influenza" post="A (H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human"/>
   <result pre="(H7N9) virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human infection with" exact="avian influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="virusArch Virol201616151239125926887968 33ZhouLRenRYangLet al.Sudden increase in human infection with avian" exact="influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="Pac Surveill Response J201781614 34LiQZhouLZhouMet al.Epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in ChinaN Engl J Med2014370652053223614499 35SuSGuMLiuDet al.Epidemiology,"/>
   <result pre="Surveill Response J201781614 34LiQZhouLZhouMet al.Epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in ChinaN Engl J Med2014370652053223614499 35SuSGuMLiuDet al.Epidemiology,"/>
   <result pre="in ChinaTrends Microbiol201725971372828734617 36ShenYLuHQiTet al.Fatal cases of human infection with" exact="avian influenza" post="A (H7N9) virus in Shanghai, China in 2013Biosci Trends201591737825787912"/>
   <result pre="ChinaTrends Microbiol201725971372828734617 36ShenYLuHQiTet al.Fatal cases of human infection with avian" exact="influenza" post="A (H7N9) virus in Shanghai, China in 2013Biosci Trends201591737825787912"/>
   <result pre="Family PlanningPrevention and control measures of Human infection with H7N9" exact="influenza" post="virus in Shanghai municipalityAvailable from: http://www.wsjsw.gov.cn/xwfb/20180525/35470.htmlAccessed November 13, 2018Chinese"/>
   <result pre="Care Med201637450151127486732 39HeYLiuPTangSet al.Live poultry market closure and control of" exact="avian influenza" post="A(H7N9), Shanghai, ChinaEmerg Infect Dis20142091565156625148432 40collab: Shanghai Municipal Agricultural"/>
   <result pre="Med201637450151127486732 39HeYLiuPTangSet al.Live poultry market closure and control of avian" exact="influenza" post="A(H7N9), Shanghai, ChinaEmerg Infect Dis20142091565156625148432 40collab: Shanghai Municipal Agricultural"/>
   <result pre="from: http://www.gov.cn/jrzg/2013-04/23/content_2386475.htmAccessed November 13, 2018Chinese Figure 1 Confirmed cases of" exact="avian influenza" post="A(H7N9) virus infections in humans, birds, and the environment"/>
   <result pre="http://www.gov.cn/jrzg/2013-04/23/content_2386475.htmAccessed November 13, 2018Chinese Figure 1 Confirmed cases of avian" exact="influenza" post="A(H7N9) virus infections in humans, birds, and the environment"/>
   <result pre="Publicly released infections in the Disease Outbreak News (http://www.who.int/csr/don/en/) or" exact="avian influenza" post="report issued by the Department of Health, Government of"/>
   <result pre="released infections in the Disease Outbreak News (http://www.who.int/csr/don/en/) or avian" exact="influenza" post="report issued by the Department of Health, Government of"/>
   <result pre="2 Age, gender, and death distributions of confirmed cases of" exact="avian influenza" post="A(H7N9) virus infection during the five epidemics in Shanghai,"/>
   <result pre="Age, gender, and death distributions of confirmed cases of avian" exact="influenza" post="A(H7N9) virus infection during the five epidemics in Shanghai,"/>
   <result pre="circle. Abbreviation: NA, neuraminidase. Table 1 Confirmed human cases of" exact="avian influenza" post="A(H7N9) virus in Shanghai as of 31 December 2017"/>
   <result pre="Abbreviation: NA, neuraminidase. Table 1 Confirmed human cases of avian" exact="influenza" post="A(H7N9) virus in Shanghai as of 31 December 2017"/>
   <result pre="2 Amino acid homology (%) of the eight genes of" exact="avian influenza" post="A(H7N9) virus strains in Shanghai, China, 2013–2017 HA NA"/>
   <result pre="Amino acid homology (%) of the eight genes of avian" exact="influenza" post="A(H7N9) virus strains in Shanghai, China, 2013–2017 HA NA"/>
   <result pre="(%) of the surface HA and NA proteins between the" exact="avian influenza" post="A(H7N9) Shanghai strains and WHO-recommended vaccine candidates A/Anhui/1/2013 A/Shanghai/02/2013"/>
   <result pre="of the surface HA and NA proteins between the avian" exact="influenza" post="A(H7N9) Shanghai strains and WHO-recommended vaccine candidates A/Anhui/1/2013 A/Shanghai/02/2013"/>
   <result pre="NA, neuraminidase. Table 4 Characterization of key molecular markers of" exact="avian influenza" post="A(H7N9) viruses in Shanghai, 2013–2017 Gene Function Mutation Amino"/>
   <result pre="neuraminidase. Table 4 Characterization of key molecular markers of avian" exact="influenza" post="A(H7N9) viruses in Shanghai, 2013–2017 Gene Function Mutation Amino"/>
   <result pre="Amino acid Human Non-human Total HA* Increased binding to human-type" exact="influenza" post="receptor G186V G 3 2 5 V 25 25"/>
   <result pre="↓, cleavage site. Table 5 Signature amino acid mutations of" exact="avian influenza" post="A(H7N9) viruses in Shanghai with WHO-recommended vaccine candidates, 2013–2017"/>
   <result pre="cleavage site. Table 5 Signature amino acid mutations of avian" exact="influenza" post="A(H7N9) viruses in Shanghai with WHO-recommended vaccine candidates, 2013–2017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6256408\results\search\disease\results.xml">
   <result pre="historical and current data regarding the reemergence of St. Louis" exact="encephalitis" post="virus (SLEV; genus Flavivirus) in the Americas. Historically, SLEV"/>
   <result pre="virus (SLEV; genus Flavivirus) in the Americas. Historically, SLEV caused" exact="encephalitis" post="outbreaks in the United States; however, it was not"/>
   <result pre="is related to the epidemic strains isolated during a human" exact="encephalitis" post="outbreak in Córdoba, Argentina, in 2005. Ecoepidemiologic studies suggest"/>
   <result pre="populations of the eared dove (amplifying host). Keywords: St. Louis" exact="encephalitis" post="virus emerging infectious disease phylogeography arbovirus viruses United States"/>
   <result pre="eared dove (amplifying host). Keywords: St. Louis encephalitis virus emerging" exact="infectious disease" post="phylogeography arbovirus viruses United States Americas South America The"/>
   <result pre="States Americas South America The disease known as St. Louis" exact="encephalitis" post="(SLE) is caused by St. Louis encephalitis virus (SLEV),"/>
   <result pre="as St. Louis encephalitis (SLE) is caused by St. Louis" exact="encephalitis" post="virus (SLEV), identified as the causative agent of a"/>
   <result pre="(Figure 1). Figure 1 Geographic distribution of historical St. Louis" exact="encephalitis" post="human cases reported in the Americas through November 2017."/>
   <result pre="a febrile human suspected to have Argentinean hemorrhagic fever. Human" exact="encephalitis" post="cases were reported sporadically until 2005, when an unprecedented"/>
   <result pre="was detected (Spearman coefficient = 0.74) (22). The frequency of" exact="encephalomyelitis" post="varied from 80% of the cases in patients &amp;lt;20"/>
   <result pre="expansion (29). Figure 2 Phylogeny and spread of St. Louis" exact="encephalitis" post="virus (SLEV) in the Americas. A) Multiple sequence alignment"/>
   <result pre="fluid. All SLEV-infected patients (6) had an initial diagnosis of" exact="dengue fever" post="or viral encephalitis; 3 cases were diagnosed as viral"/>
   <result pre="viral meningoencephalitis, and the other 3 patients had signs of" exact="hemorrhagic disease" post="(32). This finding was the first reported link of"/>
   <result pre="was the first reported link of SLE infection and human" exact="hemorrhagic disease" post="(32). A blastn analysis (https://blast.ncbi.nlm.nih.gov/Blast.cgi) comparing genomes of different"/>
   <result pre="in Kern County during a 1952 outbreak of Western equine" exact="encephalitis" post="virus (33). SLEV caused periodic epidemics in humans and"/>
   <result pre="by metagenomic next-generation sequencing to diagnose a fatal case of" exact="meningoencephalitis" post="from SLEV in a patient from Kern County, California,"/>
   <result pre="viruses, including dengue (emerged in 1990), WNV (emerged in 1999)," exact="chikungunya" post="(2013), and Zika viruses (2015), have emerged as public"/>
   <result pre="Coffey LL, Burkett-Cadena N, Day JF. Reemergence of St. Louis" exact="encephalitis" post="virus in the Americas. Emerg Infect Dis. 2018 Dec"/>
   <result pre="and viruses. References References 1. ReisenWK. Epidemiology of St. Louis" exact="encephalitis" post="virus.Adv Virus Res. 2003;61:139–83. 10.1016/S0065-3527(03)61004-314714432 2. RodriguesSG, NunesMR, CassebSM,"/>
   <result pre="CassebSM, PrazeresAS, RodriguesDS, SilvaMO, et al.Molecular epidemiology of Saint Louis" exact="encephalitis" post="virus in the Brazilian Amazon: genetic divergence and dispersal.J"/>
   <result pre="1997. p. 1133–86. 5. DayJF, StarkLM. Frequency of Saint Louis" exact="encephalitis" post="virus in humans from Florida, USA: 1990-1999.J Med Entomol."/>
   <result pre="and oviposition before, during and after a widespread St. Louis" exact="encephalitis" post="epidemic in Florida.J Med Entomol. 1999;36:176–81. 10.1093/jmedent/36.2.17610083754 7. DayJF."/>
   <result pre="Florida.J Med Entomol. 1999;36:176–81. 10.1093/jmedent/36.2.17610083754 7. DayJF. Predicting St. Louis" exact="encephalitis" post="virus epidemics: lessons from recent, and not so recent,"/>
   <result pre="10.1146/annurev.ento.46.1.11111112165 8. ShamanJ, DayJF, StieglitzM. Drought-induced amplification of Saint Louis" exact="encephalitis" post="virus, Florida.Emerg Infect Dis. 2002;8:575–80. 10.3201/eid0806.01041712023912 9. EpsteinPR, DefilippoC."/>
   <result pre="FangY, ReisenWK. Previous infection with West Nile or St. Louis" exact="encephalitis" post="viruses provides cross protection during reinfection in house finches.Am"/>
   <result pre="West Nile virus on the natural history of St. Louis" exact="encephalitis" post="virus in Florida [dissertation]. Tampa (FL): University of South"/>
   <result pre="https://scholarcommons.usf.edu/cgi/viewcontent.cgi?referer=https://www.google.com/&amp;amp;httpsredir=1&amp;amp;article=1437&amp;amp;context=etd 14. DayJF, StarkLM. Avian serology in a St. Louis" exact="encephalitis" post="epicenter before, during, and after a widespread epidemic in"/>
   <result pre="FangY, GreenEN. Experimental infection of California birds with western equine" exact="encephalomyelitis" post="and St. Louis encephalitis viruses.J Med Entomol. 2003;40:968–82. 10.1603/0022-2585-40.6.96814765678"/>
   <result pre="of California birds with western equine encephalomyelitis and St. Louis" exact="encephalitis" post="viruses.J Med Entomol. 2003;40:968–82. 10.1603/0022-2585-40.6.96814765678 17. ReisenWK, LothropHD, WheelerSS,"/>
   <result pre="West Nile virus transmission and the apparent displacement St. Louis" exact="encephalitis" post="virus in southeastern California, 2003-2006.J Med Entomol. 2008;45:494–508.18533445 18."/>
   <result pre="19. collab: Centers for Disease Control and Prevention. Saint Louis" exact="encephalitis" post="virus: epidemiology and geographic distribution; 2017 [cited 2018 Jul"/>
   <result pre="Med Argent. 1968;82:267–9. 21. MettlerNE, CasalsJ. Isolation of St. Louis" exact="encephalitis" post="virus from man in Argentina.Acta Virol. 1971;15:148–54.4396413 22. SpinsantiLI,"/>
   <result pre="GlatsteinN, ArselánS, MoralesMA, FaríasAA, et al.Human outbreak of St. Louis" exact="encephalitis" post="detected in Argentina, 2005.J Clin Virol. 2008;42:27–33. 10.1016/j.jcv.2007.11.02218249032 23."/>
   <result pre="RéV, AlmirónWR, FaríasA, VázquezA, Sanchez-SecoMP, et al.Genotype III Saint Louis" exact="encephalitis" post="virus outbreak, Argentina, 2005.Emerg Infect Dis. 2006;12:1752–4. 10.3201/eid1211.06048617283629 24."/>
   <result pre="Albrieu LlinásG, VázquezA, TenorioA, ContigianiMS. Silent circulation of St. Louis" exact="encephalitis" post="virus prior to an encephalitis outbreak in Cordoba, Argentina"/>
   <result pre="Silent circulation of St. Louis encephalitis virus prior to an" exact="encephalitis" post="outbreak in Cordoba, Argentina (2005).PLoS Negl Trop Dis. 2012;6:e1489."/>
   <result pre="10.1371/journal.pntd.000148922303490 25. DiazLA, NemethNM, BowenRA, AlmironWR, ContigianiMS. Comparison of argentinean" exact="saint louis encephalitis" post="virus non-epidemic and epidemic strain infections in an avian"/>
   <result pre="DiazLA, NemethNM, BowenRA, AlmironWR, ContigianiMS. Comparison of argentinean saint louis" exact="encephalitis" post="virus non-epidemic and epidemic strain infections in an avian"/>
   <result pre="Virulence variation among epidemic and non-epidemic strains of Saint Louis" exact="encephalitis" post="virus circulating in Argentina.Mem Inst Oswaldo Cruz. 2014;109:197–201. 10.1590/0074-027613047524810175"/>
   <result pre="KonigheimBS, BorisAS, AguilarJJ, KomarN, et al.Activity patterns of St. Louis" exact="encephalitis" post="and West Nile viruses in free ranging birds during"/>
   <result pre="West Nile viruses in free ranging birds during a human" exact="encephalitis" post="outbreak in Argentina.PLoS One. 2016;11:e0161871. 10.1371/journal.pone.016187127564679 28. DíazA, FloresFS,"/>
   <result pre="of Argentinean bird species as amplifying hosts for St. Louis" exact="encephalitis" post="virus (Flavivirus, Flaviviridae).Am J Trop Med Hyg. 2018;99:216–21. 10.4269/ajtmh.17-085629761767"/>
   <result pre="BarreroPR, ViegasM, Alvarez LópezMC, MistchenkoAS. Molecular evidence of St. Louis" exact="encephalitis" post="virus infection in patients in Buenos Aires, Argentina.J Clin"/>
   <result pre="SantosCL, SallumMA, FrancoHM, OshiroFM, RoccoIM. Genetic characterization of St. Louis" exact="encephalitis" post="virus isolated from human in São Paulo, Brazil.Mem Inst"/>
   <result pre="32. MondiniA, CardealIL, LázaroE, NunesSH, MoreiraCC, RahalP, et al.Saint Louis" exact="encephalitis" post="virus, Brazil.Emerg Infect Dis. 2007;13:176–8. 10.3201/eid1301.06090517370543 33. ReevesWC, HammonWM,"/>
   <result pre="PeckBA, MoraSJ, et al.Epidemiological aspects of the 1984 St Louis" exact="encephalitis" post="epidemic in southern California.Proc Calif Mosq Vector Control Assoc."/>
   <result pre="et al.Ecological observations on the 1989 outbreak of St. Louis" exact="encephalitis" post="virus in the southern San Joaquin Valley of California.J"/>
   <result pre="36. TuellerJE. An outbreak of illness due to St. Louis" exact="encephalitis" post="virus in the southern San Joaquin Valley, California, 1989.Proc"/>
   <result pre="CamposEG, GruwellJ, FrancyDB, WomeldorfD, et al.Antibody prevalence of St. Louis" exact="encephalitis" post="virus in avian hosts in Los Angeles, California, 1986.J"/>
   <result pre="Los Angeles area for their ability to vector St. Louis" exact="encephalitis" post="virus.Proc Calif Mosq Vector Control Assoc.1986;54:9–10. 39. ReisenWK, MilbyMM,"/>
   <result pre="ReisenWK, MilbyMM, PresserSB, HardyJL. Ecology of mosquitoes and St. Louis" exact="encephalitis" post="virus in the Los Angeles Basin of California, 1987–1990.J"/>
   <result pre="CusackR, GreenEG, FangY, et al.Persistence and amplification of St. Louis" exact="encephalitis" post="virus in the Coachella Valley of California, 2000–2001.J Med"/>
   <result pre="HardyJL, JacksonAO. Genotypic and phenotypic variation of selected Saint Louis" exact="encephalitis" post="viral strains isolated in California.Am J Trop Med Hyg."/>
   <result pre="FeiszliT, PadgettK, SimpsonJ, BarkerCM, FangY, SalasM, et al.Surveillance for mosquito-borne" exact="encephalitis" post="virus activity in California, 2015.Proc Papers Mosq Vector Control"/>
   <result pre="FeiszliT, PadgettK, SimpsonJ, BarkerCM, FangY, SalasM, et al.Surveillance for mosquito-borne" exact="encephalitis" post="virus activity in California, 2016.Proc Papers Mosq Vector Control"/>
   <result pre="2016.Proc Papers Mosq Vector Control Assoc Calif.2017;85:9–14. 45. Saint Louis" exact="encephalitis" post="virus (SLEV) in California counties 2017 YTD; updated Jan"/>
   <result pre="WilsonMR, et al.Diagnosis of fatal human case of St. Louis" exact="encephalitis" post="virus infection by metagenomic sequencing, California, 2016.Emerg Infect Dis."/>
   <result pre="HennesseyM, JonesJ, AdamsL, FischerM, et al.Concurrent outbreaks of St. Louis" exact="encephalitis" post="virus and West Nile virus disease—Arizona, 2015.MMWR Morb Mortal"/>
   <result pre="SymmesK, SunP, FangY, GarciaS, SteinerC, et al.Reemergence of St. Louis" exact="encephalitis" post="virus, California, 2015.Emerg Infect Dis. 2016;22:2185–8. 10.3201/eid2212.16080527869600"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6264817\results\search\disease\results.xml">
   <result pre="Infectious Disease Surveillance A scoping review of published literature on" exact="chikungunya" post="virus A scoping review of published literature on chikungunya"/>
   <result pre="on chikungunya virus A scoping review of published literature on" exact="chikungunya" post="virus http://orcid.org/0000-0002-5947-6690MascarenhasMariolaConceptualizationData curationFormal analysisInvestigationMethodologyProject administrationSupervisionValidationWriting – original draftWriting –"/>
   <result pre="are accessible at https://doi.org/10.5061/dryad.qd65020. Introduction Chikungunya disease is caused by" exact="chikungunya" post="virus (CHIKV), a mosquito-borne alphavirus belonging to the family"/>
   <result pre="over in pain�? [2], describing the stooped posture of many" exact="chikungunya" post="afflicted patients due to severe joint pains and arthralgias,"/>
   <result pre="forming an Indian Ocean sub-lineage within ECSA [17–20]. The large" exact="chikungunya" post="epidemic in Brazil that started in late 2013 was"/>
   <result pre="as the scientific community, and facilitate decision-making on mitigation of" exact="chikungunya" post="and/or CHIKV competent vectors. Methods A ScR protocol was"/>
   <result pre="questions: &quot;What is the current state of research knowledge on" exact="chikungunya" post="virus (CHIKV), including its pathogenesis, attributes of clinical infection"/>
   <result pre="literature. The final search algorithm included two parts, one encompassing" exact="chikungunya" post="research and the other to capture additional research on"/>
   <result pre="Central and South America due to the recent emergence of" exact="chikungunya" post="in those regions. To verify that our search algorithm"/>
   <result pre="aspects of the review question: i.e., information on CHIKV and" exact="chikungunya" post="disease, competence parameters of CHIKV vectors, or control of"/>
   <result pre="environmental factors associated with CHIKV transmission, 6) economic burden of" exact="chikungunya" post="disease, or 7) modeling studies on chikungunya or CHIKV"/>
   <result pre="economic burden of chikungunya disease, or 7) modeling studies on" exact="chikungunya" post="or CHIKV vectors. Articles that did not meet the"/>
   <result pre="Checklist. The focus area researched most extensively was epidemiology of" exact="chikungunya" post="related to hosts and vectors, with a total of"/>
   <result pre="signs, symptoms and diagnosis of CHIKV in humans. Treatment for" exact="chikungunya" post="in humans was reported in 283/2326 (12%) studies, and"/>
   <result pre="103/2326 (4%), social impact examining knowledge, attitudes and perceptions of" exact="chikungunya" post="in various target human populations in 46/2326 (2%) studies,"/>
   <result pre="in tracking the quantity of research underpinning different areas of" exact="chikungunya" post="research. This ScR focuses on the detailed characteristics of"/>
   <result pre="mitigation practices 33 − − − − − Knowledge on" exact="chikungunya" post="disease 29 − − − − − Knowledge on"/>
   <result pre="experimental or trial stages. The efficacy of drugs to treat" exact="chikungunya" post="symptoms was assessed in 3/17 (18%) controlled trial studies"/>
   <result pre="systematic and purposeful programs mainly focussed on collecting numbers of" exact="chikungunya" post="patients without a rigid action plan. Passive surveillance, mainly"/>
   <result pre="epidemics was reported in 14/126 (11%) articles where data on" exact="chikungunya" post="patients were collected in a hospital or other healthcare"/>
   <result pre="of possible sequential CHIKV infection [112]. Risk factors for developing" exact="chikungunya" post="infection in humans were investigated in 345 studies. Landscape"/>
   <result pre="in the 0–14 age group [113]. Other risk factors for" exact="chikungunya" post="were pre-existing chronic conditions such as Type 2 diabetes,"/>
   <result pre="chikungunya were pre-existing chronic conditions such as Type 2 diabetes," exact="cardiovascular disease" post="[114–117] and obesity [118–119]. CHIKV epidemics Over 70 chikungunya"/>
   <result pre="conditions such as Type 2 diabetes, cardiovascular disease [114–117] and" exact="obesity" post="[118–119]. CHIKV epidemics Over 70 chikungunya epidemics have occurred"/>
   <result pre="cardiovascular disease [114–117] and obesity [118–119]. CHIKV epidemics Over 70" exact="chikungunya" post="epidemics have occurred in several countries across many continents"/>
   <result pre="2014 [21], [249] Central America/South America/Caribbean Suriname 2015 [250] Travel-related" exact="chikungunya" post="There were 215/1159 (19%) articles reporting travel-related CHIKV infections;"/>
   <result pre="symptoms days after returning to their home countries from a" exact="chikungunya" post="endemic country where they were exposed to the virus."/>
   <result pre="virus. Of the travel-related studies, 29/215 (13%) studied prevalence of" exact="chikungunya" post="infection among travelers. Clinical manifestation of acute phase CHIKV"/>
   <result pre="of 764/2326 (33%) articles reported clinical signs and symptoms of" exact="chikungunya" post="infection, of which 269/764 (35%) were case or case"/>
   <result pre="accepted triad of CHIKV symptoms is fever (539/764, 71%), itchy" exact="rash" post="(410/764, 54%) and joint pain (506/764, 66%), however, the"/>
   <result pre="including: headache (291/764, 38%), myalgia or muscle ache (246/764, 32%)," exact="conjunctivitis" post="(82/764, 11%), gastrointestinal symptoms such as nausea, vomiting, diarrhea"/>
   <result pre="32%), conjunctivitis (82/764, 11%), gastrointestinal symptoms such as nausea, vomiting," exact="diarrhea" post="or abdominal pain (218/764, 29%), and fatigue, malaise or"/>
   <result pre="disorders and 95/764 (12%) articles described neurological symptoms associated with" exact="chikungunya" post="disease. These results do not represent the frequency of"/>
   <result pre="articles. Atypical signs and symptoms Atypical signs and symptoms of" exact="chikungunya" post="infection were described in 121/764 (16%) articles, all with"/>
   <result pre="sequelae associated with CHIKV; Table 1. Persistent post-infection morbidities included" exact="tendinitis" post="(5/239; 2%), synovitis (14/239; 6%), balance disorders (1/239; 0.4%),"/>
   <result pre="CHIKV; Table 1. Persistent post-infection morbidities included tendinitis (5/239; 2%)," exact="synovitis" post="(14/239; 6%), balance disorders (1/239; 0.4%), and tunnel syndromes"/>
   <result pre="9/239 (4%) articles that reported Guillaine-Barré Syndrome (GBS) associated with" exact="chikungunya" post="infection. Other long term complications reported were chronic arthritis"/>
   <result pre="with chikungunya infection. Other long term complications reported were chronic" exact="arthritis" post="(163/239; 68%), neurological disorders such as encephalopathies (18/239; 8%),"/>
   <result pre="arthritis (163/239; 68%), neurological disorders such as encephalopathies (18/239; 8%)," exact="acute disseminated encephalomyelitis" post="(ADEM) (5/239; 2%), and ocular disorders (17/239; 7%). These"/>
   <result pre="68%), neurological disorders such as encephalopathies (18/239; 8%), acute disseminated" exact="encephalomyelitis" post="(ADEM) (5/239; 2%), and ocular disorders (17/239; 7%). These"/>
   <result pre="suggests that hyperferritinemia may be a potential marker of chronic" exact="chikungunya" post="disease [257]. Co-infections with CHIKV in humans Chikungunya co-infections"/>
   <result pre="109/1159 (9%) articles reporting co-infections with chikungunya: dengue (77/109; 71%)," exact="malaria" post="(13/109, 12%) and zika (9/109; 8%); Table 1. There"/>
   <result pre="reported with CHIKV is compiled in S5 Table. Treatment for" exact="chikungunya" post="infections in humans Chikungunya disease is generally managed through"/>
   <result pre="(25%) studies; Table 1. Antibiotics were prescribed as treatment for" exact="chikungunya" post="in 30/283 (11%) studies. There were 7/283 (2%) studies"/>
   <result pre="(2%) studies that described the use of antiviral drugs for" exact="chikungunya" post="treatment and 29/283 (10%) studies described using an anti-malarial"/>
   <result pre="described using an anti-malarial agent such as hydroxychloroquine to treat" exact="chikungunya" post="symptoms. A randomized controlled trial examining the effectiveness of"/>
   <result pre="randomized controlled trial examining the effectiveness of chloroquine to treat" exact="chikungunya" post="concluded that there is no justification for its use"/>
   <result pre="(5%) studies described the use of traditional medicine for treating" exact="chikungunya" post="and its symptoms. The efficacy of plant-based drugs (19"/>
   <result pre="medicines (8 studies) for treating acute and chronic symptoms of" exact="chikungunya" post="was assessed in experimental studies. CHIKV transmission in humans"/>
   <result pre="and intravascular coagulation [265]. Public knowledge, attitudes and perceptions of" exact="chikungunya" post="disease and CHIKV vectors Knowledge, attitudes and perceptions about"/>
   <result pre="cross-sectional articles; Table 1. Articles on attitudes and perceptions to" exact="chikungunya" post="disease focused on concerns about toxic or environmental effects"/>
   <result pre="(3/46; 7%), perception about the severity and risks associated with" exact="chikungunya" post="disease (16/46; 35%), and perception on the efficacy of"/>
   <result pre="various protective measures (13/46; 28%). Several studies evaluated knowledge on" exact="chikungunya" post="disease (29/46; 63%), CHIKV vectors (27/46; 59%) and behavioral"/>
   <result pre="CHIKV, of which 19/23 (83%%) studied the economic burden of" exact="chikungunya" post="disease in humans, 3/23 (13%) examined the cost-benefit of"/>
   <result pre="1. There was no validated and approved ready-to-use vaccine against" exact="chikungunya" post="for humans identified from our data analyses. However, there"/>
   <result pre="103/2326 (4%) modeling studies including quantitative risk assessment articles on" exact="chikungunya" post="disease or competent CHIKV vectors. Exposure to CHIKV, illness,"/>
   <result pre="CHIKV vectors. Exposure to CHIKV, illness, or costs attributed to" exact="chikungunya" post="disease in humans was the outcome modeled in 58/103"/>
   <result pre="the other twin was severely ill due to congenitally acquired" exact="chikungunya" post="[267]. Another study examining outcomes of CHIKV infection to"/>
   <result pre="is important to keep in mind that vertical transmission of" exact="chikungunya" post="in an asymptomatic infected mother or neonate can also"/>
   <result pre="mothers and neonates in maternity units. A single case of" exact="microcephaly" post="in a neonate born to a mother with gestational"/>
   <result pre="microcephaly in a neonate born to a mother with gestational" exact="chikungunya" post="infection has been described [290]. Microcephaly is believed to"/>
   <result pre="that this could be a coincidental finding, but CHIKV associated" exact="microcephaly" post="certainly warrants future research given that CHIKV and ZIKV"/>
   <result pre="for public health authorities and physicians to be aware of" exact="chikungunya" post="disease and the possible epidemic risks associated with the"/>
   <result pre="semen [74]. Pre-existing risk factors for developing chronic sequelae Although" exact="chikungunya" post="is a self-limiting disease, it can result in long"/>
   <result pre="that pre-existing morbidities can predispose an individual to more severe" exact="chikungunya" post="disease and chronic sequelae post-CHIKV infection [110] and that"/>
   <result pre="clinical manifestation of CHIKV illness can predict progression to chronic" exact="arthritis" post="[294]. The list of pre-existing morbidities in CHIKV patients"/>
   <result pre="and confidence in any potential association that might exist. Atypical" exact="chikungunya" post="disease Several studies described atypical and severe forms of"/>
   <result pre="chikungunya disease Several studies described atypical and severe forms of" exact="chikungunya" post="disease during both acute and convalescent phases, as well"/>
   <result pre="unexpected nasal skin necrosis in a few patients with severe" exact="chikungunya" post="disease [298]. It remains unclear whether this atypical sign"/>
   <result pre="ocular disease associated with chikungunya, ranging from varied forms of" exact="uveitis" post="and other manifestations, to complete blindness [299–300]. Five studies"/>
   <result pre="and other manifestations, to complete blindness [299–300]. Five studies described" exact="acute disseminated encephalomyelitis" post="(ADEM) in CHIKV patients from India [256, 301–304]. It"/>
   <result pre="manifestations, to complete blindness [299–300]. Five studies described acute disseminated" exact="encephalomyelitis" post="(ADEM) in CHIKV patients from India [256, 301–304]. It"/>
   <result pre="these outcomes. Other neurological complications were infrequently observed across early" exact="chikungunya" post="outbreaks, however, Guillain Barré Syndrome (GBS) is a relatively"/>
   <result pre="of CHIKV [27, 156, 247, 305–306]. A study on a" exact="chikungunya" post="epidemic in French Polynesia reported an increase in the"/>
   <result pre="reported to be associated with GBS [307]. Treatment Management of" exact="chikungunya" post="illness is predominantly supportive, with analgesics, steroids and NSAIDs"/>
   <result pre="contributed significantly to the global expansion of risk areas for" exact="chikungunya" post="and also highlights the plasticity of CHIKV and its"/>
   <result pre="the literature and are compiled in this ScR. Burden of" exact="chikungunya" post="disease One of the challenges of estimating the true"/>
   <result pre="other analyses that use surveillance data as inputs. Misclassification of" exact="chikungunya" post="as dengue or zika infections could also occur as"/>
   <result pre="SugunanAP, RaiSK, VijayachariP, ShriramAN, SharmaS, et al.Short report: Outbreak of" exact="chikungunya" post="fever, Dakshina Kannada District, South India, 2008. Am J"/>
   <result pre="BoumahniB, GerardinP, MichaultA, FourmaintrauxA, SchuffeneckerI, et al.Vertical maternal-fetal transmission of" exact="chikungunya" post="virus: ten cases on Reunion among 84 pregnant women."/>
   <result pre="DuranS, SandovalI, CastellanosJE. Easy and inexpensive molecular detection of dengue," exact="chikungunya" post="and zika viruses in febrile patients. Acta Trop201611;163:32–37. 10.1016/j.actatropica.2016.07.02127477452"/>
   <result pre="burden of disease caused by co-circulation and co-infection of dengue," exact="chikungunya" post="and Zika in the Americas. Travel Med Infect Dis2016May-Jun;14(3):177–179."/>
   <result pre="14Villamil-GomezWE, Rodriguez-MoralesAJ, Uribe-GarciaAM, Gonzalez-ArismendyE, CastellanosJE, CalvoEP, et al.Zika, dengue, and" exact="chikungunya" post="co-infection in a pregnant woman from Colombia. Int J"/>
   <result pre="15KhanAH, MoritaK, ParquetMdC, HasebeF, MathengeEGM, IgarashiA. Complete nucleotide sequence of" exact="chikungunya" post="virus and evidence for an internal polyadenylation site. J"/>
   <result pre="SuarezLAC, LabayoHKM, LilesVR, SalvozaNC, KlinzingDC, et al.Complete genome sequence of" exact="chikungunya" post="virus isolated in the Philippines. Genome Announcements2014;2(3):e00336–14. 9 ref."/>
   <result pre="Virol2010;84(13):6497–6504. 63 ref. 10.1128/JVI.01603-0920410280 18PowersAM, BraultAC, TeshRB, WeaverSC. Re-emergence of" exact="chikungunya" post="and o’nyong-nyong viruses: evidence for distinct geographical lineages and"/>
   <result pre="19SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyMC, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Medicine2006;3(7):e263 44"/>
   <result pre="PLoS Medicine2006;3(7):e263 44 ref. 10.1371/journal.pmed.003026316700631 20PowersAM, LogueCH. Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus. Journal of General"/>
   <result pre="27SuryawanshiSD, DubeAH, KhadseRK, JalgaonkarSV, SathePS, ZawarSD, et al.Clinical profile of" exact="chikungunya" post="fever in patients in a tertiary care centre in"/>
   <result pre="29YoosufAA, ShihamI, MohamedAJ, AliG, LunaJM, PandavR, et al.First report of" exact="chikungunya" post="from the Maldives. Trans R Soc Trop Med Hyg2009;103(2):192–196."/>
   <result pre="et al.Importance of case definition to monitor ongoing outbreak of" exact="chikungunya" post="virus on a background of actively circulating dengue virus,"/>
   <result pre="Eurosurveillance2014;19(13). 32LedransM, CassadouS, BoucauS, HucAnaisP, LeparcGoffartI, PratC, et al.Emergence of" exact="chikungunya" post="in the French overseas territories of the Americas: organization"/>
   <result pre="Eurosurveillance; 2014 0759;19(13):2; 81 ref. 34YamanishiH, SawayamaT, MatsumuraT. Multiplication of" exact="chikungunya" post="virus in male Culex pipiens molestus. Jap J Sanit"/>
   <result pre="ref. 35ViennetE, KnopeK, FaddyHM, WilliamsCR, HarleyD. Assessing the threat of" exact="chikungunya" post="virus emergence in Australia. Commun Dis Intell Q Rep2013630;37(2):E136–43."/>
   <result pre="65 ref.19476608 37TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog200712;3(12):e20110.1371/journal.ppat.003020118069894"/>
   <result pre="Infect Dis2011115;203(2):141–143. 10.1093/infdis/jiq02621288810 48HiggsS, ZieglerSA. A nonhuman primate model of" exact="chikungunya" post="disease. J Clin Invest20103;120(3):657–660. 10.1172/JCI4239220179348 49OgdenNH, LindsayLR, CoulthartM. Is"/>
   <result pre="Invest20103;120(3):657–660. 10.1172/JCI4239220179348 49OgdenNH, LindsayLR, CoulthartM. Is there a risk of" exact="chikungunya" post="transmission in Canada? (Special Issue: Chikungunya virus.). Canada Communicable"/>
   <result pre="53KarPK, NagpalBN, DuaVK, GhoshSK, RaghavendraK, BhattRM, et al.Molecular characterization of" exact="chikungunya" post="virus from Andhra Pradesh, India. Indian J Med Res20093;129(3):335–7;"/>
   <result pre="337. 19491431 54CassadouS, BoucauS, PetitSinturelM, HucP, LeparcGoffartI, LedransM. Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin Island,"/>
   <result pre="ref. 57GouldEA, GallianP, De LamballerieX, CharrelRN. First cases of autochthonous" exact="dengue fever" post="and chikungunya fever in France: from bad dream to"/>
   <result pre="De LamballerieX, CharrelRN. First cases of autochthonous dengue fever and" exact="chikungunya" post="fever in France: from bad dream to reality!Clin Microbiol"/>
   <result pre="reality!Clin Microbiol Infect201012;16(12):1702–1704. 10.1111/j.1469-0691.2010.03386.x21040155 58McCarthyM. First case of locally acquired" exact="chikungunya" post="is reported in US. BMJ2014;349. 59YactayoS, StaplesJE, MillotV, CibrelusL,"/>
   <result pre="ChenRB, YunRM, RossiSL, PlanteKS, GuerboisM, et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="and Humans. PLoS One2015108;10(10):e013948110.1371/journal.pone.013948126447467 68BandeiraAC, CamposGS, SardiSI, RochaVF, RochaGC. Neonatal" exact="encephalitis" post="due to Chikungunya vertical transmission: First report in Brazil."/>
   <result pre="10.1016/j.idcr.2016.07.00827500084 69MussoD, TeissierA, RouaultE, TeururaiS, de PinaJJ, NhanTX. Detection of" exact="chikungunya" post="virus in saliva and urine. Virol J2016616;13:102-016-0556-9. 70KeeACL, YangS,"/>
   <result pre="Hyg1996;90(1):31–33. 5 ref. 8730305 81DialloM, ThonnonJ, TraoreLamizanaM, FontenilleD. Vectors of" exact="chikungunya" post="virus in Senegal: current data and transmission cycles. Am"/>
   <result pre="ref.24393488 85NakgoiK, NitatpattanaN, WajjwalkuW, PongsopawijitP, KaewchotS, YoksanS, et al.Dengue, Japanese" exact="encephalitis" post="and Chikungunya virus antibody prevalence among captive monkey (Macaca"/>
   <result pre="94JuppPG, McIntoshBM. Aedes furcifer and other mosquitoes as vectors of" exact="chikungunya" post="virus at Mica, northeastern Transvaal, South Africa. J Am"/>
   <result pre="Assoc1990;6(3):415–420. 13 ref. 1977875 95NakaoE, HottaS. Immunogenicity of purified, inactivated" exact="chikungunya" post="virus in monkeys. Bull World Health Organ19735;48(5):559–562. 4204490 96BinnLN,"/>
   <result pre="of viremia and antibody observed in rhesus monkeys inoculated with" exact="chikungunya" post="and other serologically related group A arboviruses. Am J"/>
   <result pre="Hyg1968;62(2):269–277. 4384491 98McIntoshBM, SweetnamJ, McGillivrayGM, De SousaJ. Laboratory transmission of" exact="chikungunya" post="virus by Mansonia (Mansonioides) africana (Theobald). Ann Trop Med"/>
   <result pre="vector studies on six mosquito and one tick species with" exact="chikungunya" post="virus. Trans R Soc Trop Med Hyg1981;75(1):15–19. 12 ref."/>
   <result pre="Med Hyg1981;75(1):15–19. 12 ref. 6115488 104SempalaSDK, KiryaBG. Laboratory transmission of" exact="chikungunya" post="virus by Aedes (Stegomyia) apicoargenteus Theobald (Diptera, Culicidae). Am"/>
   <result pre="Journal of Hygiene1956;54(2):17713346078 106JainRuchi, AcharyaAS, JyotiKhandekar, JaisManoj. Entomo-epidemiological investigations of" exact="chikungunya" post="outbreak in Delhi, India. Annals of Tropical Medicine and"/>
   <result pre="Public Health2013;6(3):297–300. 18 ref. 107PuwarTapasvi, ShethJK, KohliVijay, YadavRajpal. Prevalence of" exact="chikungunya" post="in the city of Ahmedabad, India, during the 2006"/>
   <result pre="community-based study. (Special Issue: Cost and burden of dengue and" exact="chikungunya" post="from the Americas to Asia.). Dengue Bulletin; 201034:40–45 14"/>
   <result pre="108KannanM, RajendranR, SunishIP, BalasubramaniamR, ArunachalamN, ParamsivanR, et al.A study on" exact="chikungunya" post="outbreak during 2007 in Kerala, south India. Indian J"/>
   <result pre="de MastQ, WidjajaS, SudjanaP, AntonjayaU, Ma’roefC, et al.Evidence for endemic" exact="chikungunya" post="virus infections in Bandung, Indonesia. PLoS Negl Trop Dis20131024;7(10):e248310.1371/journal.pntd.000248324205417"/>
   <result pre="Dis201654;10(5):e000463010.1371/journal.pntd.000463027144588 116BorgheriniG, PoubeauP, StaikowskyF, LoryM, MoullecNl, BecquartJP, et al.Outbreak of" exact="chikungunya" post="on Reunion Island: early clinical and laboratory features in"/>
   <result pre="18 ref. 10.1016/j.jcv.2009.06.02719640780 118PadmakumarB, JayanJB, MenonRejeesh, KottaratharaAJ. Clinical profile of" exact="chikungunya" post="sequelae, association with obesity and rest during acute phase."/>
   <result pre="JayanJB, MenonRejeesh, KottaratharaAJ. Clinical profile of chikungunya sequelae, association with" exact="obesity" post="and rest during acute phase. Southeast Asian J Trop"/>
   <result pre="context. Population2008;63(3):491–518. 121LarrieuS, BalleydierE, RenaultP, BavilleM, FilleulL. Epidemiological surveillance du" exact="chikungunya" post="on Reunion Island from 2005 to 2011. (Special chikungunya.)"/>
   <result pre="BoissonV, LamballerieXd, FavierF, FontenilleD, et al.An interdisciplinary approach to controlling" exact="chikungunya" post="outbreaks on French islands in the south-west Indian Ocean."/>
   <result pre="in five districts of Kerala affected by the epidemic of" exact="chikungunya" post="fever in 2007. Natl Med J India2010Mar-Apr;23(2):82–84. 20925203 126BletteryM,"/>
   <result pre="Rhodesia. Cent Afr J Med19639;43:351–359. 130HalsteadSB, UdomsakdiS, SingharajP, NisalakA. Dengue" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. 3. Clinical,"/>
   <result pre="Hyg1967;61(5):725–735. 4383288 132ThiruvengadamKV, KalyanasundaramV, RajgopalJ. Clinical and pathological studies on" exact="chikungunya" post="fever in Madras city. Indian J Med Res1965;53(8):729–744. 5830407"/>
   <result pre="Med Res1967;55(1):1–12. 6036047 134CareyDE, MyersRM, DeranitzCM, JadhavM, ReubenR. The 1964" exact="chikungunya" post="epidemic at vellore, South India, including observations on concurrent"/>
   <result pre="Med Res19747;62(7):1005–1010. 4435911 137GhoshSN, SheikhBH. Investigations on the outbreak of" exact="dengue fever" post="in Ajmer City, Rajasthan in 1969. Part II: Result"/>
   <result pre="Indian J Med Res1974;62(4):523–533. 4435862 138PadbidriVS, GnaneswarTT. Epidemiological investigations of" exact="chikungunya" post="epidemic at Barsi, Maharashtra state, India. J Hyg Epidemiol"/>
   <result pre="Epidemiol Microbiol Immunol1979;23(4):445–451. 575900 139FourieED, MorrisonJG. Rheumatoid arthritic syndrome after" exact="chikungunya" post="fever. South African Medical Journal1979;56(4):130–132. 494034 140SaluzzoJF, CornetM, DigoutteJP."/>
   <result pre="LarasatiRP, BangsMJ, KosimR, Djauzi, et al.Tracking the re-emergence of epidemic" exact="chikungunya" post="virus in Indonesia. Trans R Soc Trop Med Hyg2005;99(2):128–141."/>
   <result pre="Surveill200622;11(2):E060202.1. 148PaquetC, QuatresousI, SoletJL, SissokoD, RenaultP, PierreV, et al.Epidemiology of" exact="chikungunya" post="virus infection on the Island of Reunion: situation on"/>
   <result pre="2006(hors serie):2–3. 5 ref. 149LedransM, QuatresousI, RenaultP, PierreV. Outbreak of" exact="chikungunya" post="in the French Territories, 2006: lessons learned. Euro surveillance:"/>
   <result pre="SoletJL, SissokoD, BalleydierE, LarrieuS, FilleulL, et al.A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005–2006. Am J"/>
   <result pre="the Reunion Island population in the context of the 2005–2006" exact="chikungunya" post="outbreak. (Special issue—What did we learn from the chikungunya"/>
   <result pre="2005–2006 chikungunya outbreak. (Special issue—What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005–2006?) [French]. Bulletin"/>
   <result pre="153DominguezM, EconomopoulouA, SissokoD, BoissonV, GauzereBA, PierreV, et al.Atypical forms of" exact="chikungunya" post="in epidemic period, Reunion Island, France, 2005–2006. (Special issue—What"/>
   <result pre="Island, France, 2005–2006. (Special issue—What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005–2006?) [French]. Bulletin"/>
   <result pre="ref. 154BrottetE, RenaultP, GlorieuxMonturyS, FrancoJM, TurquetM, BalleydierE, et al.Epidemic of" exact="chikungunya" post="virus infection on the Reunion Island, France, 2005–2006: description"/>
   <result pre="a surveillance network. (Special issue—What did we learn from the" exact="chikungunya" post="outbreak in the Indian Ocean in 2005–2006?) [French]. Bulletin"/>
   <result pre="TalarminF, GrivardP, SouabA, SchuffeneckerI, Le RouxK, et al.Prospective study of" exact="chikungunya" post="virus acute infection in the Island of La Réunion"/>
   <result pre="Mohammed BasheeruddinD, ChowdharyT, MadhuB. Cutaneous manifestations in patients suspected of" exact="chikungunya" post="disease. Indian J Dermatol2009;54(2):128–131. 10.4103/0019-5154.5318620101307 160JainS, KadriS, VenkateshS, LalS,"/>
   <result pre="KadriS, VenkateshS, LalS, KatyalR. Epidemiological investigation of an outbreak of" exact="chikungunya" post="in hyderabad and nalgonda districts of andhra pradesh, India."/>
   <result pre="HarisoaJ, RatovonjatoJ, BiacabeS, ReynesJM, ZellerH, et al.Outbreak of dengue and" exact="chikungunya" post="fevers, Toamasina, Madagascar, 2006. Emerging Infectious Diseases2008;14(7):1135–1137. 8 ref."/>
   <result pre="6 ref. 18338714 165JainSK, KumarKaushal, BhattacharyaD, VenkateshS, JainDC, ShivLal. Chikungunya" exact="viral disease" post="in district Bhilwara (Rajasthan) India. J Commun Dis2007;39(1):25–31. 11"/>
   <result pre="ReguK, MohananMK, BoraD, DhariwalAC, et al.Study on the eco-epidemiology of" exact="chikungunya" post="in U.T of Lakshadweep. J Commun Dis2009;41(2):81–92. 22010495 167SamuelPP,"/>
   <result pre="Commun Dis2009;41(2):81–92. 22010495 167SamuelPP, KrishnamoorthiR, HamzakoyaKK, AggarwalCS. Entomo-epidemiological investigations on" exact="chikungunya" post="outbreak in the Lakshadweep islands, Indian Ocean. Indian J"/>
   <result pre="of different systems of medicines and the present scenario of" exact="chikungunya" post="in Kerala. Asian Pacific Journal of Tropical Medicine2010;3(6):443–447. 15"/>
   <result pre="40 ref. 10.1089/vbz.2008.019019874187 170DokePP, DakhureDS, PatilAV. A clinico-epidemiological study of" exact="chikungunya" post="outbreak in Maharashtra state, India. Indian J Public Health2011;55(4):313–316."/>
   <result pre="171DwibediB, SabatJ, MahapatraN, KarSK, KerkettaAS, HazraRK, et al.Rapid spread of" exact="chikungunya" post="virus infection in Orissa: India. Indian J Med Res2011;133(3):316–321."/>
   <result pre="Med Res2011;133(3):316–321. 21 ref.21441687 172SeylerT, SakdapolrakP, Sanjeevi PrasadS, DhanrajR. A" exact="chikungunya" post="outbreak in the metropolis of Chennai, India, 2006. J"/>
   <result pre="cohort study. Journal of Tropical Medicine2012. 174RazmyAM. Clinical features of" exact="chikungunya" post="infection in Sri Lanka. Asian Pacific Journal of Tropical"/>
   <result pre="AliMK, DhillonGPS. Epidemiological and entomological aspects of an outbreak of" exact="chikungunya" post="in Lakshadweep Islands, India, during 2007. Dengue Bulletin2008;32:178–185. 177SanthoshSR,"/>
   <result pre="180AngeliniR, FinarelliAC, AngeliniP, PoC, PetropulacosK, MaciniP, et al.An outbreak of" exact="chikungunya" post="fever in the province of Ravenna, Italy. Euro Surveill200796;12(9):E070906.1."/>
   <result pre="Surveill200796;12(9):E070906.1. 181RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Transfus200810;6(4):199–210. 10.2450/2008.0016-0819112735 183SeylerT, RizzoC, FinarelliAC, PoC, AlessioP, SambriV, et al.Autochthonous" exact="chikungunya" post="virus transmission may have occurred in Bologna, Italy, during"/>
   <result pre="Euro Surveill2008117;13(3):801518445394 184MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
   <result pre="27 ref. 186LeroyEM, NkogheD, OllomoB, NzeNkogueC, BecquartP, GrardG, et al.Concurrent" exact="chikungunya" post="and dengue virus infections during simultaneous outbreaks, Gabon, 2007."/>
   <result pre="187ManimundaSP, VijayachariPaluru, UppoorRaghuraj, SugunanAP, SinghSS, RaiSK, et al.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
   <result pre="AngLiWei, TanBoonHian, TangChoonSiang, OoiPengLim, JamesL, et al.Epidemiology and control of" exact="chikungunya" post="fever in Singapore. J Infect2011;62(4):263–270. 10.1016/j.jinf.2011.02.00121315108 194SamIChing, ChanYokeFun, ChanShieYien,"/>
   <result pre="10.1016/j.jcv.2009.07.01619683467 195ThavaraU, TawatsinA, PengsakulT, BhakdeenuanP, ChanamaS, AnantapreechaS, et al.Outbreak of" exact="chikungunya" post="fever in Thailand and virus detection in field population"/>
   <result pre="ref. 198NakkharaP, ChongsuvivatwongV, ThammapaloS. Risk factors for symptomatic and asymptomatic" exact="chikungunya" post="infection. Trans R Soc Trop Med Hyg2013;107(12):789–796. 30 ref."/>
   <result pre="39 ref. 22662594 202PaupyC, Kassa KassaF, CaronM, NkogheD, LeroyEM. A" exact="chikungunya" post="outbreak associated with the vector Aedes albopictus in remote"/>
   <result pre="LarrieuS, RenaultP, BavilleM, FilleulL. How to explain the re-emergence of" exact="chikungunya" post="infection in Reunion Island in 2010?Acta Trop2012;123(2):85–90. 25 ref."/>
   <result pre="209GuravYK, GopalkrishnaV, ShahPS, PatilDR, MishraM, PaingankarMS, et al.An outbreak of" exact="chikungunya" post="in Jamshedpur, Jharkhand in 2011. Indian J Med Res2012;136(5):886–889."/>
   <result pre="10.3201/eid1909.13045123968609 215MoyenN, ThibervilleS-, PastorinoB, NougairedeA, ThirionL, MombouliJ-, et al.First reported" exact="chikungunya" post="fever outbreak in the republic of Congo, 2011. PLoS"/>
   <result pre="10.3201/eid2205.15126827088593 218HorwoodP, BandeG, DaginaR, GuillaumotL, AaskovJ, PavlinB. The threat of" exact="chikungunya" post="in Oceania. Western Pac Surveill Response J201364;4(2):8–10. 10.5365/WPSAR.2013.4.2.00324015365 219HorwoodPF,"/>
   <result pre="ConanA, DuongV, LyS, NganC, BuchyP, et al.A model for a" exact="chikungunya" post="outbreak in a rural Cambodian setting: implications for disease"/>
   <result pre="Penserga EG. A three-month follow up of musculoskeletal manifestions in" exact="chikungunya" post="fever. 2014. 224BalleraJE, ZapantaMJ, de los ReyesVC, SucalditoMN, TayagE."/>
   <result pre="2014. 224BalleraJE, ZapantaMJ, de los ReyesVC, SucalditoMN, TayagE. Investigation of" exact="chikungunya" post="fever outbreak in Laguna, Philippines, 2012. Western Pac Surveill"/>
   <result pre="space, and behaviors shape the spread of infectious diseases using" exact="chikungunya" post="as a case study. Proc Natl Acad Sci U"/>
   <result pre="ShimonoT, LamaningaoP, DarcyAW, MishimaN, et al.Co-circulation of the dengue with" exact="chikungunya" post="virus during the 2013 outbreak in the southern part"/>
   <result pre="Dominica. PLoS Negl Trop Dis2015814;9(8):e000397710.1371/journal.pntd.000397726274813 228KendrickK, StanekD, BlackmoreC. Transmission of" exact="chikungunya" post="virus in the continental United States—Florida, 2014. Morbidity and"/>
   <result pre="Giron S, Delisle E, Chappert JL, et al. Monitoring of" exact="chikungunya" post="and dengue in metropolitan France, 2014. 2015;. Accessed 13."/>
   <result pre="et al. Increase in cases of guillain-barre syndrome during a" exact="chikungunya" post="outbreak, French Polynesia, 2014 to 2015. 2015;. Accessed 48,"/>
   <result pre="Mondragon-CardonaAE, Rodriguez-MoralesAJ. From imported to an endemic disease: impact of" exact="chikungunya" post="virus disease in the hospital epidemiology, Tolima, Colombia, 2014–2015."/>
   <result pre="RomeroSE, Mercado ReyesM, Campo CareyA, Alarcon CruzA. Autochthonous transmission of" exact="chikungunya" post="in Colombia, October 2014. Informe Quincenal—Epidemiologico Nacional2014;19(20):312–340. 13 ref."/>
   <result pre="247CrosbyL, PerreauC, MadeuxB, CossicJ, ArmandC, Herrmann-StorkeC, et al.Severe manifestations of" exact="chikungunya" post="virus in critically ill patients during the 2013–2014 Caribbean"/>
   <result pre="252BabuK, KiniR, PhilipsM, SubbakrishnaDK. Clinical profile of isolated viral anterior" exact="uveitis" post="in a South Indian patient population. Ocul Immunol Inflamm201410;22(5):356–359."/>
   <result pre="10.3109/09273948.2013.84148224111839 253BabuK, AdigaM, GovekarSR, KumarBR, MurthyKR. Associations of Fuchs heterochromic" exact="iridocyclitis" post="in a South Indian patient population. J Ophthalmic Inflamm"/>
   <result pre="patients. Neuroimmunomodulation2014;21(6):338–346. 10.1159/00035824024776821 256DasSuman, SarkarNirmalya, MajumderJayitri, ChatterjeeKaushani, BholanathA. Acute disseminated" exact="encephalomyelitis" post="in a child with chikungunya virus infection. Journal of"/>
   <result pre="MajumderJayitri, ChatterjeeKaushani, BholanathA. Acute disseminated encephalomyelitis in a child with" exact="chikungunya" post="virus infection. Journal of Pediatric Infectious Diseases2014;9(1):37–41. 15 ref."/>
   <result pre="10.1093/cid/ciw58927578819 260d LamballerieX, BoissonV, ReynierJC, EnaultS, CharrelRN, FlahaultA, et al.On" exact="chikungunya" post="acute infection and chloroquine treatment. Vector Borne and Zoonotic"/>
   <result pre="Diseases2008;8(6):837–840. 10 ref. 10.1089/vbz.2008.004918620511 261PatersonHE, McIntoshBM. Further studies on the" exact="chikungunya" post="outbreak in southern Rhodesia in 1962. II. Transmission experiments"/>
   <result pre="Ann Trop Med Parasitol1964;58:52–55. 14147665 262ShahKV, BaronS. Laboratory infection with" exact="chikungunya" post="virus: a case report. Indian J Med Res1965;53(7):610–613. 5827506"/>
   <result pre="Res1965;53(7):610–613. 5827506 263ParolaP, LamballerieXd, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="Falleiros-ArlantLH, DuenasL, Pleitez-NavarreteJ, SalgadoDM, CastilloJB. Congenital and perinatal complications of" exact="chikungunya" post="fever: a Latin American experience. Int J Infect Dis201610;51:85–88."/>
   <result pre="MichaultA, BintnerM, RandrianaivoH, ChokerG, et al.Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the Island of La Reunion. PLoS"/>
   <result pre="Hyg19808;83(4):165–171. 7411679 273ErasmusJH, AugusteAJ, KaelberJT, LuoH, RossiSL, FentonK, et al.A" exact="chikungunya" post="fever vaccine utilizing an insect-specific virus platform. Nat Med20161219."/>
   <result pre="PerryJG, MangiaficoJA. Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg2000;62(6):681–685. 30"/>
   <result pre="Med Hyg2000;62(6):681–685. 30 ref. 11304054 275JenyoshikawaM, TangCS, NishibuchiM. Incidence of" exact="chikungunya" post="fever in Singapore: Implications of public health measures and"/>
   <result pre="Wkly Rep2016513;65(18):479–480. doi: 10.15585/mmwr.mm6518e327171600 277MoulayD, Aziz-AlaouiMA, KwonH-. Optimal control of" exact="chikungunya" post="disease: Larvae reduction, treatment and prevention. Mathematical Biosciences and"/>
   <result pre="efficacy of two poeciliid fish in indoor cement tanks against" exact="chikungunya" post="vector Aedes aegypti in villages in Karnataka, India. BMC"/>
   <result pre="Travel Medicine1999;6(2):137–139. 15 ref. 10381967 287Lourenco-de-OliveiraR, FaillouxA. High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="Pediatr201510;61(5):386–392. 10.1093/tropej/fmv05126246086 289SenanayakeMP, SenanayakeSM, VidanageKK, GunasenaS, LamabadusuriyaSP. Vertical transmission in" exact="chikungunya" post="infection. Ceylon Med J20096;54(2):47–50. 19670548 290PeterR, KrishnanL, AnandrajV, KuruvilaS."/>
   <result pre="ReceveurMC, SissokoD, et al.Factors associated with persistence of arthralgia among" exact="chikungunya" post="virus-infected travellers: report of 42 French cases. Journal of"/>
   <result pre="SUPPL.):12–19. 302TaraphdarD, RoyBK, ChatterjeeS. Chikungunya virus infection amongst the acute" exact="encephalitis" post="syndrome cases in West Bengal, India. Indian Journal of"/>
   <result pre="ref. 10.1097/CCM.0b013e318183f2d218679124 306LebrunG, ChaddaK, RebouxAH, MartinetO, GauzereBA. Guillain-Barre syndrome after" exact="chikungunya" post="infection. Emerging Infectious Diseases2009;15(3):495–496. 8 ref. 10.3201/eid1503.07148219239775 307BenoîtRozé, FatihaNajioullah,"/>
   <result pre="ref. 312ChemYK, ZainahS, BerendamSJ, RogayahTengku, KhairulAH, ChuaKB. Molecular epidemiology of" exact="chikungunya" post="virus in Malaysia since its first emergence in 1998."/>
   <result pre="313NyariN, MaanHS, SharmaS, PandeySN, DholeTN. Identification and genetic characterization of" exact="chikungunya" post="virus from Aedes mosquito vector collected in the Lucknow"/>
   <result pre="314ContevilleLC, ZanellaL, MarinMA, FilippisAM, NogueiraRM, VicenteAC, et al.Phylogenetic analyses of" exact="chikungunya" post="virus among travelers in Rio de Janeiro, Brazil, 2014–2015."/>
   <result pre="GreigJ, YoungI, HierlihyC, MascarenhasM. Risk perceptions, attitudes, and knowledge of" exact="chikungunya" post="among the public and health professionals: a systematic review."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6276411\results\search\disease\results.xml">
   <result pre="provided the original work is properly cited. Abstract Bovine viral" exact="diarrhea" post="virus (BVDV) affects cows, pigs, sheep, goats, and other"/>
   <result pre="Province18ZD0442 Xichang CollegeLGZ201712 China Scholarship CouncilCSC201408515154 1. Introduction Bovine viral" exact="diarrhea" post="virus–1 (BVDV–1) and BVDV–2, together with classical swine fever"/>
   <result pre="genus Pestivirus, family FlaviviridaeJournal of General Virology20179882106211210.1099/jgv.0.00087328786787 5RidpathJ. F.Bovine viral" exact="diarrhea" post="virus: global statusVeterinary Clinics of North America: Food Animal"/>
   <result pre="P.EdmondsonM. A.et al.Experimental infection of pregnant goats with bovine viral" exact="diarrhea" post="virus (BVDV) 1 or 2Veterinary Research2014451p. 38 7AbeY.TamuraT.ToriiS.et al.Genetic"/>
   <result pre="Research2014451p. 38 7AbeY.TamuraT.ToriiS.et al.Genetic and antigenic characterization of bovine viral" exact="diarrhea" post="viruses isolated from cattle in Hokkaido, JapanJournal of Veterinary"/>
   <result pre="unique recent isolates of highly virulent type 2 bovine viral" exact="diarrhea" post="virus detected by deep sequencingJournal of Virology201488126983699210.1128/JVI.00620-1424719408 12YeşilbağK.AlpayG.BecherP.Variability and"/>
   <result pre="Virology201488126983699210.1128/JVI.00620-1424719408 12YeşilbağK.AlpayG.BecherP.Variability and global distribution of subgenotypes of bovine viral" exact="diarrhea" post="virusViruses20179p. 128 13MaoL.LiW.YangL.et al.Primary surveys on molecular epidemiology of"/>
   <result pre="128 13MaoL.LiW.YangL.et al.Primary surveys on molecular epidemiology of bovine viral" exact="diarrhea" post="virus 1 infecting goats in Jiangsu province, ChinaBMC Veterinary"/>
   <result pre="ChinaBMC Veterinary Research201612p. 181 14DengY.SunC.-Q.CaoS.-J.et al.High prevalence of bovine viral" exact="diarrhea" post="virus 1 in Chinese swine herdsVeterinary Microbiology20121593-449049310.1016/j.vetmic.2012.04.02322613254 15WeberM. N.SilveiraS.MachadoG.et"/>
   <result pre="swine herdsVeterinary Microbiology20121593-449049310.1016/j.vetmic.2012.04.02322613254 15WeberM. N.SilveiraS.MachadoG.et al.High frequency of bovine viral" exact="diarrhea" post="virus type 2 in Southern BrazilVirus Research2014191111712410.1016/j.virusres.2014.07.03525109547 16MariV.LosurdoM.LucenteM. S.et"/>
   <result pre="Research2014191111712410.1016/j.virusres.2014.07.03525109547 16MariV.LosurdoM.LucenteM. S.et al.Multiplex real-time RT-PCR assay for bovine viral" exact="diarrhea" post="virus type 1, type 2 and HoBi-like pestivirusJournal of"/>
   <result pre="Evolution20163371870187410.1093/molbev/msw05427004904 19NelsonD. D.DarkM. J.BradwayD. S.et al.Evidence for persistent Bovine viral" exact="diarrhea" post="virus infection in a captive mountain goat (Oreamnos americanus)Journal"/>
   <result pre="americanus)Journal of Veterinary Diagnostic Investigation200820675275910.1177/10406387080200060618987224 20XueF.ZhuY.-M.LiJ.et al.Genotyping of bovine viral" exact="diarrhea" post="viruses from cattle in China between 2005 and 2008Veterinary"/>
   <result pre="Microbiology201014337938320036078 21ZhongF.LiN.HuangX.et al.Genetic typing and epidemiologic observation of bovine viral" exact="diarrhea" post="virus in Western ChinaVirus Genes201142220420710.1007/s11262-010-0558-421132458 22GaoS.LuoJ.DuJ.et al.Serological and molecular"/>
   <result pre="infection of Bactrian camels with multiple subgenotypes of bovine viral" exact="diarrhea" post="virus in Western ChinaVeterinary Microbiology20131631-217217610.1016/j.vetmic.2012.12.01523313538 23XuX.ZhangQ.YuX.et al.Sequencing and comparative"/>
   <result pre="23XuX.ZhangQ.YuX.et al.Sequencing and comparative analysis of a pig bovine viral" exact="diarrhea" post="virus genomeVirus Research20061221-216417010.1016/j.virusres.2006.05.00516854490 Figure 1 Phylogenetic tree of a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6293039\results\search\disease\results.xml">
   <result pre="properly cited.ciy486.pdf Abstract Abstract A Ugandan child with an unexplained" exact="encephalitis" post="was investigated using viral metagenomics. Several sequences from all"/>
   <result pre="hometown of the patient. virus discovery orthobunyavirus CNS infection Uganda" exact="encephalitis" post="Funding Academic Medical Center602525 European Union Horizon 2020 Innovative721367"/>
   <result pre="She displayed decorticate posturing, had absent corneal reflexes, and had" exact="papilledema" post="on funduscopy. On laboratory examination, her haemoglobin level was"/>
   <result pre="5 total cells/mm3, and normal glucose and protein levels. A" exact="malaria" post="blood slide was negative, and the bacterial CSF culture"/>
   <result pre="syndrome of decreased consciousness, fever, and seizures in absence of" exact="malaria" post="parasitaemia (ruling out cerebral malaria) were suggestive of an"/>
   <result pre="malaria parasitaemia (ruling out cerebral malaria) were suggestive of an" exact="encephalitis" post="[6]. Consequently, real-time polymerase chain reactions (PCRs) of herpes"/>
   <result pre="an encephalitis [6]. Consequently, real-time polymerase chain reactions (PCRs) of" exact="herpes simplex" post="virus 1 and 2, varicella zoster virus, parechovirus, enterovirus,"/>
   <result pre="1 and 2, varicella zoster virus, parechovirus, enterovirus, mumps, and" exact="rubella" post="virus were performed in CSF, but all were negative."/>
   <result pre="which both are known to occur during severe forms of" exact="encephalitis" post="[9]. Alternatively, direct neuronal damage by the infection or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6293476\results\search\disease\results.xml">
   <result pre="developed that target Rev-erbα/β to improve metabolic dysfunction of diet-induced" exact="obesity" post="in mice and inhibit inflammatory response in immune cells"/>
   <result pre="were infected with O’nyong’nyong virus (ONNV; MOI 5), GFP-expressing vesicular" exact="stomatitis" post="virus (VSV-GFP; MOI 0.5), or Zika virus (ZIKV; MOI"/>
   <result pre="TNFα, CCL2, and MMP9) (Figure 2B), which are involved in" exact="rheumatoid arthritis" post="[14] and implicated in alphavirus-induced joint pathology [15]. Additional"/>
   <result pre="CCL2, and MMP9) (Figure 2B), which are involved in rheumatoid" exact="arthritis" post="[14] and implicated in alphavirus-induced joint pathology [15]. Additional"/>
   <result pre="overview. Nat Rev Rheumatol2012; 8:420–9.22565316 2.SchwartzO, AlbertMLBiology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol2010; 8:491–500.20551973 3.BurtFJ, ChenW, MinerJJ, et"/>
   <result pre="Infect Dis2017; 17:e107–17.28159534 4.RezzaG, ChenR, WeaverSCO’nyong-nyong fever: a neglected mosquito-borne" exact="viral disease." post="Pathog Glob Health2017; 111(6):271–5.28829253 5.EverettLJ, LazarMANuclear receptor Rev-erbα: up,"/>
   <result pre="4:247–61.28831712 15.ChenW, FooSS, SimsNA, et al.Arthritogenic alphaviruses: new insights into" exact="arthritis" post="and bone pathology. Trends Microbiol2015; 23:35–43.25449049"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6298241\results\search\disease\results.xml">
   <result pre="KD including fever, rash, mucosal changes, conjunctival erythema, and cervical" exact="lymphadenopathy" post="are all compatible with an infectious illness, and many"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6299979\results\search\disease\results.xml">
   <result pre="CentralLondon pmcid: 62999792274 doi: 10.1186/s13054-018-2274-8 : Research Estimating severity of" exact="influenza" post="epidemics from severe acute respiratory infections (SARI) in intensive"/>
   <result pre="infections (SARI) in the ICU and how this varies between" exact="influenza" post="epidemics. Methods We analyzed weekly ICU admissions in the"/>
   <result pre="ratio. These parameters were calculated both yearly and per separate" exact="influenza" post="epidemic (defined epidemic weeks). A SARI syndrome was defined"/>
   <result pre="syndrome was defined as admission diagnosis being any of six" exact="pneumonia" post="or pulmonary sepsis codes in the APACHE IV prognostic"/>
   <result pre="model. Influenza epidemic periods were retrieved from primary care sentinel" exact="influenza" post="surveillance data. Results Annually, an average of 13% of"/>
   <result pre="weeks (minimum 5% to maximum 25% per week). Admissions for" exact="bacterial pneumonia" post="(59%) and pulmonary sepsis (25%) contributed most to ICU"/>
   <result pre="(minimum 5% to maximum 25% per week). Admissions for bacterial" exact="pneumonia" post="(59%) and pulmonary sepsis (25%) contributed most to ICU"/>
   <result pre="(25%) contributed most to ICU SARI. Between the eight different" exact="influenza" post="epidemics under study, the value of each of the"/>
   <result pre="In the ICU there is great variation between the yearly" exact="influenza" post="epidemic periods in terms of different influenza severity parameters."/>
   <result pre="between the yearly influenza epidemic periods in terms of different" exact="influenza" post="severity parameters. The parameters also complement each other by"/>
   <result pre="Organization, thereby would provide insight into the severity of ongoing" exact="influenza" post="epidemics, which differ from season to season. Electronic supplementary"/>
   <result pre="that can be used to assess the severity of every" exact="influenza" post="epidemic, whether seasonal or pandemic, and creating a historical"/>
   <result pre="(initial) diagnoses that can be monitored as an indicator of" exact="infectious disease" post="trends, outbreaks, and burden [8]. The most important complication"/>
   <result pre="trends, outbreaks, and burden [8]. The most important complication of" exact="influenza" post="virus infection is pneumonia (primary viral or secondary bacterial"/>
   <result pre="[8]. The most important complication of influenza virus infection is" exact="pneumonia" post="(primary viral or secondary bacterial pneumonia) [9]. While costs"/>
   <result pre="and response considering that vaccination, the main control measure against" exact="influenza" post="infection, is aimed at preventing complications. A severe influenza"/>
   <result pre="against influenza infection, is aimed at preventing complications. A severe" exact="influenza" post="season may also lead to hospital capacity problems, especially"/>
   <result pre="any of the six respiratory codes for pulmonary sepsis or" exact="pneumonia" post="(Table 2). Patients can have up to two APACHE"/>
   <result pre="of patients with ILI for virological examination to determine whether" exact="influenza" post="virus is circulating in the general population [20]. Epidemic"/>
   <result pre="the nine seasons in the study period there were eight" exact="influenza" post="epidemics of varying duration (based on all age groups"/>
   <result pre="of varying duration (based on all age groups combined). While" exact="influenza" post="was circulating and ILI incidence crossed the threshold twice"/>
   <result pre="twice but not in consecutive weeks, retrospectively there was no" exact="influenza" post="epidemic in 2011/2012. We further selected ILI in patients"/>
   <result pre="complete season-years and we described ICU SARI characteristics during defined" exact="influenza" post="epidemics: incidence (cumulated over the epidemic weeks), rate (per"/>
   <result pre="incidence (i.e. the highest registered weekly SARI incidence during an" exact="influenza" post="epidemic), and the SARI/ILI ratio (the number of SARI"/>
   <result pre="first present overall yearly characteristics of SARI patients (irrespective of" exact="influenza" post="epidemic weeks); second, we provide SARI characteristics specifically per"/>
   <result pre="influenza epidemic weeks); second, we provide SARI characteristics specifically per" exact="influenza" post="epidemic. Overall ICU SARI characteristics irrespective of influenza epidemic"/>
   <result pre="specifically per influenza epidemic. Overall ICU SARI characteristics irrespective of" exact="influenza" post="epidemic periods Total ICU SARI admissions (irrespective of influenza"/>
   <result pre="of influenza epidemic periods Total ICU SARI admissions (irrespective of" exact="influenza" post="epidemics) From January 2007 to December 2016 there were"/>
   <result pre="the Netherlands. Year-to-year and week-to-week ICU SARI admissions (irrespective of" exact="influenza" post="epidemics) The overall proportion of ICU SARI admissions were"/>
   <result pre="in-ICU SARI mortality per year (all ages combined) (grey shading:" exact="influenza" post="epidemic weeks) Distribution of diagnoses in the ICU SARI-syndrome"/>
   <result pre="Distribution of diagnoses in the ICU SARI-syndrome group (irrespective of" exact="influenza" post="epidemics) The diagnoses contributing most to SARI admissions were"/>
   <result pre="Clinical severity: APACHE IV score and in-ICU mortality (irrespective of" exact="influenza" post="epidemics) While the number of ICU SARI admissions always"/>
   <result pre="0.64, p value &amp;lt;0.0001) (Fig. 1). ICU SARI characteristics during" exact="influenza" post="epidemics ICU SARI admissions during influenza epidemics The standardized"/>
   <result pre="ICU SARI characteristics during influenza epidemics ICU SARI admissions during" exact="influenza" post="epidemics The standardized ICU SARI incidence during the eight"/>
   <result pre="influenza epidemics The standardized ICU SARI incidence during the eight" exact="influenza" post="epidemics varied between 558 (in 2013/2014) and 2400 (in"/>
   <result pre="and 2400 (in 2014/2015; the latter being the longest registered" exact="influenza" post="epidemic in the Netherlands, lasting 20 weeks). Peak weekly incidence"/>
   <result pre="varied (occurring at the beginning, middle, or end of an" exact="influenza" post="epidemic (Table 3). By influenza epidemic, the ICU SARI"/>
   <result pre="middle, or end of an influenza epidemic (Table 3). By" exact="influenza" post="epidemic, the ICU SARI rate varied between 0.40 and"/>
   <result pre="adult ICU and adult ILI in sentinel GP surveillance during" exact="influenza" post="epidemics Season Influenza epidemic (week numbers)b Epidemic duration (weeks)"/>
   <result pre="dominance with slightly more A(H3N2) than A(H1N1)pdm09, low circulation of" exact="influenza" post="B. 2014/2015 49–13 and 15–17 20 2386 2368 1701"/>
   <result pre="2368 1701 1764 1.34 7 153 A(H3N2) dominance followed by" exact="influenza" post="B 2015/2016 53–11 12 1693 1693 1103 1103 1.53"/>
   <result pre="illness, NA Not applicable as there was no retrospectively registered" exact="influenza" post="epidemic aILI in the age group of 15 years and"/>
   <result pre="season 2015/2016 fThe highest registered weekly SARI incidence during an" exact="influenza" post="epidemic The relationship between ICU SARI and ILI incidence"/>
   <result pre="epidemic The relationship between ICU SARI and ILI incidence during" exact="influenza" post="epidemics (ICU SARI/ILI ratio) The three long epidemics of"/>
   <result pre="between the ICU SARI incidence and ILI incidence varies by" exact="influenza" post="epidemic and lies between 1.3 and 2.7. This means"/>
   <result pre="in the Dutch population (Table 4). In other words, per" exact="influenza" post="epidemic, the estimated ILI rate in the total Dutch"/>
   <result pre="than the ICU SARI rate. For example, in the 2015/2016" exact="influenza" post="epidemic there were 1693 adult ICU SARI admissions and"/>
   <result pre="ICU and ILI rates in the Dutch adult population during" exact="influenza" post="epidemics Season Total Dutch population size (aged 15+ years)a"/>
   <result pre="illness, NA Not applicable as there was no retrospectively registered" exact="influenza" post="epidemic aGiven for January–December of the first mentioned year"/>
   <result pre="Dutch population dThe highest registered weekly SARI incidence during an" exact="influenza" post="epidemic The dominant circulating influenza strain(s) varied between the"/>
   <result pre="weekly SARI incidence during an influenza epidemic The dominant circulating" exact="influenza" post="strain(s) varied between the epidemics with H1N1, H3N2, mixed"/>
   <result pre="epidemics with H1N1, H3N2, mixed H1N1&amp;amp;H3N2, and mixed domination with" exact="influenza" post="B occurring in the study period (Table 3). The"/>
   <result pre="depend clearly on the dominant subtype. APACHE IV score during" exact="influenza" post="epidemics On average the mean score from the APACHE"/>
   <result pre="the youngest three age-groups. The average APACHE IV score per" exact="influenza" post="epidemic varied most in the youngest age group at"/>
   <result pre="not coincide in the different age groups. In-ICU mortality during" exact="influenza" post="epidemics During the eight different influenza epidemics, the proportion"/>
   <result pre="groups. In-ICU mortality during influenza epidemics During the eight different" exact="influenza" post="epidemics, the proportion of in-ICU deaths among all medical"/>
   <result pre="proportion of ICU SARI deaths and the duration of the" exact="influenza" post="epidemic (R2 − 0.12, p value 0.78), the ICU SARI"/>
   <result pre="of ICU SARI and how these vary between the different" exact="influenza" post="epidemics in the Netherlands. It shows how different parameters,"/>
   <result pre="shows how different parameters, proposed by the WHO for monitoring" exact="influenza" post="severity [7], can vary greatly by season and that"/>
   <result pre="provide insight into different aspects of the severity of separate" exact="influenza" post="seasons. The ratio of ILI to ICU SARI admissions"/>
   <result pre="The ratio of ILI to ICU SARI admissions varied from" exact="influenza" post="epidemic to influenza epidemic confirming that the intensive care"/>
   <result pre="ILI to ICU SARI admissions varied from influenza epidemic to" exact="influenza" post="epidemic confirming that the intensive care burden of influenza"/>
   <result pre="to influenza epidemic confirming that the intensive care burden of" exact="influenza" post="is not predictable from ILI trends [25]. Depending on"/>
   <result pre="expected to be higher in respiratory seasons. During the eight" exact="influenza" post="epidemics under study, ICU SARI peaked at (min, max)"/>
   <result pre="gain allowing capacity planning instead of on-the-spur crisis management. For" exact="influenza" post="severity assessment, monitoring a SARI syndrome instead of specific"/>
   <result pre="of use as distinguishing between bacterial and viral causes of" exact="pneumonia" post="is difficult and bacterial pneumonia is often secondary to"/>
   <result pre="between bacterial and viral causes of pneumonia is difficult and" exact="bacterial pneumonia" post="is often secondary to viral infection [26–28]. Only 4.7%"/>
   <result pre="bacterial and viral causes of pneumonia is difficult and bacterial" exact="pneumonia" post="is often secondary to viral infection [26–28]. Only 4.7%"/>
   <result pre="infection [26–28]. Only 4.7% of the diagnoses are registered as" exact="viral pneumonia," post="which may be an underestimation: laboratory data are not"/>
   <result pre="SARI cases could not be determined. Furthermore, laboratory testing for" exact="influenza" post="virus or other respiratory viruses is not standard practice"/>
   <result pre="than half of patients admitted to the ICU with suspected" exact="pneumonia" post="are tested [29]. Notably in our data, in the"/>
   <result pre="admission. Another limitation is that no data were available on" exact="influenza" post="vaccination status or use of oseltamivir. In terms of"/>
   <result pre="use of oseltamivir. In terms of the highest extremes, notable" exact="influenza" post="epidemics are those of 2007/2008, 2012/2013, and 2014/2015 for"/>
   <result pre="SARI/ILI ratio indicating a lower than average ICU burden per" exact="influenza" post="infection in that year. The dominant virus in the"/>
   <result pre="The dominant virus in the following epidemic (2010/2011) was also" exact="influenza" post="virus A(H1N1)pdm09, showing no drift to the previous season"/>
   <result pre="indication of flu season severity. Mortality can be high in" exact="pneumonia" post="hospitalizations, but to date the burden of influenza mortality"/>
   <result pre="high in pneumonia hospitalizations, but to date the burden of" exact="influenza" post="mortality remains uncertain and is estimated mostly from modeling"/>
   <result pre="In our study, in-ICU mortality in patients with SARI during" exact="influenza" post="epidemics varied between 13% and 20%. To what extent"/>
   <result pre="and 20%. To what extent this reflects differing severities of" exact="influenza" post="seasons is not entirely clear because SARI can be"/>
   <result pre="or survival to hospital discharge) would improve the estimate of" exact="influenza" post="impact. An important strength of our study is that"/>
   <result pre="being relatively restrictive. In Germany, retrospectively, ICU SARI admissions during" exact="influenza" post="epidemics peaked at 17% [2], in the range of"/>
   <result pre="observed in the different epidemics. Of hospitalized SARI in Belgium," exact="influenza" post="was laboratory-diagnosed in 46%, and approximately 10% of SARI"/>
   <result pre="be around 10-fold higher than SARI in ICUs and that" exact="influenza" post="can potentially play a large role in overall SARI"/>
   <result pre="role in overall SARI admissions. Some other countries record laboratory-confirmed" exact="influenza" post="infections in ICUs, but without tracking a denominator or"/>
   <result pre="(NICE). Influenza severity measures proposed by the WHO vary by" exact="influenza" post="epidemic and cannot be deduced from ILI surveillance alone,"/>
   <result pre="score and mortality in adult ICUs (2007–2016). Footnote: gray shading:" exact="influenza" post="epidemic weeks as derived from ILI sentinel surveillance data."/>
   <result pre="In-ICU mortality and APACHE IV scores among ICU admissions during" exact="influenza" post="epidemics. Footnote: *0 consecutive weeks crossed the ILI epidemic"/>
   <result pre="affiliations. References References 1.Scientific Institute of Public Health Belgium: Seasonal" exact="influenza" post="surveillance Belgium - overview season 2016–20172017. Available from: https://epidemio.wiv-isp.be/ID/diseases/SiteAssets/Pages/Influenza/End%20of%20season%202016-2017.pdf"/>
   <result pre="description of the system and first results from five recent" exact="influenza" post="seasonsBMC Public Health201717161210.1186/s12889-017-4515-128666433 3.MeerhoffTJSimakuAUlqinakuDTorosyanLGribkovaNShimanovichVet al.Surveillance for severe acute respiratory"/>
   <result pre="Assessment (PISA): a WHO guide to assess the severity of" exact="influenza" post="epidemics and pandemics2017 18 July 2018. Available from: http://www.who.int/influenza/surveillance_monitoring/pisa/guidance/en/"/>
   <result pre="of syndromic surveillance in EuropeLancet (London, England)2011378210.1016/S0140-6736(11)60834-9 9.DavisBMAielloAEDawidSRohaniPShresthaSFoxmanBInfluenza and community-acquired" exact="pneumonia" post="interactions: the impact of order and time of infection"/>
   <result pre="and time of infection on population patternsAm J Epidemiol2012175536336710.1093/aje/kwr40222247048 10.ChalmersJCamplingJEllsburyGHawkeyPMMadhavaHSlackMCommunity-acquired" exact="pneumonia" post="in the United Kingdom: a call to actionPneumonia (Nathan)201791510.1186/s41479-017-0039-929043150"/>
   <result pre="11.WeinbergerDMHarboeZBViboudCKrauseTGMillerMMolbakKet al.Pneumococcal disease seasonality: incidence, severity and the role of" exact="influenza" post="activityEur Respir J201443383384110.1183/09031936.0005681324036243 12.Teirlinck A, Van Asten L, Brandsema"/>
   <result pre="Van Gageldonk-Lafeber A, et al. In: Annual report surveillance of" exact="influenza" post="and other respiratory infections in the Netherlands: Winter 2016/2017;"/>
   <result pre="HoekWet al.Mortality attributable to 9 common infections: significant effect of" exact="influenza" post="A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza"/>
   <result pre="common infections: significant effect of influenza A, respiratory syncytial virus," exact="influenza" post="B, norovirus, and parainfluenza in elderly personsJ Infect Dis2012206562863910.1093/infdis/jis41522723641"/>
   <result pre="in elderly personsJ Infect Dis2012206562863910.1093/infdis/jis41522723641 14.VissinkCEHuijtsSMde WitGABontenMJMangenMJHospitalization costs for community-acquired" exact="pneumonia" post="in Dutch elderly: an observational studyBMC Infect Dis20161646610.1186/s12879-016-1783-927589847 15.WelteTTorresANathwaniDClinical"/>
   <result pre="observational studyBMC Infect Dis20161646610.1186/s12879-016-1783-927589847 15.WelteTTorresANathwaniDClinical and economic burden of community-acquired" exact="pneumonia" post="among adults in EuropeThorax2012671717910.1136/thx.2009.12950220729232 16.Stichting NICE: Nationale Intensive Care"/>
   <result pre="den WijngaardCCet al.Do intensive care data on respiratory infections reflect" exact="influenza" post="epidemics?PLoS One2013812e8385410.1371/journal.pone.008385424391837 26.JosephCTogawaYShindoNBacterial and viral infections associated with influenzaInfluenza"/>
   <result pre="27.RuuskanenOLahtiEJenningsLCMurdochDRViral pneumoniaLancet (London, England)201137797731264127510.1016/S0140-6736(10)61459-6 28.BenincaEvan BovenMHagenaarsTvan der HoekWSpace-time analysis of" exact="pneumonia" post="hospitalisations in the NetherlandsPLoS One2017127e018079710.1371/journal.pone.018079728704495 29.van Someren GreveFOngDSCremerOLBontenMJBosLDde JongMDet"/>
   <result pre="influenza-like illness: BioSense, 2007-2010Epidemiol Infect2013141480581510.1017/S095026881200154922800659 31.WijngaardCCAstenLKoopmansMPPeltWNagelkerkeNJWieldersCCet al.Comparing pandemic to seasonal" exact="influenza" post="mortality: moderate impact overall but high mortality in young"/>
   <result pre="Care Med20134151229123610.1097/CCM.0b013e31827ca4e123591209 34.BoddingtonNLVerlanderNQPebodyRGDeveloping a system to estimate the severity of" exact="influenza" post="infection in England: findings from a hospital-based surveillance system"/>
   <result pre="2014/2015Epidemiol Infect201714571461147010.1017/S095026881700005X28166855 35.BolotinSPebodyRWhitePJMcMenaminJPereraLNguyen-Van-TamJSet al.A new sentinel surveillance system for severe" exact="influenza" post="in England shows a shift in age distribution of"/>
   <result pre="B, Chappert JL, et al. Intensive care unit surveillance of" exact="influenza" post="infection in France: the 2009/10 pandemic and the three"/>
   <result pre="three subsequent seasons. Euro Surveill. 2015;20(46). 37.GubbelsSKrauseTGBragstadKPernerAMolbakKGlismannSBurden and characteristics of" exact="influenza" post="A and B in Danish intensive care units during"/>
   <result pre="in Danish intensive care units during the 2009/10 and 2010/11" exact="influenza" post="seasonsEpidemiol Infect2013141476777510.1017/S095026881200147122793496 38.European Centre for Disease Prevention and Control:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6303045\results\search\disease\results.xml">
   <result pre=": Information Theory: Information Entropy Predicting antigenic variants of H1N1" exact="influenza" post="virus based on epidemics and pandemics using a stacking"/>
   <result pre="are credited.pone.0207777.pdf Abstract H1N1 is the earliest emerging subtype of" exact="influenza" post="A viruses with available genomic sequences, has caused several"/>
   <result pre="variation patterns across periods, which would help assess a new" exact="influenza" post="strain’s antigenicity. Three different feature extraction methods, i.e. residue-based,"/>
   <result pre="It would also facilitate rapid determination of antigenic variants and" exact="influenza" post="surveillance. Funding This study is supported by Ministry of"/>
   <result pre="paper and its Supporting Information files. Introduction Influenza is an" exact="infectious disease" post="that poses significant threat to public health worldwide, especially"/>
   <result pre="poses significant threat to public health worldwide, especially H1N1 of" exact="influenza" post="A virus, which caused several pandemics in history, e.g."/>
   <result pre="and neuraminidase (NA) are the most important proteins that characterize" exact="influenza" post="A viruses [3]. HA is responsible for binding the"/>
   <result pre="assay is the primary method to determine the antigenicity of" exact="influenza" post="viruses and quantitative antibody titers for vaccine selection [7]."/>
   <result pre="constructed an antigenic map to determine the antigenic evolution of" exact="influenza" post="A H3N2 virus from 1968 to 2003 [8]. Lorusso"/>
   <result pre="antigenically divergent [9]. The antigenic patterns and evolution of human" exact="influenza" post="A (H1N1) viruses were investigated by Liu et al.,"/>
   <result pre="[11, 12]. These previous works depicted the evolutionary paths of" exact="influenza" post="and provided the foundation for computational models of antigenicity"/>
   <result pre="identify antigenicity-associated sites in the hemagglutinin protein of A/H1N1 seasonal" exact="influenza" post="virus [14]. Yin et al. detected the potential critical"/>
   <result pre="one of the most crucial factors for the success of" exact="influenza" post="vaccination is the timely determination of emerging influenza virus"/>
   <result pre="success of influenza vaccination is the timely determination of emerging" exact="influenza" post="virus antigenic variants. Sun et al. provided a novel,"/>
   <result pre="al. provided a novel, experimentally validated, computational method for determining" exact="influenza" post="virus antigenicity based on HA sequences [16]. Yao et"/>
   <result pre="et al. proposed a joint random forest method for predicting" exact="influenza" post="H3N2 antigenicity from hemagglutinin sequence data [17]. Qiu et"/>
   <result pre="structural context of HA protein to calculate the antigenicity for" exact="influenza" post="virus A/H3N2 with an accuracy of 0.875 [18]. By"/>
   <result pre="By building a universal model for all HA subtypes of" exact="influenza" post="A viruses based on conserved antigenic structures, Peng et"/>
   <result pre="achieved an accuracy of 0.77 for predicting antigenic variants of" exact="avian influenza" post="H9N2 viruses [19]. Furthermore, Richard Neher et al. showed"/>
   <result pre="an accuracy of 0.77 for predicting antigenic variants of avian" exact="influenza" post="H9N2 viruses [19]. Furthermore, Richard Neher et al. showed"/>
   <result pre="of the viral population, which maps the adaptive history of" exact="influenza" post="A and suggests guidance for vaccine selection [21]. Despite"/>
   <result pre="variants for influenza, most of the models were built for" exact="influenza" post="A/H3N2. There is still insufficient knowledge on the influenza"/>
   <result pre="for influenza A/H3N2. There is still insufficient knowledge on the" exact="influenza" post="H1N1 that caused numerous epidemics all over the world."/>
   <result pre="this study, we built a stacking model to include all" exact="influenza" post="periods of H1N1 based on epidemics and pandemics for"/>
   <result pre="inferring the antigenic relation between H1N1 virus strains. We categorized" exact="influenza" post="strains into two types, pandemic-based and epidemic-based, denoted as"/>
   <result pre="way, we not only classified the antigenic relation of two" exact="influenza" post="strains within a certain period, but also compared antigenic"/>
   <result pre="residue position of HA1 protein for strains, we demonstrated that" exact="influenza" post="H1N1 went through different variations across the periods. Pearson"/>
   <result pre="help facilitate rough determination of antigenic variants, the surveillance of" exact="influenza" post="and as a reference to the selection of vaccine"/>
   <result pre="HI assay data of HA1 viral strains were obtained for" exact="influenza" post="H1N1. As for the sequence dataset of HA1, it"/>
   <result pre="five epitope regions. Model construction As we know that the" exact="influenza" post="strains in different periods may lead to various levels"/>
   <result pre="sites on HA1, which could reflect the variant patterns of" exact="influenza" post="virus antigens. Then, Pearson Correlation Coefficient (PCC) analysis was"/>
   <result pre="two different strains as a pair. Since the evolution of" exact="influenza" post="viruses is in a forward path [32], the strains"/>
   <result pre="evolve within one period to another period chronologically. For example," exact="influenza" post="strains in period 2 could only evolve directly or"/>
   <result pre="a universal model for the prediction of antigenic variants of" exact="influenza" post="H1N1 that can be applied to all types, so"/>
   <result pre="Results The HA1 viral protein, as the main antigen of" exact="influenza" post="viruses, is the immunodominant part of HA segment [36]."/>
   <result pre="in distinct variation patterns could lead to different extent of" exact="influenza" post="outbreaks through years. Fig 2 Position-dependent entropy. Moving average"/>
   <result pre="with a window size of 11 for HA1 protein if" exact="influenza" post="A virus in each period, that is period 2"/>
   <result pre="only attaining 0.05 and 0.03 respectively. It may infer the" exact="influenza" post="H1N1 strains appeared in 1977 Russia flu yielded drastic"/>
   <result pre="the results above suggested the diversity of mutation patterns of" exact="influenza" post="H1N1 in terms of pandemic and epidemic events, and"/>
   <result pre="0.36 0.36 1.00 Our analysis suggested that HA1 proteins of" exact="influenza" post="H1N1 in different periods probably experienced distinct variation patterns."/>
   <result pre="built to predict the antigenic variants of HA1 proteins of" exact="influenza" post="H1N1 for all circumstances. Logistic regression, neural network and"/>
   <result pre="curve of the stacking model predicting the antigenic variants of" exact="influenza" post="A H1N1 virus. Discussion Since the occurrence of 1918"/>
   <result pre="virus. Discussion Since the occurrence of 1918 Spanish pandemic, the" exact="influenza" post="H1N1 has been evolving and circulating up to now."/>
   <result pre="up to now. The rapid mutations of the antigenicity of" exact="influenza" post="A virus are unceasingly causing other epidemics or pandemics"/>
   <result pre="in different periods, which is in accordance with update of" exact="influenza" post="vaccines every year [39–41]. Besides, the value of moving"/>
   <result pre="variants. Meanwhile, the mutation pattern analyses demonstrated the diversity of" exact="influenza" post="virus antigens in different periods. Single model was built"/>
   <result pre="that integrated all the situations of antigenic variants prediction of" exact="influenza" post="H1N1 HA1 proteins in different types using all the"/>
   <result pre="obtain good performance on the prediction results based on different" exact="influenza" post="epidemics and pandemics, there are still some space on"/>
   <result pre="and reliability on the prediction of antigenic variants of H1N1" exact="influenza" post="A virus. The analysis also raises the perspective of"/>
   <result pre="select a proper model when predicting the antigenic variants for" exact="influenza" post="viruses in different types with few antigenic data available."/>
   <result pre="can distinguish the formation of epidemics and pandemics caused by" exact="influenza" post="H1N1 viruses. Conclusion In conclusion, we divide the influenza"/>
   <result pre="by influenza H1N1 viruses. Conclusion In conclusion, we divide the" exact="influenza" post="strains of H1N1 epidemic and pandemic events into different"/>
   <result pre="into different periods chronologically. Mutation pattern analysis of HA1 of" exact="influenza" post="A H1N1 proves that the amino acid changes and"/>
   <result pre="construction of the stacking model of prediction antigenic variants of" exact="influenza" post="H1N1 overcomes the challenge of diverse mutation variations, combining"/>
   <result pre="a path on the study of distinct antigenic evolution of" exact="influenza" post="H1N1 virus, but also gives insight on the potential"/>
   <result pre="each type for calculating the antigenic relation between strains of" exact="influenza" post="H1N1 HA proteins. (CSV) LINK Click here for additional"/>
   <result pre="MuellerJ. Updating the accounts: global mortality of the 1918-1920 &quot;Spanish�?" exact="influenza" post="pandemic. Bulletin of the History of Medicine. 2002;76(1):105–115. 10.1353/bhm.2002.002211875246"/>
   <result pre="10.1016/j.jcv.2007.10.01718340670 4RussellRJ, KerryPS, StevensDJ, SteinhauerDA, MartinSR, GamblinSJ, et al.Structure of" exact="influenza" post="hemagglutinin in complex with an inhibitor of membrane fusion."/>
   <result pre="Codon bias and frequency-dependent selection on the hemagglutinin epitopes of" exact="influenza" post="A virus. Proceedings of the National Academy of Sciences."/>
   <result pre="7De JongJ, PalacheA, BeyerW, RimmelzwaanG, BoonA, OsterhausA. Haemagglutination-inhibiting antibody to" exact="influenza" post="virus. Developments in biologicals. 2003;115:63–73. 15088777 8SmithDJ, LapedesAS, de"/>
   <result pre="RimmelzwaanGF, OsterhausAD, et al.Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. science. 2004;305(5682):371–376. 10.1126/science.109721115218094 9LorussoA, VincentAL, HarlandML, AltD, BaylesDO,"/>
   <result pre="AltD, BaylesDO, SwensonSL, et al.Genetic and antigenic characterization of H1" exact="influenza" post="viruses from United States swine from 2008. Journal of"/>
   <result pre="BarrIG, BroorS, ChadhaM, CoxNJ, et al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature. 2015;523(7559):217–220. 10.1038/nature1446026053121 12DuX,"/>
   <result pre="12DuX, DongL, LanY, PengY, WuA, ZhangY, et al.Mapping of H3N2" exact="influenza" post="antigenic evolution in China reveals a strategy for vaccine"/>
   <result pre="of antigenicity-associated sites in the hemagglutinin protein of a/h1n1 seasonal" exact="influenza" post="virus. PloS one. 2015;10(5):e012674210.1371/journal.pone.012674225978416 15Yin R, Zhou X, Ivan"/>
   <result pre="YangG, et al.Using sequence data to infer the antigenicity of" exact="influenza" post="virus. MBio. 2013;4(4):e00230–13. 10.1128/mBio.00230-1323820391 17YaoY, LiX, LiaoB, HuangL, HeP,"/>
   <result pre="2013;4(4):e00230–13. 10.1128/mBio.00230-1323820391 17YaoY, LiX, LiaoB, HuangL, HeP, WangF, et al.Predicting" exact="influenza" post="antigenicity from Hemagglutintin sequence data based on a joint"/>
   <result pre="structure context of HA protein to improve antigenicity calculation for" exact="influenza" post="virus A/H3N2. Scientific reports. 2016;6:3115610.1038/srep3115627498613 19PengY, WangD, WangJ, LiK,"/>
   <result pre="et al.A universal computational model for predicting antigenic variants of" exact="influenza" post="A virus based on conserved antigenic structures. Scientific Reports."/>
   <result pre="ShraimanBI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal" exact="influenza" post="viruses. Proceedings of the National Academy of Sciences. 2016;113(12):E1701–E1709."/>
   <result pre="2012;40(D1):D13–D25. 10.1093/nar/gkr118422140104 24ShuY, McCauleyJ. GISAID: Global initiative on sharing all" exact="influenza" post="data–from vision to reality. Eurosurveillance. 2017;22(13). 10.2807/1560-7917.ES.2017.22.13.30494 25HirstGK. The"/>
   <result pre="to reality. Eurosurveillance. 2017;22(13). 10.2807/1560-7917.ES.2017.22.13.30494 25HirstGK. The quantitative determination of" exact="influenza" post="virus and antibodies by means of red cell agglutination."/>
   <result pre="10.1084/jem.75.1.4919871167 26NdifonW, DushoffJ, LevinSA. On the use of hemagglutination-inhibition for" exact="influenza" post="surveillance: surveillance data are predictive of influenza vaccine effectiveness."/>
   <result pre="of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of" exact="influenza" post="vaccine effectiveness. Vaccine. 2009;27(18):2447–2452. 10.1016/j.vaccine.2009.02.04719368786 27LiaoYC, LeeMS, KoCY, HsiungCA."/>
   <result pre="LeeMS, KoCY, HsiungCA. Bioinformatics models for predicting antigenic variants of" exact="influenza" post="A/H3N2 virus. Bioinformatics. 2008;24(4):505–512. 10.1093/bioinformatics/btm63818187440 28ZacourM, WardBJ, BrewerA, TangP,"/>
   <result pre="A computational analysis of the antigenic properties of haemagglutinin in" exact="influenza" post="A H3N2. Bioinformatics. 2010;26(11):1403–1408. 10.1093/bioinformatics/btq16020388627 31DeemMW, PanK. The epitope"/>
   <result pre="Bioinformatics. 2010;26(11):1403–1408. 10.1093/bioinformatics/btq16020388627 31DeemMW, PanK. The epitope regions of H1-subtype" exact="influenza" post="A, with application to vaccine efficacy. Protein Engineering, Design"/>
   <result pre="al.Different evolutionary trajectories of European avian-like and classical swine H1N1" exact="influenza" post="A viruses. Journal of virology. 2009;83(11):5485–5494. 10.1128/JVI.02565-0819297491 33PolikarR. Ensemble"/>
   <result pre="36RussellR, GamblinS, HaireL, StevensD, XiaoB, HaY, et al.H1 and H7" exact="influenza" post="haemagglutinin structures extend a structural classification of haemagglutinin subtypes."/>
   <result pre="Virology. 2004;325(2):287–296. 10.1016/j.virol.2004.04.04015246268 37BurkeDF, SmithDJ. A recommended numbering scheme for" exact="influenza" post="A HA subtypes. PloS one. 2014;9(11):e11230210.1371/journal.pone.011230225391151 38BushRM, BenderCA, SubbaraoK,"/>
   <result pre="38BushRM, BenderCA, SubbaraoK, CoxNJ, FitchWM. Predicting the evolution of human" exact="influenza" post="A. Science. 1999;286(5446):1921–1925. 10.1126/science.286.5446.192110583948 39collab: Centers for Disease Control"/>
   <result pre="10.1126/science.286.5446.192110583948 39collab: Centers for Disease Control and Prevention. Updated interim" exact="influenza" post="vaccination recommendations–2004-05 influenza season. MMWR Morbidity and mortality weekly"/>
   <result pre="for Disease Control and Prevention. Updated interim influenza vaccination recommendations–2004-05" exact="influenza" post="season. MMWR Morbidity and mortality weekly report. 2004;53(50):118315614237 40FioreAE,"/>
   <result pre="Centers for Disease Control and Prevention. Prevention and control of" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
   <result pre="of the Advisory Committee on Immunization Practices (ACIP)–United States, 2012-13" exact="influenza" post="season. MMWR Morbidity and mortality weekly report. 2012;61(32):61322895385 42WilsonIA,"/>
   <result pre="report. 2012;61(32):61322895385 42WilsonIA, CoxNJ. Structural basis of immune recognition of" exact="influenza" post="virus hemagglutinin. Annual review of immunology. 1990;8(1):737–787. 10.1146/annurev.iy.08.040190.0035132188678 43BlackburneBP,"/>
   <result pre="HayAJ, GoldsteinRA. Changing selective pressure during antigenic changes in human" exact="influenza" post="H3. PLoS pathogens. 2008;4(5):e100005810.1371/journal.ppat.100005818451985 44Güneş F, Wolfinger R, Tan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6318360\results\search\disease\results.xml">
   <result pre="Ihekweazu C, Bock C-T. 2019. Complete genome sequence of a" exact="hepatitis" post="E virus genotype 1e strain from an outbreak in"/>
   <result pre="virus (HEV) is the most common causative agent of acute" exact="viral hepatitis." post="Eight HEV genotypes (HEV-1 to HEV-8) have been described,"/>
   <result pre="views of the funders. References REFERENCES 1.NanY, WuC, ZhaoQ, ZhouEM2017Zoonotic" exact="hepatitis" post="E virus: an ignored risk for public health. Front"/>
   <result pre="doi:10.3389/fmicb.2017.02396.29255453 2.van CuyckH, JugeF, RoquesP2003Phylogenetic analysis of the first complete" exact="hepatitis" post="E virus (HEV) genome from Africa. FEMS Immunol Med"/>
   <result pre="LutgehetmannM, PischkeS, WedermeyerH, HofmannJ, BockCT2018Comprehensive molecular approach for characterization of" exact="hepatitis" post="E virus genotype 3 variants. J Clin Microbiol56:e01686-17. doi:10.1128/JCM.01686-17.29514938"/>
   <result pre="doi:10.1128/JCM.01686-17.29514938 4.WangB, HarmsD, HofmannJ, CiardoD, KneubuhlA, BockCT2017Identification of a novel" exact="hepatitis" post="E virus genotype 3 strain isolated from a chronic"/>
   <result pre="hepatitis E virus genotype 3 strain isolated from a chronic" exact="hepatitis" post="E virus infection in a kidney transplant recipient in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6328934\results\search\disease\results.xml">
   <result pre="the principal findings in the analytical techniques used to study" exact="influenza" post="N-linked glycosylation, the evolutionary dynamics of N-linked glycosylation in"/>
   <result pre="determinant of disease severity and adaptive immunity, the study of" exact="influenza" post="glycobiology is of clinical as well as research interest."/>
   <result pre="influenza glycobiology is of clinical as well as research interest." exact="influenza" post="innate immunity page-count: Introduction Influenza viruses have caused epidemic"/>
   <result pre="disease remains difficult to predict and prevent. Three types of" exact="influenza" post="viruses infect humans: A, B, and C. While wild"/>
   <result pre="wild waterfowl and other birds are the primary reservoirs of" exact="influenza" post="A virus (IAV) [2], humans are the primary host"/>
   <result pre="(IAV) [2], humans are the primary host and reservoir of" exact="influenza" post="B and C viruses (IBV and ICV, respectively) [3,4]."/>
   <result pre="pigs, and dogs [7,8]. There are therefore many sources of" exact="influenza" post="virus exposed to humans. Among the three influenza types,"/>
   <result pre="sources of influenza virus exposed to humans. Among the three" exact="influenza" post="types, IAV is the greatest public health concern because"/>
   <result pre="seasonal epidemics and is responsible for ∼25% of human seasonal" exact="influenza" post="infections [14,15]. Together, seasonal epidemics of IAV and IBV"/>
   <result pre="IBV, it is not included in the composition of seasonal" exact="influenza" post="vaccines. As it is of less public health concern,"/>
   <result pre="human respiratory tracts (RT) [19]. SA-independent binding and internalization of" exact="influenza" post="virus HA also occur via specific cell-surface proteins on"/>
   <result pre="has specificity for terminal SA [27]. The primary role of" exact="influenza" post="virus NA is to cleave SA residues from virus"/>
   <result pre="1 Influenza virus surface glycoproteins (A) Schematic diagram of an" exact="influenza" post="virion, showing HA and NA (provided by CDC Influenza"/>
   <result pre="Humans are also sporadically infected with highly and low pathogenic" exact="avian influenza" post="A viruses, particularly H5, H9, and H7 HA subtypes."/>
   <result pre="are also sporadically infected with highly and low pathogenic avian" exact="influenza" post="A viruses, particularly H5, H9, and H7 HA subtypes."/>
   <result pre="lineages, the B/Victoria/2/87 and the B/Yamagata/16/88 lineages. Co-circulation of both" exact="influenza" post="B virus lineages with influenza A(H3N2) and A(H1N1) viruses"/>
   <result pre="B/Yamagata/16/88 lineages. Co-circulation of both influenza B virus lineages with" exact="influenza" post="A(H3N2) and A(H1N1) viruses during seasonal epidemics has prompted"/>
   <result pre="that include strains from both subtypes of IAV and both" exact="influenza" post="B lineages. Influenza virus glycosylation As well as simple"/>
   <result pre="simple amino acid changes, antigenic drift often involves changes in" exact="influenza" post="virus HA and NA glycosylation patterns that shield or"/>
   <result pre="[35]. Host–cell dependent glycosylation is a critical post-translational modification of" exact="influenza" post="virus HA and NA. Glycosylation in the HA stalk"/>
   <result pre="N-acetyl-galactosamine/fucose (complex glycans), or a combination (hybrid glycans) [47,48]. Some" exact="influenza" post="virus HA and NA NLG sites may contain predominantly"/>
   <result pre="[49]. In contrast with cellular proteins, the complex oligosaccharides on" exact="influenza" post="virus HA and NA are typically not sialylated, since"/>
   <result pre="date, NLG is the only type of glycosylation observed for" exact="influenza" post="virus HA and NA: there has been no O-linked"/>
   <result pre="a carbon group on a Trp side-chain) glycosylation reported for" exact="influenza" post="virus. Techniques for influenza glycoprotein analysis The simplest way"/>
   <result pre="a Trp side-chain) glycosylation reported for influenza virus. Techniques for" exact="influenza" post="glycoprotein analysis The simplest way to predict NLG addition"/>
   <result pre="to different sites [54]. Approaches for more detailed analysis of" exact="influenza" post="virus NLG have been comprehensively described in a recent"/>
   <result pre="type. Introduction of this protocol into the ordinary practice of" exact="influenza" post="laboratory will improve understanding of glycosylation-associated scientific data. Evolutionary"/>
   <result pre="will improve understanding of glycosylation-associated scientific data. Evolutionary dynamics of" exact="influenza" post="virus HA and NA N-linked glycosylation Contemporary human influenza"/>
   <result pre="of influenza virus HA and NA N-linked glycosylation Contemporary human" exact="influenza" post="virus strains have circulated in human populations for many"/>
   <result pre="as well as enhanced transmission during that period. Glycosylation of" exact="influenza" post="virus HA, especially for A(H3N2) viruses, has been shown"/>
   <result pre="This suggests that increasing levels of glycosylation may both enhance" exact="influenza" post="immune evasion in the presence of population adaptive immunity,"/>
   <result pre="reduce viral virulence or replication ability in non-immune individuals. Different" exact="influenza" post="strains have shown different patterns of glycosylation in their"/>
   <result pre="gain of glycosylation. The number of NLG sites on the" exact="influenza" post="virus HA globular head has increased from two (at"/>
   <result pre="located between stalk and head regions. Figure 2 Evolution of" exact="influenza" post="virus N-linked glycosylation (A) Mean number per year of"/>
   <result pre="recognition of glycoproteins by the adaptive immune system, glycans on" exact="influenza" post="viruses are also important for interactions with the innate"/>
   <result pre="the host. For example, terminal mannose residues are features of" exact="influenza" post="virus HA and NA, but are not typical of"/>
   <result pre="through binding to either mannose, fucose or galactose derivatives on" exact="influenza" post="virus HA and NA [78–83]. The presence and nature"/>
   <result pre="and NA [78–83]. The presence and nature of glycans on" exact="influenza" post="virus glycoproteins therefore influence the innate immune response to"/>
   <result pre="both preferentially bind mannose over the galactose-type sugars found on" exact="influenza" post="virus HA and NA [83]. Both SP-D and MBL"/>
   <result pre="response to influenza, the role of MBL in protection against" exact="influenza" post="is not as clear [95]. Different strains of influenza"/>
   <result pre="against influenza is not as clear [95]. Different strains of" exact="influenza" post="seem to have widely varying susceptibilities to SP-D and"/>
   <result pre="mice show a rise in SP-D level in airways during" exact="influenza" post="infection with either A(H1N1) or A(H3N2) IAV [96]. SP-D"/>
   <result pre="mice show enhanced viral replication, lung inflammation, and morbidity after" exact="influenza" post="infection [98,100–115], while expression of SP-D variants corrected the"/>
   <result pre="Ferrets are considered to be a better model for human" exact="influenza" post="infection [116], but the role of SP-D in the"/>
   <result pre="but the role of SP-D in the ferret model of" exact="influenza" post="infection is less clear. Although SP-D appears to reduce"/>
   <result pre="wild-type mice [117]. In humans, evidence that collectins protect against" exact="influenza" post="is mainly indirect. Decreased SP-D expression in human lungs"/>
   <result pre="expression in human lungs has been associated with fatal A(H5N1)" exact="influenza" post="cases [108]. SP-D deficient groups such as smokers and"/>
   <result pre="[108]. SP-D deficient groups such as smokers and people with" exact="chronic obstructive pulmonary disease," post="cystic fibrosis, and diabetes often suffer from more severe"/>
   <result pre="such as smokers and people with chronic obstructive pulmonary disease," exact="cystic fibrosis," post="and diabetes often suffer from more severe seasonal influenza"/>
   <result pre="cystic fibrosis, and diabetes often suffer from more severe seasonal" exact="influenza" post="disease [118–121]. Reduced serum levels of MBL in children"/>
   <result pre="with enhanced severity of A(H1N1)pdm09 infection [122]. Collectins protect against" exact="influenza" post="infection by several mechanisms. Direct binding to mannose residues"/>
   <result pre="complexes enhances phagocytosis and modulates inflammatory responses [82,101,123–127]. Collectins inhibit" exact="influenza" post="virus NA activity not only through direct binding to"/>
   <result pre="therefore act through both complement-dependent and independent mechanisms to neutralize" exact="influenza" post="virus [111,132]. Glycosylation on specific residues of HA is"/>
   <result pre="by glycan composition. Factors affecting the composition of glycans on" exact="influenza" post="glycoproteins are not well understood, but may also be"/>
   <result pre="lectins Transmembrane C-type lectin receptors (CLRs) that recognize glycans of" exact="influenza" post="virus HA and act as attachment/entry receptors are primarily"/>
   <result pre="that neither macrophages nor DCs can be productively infected with" exact="influenza" post="virus, recent studies have shown productive infection of macrophages"/>
   <result pre="HPAI as well as A(H1N1) and A(H3N2) [20,140–143]. While seasonal" exact="influenza" post="infection stimulates macrophage and DC chemokine and cytokine responses,"/>
   <result pre="single CRD. Several studies have confirmed calcium-dependent lectin-mediated interactions between" exact="influenza" post="and macrophages [20,22,25] and DC [21,23]. Such interactions could"/>
   <result pre="While there is no direct evidence that CLR interactions with" exact="influenza" post="are important for macrophage and DC activation, binding to"/>
   <result pre="[147]. Virus uptake through CLRs depends on the level of" exact="influenza" post="virus HA (but not NA) glycosylation [22]. Increased HA"/>
   <result pre="glycosylation at specific positions, resulted in a higher level of" exact="influenza" post="infection in both macrophages [20] and DCs [23,24,133]. Interaction"/>
   <result pre="route for infection of macrophages and DCs immune cells with" exact="influenza" post="viruses. Galectins The galectins constitute a family of soluble,"/>
   <result pre="β-galactosides (such as lactose [Galβ(1–4)Glc] and N-acetyllactosamine [Galβ(1–4)GlcNAc]) [148] of" exact="influenza" post="virus HA. Currently, 15 galectins have been identified in"/>
   <result pre="has been recently recognized [150,151]. The effect of galectins on" exact="influenza" post="disease seems to depend on the type of galectin"/>
   <result pre="most antibodies, lectins can bind to a wide range of" exact="influenza" post="strains, making them attractive candidates for antiviral therapies. For"/>
   <result pre="responses [179]). Despite the progress achieved in the field of" exact="influenza" post="innate immunity in recent years, our understanding of the"/>
   <result pre="to novel therapeutic and immunomodulatory approaches for the treatment of" exact="influenza" post="disease. We thank Dr Terry Tumpey of Influenza Division"/>
   <result pre="receptor ER endoplasmic reticulum FBG fibrinogen-like domain HA hemagglutinin IAV" exact="influenza" post="A virus IBV influenza B virus ICV influenza C"/>
   <result pre="FBG fibrinogen-like domain HA hemagglutinin IAV influenza A virus IBV" exact="influenza" post="B virus ICV influenza C virus MBL mannose-binding lectin"/>
   <result pre="hemagglutinin IAV influenza A virus IBV influenza B virus ICV" exact="influenza" post="C virus MBL mannose-binding lectin MGL macrophage galactose-type lectin"/>
   <result pre="BeanW.J., CormanO.T., ChambersT.M. and KawaokaY. (1992) Evolution and ecology of" exact="influenza" post="A viruses. Microbiol. Rev.56, 152–1791579108 3McCullersJ.A. and HaydenF.G. (2012)"/>
   <result pre="A viruses. Microbiol. Rev.56, 152–1791579108 3McCullersJ.A. and HaydenF.G. (2012) Fatal" exact="influenza" post="B infections: time to reexamine influenza research priorities. J."/>
   <result pre="and HaydenF.G. (2012) Fatal influenza B infections: time to reexamine" exact="influenza" post="research priorities. J. Infect. Dis.205, 870–87210.1093/infdis/jir86522291194 4TaylorR.M. (1949) Studies"/>
   <result pre="J. Infect. Dis.205, 870–87210.1093/infdis/jir86522291194 4TaylorR.M. (1949) Studies on survival of" exact="influenza" post="virus between epidemics and antigenic variants of the virus."/>
   <result pre="reservoirs and intermediate hosts: dogs, horses, and new possibilities for" exact="influenza" post="virus exposure to humans. J. Virol.89, 2990–299410.1128/JVI.03146-1425540375 6OsterhausA.D., RimmelzwaanG.F.,"/>
   <result pre="seals. Science288, 1051–105310.1126/science.288.5468.105110807575 7YuanjiG., FengenJ. and PingW. (1983) Isolation of" exact="influenza" post="C virus from pigs and experimental infection of pigs"/>
   <result pre="C virus from pigs and experimental infection of pigs with" exact="influenza" post="C virus. J. Gen. Virol.64, 177–18210.1099/0022-1317-64-1-1776296296 8OhwadaK., KitameF. and"/>
   <result pre="and HommaM. (1998) Experimental infections of dogs with type C" exact="influenza" post="virus. Microbiol. Immunol.30, 451–46010.1111/j.1348-0421.1986.tb02971.x 9TaubenbergerJ.K. and KashJ.C. (2010) Influenza"/>
   <result pre="al. (2015) One health, multiple challenges: the inter-species transmission of" exact="influenza" post="A virus. One Health1, 1–1310.1016/j.onehlt.2015.03.00126309905 14GlezenP.W., SchmierJ.K, KuehnC.M., RyanK.J."/>
   <result pre="14GlezenP.W., SchmierJ.K, KuehnC.M., RyanK.J. and OxfordJ. (2013) The burden of" exact="influenza" post="B: a structured literature review Am. J. Public Health103,"/>
   <result pre="Jaffar-BandjeeM.C., MichaultA.et al. (2014) Influenza season in Réunion dominated by" exact="influenza" post="B virus circulation associated with numerous cases of severe"/>
   <result pre="TyrrellD.A. (1968) Production of common colds in human volunteers by" exact="influenza" post="C virus. Br. Med. J.4, 153–15410.1136/bmj.4.5624.1535681050 18WrightP.F., NeumannG. and"/>
   <result pre="D’SouzaB.L (1989) Receptor binding properties of human and animal H1" exact="influenza" post="virus isolates. Virology173, 317–32210.1016/0042-6822(89)90249-32815586 20ReadingP.C., MillerJ.L. and AndersE.M. (2000)"/>
   <result pre="Involvement of the mannose receptor in infection of macrophages by" exact="influenza" post="virus. J. Virol.74, 5190–519710.1128/JVI.74.11.5190-5197.200010799594 21WangS.-F., HuangJ.C., LeeY.-M., LiuS.-J., ChanY.-J.,"/>
   <result pre="LeeY.-M., LiuS.-J., ChanY.-J., ChauY.-P.et al. (2008) DC-SIGN mediates avian H5N1" exact="influenza" post="virus infection in cis and in trans. Biochem. Biophys."/>
   <result pre="22UphamJ.P., PickettD., IrimuraT., AndersE.M. and ReadingP.C. (2010) Macrophage receptors for" exact="influenza" post="A virus: role of the macrophage galactose-type lectin and"/>
   <result pre="(2011) N-linked glycosylation facilitates sialic acid-independent attachment and entry of" exact="influenza" post="A viruses into cells expressing DC–SIGN or L–SIGN. J."/>
   <result pre="FouchierR.A.M.et al. (2013) Binding of DC-SIGN to the hemagglutinin of" exact="influenza" post="A viruses supports virus replication in DC-SIGN expressing cells."/>
   <result pre="lectin can function as an attachment and entry receptor for" exact="influenza" post="virus. J. Virol.88, 1659–167210.1128/JVI.02014-1324257596 26NgW.C., LondriganS.L., NasrN., CunninghamA.L., TurvilleS.,"/>
   <result pre="functions as a receptor for attachment and infectious entry of" exact="influenza" post="A virus. J. Virol.90, 206–22110.1128/JVI.01447-1526468543 27SaitoT., TaylorG. and WebsterR.G."/>
   <result pre="206–22110.1128/JVI.01447-1526468543 27SaitoT., TaylorG. and WebsterR.G. (1995) Steps in maturation of" exact="influenza" post="virus neuraminidase. J. Virol.69, 5011–50177541844 28VargheseJ.N. and ColmanP.M (1991)"/>
   <result pre="28VargheseJ.N. and ColmanP.M (1991) Three-dimensional structure of the neuraminidase of" exact="influenza" post="virus A/Tokyo/3/67 and 2.2 Ǻ resolution. J. Mol. Biol.221,"/>
   <result pre="(2002) Updating the accounts: global mortality of the 1918-1920 &quot;Spanish�?" exact="influenza" post="pandemic. Bull. Hist. Med.76, 105–11510.1353/bhm.2002.002211875246 33DoshiP. (2008) Trends in"/>
   <result pre="pandemic. Bull. Hist. Med.76, 105–11510.1353/bhm.2002.002211875246 33DoshiP. (2008) Trends in recorded" exact="influenza" post="mortality: United States, 1900-2004. Am. J. Public Health98, 939–94518381993"/>
   <result pre="and GrajowerB. (1990) Independent and disparate evolution in nature of" exact="influenza" post="A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad."/>
   <result pre="Sialobiology of influenza: molecular mecjanism of host range variation of" exact="influenza" post="viruses. Biol. Pharm. Bull.28, 399–40810.1248/bpb.28.39915744059 36RobertsP.C., GartenW. and KlenkH.D."/>
   <result pre="Role of conserved glycosylation sites in maturation and transport of" exact="influenza" post="virus hemagglutinin. J. Virol.67, 3048–30608497042 37OhuchiR., OhuchiM., GartenW. and"/>
   <result pre="and KlenkH.D. (1997) Oligosaccharides in the stem region maintain the" exact="influenza" post="virus hemagglutinin in the metastable form required for fusion"/>
   <result pre="sequons in antigenic properties, intracellular transport and biological activities of" exact="influenza" post="A/H2N2 virus hemagglutinin. J. Gen. Virol.83, 3067–307410.1099/0022-1317-83-12-306712466483 39OhuchiM., OhuchiR.,"/>
   <result pre="FeldmannA. and KlenkH.D. (1997) Regulation of receptor binding affinity of" exact="influenza" post="virus hemagglutinin by its carbohydrate moiety. J. Virol.71, 8377–83779343193"/>
   <result pre="host-dependent glycosylation of hemagglutinin on receptor-binding properties of H1N1 human" exact="influenza" post="A virus grown in MDCK cells and in embryonated"/>
   <result pre="al. (2016) Glycosylation changes in the globular head of H3N2" exact="influenza" post="hemagglutinin modulate receptor binding without affecting virus virulence. Sci."/>
   <result pre="AndoM. and WebsterR.G. (1987) Glycosylation affects cleavage of an H5N2" exact="influenza" post="virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci."/>
   <result pre="the cleavage site of the hemagglutinin alter the pathogenicity of" exact="influenza" post="virus A/chick/Penn/83 (H5N2). Virology168, 274–28010.1016/0042-6822(89)90267-52916326 44WagnerR., WolffT., HerwigA., PleschkaS."/>
   <result pre="(2000) Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of" exact="influenza" post="virus growth: a study by reverse genetics. J. Virol.74,"/>
   <result pre="and PaleseP. (1993) Glycosylation of neuraminidase determines the neurovirulence of" exact="influenza" post="A/WSN/33 virus. J. Virol.67, 6667–66738411368 46KornfeldR. and KornfeldS. (1985)"/>
   <result pre="631–66410.1146/annurev.bi.54.070185.0032153896128 47BasakS., PritchardD.G., BhownA.S. and CompansR.W. (1981) Glycosylation sites of" exact="influenza" post="viral glycoproteins: Characterization of tryptic glycoproteins from the A/USSR(H1N1)"/>
   <result pre="oligosaccharide distribution of the haemagglutinin from an early Hong Kong" exact="influenza" post="virus variant A/Aichi/2/68 (X-31). Biochem. J.193, 953–96210.1042/bj1930953 49SchwarzF. and"/>
   <result pre="50BasakS., TomanaM. and CompansR.W. (1985) Sialic acid is incorporated into" exact="influenza" post="hemagglutinin glycoproteins in the absence of viral neuraminidase. Virus"/>
   <result pre="PirkleJ.L. and BarrJ.R. (2009) Targeted N-linked glycosylation analysis of H5N1" exact="influenza" post="hemagglutinin by selective sample preparation and liquid chromatography/tandem mass"/>
   <result pre="AlymovaI., ParsonL.M. and CipolloJ.F. (2015) Glycosylation analysis of engineered H3N2" exact="influenza" post="A virus hemagglutinins with sequentially added historically relevant glycosylation"/>
   <result pre="profiling of serum N-Glycans for fast and efficient identification of" exact="cancer" post="associated alterations in glycosylation. Anal. Chem.82, 10208–1021510.1021/ac102860w21073175 60ZaunerG., DeelderA.M."/>
   <result pre="(2016) Integrated omics and computational glycobiology reveal structural basis for" exact="influenza" post="A virus glycan microheterogeneity and host interactions. Mol. Cell."/>
   <result pre="unbiased approach for analysis of protein glycosylation and application to" exact="influenza" post="vaccine hemagglutinin. Anal. Biochem.415, 67–8010.1016/j.ab.2011.04.01821545787 69JayaramanA., KohX., LiJ., RamanR.,"/>
   <result pre="JarvisD.L., JingX., YeZ., AumillerJ.J.et al. (2013) Comparative glycomics analysis of" exact="influenza" post="Hemagglutinin (H5N1) produced in vaccine relevant cell platforms. J."/>
   <result pre="SuR., QiH., DengW., SunY.et al. (2017) N-glycan profiles in H9N2" exact="avian influenza" post="viruses from chicken eggs and human embryonic lung fibroblast"/>
   <result pre="QiH., DengW., SunY.et al. (2017) N-glycan profiles in H9N2 avian" exact="influenza" post="viruses from chicken eggs and human embryonic lung fibroblast"/>
   <result pre="72CruzE., CainJ., CrossettB. and KayserV. (2018) Site-specific glycosylation profile of" exact="influenza" post="A (H1N1) hemagglutinin through tandem mass spectrometry. Hum. Vaccin."/>
   <result pre="(1984) A carbohydrate side chain on hemagglutinins of Hong Kong" exact="influenza" post="viruses inhibits recognition by a monoclonal antibody. Proc. Natl."/>
   <result pre="Natl. Acad. Sci. U.S.A.81, 1779–178310.1073/pnas.81.6.17796584912 75McCullersJ.A. (2014) The co-pathogenesis of" exact="influenza" post="viruses with bacteria in the lung. Nat. Rev. Microbiol.12,"/>
   <result pre="KwonS.B., LeeC.M., HanG. and SeongB.L. (2018) Glycosylation of hemagglutinin of" exact="influenza" post="A virus as a signature for ecological spillover and"/>
   <result pre="virus as a signature for ecological spillover and adaptation among" exact="influenza" post="reservoirs. Viruses10, 18310.3390/v10040183 77TripathiS., WhiteM.R. and HartshornK.L. (2015) The"/>
   <result pre="WhiteM.R. and HartshornK.L. (2015) The amazing innate immune response to" exact="influenza" post="A virus infection. Innate Immun.21, 73–9810.1177/175342591350899224217220 78GottschalkA., BelyavinG. and"/>
   <result pre="Innate Immun.21, 73–9810.1177/175342591350899224217220 78GottschalkA., BelyavinG. and BiddleF. (1972) Glycoproteins as" exact="influenza" post="virus hemagglutinin inhibitors and as cellular receptors. In Glycoproteins."/>
   <result pre="and JacksonD.C. (1990) Bovine and mouse serum beta inhibitors of" exact="influenza" post="A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci."/>
   <result pre="Two distinct serum mannose-binding lectins function as beta inhibitors of" exact="influenza" post="virus: Identification of bovine sera beta inhibitors as conglutinin."/>
   <result pre="Biol.9, 585–59010.1016/S0959-440X(99)00009-310508765 82TecleT., WhiteM.R., CrouchE.C. and HartshornK.L. (2007) Inhibition of" exact="influenza" post="viral neuraminidase activity by collectins. Arch. Virol.152, 1731–174210.1007/s00705-007-0983-417514488 83VeldhuizenE.J.A.,"/>
   <result pre="(1997) Collectin-mediated antiviral host defense in the lung: evidence from" exact="influenza" post="virus infection in mice. J. Virol.71, 8204–82129343171 97KingmaP.S., ZhangL.,"/>
   <result pre="BoydK.L., MadsenJ., HawgoodS. and McCullersJ.A. (2007) N-linked glycosylation attenuates H3N2" exact="influenza" post="viruses. J. Virol.81, 8593–860010.1128/JVI.00769-0717553891 99TateM.D, JobE.R., BrooksA.G. and ReadingP.C."/>
   <result pre="(2011) Glycosylation of the hemagglutinin modulates the sensitivity of H3N2" exact="influenza" post="viruses to innate proteins in airway secretions and virulence"/>
   <result pre="84–9210.1016/j.virol.2011.01.03621353279 100WanzeckK., BoydK.L. and McCullersJ.A. (2011) Glycan shielding of the" exact="influenza" post="virus hemagglutinin contributes to immunopathology in mice. Am. J."/>
   <result pre="101JobE.R., DengY.M., TateM.D., BottazziB., CrouchE.C., DeanM.M.et al. (2010) Pandemic H1N1" exact="influenza" post="a viruses are resistant to the antiviral activities of"/>
   <result pre="DuganV.G., JaggerB.W., LauY.F., ShengZ.M.et al. (2011) The ability of pandemic" exact="influenza" post="virus hemagglutinins to induce lower respiratory pathology is associated"/>
   <result pre="426–43410.1016/j.virol.2011.01.02921334038 103TokunagaH., UshirogawaH. and OhuchiM. (2011) The pandemic (H1N1) 2009" exact="influenza" post="virus is resistant to mannose-binding lectin. Virol. J.8, 5010.1186/1743-422X-8-5021294904"/>
   <result pre="5010.1186/1743-422X-8-5021294904 104ChengX., ZengelJ.R., XuQ. and JinH. (2012) Surface glycoproteins of" exact="influenza" post="A H3N2 virus modulate virus replication in the respiratory"/>
   <result pre="a major role in modulating the virulence of H3 subtype" exact="influenza" post="A viruses. Virology494, 143–15710.1016/j.virol.2016.01.02427110707 106YuL., ShangS., TaoR., WangC., ZhangL.,"/>
   <result pre="High doses of recombinant mannan-binding lectin inhibit the binding of" exact="influenza" post="A(H1N1)pdm09 virus with cells expressing DC-SIGN. APMIS125, 655–66410.1111/apm.1269528493491 107HartshornK.L.,"/>
   <result pre="D mRNA in human lungs in fatal cases of H5N1" exact="avian influenza." post="J. Med. Virol.83, 1410–141710.1002/jmv.2210521678446 109PanaamponJ., NgaosuwankulN., SuptawiwatO., NoisumdaengP., SangsiriwutK.,"/>
   <result pre="SiridechadilokB.et al. (2012) A novel pathogenic mechanism of highly pathogenic" exact="avian influenza" post="H5N1 viruses involves hemagglutinin mediated resistance to serum innate"/>
   <result pre="al. (2012) A novel pathogenic mechanism of highly pathogenic avian" exact="influenza" post="H5N1 viruses involves hemagglutinin mediated resistance to serum innate"/>
   <result pre="of recombinant human mannose-binding lectin on the infection of novel" exact="influenza" post="A (H7N9) virus in vitro. Biochem. Biophys. Res. Commun.458,"/>
   <result pre="Lack of pattern recognition molecule mannose-binding lectin increases susceptibility to" exact="influenza" post="A virus infection. BMC Immunol.11, 6A10.1186/1471-2172-11-6420163714 112TateM.D., BrooksA.G. and"/>
   <result pre="lectin-mediated innate host defenses in vivo modulates disease severity during" exact="influenza" post="virus infection. Immunol. Cell Biol.89, 482–49110.1038/icb.2010.11320938455 113SunX., JayaramanA., ManiprasadP.,"/>
   <result pre="virulence and antigenicity of the 1918 pandemic and seasonal H1N1" exact="influenza" post="A viruses. J. Virol.87, 8756–876610.1128/JVI.00593-1323740978 114LeVineA.M., WhitsettJ.A., HartshornK.L., CrouchE.C."/>
   <result pre="CrouchE.C. and KorfhagenT.R. (2001) Surfactant protein D enhances clearance of" exact="influenza" post="A virus from the lung in vivo. J. Immunol.167,"/>
   <result pre="EdmondsonJ., StumbaughA., AllenL., GoerkeJ.et al. (2004) Pulmanary collectins modulate strain-specific" exact="influenza" post="A virus infection and host responses. J. Virol.78, 8565–867210.1128/JVI.78.16.8565-8572.200415280465"/>
   <result pre="8565–867210.1128/JVI.78.16.8565-8572.200415280465 116BelserJ.A., EckertA.M., TumpeyT.M. and MainesT.R. (2016) Complexities in ferret" exact="influenza" post="virus pathogenesis and transmission models. Microbiol. Mol. Biol. Rev.80,"/>
   <result pre="CrouchE.C. and AndersE.M. (1998) Increased susceptibility of diabetic mice to" exact="influenza" post="virus infection: compromise of collectin-mediated host defense of the"/>
   <result pre="and surfactant protein-D are inversely related to inflammation in early" exact="cystic fibrosis." post="Am. J. Respir. Crit. Care Med.168, 685–69110.1164/rccm.200301-005OC12829455 121SimsM.W., Tal-SingerR.M.,"/>
   <result pre="al. (1993) Human mannose-binding protein functions as an opsonin for" exact="influenza" post="A viruses. J. Clin. Invest.91, 1414–142010.1172/JCI1163457682571 124HartshornK.L., CrouchE.C., WhiteM.R.,"/>
   <result pre="a protective role of pulmonary surfactant protein D (SP-D) against" exact="influenza" post="A viruses. J. Clin. Invest.94, 311–31910.1172/JCI1173238040272 125HartshornK.L., ReidK.B., WhiteM.R.,"/>
   <result pre="ReidK.B., WhiteM.R., JenseniusJ.C., MorrisS.M., TauberA.I.et al. (1996) Neutrophil deactivation by" exact="influenza" post="A viruses: mechanisms of protection after viral opsonization with"/>
   <result pre="EdaS.et al. (1999) Human mannan-binding lectin inhibits the infection of" exact="influenza" post="a virus without complement. Immunology97, 385–39210.1046/j.1365-2567.1999.00781.x10447758 128GardaiS., XiaoY.Q., DickinsonM.,"/>
   <result pre="EdaS.et al. (1999) Human mannan-binding lectin inhibits the infection of" exact="influenza" post="A virus without complement. Immunology97, 385–39210.1046/j.1365-2567.1999.00781.x10447758 133TateM.D., BrooksA.G. and"/>
   <result pre="sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype" exact="influenza" post="A virus determine sensitivity to inhibitors of the innate"/>
   <result pre="hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1" exact="influenza" post="virus by porcine surfactant protein D. Virus Res.169, 301–30510.1016/j.virusres.2012.08.00322921759"/>
   <result pre="WhiteM.R., HartshornK.L., AllenK.et al. (2013) Molecular mechanisms of inhibition of" exact="influenza" post="by surfactant protein D revealed by large-scale molecular dynamics"/>
   <result pre="site of surfactant protein D confer antiviral activity for pandemic" exact="influenza" post="A viruses. Am. J. Physiol. Lung Cell Mol. Physiol.306,"/>
   <result pre="on macrophages and dendritic cells for attachment and entry of" exact="influenza" post="virus. J. Leukoc. Biol.92, 97–10610.1189/jlb.101149222124137 138GraysonM.H. and HoltzmanM.J (2007)"/>
   <result pre="Critical role of airway macrophages in modulating disease severity during" exact="influenza" post="virus infection of mice. J. Virol.84, 7569–758010.1128/JVI.00291-1020504924 140ThitithanyanontA., EngeringA.,"/>
   <result pre="YongvanitchitK.et al. (2007) High susceptibility of human dendritic cells to" exact="avian influenza" post="H5N1 virus infection and protection by IFN-alpha and TLR"/>
   <result pre="al. (2007) High susceptibility of human dendritic cells to avian" exact="influenza" post="H5N1 virus infection and protection by IFN-alpha and TLR"/>
   <result pre="PlowdenJ.K., García-SastreA., KatzJ.M. and TumpeyT.M. (2008) H5N1 and 1918 pandemic" exact="influenza" post="virus infection results in early and excessive infiltration of"/>
   <result pre="PulendranB. and García-SastreA. (2010) Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virus."/>
   <result pre="and Schultz-CherryS. (2013) The hemagglutinin protein of highly pathogenic H5N1" exact="influenza" post="viruses overcomes an early block in the replication cycle"/>
   <result pre="BrooksA.G., ReadingP.C. and LondriganS.L. (2016) Endocytic function is critical for" exact="influenza" post="A virus infection via DC-SIGN and L-SIGN. Sci. Rep.6,"/>
   <result pre="ChenY.-H., WangS.-W., HuangY.-J., LeuC.-H., YehN.-C.et al. (2011) Galectin-1 binds to" exact="influenza" post="virus and ameliorates influenza virus pathogenesis. J. Virol.85, 10010–1002010.1128/JVI.00301-1121795357"/>
   <result pre="YehN.-C.et al. (2011) Galectin-1 binds to influenza virus and ameliorates" exact="influenza" post="virus pathogenesis. J. Virol.85, 10010–1002010.1128/JVI.00301-1121795357 152LiS.W., YangT.C., LaiC.C., HuangS.H.,"/>
   <result pre="HuangS.H., LiaoJ.M., WanL.et al. (2014) Antiviral activity of aloe-emodin against" exact="influenza" post="A virus via galectin-3 up-regulation. Eur. J. Pharmacol.738, 125–13210.1016/j.ejphar.2014.05.02824877694"/>
   <result pre="variants regulating LGALS1 (Galectin 1) expression affect human susceptibility to" exact="influenza" post="A(H7N9). Sci. Rep.5, 851710.1038/srep0851725687228 154ChenY.J., WangS.F., WengI.C., HongM.H., LoT.H.,"/>
   <result pre="WengI.C., HongM.H., LoT.H., JanJ.T.et al. (2018) Galectin-3 enhances avian H5N1" exact="influenza" post="A virus-induced pulmonary inflammation by promoting NLRP3 inflammasome activation."/>
   <result pre="(2011) T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates" exact="influenza" post="A virus-specific humoral and CD8 T-cell responses. Proc. Natl."/>
   <result pre="al. (2014) Increased levels of plasma galectin-9 in patients with" exact="influenza" post="virus infection. Tohoku J. Exp. Med.232, 263–26710.1620/tjem.232.26324695077 157ChernyyE.S., RapoportE.M.,"/>
   <result pre="KaltherH., GabiusH.J. and BovinN.V. (2011) Galectins promote the interaction of" exact="influenza" post="virus with its target cells. Biochemistry76, 958–96710.1134/S000629791108012822022970 158Nita-LazarM., BanerjeeA.,"/>
   <result pre="FriemanM.B., ChenW.H.et al. (2015) Desialylation of airway epithelial cells during" exact="influenza" post="virus infection enhances pneumococcal adhesion via galectin binding. Mol."/>
   <result pre="al. (2012) Human H-ficolin inhibits replication of seasonal and pandemic" exact="influenza" post="A viruses. J. Immunol.189, 2478–248710.4049/jimmunol.110378622851708 172WhiteM.R., TripathiS., KingmaP., TakahashiK.,"/>
   <result pre="L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits" exact="influenza" post="A virus infection both in vitro and in vivo."/>
   <result pre="D informed by evolution and x-ray rystallography enhances defenses against" exact="influenza" post="A virus in vivo. J. Biol. Chem.286, 40681–4069210.1074/jbc.M111.30067321965658 175Al-AhdalM.N.,"/>
   <result pre="(2018) Entry inhibition and modulation of pro-inflammatory immune response against" exact="influenza" post="A virus by recombinant truncated surfactant protein D. Front."/>
   <result pre="binding and sialoglycans of porcine surfactant protein D synergistically neutralize" exact="influenza" post="A virus. J. Biol. Chem.293, 10646–1066210.1074/jbc.RA117.00143029769321 178ChangW.C., HartshornK.L., WhiteM.R.,"/>
   <result pre="consisting of mannose-binding lectin and L-ficolin are potent inhibitors of" exact="influenza" post="A virus compared with mannose-binding lectin. Biochem. Pharmacol.81, 388–39510.1016/j.bcp.2010.10.01221035429"/>
   <result pre="and NeromeK. (1990) Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983. Virology175, 59–6810.1016/0042-6822(90)90186-U2309452"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6331147\results\search\disease\results.xml">
   <result pre="Flaviviruses: West Nile virus Molecular characterization of viruses associated with" exact="encephalitis" post="in São Paulo, Brazil Molecular characterization of a viral"/>
   <result pre="São Paulo, Brazil Molecular characterization of a viral etiology of" exact="encephalitis" post="http://orcid.org/0000-0002-9729-9154FerreiraJerenice E.ConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject administrationResourcesSoftwareSupervisionValidationVisualizationWriting – original draftWriting"/>
   <result pre="of this study was to characterize the prevalence of viral" exact="encephalitis" post="due to arbovirus infection of the Togaviridae and Flaviviridae"/>
   <result pre="2012 and January 2013, from patients with symptoms of acute" exact="encephalitis" post="were analyzed. Findings suggestive of viral encephalitis—elevations in cell"/>
   <result pre="tested for Flaviviruses (dengue virus 1, 2, 3 and 4," exact="yellow fever" post="virus and West Nile virus), Alphavirus (NS5 region) and"/>
   <result pre="cases, dengue viruses (DENV) in 2 CSFs and St. Louis" exact="encephalitis" post="virus (SLEV) in one case. In Group 2 there"/>
   <result pre="patients suffer from severe memory disorder, which presents as clinical" exact="dementia" post="[1]. In addition to the personal, family and social"/>
   <result pre="survive, they rarely become productive again [1,2]. The incidence of" exact="encephalitis" post="ranges from 1.5 to 8/100,000 inhabitants, being higher in"/>
   <result pre="under one year of age [3,4]. Viruses known to cause" exact="encephalitis" post="worldwide are herpesviruses, arboviruses and enteroviruses [1]. Arboviruses are"/>
   <result pre="arboviruses and enteroviruses [1]. Arboviruses are the leading cause of" exact="encephalitis" post="worldwide [2]. In developed countries, herpes simplex virus type"/>
   <result pre="the leading cause of encephalitis worldwide [2]. In developed countries," exact="herpes simplex" post="virus type 1 (HSV-1) is the leading cause of"/>
   <result pre="virus type 1 (HSV-1) is the leading cause of sporadic" exact="encephalitis" post="in adults, while Varicella zoster virus (VZV) is responsible"/>
   <result pre="for up to 22% of pediatric cases [1]. Overall, Japanese" exact="encephalitis" post="virus (JEV) is the most prevalent arbovirus associated with"/>
   <result pre="Nile virus (WNV) is the most frequent agent of arbovirus" exact="encephalitis" post="and can be found in parts of Europe, Russia,"/>
   <result pre="Similar to other countries, the most frequent cause of viral" exact="encephalitis" post="in Brazil appears to be HSV- 1, followed by"/>
   <result pre="1–4, Rocio virus (ROCV), Iguape virus (IGUV), Ilhéus virus (ILHV)," exact="yellow fever" post="virus (YFV) and Saint Louis encephalitis virus (SLEV) have"/>
   <result pre="Ilhéus virus (ILHV), yellow fever virus (YFV) and Saint Louis" exact="encephalitis" post="virus (SLEV) have also been reported at low frequency"/>
   <result pre="study was to assess the prevalence of sporadic, non-seasonal viral" exact="encephalitis" post="associated with arbovirus infection of the Togaviridae and Flaviviridae"/>
   <result pre="genders and any age group) with clinical suspicion of acute" exact="encephalitis" post="(at least two of the following symptoms: fever, altered"/>
   <result pre="thousand and one hundred beds [15, 16]. The distribution of" exact="encephalitis" post="cases were from the metropolitan region, coastal and inland"/>
   <result pre="al., for DENV serotype 2 [20]; Mantel et al., for" exact="yellow fever" post="virus- YFV [21]; and Briese et al., for WNV"/>
   <result pre="France) kit was used to identify eight human herpesviruses: HSV-1," exact="herpes simplex" post="virus type 2 (HSV-2), VZV, cytomegalovirus (CMV), Epstein- Barr"/>
   <result pre="Group 2. Identification of a possible viral etiologic agent of" exact="encephalitis" post="was accomplished in only 18 (8.0%) CSF samples from"/>
   <result pre="dengue virus (D-RT-PCR and Real Time PCR); SLEV: Saint Louis" exact="encephalitis" post="virus (D-RT-PCR); HSV-1: Herpes Simplex virus type 1 (CLART-Entherpex);"/>
   <result pre="– – – – – – – SLEV: Saint Louis" exact="encephalitis" post="virus. The prevalence of arbovirus-related encephalitis in subjects in"/>
   <result pre="– SLEV: Saint Louis encephalitis virus. The prevalence of arbovirus-related" exact="encephalitis" post="in subjects in our study was 2.4%, including 4"/>
   <result pre="prevalence of HSV and a 5.1% prevalence of VZV in" exact="encephalitis" post="patients [25]. In the present study HHV-6 and EBV"/>
   <result pre="and one from São Paulo had clinical symptoms consistent with" exact="dengue fever" post="[27–29]. Non-human SLEV infections have also been found in"/>
   <result pre="suggest that this virus is not yet a cause of" exact="encephalitis" post="in São Paulo. Epidemics of DENV and ZIKV have"/>
   <result pre="suspected cases of encephalitis. Worldwide, &amp;gt;70% of cases of presumptive" exact="encephalitis" post="cases are not associated with any known infectious agent."/>
   <result pre="exposures, remains an additional possibility. This outbreak of 500 presumed" exact="encephalitis" post="cases within a six month period was not registered"/>
   <result pre="we found only a low prevalence of arboviruses in this" exact="encephalitis" post="population, there remains a need to employ molecular tests"/>
   <result pre="in Brazil. Continuous monitoring of arbovirus as a cause of" exact="encephalitis" post="is essential for the adequate treatment of these patients"/>
   <result pre="different viruses in the central nervous system of patients with" exact="meningitis" post="or encephalitis highlights the importance of maintaining a diagnostic"/>
   <result pre="in the central nervous system of patients with meningitis or" exact="encephalitis" post="highlights the importance of maintaining a diagnostic laboratory capable"/>
   <result pre="ColombaniS, MosteC, et al.Standardized quantitative RT-PCR assays for quantitation of" exact="yellow fever" post="and chimeric yellow fever-dengue vaccines. J Virol Methods. 2008;"/>
   <result pre="27SantosCLS, SallumMAM, FrancoHM, OshiroFM, RoccoIM. Genetic characterization of St Louis" exact="encephalitis" post="virus isolated from human in São Paulo, Brasil. Mem"/>
   <result pre="LopesO, de Abreu SachettaL, CoimbraTL, PereiraLE. Isolation of St. Louis" exact="encephalitis" post="virus in south Brazil. Am J Trop Med Hyg."/>
   <result pre="208–25. 31RosaR, CostaEA, MarquesRE, OliveiraTS, FurtiniR, BomfimMR, et al.Isolation of" exact="saint louis encephalitis" post="virus from a horse with neurological disease in Brazil."/>
   <result pre="CostaEA, MarquesRE, OliveiraTS, FurtiniR, BomfimMR, et al.Isolation of saint louis" exact="encephalitis" post="virus from a horse with neurological disease in Brazil."/>
   <result pre="35HeinenLB, ZuchiN, SerraOP, CardosoBF, GondimBH, Dos SantosMA, et al.Saint Louis" exact="encephalitis" post="virus in Mato Grosso, central-western Brazil. Inst Med Trop"/>
   <result pre="10.1016/j.jcv.2007.06.00717658293 37RoccoIM, SantosCLS, BisordiI, PetrellaSMCN, PereiraLE, SouzaRP, et al.St. Louis" exact="encephalitis" post="virus: first isolation from a human in São Paulo"/>
   <result pre="46LeVT, PhanTQ, DoQH, NguyenBH, LamQB, BachV, et al.Viral etiology of" exact="encephalitis" post="in children in southern Vietnam: results of a one-"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6336248\results\search\disease\results.xml">
   <result pre="source are credited.pntd.0006919.pdf Abstract Chikungunya fever (CHIKF) is an emerging" exact="infectious disease" post="caused by an alphavirus transmitted by Aedes spp. mosquitoes."/>
   <result pre="mosquitoes. Infection with CHIKV typically causes a self-limiting febrile illness," exact="chikungunya" post="fever (CHIKF), characterized by chronic, severe joint pain, and"/>
   <result pre="Health Organization (http://www.who.int/emergencies/diseases/chikungunya/en/) and Pan American Health Organization (https://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=article&amp;amp;id=343&amp;amp;Itemid=40931&amp;amp;lang=en). CHIKV," exact="chikungunya" post="virus. Secondly, although the case–fatality rate of CHIKF is"/>
   <result pre="alphaviruses are not considered neurotropic sensu strictu [18], cases of" exact="meningoencephalitis" post="have been documented, especially during Indian outbreaks [1], and"/>
   <result pre="have been documented, especially during Indian outbreaks [1], and fatal" exact="encephalitis" post="has been reported with CHIKV infection both in Italy"/>
   <result pre="Unlike other mosquito-borne viruses such as dengue, Zika, and even" exact="yellow fever," post="CHIKV typically causes symptomatic infection, and consequently outbreaks are"/>
   <result pre="previously vaccinated with other live-attenuated alphavirus vaccines (i.e., Venezuelan equine" exact="encephalitis" post="virus), suggesting immunological interference [35]. Ultimately, development of this"/>
   <result pre="[49, 50] MV-CHIK Inst. Pasteur, Themis Bioscience Recombinant live- attenuated" exact="measles" post="vaccine expressing CHIKV virus-like particles derived from the structural"/>
   <result pre="preclinical (immunogenicity and efficacy in mice, NHPs) [48] Abbreviations: CHIKF," exact="chikungunya" post="fever; CHIKV, chikungunya virus; EILV, Eilat virus; NHP, nonhuman"/>
   <result pre="efficacy in mice, NHPs) [48] Abbreviations: CHIKF, chikungunya fever; CHIKV," exact="chikungunya" post="virus; EILV, Eilat virus; NHP, nonhuman primate; nsP3, nonstructural"/>
   <result pre="vaccine in advanced stages of clinical development employs an attenuated" exact="measles" post="virus strain as a vector to express the CHIKV"/>
   <result pre="with adequate incidence of CHIKF to demonstrate efficacy. Bottlenecks for" exact="chikungunya" post="vaccine development: Which obstacles should be removed? CHIKF outbreak"/>
   <result pre="long-term protection in endemic locations. Viral-vectored platforms such as vesicular" exact="stomatitis" post="or measles can also be rapidly adapted for new"/>
   <result pre="in endemic locations. Viral-vectored platforms such as vesicular stomatitis or" exact="measles" post="can also be rapidly adapted for new viral targets"/>
   <result pre="endemic for CHIKF, but the typical misdiagnosis of CHIKF as" exact="dengue fever" post="[56] will need to be overcome with improved surveillance"/>
   <result pre="efficacy to human protection. Further work to model arthralgia and" exact="arthritis" post="in NHPs could greatly enhance the value of preclinical"/>
   <result pre="ME, Riccardo F, Severini F, et al. Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
   <result pre="et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The"/>
   <result pre="Sitar S, Plummer SH, et al. Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
   <result pre="2014;20(8):1351–4. 10.3201/eid2008.13161525061762 7CassadouS, BoucauS, Petit-SinturelM, HucP, Leparc-GoffartI, LedransM. Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
   <result pre=".24721536 8RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Di LucaM, FortunaC, RemoliME, RiccardoF, SeveriniF, et al.Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
   <result pre="Vaccine. 2017;35(37):4851–8. 10.1016/j.vaccine.2017.07.065 .28760614 14TsetsarkinKA, ChenR, WeaverSC. Interspecies transmission and" exact="chikungunya" post="virus emergence. Curr Opin Virol. 2016;16:143–50. 10.1016/j.coviro.2016.02.00726986235 15TsetsarkinKA, ChenR,"/>
   <result pre="ChenR, YunR, RossiSL, PlanteKS, GuerboisM, et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="MakhanM, MoheeputK. Excess mortality as an epidemic intelligence tool in" exact="chikungunya" post="mapping. Euro Surveill. 2008;13(7). Epub 2008/05/01. .18445418 18ArpinoC, CuratoloP,"/>
   <result pre=".26690898 21QueyriauxB, SimonF, GrandadamM, MichelR, TolouH, BoutinJP. Clinical burden of" exact="chikungunya" post="virus infection. Lancet Infect Dis. 2008;8(1):2–3. 10.1016/S1473-3099(07)70294-3 .18156079 22SissokoD,"/>
   <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virus. Postgraduate Med J. 2013;89(1054):440–7. 10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE,"/>
   <result pre="10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
   <result pre="2011/06/23. 10.1371/journal.pntd.000119721695162 26Shepard DS. Cost and burden of dengue and" exact="chikungunya" post="from the Americas to Asia. Dengue Bulletin 2010; 34."/>
   <result pre="for South-East Asia, 2010. 27BlochD. The cost and burden of" exact="chikungunya" post="in the Americas. New Haven EliScholar, USA: Yale University;"/>
   <result pre="of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against" exact="chikungunya" post="virus. Vaccine. 2012;30(43):6142–9. 10.1016/j.vaccine.2012.07.072 .22884660 32LevittNH, RamsburgHH, HastySE, RepikPM,"/>
   <result pre="HastySE, RepikPM, ColeFE, LuptonHW. Development of an attenuated strain of" exact="chikungunya" post="virus for use in vaccine production. Vaccine. 1986;4(3):157–62. 3020820"/>
   <result pre="PerryJG, MangiaficoJA. Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62(6):681–5."/>
   <result pre="2014/01/10. 10.1093/infdis/jiu01424403555 41PlanteK, WangE, PartidosCD, WegerJ, GorchakovR, TsetsarkinK, et al.Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
   <result pre="ThomasSJ, et al.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet"/>
   <result pre="Dis. 2015;9(10):e000411910.1371/journal.pntd.000411926492074 48ErasmusJH, AugusteAJ, KaelberJT, LuoH, RossiSL, FentonK, et al.A" exact="chikungunya" post="fever vaccine utilizing an insect-specific virus platform. Nat Med."/>
   <result pre="DowdKA, MendozaFH, SaundersJG, SitarS, PlummerSH, et al.Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
   <result pre="CoudercT, NgLF, HallengardD, PowersA, LecuitM, et al.Therapeutics and vaccines against" exact="chikungunya" post="virus. Vector Borne Zoonotic Dis. 2015;15(4):250–7. 10.1089/vbz.2014.1681 .25897811 53SinghP,"/>
   <result pre="et al.Current research and clinical trials for a vaccine against" exact="chikungunya" post="virus. Vaccine Development and Therapy. 2013;3:35–46. 54WhiteheadSS, SubbaraoK. Which"/>
   <result pre="ShedlockDJ, BaoH, KawalekarOU, FagoneP, RamanathanAA, et al.A DNA vaccine against" exact="chikungunya" post="virus is protective in mice and induces neutralizing antibodies"/>
   <result pre=".29194012 63BrandlerS, RuffieC, CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant" exact="measles" post="vaccine expressing chikungunya virus-like particles is strongly immunogenic and"/>
   <result pre="CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant measles vaccine expressing" exact="chikungunya" post="virus-like particles is strongly immunogenic and protects mice from"/>
   <result pre="is strongly immunogenic and protects mice from lethal challenge with" exact="chikungunya" post="virus. Vaccine. 2013;31(36):3718–25. Epub 2013/06/08. 10.1016/j.vaccine.2013.05.086 .23742993 64HallengardD, LumFM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6346436\results\search\disease\results.xml">
   <result pre="hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and" exact="yellow fever" post="virus by real-time reverse transcription-PCR.J Clin Microbiol. 2002;40:2323–30. 10.1128/JCM.40.7.2323-2330.200212089242"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6346475\results\search\disease\results.xml">
   <result pre="infection of urban and peri-urban nonhuman primates with Zika and" exact="chikungunya" post="viruses in Brazil. mSphere. 2018;3:e00523–17. 10.1128/mSphere.00523-1729404420 10. CollinsMH, McGowanE,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6356382\results\search\disease\results.xml">
   <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The Japanese" exact="encephalitis" post="virus (JEV), a causative agent of severe viral encephalitis"/>
   <result pre="Japanese encephalitis virus (JEV), a causative agent of severe viral" exact="encephalitis" post="in humans, has a biological cycle fluctuating between transmission"/>
   <result pre="contact transmission aerosol transmission intranasal infection mice 1. Introduction Japanese" exact="encephalitis" post="(JE) is a zoonotic vector-borne viral disease, causing the"/>
   <result pre="mice 1. Introduction Japanese encephalitis (JE) is a zoonotic vector-borne" exact="viral disease," post="causing the encephalitis most frequently associated with fatal or"/>
   <result pre="encephalitis (JE) is a zoonotic vector-borne viral disease, causing the" exact="encephalitis" post="most frequently associated with fatal or severe outcomes in"/>
   <result pre="succumb to the disease. Most notably, ~50% of patients surviving" exact="encephalitis" post="suffer neurologic or psychologic sequelae [4]. Japanese encephalitis virus"/>
   <result pre="patients surviving encephalitis suffer neurologic or psychologic sequelae [4]. Japanese" exact="encephalitis" post="virus (JEV), the causative agent of JE, is a"/>
   <result pre="arboviral diseaseNat. Rev. Microbiol.2004278980110.1038/nrmicro100615378043 5.GresserI.HardyJ.L.HuS.M.SchererW.F.Factors influencing transmission of Japanese B" exact="encephalitis" post="virus by a colonized strain of Culex tritaeniorhynchus Giles,"/>
   <result pre="and birdsAm. J. Trop. Med. Hyg.1958736537310.4269/ajtmh.1958.7.36513559585 6.KonnoJ.EndoK.AgatsumaH.IshidaN.Cyclic outbreaks of Japanese" exact="encephalitis" post="among pigs and humansAm. J. Epidemiol.19668429230010.1093/oxfordjournals.aje.a1206434380585 7.SchererW.F.MoyerJ.T.IzumiT.Immunologic studies of"/>
   <result pre="among pigs and humansAm. J. Epidemiol.19668429230010.1093/oxfordjournals.aje.a1206434380585 7.SchererW.F.MoyerJ.T.IzumiT.Immunologic studies of Japanese" exact="encephalitis" post="virus in Japan. V. Maternal antibodies, antibody responses and"/>
   <result pre="of the domestic pigTrans. R. Soc. Trop. Med. Hyg.197670667210.1016/0035-9203(76)90010-91265821 9.MitchellC.J.SavageH.M.SmithG.C.FloodS.P.CastroL.T.RoppulM.Japanese" exact="encephalitis" post="on Saipan: A survey of suspected mosquito vectorsAm. J."/>
   <result pre="Trop. Med. Hyg.19934858559010.4269/ajtmh.1993.48.5858386909 10.TakashimaI.HashimotoN.WatanabeT.RosenL.Mosquito collection in endemic areas of Japanese" exact="encephalitis" post="in Hokkaido, JapanNihon Juigaku Zasshi. Jpn. J. Vet. Sci.19895194795310.1292/jvms1939.51.947"/>
   <result pre="for Non-Vector-Borne TransmissionJ. Virol.201892e01091-1810.1128/JVI.01091-1830282716 14.RicklinM.E.Garcia-NicolasO.BrechbuhlD.PythonS.ZumkehrB.NougairedeA.CharrelR.N.PosthausH.OevermannA.SummerfieldA.Vector-free transmission and persistence of Japanese" exact="encephalitis" post="virus in pigsNat. Commun.201671083210.1038/ncomms1083226902924 15.YuanL.WuR.LiuH.WenX.HuangX.WenY.MaX.YanQ.HuangY.ZhaoQ.et al.Tissue tropism and molecular"/>
   <result pre="Commun.201671083210.1038/ncomms1083226902924 15.YuanL.WuR.LiuH.WenX.HuangX.WenY.MaX.YanQ.HuangY.ZhaoQ.et al.Tissue tropism and molecular characterization of a Japanese" exact="encephalitis" post="virus strain isolated from pigs in southwest ChinaVirus Res.2016215556410.1016/j.virusres.2016.02.00126851509"/>
   <result pre="pigs in southwest ChinaVirus Res.2016215556410.1016/j.virusres.2016.02.00126851509 16.YunS.I.SongB.H.PolejaevaI.A.DaviesC.J.WhiteK.L.LeeY.M.Comparison of the live-attenuated Japanese" exact="encephalitis" post="vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14"/>
   <result pre="in vivoJ. Gen. Virol.2016972575259110.1099/jgv.0.00057427498826 17.YuY.Phenotypic and genotypic characteristics of Japanese" exact="encephalitis" post="attenuated live vaccine virus SA14-14-2 and their stabilitiesVaccine2010283635364110.1016/j.vaccine.2010.02.10520226891 18.ZhaoZ.WuG.ZhuX.YanX.DouY.LiJ.ZhuH.ZhangQ.CaiX.RNA"/>
   <result pre="enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese" exact="encephalitis" post="virus envelope proteinsVirus Res.201722991610.1016/j.virusres.2016.12.00727993624 20.YuanL.WuR.LiuH.WenX.HuangX.WenY.MaX.YanQ.HuangY.ZhaoQ.et al.The NS3 and NS4A"/>
   <result pre="as the targets of RNA interference inhibit replication of Japanese" exact="encephalitis" post="virus in vitro and in vivoGene201659418318910.1016/j.gene.2016.08.05527593564 21.FanY.C.ChenJ.M.ChiuH.C.ChenY.Y.LinJ.W.ShihC.C.ChenC.M.ChangC.C.ChangG.J.ChiouS.S.Partially neutralizing potency"/>
   <result pre="against emerging genotype I virus among children received formalin-inactivated Japanese" exact="encephalitis" post="virus vaccinePLoS Negl. Trop. Dis.20126e183410.1371/journal.pntd.000183423029592 22.LiuH.WuR.LiuK.YuanL.HuangX.WenY.MaX.YanQ.ZhaoQ.WenX.et al.Enhanced immune responses"/>
   <result pre="vaccinePLoS Negl. Trop. Dis.20126e183410.1371/journal.pntd.000183423029592 22.LiuH.WuR.LiuK.YuanL.HuangX.WenY.MaX.YanQ.ZhaoQ.WenX.et al.Enhanced immune responses against Japanese" exact="encephalitis" post="virus using recombinant adenoviruses coexpressing Japanese encephalitis virus envelope"/>
   <result pre="responses against Japanese encephalitis virus using recombinant adenoviruses coexpressing Japanese" exact="encephalitis" post="virus envelope and porcine interleukin-6 proteins in miceVirus Res.2016222344010.1016/j.virusres.2016.05.02527235810"/>
   <result pre="in miceVirus Res.2016222344010.1016/j.virusres.2016.05.02527235810 23.GermanA.C.MyintK.S.MaiN.T.PomeroyI.PhuN.H.TzartosJ.WinterP.CollettJ.FarrarJ.BarrettA.et al.A preliminary neuropathological study of Japanese" exact="encephalitis" post="in humans and a mouse modelTrans. R. Soc. Trop."/>
   <result pre="Hyg.20061001135114510.1016/j.trstmh.2006.02.00816814333 24.SaxenaV.MathurA.KrishnaniN.DholeT.N.Kinetics of cytokine profile during intraperitoneal inoculation of Japanese" exact="encephalitis" post="virus in BALB/c mice modelMicrobes Infect.2008101210121710.1016/j.micinf.2008.06.01518691668 25.AliotaM.T.CaineE.A.WalkerE.C.LarkinK.E.CamachoE.OsorioJ.E.Characterization of Lethal"/>
   <result pre="of West Nile virus confer partial protection against lethal Japanese" exact="encephalitis" post="virus challengeVet. Microbiol.201316614515310.1016/j.vetmic.2013.05.02623834965 28.LarsonE.W.DominikJ.W.SloneT.W.Aerosol stability and respiratory infectivity of"/>
   <result pre="challengeVet. Microbiol.201316614515310.1016/j.vetmic.2013.05.02623834965 28.LarsonE.W.DominikJ.W.SloneT.W.Aerosol stability and respiratory infectivity of japanese B" exact="encephalitis" post="virusInfect. Immun.1980303974016254888 29.RamakrishnaC.DesaiA.ShankarS.K.ChandramukiA.RaviV.Oral immunisation of mice with live Japanese"/>
   <result pre="encephalitis virusInfect. Immun.1980303974016254888 29.RamakrishnaC.DesaiA.ShankarS.K.ChandramukiA.RaviV.Oral immunisation of mice with live Japanese" exact="encephalitis" post="virus induces a protective immune responseVaccine1999173102310810.1016/S0264-410X(99)00137-110462246 30.DengY.Q.ZhangN.N.LiX.F.WangY.Q.TianM.QiuY.F.FanJ.W.HaoJ.N.HuangX.Y.DongH.L.et al.Intranasal infection"/>
   <result pre="the airborne routeEpidemiol. Infect.1997118717510.1017/S09502688960071579042037 Figure 1 Tissue distribution of Japanese" exact="encephalitis" post="virus (JEV) RNA in mice infected by the intranasal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6360021\results\search\disease\results.xml">
   <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract Jan Svoboda triggered investigations on non-defective avian" exact="sarcoma" post="viruses. These viruses were a critical factor in the"/>
   <result pre="of the provirus hypothesis, Jan Svoboda’s investigations of non-defective avian" exact="sarcoma" post="viruses have shaped a large and important part of"/>
   <result pre="large and important part of retrovirology. Prague strain of Rous" exact="sarcoma" post="virus oncogenesis in mammalian cells avian leukosis and sarcoma"/>
   <result pre="Rous sarcoma virus oncogenesis in mammalian cells avian leukosis and" exact="sarcoma" post="virus viral genetics oncogenes expression vectors At the beginning"/>
   <result pre="virology stands a new technique: the focus assay for Rous" exact="sarcoma" post="virus (RSV) [1]. It transformed tumor virology into a"/>
   <result pre="of tumor virology. However, there were other strains of avian" exact="sarcoma" post="in circulation, notably in Europe. These included the Prague"/>
   <result pre="Carr–Zilber and Schmidt–Ruppin strains [27,28] and the independently isolated avian" exact="sarcoma" post="virus referred to as Bratislava 77 (B77) [29]. Several"/>
   <result pre="Schmidt–Ruppin and Carr–Zilber strains of RSV and the B77 avian" exact="sarcoma" post="virus to be non-defective [39,40]. The finding of non-defectiveness"/>
   <result pre="[39,40]. The finding of non-defectiveness in several strains of avian" exact="sarcoma" post="virus changed the focus of the field. Non-defective avian"/>
   <result pre="sarcoma virus changed the focus of the field. Non-defective avian" exact="sarcoma" post="viruses carry all replicative and transforming functions on the"/>
   <result pre="their interactions. Since non-defectiveness is a unique attribute of avian" exact="sarcoma" post="viruses and has not been observed with any other"/>
   <result pre="has not been observed with any other oncogene-carrying retrovirus, avian" exact="sarcoma" post="viruses provided the only key to establishing the foundation"/>
   <result pre="Non-Conditional Mutants The first conditional mutants of a non-defective avian" exact="sarcoma" post="virus that are temperature-sensitive for their ability to transform"/>
   <result pre="from biochemical data. During the replication of cloned non-defective avian" exact="sarcoma" post="viruses, derivative viruses are generated that are no longer"/>
   <result pre="At high-virus dilution, they can be separated from the parental" exact="sarcoma" post="virus and grown independently in the cell culture. They"/>
   <result pre="of their genome is smaller than that of the parental" exact="sarcoma" post="virus. They have lost the specific viral gene encoding"/>
   <result pre="deleted in the transformation-defective viruses [46]. Oncogenic and transformation-defective avian" exact="sarcoma" post="viruses are isogenic pairs, except for the deletion of"/>
   <result pre="This became the core of a genetic interpretation of human" exact="cancer" post="[13,49,50,51]. Conditional and non-conditional mutants in replicative genes also"/>
   <result pre="applied RNA fingerprinting to non-conditional and conditional mutants of avian" exact="sarcoma" post="viruses and constructed the first map of a retroviral"/>
   <result pre="[61,62]. The oncogene jun, identified in the genome of avian" exact="sarcoma" post="virus 17, showed the importance of transcriptional regulation in"/>
   <result pre="catalytic isoform of PI 3-kinase drives tumor formation by avian" exact="sarcoma" post="virus 16 [65] and plays a major role in"/>
   <result pre="virus 16 [65] and plays a major role in human" exact="cancer" post="[66]. The genomes of several acutely oncogenic mammalian retroviruses"/>
   <result pre="cells [76,77,78,79,80]. RCAS retains the unique features of non-defective avian" exact="sarcoma" post="viruses: active replication and spreading to adjacent cells and"/>
   <result pre="been tempting to speculate on the origin of non-defective avian" exact="sarcoma" post="viruses, because they are unique among acutely oncogenic, oncogene-carrying"/>
   <result pre="advantage, because they replicate faster. Yet, in the non-defective avian" exact="sarcoma" post="viruses, the non-defective component is prevalent. In scenario 2,"/>
   <result pre="by retroviruses. There have been reports of &quot;recovered�? or &quot;rescued�?" exact="sarcoma" post="viruses [84,85,86] that arose after infection with a transformation-defective"/>
   <result pre="a genetic map of a simple retrovirus. The non-defective avian" exact="sarcoma" post="viruses led to the discovery of transformation-defective derivatives, and"/>
   <result pre="of interest. References References 1.TeminH.M.RubinH.Characteristics of an assay for Rous" exact="sarcoma" post="virus and Rous sarcoma cells in tissue cultureVirology1958666968810.1016/0042-6822(58)90114-413616179 2.HartleyJ.W.RoweW.P.Production"/>
   <result pre="1.TeminH.M.RubinH.Characteristics of an assay for Rous sarcoma virus and Rous" exact="sarcoma" post="cells in tissue cultureVirology1958666968810.1016/0042-6822(58)90114-413616179 2.HartleyJ.W.RoweW.P.Production of altered cell foci"/>
   <result pre="of altered cell foci in tissue culture by defective Moloney" exact="sarcoma" post="virus particlesProc. Natl. Acad. Sci. USA19665578078610.1073/pnas.55.4.7805219685 3.HuebnerR.J.HartleyJ.W.RoweW.P.LaneW.T.CappsW.I.Rescue of the"/>
   <result pre="Acad. Sci. USA19665578078610.1073/pnas.55.4.7805219685 3.HuebnerR.J.HartleyJ.W.RoweW.P.LaneW.T.CappsW.I.Rescue of the defective genome of Moloney" exact="sarcoma" post="virus from a noninfectious hamster tumor and the production"/>
   <result pre="from a noninfectious hamster tumor and the production of pseudotype" exact="sarcoma" post="viruses with various murine leukemia virusesProc. Natl. Acad. Sci."/>
   <result pre="and the production of pseudotype sarcoma viruses with various murine" exact="leukemia" post="virusesProc. Natl. Acad. Sci. USA1966561164116910.1073/pnas.56.4.11645230142 4.SomersK.D.KirstenW.H.Focus formation by murine"/>
   <result pre="leukemia virusesProc. Natl. Acad. Sci. USA1966561164116910.1073/pnas.56.4.11645230142 4.SomersK.D.KirstenW.H.Focus formation by murine" exact="sarcoma" post="virus: Enhancement by DEAE-dextranVirology19683615515710.1016/0042-6822(68)90129-34299388 5.KlementV.RoweW.P.HartleyJ.W.PughW.E.Mixed culture cytopathogenicity: A new"/>
   <result pre="5.KlementV.RoweW.P.HartleyJ.W.PughW.E.Mixed culture cytopathogenicity: A new test for growth of murine" exact="leukemia" post="viruses in tissue cultureProc. Natl. Acad. Sci. USA19696375375810.1073/pnas.63.3.7534186808 6.KlementV.HartleyJ.W.RoweW.P.HuebnerR.J.Recovery"/>
   <result pre="from a &quot;noninfectious�? hamster tumor induced by the Kirsten Mouse" exact="sarcoma" post="virusJ. Natl. Cancer Inst.1969439259344310099 7.KirstenW.H.SchaufV.McCoyJ.Properties of a murine sarcoma"/>
   <result pre="Mouse sarcoma virusJ. Natl. Cancer Inst.1969439259344310099 7.KirstenW.H.SchaufV.McCoyJ.Properties of a murine" exact="sarcoma" post="virusBibl. Haematol.197036246249 8.RoweW.P.PughW.E.HartleyJ.W.Plaque assay techniques for murine leukemia virusesVirology1970421136113910.1016/0042-6822(70)90362-44099080"/>
   <result pre="a murine sarcoma virusBibl. Haematol.197036246249 8.RoweW.P.PughW.E.HartleyJ.W.Plaque assay techniques for murine" exact="leukemia" post="virusesVirology1970421136113910.1016/0042-6822(70)90362-44099080 9.LevyJ.A.HartleyJ.W.RoweW.P.HuebnerR.J.Studies of FBJ osteosarcoma virus in tissue culture."/>
   <result pre="8.RoweW.P.PughW.E.HartleyJ.W.Plaque assay techniques for murine leukemia virusesVirology1970421136113910.1016/0042-6822(70)90362-44099080 9.LevyJ.A.HartleyJ.W.RoweW.P.HuebnerR.J.Studies of FBJ" exact="osteosarcoma" post="virus in tissue culture. I. Biologic characteristics of the"/>
   <result pre="of oncogenic transformation of mouse lymphocytes in vitro by Abelson" exact="leukemia" post="virusProc. Natl. Acad. Sci. USA1974714077408110.1073/pnas.71.10.40774372605 11.LevyJ.A.HartleyJ.W.RoweW.P.HuebnerR.J.Studies of FBJ osteosarcoma"/>
   <result pre="Abelson leukemia virusProc. Natl. Acad. Sci. USA1974714077408110.1073/pnas.71.10.40774372605 11.LevyJ.A.HartleyJ.W.RoweW.P.HuebnerR.J.Studies of FBJ" exact="osteosarcoma" post="virus in tissue culture. II. Autoinhibition of focus formationJ."/>
   <result pre="historical primerNat. Rev. Cancer20121263964810.1038/nrc332022898541 14.BryanW.R.MoloneyJ.B.CalnanD.Stable standard preparations of the Rous" exact="sarcoma" post="virus preserved by freezing and storage at low temperaturesJ."/>
   <result pre="sarcomaVirology19597759110.1016/0042-6822(59)90178-313636057 17.TeminH.M.Further evidence for a converted, non-virus-producing state of Rous" exact="sarcoma" post="virus-infected cellsVirology19632023524510.1016/0042-6822(63)90111-913980538 18.HanafusaH.HanafusaT.RubinH.The defectiveness of Rous sarcoma virusProc. Natl."/>
   <result pre="state of Rous sarcoma virus-infected cellsVirology19632023524510.1016/0042-6822(63)90111-913980538 18.HanafusaH.HanafusaT.RubinH.The defectiveness of Rous" exact="sarcoma" post="virusProc. Natl. Acad. Sci. USA19634957258010.1073/pnas.49.4.57213952461 19.DoughertyR.M.Di StefanoH.S.Virus particles associated"/>
   <result pre="Acad. Sci. USA19634957258010.1073/pnas.49.4.57213952461 19.DoughertyR.M.Di StefanoH.S.Virus particles associated with &quot;nonproducer�? Rous" exact="sarcoma" post="cellsVirology19652735135910.1016/0042-6822(65)90115-74285103 20.WeissR.Spontaneous virus production from &quot;non-virus producing�? Rous sarcoma"/>
   <result pre="Rous sarcoma cellsVirology19652735135910.1016/0042-6822(65)90115-74285103 20.WeissR.Spontaneous virus production from &quot;non-virus producing�? Rous" exact="sarcoma" post="cellsVirology19673271972310.1016/0042-6822(67)90049-918614073 21.KluckingS.AdkinsH.B.YoungJ.A.Resistance to infection by subgroups B, D, and"/>
   <result pre="21.KluckingS.AdkinsH.B.YoungJ.A.Resistance to infection by subgroups B, D, and E avian" exact="sarcoma" post="and leukosis viruses is explained by a premature stop"/>
   <result pre="a high-throughput assayAvian Pathol.20073628329110.1080/0307945070144924817620174 24.VogtP.K.A virus released by &quot;nonproducing�? Rous" exact="sarcoma" post="cellsProc. Natl. Acad. Sci. USA19675880180810.1073/pnas.58.3.8014293264 25.ScheeleC.M.HanafusaH.Proteins of helper-dependent RSVVirology19714540141010.1016/0042-6822(71)90341-24106352"/>
   <result pre="Acad. Sci. USA19675880180810.1073/pnas.58.3.8014293264 25.ScheeleC.M.HanafusaH.Proteins of helper-dependent RSVVirology19714540141010.1016/0042-6822(71)90341-24106352 26.RychlikovaM.SvobodaJ.Effects of anti-Rous" exact="sarcoma" post="virus sera on a hemorrhagic disease of ratsVirology19601054554710.1016/0042-6822(60)90137-914440449 27.Schmidt-RuppinK.H.Heterotransplantation"/>
   <result pre="helper-dependent RSVVirology19714540141010.1016/0042-6822(71)90341-24106352 26.RychlikovaM.SvobodaJ.Effects of anti-Rous sarcoma virus sera on a" exact="hemorrhagic disease" post="of ratsVirology19601054554710.1016/0042-6822(60)90137-914440449 27.Schmidt-RuppinK.H.Heterotransplantation of Rous Sarcoma and Rous Sarcoma"/>
   <result pre="Virus to MammalsOncologia19641724727210.1159/00022423514154027 28.ZilberL.A.Some data on the interaction of Rous" exact="sarcoma" post="virus with mammalian cellsProceedings of the International Conference on"/>
   <result pre="fowl tumorCesk. Onkol.1954123023414390628 30.SvobodaJ.Presence of chicken tumour virus in the" exact="sarcoma" post="of the adult rat inoculated after birth with Rous"/>
   <result pre="sarcoma of the adult rat inoculated after birth with Rous" exact="sarcoma" post="tissueNature196018698098110.1038/186980b0 31.SimkovicD.SmidaJ.ThurzoV.Release of tumour virus by cells of the"/>
   <result pre="of B77(RBI) virus. Expression of virus genome in the hamster" exact="sarcoma" post="cell clonesNeoplasma197522133145169490 35.SvobodaJ.ChyleP.SimkovicD.HilgertI.Demonstration of the absence of infectious Rous"/>
   <result pre="in rat tumour XC, whose structurally intact cells produce Rous" exact="sarcoma" post="when transferred to chicksFolia Biol.196397781 36.SvobodaJ.HejnarJ.GerykJ.EllederD.VernerovaZ.Retroviruses in foreign species"/>
   <result pre="and the problem of provirus silencingGene200026118118810.1016/S0378-1119(00)00481-911164049 37.LounkovaA.DraberovaE.SeniglF.TrejbalovaK.GerykJ.HejnarJ.SvobodaJ.Molecular events accompanying rous" exact="sarcoma" post="virus rescue from rodent cells and the role of"/>
   <result pre="Sci. D1966262279327964288347 39.LaiM.M.DuesbergP.H.HorstJ.VogtP.K.Avian tumor virus RNA: A comparison of three" exact="sarcoma" post="viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and"/>
   <result pre="of the src gene in the RNA genome of avian" exact="sarcoma" post="virusProc. Natl. Acad. Sci. USA1977744781478510.1073/pnas.74.11.4781200931 41.ToyoshimaK.VogtP.K.Temperature sensitive mutants of"/>
   <result pre="Natl. Acad. Sci. USA1977744781478510.1073/pnas.74.11.4781200931 41.ToyoshimaK.VogtP.K.Temperature sensitive mutants of an avian" exact="sarcoma" post="virusVirology19693993093110.1016/0042-6822(69)90030-04311641 42.FriisR.R.ToyoshimaK.VogtP.K.Conditional lethal mutants of avian sarcoma viruses. I."/>
   <result pre="of an avian sarcoma virusVirology19693993093110.1016/0042-6822(69)90030-04311641 42.FriisR.R.ToyoshimaK.VogtP.K.Conditional lethal mutants of avian" exact="sarcoma" post="viruses. I. Physiology of ts 75 and ts 149Virology19714337538910.1016/0042-6822(71)90310-24322624"/>
   <result pre="viruses. I. Physiology of ts 75 and ts 149Virology19714337538910.1016/0042-6822(71)90310-24322624 43.MartinG.S.Rous" exact="sarcoma" post="virus: A function required for the maintenance of the"/>
   <result pre="the transformed stateNature19702271021102310.1038/2271021a04317808 44.VogtP.K.Spontaneous segregation of nontransforming viruses from cloned" exact="sarcoma" post="virusesVirology19714693994610.1016/0042-6822(71)90092-44332982 45.DuesbergP.H.VogtP.K.Differences between the ribonucleic acids of transforming and"/>
   <result pre="tumor virusesProc. Natl. Acad. Sci. USA1970671673168010.1073/pnas.67.4.16734321342 46.BernsteinA.MacCormickR.MartinG.S.Transformation-defective mutants of avian" exact="sarcoma" post="viruses: The genetic relationship between conditional and nonconditional mutantsVirology19767020620910.1016/0042-6822(76)90254-3176803"/>
   <result pre="nonconditional mutantsVirology19767020620910.1016/0042-6822(76)90254-3176803 47.StehelinD.VarmusH.E.BishopJ.M.VogtP.K.DNA related to the transforming gene(s) of avian" exact="sarcoma" post="viruses is present in normal avian DNANature197626017017310.1038/260170a0176594 48.VennstromB.SheinessD.ZabielskiJ.BishopJ.M.Isolation and"/>
   <result pre="USA2014 52.HanafusaH.BaltimoreD.SmolerD.WatsonK.F.YanivA.SpiegelmanS.Absence of polymerase protein in virions of alpha-type rous" exact="sarcoma" post="virusScience19721771188119110.1126/science.177.4055.11884341568 53.BaltimoreD.VermaI.M.DrostS.MasonW.S.Temperature-sensitive DNA polymerase from Rous sarcoma virus mutantsCancer19743413951397"/>
   <result pre="of alpha-type rous sarcoma virusScience19721771188119110.1126/science.177.4055.11884341568 53.BaltimoreD.VermaI.M.DrostS.MasonW.S.Temperature-sensitive DNA polymerase from Rous" exact="sarcoma" post="virus mutantsCancer19743413951397 54.FriisR.R.MasonW.S.ChenY.C.HalpernM.S.A replication defective mutant of Rous sarcoma"/>
   <result pre="Rous sarcoma virus mutantsCancer19743413951397 54.FriisR.R.MasonW.S.ChenY.C.HalpernM.S.A replication defective mutant of Rous" exact="sarcoma" post="virus which fails to make a functional reverse transcriptaseVirology197564496210.1016/0042-6822(75)90078-146651"/>
   <result pre="on one polypeptideJ. Virol.19751512112646281 56.MasonW.S.YeaterC.BoschJ.V.WykeJ.A.FriisR.R.Fourteen temperature-sensitive replication mutants of Rous" exact="sarcoma" post="virusVirology19799922624010.1016/0042-6822(79)90003-592853 57.DuesbergP.H.WangL.-H.MellonP.MasonW.S.VogtP.K.Towards a complete genetic map of Rous sarcoma"/>
   <result pre="Rous sarcoma virusVirology19799922624010.1016/0042-6822(79)90003-592853 57.DuesbergP.H.WangL.-H.MellonP.MasonW.S.VogtP.K.Towards a complete genetic map of Rous" exact="sarcoma" post="virusAnimal Virology—Proceedings of the Fifth ICN-UCLA Symposium on Molecular"/>
   <result pre="1976BaltimoreD.HuangA.S.FoxC.F.Academic PressNew York, NY, USA1976107125 58.DuesbergP.H.WangL.H.BeemonK.KawaiS.HanafusaH.Sequences and functions of Rous" exact="sarcoma" post="virus RNAHamatol. Bluttransfus197619327340188729 59.HaywardW.S.NeelB.G.AstrinS.M.Activation of a cellular onc gene"/>
   <result pre="and ultrastructural aspectsJ. Natl. Cancer Inst.1967382512854290185 62.DuesbergP.H.BisterK.VogtP.K.The RNA of avian" exact="acute leukemia" post="virus MC29Proc. Natl. Acad. Sci. USA1977744320432410.1073/pnas.74.10.4320200913 63.MakiY.BosT.J.DavisC.StarbuckM.VogtP.K.Avian sarcoma virus"/>
   <result pre="ultrastructural aspectsJ. Natl. Cancer Inst.1967382512854290185 62.DuesbergP.H.BisterK.VogtP.K.The RNA of avian acute" exact="leukemia" post="virus MC29Proc. Natl. Acad. Sci. USA1977744320432410.1073/pnas.74.10.4320200913 63.MakiY.BosT.J.DavisC.StarbuckM.VogtP.K.Avian sarcoma virus"/>
   <result pre="avian acute leukemia virus MC29Proc. Natl. Acad. Sci. USA1977744320432410.1073/pnas.74.10.4320200913 63.MakiY.BosT.J.DavisC.StarbuckM.VogtP.K.Avian" exact="sarcoma" post="virus 17 carries the jun oncogeneProc. Natl. Acad. Sci."/>
   <result pre="in chickensJ. Gen. Virol.199172 Pt 480180710.1099/0022-1317-72-4-8011849967 68.PayneL.N.HowesK.GillespieA.M.SmithL.M.Host range of Rous" exact="sarcoma" post="virus pseudotype RSV(HPRS-103) in 12 avian species: Support for"/>
   <result pre="and characterization of subgroup J Avian Leukosis virus associated with" exact="hemangioma" post="in commercial Hy-Line chickensPoult. Sci.2018972667267410.3382/ps/pey12129788333 72.BagustT.J.FentonS.P.ReddyM.R.Detection of subgroup J"/>
   <result pre="RNA packaging locus in the 115-nucleotide direct repeat of Rous" exact="sarcoma" post="virusJ. Virol.1983486676756313966 78.HughesS.H.GreenhouseJ.J.PetropoulosC.J.SutraveP.Adaptor plasmids simplify the insertion of foreign"/>
   <result pre="Natl. Acad. Sci. USA2011108143891439610.1073/pnas.110865510821813762 82.KawaiS.HanafusaH.Isolation of defective mutant of avian" exact="sarcoma" post="virusProc. Natl. Acad. Sci. USA1973703493349710.1073/pnas.70.12.34934357873 83.DuttaA.WangL.H.HanafusaT.HanafusaH.Partial nucleotide sequence of"/>
   <result pre="virusProc. Natl. Acad. Sci. USA1973703493349710.1073/pnas.70.12.34934357873 83.DuttaA.WangL.H.HanafusaT.HanafusaH.Partial nucleotide sequence of Rous" exact="sarcoma" post="virus-29 provides evidence that the original Rous sarcoma virus"/>
   <result pre="of Rous sarcoma virus-29 provides evidence that the original Rous" exact="sarcoma" post="virus was replication defectiveJ. Virol.1985557287352991593 84.WangL.H.BecksonM.AndersonS.M.HanafusaH.Identification of the viral"/>
   <result pre="the viral sequence required for the generation of recovered avian" exact="sarcoma" post="viruses and characterization of a series of replication-defective recovered"/>
   <result pre="viruses and characterization of a series of replication-defective recovered avian" exact="sarcoma" post="virusesJ. Virol.1984498818916321772 85.SvobodaJ.GerykJ.KarakozI.RejtharA.Isolation of two transforming viruses from sarcomas"/>
   <result pre="intraembryonally with a transformation defective mutant of Prague strain Rous" exact="sarcoma" post="virusFolia Biol.198531135151 86.SvobodaJ.KandalaJ.C.GerykJ.PichrtovaJ.GuntakaR.V.A transformation-competent recombinant between v-src and Rous-associated"/>
   <result pre="89.SvobodaJ.VeselyP.VrbaM.JiranekL.Biological properties of rat cells transformed in vitro by Rous" exact="sarcoma" post="virusFolia Biol.196511251257 90.SvobodaJ.HlozanekI.MachO.Detection of chicken sarcoma virus after transfection"/>
   <result pre="in vitro by Rous sarcoma virusFolia Biol.196511251257 90.SvobodaJ.HlozanekI.MachO.Detection of chicken" exact="sarcoma" post="virus after transfection of chicken fibroblasts with DNA isolated"/>
   <result pre="isolated from mammalian cells transformed with Rous VirusFolia Biol.197218149153 91.SvobodaJ.Rous" exact="sarcoma" post="virusIntervirology19862616010.1159/0001496822437068 92.SvobodaJ.On board a raft or boat in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6360178\results\search\disease\results.xml">
   <result pre="with these terms. Abstract Several mosquito-borne Flaviviruses such as Japanese" exact="encephalitis" post="virus (JEV), West Nile virus (WNV), Dengue Virus (DENV),"/>
   <result pre="unknown (Simmonds et al., 2017). Some Flaviviruses such as Japanese" exact="encephalitis" post="virus (JEV) infect a broad range of vertebrate hosts"/>
   <result pre="and 2) viruses. Virology485, 189–198. 10.1016/j.virol.2015.07.01526280469 CaoS.LiY.YeJ.YangX.ChenL.LiuX.et al.. (2011). Japanese" exact="encephalitis" post="Virus wild strain infection suppresses dendritic cells maturation and"/>
   <result pre="CoetzerJ. A.BarnardB. J. (1977). Hydrops amnii in sheep associated with" exact="hydranencephaly" post="and arthrogryposis with wesselsbron disease and rift valley fever"/>
   <result pre="sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and" exact="rift valley fever" post="viruses as aetiological agents. Onderstepoort J. Vet. Res.44, 119–126."/>
   <result pre="reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis" exact="encephalitis" post="viruses) in French Guiana. Trans. R. Soc. Trop. Med."/>
   <result pre="365–369. 10.1016/j.vetmic.2015.02.00525724332 Espada-MuraoL. A.MoritaK. (2011). Delayed cytosolic exposure of Japanese" exact="encephalitis" post="virus double-stranded RNA impedes interferon activation and enhances viral"/>
   <result pre="Res.179, 204–211. 10.1016/j.virusres.2013.08.00924220223 Garcia-NicolasO.RicklinM. E.LinigerM.VielleN. J.PythonS.SouqueP.et al.. (2017). A Japanese" exact="encephalitis" post="virus vaccine inducing antibodies strongly enhancing in vitro infection"/>
   <result pre="Italy. Clin. Microbiol. Infect.23, 33–37. 10.1016/j.cmi.2016.09.01927677699 GuptaN.HegdeP.LecerfM.NainM.KaurM.KaliaM.et al.. (2014). Japanese" exact="encephalitis" post="virus expands regulatory T cells by increasing the expression"/>
   <result pre="of domestic pigs to West Nile virus followed by Japanese" exact="encephalitis" post="virus infection and vice versa. Acta Virol.38, 157–161. 7817897"/>
   <result pre="is critical for infection by the virulent strain of Japanese" exact="encephalitis" post="virus. Cell. Microbiol.13, 1358–1370. 10.1111/j.1462-5822.2011.01624.x21707907 ManokaranG.FinolE.WangC.GunaratneJ.BahlJ.OngE. Z.et al.. (2015)."/>
   <result pre="Science350, 217–221. 10.1126/science.aab336926138103 MansfieldK. L.Hernandez-TrianaL. M.BanyardA. C.FooksA. R.JohnsonN. (2017). Japanese" exact="encephalitis" post="virus infection, diagnosis and control in domestic animals. Vet."/>
   <result pre="RicklinM. E.Garcia-NicolasO.BrechbuhlD.PythonS.ZumkehrB.NougairedeA.et al.. (2016). Vector-free transmission and persistence of Japanese" exact="encephalitis" post="virus in pigs. Nat. Commun.7:10832. 10.1038/ncomms1083226902924 SantiniM.Vilibic-CavlekT.BarsicB.BarbicL.SavicV.StevanovicV.et al.. (2015)."/>
   <result pre="ShimojimaM.TakenouchiA.ShimodaH.KimuraN.MaedaK. (2014). Distinct usage of three C-type lectins by Japanese" exact="encephalitis" post="virus: DC-SIGN, DC-SIGNR, and LSECtin. Arch. Virol.159, 2023–2031. 10.1007/s00705-014-2042-224623090"/>
   <result pre="SooryanarainH.SapkalG. N.GoreM. M. (2012). Pathogenic and vaccine strains of Japanese" exact="encephalitis" post="virus elicit different levels of human macrophage effector functions."/>
   <result pre="(2001). Highly sulfated forms of heparin sulfate are involved in" exact="japanese encephalitis" post="virus infection. Virology286, 206–215. 10.1006/viro.2001.098611448173 SummerfieldA.HornM. P.LozanoG.CarrascoC. P.AtzeK.McCulloughK. (2003)."/>
   <result pre="Highly sulfated forms of heparin sulfate are involved in japanese" exact="encephalitis" post="virus infection. Virology286, 206–215. 10.1006/viro.2001.098611448173 SummerfieldA.HornM. P.LozanoG.CarrascoC. P.AtzeK.McCulloughK. (2003)."/>
   <result pre="Virol.150, 1249–1256. 10.1007/s00705-004-0478-515770358 ThongtanT.WikanN.WintachaiP.RattanarungsanC.SrisomsapC.CheepsunthornP.et al.. (2012). Characterization of putative Japanese" exact="encephalitis" post="virus receptor molecules on microglial cells. J. Med. Virol.84,"/>
   <result pre="microglial cells. J. Med. Virol.84, 615–623. 10.1002/jmv.2324822337301 TurtleL.SolomonT. (2018). Japanese" exact="encephalitis" post="- the prospects for new treatments. Nat. Rev. Neurol.14,"/>
   <result pre="WangP.HuK.LuoS.ZhangM.DengX.LiC.et al.. (2016). DC-SIGN as an attachment factor mediates Japanese" exact="encephalitis" post="virus infection of human dendritic cells via interaction with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6366427\results\search\disease\results.xml">
   <result pre="from unknown fever were used for screening of six arboviruses," exact="hepatitis" post="E virus and malarial using molecular techniques and serology."/>
   <result pre="was 61.3% (73/119). The highest positivity rate was 73.1% (52/73)" exact="chikungunya" post="virus; 29 males and 20 females patients were chikungunya"/>
   <result pre="(52/73) chikungunya virus; 29 males and 20 females patients were" exact="chikungunya" post="positive. Other arboviruses were circulating in low rate 20.5%"/>
   <result pre="low rate 20.5% (15/73), and 6.8% (5/73) for sindbis and" exact="rift valley fever" post="viruses respectively. Hepatitis E virus was negative in all"/>
   <result pre="respectively. Hepatitis E virus was negative in all cases and" exact="malaria" post="positivity rate 13.4% (16/119). The prevalence of arboviruses among"/>
   <result pre="of eastern region in Sudan is significantly high (61.3%). The" exact="chikungunya" post="virus is the predominant causative agent of arboviruses. Molecular"/>
   <result pre="diagnosis of this viral outbreak. KEYWORDS Arthropod-transmitted viruses mosquito-borne viruses" exact="chikungunya" post="virus Sindbis virus molecular techniques Funding Research Centre of"/>
   <result pre="socioeconomic consequences [2–5]. Mosquito-borne viruses affecting humans, these viruses include:" exact="chikungunya" post="(CHIKV), dengue fever (DFV), yellow fever (YFV), Rift Valley"/>
   <result pre="[2–5]. Mosquito-borne viruses affecting humans, these viruses include: chikungunya (CHIKV)," exact="dengue fever" post="(DFV), yellow fever (YFV), Rift Valley fever virus (RVFV),"/>
   <result pre="affecting humans, these viruses include: chikungunya (CHIKV), dengue fever (DFV)," exact="yellow fever" post="(YFV), Rift Valley fever virus (RVFV), Sindbis virus (SINV),"/>
   <result pre="virus (RVFV), Sindbis virus (SINV), and alkhurma viruses [2,6–9]. Dengue," exact="yellow fever," post="chikungunya, Rift Valley fever, alkhurma haemorrhagic fever, and Sindbis"/>
   <result pre="be interfere with other parasitic or non-parasitic infections such as" exact="malaria" post="or bacterial meningitis. Most of arbovirus infections could be"/>
   <result pre="with other parasitic or non-parasitic infections such as malaria or" exact="bacterial meningitis." post="Most of arbovirus infections could be seriously severe, resulting"/>
   <result pre="its enzootic hosts by mosquitoes, and causes polyarthritis, fever, and" exact="rash" post="[23,24] Hantaviruses have almost entirely been associated with human"/>
   <result pre="period from November 2010 to March 2011 an outbreak of" exact="hepatitis" post="E virus (HEV) among pregnant women presented at Port"/>
   <result pre="hypothesized that some of febrile patients who frequently diagnosed as" exact="malaria" post="patients may harbour one or more of the viral"/>
   <result pre="was divided into: 1.5 mL anticoagulant EDTA containers for performing" exact="malaria" post="rapid diagnostic test and the rest whole blood sample"/>
   <result pre="RVFV, CHIKV, and SINV infections. Most samples were positive for" exact="chikungunya" post="and Sindbis (73.1% and 19.4%, respectively). Out of the"/>
   <result pre="Out of the 73 arboviruses-positive samples, 49 were positive for" exact="chikungunya" post="(29 males and 20 females). In contrast to this,"/>
   <result pre="as RVFV (7.4%). Results also revealed that both SINV and" exact="malaria" post="parasite shared the same positive proportions among the detected"/>
   <result pre="by SINV 10.92% cases and RVFV (P ˂ 0.05). However," exact="malaria" post="was more dominant than RVFV, representing 10.92% cases (Figure"/>
   <result pre="10.92% cases (Figure 1). The distribution of arboviruses, HEV, and" exact="malaria" post="infection for all patients presented to the hospital with"/>
   <result pre="been summarized in Table 1. 10.1080/19932820.2018.1564511-T0001Table 1. Distribution of arboviruses," exact="hepatitis" post="E virus and malaria for all the patients with"/>
   <result pre="1. 10.1080/19932820.2018.1564511-T0001Table 1. Distribution of arboviruses, hepatitis E virus and" exact="malaria" post="for all the patients with unknown fever. Infection Children"/>
   <result pre="73.1% (52/73) CHIKV; 29 male and 20 female patients were" exact="chikungunya" post="positive. CHIKV, SINV, and RVFV in using qRT-PCR, whereas"/>
   <result pre="CHIKV, and SINV infections, previous studies shown that infection with" exact="chikungunya" post="and Sindbis viruses characterize by specific symptoms such as"/>
   <result pre="show high rates of malarial parasite infection. High prevalence of" exact="malaria" post="is usually observed in children [49]; however, in this"/>
   <result pre="usually observed in children [49]; however, in this study, most" exact="malaria" post="patients were adults (10 patients); however, only three children"/>
   <result pre="patients were adults (10 patients); however, only three children had" exact="malaria" post="positive. The African continent has witnessed a long-term decline"/>
   <result pre="witnessed a long-term decline in the prevalence of Plasmodium falciparum," exact="malaria" post="burden in the six endemic countries (Afghanistan, Djibouti, Pakistan,"/>
   <result pre="Virol J. 2016;13:144.27565893 [8]AhmedSS, SoghaierMA, MohammedS, et alConcomitant outbreaks of" exact="yellow fever" post="and hepatitis E virus in Darfur States, Sudan, 2012."/>
   <result pre="[8]AhmedSS, SoghaierMA, MohammedS, et alConcomitant outbreaks of yellow fever and" exact="hepatitis" post="E virus in Darfur States, Sudan, 2012. J Infect"/>
   <result pre="to 2011. Vector Borne Zoonotic Dis. 2015;15(8):502–511.26273812 [15]QuichaudJThe epidemiology of" exact="yellow fever" post="in Africa. Sem Med Prof Med Soc. 1955;31(38):1179–1181.13290801 [16]MahaffyAFThe"/>
   <result pre="Africa. Sem Med Prof Med Soc. 1955;31(38):1179–1181.13290801 [16]MahaffyAFThe epidemiology of" exact="yellow fever" post="in Central Africa. Trans R Soc Trop Med Hyg."/>
   <result pre="Zoonotic Dis. 2016;16(4):290–291.26974266 [22]GouldLH, OsmanMS, FarnonEC, et alAn outbreak of" exact="yellow fever" post="with concurrent chikungunya virus transmission in South Kordofan, Sudan,"/>
   <result pre="OsmanMS, FarnonEC, et alAn outbreak of yellow fever with concurrent" exact="chikungunya" post="virus transmission in South Kordofan, Sudan, 2005. Trans R"/>
   <result pre="Epidemiol Rec2007, 82(48):417–418. [32]RayisDA, JumaaAM, GasimGI, et alAn outbreak of" exact="hepatitis" post="E and high maternal mortality at Port Sudan, Eastern"/>
   <result pre="Sudan, Eastern Sudan. Pathog Glob Health. 2013;107(2):66–68.23683332 [33]EldumaAH, OsmanWMDengue and" exact="hepatitis" post="E virus infection in pregnant women in Eastern Sudan,"/>
   <result pre="Clin Virol. 2013;56(4):280–285.23290388 [35]GyarmatiP, MohammedN, NorderH, et alUniversal detection of" exact="hepatitis" post="E virus by two real-time PCR assays: taqMan and"/>
   <result pre="alFour dengue virus serotypes found circulating during an outbreak of" exact="dengue fever" post="and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004."/>
   <result pre="Front Public Health. 2014;2:169.25340047 [43]EldigailMH, AdamGK, BabikerRA, et alPrevalence of" exact="dengue fever" post="virus antibodies and associated risk factors among residents of"/>
   <result pre="2016. Virusdisease. 2018;29(3):303–307.30159364 [49]KayentaoK, FloreyLS, MihigoJ, et alImpact evaluation of" exact="malaria" post="control interventions on morbidity and all-cause child mortality in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6369168\results\search\disease\results.xml">
   <result pre="In September 1998, there was an outbreak of severe febrile" exact="encephalitis" post="among pig farmers in the state of Perak, Malaysia,"/>
   <result pre="These deaths were initially thought to be due to Japanese" exact="encephalitis" post="(JE), an endemic disease in Malaysia. However, with most"/>
   <result pre="following month, there were 11 cases of respiratory illness and" exact="encephalitis" post="amongst Singapore abattoir workers who had handled pigs imported"/>
   <result pre="respiratory and neurological syndrome�? (also known as &quot;porcine respiratory and" exact="encephalitis" post="syndrome�?), or, in peninsular Malaysia, &quot;barking pig syndrome�? (28)."/>
   <result pre="The experimental viral vectored vaccine candidates for NiV include vesicular" exact="stomatitis" post="virus, rabies virus, canarypox virus (ALVAC strain), adeno-associated virus"/>
   <result pre="viral vectored vaccine candidates for NiV include vesicular stomatitis virus," exact="rabies" post="virus, canarypox virus (ALVAC strain), adeno-associated virus (AAV), measles"/>
   <result pre="virus, rabies virus, canarypox virus (ALVAC strain), adeno-associated virus (AAV)," exact="measles" post="virus, Newcastle disease virus (NDV) and Venezuelan equine encephalitis"/>
   <result pre="(AAV), measles virus, Newcastle disease virus (NDV) and Venezuelan equine" exact="encephalitis" post="virus (40). ALVAC expressing NiV G or F (ALVAC-G"/>
   <result pre="Fund manages vaccine banks and the delivery of vaccines for" exact="avian influenza," post="rabies, foot-and-mouth disease, and peste de petit ruminants (46)."/>
   <result pre="play a major component in an emergency response against emerging" exact="infectious disease," post="with the main aim to reduce virus spread between"/>
   <result pre="the development of new human vaccines to prevent and contain" exact="infectious disease" post="epidemics. CEPI selected NiV, Lassa virus and Middle East"/>
   <result pre="cell-mediated responses (53). In 2015, a vaccine to protect against" exact="anthrax" post="was the first to be approved through the &quot;animal"/>
   <result pre="growing appreciation that pigs provide a superior animal model for" exact="influenza" post="A virus infection and immunity and should play a"/>
   <result pre="play a more prominent role as a model for human" exact="influenza" post="vaccine development (65). The success of the pig as"/>
   <result pre="at: https://www.cdc.gov/vhf/nipah/outbreaks/distribution-map.html (Accessed August 21, 2018). 10.HsuVPHossainMJParasharUDAliMMKsiazekTGKuzminIet al.. Nipah virus" exact="encephalitis" post="reemergence, Bangladesh. Emerging Infect Dis. (2004) 10:2082–7. 10.3201/eid1012.04070115663842 11.DonaldsonHLuceyD."/>
   <result pre="zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe" exact="encephalitis" post="in Malaysia. J Infect Dis. (2000) 181:1755–9. 10.1086/31545710823779 18.HuynhTTAarninkAJDruckerAVerstegenMWPig"/>
   <result pre="emergent deadly Paramyxovirus. Science (2000) 288:1432–5. 10.1126/science.288.5470.143210827955 20.LamSKChuaKB. Nipah virus" exact="encephalitis" post="outbreak in Malaysia. Clin Infect Dis. (2002) 34(Suppl. 2):S48–51."/>
   <result pre="Virol. (2006) 80:7929–38. 10.1128/jvi.00263-0616873250 42.KongDWenZSuHGeJChenWWangXet al.. Newcastle disease virus-vectored Nipah" exact="encephalitis" post="vaccines induce B and T cell responses in mice"/>
   <result pre="pneumonia. Eur Respir J. (2009) 33:182–8. 10.1183/09031936.0004630819118229 62.KhatriMDwivediVKrakowkaSManickamCAliAWangLFet al.. Swine" exact="influenza" post="H1N1 virus induces acute inflammatory immune responses in pig"/>
   <result pre="in pig lungs: a potential animal model for human H1N1" exact="influenza" post="virus. J Virol. (2010) 84:11210–8. 10.1128/jvi.01211-1020719941 63.MeurensFSummerfieldANauwynckHSaifLGerdtsV. The pig:"/>
   <result pre="J. (2009) 181:211–20. 10.1016/j.tvjl.2008.10.01619084436 65.RajaoDSVincentAL. Swine as a model for" exact="influenza" post="A virus infection and immunity. ILAR J. (2015) 56:44–52."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6369503\results\search\disease\results.xml">
   <result pre="field and added to our understanding of this new, emerging" exact="viral disease." post="Arboviral isolation from clinical samples typically employs the use"/>
   <result pre="Ae. aegypti mosquito models have shown that coinfections with the" exact="chikungunya" post="and densonucleosis viruses do not impact the infection and"/>
   <result pre="the C6/36 Aedes albopictus cell lineVirology2005337225326115919104 26SivaramABardePVGokhaleMDSinghDKMouryaDTEvidence of co-infection of" exact="chikungunya" post="and densonucleosis viruses in C6/36 cell lines and laboratory"/>
   <result pre="clinical specimensJ Clin Microbiol1992306161116131320632 29StaplefordKAMoratorioGHenningssonRChenRMatheusSEnfissiAet al.Whole-genome sequencing analysis from the" exact="chikungunya" post="virus Caribbean outbreak reveals novel evolutionary genomic elementsPLoS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6370227\results\search\disease\results.xml">
   <result pre="original author and source are credited.pbio.3000124.pdf Abstract The eradication of" exact="smallpox" post="is one of the greatest medical successes in history."/>
   <result pre="death and disease in the modern world. The eradication of" exact="smallpox" post="was one of the greatest medical successes in history."/>
   <result pre="ever exist. With a devastating 20% to 60% mortality rate," exact="smallpox" post="killed an estimated 300 million people in the 20th"/>
   <result pre="commonly recognised at the time that milkmaids, who would catch" exact="cowpox" post="from their cattle, never died of smallpox. The English"/>
   <result pre="nonlethal yet close relative of variola virus and showed that" exact="cowpox" post="infection protected a person from smallpox. However, it took"/>
   <result pre="of the devastating killer [1,2]. Health officials subsequently stopped routine" exact="smallpox" post="vaccinations because the risk of using a live virus"/>
   <result pre="me from smallpox. In fact, for most people alive today," exact="vaccinia virus" post="is simply the vaccine once used to protect people"/>
   <result pre="established a research project to study the fundamental biology of" exact="vaccinia virus." post="I was excited to study vaccinia because, independent of"/>
   <result pre="VRKs are implicated in several cancers including liver, lung, and" exact="breast cancer" post="[4–6]. As a result, this kinase family serves as"/>
   <result pre="are implicated in several cancers including liver, lung, and breast" exact="cancer" post="[4–6]. As a result, this kinase family serves as"/>
   <result pre="result, this kinase family serves as potential targets for developing" exact="cancer" post="therapeutics, with comparative studies of vaccinia B1 still guiding"/>
   <result pre="dimensions of 350 nm × 250 nm × 250 nm," exact="vaccinia virus" post="is large (for a virus!) and can be easily"/>
   <result pre="known to be employed by 20 clinically relevant viruses, including" exact="chikungunya" post="virus, dengue virus, hepatitis A virus, Lassa virus, Marburg"/>
   <result pre="by 20 clinically relevant viruses, including chikungunya virus, dengue virus," exact="hepatitis" post="A virus, Lassa virus, Marburg virus, and Ebola virus"/>
   <result pre="limit of the microscope. Fig 1 An electron micrograph of" exact="vaccinia virus." post="The three subviral structures, core (C), lateral bodies (L),"/>
   <result pre="will be able to see and understand. The eradication of" exact="smallpox" post="was undeniably a world-changing accomplishment, but vaccinia virus is"/>
   <result pre="The eradication of smallpox was undeniably a world-changing accomplishment, but" exact="vaccinia virus" post="is more than simply the vaccine that enabled this"/>
   <result pre="Vaccinia has a lot more biology to teach us. With" exact="vaccinia virus" post="as a tool, poxvirologists all over the world are"/>
   <result pre="vaccinia-related kinase References References 1RiedelS.Edward Jenner and the history of" exact="smallpox" post="and vaccination. Proc (Bayl Univ Med Cent)2005, 18, 21–25.16200144"/>
   <result pre="putative serine/threonine kinases, vrk1 and vrk2, with structural similarity to" exact="vaccinia virus" post="b1r kinase. Genomics1997, 45, 327–331. 9344656 4KimS.H.; RyuH.G.; LeeJ.;"/>
   <result pre="anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in" exact="lung cancer" post="cells. Sci Rep2015, 5, 1457010.1038/srep1457026412148 5SalzanoM.; Vazquez-CedeiraM.; Sanz-GarciaM.; ValbuenaA.;"/>
   <result pre="activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung" exact="cancer" post="cells. Sci Rep2015, 5, 1457010.1038/srep1457026412148 5SalzanoM.; Vazquez-CedeiraM.; Sanz-GarciaM.; ValbuenaA.;"/>
   <result pre="kinase 1 (vrk1) confers resistance to DNA-damaging agents in human" exact="breast cancer" post="by affecting DNA damage response. Oncotarget2014, 5, 1770–1778. 10.18632/oncotarget.167824731990"/>
   <result pre="1 (vrk1) confers resistance to DNA-damaging agents in human breast" exact="cancer" post="by affecting DNA damage response. Oncotarget2014, 5, 1770–1778. 10.18632/oncotarget.167824731990"/>
   <result pre="al.High vrk1 expression contributes to cell proliferation and survival in" exact="hepatocellular carcinoma." post="Pathol Res Pract2016, 212, 171–178. 10.1016/j.prp.2015.11.01526706601 7OlsonA.T.; RicoA.B.; WangZ.;"/>
   <result pre="212, 171–178. 10.1016/j.prp.2015.11.01526706601 7OlsonA.T.; RicoA.B.; WangZ.; DelhonG.; WiebeM.S.Deletion of the" exact="vaccinia virus" post="b1 kinase reveals essential functions of this enzyme complemented"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6370234\results\search\disease\results.xml">
   <result pre="outbreak of exanthematous febrile illness complicated by Guillain-Barre syndrome (GBS)," exact="microcephaly" post="and other birth defects [1]. ZIKV was first discovered"/>
   <result pre="flavivirus naïve, as determined by seronegativity to DENV, ZIKV, Japanese" exact="encephalitis" post="virus (JEV), West Nile Virus (WNV) and yellow fever"/>
   <result pre="ZIKV, Japanese encephalitis virus (JEV), West Nile Virus (WNV) and" exact="yellow fever" post="virus (YFV)[30]. In the DENV-exposed group, DENV exposure occurred"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6371560\results\search\disease\results.xml">
   <result pre="Health approach towards disease control and prevention. The avian-origin H7N9" exact="influenza" post="A virus outbreak in China serves as an ideal"/>
   <result pre="present the features and epidemiology of human infections with H7N9" exact="influenza" post="virus. At the early stages of the H7N9 epidemic,"/>
   <result pre="live poultry markets. As a result, zoonotic infections with H7N9" exact="influenza" post="viruses continued to enlarge in both numbers and geographic"/>
   <result pre="was only after the number of human infections with H7N9" exact="influenza" post="virus spiked in the 5th wave of the epidemic"/>
   <result pre="in substantial health and economic gains. The continual threat of" exact="avian influenza," post="as well as other emerging zoonotic viral infections, emphasizes"/>
   <result pre="Guangzhou201604020011LuJiahai Funding http://dx.doi.org/10.13039/501100010905Major Research Plan 2018ZX10101002-001-001LuJiahai Background Human infections with" exact="avian influenza" post="virus H7N9 were first identified in March 2013 in"/>
   <result pre="Funding http://dx.doi.org/10.13039/501100010905Major Research Plan 2018ZX10101002-001-001LuJiahai Background Human infections with avian" exact="influenza" post="virus H7N9 were first identified in March 2013 in"/>
   <result pre="March 2nd 2018, 1567 laboratory-confirmed cases of human infected with" exact="avian influenza" post="A(H7N9) viruses have been reported to the World Health"/>
   <result pre="2nd 2018, 1567 laboratory-confirmed cases of human infected with avian" exact="influenza" post="A(H7N9) viruses have been reported to the World Health"/>
   <result pre="ended in June 2013. In subsequent waves (2013–2018), the H7N9" exact="influenza" post="virus infection season typically started in October and lasted"/>
   <result pre="October 2016 to June 2017, the number of human H7N9" exact="influenza" post="virus infections increased to 759 cases (almost the same"/>
   <result pre="and 6 municipalities [4]. During this wave, a highly pathogenic" exact="avian influenza" post="(HPAI) virus A (H7N9) was identified in birds from"/>
   <result pre="6 municipalities [4]. During this wave, a highly pathogenic avian" exact="influenza" post="(HPAI) virus A (H7N9) was identified in birds from"/>
   <result pre="to a rapid decline in the number of human H7N9" exact="influenza" post="virus infections and only 3 cases have been reported"/>
   <result pre="we hope to prevent the next endemic/pandemic with an HxNy" exact="influenza" post="virus. In this article, we will use the outbreak"/>
   <result pre="In this article, we will use the outbreak of H7N9" exact="influenza" post="viruses in humans as an example of the benefits"/>
   <result pre="result of co-infection and genome reassortment). The NA of H7N9" exact="influenza" post="viruses isolated from human cases most closely resembles that"/>
   <result pre="South Korea [10]. In contrast, the HA of human H7N9" exact="influenza" post="viruses can be traced back to the HA of"/>
   <result pre="can be traced back to the HA of an H7N3" exact="influenza" post="virus from domestic ducks [11]. Typically, the HA of"/>
   <result pre="influenza virus from domestic ducks [11]. Typically, the HA of" exact="avian influenza" post="viruses shows a strong preference to bind to α-2,3"/>
   <result pre="virus from domestic ducks [11]. Typically, the HA of avian" exact="influenza" post="viruses shows a strong preference to bind to α-2,3"/>
   <result pre="to α-2,3 linked sialic acids whilst the HA of human" exact="influenza" post="viruses typically binds to α-2,6 linked sialic acid [12]."/>
   <result pre="respiratory tract of humans is rich in α-2,6 receptors, human" exact="influenza" post="viruses are well adapted for efficient human-to-human transmission [13]."/>
   <result pre="point mutations in viral HA (Q226L/I, G186 V), the avian H7N9" exact="influenza" post="virus increased its avidity to human receptors [13]. Thus,"/>
   <result pre="Indeed, there were at least 23 different genotypes of H7N9" exact="influenza" post="viruses detected by the end of December 2017. Among"/>
   <result pre="16 were found to have evolved from the 2013 H7N9" exact="influenza" post="viruses [21]. Although the HPAI virus H7N9 was first"/>
   <result pre="H7N9 then evolved into multiple genotypes via reassortment with H9N2" exact="influenza" post="viruses and local low pathogenic H7N9 viruses [24]. As"/>
   <result pre="H7N9 viruses [24]. As of July 2017, the HPAI H7N9" exact="influenza" post="virus has spread to more than 12 different provinces"/>
   <result pre="provinces in China [24]. Epidemiology of human infections with H7N9" exact="influenza" post="viruses Since February 2013, six waves of human H7N9"/>
   <result pre="influenza viruses Since February 2013, six waves of human H7N9" exact="influenza" post="virus infections have occurred in China. The total number"/>
   <result pre="to present day (i.e during the sixth wave). Like other" exact="influenza" post="virus strains, the H7N9 influenza virus showed increased circulation"/>
   <result pre="the sixth wave). Like other influenza virus strains, the H7N9" exact="influenza" post="virus showed increased circulation amongst both poultry and humans"/>
   <result pre="provinces [4]. Three distinct stages were noted during the H7N9" exact="influenza" post="virus epidemic. The first stage was characterized by sporadic"/>
   <result pre="in poultry populations across China, the number of human H7N9" exact="influenza" post="virus cases surged. This second stage was associated with"/>
   <result pre="came from three avian origins, with six internal genes from" exact="avian influenza" post="A (H9N2) viruses in domestic poultries, the hemagglutinin (HA)"/>
   <result pre="from three avian origins, with six internal genes from avian" exact="influenza" post="A (H9N2) viruses in domestic poultries, the hemagglutinin (HA)"/>
   <result pre="gain if implement One Health policy Among all human H7N9" exact="influenza" post="virus infections recorded to date, almost 50% of cases"/>
   <result pre="The role of LPMs in the zoonotic spread of H7N9" exact="influenza" post="viruses is further supported by the fact that positive"/>
   <result pre="In contrast, pigs are unable to sufficiently transmit the H7N9" exact="influenza" post="virus after experimental infection [18]. Poultry appeared to have"/>
   <result pre="the virus [34]. It was further argued that the H7N9" exact="influenza" post="virus should neither be named as avian influenza nor"/>
   <result pre="that the H7N9 influenza virus should neither be named as" exact="avian influenza" post="nor should the government report every human infection to"/>
   <result pre="the H7N9 influenza virus should neither be named as avian" exact="influenza" post="nor should the government report every human infection to"/>
   <result pre="transparency and inter-departmental collaboration. When human infections with the H7N9" exact="influenza" post="virus were first identified, control strategies focused on patient"/>
   <result pre="inter-departmental collaborations to prevent and control the spread of H7N9" exact="influenza" post="viruses [42]. This approach proved to be highly successful"/>
   <result pre="successful and only 3 cases of human infection with H7N9" exact="influenza" post="virus were reported in the last wave (Fig. 3)."/>
   <result pre="of &quot;One Health�?, which means solving the growing problem of" exact="infectious disease" post="via cooperation between experts in different disciplines [44]. As"/>
   <result pre="in China, &quot;Company + peasant household�?, creates opportunities for H7N9" exact="influenza" post="viruses to transmit from poultry farms to wholesale markets,"/>
   <result pre="transmit from poultry farms to wholesale markets, where different genotypes" exact="avian influenza" post="viruses can reassort. There is also a risk of"/>
   <result pre="from poultry farms to wholesale markets, where different genotypes avian" exact="influenza" post="viruses can reassort. There is also a risk of"/>
   <result pre="cut down the loop Another impediment to controlling the H7N9" exact="influenza" post="virus outbreak is the protection of sectional interests. Eliminating"/>
   <result pre="influenza virus outbreak is the protection of sectional interests. Eliminating" exact="avian influenza" post="in poultry represents a significant economic loss for the"/>
   <result pre="virus outbreak is the protection of sectional interests. Eliminating avian" exact="influenza" post="in poultry represents a significant economic loss for the"/>
   <result pre="industry. Initially, farmers and local authorities were reluctant to report" exact="avian influenza" post="outbreaks, in particular, the asymptomatic LPAI virus H7N9 cases."/>
   <result pre="Initially, farmers and local authorities were reluctant to report avian" exact="influenza" post="outbreaks, in particular, the asymptomatic LPAI virus H7N9 cases."/>
   <result pre="poultry transportations potentially contributed to the repeated waves of H7N9" exact="influenza" post="virus outbreaks in China. To a certain extent, closing"/>
   <result pre="a certain extent, closing LPMs after the start of an" exact="avian influenza" post="virus epidemic can reduce the risk of human zoonotic"/>
   <result pre="certain extent, closing LPMs after the start of an avian" exact="influenza" post="virus epidemic can reduce the risk of human zoonotic"/>
   <result pre="history [42]. Using one health to prevent the next HxNy" exact="influenza" post="virus outbreak The prevention and control of H7N9 influenza"/>
   <result pre="HxNy influenza virus outbreak The prevention and control of H7N9" exact="influenza" post="virus infections represents an important case-study in One Health."/>
   <result pre="able to collaborate and form a united response. New zoonotic" exact="influenza" post="A viruses like the H7N9 virus will continue to"/>
   <result pre="facilitate more efficient source control of the disease. Develop new" exact="influenza" post="virus vaccines and antiviral drugs and prioritize their distribution."/>
   <result pre="the agricultural sector, the number of human cases of H7N9" exact="avian influenza" post="virus infection has fallen sharply. This is a clear"/>
   <result pre="agricultural sector, the number of human cases of H7N9 avian" exact="influenza" post="virus infection has fallen sharply. This is a clear"/>
   <result pre="One Health strategy in combating zoonosis. To better control H7N9" exact="influenza" post="virus and prevent the emergence of novel influenza virus"/>
   <result pre="control H7N9 influenza virus and prevent the emergence of novel" exact="influenza" post="virus strains, we advocate establishing coordination and cooperation among"/>
   <result pre="CDC Centers of disease control HA Haemagglutinin HPAI High pathogenic" exact="avian influenza" post="LPAI Low pathogenic avian influenza LPM Live poultry market"/>
   <result pre="Centers of disease control HA Haemagglutinin HPAI High pathogenic avian" exact="influenza" post="LPAI Low pathogenic avian influenza LPM Live poultry market"/>
   <result pre="HA Haemagglutinin HPAI High pathogenic avian influenza LPAI Low pathogenic" exact="avian influenza" post="LPM Live poultry market MoA The Ministry of Agriculture"/>
   <result pre="Haemagglutinin HPAI High pathogenic avian influenza LPAI Low pathogenic avian" exact="influenza" post="LPM Live poultry market MoA The Ministry of Agriculture"/>
   <result pre="and challenge dose on the pathogenesis of H7N9 low pathogenicity" exact="avian influenza" post="virus in chickensVirology2015477728110.1016/j.virol.2015.01.01325662310 3.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection"/>
   <result pre="challenge dose on the pathogenesis of H7N9 low pathogenicity avian" exact="influenza" post="virus in chickensVirology2015477728110.1016/j.virol.2015.01.01325662310 3.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection"/>
   <result pre="virus in chickensVirology2015477728110.1016/j.virol.2015.01.01325662310 3.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection with" exact="avian influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="in chickensVirology2015477728110.1016/j.virol.2015.01.01325662310 3.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection with avian" exact="influenza" post="A(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="2016Western Pac Surveill Response J20178161410.5365/wpsar.2017.8.1.001 4.Respiratory Disease Office CfHPotDoH. Avian" exact="influenza" post="report. In. Edited by Respiratory disease office CfHPotDoH, vol."/>
   <result pre="Respiratory disease office CfHPotDoH, vol. 13; 2017. 5.OIE. Highly pathogenic" exact="avian influenza," post="China (People’s Rep. of): World Organisation for Animal Health;"/>
   <result pre="Rep. of): World Organisation for Animal Health; 2017. 6.HuangJWangCZhouZHighly pathogenic" exact="avian influenza" post="H7N9 diagnostic report in Dongan, Hunan ProvinceChina Poultry2017227072 7.Highly"/>
   <result pre="of): World Organisation for Animal Health; 2017. 6.HuangJWangCZhouZHighly pathogenic avian" exact="influenza" post="H7N9 diagnostic report in Dongan, Hunan ProvinceChina Poultry2017227072 7.Highly"/>
   <result pre="H7N9 diagnostic report in Dongan, Hunan ProvinceChina Poultry2017227072 7.Highly pathogenic" exact="avian influenza," post="China (People's Rep. of). In: World Organisation for Animal"/>
   <result pre="the People's Republic of China2018 9.China MoAotPsRo: National Guidelines for" exact="avian influenza" post="H7N9 prevention and control. In. Edited by China MoAotPsRo;"/>
   <result pre="People's Republic of China2018 9.China MoAotPsRo: National Guidelines for avian" exact="influenza" post="H7N9 prevention and control. In. Edited by China MoAotPsRo;"/>
   <result pre="by China MoAotPsRo; 2018. 10.LiuDShiWShiYWangDXiaoHLiWBiYWuYLiXYanJet al.Origin and diversity of novel" exact="avian influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="China MoAotPsRo; 2018. 10.LiuDShiWShiYWangDXiaoHLiWBiYWuYLiXYanJet al.Origin and diversity of novel avian" exact="influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="structural, and coalescent analysesLancet201338198811926193210.1016/S0140-6736(13)60938-123643111 11.ChenYLiangWYangSWuNGaoHShengJYaoHWoJFangQCuiDet al.Human infections with the emerging" exact="avian influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="and coalescent analysesLancet201338198811926193210.1016/S0140-6736(13)60938-123643111 11.ChenYLiangWYangSWuNGaoHShengJYaoHWoJFangQCuiDet al.Human infections with the emerging avian" exact="influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="al.A two-amino acid change in the hemagglutinin of the 1918" exact="influenza" post="virus abolishes transmissionScience2007315581265565910.1126/science.113621217272724 14.XiongXMartinSRHaireLFWhartonSADanielsRSBennettMSMcCauleyJWCollinsPJWalkerPASkehelJJet al.Receptor binding by an H7N9"/>
   <result pre="influenza virus abolishes transmissionScience2007315581265565910.1126/science.113621217272724 14.XiongXMartinSRHaireLFWhartonSADanielsRSBennettMSMcCauleyJWCollinsPJWalkerPASkehelJJet al.Receptor binding by an H7N9" exact="influenza" post="virus from humansNature2013499745949649910.1038/nature1237223787694 15.WangDYangLZhuWZhangYZouSBoHGaoRDongJHuangWGuoJet al.Two outbreak sources of influenza"/>
   <result pre="H7N9 influenza virus from humansNature2013499745949649910.1038/nature1237223787694 15.WangDYangLZhuWZhangYZouSBoHGaoRDongJHuangWGuoJet al.Two outbreak sources of" exact="influenza" post="A (H7N9) viruses have been established in ChinaJ Virol201690125561557310.1128/JVI.03173-1527030268"/>
   <result pre="that affect receptor binding and stability of the hemagglutinin of" exact="influenza" post="A/H7N9 virusJ Virol20169073794379910.1128/JVI.03052-1526792744 17.Benton DJ, Wharton SA, Martin SR,"/>
   <result pre="Wharton SA, Martin SR, McCauley JW. Role of neuraminidase in" exact="influenza" post="A(H7N9) virus receptor binding. J Virol. 2017;91(11). 18.Pantin-JackwoodMJMillerPJSpackmanESwayneDESustaLCosta-HurtadoMSuarezDLRole of"/>
   <result pre="2017;91(11). 18.Pantin-JackwoodMJMillerPJSpackmanESwayneDESustaLCosta-HurtadoMSuarezDLRole of poultry in the spread of novel H7N9" exact="influenza" post="virus in ChinaJ Virol20148810538110.1128/JVI.03689-1324574407 19.ZhangQShiJDengGGuoJZengXHeXKongHGuCLiXLiuJet al.H7N9 influenza viruses are"/>
   <result pre="of novel H7N9 influenza virus in ChinaJ Virol20148810538110.1128/JVI.03689-1324574407 19.ZhangQShiJDengGGuoJZengXHeXKongHGuCLiXLiuJet al.H7N9" exact="influenza" post="viruses are transmissible in ferrets by respiratory dropletScience2013341614441010.1126/science.124053223868922 20.GaoRCaoBHuYFengZWangDHuWChenJJieZQiuHXuKet"/>
   <result pre="by respiratory dropletScience2013341614441010.1126/science.124053223868922 20.GaoRCaoBHuYFengZWangDHuWChenJJieZQiuHXuKet al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med2013368201888189710.1056/NEJMoa130445923577628 21.ShiJDengGKongHGuCMaSYinXZengXCuiPChenYYangHet al.H7N9 virulent"/>
   <result pre="al.PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2" exact="avian influenza" post="virusesSci Rep201661947410.1038/srep1947426782141 23.LiYQiWQiaoJChenCLiaoMXiaoCEvolving HA and PB2 genes of influenza"/>
   <result pre="promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian" exact="influenza" post="virusesSci Rep201661947410.1038/srep1947426782141 23.LiYQiWQiaoJChenCLiaoMXiaoCEvolving HA and PB2 genes of influenza"/>
   <result pre="avian influenza virusesSci Rep201661947410.1038/srep1947426782141 23.LiYQiWQiaoJChenCLiaoMXiaoCEvolving HA and PB2 genes of" exact="influenza" post="a (H7N9) viruses in the fifth wave - increasing"/>
   <result pre="viruses in mainland ChinaJ Virol20179123 25.HanDDHanCXLiLYWangMYangJHLiMEpidemiology of human infection with" exact="avian influenza" post="a(H7N9) virus in China, 2013-2017Zhonghua Liu Xing Bing Xue"/>
   <result pre="in mainland ChinaJ Virol20179123 25.HanDDHanCXLiLYWangMYangJHLiMEpidemiology of human infection with avian" exact="influenza" post="a(H7N9) virus in China, 2013-2017Zhonghua Liu Xing Bing Xue"/>
   <result pre="in China, 2013-2017Zhonghua Liu Xing Bing Xue Za Zhi2018391444629374894 26.HuiDSCLeeNChanPKSAvian" exact="influenza" post="A (H7N9) virus infections in humans across five epidemics"/>
   <result pre="Thorac Dis20179124808481110.21037/jtd.2017.11.1729312663 27.ArtoisJJiangHWangXQinYPearcyMLaiSShiYZhangJPengZZhengJet al.Changing geographic patterns and risk factors for" exact="avian influenza" post="A(H7N9) infections in humans, ChinaEmerg Infect Dis2018241879410.3201/eid2401.17139329260681 28.PengWZhibinPFangVJLuzhaoFTsangTKHuiJLauEHYJuanYJiandongZYingQet al.Human"/>
   <result pre="Dis20179124808481110.21037/jtd.2017.11.1729312663 27.ArtoisJJiangHWangXQinYPearcyMLaiSShiYZhangJPengZZhengJet al.Changing geographic patterns and risk factors for avian" exact="influenza" post="A(H7N9) infections in humans, ChinaEmerg Infect Dis2018241879410.3201/eid2401.17139329260681 28.PengWZhibinPFangVJLuzhaoFTsangTKHuiJLauEHYJuanYJiandongZYingQet al.Human"/>
   <result pre="infections in humans, ChinaEmerg Infect Dis2018241879410.3201/eid2401.17139329260681 28.PengWZhibinPFangVJLuzhaoFTsangTKHuiJLauEHYJuanYJiandongZYingQet al.Human infection with" exact="influenza" post="A(H7N9) virus during 3 major epidemic waves, China, 2013-2015Emerg"/>
   <result pre="China, 2013-2015Emerg Infect Dis201622696497210.3201/eid2206.15175227191934 29.GuoZXiaoDLiDWangYYanTDaiBWangXThe temporal distribution of new H7N9" exact="avian influenza" post="infections based on laboratory-confirmed cases in mainland China, 2013-2017Sci"/>
   <result pre="2013-2015Emerg Infect Dis201622696497210.3201/eid2206.15175227191934 29.GuoZXiaoDLiDWangYYanTDaiBWangXThe temporal distribution of new H7N9 avian" exact="influenza" post="infections based on laboratory-confirmed cases in mainland China, 2013-2017Sci"/>
   <result pre="DL. Role of poultry in the spread of novel H7N9" exact="influenza" post="virus in China. J Virol. 2014;88(10):5381–90. ​Accessed 26 Feb"/>
   <result pre="CahaecConsultation conclusion on prevention and control of human infection with" exact="avian influenza" post="A (H7N9) virus in China from experts of health"/>
   <result pre="conclusion on prevention and control of human infection with avian" exact="influenza" post="A (H7N9) virus in China from experts of health"/>
   <result pre="of closure of live poultry markets on poultry-to-person transmission of" exact="avian influenza" post="A H7N9 virus: an ecological studyLancet2014383991654154810.1016/S0140-6736(13)61904-224183056 51.LamTTZhouBWangJChaiYShenYChenXMaCHongWChenYZhangYet al.Dissemination, divergence"/>
   <result pre="closure of live poultry markets on poultry-to-person transmission of avian" exact="influenza" post="A H7N9 virus: an ecological studyLancet2014383991654154810.1016/S0140-6736(13)61904-224183056 51.LamTTZhouBWangJChaiYShenYChenXMaCHongWChenYZhangYet al.Dissemination, divergence"/>
   <result pre="an ecological studyLancet2014383991654154810.1016/S0140-6736(13)61904-224183056 51.LamTTZhouBWangJChaiYShenYChenXMaCHongWChenYZhangYet al.Dissemination, divergence and establishment of H7N9" exact="influenza" post="viruses in ChinaNature2015522755410210510.1038/nature1434825762140 52.Xavier Roche LS, von Dobschuetz S,"/>
   <result pre="W, Julio Pinto ER, Lubroth J, Chen J. Chinese-origin H7N9" exact="avian influenza" post="spread in poultry and human exposure. In: vol. 4."/>
   <result pre="Julio Pinto ER, Lubroth J, Chen J. Chinese-origin H7N9 avian" exact="influenza" post="spread in poultry and human exposure. In: vol. 4."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6372163\results\search\disease\results.xml">
   <result pre="neglected. Before the turn of the century, West Nile virus," exact="chikungunya" post="virus, and Zika virus were among these neglected viruses"/>
   <result pre="emergence of arthropod-borne viral diseases: A global prospective on dengue," exact="chikungunya" post="and Zika fevers. Acta Trop. 2017;166:155–63. 10.1016/j.actatropica.2016.11.02027876643 3BirdBH, KsiazekTG,"/>
   <result pre="29GöertzGP, VogelsCBF, GeertsemaC, KoenraadtCJM, PijlmanGP. Mosquito co-infection with Zika and" exact="chikungunya" post="virus allows simultaneous transmission without affecting vector competence of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6373151\results\search\disease\results.xml">
   <result pre="Case Report A case report of a teenager with severe" exact="hand, foot, and mouth disease" post="with brainstem encephalitis caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000"/>
   <result pre="case report of a teenager with severe hand, foot, and" exact="mouth disease" post="with brainstem encephalitis caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000"/>
   <result pre="teenager with severe hand, foot, and mouth disease with brainstem" exact="encephalitis" post="caused by enterovirus 71 ChenYing-FuHuLan+86-15823308699kldhl629@126.comXuFengxufeng9899@163.comLiuCheng-junliucwd@163.comLiJinglijingwangyi@126.com[], 0000 0000 8653 0555grid.203458.8Intensive"/>
   <result pre="this article, unless otherwise stated. Abstract Background Hand, foot, and" exact="mouth disease" post="(HFMD) is an acute viral infection occurring mostly in"/>
   <result pre="be life-saving in these patients. Keywords HFMD Enterovirus 71 Brainstem" exact="encephalitis" post="Teenager patient Background Hand, foot, and mouth disease (HFMD)"/>
   <result pre="Enterovirus 71 Brainstem encephalitis Teenager patient Background Hand, foot, and" exact="mouth disease" post="(HFMD) is an acute viral infection occurring mostly in"/>
   <result pre="associated with severe and sometimes fatal neurological complications such as" exact="aseptic meningitis," post="acute flaccid paralysis, encephalitis, and neurogenic pulmonary edema. There"/>
   <result pre="such as aseptic meningitis, acute flaccid paralysis, encephalitis, and neurogenic" exact="pulmonary edema." post="There are very limited reports of neurological manifestations in"/>
   <result pre="on June 30, 2014 with a history of fever, skin" exact="rash" post="over hand and feet, headache, and weakness in lower"/>
   <result pre="IgM antibodies against Enterovirus, Herpes simplex virus, Cossack virus, and" exact="measles" post="virus. EV71 RNA, but not CVA16, was detected in"/>
   <result pre="clinical symptoms, a diagnosis of severe HFMD with brain stem" exact="encephalitis" post="was established by specialists in the Department of Neurology"/>
   <result pre="performed on day 3. The results were indicative of diffuse" exact="encephalopathy" post="with mixed delta and theta wave activity in the"/>
   <result pre="movement, and intelligence). Discussion and conclusions HFMD is an acute" exact="infectious disease" post="caused by a group of enteroviruses, among which EV71"/>
   <result pre="to develop severe complications such as meningitis, encephalitis, encephalomyelitis, neurogenic" exact="pulmonary edema," post="and circulatory failure [3]. Since the first report in"/>
   <result pre="severe, potentially life-threatening complications in children, such as brainstem encephalitis," exact="aseptic meningitis," post="encephalitis, flaccid paralysis, heart failure, and lung failure [11]."/>
   <result pre="neurological complications [3, 8]. Brainstem encephalitis, a distinctive form of" exact="encephalitis" post="with typical neuropathological characteristics, has been the hallmark of"/>
   <result pre="and sluggish pupillary light reflex. The diagnosis of brain stem" exact="encephalitis" post="was established based on the above clinical symptoms by"/>
   <result pre="Enterovirus 71 HEVA Human Enterovirus A HFMD Hand, foot, and" exact="mouth disease" post="PICU Paediatric intensive care unit RT-PCR Reverse-transcriptase-polymerase chain reaction"/>
   <result pre="maps and institutional affiliations. References References 1.DowningCRamirez-FortMKDoanHQet al.Coxsackievirus A6 associated" exact="hand, foot and mouth disease" post="in adults: clinical presentation and review of the literatureJ"/>
   <result pre="affiliations. References References 1.DowningCRamirez-FortMKDoanHQet al.Coxsackievirus A6 associated hand, foot and" exact="mouth disease" post="in adults: clinical presentation and review of the literatureJ"/>
   <result pre="2.NguyenNTPhamHVHoangCQet al.Epidemiological and clinical characteristics of children who died from" exact="hand, foot and mouth disease" post="in Vietnam, 2011BMC Infect Dis2014181434110.1186/1471-2334-14-341 3.OoiMHWongSCMohanAet al.Identification and validation"/>
   <result pre="clinical characteristics of children who died from hand, foot and" exact="mouth disease" post="in Vietnam, 2011BMC Infect Dis2014181434110.1186/1471-2334-14-341 3.OoiMHWongSCMohanAet al.Identification and validation"/>
   <result pre="predictors for the risk of neurological involvement in children with" exact="hand, foot, and mouth disease" post="in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and"/>
   <result pre="risk of neurological involvement in children with hand, foot, and" exact="mouth disease" post="in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and"/>
   <result pre="foot, and mouth disease in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic" exact="hand, foot and mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis200391788510.3201/eid1301.02011212533285 5.JeeYMCheonDSKimKet"/>
   <result pre="disease in SarawakBMC Infect Dis2009199310.1186/1471-2334-9-3 4.ChanKPGohKTChongCYet al.Epidemic hand, foot and" exact="mouth disease" post="caused by human enterovirus 71, SingaporeEmerg Infect Dis200391788510.3201/eid1301.02011212533285 5.JeeYMCheonDSKimKet"/>
   <result pre="2000Arch Virol200314891735174610.1007/s00705-003-0133-614505086 6.ChanLGParasharUDLyeMSet al.Deaths of children during an outbreak of" exact="hand, foot, and mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="al.Deaths of children during an outbreak of hand, foot, and" exact="mouth disease" post="in Sarawak, Malaysia: clinical and pathological characteristics of the"/>
   <result pre="for the outbreak study groupClin Infect Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of" exact="central nervous system disease" post="associated with hand, foot, and mouth disease in Japan"/>
   <result pre="the outbreak study groupClin Infect Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of central" exact="nervous system disease" post="associated with hand, foot, and mouth disease in Japan"/>
   <result pre="Dis200031367868310.1086/31403211017815 7.FujimotoTChikahiraMYoshidaSet al.Outbreak of central nervous system disease associated with" exact="hand, foot, and mouth disease" post="in Japan during the summer of 2000: detection and"/>
   <result pre="of central nervous system disease associated with hand, foot, and" exact="mouth disease" post="in Japan during the summer of 2000: detection and"/>
   <result pre="of enterovirus 71Microbiol Immunol200246962162710.1111/j.1348-0421.2002.tb02743.x12437029 8.TuPVThaoNTPereraDet al.Epidemiologic and virologic investigation of" exact="hand, foot, and mouth disease," post="southern Vietnam, 2005Emerg Infect Dis200713111733174110.3201/eid1311.07063218217559 9.LiuCCTsengHWWangSMet al.An outbreak of"/>
   <result pre="Immunol200246962162710.1111/j.1348-0421.2002.tb02743.x12437029 8.TuPVThaoNTPereraDet al.Epidemiologic and virologic investigation of hand, foot, and" exact="mouth disease," post="southern Vietnam, 2005Emerg Infect Dis200713111733174110.3201/eid1311.07063218217559 9.LiuCCTsengHWWangSMet al.An outbreak of"/>
   <result pre="characterization of enterovirus infections among pediatric patients with hand foot" exact="mouth disease," post="herpangina and influenza like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237"/>
   <result pre="enterovirus infections among pediatric patients with hand foot mouth disease," exact="herpangina" post="and influenza like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet"/>
   <result pre="among pediatric patients with hand foot mouth disease, herpangina and" exact="influenza" post="like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet al.Hand, foot,"/>
   <result pre="like illness in Thailand, 2012PLoS One201496e9888810.1371/journal.pone.009888824887237 12.XingWLiaoQViboudCet al.Hand, foot, and" exact="mouth disease" post="in China, 2008–12:an epidemiological studyLancet Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology"/>
   <result pre="2008–12:an epidemiological studyLancet Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology and control of" exact="hand, foot and mouth disease" post="in Singapore, 2001-2007Ann Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71"/>
   <result pre="Infect Dis201414430831810.1016/S1473-3099(13)70342-624485991 13.AngLWKohBKChanKPet al.Epidemiology and control of hand, foot and" exact="mouth disease" post="in Singapore, 2001-2007Ann Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71"/>
   <result pre="Acad Med Singap200938210611219271036 14.WangYZouGXiaAet al.Enterovirus 71 infection in children with" exact="hand, foot, and mouth disease" post="in Shanghai, China: epidemiology, clinical feature and diagnosisVirol J2015128310.1186/s12985-015-0308-226036928"/>
   <result pre="14.WangYZouGXiaAet al.Enterovirus 71 infection in children with hand, foot, and" exact="mouth disease" post="in Shanghai, China: epidemiology, clinical feature and diagnosisVirol J2015128310.1186/s12985-015-0308-226036928"/>
   <result pre="anti-enterovirus 71 IgM in children with severe hand, food and" exact="mouth disease" post="induced by enterovirus 71 infection and its clinical significanceZhonghua"/>
   <result pre="its clinical significanceZhonghua Er Ke Za Zhi201553535535926080665 16.KhanhTHSabanathanSThanhTTet al.Enterovirus 71-associated" exact="hand, foot, and mouth disease," post="southern Vietnam, 2011Emerg Infect Dis201218122002200510.3201/eid1812.12092923194699 17.KaminskaKMartinettiGLucchiniRet al.Coxsackievirus A6 and"/>
   <result pre="Er Ke Za Zhi201553535535926080665 16.KhanhTHSabanathanSThanhTTet al.Enterovirus 71-associated hand, foot, and" exact="mouth disease," post="southern Vietnam, 2011Emerg Infect Dis201218122002200510.3201/eid1812.12092923194699 17.KaminskaKMartinettiGLucchiniRet al.Coxsackievirus A6 and"/>
   <result pre="stem encephalitisFront Pharmacol201678227065870 21.ChiCYKhanhTHle PKTet al.Milrinone therapy for enterovirus 71-induced" exact="pulmonary edema" post="and/or neurogenic shock in children: a randomized controlled trialCrit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6373929\results\search\disease\results.xml">
   <result pre="asymptomatic to several symptomatic forms ranging in severity from classical" exact="dengue fever," post="to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome"/>
   <result pre="weekly intervals. After the final immunization, mice were inoculated with" exact="sarcoma" post="180 cells, and the resulting immune ascitic fluids were"/>
   <result pre="al. (2016) The first acute febrile illness investigation associated with" exact="dengue fever" post="in Ethiopia, 2013: A descriptive analysis. Ethiop J Health"/>
   <result pre="Act6. 18LeroyEM, NkogheD, OllomoB, Nze-NkogueC, BecquartP, et al. (2009) Concurrent" exact="chikungunya" post="and dengue virus infections during simultaneous outbreaks, Gabon, 2007."/>
   <result pre="Comparative analysis of the genome sequences and replication profiles of" exact="chikungunya" post="virus isolates within the East, Central and South African"/>
   <result pre="(2013) Oral receptivity of Aedes aegypti from Cape Verde for" exact="yellow fever," post="dengue, and chikungunya viruses. Vect Born Zoo Dis13: 37–40."/>
   <result pre="Aedes aegypti from Cape Verde for yellow fever, dengue, and" exact="chikungunya" post="viruses. Vect Born Zoo Dis13: 37–40. 42MillerB, MonathT, TabachnickW,"/>
   <result pre="Born Zoo Dis13: 37–40. 42MillerB, MonathT, TabachnickW, EzikeV (1989) Epidemic" exact="yellow fever" post="caused by an incompetent mosquito vector. Trop Med Parasitol:"/>
   <result pre="Zusammenarbeit (GTZ)40: 396–399. 43Garrett-JonesC (1964) The human blood index of" exact="malaria" post="vectors in relation to epidemiological assessment. Bull World Health"/>
   <result pre="Mechanical College. 47MoncayoAC, EdmanJD, TurellMJ (2000) Effect of eastern equine" exact="encephalomyelitis" post="virus on the survival of Aedes albopictus, Anopheles quadrimaculatus,"/>
   <result pre="Entomol37: 701–706. 11004781 48MahmoodF, ReisenWK, ChilesRE, FangY (2004) Western equine" exact="encephalomyelitis" post="virus infection affects the life table characteristics of Culex"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6375641\results\search\disease\results.xml">
   <result pre="purifying selection in vertebrate hosts [19]. Studies with Venezuelan equine" exact="encephalitis" post="virus (VEEV), for example, have shown that epizootic strains"/>
   <result pre="tested for the presence of antibodies against WNV, St. Louis" exact="encephalitis" post="(SLEV) and western equine encephalitis virus (WEEV) [26]. Seronegative"/>
   <result pre="presence of antibodies against WNV, St. Louis encephalitis (SLEV) and" exact="western equine encephalitis" post="virus (WEEV) [26]. Seronegative birds were transported to UC"/>
   <result pre="antibodies against WNV, St. Louis encephalitis (SLEV) and western equine" exact="encephalitis" post="virus (WEEV) [26]. Seronegative birds were transported to UC"/>
   <result pre="West Nile virus transmission and the apparent displacement St. Louis" exact="encephalitis" post="virus in southeastern California, 2003–2006. J Med Entomol. 2008;45(3):494–508."/>
   <result pre="competence determine the efficiency of West Nile and St. Louis" exact="encephalitis" post="virus transmission. J Med Entomol. 2005;42(3):367–75. 15962789 11FossL, PadgettK,"/>
   <result pre="the e2 envelope glycoprotein are associated with the emergence of" exact="venezuelan equine encephalitis" post="virus. J Virol. 2002;76(4):1718–30. 10.1128/JVI.76.4.1718-1730.200211799167 21WorwaG, HuttonAA, FreyM, DuggalNK,"/>
   <result pre="envelope glycoprotein are associated with the emergence of venezuelan equine" exact="encephalitis" post="virus. J Virol. 2002;76(4):1718–30. 10.1128/JVI.76.4.1718-1730.200211799167 21WorwaG, HuttonAA, FreyM, DuggalNK,"/>
   <result pre="30FangY, ReisenWK. Previous infection with West Nile or St. Louis" exact="encephalitis" post="viruses provides cross protection during reinfection in house finches."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6378603\results\search\disease\results.xml">
   <result pre="outbreaks are likely to be higher. Thresholds to prevent urban" exact="yellow fever" post="epidemics were established in the past and have been"/>
   <result pre="Felix, G.E.et al (2017) Impact of autocidal gravid ovitraps on" exact="chikungunya" post="virus incidence in Aedes aegypti (Diptera: Culicidae) in areas"/>
   <result pre="A.et al (2015) First report of Aedes aegypti transmission of" exact="chikungunya" post="virus in the Americas. American Journal of Tropical Medicine"/>
   <result pre="Cruz�?Nolasco, M.et al (2015) Arbovirus surveillance and first report of" exact="chikungunya" post="virus in wild populations of Aedes aegypti from Guerrero,"/>
   <result pre="&amp;amp; Geier, M. (2006) New tools for surveillance of adult" exact="yellow fever" post="mosquitoes: comparison of trap catches with human landing rates"/>
   <result pre="O.D., Major, C., Acevedo, V.et al (2016) Reduced incidence of" exact="chikungunya" post="virus infection in communities with ongoing Aedes aegypti mosquito"/>
   <result pre="A., Gokhale, M.et al (2012) Persistence of viral RNA in" exact="chikungunya" post="virus�?infected Aedes aegypti (Diptera: Culicidae) mosquitoes after prolonged storage"/>
   <result pre="Poletto, C. &amp;amp; Boelle, P.Y. (2017) A comparative analysis of" exact="chikungunya" post="and Zika transmission. Epidemics, 19, 43–52.28139388 Sanchez, L., Vanlerberghe,"/>
   <result pre="Ahmed, O., Faye, O.et al (2008) Entomologic investigations of a" exact="chikungunya" post="virus epidemic in the Union of the Comoros, 2005."/>
   <result pre="the Trioplex RT�?PCR assay for detection of Zika, dengue and" exact="chikungunya" post="viruses. Nature Communications, 9, 1391. Sharp, T.M., Ryff, K.R.,"/>
   <result pre="Sharp, T.M., Ryff, K.R., Alvarado, L.et al (2016) Surveillance for" exact="chikungunya" post="and dengue during the first year of chikungunya virus"/>
   <result pre="Surveillance for chikungunya and dengue during the first year of" exact="chikungunya" post="virus circulation in Puerto Rico. Journal of Infectious Diseases,"/>
   <result pre="A., Rafique, S. &amp;amp; Idrees, M. (2017) Global expansion of" exact="chikungunya" post="virus: mapping the 64�?year history. International Journal of Infectious"/>
   <result pre="Three�?way interactions between mosquito population, viral strain and temperature underlying" exact="chikungunya" post="virus transmission potential. Proceedings of the Royal Society of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6379635\results\search\disease\results.xml">
   <result pre="work is properly cited.file:IRV-13-148.pdf Abstract Background Epidemiological analysis of past" exact="influenza" post="epidemics remains essential to understand the evolution of the"/>
   <result pre="system over the last three decades to study trends in" exact="influenza" post="epidemics and describe epidemic profiles according to circulating influenza"/>
   <result pre="in influenza epidemics and describe epidemic profiles according to circulating" exact="influenza" post="viruses. Methods Influenza�?like illness (ILI) weekly incidences were estimated"/>
   <result pre="applying a periodic regression to this time series. Epidemic (co�?)dominant" exact="influenza" post="virus (sub)types were determined using French virology data. Results"/>
   <result pre="607 ILI cases were reported allowing the detection of 33" exact="influenza" post="epidemics. On average, seasonal epidemics lasted 9 weeks and"/>
   <result pre="and older age of cases. Conclusions The declining trend in" exact="influenza" post="epidemic size and height over the last 33 years"/>
   <result pre="factors like increased vaccine coverage, hygiene improvements or changing in" exact="influenza" post="viruses. However, further researches are needed to assess the"/>
   <result pre="to assess the impact of potential contributing factors to adapt" exact="influenza" post="plans. epidemics influenza influenza�?like illness primary care surveillance fig-count:"/>
   <result pre="impact of potential contributing factors to adapt influenza plans. epidemics" exact="influenza" post="influenza�?like illness primary care surveillance fig-count: table-count: page-count: word-count:"/>
   <result pre="Viruses. 2019;13:148�?157. 10.1111/irv.12620 1 INTRODUCTION Influenza is a common respiratory" exact="infectious disease," post="manifested typically by influenza�?like illness (ILI) usually defined by"/>
   <result pre="myalgia and respiratory signs.1 Although morbidity and mortality attributed to" exact="influenza" post="epidemics vary depending on circulating strains,2 influenza epidemics cause"/>
   <result pre="mortality attributed to influenza epidemics vary depending on circulating strains,2" exact="influenza" post="epidemics cause each year between 3 and 5 million"/>
   <result pre="the 2012�?2017 period.4, 5 The excess respiratory deaths due to" exact="influenza" post="seasonal epidemics were estimated to 2.9 per 100 000"/>
   <result pre="spent for medical care.8 The health and socio�?economic impact of" exact="influenza" post="epidemics, along with the need to assess the impact"/>
   <result pre="epidemics, along with the need to assess the impact of" exact="influenza" post="vaccine in the field, justify its surveillance. Real�?time monitoring"/>
   <result pre="vaccine in the field, justify its surveillance. Real�?time monitoring of" exact="influenza" post="epidemics is used by authorities and healthcare professionals to"/>
   <result pre="professionals to implement or adjust interventions. However, retrospective analysis of" exact="influenza" post="epidemics over a long period of time seems essential"/>
   <result pre="The French primary care surveillance network—called Sentinelles, participate in monitoring" exact="influenza" post="epidemics since 1984 through a sample of general practitioners"/>
   <result pre="consultation.10 ILI definition used had a high predictive value for" exact="influenza" post="although other respiratory viruses could cause ILI.11 This definition"/>
   <result pre="allowing study of trends in ILI. There were no steady" exact="influenza" post="virological database available in primary care since 1984, as"/>
   <result pre="presented here aims to study evolution of the dynamics of" exact="influenza" post="epidemics observed in primary care in France between winters"/>
   <result pre="and 2016/17 and to describe epidemic profiles according to circulating" exact="influenza" post="viruses. 2 METHODS 2.1 Study population: influenza�?like illness cases"/>
   <result pre="questions linked to public health issues. They concern: age, sex," exact="influenza" post="seasonal vaccination status (since September 1986) and whether the"/>
   <result pre="September 2014), hospitalization request (since September 1997), risk factors for" exact="influenza" post="complications except age (since September 2009), antiviral prescription (since"/>
   <result pre="in a recent study.20 Each epidemic was named by its" exact="influenza" post="season (ie, 2011/12 epidemic, refers to the epidemic period"/>
   <result pre="classified into three groups according to the time of the" exact="influenza" post="season started—called &quot;start period.�? Breaks were defined using the"/>
   <result pre="France, there was no shared and steady database about circulating" exact="influenza" post="viruses in primary care. To obtain quantitative data on"/>
   <result pre="influenza viruses in primary care. To obtain quantitative data on" exact="influenza" post="viruses circulating in primary care during past epidemics in"/>
   <result pre="season are detailed in Table 1. Table 1 Characteristics of" exact="influenza" post="epidemics in primary care detected by the Sentinelles network,"/>
   <result pre="source used for determination of virological dominance and co�?dominance by" exact="influenza" post="epidemic in France: aFrench national public health agency. bMorbidity"/>
   <result pre="Ltd, Using these collected data, virological dominance and co�?dominance by" exact="influenza" post="epidemic was established using the following decision rule adapted"/>
   <result pre="collected by the Sentinelles network allowed the detection of 32" exact="influenza" post="seasonal epidemics and one pandemic during the 33 monitored"/>
   <result pre="circulating Influenza virus dominance and co�?dominance established for the 33" exact="influenza" post="epidemics were reported in Table 1. For 22 epidemics"/>
   <result pre="(12%) viruses A and B were co�?dominant. Lastly, one pandemic" exact="influenza" post="was observed in 2009/10, dominated by A(H1N1)pdm09. Epidemics dominated"/>
   <result pre="P value = 2.10−3) (Figure 3). Figure 3 Characteristics of" exact="influenza" post="epidemics grouped by viral dominant or co�?dominant (sub)types; (A)"/>
   <result pre="RIRs were decreasing with age. Figure 4 Age distribution of" exact="influenza" post="epidemics grouped by viral dominant or co�?dominant (sub)types; (A)"/>
   <result pre="Since 1984, the primary care Sentinelles surveillance network has monitored" exact="influenza" post="epidemics in France. Its seniority, the stability of the"/>
   <result pre="and ILI definition used allowed the comparison of 32 seasonal" exact="influenza" post="epidemics and a pandemic, observed between winters 1984/85 and"/>
   <result pre="epidemic duration, which may suggest a reduction of transmissibility of" exact="influenza" post="viruses. At first sight, this can be related to"/>
   <result pre="viruses. At first sight, this can be related to the" exact="influenza" post="vaccination programme developed in France from the beginning of"/>
   <result pre="had still not been achieved. Unlike to some others countries,33" exact="influenza" post="vaccination is not recommended for children in France, although"/>
   <result pre="contributing to a larger transmissibility and risk of infection.35 Although" exact="influenza" post="vaccination might contribute to the declining trend in influenza"/>
   <result pre="Although influenza vaccination might contribute to the declining trend in" exact="influenza" post="epidemic size and height, its impact could be limited"/>
   <result pre="impact could be limited in France. Secondly, observed decrease in" exact="influenza" post="incidence rates may also be related to behaviour changes"/>
   <result pre="improvements; which might have contributed to reduce the transmissibility of" exact="influenza" post="viruses.27 Recently, the 2009 pandemic could have impacted hygiene"/>
   <result pre="that time.36 Thirdly, changes in the biological properties of circulating" exact="influenza" post="viruses may have occurred, particularly for A(H3N2) subtype 37—the"/>
   <result pre="This could be explained by acquired immunity against subtypes of" exact="influenza" post="A(H1N1) in adults and elderly encountered through past exposure"/>
   <result pre="respectively).12 Our study has some limitations. We implemented a single" exact="influenza" post="epidemic detection method among the various used worldwide.45 Based"/>
   <result pre="and we included ILI cases only during the epidemic period—where" exact="influenza" post="positivity rates of cases were the highest, allows to"/>
   <result pre="ILI consultations with a febrile ILI definition could underestimate true" exact="influenza" post="burden in the community, especially among elderly who usually"/>
   <result pre="have worse health than those consulting in primary care. Conversely," exact="influenza" post="burden in children could be overestimated relatively to adults’"/>
   <result pre="electronic data collection protocol. This stability is needed to compare" exact="influenza" post="activity and epidemiology over several decades in the community:"/>
   <result pre="understanding of past patterns, monitoring change in trends and estimating" exact="influenza" post="vaccine effectiveness.14, 18 Long�?standing surveillance systems constitute an important"/>
   <result pre="the pressure on health services and to adapt and develop" exact="influenza" post="control strategies in the coming years. In conclusion, data"/>
   <result pre="since 1984 allowed us to highlight a declining trend in" exact="influenza" post="epidemic size and height. This decrease could be related"/>
   <result pre="including increased vaccine coverage, hygiene improvements and diminished fitness of" exact="influenza" post="viruses. Future researches combining epidemiological and virological issues should"/>
   <result pre="et al. Heterogeneous case definitions used for the surveillance of" exact="influenza" post="in Europe. Eur J Epidemiol. 2003;18(8):751�?754.12974549 2ThompsonWW, ShayDK, WeintraubE,"/>
   <result pre="Epidemiol. 2003;18(8):751�?754.12974549 2ThompsonWW, ShayDK, WeintraubE, et al. Mortality associated with" exact="influenza" post="and respiratory syncytial virus in the United States. JAMA."/>
   <result pre="The potential value of crowdsourced surveillance systems in supplementing sentinel" exact="influenza" post="networks: the case of France. Euro Surveill. 2018;23(25): pii:"/>
   <result pre="ReyG, MillerM, SimonsenL, ViboudC. Mortality burden of the 2009 A/H1N1" exact="influenza" post="pandemic in France: comparison to seasonal influenza and the"/>
   <result pre="the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal" exact="influenza" post="and the A/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051.23028756 7CarratF, SahlerC,"/>
   <result pre="France. Arch Intern Med. 2002;162(16):1842�?1848.12196082 8LevyE. French economic evaluations of" exact="influenza" post="and influenza vaccination. Pharmacoeconomics. 1996;9(Suppl 3):62�?66.10160489 9collab: Équipes de"/>
   <result pre="Intern Med. 2002;162(16):1842�?1848.12196082 8LevyE. French economic evaluations of influenza and" exact="influenza" post="vaccination. Pharmacoeconomics. 1996;9(Suppl 3):62�?66.10160489 9collab: Équipes de surveillance de"/>
   <result pre="Clin Infect Dis. 1999;28(2):283�?290.10064245 12MosnierA, CainiS, DaviaudI, et al. Ten" exact="influenza" post="seasons in France: distribution and timing of influenza A"/>
   <result pre="al. Ten influenza seasons in France: distribution and timing of" exact="influenza" post="A and B circulation, 2003–2013. BMC Infect Dis. 2015;15:357.26289794"/>
   <result pre="Dis. 2015;15:357.26289794 13VilcuAM, SoutyC, EnoufV, et al. Estimation of seasonal" exact="influenza" post="vaccine effectiveness using data collected in primary care in"/>
   <result pre="14SoutyC, VilcuAM, CapaiL, et al. Early estimates of 2016/17 seasonal" exact="influenza" post="vaccine effectiveness in primary care in France. J Clin"/>
   <result pre="25, 2017. 18TurbelinC, SoutyC, PelatC, et al. Age distribution of" exact="influenza" post="like illness cases during post�?pandemic A(H3N2): comparison with the"/>
   <result pre="al. Performances of statistical methods for the detection of seasonal" exact="influenza" post="epidemics using a consensus�?based gold standard. Epidemiol Infect. 2018;146(2):168�?176.29208062"/>
   <result pre="standard. Epidemiol Infect. 2018;146(2):168�?176.29208062 21LemaitreM, CarratF. Comparative age distribution of" exact="influenza" post="morbidity and mortality during seasonal influenza epidemics and the"/>
   <result pre="Comparative age distribution of influenza morbidity and mortality during seasonal" exact="influenza" post="epidemics and the 2009 H1N1 pandemic. BMC Infect Dis."/>
   <result pre="KoelleK, FerrariMJ, BhartiN, GrenfellBT. Global patterns in seasonal activity of" exact="influenza" post="A/H3N2, A/H1N1, and B from 1997 to 2005: viral"/>
   <result pre="BrownCS, MeuwissenLE, van der VeldenJ. Epidemiological and virological assessment of" exact="influenza" post="activity in Europe, during the 2004�?2005 winter. Euro Surveill."/>
   <result pre="Disease Control and Prevention . Prevention and control of seasonal" exact="influenza" post="with vaccines. Recommendations of the Advisory Committee on Immunization"/>
   <result pre="al. The contribution of social behaviour to the transmission of" exact="influenza" post="a in a human population. PLoS Pathog. 2014;10(6):e1004206.24968312 36Van"/>
   <result pre="et al. Evolution of the receptor binding properties of the" exact="influenza" post="A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A."/>
   <result pre="ViboudC, TaubenbergerJK, HolmesEC. The genomic and epidemiological dynamics of human" exact="influenza" post="A virus. Nature. 2008;453(7195):615�?619.18418375 40LeeBE, MukhiSN, DrewsSJ. Association between"/>
   <result pre="Nature. 2008;453(7195):615�?619.18418375 40LeeBE, MukhiSN, DrewsSJ. Association between patient age and" exact="influenza" post="A subtype during influenza outbreaks. Infect Control Hosp Epidemiol."/>
   <result pre="DrewsSJ. Association between patient age and influenza A subtype during" exact="influenza" post="outbreaks. Infect Control Hosp Epidemiol. 2010;31(5):535�?537.20334548 41SimonsenL, ClarkeMJ, WilliamsonGD,"/>
   <result pre="2010;31(5):535�?537.20334548 41SimonsenL, ClarkeMJ, WilliamsonGD, StroupDF, ArdenNH, SchonbergerLB. The impact of" exact="influenza" post="epidemics on mortality: introducing a severity index. Am J"/>
   <result pre="FarrellGM, St GeorgeK, RabadanR. Differences in patient age distribution between" exact="influenza" post="A subtypes. PLoS ONE. 2009;4(8):e6832.19718262 43FergusonNM, GalvaniAP, BushRM. Ecological"/>
   <result pre="ONE. 2009;4(8):e6832.19718262 43FergusonNM, GalvaniAP, BushRM. Ecological and immunological determinants of" exact="influenza" post="evolution. Nature. 2003;422(6930):428�?433.12660783 44FlemingDM, ZambonM, BarteldsAIM, de JongJC. The"/>
   <result pre="44FlemingDM, ZambonM, BarteldsAIM, de JongJC. The duration and magnitude of" exact="influenza" post="epidemics: a study of surveillance data from sentinel general"/>
   <result pre="Epidemiol. 1999;15(5):467�?473.10442473 45CowlingBJ, WongIO, HoLM, RileyS, LeungGM. Methods for monitoring" exact="influenza" post="surveillance data. Int J Epidemiol. 2006;35(5):1314�?1321.16926216 46ValleronAJ, BouvetE, GarnerinP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6383869\results\search\disease\results.xml">
   <result pre="can cause hantavirus pulmonary syndrome (HPS) in the Americas and" exact="hemorrhagic fever with renal syndrome" post="(HFRS) in Eurasia. In recent decades, repeated outbreaks of"/>
   <result pre="some outbreaks resulting in case fatality rates of 12% (for" exact="hemorrhagic fever with renal syndrome" post="[HFRS] in Europe and Asia) and up to 40%"/>
   <result pre="(ESRI, Redlands, CA, USA) based on World Countries (http://www.arcgis.com/home/item.html?id=d974d9c6bc924ae0a2ffea0a46d71e3d). HFRS," exact="hemorrhagic fever with renal syndrome;" post="HPS, hantavirus pulmonary syndrome; NE, nephropathia epidemica; PUUV, Puumala"/>
   <result pre="hemorrhagic fever with renal syndrome; HPS, hantavirus pulmonary syndrome; NE," exact="nephropathia epidemica;" post="PUUV, Puumala virus; SEOV, Seoul virus; THAIV, Thailand virus."/>
   <result pre="linked to rodent populations in deciduous forests [30,49]. Outbreaks of" exact="nephropathia epidemica" post="(NE; a mild form of HFRS caused by PUUV"/>
   <result pre="with hantavirus infections Abbreviations: ENSO, El Niño Southern Oscillation; HFRS," exact="hemorrhagic fever with renal syndrome;" post="HPS, hantavrius pulmonary syndrome; NDVI, normalized difference vegetation index;"/>
   <result pre="HPS, hantavrius pulmonary syndrome; NDVI, normalized difference vegetation index; NE," exact="nephropathia epidemica;" post="(Y 0), during the same year; Y-n, n years"/>
   <result pre="increasingly more apparent that climatic variations have profound impacts on" exact="infectious disease" post="dynamics [75,76], especially for climate-sensitive infectious diseases; e.g., human"/>
   <result pre="2016 with permission of the publisher [127]). Dim, dimension; HFRS," exact="hemorrhagic fever with renal syndrome;" post="NDVI, normalized difference vegetation index. However, precipitation can also"/>
   <result pre="effect of immigration remained constant. Source: Adapted from [114]. HFRS," exact="hemorrhagic fever with renal syndrome." post="Vaccination programs against HFRS have been in practice for"/>
   <result pre="Feng D, et al. (2007) Landscape elements and Hantaan virus-related" exact="hemorrhagic fever with renal syndrome," post="People's Republic of China. Emerging Infectious Diseases 13(9): 1301–1306."/>
   <result pre="Epidemiol Infect143: 405–411. 10.1017/S095026881400100924787374 14JohnsonPT, de RoodeJC, FentonA (2015) Why" exact="infectious disease" post="research needs community ecology. Science349: 125950410.1126/science.125950426339035 15SmithMJ, TelferS, KallioER,"/>
   <result pre="Animal reservoir, natural and socioeconomic variations and the transmission of" exact="hemorrhagic fever with renal syndrome" post="in Chenzhou, China, 2006–2010. PLoS Negl Trop Dis8: e261510.1371/journal.pntd.000261524421910"/>
   <result pre="(2017) Anthropogenically driven environmental changes shift the ecological dynamics of" exact="hemorrhagic fever with renal syndrome." post="PLoS Pathog13: e100619810.1371/journal.ppat.100619828141833 46TianH, YuP, CazellesB, XuL, TanH, et"/>
   <result pre="available and climatic variables on the animal host density of" exact="hemorrhagic fever with renal syndrome" post="in Changsha, China. PLoS ONE8: e6153610.1371/journal.pone.006153623637849 48GuanP, HuangD, HeM,"/>
   <result pre="effects of climatic variables and reservoir on the incidence of" exact="hemorrhagic fever with renal syndrome" post="in Huludao City, China: a 17-year data analysis based"/>
   <result pre="VerstraetenWW, ClementJ, et al. (2011) A dynamic data-based model describing" exact="nephropathia epidemica" post="in Belgium. Biosyst Eng109: 77–89. 52TersagoK, VerhagenR, ServaisA, al"/>
   <result pre="McKenzieFE, RealLA, SmithDL, et al. (2005) Ecological theory to enhance" exact="infectious disease" post="control and public health policy. Front Ecol Environ3: 29–37."/>
   <result pre="Landscape and rodent community composition are associated with risk of" exact="hemorrhagic fever with renal syndrome" post="in two cities in China, 2006–2013. BMC Infect Dis18:"/>
   <result pre="Animal reservoir, natural and socioeconomic variations and the transmission of" exact="hemorrhagic fever with renal syndrome" post="in Chenzhou, China, 2006–2010. PLoS Negl Trop Dis8: e261510.1371/journal.pntd.000261524421910"/>
   <result pre="TongSL, et al. (2013) Atmospheric moisture variability and transmission of" exact="hemorrhagic fever with renal syndrome" post="in Changsha City, Mainland China, 1991–2010. PLoS Negl Trop"/>
   <result pre="348–360. 10.7589/0090-3558-48.2.34822493110 84BiP, PartonKA (2003) El Niño and incidence of" exact="hemorrhagic fever with renal syndrome" post="in China. JAMA289: 176–177. 85BiP, TongS, DonaldK, PartonK, NiJ"/>
   <result pre="ZhangF, PartonKA, TongS (1998) Seasonal rainfall variability, the incidence of" exact="hemorrhagic fever with renal syndrome," post="and prediction of the disease in low-lying areas of"/>
   <result pre="GuoWD, FangLQ, LiCP, BiP, et al. (2010) Climate variability and" exact="hemorrhagic fever with renal syndrome" post="transmission in Northeastern China. Environ Health Perspect118: 915–920. 10.1289/ehp.090150420142167"/>
   <result pre="SongS, et al. (2010) Spatiotemporal trends and climatic factors of" exact="hemorrhagic fever with renal syndrome" post="epidemic in Shandong Province, China. PLoS Negl Trop Dis4:"/>
   <result pre="(2015) Changes in rodent abundance and weather conditions potentially drive" exact="hemorrhagic fever with renal syndrome" post="outbreaks in Xi'an, China, 2005–2012. PLoS Negl Trop Dis9:"/>
   <result pre="(2004) Unhealthy landscapes: Policy recommendations on land use change and" exact="infectious disease" post="emergence. Environ Health Perspect112: 1092–1098. 10.1289/ehp.687715238283 102LambinEF, TranA, VanwambekeSO,"/>
   <result pre="ZhangLQ, FengD, et al. (2007) Landscape elements and Hantaan virus–related" exact="hemorrhagic fever with renal syndrome," post="People’s Republic of China. Emerg Infect Dis13: 1301–1306. 10.3201/eid1309.06148118252099"/>
   <result pre="LiangS, de VlasS, FengD, et al. (2006) Spatial analysis of" exact="hemorrhagic fever with renal syndrome" post="in China. BMC Infect Dis6: 7710.1186/1471-2334-6-7716638156 117KlempaB, Fichet-CalvetE, LecompteE,"/>
   <result pre="(2016) Effects of humidity variation on the hantavirus infection and" exact="hemorrhagic fever with renal syndrome" post="occurrence in subtropical China. Am J Trop Med Hyg94:"/>
   <result pre="129LiC, CuiZ, LiS, MagalhaesRJS, WangB, et al. (2013) Association between" exact="hemorrhagic fever with renal syndrome" post="epidemic and climate factors in Heilongjiang Province, China. Am"/>
   <result pre="10.4269/ajtmh.12-047324019443 130HanSS, KimS, ChoiY, KimS, KimYS (2013) Air pollution and" exact="hemorrhagic fever with renal syndrome" post="in South Korea: an ecological correlation study. BMC Public"/>
   <result pre="ZhangZ, LuL, LiX, LiuQ (2014) Meteorological factors are associated with" exact="hemorrhagic fever with renal syndrome" post="in Jiaonan County, China, 2006–2011. Int J Biometeorol58: 1031–1037."/>
   <result pre="de VlasSJ, ZhangWY, LiangS, et al. (2009) Spatiotemporal dynamics of" exact="hemorrhagic fever with renal syndrome," post="Beijing, People’s Republic of China. Emerg Infect Dis15: 2043–2045."/>
   <result pre="der GroenG, BarriosJM, et al. (2010) Beechnuts and outbreaks of" exact="nephropathia epidemica" post="(NE): of mast, mice and men. Nephrol Dial Transplant25:"/>
   <result pre="HuangH, ZhangW, WangJ, RenY, et al. (2009) The relationship between" exact="hemorrhagic fever with renal syndrome" post="cases and time series of NDVI in Dayangshu District."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6384943\results\search\disease\results.xml">
   <result pre="10.1038/s41598-019-39057-w : Article Estimation of the effective reproduction number of" exact="influenza" post="based on weekly reports in Miyazaki Prefecture YamauchiTakenoriyamauchi-t@med.showa-u.ac.jp1TakeuchiShouhei2YamanoYuko1KurodaYoshiki3NakadateToshio1[1], 0000"/>
   <result pre="of surveillance for seasonal influenza, the number of patients per" exact="influenza" post="sentinel site is counted on a weekly basis. Currently,"/>
   <result pre="reference values are set for the weekly reported number of" exact="influenza" post="cases per sentinel, and pre-epidemic and epidemic warnings are"/>
   <result pre="the validity of the reference value was also high for" exact="influenza" post="transmission. However, our results indicated the presence of secondary"/>
   <result pre="the surrounding jurisdictions for more detailed epidemic predictions. Introduction Seasonal" exact="influenza" post="is a respiratory infectious disease caused by the influenza"/>
   <result pre="more detailed epidemic predictions. Introduction Seasonal influenza is a respiratory" exact="infectious disease" post="caused by the influenza virus, and it occurs annually"/>
   <result pre="Seasonal influenza is a respiratory infectious disease caused by the" exact="influenza" post="virus, and it occurs annually during winter months. In"/>
   <result pre="virus, and it occurs annually during winter months. In Japan," exact="influenza" post="is designated as a Category V infectious disease by"/>
   <result pre="months. In Japan, influenza is designated as a Category V" exact="infectious disease" post="by the Act on the Prevention of Infectious Diseases"/>
   <result pre="Control Law) executed in 1999. Based on this law, seasonal" exact="influenza" post="is listed as a target illness of the National"/>
   <result pre="of Infectious Diseases (NESID)1, and specific medical facilities such as" exact="influenza" post="sentinel sites are expected to report the number of"/>
   <result pre="up in increments of PHC. The number of patients per" exact="influenza" post="sentinel site under the jurisdiction of each PHC is"/>
   <result pre="Public Health Institute websites. Data on the reporting criteria of" exact="influenza" post="are also provided. The administrators of influenza sentinel sites"/>
   <result pre="reporting criteria of influenza are also provided. The administrators of" exact="influenza" post="sentinel sites are expected to notify cases every Monday"/>
   <result pre="signs and symptoms, if a patient is suspected to have" exact="influenza" post="or if a patient exhibits all symptoms (i.e. sudden"/>
   <result pre="swab. Reporting criteria for sentinel hospitals are separately stipulated2. Seasonal" exact="influenza" post="is a threat to public health, and issuing of"/>
   <result pre="Pre-epidemic warnings are issued when the weekly reported number of" exact="influenza" post="cases per sentinel (Weekly CPS) in a jurisdiction of"/>
   <result pre="based on Weekly CPS, without considering the characteristic of the" exact="infectious disease." post="One of our aims was to confirm the consistency"/>
   <result pre="(i.e. the Rt based evaluation considering factors associated with the" exact="influenza" post="epidemic such as human movement, and the evaluation based"/>
   <result pre="Descriptive epidemiological data of each PHC jurisdiction During the 2010–2011" exact="influenza" post="season in Miyazaki Prefecture, the first case was reported"/>
   <result pre="type A and type B cases were prevalent during the" exact="influenza" post="season from 2010 to 2011. The number of virus"/>
   <result pre="A(H3)Hong Kong. Type B virus was sporadically detected throughout the" exact="influenza" post="season from 2010 to 2011, but the association between"/>
   <result pre="model were used to compare the weekly reported number of" exact="influenza" post="cases per sentinel, as shown in Fig. 1. When"/>
   <result pre="study, the Rt was estimated using Weekly CPS of the" exact="influenza" post="epidemic from 2010 to 2011 in Miyazaki Prefecture. Despite"/>
   <result pre="warning is probably reasonable even when the features associated with" exact="influenza" post="epidemic such as human movement and serial interval were"/>
   <result pre="lowest among the nine jurisdictions, and the estimated number of" exact="influenza" post="patients was also the lowest. At the 3rd week"/>
   <result pre="the secondary epidemic. However, the items to be notified at" exact="influenza" post="sentinel sites are surveillance period, name of medical facility,"/>
   <result pre="medical facility, sex, and age10. Because the serotype of the" exact="influenza" post="virus is not included, it is not clarified in"/>
   <result pre="problems even if they were not modified21. However, in the" exact="influenza" post="epidemic in Miyazaki Prefecture from 2010 to 2011, the"/>
   <result pre="Murakami et al. who suggested the possibility that the local" exact="influenza" post="epidemic would expand22, it is also possible that the"/>
   <result pre="would expand22, it is also possible that the distribution of" exact="influenza" post="sentinel sites or patients did not have the representative"/>
   <result pre="the number of weekly reported cases by the number of" exact="influenza" post="sentinel sites, with no coefficient reflecting the types of"/>
   <result pre="influenza sentinel sites, with no coefficient reflecting the types of" exact="influenza" post="sentinel sites. For our aim, although bias could not"/>
   <result pre="very large. In conclusion, pre-epidemic warnings based on the current" exact="influenza" post="surveillance system effectively functioned at least in the Miyazaki"/>
   <result pre="the epidemic situation considering all the available information on the" exact="infectious disease," post="such as viral serotype, viral strain, and the epidemic"/>
   <result pre="the end of the epidemic in future studies. Methods As" exact="influenza" post="epidemic data, we used Weekly CPS at a PHC"/>
   <result pre="the number of weekly reported cases by the number of" exact="influenza" post="sentinel sites. There are nine PHCs (i.e. Miyazaki city,"/>
   <result pre="45, 61, 10 and 35. Then, the number of weekly" exact="influenza" post="patients at each PHC jurisdiction was estimated by the"/>
   <result pre="was estimated by equation (1). Finally, the number of daily" exact="influenza" post="cases at each PHC jurisdiction ( \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym}"/>
   <result pre="parameters suitable for influenza, to investigate the spatial distribution of" exact="influenza" post="infection among ten regions. Publisher’s note: Springer Nature remains"/>
   <result pre="authors declare no competing interests. References References 1.TaniguchiKet al.Overview of" exact="infectious disease" post="surveillance system in Japan, 1999-2005J. Epidemiol.200717Suppl, S31310.2188/jea.17.S318239339 2.Ministry of"/>
   <result pre="Epidemiol. 151, 1039–1048, discussion 1049–1052 (2000). 5.WallingaJTeunisPDifferent epidemic curves for" exact="severe acute respiratory syndrome" post="reveal similar impacts of control measuresAm. J. Epidemiol.200416050951610.1093/aje/kwh25515353409 6.Miyazaki"/>
   <result pre="6.Miyazaki prefectural institute for public health and environment. Miyazaki prefecture" exact="infectious disease" post="weekly report back issue (2010) https://www.pref.miyazaki.lg.jp/contents/org/fukushi/eikanken/center/infectious/2010/index.html (2010). 7.Miyazaki prefectural"/>
   <result pre="7.Miyazaki prefectural institute for public health and environment. Miyazaki prefecture" exact="infectious disease" post="weekly report back issue (2011) https://www.pref.miyazaki.lg.jp/contents/org/fukushi/eikanken/center/infectious/2011/index.html (2011). 8.FavierCet al.Early"/>
   <result pre="Int. Health20061133234010.1111/j.1365-3156.2006.01560.x16553913 9.ChowellGNishiuraHBettencourtLMComparative estimation of the reproduction number for pandemic" exact="influenza" post="from daily case notification dataJ. R. Soc. Interface2007415516610.1098/rsif.2006.016117254982 10.Ministry"/>
   <result pre="courseJ. R. Soc. Interface2010729730710.1098/rsif.2009.015319570792 12.FergusonNMet al.Strategies for containing an emerging" exact="influenza" post="pandemic in Southeast AsiaNature200543720921410.1038/nature0401716079797 13.CowlingBJFangVJRileySMalik PeirisJSLeungGMEstimation of the serial"/>
   <result pre="of influenzaEpidemiology20092034434710.1097/EDE.0b013e31819d109219279492 14.LevyJWet al.The serial intervals of seasonal and pandemic" exact="influenza" post="viruses in households in Bangkok, ThailandAm. J. Epidemiol.20131771443145110.1093/aje/kws40223629874 15.WhiteLFPaganoMTransmissibility"/>
   <result pre="in households in Bangkok, ThailandAm. J. Epidemiol.20131771443145110.1093/aje/kws40223629874 15.WhiteLFPaganoMTransmissibility of the" exact="influenza" post="virus in the 1918 pandemicPLoS One20083e149810.1371/journal.pone.000149818231585 16.CauchemezSet al.Household transmission"/>
   <result pre="the 1918 pandemicPLoS One20083e149810.1371/journal.pone.000149818231585 16.CauchemezSet al.Household transmission of 2009 pandemic" exact="influenza" post="A (H1N1) virus in the United StatesN. Engl. J."/>
   <result pre="United StatesN. Engl. J. Med.20093612619262710.1056/NEJMoa090549820042753 17.LesslerJet al.Outbreak of 2009 pandemic" exact="influenza" post="A (H1N1) at a New York City schoolN. Engl."/>
   <result pre="Engl. J. Med.20093612628263610.1056/NEJMoa090608920042754 18.YangYet al.The transmissibility and control of pandemic" exact="influenza" post="A (H1N1) virusScience200932672973310.1126/science.117737319745114 19.Nishiura, H. &amp;amp; Chowell, G. Early"/>
   <result pre="geographical variation in epidemics determined from the results of an" exact="infectious disease" post="surveillance system in Japan description of epidemic patterns by"/>
   <result pre="changing critical values of the early epidemic detection system for" exact="infectious disease" post="surveillance in JapanNihon Koshu Eisei Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics"/>
   <result pre="surveillance in JapanNihon Koshu Eisei Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics of" exact="influenza" post="and pediatric diseases from infectious disease surveillance in Japan,"/>
   <result pre="Zasshi20075416817717461028 22.MurakamiYet al.Wide-area epidemics of influenza and pediatric diseases from" exact="infectious disease" post="surveillance in Japan, 1999-2005J. Epidemiol.200717SupplS233110.2188/jea.17.S2318239338 23.MurakamiYet al.Evaluation of a"/>
   <result pre="during epidemicsAm. J. Epidemiol.20131781505151210.1093/aje/kwt13324043437 26.BoellePYAnsartSCoriAValleronAJTransmission parameters of the A/H1N1 (2009)" exact="influenza" post="virus pandemic: a reviewInfluenza Other Respir Viruses2011530631610.1111/j.1750-2659.2011.00234.x21668690"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6391539\results\search\disease\results.xml">
   <result pre="pmcid: 6391539 doi: 10.1177/251513551882162510.1177_2515135518821625 : Review A review of H5Nx" exact="avian influenza" post="viruses NuñezIvette A.[], RossTed M.[], tedross@uga.edu epub: 2019-2-2collection: 201972515135518821625received:"/>
   <result pre="6391539 doi: 10.1177/251513551882162510.1177_2515135518821625 : Review A review of H5Nx avian" exact="influenza" post="viruses NuñezIvette A.[], RossTed M.[], tedross@uga.edu epub: 2019-2-2collection: 201972515135518821625received:"/>
   <result pre="the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract Highly pathogenic" exact="avian influenza" post="viruses (HPAIVs), originating from the A/goose/Guangdong/1/1996 H5 subtype, naturally"/>
   <result pre="SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract Highly pathogenic avian" exact="influenza" post="viruses (HPAIVs), originating from the A/goose/Guangdong/1/1996 H5 subtype, naturally"/>
   <result pre="transmit, infect, and adapt to the human host are reviewed." exact="avian influenza" post="avian influenza in swine avian influenza outbreaks evolution of"/>
   <result pre="infect, and adapt to the human host are reviewed. avian" exact="influenza" post="avian influenza in swine avian influenza outbreaks evolution of"/>
   <result pre="and adapt to the human host are reviewed. avian influenza" exact="avian influenza" post="in swine avian influenza outbreaks evolution of H5Nx H5N1"/>
   <result pre="adapt to the human host are reviewed. avian influenza avian" exact="influenza" post="in swine avian influenza outbreaks evolution of H5Nx H5N1"/>
   <result pre="human host are reviewed. avian influenza avian influenza in swine" exact="avian influenza" post="outbreaks evolution of H5Nx H5N1 H5Nx in humans H5Nx"/>
   <result pre="host are reviewed. avian influenza avian influenza in swine avian" exact="influenza" post="outbreaks evolution of H5Nx H5N1 H5Nx in humans H5Nx"/>
   <result pre="of H5Nx H5N1 H5Nx in humans H5Nx viruses highly pathogenic" exact="avian influenza" post="influenza replication zoonotic diseases Funding College of Veterinary Medicine,"/>
   <result pre="H5Nx H5N1 H5Nx in humans H5Nx viruses highly pathogenic avian" exact="influenza" post="influenza replication zoonotic diseases Funding College of Veterinary Medicine,"/>
   <result pre="H5N1 H5Nx in humans H5Nx viruses highly pathogenic avian influenza" exact="influenza" post="replication zoonotic diseases Funding College of Veterinary Medicine, University"/>
   <result pre="University of Georgiahttps://doi.org/10.13039/100011119 UGA-001 Georgia Research Alliancehttps://doi.org/10.13039/100008065 GRA-001 Introduction Avian" exact="influenza" post="viruses (AIVs) naturally circulate in wild aquatic birds, such"/>
   <result pre="terns.1 AIVs of the subtype H5N1 are often highly pathogenic" exact="avian influenza" post="viruses (HPAIVs), which was originally discovered in geese in"/>
   <result pre="AIVs of the subtype H5N1 are often highly pathogenic avian" exact="influenza" post="viruses (HPAIVs), which was originally discovered in geese in"/>
   <result pre="the end of 2017, 860 laboratory confirmed cases of H5N1" exact="influenza" post="virus infection from 16 different countries, resulting in 454"/>
   <result pre="conditions allow these markets to become breeding grounds for H5Nx" exact="influenza" post="virus circulation.7 Outbreaks caused by AIVs have devastated live"/>
   <result pre="the nucleoprotein and matrix proteins. Of the three types of" exact="influenza" post="viruses, Influenza A has the most genetic variation and"/>
   <result pre="endocytosis is not known, but it has been speculated that" exact="influenza" post="can use both clathrin-dependent and clathrin-independent mechanisms to enter"/>
   <result pre="an irreversible conformational change in the HA molecule on the" exact="influenza" post="virus and exposes the hydrophobic fusion peptide.16 The fusion"/>
   <result pre="6). Figure 1. Cartoon depiction of the replication cycle of" exact="influenza" post="viruses. (Step 1) Viral entry into host cell. (Step"/>
   <result pre="step 8).31 Antiviral drugs that block NA activity result in" exact="influenza" post="viruses accumulating at the membrane and cannot further disseminate"/>
   <result pre="HPAIV HA HA is located on the surface of the" exact="influenza" post="virus and it facilitates viral entry into the host"/>
   <result pre="sialic acid on the host cell surface.33 Avian-adapted strains of" exact="influenza" post="virus preferentially bind to N-acetylneuraminic acid with α-2,3-sialic acids.34"/>
   <result pre="the ubiquitous furin cellular protease.42,43 In contrast, in low pathogenic" exact="avian influenza" post="viruses (LPAIVs), that contain only one basic amino acid,"/>
   <result pre="ubiquitous furin cellular protease.42,43 In contrast, in low pathogenic avian" exact="influenza" post="viruses (LPAIVs), that contain only one basic amino acid,"/>
   <result pre="result in a lethal phenotype as tested in chickens.44 Other" exact="influenza" post="proteins such as PB2, PB1, and NP may increase"/>
   <result pre="as PB2, PB1, and NP may increase pathogenicity of an" exact="influenza" post="virus. The pathogenic phenotype of H5 viruses is not"/>
   <result pre="Hubei, Shandong, and Henan Provinces in China. Low pathogenic H5N2" exact="influenza" post="viruses naturally infect wild birds.73 However, these LPAI H5N2"/>
   <result pre="in wild-bird populations in China, Southeast Asia, and Africa.75 H5" exact="influenza" post="viruses of the clade 2.3.4.4 have been detected in"/>
   <result pre="the USA are classified as H5N2 isolates.75 Clade 2.3.4.4 H5" exact="influenza" post="viruses have caused 1537 outbreaks in birds in 14"/>
   <result pre="global surveillance efforts in order to monitor the occurance of" exact="influenza" post="H5 infections in humans. The widespread epidemic of H5Nx"/>
   <result pre="of the WHO include (a) monitoring the global occurrence of" exact="influenza" post="H5 viral infection in humans; (b) identifying and characterizing"/>
   <result pre="emergen inflluenza strains, (c) monitoring changes in transmission patterns of" exact="influenza" post="H5 viruses and detecting potential human-to-human transmission of influenza"/>
   <result pre="of influenza H5 viruses and detecting potential human-to-human transmission of" exact="influenza" post="H5 viruses; (d) monitoring unusual morbidity and mortality due"/>
   <result pre="contact pigs.86 The potential for reassortment of AIVs and mammalian" exact="influenza" post="viruses in pigs is still unknown, but swine are"/>
   <result pre="the virus to naïve pigs.92 In pigs infected with H5Nx" exact="influenza" post="viruses the virus replicated in the lower respiratory tract,"/>
   <result pre="lack of H5N1 virus-induced clinical manifestations, H5Nx and seasonal H1N1/H3N2" exact="influenza" post="viruses could co-infect the same animal resulting in a"/>
   <result pre="a reassortment event that leads to a human transmissible H5" exact="influenza" post="virus. Figure 2. Depiction of swine reassortants. Seasonal influenza"/>
   <result pre="H5 influenza virus. Figure 2. Depiction of swine reassortants. Seasonal" exact="influenza" post="from human hosts (left) can be transmitted into susceptible"/>
   <result pre="susceptible swine. Concurrent infection by avian strains (H5Nx) with seasonal" exact="influenza" post="strains can lead to reassortants, novel influenza viruses that"/>
   <result pre="(H5Nx) with seasonal influenza strains can lead to reassortants, novel" exact="influenza" post="viruses that contain genetic segments from both humans and"/>
   <result pre="infection in humans can initially present as an uncomplicated seasonal" exact="influenza" post="infection with clinical signs of fever, body aches, and"/>
   <result pre="virus from his sister 2 weeks earlier who also suffered from" exact="encephalitis" post="and died. Neither patient presented with any respiratory symptoms.99"/>
   <result pre="complications that arise from H5 viral infections include cardiac failure," exact="kidney failure," post="encephalitis, muti-organ failure, and intravascular coagulation.97,100–102 Human-to-human transmission of"/>
   <result pre="an increased number of seropositive families in northern Vietnam.103 During" exact="influenza" post="infection, a large infiltration of cytokines, inflammatory cells, and"/>
   <result pre="in infected individuals increases the morbidity and mortality rate of" exact="influenza" post="disesase.104,105 Elevated levels of proinflammatory cytokines, also known as"/>
   <result pre="often found in clinical specimens from patients infected with H5N1" exact="influenza" post="viruses.105–107 Autopsy studies revealed alveolar damage and high levels"/>
   <result pre="higher transcription of proinflammatory cytokines than seasonal H3N2 or H1N1" exact="influenza" post="viruses.108 The cytokines TNF-α and IL-β are significantly elevated"/>
   <result pre="viruses,109 and may contribute to the overall severity of H5N1" exact="influenza" post="virus infections in humans.108 As of July 2018, HPAIVs"/>
   <result pre="reading frame. PB1-F2 protein is an important virulence factor in" exact="influenza" post="viruses and can have three roles in viral infection,"/>
   <result pre="In order to combat the evolution and divergence of H5Nx" exact="avian influenza," post="a universal avian influenza vaccine (UAIV) for the human"/>
   <result pre="the evolution and divergence of H5Nx avian influenza, a universal" exact="avian influenza" post="vaccine (UAIV) for the human population should be developed."/>
   <result pre="evolution and divergence of H5Nx avian influenza, a universal avian" exact="influenza" post="vaccine (UAIV) for the human population should be developed."/>
   <result pre="span multiple age groups, taking into account pre-immunity to seasonal" exact="influenza" post="strains such as H1N1 and H3N2. Although these qualifications"/>
   <result pre="adapt to humans was reviewed. The segmented genome of the" exact="influenza" post="virus facilitates reassortment in hosts that are infected with"/>
   <result pre="hosts that are infected with more than one strain of" exact="influenza" post="virus. These reassortment events in birds and swine have"/>
   <result pre="enhanced pathogenicity. Reassortment of AIV RNA segments with seasonal human" exact="influenza" post="virus strains in swine by co-infection may not factor"/>
   <result pre="could in fact promote reassortment events upon co-infection. The next" exact="influenza" post="pandemic is inevitable and most likely will emerge from"/>
   <result pre="References References 1collab: Centers for Disease Control and Prevention. Avian" exact="influenza" post="A virus infections in humans. Atlanta, GA: Centers for"/>
   <result pre="Prevention, 2017. 2WanXF.Lessons from emergence of A/goose/Guangdong/1996-like H5N1 highly pathogenic" exact="avian influenza" post="viruses and recent influenza surveillance efforts in Southern China."/>
   <result pre="2017. 2WanXF.Lessons from emergence of A/goose/Guangdong/1996-like H5N1 highly pathogenic avian" exact="influenza" post="viruses and recent influenza surveillance efforts in Southern China."/>
   <result pre="of A/goose/Guangdong/1996-like H5N1 highly pathogenic avian influenza viruses and recent" exact="influenza" post="surveillance efforts in Southern China. Zoonoses Public Health2012; 59(Suppl."/>
   <result pre="59(Suppl. 2): 32–42.22958248 3BenderCHallHHuangJet al.Characterization of the surface proteins of" exact="influenza" post="A (H5N1) viruses isolated from humans in 1997–1998. Virology1999;"/>
   <result pre="isolated from humans in 1997–1998. Virology1999; 254: 115–123.9927579 4ChanPK.Outbreak of" exact="avian influenza" post="A (H5N1) virus infection in Hong Kong in 1997."/>
   <result pre="from humans in 1997–1998. Virology1999; 254: 115–123.9927579 4ChanPK.Outbreak of avian" exact="influenza" post="A (H5N1) virus infection in Hong Kong in 1997."/>
   <result pre="5LiKSGuanYWangJet al.Genesis of a highly pathogenic and potentially pandemic H5N1" exact="influenza" post="virus in eastern Asia. Nature2004; 430: 209–213.15241415 6collab: World"/>
   <result pre="Center, http://www.who.int/mediacentre/factsheets/avian_influenza/en/ (2017). 7GuanYSmithGJDThe emergence and diversification of panzootic H5N1" exact="influenza" post="viruses. Virus Res2013; 178: 35–43.23735533 8ZhangHHaleBGXuKet al.Viral and host"/>
   <result pre="35–43.23735533 8ZhangHHaleBGXuKet al.Viral and host factors required for avian H5N1" exact="influenza" post="A virus replication in mammalian cells. Viruses2013; 5: 1431–1446.23752648"/>
   <result pre="WHO/OIE/FAO H5N1 Evolution Working Group. Continued evolution of highly pathogenic" exact="avian influenza" post="A (H5N1): updated nomenclature. Influenza Other Respir Viruses2012; 6:"/>
   <result pre="H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian" exact="influenza" post="A (H5N1): updated nomenclature. Influenza Other Respir Viruses2012; 6:"/>
   <result pre="U S A1976; 73: 3045–3049.1067600 12McCauleyJWMahyBW.Structure and function of the" exact="influenza" post="virus genome. Biochem J1983; 211: 281–294.6191756 13WuWWSunYHPantéN.Nuclear import of"/>
   <result pre="influenza virus genome. Biochem J1983; 211: 281–294.6191756 13WuWWSunYHPantéN.Nuclear import of" exact="influenza" post="A viral ribonucleoprotein complexes is mediated by two nuclear"/>
   <result pre="sequences on viral nucleoprotein. Virol J2007; 4: 49.17547769 14LakadamyaliMRustMJZhuangX.Endocytosis of" exact="influenza" post="viruses. Microbes Infect2004; 6: 929–936.15310470 15HuYBDammerEBRenRJet al.The endosomal-lysosomal system:"/>
   <result pre="Transl Neurodegener2015; 4: 18.26448863 16SkehelJJBayleyPMBrownEBet al.Changes in the conformation of" exact="influenza" post="virus hemagglutinin at the pH optimum of virus-mediated membrane"/>
   <result pre="structure-function analysis. J Virol1994; 68: 1551–1563.7508997 19CrossTADongHSharmaMet al.M2 Protein from" exact="influenza" post="A: from multiple structures to biophysical and functional insights."/>
   <result pre="functional insights. Curr Opin Virol2012; 2: 128–133.22482709 20MartinKHeleniusA.Transport of incoming" exact="influenza" post="virus nucleocapsids into the nucleus. J Virol1991; 65: 232–244.1985199"/>
   <result pre="into the nucleus. J Virol1991; 65: 232–244.1985199 21HeleniusA.Unpacking the incoming" exact="influenza" post="virus. Cell1992; 69: 577–578.1375129 22LambRAKrugRMOrthomyxoviridae: The viruses and their"/>
   <result pre="virology. Philadelphia, PA: Lippincott-Raven Press. 23UlmanenIBroniBAKrugRM.Role of two of the" exact="influenza" post="virus core P proteins in recognizing cap 1 structures"/>
   <result pre="USA1981; 78: 7355–7359.6950380 24BlaasDPatzeltEKuechlerE.Identification of the cap binding protein of" exact="influenza" post="virus. Nucleic Acids Res1982; 10: 4803–4812.7133998 25GuilligayDTarendeauFResa-InfantePet al.The structural"/>
   <result pre="10: 4803–4812.7133998 25GuilligayDTarendeauFResa-InfantePet al.The structural basis for cap binding by" exact="influenza" post="virus polymerase subunit PB2. Nature2008; 289: 500–506. 26YadavVPanganibanATHonerZuBentrupKet al.Influenza"/>
   <result pre="trafficking and induces Golgi complex disruption. Virusdisease2016; 27: 357–368.28004015 27O’NeillRETalonJPaleseP.The" exact="influenza" post="virus NEP (NS2 protein) mediates the nuclear export of"/>
   <result pre="of viral ribonucleoproteins. EMBO J1998; 17: 288–296.9427762 28MartinKHeleniustA.Nuclear transport of" exact="influenza" post="virus ribonucleoproteins: the viral matrix protein (M1) promotes export"/>
   <result pre="67: 117–130.1913813 29WhittakerGBuiMHeleniusA.The role of nuclear import and export in" exact="influenza" post="virus infection. Trends Cell Biol1996; 6: 67–71.15157497 30GottschalkA.Neuraminidase: the"/>
   <result pre="Trends Cell Biol1996; 6: 67–71.15157497 30GottschalkA.Neuraminidase: the specific enzyme of" exact="influenza" post="virus and Vibrio cholerae. Biochim Biophys Acta1957; 23: 645–646.13426178"/>
   <result pre="Biochim Biophys Acta1957; 23: 645–646.13426178 31PalesePTobitaKUedaMet al.Characterization of temperature sensitive" exact="influenza" post="virus mutants defective in neuraminidase. Virology1974; 61: 397–410.4472498 32McKimm-BreschkinJL.Influenza"/>
   <result pre="Other Respir Viruses2013; 7(Suppl. 1): 25–36.23279894 33SauterNKBednarskiMDWurzburgBAet al.Hemagglutinins from two" exact="influenza" post="virus variants bind to sialic acid derivatives with millimolar"/>
   <result pre="proton nuclear magnetic resonance study. Biochemistry1989; 28: 8388–8396.2605190 34MatrosovichMNGambaryanASTenebergSet al.Avian" exact="influenza" post="A viruses differ from human viruses by recognition of"/>
   <result pre="HA receptor-binding site. Virology1997; 233: 224–234.9201232 35CostaTChavesAJValleRet al.Distribution patterns of" exact="influenza" post="virus receptors and viral attachment patterns in the respiratory"/>
   <result pre="al.Receptor specificity in human, avian, and equine H2 and H3" exact="influenza" post="virus isolates. Virology1994; 205: 17–23.7975212 37KlenkHDRottROrlichMet al.Activation of influenza"/>
   <result pre="H3 influenza virus isolates. Virology1994; 205: 17–23.7975212 37KlenkHDRottROrlichMet al.Activation of" exact="influenza" post="A viruses by trypsin treatment. Virology1975; 68: 426–439.173078 38ChenJLeeKHSteinhauerDAet"/>
   <result pre="al.Structure of the hemagglutinin precursor cleavage site, a determinant of" exact="influenza" post="pathogenicity and the origin of the labile conformation. Cell1998;"/>
   <result pre="409–417.9814710 39SkehelJJWileyDC.Receptor binding and membrane fusion in virus entry: the" exact="influenza" post="hemagglutinin. Annu Rev Biochem2000; 69: 531–569.10966468 40FleuryDBarrèreBBizebardTet al.A complex"/>
   <result pre="hemagglutinin. Annu Rev Biochem2000; 69: 531–569.10966468 40FleuryDBarrèreBBizebardTet al.A complex of" exact="influenza" post="hemagglutinin with a neutralizing antibody that binds outside the"/>
   <result pre="for a correlation of hemagglutinin cleavability and virulence of an" exact="avian influenza" post="A virus. J Virol1994; 68: 3120–3128.8151777 43HorimotoTKawaokaY.The hemagglutinin cleavability"/>
   <result pre="a correlation of hemagglutinin cleavability and virulence of an avian" exact="influenza" post="A virus. J Virol1994; 68: 3120–3128.8151777 43HorimotoTKawaokaY.The hemagglutinin cleavability"/>
   <result pre="J Virol1994; 68: 3120–3128.8151777 43HorimotoTKawaokaY.The hemagglutinin cleavability of a virulent" exact="avian influenza" post="virus by subtilisin-like endoproteases is influenced by the amino"/>
   <result pre="Virol1994; 68: 3120–3128.8151777 43HorimotoTKawaokaY.The hemagglutinin cleavability of a virulent avian" exact="influenza" post="virus by subtilisin-like endoproteases is influenced by the amino"/>
   <result pre="the cleavage site. Virology1995; 210: 466–470.7618281 44BogsJVeitsJGohrbandtSet al.Highly pathogenic H5N1" exact="influenza" post="viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage"/>
   <result pre="deletion serves as major virulence determinant of H5N1 highly pathogenic" exact="avian influenza" post="viruses in chicken. Sci Rep2015; 5: 13493.26306544 46SorrellEMSongHPenaLet al.A"/>
   <result pre="serves as major virulence determinant of H5N1 highly pathogenic avian" exact="influenza" post="viruses in chicken. Sci Rep2015; 5: 13493.26306544 46SorrellEMSongHPenaLet al.A"/>
   <result pre="in the neuraminidase stalk supports replication of an avian H2N2" exact="influenza" post="A virus in the respiratory tract of chickens. J"/>
   <result pre="respiratory tract of chickens. J Virol2010; 84: 11831–11840.20826691 47ZhaoZGuoZZhangCet al.Avian" exact="influenza" post="H5N6 viruses exhibit differing pathogenicities and transmissibilities in mammals."/>
   <result pre="16280.29176564 48LeeDHBertranKKwonJHet al.Evolution, global spread, and pathogenicity of highly pathogenic" exact="avian influenza" post="H5Nx clade 2.3.4.4. J Vet Sci2017; 18(Suppl. 1): 269–280.28859267"/>
   <result pre="48LeeDHBertranKKwonJHet al.Evolution, global spread, and pathogenicity of highly pathogenic avian" exact="influenza" post="H5Nx clade 2.3.4.4. J Vet Sci2017; 18(Suppl. 1): 269–280.28859267"/>
   <result pre="al.Hemagglutinin-neuraminidase balance influences the virulence phenotype of a recombinant H5N3" exact="influenza" post="A virus possessing a polybasic HA(0) cleavage site. J"/>
   <result pre="mutations increase the virulence of highly pathogenic H5N5 clade 2.3.4.4" exact="avian influenza" post="virus in mice. Arch Virol2018; 163:401–410.29090366 51HoffmannDRöhrsSRahnJet al.Pathogenicity evaluation"/>
   <result pre="increase the virulence of highly pathogenic H5N5 clade 2.3.4.4 avian" exact="influenza" post="virus in mice. Arch Virol2018; 163:401–410.29090366 51HoffmannDRöhrsSRahnJet al.Pathogenicity evaluation"/>
   <result pre="adult chicken. Vaccine2015; 33: 6997–7001.26469725 52YuYZhangZLiHet al.Biological characterizations of H5Nx" exact="avian influenza" post="viruses embodying different neuraminidases. Front Microbiol2017; 8: 1084. 53FranҫaMSBrownJD.Influenza"/>
   <result pre="chicken. Vaccine2015; 33: 6997–7001.26469725 52YuYZhangZLiHet al.Biological characterizations of H5Nx avian" exact="influenza" post="viruses embodying different neuraminidases. Front Microbiol2017; 8: 1084. 53FranҫaMSBrownJD.Influenza"/>
   <result pre="pp. 221–242. 54collab: Centers for Disease Control and Prevention. Avian" exact="influenza" post="in birds. 2017, https://www.cdc.gov/flu/avianflu/avian-in-birds.htm (accessed October 30 2017). 55DaoustPYBildtMVDRielDVet"/>
   <result pre="October 30 2017). 55DaoustPYBildtMVDRielDVet al.Replication of 2 subtypes of low-pathogenicity" exact="avian influenza" post="virus of duck and gull origins in experimentally infected"/>
   <result pre="30 2017). 55DaoustPYBildtMVDRielDVet al.Replication of 2 subtypes of low-pathogenicity avian" exact="influenza" post="virus of duck and gull origins in experimentally infected"/>
   <result pre="Pathol2012; 50: 548–559.23242805 56SpackmanEGelbJPreskenisLAet al.The pathogenesis of low pathogenicity H7" exact="avian influenza" post="viruses in chickens, ducks and turkeys. Virol J2010; 7:"/>
   <result pre="50: 548–559.23242805 56SpackmanEGelbJPreskenisLAet al.The pathogenesis of low pathogenicity H7 avian" exact="influenza" post="viruses in chickens, ducks and turkeys. Virol J2010; 7:"/>
   <result pre="ducks and turkeys. Virol J2010; 7: 331.21092107 57KuchipudiSVTellabatiMSebastianSet al.Highly pathogenic" exact="avian influenza" post="virus infection in chickens but not ducks is associated"/>
   <result pre="and turkeys. Virol J2010; 7: 331.21092107 57KuchipudiSVTellabatiMSebastianSet al.Highly pathogenic avian" exact="influenza" post="virus infection in chickens but not ducks is associated"/>
   <result pre="in organs is associated with a higher severity of H5N1" exact="influenza" post="virus infection. PLoS One2011; 6: e14561.21283521 59BurggraafSKarpalaAJBinghamJet al.H5N1 infection"/>
   <result pre="Res2014; 185(Suppl. C): 23–31.24657784 60PillaiSPSPantin-JackwoodMSuarezDLet al.Pathobiological characterization of low-pathogenicity H5" exact="avian influenza" post="viruses of diverse origins in chickens, ducks and turkeys."/>
   <result pre="185(Suppl. C): 23–31.24657784 60PillaiSPSPantin-JackwoodMSuarezDLet al.Pathobiological characterization of low-pathogenicity H5 avian" exact="influenza" post="viruses of diverse origins in chickens, ducks and turkeys."/>
   <result pre="of chickens, ducks and quails with the highly pathogenic H5N1" exact="avian influenza" post="virus. J Vet Sci2009; 10: 53–60.19255524 62collab: U.S. Department"/>
   <result pre="chickens, ducks and quails with the highly pathogenic H5N1 avian" exact="influenza" post="virus. J Vet Sci2009; 10: 53–60.19255524 62collab: U.S. Department"/>
   <result pre="update. J Microbiol2017; 55: 196–203.28243942 64ZhouNNShortridgeKFClaasECJet al.Rapid evolution of H5N1" exact="influenza" post="viruses in chickens in Hong Kong. J Virol1999; 73:"/>
   <result pre="65LiKSGuanYWangJet al.Genesis of a highly pathogenic and potentially pandemic H5N1" exact="influenza" post="virus in eastern Asia. Nature2004; 430.15386006 66SuSBiYWongGet al.Epidemiology, evolution,"/>
   <result pre="Asia. Nature2004; 430.15386006 66SuSBiYWongGet al.Epidemiology, evolution, and recent outbreaks of" exact="avian influenza" post="virus in China. J Virol2015; 89: 8671–8676.26063419 67JhungMANelsonDI.Outbreaks of"/>
   <result pre="Nature2004; 430.15386006 66SuSBiYWongGet al.Epidemiology, evolution, and recent outbreaks of avian" exact="influenza" post="virus in China. J Virol2015; 89: 8671–8676.26063419 67JhungMANelsonDI.Outbreaks of"/>
   <result pre="influenza virus in China. J Virol2015; 89: 8671–8676.26063419 67JhungMANelsonDI.Outbreaks of" exact="avian influenza" post="A (H5N2), (H5N8), and (H5N1) among birds – United"/>
   <result pre="virus in China. J Virol2015; 89: 8671–8676.26063419 67JhungMANelsonDI.Outbreaks of avian" exact="influenza" post="A (H5N2), (H5N8), and (H5N1) among birds – United"/>
   <result pre="der JeugdHPNoletBAet al.Wild bird surveillance around outbreaks of highly pathogenic" exact="avian influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="JeugdHPNoletBAet al.Wild bird surveillance around outbreaks of highly pathogenic avian" exact="influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="context of global flyways. Eurosurveillance2015; 20: 21069.25846491 69ShinJHWooCWangSJet al.Prevalence of" exact="avian influenza" post="virus in wild birds before and after the HPAI"/>
   <result pre="of global flyways. Eurosurveillance2015; 20: 21069.25846491 69ShinJHWooCWangSJet al.Prevalence of avian" exact="influenza" post="virus in wild birds before and after the HPAI"/>
   <result pre="Korea. J Microbiol2015; 53: 475–480.26115997 70GuMLiuWCaoYet al.Novel reassortant highly pathogenic" exact="avian influenza" post="(H5N5) viruses in domestic ducks, China. Emerg Infect Dis2011;"/>
   <result pre="J Microbiol2015; 53: 475–480.26115997 70GuMLiuWCaoYet al.Novel reassortant highly pathogenic avian" exact="influenza" post="(H5N5) viruses in domestic ducks, China. Emerg Infect Dis2011;"/>
   <result pre="Infect Dis2011; 17: 1060–1063.21749770 71HonSIMia KimTRocioCet al.Novel Eurasian highly pathogenic" exact="avian influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Dis2011; 17: 1060–1063.21749770 71HonSIMia KimTRocioCet al.Novel Eurasian highly pathogenic avian" exact="influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Emerg Infect Dis J2015; 21: 886. 72PasickJBerhaneYJosephTet al.Reassortant highly pathogenic" exact="influenza" post="A H5N2 virus containing gene segments related to Eurasian"/>
   <result pre="Canada, 2014. Sci Rep2015; 5: 9484.25804829 73SnoeckCJAdeyanjuATDe LandtsheerSet al.Reassortant low-pathogenic" exact="avian influenza" post="H5N2 viruses in African wild birds. J Gen Virol2011;"/>
   <result pre="2014. Sci Rep2015; 5: 9484.25804829 73SnoeckCJAdeyanjuATDe LandtsheerSet al.Reassortant low-pathogenic avian" exact="influenza" post="H5N2 viruses in African wild birds. J Gen Virol2011;"/>
   <result pre="75collab: World Health Organization. Antigenic and genetic characteristic of zoonotic" exact="influenza" post="viruses and development of candidate vaccine viruses for pandemic"/>
   <result pre="preparedness. 2017, 15p. 76ClaesFMorzariaSPDonisROEmergence and dissemination of clade 2.3.4.4 H5Nx" exact="influenza" post="viruses – how is the Asian HPAI H5 lineage"/>
   <result pre="migratory birds. J Virol2015; 89: 6521–6524.25855748 79GreeneJL.Update on the highly-pathogenic" exact="avian influenza" post="outbreak of 2014–2015. Congressional Research Service, 2015. 80collab: World"/>
   <result pre="birds. J Virol2015; 89: 6521–6524.25855748 79GreeneJL.Update on the highly-pathogenic avian" exact="influenza" post="outbreak of 2014–2015. Congressional Research Service, 2015. 80collab: World"/>
   <result pre="80collab: World Health Organization. WHO guidelines for global surveillance of" exact="influenza" post="A/H5. http://www.who.int/influenza/surveillance_monitoring/global_surveillance_h5_guidelines_06_02_2004/en/. 25p. 81ItoTCouceiroJNSSKelmSet al.Molecular basis for the generation"/>
   <result pre="25p. 81ItoTCouceiroJNSSKelmSet al.Molecular basis for the generation in pigs of" exact="influenza" post="A viruses with pandemic potential. J Virol1998; 72: 7367–7373.9696833"/>
   <result pre="82NelliRKKuchipudiSVWhiteGAet al.Comparative distribution of human and avian type sialic acid" exact="influenza" post="receptors in the pig. BMC Vet Res2010; 6: 4.20105300"/>
   <result pre="83KitikoonPVincentALGaugerPCet al.Pathogenicity and transmission in pigs of the novel a(H3N2)v" exact="influenza" post="virus isolated from humans and characterization of swine H3N2"/>
   <result pre="86: 6804–6814.22491461 84ZhouNNSenneDALandgrafJSet al.Genetic reassortment of avian, swine, and human" exact="influenza" post="A viruses in American pigs. J Virol1999; 73: 8851–8856.10482643"/>
   <result pre="in American pigs. J Virol1999; 73: 8851–8856.10482643 85MyersKPOlsenCWGrayGC.Cases of swine" exact="influenza" post="in humans: a review of the literature. Clin Infect"/>
   <result pre="literature. Clin Infect Dis2007; 44: 1084–1088.17366454 86ChoiYKNguyenTDOzakiHet al.Studies of H5N1" exact="influenza" post="virus infection of pigs by using viruses isolated in"/>
   <result pre="87BalzliCLagerKVincentAet al.Susceptibility of swine to H5 and H7 low pathogenic" exact="avian influenza" post="viruses. Influenza Other Respir Viruses2016; 10: 346–352.26946338 88KidaHItoTYasudaJet al.Potential"/>
   <result pre="al.Susceptibility of swine to H5 and H7 low pathogenic avian" exact="influenza" post="viruses. Influenza Other Respir Viruses2016; 10: 346–352.26946338 88KidaHItoTYasudaJet al.Potential"/>
   <result pre="Other Respir Viruses2016; 10: 346–352.26946338 88KidaHItoTYasudaJet al.Potential for transmission of" exact="avian influenza" post="viruses to pigs. J Gen Virol1994; 75: 2183–2188.8077918 89KaplanBSTorchettiMKLagerKMet"/>
   <result pre="Respir Viruses2016; 10: 346–352.26946338 88KidaHItoTYasudaJet al.Potential for transmission of avian" exact="influenza" post="viruses to pigs. J Gen Virol1994; 75: 2183–2188.8077918 89KaplanBSTorchettiMKLagerKMet"/>
   <result pre="90LipatovASKwonYKSarmentoLVet al.Domestic pigs have low susceptibility to H5N1 highly pathogenic" exact="avian influenza" post="viruses. PLoS Pathog2008; 4: e1000102.18617994 91WuHLuRPengXet al.Characterization of novel"/>
   <result pre="al.Domestic pigs have low susceptibility to H5N1 highly pathogenic avian" exact="influenza" post="viruses. PLoS Pathog2008; 4: e1000102.18617994 91WuHLuRPengXet al.Characterization of novel"/>
   <result pre="viruses. PLoS Pathog2008; 4: e1000102.18617994 91WuHLuRPengXet al.Characterization of novel reassortant" exact="influenza" post="A (H5N2) viruses isolated from poultry in Eastern China,"/>
   <result pre="ducks or chickens infected experimentally with A/turkey/Turkey/1/2005 (H5N1) highly pathogenic" exact="avian influenza" post="virus. Vet Microbiol2013; 162: 944–948.23266109 93CaoNZhuWChenYet al.Avian influenza A"/>
   <result pre="or chickens infected experimentally with A/turkey/Turkey/1/2005 (H5N1) highly pathogenic avian" exact="influenza" post="virus. Vet Microbiol2013; 162: 944–948.23266109 93CaoNZhuWChenYet al.Avian influenza A"/>
   <result pre="pathogenic avian influenza virus. Vet Microbiol2013; 162: 944–948.23266109 93CaoNZhuWChenYet al.Avian" exact="influenza" post="A (H5N1) virus antibodies in pigs and residents of"/>
   <result pre="farms, southern China. J Clin Virol2013; 58: 647–651.24231290 94RajabaliNLimTSokolowskiCet al.Avian" exact="influenza" post="A (H5N1) infection with respiratory failure and meningoencephalitis in"/>
   <result pre="Virol2013; 58: 647–651.24231290 94RajabaliNLimTSokolowskiCet al.Avian influenza A (H5N1) infection with" exact="respiratory failure" post="and meningoencephalitis in a Canadian traveller. Can J Infect"/>
   <result pre="94RajabaliNLimTSokolowskiCet al.Avian influenza A (H5N1) infection with respiratory failure and" exact="meningoencephalitis" post="in a Canadian traveller. Can J Infect Dis Med"/>
   <result pre="Dis Med Microbiol2015; 26: 221–223.26361492 95UngchusakKAuewarakulPDowellSFet al.Probable person-to-person transmission of" exact="avian influenza" post="A (H5N1). N Engl J Med2005; 352: 333–340.15668219 96WangHFengZShuYet"/>
   <result pre="Med Microbiol2015; 26: 221–223.26361492 95UngchusakKAuewarakulPDowellSFet al.Probable person-to-person transmission of avian" exact="influenza" post="A (H5N1). N Engl J Med2005; 352: 333–340.15668219 96WangHFengZShuYet"/>
   <result pre="352: 333–340.15668219 96WangHFengZShuYet al.Probable limited person-to-person transmission of highly pathogenic" exact="avian influenza" post="A (H5N1) virus in China. Lancet2008; 371: 1427–1434.18400288 97KortewegCGuJ.Pathology,"/>
   <result pre="333–340.15668219 96WangHFengZShuYet al.Probable limited person-to-person transmission of highly pathogenic avian" exact="influenza" post="A (H5N1) virus in China. Lancet2008; 371: 1427–1434.18400288 97KortewegCGuJ.Pathology,"/>
   <result pre="China. Lancet2008; 371: 1427–1434.18400288 97KortewegCGuJ.Pathology, molecular biology, and pathogenesis of" exact="avian influenza" post="A (H5N1) infection in humans. Am J Pathol2008; 172:"/>
   <result pre="Lancet2008; 371: 1427–1434.18400288 97KortewegCGuJ.Pathology, molecular biology, and pathogenesis of avian" exact="influenza" post="A (H5N1) infection in humans. Am J Pathol2008; 172:"/>
   <result pre="Am J Pathol2008; 172: 1155–1170.18403604 98UyekiTM.Human infection with highly pathogenic" exact="avian influenza" post="A (H5N1) Virus: review of clinical issues. Clin Infect"/>
   <result pre="J Pathol2008; 172: 1155–1170.18403604 98UyekiTM.Human infection with highly pathogenic avian" exact="influenza" post="A (H5N1) Virus: review of clinical issues. Clin Infect"/>
   <result pre="clinical issues. Clin Infect Dis2009; 49: 279–290.19522652 99de JongMDCamBVQuiPTet al.Fatal" exact="avian influenza" post="A (H5N1) in a child presenting with diarrhea followed"/>
   <result pre="issues. Clin Infect Dis2009; 49: 279–290.19522652 99de JongMDCamBVQuiPTet al.Fatal avian" exact="influenza" post="A (H5N1) in a child presenting with diarrhea followed"/>
   <result pre="al.Fatal avian influenza A (H5N1) in a child presenting with" exact="diarrhea" post="followed by coma. N Engl J Med2005; 352: 686–691.15716562"/>
   <result pre="N Engl J Med2005; 352: 686–691.15716562 100ChotpitayasunondhTUngchusakKHanshaoworakulWet al.Human disease from" exact="influenza" post="A (H5N1), Thailand, 2004. Emerg Infect Dis2005; 11: 201–209.15752436"/>
   <result pre="(H5N1), Thailand, 2004. Emerg Infect Dis2005; 11: 201–209.15752436 101HienTTLiemNTDungNTet al.Avian" exact="influenza" post="A (H5N1) in 10 patients in Vietnam. N Engl"/>
   <result pre="World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian" exact="influenza" post="A (H5N1) infection in humans. N Engl J Med2005;"/>
   <result pre="al.Mapping the innate signaling cascade essential for cytokine storm during" exact="influenza" post="virus infection. Proc Natl Acad Sci U S A2014:"/>
   <result pre="U S A2014: 201400593. 105de JongMDSimmonsCPThanhTTet al.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="archival lung tissues from five fatal cases of avian H5N1" exact="influenza" post="in Vietnam. Mod Pathol2012; 26: 357.23174938 107GaoRDongLDongJet al.A systematic"/>
   <result pre="e13315.20976271 108CheungCYPoonLLMLauASet al.Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="disease?Lancet2002; 360: 1831–1837.12480361 109LiWWangGZhangHet al.Effects of NS1 variants of H5N1" exact="influenza" post="virus on interferon induction, TNFα response and p53 activity."/>
   <result pre="World Health Organization. Cumulative number of confiremed human cases for" exact="avian influenza" post="A9H5N1) reported to WHO, 2003–1017. https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/. 111HerfstSSchrauwenEJALinsterMet al.Airborne transmission"/>
   <result pre="Health Organization. Cumulative number of confiremed human cases for avian" exact="influenza" post="A9H5N1) reported to WHO, 2003–1017. https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/. 111HerfstSSchrauwenEJALinsterMet al.Airborne transmission"/>
   <result pre="A9H5N1) reported to WHO, 2003–1017. https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/. 111HerfstSSchrauwenEJALinsterMet al.Airborne transmission of" exact="influenza" post="A/H5N1 virus between ferrets. Science2012; 336: 1534–1541.22723413 112SorrellEMSchrauwenEJALinsterMet al.Predicting"/>
   <result pre="A/H5N1 virus between ferrets. Science2012; 336: 1534–1541.22723413 112SorrellEMSchrauwenEJALinsterMet al.Predicting &quot;airborne�?" exact="influenza" post="viruses: (Trans-) mission impossible?Curr Opin Virol2011; 1: 635–642.22440921 113MainesTRChenLMVan"/>
   <result pre="receptor binding domain mutations on receptor binding and transmissibility of" exact="avian influenza" post="H5N1 viruses. Virology2011; 413: 139–147.21397290 114MehleADoudnaJA.Inhibitory activity restricts the"/>
   <result pre="binding domain mutations on receptor binding and transmissibility of avian" exact="influenza" post="H5N1 viruses. Virology2011; 413: 139–147.21397290 114MehleADoudnaJA.Inhibitory activity restricts the"/>
   <result pre="413: 139–147.21397290 114MehleADoudnaJA.Inhibitory activity restricts the function of an avian-like" exact="influenza" post="polymerase in primate cells. Cell Host Microbe2008; 4: 111–122.18692771"/>
   <result pre="cells. Cell Host Microbe2008; 4: 111–122.18692771 115TscherneDMGarcía-SastreA.Virulence determinants of pandemic" exact="influenza" post="viruses. J Clin Invest2011; 121: 6–13.21206092 116SubbaraoEKLondonWMurphyBR.A single amino"/>
   <result pre="6–13.21206092 116SubbaraoEKLondonWMurphyBR.A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host range. J"/>
   <result pre="host range. J Virol1993; 67: 1761–1764.8445709 117HattaMHattaYKimJHet al.Growth of H5N1" exact="influenza" post="A viruses in the upper respiratory tracts of mice."/>
   <result pre="of mice. PLoS Pathog2007; 3: e133. 118MehleADoudnaJA.Adaptive strategies of the" exact="influenza" post="virus polymerase for replication in humans. Proc Natl Acad"/>
   <result pre="Sci U S A2009; 106: 21312–21316.19995968 119KamalRPAlymovaIVYorkIA.Evolution and virulence of" exact="influenza" post="A virus protein PB1-F2. Int J Mol Sci2018; 19:"/>
   <result pre="single mutation in the PB1-F2 of H5N1 (HK/97) and 1918" exact="influenza" post="A viruses contributes to increased virulence. PLoS Pathog2007; 3:"/>
   <result pre="3: e141. 121HaiRSchmolkeMVargaZTet al.PB1-F2 expression by the 2009 pandemic H1N1" exact="influenza" post="virus has minimal impact on virulence in animal models."/>
   <result pre="models. J Virol2010; 84: 4442–4450.20181699 122KamalRPKumarADavisCTet al.Emergence of highly pathogenic" exact="avian influenza" post="A(H5N1) virus PB1-F2 variants and their virulence in BALB/c"/>
   <result pre="J Virol2010; 84: 4442–4450.20181699 122KamalRPKumarADavisCTet al.Emergence of highly pathogenic avian" exact="influenza" post="A(H5N1) virus PB1-F2 variants and their virulence in BALB/c"/>
   <result pre="Virol2015; 89: 5835–5846.25787281 123NolanTIzurietaPLeeBWet al.Heterologous prime-boost vaccination using an AS03B-adjuvanted" exact="influenza" post="A(H5N1) vaccine in infants and children &amp;lt;3 years of"/>
   <result pre="a universal vaccine for avian influenza: protective efficacy of modified" exact="vaccinia virus" post="Ankara and Adenovirus vaccines expressing conserved influenza antigens in"/>
   <result pre="of modified vaccinia virus Ankara and Adenovirus vaccines expressing conserved" exact="influenza" post="antigens in chickens challenged with low pathogenic avian influenza"/>
   <result pre="expressing conserved influenza antigens in chickens challenged with low pathogenic" exact="avian influenza" post="virus. Vaccine2013; 31: 670–675.23200938 125LevineMZHolidayCLiuFet al.Cross-reactive antibody responses to"/>
   <result pre="conserved influenza antigens in chickens challenged with low pathogenic avian" exact="influenza" post="virus. Vaccine2013; 31: 670–675.23200938 125LevineMZHolidayCLiuFet al.Cross-reactive antibody responses to"/>
   <result pre="Vaccine2013; 31: 670–675.23200938 125LevineMZHolidayCLiuFet al.Cross-reactive antibody responses to novel H5Nx" exact="influenza" post="viruses following homologous and heterologous prime-boost vaccination with a"/>
   <result pre="doses: what is the best use of vaccine in an" exact="influenza" post="pandemic?Epidemics2015; 13: 17–27.26616038 127CrevarCJCarterDMLeeKYJet al.Cocktail of H5N1 COBRA HA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6396361\results\search\disease\results.xml">
   <result pre="non�?commercial and no modifications or adaptations are made.file:HEP4-3-325.pdf Abstract Expanding" exact="hepatitis" post="C virus (HCV) treatment coverage is challenged by limited"/>
   <result pre="GHSS Global Health Sector Strategy on Viral Hepatitis, 2016�?2021 HCV" exact="hepatitis" post="C virus HIV human immunodeficiency virus LMICs low�? and"/>
   <result pre="risk UAE United Arab Emirates WHO World Health Organization Viral" exact="hepatitis" post="is the seventh leading cause of mortality globally.1 A"/>
   <result pre="mortality globally.1 A third of this mortality is attributed to" exact="hepatitis" post="C virus (HCV), a major cause of acute viral"/>
   <result pre="to hepatitis C virus (HCV), a major cause of acute" exact="viral hepatitis" post="and liver fibrosis, cirrhosis, and cancer.1, 2, 3, 4"/>
   <result pre="hepatitis C virus (HCV), a major cause of acute viral" exact="hepatitis" post="and liver fibrosis, cirrhosis, and cancer.1, 2, 3, 4"/>
   <result pre="and North Africa (MENA), HCV accounts for two thirds of" exact="viral hepatitis" post="mortality and disability�?adjusted life years.1, 4 Although exposure to"/>
   <result pre="North Africa (MENA), HCV accounts for two thirds of viral" exact="hepatitis" post="mortality and disability�?adjusted life years.1, 4 Although exposure to"/>
   <result pre="epidemic type, this testifies to the role of HCV in" exact="liver disease" post="in the MENA region. A wide reaching general population"/>
   <result pre="NaghaviM, FitzmauriceC, VosT, AbubakarI, et al. The global burden of" exact="viral hepatitis" post="from 1990 to 2013: findings from the Global Burden"/>
   <result pre="FitzmauriceC, VosT, AbubakarI, et al. The global burden of viral" exact="hepatitis" post="from 1990 to 2013: findings from the Global Burden"/>
   <result pre="2013. Lancet2016;388:1081�?1088.27394647 2Mohd HanafiahK, GroegerJ, FlaxmanAD, WiersmaST. Global epidemiology of" exact="hepatitis" post="C virus infection: new estimates of age�?specific antibody to"/>
   <result pre="age�?specific antibody to HCV seroprevalence. Hepatology2013;57:1333�?1342.23172780 3LavanchyD. Evolving epidemiology of" exact="hepatitis" post="C virus. Clin Microbiol Infect2011;17:107�?115.21091831 4collab: World Health Organization"/>
   <result pre="BlachS, Razavi�?ShearerK, RazaviH. Global epidemiology and genotype distribution of the" exact="hepatitis" post="C virus infection. J Hepatol2014;61(Suppl.):S45�?S57.25086286 6ChemaitellyH, MahmudS, ChaabnaK, KouyoumjianSP,"/>
   <result pre="International; 2009. 9MohamoudYA, MumtazGR, RiomeS, MillerD, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in Egypt: a systematic review and data"/>
   <result pre="and data synthesis. BMC Infect Dis2013;13:288.23799878 10KouyoumjianSP, ChemaitellyH, Abu�?RaddadLJ. Characterizing" exact="hepatitis" post="C virus epidemiology in Egypt: systematic reviews, meta�?analyses, and"/>
   <result pre="meta�?regressions. Sci Rep2018;8:1661.29374178 11QureshiH, BileKM, JoomaR, AlamSE, AfridiHU. Prevalence of" exact="hepatitis" post="B and C viral infections in Pakistan: findings of"/>
   <result pre="Hepat Mon2010;10:205�?214.22308140 13Al KanaaniZ, MahmudS, KouyoumjianSP, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in Pakistan: systematic review and meta�?analyses. R"/>
   <result pre="Nat Rev Gastroenterol Hepatol2013;10:553�?562.23817321 15collab: Advances in the treatment of" exact="hepatitis" post="C virus infection from EASL 2015: The 50th Annual"/>
   <result pre="Austria . Gastroenterol Hepatol (N Y)2015;11(Suppl. 3):1�?23. 16ChenC. Gilead’s new" exact="hepatitis" post="C drug approved by FDA, priced at $74,760. https://www.bloomberg.com/news/articles/2016-06-28/gilead-wins-fda-approval-of-hepatitis-c-drug-for-all-genotypes."/>
   <result pre="Accessed October 2, 2017. 17collab: Advances in the treatment of" exact="hepatitis" post="C virus infection from the 2016 EASL meeting: The"/>
   <result pre="HuttonDW, RaoufAA, SalamaM, HablasA, SeifeldinIA, et al. Cost�?effectiveness model for" exact="hepatitis" post="C screening and treatment: implications for Egypt and other"/>
   <result pre="KassasM, El�?SerafyM, KhairyM, ElsaeedK, et al. National treatment programme of" exact="hepatitis" post="C in Egypt: hepatitis C virus model of care."/>
   <result pre="et al. National treatment programme of hepatitis C in Egypt:" exact="hepatitis" post="C virus model of care. J Viral Hepat2017;24:262�?267.28145032 20collab:"/>
   <result pre="Organization; 2017. 26HutinYJ, BulterysM, HirnschallGO. How far are we from" exact="viral hepatitis" post="elimination service coverage targets?J Int AIDS Soc2018;21(Suppl. 2):e25050.29633520 27ZuureF,"/>
   <result pre="2017. 26HutinYJ, BulterysM, HirnschallGO. How far are we from viral" exact="hepatitis" post="elimination service coverage targets?J Int AIDS Soc2018;21(Suppl. 2):e25050.29633520 27ZuureF,"/>
   <result pre="et al. Evaluation of a risk assessment questionnaire to assist" exact="hepatitis" post="C screening in the general population. Euro Surveill2010;15:19539.20429995 28RemboldCM."/>
   <result pre="BMJ1998;317:307�?312.9685274 29ChemaitellyH, MahmudS, ChaabnaK, KouyoumjianSP, MumtazGR, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in the World Health Organization Eastern Mediterranean"/>
   <result pre="Report. In press. 30ChemaitellyH, MahmudS, RahmaniAM, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in Afghanistan: systematic review and meta�?analysis. Int"/>
   <result pre="J Infect Dis2015;40:54�?63.26417880 31FadlallaFA, MohamoudYA, MumtazGR, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in the Maghreb region: systematic review and"/>
   <result pre="review and meta�?analyses. PLoS One2015;10:e0121873.25803848 32MohamoudYA, RiomeS, Abu�?RaddadLJ. Epidemiology of" exact="hepatitis" post="C virus in the Arabian Gulf countries: systematic review"/>
   <result pre="and meta�?analysis. PLoS One2016;11:e0149966.26900839 34MahmudS, AkbarzadehV, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in Iran: systematic review and meta�?analyses. Sci"/>
   <result pre="and meta�?analyses. Sci Rep2018;8:150.29317673 35ChemaitellyH, ChaabnaK, Abu�?RaddadLJ. The epidemiology of" exact="hepatitis" post="C virus in the Fertile Crescent: systematic review and"/>
   <result pre="of a cDNA clone derived from a blood�?borne non�?A, non�?B" exact="viral hepatitis" post="genome. Science1989;244:359�?362.2523562 41KuoG, ChooQ, AlterH, GitnickG, RedekerA, PurcellR, et"/>
   <result pre="a cDNA clone derived from a blood�?borne non�?A, non�?B viral" exact="hepatitis" post="genome. Science1989;244:359�?362.2523562 41KuoG, ChooQ, AlterH, GitnickG, RedekerA, PurcellR, et"/>
   <result pre="non�?B hepatitis. Science1989;244:362�?364.2496467 42HeijnenM, MumtazGR, Abu�?RaddadLJ. Status of HIV and" exact="hepatitis" post="C virus infections among prisoners in the Middle East"/>
   <result pre="ChemaitellyH, Abu�?RaddadLJ. Individual�?level key associations and modes of exposure for" exact="hepatitis" post="C virus infection in the Middle East and North"/>
   <result pre="CowieB, HaganH, Des JarlaisD, HoryniakD, et al. Global epidemiology of" exact="hepatitis" post="B and hepatitis C in people who inject drugs:"/>
   <result pre="JarlaisD, HoryniakD, et al. Global epidemiology of hepatitis B and" exact="hepatitis" post="C in people who inject drugs: results of systematic"/>
   <result pre="50AyoubHH, Al KanaaniZ, Abu�?RaddadLJ. Characterizing the temporal evolution of the" exact="hepatitis" post="C virus epidemic in Pakistan. J Viral Hepat2018;25:670�?679.29345847 51BenovaL,"/>
   <result pre="Pakistan. J Viral Hepat2018;25:670�?679.29345847 51BenovaL, AwadSF, MillerFD, Abu�?RaddadLJ. Estimation of" exact="hepatitis" post="C virus infections resulting from vertical transmission in Egypt."/>
   <result pre="in Egypt. Hepatology2015;61:834�?842.25366418 52CuadrosDF, BranscumAJ, MillerFD, Abu�?RaddadLJ. Spatial epidemiology of" exact="hepatitis" post="C virus infection in Egypt: analyses and implications. Hepatology2014;60:1150�?1159.24913187"/>
   <result pre="and implications. Hepatology2014;60:1150�?1159.24913187 53BenovaL, MohamoudYA, CalvertC, Abu�?RaddadLJ. Vertical transmission of" exact="hepatitis" post="C virus: systematic review and meta�?analysis. Clin Infect Dis2014;59:765�?773.24928290"/>
   <result pre="meta�?analysis. Clin Infect Dis2014;59:765�?773.24928290 54AyoubHH, Abu�?RaddadLJ. Impact of treatment on" exact="hepatitis" post="C virus transmission and incidence in Egypt: a case"/>
   <result pre="ChemaitellyH, MahmudS, ChaabnaK, KouyoumjianSP, Al KanaaniZ, et al. Epidemiology of" exact="hepatitis" post="C virus among hemodialysis patients in the Middle East"/>
   <result pre="LP; 2015. 60MicallefJ, KaldorJ, DoreG. Spontaneous viral clearance following acute" exact="hepatitis" post="C infection: a systematic review of longitudinal studies. J"/>
   <result pre="viral genotype, and IL28B genotype on spontaneous clearance of acute" exact="hepatitis" post="C virus infection. Hepatology2014;59:109�?120.23908124 62AyoubHH, ChemaitellyH, OmoriR, Abu�?RaddadLJ. Hepatitis"/>
   <result pre="EasterbrookP. An educate, test, and treat programme towards elimination of" exact="hepatitis" post="C infection in Egypt: a community�?based demonstration project. Lancet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6400443\results\search\disease\results.xml">
   <result pre="transmitted by Aedes aegypti and Aedes albopictus mosquitoes. DENV causes" exact="dengue fever," post="which may progress to severe dengue. Hospital-based surveillance was"/>
   <result pre="accompanied by at least one clinical sign or symptom of" exact="dengue fever" post="such as headache, rash, arthralgia, retro-orbital pain, malaise, signs"/>
   <result pre="such as headache, rash, arthralgia, retro-orbital pain, malaise, signs of" exact="dengue hemorrhagic fever" post="or dengue shock syndrome were enrolled. A case of"/>
   <result pre="in this virus. Discussion Dengue fever is an acute, emerging" exact="infectious disease" post="caused by DENV, which is transmitted by Aedes aegypti"/>
   <result pre="host genetic background. In terms of the clinical manifestations of" exact="dengue fever" post="in the study participants, some clinical signs and symptoms"/>
   <result pre="response diversity may play roles in the pathogenesis of severe" exact="dengue fever" post="during a primary infection [39]. In conclusion, during the"/>
   <result pre="serotypes in human populations. Therefore, elucidating the immune responses to" exact="dengue fever" post="and the pathogenic mechanisms used by DENV are important"/>
   <result pre="Province and in Southeast Asian countries, indicating the possibility of" exact="dengue fever" post="becoming endemic in China, although most research has attributed"/>
   <result pre="in China, although most research has attributed the presence of" exact="dengue fever" post="in China to imported cases [12,40]. However, dengue infection"/>
   <result pre="LiL JL. A big challenge for prevention and control of" exact="dengue fever" post="in China. South Chin J Prev Med. 2007;33: 1–3."/>
   <result pre="Prev Med. 2007;33: 1–3. 18YiBT ZZ. Epidemic and control of" exact="dengue fever" post="in China. Chin Public Heal. 2002;18: 1128–1130. 19B K."/>
   <result pre="2002;18: 1128–1130. 19B K. Proposition for prevalence and monitor of" exact="dengue fever" post="in China. Chin J Vector Bio Control. 1997;8: 152–156."/>
   <result pre="e8559610.1371/journal.pone.008559624465613 25LiangWJ, HeJF, LuoHM, ZhouHQ, Yang FZK. Epidemiological analysis of" exact="dengue fever" post="in Guangdong province, 2001–2006. South Chin J Prev Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6406440\results\search\disease\results.xml">
   <result pre="identified in pigs with influenza-like illness was classified as the" exact="influenza" post="D virus (IDV) which is distantly related to the"/>
   <result pre="(IDV) which is distantly related to the previously characterized human" exact="influenza" post="C virus. Several other back-to-back studies soon suggested cattle"/>
   <result pre="natural reservoir and possible involvement of IDV in the bovine" exact="respiratory disease" post="complex was established. Not much is known about its"/>
   <result pre="Here, we review the evolution, epidemiology, virology and pathobiology of" exact="influenza" post="D virus and the possibility of transmission among various"/>
   <result pre="transmission among various hosts and potential to cause human disease." exact="influenza" post="influenza A virus (IAV) influenza B virus (IBV) influenza"/>
   <result pre="among various hosts and potential to cause human disease. influenza" exact="influenza" post="A virus (IAV) influenza B virus (IBV) influenza C"/>
   <result pre="potential to cause human disease. influenza influenza A virus (IAV)" exact="influenza" post="B virus (IBV) influenza C virus (ICV) influenza D"/>
   <result pre="disease. influenza influenza A virus (IAV) influenza B virus (IBV)" exact="influenza" post="C virus (ICV) influenza D virus (IDV) emerging pathogen"/>
   <result pre="virus (IAV) influenza B virus (IBV) influenza C virus (ICV)" exact="influenza" post="D virus (IDV) emerging pathogen epidemic pandemic respiratory illness"/>
   <result pre="acute respiratory illness and of the four known types, the" exact="influenza" post="A virus is a significant public health concern with"/>
   <result pre="antibody binding sites, this event is responsible for (i) frequent" exact="influenza" post="epidemics and (ii) the requirement of annual influenza vaccine"/>
   <result pre="(i) frequent influenza epidemics and (ii) the requirement of annual" exact="influenza" post="vaccine formulations. Genetic shift is the result of genetic"/>
   <result pre="between the genes of two or more different strains of" exact="influenza" post="virus infecting the same cell in a host. This"/>
   <result pre="avian and human IAVs [12,13,14]. Genetic shift has created novel" exact="influenza" post="virus strains with the ability to sustain efficient human-to-human"/>
   <result pre="to sustain efficient human-to-human transmission, and thus accountable for several" exact="influenza" post="pandemics in the past [4,11]. A total of 18"/>
   <result pre="have been reported to cause sustained, human-to-human transmission leading to" exact="influenza" post="epidemics [19]. Apart from the human influenza strains, there"/>
   <result pre="transmission leading to influenza epidemics [19]. Apart from the human" exact="influenza" post="strains, there are several low pathogenic avian influenza viruses"/>
   <result pre="from the human influenza strains, there are several low pathogenic" exact="avian influenza" post="viruses (LPAI) and highly pathogenic avian influenza viruses (HPAI)"/>
   <result pre="the human influenza strains, there are several low pathogenic avian" exact="influenza" post="viruses (LPAI) and highly pathogenic avian influenza viruses (HPAI)"/>
   <result pre="several low pathogenic avian influenza viruses (LPAI) and highly pathogenic" exact="avian influenza" post="viruses (HPAI) that have been in circulation in wild"/>
   <result pre="low pathogenic avian influenza viruses (LPAI) and highly pathogenic avian" exact="influenza" post="viruses (HPAI) that have been in circulation in wild"/>
   <result pre="thus are a significant cause of concern worldwide [20]. The" exact="influenza" post="B virus was first identified in the year 1940"/>
   <result pre="virus was first identified in the year 1940 [21]. Unlike" exact="influenza" post="A viruses that have a wide range of host,"/>
   <result pre="viruses that have been circulating worldwide since 1983 [26]. The" exact="influenza" post="B viruses also cause annual epidemics, but due to"/>
   <result pre="and similar to IBV, is known to cause relatively mild" exact="respiratory disease" post="in humans [28]. ICV is widely distributed throughout the"/>
   <result pre="discouraged its inclusion in the routine virological screenings. A novel" exact="influenza" post="virus, recently classified as the influenza D virus, has"/>
   <result pre="virological screenings. A novel influenza virus, recently classified as the" exact="influenza" post="D virus, has been identified in several animals, such"/>
   <result pre="the epidemiology, pathology, evolution and molecular biology of the novel" exact="influenza" post="D virus that represents a potential threat to public"/>
   <result pre="[35]. Of the approximately 3–5 million people who develop severe" exact="influenza" post="infection, almost one million die annually [35]. Both influenza"/>
   <result pre="severe influenza infection, almost one million die annually [35]. Both" exact="influenza" post="A and B viruses are known to cause annual"/>
   <result pre="ICVs and human ICVs [37]. In the year 2011, an" exact="influenza" post="C-like virus was isolated from pigs having a influenza-like"/>
   <result pre="having a influenza-like illness in the USA. The newly identified" exact="influenza" post="D virus shared approximately 50% homology with ICV and"/>
   <result pre="detected in goats and pigs [43]. The study showed that" exact="influenza" post="viremia, as an indicator of disease severity, was observed"/>
   <result pre="The authors observed that the Dromedary camels in Kenya harbored" exact="influenza" post="C or D virus antibodies suggesting a new host"/>
   <result pre="respiratory viruses along with IDV to collectively cause the bovine" exact="respiratory disease" post="(BRD) [38]. The cattle industry in the US and"/>
   <result pre="the morbidity in the USA [38]. The IDV causes mild" exact="respiratory disease" post="in experimentally infected cattle. Several studies have already been"/>
   <result pre="nasal swabs with no clinical symptoms and lesions typical of" exact="influenza" post="viruses. The study also revealed that IDV could be"/>
   <result pre="revealed that the most commonly detected viruses were the bovine" exact="rhinitis" post="A and B virus, and bovine coronavirus along with"/>
   <result pre="maximum-likelihood phylogenetic tree generated from the sequence of PB1 from" exact="influenza" post="type A, B, C and D viruses [57]. Another"/>
   <result pre="have revealed crucial functions performed by the individual genes of" exact="influenza" post="A and B viruses [58], however very little of"/>
   <result pre="little of such studies have been performed in case of" exact="influenza" post="C and D viruses. A scanning transmission electron microscopic"/>
   <result pre="of IDV is still in infancy and is unclear. The" exact="influenza" post="viruses that cause zoonotic infections in humans have been"/>
   <result pre="be transmitted among ferrets, which are the model for human" exact="influenza" post="virus infection, and guinea pigs [72]. These studies highlight"/>
   <result pre="with more number of relevant studies; however, the ability of" exact="influenza" post="viruses to acquire frequent mutations makes IDV a potential"/>
   <result pre="Infection and Management of Future Threat Since the discovery of" exact="influenza" post="viruses, annual epidemics and several pandemics have been recorded"/>
   <result pre="have been recorded to claim numerous lives. With time, the" exact="influenza" post="viruses have also shown remarkable evolutionary changes and their"/>
   <result pre="remarkable changes in the public health infrastructure. Surveillance activities against" exact="influenza" post="viruses have been implemented worldwide to timely diagnose and"/>
   <result pre="detect a wide range of respiratory viruses in the bovine" exact="respiratory disease" post="complex [76]. In a most recent study, Henritzi et"/>
   <result pre="et al. developed a tetraplex real-time RT-PCR assay for screening" exact="influenza" post="virus types A, B, C and D simultaneously [77]."/>
   <result pre="of low cost and less invasive sampling to detect novel" exact="influenza" post="viruses [79]. Aerosol surveillance for respiratory viruses at an"/>
   <result pre="[80]. Developments in the antiviral strategies and vaccine technology against" exact="influenza" post="viruses have been in action to tackle disease outbreaks."/>
   <result pre="infections [82]. Another report highlights the development of an inactivated" exact="influenza" post="D virus vaccine that was found to be immunogenic"/>
   <result pre="also leads to socio-economic loss. Among the four genera, the" exact="influenza" post="A viruses have been reported to be of significant"/>
   <result pre="105 different species of birds have been reported to harbor" exact="influenza" post="A viruses [88,89]. Most of these carriers are almost"/>
   <result pre="fly longer distances while on migration [92,93]. Until recently, the" exact="influenza" post="C viruses were known to exist as a single"/>
   <result pre="drastic antigenic change over the years, yet the unpredictability of" exact="influenza" post="viruses make this type a potential health threat. IDV"/>
   <result pre="can sustain human-to-human transmission. Advancements in several approaches to managing" exact="influenza" post="infections have led to quick and efficient control measures"/>
   <result pre="also been in action against several respiratory viruses, including human" exact="influenza" post="viruses [94,95,96,97,98,99,100,101]. It would be interesting to have such"/>
   <result pre="the disease in cattle and other potential hosts. As the" exact="influenza" post="viruses continue to evolve, there is a need of"/>
   <result pre="policy makers across the world to closely monitor the circulating" exact="influenza" post="viruses and prevent any future outbreaks. Author Contributions Conceptualization,"/>
   <result pre="References 1.Family—OrthomyxoviridaeVirus TaxonomyKingA.M.Q.AdamsM.J.CarstensE.B.LefkowitzE.J.ElsevierSan Diego, CA, USA2012749761 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a novel" exact="influenza" post="virus in cattle and Swine: Proposal for a new"/>
   <result pre="Virology of the Influenza VirusesInfluenzaSpringer USBoston, MA, USA19872532 4.KumarB.AshaK.KhannaM.RonsardL.MesekoC.A.SanicasM.The emerging" exact="influenza" post="virus threat: Status and new prospects for its therapy"/>
   <result pre="comparative accountFuture Virol.2013833534210.2217/fvl.13.18 7.MesekoC.KumarB.SanicasM.Preventing Zoonotic InfluenzaInfluenza-Therapeutics and ChallengesSaxenaS.K.IntechOpenLondon, UK20183355 8.KhannaM.KumarP.ChoudharyK.KumarB.VijayanV.K.Emerging" exact="influenza" post="virus: A global threatJ. Biosci.20083347548210.1007/s12038-008-0066-z19208973 9.KhannaM.KumarB.GuptaA.KumarP.Pandemic Influenza A H1N1"/>
   <result pre="Past and Implications for the FutureIndian J. Virol.201223121710.1007/s13337-012-0066-323729996 10.KhannaM.KumarB.GuptaN.KumarP.GuptaA.VijayanV.K.KaurH.Pandemic swine" exact="influenza" post="virus (H1N1): A threatening evolutionIndian J. Microbiol.20094936536910.1007/s12088-009-0064-323100799 11.TreanorJ.Influenza Vaccine—Outmaneuvering"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature201552612212510.1038/nature1537926416728 13.ChotheS.K.BhushanG.NisslyR.H.YehY.T.BrownJ.TurnerG.FisherJ.SewallB.J.ReederD.M.TerronesM.et al.Avian and human influenza virus compatible sialic"/>
   <result pre="of adaptation for transmissible influenza virusesNature201552612212510.1038/nature1537926416728 13.ChotheS.K.BhushanG.NisslyR.H.YehY.T.BrownJ.TurnerG.FisherJ.SewallB.J.ReederD.M.TerronesM.et al.Avian and human" exact="influenza" post="virus compatible sialic acid receptors in little brown batsSci."/>
   <result pre="a potential mixing vessel for the generation of new reassortant" exact="influenza" post="A virusesVet. Microbiol.201216030531310.1016/j.vetmic.2012.05.04322763173 15.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of influenza A"/>
   <result pre="new reassortant influenza A virusesVet. Microbiol.201216030531310.1016/j.vetmic.2012.05.04322763173 15.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of" exact="influenza" post="A virusesCurr. Top. Microbiol. Immunol.201438535937510.1007/82_2014_39624990620 16.OlsenB.MunsterV.J.WallenstenA.WaldenstromJ.OsterhausA.D.FouchierR.A.Global patterns of influenza"/>
   <result pre="of influenza A virusesCurr. Top. Microbiol. Immunol.201438535937510.1007/82_2014_39624990620 16.OlsenB.MunsterV.J.WallenstenA.WaldenstromJ.OsterhausA.D.FouchierR.A.Global patterns of" exact="influenza" post="a virus in wild birdsScience200631238438810.1126/science.112243816627734 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats"/>
   <result pre="virus in wild birdsScience200631238438810.1126/science.112243816627734 17.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 18.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of influenza"/>
   <result pre="diverse influenza A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 18.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="A virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic"/>
   <result pre="virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of" exact="avian influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 20.SuS.BiY.WongG.GrayG.C.GaoG.F.LiS.Epidemiology, Evolution, and Recent Outbreaks"/>
   <result pre="from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 19.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of avian" exact="influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 20.SuS.BiY.WongG.GrayG.C.GaoG.F.LiS.Epidemiology, Evolution, and Recent Outbreaks"/>
   <result pre="B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 23.KawanoJ.OntaT.KidaH.YanagawaR.Distribution of antibodies in animals against" exact="influenza" post="B and C virusesJpn. J. Vet. Res.1978267480739713 24.ChangC.P.NewA.E.TaylorJ.F.ChiangH.S.Influenza virus"/>
   <result pre="B VirusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 26.RotaP.A.WallisT.R.HarmonM.W.RotaJ.S.KendalA.P.NeromeK.Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 27.TaylorR.M.Studies on survival of"/>
   <result pre="influenza type B virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 27.TaylorR.M.Studies on survival of" exact="influenza" post="virus between epidemics and antigenic variants of the virusAm."/>
   <result pre="Nations Health19493917117810.2105/AJPH.39.2.17118111593 28.Crescenzo-ChaigneB.BarbezangeC.van der WerfS.Non coding extremities of the seven" exact="influenza" post="virus type C vRNA segments: Effect on transcription and"/>
   <result pre="to Type C Influenza VirusMicrobiol. Immunol.19822663964210.1111/mim.1982.26.7.6397132793 30.ManuguerraJ.C.HannounC.Saenz MdelC.VillarE.CabezasJ.A.Sero-epidemiological survey of" exact="influenza" post="C virus infection in SpainEur. J. Epidemiol.199410919410.1007/BF017174597957798 31.YuanjiG.FengenJ.PingW.MinW.JimingZ.Isolation of"/>
   <result pre="Camelids, Africa, 1991–2015Emerg. Infect. Dis. J.201723155610.3201/eid2309.170342 34.BaileyE.S.ChoiJ.Y.FieldhouseJ.K.BorkenhagenL.K.ZemkeJ.ZhangD.GrayG.C.The continual threat of" exact="influenza" post="virus infections at the human–animal interfaceWhat is new from"/>
   <result pre="from a one health perspective?Evol. Med. Public Health2018201819219810.1093/emph/eoy01330210800 35.Vaccines against" exact="influenza" post="WHO position paper—November 2012Wkly. Epidemiol. Rec.20128746147623210147 36.HauseB.M.DucatezM.CollinE.A.RanZ.LiuR.ShengZ.ArmienA.KaplanB.ChakravartyS.HoppeA.D.et al.Isolation of"/>
   <result pre="Gen. Virol.1984651857187210.1099/0022-1317-65-11-18576502138 38.MitraN.CernicchiaroN.TorresS.LiF.HauseB.M.Metagenomic characterization of the virome associated with bovine" exact="respiratory disease" post="in feedlot cattle identified novel viruses and suggests an"/>
   <result pre="cattle identified novel viruses and suggests an etiologic role for" exact="influenza" post="D virusJ. Gen. Virol.2016971771178410.1099/jgv.0.00049227154756 39.FergusonL.EckardL.EppersonW.B.LongL.-P.SmithD.HustonC.GenovaS.WebbyR.WanX.-F.Influenza D virus infection in"/>
   <result pre="Mississippi beef cattleVirology2015486283410.1016/j.virol.2015.08.03026386554 40.QuastM.SreenivasanC.SextonG.NedlandH.SingreyA.FawcettL.MillerG.LauerD.VossS.PollockS.et al.Serological evidence for the presence of" exact="influenza" post="D virus in small ruminantsVet. Microbiol.201518028128510.1016/j.vetmic.2015.09.00526414999 41.LuoJ.FergusonL.SmithD.R.WoolumsA.R.EppersonW.B.WanX.-F.Serological evidence for"/>
   <result pre="United States, 2003–2004Virology2017501889110.1016/j.virol.2016.11.00427888742 42.JiangW.-M.WangS.-C.PengC.YuJ.-M.ZhuangQ.-Y.HouG.-Y.LiuS.LiJ.-P.ChenJ.-M.Identification of a potential novel type of" exact="influenza" post="virus in Bovine in ChinaVirus Genes20144949349610.1007/s11262-014-1107-325142163 43.Shao-LunZ.HeZ.Sheng-NanC.XiaZ.TaoL.RunxiaL.Dian-HongL.Xiao-HuiW.Wen-KangW.DanW.et al.Influenza D"/>
   <result pre="49.NedlandH.WollmanJ.SreenivasanC.QuastM.SingreyA.FawcettL.Christopher-HenningsJ.NelsonE.KaushikR.S.WangD.et al.Serological evidence for the co-circulation of two lineages of" exact="influenza" post="D viruses in equine populations of the Midwest United"/>
   <result pre="CattleJ. Virol.2015891036104210.1128/JVI.02718-1425355894 56.MekataH.YamamotoM.HamabeS.TanakaH.OmatsuT.MizutaniT.HauseB.M.OkabayashiT.Molecular epidemiological survey and phylogenetic analysis of bovine" exact="influenza" post="D virus in JapanTransbound. Emerg. Dis.201865e355e36010.1111/tbed.1276529143492 57.SuS.FuX.LiG.KerlinF.VeitM.Novel Influenza D"/>
   <result pre="Thermal and Acid Stability of Influenza D VirusmSphere20172e002540021710.1128/mSphere.00254-1728808690 62.NodaT.KawaokaY.Structure of" exact="influenza" post="virus ribonucleoprotein complexes and their packaging into virionsRev. Med."/>
   <result pre="virionsRev. Med. Virol.20102038039110.1002/rmv.66620853340 63.KumarB.KhannaM.KumarP.SoodV.VyasR.BanerjeaA.C.Nucleic acid-mediated cleavage of M1 gene of" exact="influenza" post="A virus is significantly augmented by antisense molecules targeted"/>
   <result pre="cleavage siteMol. Biotechnol.201251273610.1007/s12033-011-9437-z21744034 64.KumarB.KumarP.RajputR.SaxenaL.DagaM.KhannaM.Sequence-specific cleavage of BM2 gene transcript of" exact="influenza" post="B virus by 10-23 catalytic motif containing DNA enzymes"/>
   <result pre="ModelJ. Virol.2007816890689810.1128/JVI.00170-0717459930 70.MainesT.R.ChenL.-M.MatsuokaY.ChenH.RoweT.OrtinJ.FalcónA.HienN.T.MaiL.Q.SedyaningsihE.R.et al.Lack of transmission of H5N1 avian–human reassortant" exact="influenza" post="viruses in a ferret modelProc. Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383"/>
   <result pre="D Virus in a Guinea Pig ModelJ. Virol.201589119901200110.1128/JVI.01630-1526378161 73.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of" exact="influenza" post="C virus but not influenza D virus in Scottish"/>
   <result pre="Pig ModelJ. Virol.201589119901200110.1128/JVI.01630-1526378161 73.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of influenza C virus but not" exact="influenza" post="D virus in Scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 74.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic"/>
   <result pre="Scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 74.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic evidence of exposure to" exact="influenza" post="D virus among persons with occupational contact with cattleJ."/>
   <result pre="of a new Real-Time RT-PCR assay for detection of proposed" exact="influenza" post="D virusJ. Virol. Methods2017243313410.1016/j.jviromet.2017.01.01928153610 76.KishimotoM.TsuchiakaS.RahpayaS.S.HasebeA.OtsuK.SugimuraS.KobayashiS.KomatsuN.NagaiM.OmatsuT.et al.Development of a one-run"/>
   <result pre="one-run real-time PCR detection system for pathogens associated with bovine" exact="respiratory disease" post="complexJ. Vet. Med. Sci.20177951752310.1292/jvms.16-048928070089 77.HenritziD.HoffmannB.WacheckS.PeschS.HerrlerG.BeerM.HarderT.C.A newly developed tetraplex real-time"/>
   <result pre="77.HenritziD.HoffmannB.WacheckS.PeschS.HerrlerG.BeerM.HarderT.C.A newly developed tetraplex real-time RT-PCR for simultaneous screening of" exact="influenza" post="virus types A, B, C and DInflu. Other Respir."/>
   <result pre="Viruses201913718210.1111/irv.1261330264926 78.MorenoA.LelliD.LavazzaA.SozziE.ZanniI.ChiapponiC.FoniE.CapucciL.BrocchiE.MAb-based competitive ELISA for the detection of antibodies against" exact="influenza" post="D virusTransbound. Emerg. Dis.20196626827610.1111/tbed.1301230179314 79.AndersonB.D.MaM.XiaY.WangT.ShuB.LednickyJ.A.MaM.-J.LuJ.GrayG.C.Bioaerosol Sampling in Modern Agriculture:"/>
   <result pre="81.KumarP.KhannaM.KumarB.RajputR.BanerjeaA.C.A conserved matrix epitope based DNA vaccine protects mice against" exact="influenza" post="A virus challengeAntiviral Res.201293788510.1016/j.antiviral.2011.10.02122086129 82.WanY.KangG.SreenivasanC.DaharshL.ZhangJ.FanW.WangD.MoriyamaH.LiF.LiQ.A DNA Vaccine Expressing Consensus"/>
   <result pre="by Two Lineages of Influenza D VirusJ. Virol.20189210.1128/JVI.00110-18 83.HauseB.M.HuntimerL.FalkenbergS.HenningsonJ.LechtenbergK.HalburT.An inactivated" exact="influenza" post="D virus vaccine partially protects cattle from respiratory disease"/>
   <result pre="83.HauseB.M.HuntimerL.FalkenbergS.HenningsonJ.LechtenbergK.HalburT.An inactivated influenza D virus vaccine partially protects cattle from" exact="respiratory disease" post="caused by homologous challengeVet. Microbiol.2017199475310.1016/j.vetmic.2016.12.02428110784 84.EasterdayB.C.TrainerD.O.TŮMov�?B.PereiraH.G.Evidence of Infection with"/>
   <result pre="in North AmericaVector-Borne Zoonotic Dis.2004417718910.1089/vbz.2004.4.17715631061 87.SpackmanE.StallknechtD.E.SlemonsR.D.WinkerK.SuarezD.L.ScottM.SwayneD.E.Phylogenetic analyses of type A" exact="influenza" post="genes in natural reservoir species in North America reveals"/>
   <result pre="Res.20051148910010.1016/j.virusres.2005.05.01316039745 88.MunsterV.J.BaasC.LexmondP.WaldenstromJ.WallenstenA.FranssonT.RimmelzwaanG.F.BeyerW.E.SchuttenM.OlsenB.et al.Spatial, temporal, and species variation in prevalence of" exact="influenza" post="A viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range"/>
   <result pre="A viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range of" exact="avian influenza" post="virus in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with"/>
   <result pre="viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 89.StallknechtD.E.ShaneS.M.Host range of avian" exact="influenza" post="virus in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with"/>
   <result pre="in free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with highly pathogenic" exact="avian influenza" post="H5N1 in wild birds: How sound is the evidence?Virol."/>
   <result pre="free-living birdsVet. Res. Commun.19881212514110.1007/BF003627923055662 90.FeareC.J.YasueM.Asymptomatic infection with highly pathogenic avian" exact="influenza" post="H5N1 in wild birds: How sound is the evidence?Virol."/>
   <result pre="InfectionsJ. Clin. Med.20188610.3390/jcm801000630577479 95.KhannaM.SaxenaL.RajputR.KumarB.PrasadR.Gene silencing: A therapeutic approach to combat" exact="influenza" post="virus infectionsFuture Microbiol.20151013114010.2217/fmb.14.9425598342 96.KumarB.AshaK.ChauhanS.DNAzyme mediated post-transcriptional gene silencing: A"/>
   <result pre="of antisense oligonucleotide developed against the common 3′ NCR of" exact="influenza" post="A virus genomeMol. Biotechnol.20135520321110.1007/s12033-013-9670-823729285 98.RajputR.KhannaM.KumarP.KumarB.SharmaS.GuptaN.SaxenaL.Small interfering RNA targeting the"/>
   <result pre="98.RajputR.KhannaM.KumarP.KumarB.SharmaS.GuptaN.SaxenaL.Small interfering RNA targeting the nonstructural gene 1 transcript inhibits" exact="influenza" post="A virus replication in experimental miceNucleic Acid Ther.20122241442210.1089/nat.2012.035923062009 99.MotardJ.RouxelR.PaunA.von"/>
   <result pre="experimental miceNucleic Acid Ther.20122241442210.1089/nat.2012.035923062009 99.MotardJ.RouxelR.PaunA.von MesslingV.BisaillonM.PerreaultJ.P.A novel ribozyme-based prophylaxis inhibits" exact="influenza" post="A virus replication and protects from severe diseasePLoS ONE20116e2732710.1371/journal.pone.002732722110627"/>
   <result pre="ONE20116e2732710.1371/journal.pone.002732722110627 100.ZhangZ.ZhangS.WangS.DNAzymes Dz13 target the c-jun possess antiviral activity against" exact="influenza" post="A virusesMicrob. Pathog.201710315516110.1016/j.micpath.2016.12.02428039102 101.TangX.B.HobomG.LuoD.Ribozyme mediated destruction of influenza A"/>
   <result pre="activity against influenza A virusesMicrob. Pathog.201710315516110.1016/j.micpath.2016.12.02428039102 101.TangX.B.HobomG.LuoD.Ribozyme mediated destruction of" exact="influenza" post="A virus in vitro and in vivoJ. Med. Virol.19944238539510.1002/jmv.18904204118046429"/>
   <result pre="Virol.19944238539510.1002/jmv.18904204118046429 Figure 1 Summary of the wide host range of" exact="influenza" post="viruses. Few host species are susceptible to infection by"/>
   <result pre="species are susceptible to infection by all the four known" exact="influenza" post="viruses (influenza A virus—IAV, influenza B virus—IBV, influenza C"/>
   <result pre="by all the four known influenza viruses (influenza A virus—IAV," exact="influenza" post="B virus—IBV, influenza C virus—ICV and influenza D virus—IDV),"/>
   <result pre="four known influenza viruses (influenza A virus—IAV, influenza B virus—IBV," exact="influenza" post="C virus—ICV and influenza D virus—IDV), while others are"/>
   <result pre="(influenza A virus—IAV, influenza B virus—IBV, influenza C virus—ICV and" exact="influenza" post="D virus—IDV), while others are known to be infected"/>
   <result pre="while others are known to be infected by only specific" exact="influenza" post="viruses. Cattles are the major known reservoir of influenza"/>
   <result pre="specific influenza viruses. Cattles are the major known reservoir of" exact="influenza" post="D virus; however, other small ruminants and humans have"/>
   <result pre="IDV infections in different conditions. Figure 2 Schematic representation of" exact="influenza" post="D virus. IDV is an enveloped virus with seven"/>
   <result pre="as the ion channel. jcm-08-00192-t001_Table 1Table 1 Revised classification of" exact="influenza" post="viruses in the family Orthomyxovirideae by International Committee on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6409754\results\search\disease\results.xml">
   <result pre="despite the advances in the development and wide use of" exact="influenza" post="vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or"/>
   <result pre="and wide use of influenza vaccines. Vaccination with traditional inactivate" exact="influenza" post="vaccines (IIV) or live-attenuated influenza vaccines (LAIV) remains the"/>
   <result pre="vaccines. Vaccination with traditional inactivate influenza vaccines (IIV) or live-attenuated" exact="influenza" post="vaccines (LAIV) remains the main strategy in the control"/>
   <result pre="seasonal epidemics, but it does not offer protection against new" exact="influenza" post="viruses with pandemic potential, those that have shifted. Moreover,"/>
   <result pre="have shifted. Moreover, the continual antigenic drift of seasonal circulating" exact="influenza" post="viruses, causing an antigenic mismatch that requires yearly reformulation"/>
   <result pre="causing an antigenic mismatch that requires yearly reformulation of seasonal" exact="influenza" post="vaccines, seriously compromises vaccine efficacy. Therefore, the quick optimization"/>
   <result pre="efficacy. Therefore, the quick optimization of vaccine production for seasonal" exact="influenza" post="and the development of new vaccine approaches for pandemic"/>
   <result pre="pandemic viruses is still a challenge for the prevention of" exact="influenza" post="infections. Moreover, recent reports have questioned the effectiveness of"/>
   <result pre="the current LAIV because of limited protection, mainly against the" exact="influenza" post="A virus (IAV) component of the vaccine. Although the"/>
   <result pre="a key advance in the rapid generation of recombinant attenuated" exact="influenza" post="viruses that can be used for the development of"/>
   <result pre="of these new LAIVs reveal their possible implementation in combating" exact="influenza" post="infections. However, efforts by vaccine companies and government agencies"/>
   <result pre="approving, respectively, these new vaccine methodologies for the control of" exact="influenza" post="infections. influenza virus influenza vaccines influenza inactivated vaccine (IIV)"/>
   <result pre="these new vaccine methodologies for the control of influenza infections." exact="influenza" post="virus influenza vaccines influenza inactivated vaccine (IIV) live-attenuated influenza"/>
   <result pre="vaccine methodologies for the control of influenza infections. influenza virus" exact="influenza" post="vaccines influenza inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV)"/>
   <result pre="for the control of influenza infections. influenza virus influenza vaccines" exact="influenza" post="inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV) influenza reverse"/>
   <result pre="infections. influenza virus influenza vaccines influenza inactivated vaccine (IIV) live-attenuated" exact="influenza" post="vaccine (LAIV) influenza reverse genetics recombinant influenza virus immunogenicity"/>
   <result pre="influenza vaccines influenza inactivated vaccine (IIV) live-attenuated influenza vaccine (LAIV)" exact="influenza" post="reverse genetics recombinant influenza virus immunogenicity protection efficacy 1."/>
   <result pre="vaccine (IIV) live-attenuated influenza vaccine (LAIV) influenza reverse genetics recombinant" exact="influenza" post="virus immunogenicity protection efficacy 1. Introduction 1.1. Influenza A"/>
   <result pre="is attached to galactose by an α2,3 linkage, while human" exact="influenza" post="viruses preferentially bind the sialic acid attached to galactose"/>
   <result pre="States (US), the Advisory Committee for Immunization Practices (ACIP) recommends" exact="influenza" post="vaccination every year for all persons older than six"/>
   <result pre="world by using data obtained from more than 130 national" exact="influenza" post="centers that are located in over 100 countries to"/>
   <result pre="perform the correct update of the vaccine for the following" exact="influenza" post="season [36,37]. Three types of vaccines have been approved"/>
   <result pre="for use in the human population: recombinant viral HAs, inactivated" exact="influenza" post="vaccine (IIVs), and live attenuated influenza vaccines (LAIVs) [38]."/>
   <result pre="recombinant viral HAs, inactivated influenza vaccine (IIVs), and live attenuated" exact="influenza" post="vaccines (LAIVs) [38]. The IIV, which was introduced and"/>
   <result pre="1940s, is the most common vaccine for the treatment of" exact="influenza" post="virus infections. IIVs are produced by co-infection of embryonated"/>
   <result pre="60–90% effective in preventing the morbidity and mortality associated with" exact="influenza" post="infection [44,45,46] by inducing a strong humoral immune response"/>
   <result pre="are intranasally administrated and they mimic the natural route of" exact="influenza" post="infection. They induce broader and more robust immune responses"/>
   <result pre="naive populations and provide cross-protection against heterosubtypic strains, including pandemic" exact="influenza" post="viruses. This LAIV protection profile is a highly desirable"/>
   <result pre="LAIV protection profile is a highly desirable requisite for effective" exact="influenza" post="vaccine candidates [54,55]. The strategy to produce LAIVs is"/>
   <result pre="Donor Virus (MDV) (Figure 3). The segmented nature of the" exact="influenza" post="virus genome allows for the generation of a reassortant"/>
   <result pre="avoiding viral replication in the warmer lower respiratory tract, where" exact="influenza" post="virus infection causes diseases [62]. Due to the fact"/>
   <result pre="[64]. Currently, two IAV subtypes (H1N1 and H3N2) and two" exact="influenza" post="B virus (IBV) lineages (Victoria and Yamagata) are co-circulating"/>
   <result pre="are co-circulating in humans and they are responsible for seasonal" exact="influenza" post="epidemics. The first LAIV (FluMist; MedImmune) that was approved"/>
   <result pre="LAIV Approaches to Combat Influenza Infections In the past decades," exact="influenza" post="vaccine preparation has evolved to ensure effective protection against"/>
   <result pre="should not be used during the subsequent 2016–2017 and 2017–2018" exact="influenza" post="seasons [34,86]. However, for the 2018–2019 influenza season, the"/>
   <result pre="2016–2017 and 2017–2018 influenza seasons [34,86]. However, for the 2018–2019" exact="influenza" post="season, the use of the LAIV has again been"/>
   <result pre="has several advantages over the IIV for the control of" exact="influenza" post="viral infections. These include, among others, the intranasal route"/>
   <result pre="and production for the treatment of seasonal and potential pandemic" exact="influenza" post="viral infections in humans. 1.4. Reverse Genetics Techniques for"/>
   <result pre="of Novel Influenza Vaccines Because of the changing nature of" exact="influenza" post="virus, vaccine production to develop high-yield strains as vaccine"/>
   <result pre="high-yield strains as vaccine components is a constant challenge. Manufacturing" exact="influenza" post="vaccines usually take around four to five months to"/>
   <result pre="into research has advanced our understanding of the biology of" exact="influenza" post="virus, including the mechanisms that are involved in viral"/>
   <result pre="Reverse genetics strategies have also enabled the modification of the" exact="influenza" post="viral genome to generate recombinant viruses expressing foreign proteins"/>
   <result pre="plasmid-based reverse genetics approaches have been developed to generate recombinant" exact="influenza" post="viruses [114]. Currently, the most common method delivers eight"/>
   <result pre="Currently, the generation of recombinant viruses for the development of" exact="influenza" post="vaccines for human use in the US and Europe"/>
   <result pre="[118,119,120,121,122]. Although the FDA approved the cell-based production method of" exact="influenza" post="vaccines in 2012, the global-scale infrastructure for manufacturing the"/>
   <result pre="the global-scale infrastructure for manufacturing the required amount of cell-based" exact="influenza" post="vaccines does not currently exist [123]. In fact, the"/>
   <result pre="does not currently exist [123]. In fact, the majority of" exact="influenza" post="vaccines that are currently commercialized by licensed manufactures are"/>
   <result pre="[124]. One of the reasons why the traditional method for" exact="influenza" post="vaccine production by co-infection of using chicken embryonated eggs"/>
   <result pre="aspect for the vaccine manufacturing process [40,125]. Unfortunately, most current" exact="influenza" post="viruses do not grow well in eggs and this"/>
   <result pre="this affects the efficiency of the traditional reassortment method. Therefore," exact="influenza" post="plasmid-based reverse genetics (Figure 4) represent a better, faster,"/>
   <result pre="approaches represent an excellent alternative to the traditional method for" exact="influenza" post="vaccine production and it might become the method of"/>
   <result pre="of the viral NS1 protein to protect against H3N8 canine" exact="influenza" post="virus (CIV) [138]. Interestingly, in vitro, these viruses replicated"/>
   <result pre="of the virus in vivo in a mouse model of" exact="influenza" post="infection and ex vivo in canine tracheal explants, with"/>
   <result pre="develop a platform to allow for the efficient growth of" exact="influenza" post="H3 subtypes in eggs, the authors also generated viruses"/>
   <result pre="vaccine candidates for their safe implementation as immunogenic and protective" exact="influenza" post="vaccines. 2.4. LAIVs Based on the Modification of the"/>
   <result pre="be used to develop both monovalent and/or bivalent vaccines against" exact="influenza" post="strains or different respiratory pathogens. In order to study"/>
   <result pre="pathogenic human or avian IAVs, such as the 1918 Spanish" exact="influenza" post="(A/Brevig Mission/18 H1N1) and HPAIV (A/Vietnam/1203/04 H5N1) [106]. In"/>
   <result pre="antigen from another pathogen, Masic et al. generated a swine" exact="influenza" post="virus (SIV) by fusing the H3 HA ectodomain from"/>
   <result pre="a monovalent M2SR-based LAIV based on 5 gene segments from" exact="influenza" post="PR8 and the HA and NA glycoproteins from an"/>
   <result pre="the primary and most cost-effective strategy to prevent and control" exact="influenza" post="infections in human and animal populations. The continued evaluation"/>
   <result pre="continued evaluation of the safety, immunogenicity, and effectiveness of seasonal" exact="influenza" post="vaccines is needed to ensure low rates of influenza"/>
   <result pre="seasonal influenza vaccines is needed to ensure low rates of" exact="influenza" post="infection among children and adults. However, efforts should be"/>
   <result pre="provide better protection than their IIV counterparts. However, in past" exact="influenza" post="seasons, a suboptimal protection was observed mainly against the"/>
   <result pre="Although the LAIV was approved for use during the 2018–2019" exact="influenza" post="season, the reduced effectiveness of the quadrivalent LAIV remains"/>
   <result pre="of preventing or ameliorating the effects of seasonal and/or pandemic" exact="influenza" post="by providing broader and more long-lasting immune protection than"/>
   <result pre="strategic plan that was recently proposed for developing a universal" exact="influenza" post="vaccine [224]. This universal vaccine should be at least"/>
   <result pre="update on the progress that has been made in the" exact="influenza" post="vaccination field in the last five years to improve"/>
   <result pre="We want to thank all the work conducted by the" exact="influenza" post="researchers reference in this document that has contributed to"/>
   <result pre="a new approach for the development of LAIV. Research on" exact="influenza" post="in our laboratory is partially supported by the New"/>
   <result pre="the viral life cycleYale J. Biol. Med.20098215315920027280 5.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826Suppl. 4D49D5310.1016/j.vaccine.2008.07.03919230160 6.NeumannG.BrownleeG.G.FodorE.KawaokaY.Orthomyxovirus replication, transcription, and polyadenylationCurr. Top. Microbiol."/>
   <result pre="replication, transcription, and polyadenylationCurr. Top. Microbiol. Immunol.200428312114315298169 7.FujiiY.GotoH.WatanabeT.YoshidaT.KawaokaY.Selective incorporation of" exact="influenza" post="virus RNA segments into virionsProc. Natl. Acad. Sci. USA20031002002200710.1073/pnas.043777210012574509"/>
   <result pre="8.ImaiM.KawaokaY.The role of receptor binding specificity in interspecies transmission of" exact="influenza" post="virusesCurr. Opin. Virol.2012216016710.1016/j.coviro.2012.03.00322445963 9.NichollsJ.M.ChanR.W.RussellR.J.AirG.M.PeirisJ.S.Evolving complexities of influenza virus and"/>
   <result pre="interspecies transmission of influenza virusesCurr. Opin. Virol.2012216016710.1016/j.coviro.2012.03.00322445963 9.NichollsJ.M.ChanR.W.RussellR.J.AirG.M.PeirisJ.S.Evolving complexities of" exact="influenza" post="virus and its receptorsTrends Microbiol.20081614915710.1016/j.tim.2008.01.00818375125 10.HarrisonS.C.Viral membrane fusionNat. Struct."/>
   <result pre="its receptorsTrends Microbiol.20081614915710.1016/j.tim.2008.01.00818375125 10.HarrisonS.C.Viral membrane fusionNat. Struct. Mol. Biol.20081569069810.1038/nsmb.145618596815 11.Resa-InfanteP.JorbaN.ColomaR.OrtinJ.The" exact="influenza" post="virus RNA synthesis machine: Advances in its structure and"/>
   <result pre="13.WiseH.M.HutchinsonE.C.JaggerB.W.StuartA.D.KangZ.H.RobbN.SchwartzmanL.M.KashJ.C.FodorE.FirthA.E.et al.Identification of a novel splice variant form of the" exact="influenza" post="A virus M2 ion channel with an antigenically distinct"/>
   <result pre="with an antigenically distinct ectodomainPLoS Pathog.20128e100299810.1371/journal.ppat.100299823133386 14.PatersonD.FodorE.Emerging roles for the" exact="influenza" post="A virus nuclear export protein (NEP)PLoS Pathog.20128e100301910.1371/journal.ppat.100301923236273 15.HaiR.SchmolkeM.VargaZ.T.ManicassamyB.WangT.T.BelserJ.A.PearceM.B.Garcia-SastreA.TumpeyT.M.PaleseP.PB1-F2 expression"/>
   <result pre="protein (NEP)PLoS Pathog.20128e100301910.1371/journal.ppat.100301923236273 15.HaiR.SchmolkeM.VargaZ.T.ManicassamyB.WangT.T.BelserJ.A.PearceM.B.Garcia-SastreA.TumpeyT.M.PaleseP.PB1-F2 expression by the 2009 pandemic H1N1" exact="influenza" post="virus has minimal impact on virulence in animal modelsJ."/>
   <result pre="in animal modelsJ. Virol.2010844442445010.1128/JVI.02717-0920181699 16.JaggerB.W.WiseH.M.KashJ.C.WaltersK.A.WillsN.M.XiaoY.L.DunfeeR.L.SchwartzmanL.M.OzinskyA.BellG.L.et al.An overlapping protein-coding region in" exact="influenza" post="A virus segment 3 modulates the host responseScience201233719920410.1126/science.122221322745253 17.ShimizuT.TakizawaN.WatanabeK.NagataK.KobayashiN.Crucial"/>
   <result pre="segment 3 modulates the host responseScience201233719920410.1126/science.122221322745253 17.ShimizuT.TakizawaN.WatanabeK.NagataK.KobayashiN.Crucial role of the" exact="influenza" post="virus NS2 (NEP) C-terminal domain in M1 binding and"/>
   <result pre="and nuclear export of vRNPFEBS Lett.2011585414610.1016/j.febslet.2010.11.01721081124 18.PohlM.O.LanzC.StertzS.Late stages of the" exact="influenza" post="A virus replication cycle—A tight interplay between virus and"/>
   <result pre="and assembly of viral membrane proteinsVirology199319354556210.1006/viro.1993.11648460475 20.GerberM.IselC.MoulesV.MarquetR.Selective packaging of the" exact="influenza" post="A genome and consequences for genetic reassortmentTrends Microbiol.20142244645510.1016/j.tim.2014.04.00124798745 21.RossmanJ.S.LambR.A.Influenza"/>
   <result pre="membrane scissionCell201014290291310.1016/j.cell.2010.08.02920850012 23.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic and antigenic sites in" exact="influenza" post="virus neuraminidaseNature1983303414410.1038/303041a06188957 24.TisoncikJ.R.GuoY.CorderoK.S.YuJ.WangJ.CaoY.RongL.Identification of critical residues of influenza neuraminidase"/>
   <result pre="sites in influenza virus neuraminidaseNature1983303414410.1038/303041a06188957 24.TisoncikJ.R.GuoY.CorderoK.S.YuJ.WangJ.CaoY.RongL.Identification of critical residues of" exact="influenza" post="neuraminidase in viral particle releaseVirol. J.201181410.1186/1743-422X-8-1421232128 25.ThompsonW.W.ShayD.K.WeintraubE.BrammerL.BridgesC.B.CoxN.J.FukudaK.Influenza-associated hospitalizations in"/>
   <result pre="for why some countries were harder hit by the pandemic" exact="influenza" post="virus in 2009—A global mortality impact modeling studyBMC Infect."/>
   <result pre="impact modeling studyBMC Infect. Dis.20171764210.1186/s12879-017-2730-028946870 29.MolinariN.A.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the US: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 30.DorratoltajN.MaratheA.LewisB.L.SwarupS.EubankS.G.AbbasK.M.Epidemiological"/>
   <result pre="disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 30.DorratoltajN.MaratheA.LewisB.L.SwarupS.EubankS.G.AbbasK.M.Epidemiological and economic impact of pandemic" exact="influenza" post="in Chicago: Priorities for vaccine interventionsPLoS Comput. Biol.201713e100552110.1371/journal.pcbi.100552128570660 31.MostafaA.AbdelwhabE.M.MettenleiterT.C.PleschkaS.Zoonotic"/>
   <result pre="VaccinesMMWR Recomm. Rep.20166515410.15585/mmwr.rr6505a127560619 35.HampsonA.BarrI.CoxN.DonisR.O.SiddhivinayakH.JerniganD.KatzJ.McCauleyJ.MottaF.OdagiriT.et al.Improving the selection and development of" exact="influenza" post="vaccine viruses—Report of a WHO informal consultation on improving"/>
   <result pre="influenza vaccine viruses—Report of a WHO informal consultation on improving" exact="influenza" post="vaccine virus selection, Hong Kong SAR, China, 18–20 November"/>
   <result pre="selection and recent studies on the global migration of seasonal" exact="influenza" post="virusesVaccine200826Suppl. 4D31D3410.1016/j.vaccine.2008.07.07819230156 38.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of influenza control through"/>
   <result pre="migration of seasonal influenza virusesVaccine200826Suppl. 4D31D3410.1016/j.vaccine.2008.07.07819230156 38.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of" exact="influenza" post="control through vaccination: From the first monovalent vaccine to"/>
   <result pre="Influenza Virus in Chick EmbryosJ. Exp. Med.19447917318310.1084/jem.79.2.17319871361 40.WongS.S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 41.CoxR.J.BrokstadK.A.OgraP.Influenza virus: Immunity and vaccination strategies."/>
   <result pre="Comparison of the immune response to inactivated and live, attenuated" exact="influenza" post="vaccinesScand. J. Immunol.20045911510.1111/j.0300-9475.2004.01382.x14723616 42.LaverW.G.WebsterR.G.Preparation and immunogenicity of an influenza"/>
   <result pre="attenuated influenza vaccinesScand. J. Immunol.20045911510.1111/j.0300-9475.2004.01382.x14723616 42.LaverW.G.WebsterR.G.Preparation and immunogenicity of an" exact="influenza" post="virus hemagglutinin and neuraminidase subunit vaccineVirology19766951152210.1016/0042-6822(76)90481-51258359 43.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok, a recombinant"/>
   <result pre="virus hemagglutinin and neuraminidase subunit vaccineVirology19766951152210.1016/0042-6822(76)90481-51258359 43.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok, a recombinant hemagglutinin" exact="influenza" post="vaccineInfluenza Other Respir. Viruses2008221121910.1111/j.1750-2659.2008.00053.x19453397 44.BeyerW.E.PalacheA.M.de JongJ.C.OsterhausA.D.Cold-adapted live influenza vaccine"/>
   <result pre="recombinant hemagglutinin influenza vaccineInfluenza Other Respir. Viruses2008221121910.1111/j.1750-2659.2008.00053.x19453397 44.BeyerW.E.PalacheA.M.de JongJ.C.OsterhausA.D.Cold-adapted live" exact="influenza" post="vaccine versus inactivated vaccine: Systemic vaccine reactions, local and"/>
   <result pre="and vaccine efficacy. A meta-analysisVaccine2002201340135310.1016/S0264-410X(01)00471-611818152 45.KatayoseM.HosoyaM.HanedaT.YamaguchiH.KawasakiY.SatoM.WrightP.F.The effectiveness of trivalent inactivated" exact="influenza" post="vaccine in children over six consecutive influenza seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness"/>
   <result pre="of trivalent inactivated influenza vaccine in children over six consecutive" exact="influenza" post="seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness of seasonal influenza vaccines in children—A systematic"/>
   <result pre="in children over six consecutive influenza seasonsVaccine2011291844184910.1016/j.vaccine.2010.12.04921195802 46.LuksicI.ClayS.FalconerR.PulanicD.RudanI.CampbellH.NairH.Effectiveness of seasonal" exact="influenza" post="vaccines in children—A systematic review and meta-analysisCroat Med. J.20135413514510.3325/cmj.2013.54.13523630141"/>
   <result pre="review and meta-analysisCroat Med. J.20135413514510.3325/cmj.2013.54.13523630141 47.CoxR.J.BrokstadK.A.The postvaccination antibody response to" exact="influenza" post="virus proteinsAPMIS199910728929610.1111/j.1699-0463.1999.tb01556.x10223301 48.SalettiG.GerlachT.RimmelzwaanG.F.Influenza vaccines: ‘tailor-made’ or ‘one fits all’Curr."/>
   <result pre="of T cell receptor repertoire in response to subunit inactivated" exact="influenza" post="vaccineVaccine2018361599160510.1016/j.vaccine.2018.02.02729454515 50.HoftD.F.LottenbachK.R.BlazevicA.TuranA.BlevinsT.P.PacatteT.P.YuY.MitchellM.C.HoftS.G.BelsheR.B.Comparisons of the Humoral and Cellular Immune Responses"/>
   <result pre="Immunol.20172410.1128/CVI.00414-16 51.ForrestB.D.PrideM.W.DunningA.J.CapedingM.R.ChotpitayasunondhT.TamJ.S.RappaportR.EldridgeJ.H.GruberW.C.Correlation of cellular immune responses with protection against culture-confirmed" exact="influenza" post="virus in young childrenClin. Vaccine Immunol.2008151042105310.1128/CVI.00397-0718448618 52.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and"/>
   <result pre="virus in young childrenClin. Vaccine Immunol.2008151042105310.1128/CVI.00397-0718448618 52.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and inactivated" exact="influenza" post="vaccines induce similar humoral responses, but only live vaccines"/>
   <result pre="antibody and T-cell responses elicited by licensed inactivated- and live-attenuated" exact="influenza" post="vaccines against H3N2 hemagglutininHum. Immunol.20117246346910.1016/j.humimm.2011.03.00121414368 55.ChengX.ZengelJ.R.SuguitanA.L.Jr.XuQ.WangW.LinJ.JinH.Evaluation of the humoral"/>
   <result pre="cellular immune responses elicited by the live attenuated and inactivated" exact="influenza" post="vaccines and their roles in heterologous protection in ferretsJ."/>
   <result pre="Dis.201320859460210.1093/infdis/jit20723656978 56.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
   <result pre="flu vaccineAm. Soc. Microbiol. News200369426427 58.MaassabH.F.Adaptation and growth characteristics of" exact="influenza" post="virus at 25 degrees CNature196721361261410.1038/213612a06040602 59.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes"/>
   <result pre="CNature196721361261410.1038/213612a06040602 59.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 60.MurphyB.R.CoelinghK.Principles underlying the development"/>
   <result pre="60.MurphyB.R.CoelinghK.Principles underlying the development and use of live attenuated cold-adapted" exact="influenza" post="A and B virus vaccinesViral Immunol.20021529532310.1089/0882824026006624212081014 61.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a"/>
   <result pre="B virus vaccinesViral Immunol.20021529532310.1089/0882824026006624212081014 61.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated" exact="influenza" post="virus that permits in vivo analysis of enhancements to"/>
   <result pre="vivo analysis of enhancements to the safety of live attenuated" exact="influenza" post="virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 62.AbramsonJ.S.Intranasal, cold-adapted, live, attenuated influenza vaccinePediatr."/>
   <result pre="live attenuated influenza virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 62.AbramsonJ.S.Intranasal, cold-adapted, live, attenuated" exact="influenza" post="vaccinePediatr. Infect. Dis. J.1999181103110410.1097/00006454-199912000-0001710608635 63.JinH.ChenZ.Production of live attenuated influenza"/>
   <result pre="attenuated influenza vaccinePediatr. Infect. Dis. J.1999181103110410.1097/00006454-199912000-0001710608635 63.JinH.ChenZ.Production of live attenuated" exact="influenza" post="vaccines against seasonal and potential pandemic influenza virusesCurr. Opin."/>
   <result pre="of live attenuated influenza vaccines against seasonal and potential pandemic" exact="influenza" post="virusesCurr. Opin. Virol.20146343910.1016/j.coviro.2014.02.00824705137 64.SongJ.H.NguyenH.H.CuburuN.HorimotoT.KoS.Y.ParkS.H.CzerkinskyC.KweonM.N.Sublingual vaccination with influenza virus protects"/>
   <result pre="and potential pandemic influenza virusesCurr. Opin. Virol.20146343910.1016/j.coviro.2014.02.00824705137 64.SongJ.H.NguyenH.H.CuburuN.HorimotoT.KoS.Y.ParkS.H.CzerkinskyC.KweonM.N.Sublingual vaccination with" exact="influenza" post="virus protects mice against lethal viral infectionProc. Natl. Acad."/>
   <result pre="Acad. Sci. USA20081051644164910.1073/pnas.070868410518227512 65.ZielinskiM.R.SouzaG.TaishiP.BohnetS.G.KruegerJ.M.Olfactory bulb and hypothalamic acute-phase responses to" exact="influenza" post="virus: Effects of immunizationNeuroimmunomodulation20132032333310.1159/00035171623948712 66.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation influenza"/>
   <result pre="to influenza virus: Effects of immunizationNeuroimmunomodulation20132032333310.1159/00035171623948712 66.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation" exact="influenza" post="vaccines: Recipes for success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 67.TalbotT.R.CrockerD.D.PetersJ.DoersamJ.K.IkizlerM.R.SannellaE.WrightP.E.EdwardsK.M.Duration of virus shedding after"/>
   <result pre="success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 67.TalbotT.R.CrockerD.D.PetersJ.DoersamJ.K.IkizlerM.R.SannellaE.WrightP.E.EdwardsK.M.Duration of virus shedding after trivalent intranasal live attenuated" exact="influenza" post="vaccination in adultsInfect. Control Hosp. Epidemiol.20052649450010.1086/50257415954490 68.CarterN.J.CurranM.P.Live attenuated influenza"/>
   <result pre="attenuated influenza vaccination in adultsInfect. Control Hosp. Epidemiol.20052649450010.1086/50257415954490 68.CarterN.J.CurranM.P.Live attenuated" exact="influenza" post="vaccine (FluMist(R); Fluenz): A review of its use in"/>
   <result pre="A review of its use in the prevention of seasonal" exact="influenza" post="in children and adultsDrugs2011711591162210.2165/11206860-000000000-0000021861544 69.RhorerJ.AmbroseC.S.DickinsonS.HamiltonH.OlekaN.A.MalinoskiF.J.WittesJ.Efficacy of live attenuated influenza"/>
   <result pre="seasonal influenza in children and adultsDrugs2011711591162210.2165/11206860-000000000-0000021861544 69.RhorerJ.AmbroseC.S.DickinsonS.HamiltonH.OlekaN.A.MalinoskiF.J.WittesJ.Efficacy of live attenuated" exact="influenza" post="vaccine in children: A meta-analysis of nine randomized clinical"/>
   <result pre="cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated" exact="influenza" post="FluMist vaccinesVirology200838035436210.1016/j.virol.2008.08.01018804834 72.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of influenza with"/>
   <result pre="live attenuated influenza FluMist vaccinesVirology200838035436210.1016/j.virol.2008.08.01018804834 72.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of" exact="influenza" post="with vaccines: Recommendations of the Advisory Committee on Immunization"/>
   <result pre="Vaccine EffectivenessVaccines201862810.3390/vaccines602002829883414 75.ManzoliL.IoannidisJ.P.FlaccoM.E.De VitoC.VillariP.Effectiveness and harms of seasonal and pandemic" exact="influenza" post="vaccines in children, adults and elderly: A critical review"/>
   <result pre="15 meta-analysesHum. Vaccines Immunother.2012885186210.4161/hv.1991722777099 76.WilsonI.A.CoxN.J.Structural basis of immune recognition of" exact="influenza" post="virus hemagglutininAnnu. Rev. Immunol.1990873777110.1146/annurev.iy.08.040190.0035132188678 77.SinganayagamA.ZambonM.LalvaniA.BarclayW.Urgent challenges in implementing live"/>
   <result pre="virus hemagglutininAnnu. Rev. Immunol.1990873777110.1146/annurev.iy.08.040190.0035132188678 77.SinganayagamA.ZambonM.LalvaniA.BarclayW.Urgent challenges in implementing live attenuated" exact="influenza" post="vaccineLancet Infect. Dis.201818e25e3210.1016/S1473-3099(17)30360-228780285 78.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of influenza vaccines:"/>
   <result pre="live attenuated influenza vaccineLancet Infect. Dis.201818e25e3210.1016/S1473-3099(17)30360-228780285 78.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 79.AmbroseC.S.LevinM.J.BelsheR.B.The"/>
   <result pre="Dis.201212364410.1016/S1473-3099(11)70295-X22032844 79.AmbroseC.S.LevinM.J.BelsheR.B.The relative efficacy of trivalent live attenuated and inactivated" exact="influenza" post="vaccines in children and adultsInfluenza Other. Respir. Viruses20115677510.1111/j.1750-2659.2010.00183.x21306569 80.JeffersonT.RivettiA.Di"/>
   <result pre="children and adultsInfluenza Other. Respir. Viruses20115677510.1111/j.1750-2659.2010.00183.x21306569 80.JeffersonT.RivettiA.Di PietrantonjC.DemicheliV.FerroniE.Vaccines for preventing" exact="influenza" post="in healthy childrenCochrane Database Syst. Rev.2008CD00487910.1002/14651858.CD004879.pub418425905 81.ChungJ.R.FlanneryB.ThompsonM.G.GaglaniM.JacksonM.L.MontoA.S.NowalkM.P.TalbotH.K.TreanorJ.J.BelongiaE.A.et al.Seasonal Effectiveness"/>
   <result pre="Live Attenuated and Inactivated Influenza VaccinePediatrics2016137e2015327910.1542/peds.2015-327926738884 82.McLeanH.Q.CaspardH.GriffinM.R.PoehlingK.A.GaglaniM.BelongiaE.A.TalbotH.K.PetersT.R.MurthyK.AmbroseC.S.Effectiveness of live attenuated" exact="influenza" post="vaccine and inactivated influenza vaccine in children during the"/>
   <result pre="Influenza VaccinePediatrics2016137e2015327910.1542/peds.2015-327926738884 82.McLeanH.Q.CaspardH.GriffinM.R.PoehlingK.A.GaglaniM.BelongiaE.A.TalbotH.K.PetersT.R.MurthyK.AmbroseC.S.Effectiveness of live attenuated influenza vaccine and inactivated" exact="influenza" post="vaccine in children during the 2014–2015 seasonVaccine2017352685269310.1016/j.vaccine.2017.03.08528408121 83.PoehlingK.A.CaspardH.PetersT.R.BelongiaE.A.CongeniB.GaglaniM.GriffinM.R.IrvingS.A.KavathekarP.K.McLeanH.Q.et al.2015-2016"/>
   <result pre="States, 2018–19 Influenza SeasonMMWR Morb. Mortal. Wkly. Rep.20186764364510.15585/mmwr.mm6722a529879095 88.PebodyR.McMenaminJ.NohynekH.Live attenuated" exact="influenza" post="vaccine (LAIV): Recent effectiveness results from the USA and"/>
   <result pre="the editor: Potential causes of the decreased effectiveness of the" exact="influenza" post="A(H1N1)pdm09 strain in live attenuated influenza vaccinesEurosurveill2016213039410.2807/1560-7917.ES.2016.21.45.30394 90.SridharS.BegomS.BerminghamA.HoschlerK.AdamsonW.CarmanW.BeanT.BarclayW.DeeksJ.J.LalvaniA.Cellular immune"/>
   <result pre="decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated" exact="influenza" post="vaccinesEurosurveill2016213039410.2807/1560-7917.ES.2016.21.45.30394 90.SridharS.BegomS.BerminghamA.HoschlerK.AdamsonW.CarmanW.BeanT.BarclayW.DeeksJ.J.LalvaniA.Cellular immune correlates of protection against symptomatic pandemic"/>
   <result pre="Med.2013191305131210.1038/nm.335024056771 91.ElderfieldR.A.WatsonS.J.GodleeA.AdamsonW.E.ThompsonC.I.DunningJ.Fernandez-AlonsoM.BlumenkrantzD.HussellT.InvestigatorsM.et al.Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09" exact="influenza" post="virus in humans in the United KingdomJ. Virol.201488132691328310.1128/JVI.01636-1425210166 92.RussierM.YangG.RehgJ.E.WongS.S.MostafaH.H.FabrizioT.P.BarmanS.KraussS.WebsterR.G.WebbyR.J.et"/>
   <result pre="the United KingdomJ. Virol.201488132691328310.1128/JVI.01636-1425210166 92.RussierM.YangG.RehgJ.E.WongS.S.MostafaH.H.FabrizioT.P.BarmanS.KraussS.WebsterR.G.WebbyR.J.et al.Molecular requirements for a pandemic" exact="influenza" post="virus: An acid-stable hemagglutinin proteinProc. Natl. Acad. Sci. USA20161131636164110.1073/pnas.152438411326811446"/>
   <result pre="and thermal stability of the hemagglutinin of pandemic live attenuated" exact="influenza" post="virus vaccinesJ. Virol.201488123741238410.1128/JVI.01107-1425122789 94.LaurieK.L.GuarnacciaT.A.CarolanL.A.YanA.W.AbanM.PetrieS.CaoP.HeffernanJ.M.McVernonJ.MosseJ.et al.Interval Between Infections and Viral"/>
   <result pre="95.CaspardH.CoelinghK.L.MalloryR.M.AmbroseC.S.Association of vaccine handling conditions with effectiveness of live attenuated" exact="influenza" post="vaccine against H1N1pdm09 viruses in the United StatesVaccine2016345066507210.1016/j.vaccine.2016.08.07927613072 96.GouldP.S.EastonA.J.DimmockN.J.Live"/>
   <result pre="Virol.20179110.1128/JVI.02211-1627928017 100.FriedeM.PalkonyayL.AlfonsoC.PervikovY.TorelliG.WoodD.KienyM.P.WHO initiative to increase global and equitable access to" exact="influenza" post="vaccine in the event of a pandemic: Supporting developing"/>
   <result pre="production capacity through technology transferVaccine201129Suppl. 1A2A710.1016/j.vaccine.2011.02.07921684422 101.BurgessT.H.MurrayC.K.BavaroM.F.LandrumM.L.O’BryanT.A.RosasJ.G.CammarataS.M.MartinN.J.EwingD.RaviprakashK.et al.Self-administration of intranasal" exact="influenza" post="vaccine: Immunogenicity and volunteer acceptanceVaccine2015333894389910.1016/j.vaccine.2015.06.06126117150 102.BakerS.F.NogalesA.FinchC.TuffyK.M.DommW.PerezD.R.TophamD.J.Martinez-SobridoL.Influenza A and B"/>
   <result pre="reassortment through compatible viral packaging signalsJ. Virol.201488107781079110.1128/JVI.01440-1425008914 103.JacksonD.ElderfieldR.A.BarclayW.S.Molecular studies of" exact="influenza" post="B virus in the reverse genetics eraJ. Gen. Virol.20119211710.1099/vir.0.026187-020926635"/>
   <result pre="in the reverse genetics eraJ. Gen. Virol.20119211710.1099/vir.0.026187-020926635 104.Martinez-SobridoL.Garcia-SastreA.Generation of recombinant" exact="influenza" post="virus from plasmid DNAJ. Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to"/>
   <result pre="from plasmid DNAJ. Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to make an" exact="influenza" post="virus—Review of influenza virus reverse genetics methodsInfluenza Other. Respir."/>
   <result pre="Vis. Exp.201010.3791/205720729804 105.EngelhardtO.G.Many ways to make an influenza virus—Review of" exact="influenza" post="virus reverse genetics methodsInfluenza Other. Respir. Viruses2013724925610.1111/j.1750-2659.2012.00392.x22712782 106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green"/>
   <result pre="reverse genetics methodsInfluenza Other. Respir. Viruses2013724925610.1111/j.1750-2659.2012.00392.x22712782 106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green fluorescent protein-expressing" exact="influenza" post="viruses for the detection of influenza virus neutralizing antibodiesJ."/>
   <result pre="106.Martinez-SobridoL.CadaganR.SteelJ.BaslerC.F.PaleseP.MoranT.M.Garcia-SastreA.Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of" exact="influenza" post="virus neutralizing antibodiesJ. Virol.2010842157216310.1128/JVI.01433-0919939917 107.NogalesA.BakerS.F.DommW.Martinez-SobridoL.Development and applications of single-cycle"/>
   <result pre="virus neutralizing antibodiesJ. Virol.2010842157216310.1128/JVI.01433-0919939917 107.NogalesA.BakerS.F.DommW.Martinez-SobridoL.Development and applications of single-cycle infectious" exact="influenza" post="A virus (sciIAV)Virus Res.2016216264010.1016/j.virusres.2015.07.01326220478 108.NogalesA.BakerS.F.Martinez-SobridoL.Replication-competent influenza A viruses expressing"/>
   <result pre="applications of single-cycle infectious influenza A virus (sciIAV)Virus Res.2016216264010.1016/j.virusres.2015.07.01326220478 108.NogalesA.BakerS.F.Martinez-SobridoL.Replication-competent" exact="influenza" post="A viruses expressing a red fluorescent proteinVirology201547620621610.1016/j.virol.2014.12.00625553516 109.BreenM.NogalesA.BakerS.F.Martinez-SobridoL.Replication-Competent Influenza"/>
   <result pre="In Vitro and In Vivo StudiesPLoS ONE201611e014772310.1371/journal.pone.014772326809059 111.RodriguezL.NogalesA.MurciaP.R.ParrishC.R.Martinez-SobridoL.A bivalent live-attenuated" exact="influenza" post="vaccine for the control and prevention of H3N8 and"/>
   <result pre="for the control and prevention of H3N8 and H3N2 canine" exact="influenza" post="virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine"/>
   <result pre="of H3N8 and H3N2 canine influenza virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a"/>
   <result pre="influenza virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 112.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine influenza virus live-attenuated"/>
   <result pre="for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 113.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine" exact="influenza" post="virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 114.NogalesA.Martinez-SobridoL.Reverse Genetics Approaches for the Development"/>
   <result pre="J. Mol. Sci.2016182010.3390/ijms1801002028025504 115.HoffmannE.NeumannG.KawaokaY.HobomG.WebsterR.G.A DNA transfection system for generation of" exact="influenza" post="A virus from eight plasmidsProc. Natl. Acad. Sci. USA2000976108611310.1073/pnas.10013369710801978"/>
   <result pre="Natl. Acad. Sci. USA2000976108611310.1073/pnas.10013369710801978 116.HoffmannE.NeumannG.HobomG.WebsterR.G.KawaokaY.&quot;Ambisense�? approach for the generation of" exact="influenza" post="A virus: vRNA and mRNA synthesis from one templateVirology200026731031710.1006/viro.1999.014010662626"/>
   <result pre="Viruses by Reverse GeneticsWHOGeneva, Switzerland2005 118.PerdueM.L.ArnoldF.LiS.DonabedianA.CioceV.WarfT.HuebnerR.The future of cell culture-based" exact="influenza" post="vaccine productionExpert Rev. Vaccines2011101183119410.1586/erv.11.8221854311 119.HegdeN.R.Cell culture-based influenza vaccines: A"/>
   <result pre="of cell culture-based influenza vaccine productionExpert Rev. Vaccines2011101183119410.1586/erv.11.8221854311 119.HegdeN.R.Cell culture-based" exact="influenza" post="vaccines: A necessary and indispensable investment for the futureHum."/>
   <result pre="Methods2013193284110.1016/j.jviromet.2013.04.02023684847 123.HardingA.T.HeatonN.S.Efforts to Improve the Seasonal Influenza VaccineVaccines201861910.3390/vaccines6020019 124.BarrI.G.DonisR.O.KatzJ.M.McCauleyJ.W.OdagiriT.TrusheimH.TsaiT.F.WentworthD.E.Cell culture-derived" exact="influenza" post="vaccines in the severe 2017–2018 epidemic season: A step"/>
   <result pre="in the severe 2017–2018 epidemic season: A step towards improved" exact="influenza" post="vaccine effectivenessNPJ Vaccines201834410.1038/s41541-018-0079-z30323955 125.FulviniA.A.RamanunninairM.LeJ.PokornyB.A.ArroyoJ.M.SilvermanJ.DevisR.BucherD.Gene constellation of influenza A virus"/>
   <result pre="step towards improved influenza vaccine effectivenessNPJ Vaccines201834410.1038/s41541-018-0079-z30323955 125.FulviniA.A.RamanunninairM.LeJ.PokornyB.A.ArroyoJ.M.SilvermanJ.DevisR.BucherD.Gene constellation of" exact="influenza" post="A virus reassortants with high growth phenotype prepared as"/>
   <result pre="seed candidates for vaccine productionPLoS ONE20116e2082310.1371/journal.pone.002082321695145 126.Del GiudiceG.RappuoliR.Inactivated and adjuvanted" exact="influenza" post="vaccinesCurr. Top. Microbiol. Immunol.201538615118010.1007/82_2014_40625038938 127.NicolsonC.MajorD.WoodJ.M.RobertsonJ.S.Generation of influenza vaccine viruses"/>
   <result pre="GiudiceG.RappuoliR.Inactivated and adjuvanted influenza vaccinesCurr. Top. Microbiol. Immunol.201538615118010.1007/82_2014_40625038938 127.NicolsonC.MajorD.WoodJ.M.RobertsonJ.S.Generation of" exact="influenza" post="vaccine viruses on Vero cells by reverse genetics: An"/>
   <result pre="for delayed selection intensifyNat. Med.20152129729810.1038/nm0415-29725849262 130.HaleB.G.RandallR.E.OrtinJ.JacksonD.The multifunctional NS1 protein of" exact="influenza" post="A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 131.TisoncikJ.R.BillharzR.BurmakinaS.BelisleS.E.ProllS.C.KorthM.J.Garcia-SastreA.KatzeM.G.The NS1 protein of influenza"/>
   <result pre="of influenza A virusesJ. Gen. Virol.2008892359237610.1099/vir.0.2008/004606-018796704 131.TisoncikJ.R.BillharzR.BurmakinaS.BelisleS.E.ProllS.C.KorthM.J.Garcia-SastreA.KatzeM.G.The NS1 protein of" exact="influenza" post="A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome"/>
   <result pre="Restores Its Ability to Inhibit Host Gene ExpressionJ. Virol.20179110.1128/JVI.00877-1728835506 138.NogalesA.HuangK.ChaucheC.DeDiegoM.L.MurciaP.R.ParrishC.R.Martinez-SobridoL.Canine" exact="influenza" post="viruses with modified NS1 proteins for the development of"/>
   <result pre="in interferon-deficient systemsVirology199825232433010.1006/viro.1998.95089878611 143.FalconA.M.Fernandez-SesmaA.NakayaY.MoranT.M.OrtinJ.Garcia-SastreA.Attenuation and immunogenicity in mice of temperature-sensitive" exact="influenza" post="viruses expressing truncated NS1 proteinsJ. Gen. Virol.2005862817282110.1099/vir.0.80991-016186237 144.ChenC.FanW.LiJ.ZhengW.ZhangS.YangL.LiuD.LiuW.SunL.A Promising"/>
   <result pre="Influenza Vaccine VirusFront. Cell. Infect. Microbiol.2018812710.3389/fcimb.2018.0012729765910 145.LambR.A.ChoppinP.W.Segment 8 of the" exact="influenza" post="virus genome is unique in coding for two polypeptidesProc."/>
   <result pre="for two polypeptidesProc. Natl. Acad. Sci. USA1979764908491210.1073/pnas.76.10.4908291907 146.QuinlivanM.ZamarinD.Garcia-SastreA.CullinaneA.ChambersT.PaleseP.Attenuation of equine" exact="influenza" post="viruses through truncations of the NS1 proteinJ. Virol.2005798431843910.1128/JVI.79.13.8431-8439.200515956587 147.RichtJ.A.LekcharoensukP.LagerK.M.VincentA.L.LoiaconoC.M.JankeB.H.WuW.H.YoonK.J.WebbyR.J.SolorzanoA.et"/>
   <result pre="the NS1 proteinJ. Virol.2005798431843910.1128/JVI.79.13.8431-8439.200515956587 147.RichtJ.A.LekcharoensukP.LagerK.M.VincentA.L.LoiaconoC.M.JankeB.H.WuW.H.YoonK.J.WebbyR.J.SolorzanoA.et al.Vaccination of pigs against swine" exact="influenza" post="viruses by using an NS1-truncated modified live-virus vaccineJ. Virol.200680110091101810.1128/JVI.00787-0616943300"/>
   <result pre="live-virus vaccineJ. Virol.200680110091101810.1128/JVI.00787-0616943300 148.SolorzanoA.WebbyR.J.LagerK.M.JankeB.H.Garcia-SastreA.RichtJ.A.Mutations in the NS1 protein of swine" exact="influenza" post="virus impair anti-interferon activity and confer attenuation in pigsJ."/>
   <result pre="149.VincentA.L.MaW.LagerK.M.JankeB.H.WebbyR.J.Garcia-SastreA.RichtJ.A.Efficacy of intranasal administration of a truncated NS1 modified live" exact="influenza" post="virus vaccine in swineVaccine2007257999800910.1016/j.vaccine.2007.09.01917933442 150.KappesM.A.SandbulteM.R.PlattR.WangC.LagerK.M.HenningsonJ.N.LorussoA.VincentA.L.LovingC.L.RothJ.A.et al.Vaccination with NS1-truncated H3N2"/>
   <result pre="virus vaccine in swineVaccine2007257999800910.1016/j.vaccine.2007.09.01917933442 150.KappesM.A.SandbulteM.R.PlattR.WangC.LagerK.M.HenningsonJ.N.LorussoA.VincentA.L.LovingC.L.RothJ.A.et al.Vaccination with NS1-truncated H3N2 swine" exact="influenza" post="virus primes T cells and confers cross-protection against an"/>
   <result pre="cross-protection against an H1N1 heterosubtypic challenge in pigsVaccine20123028028810.1016/j.vaccine.2011.10.09822067263 151.SteelJ.LowenA.C.PenaL.AngelM.SolorzanoA.AlbrechtR.PerezD.R.Garcia-SastreA.PaleseP.Live attenuated" exact="influenza" post="viruses containing NS1 truncations as vaccine candidates against H5N1"/>
   <result pre="candidates against H5N1 highly pathogenic avian influenzaJ. Virol.2009831742175310.1128/JVI.01920-0819073731 152.WangL.SuarezD.L.Pantin-JackwoodM.MibayashiM.Garcia-SastreA.SaifY.M.LeeC.W.Characterization of" exact="influenza" post="virus variants with different sizes of the non-structural (NS)"/>
   <result pre="the non-structural (NS) genes and their potential as a live" exact="influenza" post="vaccine in poultryVaccine2008263580358610.1016/j.vaccine.2008.05.00118539366 153.ChoiE.H.SongM.S.ParkS.J.PascuaP.N.BaekY.H.KwonH.I.KimE.H.KimS.JangH.K.PooH.et al.Development of a dual-protective live"/>
   <result pre="of a dual-protective live attenuated vaccine against H5N1 and H9N2" exact="avian influenza" post="viruses by modifying the NS1 geneArch. Virol.20151601729174010.1007/s00705-015-2442-y25959557 154.JangH.NgunjiriJ.M.LeeC.W.Association between"/>
   <result pre="a dual-protective live attenuated vaccine against H5N1 and H9N2 avian" exact="influenza" post="viruses by modifying the NS1 geneArch. Virol.20151601729174010.1007/s00705-015-2442-y25959557 154.JangH.NgunjiriJ.M.LeeC.W.Association between"/>
   <result pre="in ChickensPLoS ONE201611e015660310.1371/journal.pone.015660327257989 155.JangH.ElaishM.KcM.AbundoM.C.GhorbaniA.NgunjiriJ.M.LeeC.W.Efficacy and synergy of live-attenuated and inactivated" exact="influenza" post="vaccines in young chickensPLoS ONE201813e019528510.1371/journal.pone.019528529624615 156.BaskinC.R.Bielefeldt-OhmannH.Garcia-SastreA.TumpeyT.M.Van HoevenN.CarterV.S.ThomasM.J.ProllS.SolorzanoA.BillharzR.et al.Functional genomic"/>
   <result pre="immune response resulting from vaccination of macaques with an NS1-truncated" exact="influenza" post="virusJ. Virol.200781118171182710.1128/JVI.00590-0717715226 157.PicaN.LangloisR.A.KrammerF.MargineI.PaleseP.NS1-truncated live attenuated virus vaccine provides robust"/>
   <result pre="mice from viral challengeJ. Virol.201286102931030110.1128/JVI.01131-1222787224 158.WacheckV.EgorovA.GroissF.PfeifferA.FuerederT.HoeflmayerD.KundiM.Popow-KrauppT.Redlberger-FritzM.MuellerC.A.et al.A novel type of" exact="influenza" post="vaccine: Safety and immunogenicity of replication-deficient influenza virus created"/>
   <result pre="novel type of influenza vaccine: Safety and immunogenicity of replication-deficient" exact="influenza" post="virus created by deletion of the interferon antagonist NS1J."/>
   <result pre="Acad. Sci. USA2000974309431410.1073/pnas.07052599710725408 160.MosslerC.GroissF.WolztM.WolschekM.SeipeltJ.MusterT.Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 161.WangX.BaslerC.F.WilliamsB.R.SilvermanR.H.PaleseP.Garcia-SastreA.Functional replacement of the carboxy-terminal"/>
   <result pre="lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 161.WangX.BaslerC.F.WilliamsB.R.SilvermanR.H.PaleseP.Garcia-SastreA.Functional replacement of the carboxy-terminal two-thirds of the" exact="influenza" post="A virus NS1 protein with short heterologous dimerization domainsJ."/>
   <result pre="Influenza VirusesPLoS ONE201611e015437610.1371/journal.pone.015437627119730 168.WongE.H.SmithD.K.RabadanR.PeirisM.PoonL.L.Codon usage bias and the evolution of" exact="influenza" post="A viruses. Codon Usage Biases of Influenza VirusBMC Evol."/>
   <result pre="viruses. Codon Usage Biases of Influenza VirusBMC Evol. Biol.20101025310.1186/1471-2148-10-25320723216 169.GoniN.IriarteA.ComasV.SonoraM.MorenoP.MoratorioG.MustoH.CristinaJ.Pandemic" exact="influenza" post="A virus codon usage revisited: Biases, adaptation and implications"/>
   <result pre="171.ZhouT.GuW.MaJ.SunX.LuZ.Analysis of synonymous codon usage in H5N1 virus and other" exact="influenza" post="A virusesBiosystems200581778610.1016/j.biosystems.2005.03.00215917130 172.JenkinsG.M.HolmesE.C.The extent of codon usage bias in"/>
   <result pre="human RNA viruses and its evolutionary originVirus Res.2003921710.1016/S0168-1702(02)00309-X12606071 173.MuellerS.ColemanJ.R.PapamichailD.WardC.B.NimnualA.FutcherB.SkienaS.WimmerE.Live attenuated" exact="influenza" post="virus vaccines by computer-aided rational designNat. Biotechnol.20102872372610.1038/nbt.163620543832 174.YangC.SkienaS.FutcherB.MuellerS.WimmerE.Deliberate reduction"/>
   <result pre="designNat. Biotechnol.20102872372610.1038/nbt.163620543832 174.YangC.SkienaS.FutcherB.MuellerS.WimmerE.Deliberate reduction of hemagglutinin and neuraminidase expression of" exact="influenza" post="virus leads to an ultraprotective live vaccine in miceProc."/>
   <result pre="expression: Codon usage bias manipulation for the generation of novel" exact="influenza" post="A virus vaccinesFuture Virol.20151071573010.2217/fvl.15.3126213563 176.FanR.L.ValkenburgS.A.WongC.K.LiO.T.NichollsJ.M.RabadanR.PeirisJ.S.PoonL.L.Generation of Live Attenuated Influenza"/>
   <result pre="generated by codon-pair bias de-optimization of the 2009 pandemic H1N1" exact="influenza" post="virus, in ferretsVaccine20163456357010.1016/j.vaccine.2015.11.05426655630 178.NogalesA.BakerS.F.Ortiz-RianoE.DewhurstS.TophamD.J.Martinez-SobridoL.Influenza A virus attenuation by codon"/>
   <result pre="pathways occurs in lung epithelial cells infected with low pathogenic" exact="avian influenza" post="virusesPLoS ONE20127e3373210.1371/journal.pone.003373222470468 182.ColemanJ.R.PapamichailD.SkienaS.FutcherB.WimmerE.MuellerS.Virus attenuation by genome-scale changes in codon"/>
   <result pre="occurs in lung epithelial cells infected with low pathogenic avian" exact="influenza" post="virusesPLoS ONE20127e3373210.1371/journal.pone.003373222470468 182.ColemanJ.R.PapamichailD.SkienaS.FutcherB.WimmerE.MuellerS.Virus attenuation by genome-scale changes in codon"/>
   <result pre="Dis.20141448010.1186/1471-2334-14-48025186370 185.ParvinR.BegumJ.A.NooruzzamanM.ChowdhuryE.H.IslamM.R.VahlenkampT.W.Review analysis and impact of co-circulating H5N1 and H9N2" exact="avian influenza" post="viruses in BangladeshEpidemiol. Infect.20181461259126610.1017/S095026881800129229781424 186.PenaL.SuttonT.ChockalingamA.KumarS.AngelM.ShaoH.ChenH.LiW.PerezD.R.Influenza viruses with rearranged genomes"/>
   <result pre="185.ParvinR.BegumJ.A.NooruzzamanM.ChowdhuryE.H.IslamM.R.VahlenkampT.W.Review analysis and impact of co-circulating H5N1 and H9N2 avian" exact="influenza" post="viruses in BangladeshEpidemiol. Infect.20181461259126610.1017/S095026881800129229781424 186.PenaL.SuttonT.ChockalingamA.KumarS.AngelM.ShaoH.ChenH.LiW.PerezD.R.Influenza viruses with rearranged genomes"/>
   <result pre="That Are Antigenically Stable during Growth in EggsMBio2017810.1128/mBio.00669-1728588131 188.LuB.ZhouH.YeD.KembleG.JinH.Improvement of" exact="influenza" post="A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by"/>
   <result pre="human cellsBiotechnol. J.2013881182110.1002/biot.20120036423450727 193.ShihF.F.CerasoliD.M.CatonA.J.A major T cell determinant from the" exact="influenza" post="virus hemagglutinin (HA) can be a cryptic self peptide"/>
   <result pre="transgenic miceInt. Immunol.1997924926110.1093/intimm/9.2.2499040007 194.InagakiA.GotoH.KakugawaS.OzawaM.KawaokaY.Competitive incorporation of homologous gene segments of" exact="influenza" post="A virus into virionsJ. Virol.201286102001020210.1128/JVI.01204-1222740412 195.MarshG.A.HatamiR.PaleseP.Specific residues of the"/>
   <result pre="influenza A virus into virionsJ. Virol.201286102001020210.1128/JVI.01204-1222740412 195.MarshG.A.HatamiR.PaleseP.Specific residues of the" exact="influenza" post="A virus hemagglutinin viral RNA are important for efficient"/>
   <result pre="important for efficient packaging into budding virionsJ. Virol.2007819727973610.1128/JVI.01144-0717634232 196.OzawaM.VictorS.T.TaftA.S.YamadaS.LiC.HattaM.DasS.C.TakashitaE.KakugawaS.MaherE.A.et al.Replication-incompetent" exact="influenza" post="A viruses that stably express a foreign geneJ. Gen."/>
   <result pre="Gen. Virol.2011922879288810.1099/vir.0.037648-021880840 197.BottiniA.DeS.K.BaatenB.J.WuB.BarileE.SoonthornvacharinS.StebbinsJ.L.BradleyL.M.ChandaS.K.PellecchiaM.Identification of small molecules that interfere with H1N1" exact="influenza" post="A viral replicationChemMedChem201272227223510.1002/cmdc.20120045323139022 198.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution"/>
   <result pre="A viral replicationChemMedChem201272227223510.1002/cmdc.20120045323139022 198.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistanceScience20103281272127510.1126/science.118781620522774 199.BloomJ.D.NayakJ.S.BaltimoreD.A computational-experimental approach identifies mutations that enhance"/>
   <result pre="approach identifies mutations that enhance surface expression of an oseltamivir-resistant" exact="influenza" post="neuraminidasePLoS ONE20116e2220110.1371/journal.pone.002220121799795 200.HooperK.A.CroweJ.E.Jr.BloomJ.D.Influenza viruses with receptor-binding N1 neuraminidases occur"/>
   <result pre="attenuation in cell culture or miceJ. Virol.2015893737374510.1128/JVI.00012-1525609803 201.VictorS.T.WatanabeS.KatsuraH.OzawaM.KawaokaY.A replication-incompetent PB2-knockout" exact="influenza" post="A virus vaccine vectorJ. Virol.2012864123412810.1128/JVI.06232-1122301144 202.UrakiR.KisoM.Iwatsuki-HorimotoK.FukuyamaS.TakashitaE.OzawaM.KawaokaY.A novel bivalent vaccine"/>
   <result pre="vectorJ. Virol.2012864123412810.1128/JVI.06232-1122301144 202.UrakiR.KisoM.Iwatsuki-HorimotoK.FukuyamaS.TakashitaE.OzawaM.KawaokaY.A novel bivalent vaccine based on a PB2-knockout" exact="influenza" post="virus protects mice from pandemic H1N1 and highly pathogenic"/>
   <result pre="H1N1 and highly pathogenic H5N1 virus challengesJ. Virol.2013877874788110.1128/JVI.00076-1323658445 203.KobayashiH.Iwatsuki-HorimotoK.KisoM.UrakiR.IchikoY.TakimotoT.KawaokaY.A replication-incompetent" exact="influenza" post="virus bearing the HN glycoprotein of human parainfluenza virus"/>
   <result pre="of human parainfluenza virus as a bivalent vaccineVaccine2013316239624610.1016/j.vaccine.2013.10.02924144478 204.FonsecaW.OzawaM.HattaM.OrozcoE.MartinezM.B.KawaokaY.A recombinant" exact="influenza" post="virus vaccine expressing the F protein of respiratory syncytial"/>
   <result pre="F protein of respiratory syncytial virusArch. Virol.20141591067107710.1007/s00705-013-1932-z24292020 205.BakerS.F.GuoH.AlbrechtR.A.Garcia-SastreA.TophamD.J.Martinez-SobridoL.Protection against lethal" exact="influenza" post="with a viral mimicJ. Virol.2013878591860510.1128/JVI.01081-1323720727 206.GuoH.BakerS.F.Martinez-SobridoL.TophamD.J.Induction of CD8 T"/>
   <result pre="cell heterologous protection by a single dose of single-cycle infectious" exact="influenza" post="virusJ. Virol.201488120061201610.1128/JVI.01847-1425100831 207.PowellT.J.SilkJ.D.SharpsJ.FodorE.TownsendA.R.Pseudotyped influenza A virus as a vaccine"/>
   <result pre="a single dose of single-cycle infectious influenza virusJ. Virol.201488120061201610.1128/JVI.01847-1425100831 207.PowellT.J.SilkJ.D.SharpsJ.FodorE.TownsendA.R.Pseudotyped" exact="influenza" post="A virus as a vaccine for the induction of"/>
   <result pre="Virol.201286133971340610.1128/JVI.01820-1223015719 208.KatsuraH.Iwatsuki-HorimotoK.FukuyamaS.WatanabeS.SakabeS.HattaY.MurakamiS.ShimojimaM.HorimotoT.KawaokaY.A replication-incompetent virus possessing an uncleavable hemagglutinin as an" exact="influenza" post="vaccineVaccine2012306027603310.1016/j.vaccine.2012.07.05922867723 209.KatsuraH.PiaoZ.Iwatsuki-HorimotoK.AkedaY.WatanabeS.HorimotoT.OishiK.KawaokaY.A bivalent vaccine based on a replication-incompetent influenza"/>
   <result pre="an influenza vaccineVaccine2012306027603310.1016/j.vaccine.2012.07.05922867723 209.KatsuraH.PiaoZ.Iwatsuki-HorimotoK.AkedaY.WatanabeS.HorimotoT.OishiK.KawaokaY.A bivalent vaccine based on a replication-incompetent" exact="influenza" post="virus protects against Streptococcus pneumoniae and influenza virus infectionJ."/>
   <result pre="on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and" exact="influenza" post="virus infectionJ. Virol.201488134101341710.1128/JVI.01205-1425210171 210.ShinyaK.FujiiY.ItoH.ItoT.KawaokaY.Characterization of a neuraminidase-deficient influenza a"/>
   <result pre="pneumoniae and influenza virus infectionJ. Virol.201488134101341710.1128/JVI.01205-1425210171 210.ShinyaK.FujiiY.ItoH.ItoT.KawaokaY.Characterization of a neuraminidase-deficient" exact="influenza" post="a virus as a potential gene delivery vector and"/>
   <result pre="delivery vector and a live vaccineJ. Virol.2004783083308810.1128/JVI.78.6.3083-3088.200414990727 211.MasicA.PyoH.M.BabiukS.ZhouY.An eight-segment swine" exact="influenza" post="virus harboring H1 and H3 hemagglutinins is attenuated and"/>
   <result pre="in pigsJ. Virol.201387101141012510.1128/JVI.01348-1323843633 212.PyoH.M.ZhouY.Protective efficacy of intranasally administered bivalent live" exact="influenza" post="vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 213.HattaY.BoltzD.SarawarS.KawaokaY.NeumannG.BilselP.M2SR, a"/>
   <result pre="and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 213.HattaY.BoltzD.SarawarS.KawaokaY.NeumannG.BilselP.M2SR, a novel live" exact="influenza" post="vaccine, protects mice and ferrets against highly pathogenic avian"/>
   <result pre="highly pathogenic avian influenzaVaccine2017354177418310.1016/j.vaccine.2017.06.03928668565 214.SarawarS.HattaY.WatanabeS.DiasP.NeumannG.KawaokaY.BilselP.M2SR, a novel live single replication" exact="influenza" post="virus vaccine, provides effective heterosubtypic protection in miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use"/>
   <result pre="vaccine, provides effective heterosubtypic protection in miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use of GFP-expressing" exact="influenza" post="viruses for the detection of influenza virus A/H5N1 neutralizing"/>
   <result pre="miceVaccine2016345090509810.1016/j.vaccine.2016.08.06127595896 215.RimmelzwaanG.F.VerburghR.J.NieuwkoopN.J.BestebroerT.M.FouchierR.A.OsterhausA.D.Use of GFP-expressing influenza viruses for the detection of" exact="influenza" post="virus A/H5N1 neutralizing antibodiesVaccine2011293424343010.1016/j.vaccine.2011.02.08221396410 216.BakerS.F.NogalesA.SantiagoF.W.TophamD.J.Martinez-SobridoL.Competitive detection of influenza neutralizing"/>
   <result pre="detection of influenza virus A/H5N1 neutralizing antibodiesVaccine2011293424343010.1016/j.vaccine.2011.02.08221396410 216.BakerS.F.NogalesA.SantiagoF.W.TophamD.J.Martinez-SobridoL.Competitive detection of" exact="influenza" post="neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay"/>
   <result pre="217.ChenJ.LeeK.H.SteinhauerD.A.StevensD.J.SkehelJ.J.WileyD.C.Structure of the hemagglutinin precursor cleavage site, a determinant of" exact="influenza" post="pathogenicity and the origin of the labile conformationCell19989540941710.1016/S0092-8674(00)81771-79814710 218.MoorthyN.S.PoongavanamV.PratheepaV.Viral"/>
   <result pre="vaccineJ. Virol.2009835947595010.1128/JVI.00450-0919321619 220.WatanabeT.WatanabeS.KimJ.H.HattaM.KawaokaY.Novel approach to the development of effective H5N1" exact="influenza" post="A virus vaccines: Use of M2 cytoplasmic tail mutantsJ."/>
   <result pre="Virol.2008822486249210.1128/JVI.01899-0718160446 221.HattaY.HattaM.BilselP.NeumannG.KawaokaY.An M2 cytoplasmic tail mutant as a live attenuated" exact="influenza" post="vaccine against pandemic (H1N1) 2009 influenza virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation"/>
   <result pre="as a live attenuated influenza vaccine against pandemic (H1N1) 2009" exact="influenza" post="virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation of influenza A viruses as live"/>
   <result pre="vaccine against pandemic (H1N1) 2009 influenza virusVaccine2011292308231210.1016/j.vaccine.2011.01.02321272601 222.SiL.XuH.ZhouX.ZhangZ.TianZ.WangY.WuY.ZhangB.NiuZ.ZhangC.et al.Generation of" exact="influenza" post="A viruses as live but replication-incompetent virus vaccinesScience20163541170117310.1126/science.aah586927934767 223.NormanlyJ.KleinaL.G.MassonJ.M.AbelsonJ.MillerJ.H.Construction"/>
   <result pre="of Allergy and Infectious DiseasesJ. Infect. Dis.201821834735410.1093/infdis/jiy10329506129 225.SauttoG.A.KirchenbaumG.A.RossT.M.Towards a universal" exact="influenza" post="vaccine: Different approaches for one goalVirol. J.2018151710.1186/s12985-017-0918-y29370862 Figure 1"/>
   <result pre="replication and gene transcription. Figure 2 Production of the inactivated" exact="influenza" post="vaccine (IIV): To prepare IIV, 10–11 days old chicken"/>
   <result pre="then administrated intramuscularly (IM). Figure 3 Generation of the live-attenuated" exact="influenza" post="vaccine (LAIV): The LAIV is produced by co-infection of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6409972\results\search\disease\results.xml">
   <result pre="in South Africa. Two percent is the percentage suffering from" exact="retinitis" post="among clinical cases [7]. It cannot be directly deduced"/>
   <result pre="Insights from three Distinct RegionsAm. J. Trop. Med. Hyg.20077679580010.4269/ajtmh.2007.76.79517488893 46.DaubneyR.HudsonJ.R.GarnhamP.C.Enzootic" exact="hepatitis" post="or rift valley fever. An undescribed virus disease of"/>
   <result pre="three Distinct RegionsAm. J. Trop. Med. Hyg.20077679580010.4269/ajtmh.2007.76.79517488893 46.DaubneyR.HudsonJ.R.GarnhamP.C.Enzootic hepatitis or" exact="rift valley fever." post="An undescribed virus disease of sheep cattle and man"/>
   <result pre="(11.6%) 2.6 (0.7–9.8) 0.170 No 6/95 (6.3%) 1 (base) Chronic" exact="liver disease" post="Eliminated Yes 1/2 (50%) 11.8 (0.6–229) 0.102 No 10/136"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410043\results\search\disease\results.xml">
   <result pre="(CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The recent explosive pandemic of" exact="chikungunya" post="virus (CHIKV) followed by Zika (ZIKV) virus infections occurring"/>
   <result pre="(i) the Flaviviridae (genus flavivirus) which includes West Nile (WNV)," exact="yellow fever" post="(YFV), dengue (DENV) and Zika (ZIKV) viruses and (ii)"/>
   <result pre="arthralgia with CIKV infection, haemorrhagic fever with DENV infection and" exact="microcephaly" post="and other neurological manifestations with ZIKV infection [1,6,16]. It"/>
   <result pre="region of related flaviviruses, including DENGV, ZIKV, YFV and Japanese" exact="encephalitis" post="viruses, to KIR2DS2. The other activating NK receptors are:"/>
   <result pre="This was shown in a 3-month-old girl with a T−B+NK+" exact="severe combined immunodeficiency" post="phenotype who recovered from cytomegalovirus (CMV) infection without antiviral"/>
   <result pre="made in the context of CHIKV [45], Hantavirus [52] and" exact="viral hepatitis" post="B and C [53,54]. Until now, the presence and"/>
   <result pre="in the context of CHIKV [45], Hantavirus [52] and viral" exact="hepatitis" post="B and C [53,54]. Until now, the presence and"/>
   <result pre="consistent with those obtained in degenerative joint disease associated with" exact="osteoarthritis" post="in which synovial tissue-infiltrating NK cells displayed impaired IFN-γ"/>
   <result pre="as a major pathogen following an outbreak of fever and" exact="encephalitis" post="in New York, USA in 1999, where deaths in"/>
   <result pre="to Guillain-Barré syndrome in adults and multiple neurodevelopmental defects, including" exact="microcephaly" post="in infants born of mothers infected during the first"/>
   <result pre="Of note, in other flavivirus infections, such as WNV and" exact="tick-borne encephalitis" post="(TBEV), another flavivirus transmitted to humans by ticks, specific"/>
   <result pre="note, in other flavivirus infections, such as WNV and tick-borne" exact="encephalitis" post="(TBEV), another flavivirus transmitted to humans by ticks, specific"/>
   <result pre="dengue virus transmissionPLoS Negl. Trop. Dis.20104e64610.1371/journal.pntd.000064620520794 6.PetitdemangeC.WauquierN.VieillardV.Control of immunopathology during" exact="chikungunya" post="virus infectionJ. Allergy Clin. Immunol.201513584685510.1016/j.jaci.2015.01.03925843597 7.ShepardD.S.UndurragaE.A.HalasaY.A.StanawayJ.D.The global economic burden"/>
   <result pre="host interferon response in zebrafishPLoS Pathog.20139e100361910.1371/journal.ppat.100361924039582 11.SchwartzO.AlbertM.L.Biology and pathogenesis of" exact="chikungunya" post="virusNat. Rev. Microbiol.2010849150010.1038/nrmicro236820551973 12.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel chikungunya vaccine candidate with"/>
   <result pre="11.SchwartzO.AlbertM.L.Biology and pathogenesis of chikungunya virusNat. Rev. Microbiol.2010849150010.1038/nrmicro236820551973 12.PlanteK.WangE.PartidosC.D.WegerJ.GorchakovR.TsetsarkinK.BorlandE.M.PowersA.M.SeymourR.StinchcombD.T.et al.Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
   <result pre="threat?Emerg. Microbes Infect.2018716310.1038/s41426-018-0163-530254258 45.PetitdemangeC.BecquartP.WauquierN.BéziatV.DebréP.LeroyE.M.VieillardV.Unconventional repertoire profile is imprinted during acute" exact="chikungunya" post="infection for natural killer cells polarization toward cytotoxicityPLoS Pathog.20117e100226810.1371/journal.ppat.100226821966274"/>
   <result pre="of NK and NKT-like populations during the early stages of" exact="chikungunya" post="infectionFront. Microbiol.2015689510.3389/fmicb.2015.0089526388848 48.FoxJ.M.DiamondM.S.Immune-Mediated Protection and Pathogenesis of Chikungunya VirusJ."/>
   <result pre="Exp. Med.2011208132110.1084/jem.2010076221173105 53.OlivieroB.VarchettaS.PaudiceE.MicheloneG.ZaramellaM.MavilioD.De FilippiF.BrunoS.MondelliM.U.Natural killer cell functional dichotomy in chronic" exact="hepatitis" post="B and chronic hepatitis C virus infectionsGastroenterology20091371151116010.1053/j.gastro.2009.05.04719470388 54.BéziatV.DalgardO.AsselahT.HalfonP.BedossaP.BoudifaA.HervierB.TheodorouI.MartinotM.DebréP.et al.CMV"/>
   <result pre="killer cell functional dichotomy in chronic hepatitis B and chronic" exact="hepatitis" post="C virus infectionsGastroenterology20091371151116010.1053/j.gastro.2009.05.04719470388 54.BéziatV.DalgardO.AsselahT.HalfonP.BedossaP.BoudifaA.HervierB.TheodorouI.MartinotM.DebréP.et al.CMV drives clonal expansion of"/>
   <result pre="expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic" exact="hepatitis" post="patientsEur. J. Immunol.20124244745710.1002/eji.20114182622105371 55.RölleA.BrodinP.Immune Adaptation to Environmental Influence: The"/>
   <result pre="Acute Joint PathologyJ. Virol.2015897955796910.1128/JVI.00909-1525995257 62.HussR.S.HuddlestonJ.I.GoodmanS.B.ButcherE.C.ZabelB.A.Synovial tissue-infiltrating natural killer cells in" exact="osteoarthritis" post="and periprosthetic inflammationArthritis Rheum.2010623799380510.1002/art.2775120848566 63.JaimeP.García-GuerreroN.EstellaR.PardoJ.García-�?lvarezF.Martinez-LostaoL.CD56+/CD16− Natural Killer cells expressing"/>
   <result pre="NY, USA1951 65.JiaX.Y.BrieseT.JordanI.RambautA.ChiH.C.MackenzieJ.S.HallR.A.ScherretJ.LipkinW.I.Genetic analysis of West Nile New York 1999" exact="encephalitis" post="virusLancet19993541971197210.1016/S0140-6736(99)05384-210622305 66.NgonoA.E.ShrestaS.Immune Response to Dengue and ZikaAnnu. Rev. Immunol.20183627930810.1146/annurev-immunol-042617-05314229345964"/>
   <result pre="PatientsFront. Immunol.2015650710.3389/fimmu.2015.0050726500647 77.NevesP.C.MatosD.C.MarcovistzR.GallerR.TLR expression and NK cell activation after human" exact="yellow fever" post="vaccinationVaccine2009275543554910.1016/j.vaccine.2009.07.02819647065 78.MarquardtN.IvarssonM.A.BlomK.GonzalezV.D.BraunM.FalconerK.GustafssonR.Fogdell-HahnA.SandbergJ.K.MichaëlssonJ.The Human NK Cell Response to Yellow Fever"/>
   <result pre="virus (BOUV), Dengue virus (DENV), Israel Turkey meningoencephalomyelitis (ITV), Japanese" exact="encephalitis" post="virus (JEV), Jugra virus (JUGV), Kokobera virus (KOKV), Lamni"/>
   <result pre="virus (JUGV), Kokobera virus (KOKV), Lamni virus (LAMV), Murray Valley" exact="encephalitis" post="virus (MVEV), Nouanamé virus (NOUV), Rabensburg virus (RABV), Saint"/>
   <result pre="virus (MVEV), Nouanamé virus (NOUV), Rabensburg virus (RABV), Saint Louis" exact="encephalitis" post="virus (SLEV), Spondweni virus (SPOV), Tembusu virus (TMUV), T’Ho"/>
   <result pre="Usutu virus (USUV), Wesselsbron virus (WESSV), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV) and Zika virus (ZIKV). Alphaviruses: Barmah forest"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410066\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The" exact="influenza" post="virus-host interaction is a classic arms race. The recurrent"/>
   <result pre="classic arms race. The recurrent and evolving nature of the" exact="influenza" post="virus family allows a single host to be infected"/>
   <result pre="host to be infected several times. Locked in co-evolution, recurrent" exact="influenza" post="virus infection elicits continual refinement of the host immune"/>
   <result pre="host immune system. Here we give historical context of circulating" exact="influenza" post="viruses to understand how the individual immune history is"/>
   <result pre="the individual immune history is mirrored by the history of" exact="influenza" post="virus circulation. Original Antigenic Sin was first proposed as"/>
   <result pre="first proposed as the negative influence of the host’s first" exact="influenza" post="virus infection on the next and Imprinting modernizes Antigenic"/>
   <result pre="the continual refinement of the host immune system with each" exact="influenza" post="virus infection. We discuss imprinting and the interplay of"/>
   <result pre="influenza virus infection. We discuss imprinting and the interplay of" exact="influenza" post="virus homology, vaccination, and host age establishing preimmunity. We"/>
   <result pre="for future investigation. Understanding the effects of antigenic variable recurrent" exact="influenza" post="virus infection on immune refinement will advance vaccination strategies,"/>
   <result pre="as pandemic preparedness. immune response original antigenic sin imprinting preimmunity" exact="influenza" post="virus antigenic drift antigenic shift orthomyxoviridae Spanish influenza pandemic"/>
   <result pre="imprinting preimmunity influenza virus antigenic drift antigenic shift orthomyxoviridae Spanish" exact="influenza" post="pandemic 1. Introduction: Influenza Viruses are the Archetype Emerging"/>
   <result pre="the ability to infect the vulnerable human population [4]. Yearly," exact="influenza" post="viruses infect between 5% and 15% of the population"/>
   <result pre="that every person will be infected or exposed to the" exact="influenza" post="virus by the time they are four years old."/>
   <result pre="time they are four years old. Furthermore, considering prominent government-supported" exact="influenza" post="vaccination programs, the age of first influenza virus exposure"/>
   <result pre="considering prominent government-supported influenza vaccination programs, the age of first" exact="influenza" post="virus exposure is most likely lower. Since influenza viruses"/>
   <result pre="of first influenza virus exposure is most likely lower. Since" exact="influenza" post="viruses cycle yearly in the human population and the"/>
   <result pre="previous infection is not life-long [6], people are exposed to" exact="influenza" post="viruses recurrently. This means that everyone, with the exception"/>
   <result pre="that everyone, with the exception of newborn infants, has an" exact="influenza" post="immune history. Humans build a complex immune history due"/>
   <result pre="a complex immune history due to repeated exposures with new" exact="influenza" post="strains from infection and seasonal vaccinations. The influence of"/>
   <result pre="1960s. Dr. Thomas Francis Jr. suggested that a person’s first" exact="influenza" post="virus infection would be deleterious to the clinical outcome"/>
   <result pre="Immune history is not simply composed of the host’s first" exact="influenza" post="virus infection. Rather, the interaction between the immune system"/>
   <result pre="virus infection. Rather, the interaction between the immune system and" exact="influenza" post="viruses is dynamic with each exposure. Each host-pathogen interaction"/>
   <result pre="stalk [15]. The constant circulation of a heterogeneous pool of" exact="influenza" post="viruses allows for many possible permutations for viral infection"/>
   <result pre="Heterotypic sequential infections (Table 1). The influence of a previous" exact="influenza" post="virus exposure on the outcome of a subsequent infection"/>
   <result pre="infection may be both beneficial and deleterious. A person’s first" exact="influenza" post="infection is a significant event, the imprinting event, which"/>
   <result pre="memory cells [16]. Subsequent infections lead to cumulative effects of" exact="influenza" post="viruses on the immune background which shape future responses"/>
   <result pre="responses [17]. We propose that a person’s immune history of" exact="influenza" post="virus infections should be known as preimmunity. The schematic"/>
   <result pre="an individual’s immune landscape may evolve during seasonal exposures to" exact="influenza" post="viruses and vaccinations (Figure 1). The imprinting event that"/>
   <result pre="target surface and internal viral epitopes specific to this first" exact="influenza" post="virus which remain prominent throughout life [18]. Most antibodies"/>
   <result pre="to antibody specificity and B cell longevity. Following a new" exact="influenza" post="virus infection, the resulting immune constellation is dependent on"/>
   <result pre="the pre-existing immune specificity and the characteristics of the next" exact="influenza" post="virus infection (virus strain, subtype, lineage, or type). Below"/>
   <result pre="subtype, lineage, or type). Below we review the literature surrounding" exact="influenza" post="virus immune imprinting and preimmunity. We first outline the"/>
   <result pre="preimmunity. We first outline the development of preimmunity by discussing" exact="influenza" post="virology, influenza history, and primary immune responses. This sets"/>
   <result pre="first outline the development of preimmunity by discussing influenza virology," exact="influenza" post="history, and primary immune responses. This sets the stage"/>
   <result pre="of host preimmunity will contribute to the next generation of" exact="influenza" post="vaccines. 2. Influenza Virus Biology Enables Frequent Antigenic Change"/>
   <result pre="Enables Frequent Antigenic Change The segmented RNA genome of the" exact="influenza" post="virus family (Orthomyxoviridae) facilitates antigenic variability [20]. The family"/>
   <result pre="types: A, B, C (Figure 2), and D [21,22]. Briefly," exact="influenza" post="C and D viruses are not regarded as health"/>
   <result pre="D viruses are not regarded as health threats. In humans," exact="influenza" post="C virus causes mild illness while type D virus"/>
   <result pre="virus is incapable of human infection [23]. The surface of" exact="influenza" post="C virus is defined by a single spike protein"/>
   <result pre="capabilities, and enzymatic activity for egress [23]. Although antibodies to" exact="influenza" post="C virus are detected early in life [23], little"/>
   <result pre="NA [25] surface proteins are the immunodominant proteins of the" exact="influenza" post="virus which is why they have been the focus"/>
   <result pre="the rearrangement of genomic RNA segments between two or more" exact="influenza" post="viruses [41]. Antigenic Drift leads to seasonal influenza epidemics"/>
   <result pre="or more influenza viruses [41]. Antigenic Drift leads to seasonal" exact="influenza" post="epidemics while shift is the cause of pandemic influenza"/>
   <result pre="seasonal influenza epidemics while shift is the cause of pandemic" exact="influenza" post="virus outbreaks [41]. Both avenues lead to antigenically divergent"/>
   <result pre="Using experimental studies, the early stages of a host’s first" exact="influenza" post="virus infection have been defined by the antiviral response"/>
   <result pre="By summarizing the knowledge of the immune responses to primary" exact="influenza" post="virus infection we create a reference point for the"/>
   <result pre="dissemination, and recruiting effector cells for viral clearance [42]. Since" exact="influenza" post="viruses are transmitted through the respiratory route, the initial"/>
   <result pre="through the respiratory route, the initial site of infection for" exact="influenza" post="viruses is the respiratory epithelium [40,43,44,45]. Specifically, ciliated pseudostratified"/>
   <result pre="immune cells for viral clearance [40]. NK cells aid in" exact="influenza" post="viral clearance by recognizing and lysing influenza virus-infected cells"/>
   <result pre="cells aid in influenza viral clearance by recognizing and lysing" exact="influenza" post="virus-infected cells [46]. Alveolar macrophages phagocytose virus infected cells"/>
   <result pre="bridging innate immunity to the targeted adaptive immune responses during" exact="influenza" post="virus infection [50]. Conventional DCs sit under the epithelium"/>
   <result pre="survey the airway environment with their dendrites [34]. Detection of" exact="influenza" post="virus initiates DC up-regulation of the chemokine receptor CCR7"/>
   <result pre="to kill virus infected cells. Global gene expression analysis of" exact="influenza" post="infection in ferrets has shown that the host immune"/>
   <result pre="this review will concentrate on the humoral immune response during" exact="influenza" post="virus infection in the preimmune host. With this in"/>
   <result pre="migrate to the lymph node transporting with them the acquired" exact="influenza" post="virus antigen. In the lymph node, naïve CD8+ T"/>
   <result pre="T cells have greater potential for cross-reactivity between antigenically divergent" exact="influenza" post="virus strains since these cells can target internal conserved"/>
   <result pre="T cell specific clones can increase the recovery time of" exact="influenza" post="virus secondary infections. The primary humoral response to infection"/>
   <result pre="plasma cells producing antibodies targeted at viral epitopes. During primary" exact="influenza" post="virus infection, a large and diverse pool of antibodies"/>
   <result pre="of antibodies are produced and circulated [17]. Animal modeling of" exact="influenza" post="virus infection in naïve hosts has shown that most"/>
   <result pre="memory B cells are lifelong since antibodies specific to historical" exact="influenza" post="viruses have been detected in humans decades after initial"/>
   <result pre="Immunological Memory Infection-reinfection or sequential infection experiments attempt to recapitulate" exact="influenza" post="seasonality using animal models. The host is primed with"/>
   <result pre="using animal models. The host is primed with an initial" exact="influenza" post="virus before a challenge with a secondary infection following"/>
   <result pre="[13]. Above we defined the exposure permutations in terms of" exact="influenza" post="virus antigenicity as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, and"/>
   <result pre="contraction phase of the primary adaptive immune response. For the" exact="influenza" post="virus-host interaction, the interval of time between a primary"/>
   <result pre="Virus Circulation Mirrors the Human Influenza Background The history of" exact="influenza" post="virus circulation is encompassed within the individual. In each"/>
   <result pre="will briefly review the modern history (past ~150 years) of" exact="influenza" post="virus circulation to understand the epidemiological and immunological outcomes"/>
   <result pre="virus circulation to understand the epidemiological and immunological outcomes of" exact="influenza" post="virus infection and vaccination. The influenza A virus was"/>
   <result pre="and immunological outcomes of influenza virus infection and vaccination. The" exact="influenza" post="A virus was first identified as the etiological agent"/>
   <result pre="virus was first identified as the etiological agent of human" exact="influenza" post="in 1933 shortly after the advent of electron microscopy"/>
   <result pre="the agent responsible for influenza-like epidemics/pandemics such as the 1918" exact="influenza" post="pandemic were not readily determined [74]. The constructed timeline"/>
   <result pre="timeline (Figure 3) starting in 1889 shows the history of" exact="influenza" post="A and B virus circulation in the human population."/>
   <result pre="human population. There have been six presumptive pandemics caused by" exact="influenza" post="A viruses since 1889 that have defined the immunological"/>
   <result pre="the 1918 pandemic occurred prior to the discovery of the" exact="influenza" post="virus [1,6]. The etiology of these disease outbreaks was"/>
   <result pre="The H2N2 virus was usurped by the introduction of the" exact="influenza" post="A virus subtype H3N2 of swine origin which emerged"/>
   <result pre="be the population’s previous immunity to sub-immunodominant domains on the" exact="influenza" post="virus, i.e., the HA stalk and the neuraminidase [28]."/>
   <result pre="stalk and the neuraminidase [28]. H3N2 circulated as the only" exact="influenza" post="A virus for nine years, until H1N1 resurfaced in"/>
   <result pre="emergence of an antigenically novel H1N1 &quot;lineage�? caused the sixth" exact="influenza" post="virus pandemic [80]. The virus, which was a reassortment"/>
   <result pre="The virus, which was a reassortment of human, swine, and" exact="avian influenza" post="viruses, replaced the former seasonal H1N1 virus &quot;lineage�? which"/>
   <result pre="virus, which was a reassortment of human, swine, and avian" exact="influenza" post="viruses, replaced the former seasonal H1N1 virus &quot;lineage�? which"/>
   <result pre="and imprinting [81]. Human infections of zoonotic strains of other" exact="influenza" post="A virus subtypes such as H5N1, H6N2, H7N1, H7N7,"/>
   <result pre="hundreds of human infections [81,83]. During 1891 to present day," exact="influenza" post="B viruses have been co-circulating, creating a complex immune"/>
   <result pre="Influenza B was identified in 1942 and added to the" exact="influenza" post="vaccine to create a bivalent vaccine [73] (Figure 3)."/>
   <result pre="a bivalent vaccine [73] (Figure 3). The WHO initiated circulating" exact="influenza" post="virus surveillance in 1973, which led to the discovery"/>
   <result pre="in the late 1980s [73]. By viewing the history of" exact="influenza" post="virus circulation through the lens of imprinting, researchers can"/>
   <result pre="make assumptions about individual host imprinting and immune history. The" exact="influenza" post="virus strain that an individual imprinted upon can be"/>
   <result pre="of H1N1 viruses since it was the only subtype of" exact="influenza" post="A circulating in those years [16]. Those born between"/>
   <result pre="Since there was a sequential emergence and replacement of the" exact="influenza" post="A virus subtypes (H1N1, H2N2, and H3N2) the current"/>
   <result pre="much variability for imprinted immunity. Moreover, the sequential nature of" exact="influenza" post="virus circulation has led to heterosubtypic infection-reinfections throughout history."/>
   <result pre="(sH1N1) imprinting with a 2009 H1N1 reinfection (sH1N1-&amp;gt;2009 H1N1). Since," exact="influenza" post="B viruses have co-circulated during A virus flux, there"/>
   <result pre="during A virus flux, there is further complexity to human" exact="influenza" post="virus preimmunity. Studies are only beginning to uncover the"/>
   <result pre="of Preimmunity We know that extrapolating results from naïve animal" exact="influenza" post="virus studies to human disease is limited due the"/>
   <result pre="to human disease is limited due the existence of human" exact="influenza" post="preimmunity [87]. Below we review the recent literature of"/>
   <result pre="preimmunity [87]. Below we review the recent literature of sequential" exact="influenza" post="virus infection using laboratory-controlled experiments with animal models of"/>
   <result pre="influenza virus infection using laboratory-controlled experiments with animal models of" exact="influenza" post="preimmunity. The conclusions are then synthesized with findings from"/>
   <result pre="preimmune host is re-exposed to the same or slightly drifted" exact="influenza" post="virus strain. To investigate the nuanced humoral antibody changes"/>
   <result pre="of age) and adults (28–74 years of age) following seasonal" exact="influenza" post="virus vaccination. The samples were subjected to HAI and"/>
   <result pre="hypothesize that the generation of this antibody occurred following sequential" exact="influenza" post="infections which occurred during the donor’s lifetime which encompassed"/>
   <result pre="exposures to sequential MsHe viruses in the course of historical" exact="influenza" post="pandemics: H2N2 -&amp;gt; H3N2 -&amp;gt; H1N1. Relatedly, other researchers"/>
   <result pre="stalk reactive antibodies, a wider breadth of protection against evolving" exact="influenza" post="viruses may be achieved [31,99]. Specifically, one strategy has"/>
   <result pre="chimeric HA molecule containing the stalk region from the original" exact="influenza" post="HA protein but an HA head containing little a.a."/>
   <result pre="far more complex than that of experimental animal models, personal" exact="influenza" post="virus exposure history can be deduced. As discussed previously,"/>
   <result pre="previously, cross-referencing a person’s birth year against the history of" exact="influenza" post="A and B virus circulation we can surmise a"/>
   <result pre="The data suggested that antibodies previously generated from past seasonal" exact="influenza" post="virus infections (MsHe infection) had a negative impact on"/>
   <result pre="virus in sequence. Each year, H1N1, H3N2, B-Yamagata, and B-Victoria" exact="influenza" post="virus strains circulate in the human population. Despite the"/>
   <result pre="population. Despite the continuing circulation of both A and B" exact="influenza" post="viruses, there is a paucity of information regarding heterotypic"/>
   <result pre="interseasonal as well as intraseasonal. In the northern hemisphere, the" exact="influenza" post="season begins in October lasting until April and peaks"/>
   <result pre="until April and peaks early January. Typically, in each season" exact="influenza" post="A cases are prominent in the first half to"/>
   <result pre="first half to three quarters of the season [101,102]. As" exact="influenza" post="A human cases begin to decline, there is an"/>
   <result pre="to decline, there is an increase in the prominence of" exact="influenza" post="B viruses [101,102] suggesting viral interference or the opportunistic"/>
   <result pre="viruses [101,102] suggesting viral interference or the opportunistic infection of" exact="influenza" post="B viruses in immunosuppressed hosts. One human study documented"/>
   <result pre="medical intervention were documented to have been infected with an" exact="influenza" post="A strain and then reinfected with an influenza B"/>
   <result pre="with an influenza A strain and then reinfected with an" exact="influenza" post="B virus during the same season [103]. All children"/>
   <result pre="without cross-protection. Moreover, other studies have showed prominent co-infections of" exact="influenza" post="A and influenza B viruses [104]. Further study is"/>
   <result pre="other studies have showed prominent co-infections of influenza A and" exact="influenza" post="B viruses [104]. Further study is needed to understand"/>
   <result pre="is needed to understand the mechanisms of immune activation or" exact="suppression" post="during sequential heterotypic and co-infections of two influenza virus"/>
   <result pre="activation or suppression during sequential heterotypic and co-infections of two" exact="influenza" post="virus types. 7. Vaccination Preimmunity May Influence Future Vaccination"/>
   <result pre="Vaccination Preimmunity May Influence Future Vaccination Outcome Despite immune history," exact="influenza" post="viruses are a recurrent and as yet unsolved public"/>
   <result pre="estimated at 500,000 people worldwide by the WHO [79,102,105]. Yearly" exact="influenza" post="vaccination is recommended by the National Advisory Committee on"/>
   <result pre="Health Organization (WHO) as the most effective strategy for reducing" exact="influenza" post="burden [22,106,107]. The low effectiveness of the seasonal influenza"/>
   <result pre="reducing influenza burden [22,106,107]. The low effectiveness of the seasonal" exact="influenza" post="vaccine has been attributed to the frequent mutations in"/>
   <result pre="has previously been linked by some researchers to repeated seasonal" exact="influenza" post="vaccination in specific antigenically-defined influenza seasons [11]. These effects"/>
   <result pre="some researchers to repeated seasonal influenza vaccination in specific antigenically-defined" exact="influenza" post="seasons [11]. These effects of repeated vaccination was first"/>
   <result pre="statistically determined protective advantage compared to unvaccinated children during seasonal" exact="influenza" post="virus circulation [9,109]. Loss of protection due to repeated"/>
   <result pre="to a greater percentage of vaccinated people testing positive for" exact="influenza" post="virus infections [11]. The evidence supporting the antigen distance"/>
   <result pre="distance hypothesis as a mechanism of reduced effectiveness for specific" exact="influenza" post="seasons remains a hypothesis and is not presented here"/>
   <result pre="hypothesis and is not presented here as leverage for skipping" exact="influenza" post="virus vaccinations. More studies of vaccination effectiveness in other"/>
   <result pre="Furthermore, there are numerous publications supporting the regular use of" exact="influenza" post="vaccinations in children, adults, and pregnant women following rigorous"/>
   <result pre="these analyses support vaccine induced protection against severe disease following" exact="influenza" post="virus infection, as well as improved neonatal outcomes when"/>
   <result pre="of subsequent infections. Previous studies investigating the immune re-encounter with" exact="influenza" post="viral antigens or live virus infection are frequently designed"/>
   <result pre="This design would more accurately reflect the seasonal exposures of" exact="influenza" post="viruses in humans. Longer recovery times for animal experiments"/>
   <result pre="the adaptive immune memory phase will uncover immune mechanisms relating" exact="influenza" post="pathogenesis. Furthermore, since most studies are focused on the"/>
   <result pre="and functions. The standard methodology for assessing immune activation following" exact="influenza" post="virus infection is the HAI (hemagglutinin inhibition) assay which"/>
   <result pre="known that children and infants have different clinical outcomes to" exact="influenza" post="virus infection and vaccination compared to adults [120,121,122]. Infants"/>
   <result pre="Infants and young children are high-risk groups for developing severe" exact="respiratory disease" post="leading to hospitalization following influenza virus infection [102,107], which"/>
   <result pre="groups for developing severe respiratory disease leading to hospitalization following" exact="influenza" post="virus infection [102,107], which may be due to the"/>
   <result pre="Associated Lymphoid Tissue) in the lungs of young animals following" exact="influenza" post="virus infection [125,126]. Despite this evidence, we are unaware"/>
   <result pre="[125,126]. Despite this evidence, we are unaware of any sequential" exact="influenza" post="animal models that imprint during infancy and reinfect during"/>
   <result pre="postpartum [127], it is essential that animal models of recurrent" exact="influenza" post="infection take age into account. Having a more complete"/>
   <result pre="take age into account. Having a more complete understanding of" exact="influenza" post="infection during youth and the immunity gained will guide"/>
   <result pre="immune memory for antigenically variable and dynamic pathogens such as" exact="influenza" post="viruses is limited. The human studies from Andrews and"/>
   <result pre="Concluding Statement The host pathogen interaction of antigenically-evolving and variable" exact="influenza" post="viruses leads to a complex host immune background. Preimmunity"/>
   <result pre="immune background. Preimmunity blends age, immune function, and sequence of" exact="influenza" post="virus infections. By analyzing consecutive influenza virus exposures as"/>
   <result pre="function, and sequence of influenza virus infections. By analyzing consecutive" exact="influenza" post="virus exposures as monosubtypic homologous, monosubtypic heterologous, heterosubtypic, or"/>
   <result pre="future vaccine design and offer insight into an effective universal" exact="influenza" post="vaccine. Although this has been the strategy of universal"/>
   <result pre="influenza vaccine. Although this has been the strategy of universal" exact="influenza" post="vaccine development targeting the HA stalk domain [61], there"/>
   <result pre="memory B cell mechanisms. Findings from animal models of sequential" exact="influenza" post="virus infection may be extrapolated to the knowledge gaps"/>
   <result pre="studies. Understanding how the human immune response changes over sequential" exact="influenza" post="infections and vaccinations will inform the rational development of"/>
   <result pre="Understanding Patterns of Emergence and TransmissionPathogens201656610.3390/pathogens504006627929449 3.BarberisI.MylesP.AultS.K.BragazziN.L.MartiniM.History and evolution of" exact="influenza" post="control through vaccination: From the first monovalent vaccine to"/>
   <result pre="4.NeuK.E.Henry DunandC.J.WilsonP.C.Heads, stalks and everything else: How can antibodies eradicate" exact="influenza" post="as a human disease?Curr. Opin. Immunol.201642485510.1016/j.coi.2016.05.01227268395 5.collab: WHOBiologicals: InfluenzaAvailable"/>
   <result pre="InfluenzaAvailable online: https://www.who.int/biologicals/vaccines/influenza/en/(accessed on December 2018) 6.HayA.J.GregoryV.DouglasA.R.LinY.P.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. Lond. B Biol. Sci.20013561861187010.1098/rstb.2001.099911779385 7.FrancisT.J.On"/>
   <result pre="Original Antigenic SinProc. Am. Philos. Soc.1960104572578 8.FonvilleJ.M.WilksS.H.JamesS.L.FoxA.VentrescaM.AbanM.XueL.JonesT.C.LeN.M.H.PhamQ.T.et al.Antibody landscapes after" exact="influenza" post="virus infection or vaccinationScience2014346996100010.1126/science.125642725414313 9.MontoA.S.MaloshR.E.PetrieJ.G.MartinE.T.The Doctrine of Original Antigenic"/>
   <result pre="Good From EvilJ. Infect. Dis.20172151782178810.1093/infdis/jix17328398521 10.LesslerJ.RileyS.ReadJ.M.WangS.ZhuH.SmithG.J.GuanY.JiangC.Q.CummingsD.A.Evidence for antigenic seniority in" exact="influenza" post="A (H3N2) antibody responses in southern ChinaPLoS Pathog.20128e100280210.1371/journal.ppat.100280222829765 11.SkowronskiD.M.ChambersC.De"/>
   <result pre="2010–2011 to 2014–2015J. Infect. Dis.20172151059109910.1093/infdis/jix07428180277 12.MillerM.S.GardnerT.J.KrammerF.AguadoL.C.TortorellaD.BaslerC.F.PaleseP.Neutralizing antibodies against previously encountered" exact="influenza" post="virus strains increase over time: A longitudinal analysisSci. Transl."/>
   <result pre="over time: A longitudinal analysisSci. Transl. Med.20135198ra10710.1126/scitranslmed.300663723946196 13.FangY.BannerD.KelvinA.A.HuangS.S.PaigeC.J.CorfeS.A.KaneK.P.BleackleyR.C.RoweT.LeonA.J.et al.Seasonal H1N1" exact="influenza" post="virus infection induces cross-protective pandemic H1N1 virus immunity through"/>
   <result pre="responses to influenzaSci. Transl. Med.20157316ra19210.1126/scitranslmed.aad052226631631 15.KrammerF.PaleseP.Advances in the development of" exact="influenza" post="virus vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1"/>
   <result pre="vaccinesNat. Rev. Drug Discov.20151416718210.1038/nrd452925722244 16.GosticK.M.AmbroseM.WorobeyM.Lloyd-SmithJ.O.Potent protection against H5N1 and H7N9" exact="influenza" post="via childhood hemagglutinin imprintingScience201635472272610.1126/science.aag132227846599 17.HenryC.PalmA.E.KrammerF.WilsonP.C.From Original Antigenic Sin to"/>
   <result pre="Immunol.201839707910.1016/j.it.2017.08.00328867526 18.HancockK.VeguillaV.LuX.ZhongW.ButlerE.N.SunH.LiuF.DongL.DeVosJ.R.GargiulloP.M.et al.Cross-reactive antibody responses to the 2009 pandemic H1N1" exact="influenza" post="virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and influenza virus"/>
   <result pre="pandemic H1N1 influenza virusN. Engl. J. Med.20093611945195210.1056/NEJMoa090645319745214 19.CobeyS.HensleyS.E.Immune history and" exact="influenza" post="virus susceptibilityCurr. Opin. Virol.20172210511110.1016/j.coviro.2016.12.00428088686 20.LewnardJ.A.CobeyS.Immune History and Influenza Vaccine"/>
   <result pre="December 2018) 23.HerrlerG.KlenkH.D.Structure and function of the HEF glycoprotein of" exact="influenza" post="C virusAdv. Virus Res.1991402132341957719 24.LofgrenE.FeffermanN.H.NaumovY.N.GorskiJ.NaumovaE.N.Influenza seasonality: Underlying causes and"/>
   <result pre="seasonality: Underlying causes and modeling theoriesJ. Virol.2007815429543610.1128/JVI.01680-0617182688 25.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish influenza"/>
   <result pre="of influenza virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 26.TumpeyT.M.BaslerC.F.AguilarP.V.ZengH.SolorzanoA.SwayneD.E.CoxN.J.KatzJ.M.TaubenbergerJ.K.PaleseP.et al.Characterization of the reconstructed 1918 Spanish" exact="influenza" post="pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase"/>
   <result pre="reconstructed 1918 Spanish influenza pandemic virusScience2005310778010.1126/science.111939216210530 27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918" exact="influenza" post="virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do influenza virus subtypes die"/>
   <result pre="27.TaubenbergerJ.K.ReidA.H.LourensR.M.WangR.JinG.FanningT.G.Characterization of the 1918 influenza virus polymerase genesNature200543788989310.1038/nature0423016208372 28.PaleseP.WangT.T.Why do" exact="influenza" post="virus subtypes die out? A hypothesisMBio20112e00150-1110.1128/mBio.00150-1121878571 29.KrammerF.PicaN.HaiR.TanG.S.PaleseP.Hemagglutinin Stalk-Reactive Antibodies"/>
   <result pre="Virol.201286103021030710.1128/JVI.01336-1222787225 30.PicaN.HaiR.KrammerF.WangT.T.MaamaryJ.EgginkD.TanG.S.KrauseJ.C.MoranT.SteinC.R.et al.Hemagglutinin stalk antibodies elicited by the 2009 pandemic" exact="influenza" post="virus as a mechanism for the extinction of seasonal"/>
   <result pre="AntibodiesJ. Virol.2015901116112810.1128/JVI.02372-1526559834 32.PaquetteS.G.HuangS.S.BannerD.XuL.LeomicronnA.KelvinA.A.KelvinD.J.Impaired heterologous immunity in aged ferrets during sequential" exact="influenza" post="A H1N1 infectionVirology2014464–46517718310.1016/j.virol.2014.07.013 33.GamblinS.J.SkehelJ.J.Influenza hemagglutinin and neuraminidase membrane glycoproteinsJ."/>
   <result pre="34.ChenX.LiuS.GorayaM.U.MaaroufM.HuangS.ChenJ.L.Host Immune Response to Influenza A Virus InfectionFront. Immunol.2018932010.3389/fimmu.2018.0032029556226 35.HuangS.S.BannerD.PaquetteS.G.LeonA.J.KelvinA.A.KelvinD.J.Pathogenic" exact="influenza" post="B virus in the ferret model establishes lower respiratory"/>
   <result pre="respiratory tract infectionJ. Gen. Virol.2014952127213910.1099/vir.0.064352-024989173 36.BodewesR.MorickD.de MutsertG.OsingaN.BestebroerT.van der VlietS.SmitsS.L.KuikenT.RimmelzwaanG.F.FouchierR.A.et al.Recurring" exact="influenza" post="B virus infections in sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern"/>
   <result pre="sealsEmerg. Infect. Dis.20131951151210.3201/eid1903.12096523750359 37.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern of the hemagglutinin gene of" exact="influenza" post="B viruses isolated in Japan: Cocirculating lineages in the"/>
   <result pre="monoclonal antibody that targets the fusion domain of group 2" exact="influenza" post="A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to influenza virus"/>
   <result pre="group 2 influenza A virus hemagglutininJ. Virol.201488135801359210.1128/JVI.02289-1425210195 40.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 41.ChenJ.DengY.M.Influenza virus antigenic variation, host"/>
   <result pre="&amp;amp; adaptive immunityFuture Virol.2011695196221909336 43.ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProc."/>
   <result pre="autopsy cases with 2009 H1N1 virus infectionMod. Pathol.20122511310.1038/modpathol.2011.12521874012 45.PanW.DongZ.LiF.MengW.FengL.NiuX.LiC.LuoQ.LiZ.SunC.et al.Visualizing" exact="influenza" post="virus infection in living miceNat. Commun.20134236910.1038/ncomms336924022374 46.PulendranB.MaddurM.S.Innate immune sensing"/>
   <result pre="respond to different microbial antigensJ. Exp. Med.200119486386910.1084/jem.194.6.86311561001 49.IchinoheT.LeeH.K.OguraY.FlavellR.IwasakiA.Inflammasome recognition of" exact="influenza" post="virus is essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171"/>
   <result pre="essential for adaptive immune responsesJ. Exp. Med.2009206798710.1084/jem.2008166719139171 50.WaithmanJ.MinternJ.D.Dendritic cells and" exact="influenza" post="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of"/>
   <result pre="A virus infectionVirulence2012360360810.4161/viru.2186423076333 51.LeonA.J.BannerD.XuL.RanL.PengZ.YiK.ChenC.XuF.HuangJ.ZhaoZ.et al.Sequencing, annotation, and characterization of the" exact="influenza" post="ferret infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets"/>
   <result pre="infectomeJ. Virol.2013871957196610.1128/JVI.02476-1223236062 52.RoweT.LeonA.J.CrevarC.J.CarterD.M.XuL.RanL.FangY.CameronC.M.CameronM.J.BannerD.et al.Modeling host responses in ferrets during A/California/07/2009" exact="influenza" post="infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from"/>
   <result pre="influenza infectionVirology201040125726510.1016/j.virol.2010.02.02020334888 53.SunJ.BracialeT.J.Role of T cell immunity in recovery from" exact="influenza" post="virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human influenza viruses and CD8(+)"/>
   <result pre="immunity in recovery from influenza virus infectionCurr. Opin. Virol.2013342542910.1016/j.coviro.2013.05.00123721865 54.GrantE.J.Quinones-ParraS.M.ClemensE.B.KedzierskaK.Human" exact="influenza" post="viruses and CD8(+) T cell responsesCurr. Opin. Virol.20161613214210.1016/j.coviro.2016.01.01626974887 55.HuffordM.M.KimT.S.SunJ.BracialeT.J.Antiviral"/>
   <result pre="vivoJ. Immunol.20111864599460810.4049/jimmunol.100197221389258 57.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute" exact="influenza" post="virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 58.McKinstryK.K.StruttT.M.BuckA.CurtisJ.D.DibbleJ.P.HustonG.TigheM.HamadaH.SellS.DuttonR.W.et al.IL-10 deficiency"/>
   <result pre="and vaccinesCurr. Opin. Virol.2013352153010.1016/j.coviro.2013.07.00723978327 62.BuiH.H.PetersB.AssarssonE.MbawuikeI.SetteA.Ab and T cell epitopes of" exact="influenza" post="A virus, knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302"/>
   <result pre="knowledge and opportunitiesProc. Natl. Acad. Sci. USA200710424625110.1073/pnas.060933010417200302 63.EllebedyA.H.WebbyR.J.Influenza vaccinesVaccine200927D65D6810.1016/j.vaccine.2009.08.03819837290 64.MontoA.S.Seasonal" exact="influenza" post="and vaccination coverageVaccine201028D33D4410.1016/j.vaccine.2010.08.02720713259 65.TangyeS.G.TarlintonD.M.Memory B cells: Effectors of long-lived"/>
   <result pre="longevity of natural killer cellsImmunol. Rev.2010236839410.1111/j.1600-065X.2010.00900.x20636810 69.ChiuC.EllebedyA.H.WrammertJ.AhmedR.B cell responses to" exact="influenza" post="infection and vaccinationCurr. Top. Microbiol. Immunol.201538638139825193634 70.LipsitchM.ViboudC.Influenza seasonality: Lifting"/>
   <result pre="the fogProc. Natl. Acad. Sci. USA20091063645364610.1073/pnas.090093310619276125 71.SmithW.AndrewesC.H.LaidlawP.A virus isolated from" exact="influenza" post="patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of influenza B viruses,"/>
   <result pre="virus isolated from influenza patientsLancet1933225666810.1016/S0140-6736(00)78541-2 72.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of" exact="influenza" post="B viruses, which caused a large epidemic in 2011–2012,"/>
   <result pre="large epidemic in 2011–2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of" exact="influenza" post="viruses and influenza vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical"/>
   <result pre="2011–2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 73.HannounC.The evolving history of influenza viruses and" exact="influenza" post="vaccinesExpert Rev. Vacc.2013121085109410.1586/14760584.2013.82470924024871 74.TaubenbergerJ.K.ReidA.H.JanczewskiT.A.FanningT.G.Integrating historical, clinical and molecular genetic"/>
   <result pre="to explain the origin and virulence of the 1918 Spanish" exact="influenza" post="virusPhilos. Trans. R Soc. Lond. B Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis"/>
   <result pre="Biol. Sci.20013561829183910.1098/rstb.2001.102011779381 75.WorobeyM.HanG.Z.RambautA.Genesis and pathogenesis of the 1918 pandemic H1N1" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization"/>
   <result pre="Acad. Sci. USA20141118107811210.1073/pnas.132419711124778238 76.TaubenbergerJ.K.ReidA.H.KrafftA.E.BijwaardK.E.FanningT.G.Initial genetic characterization of the 1918 &quot;Spanish&quot;" exact="influenza" post="virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza virusesProc. Natl."/>
   <result pre="the 1918 &quot;Spanish&quot; influenza virusScience19972751793179610.1126/science.275.5307.17939065404 77.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1"/>
   <result pre="influenza virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 78.WertheimJ.O.The re-emergence of H1N1" exact="influenza" post="virus in 1977: A cautionary tale for estimating divergence"/>
   <result pre="United StatesAvailable online: https://www.cdc.gov/flu/about/disease/burden-averted-vaccination.htm.(accessed on December 2018) 80.ShindeV.BridgesC.B.UyekiT.M.ShuB.BalishA.XuX.LindstromS.GubarevaL.V.DeydeV.GartenR.J.et al.Triple-reassortant swine" exact="influenza" post="A (H1) in humans in the United States, 2005–2009N."/>
   <result pre="United States, 2005–2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of" exact="avian influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
   <result pre="States, 2005–2009N. Engl. J. Med.20093602616262510.1056/NEJMoa090381219423871 81.LaiS.QinY.CowlingB.J.RenX.WardropN.A.GilbertM.TsangT.K.WuP.FengL.JiangH.et al.Global epidemiology of avian" exact="influenza" post="A H5N1 virus infection in humans, 1997–2015: A systematic"/>
   <result pre="of individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="individual case dataLancet Infect. Dis.201616e108e11810.1016/S1473-3099(16)00153-527211899 82.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="Influenza Virus: Evidence for Anti-PA-X AntibodiesJ. Virol.2016909383939310.1128/JVI.01408-1627512055 84.PeirisM.YuenK.Y.LeungC.W.ChanK.H.IpP.L.LaiR.W.OrrW.K.ShortridgeK.F.Human infection with" exact="influenza" post="H9N2Lancet199935491691710.1016/S0140-6736(99)03311-510489954 85.collab: CDCHuman Infection with Highly Pathogenic A(H7N7) Avian"/>
   <result pre="Secondary Immune Responses to Influenza VirusesPLoS Pathog.201612e100580610.1371/journal.ppat.100580627537358 89.DuttaA.HuangC.T.LinC.Y.ChenT.C.LinY.C.ChangC.S.HeY.C.Sterilizing immunity to" exact="influenza" post="virus infection requires local antigen-specific T cell response in"/>
   <result pre="in the lungsSci. Rep.201663297310.1038/srep3297327596047 90.EllebedyA.H.AhmedR.Re-engaging cross-reactive memory B cells: The" exact="influenza" post="puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.O’NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza"/>
   <result pre="The influenza puzzleFront. Immunol.201235310.3389/fimmu.2012.0005322566934 91.O’NeillE.KraussS.L.RiberdyJ.M.WebsterR.G.WoodlandD.L.Heterologous protection against lethal A/HongKong/156/97 (H5N1)" exact="influenza" post="virus infection in C57BL/6 miceJ. Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of"/>
   <result pre="Gen. Virol.2000812689269610.1099/0022-1317-81-11-268911038381 92.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of antinucleoprotein IgG to heterosubtypic immunity against" exact="influenza" post="virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal influenza A virus"/>
   <result pre="heterosubtypic immunity against influenza virusJ. Immunol.20111864331433910.4049/jimmunol.100305721357542 93.LaurieK.L.CarolanL.A.MiddletonD.LowtherS.KelsoA.BarrI.G.Multiple infections with seasonal" exact="influenza" post="A virus induce cross-protective immunity against A(H1N1) pandemic influenza"/>
   <result pre="seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic" exact="influenza" post="virus in a ferret modelJ. Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune"/>
   <result pre="Infect. Dis.20102021011102010.1086/65618820715930 94.LiY.MyersJ.L.BostickD.L.SullivanC.B.MadaraJ.LindermanS.L.LiuQ.CarterD.M.WrammertJ.EspositoS.et al.Immune history shapes specificity of pandemic H1N1" exact="influenza" post="antibody responsesJ. Exp. Med.20132101493150010.1084/jem.2013021223857983 95.KosikovaM.LiL.RadvakP.YeZ.WanX.F.XieH.Imprinting of Repeated Influenza A/H3"/>
   <result pre="and Transmission in FerretsJ. Virol.2015903268327310.1128/JVI.02481-1526719251 100.MonsalvoA.C.BatalleJ.P.LopezM.F.KrauseJ.C.KlemencJ.HernandezJ.Z.MaskinB.BugnaJ.RubinsteinC.AguilarL.et al.Severe pandemic 2009 H1N1" exact="influenza" post="disease due to pathogenic immune complexesNat. Med.20111719519910.1038/nm.226221131958 101.collab: PHACFluwatch,"/>
   <result pre="mediocre?Science20173571222122310.1126/science.357.6357.122228935783 109.HoskinsT.W.DaviesJ.R.SmithA.J.MillerC.L.AllchinA.Assessment of inactivated influenza-A vaccine after three outbreaks of" exact="influenza" post="A at Christ’s HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against"/>
   <result pre="HospitalLancet19791333510.1016/S0140-6736(79)90468-983475 110.SkowronskiD.M.ChambersC.De SerresG.SabaiducS.WinterA.L.DickinsonJ.A.GubbayJ.B.DrewsS.J.FonsecaK.CharestH.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010–2011 to"/>
   <result pre="of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal" exact="influenza" post="virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal"/>
   <result pre="influenza virus vaccineJ. Infect. Dis.20001811133113710.1086/31532310720541 112.LeggeA.DoddsL.MacDonaldN.E.ScottJ.McNeilS.Rates and determinants of seasonal" exact="influenza" post="vaccination in pregnancy and association with neonatal outcomesCMAJ2014186E157E16410.1503/cmaj.13049924396098 113.ThompsonM.G.KwongJ.C.ReganA.K.KatzM.A.DrewsS.J.Azziz-BaumgartnerE.KleinN.P.ChungH.EfflerP.V.FeldmanB.S.et"/>
   <result pre="Design Study, 2010–2016Clin. Infec.t Dis.201810.1093/cid/ciy73730307490 114.NicholK.L.MendelmanP.M.MallonK.P.JacksonL.A.GorseG.J.BelsheR.B.GlezenW.P.WittesJ.Effectiveness of live, attenuated intranasal" exact="influenza" post="virus vaccine in healthy, working adults: A randomized controlled"/>
   <result pre="system, co-administered or sequentially administered with an inactivated trivalent seasonal" exact="influenza" post="vaccineBMC Infect. Dis.20121227910.1186/1471-2334-12-27923110320 122.LangleyJ.M.WangL.AggarwalN.BuesoA.ChandrasekaranV.CousinL.HalperinS.A.LiP.LiuA.McNeilS.et al.Immunogenicity and Reactogenicity of an"/>
   <result pre="Multicenter, Multicountry, Clinical TrialJ. Pediatr. Infect. Dis. Soc.2015424225110.1093/jpids/piu09826336604 123.CollieM.H.RushtonD.I.SweetC.SmithH.Studies of" exact="influenza" post="virus infection in newborn ferretsJ. Med. Microbiol.19801356157110.1099/00222615-13-4-5617431374 124.PaquetteS.G.BannerD.HuangS.S.AlmansaR.LeonA.XuL.BartoszkoJ.KelvinD.J.KelvinA.A.Influenza Transmission"/>
   <result pre="infections and vaccinations. The schematic illustrates possible immune fluctuations following" exact="influenza" post="virus infection or vaccination. Immune fluctuations and potential protection"/>
   <result pre="genetic and antigenic relatedness. Immune specificity that is gained during" exact="influenza" post="virus immune imprinting during infancy or childhood leading to"/>
   <result pre="basic 2 (PB2). Figure 3 Timeline of the history of" exact="influenza" post="virus circulation in humans since 1890s. The timeline shows"/>
   <result pre="in humans since 1890s. The timeline shows the history of" exact="influenza" post="virus type A and B circulation since 1890. There"/>
   <result pre="pandemic of ~1891 occurred prior to the discovery of the" exact="influenza" post="virus and is known only by historical medical records."/>
   <result pre="circulation from the 1977 lineage. In addition to circulating seasonal" exact="influenza" post="viruses, avian virus spillover events also lead to human"/>
   <result pre="virus spillover events occurred in 1997 and 2013 for the" exact="influenza" post="A viruses H5N1 and H7N9, respectively. During this time"/>
   <result pre="A viruses H5N1 and H7N9, respectively. During this time period," exact="influenza" post="B viruses have also co-circulated in humans. *Image credit"/>
   <result pre="humans. *Image credit CDC for the 1918 pandemic and the" exact="influenza" post="virion [79]. Figure 4 Influenza immune imprinting and the"/>
   <result pre="Figure 4 Influenza immune imprinting and the history of circulating" exact="influenza" post="viruses. The timeline illustrates the relationship between virus circulation"/>
   <result pre="viruses. The timeline illustrates the relationship between virus circulation and" exact="influenza" post="virus immune imprinting at infancy. Several published studies have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410127\results\search\disease\results.xml">
   <result pre="Rift Valley fever (RVF) is an emerging transboundary, mosquito-borne, zoonotic" exact="viral disease" post="caused high morbidity and mortality in both human and"/>
   <result pre="1. Introduction Rift Valley Fever (RVF) is an acute, arthropod-borne" exact="viral disease" post="of sheep, goats, cattle, camels, and humans caused by"/>
   <result pre="coma encephalitis, and visual hallucination [46], (2) ocular complications including" exact="retinitis" post="and vision loss [47], and (3) hemorrhagic fever with"/>
   <result pre="(4) RVFV disease notification, (5) daily reporting of RVF and" exact="encephalitis" post="cases in humans, (6) surveillance and regular visits to"/>
   <result pre="Crimean-Congo hemorrhagic fever virus, and preM and E genes of" exact="tick-borne encephalitis" post="virus [107]. The DNA vaccine combination produced protective antibodies"/>
   <result pre="hemorrhagic fever virus, and preM and E genes of tick-borne" exact="encephalitis" post="virus [107]. The DNA vaccine combination produced protective antibodies"/>
   <result pre="and One Health Approach RVFV is a highly fatal endemic" exact="viral disease" post="in Egypt and was included by the OIE in"/>
   <result pre="2.MoutaillerS.RocheB.ThibergeJ.-M.CaroV.RougeonF.FaillouxA.-B.Host alternation is necessary to maintain the genome stability of" exact="rift valley fever" post="virusPLoS Negl. Trop. Dis.20115e115610.1371/journal.pntd.000115621629727 3.GerrardS.R.NicholS.T.Synthesis, proteolytic processing and complex"/>
   <result pre="and complex formation of N-terminally nested precursor proteins of the" exact="rift valley fever" post="virus glycoproteinsVirology200735712413310.1016/j.virol.2006.08.00216963099 4.IkegamiT.MakinoS.The pathogenesis of rift valley feverViruses2011349351910.3390/v305049321666766 5.MullerR.PochO.DelarueM.BishopD.H.BouloyM.Rift"/>
   <result pre="regions conserved in RNA-dependent polymerasesJ. Gen. Virol.1994751345135210.1099/0022-1317-75-6-13457515937 6.BillecocqA.SpiegelM.VialatP.KohlA.WeberF.BouloyM.HallerO.Nss protein of" exact="rift valley fever" post="virus blocks interferon production by inhibiting host gene transcriptionJ."/>
   <result pre="8.SuzichJ.KakachL.CollettM.Expression strategy of a phlebovirus: biogenesis of proteins from the" exact="rift valley fever" post="virus M segmentJ. Virol.199064154915552319645 9.IkegamiT.Molecular biology and genetic diversity"/>
   <result pre="virus M segmentJ. Virol.199064154915552319645 9.IkegamiT.Molecular biology and genetic diversity of" exact="rift valley fever" post="virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic hepatitis or rift valley fever. An"/>
   <result pre="and genetic diversity of rift valley fever virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic" exact="hepatitis" post="or rift valley fever. An undescribed virus disease of"/>
   <result pre="diversity of rift valley fever virusAntivi. Res.20129529331010.1016/j.antiviral.2012.06.001 10.DaubneyR.HudsonJ.GarnhamP.Enzootic hepatitis or" exact="rift valley fever." post="An undescribed virus disease of sheep cattle and man"/>
   <result pre="of the regional and national socio-economic impacts of the 2007" exact="rift valley fever" post="outbreak in KenyaAm. J. Trop. Med. Hyg.201083525710.4269/ajtmh.2010.09-029120682906 13.Al-AfaleqA.HusseinM.The status"/>
   <result pre="outbreak in KenyaAm. J. Trop. Med. Hyg.201083525710.4269/ajtmh.2010.09-029120682906 13.Al-AfaleqA.HusseinM.The status of" exact="rift valley fever" post="in animals in Saudi Arabia: A mini reviewVector Borne"/>
   <result pre="as biological weapons: Medical and public health managementJAMA20022872391240510.1001/jama.287.18.239111988060 17.BaudinM.JumaaA.M.JommaH.J.E.KarsanyM.S.BuchtG.NaslundJ.AhlmC.EvanderM.MohamedN.Association of" exact="rift valley fever" post="virus infection with miscarriage in Sudanese women: A cross-sectional"/>
   <result pre="and practices that affect community involvement in the control of" exact="rift valley fever" post="outbreaksPLoS Negl. Trop. Dis.201711e000538310.1371/journal.pntd.000538328207905 19.DrakeJ.M.HassanA.N.BeierJ.C.A statistical model of rift"/>
   <result pre="valley fever outbreaksPLoS Negl. Trop. Dis.201711e000538310.1371/journal.pntd.000538328207905 19.DrakeJ.M.HassanA.N.BeierJ.C.A statistical model of" exact="rift valley fever" post="activity in EgyptJ. Soc. Vector Ecol.20133825125910.1111/j.1948-7134.2013.12038.x 20.McElroyA.AlbariñoC.G.NicholS.T.Development of a"/>
   <result pre="and coding strategies of the S RNAs of Toscana and" exact="rift valley fever" post="viruses compared to those of Punta Toro, Sicilian Sandfly"/>
   <result pre="25.BrennanB.WelchS.ElliottR.The consequences of reconfiguring the Ambisense S genome segment of" exact="rift valley fever" post="virus on viral replication in mammalian and mosquito cells"/>
   <result pre="trade of cattle and camels and the derived risk of" exact="rift valley fever" post="introduction into and transmission within EgyptPLoS Negl. Trop. Dis.201812e000614310.1371/journal.pntd.000614329351273"/>
   <result pre="transmission within EgyptPLoS Negl. Trop. Dis.201812e000614310.1371/journal.pntd.000614329351273 27.CorwinA.HabibM.WattsD.OlsonJ.DarwishM.HibbsR.KilpatrickM.Prevalence of antibody to" exact="rift valley fever" post="virus in the Nile river delta of Egypt, 13"/>
   <result pre="Hyg. (Lond.)19859424124410.1017/S00221724000614413989285 34.LabudaM.NuttallP.Tick-borne virusesParasitology2004129S221S24510.1017/S003118200400522015938513 35.DialloD.BaY.DiaI.LassanaK.DialloM.Use of insecticide-treated cattle to control" exact="rift valley fever" post="and west Nile virus vectors in SenegalBull. Soc. Pathol."/>
   <result pre="governorate, EgyptJ. Med. Entomol.19953257357710.1093/jmedent/32.5.5737473609 38.TurellM.J.PresleyS.M.GadA.M.CopeS.E.DohmD.J.MorrillJ.C.ArthurR.R.Vector competence of Egyptian mosquitoes for" exact="rift valley fever" post="virusAm. J. Trop. Med. Hyg.19965413613910.4269/ajtmh.1996.54.1368619436 39.KenawyM.A.BeierJ.C.ZimmermanJ.H.el SaidS.AbbassyM.M.Host-feeding patterns of"/>
   <result pre="feeding of mosquitoes (diptera: Culicidae) associated with the recurrence of" exact="rift valley fever" post="in EgyptJ. Med. Entomol.19993670971410593070 41.HanafiH.A.FryauffD.J.SaadM.D.SolimanA.K.MoharebE.W.MedhatI.EarhartK.C.Virus isolations and high population"/>
   <result pre="implicate culex antennatus (becker) (diptera: Culicidae) as a vector of" exact="rift valley fever" post="virus during an outbreak in the Nile delta of"/>
   <result pre="ValB.P.RivasR.IglesiasJ.RodriguezF.SolanesD.et al.Experimental infection of young adult European breed sheep with" exact="rift valley fever" post="virus field isolatesVector Borne Zoonotic Dis.20101068969610.1089/vbz.2009.020520854022 44.ArcherB.N.ThomasJ.WeyerJ.CengimboA.LandohD.E.JacobsC.NtuliS.ModiseM.MathonsiM.MashishiM.S.et al.Epidemiologic investigations"/>
   <result pre="isolatesVector Borne Zoonotic Dis.20101068969610.1089/vbz.2009.020520854022 44.ArcherB.N.ThomasJ.WeyerJ.CengimboA.LandohD.E.JacobsC.NtuliS.ModiseM.MathonsiM.MashishiM.S.et al.Epidemiologic investigations into outbreaks of" exact="rift valley fever" post="in humans, South Africa, 2008–2011Emerg. Infect. Dis201319191810.3201/eid1912.12152729360021 45.LaBeaudA.MuchiriE.NdzovuM.MwanjeM.MuiruriS.PetersC.KingC.H.Interepidemic rift"/>
   <result pre="valley fever in humans, South Africa, 2008–2011Emerg. Infect. Dis201319191810.3201/eid1912.12152729360021 45.LaBeaudA.MuchiriE.NdzovuM.MwanjeM.MuiruriS.PetersC.KingC.H.Interepidemic" exact="rift valley fever" post="virus seropositivity, northeastern KenyaEmer. Infect. Dis.2008141240124610.3201/eid1408.08008218680647 46.SeufiA.GalalF.Role of culex"/>
   <result pre="of culex and anopheles mosquito species as potential vectors of" exact="rift valley fever" post="virus in Sudan outbreak, 2007BMC Infect. Dis.2010106510.1186/1471-2334-10-6520222979 47.YoserS.L.ForsterD.J.RaoN.A.Systemic viral"/>
   <result pre="infections and their retinal and choroidal manifestationsSurv. Ophthalmol.19933731335210.1016/0039-6257(93)90064-E8387231 48.MuiruriS.PetersC.J.Clinton WhiteA.LeDucJ.KingC.H.NjengaM.K.MuchiriE.M.Severe" exact="rift valley fever" post="may present with a characteristic clinical syndromeAmer. J. Trop."/>
   <result pre="J. Trop. Med. Hyg.20108237137520207858 49.KortekaasJ.OreshkovaN.van KeulenL.KantJ.BoschB.J.BouloyM.MoulinV.GoovaertsD.MoormannR.J.Comparative efficacy of two next-generation" exact="rift valley fever" post="vaccinesVaccine2014324901490810.1016/j.vaccine.2014.07.03725050973 50.El-MekkiA.A.Female gender: A risk factor for acquiring rift"/>
   <result pre="valley fever vaccinesVaccine2014324901490810.1016/j.vaccine.2014.07.03725050973 50.El-MekkiA.A.Female gender: A risk factor for acquiring" exact="rift valley fever" post="virus infection in Jazan region, southwestern Saudi ArabiaMed. J."/>
   <result pre="Cairo Uni.201482201205 51.NyakarahukaL.de St MauriceA.PurpuraL.ErvinE.BalinandiS.TumusiimeA.KyondoJ.MuleiS.TusiimeP.LutwamaJ.et al.Prevalence and risk factors of" exact="rift valley fever" post="in humans and animals from kabale district in southwestern"/>
   <result pre="district in southwestern Uganda, 2016PLoS Negl. Trop. Dis.201812e000641210.1371/journal.pntd.000641229723189 52.KamalS.A.Observations on" exact="rift valley fever" post="virus and vaccines in EgyptVirol. J.2011853210.1186/1743-422X-8-53222152149 53.MeeganJ.M.The rift valley"/>
   <result pre="rift valley fever virus and vaccines in EgyptVirol. J.2011853210.1186/1743-422X-8-53222152149 53.MeeganJ.M.The" exact="rift valley fever" post="epizootic in Egypt 1977–1978. Description of the epizzotic and"/>
   <result pre="Soc. Trop Med. Hyg.19797361862310.1016/0035-9203(79)90004-X 54.KamalS.A.Pathological studies on postvaccinal reactions of" exact="rift valley fever" post="in goatsVirol. J.200969410.1186/1743-422X-6-9419580675 55.SamyA.M.PetersonA.T.HallM.Phylogeography of rift valley fever virus"/>
   <result pre="reactions of rift valley fever in goatsVirol. J.200969410.1186/1743-422X-6-9419580675 55.SamyA.M.PetersonA.T.HallM.Phylogeography of" exact="rift valley fever" post="virus in Africa and the Arabian peninsulaPLoS Negl. Trop."/>
   <result pre="Egypt. October–December 1977J. Egypt Public Health Assoc.197853123128572393 59.GrobbelaarA.A.WeyerJ.LemanP.A.KempA.PaweskaJ.T.SwanepoelR.Molecular epidemiology of" exact="rift valley fever" post="virusEmerg. Infect. Dis.2011172270227610.3201/eid1712.11103522172568 60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of rift valley fever in"/>
   <result pre="epidemiology of rift valley fever virusEmerg. Infect. Dis.2011172270227610.3201/eid1712.11103522172568 60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of" exact="rift valley fever" post="in EgyptLancet19933421149115010.1016/0140-6736(93)92128-G7901480 61.TahaM.ElianK.MarcossT.MS EmanA.L.Monitoring of rift valley fever virus"/>
   <result pre="60.ArthurR.R.el-SharkawyM.S.CopeS.E.BotrosB.A.OunS.MorrillJ.C.ShopeR.E.HibbsR.G.DarwishM.A.ImamI.Z.Recurrence of rift valley fever in EgyptLancet19933421149115010.1016/0140-6736(93)92128-G7901480 61.TahaM.ElianK.MarcossT.MS EmanA.L.Monitoring of" exact="rift valley fever" post="virus in Egypt during year 2000 using Elisa for"/>
   <result pre="Egypt2018Available online: https://www.who.int/news-room/fact-sheets/detail/rift-valley-fever(accessed on 19 February 2018) 64.MarawanM.A.EbiedM.H.GalilaE.M.YoussefA.I.HassanK.Z.Epidemiological studies on" exact="rift valley fever" post="disease in EgyptBenha Vet. Med. J.201223171184 65.MrozC.GwidaM.El-AshkerM.El-DiastyM.El-BeskawyM.ZieglerU.EidenM.GroschupM.H.Seroprevalence of rift"/>
   <result pre="valley fever disease in EgyptBenha Vet. Med. J.201223171184 65.MrozC.GwidaM.El-AshkerM.El-DiastyM.El-BeskawyM.ZieglerU.EidenM.GroschupM.H.Seroprevalence of" exact="rift valley fever" post="virus in livestock during inter-epidemic period in Egypt, 2014/15BMC"/>
   <result pre="insights into pathogenesis and preventionJ. Virol.2011856098610510.1128/JVI.02641-1021450816 67.JostC.C.NzietchuengS.KihuS.BettB.NjoguG.SwaiE.S.MarinerJ.C.Epidemiological assessment of the" exact="rift valley fever" post="outbreak in Kenya and Tanzania in 2006 and 2007Am."/>
   <result pre="via livestock vaccinationCurr. Opin. Virol.2012231532310.1016/j.coviro.2012.02.01722463980 70.NiklassonB.S.MeadorsG.F.PetersC.J.Active and passive immunization against" exact="rift valley fever" post="virus infection in Syrian hamstersActa. Pathol. Microbiol. Immunol. Scand."/>
   <result pre="71.IkegamiT.MakinoS.Rift valley fever vaccinesVaccine200927Suppl. 4D69D7210.1016/j.vaccine.2009.07.04619837291 72.RandallR.GibbsC.J.Jr.AulisioC.G.BinnL.N.HarrisonV.R.The development of a formalin-killed" exact="rift valley fever" post="virus vaccine for use in manJ. Immunol.19628966067113990748 73.FaburayB.LaBeaudA.D.McVeyD.S.WilsonW.C.RichtJ.A.Current status"/>
   <result pre="virus vaccine for use in manJ. Immunol.19628966067113990748 73.FaburayB.LaBeaudA.D.McVeyD.S.WilsonW.C.RichtJ.A.Current status of" exact="rift valley fever" post="vaccine developmentVaccines (Basel)20175859110.3390/vaccines5030029 74.NiklassonB.PetersC.J.BengtssonE.NorrbyE.Rift valley fever virus vaccine trial:"/>
   <result pre="of neutralizing antibody response in humansVaccine1985312312710.1016/0264-410X(85)90061-14036271 75.PittmanP.R.LiuC.T.CannonT.L.MakuchR.S.MangiaficoJ.A.GibbsP.H.PetersC.J.Immunogenicity of an inactivated" exact="rift valley fever" post="vaccine in humans: A 12-year experienceVaccine19991818118910.1016/S0264-410X(99)00218-210501248 76.BotrosB.OmarA.ElianK.MohamedG.SolimanA.SalibA.SalmanD.SaadM.EarhartK.Adverse response of"/>
   <result pre="of non-indigenous cattle of European breeds to live attenuated Smithburn" exact="rift valley fever" post="vaccineJ. Med. Virol.20067878779110.1002/jmv.2062416628582 77.CaplenH.PetersC.J.BishopD.H.Mutagen-directed attenuation of rift valley fever"/>
   <result pre="Smithburn rift valley fever vaccineJ. Med. Virol.20067878779110.1002/jmv.2062416628582 77.CaplenH.PetersC.J.BishopD.H.Mutagen-directed attenuation of" exact="rift valley fever" post="virus as a method for vaccine developmentJ. Gen. Virol.1985662271227710.1099/0022-1317-66-10-22714045430"/>
   <result pre="reassortant viruses to map attenuating and temperature-sensitive mutations of the" exact="rift valley fever" post="virus mp-12 vaccineVaccine1990836937510.1016/0264-410X(90)90096-52396475 79.MorrillJ.C.MebusC.A.PetersC.J.Safety and efficacy of a mutagen-attenuated"/>
   <result pre="fever virus mp-12 vaccineVaccine1990836937510.1016/0264-410X(90)90096-52396475 79.MorrillJ.C.MebusC.A.PetersC.J.Safety and efficacy of a mutagen-attenuated" exact="rift valley fever" post="virus vaccine in cattleAm. J. Vet. Res.199758110411099328662 80.MorrillJ.C.PetersC.J.Protection of"/>
   <result pre="mp-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent" exact="rift valley fever" post="virusJ. Infect. Dis.201120422923610.1093/infdis/jir24921673033 81.MansfieldK.L.BanyardA.C.McElhinneyL.JohnsonN.HortonD.L.Hernandez-TrianaL.M.FooksA.R.Rift valley fever virus: A review"/>
   <result pre="and implications for emergence in europeVaccine2015335520553110.1016/j.vaccine.2015.08.02026296499 82.KortekaasJ.OreshkovaN.Cobos-JimenezV.VloetR.P.PotgieterC.A.MoormannR.J.Creation of a nonspreading" exact="rift valley fever" post="virusJ. Virol.201185126221263010.1128/JVI.00841-1121957302 83.MullerR.SaluzzoJ.F.LopezN.DreierT.TurellM.SmithJ.BouloyM.Characterization of clone 13, a naturally attenuated"/>
   <result pre="83.MullerR.SaluzzoJ.F.LopezN.DreierT.TurellM.SmithJ.BouloyM.Characterization of clone 13, a naturally attenuated avirulent isolate of" exact="rift valley fever" post="virus, which is altered in the small segmentAm. J."/>
   <result pre="Hyg.19955340541110.4269/ajtmh.1995.53.4057485695 84.DunguB.LouwI.LubisiA.HunterP.von TeichmanB.F.BouloyM.Evaluation of the efficacy and safety of the" exact="rift valley fever" post="clone 13 vaccine in sheepVaccine2010284581458710.1016/j.vaccine.2010.04.08520470792 85.von TeichmanB.EngelbrechtA.ZuluG.DunguB.PardiniA.BouloyM.Safety and efficacy"/>
   <result pre="clone 13 vaccine in sheepVaccine2010284581458710.1016/j.vaccine.2010.04.08520470792 85.von TeichmanB.EngelbrechtA.ZuluG.DunguB.PardiniA.BouloyM.Safety and efficacy of" exact="rift valley fever" post="smithburn and clone 13 vaccines in calvesVaccine2011295771577710.1016/j.vaccine.2011.05.05521664400 86.NjengaM.K.NjagiL.ThumbiS.M.KahaririS.GithinjiJ.OmondiE.BadenA.MurithiM.PaweskaJ.IthondekaP.M.et al.Randomized"/>
   <result pre="controlled field trial to assess the immunogenicity and safety of" exact="rift valley fever" post="clone 13 vaccine in livestockPLoS Negl. Trop. Dis.20159e000355010.1371/journal.pntd.000355025756501 87.DoddK.A.McElroyA.K.JonesT.L.ZakiS.R.NicholS.T.SpiropoulouC.F.Rift"/>
   <result pre="vaccine in livestockPLoS Negl. Trop. Dis.20159e000355010.1371/journal.pntd.000355025756501 87.DoddK.A.McElroyA.K.JonesT.L.ZakiS.R.NicholS.T.SpiropoulouC.F.Rift valley fever virus" exact="encephalitis" post="is associated with an ineffective systemic immune response and"/>
   <result pre="immunocompetent mouse modelPLoS Negl. Trop. Dis.20148e287410.1371/journal.pntd.000287424922480 88.VialatP.BillecocqA.KohlA.BouloyM.The s segment of" exact="rift valley fever" post="phlebovirus (bunyaviridae) carries determinants for attenuation and virulence in"/>
   <result pre="and stillbirthsPLoS Negl. Trop. Dis.201610e000455010.1371/journal.pntd.000455027031621 90.DaouamS.FakriF.EnnajiM.El arkamA.TadlaouiK.OuraC.ElharrakM.Heat stability of the" exact="rift valley fever" post="virus clone 13 live vaccinesTrials Vaccinol.20143616410.1016/j.trivac.2014.03.001 91.DaouamS.GhzalF.ArkamA.E.NaouliY.JazouliM.EnnajiM.M.TadlaouiK.O.OuraC.El HarrakM.Evaluation of"/>
   <result pre="of the safety and efficacy of a live attenuated thermostable" exact="rift valley fever" post="vaccine in sheep, goats and cattleJ. Vaccines Vaccin.20156295 92.PapinJ.F.VerardiP.H.JonesL.A.Monge-NavarroF.BraultA.C.HolbrookM.R.WorthyM.N.FreibergA.N.YilmaT.D.Recombinant"/>
   <result pre="fever vaccine in sheep, goats and cattleJ. Vaccines Vaccin.20156295 92.PapinJ.F.VerardiP.H.JonesL.A.Monge-NavarroF.BraultA.C.HolbrookM.R.WorthyM.N.FreibergA.N.YilmaT.D.Recombinant" exact="rift valley fever" post="vaccines induce protective levels of antibody in baboons and"/>
   <result pre="in miceProc. Natl. Acad. Sci. USA2011108149261493110.1073/pnas.111214910821873194 93.SoiR.K.RurangirwaF.R.McGuireT.C.RwamboP.M.DeMartiniJ.C.CrawfordT.B.Protection of sheep against" exact="rift valley fever" post="virus and sheep poxvirus with a recombinant capripoxvirus vaccineClin."/>
   <result pre="feverSci. Rep.201662061710.1038/srep2061726847478 96.WarimweG.M.LorenzoG.Lopez-GilE.Reyes-SandovalA.CottinghamM.G.SpencerA.J.CollinsK.A.DicksM.D.MilicicA.LallA.et al.Immunogenicity and efficacy of a chimpanzee adenovirus-vectored" exact="rift valley fever" post="vaccine in miceVirol. J.20131034910.1186/1743-422X-10-34924304565 97.Lopez-GilE.LorenzoG.HeviaE.BorregoB.EidenM.GroschupM.GilbertS.C.BrunA.A single immunization with MVA"/>
   <result pre="RVFV infectionPLoS Negl. Trop. Dis.20137e230910.1371/journal.pntd.000230923875044 98.KortekaasJ.AntonisA.F.KantJ.VloetR.P.VogelA.OreshkovaN.de BoerS.M.BoschB.J.MoormannR.J.Efficacy of three candidate" exact="rift valley fever" post="vaccines in sheepVaccine2012303423342910.1016/j.vaccine.2012.03.02722449427 99.KortekaasJ.DekkerA.de BoerS.M.WeerdmeesterK.VloetR.P.de WitA.A.PeetersB.P.MoormannR.J.Intramuscular inoculation of calves"/>
   <result pre="experimental newcastle disease virus-based vector vaccine elicits neutralizing antibodies against" exact="rift valley fever" post="virusVaccine2010282271227610.1016/j.vaccine.2010.01.00120079874 100.HeiseM.T.WhitmoreA.ThompsonJ.ParsonsM.GrobbelaarA.A.KempA.PaweskaJ.T.MadricK.WhiteL.J.SwanepoelR.et al.An alphavirus replicon-derived candidate vaccine against rift"/>
   <result pre="valley fever virusVaccine2010282271227610.1016/j.vaccine.2010.01.00120079874 100.HeiseM.T.WhitmoreA.ThompsonJ.ParsonsM.GrobbelaarA.A.KempA.PaweskaJ.T.MadricK.WhiteL.J.SwanepoelR.et al.An alphavirus replicon-derived candidate vaccine against" exact="rift valley fever" post="virusEpidemiol. Infect.20091371309131810.1017/S095026880800169619171081 101.SaidA.ElmanzalawyM.MaG.DamianiA.M.OsterriederN.An equine herpesvirus type 1 (EHV-1) vector"/>
   <result pre="virusEpidemiol. Infect.20091371309131810.1017/S095026880800169619171081 101.SaidA.ElmanzalawyM.MaG.DamianiA.M.OsterriederN.An equine herpesvirus type 1 (EHV-1) vector expressing" exact="rift valley fever" post="virus (RVFV) GN and GC induces neutralizing antibodies in"/>
   <result pre="future?Arch. Immunol. Ther. Exp.20075538739810.1007/s00005-007-0044-418060369 107.SpikK.ShurtleffA.McElroyA.K.GuttieriM.C.HooperJ.W.SchmalJohnC.Immunogenicity of combination DNA vaccines for" exact="rift valley fever" post="virus, tick-borne encephalitis virus, hantaan virus, and crimean congo"/>
   <result pre="107.SpikK.ShurtleffA.McElroyA.K.GuttieriM.C.HooperJ.W.SchmalJohnC.Immunogenicity of combination DNA vaccines for rift valley fever virus," exact="tick-borne encephalitis" post="virus, hantaan virus, and crimean congo hemorrhagic fever virusVaccine2006244657466610.1016/j.vaccine.2005.08.03416174542"/>
   <result pre="of combination DNA vaccines for rift valley fever virus, tick-borne" exact="encephalitis" post="virus, hantaan virus, and crimean congo hemorrhagic fever virusVaccine2006244657466610.1016/j.vaccine.2005.08.03416174542"/>
   <result pre="immune responses and protective efficacy in mice after immunisation with" exact="rift valley fever" post="virus cDNA constructsVirol. J.20096610.1186/1743-422X-6-619149901 109.LorenzoG.Martin-FolgarR.HeviaE.BoshraH.BrunA.Protection against lethal rift valley"/>
   <result pre="rift valley fever virus cDNA constructsVirol. J.20096610.1186/1743-422X-6-619149901 109.LorenzoG.Martin-FolgarR.HeviaE.BoshraH.BrunA.Protection against lethal" exact="rift valley fever" post="virus (RVFV) infection in transgenic ifnar(-/-) mice induced by"/>
   <result pre="110.HabjanM.PenskiN.SpiegelM.WeberF.T7 RNA polymerase-dependent and -independent systems for cdna-based rescue of" exact="rift valley fever" post="virusJ. Gen. Virol.2008892157216610.1099/vir.0.2008/002097-018753225 111.LiuL.CelmaC.C.RoyP.Rift valley fever virus structural proteins:"/>
   <result pre="particles expressing the nucleocapsid gene as an efficient vaccine against" exact="rift valley fever" post="virusVector Borne Zoonotic Dis.20101070170310.1089/vbz.2009.024820854024 113.BeyerT.HerrmannM.ReiserC.BertlingW.HessJ.Bacterial carriers and virus-like-particles as"/>
   <result pre="Targ. Infect. Disord.2001128730210.2174/1568005014605973 114.MandellR.B.KoukuntlaR.MoglerL.J.CarzoliA.K.HolbrookM.R.MartinB.K.VahanianN.LinkC.J.FlickR.Novel suspension cell-based vaccine production systems for" exact="rift valley fever" post="virus-like particlesJ. Virol. Methods201016925926810.1016/j.jviromet.2010.07.01520655330 115.NaslundJ.LagerqvistN.HabjanM.LundkvistA.EvanderM.AhlmC.WeberF.BuchtG.Vaccination with virus-like particles protects"/>
   <result pre="115.NaslundJ.LagerqvistN.HabjanM.LundkvistA.EvanderM.AhlmC.WeberF.BuchtG.Vaccination with virus-like particles protects mice from lethal infection of" exact="rift valley fever" post="virusVirology200938540941510.1016/j.virol.2008.12.01219157482 116.FaburayB.WilsonW.C.GaudreaultN.N.DavisA.S.ShivannaV.BawaB.SunwooS.Y.MaW.DroletB.S.MorozovI.et al.A recombinant rift valley fever virus glycoprotein"/>
   <result pre="lethal infection of rift valley fever virusVirology200938540941510.1016/j.virol.2008.12.01219157482 116.FaburayB.WilsonW.C.GaudreaultN.N.DavisA.S.ShivannaV.BawaB.SunwooS.Y.MaW.DroletB.S.MorozovI.et al.A recombinant" exact="rift valley fever" post="virus glycoprotein subunit vaccine confers full protection against rift"/>
   <result pre="valley fever virus glycoprotein subunit vaccine confers full protection against" exact="rift valley fever" post="challenge in sheepSci. Rep.201662771910.1038/srep2771927296136 117.FaburayB.LebedevM.McVeyD.S.WilsonW.MorozovI.YoungA.RichtJ.A.A glycoprotein subunit vaccine elicits"/>
   <result pre="in sheepSci. Rep.201662771910.1038/srep2771927296136 117.FaburayB.LebedevM.McVeyD.S.WilsonW.MorozovI.YoungA.RichtJ.A.A glycoprotein subunit vaccine elicits a strong" exact="rift valley fever" post="virus neutralizing antibody response in sheepVector Borne Zoonotic Dis.20141474675610.1089/vbz.2014.165025325319"/>
   <result pre="119.StobartC.C.MooreM.L.RNA virus reverse genetics and vaccine designViruses201462531255010.3390/v607253124967693 120.Wichgers SchreurP.J.OreshkovaN.MoormannR.J.KortekaasJ.Creation of" exact="rift valley fever" post="viruses with four-segmented genomes reveals flexibility in bunyavirus genome"/>
   <result pre="packagingJ. Virol.201488108831089310.1128/JVI.00961-1425008937 121.ChenH.AngelM.LiW.FinchC.GonzalezA.S.SuttonT.SantosJ.PerezD.R.All-in-one bacmids: An efficient reverse genetics strategy for" exact="influenza" post="a virus vaccinesJ. Virol.201488100131002510.1128/JVI.01468-1424942589 122.HuB.JiangJ.ZhanJ.LiG.JiangY.GuanX.ChenY.FangZ.Development of a reverse genetics"/>
   <result pre="viral RNA for the rescue of infectious virulent and avirulent" exact="rift valley fever" post="virusesVirology200837837738410.1016/j.virol.2008.05.03318614193 124.IkegamiT.WonS.PetersC.J.MakinoS.Rescue of infectious rift valley fever virus entirely"/>
   <result pre="virulent and avirulent rift valley fever virusesVirology200837837738410.1016/j.virol.2008.05.03318614193 124.IkegamiT.WonS.PetersC.J.MakinoS.Rescue of infectious" exact="rift valley fever" post="virus entirely from cDNA, analysis of virus lacking the"/>
   <result pre="in adult and pregnant sheepJ. Virol.201185129011290910.1128/JVI.06046-1121976656 126.MorrillJ.C.LaughlinR.C.LokugamageN.WuJ.PughR.KananiP.AdamsL.G.MakinoS.PetersC.J.Immunogenicity of a recombinant" exact="rift valley fever" post="mp-12-nsm deletion vaccine candidate in calvesVaccine2013314988499410.1016/j.vaccine.2013.08.00323994375 127.WeingartlH.M.NfonC.K.ZhangS.MarszalP.WilsonW.C.MorrillJ.C.BettingerG.E.PetersC.J.Efficacy of a"/>
   <result pre="mp-12-nsm deletion vaccine candidate in calvesVaccine2013314988499410.1016/j.vaccine.2013.08.00323994375 127.WeingartlH.M.NfonC.K.ZhangS.MarszalP.WilsonW.C.MorrillJ.C.BettingerG.E.PetersC.J.Efficacy of a recombinant" exact="rift valley fever" post="virus mp-12 with nsm deletion as a vaccine candidate"/>
   <result pre="vaccine candidate in sheepVaccine2014322345234910.1016/j.vaccine.2013.12.06424462482 128.SmithD.R.JohnstonS.C.PiperA.BottoM.DonnellyG.ShamblinJ.AlbarinoC.G.HensleyL.E.SchmaljohnC.NicholS.T.et al.Attenuation and efficacy of live-attenuated" exact="rift valley fever" post="virus vaccine candidates in non-human primatesPLoS Negl. Trop. Dis.201812e000647410.1371/journal.pntd.000647429742102"/>
   <result pre="Dis.201812e000647410.1371/journal.pntd.000647429742102 129.YoussefB.Study the immune response for sheep and cattle with" exact="rift valley fever" post="inactivated and attenuated vaccineAlex J. Med. Sci.2004208597 Figure 1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410217\results\search\disease\results.xml">
   <result pre="of effective therapeutic strategies, vector control measures, and eradication actions." exact="chikungunya" post="virus viral tropism arthropod vectors animal hosts pathogenesis vertical"/>
   <result pre="the midgut to secondary organs, as follows: (i) newly formed" exact="chikungunya" post="virions accumulate at the level of the midgut basal"/>
   <result pre="important for the efficient infection of alphaviruses (i.e., Eastern equine" exact="encephalitis" post="virus (EEEV) and Venezuelan equine encephalitis virus (VEEV)), have"/>
   <result pre="alphaviruses (i.e., Eastern equine encephalitis virus (EEEV) and Venezuelan equine" exact="encephalitis" post="virus (VEEV)), have been implicated in CHIKV attachment (reviewed"/>
   <result pre="for clinicians, nowadays, is to differentiate the clinical signs of" exact="chikungunya" post="from those of Zika and dengue fever, especially when"/>
   <result pre="the clinical signs of chikungunya from those of Zika and" exact="dengue fever," post="especially when these viruses are co-circulating. Unlike ZIKV and"/>
   <result pre="the bite of Aedes spp. mosquito vectors, and causes the" exact="chikungunya" post="virus disease (CHIKD), characterized, in the acute phase, by"/>
   <result pre="can occur, and range from photophobia to retro-orbital pain and" exact="conjunctivitis" post="[95]. Chikungunya chronic disease is characterized by the persistence"/>
   <result pre="may present for several weeks to months, and may mimic" exact="rheumatoid arthritis." post="Rodriguez-Morales and coworkers systematically reviewed the data on post-chikungunya"/>
   <result pre="systematically reviewed the data on post-chikungunya infection with chronic inflammatory" exact="arthritis" post="in reports published from 2007 to 2015, and calculated"/>
   <result pre="to the occurrence of severe manifestations [100,101,102]. Unusual manifestations of" exact="chikungunya" post="infection comprise cardiovascular, renal, cutaneous, ocular, hepatic, and respiratory"/>
   <result pre="(approximately 0.1% of CHIKV infection develops neurological disorders), most commonly" exact="encephalitis" post="and encephalopathy, prompted the investigation of CHIKV tropism for"/>
   <result pre="the central nervous system (CNS) [107]. Acute flaccid paralysis and" exact="meningoencephalitis" post="have also been described [99,108,109]. Moreover, Guillain–Barré syndrome (GBS),"/>
   <result pre="described [99,108,109]. Moreover, Guillain–Barré syndrome (GBS), an acute inflammatory demyelinating" exact="polyneuropathy" post="that usually occurs after infection by a variety of"/>
   <result pre="Importantly, the inhibition of monocytes/macrophages recruitment or macrophages depletion attenuated" exact="arthritis" post="and joint swelling in mouse models [165,167], but resulted"/>
   <result pre="in vitro infection of human cells demonstrated the susceptibility of" exact="neuroblastoma" post="cells (neural crest derived cells) [172,173], and of glial"/>
   <result pre="cells [176,177] to CHIKV. The apoptosis observed in CHIKV infected" exact="neuroblastoma" post="cells and astrocytes suggests a direct implication of viral"/>
   <result pre="CHIKV patients. Ocular diseases present mainly as retro-orbital pain or" exact="conjunctivitis" post="at the time of CHIKV systemic illness, and predominantly"/>
   <result pre="of CHIKV systemic illness, and predominantly as uveitis, retinitis, or" exact="optic neuritis" post="in later phases and recurrences [107,183,184,185,186]. The presence of"/>
   <result pre="organs targeted by CHIKV may explain the rare consequences of" exact="chikungunya" post="infection, and the clinical manifestations observed in patients (i.e.,"/>
   <result pre="use recombinant replication-deficient viruses as antigen delivery vectors (i.e., the" exact="measles" post="virus (MV-CHIV) and adenovirus derived from a chimpanzee (ChAdOx))"/>
   <result pre="the Entebbe peninsulaTrans. R. Soc. Trop. Med. Hyg.19585225825913556870 3.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence of" exact="chikungunya" post="and o’nyong-nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="Viruses Causing the Indian Ocean OutbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 6.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection with" exact="chikungunya" post="virus in Italy: An outbreak in a temperate regionLancet20073701840184610.1016/S0140-6736(07)61779-618061059"/>
   <result pre="goegraphic strains of Aedes albopictus in susceptibility to infection with" exact="chikungunya" post="virusAm. J. Trop. Med. Hyg.19762532633510.4269/ajtmh.1976.25.3261259092 16.TsetsarkinK.A.ChenR.ShermanM.B.WeaverS.C.Chikungunya virus: Evolution and"/>
   <result pre="genetic determinants of emergenceCurr. Opin. Virol.2011131031710.1016/j.coviro.2011.07.00421966353 17.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 18.ThibervilleS.-D.MoyenN.Dupuis-MaguiragaL.NougairedeA.GouldE.A.RoquesP.de"/>
   <result pre="FranceEmerg. Infect. Dis.20111791091310.3201/eid1705.10187321529410 21.BordiL.CarlettiF.LalleE.ColavitaF.MeschiS.Di CaroA.NicastriE.ScognamiglioP.VairoF.Di LalloD.et al.Molecular characterization of autochthonous" exact="chikungunya" post="cluster in latium region, ItalyEmerg. Infect. Dis.20182417818010.3201/eid2401.171605 22.TsetsarkinK.A.WeaverS.C.Sequential Adaptive"/>
   <result pre="and Its Epidemic EmergencePLoS Pathog.20117e100241210.1371/journal.ppat.100241222174678 23.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
   <result pre="LevelPLoS ONE20138e5754810.1371/journal.pone.005754823437397 25.JuppP.G.McIntoshB.M.Aedes furcifer and other mosquitoes as vectors of" exact="chikungunya" post="virus at Mica, northeastern Transvaal, South AfricaJ. Am. Mosq."/>
   <result pre="vector studies on six mosquito and one tick species with" exact="chikungunya" post="virusTrans. R. Soc. Trop. Med. Hyg.198175151910.1016/0035-9203(81)90005-56115488 27.DialloM.ThonnonJ.Traore-lamizanaM.FontenilleD.Vectors of Chikungunya"/>
   <result pre="transmission cyclesAm. J. Trop. Med. Hyg.19996028128610.4269/ajtmh.1999.60.28110072152 28.McIntoshB.M.PatersonH.E.McGillivrayG.DesousaJ.Further studies on the" exact="chikungunya" post="outbreak in Rhodesia. I. Mosquitoes, wild primates and birds"/>
   <result pre="Aedes bromeliae and Aedes vitattus mosquito populations from Kenya for" exact="chikungunya" post="virusPLoS Negl. Trop. Dis.201812e000674610.1371/journal.pntd.000674630321181 35.RichardV.PaoaafaiteT.Cao-LormeauV.-M.Vector Competence of Aedes aegypti"/>
   <result pre="of arboviruses in citiesPLoS Negl. Trop. Dis.20171111710.1371/journal.pntd.000566728650959 37.Lourenço-de-OliveiraR.FaillouxA.B.High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="new European invader Aedes (Finlaya) koreicus: A potential vector of" exact="chikungunya" post="virusPathog. Glob. Health201811210711410.1080/20477724.2018.146478029737236 41.FrosJ.J.GeertsemaC.ZouacheK.BaggenJ.DomeradzkaN.Van LeeuwenD.M.FlipseJ.VlakJ.M.FaillouxA.B.PijlmanG.P.Mosquito Rasputin interacts with chikungunya"/>
   <result pre="of chikungunya virusPathog. Glob. Health201811210711410.1080/20477724.2018.146478029737236 41.FrosJ.J.GeertsemaC.ZouacheK.BaggenJ.DomeradzkaN.Van LeeuwenD.M.FlipseJ.VlakJ.M.FaillouxA.B.PijlmanG.P.Mosquito Rasputin interacts with" exact="chikungunya" post="virus nsP3 and determines the infection rate in Aedes"/>
   <result pre="method on susceptibility of Aedes aegypti and Aedes albopictus to" exact="chikungunya" post="virusJ. Med. Entomol.20094639539910.1603/033.046.022819351094 43.LeeR.C.H.HapuarachchiH.C.ChenK.C.HussainK.M.ChenH.LowS.L.NgL.C.LinR.NgM.M.L.ChuJ.J.H.Mosquito Cellular Factors and Functions in"/>
   <result pre="digestionPLoS Negl. Trop. Dis.20171112610.1371/journal.pntd.000597628961239 45.DongS.KantorA.M.LinJ.PassarelliA.L.ClemR.J.FranzA.W.E.Infection pattern and transmission potential of" exact="chikungunya" post="virus in two New World laboratory-adapted Aedes aegypti strainsSci."/>
   <result pre="New World laboratory-adapted Aedes aegypti strainsSci. Rep.201662472910.1038/srep2472927102548 46.KantorA.M.GrantD.G.BalaramanV.WhiteT.A.FranzA.W.E.Ultrastructural analysis of" exact="chikungunya" post="virus dissemination from the midgut of the yellow fever"/>
   <result pre="analysis of chikungunya virus dissemination from the midgut of the" exact="yellow fever" post="mosquito, aedes aegyptiViruses20181057110.3390/v1010057130340365 47.BowersD.F.ColemanC.G.BrownD.T.Sindbis virus-associated pathology in Aedes albopictus"/>
   <result pre="in salivary glands of the mosquito aedes albopictusViruses201575902590710.3390/v711291726593936 52.Tchankouo-NguetcheuS.BourguetE.LenormandP.RousselleJ.-C.NamaneA.ChoumetV.Infection by" exact="chikungunya" post="virus modulates the expression of several proteins in Aedes"/>
   <result pre="Aedes aegypti salivary glandsParasit. Vectors2012526410.1186/1756-3305-5-26423153178 53.Le CoupanecA.Tchankouo-NguetcheuS.RouxP.KhunH.HuerreM.Morales-VargasR.EnguehardM.LavilletteD.MisséD.ChoumetV.Co-infection of mosquitoes with" exact="chikungunya" post="and dengue viruses reveals modulation of the replication of"/>
   <result pre="Reveals Impact on Egg-Laying PathwaysJ. Med. Entomol.2018551580158710.1093/jme/tjy09729931258 58.ThavaraU.TawatsinA.PengsakulT.BhakdeenuanP.ChanamaS.AnantapreechaS.MolitoC.ChompoosriJ.ThammapaloS.SawanpanyalertP.et al.Outbreak of" exact="chikungunya" post="fever in Thailand and virus detection in field population"/>
   <result pre="Trop. Med. Public Health20094095196219842379 59.JainJ.KushwahR.B.S.SinghS.S.SharmaA.AdakT.SinghO.P.BhatnagarR.K.SubbaraoS.K.SunilS.Evidence for natural vertical transmission of" exact="chikungunya" post="viruses in field populations of Aedes aegypti in Delhi"/>
   <result pre="preliminary reportActa Trop.2016162465510.1016/j.actatropica.2016.06.00427282096 60.ChompoosriJ.ThavaraU.TawatsinA.BoonsermR.PhumeeA.SangkitpornS.SiriyasatienP.Vertical transmission of Indian Ocean Lineage of" exact="chikungunya" post="virus in Aedes aegypti and Aedes albopictus mosquitoesParasit. Vectors2016922710.1186/s13071-016-1505-627108077"/>
   <result pre="Virus in Aedes aegyptiPLoS Negl. Trop. Dis.20148e299010.1371/journal.pntd.000299025080107 62.WongH.V.VythilingamI.SulaimanW.Y.W.LullaA.MeritsA.ChanY.F.SamI.C.Detection of persistent" exact="chikungunya" post="virus RNA but not infectious virus in experimental vertical"/>
   <result pre="arbovirusesAnnu. Rev. Entomol.19832822926210.1146/annurev.en.28.010183.0013056131642 65.MascarenhasM.GarasiaS.BerthiaumeP.CorrinT.GreigJ.NgV.YoungI.WaddellL.A scoping review of published literature on" exact="chikungunya" post="virusPLoS ONE201813e020755410.1371/journal.pone.020755430496207 66.AlthouseB.M.GuerboisM.CummingsD.A.T.DiopO.M.FayeO.FayeA.DialloD.SadioB.D.SowA.FayeO.et al.Role of monkeys in the sylvatic"/>
   <result pre="ONE201813e020755410.1371/journal.pone.020755430496207 66.AlthouseB.M.GuerboisM.CummingsD.A.T.DiopO.M.FayeO.FayeA.DialloD.SadioB.D.SowA.FayeO.et al.Role of monkeys in the sylvatic cycle of" exact="chikungunya" post="virus in SenegalNat. Commun.2018911010.1038/s41467-018-03332-729317637 67.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic circulation of chikungunya virus"/>
   <result pre="cycle of chikungunya virus in SenegalNat. Commun.2018911010.1038/s41467-018-03332-729317637 67.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic circulation of" exact="chikungunya" post="virus in East Africa: Serological evidence in non-human Kenyan"/>
   <result pre="Kenyan primatesAm. J. Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 68.OsterriethP.RatheE.Deleplanque-LiegeoisP.[Simultaneous isolation of the" exact="yellow fever" post="and Chikungunya viruses at Bili (Haut-Uele, Belgian Congo)]Ann. la"/>
   <result pre="Transplant.20016431031610.4269/ajtmh.2001.64.310 74.SamI.C.ChuaC.L.Rovie-RyanJ.J.FuJ.Y.L.TongC.SitamF.T.ChanY.F.Chikungunya virus in macaques, MalaysiaEmerg. Infect. Dis.2015211683168510.3201/eid2109.15043926291585 75.NakgoiK.NitatpattanaN.WajjwalkuW.PongsopawijitP.KaewchotS.YoksanS.SiripolwatV.SourisM.GonzalezJ.P.Dengue, Japanese" exact="encephalitis" post="and Chikungunya virus antibody prevalence among captive monkey (Macaca"/>
   <result pre="monkeys in the Philippines.pdfJ. Med. Primatol.200332899410.1034/j.1600-0684.2003.00015.x12823631 78.ApandiY.NazniW.A.AzleenZ.A.N.VythilingamI.NoorazianM.Y.AzahariA.H.ZainahS.LeeH.L.The first isolation of" exact="chikungunya" post="virus from non-human primates in MalaysiaJ. Gen. Mol. Virol.200913539"/>
   <result pre="in BrazilmSphere20183e00523-1710.1128/mSphere.00523-1729404420 80.Bosco-LauthA.M.HartwigA.E.BowenR.A.Reptiles and amphibians as potential reservoir hosts of" exact="chikungunya" post="virusAm. J. Trop. Med. Hyg.20189884184410.4269/ajtmh.17-073029313469 81.Bosco-LauthA.M.NemethN.M.KohlerD.J.BowenR.A.Viremia in North American"/>
   <result pre="in North American mammals and birds after experimental infection with" exact="chikungunya" post="virusesAm. J. Trop. Med. Hyg.20169450450610.4269/ajtmh.15-069626666699 82.McIntoshB.M.Antibody against Chikungunya virus"/>
   <result pre="Southern AfricaS. Afr. J. Med. Sci.19703565744398581 83.van Duijl-RichterM.K.S.HoornwegT.E.Rodenhuis-ZybertI.A.SmitJ.M.Early events in" exact="chikungunya" post="virus infection—From virus cell binding to membrane fusionViruses201573647367410.3390/v707279226198242 84.WintachaiP.WikanN.KuadkitkanA.JaimipukT.UbolS.PulmanausahakulR.AuewarakulP.KasinrerkW.WengW.Y.PanyasrivanitM.et"/>
   <result pre="virus receptor proteinJ. Med. Virol.2012841757177010.1002/jmv.2340322997079 85.WintachaiP.ThuaudF.BasmadjianC.RoytrakulS.UbolS.DésaubryL.SmithD.R.Assessment of flavaglines as potential" exact="chikungunya" post="virus entry inhibitorsMicrobiol. Immunol.20155912914110.1111/1348-0421.1223025643977 86.ZhangR.KimA.S.FoxJ.M.NairS.BasoreK.KlimstraW.B.RimkunasR.FongR.H.LinH.PoddarS.et al.Mxra8 is a receptor"/>
   <result pre="Mosquito Cell LineIntervirology20186024726210.1159/000489308 88.FongsaranC.JirakanwisalK.KuadkitkanA.WikanN.WintachaiP.ThepparitC.UbolS.PhaonakropN.RoytrakulS.SmithD.R.Involvement of ATP synthase β subunit in" exact="chikungunya" post="virus entry into insect cellsArch. Virol.20141593353336410.1007/s00705-014-2210-425168043 89.HabyM.M.PinartM.EliasV.ReveizL.Prevalence of asymptomatic"/>
   <result pre="and the eyeInt. J. Retin. Vitr.20173410.1186/s40942-016-0057-428163928 96.FourieE.D.MorrisonJ.G.Rheumatoid arthritic syndrome after" exact="chikungunya" post="feverS. Afr. Med. J.197956130132494034 97.AalstV.NelenC.M.GoorhuisA.StijnisC.GrobuschM.P.Long-term sequelae of chikungunya virus"/>
   <result pre="syndrome after chikungunya feverS. Afr. Med. J.197956130132494034 97.AalstV.NelenC.M.GoorhuisA.StijnisC.GrobuschM.P.Long-term sequelae of" exact="chikungunya" post="virus disease: A systematic reviewTravel Med. Infect. Dis.20171582210.1016/j.tmaid.2017.01.00428163198 98.Rodríguez-MoralesA.J.Cardona-OspinaJ.A.Fernanda"/>
   <result pre="the 2017 Italian OutbreakOpen Forum Infect. Dis.20185ofy27610.1093/ofid/ofy27630539034 101.LemantJ.BoissonV.WinerA.ThibaultL.AndréH.TixierF.LemercierM.AntokE.CrestaM.P.GrivardP.et al.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the reunion island"/>
   <result pre="the reunion island outbreak in 2005–2006Crit. Care Med.2008362536254110.1097/CCM.0b013e318183f2d218679124 102.RenaultP.BalleydierE.D’OrtenzioE.BâvilleM.FilleulL.Epidemiology of" exact="chikungunya" post="infection on Reunion Island, Mayotte, and neighboring countriesMédecine Mal."/>
   <result pre="Island, Mayotte, and neighboring countriesMédecine Mal. Infect.2012429310110.1016/j.medmal.2011.12.002 103.RajapakseS.RodrigoC.RajapakseA.Atypical manifestations of" exact="chikungunya" post="infectionTrans. R. Soc. Trop. Med. Hyg.2010104899610.1016/j.trstmh.2009.07.03119716149 104.MercadoM.Acosta-ReyesJ.ParraE.GuzmánL.BeltránM.GasqueP.Mejía-GarcíaC.ViasusD.Renal involvement in"/>
   <result pre="Soc. Trop. Med. Hyg.2010104899610.1016/j.trstmh.2009.07.03119716149 104.MercadoM.Acosta-ReyesJ.ParraE.GuzmánL.BeltránM.GasqueP.Mejía-GarcíaC.ViasusD.Renal involvement in fatal cases of" exact="chikungunya" post="virus infectionJ. Clin. Virol.2018103161810.1016/j.jcv.2018.03.00929604514 105.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal"/>
   <result pre="Virol.2018103161810.1016/j.jcv.2018.03.00929604514 105.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of" exact="chikungunya" post="fever: A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 106.DuttaP.SharmaA.A case of atypical"/>
   <result pre="ophthalmoplegia after Chikungunya feverInt. Ophthalmol.20183883783910.1007/s10792-017-0529-z28397145 107.MehtaR.GerardinP.de BritoC.A.A.SoaresC.N.FerreiraM.L.B.SolomonT.The neurological complications of" exact="chikungunya" post="virus: A systematic reviewRev. Med. Virol.201828e197810.1002/rmv.197829671914 108.ShardaM.MeenaH.Neurological complications in"/>
   <result pre="Phys. India200755765769 109.SinghS.S.ManimundaS.P.SugunanA.P.VijayachariP.Four cases of acute flaccid paralysis associated with" exact="chikungunya" post="virus infectionEpidemiol. Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-Barré syndrome complicating a chikungunya virus"/>
   <result pre="associated with chikungunya virus infectionEpidemiol. Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-Barré syndrome complicating a" exact="chikungunya" post="virus infectionNeurology2007692105210710.1212/01.wnl.0000277267.07220.8818040016 111.AcevedoN.WaggonerJ.RodriguezM.RiveraL.LandivarJ.PinskyB.ZambranoH.Zika virus, chikungunya virus, and dengue virus"/>
   <result pre="Infect.20081361277128010.1017/S095026880700973918634716 110.WielanekA.C.MonredonJ.D.AmraniM.E.RogerJ.C.ServeauxJ.P.Guillain-Barré syndrome complicating a chikungunya virus infectionNeurology2007692105210710.1212/01.wnl.0000277267.07220.8818040016 111.AcevedoN.WaggonerJ.RodriguezM.RiveraL.LandivarJ.PinskyB.ZambranoH.Zika virus," exact="chikungunya" post="virus, and dengue virus in cerebrospinal fluid from adults"/>
   <result pre="SilvaM.T.T.Rosala-HallasA.JardimM.R.BurnsideG.PamplonaL.BhojakM.et al.The spectrum of neurological disease associated with Zika and" exact="chikungunya" post="viruses in adults in Rio de Janeiro, Brazil: A"/>
   <result pre="for Viral InfectionCell. Physiol. Biochem.2018512377239610.1159/00049589730537741 115.SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.KraxnerA.TschoppJ.HiggsS.MichaultA.et al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960"/>
   <result pre="Inhibits Type I/II Interferon-Stimulated JAK-STAT SignalingJ. Virol.201084108771088710.1128/JVI.00949-1020686047 118.JonesP.H.MaricM.MadisonM.N.MauryW.RollerR.J.OkeomaC.M.BST-2/tetherin-mediated restriction of" exact="chikungunya" post="(CHIKV) VLP budding is counteracted by CHIKV non-structural protein"/>
   <result pre="SeverityPLoS Negl. Trop. Dis.20115e127910.1371/journal.pntd.000127921858242 124.MichlmayrD.PakT.R.RahmanA.H.AmirE.D.KimE.Kim-SchulzeS.SuprunM.StewartM.G.ThomasG.P.BalmasedaA.et al.Comprehensive innate immune profiling of" exact="chikungunya" post="virus infection in pediatric casesMol. Syst. Biol.201814e786210.15252/msb.2017786230150281 125.PooY.S.RuddP.A.GardnerJ.WilsonJ.A.C.LarcherT.ColleM.A.LeT.T.NakayaH.I.WarrilowD.AllcockR.et al.Multiple"/>
   <result pre="in Southeastern SenegalAm. J. Primatol.201076466 133.LumF.-M.NgL.F.P.Cellular and molecular mechanisms of" exact="chikungunya" post="pathogenesisAntiviral Res.201512016517410.1016/j.antiviral.2015.06.00926092642 134.HawmanD.W.StoermerK.A.MontgomeryS.A.PalP.OkoL.DiamondM.S.MorrisonT.E.Chronic Joint Disease Caused by Persistent Chikungunya"/>
   <result pre="Immunol.201319025926910.4049/jimmunol.120217723209328 136.PartidosC.D.WegerJ.BrewooJ.SeymourR.BorlandE.M.LedermannJ.P.PowersA.M.WeaverS.C.StinchcombD.T.OsorioJ.E.Probing the attenuation and protective efficacy of a candidate" exact="chikungunya" post="virus vaccine in mice with compromised interferon (IFN) signalingVaccine2011293067307310.1016/j.vaccine.2011.01.07621300099"/>
   <result pre="human dermal fibroblastsInfect. Genet. Evol.20153240140810.1016/j.meegid.2015.03.02525847693 140.SourisseauM.SchilteC.CasartelliN.TrouilletC.Guivel-BenhassineF.RudnickaD.Sol-FoulonN.Le RouxK.PrevostM.C.FsihiH.et al.Characterization of reemerging" exact="chikungunya" post="virusPLoS Pathog.200730804081710.1371/journal.ppat.003008917604450 141.WichitS.DiopF.HamelR.TalignaniL.FerrarisP.CornelieS.LiegeoisF.ThomasF.YsselH.MisséD.Aedes Aegypti saliva enhances chikungunya virus replication"/>
   <result pre="al.Characterization of reemerging chikungunya virusPLoS Pathog.200730804081710.1371/journal.ppat.003008917604450 141.WichitS.DiopF.HamelR.TalignaniL.FerrarisP.CornelieS.LiegeoisF.ThomasF.YsselH.MisséD.Aedes Aegypti saliva enhances" exact="chikungunya" post="virus replication in human skin fibroblasts via inhibition of"/>
   <result pre="are risk factors for severe diseasePLoS Pathog.20084e2910.1371/journal.ppat.004002918282093 143.PuipromO.Morales VargasR.E.PotiwatR.ChaichanaP.IkutaK.RamasootaP.OkabayashiT.Characterization of" exact="chikungunya" post="virus infection of a human keratinocyte cell line: Role"/>
   <result pre="suppressing the host immune responseInfect. Genet. Evol.20131721021510.1016/j.meegid.2013.04.00523583544 144.BernardE.HamelR.NeyretA.EkchariyawatP.MolèsJ.P.SimmonsG.ChazalN.DesprèsP.MisséD.BriantL.Human keratinocytes restrict" exact="chikungunya" post="virus replication at a post-fusion stepVirology201547611010.1016/j.virol.2014.11.01325496825 145.RuddP.A.WilsonJ.GardnerJ.LarcherT.BabaritC.LeT.T.AnrakuI.KumagaiY.LooY.-M.GaleM.et al.Interferon Response"/>
   <result pre="responses of human melanocytes in infectious diseasesJ. Infect.20157141342110.1016/j.jinf.2015.06.00626092350 149.ParolaP.de LamballerieX.JourdanJ.RoveryC.VaillantV.MinodierP.BrouquiP.FlahaultA.RaoultD.CharrelR.N.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islandsEmerg."/>
   <result pre="151.Ruiz SilvaM.Van Der Ende-MetselaarH.MulderH.L.SmitJ.M.Rodenhuis-ZybertI.A.Mechanism and role of MCP-1 upregulation upon" exact="chikungunya" post="virus infection in human peripheral blood mononuclear cellsSci. Rep.201661910.1038/srep3228828442746"/>
   <result pre="blood mononuclear cellsSci. Rep.201661910.1038/srep3228828442746 152.Ruiz SilvaM.Aguilar BriseñoJ.A.UpasaniV.van der Ende-MetselaarH.SmitJ.M.Rodenhuis-ZybertI.A.Suppression of" exact="chikungunya" post="virus replication and differential innate responses of human peripheral"/>
   <result pre="during co-infection with dengue virusPLoS Negl. Trop. Dis.201711e000571210.1371/journal.pntd.000571228644900 153.LaughhunnA.HuangY.-J.S.VanlandinghamD.L.LanteriM.C.StassinopoulosA.Inactivation of" exact="chikungunya" post="virus in blood components treated with amotosalen/ultraviolet A light"/>
   <result pre="and monocytes/macrophages in CHIKV-induced arthralgia/arthritisVirus Res.201317717918810.1016/j.virusres.2013.08.01124012515 160.LokireddyS.VemulaS.VaddeR.Connective tissue metabolism in" exact="chikungunya" post="patientsVirol. J.200853110.1186/1743-422X-5-3118302795 161.HerreroL.J.FooS.-S.ShengK.-C.ChenW.ForwoodM.R.BucalaR.MahalingamS.Pentosan Polysulfate: A Novel Glycosaminoglycan-Like Molecule for"/>
   <result pre="Alphavirus-Induced Cartilage Destruction and Inflammatory DiseaseJ. Virol.2015898063807610.1128/JVI.00224-1526018160 162.KuoS.C.WangY.M.HoY.J.ChangT.Y.LaiZ.Z.TsuiP.Y.WuT.Y.LinC.C.Suramin treatment reduces" exact="chikungunya" post="pathogenesis in miceAntiviral Res.2016134899610.1016/j.antiviral.2016.07.02527577529 163.NoretM.HerreroL.RulliN.RolphM.SmithP.N.LiR.W.RoquesP.GrasG.MahalingamS.Interleukin 6, RANKL, and osteoprotegerin"/>
   <result pre="in miceAntiviral Res.2016134899610.1016/j.antiviral.2016.07.02527577529 163.NoretM.HerreroL.RulliN.RolphM.SmithP.N.LiR.W.RoquesP.GrasG.MahalingamS.Interleukin 6, RANKL, and osteoprotegerin expression by" exact="chikungunya" post="virus-infected human osteoblastsJ. Infect. Dis.201220645545710.1093/infdis/jis36822634878 164.GoupilB.A.McNultyM.A.MartinM.J.McCrackenM.K.ChristoffersonR.C.MoresC.N.Novel Lesions of Bones"/>
   <result pre="do not knowRev. Med. Virol.20091912112910.1002/rmv.60619274635 170.ThiruvengadamK.V.KalyanasundaramV.RajgopalJ.Clinical and pathological studies on" exact="chikungunya" post="fever in Madras cityIndian J. Med. Res.1965537297445830407 171.GanesanK.DiwanA.ShankarS.K.DesaiS.B.SainaniG.S.KatrakS.M.Chikungunya encephalomyeloradiculitis:"/>
   <result pre="findingsAm. J. Neuroradiol.2008291636163710.3174/ajnr.A113318566010 172.DhanwaniR.KhanM.BhaskarA.S.B.SinghR.PatroI.K.RaoP.V.L.ParidaM.M.Characterization of Chikungunya virus infection in human" exact="neuroblastoma" post="SH-SY5Y cells: Role of apoptosis in neuronal cell deathVirus"/>
   <result pre="Cells Restricts Chikungunya Virus ReplicationJ. Proteome Res.2017164144415510.1021/acs.jproteome.7b0051328959884 176.AbereB.WikanN.UbolS.AuewarakulP.PaemaneeA.KittisenachaiS.RoytrakulS.SmithD.R.Proteomic analysis of" exact="chikungunya" post="virus infected microgial cellsPLoS ONE20127e3480010.1371/journal.pone.003480022514668 177.WikanN.SakoonwatanyooP.UbolS.YoksanS.SmithD.R.Chikungunya virus infection of"/>
   <result pre="east, central and south African lineagePLoS ONE20127e3110210.1371/journal.pone.003110222299053 178.ChiamC.W.ChanY.F.OngK.C.WongK.T.SamI.C.Neurovirulence comparison of" exact="chikungunya" post="virus isolates of the Asian and East/Central/South African genotypes"/>
   <result pre="of viral neuroinvasion in the zebrafish reveals that Sindbis and" exact="chikungunya" post="viruses favour different entry routesDis. Model. Mech.20171084785710.1242/dmm.02923128483796 183.MahendradasP.AvadhaniK.ShettyR.Chikungunya and"/>
   <result pre="184.LinJ.ChenR.W.S.HazanA.WeissM.Chikungunya Virus Infection Manifesting as Intermediate UveitisOcul. Immunol. Inflamm.20182668068210.1080/09273948.2016.126334028010143 185.SalceanuS.O.RamanV.Recurrent" exact="chikungunya" post="retinitisBMJ Case Rep.2018201810.1136/bcr-2017-22286430150331 186.Ulloa-PadillaJ.P.DavilaP.J.IzquierdoN.J.Garcia-RodriguezO.JimenezI.Z.Ocular Symptoms and Signs of Chikungunya"/>
   <result pre="Fever in Puerto RicoP. R. Health Sci. J.201837838729905918 187.MahendradasP.ShettyR.MalathiJ.MadhavanH.N.Chikungunya virus" exact="iridocyclitis" post="in Fuchs’ heterochromic iridocyclitisIndian J. Ophthalmol.20105854554710.4103/0301-4738.7170720952847 188.BabuK.MurthyG.Chikungunya virus iridocyclitis"/>
   <result pre="virus iridocyclitis in Fuchs’ heterochromic iridocyclitisIndian J. Ophthalmol.20105854554710.4103/0301-4738.7170720952847 188.BabuK.MurthyG.Chikungunya virus" exact="iridocyclitis" post="in Fuchs′ heterochromic iridocyclitisIndian J. Ophthalmol.2012607310.4103/0301-4738.9049522218256 189.CoudercT.GangneuxN.ChrétienF.CaroV.Le LuongT.DuclouxB.TolouH.LecuitM.GrandadamM.Chikungunya virus"/>
   <result pre="and Not Purified in MosquitoesJ. Virol.2014888213822610.1128/JVI.01032-1424829346 191.ChuaH.H.RashidK.A.LawW.C.HamizahA.ChemY.K.KhairulA.H.ChuaK.B.A fatal case of" exact="chikungunya" post="virus infection with liver involvementMed. J. Malaysia201065838421265260 192.DavisJ.L.HodgeH.M.CampbellW.E.Growth of"/>
   <result pre="chikungunya virus infection with liver involvementMed. J. Malaysia201065838421265260 192.DavisJ.L.HodgeH.M.CampbellW.E.Growth of" exact="chikungunya" post="virus in baby hamster kidney cell (BHK-21-clone 13) suspension"/>
   <result pre="hamster kidney cell (BHK-21-clone 13) suspension culturesAppl. Microbiol.1971213383415549705 193.GardnerJ.RuddP.A.ProwN.A.BelarbiE.RoquesP.LarcherT.GreshL.BalmasedaA.HarrisE.SchroderW.A.et al.Infectious" exact="chikungunya" post="virus in the saliva of mice, monkeys and humansPLoS"/>
   <result pre="the diagnosis of emerging virusesBMC Infect. Dis.20181870710.1186/s12879-018-3611-x30594124 195.MussoD.TeissierA.RouaultE.TeururaiS.de PinaJ.-J.NhanT.-X.Detection of" exact="chikungunya" post="virus in saliva and urineVirol. J.20161310210.1186/s12985-016-0556-927306056 196.Contopoulos-IoannidisD.Newman-LindsayS.ChowC.LaBeaudA.D.Mother-to-child transmission of"/>
   <result pre="Chemother.201863e01389-1810.1128/AAC.01389-1830455237 210.FrancoE.J.RodriquezJ.L.PomeroyJ.J.HanrahanK.C.BrownA.N.The effectiveness of antiviral agents with broad-spectrum activity against" exact="chikungunya" post="virus varies between host cell linesAntivir. Chem. Chemother.20182620402066188075810.1177/204020661880758030354193 211.ChopraA.SalujaM.VenugopalanA.Effectiveness"/>
   <result pre="Arthritis Following Chikungunya Virus InfectionArthritis Rheumatol.20146631932610.1002/art.3822124504804 212.de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of" exact="chikungunya" post="virus infectionInfect. Disord. Drug Targets2009910110410.2174/18715260978784771219275698 213.KhanM.SanthoshS.R.TiwariM.Lakshmana RaoP.V.ParidaM.Assessment of in"/>
   <result pre="of in vitro prophylactic and therapeutic efficacy of chloroquine against" exact="chikungunya" post="virus in vero cellsJ. Med. Virol.20108281782410.1002/jmv.2166320336760 214.RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.et al.Paradoxical"/>
   <result pre="Virol.20108281782410.1002/jmv.2166320336760 214.RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de LamballerieX.et al.Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya" post="virus infectionViruses20181026810.3390/v10050268 215.SmithS.A.SilvaL.A.FoxJ.M.FlyakA.I.KoseN.SapparapuG.KhomandiakS.AshbrookA.W.KahleK.M.FongR.H.et al.Isolation and Characterization of Broad and"/>
   <result pre="mosquito-borne arbovirus controlPLoS Negl. Trop. Dis.201913e000682210.1371/journal.pntd.000682230605475 Figure 1 Sites of" exact="chikungunya" post="virus replication in the Aedes mosquito vector. Figure 2"/>
   <result pre="vector. Figure 2 Examples of tissue and cell tropism of" exact="chikungunya" post="virus. Chikungunya virus (CHIKV) infected cells in skin (A);"/>
   <result pre="viruses-11-00175-t001_Table 1Table 1 Reported natural vertebrate animal hosts of the" exact="chikungunya" post="virus. NHPs—non-human primates. World Region Species Common Name Method"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6410223\results\search\disease\results.xml">
   <result pre="causing more than 700,000 deaths annually. Mosquito-transmitted viruses, such as" exact="yellow fever," post="dengue, West Nile, chikungunya, and Zika viruses, have re-emerged"/>
   <result pre="Humans have known about arboviruses since the 15th century when" exact="yellow fever" post="was first described as devastating the human populations in"/>
   <result pre="arboviruses that have caused recent epidemics are the flaviviruses, including" exact="yellow fever," post="dengue, West Nile, and Zika, and the Toga viruses,"/>
   <result pre="Control and Prevention (CDC) of the United States estimates that" exact="yellow fever" post="virus (YFV) causes 200,000 cases and 30,000 deaths globally"/>
   <result pre="Americas by 2014. Over half a million autochthonous and 3700" exact="microcephaly" post="cases had been reported by January 2018 according to"/>
   <result pre="as the enhanced likelihood of developing fever, joint pains, and" exact="rash" post="in those infected with CHIKV [25]. The SNP in"/>
   <result pre="Non-integrin (DC-SIGN)) promoter region could contribute to the pathogenesis of" exact="dengue hemorrhagic fever" post="(DHF) in Thai and Taiwanese populations [29,30]. The SNP"/>
   <result pre="in neural progenitor cells and promote apoptosis, possibly producing the" exact="microcephaly" post="and other pathologies seen in pregnant women during the"/>
   <result pre="of a number of flaviviruses including YFV, WNV, Japanese encephalitis," exact="tick-borne encephalitis," post="DENV, and ZIKV is secreted out of host cells"/>
   <result pre="1.BryantJ.E.HolmesE.C.BarrettA.D.Out of Africa: A molecular perspective on the introduction of" exact="yellow fever" post="virus into the AmericasPLoS Pathog.20073e7510.1371/journal.ppat.003007517511518 2.GublerD.J.Resurgent vector-borne diseases as"/>
   <result pre="February 2019) 4.BrentS.E.WattsA.CetronM.GermanM.KraemerM.U.BogochI.I.BradyO.J.HayS.I.CreatoreM.I.KhanK.International travel between global urban centres vulnerable to" exact="yellow fever" post="transmissionBull. World Health Organ.201896343354B10.2471/BLT.17.20565829875519 5.BhattS.GethingP.W.BradyO.J.MessinaJ.P.FarlowA.W.MoyesC.L.DrakeJ.M.BrownsteinJ.S.HoenA.G.SankohO.et al.The global distribution and"/>
   <result pre="Infect. Dis.20152122011202010.1093/infdis/jiv32126063222 25.DuttaS.K.TripathiA.Association of toll-like receptor polymorphisms with susceptibility to" exact="chikungunya" post="virus infectionVirology201751120721310.1016/j.virol.2017.08.00928888110 26.Xavier-CarvalhoC.GibsonG.BrasilP.FerreiraR.X.de Souza SantosR.Goncalves CruzO.de OliveiraS.A.de Sa CarvalhoM.PachecoA.G.KubelkaC.F.et"/>
   <result pre="Genet.20053750751310.1038/ng155015838506 30.WangL.ChenR.F.LiuJ.W.LeeI.K.LeeC.P.KuoH.C.HuangS.K.YangK.D.DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with" exact="dengue hemorrhagic fever" post="and correlated to DC-SIGN expression and immune augmentationPLoS Negl."/>
   <result pre="HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection," exact="dengue hemorrhagic fever" post="and dengue shock syndromePLoS Negl. Trop. Dis.20082e30418827882 40.LokeH.BethellD.B.PhuongC.X.DungM.SchneiderJ.WhiteN.J.DayN.P.FarrarJ.HillA.V.Strong HLA"/>
   <result pre="allele, a possible severity risk factor of hemorrhagic manifestation in" exact="dengue fever" post="patientsTissue Antigens20046446947210.1111/j.1399-0039.2004.00304.x15361124 49.SantosA.C.de MouraE.L.FerreiraJ.M.SantosB.R.AlvesV.M.de FariasK.F.de Souza FigueiredoE.V.Meta-Analysis of the"/>
   <result pre="nonstructural protein NS1 is a dimerVirology198816218719610.1016/0042-6822(88)90408-42827377 73.PostP.R.CarvalhoR.GallerR.Glycosylation and secretion of" exact="yellow fever" post="virus nonstructural protein NS1Virus Res.19911829130210.1016/0168-1702(91)90025-Q1828321 74.FanW.F.MasonP.W.Membrane association and secretion"/>
   <result pre="protein NS1Virus Res.19911829130210.1016/0168-1702(91)90025-Q1828321 74.FanW.F.MasonP.W.Membrane association and secretion of the Japanese" exact="encephalitis" post="virus NS1 protein from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The"/>
   <result pre="protein from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The NS1 protein of" exact="tick-borne encephalitis" post="virus forms multimeric species upon secretion from the host"/>
   <result pre="from cells expressing NS1 cDNAVirology199017747047610.1016/0042-6822(90)90511-O2142554 75.CrooksA.J.LeeJ.M.EasterbrookL.M.TimofeevA.V.StephensonJ.R.The NS1 protein of tick-borne" exact="encephalitis" post="virus forms multimeric species upon secretion from the host"/>
   <result pre="in Rio de Janeiro, BrazilPLoS Curr.2017910.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727 82.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 83.NiyasK.P.AbrahamR.UnnikrishnanR.N.MathewT.NairS.ManakkadanA.IssacA.SreekumarE.Molecular characterization"/>
   <result pre="larvae from Kerala, South IndiaVirol. J.2010718910.1186/1743-422X-7-18920704755 84.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 85.BraultA.C.HuangC.Y.LangevinS.A.KinneyR.M.BowenR.A.RameyW.N.PanellaN.A.HolmesE.C.PowersA.M.MillerB.R.A"/>
   <result pre="DSS [51] Phospholipase PLCE1 Increased risk for DSS [52,53] DHF:" exact="dengue hemorrhagic fever," post="DSS: dengue shock syndrome, UTR: untranslated region, *: Locus"/>
   <result pre="[71] NS1/A188V Enhanced NS1 secretability in the host blood, immune" exact="suppression" post="in mosquitoes [78] CHIKV E1/K211T Increased fitness in Ae."/>
   <result pre="in Culex spp. mosquitoes [86,87] sfRNA: subgenomic flaviviral RNA, DHF:" exact="dengue hemorrhagic fever," post="E: envelope, NS: nonstructural, UTR: untranslated genomic region."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6429326\results\search\disease\results.xml">
   <result pre="are asymptomatic, ZIKV infection during pregnancy is increasingly associated with" exact="microcephaly" post="and other fetal developmental abnormalities. In the last few"/>
   <result pre="Global emergence of arboviruses such as dengue virus (DENV), chikungunya," exact="yellow fever" post="virus (YFV), and Zika virus (ZIKV) has become possible"/>
   <result pre="[2,3]. ZIKV belongs to the Flaviviridae family along with Japanese" exact="encephalitis" post="virus (JEV), West Nile virus (WNV), and DENV, all"/>
   <result pre="phenotypes including Guillain–Barré syndrome, meningoencephalitis, and fetal abnormalities such as" exact="microcephaly" post="and spontaneous abortion [6]. Up to date, diagnosis of"/>
   <result pre="an etiological link between ZIKV infection and birth defects like" exact="microcephaly" post="in Brazil [7,9]. Congenital abnormalities induced by ZIKV infection"/>
   <result pre="transmission. Despite the prevalence of birth defects, diagnosis of congenital" exact="microcephaly" post="remains a challenge due to the existence of various"/>
   <result pre="to both the mother and fetus [27]. As previously mentioned," exact="microcephaly" post="is a severe consequence of ZIKV infection in the"/>
   <result pre="are associated with delayed development and birth defects, such as" exact="microcephaly" post="in the mouse model [30]. Prenatal infection of ZIKV"/>
   <result pre="an immune privilege organ, an ocular ZIKV infection manifests as" exact="conjunctivitis" post="and pan-uveitis, the former being the more common form"/>
   <result pre="the main suppressors of type I IFN induction through the" exact="suppression" post="of TBK1/IRF3 pathways. Figure 2 describes diverse mechanisms by"/>
   <result pre="NS4B contains a N-terminal region that blocks IFN response through" exact="suppression" post="of IFN-α and β signaling [100]. Furthermore, NS1 and"/>
   <result pre="order to suppress Akt-mTOR signaling in the host cell. The" exact="suppression" post="of Akt-mTOR signaling pathway leads to an upregulation of"/>
   <result pre="is another natural compound that inhibited ZIKV entry in human" exact="osteosarcoma" post="cells (U2OS), human brain microvascular endothelial cells, and human"/>
   <result pre="line Jeg-3, and was also active against DENV, WNV, and" exact="chikungunya" post="virus [115]. Furthermore, berberine and emodin showed strong inhibitory"/>
   <result pre="of Zika virus and its new clinical syndromesNature201856057310.1038/s41586-018-0446-y30158602 7.FaizanM.I.AbdullahM.AliS.NaqviI.H.AhmedA.ParveenS.Zika virus-induced" exact="microcephaly" post="and its possible molecular mechanismIntervirology20165915215810.1159/00045295028081529 8.AdebanjoT.Godfred-CatoS.ViensL.FischerM.StaplesJ.E.Kuhnert-TallmanW.WalkeH.OduyeboT.PolenK.PeacockG.et al.Update: Interim Guidance"/>
   <result pre="Zika Virus Infection—United StatesMMWR Morb. Mortal. Wkly. Rep.2017661089109910.15585/mmwr.mm6641a129049277 9.JaenischT.RosenbergerK.D.BritoC.BradyO.BrasilP.MarquesE.T.J.Risk of" exact="microcephaly" post="after Zika virus infection in Brazil, 2015 to 2016Bull."/>
   <result pre="Investig. Dermatol.201813939139910.1016/j.jid.2018.07.03830218650 27.De CarvalhoN.S.De CarvalhoB.F.FugaçaC.A.DórisB.BiscaiaE.S.Zika virus infection during pregnancy and" exact="microcephaly" post="occurrence: A review of literature and Brazilian dataBraz. J."/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: A case studyLancet Infect. Dis.20161665366010.1016/S1473-3099(16)00095-526897108 50.BrasilP.PereiraJ.P.Jr.MoreiraM.E.Ribeiro NogueiraR.M.DamascenoL.WakimotoM.RabelloR.S.ValderramosS.G.HalaiU.-A.SallesT.S.Zika"/>
   <result pre="to fetal brain infectionCell20161661247125610.1016/j.cell.2016.08.00427565347 59.MinerJ.J.SeneA.RichnerJ.M.SmithA.M.SantefordA.BanN.Weger-LucarelliJ.ManzellaF.RückertC.GoveroJ.J.C.Zika virus infection in mice causes" exact="panuveitis" post="with shedding of virus in tearsCell Rep.2016163208321810.1016/j.celrep.2016.08.07927612415 60.SinghS.KumarA.J.V.Ocular Manifestations"/>
   <result pre="of cell damage in central nervous system of fatal cases" exact="microcephaly" post="by Zika virusSci. Rep.20188110.1038/s41598-017-17765-529311619 73.WangW.LiG.DeW.LuoZ.PanP.TianM.WangY.XiaoF.LiA.WuK.et al.Zika virus infection induces"/>
   <result pre="inhibit Zika virus replicationCell Rep.2016152323233010.1016/j.celrep.2016.05.07427268505 89.ChesarinoN.M.McMichaelT.M.YountJ.S.E3 ubiquitin ligase NEDD4 promotes" exact="influenza" post="virus infection by decreasing levels of the antiviral protein"/>
   <result pre="92.HuangI.-C.BaileyC.C.WeyerJ.L.RadoshitzkyS.R.BeckerM.M.ChiangJ.J.BrassA.L.AhmedA.A.ChiX.DongL.J.P.Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and" exact="influenza" post="A virusPLoS Pathog.20117e100125810.1371/journal.ppat.100125821253575 93.PerreiraJ.M.ChinC.R.FeeleyE.M.BrassA.L.J.J.IFITMs restrict the replication of multiple"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6430813\results\search\disease\results.xml">
   <result pre="Several neurological complications, such as Guillain-Barré syndrome in adults4, and" exact="microcephaly" post="in neonates5, are associated with ZIKV infection. As a"/>
   <result pre="to ZIKV, the RNA of other flaviviruses, such as DENV26,42," exact="yellow fever" post="virus43, and West Nile viruses (WNV)44 have also been"/>
   <result pre="Zika virus in the cerebrospinal fluid of 30 neonates with" exact="microcephaly" post="in BrazilLancet20163871811181210.1016/S0140-6736(16)30253-7 6.BuenoMGMartinezNAbdallaLDuarteDSCChameMAnimals in the Zika virus life cycle:"/>
   <result pre="cultured in SIRC cells from a patient suspected of having" exact="rubella" post="virusRev. Inst. Med. Trop. Sao Paulo201860e1529557985 18.FonsecaKet al.First case"/>
   <result pre="Nov 2018. 31.HeinzFXet al.Structural changes and functional control of the" exact="tick-borne encephalitis" post="virus glycoprotein E by the heterodimeric association with protein"/>
   <result pre="2018. 31.HeinzFXet al.Structural changes and functional control of the tick-borne" exact="encephalitis" post="virus glycoprotein E by the heterodimeric association with protein"/>
   <result pre="in plasmaTrans. R. Soc. Trop. Med. Hyg.200710173873910.1016/j.trstmh.2007.02.00717418320 43.DomingoCet al.Detection of" exact="yellow fever" post="17D genome in urineJ. Clin. Microbiol.20114976076210.1128/JCM.01775-1021106799 44.TonryJHet al.West Nile"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6433041\results\search\disease\results.xml">
   <result pre="virus Gabek Forest phlebovirus Disease outbreaks caused by Zika, dengue," exact="yellow fever," post="chikungunya, and Rift Valley fever viruses illustrate the threat"/>
   <result pre="as sand flies. Sand flies transmit protozoan parasites that cause" exact="leishmaniasis" post="as well as phleboviruses (order Bunyavirales, family Phenuiviridae, genus"/>
   <result pre="are of public health importance, especially Toscana virus, which causes" exact="meningitis" post="and encephalitis in humans (8–10). The International Committee for"/>
   <result pre="public health importance, especially Toscana virus, which causes meningitis and" exact="encephalitis" post="in humans (8–10). The International Committee for the Taxonomy"/>
   <result pre="genus Phlebovirus: Rift Valley fever virus (RVFV), severe fever with" exact="thrombocytopenia" post="syndrome (SFTS) virus, Uukuniemi phlebovirus, Bujaru phlebovirus, Candiru phlebovirus,"/>
   <result pre="H02 Marigat 10/F Student Fever/chills, cough, head/joint/muscle aches, eye pain," exact="diarrhea" post="1:20 None None None H03 Marigat 18/F Student Fever/chills,"/>
   <result pre="1:40 None None None H07 Sangailu 25/M Herdsman Fever/chills, headache," exact="diarrhea" post="1:320 1:1,280 None None H08 Sangailu 42/F Housewife Fever/chills,"/>
   <result pre="None None None H10 Sangailu 24/M Herder Fever/chills, head/joint/muscle aches," exact="diarrhea" post="1:320 None None None H11 Sangailu 53/F Housewife Fever,"/>
   <result pre="Ethiopia, which, for a long time, had remained misdiagnosed as" exact="malaria" post="(48), as well as an outbreak of febrile illness"/>
   <result pre="SolimanBA, El-TiganiA, KhalidIO, et al.Evaluation of arthropod-borne viruses and other" exact="infectious disease" post="pathogens as the causes of febrile illnesses in the"/>
   <result pre="of Aedes aegypti from three distinct cities in Kenya for" exact="chikungunya" post="virus.PLoS Negl Trop Dis. 2017;11:e0005860. 10.1371/journal.pntd.000586028820881 33. WuY, ZhuY,"/>
   <result pre="GorciiM, KidarA, et al.Phlebotomine (Diptera, Psychodidae) bloodmeal sources in Tunisian" exact="cutaneous leishmaniasis" post="foci: could Sergentomyia minuta, which is not an exclusive"/>
   <result pre="KidarA, et al.Phlebotomine (Diptera, Psychodidae) bloodmeal sources in Tunisian cutaneous" exact="leishmaniasis" post="foci: could Sergentomyia minuta, which is not an exclusive"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6433249\results\search\disease\results.xml">
   <result pre="The four RT-iiPCRs did not react with Zika virus and" exact="chikungunya" post="virus; tests with serial dilutions of the four DENV"/>
   <result pre="two other viruses (Zika virus MR766, Zika virus PRVABC59, and" exact="chikungunya" post="virus CK9500004) known to cause febrile illness or skin"/>
   <result pre="chikungunya virus CK9500004) known to cause febrile illness or skin" exact="rash" post="illness were tested. All four singleplex DENV serotyping RT-iiPCR"/>
   <result pre="the other three non-targeted dengue virus serotypes, Zika virus and" exact="chikungunya" post="virus in the exclusivity test panel (Table 2), indicating"/>
   <result pre="negative negative negative DENV, dengue virus; ZIKV, Zika virus; CHIKV," exact="chikungunya" post="virus; PFU, plaque forming unit; RT-iiPCR, reverse transcription-insulated isothermal"/>
   <result pre="HuangJ-H, LinW-R, et al.Effect of serotypes on clinical manifestations of" exact="dengue fever" post="in adults. Journal of microbiology, immunology, and infection ="/>
   <result pre="LeePC, ChaiHC. Development of insulated isothermal PCR for rapid on-site" exact="malaria" post="detection. Malaria Journal. 2016;15(1):134 Epub 2016/03/05. [pii]. 10.1186/s12936-016-1183-z26931146 28BalasuriyaUB,"/>
   <result pre="LeePY, TiwariA, SkillmanA, NamB, ChambersTM, et al.Rapid detection of equine" exact="influenza" post="virus H3N8 subtype by insulated isothermal RT-PCR (iiRT-PCR) assay"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6440137\results\search\disease\results.xml">
   <result pre="Research Article Spatiotemporal characteristics and primary influencing factors of typical" exact="dengue fever" post="epidemics in China ZhengLanzhenglan1007@163.com1234RenHong-Yanrenhy@lreis.ac.cnrenhy@igsnrr.ac.cn2ShiRun-Herhshi@geo.ecnu.edu.cn134LuLiangluliang@icdc.cn5[1], 0000 0004 0369 6365grid.22069.3fKey Laboratory"/>
   <result pre="Abstract Background Dengue fever (DF) is a common mosquito-borne viral" exact="infectious disease" post="in the world, and increasingly severe DF epidemics in"/>
   <result pre="the United Nations. Background Dengue fever (DF) is an acute" exact="infectious disease" post="caused by the dengue virus, which is transmitted by"/>
   <result pre="characteristics of spatial aggregation. Table 2 Spatial autocorrelation analysis of" exact="dengue fever" post="cases in the Pearl River Delta and the Border"/>
   <result pre="0.01 &amp;lt;  0.01 &amp;lt;  0.01 &amp;lt;  0.05 &amp;lt;  0.01 boldface:" exact="dengue fever" post="cases showed significant characteristics on this grid scale Fig."/>
   <result pre="grids of 3 km × 3 km, and b PRD grids of 4 km × 4 km; DF:" exact="dengue fever;" post="PRD: Pearl River Delta; BYM: Border of Yunnan and"/>
   <result pre="23.7 °C (wider distribution). Fig. 6 Generalized additive models-estimated relationships between" exact="dengue fever" post="cases and influencing factors; a Pearl River Delta (PRD),"/>
   <result pre="line shows the smooth fitting curve for the logarithm of" exact="dengue fever" post="cases. The dashed line represents the 95% confidence intervals."/>
   <result pre="of the independent variables. The y-axis indicates the logarithm of" exact="dengue fever" post="cases fitting values. Edf represents the estimated degrees of"/>
   <result pre="smooth function, which is used to represent its relationship with" exact="dengue fever" post="cases Compared with the PRD, the DF epidemic in"/>
   <result pre="declare that they have no competing interests. References References 1.WuJYLunZRJamesAAChenXGReview:" exact="dengue fever" post="in mainland ChinaAm J Trop Med Hyg20108366467110.4269/ajtmh.2010.09-075520810836 2.GuoCZhouZWenZLiuYZengCXiaoDet al.Global"/>
   <result pre="in Guangdong, ChinaPLoS One201611e016621110.1371/journal.pone.016621127861514 7.WangJChenHHuangMZhangYXieJYanYet al.Epidemiological and etiological investigation of" exact="dengue fever" post="in the Fujian province of China during 2004–2014Sci China"/>
   <result pre="Southeast ChinaInt J Environ Res Public Health20171449410.3390/ijerph14050494 10.HuangXYMaHXWangHFDuYHSuJLiXLet al.Outbreak of" exact="dengue fever" post="in Central China, 2013Biomed Environ Sci20142789489725374022 11.FanJLinHWangCBaiLYangSChuCet al.Identifying the"/>
   <result pre="Province, China from 2005 to 2011Epidemiol Infect201414263464310.1017/S095026881300151923823182 12.LiuCLiuQLinHXinBNieJSpatial analysis of" exact="dengue fever" post="in Guangdong Province, China, 2001–2006Asia Pac J Public Health201426586610.1177/101053951247235623343642"/>
   <result pre="2001–2006Asia Pac J Public Health201426586610.1177/101053951247235623343642 13.YuALuoYYangYYanHZhouHInvestigation of the prevalence of" exact="dengue fever" post="in the port of Menglian, Yunnan ProvinceJ Pathogen Biol201510442445"/>
   <result pre="Menglian, Yunnan ProvinceJ Pathogen Biol201510442445 14.YangMJiangJGuoXWuCZhouHEpidemiological analysis and investigation of" exact="dengue fever" post="in Yunnan Province from 2009 to 2014J Pathogen Biol201510738742"/>
   <result pre="China: a reviewGlob Health201391010.1186/1744-8603-9-10 20.Cardoso-LeiteRVilarinhoACNovaesMCTonettoAFVilardiGCGuillermo-FerreiraRRecent and future environmental suitability to" exact="dengue fever" post="in Brazil using species distribution modelTrans R Soc Trop"/>
   <result pre="effects of socioeconomic and environmental factors on the incidence of" exact="dengue fever" post="in the Pearl River Delta, China, 2013PLoS Negl Trop"/>
   <result pre="al.Ecological niche modeling identifies fine-scale areas at high risk of" exact="dengue fever" post="in the Pearl River Delta, ChinaInt J Environ Res"/>
   <result pre="Res Public Health20171461910.3390/ijerph14060619 25.RenHZhengLLiQYuanWLuLExploring determinants of spatial variations in the" exact="dengue fever" post="epidemic using geographically weighted regression model: a case study"/>
   <result pre="in Guangdong ProvinceJ Fourth Mil Med Univ.20032417201724 30.RenHXuDShiXXuJZhuangDYangGCharacterisation of gastric" exact="cancer" post="and its relation to environmental factors: a case study"/>
   <result pre="poisson regression modelAsia Pac J Public Health201426485710.1177/101053951349019523761588 38.HoppMFoleyJAWorldwide fluctuations in" exact="dengue fever" post="cases related to climate variabilityClim Res200325859410.3354/cr025085 39.BangsMJLarasatiRPCorwinALWuryadiSClimatic factors associated"/>
   <result pre="in Guangdong, ChinaSci Total Environ2018622–325225910.1016/j.scitotenv.2017.11.314 46.ChenQQMengYJLiYQiXPFrequency, duration and intensity of" exact="dengue fever" post="epidemic risk in townships in Pearl River Delta and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6441045\results\search\disease\results.xml">
   <result pre="practice and epidemiologic investigation for a broad range of bacterial" exact="infectious disease" post="pathogens, and increasingly used for viral pathogens, and especially"/>
   <result pre="plot reveals temporal changes of epidemic spread in HIV and" exact="hepatitis" post="C virus (HCV)Proc. Natl. Acad. Sci. USA201311022823310.1073/pnas.120796511023248286 11.GrabowskiMKet al.The"/>
   <result pre="transmission risk: implications for intervention and controlJ. Infect. Dis.20182171522152910.1093/infdis/jiy04429506269 19.DidelotXFraserCGardyJColijnCGenomic" exact="infectious disease" post="epidemiology in partially sampled and ongoing outbreaksMol. Biol. Evol.201734997100728100788"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6443840\results\search\disease\results.xml">
   <result pre="Host-Pathogen Interactions During Arboviral Infections West Nile virus dengue virus" exact="chikungunya" post="virus tick-borne encephalitis virus Japanese encephalitis virus Zika virus"/>
   <result pre="During Arboviral Infections West Nile virus dengue virus chikungunya virus" exact="tick-borne encephalitis" post="virus Japanese encephalitis virus Zika virus systems biology immunity"/>
   <result pre="Arboviral Infections West Nile virus dengue virus chikungunya virus tick-borne" exact="encephalitis" post="virus Japanese encephalitis virus Zika virus systems biology immunity"/>
   <result pre="Nile virus dengue virus chikungunya virus tick-borne encephalitis virus Japanese" exact="encephalitis" post="virus Zika virus systems biology immunity fig-count: table-count: equation-count:"/>
   <result pre="(e.g., Bluetongue virus), Orthomyxoviridae (e.g., Bourbon virus), Rhabdoviridae (e.g., vesicular" exact="stomatitis" post="virus), Togaviridae (e.g., equine encephalitis and chikungunya viruses), or"/>
   <result pre="Bourbon virus), Rhabdoviridae (e.g., vesicular stomatitis virus), Togaviridae (e.g., equine" exact="encephalitis" post="and chikungunya viruses), or Flaviviridae (e.g., tick-borne encephalitis, dengue,"/>
   <result pre="Rhabdoviridae (e.g., vesicular stomatitis virus), Togaviridae (e.g., equine encephalitis and" exact="chikungunya" post="viruses), or Flaviviridae (e.g., tick-borne encephalitis, dengue, Japanese encephalitis,"/>
   <result pre="Togaviridae (e.g., equine encephalitis and chikungunya viruses), or Flaviviridae (e.g.," exact="tick-borne encephalitis," post="dengue, Japanese encephalitis, West Nile, Zika, and yellow fever"/>
   <result pre="(e.g., tick-borne encephalitis, dengue, Japanese encephalitis, West Nile, Zika, and" exact="yellow fever" post="viruses) (Hanley and Weaver, 2008). Flaviviruses pose a major"/>
   <result pre="for any flavivirus and no approved vaccines other than for" exact="yellow fever" post="and Japanese encephalitis viruses, indicating an unmet need in"/>
   <result pre="no approved vaccines other than for yellow fever and Japanese" exact="encephalitis" post="viruses, indicating an unmet need in medicine. Moreover, diabetic"/>
   <result pre="humans are often neurotropic and can cause acute neuroinflammation or" exact="tick-borne encephalitis" post="(TBE) disease. Cases of TBE are highest in the"/>
   <result pre="are often neurotropic and can cause acute neuroinflammation or tick-borne" exact="encephalitis" post="(TBE) disease. Cases of TBE are highest in the"/>
   <result pre="(CHK2), which regulates the cell cycle, is activated during Japanese" exact="encephalitis" post="virus (JEV) infection to aid in its replication. As"/>
   <result pre="including new vaccines and monoclonal antibodies, to diagnose and combat" exact="viral disease." post="With regard to cellular markers and tropism of flaviviral"/>
   <result pre="other flaviviral infections, particularly DENV, with which ZIKV co-circulates, or" exact="yellow fever" post="virus, for which there is a vaccine, could facilitate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6445942\results\search\disease\results.xml">
   <result pre="Creative Commons Attribution 4.0 International license.mBio.00521-19.pdf Since 2014, acute flaccid" exact="myelitis" post="(AFM), a long-recognized condition associated with polioviruses, nonpolio enteroviruses,"/>
   <result pre="aspect of AFM reemergence. Abstract ABSTRACT Since 2014, acute flaccid" exact="myelitis" post="(AFM), a long-recognized condition associated with polioviruses, nonpolio enteroviruses,"/>
   <result pre="that the AFM epidemic offers important clues to mechanisms of" exact="viral disease" post="emergence. KEYWORDS acute flaccid myelitis emerging diseases enterovirus neurology"/>
   <result pre="clues to mechanisms of viral disease emergence. KEYWORDS acute flaccid" exact="myelitis" post="emerging diseases enterovirus neurology fig-count: table-count: equation-count: ref-count: page-count:"/>
   <result pre="In recent decades, new human infectious diseases such as HIV/AIDS," exact="severe acute respiratory syndrome" post="(SARS), and Nipah virus infection, among others have emerged."/>
   <result pre="and natural disasters (e.g., cholera), and viral evolution (e.g., poultry-adapted" exact="influenza" post="A H5N1 and H7N9) (1). Joining this list is"/>
   <result pre="and H7N9) (1). Joining this list is epidemic acute flaccid" exact="myelitis" post="(AFM), characterized by sudden denervation-associated muscle paralysis of healthy"/>
   <result pre="(and occasionally adults) in one or more limbs that mimics" exact="poliomyelitis" post="but which is not caused by polioviruses (2). AFM"/>
   <result pre="of acute flaccid paralysis (AFP) (9, 10), in which cord" exact="myelitis" post="is documented, typically by magnetic resonance imaging (MRI) visualization"/>
   <result pre="endemically and epidemically every late summer/fall, causing localized outbreaks of" exact="aseptic meningitis" post="and other conditions. Although immunity to NPEVs is near-universal"/>
   <result pre="and epidemically every late summer/fall, causing localized outbreaks of aseptic" exact="meningitis" post="and other conditions. Although immunity to NPEVs is near-universal"/>
   <result pre="can sufficiently dilute it. Such patterns were well described for" exact="measles" post="and other childhood diseases in the prevaccine era. NPEVs,"/>
   <result pre="that had been reemerging globally since 2008 to cause pandemic" exact="respiratory disease" post="(16, 21). The reemergence of EV-D68 was itself unprecedented."/>
   <result pre="The reemergence of EV-D68 was itself unprecedented. Although acute hemorrhagic" exact="conjunctivitis" post="associated with EVA24v and with EV-D70 had caused global"/>
   <result pre="associated with cases of cranial nerve paralysis, bulbar paralysis, and" exact="meningoencephalitis" post="(3, 20). Once viral damage to gray matter has"/>
   <result pre="LanciottiR, NixWA, SakthivelSK, SchmidDS, SewardJF, TongS, ObersteMS, PallanschM, FeikinD2016Acute flaccid" exact="myelitis" post="in the United States, August-December 2014: results of nationwide"/>
   <result pre="SamI-C, RampalS, WanNorAmalinaW, NurAtifahG, VerasahibK, OngCC, MohdAdibM, ChanYF2016Cyclical patterns of" exact="hand, foot and mouth disease" post="caused by enterovirus A71 in Malaysia. PLoS Negl Trop"/>
   <result pre="NurAtifahG, VerasahibK, OngCC, MohdAdibM, ChanYF2016Cyclical patterns of hand, foot and" exact="mouth disease" post="caused by enterovirus A71 in Malaysia. PLoS Negl Trop"/>
   <result pre="PadillaT, StroberJB, AldrovandiG, WadfordDA, ChiuCY, XiaD, HarrimanK, WattJP, GlaserCA2015Acute flaccid" exact="myelitis" post="of unknown etiology in California, 2012-2015. JAMA314:2663–2671. doi:10.1001/jama.2015.17275.26720027 20.GreningerAL,"/>
   <result pre="ChiuCY2015A novel outbreak enterovirus D68 strain associated with acute flaccid" exact="myelitis" post="cases in the USA (2012–14): a retrospective cohort study."/>
   <result pre="40.EvansWJ, HurstBL, PetersonCJ, van WettereAJ, DayCW, SmeeDF, TarbetEB2019Development of a" exact="respiratory disease" post="model for enterovirus D68 in 4-week old mice for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6455116\results\search\disease\results.xml">
   <result pre="hemisphere. ZIKV has been associated with severe symptoms including infant" exact="microcephaly" post="and Guillain-Barré syndrome, stimulating interest in understanding factors governing"/>
   <result pre="time, ZIKV infection has been associated with severe symptoms including" exact="microcephaly" post="in infants infected as fetuses, and Guillain-Barré syndrome in"/>
   <result pre="such factor for multiple viruses including dengue virus (DV), Japanese" exact="encephalitis" post="virus (JEV), Hazara virus, and rotavirus, where it may"/>
   <result pre="in controlling viral replication in multiple virus types, including DV," exact="influenza" post="A virus, rabies virus and others [20–23]. Here, we"/>
   <result pre="replication in multiple virus types, including DV, influenza A virus," exact="rabies" post="virus and others [20–23]. Here, we demonstrate that Hsp70"/>
   <result pre="pathogenesis of many viruses [27]. For example, HIV, rotavirus, and" exact="influenza" post="virus replication are negatively regulated by Hsp70, whereas dengue,"/>
   <result pre="replication are negatively regulated by Hsp70, whereas dengue, Japanese encephalitis," exact="hepatitis" post="C and Hazara viruses utilize Hsp70 for replication [17,18,21,28–31]."/>
   <result pre="70 on Neuro2a cells is a putative receptor for Japanese" exact="encephalitis" post="virus. Virology. 2009;385:47–57. doi: 10.1016/j.virol.2008.10.02519068261 17BroquetAH, LenoirC, GardetA, et"/>
   <result pre="doi: 10.1371/journal.pone.001654621390211 22LahayeX, VidyA, FouquetB, et al.Hsp70 protein positively regulates" exact="rabies" post="virus infection. J Virol. 2012;86:4743–4751. doi: 10.1128/JVI.06501-1122345440 23Baquero-PerezB, WhitehouseA.Hsp70"/>
   <result pre="ChowLP, et al.Heat shock protein 72 is associated with the" exact="hepatitis" post="C virus replicase complex and enhances viral RNA replication."/>
   <result pre="is related to thermal inhibition of nuclear export of the" exact="influenza" post="virus ribonucleoprotein complex. J Virol. 2004;78:1263–1270. doi: 10.1128/JVI.78.3.1263-1270.200414722281 30IordanskiyS,"/>
   <result pre="al.Heparan sulfate-mediated binding of infectious dengue virus type 2 and" exact="yellow fever" post="virus. Virology. 2002;292:162–168. doi: 10.1006/viro.2001.123211878919 34LiYH, TaoPZ, LiuYZ, et"/>
   <result pre="ligand of heat shock protein 90, inhibits the replication of" exact="herpes simplex" post="virus type 1 in vitro. Antimicrob Agents Chemother. 2004;48:867–872."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6455256\results\search\disease\results.xml">
   <result pre="10.1080/22221751.2018.1559709 : Article The clinically licensed antifungal drug itraconazole inhibits" exact="influenza" post="virus in vitro and in vivo Emerging Microbes &amp;amp;"/>
   <result pre="ABSTRACT Influenza A virus (IAV) is a common pathogen of" exact="respiratory disease." post="The IAV-induced seasonal epidemics and the sporadic pandemics are"/>
   <result pre="indicate a promising therapeutic potential of at least itraconazole in" exact="influenza" post="therapy. KEYWORDS Influenza A virus posaconazole itraconazole interferon response"/>
   <result pre="as well as the A431 cell line are derived from" exact="cancer" post="cells (human lung adenocarcinoma and epidermoid carcinoma, respectively), we"/>
   <result pre="subsequently, the OD562 was measured. Viruses and infections The human" exact="influenza" post="virus strains A/Puerto-Rico/8/34 Münster (H1N1) (PR8M), seasonal A/Pan/99 (H3N2)"/>
   <result pre="(H3N2) (PAN), A/seal/Mass/1-SC35M/1980 (H7N7) (SC35M), B/Lee/1940 (Lee), and the vesicular" exact="stomatitis" post="virus (VSV) strain were from the virus strain collection"/>
   <result pre="Antiviral Res. 2013;97:206–210. doi: 10.1016/j.antiviral.2012.12.01623274624 2FauciAS.Emerging and re-emerging infectious diseases:" exact="influenza" post="as a prototype of the host-pathogen balancing act. Cell."/>
   <result pre="Ther. 2012;10:1221–1223. doi: 10.1586/eri.12.12523241176 4MillerMS, PaleseP.Peering into the crystal ball:" exact="influenza" post="pandemics and vaccine efficacy. Cell. 2014;157:294–299. doi: 10.1016/j.cell.2014.03.02324725400 5de"/>
   <result pre="6Villalón-LetelierF, BrooksAG, SaundersPM, et al.Host cell restriction factors that limit" exact="influenza" post="a infection. Viruses. 2017;9:1–18. doi: 10.3390/v9120376 7EdingerTO, PohlMO, StertzS.Entry"/>
   <result pre="a infection. Viruses. 2017;9:1–18. doi: 10.3390/v9120376 7EdingerTO, PohlMO, StertzS.Entry of" exact="influenza" post="A virus: host factors and antiviral targets. J. Gen."/>
   <result pre="KartenbeckJ, et al.Host cell factors and functions involved in vesicular" exact="stomatitis" post="virus entry. J Virol. 2009;83:440–453. doi: 10.1128/JVI.01864-0818971266 9BouvierNM, PaleseP.The"/>
   <result pre="entry. J Virol. 2009;83:440–453. doi: 10.1128/JVI.01864-0818971266 9BouvierNM, PaleseP.The biology of" exact="influenza" post="viruses. Vaccine. 2008;26:49–53. doi: 10.1016/j.vaccine.2008.07.039 10MusiolA, GranS, EhrhardtC, et"/>
   <result pre="10MusiolA, GranS, EhrhardtC, et al.Annexin A6-balanced late endosomal cholesterol controls" exact="influenza" post="a replication and propagation. MBio. 2013;4:1–11. doi: 10.1128/mBio.00608-13 11UrataS,"/>
   <result pre="(S1P) are required for efficient replication of severe fever with" exact="thrombocytopenia" post="syndrome virus. Biochem Biophys Res Commun. 2018;503(2):631–636. doi: 10.1016/j.bbrc.2018.06.05329906459"/>
   <result pre="13HofmannS, et al.Complex lipid metabolic remodeling is required for efficient" exact="hepatitis" post="C virus replication. Biochim Biophys Acta. 2018;1863:1041–1056. doi: 10.1016/j.bbalip.2018.06.002"/>
   <result pre="10.1016/j.cell.2015.11.04526686653 17BrassAL, et al.The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and Dengue virus."/>
   <result pre="Cell Host Microbe. 2013;13:452–464. doi: 10.1016/j.chom.2013.03.00623601107 19DesaiTM, et al.IFITM3 restricts" exact="influenza" post="A virus entry by blocking the formation of fusion"/>
   <result pre="virus-endosome Hemifusion. PLoS Pathog. 2014;10:e1004048. doi: 10.1371/journal.ppat.100404824699674 20SunX, WhittakerGR.Role for" exact="influenza" post="virus envelope cholesterol in virus entry and infection. J"/>
   <result pre="accumulation is a host cell-protective mechanism inhibiting endosomal escape of" exact="influenza" post="A virus. MBio. 2018;9:e01345–18. doi: 10.1128/mBio.01345-1830042202 25MosmannT.Rapid colorimetric assay"/>
   <result pre="2018;9:2229. doi: 10.3389/fimmu.2018.0222930323812 27JiaoP, FanW, SunY, et al.[Research advance of" exact="influenza" post="B viruses]. Sheng Wu Gong Cheng Xue Bao. 2018;34:821–831.29943528"/>
   <result pre="Bao. 2018;34:821–831.29943528 28DesmyterJ, MelnickJL, RawlsWE.Defectiveness of interferon production and of" exact="rubella" post="virus interference in a line of African green monkey"/>
   <result pre="Virol. 1968;2:955–961.4302013 29HolzingerD, et al.Induction of MxA gene expression by" exact="influenza" post="A virus requires type I or type III interferon"/>
   <result pre="a high K+ concentration is required for efficient uncoating of" exact="influenza" post="A virus cores after penetration. J Virol. 2014;88:13029–13046. doi:"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect"/>
   <result pre="as an antiviral strategy: Aerosolized LASAG for the treatment of" exact="influenza" post="in hospitalized patients. Emerg Microbes Infect. 2018;7:21. doi: 10.1038/s41426-018-0023-329511170"/>
   <result pre="of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic" exact="avian influenza" post="virus in vitro and in vivo. Antiviral Res. 2011;92:195–203."/>
   <result pre="the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian" exact="influenza" post="virus in vitro and in vivo. Antiviral Res. 2011;92:195–203."/>
   <result pre="Immunol. 2014;14:36–49. doi: 10.1038/nri358124362405 45de VriesE, et al.Dissection of the" exact="influenza" post="a virus endocytic routes reveals macropinocytosis as an alternative"/>
   <result pre="2011;7:e1001329. doi: 10.1371/journal.ppat.100132921483486 46IvanovicT, et al.Kinetics of proton transport into" exact="influenza" post="virions by the viral M2 channel. PLoS One. 2012;7:e31566."/>
   <result pre="al.High-content analysis of sequential events during the early phase of" exact="influenza" post="A virus infection. PLoS One. 2013;8:1–9. 48LinTY, et al.Amphotericin"/>
   <result pre="virus infection. PLoS One. 2013;8:1–9. 48LinTY, et al.Amphotericin B increases" exact="influenza" post="A virus infection by preventing IFITM3-mediated restriction. Cell Rep."/>
   <result pre="doi: 10.1146/annurev-virology-031413-08553725599080 50BarmanS, NayakDP.Lipid raft disruption by cholesterol depletion enhances" exact="influenza" post="A virus budding from MDCK cells. J Virol. 2007;81:12169–12178."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6456646\results\search\disease\results.xml">
   <result pre="comply with these terms. Abstract Human immunodeficiency virus (HIV)-1 and" exact="hepatitis" post="C virus (HCV) are major contributors to the global"/>
   <result pre="recombinant DNA represents a feasible therapeutic intervention to even cure" exact="cervical cancer," post="highlighting the potential of using DNA for human vaccinations."/>
   <result pre="of an efficacious vaccine against these viral infections. DNA vaccine" exact="hepatitis" post="C human immunodeficiency virus HIV/AIDS HCV tissue-resident memory T"/>
   <result pre="equation-count: ref-count: page-count: word-count: Introduction Human immunodeficiency virus (HIV)-1 and" exact="hepatitis" post="C virus (HCV) are significant contributors to the global"/>
   <result pre="virus that primarily infects and replicates in hepatocytes. In primary" exact="hepatitis" post="C infection, ~25% of patients naturally clear the virus"/>
   <result pre="vaccine has been tested for therapeutic vaccination against HCV. 12" exact="hepatitis" post="C patients suffering from chronic disease received three doses"/>
   <result pre="the future given the success of using DAA to cure" exact="hepatitis" post="C patients. DNA vaccines against HIV-1 have been tested"/>
   <result pre="I and II clinical trials especially in the context of" exact="cancer" post="(Kim et al., 2014; Trimble et al., 2015). However,"/>
   <result pre="10.1371/journal.ppat.100531526745376 BaileyJ. R.BarnesE.CoxA. L. (2019). Approaches, progress, and challenges to" exact="hepatitis" post="C vaccine development. Gastroenterology156, 418–4430. 10.1053/j.gastro.2018.08.06030268785 BaileyJ. R.FlyakA. I.CohenV."/>
   <result pre="al.. (2017). Broadly neutralizing antibodies with few somatic mutations and" exact="hepatitis" post="C virus clearance. JCI Insight2:e92872. 10.1172/jci.insight.9287228469084 BakariM.AboudS.NilssonC.FrancisJ.BumaD.MoshiroC.et al.. (2011)."/>
   <result pre="Lancet392, 232–243. 10.1016/S0140-6736(18)31364-330047376 BaumertT. F.FauvelleC.ChenD. Y.LauerG. M. (2014). A prophylactic" exact="hepatitis" post="C virus vaccine: a distant peak still worth climbing."/>
   <result pre="M.HedskogC.ParhyB.HylandR. H.StammL. M.BrainardD. M.et al.. (2018). Identification of a novel" exact="hepatitis" post="C virus genotype from Punjab, India: expanding classification of"/>
   <result pre="hepatitis C virus genotype from Punjab, India: expanding classification of" exact="hepatitis" post="C virus into 8 genotypes. J. Infect. Dis.218, 1722–1729."/>
   <result pre="al.. (2011). Sequential bottlenecks drive viral evolution in early acute" exact="hepatitis" post="C virus infection. PLoS Pathog.7:e1002243. 10.1371/journal.ppat.100224321912520 BurtonD. R.HangartnerL. (2016)."/>
   <result pre="1467–1479. 10.1002/ijc.3116629159802 CuburuN.WangK.GoodmanK. N.PangY. Y.ThompsonC. D.LowyD. R.et al.. (2015). Topical" exact="herpes simplex" post="virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing"/>
   <result pre="EpsteinJ. E.TewariK.LykeK. E.SimB. K.BillingsleyP. F.LaurensM. B.et al.. (2011). Live attenuated" exact="malaria" post="vaccine designed to protect through hepatic CD8(+) T cell"/>
   <result pre="Liver-resident memory CD8(+) T cells form a front-line defense against" exact="malaria" post="liver-stage infection. Immunity45, 889–902. 10.1016/j.immuni.2016.08.01127692609 FerraroB.MorrowM. P.HutnickN. A.ShinT. H.LuckeC."/>
   <result pre="nonlymphoid tissue that provide enhanced local immunity during infection with" exact="herpes simplex" post="virus. Nat. Immunol.10, 524–530. 10.1038/ni.171819305395 collab: German Advisory Committee"/>
   <result pre="M.et al.. (2018). Prime and target immunization protects against liver-stage" exact="malaria" post="in mice. Sci. Transl. Med.10:eaap9128. 10.1126/scitranslmed.aap912830257955 GrebelyJ.PrinsM.HellardM.CoxA. L.OsburnW. O.LauerG.et"/>
   <result pre="J.et al.. (2015). A multiantigenic DNA vaccine that induces broad" exact="hepatitis" post="C virus-specific T-cell responses in mice. J. Virol.89, 7991–8002."/>
   <result pre="region vaccines vectored by plasmid DNA, simian adenovirus and modified" exact="vaccinia virus" post="ankara administered to human immunodeficiency virus type 1-uninfected adults"/>
   <result pre="HoughtonM. (2011). Prospects for prophylactic and therapeutic vaccines against the" exact="hepatitis" post="C viruses. Immunol. Rev.239, 99–108. 10.1111/j.1600-065X.2010.00977.x21198667 IshizukaA. S.LykeK. E.DeZureA.BerryA."/>
   <result pre="IshizukaA. S.LykeK. E.DeZureA.BerryA. A.RichieT. L.MendozaF. H.et al. (2016). Protection against" exact="malaria" post="at 1 year and immune correlates following PfSPZ vaccination."/>
   <result pre="antigen-specific immunity. Vaccine15, 1049–1056.9269046 OlsenT. M.StoneB. C.ChuenchobV.MurphyS. C. (2018). Prime-and-Trap" exact="malaria" post="vaccination to generate protective CD8(+) liver-resident memory T cells."/>
   <result pre="OsburnW. O.SniderA. E.WellsB. L.LatanichR.BaileyJ. R.ThomasD. L.et al.. (2014). Clearance of" exact="hepatitis" post="C infection is associated with the early appearance of"/>
   <result pre="A.KlarquistJ.PalmerB. E.PawlotskyJ. M.Golden-MasonL.et al.. (2008). Spontaneous recovery in acute human" exact="hepatitis" post="C virus infection: functional T-cell thresholds and relative importance"/>
   <result pre="10.1128/jvi.01581-0718045940 StoneJ.MartinN. K.HickmanM.HellardM.ScottN.McBrydeE.et al.. (2016). The potential impact of a" exact="hepatitis" post="C vaccine for people who inject drugs: is a"/>
   <result pre="standard of care therapy in patients with genotype 1 chronic" exact="hepatitis" post="C. Mol. Ther.21, 1796–1805. 10.1038/mt.2013.11923752314 collab: WHO (2017). Global"/>
   <result pre="2018). WijesundaraD. K.GummowJ.LiY.YuW.QuahB. J.RanasingheC.et al.. (2018). Induction of genotype cross-reactive," exact="hepatitis" post="C virus-specific, cell-mediated immunity in DNA-vaccinated mice. J. Virol.92:e02133-17."/>
   <result pre="(2014). A novel challenge model to evaluate the efficacy of" exact="hepatitis" post="C virus vaccines in mice. Vaccine32, 3409–3416. 10.1016/j.vaccine.2014.04.01424742491 ZhangX."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6460799\results\search\disease\results.xml">
   <result pre="single-stranded RNA) [2, 3]. Viruses from the Flaviviridae family include" exact="yellow fever" post="virus (YFV), dengue virus (DENV), Japanese encephalitis virus (JEV),"/>
   <result pre="family include yellow fever virus (YFV), dengue virus (DENV), Japanese" exact="encephalitis" post="virus (JEV), West Nile virus (WNV) and Zika virus"/>
   <result pre="pregnant women and are associated with birth defects, such as" exact="microcephaly" post="in prenatally infected infants [7]. In February 2016, ZIKV"/>
   <result pre="[8, 10]. Members that belong to the Togaviridae family include" exact="chikungunya" post="virus (CHIKV), Sindbis virus (SINV), Semliki Forest virus (SFV)"/>
   <result pre="extent, in Drosophila [95–97]. In Drosophila, antiviral autophagy against vesicular" exact="stomatitis" post="virus (VSV) and Rift Valley fever virus (RVFV) is"/>
   <result pre="enhanced susceptibility to Plasmodium infection, thus increased the risk of" exact="malaria" post="transmission by these mosquitoes [114]. CRISPR/Cas9 genetically-modified mosquitoes The"/>
   <result pre="that is important for parasite’s midgut infection stage to block" exact="malaria" post="transmission [101]. Conclusions Currently there are no suitable vaccines"/>
   <result pre="Abbreviations PRRs pattern recognition receptors PAMPs pathogen-associated molecular patterns YFV" exact="yellow fever" post="virus DENV dengue virus JEV Japanese encephalitis virus WNV"/>
   <result pre="patterns YFV yellow fever virus DENV dengue virus JEV Japanese" exact="encephalitis" post="virus WNV West Nile virus ZIKV Zika virus CHIKV"/>
   <result pre="encephalitis virus WNV West Nile virus ZIKV Zika virus CHIKV" exact="chikungunya" post="virus SINV Sindbis virus SFV Semliki Forest virus RRV"/>
   <result pre="Aubergine Ago3 Argonaute 3 piRISC piRNA-induced silencing complex VSV vesicular" exact="stomatitis" post="virus CRISPR/Cas9 clustered regularly interspaced short palindromic repeats/CRISPR associated"/>
   <result pre="Biotechnol.2014985807582210.1007/s00253-014-5792-624811407 64.VizioliJBuletPHoffmannJAKafatosFCMüllerH-MDimopoulosGGambicin: a novel immune responsive antimicrobial peptide from the" exact="malaria" post="vector Anopheles gambiaeProc Natl Acad Sci USA2001981263010.1073/pnas.22146679811606751 65.BartholomayLCFuchsJFChengLLBeckETVizioliJLowenbergerCet al.Reassessing"/>
   <result pre="67.VizioliJBuletPCharletMLowenbergerCBlassCMullerHMet al.Cloning and analysis of a cecropin gene from the" exact="malaria" post="vector mosquito, Anopheles gambiaeInsect Mol Biol.20009758410.1046/j.1365-2583.2000.00164.x10672074 68.JupatanakulNSimSAngleró-RodríguezYISouza-NetoJDasSPotiKEet al.Engineered Aedes"/>
   <result pre="Dis.20115e138510.1371/journal.pntd.000138522102922 70.McFarlaneMArias-GoetaCMartinEO’HaraZLullaAMoussonLet al.Characterization of Aedes aegypti innate-immune pathways that limit" exact="chikungunya" post="virus replicationPLoS Negl Trop Dis.20148e299410.1371/journal.pntd.000299425058001 71.FrosJJLiuWJProwNAGeertsemaCLigtenbergMVanlandinghamDLet al.Chikungunya virus nonstructural"/>
   <result pre="97.ShellySLukinovaNBambinaSBermanACherrySAutophagy is an essential component of Drosophila immunity against vesicular" exact="stomatitis" post="virusImmunity.20093058859810.1016/j.immuni.2009.02.00919362021 98.ZhangJLanYLiMYLamersMMFusade-BoyerMKlemmEet al.Flaviviruses exploit the lipid droplet protein AUP1"/>
   <result pre="transmissionNature.201147645410.1038/nature1035621866160 101.DongYSimõesMLMaroisEDimopoulosGCRISPR/Cas9 -mediated gene knockout of Anopheles gambiae FREP1 suppresses" exact="malaria" post="parasite infectionPLoS Pathog.201814e100689810.1371/journal.ppat.100689829518156 102.CarvalhoDOMcKemeyARGarzieraLLacroixRDonnellyCAAlpheyLet al.Suppression of a field population"/>
   <result pre="Dis.20148e296510.1371/journal.pntd.000296525010200 114.HughesGLRiveroARasgonJLWolbachia can enhance Plasmodium infection in mosquitoes: implications for" exact="malaria" post="control?PLoS Pathog.201410e100418210.1371/journal.ppat.100418225187984 115.KistlerKEVosshallLBMatthewsBJGenome engineering with CRISPR-Cas9 in the mosquito"/>
   <result pre="al.Highly efficient Cas9-mediated gene drive for population modification of the" exact="malaria" post="vector mosquito Anopheles stephensiProc Natl Acad Sci USA2015112E673610.1073/pnas.152107711226598698 117.LiMBuiMYangTBowmanCSWhiteBJAkbariOSGermline"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6463034\results\search\disease\results.xml">
   <result pre="in 2015 in Brazil mainly due to its association with" exact="microcephaly" post="in newborns. Although most infections in adults are asymptomatic"/>
   <result pre="persist in the male genital tract, which could lead to" exact="infertility" post="[4]. After its explosion in Brazil, the virus rapidly"/>
   <result pre="combining clinical findings, animal, organoid, and cell culture results, ZIKV-induced" exact="microcephaly" post="was found to be the result of the marked"/>
   <result pre="thus reducing brain size. In addition to this &quot;direct effect�?," exact="placental insufficiency" post="and inflammatory responses during the infection would also contribute"/>
   <result pre="with vaccination for the control of other flaviviral diseases like" exact="yellow fever," post="Japanese encephalitis, or tick-borne-encephalitis invite optimism. However, the experience"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6465516\results\search\disease\results.xml">
   <result pre="and North America. In Brazil, during ZIKV outbreak thousands of" exact="microcephaly" post="cases occurred that caused a state of urgency among"/>
   <result pre="The evidences supporting the association of ZIKV infection with congenital" exact="microcephaly" post="and fetal brain tissue damage is rapidly increasing, and"/>
   <result pre="mechanism of ZIKV infection causing microcephaly. Zika virus emerging infection" exact="microcephaly" post="neurological disorders public health fig-count: table-count: equation-count: ref-count: page-count:"/>
   <result pre="a mosquito-borne, single-stranded RNA, flavivirus that is closely related to" exact="yellow fever" post="virus (YFV), Japanese encephalitis virus (JEV) and dengue virus"/>
   <result pre="that is closely related to yellow fever virus (YFV), Japanese" exact="encephalitis" post="virus (JEV) and dengue virus (DENV). It can adapt"/>
   <result pre="ambiguities in previously reported data (9), the ZIKV association with" exact="microcephaly" post="was considered ambiguous. However, the World Health Organization situation"/>
   <result pre="genuine facts that ZIKV infection is the cause of congenital" exact="microcephaly" post="(11). Figure 1 Zika virus infection is transmitted to"/>
   <result pre="emerged as a profoundly important public health concern when congenital" exact="microcephaly" post="and other fetal/neonatal abnormalities were recorded in infected pregnant"/>
   <result pre="fetal/neonatal abnormalities were recorded in infected pregnant women (12). Congenital" exact="microcephaly" post="is a rarely occurring neurological birth defect, characterized by"/>
   <result pre="there is no universally accepted and uniform diagnostic standard of" exact="microcephaly" post="(15). The possible etiologies may include environmental or genetic"/>
   <result pre="other prenatal viral infections e.g., cytomegalovirus, syphilis, rubella, herpesvirus, and" exact="toxoplasmosis" post="(TORCHES) (7). Intriguingly, it was not included in the"/>
   <result pre="microorganisms until 2015 (7, 16). The number of suspected congenital" exact="microcephaly" post="cases associated with ZIKV in Brazil had increased to"/>
   <result pre="of International Concern (PHEIC) on February 2016, when recorded congenital" exact="microcephaly" post="cases soared up in the geographically widespread ZIKV epidemic"/>
   <result pre="and Puerto Rico. In USA, the first ZIKV associated congenital" exact="microcephaly" post="case was reported in Hawaii, in 2016 (21). Due"/>
   <result pre="as happened in the Yap Island. Its potential association with" exact="microcephaly" post="has been reported in the French Polynesia, Brazil, America,"/>
   <result pre="From 2014-15, Brazil reported multiple cases of illness and skin" exact="rash" post="to the World Health Organization (WHO), occurring in the"/>
   <result pre="In these states (February to April 2015), around 7,000 skin" exact="rash" post="cases were reported but no identification tests were performed"/>
   <result pre="and November 2015. It caused a 20-fold increase in the" exact="microcephaly" post="cases in Brazil, whereas, around 1,248 new suspected cases"/>
   <result pre="(11). In the Brazilian state, Bahia, multiple cases of acute" exact="rash" post="were followed by increased number of microcephalic fetuses (13),"/>
   <result pre="average of 163 (5.6 per 100,000 live birth) cases of" exact="microcephaly" post="occurred annually before 2015 ZIKA epidemic in Brazil, while"/>
   <result pre="while 3,530 (121.7 per 100,000 live births) suspected cases of" exact="microcephaly" post="were reported in 2015, including 46 death cases (16)."/>
   <result pre="damage to cerebral tissue (12). Here we discussed ZIKV related" exact="microcephaly" post="clinical manifestations to better understand the outcomes of this"/>
   <result pre="reported that 8 out of 19 identified cases had severe" exact="microcephaly" post="with major brain lesions, five had visible malformations and"/>
   <result pre="placental barrier (27). Cauchemez et al. calculated the risk of" exact="microcephaly" post="during ZIKV outbreak in French Polynesian outbreak (Sept, 2013,"/>
   <result pre="by authors (28). While another report presented 22% risk of" exact="microcephaly" post="during first trimester. Similarly, a more recent cohort study"/>
   <result pre="case report, HC declined from 47th to 24th percentile without" exact="microcephaly" post="and intracranial calcifications (15). The infant's cerebrospinal fluid sample"/>
   <result pre="to understand and explain the cellular and molecular basis of" exact="microcephaly" post="development, level of selective neurotropism (25), spectrum of changes"/>
   <result pre="fetal brain. Dang et al. (41) investigated the ZIKV and" exact="microcephaly" post="relationship by using cerebral organoids derived human embryonic stem"/>
   <result pre="disrupt neurogenetic pathways, affects apoptosis, and plays crucial role in" exact="microcephaly" post="(41). Garcez et al. (42) used human-induced pluripotent stem"/>
   <result pre="model derived from human-induced pluripotent stem cells, which resulted in" exact="microcephaly" post="like symptoms, such as increased cell death, decline in"/>
   <result pre="ZIKV Related Studies Despite the evidences supporting ZIKV association with" exact="microcephaly" post="and neonatal/fetal brain congenital abnormalities, scientists from different backgrounds"/>
   <result pre="abnormalities, scientists from different backgrounds suggest that clinical symptoms of" exact="microcephaly" post="are shared by various other congenital infections (e.g., cytomegalovirus),"/>
   <result pre="congenital infections (e.g., cytomegalovirus), and arboviruses that can potentially cause" exact="microcephaly" post="(31, 46). Furthermore, approximately 80% of ZIKV infected patients"/>
   <result pre="this hypothesis is considered true the ratio of ZIKV related" exact="microcephaly" post="cases are still ambiguous (1). An American reported case"/>
   <result pre="pregnancy has the highest risk of laboratory-confirmed ZIKV transmission and" exact="microcephaly" post="as compared to 2nd and 3rd trimesters that have"/>
   <result pre="study conducted by Cauchemez et al. estimated 1% risk of" exact="microcephaly" post="to the fetuses/neonates, as discussed earlier, has provided crucial"/>
   <result pre="status directly that may add to a false diagnosis of" exact="microcephaly" post="as malnutrition and can negatively impact fetal growth and"/>
   <result pre="circumference (1, 5, 48). In Brazil, the diagnostic standard of" exact="microcephaly" post="after December 2015 illustrating results with more specificity and"/>
   <result pre="specificity and sensitivity, pondered a question about the prevalence of" exact="microcephaly" post="during 2015 (about 20 cases/10,000 births) as compared to"/>
   <result pre="and post-diagnosis follow-up is cautious and necessary for correctly diagnosing" exact="microcephaly" post="ascribed to ZIKV because incorrect diagnosis may exaggerate, limit"/>
   <result pre="out other viral infections to confirm the ZIKV link with" exact="microcephaly" post="is quite important (32), as during previous ZIKV epidemic"/>
   <result pre="diseases (11, 47), for instance, West Nile virus (WNV), Japanese" exact="encephalitis" post="viruses, Dengue virus (DENV) and the yellow fever virus"/>
   <result pre="virus (WNV), Japanese encephalitis viruses, Dengue virus (DENV) and the" exact="yellow fever" post="virus (46) that are genetically similar to ZIKV. ZIKV"/>
   <result pre="can only be used in predicting the course of a" exact="microcephaly" post="outbreak (46). ZIKV epidemic in Cape Verde (2015–2016), probably"/>
   <result pre="mosquitoes, resulted in thousands of infection cases without causing any" exact="neurological disorder" post="(20). Calvet et al. report on ZIKV genomic RNA"/>
   <result pre="broad range of time interval (average, 13 weeks) since fetal" exact="microcephaly" post="was first diagnosed, and maternal clinical symptoms appeared. In"/>
   <result pre="ZIKV epidemic could predict profound increase in the number of" exact="microcephaly" post="cases, almost 5–10 months later. During this time maternal"/>
   <result pre="it is inappropriate to predict the total expected number of" exact="microcephaly" post="cases in Brazil and in the rest of the"/>
   <result pre="control group of these limited number of samples had a" exact="rash" post="like symptoms during pregnancy, but the cause of rash"/>
   <result pre="a rash like symptoms during pregnancy, but the cause of" exact="rash" post="was not analyzed or diagnosed clearly (39). Moreover, it"/>
   <result pre="both mouse and human neural progenitor cells (NPCs), resulting in" exact="microcephaly" post="in the mouse fetus, and higher mortality in neonatal"/>
   <result pre="more infectious to human NPCs, by contributing to the increased" exact="microcephaly" post="rate in recent ZIKV epidemics (53). Is it possible"/>
   <result pre="reason of neurotropism. Although evidences are supporting ZIKV relationship with" exact="microcephaly" post="and other brain injuries, yet information about its epidemiology,"/>
   <result pre="than dengue neutralizing antibody can be a useful approach. Other" exact="arthritis" post="causing infections causing such as, CHIKV, DENV, malaria, Rubella,"/>
   <result pre="and go through follow-up cohorts and calculate potential risk of" exact="microcephaly" post="throughout women pregnancy, along with proper investigation of materno-fetal"/>
   <result pre="surface groups that can be potentially used against sexually transmitted" exact="herpes simplex" post="virus (HSV), human immunodeficiency virus (HIV), and human papillomavirus"/>
   <result pre="and virosomal (liposome) vaccine is used for the treatment of" exact="influenza" post="and hepatitis A virus (HAV) (69–71). Similarly, another therapeutic"/>
   <result pre="(liposome) vaccine is used for the treatment of influenza and" exact="hepatitis" post="A virus (HAV) (69–71). Similarly, another therapeutic vaccine for"/>
   <result pre="(72). Another example is use of wet lipid nanoparticles against" exact="hepatitis" post="B virus (HBV) that target 3 sites on the"/>
   <result pre="ZIKV. Conclusions Apart West Nile virus (78), thousands of congenital" exact="microcephaly" post="cases, fetal brain tissue damage and neurological syndromes have"/>
   <result pre="a relative stable virus is on a rise. Although congenital" exact="microcephaly" post="is a rare disorder however, due to lack of"/>
   <result pre="XimenesRAde Barros Miranda-FilhoDMontarroyosURde MeloAPLet al.Association between Zika virus infection and" exact="microcephaly" post="in Brazil, January to May, 2016: preliminary report of"/>
   <result pre="(2016) 16:2576–92. 10.1016/j.celrep.2016.08.03827568284 CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.. Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013–15: a retrospective study. Lancet. (2016)"/>
   <result pre="47:6–7. 10.1002/uog.1583126731034 AshwalSMichelsonDPlawnerLDobynsWB. Practice parameter: evaluation of the child with" exact="microcephaly" post="(an evidence-based review) report of the quality standards Subcommittee"/>
   <result pre="Zika virus infection is neurotropic in fetuses and infants with" exact="microcephaly" post="following transplacental transmission. Arch Pathol Lab Med. (2016) 141:68–72."/>
   <result pre="Cavalcanti Souza CruzDTenorioMvan der LindenAPenaLJet al.. Computed tomographic findings in" exact="microcephaly" post="associated with Zika virus. N Engl J Med. (2016)"/>
   <result pre="Zika virus infection and stillbirths: a case of hydrops fetalis," exact="hydranencephaly" post="and fetal demise. PLoS Negl Trop Dis. (2016) 10:e0004517."/>
   <result pre="LiCXuDYeQHongSJiangYLiuXet al.Zika virus disrupts neural progenitor development and leads to" exact="microcephaly" post="in mice. Cell Stem Cell. (2016) 19:120–6. 10.1016/j.stem.2016.04.01727179424 TangHHammackCOgdenSCWenZQianXLiYet"/>
   <result pre="113:14408–14413. 10.1073/pnas.161802911327911847 TeixeiraMGCosta MdaCde OliveiraWKNunesMLRodriguesLC. The epidemic of Zika virus–related" exact="microcephaly" post="in Brazil: detection, control, etiology, and future scenarios. Am"/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: a case study. Lancet Infect Dis. (2016)"/>
   <result pre="Variation of the specificity of the human antibody responses after" exact="tick-borne encephalitis" post="virus infection and vaccination. J Virol. (2014) 88:13845–57. 10.1128/JVI.02086-1425253341"/>
   <result pre="of the specificity of the human antibody responses after tick-borne" exact="encephalitis" post="virus infection and vaccination. J Virol. (2014) 88:13845–57. 10.1128/JVI.02086-1425253341"/>
   <result pre="(2016) 2016:2405954. 10.1155/2016/240595428053975 KimKY. Nanotechnology platforms and physiological challenges for" exact="cancer" post="therapeutics. Nanomedicine. (2007) 3:103–10. 10.1016/j.nano.2006.12.00217442621 IslanGADuránMCacicedoMLNakazatoGKobayashiRKTMartinezDSTet al.. Nanopharmaceuticals as"/>
   <result pre="Release. (2017) 252:28–49. 10.1016/j.jconrel.2017.03.00828279798 BovierPAEpaxal®: a virosomal vaccine to prevent" exact="hepatitis" post="A infection. Expert Rev Vaccines. (2008) 7:1141–50. 10.1586/14760584.7.8.114118844588 HerzogEByrneHJDavorenMCaseyADuschlAOostinghGJ."/>
   <result pre="SetoW-KHuiAJWongVW-SWongGL-HLiuKS-HLaiC-Let al.. Treatment cessation of entecavir in Asian patients with" exact="hepatitis" post="B e antigen negative chronic hepatitis B: a multicentre"/>
   <result pre="in Asian patients with hepatitis B e antigen negative chronic" exact="hepatitis" post="B: a multicentre prospective study. Gut. (2015) 64:667–72. 10.1136/gutjnl-2014-30723724833635"/>
   <result pre="multicentre prospective study. Gut. (2015) 64:667–72. 10.1136/gutjnl-2014-30723724833635 SetoW-KWongD-HChanT-YHwangY-YFungJLiuKS-Het al.Association of" exact="hepatitis" post="B core-related antigen with hepatitis B virus reactivation in"/>
   <result pre="64:667–72. 10.1136/gutjnl-2014-30723724833635 SetoW-KWongD-HChanT-YHwangY-YFungJLiuKS-Het al.Association of hepatitis B core-related antigen with" exact="hepatitis" post="B virus reactivation in occult viral carriers undergoing high-risk"/>
   <result pre="Changes of HBsAg and HBV DNA levels in Chinese chronic" exact="hepatitis" post="B patients after 5 years of entecavir treatment. J"/>
   <result pre="active-controlled trial. Lancet. (2011) 378:238–46. 10.1016/S0140-6736(11)60936-721763936 SavastaSRovidaFFoiadelliTCampanaAMPercivalleEMarsegliaGLet al.. West-Nile virus" exact="encephalitis" post="in an immunocompetent pediatric patient: successful recovery. Ital J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466003\results\search\disease\results.xml">
   <result pre="is important to understand the role of meteorological factors in" exact="influenza" post="virus (IV) epidemics. In this study, we investigated the"/>
   <result pre="surveillance and promote development of accurate predictive models for future" exact="influenza" post="outbreaks in the region. influenza epidemics weather temperature UV"/>
   <result pre="accurate predictive models for future influenza outbreaks in the region." exact="influenza" post="epidemics weather temperature UV 1. Introduction Influenza A (H1N1"/>
   <result pre="also been suggested to have an influence on the seasonal" exact="influenza" post="epidemics in temperate climates [12,13]. In fact, temperature, humidity,"/>
   <result pre="(genetic and social) may be valuable indicators to include in" exact="influenza" post="surveillance for accurate prediction of future influenza outbreaks in"/>
   <result pre="to include in influenza surveillance for accurate prediction of future" exact="influenza" post="outbreaks in different climate zones. In this study, we"/>
   <result pre="highlighted an important role of temperature and UV index in" exact="influenza" post="epidemics in Northern Europe. 2. Materials and Methods 2.1."/>
   <result pre="2.1. The &quot;NorthernFlu�? Consortium To better understand the etiology of" exact="influenza" post="epidemics in Norway, Sweden, Finland, Estonia, Latvia and Lithuania"/>
   <result pre="Data Collection Weekly statistics of the specimens’ number positive for" exact="influenza" post="across six analyzed countries were collected from the World"/>
   <result pre="Global Influenza Surveillance and Response System (GISRS) and other national" exact="influenza" post="reference laboratories collaborating actively with GISRS, or were uploaded"/>
   <result pre="The FluNet database provided weekly statistics of specimens positive for" exact="influenza" post="viruses, whereas meteorological factor data were measured daily. Therefore,"/>
   <result pre="order to investigate the potential relationship between meteorological factors and" exact="influenza" post="activity (number of IV positive specimens) in all analyzed"/>
   <result pre="The Pearson correlation coefficient (r) between each meteorological factor and" exact="influenza" post="activity was calculated using the &quot;stats�? R package with"/>
   <result pre="was optimized to find the most predictive meteorological factors of" exact="influenza" post="activity. More specifically, for each country, the time-series measurements"/>
   <result pre="media was replaced with fresh GM-CSF free macrophage media. GFP-expressing" exact="influenza" post="A/PR8-NS116-GFP strain (PR8-GFP) was purified by centrifugation in sucrose"/>
   <result pre="specimens in six countries, only 11% were classified: 3744 were" exact="influenza" post="A viruses (71% of A/H3 and 29% of A/H1)"/>
   <result pre="(71% of A/H3 and 29% of A/H1) and 2866 were" exact="influenza" post="B viruses (97% of B/Yamagata and 3% of B/Victoria)."/>
   <result pre="14th weeks of 2018 (Figure 1), while the peak of" exact="influenza" post="occurred between 29 January, 2018 and 11 March, 2018"/>
   <result pre="weeks). The only exception was Latvia, where the peak of" exact="influenza" post="activity occurred between the 9th and 12th weeks (Figure"/>
   <result pre="revealed that temperature was the most predictive meteorological factor of" exact="influenza" post="activity in all six Northern European countries (Figure 2)."/>
   <result pre="and UV indexes, we performed in vitro experiments. Purified GFP-encoding" exact="influenza" post="A/Puerto Rico/1934 virus (PR8-GFP) was incubated at different temperatures"/>
   <result pre="cells (Figure 4B,C). We performed similar experiment using clinical A/H1N1(pdm09)" exact="influenza" post="isolate and human PBMC-derived macrophages. Viruses exposed to high"/>
   <result pre="onset. It was proposed that fewer people were infected with" exact="influenza" post="during warm winters, thereby leaving an unnaturally large fraction"/>
   <result pre="It was shown that low winter temperatures correlated with both" exact="influenza" post="incidence and global mortality, which mainly affected those aged"/>
   <result pre="the world, and help to develop accurate predictive models of" exact="influenza" post="epidemics. Moreover, the combination of epidemiological, meteorological and genetic"/>
   <result pre="epidemiological, meteorological and genetic studies could unravel the evolution of" exact="influenza" post="viruses and, consequently, improve early intervention and long-term control"/>
   <result pre="consequently, improve early intervention and long-term control strategies of future" exact="influenza" post="outbreaks. Acknowledgments We gratefully acknowledge WHO, NICs, GISRS, NWS,"/>
   <result pre="The following are available online at https://www.mdpi.com/1999-4915/11/3/207/s1. Figure S1: Weekly" exact="influenza" post="virus activity and daily temperatures across six Northern European"/>
   <result pre="1 September 2017 and 31 August 2018. Figure S2: Weekly" exact="influenza" post="virus activity and daily UV indices across six Northern"/>
   <result pre="S4: Effect of temperature and UV radiation on infectivity of" exact="influenza" post="A/Puerto Rico/8/1934 (PR8-GFP) and A/Helsinki/P18/2009(pdm09) strains. LINK Click here"/>
   <result pre="Interest The authors declare no conflicts of interest. Abbreviations IV" exact="influenza" post="virus IAV influenza A virus UV ultraviolet GFP green"/>
   <result pre="declare no conflicts of interest. Abbreviations IV influenza virus IAV" exact="influenza" post="A virus UV ultraviolet GFP green fluorescent protein RPE"/>
   <result pre="4.KashJ.C.TaubenbergerJ.K.The role of viral, host, and secondary bacterial factors in" exact="influenza" post="pathogenesisAm. J. Pathol.20151851528153610.1016/j.ajpath.2014.08.03025747532 5.SooryanarainH.ElankumaranS.Environmental role in influenza virus outbreaksAnnu."/>
   <result pre="bacterial factors in influenza pathogenesisAm. J. Pathol.20151851528153610.1016/j.ajpath.2014.08.03025747532 5.SooryanarainH.ElankumaranS.Environmental role in" exact="influenza" post="virus outbreaksAnnu. Rev. Anim. Biosci.2015334737310.1146/annurev-animal-022114-11101725422855 6.Gomez-BarrosoD.Leon-GomezI.Delgado-SanzC.LarrauriA.Climatic Factors and Influenza"/>
   <result pre="Israeli DistrictsPLoS ONE201510e013470110.1371/journal.pone.013470126309214 10.LowenA.C.SteelJ.Roles of humidity and temperature in shaping" exact="influenza" post="seasonalityJ. Virol.2014887692769510.1128/JVI.03544-1324789791 11.PeciA.WinterA.L.LiL.GnaneshanS.LiuJ.MubarekaS.GubbayJ.B.Effect of absolute and relative humidity, temperature"/>
   <result pre="of absolute and relative humidity, temperature and wind speed on" exact="influenza" post="activity in Toronto, CanadaAppl. Environ. Microbiol.201910.1128/AEM.02426-1830610079 12.CharlandK.M.BuckeridgeD.L.SturtevantJ.L.MeltonF.ReisB.Y.MandlK.D.BrownsteinJ.S.Effect of environmental"/>
   <result pre="Microbiol.201910.1128/AEM.02426-1830610079 12.CharlandK.M.BuckeridgeD.L.SturtevantJ.L.MeltonF.ReisB.Y.MandlK.D.BrownsteinJ.S.Effect of environmental factors on the spatio-temporal patterns of" exact="influenza" post="spreadEpidemiol. Infect.20091371377138710.1017/S095026880900228319296868 13.SagripantiJ.L.LytleC.D.Inactivation of influenza virus by solar radiationPhotochem."/>
   <result pre="on the spatio-temporal patterns of influenza spreadEpidemiol. Infect.20091371377138710.1017/S095026880900228319296868 13.SagripantiJ.L.LytleC.D.Inactivation of" exact="influenza" post="virus by solar radiationPhotochem. Photobiol.2007831278128210.1111/j.1751-1097.2007.00177.x17880524 14.FluNetAvailable online: http://www.who.int/influenza/gisrs_laboratory/flunet/en/(accessed on"/>
   <result pre="on 10 October 2018) 15.DenisovaO.V.KakkolaL.FengL.StenmanJ.NagarajA.LampeJ.YadavB.AittokallioT.KaukinenP.AholaT.et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit" exact="influenza" post="a virus infectionJ. Biol. Chem.2012287353243533210.1074/jbc.M112.39214222910914 16.PirhonenJ.SarenevaT.KurimotoM.JulkunenI.MatikainenS.Virus infection activates IL-1"/>
   <result pre="a caspase-1-dependent pathwayJ. Immunol.19991627322732910358182 17.ReimerC.B.BakerR.S.van FrankR.M.NewlinT.E.ClineG.B.AndersonN.G.Purification of large quantities of" exact="influenza" post="virus by density gradient centrifugationJ. Virol.19671120712165621490 18.KittelC.SereinigS.FerkoB.StasakovaJ.RomanovaJ.WolkerstorferA.KatingerH.EgorovA.Rescue of influenza"/>
   <result pre="of influenza virus by density gradient centrifugationJ. Virol.19671120712165621490 18.KittelC.SereinigS.FerkoB.StasakovaJ.RomanovaJ.WolkerstorferA.KatingerH.EgorovA.Rescue of" exact="influenza" post="virus expressing GFP from the NS1 reading frameVirology2004324677310.1016/j.virol.2004.03.03515183054 19.LakspereT.TynellJ.KaloinenM.VanledeM.ParsonsA.IkonenN.Kallio-KokkoH.KanteleA.MattilaP.AlmusaH.et"/>
   <result pre="Patients from 2009 to 2013Genome Announc.20142e01004-1310.1128/genomeA.01004-1324435855 20.TameriusJ.D.ShamanJ.AlonsoW.J.Bloom-FeshbachK.UejioC.K.ComrieA.ViboudC.Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climatesPLoS Pathog.20139e100319410.1371/annotation/df689228-603f-4a40-bfbf-a38b13f8814723505366 21.BallesterJ.RodóX.RobineJ.M.HerrmannF.R.European seasonal"/>
   <result pre="across temperate and tropical climatesPLoS Pathog.20139e100319410.1371/annotation/df689228-603f-4a40-bfbf-a38b13f8814723505366 21.BallesterJ.RodóX.RobineJ.M.HerrmannF.R.European seasonal mortality and" exact="influenza" post="incidence due to winter temperature variabilityNat. Clim. Chang.2016692793010.1038/nclimate3070 22.TowersS.ChowellG.HameedR.JastrebskiM.KhanM.MeeksJ.MubayiA.HarrisG.Climate"/>
   <result pre="22.TowersS.ChowellG.HameedR.JastrebskiM.KhanM.MeeksJ.MubayiA.HarrisG.Climate change and influenza: The likelihood of early and severe" exact="influenza" post="seasons following warmer than average wintersPLoS Curr.2013510.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f13824045424 23.GeierD.A.KernJ.K.GeierM.R.A longitudinal"/>
   <result pre="than average wintersPLoS Curr.2013510.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f13824045424 23.GeierD.A.KernJ.K.GeierM.R.A longitudinal ecological study of seasonal" exact="influenza" post="deaths in relation to climate conditions in the United"/>
   <result pre="10 October 2018) Figure 1 Weekly number of detections of" exact="influenza" post="viruses in six Northern European countries, 2017–2018. (A). Map"/>
   <result pre="(temperature, UV index, humidity, wind speed, precipitation, and pressure) and" exact="influenza" post="activity in six Northern Europe countries (Norway, Sweden, Finland,"/>
   <result pre="of a machine learning Random Forest model trained to predict" exact="influenza" post="activity. The contribution is measured as percentage mean decrease"/>
   <result pre="more important the factor). (B) Correlation between meteorological factors and" exact="influenza" post="activity. Absolute values of Pearson correlation coefficient (95% confidence"/>
   <result pre="(temperature, UV index, humidity, wind speed, precipitation, and pressure) and" exact="influenza" post="activity in six Northern Europe countries averaged for the"/>
   <result pre="34 of 2017. (Left) Correlation analysis between meteorological factors and" exact="influenza" post="activity. (Right) Contribution of each meteorological factor to predictive"/>
   <result pre="performance of machine-learning Random Forest models trained to predict the" exact="influenza" post="virus (IV) activity in six Northern European countries. Contribution"/>
   <result pre="Effect of temperature and UV radiation on infectivity of GFP-encoding" exact="influenza" post="A virus (PR8-GFP). (A) PR8-GFP was incubated at indicated"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466125\results\search\disease\results.xml">
   <result pre="are responsible for almost a fifth of all cases of" exact="gastroenteritis" post="worldwide. New strains evolve every 2–4 years by escaping"/>
   <result pre="receptors 1. Introduction Noroviruses are the major cause of epidemic" exact="gastroenteritis" post="in humans and, as such, are important pathogens (for"/>
   <result pre="crystal structure of NV (&quot;compressed state�?), the structure of rabbit" exact="hemorrhagic disease" post="virus (RHDV) VLP was also determined [20]. The structure"/>
   <result pre="with Its Receptor Feline calicivirus (FCV) causes respiratory illness and" exact="stomatitis" post="in cats [37]. FCV interacts with a 2,6 sialic"/>
   <result pre="and epidemiologic trends of caliciviruses associated with outbreaks of acute" exact="gastroenteritis" post="in the united states, 2000–2004J. Infect. Dis.200619341342110.1086/49931516388489 4.SiebengaJ.J.VennemaH.DuizerE.KoopmansM.P.Gastroenteritis caused"/>
   <result pre="al.High-resolution cryo-electron microscopy structures of murine norovirus 1 and rabbit" exact="hemorrhagic disease" post="virus reveal marked flexibility in the receptor binding domainsJ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466164\results\search\disease\results.xml">
   <result pre="viruses mouse models knockout mice transgenic mice humanized mice HIV" exact="influenza" post="dengue 1. Introduction Infectious diseases caused by human pathogenic"/>
   <result pre="(HIV) infections [1]. More than 90 million new cases of" exact="influenza" post="occur every year in children aged less than five"/>
   <result pre="transgenic mice include mice expressing a transgenic TCR specific to" exact="influenza" post="virus hemagglutinin (HA) in the context of the major"/>
   <result pre="activation of CD8+T cells [4,5]. Furthermore, many human viruses like" exact="hepatitis" post="viruses, polioviruses, papillomaviruses, HIV, and measles are not infectious"/>
   <result pre="many human viruses like hepatitis viruses, polioviruses, papillomaviruses, HIV, and" exact="measles" post="are not infectious to wild-type mice, but the transgenic"/>
   <result pre="advantages and restrictions; hence, selecting an appropriate model for a" exact="viral disease" post="of interest is of paramount importance. Schematic representation of"/>
   <result pre="the most significant inventions in modern medicine, providing effective virus" exact="suppression" post="and radically enhancing the quality of life and life"/>
   <result pre="mice [33]; 3′ half of the HIV genome, causing severe" exact="nephropathy" post="[34]; and expression of HIV-1 Tat or Nef proteins,"/>
   <result pre="Influenza A pandemics have caused considerable disease and deaths. While" exact="influenza" post="A and B cause only acute febrile illness in"/>
   <result pre="[64]. Influenza infections may promote and intensify numerous conditions like" exact="chronic obstructive pulmonary disease" post="(COPD) [65] and, asthma [66]; They can increase the"/>
   <result pre="numerous conditions like chronic obstructive pulmonary disease (COPD) [65] and," exact="asthma" post="[66]; They can increase the risk of a cerebro-vascular"/>
   <result pre="women [68]. Though antiviral therapies, drugs, and vaccines are available," exact="influenza" post="viruses still threaten humans and animals all over the"/>
   <result pre="have played a significant role in delineating the pathogenesis of" exact="influenza" post="and in the development of vaccines and therapeutics against"/>
   <result pre="adapted strains of influenza. DBA/2j is highly susceptible to non-adapted" exact="influenza" post="strains [72,73,74]. The most common symptoms exhibited by the"/>
   <result pre="However, depending on the dose and the strains of the" exact="influenza" post="virus used, the infection might be lethal. The most"/>
   <result pre="be lethal. The most commonly used mouse adapted strains of" exact="influenza" post="include H1N1 influenza A/Puerto Rico/8/34 (PR8) or H1N1 influenza"/>
   <result pre="most commonly used mouse adapted strains of influenza include H1N1" exact="influenza" post="A/Puerto Rico/8/34 (PR8) or H1N1 influenza A/WSN/1933 (WSN). However,"/>
   <result pre="of influenza include H1N1 influenza A/Puerto Rico/8/34 (PR8) or H1N1" exact="influenza" post="A/WSN/1933 (WSN). However, certain strains, such as the 1918"/>
   <result pre="(WSN). However, certain strains, such as the 1918 H1N1 pandemic" exact="influenza" post="A and the 2009 H1N1 pandemic influenza A, do"/>
   <result pre="1918 H1N1 pandemic influenza A and the 2009 H1N1 pandemic" exact="influenza" post="A, do not require adaptation to infect mice [72,73]."/>
   <result pre="[72,73]. The lack of suitable small-animal models for studies of" exact="influenza" post="pathogenesis and for the development of vaccines and antivirals"/>
   <result pre="widely used in understanding the two most important aspects of" exact="influenza" post="virus, namely: (i) how the early inflammatory response to"/>
   <result pre="influenza virus, namely: (i) how the early inflammatory response to" exact="influenza" post="virus leads to the progression of lung diseases; and"/>
   <result pre="and parental strains differ in virulence. IL-1R1−/− mice infected with" exact="influenza" post="virus were used to demonstrate the role of IL-1α"/>
   <result pre="on IL-18−/− mice revealed the importance of IL-18 in restricting" exact="influenza" post="virus replication in lungs by augmenting the NK cell"/>
   <result pre="role in innate immunity and in moderating lung pathology in" exact="influenza" post="pneumonia [77]. Mice models knocked out for multiple genes"/>
   <result pre="in innate immunity and in moderating lung pathology in influenza" exact="pneumonia" post="[77]. Mice models knocked out for multiple genes can"/>
   <result pre="for studying the combined effects of different molecules on the" exact="influenza" post="pathogenesis. TKO mice (Table 1) deficient in the three"/>
   <result pre="contribution of the TNF and IL-1 inflammatory response to H5N1" exact="influenza" post="A infection. Triple mutant C57BL/6J x 129S background mice"/>
   <result pre="mice (TNF-R KO, C57BL/6J x 129Sv-Tnfrsf1atm1Imx Tnfrsf1btm1Imx/J)] infected with H5N1" exact="influenza" post="A were observed to have longer survival, less morbidity,"/>
   <result pre="that TNF and IL-1 contribute to the pathogenesis of H5N1" exact="influenza" post="A virus [78]. The anti inflammatory role of fatty"/>
   <result pre="role of fatty acid binding protein 5 (FABP5) in H1N1" exact="influenza" post="A virus infection has been demonstrated using FABP5−/− mice."/>
   <result pre="using FABP5−/− mice. Infection of C57BL/6J background mice with H1N1" exact="influenza" post="A virus from which the FABP5 (FABP5−/−) gene had"/>
   <result pre="due to genetic mutations and reassortments. A reassortant seasonal H3N2" exact="influenza" post="A virus containing the PA gene of highly pathogenic"/>
   <result pre="influenza A virus containing the PA gene of highly pathogenic" exact="avian influenza" post="H5N1 influenza A caused severe pneumonia in Casp 1−/−"/>
   <result pre="A virus containing the PA gene of highly pathogenic avian" exact="influenza" post="H5N1 influenza A caused severe pneumonia in Casp 1−/−"/>
   <result pre="containing the PA gene of highly pathogenic avian influenza H5N1" exact="influenza" post="A caused severe pneumonia in Casp 1−/− mice [80]."/>
   <result pre="of highly pathogenic avian influenza H5N1 influenza A caused severe" exact="pneumonia" post="in Casp 1−/− mice [80]. Knockout mice models have"/>
   <result pre="differences in the pathogenicity between reassortment and parental strains of" exact="influenza" post="virus differences that may not be easily observed in"/>
   <result pre="Models of Influenza A Highly pathogenic avian H5 and H7" exact="influenza" post="A viruses continue to cross the species barrier and"/>
   <result pre="in providing an effective innate immune response to control the" exact="influenza" post="virus [83]. Tg mice expressing the entire human MX"/>
   <result pre="(Table 2) exhibit a higher resistance to H5 and H7" exact="influenza" post="A viruses, but are susceptible to H1N1 and H3N2"/>
   <result pre="influenza A viruses, but are susceptible to H1N1 and H3N2" exact="influenza" post="A viruses. Moreover, it was also shown that engineered"/>
   <result pre="viruses. Moreover, it was also shown that engineered avian H7N7" exact="influenza" post="virus with signature mutations found in human viruses was"/>
   <result pre="of Tg mice, researchers can implement new strategies against the" exact="influenza" post="virus. Wang et al. [85] came up with a"/>
   <result pre="RNA (ShRNA) to disrupt the activity of hemagglutinin (HA) of" exact="influenza" post="A virus, thereby inhibiting the virus. They developed a"/>
   <result pre="that specifically targets the conserved sequence of the HA of" exact="influenza" post="A virus. The Tg mice displayed a constant ability"/>
   <result pre="virus. The Tg mice displayed a constant ability to reduce" exact="influenza" post="A virus infection and replication, suggesting the utility of"/>
   <result pre="the utility of an shRNA-based approach to prevent and control" exact="influenza" post="virus infections in animals [85]. Tg mice expressing the"/>
   <result pre="vaccine and to a modified vaccinia Ankara vectored vaccine expressing" exact="influenza" post="virus epitopes. The studies reported that CD8+ T cells"/>
   <result pre="vaccinated HLA-DR3 expressing mice were challenged with pandemic 2009 H1N1" exact="influenza" post="A [88]. Therefore, Tg mice expressing HLA class I"/>
   <result pre="evaluating the CD8+ and CD4+ T cell responses to different" exact="influenza" post="A vaccine candidates. 3.3. Humanized Mouse Models of Influenza"/>
   <result pre="development, the preclinical analysis of the human immune response against" exact="influenza" post="vaccines, and the evaluation of vaccine cytotoxicity. Direct manipulation"/>
   <result pre="strategy, which will help the individuals to protect themselves against" exact="influenza" post="virus [89]. An advanced strategy of augmenting the innate"/>
   <result pre="strategy of augmenting the innate and adaptive immune response to" exact="infectious disease" post="is to expand the γδ-T cells using phosphoantigens [90,91,92]."/>
   <result pre="huPBMC sreconstituted immunodeficient Rag2−/−γc−/− mice (Table 3) infected with H1N1" exact="influenza" post="A and H5N1 influneza A, phosphoantigen selectively activated and"/>
   <result pre="responses with virus-neutralizing activity are considered the best vaccines against" exact="influenza" post="virus infection. Due to the sequence variations in the"/>
   <result pre="the envelope antigens HA and neuraminidase (NA), multiple subtypes of" exact="influenza" post="A virus have evolved and complicated the effective vaccine"/>
   <result pre="a result, for adults who usually have exposure to seasonal" exact="influenza" post="viruses, an annual single dose of the vaccine, boosting"/>
   <result pre="vaccine, boosting the humoral immune response, is sufficient. For emerging" exact="influenza" post="viruses, a single dose of a vaccine is sufficient"/>
   <result pre="to develop cross-reactive human anti-influenza monoclonal antibodies (hu-mAb) to study" exact="influenza" post="infection and investigate the efficacy of anti-influenza antibody-based therapeutics"/>
   <result pre="targeted the HA protein of H1N1 was able to clear" exact="influenza" post="infection in DRAGA mice [97]. The efficacy of vaccines"/>
   <result pre="establishing a humanized mouse model to demonstrate the evaluation of" exact="influenza" post="vaccine safety based on the expression of bio marker"/>
   <result pre="belongs to the family Flaviviridae and is closely related to" exact="hepatitis" post="C, West Nile, Zika, [100] and Japanese encephalitis viruses."/>
   <result pre="related to hepatitis C, West Nile, Zika, [100] and Japanese" exact="encephalitis" post="viruses. These family virus outbreaks are being reported throughout"/>
   <result pre="encephalitis-like symptoms and neurotoxicity. Moreover, anti TNF-α antibodies reduced dengue" exact="encephalitis" post="and mortality, suggesting anti TNF-α-based therapeutics for dengue encephalitis"/>
   <result pre="dengue encephalitis and mortality, suggesting anti TNF-α-based therapeutics for dengue" exact="encephalitis" post="[115]. Since mice lacking the IFN-α/β receptor are susceptible"/>
   <result pre="the clinical symptoms of dengue with a fever, rash, and" exact="thrombocytopenia" post="[118]. Antibody responses mimicking primary dengue infection have been"/>
   <result pre="model for research purposes. An ideal animal model for human" exact="viral disease" post="should closely recapitulate the spectrum of clinical symptoms and"/>
   <result pre="Such conditional KO and Tg mice are available for studying" exact="cancer" post="and need to be developed for studying viral diseases."/>
   <result pre="2018) 2.NairH.BrooksW.A.KatzM.RocaA.BerkleyJ.A.MadhiS.A.SimmermanJ.M.GordonA.SatoM.HowieS.et al.Global burden of respiratory infections due to seasonal" exact="influenza" post="in young children: A systematic review and meta-analysisLancet20113781917193010.1016/S0140-6736(11)61051-922078723 3.BarrilaJ.RadtkeA.L.CrabbéA.SarkerS.F.Herbst-KralovetzM.M.OttC.M.NickersonC.A.Organotypic"/>
   <result pre="interactionsNat. Rev. Microbiol.2010879180110.1038/nrmicro242320948552 4.BotA.CasaresS.BotS.Von BoehmerH.BonaC.Cellular mechanisms involved in protection against" exact="influenza" post="virus infection in transgenic mice expressing a TCR receptor"/>
   <result pre="the experts�? 2015 workshop summaryAIDS Res. Hum. Retrovir.20163210911910.1089/aid.2015.025826670361 55.HorwitzJ.A.Halper-StrombergA.MouquetH.GitlinA.D.TretiakovaA.EisenreichT.R.MalbecM.GravemannS.BillerbeckE.DornerM.et al.HIV-1" exact="suppression" post="and durable control by combining single broadly neutralizing antibodies"/>
   <result pre="COPDInt. J. Chron Obstruct. Pulmon. Dis.200725510.2147/copd.2007.2.1.5518044066 66.KimM.H.SongW.J.YangM.S.LeeS.H.KwonJ.W.KimS.H.KangH.R.ParkH.W.ChoY.J.ChoS.H.et al.Clinical course of" exact="asthma" post="patients with H1N1 influenza infection and oseltamivirMinerva Med.201810971428880061 67.BarnesM.HeywoodA.E.MahimboA.RahmanB.NewallA.T.MacintyreC.R.Acute"/>
   <result pre="Pulmon. Dis.200725510.2147/copd.2007.2.1.5518044066 66.KimM.H.SongW.J.YangM.S.LeeS.H.KwonJ.W.KimS.H.KangH.R.ParkH.W.ChoY.J.ChoS.H.et al.Clinical course of asthma patients with H1N1" exact="influenza" post="infection and oseltamivirMinerva Med.201810971428880061 67.BarnesM.HeywoodA.E.MahimboA.RahmanB.NewallA.T.MacintyreC.R.Acute myocardial infarction and influenza:"/>
   <result pre="and influenza: A meta-analysis of case–control studiesHeart20151011738174710.1136/heartjnl-2015-30769126310262 68.Stanwell-SmithR.ParkerA.M.ChakravertyP.SoltanpoorN.SimpsonC.N.Possible association of" exact="influenza" post="A with fetal loss: Investigation of a cluster of"/>
   <result pre="69.PaleseP.Influenza: Old and new threatsNat. Med.200410S8210.1038/nm114115577936 70.HorimotoT.KawaokaY.Pandemic threat posed by" exact="avian influenza" post="A virusesClin. Microbiol. Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the"/>
   <result pre="Old and new threatsNat. Med.200410S8210.1038/nm114115577936 70.HorimotoT.KawaokaY.Pandemic threat posed by avian" exact="influenza" post="A virusesClin. Microbiol. Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the"/>
   <result pre="Rev.20011412914910.1128/CMR.14.1.129-149.200111148006 71.GuarnacciaT.CarolanL.A.Maurer-StrohS.LeeR.T.JobE.ReadingP.C.PetrieS.McCawJ.M.McVernonJ.HurtA.C.et al.Antigenic drift of the pandemic 2009 A (H1N1)" exact="influenza" post="virus in A ferret modelPLoS Pathog.20139100335410.1371/journal.ppat.1003354 72.MargineI.KrammerF.Animal models for"/>
   <result pre="influenza virus in A ferret modelPLoS Pathog.20139100335410.1371/journal.ppat.1003354 72.MargineI.KrammerF.Animal models for" exact="influenza" post="viruses: Implications for universal vaccine developmentPathogens2014384587410.3390/pathogens304084525436508 73.BlazejewskaP.KoscinskiL.ViegasN.AnhlanD.LudwigS.SchughartK.Pathogenicity of different"/>
   <result pre="viruses: Implications for universal vaccine developmentPathogens2014384587410.3390/pathogens304084525436508 73.BlazejewskaP.KoscinskiL.ViegasN.AnhlanD.LudwigS.SchughartK.Pathogenicity of different PR8" exact="influenza" post="A virus variants in mice is determined by both"/>
   <result pre="host factorsVirology2011412364510.1016/j.virol.2010.12.04721256531 74.SrivastavaB.BłażejewskaP.HeßmannM.BruderD.GeffersR.MauelS.GruberA.D.SchughartK.Host genetic background strongly influences the response to" exact="influenza" post="a virus infectionsPLoS ONE20094e485710.1371/journal.pone.000485719293935 75.SchmitzN.KurrerM.BachmannM.F.KopfM.Interleukin-1 is responsible for acute"/>
   <result pre="responsible for acute lung immunopathology but increases survival of respiratory" exact="influenza" post="virus infectionJ. Virol.2005796441644810.1128/JVI.79.10.6441-6448.200515858027 76.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system"/>
   <result pre="virus infectionJ. Virol.2005796441644810.1128/JVI.79.10.6441-6448.200515858027 76.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system against" exact="influenza" post="virus infection by augmenting natural killer cell-mediated cytotoxicityJ. Gen."/>
   <result pre="77.ThomasP.G.DashP.AldridgeJ.R.Jr.EllebedyA.H.ReynoldsC.FunkA.J.MartinW.J.LamkanfiM.WebbyR.J.BoydK.L.et al.NLRP3 (NALP3/CIAS1/Cryopyrin) mediates key innate and healing responses to" exact="influenza" post="A virus via the regulation of caspase-1Immunity.20093056610.1016/j.immuni.2009.02.00619362023 78.PerroneL.A.SzretterK.J.KatzJ.M.MizgerdJ.P.TumpeyT.M.Mice lacking"/>
   <result pre="H5N1 virusJ. Infect. Dis.20102021161117010.1086/65636520815704 79.GallyF.KosmiderB.WeaverM.R.PateK.M.HartshornK.L.Oberley-DeeganR.E.FABP5 deficiency enhances susceptibility to H1N1" exact="influenza" post="A virus-induced lung inflammationAm. J. Physiol. Lung Cell. Mol."/>
   <result pre="Cell. Mol. Physiol.2013305647210.1152/ajplung.00276.2012 80.HuangC.H.ChenC.J.YenC.T.YuC.P.HuangP.N.KuoR.L.LinS.J.ChangC.K.ShihS.R.Caspase-1 deficient mice are more susceptible to" exact="influenza" post="A virus infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic"/>
   <result pre="virus infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of" exact="avian influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of influenza A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763"/>
   <result pre="infection with PA variationJ. Infect. Dis.20132081898190510.1093/infdis/jit38123901080 81.WatanabeT.WatanabeS.MaherE.A.NeumannG.KawaokaY.Pandemic potential of avian" exact="influenza" post="A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of influenza A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763"/>
   <result pre="potential of avian influenza A (H7N9) virusesTrends Microbiol.20142262363110.1016/j.tim.2014.08.00825264312 82.NeumannG.KawaokaY.Transmission of" exact="influenza" post="A virusesVirology201547923424610.1016/j.virol.2015.03.00925812763 83.HallerO.StaeheliP.SchwemmleM.KochsG.Mx GTPases: Dynamin-like antiviral machines of innate"/>
   <result pre="innate immunityTrends Microbiol.20152315416310.1016/j.tim.2014.12.00325572883 84.DeegC.M.HassanE.MutzP.RheinemannL.GotzV.MagarL.SchillingM.KallfassC.NurnbergerC.SoubiesS.et al.In vivo evasion of MxA by" exact="avian influenza" post="viruses requires human signature in the viral nucleoproteinJ. Exp."/>
   <result pre="immunityTrends Microbiol.20152315416310.1016/j.tim.2014.12.00325572883 84.DeegC.M.HassanE.MutzP.RheinemannL.GotzV.MagarL.SchillingM.KallfassC.NurnbergerC.SoubiesS.et al.In vivo evasion of MxA by avian" exact="influenza" post="viruses requires human signature in the viral nucleoproteinJ. Exp."/>
   <result pre="signature in the viral nucleoproteinJ. Exp. Med.20172141239124810.1084/jem.2016103328396461 85.WangS.ChenC.YangZ.ChiX.ZhangJ.ChenJ.L.Targeted disruption of" exact="influenza" post="A virus hemagglutinin in genetically modified mice reduces viral"/>
   <result pre="HLA-A2. 1 transgenic miceVirol. J.2016135610.1186/s12985-016-0513-727036323 87.Di MarioG.SciaraffiaE.FacchiniM.GubinelliF.SopranaE.PanigadaM.BernasconiV.GarulliB.SiccardiA.DonatelliI.et al.Protective immunity against" exact="influenza" post="in HLA-A2 transgenic mice by modified vaccinia virus Ankara"/>
   <result pre="al.Protective immunity against influenza in HLA-A2 transgenic mice by modified" exact="vaccinia virus" post="Ankara vectored vaccines containing internal influenza proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473"/>
   <result pre="mice by modified vaccinia virus Ankara vectored vaccines containing internal" exact="influenza" post="proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473 88.MoiseL.TassoneR.LatimerH.TerryF.LevitzL.HaranJ.P.RossT.M.BoyleC.MartinW.D.De GrootA.S.Immunization with cross-conserved H1N1 influenza"/>
   <result pre="internal influenza proteinsPathog. Glob. Health2017111768210.1080/20477724.2016.127546528079473 88.MoiseL.TassoneR.LatimerH.TerryF.LevitzL.HaranJ.P.RossT.M.BoyleC.MartinW.D.De GrootA.S.Immunization with cross-conserved H1N1" exact="influenza" post="CD4+ T-cell epitopes lowers viral burden in HLA DR3"/>
   <result pre="DR3 transgenic miceHum. Vaccin Immunother.201392060206810.4161/hv.2651124045788 89.PeirisJ.M.PoonL.L.GuanY.Emergence of a novel swine-origin" exact="influenza" post="A virus (S-OIV) H1N1 virus in humansJ. Clin. Virol.20094516917310.1016/j.jcv.2009.06.00619540800"/>
   <result pre="94.RichardsK.A.TophamD.ChavesF.A.SantA.J.Cutting edge: CD4 T cells generated from encounter with seasonal" exact="influenza" post="viruses and vaccines have broad protein specificity and can"/>
   <result pre="live pandemic H1N1 virusJ. Immunol.2010100139510.4049/jimmunol.100139520889549 95.MulliganM.J.BernsteinD.I.WinokurP.RuppR.AndersonE.RouphaelN.DickeyM.StapletonJ.T.EdupugantiS.SpearmanP.et al.Serological responses to an" exact="avian influenza" post="A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant:"/>
   <result pre="pandemic H1N1 virusJ. Immunol.2010100139510.4049/jimmunol.100139520889549 95.MulliganM.J.BernsteinD.I.WinokurP.RuppR.AndersonE.RouphaelN.DickeyM.StapletonJ.T.EdupugantiS.SpearmanP.et al.Serological responses to an avian" exact="influenza" post="A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant:"/>
   <result pre="preclinical humanized mouse model to evaluate acute toxicity of an" exact="influenza" post="vaccineOncotarget201892575110.18632/oncotarget.2539929899819 100.AlagarasuK.BachalR.V.BhagatA.B.ShahP.S.DayarajC.Elevated levels of vitamin D and deficiency of"/>
   <result pre="multiplex real-time RT-PCR assay for simultaneous detection of dengue and" exact="chikungunya" post="virusesArch. Virol.201516032332710.1007/s00705-014-2217-x25233940 102.ZompiS.HarrisE.Animal models of dengue virus infectionViruses20124628210.3390/v401006222355452 103.FalzaranoD.BenteD.A.Animal"/>
   <result pre="antiviral drug testingJ. Virol.2014882205221810.1128/JVI.03085-1324335303 127.MotaJ.Rico-HesseR.Humanized mice show clinical signs of" exact="dengue fever" post="according to infecting virus genotypeJ. Virol.2009838638864510.1128/JVI.00581-0919535452 128.CoxJ.MotaJ.Sukupolvi-PettyS.DiamondM.S.Rico-HesseR.Mosquito bite delivery"/>
   <result pre="human diseaseTransgenic Res.20122132734910.1007/s11248-011-9537-321800101 134.Ostrand-RosenbergS.Animal models of tumor immunity, immunotherapy and" exact="cancer" post="vaccinesCurr. Opin. Immunol.20041614315010.1016/j.coi.2004.01.00315023405 135.BouabeH.OkkenhaugK.Gene Targeting in Mice: A ReviewMethods"/>
   <result pre="and caspase deficient. Innate immunity and moderating lung pathology in" exact="influenza" post="pneumonia [77] C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory"/>
   <result pre="caspase deficient. Innate immunity and moderating lung pathology in influenza" exact="pneumonia" post="[77] C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory response"/>
   <result pre="C57BL/6J (FABP5−/−) Deletion of FABP5. Anti inflammatory response against H1N1" exact="influenza" post="A [79] 3. Dengue 129Sv(ev) (AG129 KO) Type I&amp;amp;"/>
   <result pre="a 3.1-kb deletion in the Gag and Pol regions HIV-associated" exact="nephropathy" post="[42] 2. Influenza B6.SJL Tg Mice MX1, MX2, FAM3B"/>
   <result pre="Mice MX1, MX2, FAM3B and TMPRSS2 genes Zoonotic transmission of" exact="influenza" post="A viruses [83,84] BALB/c. Tg Influenza A HA Sh-RNAcodes"/>
   <result pre="of heamagglutinin Prevention and control of a viral zoonosis of" exact="influenza" post="[84,85] 3. Dengue C57BL/6J Tg HLA-A*02:01 and B10. Tg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466311\results\search\disease\results.xml">
   <result pre="as a dengue-like illness with arthralgia in Africa and febrile" exact="hemorrhagic disease" post="in Asia. Soon after the 2005 emergence, severe CNS"/>
   <result pre="cause of dengue-like illness with arthralgia in Africa and febrile" exact="hemorrhagic disease" post="in Asia [4,5,6,7,8,9,10,11]. Prior to the 2005 emergence of"/>
   <result pre="Prior to the 2005 emergence of CHIKV on Reunion Island," exact="chikungunya" post="fever (CHIKF) was commonly misdiagnosed as dengue [12,13]. Misdiagnosis"/>
   <result pre="[17]. Ten of the 11 infants developed a macular erythematous" exact="rash" post="[17]. Diarrhea was seen in four infants and severe"/>
   <result pre="African genotype and was described as a febrile illness with" exact="rash" post="and joint pain from which all children recovered [26,27]."/>
   <result pre="children and the very young typically involved biphasic fever and" exact="rash" post="with the occasional description of pain and/or hemorrhage (Table"/>
   <result pre="Here, most infants less than six months of age exhibited" exact="rash" post="and dehydration while children between 3 and 18 years"/>
   <result pre="including hyperpigmentation, pre-term birth, fever, and various cardiac defects including" exact="atrial septal defect," post="patent ductus arteriosus, and persistent foramen ovale [38]. Third"/>
   <result pre="birth, fever, and various cardiac defects including atrial septal defect," exact="patent ductus arteriosus," post="and persistent foramen ovale [38]. Third trimester and term"/>
   <result pre="Senegal and India reported dengue-like illness or undifferentiated fever with" exact="rash" post="(Table 1) [34,41,44,45]. Furthermore, CHIKV infection of fetuses, neonates,"/>
   <result pre="for pathogenesis. Studies aimed at characterizing the A226V mutation in" exact="neuroblastoma" post="cells and mice found significant differences in innate immune"/>
   <result pre="infected with CHIKV ECSA K211E mutation developed a macular erythematous" exact="rash" post="and fever, which progressed into encephalitis with generalized seizures"/>
   <result pre="developed a macular erythematous rash and fever, which progressed into" exact="encephalitis" post="with generalized seizures [77,84]. Fortunately, the infant fully recovered"/>
   <result pre="[94]. In another report of vertically infected twins, both developed" exact="encephalopathy" post="and seizures and MRI scans showed hemorrhagic leukoencephalopathy [125]."/>
   <result pre="that the infant died [74]. A second infant developed fever," exact="rash" post="and seizure caused by diffuse white matter lesions [74]."/>
   <result pre="Norte de Santander, Colombia presented with fever, cutaneous eruptions, and" exact="diarrhea" post="[64]. Many infants developed severe mucocutaneous, ulcerative lesions, the"/>
   <result pre="with mild dengue-like illness, but the newborns presented with maculopapular" exact="rash" post="(one with bullous dermatitis) [62]. Severe disease including meningoencephalitis,"/>
   <result pre="rash (one with bullous dermatitis) [62]. Severe disease including meningoencephalitis," exact="necrotizing enterocolitis," post="myocarditis, and respiratory distress were reported for the infants"/>
   <result pre="Three of the eight infants died including two infants with" exact="necrotizing enterocolitis" post="[62]. In Segovia, Colombia, a vertically infected infant developed"/>
   <result pre="[62]. In Segovia, Colombia, a vertically infected infant developed fever," exact="rash" post="and respiratory distress requiring ventilator support [136]. The patient"/>
   <result pre="children presented with fever, arthralgia, and a marked absence of" exact="rash" post="or other cutaneous symptoms [68]. A case report of"/>
   <result pre="addition, both infants developed significant idiopathic abdominal distension leading to" exact="rectal prolapse" post="[71]. Genetic analysis of this strain showed a valine"/>
   <result pre="Here, perinatal transmission of this particular CHIKV-WH genotype resulted in" exact="rash" post="followed by eczema [72]. 4.4.7. nsP4: R99Q During the"/>
   <result pre="were hospitalized [76]. The most common symptoms reported were fever," exact="rash" post="and edema of the hands and feet indicating possible"/>
   <result pre="and systematics of the alphavirusesJ. Virol.200175101181013110.1128/JVI.75.21.10118-10131.200111581380 3.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.C.LavenirR.PardigonN.ReynesJ.M.PettinelliF.et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 4.MasonP.J.HaddowA.J.An epidemic"/>
   <result pre="studies during an outbreak of dengue-like disease caused by the" exact="chikungunya" post="virusBull. World Health Organ.19734937404545155 7.Muyembe-TamfumJ.J.PeyrefitteC.N.YogoleloR.Mathina BasisyaE.KoyangeD.PukutaE.MashakoM.TolouH.DurandJ.P.Epidemic of chikungunya virus"/>
   <result pre="by the chikungunya virusBull. World Health Organ.19734937404545155 7.Muyembe-TamfumJ.J.PeyrefitteC.N.YogoleloR.Mathina BasisyaE.KoyangeD.PukutaE.MashakoM.TolouH.DurandJ.P.Epidemic of" exact="chikungunya" post="virus in 1999 and 200 in the democratic Republic"/>
   <result pre="Burma, 1970–1972Bull. World Health Organ.1974512272354282477 10.ThaungU.MingC.K.SweT.TheinS.Epidemiological features of dengue and" exact="chikungunya" post="infections in BurmaSoutheast Asian J. Trop. Med. Public Health19756276283126493"/>
   <result pre="outbreakJ. Gynecol. Obstet. Biol. Reprod.20063557858310.1016/S0368-2315(06)76447-X 15.TouretY.RandrianaivoH.MichaultA.SchuffeneckerI.KauffmannE.LengletY.BarauG.FourmaintrauxA.Early maternal-fetal transmission of the" exact="chikungunya" post="virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 16.RobillardP.Y.BoumahniB.GérardinP.MichaultA.FourmaintrauxA.SchuffeneckerI.CarbonnierM.DjémiliS.ChokerG.Roge-WolterM.et al.Vertical maternal fetal transmission of the"/>
   <result pre="chikungunya virusPresse Med.2006351656165810.1016/S0755-4982(06)74874-617086120 16.RobillardP.Y.BoumahniB.GérardinP.MichaultA.FourmaintrauxA.SchuffeneckerI.CarbonnierM.DjémiliS.ChokerG.Roge-WolterM.et al.Vertical maternal fetal transmission of the" exact="chikungunya" post="virus: Ten cases among 84 pregnant womenPresse Med.20063578578810.1016/S0755-4982(06)74690-516710146 17.JadhavM.NamboodripadM.CarmanR.H.CareyD.E.MyersR.M.Chikungunya"/>
   <result pre="Vietnamese children in SaigonBull. Soc. Pathol. Exot. Fil.196760353359 19.CareyD.E.MyersR.M.DeRanitzC.M.JadhavM.ReubenR.The 1964" exact="chikungunya" post="epidemic at Vellore, South India, including observations on concurrent"/>
   <result pre="observations on concurrent dengueTrans. R. Soc. Trop. Med. Hyg.19696343444510.1016/0035-9203(69)90030-35821266 20.HalsteadS.B.UdomsakdiS.SingharajP.NisalakA.Dengue" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. 3. Clinical,"/>
   <result pre="in non-indigenous white personsAm. J. Trop. Med. Hyg.19691898499610.4269/ajtmh.1969.18.9845355244 21.NimmannityaS.HalsteadS.B.CohenS.N.MargiottaM.R.Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. I. Observations"/>
   <result pre="patients with hemorrhagic feverAm. J. Trop. Med. Hyg.19691895497110.4269/ajtmh.1969.18.9545355242 22.HalsteadS.B.NimmannityaS.MargiottaM.R.Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. II. Observations"/>
   <result pre="on disease in outpatientsAm. J. Trop. Med. Hyg.19691897298310.4269/ajtmh.1969.18.9725355243 23.HalsteadS.B.ScanlonJ.E.UmpaivitP.UdomsakdiS.Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. IV. Epidemiologic"/>
   <result pre="the Bangkok metropolitan areaAm. J. Trop. Med. Hyg.196918997102110.4269/ajtmh.1969.18.9974390977 24.HalsteadS.B.UdomsakdiS.ScanlonJ.E.RohitayodhinS.Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. V. Epidemiologic"/>
   <result pre="observations outside BangkokAm. J. Trop. Med. Hyg.1969181022103310.4269/ajtmh.1969.18.10224390976 25.PowersA.M.LogueC.H.Changing patterns of" exact="chikungunya" post="virus: Re-emergence of a zoonotic arbovirusJ. Gen. Virol.2007882363237710.1099/vir.0.82858-017698645 26.TomoriO.FagbamiA.FabiyiA.The"/>
   <result pre="of a zoonotic arbovirusJ. Gen. Virol.2007882363237710.1099/vir.0.82858-017698645 26.TomoriO.FagbamiA.FabiyiA.The 1974 epidemic of" exact="chikungunya" post="fever in children in IbadanTrop. Geogr. Med.1975274134171216323 27.MooreD.L.ReddyS.AkinkugbeF.M.LeeV.H.David-WestT.S.CauseyO.R.CareyD.E.An epidemic"/>
   <result pre="fever in children in IbadanTrop. Geogr. Med.1975274134171216323 27.MooreD.L.ReddyS.AkinkugbeF.M.LeeV.H.David-WestT.S.CauseyO.R.CareyD.E.An epidemic of" exact="chikungunya" post="fever at Ibadan, Nigeria, 1969Ann. Trop. Med. Parasitol.197468596810.1080/00034983.1974.116869254152305 28.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence"/>
   <result pre="fever at Ibadan, Nigeria, 1969Ann. Trop. Med. Parasitol.197468596810.1080/00034983.1974.116869254152305 28.PowersA.M.BraultA.C.TeshR.B.WeaverS.C.Re-emergence of" exact="chikungunya" post="and o’nyong-nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="haemorrhagic manifestation in CalcuttaIndian J. Pathol. Bacteriol.196691231275930492 30.VossJ.E.VaneyM.-C.DuquerroyS.VonrheinC.Girard-BlancC.CrubletE.ThompsonA.BricogneG.ReyF.A.Glycoprotein organization of" exact="chikungunya" post="virus particles revealed by X-ray crystallographyNature201046870910.1038/nature0955521124458 31.BasileA.J.BiggerstaffB.J.KosoyO.L.JunnaS.R.PanellaN.A.PowersA.M.StarkL.M.NemethN.M.Removal of species"/>
   <result pre="34.SivaR.B.PatelA.K.KabraS.K.LodhaR.RatageriV.H.RayP.Virus load and clinical features during the acute phase of" exact="chikungunya" post="infection in childrenPLoS ONE201914e021103630707708 35.InamadarA.C.PalitA.SampagaviV.V.RaghunathS.DeshmukhN.S.Cutaneous manifestations of chikungunya fever:"/>
   <result pre="phase of chikungunya infection in childrenPLoS ONE201914e021103630707708 35.InamadarA.C.PalitA.SampagaviV.V.RaghunathS.DeshmukhN.S.Cutaneous manifestations of" exact="chikungunya" post="fever: Observations made during a recent outbreak in South"/>
   <result pre="in South IndiaInt. J. Dermatol.20084715415910.1111/j.1365-4632.2008.03478.x18211486 36.RobinS.RamfulD.Le SeachF.Jaffar-BandjeeM.C.RigouG.AlessandriJ.L.Neurologic manifestations of pediatric" exact="chikungunya" post="infectionJ. Child Neurol.2008231028103510.1177/088307380831415118287573 37.LewthwaiteP.VasanthapuramR.OsborneJ.C.BegumA.PlankJ.L.ShankarM.V.HewsonR.DesaiA.BeechingN.J.RavikumarR.et al.Chikungunya virus and central nervous"/>
   <result pre="system infections in children, IndiaEmerg. Infect. Dis.20091532933110.3201/eid1502.08090219193287 38.SenanayakeM.P.SenanayakeS.M.VidanageK.K.GunasenaS.LamabadusuriyaS.P.Vertical transmission in" exact="chikungunya" post="infectionCeylon Med. J.200954475010.4038/cmj.v54i2.86519670548 39.HapuarachchiH.C.BandaraK.B.SumanadasaS.D.HapugodaM.D.LaiY.L.LeeK.S.TanL.K.LinR.T.NgL.F.BuchtG.et al.Re-emergence of chikungunya virus in"/>
   <result pre="38.SenanayakeM.P.SenanayakeS.M.VidanageK.K.GunasenaS.LamabadusuriyaS.P.Vertical transmission in chikungunya infectionCeylon Med. J.200954475010.4038/cmj.v54i2.86519670548 39.HapuarachchiH.C.BandaraK.B.SumanadasaS.D.HapugodaM.D.LaiY.L.LeeK.S.TanL.K.LinR.T.NgL.F.BuchtG.et al.Re-emergence of" exact="chikungunya" post="virus in South-East Asia: Virological evidence from Sri Lanka"/>
   <result pre="with different characteristicsAm. J. Trop. Med. Hyg.20098186586810.4269/ajtmh.2009.09-000919861623 41.PeyrefitteC.N.BessaudM.PastorinoB.A.GravierP.PlumetS.MerleO.L.MoltiniI.CoppinE.TockF.DariesW.et al.Circulation of" exact="chikungunya" post="virus in Gabon, 2006–2007J. Med. Virol.20088043043310.1002/jmv.2109018205212 42.RianthavornP.PrianantathavornK.WuttirattanakowitN.TheamboonlersA.PoovorawanY.An outbreak of"/>
   <result pre="chikungunya virus in Gabon, 2006–2007J. Med. Virol.20088043043310.1002/jmv.2109018205212 42.RianthavornP.PrianantathavornK.WuttirattanakowitN.TheamboonlersA.PoovorawanY.An outbreak of" exact="chikungunya" post="in southern Thailand from 2008 to 2009 caused by"/>
   <result pre="mutationInt. J. Infect. Dis.201014Suppl. 3e161e16510.1016/j.ijid.2010.01.001 43.TheamboonlersA.RianthavornP.PraianantathavornK.WuttirattanakowitN.PoovorawanY.Clinical and molecular characterization of" exact="chikungunya" post="virus in south ThailandJpn. J. Infect. Dis.20096230330519628911 44.LaoprasopwattanaK.SuntharasajT.PetmaneeP.SuddeaugraiO.GeaterA.Chikungunya and"/>
   <result pre="southeastern Senegal in 2009–2010Open Forum Infect. Dis.20185ofx25910.1093/ofid/ofx25929354659 46.WahidB.AliA.RafiqueS.IdreesM.Global expansion of" exact="chikungunya" post="virus: Mapping the 64-year historyInt. J. Infect. Dis.201758697610.1016/j.ijid.2017.03.00628288924 47.CuiJ.GaoM.RenX.Phylogeny"/>
   <result pre="64-year historyInt. J. Infect. Dis.201758697610.1016/j.ijid.2017.03.00628288924 47.CuiJ.GaoM.RenX.Phylogeny and homologous recombination in" exact="chikungunya" post="virusesInfect. Genet. Evol.2011111957196310.1016/j.meegid.2011.08.02621925290 48.RaghavendharB.S.RayP.RatagiriV.H.SharmaB.S.KabraS.K.LodhaR.Evaluation of chikungunya virus infection in"/>
   <result pre="and homologous recombination in chikungunya virusesInfect. Genet. Evol.2011111957196310.1016/j.meegid.2011.08.02621925290 48.RaghavendharB.S.RayP.RatagiriV.H.SharmaB.S.KabraS.K.LodhaR.Evaluation of" exact="chikungunya" post="virus infection in children from India during 2009–2010: A"/>
   <result pre="studyJ. Med. Virol.20168892393010.1002/jmv.2443326581026 49.ShrivastavaA.Waqar BegM.GujratiC.GopalanN.RaoP.V.Management of a vertically transmitted neonatal" exact="chikungunya" post="thrombocytopeniaIndian J. Pediatr.2011781008100910.1007/s12098-011-0371-721328079 50.NiyasK.P.AbrahamR.UnnikrishnanR.N.MathewT.NairS.ManakkadanA.IssacA.SreekumarE.Molecular characterization of chikungunya virus isolates"/>
   <result pre="vertically transmitted neonatal chikungunya thrombocytopeniaIndian J. Pediatr.2011781008100910.1007/s12098-011-0371-721328079 50.NiyasK.P.AbrahamR.UnnikrishnanR.N.MathewT.NairS.ManakkadanA.IssacA.SreekumarE.Molecular characterization of" exact="chikungunya" post="virus isolates from clinical samples and adult aedes albopictus"/>
   <result pre="from larvae from Kerala, south IndiaVirol. J.2010718910.1186/1743-422X-7-18920704755 51.NkogheD.KassaR.F.CaronM.GrardG.MomboI.BikieB.PaupyC.BecquartP.BisvigouU.LeroyE.M.Clinical forms of" exact="chikungunya" post="in Gabon, 2010PLoS Negl. Trop. Dis.20126e151710.1371/journal.pntd.000151722348166 52.NkogheD.KassaR.F.BisvigouU.CaronM.GrardG.LeroyE.M.No clinical or"/>
   <result pre="2010PLoS Negl. Trop. Dis.20126e151710.1371/journal.pntd.000151722348166 52.NkogheD.KassaR.F.BisvigouU.CaronM.GrardG.LeroyE.M.No clinical or biological difference between" exact="chikungunya" post="and dengue fever during the 2010 Gabonese outbreakInfect. Dis."/>
   <result pre="Trop. Dis.20126e151710.1371/journal.pntd.000151722348166 52.NkogheD.KassaR.F.BisvigouU.CaronM.GrardG.LeroyE.M.No clinical or biological difference between chikungunya and" exact="dengue fever" post="during the 2010 Gabonese outbreakInfect. Dis. Rep.20124e510.4081/idr.2012.e524470935 53.HorwoodP.F.DuongV.LaurentD.MeyC.SothyH.SantyK.RichnerB.HengS.HemS.ChevalJ.et al.Aetiology"/>
   <result pre="the 2010 Gabonese outbreakInfect. Dis. Rep.20124e510.4081/idr.2012.e524470935 53.HorwoodP.F.DuongV.LaurentD.MeyC.SothyH.SantyK.RichnerB.HengS.HemS.ChevalJ.et al.Aetiology of acute" exact="meningoencephalitis" post="in Cambodian children, 2010–2013Emerg. Microbes Infect.20176e3510.1038/emi.2017.1528536430 54.DuongV.AndriesA.C.NganC.SokT.RichnerB.Asgari-JirhandehN.BjorgeS.HuyR.LyS.LaurentD.et al.Reemergence of"/>
   <result pre="meningoencephalitis in Cambodian children, 2010–2013Emerg. Microbes Infect.20176e3510.1038/emi.2017.1528536430 54.DuongV.AndriesA.C.NganC.SokT.RichnerB.Asgari-JirhandehN.BjorgeS.HuyR.LyS.LaurentD.et al.Reemergence of" exact="chikungunya" post="virus in CambodiaEmerg. Infect. Dis.2012182066206910.3201/eid1812.12047123171736 55.PatilJ.MoreA.PatilP.JadhavS.NewaseP.AgarwalM.AmdekarS.RautC.G.ParasharD.CherianS.S.Genetic characterization of chikungunya"/>
   <result pre="of chikungunya virus in CambodiaEmerg. Infect. Dis.2012182066206910.3201/eid1812.12047123171736 55.PatilJ.MoreA.PatilP.JadhavS.NewaseP.AgarwalM.AmdekarS.RautC.G.ParasharD.CherianS.S.Genetic characterization of" exact="chikungunya" post="viruses isolated during the 2015–2017 outbreaks in different states"/>
   <result pre="children presenting with nonspecific febrile illness during an epidemic of" exact="dengue fever" post="in Lahore, PakistanMerit Res. J. Med. Med Sci.201536973 58.ElfvingK.ShakelyD.AnderssonM.BaltzellK.AliA.S.BachelardM.FalkK.I.LjungA.MsellemM.I.OmarR.S.et"/>
   <result pre="Zanzibar—Aetiologies, antibiotic treatment and outcomePLoS ONE201611e014605410.1371/journal.pone.014605426821179 59.KajegukaD.C.KaayaR.D.MwakalingaS.NdossiR.NdaroA.ChilongolaJ.O.MoshaF.W.SchiolerK.L.KavisheR.A.AlifrangisM.Prevalence of dengue and" exact="chikungunya" post="virus infections in north-eastern Tanzania: A cross sectional study"/>
   <result pre="among participants presenting with malaria-like symptomsBMC Infect. Dis.20161618310.1186/s12879-016-1511-527112553 60.ChipwazaB.MugasaJ.P.SelemaniM.AmuriM.MoshaF.NgatungaS.D.GwakisaP.S.Dengue and" exact="chikungunya" post="fever among viral diseases in outpatient febrile children in"/>
   <result pre="Negl. Trop. Dis.20148e333510.1371/journal.pntd.000333525412076 61.Paternina-CaicedoA.De la Hoz-RestrepoF.Diaz-QuijanoF.Caicedo-TorresW.Auxiliadora Badillo-ViloriaM.Bula-AnichiaricoD.Alvis-GuzmanN.MattarS.ConstenlaD.Pinzon-RedondoH.Features of dengue and" exact="chikungunya" post="infections of Colombian children under 24 months of age"/>
   <result pre="of age admitted to the emergency departmentJ. Trop. Pediatr.201864313710.1093/tropej/fmx02428444295 62.Villamil-GomezW.Alba-SilveraL.Menco-RamosA.Gonzalez-VergaraA.Molinares-PalaciosT.Barrios-CorralesM.Rodriguez-MoralesA.J.Congenital" exact="chikungunya" post="virus infection in Sincelejo, Colombia: A case seriesJ. Trop."/>
   <result pre="in Sincelejo, Colombia: A case seriesJ. Trop. Pediatr.20156138639210.1093/tropej/fmv05126246086 63.MuiangaA.PintoG.MassangaieM.AliS.OludeleJ.TivaneA.FalkK.I.LagerqvistN.GudoE.S.Antibodies against" exact="chikungunya" post="in northern Mozambique during dengue outbreak, 2014Vector Borne Zoonotic"/>
   <result pre="Zoonotic Dis.20181844544910.1089/vbz.2017.226129733254 64.MuñozC.M.CastilloJ.O.SalasD.ValderramaM.A.RangelC.T.VargasH.P.SilvaD.C.Atypical mucocutaneous manifestations in neonates and infants with" exact="chikungunya" post="fever in the municipalities of Cúcuta, Los Patios and"/>
   <result pre="Chikungunya and mayaroRev. Soc. Bras. Med. Trop.20144767768310.1590/0037-8682-0246-201425626645 66.MattarS.MirandaJ.PinzonH.TiqueV.BolanosA.AponteJ.ArrietaG.GonzalezM.BarriosK.ContrerasH.et al.Outbreak of" exact="chikungunya" post="virus in the north Caribbean area of Colombia: Clinical"/>
   <result pre="phylogenetic analysisJ. Infect. Dev. Ctries.201591126113210.3855/jidc.667026517488 67.RodasJ.D.KautzT.CamachoE.PaterninaL.GuzmanH.DiazF.J.BlancoP.TeshR.WeaverS.C.Genetic characterization of northwestern Colombian" exact="chikungunya" post="virus strains from the 2014–2015 epidemicAm. J. Trop. Med."/>
   <result pre="from the 2014–2015 epidemicAm. J. Trop. Med. Hyg.20169563964610.4269/ajtmh.16-009127430542 68.PhamP.N.WilliamsL.T.ObotU.PadillaL.A.AungM.AkinyemijuT.F.CarsonA.P.JollyP.E.Epidemiology of" exact="chikungunya" post="fever outbreak in western Jamaica during July–December 2014Res. Rep."/>
   <result pre="Jamaica during July–December 2014Res. Rep. Trop. Med.2017871610.2147/RRTM.S12203229375245 69.LanciottiR.S.LambertA.J.Phylogenetic analysis of" exact="chikungunya" post="virus strains circulating in the western hemisphereAm. J. Trop."/>
   <result pre="J. Trop. Med. Hyg.20169480080310.4269/ajtmh.15-037526856917 70.FreitasA.R.R.GerardinP.KassarL.DonalisioM.R.Excess deaths associated with the 2014" exact="chikungunya" post="epidemic in JamaicaPathog. Glob. Health201910.1080/20477724.2019.157411130714498 71.Evans-GilbertT.Chikungunya and neonatal immunity:"/>
   <result pre="JamaicaPathog. Glob. Health201910.1080/20477724.2019.157411130714498 71.Evans-GilbertT.Chikungunya and neonatal immunity: Fatal vertically transmitted" exact="chikungunya" post="infectionAm. J. Trop. Med. Hyg.20179691391510.4269/ajtmh.16-049128167590 72.Rodriguez-NievesM.Garcia-GarciaI.Garcia-FragosoL.Perinatally acquired chikungunya infection:"/>
   <result pre="vertically transmitted chikungunya infectionAm. J. Trop. Med. Hyg.20179691391510.4269/ajtmh.16-049128167590 72.Rodriguez-NievesM.Garcia-GarciaI.Garcia-FragosoL.Perinatally acquired" exact="chikungunya" post="infection: The Puerto Rico experiencePediatr. Infect. Dis. J.201635116310.1097/INF.0000000000001261 73.BallJ.D.ElbadryM.A.TelismaT.WhiteS.K.ChavannesS.AnilisM.G.ProsperiM.CummingsD.A.T.LednickyJ.A.MorrisJ.G.Jr.et"/>
   <result pre="experiencePediatr. Infect. Dis. J.201635116310.1097/INF.0000000000001261 73.BallJ.D.ElbadryM.A.TelismaT.WhiteS.K.ChavannesS.AnilisM.G.ProsperiM.CummingsD.A.T.LednickyJ.A.MorrisJ.G.Jr.et al.Clinical and epidemiologic patterns of" exact="chikungunya" post="virus infection and coincident arboviral disease in a school"/>
   <result pre="EnterB.J.D.HuibersM.H.W.van RooijL.SteingroverR.van HensbroekM.B.VoigtR.R.HolJ.Perinatal outcomes in vertically infected neonates during a" exact="chikungunya" post="outbreak on the island of curacaoAm. J. Trop. Med."/>
   <result pre="Nicaragua, 2014–2015Am. J. Trop. Med. Hyg.20169440040310.4269/ajtmh.15-049726643533 78.BalmasedaA.GordonA.GreshL.OjedaS.SaborioS.TellezY.SanchezN.KuanG.HarrisE.Clinical attack rate of" exact="chikungunya" post="in a cohort of Nicaraguan childrenAm. J. Trop. Med."/>
   <result pre="in children and adults in Managua, Nicaragua, after the first" exact="chikungunya" post="epidemic, 2014–2015PLoS Negl. Trop. Dis.201610e000477310.1371/journal.pntd.000477327322692 80.Stewart-IbarraA.M.RyanS.J.KennesonA.KingC.A.AbbottM.Barbachano-GuerreroA.Beltran-AyalaE.Borbor-CordovaM.J.CardenasW.B.CuevaC.et al.The burden of"/>
   <result pre="chikungunya epidemic, 2014–2015PLoS Negl. Trop. Dis.201610e000477310.1371/journal.pntd.000477327322692 80.Stewart-IbarraA.M.RyanS.J.KennesonA.KingC.A.AbbottM.Barbachano-GuerreroA.Beltran-AyalaE.Borbor-CordovaM.J.CardenasW.B.CuevaC.et al.The burden of" exact="dengue fever" post="and chikungunya in southern coastal Ecuador: Epidemiology, clinical presentation,"/>
   <result pre="Negl. Trop. Dis.201610e000477310.1371/journal.pntd.000477327322692 80.Stewart-IbarraA.M.RyanS.J.KennesonA.KingC.A.AbbottM.Barbachano-GuerreroA.Beltran-AyalaE.Borbor-CordovaM.J.CardenasW.B.CuevaC.et al.The burden of dengue fever and" exact="chikungunya" post="in southern coastal Ecuador: Epidemiology, clinical presentation, and phylogenetics"/>
   <result pre="prospective studyAm. J. Trop. Med. Hyg.2018981444145910.4269/ajtmh.17-076229512482 81.EscobarM.NietoA.J.Loaiza-OsorioS.BaronaJ.S.RossoF.Pregnant women hospitalized with" exact="chikungunya" post="virus infection, Colombia, 2015Emerg. Infect. Dis.201723177710.3201/eid2311.17048029047427 82.SahadeoN.S.D.AllicockO.M.De SalazarP.M.AugusteA.J.WidenS.OlowokureB.GutierrezC.ValadereA.M.Polson-EdwardsK.WeaverS.C.et al.Understanding"/>
   <result pre="Infect. Dis.201723177710.3201/eid2311.17048029047427 82.SahadeoN.S.D.AllicockO.M.De SalazarP.M.AugusteA.J.WidenS.OlowokureB.GutierrezC.ValadereA.M.Polson-EdwardsK.WeaverS.C.et al.Understanding the evolution and spread of" exact="chikungunya" post="virus in the Americas using complete genome sequencesVirus Evol.20173vex01010.1093/ve/vex01028480053"/>
   <result pre="the Americas using complete genome sequencesVirus Evol.20173vex01010.1093/ve/vex01028480053 83.LyraP.P.CamposG.S.BandeiraI.D.SardiS.I.CostaL.F.SantosF.R.RibeiroC.A.JardimA.M.SantiagoA.C.de OliveiraP.M.et al.Congenital" exact="chikungunya" post="virus infection after an outbreak in Salvador, Bahia, BrazilAJP"/>
   <result pre="infection after an outbreak in Salvador, Bahia, BrazilAJP Rep.20166e299e30027555980 84.BandeiraA.C.CamposG.S.SardiS.I.RochaV.F.RochaG.C.Neonatal" exact="encephalitis" post="due to chikungunya vertical transmission: First report in BrazilIDCases20165575910.1016/j.idcr.2016.07.00827500084"/>
   <result pre="outbreak in Salvador, Bahia, BrazilAJP Rep.20166e299e30027555980 84.BandeiraA.C.CamposG.S.SardiS.I.RochaV.F.RochaG.C.Neonatal encephalitis due to" exact="chikungunya" post="vertical transmission: First report in BrazilIDCases20165575910.1016/j.idcr.2016.07.00827500084 85.SaP.K.O.NunesM.M.LeiteI.R.CampeloM.LeaoC.F.R.SouzaJ.R.CastellanoL.R.FernandesA.I.V.Chikungunya virus infection"/>
   <result pre="four fatal casesRev. Soc. Bras. Med. Trop.20175026526810.1590/0037-8682-0375-201628562768 86.RamosR.VianaR.Brainer-LimaA.FloreAncioT.CarvalhoM.D.van der LindenV.AmorimA.RochaM.A.MedeirosF.Perinatal" exact="chikungunya" post="virus-associated encephalitis leading to postnatal-onset microcephaly and optic atrophyPediatr."/>
   <result pre="casesRev. Soc. Bras. Med. Trop.20175026526810.1590/0037-8682-0375-201628562768 86.RamosR.VianaR.Brainer-LimaA.FloreAncioT.CarvalhoM.D.van der LindenV.AmorimA.RochaM.A.MedeirosF.Perinatal chikungunya virus-associated" exact="encephalitis" post="leading to postnatal-onset microcephaly and optic atrophyPediatr. Infect. Dis."/>
   <result pre="Trop.20175026526810.1590/0037-8682-0375-201628562768 86.RamosR.VianaR.Brainer-LimaA.FloreAncioT.CarvalhoM.D.van der LindenV.AmorimA.RochaM.A.MedeirosF.Perinatal chikungunya virus-associated encephalitis leading to postnatal-onset" exact="microcephaly" post="and optic atrophyPediatr. Infect. Dis. J.201837949510.1097/INF.000000000000169028737626 87.SamraJ.A.HagoodN.L.SummerA.MedinaM.T.HoldenK.R.Clinical features and"/>
   <result pre="J.201837949510.1097/INF.000000000000169028737626 87.SamraJ.A.HagoodN.L.SummerA.MedinaM.T.HoldenK.R.Clinical features and neurologic complications of children hospitalized with" exact="chikungunya" post="virus in HondurasJ. Child Neurol.20173271271610.1177/088307381770187928459170 88.Cigarroa-ToledoN.BlitvichB.J.Cetina-TrejoR.C.Talavera-AguilarL.G.Baak-BaakC.M.Torres-ChableO.M.HamidM.N.FriedbergI.Gonzalez-MartinezP.Alonzo-SalomonG.et al.Chikungunya virus in"/>
   <result pre="aedes aegypti mosquitoes, Yucatan, MexicoEmerg. Infect. Dis.2016221804180710.3201/eid2210.15208727347760 89.AntonioV.S.MuiangaA.F.WieselerJ.PereiraS.A.MonteiroV.O.MulaF.CheleneI.ChongoI.S.OludeleJ.O.KummererB.M.et al.Seroepidemiology of" exact="chikungunya" post="virus among febrile patients in eight health facilities in"/>
   <result pre="and northern Mozambique, 2015–2016Vector Borne Zoonotic Dis.20181831131610.1089/vbz.2017.222729672219 90.KolawoleO.M.BelloK.E.SerikiA.A.IrekeolaA.A.Serological survey of" exact="chikungunya" post="virus in Ilorin metropolis, NigeriaBraz. J. Infect. Dis. Off."/>
   <result pre="Dis. Off. Publ. Braz. Soc. Infect. Dis.20172136536610.1016/j.bjid.2016.12.007 91.WaggonerJ.BrichardJ.MutukuF.NdengaB.HeathC.J.Mohamed-HadleyA.SahooM.K.VululeJ.LefterovaM.BanaeiN.et al.Malaria and" exact="chikungunya" post="detected using molecular diagnostics among febrile Kenyan childrenOpen Forum"/>
   <result pre="molecular diagnostics among febrile Kenyan childrenOpen Forum Infect. Dis.20174ofx11010.1093/ofid/ofx11028702473 92.KumarD.JajooM.SaigalK.Neonatal" exact="chikungunya" post="during 2016 Delhi epidemicIndian J. Pediatr.20178433433510.1007/s12098-017-2311-728210954 93.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and"/>
   <result pre="Pediatr.20178433433510.1007/s12098-017-2311-728210954 93.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of" exact="chikungunya" post="fever: A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 94.MariaA.VallamkondaN.ShuklaA.BhattA.SachdevN.Encephalitic presentation of neonatal"/>
   <result pre="neonatal chikungunya: A case seriesIndian Pediatr.20185567167410.1007/s13312-018-1356-730218513 95.VasconcellosA.F.SilvaJ.M.F.de OliveiraA.S.PradoP.S.NagataT.ResendeR.O.Genome sequences of" exact="chikungunya" post="virus isolates circulating in midwestern BrazilArch. Virol.20191641205120810.1007/s00705-019-04174-430729309 96.DiasJ.P.CostaM.CamposG.S.PaixaoE.S.NatividadeM.S.BarretoF.R.ItaparicaM.S.C.GoesC.OliveiraF.L.S.SantanaE.B.et al.Seroprevalence"/>
   <result pre="virus isolates circulating in midwestern BrazilArch. Virol.20191641205120810.1007/s00705-019-04174-430729309 96.DiasJ.P.CostaM.CamposG.S.PaixaoE.S.NatividadeM.S.BarretoF.R.ItaparicaM.S.C.GoesC.OliveiraF.L.S.SantanaE.B.et al.Seroprevalence of" exact="chikungunya" post="virus after its emergence in BrazilEmerg. Infect. Dis.20182461762410.3201/eid2404.17137029553317 97.RahmanM.YamagishiJ.RahimR.HasanA.SobhanA.East/central/south"/>
   <result pre="emergence in BrazilEmerg. Infect. Dis.20182461762410.3201/eid2404.17137029553317 97.RahmanM.YamagishiJ.RahimR.HasanA.SobhanA.East/central/south african genotype in a" exact="chikungunya" post="outbreak, Dhaka, Bangladesh, 2017Emerg. Infect. Dis.20192537037210.3201/eid2502.18018830666947 98.GerardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.LengletY.TouretY.BouveretA.GrivardP.et al.Multidisciplinary prospective"/>
   <result pre="Bangladesh, 2017Emerg. Infect. Dis.20192537037210.3201/eid2502.18018830666947 98.GerardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.LengletY.TouretY.BouveretA.GrivardP.et al.Multidisciplinary prospective study of mother-to-child" exact="chikungunya" post="virus infections on the island of La ReunionPLoS Med.20085e6010.1371/journal.pmed.005006018351797"/>
   <result pre="India, and Reunion IslandEmerg. Infect. Dis.200814132710.3201/eid1408.08020118680676 102.RamfulD.CarbonnierM.PasquetM.BouhmaniB.GhazouaniJ.NoormahomedT.BeullierG.AttaliT.SamperizS.FourmaintrauxA.et al.Mother-to-child transmission of" exact="chikungunya" post="virus infectionPediatr. Infect. Dis. J.20072681181510.1097/INF.0b013e3180616d4f17721376 103.RamfulD.SamperizS.FritelX.MichaultA.Jaffar-BandjeeM.C.RollotO.BoumahniB.GerardinP.Antibody kinetics in infants"/>
   <result pre="infectionPediatr. Infect. Dis. J.20072681181510.1097/INF.0b013e3180616d4f17721376 103.RamfulD.SamperizS.FritelX.MichaultA.Jaffar-BandjeeM.C.RollotO.BoumahniB.GerardinP.Antibody kinetics in infants exposed to" exact="chikungunya" post="virus infection during pregnancy reveals absence of congenital infectionJ."/>
   <result pre="during pregnancy reveals absence of congenital infectionJ. Infect. Dis.20142091726173010.1093/infdis/jit81424338351 104.MaronB.J.TajikA.J.RuttenbergH.D.GrahamT.P.AtwoodG.F.VictoricaB.E.LieJ.T.RobertsW.C.Hypertrophic" exact="cardiomyopathy" post="in infants: Clinical features and natural historyCirculation19826571710.1161/01.CIR.65.1.76458422 105.SewellE.K.KeeneS.Perinatal care"/>
   <result pre="infants with congenital birth defectsClin. Perinatol.20184521323010.1016/j.clp.2018.01.00729747884 106.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 107.PriyaR.PatroI.K.ParidaM.M.Tlr3"/>
   <result pre="mediated innate immune response in mice brain following infection with" exact="chikungunya" post="virusVirus Res.201418919420510.1016/j.virusres.2014.05.01024905288 108.JohnsonB.W.RussellB.J.GoodmanC.H.Laboratory diagnosis of chikungunya virus infections and"/>
   <result pre="brain following infection with chikungunya virusVirus Res.201418919420510.1016/j.virusres.2014.05.01024905288 108.JohnsonB.W.RussellB.J.GoodmanC.H.Laboratory diagnosis of" exact="chikungunya" post="virus infections and commercial sources for diagnostic assaysJ. Infect."/>
   <result pre="and commercial sources for diagnostic assaysJ. Infect. Dis.2016214S471S47410.1093/infdis/jiw27427920176 109.YapG.PokK.Y.LaiY.L.HapuarachchiH.C.ChowA.LeoY.S.TanL.K.NgL.C.Evaluation of" exact="chikungunya" post="diagnostic assays: Differences in sensitivity of serology assays in"/>
   <result pre="independent outbreaksPLoS Negl. Trop. Dis.20104e75310.1371/journal.pntd.000075320651930 110.PetersenL.R.PowersA.M.Chikungunya: EpidemiologyF1000Research201658210.12688/f1000research.7171.1 111.AzamiN.A.MoiM.L.TakasakiT.Neutralization assay for" exact="chikungunya" post="virus infection: Plaque reduction neutralization testMethods Mol. Biol.2016142627328227233280 112.collab:"/>
   <result pre="with east central South African (ECSA) or ECSA-diverged clades of" exact="chikungunya" post="virusClin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.20196817117210.1093/cid/ciy53429982440"/>
   <result pre="Dis. Off. Publ. Infect. Dis. Soc. Am.2018671760176710.1093/cid/ciy35629697796 115.SaluzzoJ.F.CornetM.DigoutteJ.P.Outbreak of a" exact="chikungunya" post="virus epidemic in western Senegal in 1982Dakar Méd.1983284975006323109 116.ThonnonJ.SpiegelA.DialloM.DialloA.FontenilleD.Chikungunya"/>
   <result pre="and 1997Bull. Soc. Pathol. Exot.199992798210399593 117.Furuya-KanamoriL.LiangS.MilinovichG.Soares MagalhaesR.J.ClementsA.C.A.HuW.BrasilP.FrentiuF.D.DunningR.YakobL.Co-distribution and co-infection of" exact="chikungunya" post="and dengue virusesBMC Infect. Dis.2016168410.1186/s12879-016-1417-226936191 118.OlajigaO.M.AdesoyeO.E.EmilolorunA.P.AdeyemiA.J.AdeyefaE.O.AderibigbeI.A.AdejumoS.A.AdebimpeW.O.OpaleyeO.O.SuleW.F.et al.Chikungunya virus seroprevalence"/>
   <result pre="southwest Nigeria: A preliminary assessmentImmunol. Investig.20174655256510.1080/08820139.2017.131938328742401 119.PellotA.S.AlessandriJ.L.RobinS.SamperizS.AttaliT.BrayerC.PasquetM.Jaffar-BandjeeM.C.BenhamouL.S.Tiran-RajaoferaI.et al.Severe forms of" exact="chikungunya" post="virus infection in a pediatric intensive care unit on"/>
   <result pre="mouse neuronal cells following infection with novel ECSA genotype of" exact="chikungunya" post="virus with and without e1:A226v mutationInfect. Genet. Evol.20132039640610.1016/j.meegid.2013.09.03024126361 121.KumarR.SharmaM.K.JainS.K.YadavS.K.SinghalA.K.Cutaneous"/>
   <result pre="with and without e1:A226v mutationInfect. Genet. Evol.20132039640610.1016/j.meegid.2013.09.03024126361 121.KumarR.SharmaM.K.JainS.K.YadavS.K.SinghalA.K.Cutaneous manifestations of" exact="chikungunya" post="fever: Observations from an outbreak at a tertiary care"/>
   <result pre="Rajasthan, IndiaIndian Dermatol. Online J.2017833634228979866 122.KumarS.AgrawalG.WazirS.KumarA.DubeyS.BaldeM.YadavB.S.Experience of perinatal and neonatal" exact="chikungunya" post="virus (CHIKV) infection in a tertiary care neonatal centre"/>
   <result pre="India in 2016: A case seriesJ. Trop. Pediatr.201810.1093/tropej/fmy03229893939 123.GuptaD.BoseA.RoseW.Acquired neonatal" exact="chikungunya" post="encephalopathyIndian J. Pediatr.2015821065106610.1007/s12098-015-1751-125865267 124.VasaniR.KanhereS.ChaudhariK.PhadkeV.MukherjeeP.GuptaS.KasliwalC.PoojaryS.Congenital chikungunya—A cause of neonatal hyperpigmentationPediatr."/>
   <result pre="J. Pediatr.2015821065106610.1007/s12098-015-1751-125865267 124.VasaniR.KanhereS.ChaudhariK.PhadkeV.MukherjeeP.GuptaS.KasliwalC.PoojaryS.Congenital chikungunya—A cause of neonatal hyperpigmentationPediatr. Dermatol.20163320921210.1111/pde.1265026205895 125.KarthigaV.KommuP.P.KrishnanL.Perinatal" exact="chikungunya" post="in twinsJ. Pediatr. Neurosci.20161122322427857791 126.ChastelC.Human infections in Cambodia by"/>
   <result pre="in twinsJ. Pediatr. Neurosci.20161122322427857791 126.ChastelC.Human infections in Cambodia by the" exact="chikungunya" post="virus or an apparently closely related agent. II. Experimental"/>
   <result pre="agent. II. Experimental pathological anatomyBull. Soc. Pathol. Exot. Fil.196356915924 127.HuangJ.H.YangC.F.SuC.L.ChangS.F.ChengC.H.YuS.K.LinC.C.ShuP.Y.Imported" exact="chikungunya" post="virus strains, Taiwan, 2006–2009Emerg. Infect. Dis.2009151854185610.3201/eid1511.09039819891886 128.LarkT.KeckF.NarayananA.Interactions of alphavirus"/>
   <result pre="proteinsFront. Microbiol.20178265210.3389/fmicb.2017.0265229375517 129.MeshramC.D.AgbackP.ShiliaevN.UrakovaN.MobleyJ.A.AgbackT.FrolovaE.I.FrolovI.Multiple host factors interact with hypervariable domain of" exact="chikungunya" post="virus nsP3 and determine viral replication in cell-specific modeJ."/>
   <result pre="virulenceJ. Gen. Virol.20068793794710.1099/vir.0.81406-016528043 132.FoyN.J.AkhrymukM.ShustovA.V.FrolovaE.I.FrolovI.Hypervariable domain of nonstructural protein nsP3 of" exact="venezuelan equine encephalitis" post="virus determines cell-specific mode of virus replicationJ. Virol.2013877569758410.1128/JVI.00720-1323637407 133.VihinenH.AholaT.TuittilaM.MeritsA.KaariainenL.Elimination"/>
   <result pre="Virol.20068793794710.1099/vir.0.81406-016528043 132.FoyN.J.AkhrymukM.ShustovA.V.FrolovaE.I.FrolovI.Hypervariable domain of nonstructural protein nsP3 of venezuelan equine" exact="encephalitis" post="virus determines cell-specific mode of virus replicationJ. Virol.2013877569758410.1128/JVI.00720-1323637407 133.VihinenH.AholaT.TuittilaM.MeritsA.KaariainenL.Elimination"/>
   <result pre="replicase protein nsP3J. Biol. Chem.20012765745575210.1074/jbc.M00607720011104756 134.Mendez-DominguezN.Achach-AsafJ.A.Basso-GarciaL.M.Quinones-PachecoY.B.Gomez-CarroS.Septic shock secondary to non-congenital" exact="chikungunya" post="fever in a young infant: A clinical caseRev. Chil."/>
   <result pre="infant: A clinical caseRev. Chil. Pediatr.20168714314727032486 135.ShrinetJ.JainS.SharmaA.SinghS.S.MathurK.RanaV.BhatnagarR.K.GuptaB.GaindR.DebM.et al.Genetic characterization of" exact="chikungunya" post="virus from New Delhi reveal emergence of a new"/>
   <result pre="new molecular signature in Indian isolatesVirol. J.2012910010.1186/1743-422X-9-10022632412 136.Cardona-CorreaS.E.Castano-JaramilloL.M.Quevedo-VelezA.Vertical transmission of" exact="chikungunya" post="virus infection. Case reportRev. Chil. Pediatr.20178828528810.4067/S0370-4106201700020001528542664 137.DubrocqG.WangK.SpaederM.C.HahnA.Septic shock secondary"/>
   <result pre="virus infection. Case reportRev. Chil. Pediatr.20178828528810.4067/S0370-4106201700020001528542664 137.DubrocqG.WangK.SpaederM.C.HahnA.Septic shock secondary to" exact="chikungunya" post="virus in a 3-month-old traveler returning from HondurasJ. Pediatr."/>
   <result pre="the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during" exact="chikungunya" post="virus genome replication and transcriptionPLoS Pathog.201915e100723910.1371/journal.ppat.100723930668592 141.PietiläM.K.HellströmK.AholaT.Alphavirus polymerase and"/>
   <result pre="polymerase and RNA replicationVirus Res.2017234445710.1016/j.virusres.2017.01.00728104453 142.GunturizM.L.CortésL.CuevasE.L.ChaparroP.E.OspinaM.L.Congenital cerebral toxoplasmosis, zika and" exact="chikungunya" post="virus infections: A case reportBiomédica20183814415210.7705/biomedica.v38i0.365230184357 143.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhaes-BarbosaM.C.BrindeiroR.M.MedronhoR.A.da CunhaA.Co-infection with"/>
   <result pre="infections: A case reportBiomédica20183814415210.7705/biomedica.v38i0.365230184357 143.Prata-BarbosaA.Cleto-YamaneT.L.RobainaJ.R.GuastavinoA.B.de Magalhaes-BarbosaM.C.BrindeiroR.M.MedronhoR.A.da CunhaA.Co-infection with zika and" exact="chikungunya" post="viruses associated with fetal death—A case reportInt. J. Infect."/>
   <result pre="Dis.201872252710.1016/j.ijid.2018.04.432029738826 144.TazeenA.AbdullahM.HisamuddinM.AliS.NaqviI.H.VermaH.N.AhmedA.ParveenS.Concurrent infection with plasmodium vivax and the dengue and" exact="chikungunya" post="viruses in a paediatric patient from New Delhi, India"/>
   <result pre="flavivirusesTrends Microbiol.20091751452110.1016/j.tim.2009.08.00219796949 Figure 1 Consequences of congenital, perinatal, and pediatric" exact="chikungunya" post="infections are increasing. Chikungunya infection in newborns, infants, and"/>
   <result pre="identified in the associated report. viruses-11-00294-t001_Table 1Table 1 Symptoms of" exact="chikungunya" post="fever are associated with new viral genotypes. Chikungunya outbreaks"/>
   <result pre="associated with new viral genotypes. Chikungunya outbreaks with descriptions of" exact="chikungunya" post="fever in children, infants, and neonates are matched with"/>
   <result pre="of vertical transmission resulting in respiratory distress, fever, and maculopapular" exact="rash" post="ECSAE1: A226V [48,49,50] 2010 Gabon Rash ECSA [51,52] 2011"/>
   <result pre="of Acute Meningoencephalitis ECSAE1: A226V [53,54] 2011 Yemen Fever, arthralgia," exact="rash" post="ECSA E2: V264A [55,56] 2011 Pakistan Fever, arthralgia, rash"/>
   <result pre="arthralgia, rash ECSA E2: V264A [55,56] 2011 Pakistan Fever, arthralgia," exact="rash" post="ECSA E2: V264A [55,57] 2011 Tanzania Dengue-like illness ECSA"/>
   <result pre="cough ECSA [59,60] 2013/2014 Colombia (Cartagena) Congenital infections respiratory distress," exact="necrotizing enterocolitis," post="meningoencephalitis, myocarditis, pericarditis and death Asian-WH [61,62] 2014 Mozambique"/>
   <result pre="Colombia (Cartagena) Congenital infections respiratory distress, necrotizing enterocolitis, meningoencephalitis, myocarditis," exact="pericarditis" post="and death Asian-WH [61,62] 2014 Mozambique Dengue-like illness ECSA"/>
   <result pre="children with exanthema and open blisters. Neonates with fever, lethargy," exact="pulmonary edema," post="encephalitis Asian-WH [82,83,84,85,86] 2014/2015 Honduras Fever, Rash, seizures, meningoencephalitis"/>
   <result pre="exanthema and open blisters. Neonates with fever, lethargy, pulmonary edema," exact="encephalitis" post="Asian-WH [82,83,84,85,86] 2014/2015 Honduras Fever, Rash, seizures, meningoencephalitis Asian-WHNSP1:"/>
   <result pre="pulmonary edema, encephalitis Asian-WH [82,83,84,85,86] 2014/2015 Honduras Fever, Rash, seizures," exact="meningoencephalitis" post="Asian-WHNSP1: K224N [69,87] 2015 Yucatan Fever, Exanthema, blisters Asian-WH"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6466451\results\search\disease\results.xml">
   <result pre="illness and persistent disabling arthritis. The rheumatic symptoms associated with" exact="chikungunya" post="virus (CHIKV) infection include polyarthralgia, polyarthritis, morning stiffness, joint"/>
   <result pre="polyarthralgia, polyarthritis, morning stiffness, joint edema, and erythema. Chronic CHIK" exact="arthritis" post="(CCA) often causes severe pain and associated disability. The"/>
   <result pre="been shown to be effective in preliminary studies in CCA." exact="chikungunya" post="virus chronic chikungunya arthritis pathogenesis methotrexate 1. Introduction Chikungunya"/>
   <result pre="be effective in preliminary studies in CCA. chikungunya virus chronic" exact="chikungunya" post="arthritis pathogenesis methotrexate 1. Introduction Chikungunya virus (CHIKV) is"/>
   <result pre="effective in preliminary studies in CCA. chikungunya virus chronic chikungunya" exact="arthritis" post="pathogenesis methotrexate 1. Introduction Chikungunya virus (CHIKV) is a"/>
   <result pre="of the Togaviridae family [1,2]. Like many other arboviral diseases," exact="chikungunya" post="fever (CHIKF) is transmitted by mosquito vectors, primarily Aedes"/>
   <result pre="and intense fatigue, often accompanied by anorexia, nausea, vomiting, and" exact="diarrhea" post="[9]. In most reports, almost all of the infected"/>
   <result pre="CHIKF lasts approximately 10 days [4]. Neurological complications, including encephalitis," exact="optic neuritis," post="facial paralysis, sensorineural deafness, and Guillain–Barré syndrome, can occur"/>
   <result pre="the disease resolves in some patients, but 25%–40% develop chronic" exact="arthritis" post="that includes musculoskeletal pain, arthralgia, or frank arthritis, lasting"/>
   <result pre="uncertain, there is no existing consensus as to how chronic" exact="chikungunya" post="arthritis (CCA) should be treated. In addition to symptomatic"/>
   <result pre="there is no existing consensus as to how chronic chikungunya" exact="arthritis" post="(CCA) should be treated. In addition to symptomatic treatment"/>
   <result pre="others, there is transient improvement after CHIKF followed by persisitent" exact="arthritis" post="[4,12,23]. In several studies, 25% to 62% of patients"/>
   <result pre="CHIKF [23,24]. Even at the 36-month follow-up, the prevalence of" exact="arthritis" post="has been reported to be as high as 60%"/>
   <result pre="Colombian patients evaluated at 26 weeks after disease onset, persistent" exact="arthritis" post="was found in 54%, morning stiffness in 49%, joint"/>
   <result pre="In a Reunion Island study (2005–2006) of 88 patients, chronic" exact="arthritis" post="occurred in 93%, 57%, and 47% at 3, 15,"/>
   <result pre="24 months, respectively [24]. In another Colombian cohort (2014–2015), persistent" exact="arthritis" post="was less frequent, with 12% affected at the 18-month"/>
   <result pre="polyarthralgia, polyarthritis, morning stiffness, joint edema, and joint redness. CHIK" exact="arthritis" post="often causes severe pain and associated disability [21,27]. The"/>
   <result pre="of whom developed CIR-CHIK classified as mimicking four clinical patterns—rheumatoid" exact="arthritis" post="(RA), seronegative spondyloarthritis (SpA), fibromyalgia (FM), or undifferentiated polyarthritis"/>
   <result pre="as mimicking four clinical patterns—rheumatoid arthritis (RA), seronegative spondyloarthritis (SpA)," exact="fibromyalgia" post="(FM), or undifferentiated polyarthritis (UP), defined as the presence"/>
   <result pre="or undifferentiated polyarthritis (UP), defined as the presence of inflammatory" exact="arthritis" post="affecting more than four joints of greater than 6"/>
   <result pre="2011), 57% developed post-viral polyarthralgia, 22% inflammatory polyarthritis, and 19.5%" exact="tenosynovitis" post="during a 15-month period [29]. Several of these patients’"/>
   <result pre="of these patients’ diseases were reported to mimic RA and" exact="psoriatic arthritis" post="(PsA) [13,30,33]. Similarly, Schilte et al. [25] studied 180"/>
   <result pre="these patients’ diseases were reported to mimic RA and psoriatic" exact="arthritis" post="(PsA) [13,30,33]. Similarly, Schilte et al. [25] studied 180"/>
   <result pre="Similarly, Schilte et al. [25] studied 180 patients with CHIKV" exact="arthritis" post="of 36 months duration in whom the hands, wrists,"/>
   <result pre="affected. Around 60%–80% of the patients had intermittent arthritis, while" exact="arthritis" post="was unremitting in 20%–40%. Among 173 patients with CHIKV"/>
   <result pre="more frequent. In 39 Colombian patients with CHIKF, 90% developed" exact="arthritis" post="that met the RA ACR/EULAR criteria [35]. In a"/>
   <result pre="both RF and anti-CCP antibody. In addition, this patient developed" exact="neutropenia" post="and splenomegaly within 1 year after the onset of"/>
   <result pre="antibody [13,31]. There may be two different groups of chronic" exact="arthritis" post="patients being reported—CCA patients who are negative for RF"/>
   <result pre="while 20 patients (40%) also had arthritis, with clinically evident" exact="synovitis" post="(Figure 1). Arthralgia was most common in the hands"/>
   <result pre="with arthritis, all 20 had hand involvement. Other joints with" exact="arthritis" post="included wrists in 16 (32%), ankles in 12 (24%),"/>
   <result pre="including 6 with &quot;chronic inflammatory rheumatism�? [12]. Sissoko [32] observed" exact="osteoarthritis" post="in 38 of 147 (26%) patients who were followed"/>
   <result pre="small study, Zeana [42] reported preexisting rheumatic disease, including osteoarthritis," exact="carpal tunnel syndrome," post="retrocalcaneal bursitis, and lateral epicondylitis. Essackjee [33] found that"/>
   <result pre="relationship between these conditions and the clinical expression of CHIK" exact="arthritis" post="or the response to treatment [41]. Suggested risk factors"/>
   <result pre="to long-term disease include female sex, age greater than 45," exact="diabetes mellitus," post="hypertension, dyslipidemia, and previous rheumatic disease [43]. In addition,"/>
   <result pre="severe initial CHIKV infection predicted a greater likelihood of long-term" exact="arthritis" post="[44]. 3. Replication Cycle of Chikungunya Virus The transmission"/>
   <result pre="of these cytokines were specific for patients who develop chronic" exact="arthritis" post="[65]. A study of the cytokine profile of patients"/>
   <result pre="pathology and immune activation [73]. In the mouse model, chronic" exact="arthritis" post="may be related to persistent, replicating, transcriptionally active CHIKV"/>
   <result pre="suggesting that viral persistence may not be necessary for persistent" exact="arthritis" post="[75]. The authors suggested that autoantigens or autoreactive lymphocytes"/>
   <result pre="been suggested, including the inhibition of purine and pyrimidine synthesis," exact="suppression" post="of transmethylation reactions with accumulation of polyamines, reduction of"/>
   <result pre="antigen-dependent T-cell proliferation, and promotion of adenosine release with adenosine-mediated" exact="suppression" post="of inflammation [77,78]. In RA, the anti-inflammatory effects of"/>
   <result pre="MTX in animal models of both acute inflammation and adjuvant" exact="arthritis" post="[77,81]. As CCA is similar to RA [26,30,36] and"/>
   <result pre="properties and relationship to the epidemicJ. Hyg (Lond).19565417719110.1017/S002217240004444213346078 6.YactoyoS.StaplesJ.E.MillotV.CibrelusL.Ramon-PardoP.Epidemiology of" exact="chikungunya" post="in the AmericasJ. Infect. Dis.201621444144510.1093/infdis/jiw390 7.WahidB.AliA.RafiqueS.IdreesM.Global expansion of chikungunya"/>
   <result pre="of chikungunya in the AmericasJ. Infect. Dis.201621444144510.1093/infdis/jiw390 7.WahidB.AliA.RafiqueS.IdreesM.Global expansion of" exact="chikungunya" post="virus: Mapping the 64-year historyInt. J. Infect. Dis.201758697610.1016/j.ijid.2017.03.00628288924 8.AmaralJ.K.SchoenR.T.Chikungunya"/>
   <result pre="EmergenceAm. J. Trop. Med. Hyg.20169439339610.4269/ajtmh.15-030826643536 11.MehtaR.GerardinP.de BritoC.SoaresC.N.FerreiraM.SolomonT.The neurological complications of" exact="chikungunya" post="virus: A. systematic reviewRev. Medical. Virol.201828e197810.1002/rmv.1978 12.Rodríguez-MoralesA.J.Cardona-OspinaJ.A.Fernanda Urbano-GarzónS.Sebastian Hurtado-ZapataJ.Prevalence"/>
   <result pre="VirusClin. Microbiol. Rev.201731e00104-1610.1128/CMR.00104-1629237708 16.ReisingerE.C.TschismarovR.BeublerE.WiedermannU.FirbasC.LoebermannM.RamsauerK.Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: A double-blind, randomised, placebo-controlled and active-controlled"/>
   <result pre="Patient ManagementArthritis Rheumatol.201710.1002/art.40403 18.SimonF.JavelleE.CabieA.BouquillardE.TroisgrosO.GentileG.Leparc-GoffartI.HoenB.GandjbakhchF.Rene-CorailP.et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014Med. Mal. Infect.20154524326310.1016/j.medmal.2015.05.00726119684 19.Martí-CarvajalA.Ramon-PardoP.JavelleE.SimonF.AldighieriS.HorvathH.ReveizL.Interventions"/>
   <result pre="presentations). November 2014Med. Mal. Infect.20154524326310.1016/j.medmal.2015.05.00726119684 19.Martí-CarvajalA.Ramon-PardoP.JavelleE.SimonF.AldighieriS.HorvathH.ReveizL.Interventions for treating patients with" exact="chikungunya" post="virus infection-related rheumatic and musculoskeletal disorders: A systematic reviewPLoS"/>
   <result pre="and musculoskeletal disorders: A systematic reviewPLoS ONE201712e017902810.1371/journal.pone.017902828609439 20.AmaralJ.K.SutariaR.SchoenR.T.Treatment of chronic" exact="chikungunya" post="arthritis with methotrexate: A systematic reviewArthritis Care Res.201810.1002/acr.23519 21.MarimoutouC.FerraroJ.JavelleE.DeparisX.SimonF.Chikungunya"/>
   <result pre="musculoskeletal disorders: A systematic reviewPLoS ONE201712e017902810.1371/journal.pone.017902828609439 20.AmaralJ.K.SutariaR.SchoenR.T.Treatment of chronic chikungunya" exact="arthritis" post="with methotrexate: A systematic reviewArthritis Care Res.201810.1002/acr.23519 21.MarimoutouC.FerraroJ.JavelleE.DeparisX.SimonF.Chikungunya infection:"/>
   <result pre="studyInt. J. Clin. Pract.2011651306131210.1111/j.1742-1241.2011.02792.x22093538 30.BouquillardÉ.CombeB.A report of 21 cases of" exact="rheumatoid arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint."/>
   <result pre="J. Clin. Pract.2011651306131210.1111/j.1742-1241.2011.02792.x22093538 30.BouquillardÉ.CombeB.A report of 21 cases of rheumatoid" exact="arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint."/>
   <result pre="6-year experience from Reunion IslandBMC Infect Dis.201414Suppl. 2O2010.1186/1471-2334-14-S2-O20 32.SissokoD.MalvyD.EzzedineK.RenaultP.MoscettiF.LedransM.PierreV.Post epidemic" exact="chikungunya" post="disease on Reunion Island: Course of rheumatic manifestations and"/>
   <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virusPostgrad. Med. J.20138944044710.1136/postgradmedj-2012-13147723645664 34.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.GuruprasadD.R.Clinical progression of chikungunya fever during"/>
   <result pre="after infection with chikungunya virusPostgrad. Med. J.20138944044710.1136/postgradmedj-2012-13147723645664 34.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.GuruprasadD.R.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
   <result pre="39 cases in ColombiaClin. Rheumatol.20153583183210.1007/s10067-015-3041-826242471 36.MinerJ.J.Aw YeangH.X.FoxJ.M.TaffnerS.MalkovaO.N.OhS.T.KimA.H.J.DiamondM.S.LenschowD.J.YokoyamaW.M.Brief report: Chikungunya viral" exact="arthritis" post="in the united states: A mimic of seronegative rheumatoid"/>
   <result pre="states: A mimic of seronegative rheumatoid arthritisArthritis Rheumatol.2015671214122010.1002/art.3902725605621 37.ChaaithanyaI.K.MuruganandamN.RaghurajU.SugunanA.P.RajeshR.AnweshM.VijayachariP.Chronic inflammatory" exact="arthritis" post="with persisting bony erosions in patients following chikungunya infectionIndian"/>
   <result pre="37.ChaaithanyaI.K.MuruganandamN.RaghurajU.SugunanA.P.RajeshR.AnweshM.VijayachariP.Chronic inflammatory arthritis with persisting bony erosions in patients following" exact="chikungunya" post="infectionIndian J. Med. Res.2014140142145Retrieved March 10, 201725222790 38.ChopraA.AnuradhaV.Lagoo-JoshiV.KunjirV.SalviS.SalujaM.Chikungunya virus"/>
   <result pre="return from the CaribbeanTravel Med. Infect. Dis.201614212510.1016/j.tmaid.2016.01.00926872414 43.GérardinP.FianuA.MichaultA.MussardC.BoussaïdK.RollotO.GrivardP.KassabS.BouquillardE.BorgheriniG.et al.Predictors of" exact="chikungunya" post="rheumatism: A prognostic survey ancillary to the TELECHIK cohort"/>
   <result pre="studyArthritis Res. Ther.201315R910.1186/ar413723302155 44.YaseenH.M.SimonF.DeparisX.MarimoutouC.Identification of initial severity determinants to predict" exact="arthritis" post="after chikungunya infection in a cohort of French gendarmesBMC"/>
   <result pre="Ther.201315R910.1186/ar413723302155 44.YaseenH.M.SimonF.DeparisX.MarimoutouC.Identification of initial severity determinants to predict arthritis after" exact="chikungunya" post="infection in a cohort of French gendarmesBMC Musculoskelet Disord.20141510.1186/1471-2474-15-249"/>
   <result pre="as Targets of Chikungunya Virus InfectionPLoS ONE.20072e52710.1371/journal.pone.000052717565380 52.SourisseauM.SchwartzO.Characterization of reemerging" exact="chikungunya" post="virusPlos Pathog.200730804081710.1371/journal.ppat.0030089 53.AshokA.AtwoodW.J.Contrasting Roles of Endosomal pH and the"/>
   <result pre="cellular and chemicalCell Death Differ.200614737810.1038/sj.cdd.440203416946729 59.SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.KraxnerA.TschoppJ.HiggsS.MichaultA.et al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960"/>
   <result pre="an Innate Immune ResponseJ. Immunol.20101845903591310.4049/jimmunol.090418120404274 61.ChirathawornC.L.PoovorawanY.LertmaharitS.WuttirattanakowitN.Cytokine levels in patients with" exact="chikungunya" post="virus infectionAsian Pac. J. Trop Med.2013663163410.1016/S1995-7645(13)60108-X23790334 62.MinerJ.J.LenschowD.J.Editorial: Lessons Learned"/>
   <result pre="Rheumatol.20187047747910.1002/art.4042129361204 63.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.GuichardE.RiberaA.HenniT.TalletF.et al.Persistent chronic inflammation and infection by" exact="chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
   <result pre="responseJ. Immunol.20101845914592710.4049/jimmunol.090025520404278 64.ChaaitanyaI.K.MuruganandamN.SundaramS.G.KawalekarO.SugunanA.P.ManimundaS.P.GhosalS.R.MuthumaniK.VijayachariP.Role of pro-inflammatory cytokines and chemokines in chronic" exact="arthropathy" post="in CHIKV infectionViral. Immunol.20112426527110.1089/vim.2010.012321830898 65.ChowA.HerZ.OngE.K.ChenJ.DimatatacF.KwekD.J.NgL.F.Persistent Arthralgia Induced by Chikungunya"/>
   <result pre="cell functionality and increased TNF-α production as biomarkers of chronic" exact="chikungunya" post="arthritis and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic chikungunya virus musculoskeletal"/>
   <result pre="functionality and increased TNF-α production as biomarkers of chronic chikungunya" exact="arthritis" post="and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic chikungunya virus musculoskeletal disease:"/>
   <result pre="biomarkers of chronic chikungunya arthritis and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic" exact="chikungunya" post="virus musculoskeletal disease: What are the underlying mechanisms?Future Microbiol.20161133133410.2217/fmb.15.14726939523"/>
   <result pre="74.PooY.S.RuddP.A.GardnerJ.WilsonJ.A.LarcherT.SuhrbierA.Multiple immune factors are involved in controlling acute and chronic" exact="chikungunya" post="virus infectionPLoS Negl. Trop Dis.20148e335410.1371/journal.pntd.000335425474568 75.ChangA.Y.MartinsK.A.EncinalesL.ReidS.P.AcuñaM.EncinalesC.FiresteinG.S.Chikungunya Arthritis Mechanisms in"/>
   <result pre="Woman, 82 years old, 2 years after CHIKV infection. Intense" exact="arthritis" post="of metacarpophalangeal joints and wrist. Figure 2 Cytokines that"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6467424\results\search\disease\results.xml">
   <result pre="recent epidemics have seen more severe disease manifestations, such as" exact="microcephaly" post="and central nervous malformations in neonates [17, 18], and"/>
   <result pre="MercierA, LepersC, HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue," exact="chikungunya" post="and Zika virus infections—an unprecedented epidemic wave of mosquito-borne"/>
   <result pre="BompardP, DubT, Guillemette-ArturP, Eyrolle-GuignotD, et al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013–15: a retrospective study. Lancet. 2016;387:2125–2132."/>
   <result pre="TidedM, MachiengP, et al.Aedes hensilli as a potential vector of" exact="chikungunya" post="and Zika viruses. PloS Negl Trop Dis. 2014;8: e318810.1371/journal.pntd.000318825299181"/>
   <result pre="albopictus and Aedes aegypti in the emergence of dengue and" exact="chikungunya" post="in Central Africa. Vector Borne Zoonotic Dis. 2010;10: 259–266."/>
   <result pre="259–266. 10.1089/vbz.2009.000519725769 42TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog."/>
   <result pre="FrentiuFD, McElroyK, DayA, et al.Impact of Wolbachia on infection with" exact="chikungunya" post="and yellow fever viruses in the mosquito vector Aedes"/>
   <result pre="DayA, et al.Impact of Wolbachia on infection with chikungunya and" exact="yellow fever" post="viruses in the mosquito vector Aedes aegypti. PloS Negl"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6468063\results\search\disease\results.xml">
   <result pre="al.): The causes of long�?term trends in the epidemiology of" exact="influenza" post="LETTER TO THE EDITOR CainiSaveriohttps://orcid.org/0000-0002-2262-1102s.caini@nivel.nl1PagetJohnhttps://orcid.org/0000-0002-1503-24811[1], Netherlands Institute for Health"/>
   <result pre="read Souty et al's1 paper on the declining size of" exact="influenza" post="epidemics in France during 1984�?2017 with interest. The authors"/>
   <result pre="Sprujit et al2 failed to find a convincing association between" exact="influenza" post="vaccination coverage and influenza�?like illness in fourteen European countries."/>
   <result pre="epidemiological evidence that supports the notion that the occurrence of" exact="influenza" post="epidemics is driven by climatic parameters, in particular absolute"/>
   <result pre="and host susceptibility are enhanced, thus favoring the transmission of" exact="influenza" post="viruses and the onset of epidemics.5 Researchers have long"/>
   <result pre="are often hypothesized as possible drivers of long�?term trends in" exact="influenza" post="incidence (eg, hygienic standards, social contact patterns, household size,"/>
   <result pre="de LangeMM, DijkstraF, DonkerGA, van der HoekW. Long�?term correlation between" exact="influenza" post="vaccination coverage and incidence of influenza�?like illness in 14"/>
   <result pre="2019. 4TameriusJD, ShamanJ, AlonsoWJ, et al. Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e1003194.23505366"/>
   <result pre="ViboudC, GrenfellBT, LipsitchM. Absolute humidity and the seasonal onset of" exact="influenza" post="in the continental United States. PLoS Biol. 2010;8(2)e1000316.20186267 6TowersS,"/>
   <result pre="Climate change and influenza: the likelihood of early and severe" exact="influenza" post="seasons following warmer than average winters. PLoS Curr. 2013;5."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6468813\results\search\disease\results.xml">
   <result pre="Here, we discuss the current knowledge on the interactions between" exact="influenza" post="A virus (IAV), the causative agent for most of"/>
   <result pre="in the endoplasmic reticulum that are affected by this virus." exact="influenza" post="A virus (IAV) virus–host interaction proteostasis protein quality control"/>
   <result pre="machinery, with focus on proteostasis imbalance, throughout the course of" exact="influenza" post="A virus (IAV) life-cycle and explore its significance for"/>
   <result pre="significance for infection efficiency. Although information on the interplay between" exact="influenza" post="B virus (IBV) and host-cell proteostasis is scarce, we"/>
   <result pre="epidemics in humans as well as the for the major" exact="influenza" post="pandemics in the last century, associated with high morbidity"/>
   <result pre="responses and the proteostasis maintenance. Currently, the permanent risk of" exact="influenza" post="epidemics and pandemics is due to the continuous viral"/>
   <result pre="synthesis [39]. This process was suggested to be distinct among" exact="influenza" post="viruses, since IBV polymerase possesses a distinct cap recognition"/>
   <result pre="of infection, essentially to identify unanticipated cellular factors required for" exact="influenza" post="replication and pathogenicity, or related to host antiviral responses,"/>
   <result pre="as a consequence of the reassortment of avian and human" exact="influenza" post="virus’s gene segments, which requires an adaptation of the"/>
   <result pre="that RNA-directed RNA polymerase catalytic subunit (PB1) protein from the" exact="avian influenza" post="pandemic virus H3N2 (1698) evolved in humans to reduce"/>
   <result pre="RNA-directed RNA polymerase catalytic subunit (PB1) protein from the avian" exact="influenza" post="pandemic virus H3N2 (1698) evolved in humans to reduce"/>
   <result pre="to be involved in the assembly and nuclear transport of" exact="influenza" post="RNA polymerase subunits [64] and stimulates its RNA synthesis"/>
   <result pre="3). A functional UPS is important for the replication of" exact="influenza" post="viruses, in order to maintain proper function and the"/>
   <result pre="using specific inhibitors can lead to the sequestration of incoming" exact="influenza" post="particles in cytoplasmic endosomes, directly affecting the early stages"/>
   <result pre="ubiquitination process as necessary for IAV entry and replication. However," exact="influenza" post="proteins can be targeted for ubiquitin-mediated degradation as an"/>
   <result pre="such an extent that TRIM41 deficiency increases host susceptibility to" exact="influenza" post="[79] (Figure 3). On the other hand, IAV has"/>
   <result pre="efficiently replicate, in particular to allow the nuclear import of" exact="influenza" post="particles and to permit its genome replication. When the"/>
   <result pre="Yet, chemical genomics identified PERK as a cellular target for" exact="influenza" post="virus inhibition, as, according to the authors [121], IAV"/>
   <result pre="and Exploiting Proteome Organization during Viral InfectionJ. Virol.201791e00268-1710.1128/JVI.00268-1728679763 9.HeatonN.S.MoshkinaN.FenouilR.GardnerT.J.AguirreS.ShahP.S.ZhaoN.ManganaroL.HultquistJ.NoelJ.et al.Limiting" exact="influenza" post="virus, HIV and dengue virus infection by targeting viral"/>
   <result pre="overall benefits still hotly debated?J. Prev. Med. Hyg.201556E37E4310.15167/2421-4248/jpmh2015.56.1.47426789831 19.ShaoW.LiX.GorayaM.U.WangS.ChenJ.L.Evolution of" exact="influenza" post="a virus by mutation and re-assortmentInt. J. Mol. Sci.201718165010.3390/ijms18081650"/>
   <result pre="the cellular 3’-end processing machineryEMBO J.1999182273228310.1093/emboj/18.8.227310205180 26.Bercovich-KinoriA.TaiJ.GelbartI.A.ShitritA.Ben-MosheS.DroriY.ItzkovitzS.MandelboimM.Stern-GinossarN.A systematic view on" exact="influenza" post="induced host shutoffElife2016512010.7554/eLife.18311 27.WangW.KrugR.M.The RNA-Binding and Effector Domains of"/>
   <result pre="a Translational Activator of Influenza VirusMol. Cell. Biol.2000206259626810.1128/MCB.20.17.6259-6268.200010938102 30.SalvatoreM.BaslerC.F.ParisienJ.-P.HorvathC.M.BourmakinaS.ZhengH.MusterT.PaleseP.García-SastreA.Effects of" exact="influenza" post="A virus NS1 protein on protein expression: The NS1"/>
   <result pre="the RNA-Dependent Protein Kinase PKRJ. Virol.20179110.1128/JVI.00198-1728250123 34.MinJ.-Y.LiS.SenG.C.KrugR.M.A site on the" exact="influenza" post="A virus NS1 protein mediates both inhibition of PKR"/>
   <result pre="ActivityJ. Virol.2000748781878410.1128/JVI.74.18.8781-8784.200010954584 37.MinJ.-Y.KrugR.M.The primary function of RNA binding by the" exact="influenza" post="A virus NS1 protein in infected cells: Inhibiting the"/>
   <result pre="Viral InfectionsCell Host Microbe20151746647710.1016/j.chom.2015.02.01025816776 39.KoppsteinD.AshourJ.BartelD.P.Sequencing the cap-snatching repertoire of H1N1" exact="influenza" post="provides insight into the mechanism of viral transcription initiationNucleic"/>
   <result pre="host shutoffElife20165e2075510.7554/eLife.2075527644108 45.VesterD.RappE.GadeD.GenzelY.ReichlU.Quantitative analysis of cellular proteome alterations in human" exact="influenza" post="A virus-infected mammalian cell linesProteomics200993316332710.1002/pmic.20080089319504497 46.KroekerA.L.EzzatiP.CoombsK.M.HalaykoA.J.Influenza A infection of"/>
   <result pre="Primary MacrophagesPLoS Pathog.2011710.1371/journal.ppat.1001340 49.AlbersS.CzechA.Exploiting tRNAs to Boost VirulenceLife20166410.3390/life6010004 50.Pavon-EternodM.DavidA.DittmarK.BerglundP.PanT.BenninkJ.R.YewdellJ.W.Vaccinia and" exact="influenza" post="A viruses select rather than adjust tRNAs to optimize"/>
   <result pre="Codon Usage toward Interferon-Altered tRNA PoolsMBio20189e01222-1810.1128/mBio.01222-1829970470 52.WangR.ZhangY.-Y.LuJ.-S.XiaB.-H.YangZ.-X.ZhuX.-D.ZhouX.-W.HuangP.-T.The highly pathogenic H5N1" exact="influenza" post="A virus down-regulated several cellular MicroRNAs which target viral"/>
   <result pre="and OAS2Mol. Ther. Nucleic Acids20191450951910.1016/j.omtn.2018.12.01430753994 56.KeshavarzM.Dianat-MoghadamH.SofianiV.H.KarimzadehM.ZargarM.MoghoofeiM.BiglariH.GhorbaniS.NahandJ.S.MirzaeiH.MiRNA-based strategy for modulation of" exact="influenza" post="A virus infectionEpigenomics20181082984410.2217/epi-2017-017029888954 57.HartlF.U.BracherA.Hayer-hartlM.Molecular chaperones in protein folding and"/>
   <result pre="vitroNucleic Acids Res.2008363389340010.1093/nar/gkn17718442994 59.BatraJ.TripathiS.KumarA.KatzJ.M.CoxN.J.LalR.B.SambharaS.LalS.K.Human Heat shock protein 40 (Hsp40/DnaJB1) promotes" exact="influenza" post="A virus replication by assisting nuclear import of viral"/>
   <result pre="ActivityJ. Virol.201488140781408910.1128/JVI.02475-1425253355 61.LiG.ZhangJ.TongX.LiuW.YeX.Heat shock protein 70 inhibits the activity of" exact="influenza" post="a virus ribonucleoprotein and blocks the replication of virus"/>
   <result pre="Vitro and In VivoPLoS ONE2011610.1371/journal.pone.0016546 62.ManzoorR.KurodaK.YoshidaR.TsudaY.FujikuraD.MiyamotoH.KajiharaM.KidaH.TakadaA.Heat shock protein 70 modulates" exact="influenza" post="A virus polymerase activityJ. Biol. Chem.20142897599761410.1074/jbc.M113.50779824474693 63.ShimizuK.IguchiA.GomyouR.OnoY.Influenza Virus Inhibits"/>
   <result pre="65.MomoseF.NaitoT.YanoK.SugimotoS.MorikawaY.NagataK.Identification of Hsp90 as a stimulatory host factor involved in" exact="influenza" post="virus RNA synthesisJ. Biol. Chem.2002277453064531410.1074/jbc.M20682220012226087 66.ChaseG.DengT.FodorE.LeungB.W.MayerD.SchwemmleM.BrownleeG.Hsp90 inhibitors reduce influenza"/>
   <result pre="in influenza virus RNA synthesisJ. Biol. Chem.2002277453064531410.1074/jbc.M20682220012226087 66.ChaseG.DengT.FodorE.LeungB.W.MayerD.SchwemmleM.BrownleeG.Hsp90 inhibitors reduce" exact="influenza" post="virus replication in cell cultureVirology200837743143910.1016/j.virol.2008.04.04018570972 67.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with"/>
   <result pre="influenza virus replication in cell cultureVirology200837743143910.1016/j.virol.2008.04.04018570972 67.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with" exact="influenza" post="virus M2 protein: Implications for PKR signaling pathwayProtein Cell2010194495510.1007/s13238-010-0115-x21204021"/>
   <result pre="through a PKR-Mediated MechanismJ. Virol.2007812221223010.1128/JVI.02151-0617166899 70.WatanabeK.FuseT.AsanoI.TsukaharaF.MaruY.NagataK.KitazatoK.KobayashiN.Identification of Hsc70 as an" exact="influenza" post="virus matrix protein (M1) binding factor involved in the"/>
   <result pre="in the virus life cycleFEBS Lett.20065805785579010.1016/j.febslet.2006.09.04017022977 71.HalderU.C.BagchiP.ChattopadhyayS.DuttaD.Chawla-SarkarM.Cell death regulation during" exact="influenza" post="A virus infection by matrix (M1) protein: A model"/>
   <result pre="the cellular survival pathwayCell Death Dis.20112e19710.1038/cddis.2011.7521881599 72.ZhangC.YangY.ZhouX.YangZ.LiuX.CaoZ.SongH.HeY.HuangP.The NS1 protein of" exact="influenza" post="a virus interacts with heat shock protein Hsp90 in"/>
   <result pre="system: Molecular mechanism of viral pathogenesisCurr. Opin. Virol.20161711010.1016/j.coviro.2015.09.00526426962 74.RudnickaA.YamauchiY.Ubiquitin in" exact="influenza" post="virus entry and innate immunityViruses2016829310.3390/v810029327783058 75.WidjajaI.de VriesE.TscherneD.M.Garcia-SastreA.RottierP.J.M.de HaanC.A.M.Inhibition of"/>
   <result pre="ubiquitin-vacuolar protein sorting system is selectively required during entry of" exact="influenza" post="virus into host cellsTraffic2003485786810.1046/j.1398-9219.2003.0140.x14617349 77.FuB.WangL.DingH.SchwambornJ.C.LiS.DorfM.E.TRIM32 Senses and Restricts Influenza"/>
   <result pre="Host Microbe2009543944910.1016/j.chom.2009.04.00619454348 81.KoliopoulosM.G.LethierM.Van Der VeenA.G.HaubrichK.HennigJ.KowalinskiE.StevensR.V.MartinS.R.Reis E SousaC.CusackS.et al.Molecular mechanism of" exact="influenza" post="A NS1-mediated TRIM25 recognition and inhibitionNat. Commun.2018910.1038/s41467-018-04214-8 82.RajsbaumR.AlbrechtR.A.WangM.K.MaharajN.P.VersteegG.A.Nistal-VillánE.García-SastreA.GackM.U.Species-Specific Inhibition"/>
   <result pre="Viral RNA ReplicationMBio20178e00597-1710.1128/mBio.00597-1728536288 87.LiaoT.L.WuC.Y.SuW.C.JengK.S.LaiM.M.C.Ubiquitination and deubiquitination of NP protein regulates" exact="influenza" post="A virus RNA replicationEMBO J.2010293879389010.1038/emboj.2010.25020924359 88.KošíkI.PráznovskáM.KošíkováM.BobišováZ.HollýJ.Vare�?kováE.KostolanskýF.RussG.The ubiquitination of the"/>
   <result pre="influenza A virus RNA replicationEMBO J.2010293879389010.1038/emboj.2010.25020924359 88.KošíkI.PráznovskáM.KošíkováM.BobišováZ.HollýJ.Vare�?kováE.KostolanskýF.RussG.The ubiquitination of the" exact="influenza" post="a virus PB1-F2 protein is crucial for its biological"/>
   <result pre="for its biological functionPLoS ONE201510e011847710.1371/journal.pone.011847725866881 89.LiuG.ZhongM.GuoC.KomatsuM.XuJ.WangY.KitazatoK.Autophagy is involved in regulating" exact="influenza" post="A virus RNA and protein synthesis associated with both"/>
   <result pre="signaling pathwayInt. J. Biochem. Cell Biol.20167210010810.1016/j.biocel.2016.01.01226794463 90.ZhouZ.JiangX.LiuD.FanZ.HuX.YanJ.WangM.GaoG.F.Autophagy is involved in" exact="influenza" post="A virus replicationAutophagy2009532132810.4161/auto.5.3.740619066474 91.YeganehB.GhavamiS.RahimM.N.KlonischT.HalaykoA.J.CoombsK.M.Autophagy activation is required for influenza"/>
   <result pre="in influenza A virus replicationAutophagy2009532132810.4161/auto.5.3.740619066474 91.YeganehB.GhavamiS.RahimM.N.KlonischT.HalaykoA.J.CoombsK.M.Autophagy activation is required for" exact="influenza" post="A virus-induced apoptosis and replicationBiochim. Biophys. Acta Mol. Cell"/>
   <result pre="replicationBiochim. Biophys. Acta Mol. Cell Res.2018186536437810.1016/j.bbamcr.2017.10.01429108912 92.FeiziN.MehrbodP.RomaniB.SoleimanjahiH.BamdadT.FeiziA.JazaeriE.O.TarghiH.S.SalehM.JamaliA.et al.Autophagy induction regulates" exact="influenza" post="virus replication in a time-dependent mannerJ. Med. Microbiol.20176653654110.1099/jmm.0.00045528463668 93.WangR.ZhuY.ZhaoJ.RenC.LiP.ChenH.JinM.ZhouH.Autophagy"/>
   <result pre="In VitroJ. Virol.201993e01984-1810.1128/JVI.01984-1830541828 94.PerotB.P.BoussierJ.YatimN.RossmanJ.S.IngersollM.A.AlbertM.L.Autophagy diminishes the early interferon-β response to" exact="influenza" post="A virus resulting in differential expression of interferon-stimulated genesCell"/>
   <result pre="in Influenza Virus-Infected Dendritic CellsJ. Immunol.200517589189810.4049/jimmunol.175.2.89116002687 99.VidicJ.RichardC.A.PéchouxC.Da CostaB.BerthoN.MazeratS.DelmasB.ChevalierC.Amyloid assemblies of" exact="influenza" post="a virus PB1-F2 protein damage membrane and induce cytotoxicityJ."/>
   <result pre="Innate Immune Response Mediated by MDA5 and MAVSJ. Virol.2012868245825810.1128/JVI.00215-1222623778 103.NingY.J.WangM.DengM.ShenS.LiuW.CaoW.C.DengF.WangY.Y.HuZ.WangH.Viral" exact="suppression" post="of innate immunity via spatial isolation of TBK1/IKKε from"/>
   <result pre="of viral glycoproteins in the ER impacts the production of" exact="influenza" post="A virusVirus Res.2008136919710.1016/j.virusres.2008.04.02818550190 115.DanielsR.KurowskiB.JohnsonA.E.HebertD.N.N-Linked Glycans Direct the Cotranslational Folding"/>
   <result pre="Viruses by an ER Stress PathwayCell Rep.2015111591160310.1016/j.celrep.2015.05.01226051937 118.FrabuttD.A.WangB.RiazS.SchwartzR.C.ZhengY.-H.Innate sensing of" exact="influenza" post="A virus hemagglutinin glycoproteins by the host endoplasmic reticulum"/>
   <result pre="the transcription and translation machinery in (a) uninfected and (b)" exact="influenza" post="A virus (IAV)-infected cells. (a) After being transcribed and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6472721\results\search\disease\results.xml">
   <result pre=": Viral Pathogens : Flaviviruses: Zika Virus Epidemiological trend of" exact="chikungunya" post="outbreak in Pakistan: 2016–2018 BadarNazish12SalmanMuhammad1AnsariJamil1IkramAamer1QaziJavaria2AlamMuhammad Masroor1*[1], Department of Virology,"/>
   <result pre="last three decades, despite a recent trend of increasingly frequent" exact="chikungunya" post="cases, first detected in December 2016. Chikungunya infection is"/>
   <result pre="total 1,549 samples tested through July 31, 2018, we found" exact="chikungunya" post="and dengue infection in 776 (50%) and 109 (7%)"/>
   <result pre="diseases in the coming years. Fig 1 Epidemiological curve of" exact="chikungunya" post="cases reported at NIH, Islamabad. Red bars indicate the"/>
   <result pre="bars indicate the number of patients who tested positive for" exact="chikungunya" post="RNA using real-time reverse transcriptase PCR, green squares indicate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473099\results\search\disease\results.xml">
   <result pre="significant morbidity and mortality, our arsenal of options to treat" exact="influenza" post="A virus (IAV) infections remains limited and is challenged"/>
   <result pre="classes to modulate the immune response induced after IAV infections." exact="influenza" post="treatment response modifiers antiviral immune response immunomodulators Funding Alexander"/>
   <result pre="with ~500,000 annual deaths worldwide. IVs can cause severe acute" exact="respiratory disease" post="especially in high-risk populations like children, the elderly and"/>
   <result pre="populations like children, the elderly and the immunocompromised. While both" exact="influenza" post="A and B viruses (IAV and IBV, respectively) cause"/>
   <result pre="significant damage or destruction of the respiratory epithelium leading to" exact="acute respiratory distress syndrome" post="(ARDS) (7, 8). Clinical treatment options for severe influenza"/>
   <result pre="distress syndrome (ARDS) (7, 8). Clinical treatment options for severe" exact="influenza" post="virus infections remain limited and relying heavily on the"/>
   <result pre="36). ANGPTL4 was significantly elevated in lung biopsies from IAV-induced" exact="pneumonia" post="patients (16). In mouse studies, neutralizing anti-ANGPTL4 Abs reduced"/>
   <result pre="IAV infections (37). Neutrophil extracellular traps (NETs) released during IAV-induced" exact="pneumonia" post="into the alveolar space caused alveolar damage (38). The"/>
   <result pre="inhibitor zanamivir that is used for the treatment of human" exact="influenza" post="patients (21). Both cellular and viral FADD-like IL-1β-converting enzyme-inhibitory"/>
   <result pre="10 amino acids from the α2 helix of the Kaposi's" exact="sarcoma" post="herpes virus (KSHV) death effector domain 1 protein. A"/>
   <result pre="of SphK1 was shown to decrease IAV RNA synthesis via" exact="suppression" post="of NFkB activation (69). Treatment of mice with specific"/>
   <result pre="Netherlands, UK and USA reported an association of reduced IAV-related" exact="pneumonia" post="and lower case fatality due to lower respiratory tract"/>
   <result pre="of the immune status spectrum and underlying conditions of high-risk" exact="influenza" post="patients (young, immunocompromised, non-naive, obese, pregnant, or aged). Using"/>
   <result pre="to space limitations. References References 1.van de SandtCEKreijtzJHRimmelzwaanGF. Evasion of" exact="influenza" post="A viruses from innate and adaptive immune responses. Viruses."/>
   <result pre="responses. Viruses. (2012) 4:1438–76. 10.3390/v409143823170167 2.ChenXLiuSGorayaMUMaaroufMHuangSChenJL. Host immune response to" exact="influenza" post="A virus infection. Front Immunol. (2018) 9:320. 10.3389/fimmu.2018.0032029556226 3.TakeuchiOAkiraS."/>
   <result pre="(2010) 32:305–15. 10.1016/j.immuni.2010.03.01220346772 5.PangIKIwasakiA. Inflammasomes as mediators of immunity against" exact="influenza" post="virus. Trends Immunol. (2011) 32:34–41. 10.1016/j.it.2010.11.00421147034 6.SandersCJDohertyPCThomasPG. Respiratory epithelial"/>
   <result pre="32:34–41. 10.1016/j.it.2010.11.00421147034 6.SandersCJDohertyPCThomasPG. Respiratory epithelial cells in innate immunity to" exact="influenza" post="virus infection. Cell Tissue Res. (2011) 343:13–21. 10.1007/s00441-010-1043-z20848130 7.KuikenTRiteauBFouchierRARimmelzwaanGF."/>
   <result pre="infection. Cell Tissue Res. (2011) 343:13–21. 10.1007/s00441-010-1043-z20848130 7.KuikenTRiteauBFouchierRARimmelzwaanGF. Pathogenesis of" exact="influenza" post="virus infections: the good, the bad and the ugly."/>
   <result pre="Curr Opin Virol. (2012) 2:276–86. 10.1016/j.coviro.2012.02.01322709515 8.ShortKRKroezeEFouchierRAMKuikenT. Pathogenesis of influenza-induced" exact="acute respiratory distress syndrome." post="Lancet Infect Dis. (2014) 14:57–69. 10.1016/S1473-3099(13)70286-X24239327 9.ZambonM. Developments in"/>
   <result pre="10.de JongMDThanhTTKhanhTHHienVMSmithGJDChauNVet al.Brief report - Oseltamivir resistance during treatment of" exact="influenza" post="A (H5N1) infection. N Engl J Med. (2005) 353:2667–72."/>
   <result pre="(2005) 353:2667–72. 10.1056/NEJMoa05451216371632 11.ChanPKLeeNZamanMAdisasmitoWCokerRHanshaoworakulWet al.. Determinants of antiviral effectiveness in" exact="influenza" post="virus A subtype H5N1. J Infect Dis. (2012) 206:1359–66."/>
   <result pre="between adverse clinical outcome in human disease caused by novel" exact="influenza" post="A H7N9 virus and sustained viral shedding and emergence"/>
   <result pre="support treatment and prophylaxis based on population modeling of seasonal" exact="influenza" post="A outbreaks. EBioMedicine. (2016) 5:147–55. 10.1016/j.ebiom.2016.02.02127077121 14.AliOTakasTNyborgACJensenKMDubovskyFMalloryRA phase 2a"/>
   <result pre="of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human" exact="influenza" post="A virus challenge model. Antimicrob Agents Chemother. (2017) 61:e01154-17."/>
   <result pre="al.. Angiopoietin-like 4 increases pulmonary tissue leakiness and damage during" exact="influenza" post="pneumonia. Cell Rep. (2015) 10:654–63. 10.1016/j.celrep.2015.01.01125660016 17.SunSZhaoGLiuCFanWZhouXZengLet al.. Treatment"/>
   <result pre="60:586–95. 10.1093/cid/ciu88725433014 18.BrincksELKatewaAKucabaTAGriffithTSLeggeKL. CD8 T cells utilize TRAIL to control" exact="influenza" post="virus infection. J Immunol. (2008) 181:4918–25. 10.4049/jimmunol.181.7.491818802095 19.HeroldSSteinmuellerMvon WulffenWCakarovaLPintoRPleschkaSet"/>
   <result pre="(2008) 181:4918–25. 10.4049/jimmunol.181.7.491818802095 19.HeroldSSteinmuellerMvon WulffenWCakarovaLPintoRPleschkaSet al.. Lung epithelial apoptosis in" exact="influenza" post="virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand."/>
   <result pre="10.1002/1521-4141(200109)31:9&amp;lt;2566::AID-IMMU2566&amp;gt;3.0.CO;2-L11536154 21.BarlowPGSvobodaPMackellarANashAAYorkIAPohlJet al.. Antiviral activity and increased host defense against" exact="influenza" post="infection elicited by the human cathelicidin LL-37. PLoS ONE."/>
   <result pre="ONE. (2011) 6:e25333. 10.1371/journal.pone.002533322031815 22.MoonHJNikapitiyaCLeeHCParkMEKimJHKimTHet al.. Inhibition of highly pathogenic" exact="avian influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="(2011) 6:e25333. 10.1371/journal.pone.002533322031815 22.MoonHJNikapitiyaCLeeHCParkMEKimJHKimTHet al.. Inhibition of highly pathogenic avian" exact="influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="possess antiviral activity against highly pathogenic avian and human pandemic" exact="influenza" post="A viruses. Biol Chem. (2012) 393:525–34. 10.1515/hsz-2011-027022628315 24.XieJZhangSHuYLiDCuiJXueJet al.."/>
   <result pre="393:525–34. 10.1515/hsz-2011-027022628315 24.XieJZhangSHuYLiDCuiJXueJet al.. Regulatory roles of c-jun in H5N1" exact="influenza" post="virus replication and host inflammation. Biochim Biophys Acta. (2014)."/>
   <result pre="A):2479–88. 10.1016/j.bbadis.2014.04.01724780373 25.BorgelingYSchmolkeMViemannDNordhoffCRothJLudwigS. Inhibition of p38 mitogen-activated protein kinase impairs" exact="influenza" post="virus-induced primary and secondary host gene responses and protects"/>
   <result pre="al.. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic" exact="avian influenza" post="A virus. Antiviral Res. (2013) 99:336–44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.."/>
   <result pre="The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian" exact="influenza" post="A virus. Antiviral Res. (2013) 99:336–44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.."/>
   <result pre="(2013) 99:336–44. 10.1016/j.antiviral.2013.06.00823811282 28.YanguezEHunzikerADobayMPYildizSSchadingSElshinaEet al.. Phosphoproteomic-based kinase profiling early in" exact="influenza" post="virus infection identifies GRK2 as antiviral drug target. Nat"/>
   <result pre="10.1038/s41467-018-06119-y30206219 29.XiaCSeoYJStudstillCJVijayanMWolfJJHahmB. Transient inhibition of sphingosine kinases confers protection to" exact="influenza" post="A virus infected mice. Antiviral Res. (2018) 158:171–7. 10.1016/j.antiviral.2018.08.01030125617"/>
   <result pre="Antiviral Res. (2018) 158:171–7. 10.1016/j.antiviral.2018.08.01030125617 30.KhoufacheKBerriFNackenWVogelABDelenneMCamererEet al.. PAR1 contributes to" exact="influenza" post="A virus pathogenicity in mice. J Clin Invest. (2013)"/>
   <result pre="al.. TNF/iNOS-producing dendritic cells are the necessary evil of lethal" exact="influenza" post="virus infection.Proc Natl Acad Sci USA. (2009) 106:5306–11. 10.1073/pnas.090065510619279209"/>
   <result pre="proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal" exact="influenza" post="virus challenge in mice. Influenza Other Respir Viruses. (2010)"/>
   <result pre="mice. Influenza Other Respir Viruses. (2010) 4:307–11. 10.1111/j.1750-2659.2010.00155.x20716159 34.DavidsonS. Treating" exact="influenza" post="infection, from now and into the future. Front Immunol."/>
   <result pre="Inflamm Res. (2014) 63:13–22. 10.1007/s00011-013-0678-024173241 37.PerroneLAPlowdenJKGarcia-SastreAKatzJMTumpeyTM. H5N1 and 1918 pandemic" exact="influenza" post="virus infection results in early and excessive infiltration of"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitis. Am J Pathol. (2011) 179:199–210. 10.1016/j.ajpath.2011.03.01321703402 39.YousefiSMihalacheCKozlowskiESchmidISimonHU. Viable"/>
   <result pre="Cell Death Differ. (2009) 16:1438–44. 10.1038/cdd.2009.9619609275 40.JulkunenISarenevaTPirhonenJRonniTMelenKMatikainenS. Molecular pathogenesis of" exact="influenza" post="A virus infection and virus-induced regulation of cytokine gene"/>
   <result pre="10.1016/S1359-6101(00)00026-511325600 41.IwaiAShiozakiTMiyazakiT. Relevance of signaling molecules for apoptosis induction on" exact="influenza" post="A virus replication. Biochem Biophys Res Commun. (2013) 441:531–7."/>
   <result pre="of host cytokine responses in the pathogenesis of avian H5N1" exact="influenza" post="viruses in mice. J Virol. (2007) 81:2736–44. 10.1128/JVI.02336-0617182684 43.PeirisJSCheungCYLeungCYNichollsJMInnate"/>
   <result pre="mice. J Virol. (2007) 81:2736–44. 10.1128/JVI.02336-0617182684 43.PeirisJSCheungCYLeungCYNichollsJMInnate immune responses to" exact="influenza" post="A H5N1: friend or foe?Trends Immunol. (2009) 30:574–84. 10.1016/j.it.2009.09.00419864182"/>
   <result pre="Immunol. (2009) 30:574–84. 10.1016/j.it.2009.09.00419864182 44.GuoXJThomasPG. New fronts emerge in the" exact="influenza" post="cytokine storm. Semin Immunopathol. (2017) 39:541–50. 10.1007/s00281-017-0636-y28555383 45.HsiehINHartshornKL. The"/>
   <result pre="(2017) 39:541–50. 10.1007/s00281-017-0636-y28555383 45.HsiehINHartshornKL. The role of antimicrobial peptides in" exact="influenza" post="virus infection and their potential as antiviral and immunomodulatory"/>
   <result pre="32:4650–8. 10.1021/bi00068a0247683492 50.SieczkarskiSBBrownHAWhittakerGR. Role of protein kinase C betaII in" exact="influenza" post="virus entry via late endosomes. J Virol. (2003) 77:460–9."/>
   <result pre="of focal adhesion kinase in cytoplasmic entry and replication of" exact="influenza" post="A viruses. J Virol. (2014) 88:6714–28. 10.1128/JVI.00530-1424696469 55.ChoiMSHeoJYiCMBanJLeeNJLeeNRet al.."/>
   <result pre="protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and" exact="influenza" post="A virus replication by inhibiting virus-induced p38 MAPK activation."/>
   <result pre="56.ElbaheshHBergmannSRussellCJ. Focal adhesion kinase (FAK) regulates polymerase activity of multiple" exact="influenza" post="A virus subtypes. Virology. (2016) 499:369–74. 10.1016/j.virol.2016.10.00227743963 57.ZhangJRuanTShengTWangJSunJWangJet al.."/>
   <result pre="57.ZhangJRuanTShengTWangJSunJWangJet al.. Role of c-Jun terminal kinase (JNK) activation in" exact="influenza" post="A virus-induced autophagy and replication. Virology. (2018) 526:1–12. 10.1016/j.virol.2018.09.02030316042"/>
   <result pre="of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic" exact="avian influenza" post="virus in vitro and in vivo. Antiviral Res. (2011)"/>
   <result pre="the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian" exact="influenza" post="virus in vitro and in vivo. Antiviral Res. (2011)"/>
   <result pre="MEK inhibitors and oseltamivir leads to synergistic antiviral effects after" exact="influenza" post="A virus infection in vitro. Antiviral Res. (2013) 98:319–24."/>
   <result pre="17:5858–62. 10.1016/j.bmcl.2007.08.02217869512 65.EhrhardtCRuckleAHrinciusERHaasbachEAnhlanDAhmannKet al.. The NF-kappaB inhibitor SC75741 efficiently blocks" exact="influenza" post="virus propagation and confers a high barrier for development"/>
   <result pre="RNA synthesis and nuclear export of viral ribonucleoprotein complex upon" exact="influenza" post="virus infection. PLoS ONE. (2013) 8:e75005. 10.1371/journal.pone.007500524137500 70.CoughlinSRCamererE. PARticipation"/>
   <result pre="expression and in vivo lung function of protease-activated receptors during" exact="influenza" post="A virus infection in mice. Am J Physiol Lung"/>
   <result pre="and prophylaxis. Clin Infect Dis. (2006) 43:199–205. 10.1086/50511616779747 73.FedsonDS. Treating" exact="influenza" post="with statins and other immunomodulatory agents. Antiviral Res. (2013)"/>
   <result pre="[Experience in the management of the severe form of human" exact="influenza" post="A H1N1 pneumonia in an intensive care unit]. Cir"/>
   <result pre="management of the severe form of human influenza A H1N1" exact="pneumonia" post="in an intensive care unit]. Cir Cir. (2011) 79:409–16.22385760"/>
   <result pre="use of statins and mortality among patients hospitalized with laboratory-confirmed" exact="influenza" post="virus infections: a multistate study. J Infect Dis. (2012)"/>
   <result pre="80.HaoLSakuraiAWatanabeTSorensenENidomCANewtonMAet al.. Drosophila RNAi screen identifies host genes important for" exact="influenza" post="virus replication. Nature. (2008) 454:890–3. 10.1038/nature0715118615016 81.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The"/>
   <result pre="10.1038/nature0715118615016 81.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and dengue virus."/>
   <result pre="al.. Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature. (2010) 463:818–22. 10.1038/nature0876020081832 85.KonigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human"/>
   <result pre="(2010) 463:818–22. 10.1038/nature0876020081832 85.KonigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human host factors required for" exact="influenza" post="virus replication. Nature. (2010) 463:813–7. 10.1038/nature0869920027183 86.TrippRAMark TompkinsS. Antiviral"/>
   <result pre="88.HanJPerezJTChenCLiYBenitezAKandasamyMet al.. Genome-wide CRISPR/Cas9 screen identifies host factors essential for" exact="influenza" post="virus replication. Cell Rep. (2018) 23:596–607. 10.1016/j.celrep.2018.03.04529642015 89.LiCCWangXJWangHR. Repurposing"/>
   <result pre="23:596–607. 10.1016/j.celrep.2018.03.04529642015 89.LiCCWangXJWangHR. Repurposing host-based therapeutics to control coronavirus and" exact="influenza" post="virus. Drug Discov Today. (2019) 24:726–36. 10.1016/j.drudis.2019.01.01830711575 90.PizzornoATerrierONicolas de"/>
   <result pre="10.1016/j.drudis.2019.01.01830711575 90.PizzornoATerrierONicolas de LamballerieCJulienTPadeyBTraversierAet al.. Repurposing of drugs as novel" exact="influenza" post="inhibitors from clinical gene expression infection signatures. Front Immunol."/>
   <result pre="infection signatures. Front Immunol. (2019) 10:60. 10.3389/fimmu.2019.0006030761132 91.WangLFuBLiWPatilGLiuLDorfMEet al.. Comparative" exact="influenza" post="protein interactomes identify the role of plakophilin 2 in"/>
   <result pre="Nat Commun. (2017) 8:13876. 10.1038/ncomms1387628169297 92.AckermanEEKawakamiEKatohMWatanabeTWatanabeSTomitaYet al.. Network-guided discovery of" exact="influenza" post="virus replication host factors. MBio. (2018) 9:e02002-18. 10.1128/mBio.02002-1830563907 93.WatanabeTWatanabeSKawaokaY."/>
   <result pre="MBio. (2018) 9:e02002-18. 10.1128/mBio.02002-1830563907 93.WatanabeTWatanabeSKawaokaY. Cellular networks involved in the" exact="influenza" post="virus life cycle. Cell Host Microbe. (2010) 7:427–39. 10.1016/j.chom.2010.05.00820542247"/>
   <result pre="7:427–39. 10.1016/j.chom.2010.05.00820542247 94.de ChasseyBMeyniel-SchicklinLAublin-GexAAndrePLotteauV. Genetic screens for the control of" exact="influenza" post="virus replication: from meta-analysis to drug discovery. Mol Biosyst."/>
   <result pre="(2012) 8:1297–303. 10.1039/c2mb05416g22307679 95.TripathiSPohlMOZhouYRodriguez-FrandsenAWangGSteinDAet al.. Meta- and orthogonal integration of" exact="influenza" post="&quot;OMICs�? data defines a role for UBR4 in virus"/>
   <result pre="the T cell response to a clinically significant dose of" exact="influenza" post="virus is regulated by TRAIL.J Immunol. (2011) 187:4581–8. 10.4049/jimmunol.100224121940678"/>
   <result pre="187:4581–8. 10.4049/jimmunol.100224121940678 97.DavidsonSCrottaSMcCabeTMWackA. Pathogenic potential of interferon alphabeta in acute" exact="influenza" post="infection. Nat Commun. (2014) 5:3864. 10.1038/ncomms486424844667 98.KakkolaLDenisovaOVTynellJViiliainenJYsenbaertTMatosRCet al.. Anticancer"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6473713\results\search\disease\results.xml">
   <result pre="out of the five Darfur states. We reported the first" exact="dengue fever" post="outbreak in the Darfur region. Our results highlight the"/>
   <result pre="Darfur Sudan 1. Introduction Dengue fever (DF) is a mosquito-borne" exact="viral disease" post="caused by one of four closely-related dengue virus serotypes"/>
   <result pre="a self-limiting flu-like illness to the fatal severe form of" exact="dengue hemorrhagic fever" post="or dengue shock syndrome [1,3]. Dengue is a rapidly"/>
   <result pre="the area has recently suffered from one of the worst" exact="yellow fever" post="epidemics worldwide [25,26,27]. The outbreak of yellow fever was"/>
   <result pre="the worst yellow fever epidemics worldwide [25,26,27]. The outbreak of" exact="yellow fever" post="was influenced by the living condition in a humanitarian"/>
   <result pre="this communication, we report the first outbreak of dengue and" exact="dengue hemorrhagic fever" post="along with West Nile virus and Crimean–Congo hemorhagic fever"/>
   <result pre="case and tested for the major arboviral infectious agents of" exact="dengue fever" post="(DF), yellow fever (YF), Rift Valley fever (RVF), Crimean–Congo"/>
   <result pre="for the major arboviral infectious agents of dengue fever (DF)," exact="yellow fever" post="(YF), Rift Valley fever (RVF), Crimean–Congo Hemorrhagic Fever (CCHF),"/>
   <result pre="fever (RVF), Crimean–Congo Hemorrhagic Fever (CCHF), West Nile virus (WNV)," exact="chikungunya" post="virus (CHIKV), and Zika virus (ZIKV). Arboviral-specific enzyme-linked immunosorbent"/>
   <result pre="samples (Table 1). Molecular analysis confirmed 32 positive cases of" exact="dengue fever" post="out of the 204 (15.7%) from 11 localities in"/>
   <result pre="East Darfur (Table 1). No cases of Zika virus (ZIKV)," exact="yellow fever" post="(YF), chikungunya virus (CHIKV), or Rift Valley fever (RVF)"/>
   <result pre="1). No cases of Zika virus (ZIKV), yellow fever (YF)," exact="chikungunya" post="virus (CHIKV), or Rift Valley fever (RVF) were detected"/>
   <result pre="Discussion In this communication, we investigated the first outbreak of" exact="dengue fever" post="in the Darfur area and we confirmed the presence"/>
   <result pre="of Darfur, except East Darfur. We believe the prevalence of" exact="dengue fever" post="cases might be higher than reported here because of"/>
   <result pre="detected DENV infections presented with bleeding, suggesting the involvement of" exact="dengue hemorrhagic fever," post="one of the severe forms of the disease according"/>
   <result pre="the early 1900s [19,23,27]. Darfur has a recent history of" exact="yellow fever" post="epidemics [25,29], but DENV has only been detected in"/>
   <result pre="North Darfur, for the first time in 2014. Compared to" exact="dengue fever," post="similarly high infections of yellow fever among children and"/>
   <result pre="in 2014. Compared to dengue fever, similarly high infections of" exact="yellow fever" post="among children and young adults have recently been reported"/>
   <result pre="between infection and gender [29]. The severe clinical presentations of" exact="dengue fever" post="cases during this outbreak seems to suggest a lack"/>
   <result pre="DENV infection. Most of these cases were treated as severe" exact="malaria" post="cases, which is a common confusion in resource-limited settings"/>
   <result pre="of the population to the risk of infectious diseases, including" exact="dengue fever" post="and other arboviral infections, and made the health system"/>
   <result pre="the area, as some of those troops are coming from" exact="dengue fever" post="endemic areas [18,27]. Another possible scenario for introducing DENV"/>
   <result pre="the area is through immigrants from neighboring countries with endemic" exact="dengue fever," post="who came to work in the local gold mines"/>
   <result pre="This situation has most likely contributed to the epidemic of" exact="yellow fever" post="in the same area in 2012 [8,29,31]. One of"/>
   <result pre="of the risk factors influencing the emergence and outbreaks of" exact="dengue fever" post="in the area. Furthermore, we highlight the need to"/>
   <result pre="continuing global threatNat. Rev. Microbiol.20108S7S1610.1038/nrmicro246021079655 7.Van KleefE.BambrickH.HalesS.The geographic distribution of" exact="dengue fever" post="and the potential influence of global climate changeAvailable online:"/>
   <result pre="the Conflict in DarfurWorld Bank Econ. Rev.20102438641110.1093/wber/lhq019 29.AhmedS.S.SoghaierM.A.MohammedS.KhogaliH.S.OsmanM.M.AbdallaA.M.Concomitant outbreaks of" exact="yellow fever" post="and hepatitis E virus in Darfur States, Sudan, 2012J."/>
   <result pre="DarfurWorld Bank Econ. Rev.20102438641110.1093/wber/lhq019 29.AhmedS.S.SoghaierM.A.MohammedS.KhogaliH.S.OsmanM.M.AbdallaA.M.Concomitant outbreaks of yellow fever and" exact="hepatitis" post="E virus in Darfur States, Sudan, 2012J. Infect. Dev."/>
   <result pre="area of Greater Darfur (in the light blue color, and" exact="dengue fever" post="endemic areas in Sudan (the darker blue). Figure 2"/>
   <result pre="(the darker blue). Figure 2 Epidemic curve of the first" exact="dengue fever" post="outbreak in Greater Darfur showing the development of the"/>
   <result pre="boxes. Figure 3 Clinical presentations of the confirmed cases of" exact="dengue fever." post="tropicalmed-04-00043-t001_Table 1Table 1 Number of hemorrhagic fever suspected cases,"/>
   <result pre="1 0 0 1:0 Total 32 6 3 - DF:" exact="dengue fever;" post="WNV: West Nile virus; CCHFV: Crimean–Congo hemorrhagic fever. F:M"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6474636\results\search\disease\results.xml">
   <result pre="1 This essay focuses on the most extreme bottleneck in" exact="viral disease" post="emergence: The replication of animal viruses in their first"/>
   <result pre="human versions of the cellular receptors used by poliovirus and" exact="hepatitis" post="C viruses leads to enhanced viral infection because these"/>
   <result pre="human CD81, OCLN receptors, and lack STAT1 [38] Epstein–Barr virus/Kaposi" exact="sarcoma" post="herpesvirus Mouse Highly species specific in pathogenicity and disease"/>
   <result pre="family member A (ANP32A) is a key cofactor required for" exact="influenza" post="virus replication [55,56]. Avian influenza viruses require a mutation"/>
   <result pre="a key cofactor required for influenza virus replication [55,56]. Avian" exact="influenza" post="viruses require a mutation in their PB2 polymerase subunit"/>
   <result pre="mutation, this human transcriptional activator provides a potent block to" exact="avian influenza" post="virus replication in humans. As another example, RanBP2 is"/>
   <result pre="this human transcriptional activator provides a potent block to avian" exact="influenza" post="virus replication in humans. As another example, RanBP2 is"/>
   <result pre="Replication in Human Cells Viral Mutations that Overcome Barriera Avian" exact="influenza" post="viruses α-2,6–linked sialic acidreceptor Mutations in receptor binding site"/>
   <result pre="from bats) NPC1breceptor Mutation in viral surface glycoprotein [69–71]b Feline" exact="leukemia" post="virus APOBEC3restriction factor Not yet zoonotic (escape path not"/>
   <result pre="mosquitos or ticks Alkhumra virusBanzi virusBussuquara virusEdge Hill virusIlheus virusJapanese" exact="encephalitis" post="virusKokobera virusKoutango virusKyasanur forest disease virusLangat virusLouping-ill virusMurray Valley"/>
   <result pre="encephalitis virusKokobera virusKoutango virusKyasanur forest disease virusLangat virusLouping-ill virusMurray Valley" exact="encephalitis" post="virus Omsk hemorrhagic fever virusPowassan virusRocio virusSepik virusSpondweni virusSt."/>
   <result pre="virus Omsk hemorrhagic fever virusPowassan virusRocio virusSepik virusSpondweni virusSt. Louis" exact="encephalitis" post="virusSylvatic dengue virusTick-borne encephalitis virusUsutu virusWesselsbron virusWest Nile virusYellow"/>
   <result pre="virusPowassan virusRocio virusSepik virusSpondweni virusSt. Louis encephalitis virusSylvatic dengue virusTick-borne" exact="encephalitis" post="virusUsutu virusWesselsbron virusWest Nile virusYellow fever virusZika virus Dengue"/>
   <result pre="1–4Hepatitis C virus Orthomyxoviridaezoonotic orthomyxoviruses typically associated with birds Avian" exact="influenza" post="A viruses (multiple)Dhori virus Quaranfil virusThogoto virus Influenza A,"/>
   <result pre="HTLV, human T-lymphotropic virus; MERS, Middle East respiratory syndrome; SARS," exact="severe acute respiratory syndrome;" post="SIV, simian immunodeficiency virus; SIVcpz, SIV of chimpanzees; SIVgor,"/>
   <result pre="replication in a multiple-drug–treated host. Alarmingly, some of the H5N1" exact="influenza" post="viruses that are currently circulating in the avian reservoir"/>
   <result pre="NPC intracellular cholesterol transporter 1; PDB, Protein Data Bank; SARS," exact="severe acute respiratory syndrome;" post="TfR1, transferrin receptor 1. Box 3. Lessons in zoonosis"/>
   <result pre="spread in the new host. For instance, a less pathogenic" exact="influenza" post="virus variant that causes lower levels of inflammation and"/>
   <result pre="and increased nasal secretions, which serve as major routes for" exact="influenza" post="virus transmission. However, factors external to the virus are"/>
   <result pre="integral to transmission. If a poorly spreading virus, like the" exact="influenza" post="variant just mentioned, emerged in a densely populated megacity,"/>
   <result pre="further refinement in humans. On the other hand, if an" exact="influenza" post="virus variant arises with characteristics that make it excellent"/>
   <result pre="Ebola is that it spreads through love�? [114]. The 1918" exact="influenza" post="virus emerged during World War I and spread well"/>
   <result pre="the soldiers shown are very likely infected with the 1918" exact="influenza" post="virus at the time the photo was taken. The"/>
   <result pre="2 NPC1 NPC intracellular cholesterol transporter 1 OCLN occludin PB2" exact="influenza" post="virus polymerase PB2 PDB Protein Data Bank PVR PVR"/>
   <result pre="SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 SARS" exact="severe acute respiratory syndrome" post="SHIV SIVmac/HIV chimeric virus SIV simian immunodeficiency virus SIVcpz"/>
   <result pre="10.1093/acprof:oso/9780199207466.003.0016 2HeesterbeekH, AndersonRM, AndreasenV, BansalS, De AngelisD, DyeC, et al.Modeling" exact="infectious disease" post="dynamics in the complex landscape of global health. Science."/>
   <result pre="HorwitzJA, DonovanBM, LabittRN, BudellWC, FrilingT, et al.Completion of the entire" exact="hepatitis" post="C virus life cycle in genetically humanized mice. Nature."/>
   <result pre="MoncorgéO, FriseR, MistryB, JamesJ, et al.Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature. 2016;529: 101–104. 10.1038/nature1647426738596"/>
   <result pre="vitro assessment of attachment pattern and replication efficiency of H5N1" exact="influenza" post="A viruses with altered receptor specificity. J Virol. 2010;84:"/>
   <result pre="62LipsitchM, BarclayW, RamanR, RussellCJ, BelserJA, CobeyS, et al.Viral factors in" exact="influenza" post="pandemic risk assessment. eLife. 2016;5: 316ra19210.7554/eLife.1849127834632 63LongJS, MistryB, HaslamSM,"/>
   <result pre="316ra19210.7554/eLife.1849127834632 63LongJS, MistryB, HaslamSM, BarclayWS. Host and viral determinants of" exact="influenza" post="A virus species specificity.Nat Rev Micro. 2019;17: 67–81. 10.1038/s41579-018-0115-z30487536"/>
   <result pre="effect of the PB2 mutation 627K on highly pathogenic H5N1" exact="avian influenza" post="virus is dependent on the virus lineage. J Virol."/>
   <result pre="of the PB2 mutation 627K on highly pathogenic H5N1 avian" exact="influenza" post="virus is dependent on the virus lineage. J Virol."/>
   <result pre="66SheahanT, RockxB, DonaldsonE, SimsA, PicklesR, CortiD, et al.Mechanisms of zoonotic" exact="severe acute respiratory syndrome" post="coronavirus host range expansion in human airway epithelium. J"/>
   <result pre="SimmonsCP, ThanhTT, HienVM, SmithGJD, ChauTNB, et al.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="96DemoginesA, FarzanM, SawyerSL. Evidence for ACE2-utilizing coronaviruses (CoVs) related to" exact="severe acute respiratory syndrome" post="CoV in bats. J Virol. 2012;86: 6350–6353. 10.1128/JVI.00311-1222438550 97KaelberJT,"/>
   <result pre="2008;451: 990–993. 10.1038/nature0653618288193 116HanBA, DrakeJM. Future directions in analytics for" exact="infectious disease" post="intelligence: Toward an integrated warning system for emerging pathogens."/>
   <result pre="292–294. 10.2471/BLT.17.20500529695886 118BarryJM. The site of origin of the 1918" exact="influenza" post="pandemic and its public health implications. J Transl Med."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6476056\results\search\disease\results.xml">
   <result pre="HIV infection, even in areas with high levels of viral" exact="suppression" post="and large syringe services programs (SSPs). Investigation and Findings"/>
   <result pre="of U.S. counties with the highest risk for HIV and" exact="hepatitis" post="C virus outbreaks among persons who inject drugs (3)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6480969\results\search\disease\results.xml">
   <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract The 2009 pandemic" exact="influenza" post="virus caused the majority of the influenza A virus"/>
   <result pre="The 2009 pandemic influenza virus caused the majority of the" exact="influenza" post="A virus infections in China in 2009. It arrived"/>
   <result pre="to humans by direct body contact or respiratory droplets. The" exact="infectious disease" post="can spread widely as people carrying pathogens travel and"/>
   <result pre="people who travel daily along the interstate highways during the" exact="influenza" post="season is larger than 3.8 million, which is over"/>
   <result pre="and Foshan city in China [5]. For the highly pathogenic" exact="avian influenza," post="national highways were one of the most important predictive"/>
   <result pre="[16]. In the United States, the genetic distances between seasonal" exact="influenza" post="A (H1N1) viruses were found to correlate with the"/>
   <result pre="kilometers, and the role of this road-based travel in facilitating" exact="influenza" post="transmission should not be neglected [6]. Research on the"/>
   <result pre="be neglected [6]. Research on the spread of the 2009" exact="influenza" post="A (H1N1) virus in the Republic of Korea showed"/>
   <result pre="has been reported to partially affect the transmission of seasonal" exact="influenza" post="in U.S. cities [21]. Other socioeconomic factors like population"/>
   <result pre="unemployment were significantly associated with the mortality from the 1918" exact="influenza" post="pandemic in Chicago [19]. As for the 2009 influenza"/>
   <result pre="1918 influenza pandemic in Chicago [19]. As for the 2009" exact="influenza" post="pandemic in China, it has been suggested that the"/>
   <result pre="network and socioeconomic factors on the diffusion of the 2009" exact="influenza" post="pandemic. 2. Materials and Methods 2.1. Data The suspected"/>
   <result pre="and Methods 2.1. Data The suspected and laboratory-confirmed cases of" exact="influenza" post="A (H1N1) used in this study were obtained from"/>
   <result pre="transportation and the spatial distance to the spread of the" exact="influenza" post="virus, we used spatial autoregressive models [33] performed in"/>
   <result pre="nearly all Chinese cities had been exposed to the emerging" exact="influenza" post="virus. 3.2. Characteristics of the National Highway Network The"/>
   <result pre="traffic and other socioeconomic factors on the nationwide spread of" exact="influenza" post="A (H1N1) across China in 2009. We constructed a"/>
   <result pre="week and Multicenter Distance, we understand the transmission process of" exact="influenza" post="A (H1N1) as follows: At the very beginning, internationally"/>
   <result pre="traffic, as well as socioeconomic factors and the spread of" exact="influenza" post="A (H1N1), we conducted spatial regression analyses. When the"/>
   <result pre="significantly associated with the arrival time of the first confirmed" exact="influenza" post="A (H1N1) case in each Chinese county in 2009"/>
   <result pre="between 5–24 years old were most affected by the 2009" exact="influenza" post="A (H1N1) in China. Therefore, our positive association between"/>
   <result pre="would tend to conduct stronger intervention measures to control the" exact="infectious disease," post="reducing the cumulative incidence. When the onset week was"/>
   <result pre="be the true first person who was infected by the" exact="influenza" post="virus in a given city. It is possible that"/>
   <result pre="taken place. As the reservoir of the 2009 pandemic H1N1" exact="influenza" post="virus, pigs can carry this virus, can transmit it"/>
   <result pre="reported that school students were more susceptible to the 2009" exact="influenza" post="A (H1N1) than other age groups in China [37]"/>
   <result pre="in China [37] and that schools were high-risk areas for" exact="influenza" post="outbreaks and should be the focus for prevention [22,40]."/>
   <result pre="of road transportation in the spatial diffusion of the 2009" exact="influenza" post="A (H1N1) virus in mainland China. It has been"/>
   <result pre="is a significant factor in the global spread of the" exact="influenza" post="virus, short-range daily travel on the ground is more"/>
   <result pre="than air travel for the spatial transmission of the 2009" exact="influenza" post="A (H1N1) virus in China. Unlike some countries in"/>
   <result pre="in Europe and America which experienced two infection peaks of" exact="influenza" post="during 2009, China had only one autumn-winter wave in"/>
   <result pre="it is much more difficult to restrict the diffusion of" exact="influenza" post="virus by road travel. In this respect, the role"/>
   <result pre="not only have direct impacts on the development of an" exact="influenza" post="pandemic but also indirectly exert an influence by stimulating"/>
   <result pre="and socioeconomic factors in the face of a newly emerging" exact="influenza" post="pandemic, especially in the early stages. For instance, although"/>
   <result pre="of the percentage of respiratory specimens tested positive for the" exact="influenza" post="virus, the number of reported cases was much less"/>
   <result pre="of infected individuals [34]. It was observed globally in many" exact="influenza" post="outbreaksthat not all cases were reported to the medical"/>
   <result pre="be constructed to investigate the diffusion process of the 2009" exact="influenza" post="A (H1N1) under the effects of socioeconomic factors. 5."/>
   <result pre="factors had significant impacts on the diffusion of the 2009" exact="influenza" post="A (H1N1) virus at the city level in mainland"/>
   <result pre="should be candidates for the prevention and control of future" exact="influenza" post="pandemics. Acknowledgments We would like to thank Jun Cai,"/>
   <result pre="Rev. E Stat. Nonlinear Soft Matter Phys.20097901611110.1103/PhysRevE.79.016111 5.LiQ.CaoW.RenH.JiZ.JiangH.Spatiotemporal responses of" exact="dengue fever" post="transmission to the road network in an urban areaActa"/>
   <result pre="Transp. Eng.20055120123 9.WengW.NiS.Evaluation of containment and mitigation strategies for an" exact="influenza" post="A pandemic in ChinaSimulation20159140741610.1177/0037549715581637 10.FangL.Q.WangL.P.de VlasS.J.LiangS.TongS.L.LiY.L.LiY.P.QianQ.YangH.ZhouM.G.et al.Distribution and risk"/>
   <result pre="ChinaSimulation20159140741610.1177/0037549715581637 10.FangL.Q.WangL.P.de VlasS.J.LiangS.TongS.L.LiY.L.LiY.P.QianQ.YangH.ZhouM.G.et al.Distribution and risk factors of 2009 pandemic" exact="influenza" post="A (H1N1) in mainland ChinaAm. J. Epidemiol.201217589089710.1093/aje/kwr41122491083 11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental"/>
   <result pre="Epidemiol.201217589089710.1093/aje/kwr41122491083 11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental factors contributing to the spread of H5N1" exact="avian influenza" post="in mainland ChinaPLoS ONE20083e226810.1371/journal.pone.000226818509468 12.MeiS.ChenB.ZhuY.LeesM.H.BoukhanovskyA.V.SlootP.M.A.Simulating city-level airborne infectious diseasesComput."/>
   <result pre="11.FangL.Q.de VlasS.J.LiangS.LoomanC.W.GongP.XuB.YanL.YangH.RichardusJ.H.CaoW.C.Environmental factors contributing to the spread of H5N1 avian" exact="influenza" post="in mainland ChinaPLoS ONE20083e226810.1371/journal.pone.000226818509468 12.MeiS.ChenB.ZhuY.LeesM.H.BoukhanovskyA.V.SlootP.M.A.Simulating city-level airborne infectious diseasesComput."/>
   <result pre="Int. Health200914Suppl. 1142010.1111/j.1365-3156.2008.02189.x19508436 14.TeurlaiM.HuyR.CazellesB.DubozR.BaehrC.VongS.Can human movements explain heterogeneous propagation of" exact="dengue fever" post="in Cambodia?PLoS Negl. Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for"/>
   <result pre="Negl. Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for the highly pathogenic" exact="avian influenza" post="in Mainland China using meta-modelingChin. Sci. Bull.2010554168417810.1007/s11434-010-4225-x 16.YupianaY.de VlasS.J.AdnanN.M.RichardusJ.H.Risk"/>
   <result pre="Trop. Dis.20126e195710.1371/journal.pntd.000195723236536 15.CaoC.XuM.ChangC.XueY.ZhongS.FangL.CaoW.ZhangH.GaoM.HeQ.et al.Risk analysis for the highly pathogenic avian" exact="influenza" post="in Mainland China using meta-modelingChin. Sci. Bull.2010554168417810.1007/s11434-010-4225-x 16.YupianaY.de VlasS.J.AdnanN.M.RichardusJ.H.Risk"/>
   <result pre="VlasS.J.AdnanN.M.RichardusJ.H.Risk factors of poultry outbreaks and human cases of H5N1" exact="avian influenza" post="virus infection in West Java Province, IndonesiaInt. J. Infect."/>
   <result pre="factors of poultry outbreaks and human cases of H5N1 avian" exact="influenza" post="virus infection in West Java Province, IndonesiaInt. J. Infect."/>
   <result pre="using commuting flow for national spread of the 2009 H1N1" exact="influenza" post="virus in the Republic of KoreaJ. Biol.201845432032910.1016/j.jtbi.2018.06.01629940195 18.TianH.HuS.CazellesB.ChowellG.GaoL.LaineM.LiY.YangH.LiY.YangQ.et al.Urbanization"/>
   <result pre="hantavirus epidemics in citiesProc. Natl. Acad. Sci. USA20181154707471210.1073/pnas.171276711529666240 19.GrantzK.H.RaneM.S.SaljeH.GlassG.E.SchachterleS.E.CummingsD.A.Disparities in" exact="influenza" post="mortality and transmission related to sociodemographic factors within Chicago"/>
   <result pre="of 1918Proc. Natl. Acad. Sci. USA2016113138391384410.1073/pnas.161283811327872284 20.WangL.WangJ.XuC.LiuT.Modelling input-output flows of" exact="severe acute respiratory syndrome" post="in mainland ChinaBMC Public Health20161619110.1186/s12889-016-2867-626924026 21.DalzielB.D.KisslerS.GogJ.R.ViboudC.BjørnstadO.N.MetcalfC.J.E.GrenfellB.T.Urbanization and humidity shape"/>
   <result pre="ChinaBMC Public Health20161619110.1186/s12889-016-2867-626924026 21.DalzielB.D.KisslerS.GogJ.R.ViboudC.BjørnstadO.N.MetcalfC.J.E.GrenfellB.T.Urbanization and humidity shape the intensity of" exact="influenza" post="epidemics in U.S. citiesScience2018362757910.1126/science.aat603030287659 22.XiaoH.LinX.ChowellG.HuangC.GaoL.ChenB.WangZ.ZhouL.HeX.LiuH.Urban structure and the risk"/>
   <result pre="epidemics in U.S. citiesScience2018362757910.1126/science.aat603030287659 22.XiaoH.LinX.ChowellG.HuangC.GaoL.ChenB.WangZ.ZhouL.HeX.LiuH.Urban structure and the risk of" exact="influenza" post="A(H1N1) outbreaks in municipal districtsSci. Bull.20145955456210.1007/s11434-013-0084-6 23.MATLAB and Statistics"/>
   <result pre="flowsJ. Reg. Sci.20104894196710.1111/j.1467-9787.2008.00573.x 34.Cui-LingX.U.SunS.H.ZhangY.P.ShiJ.H.XiangN.J.WangL.J.YuanF.ChenM.ChenT.YangJ.Epidemiological characteristics of confirmed cases of pandemic" exact="influenza" post="A(H1N1) 2009 in mainland China, 2009-2010Dis. Surveill.201126780784 35.LeeS.S.WongN.S.The clustering"/>
   <result pre="China, 2009-2010Dis. Surveill.201126780784 35.LeeS.S.WongN.S.The clustering and transmission dynamics of pandemic" exact="influenza" post="A (H1N1) 2009 cases in Hong KongJ. Infect.20116327428010.1016/j.jinf.2011.03.01121601284 36.TellierR.Aerosol"/>
   <result pre="(H1N1) 2009 cases in Hong KongJ. Infect.20116327428010.1016/j.jinf.2011.03.01121601284 36.TellierR.Aerosol transmission of" exact="influenza" post="A virus: A review of new studiesJ. R. Soc."/>
   <result pre="dynamics, border entry screening, and school holidays during the 2009" exact="influenza" post="A (H1N1) pandemic, ChinaEmerg. Infect. Dis.20121875876610.3201/eid1805.11035622515989 38.HolmesE.C.GrenfellB.T.Discovering the phylodynamics"/>
   <result pre="Biol.20095e100050510.1371/journal.pcbi.100050519855824 39.BootsmaM.C.J.FergusonN.M.The effect of public health measures on the 1918" exact="influenza" post="pandemic in U.S. citiesProc. Natl. Acad. Sci. USA20071047588759310.1073/pnas.061107110417416677 40.CauchemezS.FergusonN.M.WachtelC.TegnellA.SaourG.DuncanB.NicollA.Closure"/>
   <result pre="citiesProc. Natl. Acad. Sci. USA20071047588759310.1073/pnas.061107110417416677 40.CauchemezS.FergusonN.M.WachtelC.TegnellA.SaourG.DuncanB.NicollA.Closure of schools during an" exact="influenza" post="pandemicLancet Infect. Dis.2009947348110.1016/S1473-3099(09)70176-819628172 41.CaiJ.XuB.ChanK.K.Y.ZhangX.ZhangB.ChenZ.XuB.Roles of Different Transport Modes in"/>
   <result pre="labeled with their names. Figure 2 The development of the" exact="influenza" post="pandemic in mainland China in 2009: (a) The weekly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6489371\results\search\disease\results.xml">
   <result pre="Oswaldo Cruz201811310e18027830427974 2NunesMRTPalaciosGCardosoJFMartinsLCSousaECde LimaCPSet al.Genomic and phylogenetic characterization of Brazilian" exact="yellow fever" post="virus strainsJ Virol132201986241326313271http://www.ncbi.nlm.nih.gov/pubmed/23015713 3MirDDelatorreEBonaldoMLourenço-de-OliveiraRVicenteACBelloGPhylodynamics of Yellow Fever virus in"/>
   <result pre="Dis2017119127 44MondetBVasconcelosPFCTravassos da RosaAPATravassos da RosaESRodriguesSGTravassos da RosaJFSet al.Isolation of" exact="yellow fever" post="virus from Nulliparous Haemagogus (Haemagogus) janthinomys in Eastern Amazonia0922019214750http://www.ncbi.nlm.nih.gov/pubmed/12656130"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6502353\results\search\disease\results.xml">
   <result pre="environments through changes in its viral genome. Using as model" exact="chikungunya" post="virus, which had explosively spread in the Americas and"/>
   <result pre="initiate and modulate antiviral immunity [42] and (ii) Eastern equine" exact="encephalitis" post="virus (EEEV) contains at its 3’UTR a binding site"/>
   <result pre="evidence of alphavirus recombination is the emergence of Western equine" exact="encephalitis" post="virus (WEEV), which arose from a recombination event between"/>
   <result pre="(WEEV), which arose from a recombination event between Eastern equine" exact="encephalitis" post="virus (EEEV) and a Sindbis-like virus. Also, RNA recombination"/>
   <result pre="359–364. 9444021 11LanciottiRS, ValadereAM (2014) Transcontinental movement of Asian genotype" exact="chikungunya" post="virus. Emerg Infect Dis20: 1400–1402. 10.3201/eid2008.14026825076384 12FredericksAC, Fernandez-SesmaA (2014)"/>
   <result pre="1400–1402. 10.3201/eid2008.14026825076384 12FredericksAC, Fernandez-SesmaA (2014) The burden of dengue and" exact="chikungunya" post="worldwide: implications for the southern United States and California."/>
   <result pre="California. Ann Glob Health80: 466–475. 10.1016/j.aogh.2015.02.00625960096 13WeaverSC (2014) Arrival of" exact="chikungunya" post="virus in the new world: prospects for spread and"/>
   <result pre="10.1016/j.jmoldx.2012.10.00423313361 15TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS (2007) A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog3:"/>
   <result pre="EastmondB, VelezD, LounibosLP, et al. (2017) Transmission risk of two" exact="chikungunya" post="lineages by invasive mosquito vectors from Florida and the"/>
   <result pre="Comparative analysis of the genome sequences and replication profiles of" exact="chikungunya" post="virus isolates within the East, Central and South African"/>
   <result pre="TsetsarkinKA, AdamsAP, GarciaTI, et al. (2010) Genome-scale phylogenetic analyses of" exact="chikungunya" post="virus reveal independent emergences of recent epidemics and various"/>
   <result pre="al. (2017) First report of naturally infected Aedes aegypti with" exact="chikungunya" post="virus genotype ECSA in the Americas. PLoS Negl Trop"/>
   <result pre="(2009) Epistatic roles of E2 glycoprotein mutations in adaption of" exact="chikungunya" post="virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS"/>
   <result pre="Hyg95: 894–896. 10.4269/ajtmh.16-032327402518 64Villamil-GomezWE, Gonzalez-CamargoO, Rodriguez-AyubiJ, Zapata-SerpaD, Rodriguez-MoralesAJ (2016) Dengue," exact="chikungunya" post="and Zika co-infection in a patient from Colombia. J"/>
   <result pre="Soares MagalhaesRJ, ClementsAC, et al. (2016) Co-distribution and co-infection of" exact="chikungunya" post="and dengue viruses. BMC Infect Dis16: 8410.1186/s12879-016-1417-226936191 66JainJ, DubeySK,"/>
   <result pre="Res Commun492: 608–616. 10.1016/j.bbrc.2017.02.00828189673 67CoffeyLL, VignuzziM (2011) Host alternation of" exact="chikungunya" post="virus increases fitness while restricting population diversity and adaptability"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6504036\results\search\disease\results.xml">
   <result pre="accuracy of a rapid RT-PCR assay for point-of-care detection of" exact="influenza" post="A/B virus at emergency department admission: A prospective evaluation"/>
   <result pre="at emergency department admission: A prospective evaluation during the 2017/2018" exact="influenza" post="season Rapid RT-PCR assay to detect influenza A/B in"/>
   <result pre="during the 2017/2018 influenza season Rapid RT-PCR assay to detect" exact="influenza" post="A/B in the emergency department http://orcid.org/0000-0002-4301-4213MaignanMaximeConceptualizationData curationFormal analysisFunding acquisitionInvestigationMethodologyProject"/>
   <result pre="this study and are currently working outside the field of" exact="influenza" post="diagnosis or treatment. MM and DV received a grant"/>
   <result pre="investigate the performance of a rapid RT-PCR assay to detect" exact="influenza" post="A/B at emergency department admission. Methods This single-center prospective"/>
   <result pre="Rapid RT-PCR assay performed by nurses at triage to detect" exact="influenza" post="A/B is feasible and highly accurate. Funding Roche Diagnosticshttp://orcid.org/0000-0002-4301-4213MaignanMaxime"/>
   <result pre="department stay lengths, bed use and premature patient departures during" exact="influenza" post="epidemics.[3–5] During influenza epidemics, the management of patients attending"/>
   <result pre="bed use and premature patient departures during influenza epidemics.[3–5] During" exact="influenza" post="epidemics, the management of patients attending the emergency department"/>
   <result pre="assess the diagnostic accuracy of a rapid RT-PCR assay for" exact="influenza" post="A/B by nurses at a triage point of care."/>
   <result pre="The study took place in January 2018, when the 2017/2018" exact="influenza" post="season was at its peak. All patients were screened"/>
   <result pre="results from the triage assay. At triage, the Roche cobas" exact="influenza" post="A/B Nucleic Acid test, a Clinical Laboratory Improvement Amendments"/>
   <result pre="RT-PCR assay (cobas Liat system) performed at triage to detect" exact="influenza" post="A/B, therefore RSV detection was not evaluated. The primary"/>
   <result pre="the diagnostic accuracy of the rapid RT-PCR assay to detect" exact="influenza" post="A/B, including sensitivity, specificity and the negative and positive"/>
   <result pre="RT-PCR performed in the department of virology using the Human" exact="influenza" post="A/B PCR kit—R-DiaFlu (Diagenode Diagnostics, Ougrée, Belgium) was considered"/>
   <result pre="a sample was also sent for analysis to the national" exact="influenza" post="virus reference center (Centre National de Référence du Virus"/>
   <result pre="the estimation that 45% of samples would be positive to" exact="influenza" post="A or B, a sample size of 173 patients"/>
   <result pre="(52%) patients: 28 (15%) patients had a positive result for" exact="influenza" post="A, 44 (24%) patients had a positive result for"/>
   <result pre="influenza A, 44 (24%) patients had a positive result for" exact="influenza" post="B and 25 (13%) patients had a positive result"/>
   <result pre="laboratory assay results. Of these three, two positive results for" exact="influenza" post="A at triage were found to be negative in"/>
   <result pre="national reference center. The third result discrepancy was a negative" exact="influenza" post="B triage result that was found to be positive"/>
   <result pre="rapid RT-PCR assay at triage had a global sensitivity for" exact="influenza" post="A/B of 0.98 (95% CI: 0.91–1.00) and a specificity"/>
   <result pre="(IQR: 35–42). Discussion This study demonstrated that the detection of" exact="influenza" post="A/B virus using rapid RT-PCR assay at triage performed"/>
   <result pre="specificity of the cobas Liat system for the detection of" exact="influenza" post="A/B was higher than 0.98, even when performed by"/>
   <result pre="Direct comparison of rapid molecular tests for the detection of" exact="influenza" post="was carried out under laboratory conditions using samples from"/>
   <result pre="further studies are necessary to assess the clinical impact of" exact="influenza" post="RT-PCR assay at triage in order to evaluate its"/>
   <result pre="[36,38] and antiviral treatment [37], especially for patients with an" exact="influenza" post="negative diagnosis, highlighting the importance of tests that have"/>
   <result pre="had several limitations. First, the percentage of positive results for" exact="influenza" post="was lower than that anticipated in the sample size"/>
   <result pre="be noted that the results may differ slightly depending on" exact="influenza" post="strains and epidemics. Third, this study was conducted in"/>
   <result pre="department were not included. Not all patients who actually have" exact="influenza" post="have fever, particularly older people, which may have led"/>
   <result pre="has the potential to dramatically improve patient care during seasonal" exact="influenza" post="epidemics. This study demonstrated the feasibility and the high"/>
   <result pre="and the high accuracy of rapid RT-PCR assay to detect" exact="influenza" post="A/B when performed by trained nurses at triage. Further"/>
   <result pre="Australas. 2018;30(1):77–80. 10.1111/1742-6723.1280828544364 4SchanzerDL, SchwartzB. Impact of seasonal and pandemic" exact="influenza" post="on emergency department visits, 2003–2010, Ontario, Canada. Acad Emerg"/>
   <result pre="10.1111/acem.1211123701347 5BeysardN, YersinB, MeylanP, HugliO, CarronP-N. Impact of the 2014–2015" exact="influenza" post="season on the activity of an academic emergency department."/>
   <result pre="J Emerg Med. 2016;50(3):536–42. 10.1016/j.jemermed.2015.10.01326763858 7Esteve-EsteveM, Bautista-RenteroD, Zanón-ViguerV. Risk of" exact="influenza" post="transmission in a hospital emergency department during the week"/>
   <result pre="8ChuHY, EnglundJA, HuangD, ScottE, ChanJD, JainR, et al.Impact of rapid" exact="influenza" post="PCR testing on hospitalization and antiviral use: A retrospective"/>
   <result pre="NEAR isothermal nucleic acid amplification assay for the detection of" exact="influenza" post="using adult nasopharyngeal specimens. J Clin Virol. 2017;94:86–90. 10.1016/j.jcv.2017.07.01228772170"/>
   <result pre="17MelchersWJG, KuijpersJ, SicklerJJ, Rahamat-LangendoenJ. Lab-in-a-tube: Real-time molecular point-of-care diagnostics for" exact="influenza" post="A and B using the cobas Liat system. J"/>
   <result pre="Flu PCR test and the OSOM immunochromatographic rapid test for" exact="influenza" post="A and B virus among adult patients in the"/>
   <result pre="&amp;amp; B point of care test for the diagnosis of" exact="influenza" post="in an ED. Am J Emerg Med. 2018;36(6):916–21. 10.1016/j.ajem.2017.10.04629137903"/>
   <result pre="ChoiSH, LimCS. The use of saliva specimens for detection of" exact="influenza" post="A and B viruses by rapid influenza diagnostic tests."/>
   <result pre="for detection of influenza A and B viruses by rapid" exact="influenza" post="diagnostic tests. J Virol Methods. 2017;243:15–19. 10.1016/j.jviromet.2017.01.01328111058 30ValentinT, KieslingerP,"/>
   <result pre="et al.Prospective evaluation of three rapid molecular tests for seasonal" exact="influenza" post="in patients presenting at an emergency unit. J Clin"/>
   <result pre="PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of" exact="influenza" post="virus infection. Clin Microbiol Infect. 2018. 33YoungsJ, IqbalY, GlassS,"/>
   <result pre="GlassS, RileyP, PopeC, PlancheT, et al.Implementation of the cobas Liat" exact="influenza" post="point-of-care test into an emergency department during a high-incidence"/>
   <result pre="HarterK. An intervention to improve compliance with transmission precautions for" exact="influenza" post="in the emergency department: successes and challenges. J Emerg"/>
   <result pre="201914 37YoungsJ, MarshallB, FarragherM, WhitneyL, GlassS, PopeC, et al.Implementation of" exact="influenza" post="point-of-care testing and patient cohorting during a high-incidence season:"/>
   <result pre="RashidH, BooyR. Emergence of oseltamivir resistance: control and management of" exact="influenza" post="before, during and after the pandemic. Infect Disord Drug"/>
   <result pre="2013;13(1):34–45. 23675925 41HussainM, GalvinHD, HawTY, NutsfordAN, HusainM. Drug resistance in" exact="influenza" post="A virus: the epidemiology and management. Infect Drug Resist."/>
   <result pre="42MontoAS, GravensteinS, ElliottM, ColopyM, SchweinleJ. Clinical signs and symptoms predicting" exact="influenza" post="infection. Arch Intern Med. 2000;160(21):3243–7. 11088084"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6504110\results\search\disease\results.xml">
   <result pre="to 86 countries [7], and is a documented cause of" exact="microcephaly" post="in infants when transmitted vertically from an infected mother"/>
   <result pre="is often similar; undifferentiated fever, headache, nausea/vomiting, persistent myalgia/arthralgia, and" exact="rash" post="[11]. Although PCR assays that can discriminate between these"/>
   <result pre="emergence of arthropod-borne viral diseases: A global prospective on dengue," exact="chikungunya" post="and zika fevers. Acta Trop166: 155–163. 10.1016/j.actatropica.2016.11.02027876643 12FayeO, FayeO,"/>
   <result pre="10.1128/JCM.01734-0617135444 16TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS (2007) A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog3:"/>
   <result pre="et al. (2011) Genomic polymorphism of the pandemic A (H1N1)" exact="influenza" post="viruses correlates with viral replication, virulence, and pathogenicity in"/>
   <result pre="222D/G polymorphism facilitates fast intra-host evolution of pandemic (H1N1) 2009" exact="influenza" post="A viruses. PLoS One9: e10423310.1371/journal.pone.010423325162520 20MateoR, MateuMG (2007) Deterministic,"/>
   <result pre="VerhelstJ, VuylstekeM, SaelensX (2015) Analysis of the genetic diversity of" exact="influenza" post="A viruses using next-generation DNA sequencing. BMC Genomics16: 7910.1186/s12864-015-1284-z25758772"/>
   <result pre="Rodriguez-MoralesAJ, Uribe-GarciaAM, Gonzalez-ArismendyE, CastellanosJE, et al. (2016) Zika, dengue, and" exact="chikungunya" post="co-infection in a pregnant woman from Colombia. Int J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6514027\results\search\disease\results.xml">
   <result pre="several important human viral pathogens, including human immunodeficient virus (HIV)," exact="hepatitis" post="B virus (HBV), hepatitis C virus (HCV), Kaposi’s sarcoma-associated"/>
   <result pre="pathogens, including human immunodeficient virus (HIV), hepatitis B virus (HBV)," exact="hepatitis" post="C virus (HCV), Kaposi’s sarcoma-associated herpesvirus (KSHV), Coronaviruses, flaviviruses,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6514695\results\search\disease\results.xml">
   <result pre="virus and dengue virus), togaviruses (Chikungunya virus and Mayaro virus)," exact="influenza" post="virus, human immunodeficiency virus, and hepatitis B virus. This"/>
   <result pre="virus and Mayaro virus), influenza virus, human immunodeficiency virus, and" exact="hepatitis" post="B virus. This review will describe some of the"/>
   <result pre="the extract possesses potent antiviral activities against numerous viruses, particularly" exact="hepatitis" post="C virus (HCV). Consequently, silymarin is the most commonly"/>
   <result pre="the European Medicines Agency (EMA) for the prevention of recurrent" exact="hepatitis" post="C in liver transplant recipients in 2010 [5]. To"/>
   <result pre="are (+)ssRNA viruses that include important human pathogens such as" exact="hepatitis" post="C virus (HCV) and dengue virus (DENV). HCV is"/>
   <result pre="C) that can lead to end-stage liver diseases such as" exact="cirrhosis" post="and hepatocellular carcinoma (HCC) [6]. DENV, on the other"/>
   <result pre="can lead to end-stage liver diseases such as cirrhosis and" exact="hepatocellular carcinoma" post="(HCC) [6]. DENV, on the other hand, is the"/>
   <result pre="DENV, on the other hand, is the etiologic agent of" exact="dengue fever" post="(DF) and the more severe dengue hemorrhagic fever (DHF)"/>
   <result pre="etiologic agent of dengue fever (DF) and the more severe" exact="dengue hemorrhagic fever" post="(DHF) and dengue shock syndrome (DSS), which are fatal"/>
   <result pre="significant cytotoxicity. Further examination revealed that the silymarin-mediated inhibition of" exact="influenza" post="replication occurred through inhibition of late mRNA synthesis. However,"/>
   <result pre="whether or not silymarin could modulate other phases of the" exact="influenza" post="life cycle was not investigated. The other study that"/>
   <result pre="al. [23]. Due to the importance of autophagy in promoting" exact="influenza" post="replication, these authors elegantly designed a bimolecular fluorescence complementation-fluorescence"/>
   <result pre="IAV replication as well as several physiological processes induced by" exact="influenza" post="replication, such as oxidative stress and the activation of"/>
   <result pre="the HeLa cell line TZM-bl, PBMCs, and the human T" exact="lymphoblastic leukemia" post="cell line CME in vitro. Mechanistic studies revealed that"/>
   <result pre="HeLa cell line TZM-bl, PBMCs, and the human T lymphoblastic" exact="leukemia" post="cell line CME in vitro. Mechanistic studies revealed that"/>
   <result pre="year due to the HBV-associated end-stage liver diseases such as" exact="cirrhosis" post="and HCC [30]. Although effective vaccines against the virus"/>
   <result pre="contrast, silymarin treatment could not block the progression of established" exact="cancer" post="in mice and had no significant effect on the"/>
   <result pre="we review the antiviral effect of silymarin-associated drugs in chronic" exact="hepatitis" post="C, liver transplantation, and difficult-to-treat HIV/HCV coinfected patients. 3.1."/>
   <result pre="of silymarin or its component silibinin in patients with chronic" exact="hepatitis" post="C. Oral administration of silymarin capsules ranging from 140"/>
   <result pre="treatment dose-dependently and continuously decreased HCV viral load in chronic" exact="hepatitis" post="C patients who were previously non-responders to the Peg-IFN+RBV"/>
   <result pre="Following Ferenci’s study, Biermer et al. also reported a successful" exact="suppression" post="of HCV viremia to undetectable level in a Peg-IFN+RBV"/>
   <result pre="IFN-containing treatments. 3.2. Liver Transplantation in Hepatitis C HCV-associated liver" exact="cirrhosis" post="and HCC are common indications for liver transplantation. The"/>
   <result pre="volunteers [62]. The recent phase II trial demonstrated in chronic" exact="hepatitis" post="C patients who received silymarin capsules that serum level"/>
   <result pre="which likely affected the efficacy outcome of the drug against" exact="hepatitis" post="C [35]. The above factors contribute to the poor"/>
   <result pre="most clinical trials and case studies, including those against chronic" exact="hepatitis" post="C and HIV/HCV coinfection, employed the more water-soluble salt-derivatives"/>
   <result pre="accumulation in the liver highlight an advantage for application against" exact="viral hepatitis," post="including hepatitis C, and underscores its potency for further"/>
   <result pre="liver highlight an advantage for application against viral hepatitis, including" exact="hepatitis" post="C, and underscores its potency for further development as"/>
   <result pre="hepatoprotective and antiviral activity makes them ideal candidates, particularly for" exact="hepatitis" post="C with the greatest number of preclinical and clinical"/>
   <result pre="a potential treatment strategy, particularly for the treatment of chronic" exact="viral hepatitis." post="Further research to improve the bioavailability, delivery, as well"/>
   <result pre="https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu310828(accessed on 23 March 2019) 6.AlterH.J.SeeffL.B.Recovery, persistence, and sequelae in" exact="hepatitis" post="C virus infection: A perspective on long-term outcomeSemin. Liver"/>
   <result pre="long-term outcomeSemin. Liver Dis.200020173510895429 7.FrancoL.PalaciosG.MartinezJ.A.VázquezA.SavjiN.De OryF.Sanchez-SecoM.P.MartínD.LipkinW.I.TenorioA.First report of sylvatic DENV-2-associated" exact="dengue hemorrhagic fever" post="in West AfricaPLoS Negl. Trop. Dis.20115e125110.1371/journal.pntd.000125121829739 8.PolyakS.J.MorishimaC.ShuhartM.C.WangC.C.LiuY.LeeD.Y.Inhibition of T-Cell"/>
   <result pre="of Hepatitis C Virus RNA-Dependent RNA PolymeraseGastroenterology20101381112112210.1053/j.gastro.2009.11.05319962982 12.BlaisingJ.LévyP.L.GondeauC.PhelipC.VarbanovM.TeissierE.RuggieroF.PolyakS.J.OberliesN.H.IvanovicT.et al.Silibinin inhibits" exact="hepatitis" post="C virus entry into hepatocytes by hindering clathrin-dependent traffickingCell."/>
   <result pre="into hepatocytes by hindering clathrin-dependent traffickingCell. Microbiol.2013151866188210.1111/cmi.1215523701235 13.Esser-NobisK.Romero-BreyI.GantenT.M.GouttenoireJ.HarakC.KleinR.SchemmerP.BinderM.SchnitzlerP.MoradpourD.et al.Analysis of" exact="hepatitis" post="C virus resistance to Silibinin in vitro and in"/>
   <result pre="silybin fatty acid conjugatesEur. J. Med. Chem.2010451059106710.1016/j.ejmech.2009.11.05620036447 22.SongJ.ChoiH.Silymarin efficacy against" exact="influenza" post="A virus replicationPhytomedicine20111883283510.1016/j.phymed.2011.01.02621377857 23.DaiJ.-P.WuL.-Q.LiR.ZhaoX.-F.WanQ.-Y.ChenX.-X.LiW.-Z.WangG.-F.LiK.-S.Identification of 23-(S)-2-Amino-3-Phenylpropanoyl-Silybin as an Antiviral"/>
   <result pre="its association with enhancement of phase II enzymes: Implications in" exact="cancer" post="chemopreventionCarcinogenesis1999202101210810.1093/carcin/20.11.210110545412 25.RoeB.HallW.W.Cellular and molecular interactions in coinfection with hepatitis"/>
   <result pre="in cancer chemopreventionCarcinogenesis1999202101210810.1093/carcin/20.11.210110545412 25.RoeB.HallW.W.Cellular and molecular interactions in coinfection with" exact="hepatitis" post="C virus and human immunodeficiency virusExpert Rev. Mol. Med.2008101010.1017/S1462399408000847"/>
   <result pre="on cellular metabolismVirology20144499610310.1016/j.virol.2013.11.00324418542 28.LaniR.HassandarvishP.ChiamC.W.MoghaddamE.ChuJ.J.H.RausaluK.MeritsA.HiggsS.VanLandinghamD.Abu BakarS.et al.Antiviral activity of silymarin against" exact="chikungunya" post="virusSci. Rep.201551142110.1038/srep1142126078201 29.CaminiF.C.Da SilvaT.F.CaetanoC.C.D.S.AlmeidaL.T.FerrazA.C.VitoretiV.M.A.SilvaB.D.M.SilvaS.D.Q.De MagalhãesJ.C.MagalhãesC.L.D.B.Antiviral activity of silymarin against"/>
   <result pre="American ParentsJ. Immigr. Minor. Heal.20172094395010.1007/s10903-017-0609-128639095 31.UmetsuT.InoueJ.KogureT.KakazuE.NinomiyaM.IwataT.TakaiS.NakamuraT.SanoA.ShimosegawaT.Inhibitory effect of silibinin on" exact="hepatitis" post="B virus entryBiochem. Biophys. Rep.201814202510.1016/j.bbrep.2018.03.00329872730 32.WuY.-F.FuS.-L.KaoC.-H.YangC.-W.LinC.-H.HsuM.-T.TsaiT.-F.Chemopreventive Effect of Silymarin"/>
   <result pre="MiceCancer Res.2008682033204210.1158/0008-5472.CAN-07-245018339886 33.TanamlyM.TadrosF.LabeebS.MakldH.MikhailN.Abdel-HamidM.ShehataM.Abu-BakiL.MedhatA.MagderL.et al.Randomised double-blinded trial evaluating silymarin for chronic" exact="hepatitis" post="C in an Egyptian village: Study description and 12-month"/>
   <result pre="description and 12-month resultsDig. Liver Dis.20043675275910.1016/j.dld.2004.06.01515571006 34.GabbayE.ZigmondE.PappoO.HemedN.RoweM.ZabreckyG.CohenR.IlanY.Antioxidant therapy for chronic" exact="hepatitis" post="C after failure of interferon: Results of phase II"/>
   <result pre="trialWorld J. Gastroenterol.2007135317532310.3748/wjg.v13.i40.531717879400 35.FriedM.W.NavarroV.J.AfdhalN.BelleS.H.WahedA.S.HawkeR.L.DooE.MeyersC.M.ReddyK.R.SilymarinN.et al.Effect of silymarin (milk thistle) on" exact="liver disease" post="in patients with chronic hepatitis C unsuccessfully treated with"/>
   <result pre="silymarin (milk thistle) on liver disease in patients with chronic" exact="hepatitis" post="C unsuccessfully treated with interferon therapy: A randomized controlled"/>
   <result pre="al.Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic" exact="hepatitis" post="C treated with pegylated interferon alpha and ribavirinAm. J."/>
   <result pre="39.FerenciP.ScherzerT.M.KerschnerH.RutterK.BeinhardtS.HoferH.Schöniger–HekeleM.HolzmannH.Steindl–MundaP.Silibinin is a potent antiviral agent in patients with chronic" exact="hepatitis" post="C not responding to pegylated interferon/ribavirin therapyGastroenterology20081351561156710.1053/j.gastro.2008.07.07218771667 40.GuedjJ.DahariH.PohlR.-T.FerenciP.PerelsonA.S.Understanding silibinin’s"/>
   <result pre="RecipientsAvailable online: https://www.uptodate.com/contents/hepatitis-c-virus-infection-in-liver-transplant-candidates-and-recipients(accessed on 10 March 2019) 46.NeumannU.BiermerM.EurichD.NeuhausP.BergT.Successful prevention of" exact="hepatitis" post="C virus (HCV) liver graft reinfection by silibinin mono-therapyJ."/>
   <result pre="infection after orthotopic liver transplantation in a patient with chronic" exact="hepatitis" post="CJ. Hepatol.20115459159210.1016/j.jhep.2010.09.00921106270 48.EurichD.BahraM.BergT.Boas-KnoopS.BiermerM.NeuhausR.NeuhausP.NeumannU.Treatment of hepatitis C-virus-reinfection after liver transplant"/>
   <result pre="in a patient with chronic hepatitis CJ. Hepatol.20115459159210.1016/j.jhep.2010.09.00921106270 48.EurichD.BahraM.BergT.Boas-KnoopS.BiermerM.NeuhausR.NeuhausP.NeumannU.Treatment of" exact="hepatitis" post="C-virus-reinfection after liver transplant with silibinin in nonresponders to"/>
   <result pre="with silibinin, pegylated interferon and ribavirin in a patient with" exact="hepatitis" post="C virus genotype 3 reinfection after liver transplantation: A"/>
   <result pre="Nanosci. Nanotechnol.2012122022202710.1166/jnn.2012.517322755015 76.PolyakS.J.FerenciP.PawlotskyJ.M.Hepatoprotective and antiviral functions of silymarin components in" exact="hepatitis" post="C virus infectionHepatology2013571262127110.1002/hep.2617923213025 Figure 1 Chemical structures of silibinin,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6515236\results\search\disease\results.xml">
   <result pre="A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 9.CauchemezS.BesnardM.BompardP.DubT.Guillemette-ArturP.Eyrolle-GuignotD.SaljeH.Van KerkhoveM.D.AbadieV.GarelC.et al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013–15: A retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-626993883 10.ChenJ.LiangY.YiP.XuL.HawkinsH.K.RossiS.L.SoongL.CaiJ.MenonR.SunJ.Outcomes of"/>
   <result pre="of dengue virus by curcuminoidsAntivir. Res2019162717810.1016/j.antiviral.2018.12.00230529358 25.MounceB.C.CesaroT.CarrauL.ValletT.VignuzziM.Curcumin inhibits Zika and" exact="chikungunya" post="virus infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 26.SharmaN.MuraliA.SinghS.K.GiriR.Epigallocatechin gallate,"/>
   <result pre="and antioxidant activitiesJ. Ethnopharmacol.200495192610.1016/j.jep.2004.05.02315374602 40.CallandN.AlbeckaA.BelouzardS.WychowskiC.DuverlieG.DescampsV.HoberD.DubuissonJ.RouilléY.SéronK.(−)-Epigallocatechin-3-gallate is a new inhibitor of" exact="hepatitis" post="C virus entryHepatology20125572072910.1002/hep.2480322105803 41.CallandN.SahucM.-E.BelouzardS.PèneV.BonnafousP.MesalamA.A.DeloisonG.DescampsV.SahpazS.WychowskiC.et al.Polyphenols Inhibit Hepatitis C Virus"/>
   <result pre="ActionJ. Virol.201589100531006310.1128/JVI.01473-1526202241 42.WeberC.SlivaK.Von RheinC.KümmererB.M.SchnierleB.S.The green tea catechin, epigallocatechin gallate inhibits" exact="chikungunya" post="virus infectionAntivir. Res.20151131310.1016/j.antiviral.2014.11.00125446334 43.YamaguchiK.HondaM.IkigaiH.HaraY.ShimamuraT.Inhibitory effects of (−)-epigallocatechin gallate on"/>
   <result pre="44.YangZ.-F.BaiL.-P.HuangW.-B.LiX.-Z.ZhaoS.-S.ZhongN.-S.JiangZ.-H.Comparison of in vitro antiviral activity of tea polyphenols against" exact="influenza" post="A and B viruses and structure–activity relationship analysisFitoterapia201493475310.1016/j.fitote.2013.12.01124370660 45.AraújoS.D.S.FernandesT.C.C.CardonaY.T.AlmeidaP.M.D.Marin-MoralesM.A.Dos"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6517316\results\search\disease\results.xml">
   <result pre="(http://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Acute lower respiratory tract infections (ALRTI) such as" exact="pneumonia" post="and bronchiolitis are major causes of mortality and morbidity"/>
   <result pre="Acute lower respiratory tract infections (ALRTI) such as pneumonia and" exact="bronchiolitis" post="are major causes of mortality and morbidity in children"/>
   <result pre="each year in developing countries. Among these ALRTI, acute viral" exact="bronchiolitis" post="remains a major public health problem, affecting millions of"/>
   <result pre="2009 [3]. The majority of these deaths are due to" exact="pneumonia" post="[4]. Table 1 Positivity rate by age [alt-text] Table"/>
   <result pre="risk factors (very young age, prematurity) or comorbidity (heart disease," exact="neuromuscular disease," post="severe malnutrition) may have constituted hospitalization criteria. We sought"/>
   <result pre="by nasal or nasopharyngeal aspiration for the following respiratory viruses:" exact="influenza" post="virus, RSV, coronavirus, adenovirus, rhinovirus, metapneumovirus and parainfluenza viruses"/>
   <result pre="and stored at 4°C until it was sent to the" exact="influenza" post="and respiratory virus laboratory of the Pasteur Institute in"/>
   <result pre="of 450 μL was tested for the presence of the" exact="influenza" post="virus, then for RSV and HMPV. Another aliquot was"/>
   <result pre="the proportion of children in whom the following were identified:" exact="influenza" post="virus, RSV, rhinovirus, coronavirus, adenovirus, HMPV and parainfluenza virus."/>
   <result pre="= 27), metapneumovirus (n = 26), adenovirus (n = 9)," exact="influenza" post="virus (n = 6) and parainfluenza type 3 (n"/>
   <result pre="are RSV (48%), HRV (23%), HMPV (22%), adenovirus (7.5%) and" exact="influenza" post="(5%). RSV is the most frequently implicated, regardless of"/>
   <result pre="age is identified as the main risk factor for severe" exact="bronchiolitis" post="[22]. Acute viral bronchiolitis does not spare newborns [23]."/>
   <result pre="the main risk factor for severe bronchiolitis [22]. Acute viral" exact="bronchiolitis" post="does not spare newborns [23]. Very young infants are"/>
   <result pre="with lower defenses at this age, lead to more severe" exact="bronchiolitis" post="requiring hospitalization [1], [21]. The majority of positive RSV"/>
   <result pre="making it possible to link many ALRTI, including bronchiolitis, pneumonia," exact="influenza" post="syndromes and asthma exacerbations, to this virus. HRV (of"/>
   <result pre="to link many ALRTI, including bronchiolitis, pneumonia, influenza syndromes and" exact="asthma" post="exacerbations, to this virus. HRV (of the Picornaviridae family,"/>
   <result pre="children. The percentage of children for whom the diagnosis of" exact="pneumonia" post="was retained is higher (26.9%) than among children not"/>
   <result pre="Clin Microbiol50200523562362 7ScagnolariM.F.PerangeliB.E.De AngelisA.G.MorettiB.R.Respiratory syncytial virus, human bocavirus and rhinovirus" exact="bronchiolitis" post="in infantsArch Dis Chil9520103541 8NiangM.N.DiopO.M.SarrF.D.GoudiabyD.Malou-SompyH.NdiayeK.Viral etiology of respiratory infections"/>
   <result pre="of respiratory viruses in clinical specimens from children with acute" exact="respiratory disease" post="in IranPediatr Infect Dis J29201093193320879092 10DonM.FasoliL.PaldaniusM.VainionpääR.KleemolaM.RätyR.Aetiology of community acquired"/>
   <result pre="Suppl. l2004S25S3214730267 39XepapadakiP.PsarrasS.BossiosA.TsoliaM.GourgiotisD.Liapi-AdamidouG.Human metapneumovirus as a causative agent of acute" exact="bronchiolitis" post="in infantsJ Clin Virol30200426727015135747 40MammasI.N.KoutsaftikiC.NikaE.VagiaF.ZaravinosA.PriftisK.N.Detection of human metapneumovirus in"/>
   <result pre="respiratory syncytial virus bronchiolitisEmerg Infect Dis9200337237512643835 45BerkleyJ.A.MunywokiP.NgamaM.KazunguS.AbwaoJ.BettA.Viral etiology of severe" exact="pneumonia" post="among Kenyan infants and childrenJAMA30320102051205720501927 Appendix A Supplementary data"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6518302\results\search\disease\results.xml">
   <result pre="October 2015, a growing number of cases of newborns with" exact="microcephaly" post="were reported in Pernambuco. In November, after confirmation of"/>
   <result pre="state of Paraíba, the association between the virus infection and" exact="microcephaly" post="was confirmed [6]. ZIKV spread rapidly throughout Brazil, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6518542\results\search\disease\results.xml">
   <result pre="Original Paper Association of meteorological factors with seasonal activity of" exact="influenza" post="A subtypes and B lineages in subtropical western China"/>
   <result pre="the original work is properly cited.S0950268818003485a.pdf The seasonality of individual" exact="influenza" post="subtypes/lineages and the association of influenza epidemics with meteorological"/>
   <result pre="The seasonality of individual influenza subtypes/lineages and the association of" exact="influenza" post="epidemics with meteorological factors in the tropics/subtropics have not"/>
   <result pre="of the 2009 H1N1 pandemic on the prevalence of seasonal" exact="influenza" post="virus remains to be explored. Using wavelet analysis, the"/>
   <result pre="the upper reaches of the Yangtze River. The relationship between" exact="influenza" post="epidemics and local climatic variables was examined based on"/>
   <result pre="was examined based on regression models. The temporal distribution of" exact="influenza" post="subtypes/lineages during the pre-pandemic (2006–2009), pandemic (2009) and post-pandemic"/>
   <result pre="A total of 6892 respiratory specimens were collected and 737" exact="influenza" post="viruses were isolated. A/H3N2 showed an annual cycle with"/>
   <result pre="lower absolute humidity. The role of weather conditions in regulating" exact="influenza" post="epidemics could be complicated since the diverse viral transmission"/>
   <result pre="Differences in seasonality and different associations with meteorological factors by" exact="influenza" post="subtypes/lineages should be considered in epidemiological studies in the"/>
   <result pre="and control measures is of significant importance. Key words Humidity" exact="influenza" post="A subtypes influenza B lineages meteorological factors pandemic seasonality"/>
   <result pre="is of significant importance. Key words Humidity influenza A subtypes" exact="influenza" post="B lineages meteorological factors pandemic seasonality subtropical western China"/>
   <result pre="China fig-count: table-count: ref-count: page-count: Introduction Type A and B" exact="influenza" post="viruses have caused significant morbidity, mortality and economic burden"/>
   <result pre="winter in temperate regions [3, 4]. However, seasonal activity of" exact="influenza" post="virus in the tropics/subtropics has not been well characterised."/>
   <result pre="low levels of absolute humidity (AH) are strongly associated with" exact="influenza" post="epidemics in temperate regions [6–8]. In the tropics/subtropics, however,"/>
   <result pre="regions [6–8]. In the tropics/subtropics, however, the climatic drivers of" exact="influenza" post="epidemics are inconsistent. Increased seasonal activity of influenza virus"/>
   <result pre="drivers of influenza epidemics are inconsistent. Increased seasonal activity of" exact="influenza" post="virus was reported to be associated with higher humidity"/>
   <result pre="or contradictory effects were observed in other locales [9–11]. Currently," exact="influenza" post="A virus subtype H3N2 (A/H3N2) and the 2009 pandemic"/>
   <result pre="influenza A virus subtype H3N2 (A/H3N2) and the 2009 pandemic" exact="influenza" post="A virus subtype H1N1 (A/H1N1pdm09), as well as two"/>
   <result pre="influenza A virus subtype H1N1 (A/H1N1pdm09), as well as two" exact="influenza" post="B lineages, B/Victoria/2/1987-like (Victoria) and B/Yamagata/16/1988-like (Yamagata), co-circulate in"/>
   <result pre="H1N1 pandemic. After the pandemic, A/H1N1pdm09 replaced the pre-existing seasonal" exact="influenza" post="A virus subtype H1N1 (seasonal A/H1N1) [12–15]. The epidemic"/>
   <result pre="virus subtype H1N1 (seasonal A/H1N1) [12–15]. The epidemic peaks of" exact="influenza" post="type A and B have been reported to coincide"/>
   <result pre="[16, 17]. However, epidemiological studies on the seasonality of individual" exact="influenza" post="A subtypes and B lineages are limited; and the"/>
   <result pre="of the pandemic on the seasonal activity of the resident" exact="influenza" post="subtypes/lineages remain to be explored. The objectives of this"/>
   <result pre="study were to characterise and compare the temporal distribution of" exact="influenza" post="subtypes/lineages during the pre-pandemic, pandemic and post-pandemic years, as"/>
   <result pre="post-pandemic years, as well as to examine the relationships between" exact="influenza" post="epidemics and meteorological factors in a subtropical city in"/>
   <result pre="subtropical city in detail. Since the diverse seasonal patterns of" exact="influenza" post="virus in the tropics/subtropics, analysing surveillance data with greater"/>
   <result pre="Yamagata were characterised; and the relationship between seasonal activity of" exact="influenza" post="virus and climate variables was assessed. We also calculated"/>
   <result pre="climate variables was assessed. We also calculated the frequency of" exact="influenza" post="B vaccination mismatches. Materials and methods Influenza surveillance data"/>
   <result pre="Influenza surveillance was conducted year-round based on a sentinel hospital-based" exact="influenza" post="surveillance system, including two Grade III level A hospitals"/>
   <result pre="to inoculate clinical specimens. The types, subtypes and lineages of" exact="influenza" post="isolates were identified by haemagglutination inhibition (HI) test and/or"/>
   <result pre="test were used to identify types, subtypes and lineages of" exact="influenza" post="isolates. From 2009 to 2015, both virus culture and"/>
   <result pre="subtyped using virus culture and HI test. ILI consultation and" exact="influenza" post="virologic surveillance were carried out based on the guideline"/>
   <result pre="surveillance were carried out based on the guideline for national" exact="influenza" post="surveillance [19]. The primers and probes used for rRT-PCR"/>
   <result pre="China. Data were collected based on the guideline for national" exact="influenza" post="surveillance [19] coordinated and supported by the Chinese Center"/>
   <result pre="six post-pandemic years (2010–2015) were included in the analyses. Unsubtyped" exact="influenza" post="A virus-positive isolates were allocated to A/H3N2, seasonal A/H1N1"/>
   <result pre="each lineage, excluding 2010 when 24 out of 33 (72.3%)" exact="influenza" post="B virus-positive specimens were not determined. Because the A/H1N1pdm09"/>
   <result pre="which were calculated as monthly numbers of positive specimens (all" exact="influenza" post="viruses, or each A subtype, or each B lineage)"/>
   <result pre="P &amp;lt; 0.05 was considered as statistically significant. The updated" exact="influenza" post="vaccine based on recommendations from the WHO is used"/>
   <result pre="nine vaccination years were included. Correlations of seasonal activity of" exact="influenza" post="subtypes/lineages with monthly mean temperature, VP and RH, as"/>
   <result pre="(SPSS Inc., Chicago, IL, USA). Results Seasonality and periodicity of" exact="influenza" post="epidemics in Panzhihua A total of 6892 respiratory specimens"/>
   <result pre="Panzhihua A total of 6892 respiratory specimens were collected and" exact="influenza" post="viruses were isolated from 737 (10.69%) specimens during 2006–2015"/>
   <result pre="from 737 (10.69%) specimens during 2006–2015 (Table 1). The composite" exact="influenza" post="virus activity including all laboratory-confirmed influenza viruses exhibited non-stationary"/>
   <result pre="(Table 1). The composite influenza virus activity including all laboratory-confirmed" exact="influenza" post="viruses exhibited non-stationary periodicity (Fig. 1). Semi-annual cycles (P"/>
   <result pre="not identified during the other surveillance years. Fig. 1. Composite" exact="influenza" post="virus activity in Panzhihua during 2006–2015. (a) The monthly"/>
   <result pre="Panzhihua during 2006–2015. (a) The monthly positive rate of all" exact="influenza" post="viruses combined and the monthly positive numbers of laboratory-confirmed"/>
   <result pre="(b) Wavelet power spectrum of the monthly activity of all" exact="influenza" post="viruses combined. Black lines highlight periodicities that reach statistical"/>
   <result pre="square-root transformed. Table 1. Number, positive rates and proportions of" exact="influenza" post="virus by season in Panzhihua, 2006–2015 No. (frequencya) of"/>
   <result pre="influenza virus by season in Panzhihua, 2006–2015 No. (frequencya) of" exact="influenza" post="A subtypes and B lineages Proportionb of influenza A"/>
   <result pre="(frequencya) of influenza A subtypes and B lineages Proportionb of" exact="influenza" post="A subtypes and B lineages Year Specimens, No. Positive"/>
   <result pre="(2.70%) 59.43% 24.97% 5.43% 29.04% 40.30% 11.80% 25.24% Differences of" exact="influenza" post="virus-positive rates between the years before, during and after"/>
   <result pre="statistically significant (P &amp;lt; 0.05). aThe positive rate of laboratory-confirmed" exact="influenza" post="cases among all specimens collected. bThe proportion of subtype-"/>
   <result pre="bThe proportion of subtype- or lineage-positive cases among all laboratory-confirmed" exact="influenza" post="cases. cA total of two isolates were of mixed"/>
   <result pre="two isolates were of mixed infections. dA total of 24" exact="influenza" post="B isolates in 2010 were not characterised into lineages."/>
   <result pre="each subtype/lineage in Panzhihua, 184, 40, 214, 87 and 186" exact="influenza" post="cases of A/H3N2, seasonal A/H1N1, A/H1N1pdm09, Victoria and Yamagata"/>
   <result pre="years (Fig. 2b and Fig. S1). Fig. 2. Monthly average" exact="influenza" post="virus activity and climatic parameters in Panzhihua during 2006–2015."/>
   <result pre="2006–2015. (a) The monthly average positive rates (square-root transformed) of" exact="influenza" post="A subtypes. Error bars show standard errors based on"/>
   <result pre="variation between years. (b) The same as A, but for" exact="influenza" post="B lineages. (c) Temperature, vapour pressure, and relative humidity."/>
   <result pre="and relative humidity. (d) Precipitation and sunshine hours. Association of" exact="influenza" post="epidemics with climatic parameters The monthly statistics for the"/>
   <result pre="h. The relationship between climate variables and the activity of" exact="influenza" post="subtypes/lineages was evaluated on a monthly basis. Table 2"/>
   <result pre="2 shows the Spearman's rank correlation coefficients between the monthly" exact="influenza" post="virus prevalence data and meteorological factors. A/H3N2 activity was"/>
   <result pre="0.044). Table 2. Spearman's rank correlation between meteorological factors and" exact="influenza" post="activity in Panzhihua, 2006–2015 Spearman's rank correlation Temperature (°C)"/>
   <result pre="prevalence pattern of A/H1N1pdm09 during inter-pandemic years. Subtype/lineage distributions of" exact="influenza" post="epidemics Overall, 59.4% and 40.3% of influenza-positive cases during"/>
   <result pre="were significantly higher than in the pre-pandemic period. The predominant" exact="influenza" post="subtypes/lineages observed in Panzhihua are shown in Figure 1a"/>
   <result pre="were at least two subtypes/lineages co-circulating each year. One of" exact="influenza" post="A subtypes or one of B lineages predominated in"/>
   <result pre="in most years, except in 2012 and 2013 when an" exact="influenza" post="A subtype and a B lineage were codominant. Influenza"/>
   <result pre="and 2010 and A/H1N1pdm09 were not detected in 2015. Two" exact="influenza" post="B lineages co-circulated in many years, except in 2013–2015"/>
   <result pre="when Yamagata were not detected. So far, only trivalent inactivated" exact="influenza" post="vaccine (TIV) have been available in the market in"/>
   <result pre="in the market in China. It was shown that the" exact="influenza" post="B strain included in TIV did not match the"/>
   <result pre="nine vaccination years studied (Fig. 3). Fig. 3. Proportion of" exact="influenza" post="B lineages in Panzhihua by vaccination year (September 2006–August"/>
   <result pre="represent Victoria, white boxes represent Yamagata and grey boxes represent" exact="influenza" post="B isolates that were not determined. Horizontal bars on"/>
   <result pre="not determined. Horizontal bars on the top show the WHO-recommended" exact="influenza" post="B vaccine lineage. Discussion Ten-year surveillance demonstrated non-stationary seasonality"/>
   <result pre="vaccine lineage. Discussion Ten-year surveillance demonstrated non-stationary seasonality of composite" exact="influenza" post="virus activity in Panzhihua. Although well-defined seasonal patterns, such"/>
   <result pre="also reported [4, 5, 30]. However, the seasonality of individual" exact="influenza" post="subtypes/lineages and the seasonal drivers remain to be investigated."/>
   <result pre="be investigated. Our study found that the seasonal patterns among" exact="influenza" post="subtypes/lineages were not the same and the associations with"/>
   <result pre="southern China, which found that RH was positively correlated with" exact="influenza" post="A activity [10, 21, 32]. However, lower RH was"/>
   <result pre="lower RH was also found to be associated with higher" exact="influenza" post="A activity in subtropical Japan [11]. The periodicity of"/>
   <result pre="showed an annual cycle, respectively, as previous studies of both" exact="influenza" post="B lineages combined [30]. Our study found that the"/>
   <result pre="activity was negatively associated with AH. The inverse association between" exact="influenza" post="B activity and humidity was different from previous studies"/>
   <result pre="Kong and Okinawa, which showed that the epidemics of all" exact="influenza" post="B viruses combined could be promoted by higher RH/AH"/>
   <result pre="RH/AH [10, 11]. Animal experiments demonstrated that transmission of both" exact="influenza" post="B lineages could be enhanced at colder temperature [34]."/>
   <result pre="at colder temperature [34]. But the impact of humidity on" exact="influenza" post="B transmission remains to be examined. Differences in seasonality"/>
   <result pre="findings suggested that the different effects of weather conditions on" exact="influenza" post="subtypes/lineages might be related to the regional heterogeneity of"/>
   <result pre="influenza subtypes/lineages might be related to the regional heterogeneity of" exact="influenza" post="seasonality. Animal experiments showed that aerosol transmission of type"/>
   <result pre="experiments showed that aerosol transmission of type A and B" exact="influenza" post="strains was highly effective at low temperature (5 °C)"/>
   <result pre="spring and early summer. Therefore, the association of temperature with" exact="influenza" post="epidemics might not be significant. Our analyses showed that"/>
   <result pre="significant. Our analyses showed that the associations between humidity and" exact="influenza" post="activity varied by subtype/lineage in Panzhihua. This might indicate"/>
   <result pre="indicate that at the context of a subtropical city, each" exact="influenza" post="subtype/lineage could have a most suitable humidity with different"/>
   <result pre="humidity with different temperature condition. RH might perform effects on" exact="influenza" post="virus transmission at different level [35, 36]. Aerosol transmission"/>
   <result pre="virus transmission at different level [35, 36]. Aerosol transmission of" exact="influenza" post="A could be maximal at low RH (20% and"/>
   <result pre="(80%). Notably, effective transmission (75% or 100%) of type A" exact="influenza" post="virus was also observed at 20 °C and 65%"/>
   <result pre="and Suzhou, showed that higher RH was correlated with higher" exact="influenza" post="A activity [10, 21, 32]. However, these studies did"/>
   <result pre="activity [10, 21, 32]. However, these studies did not analyze" exact="influenza" post="A subtypes or influenza B lineages separately. In addition,"/>
   <result pre="However, these studies did not analyze influenza A subtypes or" exact="influenza" post="B lineages separately. In addition, RH is a measure"/>
   <result pre="of a gas. It is suggested that aerosol transmission of" exact="influenza" post="virus shows a direct dependence on AH, rather than"/>
   <result pre="humidity (either RH or AH) and temperature affect transmission of" exact="influenza" post="subtypes/lineages by more than one mechanism. It is suggested"/>
   <result pre="and post-pandemic years. However, periodicity changes were not detected for" exact="influenza" post="virus in Panzhihua, which was identified in Chengdu in"/>
   <result pre="The interaction between the novel pandemic strain and other resident" exact="influenza" post="viruses, virus virulence variation and host susceptibility might be"/>
   <result pre="might be related to the changes in positive rates of" exact="influenza" post="subtypes/lineages. Understanding the seasonal pattern and the climatic drivers"/>
   <result pre="subtypes/lineages. Understanding the seasonal pattern and the climatic drivers of" exact="influenza" post="virus is of significant importance for predicting epidemic timing"/>
   <result pre="in seasonality by subtype/lineage indicated that except for the winter" exact="influenza" post="epidemics, the summer–autumn peak of A/H3N2 should also be"/>
   <result pre="be considered in vaccination campaign in Panzhihua. Moreover, since the" exact="influenza" post="B strain included in TIV did not match the"/>
   <result pre="the nine vaccination years, it is suggested to use quadrivalent" exact="influenza" post="vaccine (QIV) to provide broad protection against all circulating"/>
   <result pre="for individual subtypes/lineages since the 2009 H1N1 pandemic. Therefore, year-round" exact="influenza" post="surveillance is needed to be strengthened to monitor on-going"/>
   <result pre="be more appropriate. Second, the relationship between seasonal activity of" exact="influenza" post="virus and some other seasonal drivers, such as virus"/>
   <result pre="virus culture and rRT-PCR assay might have different sensitivity of" exact="influenza" post="virus detection [40]. However, the subtype/lineage distribution and seasonality"/>
   <result pre="[41]. Our wavelet analysis results showed that the periodicity of" exact="influenza" post="subtypes/lineages were consistent during 2006–2015 in Panzhihua, except for"/>
   <result pre="study expands our knowledge regarding the epidemiological characteristics of individual" exact="influenza" post="subtypes/lineages as well as the association with meteorological factors"/>
   <result pre="be related to the diverse transmission modes and mechanism of" exact="influenza" post="virus. Studies of influenza seasonality and its relationship with"/>
   <result pre="diverse transmission modes and mechanism of influenza virus. Studies of" exact="influenza" post="seasonality and its relationship with climatic drivers should therefore"/>
   <result pre="for individual subtypes/lineages. Moreover, it is necessary to increase year-round" exact="influenza" post="surveillance and develop subtype/lineage-specific prevention and control measures. In"/>
   <result pre="In addition, QIV is recommended to provide protection against both" exact="influenza" post="B lineages. Acknowledgements We thank all the clinicians, and"/>
   <result pre="laboratory, research and administrative staff who took part in the" exact="influenza" post="surveillance. Conflict of interest None. Supplementary material For supplementary"/>
   <result pre="the manuscript. References References 1.SimonsenL (1999) The global impact of" exact="influenza" post="on morbidity and mortality. Vaccine17, S3–S10.10471173 2.LipsitchMet al. (2009)"/>
   <result pre="2.LipsitchMet al. (2009) Managing and reducing uncertainty in an emerging" exact="influenza" post="pandemic. New England Journal of Medicine361, 112–115.19474417 3.ViboudCet al."/>
   <result pre="of Sciences of the USA106, 3645–3646.19276125 5.TameriusJet al. (2011) Global" exact="influenza" post="seasonality: reconciling patterns across temperate and tropical. Environmental Health"/>
   <result pre="6.ShamanJet al. (2010) Absolute humidity and the seasonal onset of" exact="influenza" post="in the continental United States. PLoS Biology8, e1000316.20186267 7.ShamanJ,"/>
   <result pre="of Epidemiology173, 127–135.21081646 8.ShamanJ and KohnM (2009) Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. Proceedings of the National Academy"/>
   <result pre="the USA106, 3243–3248.19204283 9.TameriusJet al. (2013) Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathogens9, e1003194.23505366"/>
   <result pre="and tropical climates. PLoS Pathogens9, e1003194.23505366 10.ChanPKet al. (2009) Seasonal" exact="influenza" post="activity in Hong Kong and its association with meteorological"/>
   <result pre="of Medical Virology81, 1797–1806.19697414 11.IhaYet al. (2016) Comparative epidemiology of" exact="influenza" post="A and B viral infection in a subtropical region:"/>
   <result pre="of the spring and fall waves of the H1N1/2009 pandemic" exact="influenza" post="virus in the United States. Journal of Virology85, 828–834.21068250"/>
   <result pre="828–834.21068250 13.BaillieGJet al. (2012) Evolutionary dynamics of local pandemic H1N1/2009" exact="influenza" post="virus lineages revealed by whole-genome analysis. Journal of Virology86,"/>
   <result pre="11–18.22013031 14.FraserCet al. (2009) Pandemic potential of a strain of" exact="influenza" post="A (H1N1): early findings. Science324, 1557–1561.19433588 15.GartenRJet al. (2009)"/>
   <result pre="al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humans. Science325, 197–201.19465683 16.CainiSet al. (2016)"/>
   <result pre="in humans. Science325, 197–201.19465683 16.CainiSet al. (2016) Temporal patterns of" exact="influenza" post="A and B in tropical and temperate countries-what are"/>
   <result pre="B in tropical and temperate countries-what are the lessons for" exact="influenza" post="vaccination. PLoS ONE11, e0152310.27031105 17.CainiSet al. (2016) Divergent seasonal"/>
   <result pre="PLoS ONE11, e0152310.27031105 17.CainiSet al. (2016) Divergent seasonal patterns of" exact="influenza" post="types A and B across latitude gradient in tropical"/>
   <result pre="for Disease Control and Prevention (2010) The guideline for national" exact="influenza" post="surveillance. Beijing. 20.collab: National Meteorological Information Center, CMA, Beijing."/>
   <result pre="(Accessed 7 August 2018). 21.WangXLet al. (2017) Different responses of" exact="influenza" post="epidemic to weather factors among Shanghai, Hong Kong, and"/>
   <result pre="spread of influenza. Science312, 447–451.16574822 23.AlonsoWJet al. (2007) Seasonality of" exact="influenza" post="in Brazil: a traveling wave from the Amazon to"/>
   <result pre="E75, 016707. 26.ChengXet al. (2013) Epidemiological dynamics and phylogeography of" exact="influenza" post="virus in southern China. The Journal of Infectious Disease207,"/>
   <result pre="Beijing: China Statistics Press. 30.YuHet al. (2013) Characterization of regional" exact="influenza" post="seasonality patterns in China and implications for vaccination strategies:"/>
   <result pre="PLoS Medicine10, e1001552.24348203 31.YangLet al. (2015) Age-specific epidemic waves of" exact="influenza" post="and respiratory syncytial virus in a subtropical city. Scientific"/>
   <result pre="Virology159, 631–639.24114148 33.ZhaoXet al. (2016) Meteorological influence on the 2009" exact="influenza" post="a (H1N1) pandemic in mainland China. Environmental Earth Sciences75,"/>
   <result pre="China. Environmental Earth Sciences75, 1–9. 34.PicaNet al. (2012) Transmission of" exact="influenza" post="B viruses in the guinea pig. Journal of Virology86,"/>
   <result pre="36.SteelJ, PaleseP and LowenAC (2011) Transmission of a 2009 pandemic" exact="influenza" post="virus shows a sensitivity to temperature and humidity similar"/>
   <result pre="transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of" exact="influenza" post="A virus infection in different age groups. Journal of"/>
   <result pre="Microbiology40, 2051–2056.12037063 41.ChiarellaFCet al. (2017) Characterization and circulation of seasonal" exact="influenza" post="viruses in Madrid, 2010–2016. Journal of Medical Virology89, 1726–1733.28504416"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6519843\results\search\disease\results.xml">
   <result pre="periods. Author summary Rift Valley fever (RVF) is a mosquito-transmitted" exact="viral disease" post="that may cause large epidemics in domestic livestock and"/>
   <result pre="but in severe cases can result in encephalopathy, haemorrhagic signs," exact="retinopathy" post="and even death. The disease in ruminants may be"/>
   <result pre="death. The disease in ruminants may be characterized by necrotic" exact="hepatitis" post="but may also be inapparent or mild, and in"/>
   <result pre="RVF in humans in the area; however, the fact that" exact="malaria" post="is common there may result in other causes of"/>
   <result pre="that region and that most RVF cases are misdiagnosed as" exact="malaria" post="[61]. Therefore, the current status and potential impact of"/>
   <result pre="Oxford University Press; 2004 p. 1037–70. 3DaubneyR, HudsonJR, GarnhamPC. Enzootic" exact="hepatitis" post="or Rift Valley fever. An undescribed virus disease of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6527025\results\search\disease\results.xml">
   <result pre="roles of apoptosis, autophagy and unfolded protein response in arbovirus," exact="influenza" post="virus, and HIV infections P. MEHRBOD ET AL. VIRULENCE"/>
   <result pre="Beclin-1. In this review article we first briefly discuss arboviruses," exact="influenza" post="virus, and HIV and then describe the concepts of"/>
   <result pre="are involved in the regulation of cellular responses to arboviruses," exact="influenza" post="virus and HIV infections. Abbreviation: AIDS: Acquired Immunodeficiency Syndrome;"/>
   <result pre="thus, it is being explored as a potential tool for" exact="cancer" post="treatment [6]. Vaccines are a common defense against virus"/>
   <result pre="derived from whole or subunits of viruses. For example, the" exact="hepatitis" post="B vaccine was developed from the viral surface antigens"/>
   <result pre="pollution. Example of viruses The following three virus groups (arboviruses," exact="influenza" post="virus, and human immunodeficiency virus – HIV) will be"/>
   <result pre="[12]. In 2015, Zika virus (ZIKV) was reported to cause" exact="microcephaly" post="and microencephaly in infants born to infected mothers [13]."/>
   <result pre="additional genera [16]. However, most human outbreaks are caused by" exact="influenza" post="type A virus (IAV). IAV has several subtypes which"/>
   <result pre="(CMV – a herpesvirus) and Flaviviruses (DENV, ZIKV and Japanese" exact="encephalitis" post="virus (JEV)) induce the host UPR response, which promotes"/>
   <result pre="protein folding and successful viral replication, while other viruses like" exact="herpes simplex" post="virus type 1 (HSV-1) work to downregulate the IRE1/XBP-1"/>
   <result pre="the manifestation of virus-induced effects like ZIKV-induced development of microcephaly," exact="influenza" post="virus-induced inflammatory damage, and reactivation of HSV-1 in previously"/>
   <result pre="oxidative stress, are also used by viruses like ZIKV and" exact="influenza" post="virus to promote viral replication and increase virally induced"/>
   <result pre="are involved in the regulation of viral infection in arboviruses," exact="influenza" post="virus, and HIV. Apoptosis The term apoptosis was introduced"/>
   <result pre="autophagy influences outcomes in disorders such as neurodegeneration, immunity, and" exact="cancer" post="[59,64–69]. Historically, research in the autophagy field was initiated"/>
   <result pre="are degraded in the lysosomes. CMA has been implicated in" exact="cancer" post="[115]. Autophagy and viral infection Autophagy has harmonized with"/>
   <result pre="[156]. Regarding WNV, which is a neurotropic flavivirus responsible for" exact="meningitis" post="and encephalitis, its replication is autophagy independent; however, it"/>
   <result pre="Chikungunya virus (CHIKV)-infected HEK293 (human embryonic kidney) cells [148]. Epizootic" exact="hemorrhagic disease" post="virus (EHDV) induces autophagy, apoptosis, activates c-Jun N-terminal kinase"/>
   <result pre="in processes such as autophagy [169]. A study on vesicular" exact="stomatitis" post="virus (VSV), showed that the interaction of PRR-PAMP with"/>
   <result pre="[131]] . DENV: Dengue virus; ZIKV: Zika virus; JEV: Japanese" exact="encephalitis" post="virus; CHIKV: Chikungunya virus; TBEV: tick-borne encephalitis virus; VSV:"/>
   <result pre="Zika virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; TBEV:" exact="tick-borne encephalitis" post="virus; VSV: vesicular stomatitis virus. Several studies were conducted"/>
   <result pre="virus; JEV: Japanese encephalitis virus; CHIKV: Chikungunya virus; TBEV: tick-borne" exact="encephalitis" post="virus; VSV: vesicular stomatitis virus. Several studies were conducted"/>
   <result pre="virus; CHIKV: Chikungunya virus; TBEV: tick-borne encephalitis virus; VSV: vesicular" exact="stomatitis" post="virus. Several studies were conducted on ZIKV. The results"/>
   <result pre="was demonstrated that Brazilian ZIKV crosses the placenta and causes" exact="microcephaly" post="by targeting cortical progenitor cells, inducing cell death by"/>
   <result pre="restrict ZIKV infection and to control neuronal infection [175]. Tick-borne" exact="encephalitis" post="virus (TBEV), which is an important travel-associated arbovirus, replicates"/>
   <result pre="was demonstrated that Brazilian ZIKV crosses the placenta and causes" exact="microcephaly" post="[175] Studied Drosophila brain system Suggested an essential role"/>
   <result pre="autophagosome formation CHIKV: Chikungunya virus; DENV: Dengue virus; EHDV: Epizootic" exact="hemorrhagic disease" post="virus; JEV: Japanese encephalitis virus; RVFV: Rift Valley fever"/>
   <result pre="DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; TBEV: Tick-borne encephalitis"/>
   <result pre="Japanese encephalitis virus; RVFV: Rift Valley fever virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus;"/>
   <result pre="Rift Valley fever virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular" exact="stomatitis" post="virus; WNV: West Nile virus; ZIKV: Zika virus. Arboviruses"/>
   <result pre="virus; ZIKV: Zika virus; WNV: West Nile virus; JEV: Japanese" exact="encephalitis" post="virus; CHIKV: Chikungunya virus; CCHFV: Crimean Congo hemorrhagic fever"/>
   <result pre="has anti-apoptotic functions which can block or delay apoptosis by" exact="suppression" post="of the PI3-kinase-dependent process at the early stage of"/>
   <result pre="initiation of apoptosis (Figure 2) [202]. In another experiment, mouse" exact="neuroblastoma" post="cell line N18 was infected with UV-inactivated JEV (UV-JEV)."/>
   <result pre="death through a ROS-dependent and NF-kB-mediated pathway [203]. The initial" exact="suppression" post="of UV-JEV-induced cell death, followed by co-infection with active"/>
   <result pre="demonstrated that JEV may trigger cell survival signaling in mouse" exact="neuroblastoma" post="N18 and human neuronal NT-2 cells to modify cellular"/>
   <result pre="including hepatocytes, monocytes, endothelial cells, dendritic cells, mast cells, and" exact="neuroblastoma" post="cells. However, the mechanisms are not yet fully understood."/>
   <result pre="neuronal cells to infection by this virus [222]. Saint Louis" exact="encephalitis" post="virus (SLEV) is a neglected flavivirus. Its epidemic strain,"/>
   <result pre="EGFR-co-amplified and overexpressed protein (ECOP) [203] Studied JEV in mouse" exact="neuroblastoma" post="cell line N18 N18 was infected with UV-inactivated JEV"/>
   <result pre="ROS-dependent and NF-kB-mediated pathway [203] Studied JEV replication The initial" exact="suppression" post="of UV-JEV-induced cell death, followed by co-infection with active"/>
   <result pre="fever virus; CHIKV: Chikungunya virus; DENV: Dengue virus; EHDV: Epizootic" exact="hemorrhagic disease" post="virus; JEV: Japanese encephalitis virus; RVFV: Rift Valley fever"/>
   <result pre="DENV: Dengue virus; EHDV: Epizootic hemorrhagic disease virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; SINV: Sindbis virus;"/>
   <result pre="Rift Valley fever virus; SINV: Sindbis virus; SLEV: Saint Louis" exact="encephalitis" post="virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular stomatitis virus;"/>
   <result pre="SINV: Sindbis virus; SLEV: Saint Louis encephalitis virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VSV: Vesicular stomatitis virus; WNV: West Nile virus;"/>
   <result pre="Saint Louis encephalitis virus; TBEV: Tick-borne encephalitis virus; VSV: Vesicular" exact="stomatitis" post="virus; WNV: West Nile virus; ZIKV: Zika virus. Arboviruses"/>
   <result pre="viruses. Another study showed the activation of XBP1 pathway when" exact="neuroblastoma" post="N18 cells were infected with the arboviruses JEV and"/>
   <result pre="and BHK-21 cells, respectively [233,234]. Another study showed that A547" exact="ovarian cancer" post="cells infected with DENV elicited the UPR signaling response"/>
   <result pre="BHK-21 cells, respectively [233,234]. Another study showed that A547 ovarian" exact="cancer" post="cells infected with DENV elicited the UPR signaling response"/>
   <result pre="[235] Studied UPR involvement in DENV infection Showed that A547" exact="ovarian cancer" post="cells infected with DENV elicited the UPR signaling responseDifferent"/>
   <result pre="Studied UPR involvement in DENV infection Showed that A547 ovarian" exact="cancer" post="cells infected with DENV elicited the UPR signaling responseDifferent"/>
   <result pre="dependent manner. CHIKV: Chikungunya virus; DENV: Dengue virus; JEV: Japanese" exact="encephalitis" post="virus; RVFV: Rift Valley fever virus; SINV: Sindbis virus;"/>
   <result pre="RVFV: Rift Valley fever virus; SINV: Sindbis virus; TBEV: Tick-borne" exact="encephalitis" post="virus; VEEV: Venezuelan equine encephalitis virus; WNV: West Nile"/>
   <result pre="SINV: Sindbis virus; TBEV: Tick-borne encephalitis virus; VEEV: Venezuelan equine" exact="encephalitis" post="virus; WNV: West Nile viruss. Influenza virus and autophagy"/>
   <result pre="autophagy [259]. It has been proposed that the highly pathogenic" exact="avian influenza" post="virus, H5N1, induces autophagy in MEF cells by suppressing"/>
   <result pre="[259]. It has been proposed that the highly pathogenic avian" exact="influenza" post="virus, H5N1, induces autophagy in MEF cells by suppressing"/>
   <result pre="also contains an LC3-interacting region (LIR) which is required for" exact="influenza" post="virus subversion of autophagy; this leads to LC3 redistribution"/>
   <result pre="illustrated in Figure 4 and a summary of autophagy and" exact="influenza" post="virus infection is summarized in Table 4. 10.1080/21505594.2019.1605803-T0004Table 4."/>
   <result pre="infection is summarized in Table 4. 10.1080/21505594.2019.1605803-T0004Table 4. Summary of" exact="influenza" post="virus infection and autophagy pathway. Reference Summary of the"/>
   <result pre="cells and molecular mechanism underlying the reduction of SOD1 during" exact="influenza" post="infection Supported the critical role of autophagy in the"/>
   <result pre="(NY55), A/Puerto Rico/8/1934 (H1N1) (PR8), and 2009 pandemic swine origin" exact="influenza" post="virus (SOIV) (A/California/07/2009) [278]. Apoptosis and autophagy in IAV"/>
   <result pre="Bax was activated at 24 hpi. Lack of Bax prevented" exact="influenza" post="A virus-induced apoptosis and caused diminished viral replication [280]."/>
   <result pre="for this induction [286]. It has been suggested that the" exact="influenza" post="virus could facilitate the progress of its pathogenesis and"/>
   <result pre="apoptosis pathway (Figure 5) [301]. The polymerase acidic protein of" exact="influenza" post="virus (PA)-X, encoded by the PA mRNA as an"/>
   <result pre="immune response to H5N1. This was mediated by AvIFIT binding" exact="influenza" post="NP protein, which increased the expression of IRF1, IRF7,"/>
   <result pre="pro-inflammatory responses against IAV infection [307]. High antibody response to" exact="influenza" post="vaccine showed decrease in post-vaccination tumor necrosis factor-like weak"/>
   <result pre="epithelial cells with IAV along with antioxidant treatment could decrease" exact="influenza" post="virus replication and apoptosis induction [309]. To screen some"/>
   <result pre="other) proteins. Additional studies examined the role of P53 in" exact="influenza" post="infection, and apoptosis induction via attenuation of host ubiquitin"/>
   <result pre="promising antiviral targets against H1N1 IAV [317]. The interaction of" exact="influenza" post="A virus with the host apoptosis pathway is illustrated"/>
   <result pre="illustrated in Figure 5 and a summary of apoptosis and" exact="influenza" post="virus infection is summarized in Table 5. 10.1080/21505594.2019.1605803-T0005Table 5."/>
   <result pre="infection is summarized in Table 5. 10.1080/21505594.2019.1605803-T0005Table 5. Summary of" exact="influenza" post="virus infection and apoptosis pathway. Reference Summary of the"/>
   <result pre="Induction of apoptosis in neutrophils and NK cells [289][290][284][292]–294[295] -Studied" exact="influenza" post="virus NS1 protein -Caspase-1 activation, fast apoptosis and release"/>
   <result pre="apoptosis-Siva-1 involvement for IAV replication through caspase activation [296] Studied" exact="influenza" post="virus (A/California/2009(H1N1) strain) NP protein in A549 cells Apoptosis"/>
   <result pre="AvIFIT protein, similar to human IFIT2 induces apoptosis by binding" exact="influenza" post="NP protein and enhancing the IFN signaling-Attenuation of host"/>
   <result pre="which may act synergistically with UPR-mediated transcriptional activation to help" exact="influenza" post="virus escape from both PKR- and PERK-mediated translational repression"/>
   <result pre="which is independent of PERK [321,322]. Recently, scientists showed that" exact="influenza" post="virus HA glycoprotein induced a strong innate antiviral response"/>
   <result pre="IAV infection through the IRE1 pathway [318]. The interaction of" exact="influenza" post="A virus with the host UPR pathway is illustrated"/>
   <result pre="illustrated in Figure 6 and a summary of UPR and" exact="influenza" post="virus infection is summarized in Table 6. 10.1080/21505594.2019.1605803-T0006Table 6."/>
   <result pre="infection is summarized in Table 6. 10.1080/21505594.2019.1605803-T0006Table 6. Summary of" exact="influenza" post="virus infection and UPR pathway. Reference Summary of the"/>
   <result pre="ATG7, and LC3II in post-mortem brains of HIV patients with" exact="encephalitis" post="[324]. HIV and apoptosis Patients infected with HIV experience"/>
   <result pre="with CXCR4 can also cause MMP (mitochondrial membrane permeabilization) through" exact="pertussis" post="toxin-sensitive G protein (Gia) P38 MPAK pathway and/or through"/>
   <result pre="inhibition can successfully affect symptoms of viral infection in a" exact="hepatitis" post="c drug irresponsive population [335]. Therefore, there could be"/>
   <result pre="2018. [6]GongJ, SachdevE, MitaAC, et alClinical development of reovirus for" exact="cancer" post="therapy: an oncolytic virus with immune-mediated antitumor activity. World"/>
   <result pre="p. 1647–1689. [17]TongSX, LiY, RivaillerP, et alA distinct lineage of" exact="influenza" post="A virus from bats. Proceedings of the National Academy"/>
   <result pre="National Academy of Sciences109 (2012) 4269–4274 [18]collab: Prevention CfDCaTypes of" exact="influenza" post="viruses. 20162016 617]; Available from: http://www.cdc.gov/flu/about/viruses/types.htm. [19]SellersSA, HaganRS, HaydenFG,"/>
   <result pre="burden of influenza: A review of the extra-pulmonary complications of" exact="influenza" post="infection. Influenza Other Respir Viruses. 2017;11:372–393.28745014 [20]KwongJC, SchwartzKL, CampitelliMAAcute"/>
   <result pre="Respir Viruses. 2017;11:372–393.28745014 [20]KwongJC, SchwartzKL, CampitelliMAAcute myocardial infarction after laboratory-confirmed" exact="influenza" post="infection REPLY. N Engl J Med. 2018;378:2540–2541. [21]BreseeJ, FitznerJ,"/>
   <result pre="influenza. Emerg Infect Dis. 2018;24:1173–1177.29912681 [22]SauttoGA, KirchenbaumGA, RossTMTowards a universal" exact="influenza" post="vaccine: different approaches for one goal. Virol J. 2018;15:17."/>
   <result pre="[31]LiuMM, ChenFZ, LiuT, et alThe role of oxidative stress in" exact="influenza" post="virus infection. Microbes Infect. 2017;19:580–586.28918004 [32]OngHK, SooBPC, ChuKL, et"/>
   <result pre="2018;21:63-+. [34]PrestonCM, NichollMJInduction of cellular stress overcomes the requirement of" exact="herpes simplex" post="virus type 1 for immediate-early protein ICP0 and reactivates"/>
   <result pre="2016;5:2804.27990281 [44]SarosiekKA, LetaiADirectly targeting the mitochondrial pathway of apoptosis for" exact="cancer" post="therapy using BH3 mimetics - recent successes, current challenges"/>
   <result pre="[50]KaczanowskiSApoptosis: its origin, history, maintenance and the medical implications for" exact="cancer" post="and aging. Phys Biol. 2016;13:031001.27172135 [51]FadeelB, OrreniusS, ZhivotovskyBApoptosis in"/>
   <result pre="beta 1 induced epithelial to mesenchymal transition in non-small cell" exact="lung cancer" post="cells. Biochim Biophys Acta, Mol Cell Res. 2018;1865:749–768.29481833 [60]Hombach-KlonischS,"/>
   <result pre="1 induced epithelial to mesenchymal transition in non-small cell lung" exact="cancer" post="cells. Biochim Biophys Acta, Mol Cell Res. 2018;1865:749–768.29481833 [60]Hombach-KlonischS,"/>
   <result pre="autophagy and epithelial to mesenchymal transition in the non-small cell" exact="lung cancer" post="cells. Methods Mol Biol. 2019;1854:87–103.29101677 [70]NovikoffAB, BeaufayH, De DuveCElectron"/>
   <result pre="and epithelial to mesenchymal transition in the non-small cell lung" exact="cancer" post="cells. Methods Mol Biol. 2019;1854:87–103.29101677 [70]NovikoffAB, BeaufayH, De DuveCElectron"/>
   <result pre="J Gastroenterol. 2015;21:13225–13239.26715805 [79]AlavianSM, AndeSR, CoombsKM, et alVirus-triggered autophagy in" exact="viral hepatitis" post="- possible novel strategies for drug development. J Viral"/>
   <result pre="Gastroenterol. 2015;21:13225–13239.26715805 [79]AlavianSM, AndeSR, CoombsKM, et alVirus-triggered autophagy in viral" exact="hepatitis" post="- possible novel strategies for drug development. J Viral"/>
   <result pre="regulation of different types of autophagy and their participation in" exact="cancer" post="pathogenesis. Oncotarget. 2018;9:34413–34428.30344951 [91]WhiteE, MehnertJM, ChanCSAutophagy, Metabolism, and Cancer."/>
   <result pre="self-digestion. Nature. 2008;451:1069–1075.18305538 [111]McAlindenKD, DeshpandeDA, GhavamiS, et alAutophagy activation in" exact="asthma" post="airways remodeling. Am J Respir Cell Mol Biol. 2018."/>
   <result pre="Microbe. 2010;7:115–127.20159618 [124]GannagéM, DormannD, AlbrechtR, et alMatrix protein 2 of" exact="influenza" post="A virus blocks autophagosome fusion with lysosomes. Cell Host"/>
   <result pre="2013;12:703–719.23989796 [134]McGrathEP, LogueSE, MnichK, et alThe unfolded protein response in" exact="breast cancer." post="Cancers (Basel). 2018;10:10. [135]DejeansN, BarrosoK, Fernandez-ZapicoME, et alNovel roles"/>
   <result pre="viral replication. Virol J. 2011;8:432.21902836 [149]ShaiB, SchmuklerE, YanivR, et alEpizootic" exact="hemorrhagic disease" post="virus induces and benefits from cell stress, autophagy, and"/>
   <result pre="amphisomes. J Gen Virol. 2009;90:448–456.19141455 [153]SharmaM, BhattacharyyaS, NainM, et alJapanese" exact="encephalitis" post="virus replication is negatively regulated by autophagy and occurs"/>
   <result pre="protein response. Front Microbiol. 2015;5. [161]SharmaM, BhattacharyyaS, SharmaKB, et alJapanese" exact="encephalitis" post="virus activates autophagy through XBP1 and ATF6 ER stress"/>
   <result pre="West Nile virus encephalitis. J Virol. 2007;81:2614–2623.17192305 [180]SunJ, YuY, DeubelVJapanese" exact="encephalitis" post="virus NS1′ protein depends on pseudoknot secondary structure and"/>
   <result pre="alNucleophosmin (NPM1)/B23 in the proteome of human astrocytic cells restricts" exact="chikungunya" post="virus replication. J Proteome Res. 2017;16:4144–4155.28959884 [194]ChiamCW, ChanYF, OngKC,"/>
   <result pre="antiapoptotic factors. J Virol. 2012;86:5278–5287.22345437 [202]YangT-C, Lai-C-C, ShiuS-L, et alJapanese" exact="encephalitis" post="virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK/p38 MAPK activation"/>
   <result pre="cells. Microbes Infect. 2010;12:643–651.20430109 [203]LinR-J, LiaoC-L, LinY-LReplication-incompetent virions of Japanese" exact="encephalitis" post="virus trigger neuronal cell death by oxidative stress in"/>
   <result pre="[204]MelianEB, HinzmanE, NagasakiT, et alNS1′ of flaviviruses in the Japanese" exact="encephalitis" post="virus serogroup is a product of ribosomal frameshifting and"/>
   <result pre="not antiviral function of Human bcl-2 assists establishment of Japanese" exact="encephalitis" post="virus persistence in cultured cells. J Virol. 1998;72:9844–9854.9811720 [206]Al-ObaidiMMJ,"/>
   <result pre="cultured cells. J Virol. 1998;72:9844–9854.9811720 [206]Al-ObaidiMMJ, BahadoranA, HarLS, et alJapanese" exact="encephalitis" post="virus disrupts blood-brain barrier and modulates apoptosis proteins in"/>
   <result pre="Med Virol. 2009;81:1069–1081.19382257 [211]AustinD, BaerA, LundbergL, et alp53 activation following" exact="rift valley fever" post="virus infection contributes to cell death and viral production."/>
   <result pre="PLoS ONE. 2012;7:e36327.22574148 [212]WonS, IkegamiT, PetersC, et alNSm protein of" exact="rift valley fever" post="virus suppresses virus-induced apoptosis. J Virol. 2007;81:13335–13345.17913816 [213]IkegamiT, NarayananK,"/>
   <result pre="in mice induced by an epidemic strain of Saint Louis" exact="encephalitis" post="virus isolated in Argentina. Front Microbiol. 2018;9. [224]WangH, GortT,"/>
   <result pre="[236]AlbornozA, CarlettiT, CorazzaG, et alThe stress granule component TIA-1 binds" exact="tick-borne encephalitis" post="virus RNA and is recruited to perinuclear sites of"/>
   <result pre="CarlettiT, CorazzaG, et alThe stress granule component TIA-1 binds tick-borne" exact="encephalitis" post="virus RNA and is recruited to perinuclear sites of"/>
   <result pre="to inhibit viral translation. J Virol. 2014;88:6611–6622.24696465 [237]YuCY, AchaziK, NiedrigMTick-borne" exact="encephalitis" post="virus triggers inositol-requiring enzyme 1 (IRE1) and transcription factor"/>
   <result pre="Virol. 2016;90:3558–3572.26792742 [239]ZhouZ, JiangX, LiuD, et alAutophagy is involved in" exact="influenza" post="A virus replication. Autophagy. 2009;5:321–328.19066474 [240]YeganehB, GhavamiS, KroekerAL, et"/>
   <result pre="virus replication. Autophagy. 2009;5:321–328.19066474 [240]YeganehB, GhavamiS, KroekerAL, et alSuppression of" exact="influenza" post="a virus replication in human lung epithelial cells by"/>
   <result pre="Liver Physiol. 2015;308:L270–L286. [241]LawAH-Y, LeeDC-W, YuenK-Y, et alCellular response to" exact="influenza" post="virus infection: a potential role for autophagy in CXCL10"/>
   <result pre="developmental biology. Elsevier; 2010;21: 699–711.20403453 [247]RossmanJS, LambRAAutophagy, apoptosis, and the" exact="influenza" post="virus M2 protein. Cell Host Microbe. 2009;6:367–380.19837376 [248]SchmidDAutophagy delivers"/>
   <result pre="specific inhibitor of vacuolar-type proton pump, on the growth of" exact="influenza" post="A and B viruses in MDCK cells. Antiviral Res."/>
   <result pre="1995;27:425–430.8540761 [250]MehrbodP, Hair-BejoM, IbrahimTAT, et alSimvastatin modulates cellular components in" exact="influenza" post="A virus-infected cells. Int J Mol Med. 2014;34:61–73.24788303 [251]ComberJD,"/>
   <result pre="Med. 2014;34:61–73.24788303 [251]ComberJD, RobinsonTM, SicilianoNA, et alFunctional macroautophagy induction by" exact="influenza" post="A virus without a contribution to major histocompatibility complex"/>
   <result pre="2011;85:6453–6463.21525345 [252]ZhuH-Y, HanL, ShiX-L, et alBaicalin inhibits autophagy induced by" exact="influenza" post="A virus H3N2. Antiviral Res. 2015;113:62–70.25446340 [253]HaleBG, JacksonD, ChenYH,"/>
   <result pre="(2006) 14194–14199 [254]RenY, LiC, FengL, et alProton channel activity of" exact="influenza" post="A virus matrix protein 2 contributes to autophagy arrest."/>
   <result pre="[256]SuWC, YuWY, HuangSH, et alUbiquitination of the cytoplasmic domain of" exact="influenza" post="A virus M2 protein is crucial for production of"/>
   <result pre="2011;7:645–646.21460623 [258]LiuG, ZhongM, GuoC, et alAutophagy is involved in regulating" exact="influenza" post="A virus RNA and protein synthesis associated with both"/>
   <result pre="of cellular degradation. Science. 2000;290:1717–1721.11099404 [260]MaJ, SunQ, MiR, et alAvian" exact="influenza" post="A virus H5N1 causes autophagy-mediated cell death through suppression"/>
   <result pre="alAvian influenza A virus H5N1 causes autophagy-mediated cell death through" exact="suppression" post="of mTOR signaling. J Genet Genome. 2011;38:533–537. [261]SunY, LiC,"/>
   <result pre="et alInhibition of autophagy ameliorates acute lung injury caused by" exact="avian influenza" post="A H5N1 infection. Sci Signal. 2012;5:1r16. [262]EhrhardtC, MarjukiH, WolffT,"/>
   <result pre="alInhibition of autophagy ameliorates acute lung injury caused by avian" exact="influenza" post="A H5N1 infection. Sci Signal. 2012;5:1r16. [262]EhrhardtC, MarjukiH, WolffT,"/>
   <result pre="MarjukiH, WolffT, et alBivalent role of the phosphatidylinositol-3-kinase (PI3K) during" exact="influenza" post="virus infection and host cell defence. Cell Microbiol. 2006;8:1336–1348.16882036"/>
   <result pre="signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during" exact="influenza" post="A infection. Virology. 2014;452–453:175–190. [264]PulestonDJ, ZhangH, PowellTJ, et alAutophagy"/>
   <result pre="by Vici Syndrome Gene Epg5 and additional autophagy genes promotes" exact="influenza" post="pathogenesis. Cell Host Microbe. 2016;19:102–113.26764600 [266]ZhaoH, ZhaoYG, WangX, et"/>
   <result pre="BoussierJ, YatimN, et alAutophagy diminishes the early interferon-β response to" exact="influenza" post="A virus resulting in differential expression of interferon-stimulated genes."/>
   <result pre="Nat Immunol. 2013;14:480–488.23525089 [271]FeiziN, MehrbodP, RomaniB, et alAutophagy induction regulates" exact="influenza" post="virus replication in a time-dependent manner. J Med Microbiol."/>
   <result pre="Microbiol. 2017;2:1543–1557.28871090 [273]MoonHJ, NikapitiyaC, LeeH-C, et alInhibition of highly pathogenic" exact="avian influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="2017;2:1543–1557.28871090 [273]MoonHJ, NikapitiyaC, LeeH-C, et alInhibition of highly pathogenic avian" exact="influenza" post="(HPAI) virus by a peptide derived from vFLIP through"/>
   <result pre="[275]WuQM, LiuSL, ChenG, et alUncovering the Rab5-independent autophagic trafficking of" exact="influenza" post="A virus by quantum-dot-based single-virus tracking. Small. 2018;14:e1702841.29409147 [276]MoriI,"/>
   <result pre="[276]MoriI, KomatsuT, TakeuchiK, et alIn vivo induction of apoptosis by" exact="influenza" post="virus. J Gen Virol. 1995;76:2869–2873.7595397 [277]YangN, HongX, YangP, et"/>
   <result pre="2013;87:1049–1060.23135712 [279]YeganehB, GhavamiS, RahimMN, et alAutophagy activation is required for" exact="influenza" post="A virus-induced apoptosis and replication. Biochim Biophys Acta, Mol"/>
   <result pre="Res. 2018;1865:364–378.29108912 [280]McLeanJE, DatanE, MatassovD, et alLack of Bax prevents" exact="influenza" post="A virus-induced apoptosis and causes diminished viral replication. J"/>
   <result pre="OlsenCW, Dybdahl-SissokoN, et alApoptosis: a mechanism of cell killing by" exact="influenza" post="A and B viruses. J Virol. 1994;68:3667–3673.8189504 [282]OlsenCW, KehrenJC,"/>
   <result pre="viruses. J Virol. 1994;68:3667–3673.8189504 [282]OlsenCW, KehrenJC, Dybdahl-SissokoNR, et albcl-2 alters" exact="influenza" post="virus yield, spread, and hemagglutinin glycosylation. J Virol. 1996;70:663–666.8523590"/>
   <result pre="[283]GuanZ, ShiN, SongY, et alInduction of the cellular microRNA-29c by" exact="influenza" post="virus contributes to virus-mediated apoptosis through repression of antiapoptotic"/>
   <result pre="Biochem Biophys Res Commun. 2012;425:662–667.22850539 [284]LudwigS, WangX, EhrhardtC, et alThe" exact="influenza" post="A virus NS1 protein inhibits activation of Jun N-Terminal"/>
   <result pre="Virol. 2002;76:11166–11171.12368362 [285]LuX, MasicA, LiY, et alThe PI3K/Akt pathway inhibits" exact="influenza" post="A virus-induced Bax-mediated apoptosis by negatively regulating the JNK"/>
   <result pre="a transcriptome-driven network at the early stage of infection with" exact="influenza" post="A H1N1 in human lung alveolar epithelial cells. Biomol"/>
   <result pre="infections. Open Virol J. 2009;3:52–59.19572056 [288]MaoH, LiuY, SiaSF, et alAvian" exact="influenza" post="virus directly infects human natural killer cells and inhibits"/>
   <result pre="DengJ, LiC, et alCharacterization of the 2009 pandemic A/Beijing/501/2009 H1N1" exact="influenza" post="strain in human airway epithelial cells and ferrets. PLoS"/>
   <result pre="ferrets. PLoS ONE. 2012;7:e46184.23049974 [293]ZhangC, YangY, ZhouX, et alHighly pathogenic" exact="avian influenza" post="A virus H5N1 NS1 protein induces caspase-dependent apoptosis in"/>
   <result pre="PLoS ONE. 2012;7:e46184.23049974 [293]ZhangC, YangY, ZhouX, et alHighly pathogenic avian" exact="influenza" post="A virus H5N1 NS1 protein induces caspase-dependent apoptosis in"/>
   <result pre="[295]ShiozakiT, IwaiA, KawaokaY, et alRequirement for Siva-1 for replication of" exact="influenza" post="A virus through apoptosis induction. J Gen Virol. 2011;92:315–325.21048035"/>
   <result pre="FEBS Lett. 2009;583:2517–2520.19596000 [298]TinocoR, CarretteF, HenriquezML, et alFucosyltransferase induction during" exact="influenza" post="virus infection is required for the generation of functional"/>
   <result pre="YanoM, et alPrion protein protects mice from lethal infection with" exact="influenza" post="A viruses. PLoS Pathog. 2018;14:e1007049.29723291 [300]YangW, QuS, LiuQ, et"/>
   <result pre="A viruses. PLoS Pathog. 2018;14:e1007049.29723291 [300]YangW, QuS, LiuQ, et alAvian" exact="influenza" post="virus A/chicken/Hubei/489/2004 (H5N1) induces caspase-dependent apoptosis in a cell-specific"/>
   <result pre="the virulence of pandemic 2009 H1N1 and highly pathogenic H5N1" exact="avian influenza" post="viruses. Sci Rep. 2015;5:8262.25652161 [303]GaoZ, HuJ, WangX, et alThe"/>
   <result pre="virulence of pandemic 2009 H1N1 and highly pathogenic H5N1 avian" exact="influenza" post="viruses. Sci Rep. 2015;5:8262.25652161 [303]GaoZ, HuJ, WangX, et alThe"/>
   <result pre="nucleolin acts as an antiviral factor during highly pathogenic H5N1" exact="avian influenza" post="virus infection. Arch Virol. 2018;163:2775–2786.. [304]StawowczykM, Van ScoyS, KumarKP,"/>
   <result pre="acts as an antiviral factor during highly pathogenic H5N1 avian" exact="influenza" post="virus infection. Arch Virol. 2018;163:2775–2786.. [304]StawowczykM, Van ScoyS, KumarKP,"/>
   <result pre="Immunol. 2018;84:71–81.29428489 [306]WeinAN, DunbarPR, McMasterSR, et alIL-36γ protects against severe" exact="influenza" post="infection by promoting lung alveolar macrophage survival and limiting"/>
   <result pre="manner. J Virol. 2018;92:e00396–18.29743359 [308]Keshtkar-JahromiM, OuyangM, KeshtkarjahromiM, et alEffect of" exact="influenza" post="vaccine on tumor necrosis factor-like Weak inducer of apoptosis"/>
   <result pre="pro-inflammatory mediators in alveolar type II epithelial cells infected with" exact="influenza" post="virus A and B and with respiratory syncytial virus"/>
   <result pre="Microbiol. 2018;213:5–14.29292004 [311]CoombsKM, BerardA, XuW, et alQuantitative proteomic analyses of" exact="influenza" post="virus-infected cultured human lung cells. J Virol. 2010;84:10888–10906.20702633 [312]SimonPF,"/>
   <result pre="J Virol. 2010;84:10888–10906.20702633 [312]SimonPF, de La VegaMA, ParadisE, et alAvian" exact="influenza" post="viruses that cause highly virulent infections in humans exhibit"/>
   <result pre="signaling pathways are temporally high-jacked by the highly pathogenic 1918" exact="influenza" post="virus. EBioMedicine. 2018;32:142–163.29866590 [314]KroekerAL, EzzatiP, HalaykoAJ, et alResponse of"/>
   <result pre="HalaykoAJ, et alResponse of primary human airway epithelial cells to" exact="influenza" post="infection: a quantitative proteomic study. J Proteome Res. 2012;11:4132–4146.22694362"/>
   <result pre="Proteome Res. 2013;12:3139–3151.23750822 [316]NailwalH, SharmaS, MayankAK, et alThe nucleoprotein of" exact="influenza" post="A virus induces p53 signaling and apoptosis via attenuation"/>
   <result pre="Death Dis. 2015;6:e1768.25996295 [317]LiY, LinZ, GuoM, et alInhibition of H1N1" exact="influenza" post="virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through"/>
   <result pre="15920–15925 [322]GoodmanAG, SmithJA, BalachandranS, et alThe cellular protein P58IPK regulates" exact="influenza" post="virus mRNA translation and replication through a PKR-mediated mechanism."/>
   <result pre="J Virol. 2007;81:2221–2230.17166899 [323]FrabuttDA, WangB, RiazS, et alInnate sensing of" exact="influenza" post="A virus hemagglutinin glycoproteins by the host endoplasmic reticulum"/>
   <result pre="chloroquine on some clinical and biochemical parameters in non-response chronic" exact="hepatitis" post="C virus infection patients: pilot clinical trial. Acta Biomed."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6527078\results\search\disease\results.xml">
   <result pre="an immunoglobulin Y-alkaline phosphatase bioconjugate as a diagnostic tool for" exact="influenza" post="A virus B. OZKAN ET AL. BIOENGINEERED OzkanBusraaBudama-KilincYaseminaCakir-KocRabiaaMeseSevimbBadurSelimc[a], Department"/>
   <result pre="original work is properly cited.kbie-10-01-1586054.pdf Abstract ABSTRACT The diagnosis of" exact="influenza" post="A virus is essential since it can be confused"/>
   <result pre="A virus is essential since it can be confused with" exact="influenza" post="A like illness and lead to inaccurate drug prescription."/>
   <result pre="all virus subtypes, was used as a diagnostic marker of" exact="influenza" post="A. For the first time, M2e-specific IgY antibody was"/>
   <result pre="as Influenza A via the RT-PCR method. KEYWORDS Immunoglobulin Y" exact="influenza" post="A alkaline phosphatase ELISA methods diagnosis Funding The Scientific"/>
   <result pre="on an M2e peptide-specific IgY antibody for the diagnosis of" exact="influenza" post="A infection’ (Project No: 115S132); The Scientific and Technological"/>
   <result pre="in the winter season [1,2] The annual epidemics caused by" exact="influenza" post="A can be attributed to major mutations in the"/>
   <result pre="HA and NA, the M protein on the surface of" exact="influenza" post="A virus is the most conserved structural protein and"/>
   <result pre="is the most conserved structural protein and is similar among" exact="influenza" post="A virus species [6]. The M gene of influenza"/>
   <result pre="among influenza A virus species [6]. The M gene of" exact="influenza" post="A virus encodes M1 (a capsid protein) and M2"/>
   <result pre="composed of 24 amino acids, is highly conserved among human" exact="influenza" post="A viruses [2,8,12,15–18]. In particular, the N-terminal epitope of"/>
   <result pre="M2e, SLLTEVET (residues 2–9), is conserved among all subtypes of" exact="influenza" post="A viruses [2]. Furthermore, M2e is highly expressed on"/>
   <result pre="considered to be an excellent tool for the diagnosis of" exact="influenza" post="A virus [6]. The diagnosis of influenza A virus"/>
   <result pre="the diagnosis of influenza A virus [6]. The diagnosis of" exact="influenza" post="A virus is required for preventing outbreaks at health"/>
   <result pre="(ILIs) [20] . Various methods have been used to diagnose" exact="influenza" post="A, such as serologic tests, molecular methods, viral culture,"/>
   <result pre="is commonly used for the rapid and specific detection of" exact="influenza" post="A antigens particularly in clinical applications [22–24]. Monoclonal antibodies"/>
   <result pre="IgY antibody to ALP using glutaraldehyde for the detection of" exact="influenza" post="A. The novel structure was characterized by fluorescence and"/>
   <result pre="M2e-specific IgY-ALP conjugation and validate nasopharyngeal specimens tested positive for" exact="influenza" post="A by real-time reverse transcriptase PCR (rRT-PCR). Results The"/>
   <result pre="M2e-specific IgY-ALP bioconjugate in samples tested positive or negative for" exact="influenza" post="A. The cut-off value of the data was around"/>
   <result pre="is 0.257. Discussion Among the various methods used to identify" exact="influenza" post="A virus [35], ELISA is an attractive choice in"/>
   <result pre="[36]. In this study, IgY antibody, which is specific for" exact="influenza" post="A M2e peptide antigen, was conjugated with ALP enzyme"/>
   <result pre="the M2e peptide sequence is a common region among most" exact="influenza" post="subtypes including H1N1 and H3N2. In some cases, despite"/>
   <result pre="the value of M2e peptide for the diagnosis of the" exact="influenza" post="virus [39] and our present study also showed the"/>
   <result pre="as a diagnostic marker that can detect different types of" exact="influenza" post="A viruses. This study aims to demonstrate that the"/>
   <result pre="viruses. This study aims to demonstrate that the production of" exact="influenza" post="A virus M2e peptide sequence-specific IgY antibody, which was"/>
   <result pre="the conjugate of this IgY antibody and ALP enzyme, for" exact="influenza" post="A diagnosis in ELISA. Thus, a novel diagnostic method"/>
   <result pre="use of the anti-M2e-specific IgY antibody for the detection of" exact="influenza" post="A virus was developed. The results obtained suggest that"/>
   <result pre="and treatment group. In total, 15 hens were immunized with" exact="influenza" post="A virus, and five hens were used as the"/>
   <result pre="EZ1 Advanced XL device following the manufacturer’s instructions. Influenza A," exact="influenza" post="AH3, influenza AH1, influenza AH1pdm, RNase P forward primer"/>
   <result pre="XL device following the manufacturer’s instructions. Influenza A, influenza AH3," exact="influenza" post="AH1, influenza AH1pdm, RNase P forward primer and reverse"/>
   <result pre="following the manufacturer’s instructions. Influenza A, influenza AH3, influenza AH1," exact="influenza" post="AH1pdm, RNase P forward primer and reverse primer, and"/>
   <result pre="was selected as the target region for the detection of" exact="influenza" post="A. The hemaglutinin gene region was selected for sub-typing."/>
   <result pre="rRT-PCR. References References [1]PoonLL, LeungCS, ChanKH, et alDetection of human" exact="influenza" post="A viruses by loop-mediated isothermal amplification. J Clin Microbiol."/>
   <result pre="J Clin Microbiol. 2005;43:427–430.15635005 [2]De FiletteM, MartensW, RooseK, et alAn" exact="influenza" post="A vaccine based on tetrameric ectodomain of matrix protein"/>
   <result pre="Trends in infectious diseases. India: InTech; 2014. [5]AmanoY, ChengQ.Detection of" exact="influenza" post="virus: traditional approaches and development of biosensors. Anal Bioanal"/>
   <result pre="2005;381:156–164.15592819 [6]BucherD, MikhailA, PoppleS, et alRapid detection of type A" exact="influenza" post="viruses with monoclonal antibodies to the M protein (M1)"/>
   <result pre="peptide vaccine protects mice from lethal challenge with divergent H5N1" exact="influenza" post="viruses. Virol J. 2010;7:9.20082709 [9]YongCY, YeapSK, HoKL, et alPotential"/>
   <result pre="J. 2010;7:9.20082709 [9]YongCY, YeapSK, HoKL, et alPotential recombinant vaccine against" exact="influenza" post="A virus based on M2e displayed on nodaviral capsid"/>
   <result pre="antibody response to native form of matrix protein 2 of" exact="influenza" post="A viruses. J Immunol Methods. 2011;369:115–124.21570401 [11]HemmatzadehF, SumarningsihS, TariganS,"/>
   <result pre="M2e protein-based ELISA: A novel and inexpensive approach for differentiating" exact="avian influenza" post="infected chickens from vaccinated ones. PloS one. 2013;8:e56801.23437243 [12]De"/>
   <result pre="protein-based ELISA: A novel and inexpensive approach for differentiating avian" exact="influenza" post="infected chickens from vaccinated ones. PloS one. 2013;8:e56801.23437243 [12]De"/>
   <result pre="ones. PloS one. 2013;8:e56801.23437243 [12]De FiletteM, JouWM, BirkettA, et alUniversal" exact="influenza" post="A vaccine: optimization of M2-based constructs. Virology. 2005;337:149–161.15914228 [13]ZebedeeSL,"/>
   <result pre="alA lipopeptide based on the M2 and HA proteins of" exact="influenza" post="A viruses induces protective antibody. Immunol Cell Biol. 2010;88:605–611.20177411"/>
   <result pre="Biol. 2010;88:605–611.20177411 [15]LeeY-N, KimM-C, LeeY-T, et alMechanisms of cross-protection by" exact="influenza" post="virus M2-based vaccines. Immune Netw. 2015;15:213–221.26557805 [16]ZengW, TanACL, HorrocksK,"/>
   <result pre="HorrocksK, et alA lipidated form of the extracellular domain of" exact="influenza" post="M2 protein as a self-adjuvanting vaccine candidate. Vaccine. 2015;33:3526–3532.26049002"/>
   <result pre="effects of an M2-specific monoclonal antibody on different strains of" exact="influenza" post="A virus. Jpn J Vet Res. 2012;60:71–83.23094582 [18]MardanovaES, KotlyarovRY,"/>
   <result pre="[18]MardanovaES, KotlyarovRY, KuprianovVV, et alRapid high-yield expression of a candidate" exact="influenza" post="vaccine based on the ectodomain of M2 protein linked"/>
   <result pre="flagellin in plants using viral vectors. BMC Biotechnol. 2015;15:42.26022390 [19]SaelensXThe" exact="influenza" post="matrix protein 2 as a vaccine target. Future Medicine"/>
   <result pre="167-178. [20]BoivinG, HardyI, KressAEvaluation of a rapid optical immunoassay for" exact="influenza" post="viruses (FLU OIA test) in comparison with cell culture"/>
   <result pre="on emerging diagnostic assay for viral detection: the case of" exact="avian influenza" post="virus. Mol Biol Rep. 2015;42:187–199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et"/>
   <result pre="emerging diagnostic assay for viral detection: the case of avian" exact="influenza" post="virus. Mol Biol Rep. 2015;42:187–199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et"/>
   <result pre="Rep. 2015;42:187–199.25245956 [22]SoemaPC, KompierR, AmorijJ-P, et alCurrent and next generation" exact="influenza" post="vaccines: formulation and production strategies. Eur J Pharm Biopharm."/>
   <result pre="production strategies. Eur J Pharm Biopharm. 2015;94:251–263.26047796 [23]KumarS, HenricksonKJUpdate on" exact="influenza" post="diagnostics: lessons from the novel H1N1 influenza A pandemic."/>
   <result pre="[23]KumarS, HenricksonKJUpdate on influenza diagnostics: lessons from the novel H1N1" exact="influenza" post="A pandemic. Clin Microbiol Rev. 2012;25:344–361.22491775 [24]CoughlanL, LambeTMeasuring cellular"/>
   <result pre="a universally conserved m2e and hemagglutinin peptide-based elisa method against" exact="influenza" post="a. J Clin Anal Med. 2017;8:320–323. [36]EngvallE, PerlmannPEnzyme-linked immunosorbent"/>
   <result pre="alSynthesis and immunogenicity assessment of elastin-like polypeptide-M2e construct as an" exact="influenza" post="antigen. Nano Life. 2014;4:1450004.25825595 [38]KhuranaS, SasonoP, FoxA, et alH5N1-SeroDetect"/>
   <result pre="PLoS One. 2012;7:e40391.22808150 [44]collab: WHOCDC protocol of realtime RTPCR for" exact="influenza" post="A(H1N1). USA: WHO; 2009. [45]collab: WHOWHO information for molecular"/>
   <result pre="USA: WHO; 2009. [45]collab: WHOWHO information for molecular diagnosis of" exact="influenza" post="virus – update. China: WHO; 2018. [46]HeQ, VelumaniS, DuQ,"/>
   <result pre="China: WHO; 2018. [46]HeQ, VelumaniS, DuQ, et alDetection of H5" exact="avian influenza" post="viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal"/>
   <result pre="WHO; 2018. [46]HeQ, VelumaniS, DuQ, et alDetection of H5 avian" exact="influenza" post="viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6531038\results\search\disease\results.xml">
   <result pre="in recent years because of its causal association with severe" exact="microcephaly" post="and other congenital malformations. The diagnosis of viral infections"/>
   <result pre="confirmed ZIKV infection in utero, showed at birth a severe" exact="microcephaly" post="and clinical characteristics of fetal brain disruption sequence compatible"/>
   <result pre="regarding serological response in the ZIKV congenital infection. Keywords arboviruses" exact="microcephaly" post="serologic test syndrome ZIKA Virus 1 Introduction Zika virus"/>
   <result pre="recent years, mainly because of its causal association with severe" exact="microcephaly" post="and other congenital malformations.[1–4] The diagnosis of viral infections"/>
   <result pre="to dengue virus (DENV) tested positive, but was negative for" exact="chikungunya" post="virus. Fetal neurosonography and magnetic resonance imaging (MRI) revealed"/>
   <result pre="parenchyma calcifications, and severe atrophy (Fig. 2). Genetic, Toxoplasma gondii," exact="rubella" post="virus, cytomegalovirus, herpes virus I and II, and HIV"/>
   <result pre="contractures. Postnatal ultrasonography, computed tomography and MRI studies confirmed the" exact="microcephaly" post="with a thinned corpus callosum and brain atrophy with"/>
   <result pre="(A), axial (B), and sagittal (C) T2-weighted MR images showing" exact="microcephaly" post="and skull collapse. There is moderate ventricular dilatation, enlargement"/>
   <result pre="= ribonucleic acid, RT-PCR = reverse-transcriptase-polymerase-chain-reaction, TORCH = Toxoplasma gondii," exact="rubella" post="virus, cytomegalovirus, herpes virus I and II, and HIV,"/>
   <result pre="[6]MaldonadoYAReadJScollab: Committee on Infectious Diseases. Diagnosis, treatment, and prevention of" exact="congenital toxoplasmosis" post="in the United States. Pediatrics2017;139: [7]SinghAEGuenetteTGratrixJet al.Seroreversion of treponemal"/>
   <result pre="Committee on Infectious Diseases. Diagnosis, treatment, and prevention of congenital" exact="toxoplasmosis" post="in the United States. Pediatrics2017;139: [7]SinghAEGuenetteTGratrixJet al.Seroreversion of treponemal"/>
   <result pre="tests in infants meeting Canadian surveillance criteria for confirmed early" exact="congenital syphilis." post="Pediatr Infect Dis J2013;32:199–202.22976052 [8]PetersenEEStaplesJEMeaney-DelmanDet al.Interim guidelines for pregnant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6531141\results\search\disease\results.xml">
   <result pre="by non-ON1 strains. ON1 infection is more commonly diagnosed with" exact="bronchiolitis" post="and wheezing is a more common symptoms. However, for"/>
   <result pre="human respiratory syncytial virus genotype ON1 found in infants with" exact="pneumonia" post="in Beijing. China Emerg Microbes Infect2013;2:e22.26038462 [25]LiuJMuYDongWet al.Genetic variation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6532103\results\search\disease\results.xml">
   <result pre="Riel D. 2019. Viral factors important for efficient replication of" exact="influenza" post="A viruses in cells of the central nervous system."/>
   <result pre="is one of the most common extrarespiratory tract complications of" exact="influenza" post="A virus infections, and the frequency and severity differ"/>
   <result pre="the frequency and severity differ between seasonal, pandemic, and zoonotic" exact="influenza" post="viruses. However, little is known about the interaction of"/>
   <result pre="cells of the CNS. Differences among seasonal, pandemic, and zoonotic" exact="influenza" post="viruses in replication efficacy in CNS cells, in vitro,"/>
   <result pre="these viral factors and detailed knowledge of the interaction between" exact="influenza" post="virus and CNS cells are important to prevent and"/>
   <result pre="is one of the most common extrarespiratory tract complications of" exact="influenza" post="A virus infections. Remarkably, zoonotic H5N1 virus infections are"/>
   <result pre="more frequently associated with CNS disease than seasonal or pandemic" exact="influenza" post="viruses. Little is known about the interaction between influenza"/>
   <result pre="pandemic influenza viruses. Little is known about the interaction between" exact="influenza" post="A viruses and cells of the CNS; therefore, it"/>
   <result pre="the replication kinetics of a seasonal, pandemic, zoonotic, and lab-adapted" exact="influenza" post="A virus in human neuron-like (SK-N-SH) and astrocyte-like (U87-MG)"/>
   <result pre="cells and primary mouse cortex neurons. In general, highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 virus replicated most efficiently in all cells,"/>
   <result pre="and primary mouse cortex neurons. In general, highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 virus replicated most efficiently in all cells,"/>
   <result pre="sialic acids allowing efficient attachment contribute to the ability of" exact="influenza" post="A viruses to replicate efficiently in cells of the"/>
   <result pre="on potential viral factors important for the neurotropic potential of" exact="influenza" post="A viruses. IMPORTANCE Central nervous system (CNS) disease is"/>
   <result pre="is one of the most common extrarespiratory tract complications of" exact="influenza" post="A virus infections, and the frequency and severity differ"/>
   <result pre="the frequency and severity differ between seasonal, pandemic, and zoonotic" exact="influenza" post="viruses. However, little is known about the interaction of"/>
   <result pre="cells of the CNS. Differences among seasonal, pandemic, and zoonotic" exact="influenza" post="viruses in replication efficacy in CNS cells, in vitro,"/>
   <result pre="these viral factors and detailed knowledge of the interaction between" exact="influenza" post="virus and CNS cells are important to prevent and"/>
   <result pre="potentially lethal CNS disease. KEYWORDS CNS disease H1N1 H3N2 H5N1" exact="influenza" post="A virus encephalitis extrarespiratory pathogenesis viral replication virus attachment"/>
   <result pre="disease. KEYWORDS CNS disease H1N1 H3N2 H5N1 influenza A virus" exact="encephalitis" post="extrarespiratory pathogenesis viral replication virus attachment Funding ESCMID van"/>
   <result pre="word-count: INTRODUCTION One of the most common extrarespiratory complications of" exact="influenza" post="virus infection is central nervous system (CNS) disease (1,"/>
   <result pre="range from mild febrile seizures to severe or even fatal" exact="meningoencephalitis" post="(2, 3). Although most studies on influenza virus-associated CNS"/>
   <result pre="or even fatal meningoencephalitis (2, 3). Although most studies on" exact="influenza" post="virus-associated CNS disease have focused on influenza A viruses,"/>
   <result pre="most studies on influenza virus-associated CNS disease have focused on" exact="influenza" post="A viruses, viruses of type B are also able"/>
   <result pre="observed (2, 4). Influenza A viruses, hereinafter referred to as" exact="influenza" post="virus, have been linked to CNS disease since the"/>
   <result pre="as well as during seasonal epidemics, with sporadic detection of" exact="influenza" post="virus in the CNS or cerebral spinal fluid (CSF)"/>
   <result pre="CNS or cerebral spinal fluid (CSF) of humans (13–15). Zoonotic" exact="influenza" post="viruses only occasionally infect humans, but when they do,"/>
   <result pre="frequently associated with severe and systemic disease (1). Highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 and H7N9 viruses, two recent zoonotic influenza"/>
   <result pre="associated with severe and systemic disease (1). Highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 and H7N9 viruses, two recent zoonotic influenza"/>
   <result pre="avian influenza (HPAI) H5N1 and H7N9 viruses, two recent zoonotic" exact="influenza" post="viruses, are both associated with CNS disease (16–19). The"/>
   <result pre="(16–19). The HPAI H5N1 virus is possibly the most neurotropic" exact="influenza" post="virus known and has frequently been associated with CNS"/>
   <result pre="order to infect, replicate in, and spread throughout the CNS," exact="influenza" post="viruses first have to be able to enter the"/>
   <result pre="have to be able to enter the CNS. Entry of" exact="influenza" post="viruses into the CNS can occur via, for example,"/>
   <result pre="nerves and possibly other cranial nerves. The primary targets of" exact="influenza" post="viruses are, however, epithelial cells of the respiratory tract"/>
   <result pre="sialic acids (SA) present on host cells (33). Human and" exact="avian influenza" post="viruses attach preferentially to α-2,6- and α-2,3-linked SA, respectively,"/>
   <result pre="acids (SA) present on host cells (33). Human and avian" exact="influenza" post="viruses attach preferentially to α-2,6- and α-2,3-linked SA, respectively,"/>
   <result pre="and regions with and without detectable SA are infected with" exact="influenza" post="viruses (34). In another study, it was found that"/>
   <result pre="SA receptors have been found to be present on human" exact="neuroblastoma" post="SK-N-SH and SH-SY5Y and human glioblastoma T98G cell lines"/>
   <result pre="HA cleavage mechanism all seem to play important roles in" exact="influenza" post="virus infection and cell tropism as well as replication"/>
   <result pre="not much is known about the replication efficiency of different" exact="influenza" post="viruses, especially seasonal viruses, in cells of the CNS."/>
   <result pre="in cells of the CNS between seasonal, zoonotic, and pandemic" exact="influenza" post="viruses is currently lacking. Similarly, insights into the roles"/>
   <result pre="pandemic H1N1 (pH1N1), HPAI H5N1, and WSN viruses in human" exact="neuroblastoma" post="(SK-N-SH), human astrocytoma (U87-MG), primary mouse cortex neurons (pmCortex),"/>
   <result pre="HPAI H5N1, and WSN viruses in human neuroblastoma (SK-N-SH), human" exact="astrocytoma" post="(U87-MG), primary mouse cortex neurons (pmCortex), and Madin-Darby canine"/>
   <result pre="are viral factors that contribute to the neurotropic potential of" exact="influenza" post="viruses. This fits with the facts that HPAI H5N1"/>
   <result pre="is not the only viral factor involved in replication of" exact="influenza" post="viruses in cells of the CNS. The lack of"/>
   <result pre="explained by both inefficient attachment and infection. Efficient replication of" exact="influenza" post="viruses in cells of the CNS seems to depend"/>
   <result pre="hypothesis that for efficient replication in cells of the CNS," exact="influenza" post="viruses require alternative HA cleavage, as shown for the"/>
   <result pre="the respiratory tract. Previous studies on the replication kinetics of" exact="influenza" post="viruses in cells of the CNS revealed some differences,"/>
   <result pre="suggests that, at least for replication within the CNS, neurotropic" exact="influenza" post="viruses contain an alternative HA cleavage mechanism and prefer"/>
   <result pre="and prefer α-2,3-linked sialic acids. MATERIALS AND METHODS Cells. Human" exact="neuroblastoma" post="(neuron like, SK-N-SH) and human glioblastoma (astrocyte like, U87-MG)"/>
   <result pre="kidney (MDCK) cells, since these cells are extensively used for" exact="influenza" post="virus propagation. MDCK cells were maintained in EMEM supplemented"/>
   <result pre="Dako, Denmark) in PBS for 10 min on ice. Next," exact="influenza" post="A virus was detected using a monoclonal antibody against"/>
   <result pre="influenza A virus was detected using a monoclonal antibody against" exact="influenza" post="A virus nucleoprotein (clone HB-65, 1 μg/ml; ATCC) or"/>
   <result pre="was calculated and used for further analysis. Virus attachment. For" exact="influenza" post="virus histochemistry, viruses were grown, inactivated, and labeled as"/>
   <result pre="an ESCMID research grant. References REFERENCES 1.KuikenT, TaubenbergerJK2008Pathology of human" exact="influenza" post="revisited. Vaccine26:D59–D66. doi:10.1016/j.vaccine.2008.07.025.19230162 2.SellersSA, HaganRS, HaydenFG, FischerWAII.2017The hidden burden"/>
   <result pre="burden of influenza: a review of the extra-pulmonary complications of" exact="influenza" post="infection. Influenza Other Respir Viruses11:372–393. doi:10.1111/irv.12470.28745014 3.TooveyS2008Influenza-associated central nervous"/>
   <result pre="4.PopescuCP, FlorescuSA, LupulescuE, ZahariaM, TardeiG, LazarM, CeausuE, RutaSM2017Neurologic complications of" exact="influenza" post="B virus infection in adults, Romania. Emerg Infect Dis23:574–581."/>
   <result pre="in adults, Romania. Emerg Infect Dis23:574–581. doi:10.3201/eid2304.161317.28322689 5.MauriziCP2010Influenza caused epidemic" exact="encephalitis" post="(encephalitis lethargica): the circumstantial evidence and a challenge to"/>
   <result pre="HamHJ, AndewegAC, BushmakerT, ScottDP, SaturdayG, MunsterVJ, FeldmannH, van RielD20181918 H1N1" exact="influenza" post="virus replicates and induces pro-inflammatory cytokine responses in extrarespiratory"/>
   <result pre="extrarespiratory tissues of ferrets. J Infect Dis217:1237–1246. doi:10.1093/infdis/jiy003.29329410 7.FlewettTH, HoultJG1958Influenzal" exact="encephalopathy" post="and postinfluenzal encephalitis. Lancet2:11–15.13564746 8.McConkeyCB, DawsRA1958Neurological disorders associated with"/>
   <result pre="South-east Wales. Br Med J1:369–373. doi:10.1136/bmj.1.5745.369.4322460 10.ThraenhartO, SchleyG, KuwertE1975Isolation of" exact="influenza" post="virus &quot;A/Hong Kong/1/68 (H3N2)�? from liquor cerebrospinalis of patients"/>
   <result pre="SnellingT, WhiteheadB, JonesC, HeronL, McCaskillM, MacartneyK, ElliottEJ, BooyR2012Neurologic complications of" exact="influenza" post="A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology79:1474–1481. doi:10.1212/WNL.0b013e31826d5ea7.22993280 12.SimonM,"/>
   <result pre="pediatric hospitals. Neurology79:1474–1481. doi:10.1212/WNL.0b013e31826d5ea7.22993280 12.SimonM, HernuR, CourM, CasalegnoJS, LinaB, ArgaudL2013Fatal" exact="influenza" post="A(H1N1)pdm09 encephalopathy in immunocompetent man. Emerg Infect Dis19:1005–1007. doi:10.3201/eid1906.130062.23735733"/>
   <result pre="Neurology79:1474–1481. doi:10.1212/WNL.0b013e31826d5ea7.22993280 12.SimonM, HernuR, CourM, CasalegnoJS, LinaB, ArgaudL2013Fatal influenza A(H1N1)pdm09" exact="encephalopathy" post="in immunocompetent man. Emerg Infect Dis19:1005–1007. doi:10.3201/eid1906.130062.23735733 13.van RielD,"/>
   <result pre="VerdijkRM, GeurtsvanKesselC, van der VriesE, van RossumAM, OsterhausAD, KuikenT2014Evidence for" exact="influenza" post="virus CNS invasion along the olfactory route in an"/>
   <result pre="MakiN, TogariH, WadaY1998PCR on cerebrospinal fluid to show influenza-associated acute" exact="encephalopathy" post="or encephalitis. Lancet352:873–875. doi:10.1016/S0140-6736(98)12449-2.9742980 15.Fernandez-BlazquezA, Castanon-ApilanezM, Alvarez-ArguellesME, Sabater-CabreraC, Rojo-AlbaS,"/>
   <result pre="Sabater-CabreraC, Rojo-AlbaS, BogaJA, de la TassaGM, Quindos FernandezB, MelonS5112018Neuroinvasion of" exact="influenza" post="A/H3N2: a fatal case in an immunocompetent adult. J"/>
   <result pre="VoMH, TranTT, NguyenBH, BeldM, LeTP, TruongHK, NguyenVV, TranTH, DoQH, FarrarJ2005Fatal" exact="avian influenza" post="A (H5N1) in a child presenting with diarrhea followed"/>
   <result pre="TranTT, NguyenBH, BeldM, LeTP, TruongHK, NguyenVV, TranTH, DoQH, FarrarJ2005Fatal avian" exact="influenza" post="A (H5N1) in a child presenting with diarrhea followed"/>
   <result pre="FarrarJ2005Fatal avian influenza A (H5N1) in a child presenting with" exact="diarrhea" post="followed by coma. N Engl J Med352:686–691. doi:10.1056/NEJMoa044307.15716562 18.GaoR,"/>
   <result pre="GaoGF, WuG, WangY, YuanZ, ShuY2013Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N Engl J Med368:1888–1897. doi:10.1056/NEJMoa1304459.23577628 19.UyekiTM,"/>
   <result pre="(H7N9) virus. N Engl J Med368:1888–1897. doi:10.1056/NEJMoa1304459.23577628 19.UyekiTM, KatzJM, JerniganDB2017Novel" exact="influenza" post="A viruses and pandemic threats. Lancet389:2172–2174. doi:10.1016/S0140-6736(17)31274-6.28589883 20.ThanawongnuwechR, AmonsinA,"/>
   <result pre="TunakE, SongsermT, VivatthanavanichV, LekdumrongsakT, KesdangsakonwutS, TunhikornS, PoovorawanY2005Probable tiger-to-tiger transmission of" exact="avian influenza" post="H5N1. Emerg Infect Dis11:699–701. doi:10.3201/eid1105.050007.15890122 21.KeawcharoenJ, OraveerakulK, KuikenT, FouchierRA,"/>
   <result pre="SongsermT, VivatthanavanichV, LekdumrongsakT, KesdangsakonwutS, TunhikornS, PoovorawanY2005Probable tiger-to-tiger transmission of avian" exact="influenza" post="H5N1. Emerg Infect Dis11:699–701. doi:10.3201/eid1105.050007.15890122 21.KeawcharoenJ, OraveerakulK, KuikenT, FouchierRA,"/>
   <result pre="PayungpornS, NoppornpanthS, WattanodornS, TheambooniersA, TantilertcharoenR, PattanarangsanR, AryaN, RatanakornP, OsterhausDM, PoovorawanY2004Avian" exact="influenza" post="H5N1 in tigers and leopards. Emerg Infect Dis10:2189–2191. doi:10.3201/eid1012.040759.15663858"/>
   <result pre="stone marten (Martes foina) after natural infection with highly pathogenic" exact="avian influenza" post="virus subtype H5N1. J Comp Pathol137:155–159. doi:10.1016/j.jcpa.2007.06.001.17689552 24.SchrauwenEJ, HerfstS,"/>
   <result pre="marten (Martes foina) after natural infection with highly pathogenic avian" exact="influenza" post="virus subtype H5N1. J Comp Pathol137:155–159. doi:10.1016/j.jcpa.2007.06.001.17689552 24.SchrauwenEJ, HerfstS,"/>
   <result pre="HattaY, GaoP, OzawaM, LeQM, KawaokaY2011Subclinical brain injury caused by H5N1" exact="influenza" post="virus infection. J Virol85:5202–5207. doi:10.1128/JVI.00239-11.21389133 26.BodewesR, KreijtzJH, van AmerongenG,"/>
   <result pre="KimuraT, OchiaiK, UmemuraT2002The invasion routes of neurovirulent A/Hong Kong/483/97 (H5N1)" exact="influenza" post="virus into the central nervous system after respiratory infection"/>
   <result pre="MiddletonD2012Multiple routes of invasion of wild-type clade 1 highly pathogenic" exact="avian influenza" post="H5N1 virus into the central nervous system (CNS) after"/>
   <result pre="routes of invasion of wild-type clade 1 highly pathogenic avian" exact="influenza" post="H5N1 virus into the central nervous system (CNS) after"/>
   <result pre="doi:10.1007/s00401-012-1010-8.22763823 29.ShinyaK, ShimadaA, ItoT, OtsukiK, MoritaT, TanakaH, TakadaA, KidaH, UmemuraT2000Avian" exact="influenza" post="virus intranasally inoculated infects the central nervous system of"/>
   <result pre="OzakiH, TakadaA, UmemuraT, KidaH2003Neurotropism of the 1997 Hong Kong H5N1" exact="influenza" post="virus in mice. Vet Microbiol95:1–13. doi:10.1016/S0378-1135(03)00132-9.12860072 31.MatsudaK, ParkCH, SundenY,"/>
   <result pre="nerve is one route of transneural invasion for intranasally inoculated" exact="influenza" post="a virus in mice. Vet Pathol41:101–107. doi:10.1354/vp.41-2-101.15017022 32.van RielD,"/>
   <result pre="32.van RielD, MunsterVJ, de WitE, RimmelzwaanGF, FouchierRA, OsterhausAD, KuikenT2007Human and" exact="avian influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="RielD, MunsterVJ, de WitE, RimmelzwaanGF, FouchierRA, OsterhausAD, KuikenT2007Human and avian" exact="influenza" post="viruses target different cells in the lower respiratory tract"/>
   <result pre="KawaokaY2012The role of receptor binding specificity in interspecies transmission of" exact="influenza" post="viruses. Curr Opin Virol2:160–167. doi:10.1016/j.coviro.2012.03.003.22445963 34.KimM, YuJE, LeeJH, ChangBJ,"/>
   <result pre="34.KimM, YuJE, LeeJH, ChangBJ, SongCS, LeeB, PaikDJ, NahmSS2013Comparative analyses of" exact="influenza" post="virus receptor distribution in the human and mouse brains."/>
   <result pre="Am J Pathol164:419–428. doi:10.1016/S0002-9440(10)63132-X.14742248 36.NgYP, LeeSM, CheungTK, NichollsJM, PeirisJS, IpNY2010Avian" exact="influenza" post="H5N1 virus induces cytopathy and proinflammatory cytokine responses in"/>
   <result pre="WangJR, ChangCF2012Cell surface sialylation affects binding of enterovirus 71 to" exact="rhabdomyosarcoma" post="and neuroblastoma cells. BMC Microbiol12:162. doi:10.1186/1471-2180-12-162.22853823 38.StevensJ, BlixtO, GlaserL,"/>
   <result pre="surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and" exact="neuroblastoma" post="cells. BMC Microbiol12:162. doi:10.1186/1471-2180-12-162.22853823 38.StevensJ, BlixtO, GlaserL, TaubenbergerJK, PaleseP,"/>
   <result pre="WilsonIA2006Glycan microarray analysis of the hemagglutinins from modern and pandemic" exact="influenza" post="viruses reveals different receptor specificities. J Mol Biol355:1143–1155. doi:10.1016/j.jmb.2005.11.002.16343533"/>
   <result pre="different receptor specificities. J Mol Biol355:1143–1155. doi:10.1016/j.jmb.2005.11.002.16343533 39.WuW, AirGM2004Binding of" exact="influenza" post="viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin"/>
   <result pre="on macrophages and dendritic cells for attachment and entry of" exact="influenza" post="virus. J Leukoc Biol92:97–106. doi:10.1189/jlb.1011492.22124137 41.BertramS, GlowackaI, SteffenI, KuhlA,"/>
   <result pre="41.BertramS, GlowackaI, SteffenI, KuhlA, PohlmannS2010Novel insights into proteolytic cleavage of" exact="influenza" post="virus hemagglutinin. Rev Med Virol20:298–310. doi:10.1002/rmv.657.20629046 42.SchrauwenEJ, de GraafM,"/>
   <result pre="42.SchrauwenEJ, de GraafM, HerfstS, RimmelzwaanGF, OsterhausAD, FouchierRA2014Determinants of virulence of" exact="influenza" post="A virus. Eur J Clin Microbiol Infect Dis33:479–490. doi:10.1007/s10096-013-1984-8.24078062"/>
   <result pre="therapeutics. Eur J Cell Biol94:375–383. doi:10.1016/j.ejcb.2015.05.013.26095298 44.Bottcher-FriebertshauserE, KlenkHD, GartenW2013Activation of" exact="influenza" post="viruses by proteases from host cells and bacteria in"/>
   <result pre="of a multibasic cleavage site in the haemagglutinin of human" exact="influenza" post="H3N2 virus does not increase pathogenicity in ferrets. J"/>
   <result pre="YamamotoT, OkadaH1995The substantia nigra is a major target for neurovirulent" exact="influenza" post="A virus. J Exp Med181:2161–2169. doi:10.1084/jem.181.6.2161.7760004 50.AronssonF, RobertsonB, LjunggrenHG,"/>
   <result pre="doi:10.1084/jem.181.6.2161.7760004 50.AronssonF, RobertsonB, LjunggrenHG, KristenssonK2003Invasion and persistence of the neuroadapted" exact="influenza" post="virus A/WSN/33 in the mouse olfactory system. Viral Immunol16:415–423."/>
   <result pre="LoJYC, PeirisM, LeungCW2018Influenza A(H5N1) virus infection in a child with" exact="encephalitis" post="complicated by obstructive hydrocephalus. Clin Infect Dis66:136–139. doi:10.1093/cid/cix707.29020163 52.PringproaK,"/>
   <result pre="A(H5N1) virus infection in a child with encephalitis complicated by" exact="obstructive hydrocephalus." post="Clin Infect Dis66:136–139. doi:10.1093/cid/cix707.29020163 52.PringproaK, RungsiwiwutR, TantilertcharoenR, PraphetR, PruksananondaK,"/>
   <result pre="cells-derived neural progenitors upon inoculation with highly- pathogenic avian H5N1" exact="influenza" post="virus. PLoS One10:e0135850. doi:10.1371/journal.pone.0135850.26274828 53.LinX, WangR, ZhangJ, SunX, ZouZ,"/>
   <result pre="by microarray analysis. Viruses7:2618–2640. doi:10.3390/v7052618.26008703 54.NgYP, YipTF, PeirisJSM, IpNY, LeeS2018Avian" exact="influenza" post="A H7N9 virus infects human astrocytes and neuronal cells"/>
   <result pre="55.ZhangZ, ZhangJ, HuangK, LiKS, YuenKY, GuanY, ChenH, NgWF2009Systemic infection of" exact="avian influenza" post="A virus H5N1 subtype in humans. Hum Pathol40:735–739. doi:10.1016/j.humpath.2008.08.015.19121843"/>
   <result pre="ZhangJ, HuangK, LiKS, YuenKY, GuanY, ChenH, NgWF2009Systemic infection of avian" exact="influenza" post="A virus H5N1 subtype in humans. Hum Pathol40:735–739. doi:10.1016/j.humpath.2008.08.015.19121843"/>
   <result pre="Hum Pathol40:735–739. doi:10.1016/j.humpath.2008.08.015.19121843 56.ZitzowLA, RoweT, MorkenT, ShiehWJ, ZakiS, KatzJM2002Pathogenesis of" exact="avian influenza" post="A (H5N1) viruses in ferrets. J Virol76:4420–4429. doi:10.1128/JVI.76.9.4420-4429.2002.11932409 57.LipatovAS,"/>
   <result pre="Pathol40:735–739. doi:10.1016/j.humpath.2008.08.015.19121843 56.ZitzowLA, RoweT, MorkenT, ShiehWJ, ZakiS, KatzJM2002Pathogenesis of avian" exact="influenza" post="A (H5N1) viruses in ferrets. J Virol76:4420–4429. doi:10.1128/JVI.76.9.4420-4429.2002.11932409 57.LipatovAS,"/>
   <result pre="KraussS, GuanY, PeirisM, RehgJE, PerezDR, WebsterRG2003Neurovirulence in mice of H5N1" exact="influenza" post="virus genotypes isolated from Hong Kong poultry in 2001."/>
   <result pre="HashikawaT, KurataT2004Productive infection in the murine central nervous system with" exact="avian influenza" post="virus A (H5N1) after intranasal inoculation. Acta Neuropathol108:485–492. doi:10.1007/s00401-004-0909-0.15480712"/>
   <result pre="KurataT2004Productive infection in the murine central nervous system with avian" exact="influenza" post="virus A (H5N1) after intranasal inoculation. Acta Neuropathol108:485–492. doi:10.1007/s00401-004-0909-0.15480712"/>
   <result pre="HalfmannP, KawaokaY2001Molecular basis for high virulence of Hong Kong H5N1" exact="influenza" post="A viruses. Science293:1840–1842. doi:10.1126/science.1062882.11546875 60.MunsterVJ, SchrauwenEJ, de WitE, van"/>
   <result pre="a multibasic cleavage motif into the hemagglutinin of a low-pathogenic" exact="avian influenza" post="H6N1 virus induces a highly pathogenic phenotype. J Virol84:7953–7960."/>
   <result pre="multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian" exact="influenza" post="H6N1 virus induces a highly pathogenic phenotype. J Virol84:7953–7960."/>
   <result pre="Virol84:7953–7960. doi:10.1128/JVI.00449-10.20519405 61.RimmelzwaanGF, KuikenT, van AmerongenG, BestebroerTM, FouchierRA, OsterhausAD2001Pathogenesis of" exact="influenza" post="A (H5N1) virus infection in a primate model. J"/>
   <result pre="CherninskyA, KarlssonH, Grassi-ZucconiG, BertiniG, HarkanyT, LjungbergK, LiljestromP, HokfeltTG, BentivoglioM, KristenssonK2016H1N1" exact="influenza" post="virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory"/>
   <result pre="63.LiS, SchulmanJ, ItamuraS, PaleseP1993Glycosylation of neuraminidase determines the neurovirulence of" exact="influenza" post="A/WSN/33 virus. J Virol67:6667–6673.8411368 64.GotoH, WellsK, TakadaA, KawaokaY2001Plasminogen-binding activity"/>
   <result pre="WellsK, TakadaA, KawaokaY2001Plasminogen-binding activity of neuraminidase determines the pathogenicity of" exact="influenza" post="A virus. J Virol75:9297–9301. doi:10.1128/JVI.75.19.9297-9301.2001.11533192 65.TumpeyTM, BaslerCF, AguilarPV, ZengH,"/>
   <result pre="CoxNJ, KatzJM, TaubenbergerJK, PaleseP, Garcia-SastreA2005Characterization of the reconstructed 1918 Spanish" exact="influenza" post="pandemic virus. Science310:77–80. doi:10.1126/science.1119392.16210530 66.ChaipanC, KobasaD, BertramS, GlowackaI, SteffenI,"/>
   <result pre="TakedaM, BuggeTH, KimS, ParkY, MarziA, PohlmannS2009Proteolytic activation of the 1918" exact="influenza" post="virus hemagglutinin. J Virol83:3200–3211. doi:10.1128/JVI.02205-08.19158246 67.SantiniM, KutlesaM, ZarkovicK, DrazenovicV,"/>
   <result pre="Virol83:3200–3211. doi:10.1128/JVI.02205-08.19158246 67.SantiniM, KutlesaM, ZarkovicK, DrazenovicV, BarsicB2012Influenza A 2009 H1N1" exact="encephalitis" post="in adults with viral RNA in cerebrospinal fluid. Scand"/>
   <result pre="spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic" exact="avian influenza" post="H5N1 virus infections in ferrets. PLoS One7:e42343. doi:10.1371/journal.pone.0042343.22905124 69.MinJY,"/>
   <result pre="dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian" exact="influenza" post="H5N1 virus infections in ferrets. PLoS One7:e42343. doi:10.1371/journal.pone.0042343.22905124 69.MinJY,"/>
   <result pre="One7:e42343. doi:10.1371/journal.pone.0042343.22905124 69.MinJY, ChenGL, SantosC, LamirandeEW, MatsuokaY, SubbaraoK2010Classical swine H1N1" exact="influenza" post="viruses confer cross protection from swine-origin 2009 pandemic H1N1"/>
   <result pre="influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1" exact="influenza" post="virus infection in mice and ferrets. Virology408:128–133. doi:10.1016/j.virol.2010.09.009.20926110 70.HosseiniS,"/>
   <result pre="WilkE, Michaelsen-PreusseK, GerhauserI, BaumgartnerW, GeffersR, SchughartK, KorteM2018Long-term neuroinflammation induced by" exact="influenza" post="A virus infection and the impact on hippocampal neuron"/>
   <result pre="72.de WitE, SpronkenMI, VervaetG, RimmelzwaanGF, OsterhausAD, FouchierRA2007A reverse-genetics system for" exact="influenza" post="A virus using T7 RNA polymerase. J Gen Virol88:1281–1287."/>
   <result pre="titration of infectious virus and immunofluorescence as methods for monitoring" exact="influenza" post="virus replication in vitro. J Virol Methods74:57–66. doi:10.1016/S0166-0934(98)00071-8.9763129 74.KärberG1931Beitrag"/>
   <result pre="Arch Exp Pathol Pharmakol162:480–483. doi:10.1007/BF01863914. 75.Böttcher-FriebertshäuserE, SteinDA, KlenkHD, GartenW2011Inhibition of" exact="influenza" post="virus infection in human airway cell cultures by an"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6534195\results\search\disease\results.xml">
   <result pre="(hazard ratio [HR], 0.24; 95% confidence interval [CI], .14–.44) or" exact="influenza" post="virus (HR, 0.52; 95% CI, .38–.73) conferred relative protection"/>
   <result pre="be protected against subsequent infection with adenovirus, coronavirus, enterovirus/rhinovirus, and" exact="influenza" post="virus (P = .062–.093), while men with influenza virus–positive"/>
   <result pre="enterovirus/rhinovirus, and influenza virus (P = .062–.093), while men with" exact="influenza" post="virus–positive FRI episodes tended be protected against subsequent infection"/>
   <result pre="protected against subsequent infection with adenovirus (P = .044) and" exact="influenza" post="virus (P = .081). Conclusion Prior adenovirus or influenza"/>
   <result pre="and influenza virus (P = .081). Conclusion Prior adenovirus or" exact="influenza" post="virus infection conferred cross-protection against subsequent FRI episodes relative"/>
   <result pre="viruses. As previously reported, the rollout of routine trivalent seasonal" exact="influenza" post="vaccination in the Singapore Armed Forces was accompanied by"/>
   <result pre="accompanied by a dramatic decline in the incidence of laboratory-confirmed" exact="influenza" post="virus infections but a much less noticeable decrease in"/>
   <result pre="data, to account for some degree of replacement for the" exact="influenza" post="virus infections averted through vaccination [15]. In this article,"/>
   <result pre="15 December 2009 and 31 December 2014, during which inactivated" exact="influenza" post="vaccine was routinely administered to recruits who did not"/>
   <result pre="did not have any contraindications. This was initially a monovalent" exact="influenza" post="vaccine (MIV) containing only 2009 pandemic influenza A(H1N1) virus"/>
   <result pre="initially a monovalent influenza vaccine (MIV) containing only 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), for recruits who enlisted between 11"/>
   <result pre="4 October 2010. The MIV was superseded by a trivalent" exact="influenza" post="vaccine (TIV) that included A(H1N1)pdm09, for recruits who enlisted"/>
   <result pre="C, Levels within multilevel analysis. AdV, adenovirus; CoV, coronavirus; FluV," exact="influenza" post="virus; hMPV, human metapneumovirus; NA, not applicable; RSV, respiratory"/>
   <result pre="and other CoVs; enteroviruses and rhinoviruses (ERVs); human metapneumovirus (hMPV);" exact="influenza" post="virus (FluV)—influenza A(H3N2) virus, 2009 pandemic influenza A(H1N1) virus"/>
   <result pre="human metapneumovirus (hMPV); influenza virus (FluV)—influenza A(H3N2) virus, 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), influenza A(H1N1) virus, influenza A virus–positive"/>
   <result pre="virus (FluV)—influenza A(H3N2) virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09)," exact="influenza" post="A(H1N1) virus, influenza A virus–positive samples for which the"/>
   <result pre="virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H1N1) virus," exact="influenza" post="A virus–positive samples for which the subtype was undetermined,"/>
   <result pre="A virus–positive samples for which the subtype was undetermined, and" exact="influenza" post="B virus; human parainfluenza virus (hPIV)—types 1–4; and respiratory"/>
   <result pre="and ethnicity, type of BMT intake, history of smoking and" exact="asthma" post="(including childhood asthma), and receipt of influenza vaccine before"/>
   <result pre="of smoking and asthma (including childhood asthma), and receipt of" exact="influenza" post="vaccine before the FRI episode. Assessment of whether the"/>
   <result pre="years), and 99.9% were male. A total of 83.6% received" exact="influenza" post="vaccine in the past 1 year (with only 113"/>
   <result pre="1.95 (1.18–3.25)  Current 1253 120 (9.6) 1.48 (1.19–1.85) History of" exact="asthma" post=" No 4340 326 (7.5) Reference .812  Yes 1337 97"/>
   <result pre=" Yes 1337 97 (7.3) .08 (.07–.09) Influenza vaccinationc  No recent" exact="influenza" post="vaccination 930 97 (10.4) Reference .003  MIV for A(H1N1)pdm09"/>
   <result pre="TIV 47 3 (6.4) .59 (.18–1.92) Abbreviations: A(H1N1)pdm09, 2009 pandemic" exact="influenza" post="A(H1N1) virus; BMT, basic military training; CI, confidence interval;"/>
   <result pre="virus; BMT, basic military training; CI, confidence interval; MIV, monovalent" exact="influenza" post="vaccine; OR, odds ratio; TIV, trivalent influenza vaccine. aBy"/>
   <result pre="interval; MIV, monovalent influenza vaccine; OR, odds ratio; TIV, trivalent" exact="influenza" post="vaccine. aBy the Fisher exact test, comparing participants with"/>
   <result pre="870 [14.2%], including 138, 137, and 568 positive for A(H1N1)pdm09," exact="influenza" post="A(H3N2) virus, and influenza B virus, respectively), AdV (in"/>
   <result pre="137, and 568 positive for A(H1N1)pdm09, influenza A(H3N2) virus, and" exact="influenza" post="B virus, respectively), AdV (in 677 [11.0%], including 121"/>
   <result pre="0 (0.0)a Abbreviations: AdV, adenovirus; CoV, coronavirus; ERV, enterovirus/rhinovirus; FluV," exact="influenza" post="virus; hMPV, human metapneumovirus; hPIV, human parainfluenza virus; RSV,"/>
   <result pre="a sharp decline following routine administration of TIV. However, considerable" exact="influenza" post="A(H3N2) virus and influenza B virus activity was observed"/>
   <result pre="routine administration of TIV. However, considerable influenza A(H3N2) virus and" exact="influenza" post="B virus activity was observed from April 2013 through"/>
   <result pre="B and D, Distribution of FRI episodes due to any" exact="influenza" post="virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2)"/>
   <result pre="of FRI episodes due to any influenza virus, 2009 pandemic" exact="influenza" post="A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2) virus, and influenza B"/>
   <result pre="to any influenza virus, 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09)," exact="influenza" post="A(H3N2) virus, and influenza B virus, by calendar time"/>
   <result pre="2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09), influenza A(H3N2) virus, and" exact="influenza" post="B virus, by calendar time (B) and week after"/>
   <result pre="BMT enlistment (D). Gray shading denotes the period when trivalent" exact="influenza" post="vaccine was routinely administered to incoming recruits. Prior Infection"/>
   <result pre="virus. B, Exposure status for adenovirus. C, Exposure status for" exact="influenza" post="virus. P values were calculated by log-rank tests to"/>
   <result pre="AdV, adenovirus; CI, confidence interval; CoV, coronavirus; ERV, enterovirus/rhinovirus; FluV," exact="influenza" post="virus; HR, hazard ratio; hMPV, human metapneumovirus; hPIV, human"/>
   <result pre="BMT intake, age, ethnicity, smoking history, history of asthma, and" exact="influenza" post="vaccination. cNot adjusted for FRI incidence rate by time"/>
   <result pre="infection. The observation of influenza’s protection against subsequent episodes of" exact="influenza" post="(mostly due to other types/subtypes in our data, in"/>
   <result pre="interference after accounting for seasonal factors, suggesting that epidemics of" exact="influenza" post="virus and rhinovirus infection tend to shift the timing"/>
   <result pre="inversely associated with the probability of observing adenovirus [12] and" exact="influenza" post="virus infections, with the latter 2 viral infections framed"/>
   <result pre="weak, time-limited protection, with the stronger effects from adenovirus and" exact="influenza" post="virus becoming apparent when aggregating data over the full"/>
   <result pre="to explain the extent of cross-protection observed with adenovirus and" exact="influenza" post="virus infections relative to other FRI episodes. Other proposed"/>
   <result pre="suspected on the basis of time-series analyses, such as how" exact="influenza" post="epidemics potentially delay RSV epidemics [8, 25]. They also"/>
   <result pre="for mechanisms on common factors induced by both adenovirus and" exact="influenza" post="virus. Notably, our previous studies suggest that infections with"/>
   <result pre="relative cross-protection against subsequent FRI episodes conferred by adenovirus and" exact="influenza" post="virus infections. In summary, our study demonstrated broad-based viral"/>
   <result pre="a population of military recruits. Infections from the adenovirus and" exact="influenza" post="virus families conferred significant cross-protective effects against subsequent FRI"/>
   <result pre="Clin1988; 38:280–90.2458172 4.ChanKF, CarolanLA, KorenkovD, et al.Investigating viral interference between" exact="influenza" post="a virus and human respiratory syncytial virus in a"/>
   <result pre="5.Costa-HurtadoM, AfonsoCL, MillerPJ, et al.Virus interference between H7N2 low pathogenic" exact="avian influenza" post="virus and lentogenic Newcastle disease virus in experimental co-infections"/>
   <result pre="AfonsoCL, MillerPJ, et al.Virus interference between H7N2 low pathogenic avian" exact="influenza" post="virus and lentogenic Newcastle disease virus in experimental co-infections"/>
   <result pre="infections and viral hierarchy are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. J Infect Dis2015;"/>
   <result pre="One2015; 10:e0125447.25928217 8.AstenL van, BijkerkP, FanoyE, et al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
   <result pre="9.ZhengX, SongZ, LiY, ZhangJ, WangX-LPossible interference between seasonal epidemics of" exact="influenza" post="and other respiratory viruses in Hong Kong, 2014–2017. BMC"/>
   <result pre="OttmannM, DuchampMB, et al.Rhinoviruses delayed the circulation of the pandemic" exact="influenza" post="A (H1N1) 2009 virus in France. Clin Microbiol Infect2010;"/>
   <result pre="Microbiol Infect2010; 16:326–9.20121829 14.HoHP, ZhaoX, PangJ, et al.Effectiveness of seasonal" exact="influenza" post="vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel"/>
   <result pre="ChenMI-C, et al.Rate of decline of antibody titers to pandemic" exact="influenza" post="A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays"/>
   <result pre="BMC Infect Dis2014; 14:414.25066592 18.YoungB, SadaranganiS, JiangL, Wilder-SmithA, ChenMIDuration of" exact="influenza" post="vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of"/>
   <result pre="19.YoungB, ZhaoX, CookAR, ParryCM, Wilder-SmithA, I-ChengMCDo antibody responses to the" exact="influenza" post="vaccine persist year-round in the elderly? A systematic review"/>
   <result pre="35:212–21.27939013 20.GohEH, JiangL, HsuJP, et al.Epidemiology and relative severity of" exact="influenza" post="subtypes in Singapore in the post-pandemic period from 2009"/>
   <result pre="2010. Clin Infect Dis2017; 65:1905–13.29028950 21.Schultz-CherrySViral interference: the case of" exact="influenza" post="viruses. J Infect Dis2015; 212:1690–1.25943204 22.TakedaK, AkiraSToll-like receptors. Curr"/>
   <result pre="One2016; 11:e0155589.27196110 25.AnestadGInterference between outbreaks of respiratory syncytial virus and" exact="influenza" post="virus infection. Lancet1982; 1:502. 26.LauY-F, KohW-HV, KanC, et al.Epidemiologic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6536658\results\search\disease\results.xml">
   <result pre="We respectively, reviewed the data of patients with KD, influenza," exact="aseptic meningitis," post="exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis"/>
   <result pre="reviewed the data of patients with KD, influenza, aseptic meningitis," exact="exanthem" post="subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis (APN),"/>
   <result pre="influenza, aseptic meningitis, exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia," exact="acute pyelonephritis" post="(APN), Henoch-Schönlein purpura (HSP), acute poststreptococcal glomerulonephritis (APSGN), and"/>
   <result pre="aseptic meningitis, exanthem subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute" exact="pyelonephritis" post="(APN), Henoch-Schönlein purpura (HSP), acute poststreptococcal glomerulonephritis (APSGN), and"/>
   <result pre="subitum (ES), Mycoplasma pneumoniae (MP) pneumonia, acute pyelonephritis (APN), Henoch-Schönlein" exact="purpura" post="(HSP), acute poststreptococcal glomerulonephritis (APSGN), and childhood asthma. We"/>
   <result pre="(MP) pneumonia, acute pyelonephritis (APN), Henoch-Schönlein purpura (HSP), acute poststreptococcal" exact="glomerulonephritis" post="(APSGN), and childhood asthma. We compared and interpreted epidemiological"/>
   <result pre="bell-shape patterns. In annual-case pattern, there were epidemic years in" exact="aseptic meningitis" post="and MP pneumonia, and the fluctuated annual cases were"/>
   <result pre="patterns. In annual-case pattern, there were epidemic years in aseptic" exact="meningitis" post="and MP pneumonia, and the fluctuated annual cases were"/>
   <result pre="of decreasing cases were seen in APSGN, HSP, and childhood" exact="asthma" post="in recent years. In seasonal frequency, influenza or aseptic"/>
   <result pre="HSP, and childhood asthma in recent years. In seasonal frequency," exact="influenza" post="or aseptic meningitis occurred in mainly winter or summer"/>
   <result pre="childhood asthma in recent years. In seasonal frequency, influenza or" exact="aseptic meningitis" post="occurred in mainly winter or summer season, respectively. HSP"/>
   <result pre="asthma in recent years. In seasonal frequency, influenza or aseptic" exact="meningitis" post="occurred in mainly winter or summer season, respectively. HSP"/>
   <result pre="itself or ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology" exact="acute pyelonephritis" post="exanthem subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
   <result pre="or ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology acute" exact="pyelonephritis" post="exanthem subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count:"/>
   <result pre="ubiquitously existing human reservoirs. Kawasaki disease etiology epidemiology acute pyelonephritis" exact="exanthem" post="subitum microbiota fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction"/>
   <result pre="a nation and neighboring countries, which is contrasting to common" exact="infectious disease" post="epidemics. KD pathogen(s) should satisfy with the epidemiological characteristics"/>
   <result pre="or infection-related immune mediated diseases such as systemic juvenile idiopathic" exact="rheumatoid arthritis" post="or acute rheumatic fever (ARF). However, extensive studies searching"/>
   <result pre="infection-related immune mediated diseases such as systemic juvenile idiopathic rheumatoid" exact="arthritis" post="or acute rheumatic fever (ARF). However, extensive studies searching"/>
   <result pre="diseases such as systemic juvenile idiopathic rheumatoid arthritis or acute" exact="rheumatic fever" post="(ARF). However, extensive studies searching for the etiologic agent(s)"/>
   <result pre="infection-related immune-mediated diseases, including KD, childhood idiopathic thrombocytopenia, and Henoch-Schönlein" exact="purpura" post="(HSP) have low prevalence in older children and adults."/>
   <result pre="the epidemiological profiles in KD were similar to those in" exact="acute pyelonephritis" post="(APN) or exanthema subitum (ES). We discussed the implications"/>
   <result pre="epidemiological profiles in KD were similar to those in acute" exact="pyelonephritis" post="(APN) or exanthema subitum (ES). We discussed the implications"/>
   <result pre="KD were similar to those in acute pyelonephritis (APN) or" exact="exanthema subitum" post="(ES). We discussed the implications of these findings in"/>
   <result pre="characteristics of patients diagnosed with Mycoplasma pneumoniae (MP) pneumonia, influenza," exact="aseptic meningitis," post="APN, ES, acute poststreptococcal glomerulonephritis (APSGN), HSP, childhood asthma"/>
   <result pre="pneumoniae (MP) pneumonia, influenza, aseptic meningitis, APN, ES, acute poststreptococcal" exact="glomerulonephritis" post="(APSGN), HSP, childhood asthma (or recurrent wheezing episode), and"/>
   <result pre="aseptic meningitis, APN, ES, acute poststreptococcal glomerulonephritis (APSGN), HSP, childhood" exact="asthma" post="(or recurrent wheezing episode), and KD. As an exception,"/>
   <result pre="episode), and KD. As an exception, the subjects diagnosed with" exact="influenza" post="in this study were selected from outpatients who were"/>
   <result pre="this study were selected from outpatients who were positive for" exact="influenza" post="in rapid diagnostic testing during the winter of influenza"/>
   <result pre="for influenza in rapid diagnostic testing during the winter of" exact="influenza" post="seasons. The diagnosis or selection criteria in each disease"/>
   <result pre="of diseases was over 10 years; for infectious diseases, MP" exact="pneumonia" post="(2003–2012, n = 779) (12), influenza (2010–2017, n ="/>
   <result pre="for infectious diseases, MP pneumonia (2003–2012, n = 779) (12)," exact="influenza" post="(2010–2017, n = 2,163) [(13, 14), unpublished observation], aseptic"/>
   <result pre="(12), influenza (2010–2017, n = 2,163) [(13, 14), unpublished observation]," exact="aseptic meningitis" post="(1987–2003, n = 2,201) (15), APN (2005–2015, n ="/>
   <result pre="influenza (2010–2017, n = 2,163) [(13, 14), unpublished observation], aseptic" exact="meningitis" post="(1987–2003, n = 2,201) (15), APN (2005–2015, n ="/>
   <result pre="(17), HSP (1987–2015, n = 515) (unpublished observation) and childhood" exact="asthma" post="(or recurrent wheezing episode) (2003–2014, n = 384) (18),"/>
   <result pre="disease 1987–2016 942 31 1.7:1 2.2 ± 1.6 1 Mycoplasma" exact="pneumonia" post="2003–2012 779 78 1.1:1 5.0 ± 3.2 4 Influenza"/>
   <result pre="Influenza 2010–2018 2,163* 270 1.1:1 5.4 ± 3.8 3–5 Aseptic" exact="meningitis" post="1987–1998 2,201 115 2:1 6.0 ± 3.9 4–6 Acute"/>
   <result pre="meningitis 1987–1998 2,201 115 2:1 6.0 ± 3.9 4–6 Acute" exact="pyelonephritis" post="2005–2015 320 29 1.4:1 1.5 ± 3.4 0 Exanthem"/>
   <result pre="APSGN 1987–2014 99 4 2.3:1 8.3 ± 2.7 7–9 Henoch-Shönlein" exact="purpura" post="1987–2015 515 18 1.2:1 6.5 ± 3.0 5 Childhood"/>
   <result pre="purpura 1987–2015 515 18 1.2:1 6.5 ± 3.0 5 Childhood" exact="asthma" post="2003–2014 384 32 1.2:1 5.6 ± 3.5 2–4 *Outpatients;"/>
   <result pre="and the lower M:F ratios were seen in ES, MP" exact="pneumonia" post="and influenza (1.1:1, respectively), and KD showed 1.7:1 ratio"/>
   <result pre="lower M:F ratios were seen in ES, MP pneumonia and" exact="influenza" post="(1.1:1, respectively), and KD showed 1.7:1 ratio in this"/>
   <result pre="ages were changed in the epidemic diseases such as MP" exact="pneumonia" post="and influenza over time [(12), unpublished observation]. Figure 1"/>
   <result pre="changed in the epidemic diseases such as MP pneumonia and" exact="influenza" post="over time [(12), unpublished observation]. Figure 1 Age distribution"/>
   <result pre="of pathogens, such as macrolide-resistant strains were noted in MP" exact="pneumonia" post="and in aseptic meningitis caused by mainly enteroviruses; all"/>
   <result pre="as macrolide-resistant strains were noted in MP pneumonia and in" exact="aseptic meningitis" post="caused by mainly enteroviruses; all had similar patterns with"/>
   <result pre="macrolide-resistant strains were noted in MP pneumonia and in aseptic" exact="meningitis" post="caused by mainly enteroviruses; all had similar patterns with"/>
   <result pre="were different in 2009 pandemic and seasonal influenza, across seasonal" exact="influenza" post="after 2009 pandemic [(14), unpublished observation]. Relatively an even,"/>
   <result pre="seen in the fall and winter in MP pneumonia. Aseptic" exact="meningitis" post="was noted mainly during the summer whereas influenza mainly"/>
   <result pre="pneumonia. Aseptic meningitis was noted mainly during the summer whereas" exact="influenza" post="mainly during winter and early spring seasons. There was"/>
   <result pre="Seasonality Kawasaki disease 22.9 27.7 23.1 26.2 No seasonality Mycoplasma" exact="pneumonia" post="11.2 19.1 48.4 21.3 Fall predominance Influenza 45.3 0.2"/>
   <result pre="Fall predominance Influenza 45.3 0.2 0.1 54.4 Spring, winter Aseptic" exact="meningitis" post="22.2 63.5 12.3 1.9 Summer predominance Acute pyelonephritis 26.9"/>
   <result pre="winter Aseptic meningitis 22.2 63.5 12.3 1.9 Summer predominance Acute" exact="pyelonephritis" post="26.9 27.8 23.1 22.2 No seasonality Exanthem subitum 28.4"/>
   <result pre="No seasonality APSGN 21.2 12.1 30.3 36.4 Winter, fall Henoch-Shönlein" exact="purpura" post="31.1 13.6 29.1 26.2 Low in summer Childhood asthma"/>
   <result pre="Henoch-Shönlein purpura 31.1 13.6 29.1 26.2 Low in summer Childhood" exact="asthma" post="26.8 13.5 43 16.7 Fall, Spring APSGN, acute poststreptococcal"/>
   <result pre="normal flora from initially being an exogenous pathogen. For examples," exact="measles" post="in immune-innocent populations in the past and acquired immunodeficiency"/>
   <result pre="On the other hand, the pathogens causing APN or acute" exact="otitis media," post="such as E. coli or Streptococcus pneumoniae, could be"/>
   <result pre="In the annual-case pattern, cyclic epidemics were noted in MP" exact="pneumonia" post="and aseptic meningitis, and marked fluctuated cases with a"/>
   <result pre="annual-case pattern, cyclic epidemics were noted in MP pneumonia and" exact="aseptic meningitis," post="and marked fluctuated cases with a different peak week"/>
   <result pre="in the host after the initial infection as shown in" exact="herpes zoster," post="herpes labialis, and reactivation of cytomegalovirus and Epstein-Barr virus"/>
   <result pre="has been reported in a variety of diseases, including obesity," exact="autism" post="spectrum disorders, allergic diseases, cancers, and autoimmune diseases such"/>
   <result pre="be less virulent compared to initial external pathogens. For example," exact="scarlet fever" post="caused by Group A beta-hemolytic streptococcus (GAS) was a"/>
   <result pre="severe disease in the past, with two notorious complications: acute" exact="rheumatic fever" post="(ARF) and APSGN. Now, scarlet fever, ARF and APSGN"/>
   <result pre="two notorious complications: acute rheumatic fever (ARF) and APSGN. Now," exact="scarlet fever," post="ARF and APSGN have become rare diseases with a"/>
   <result pre="milder clinical phenotype in the developed countries (17, 45). However," exact="pharyngitis" post="caused by GAS without complications is not uncommon, and"/>
   <result pre="diseases take on milder phenotypes over time, as shown in" exact="scarlet fever," post="pandemic influenza, and AIDS (13, 45, 50). It was"/>
   <result pre="and other symptoms, such as carditis, arthritis, and rarely skin" exact="rash" post="(erythema marginatum), develop (49). The majority of patients with"/>
   <result pre="severely affected patients have long-term complications such as severe rheumatic" exact="heart disease" post="or chronic renal failure, similar to giant coronary artery"/>
   <result pre="group streptococci, other bacteria or viruses are associated with postinfectious" exact="glomerulonephritis" post="or heart tissue inflammation, including myocarditis and possibly heart"/>
   <result pre="are associated with postinfectious glomerulonephritis or heart tissue inflammation, including" exact="myocarditis" post="and possibly heart valve diseases, without evidence of GAS"/>
   <result pre="outbreaks of infectious diseases such as MP pneumonia, influenza, and" exact="aseptic meningitis" post="in our city had occurred concurrently with nationwide epidemics."/>
   <result pre="of infectious diseases such as MP pneumonia, influenza, and aseptic" exact="meningitis" post="in our city had occurred concurrently with nationwide epidemics."/>
   <result pre="Circulation. (2017) 135:e927–99. 10.1161/CIR.000000000000048428356445 8.KühneT. Diagnosis and management of immune" exact="thrombocytopenia" post="in childhood. Hamostaseologie. (2017) 37:36–44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-Schönlein purpura"/>
   <result pre="immune thrombocytopenia in childhood. Hamostaseologie. (2017) 37:36–44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-Schönlein" exact="purpura" post="nephritis in children: incidence, pathogenesis and management. World J"/>
   <result pre="thrombocytopenia in childhood. Hamostaseologie. (2017) 37:36–44. 10.5482/HAMO-16-06-001727699328 9.ChenJYMaoJH. Henoch-Schönlein purpura" exact="nephritis" post="in children: incidence, pathogenesis and management. World J Pediatr."/>
   <result pre="(2007) 69:642–51. 10.1016/j.mehy.2006.12.05117337130 12.KimEKYounYSRhimJWShinMSKangJHLeeKY. Epidemiological comparison of three Mycoplasma pneumoniae" exact="pneumonia" post="epidemics in a single hospital over 10 years. Korean"/>
   <result pre="(2011) 11:225. 10.1186/1471-2334-11-22521864391 15.LeeKYBurgnerDLeeHSHongJHLeeMHKangJHet al.. The changing epidemiology of pediatric" exact="aseptic meningitis" post="in Daejeon, Korea from 1987 to 2003. BMC Infect"/>
   <result pre="11:225. 10.1186/1471-2334-11-22521864391 15.LeeKYBurgnerDLeeHSHongJHLeeMHKangJHet al.. The changing epidemiology of pediatric aseptic" exact="meningitis" post="in Daejeon, Korea from 1987 to 2003. BMC Infect"/>
   <result pre="(2005) 5:97. 10.1186/1471-2334-5-9716262909 16.HuhSMParkBKKangHMRhimJWSuhJSLeeKYClinical implications of DMSA scan in childhood" exact="acute pyelonephritis." post="Child Kidney Dis. (2017) 21:107–13. 10.3339/jkspn.2017.21.2.107 17.KuemSWHurSMYounYSRhimJWSuhJSLeeKYChanges in acute"/>
   <result pre="Dis. (2015) 19:112–7. 10.3339/chikd.2015.19.2.112 18.RhimJWKangHMYangEAKYLee. Epidemiological relationship between Mycoplasma pneumoniae" exact="pneumonia" post="and recurrent wheezing episode in children: an observational study"/>
   <result pre="Clin North Am. (2011) 29:637–53. 10.1016/j.emc.2011.04.00421782079 24.LeeKYNew insights for febrile" exact="urinary tract infection" post="(acute pyelonephritis) in children. Child Kidney Dis. (2016) 20:37–44."/>
   <result pre="human herpesvirus 6 in different age groups, in children with" exact="exanthema subitum," post="other acute exanthematous childhood diseases, Kawasaki syndrome, and acute"/>
   <result pre="nationwide survey. J Epidemiol. (2015) 25:239–45. 10.2188/jea.JE2014008925716368 33.CaniPDDelzenneNM. Interplay between" exact="obesity" post="and associated metabolic disorders: new insights into the gut"/>
   <result pre="34.DoenyasC. Gut microbiota, inflammation, and probiotics on neural development in" exact="autism" post="spectrum disorder. Neuroscience. (2018) 374:271–86. 10.1016/j.neuroscience.2018.01.06029427656 35.HörmannspergerGClaveTHallerD. Gut matters:"/>
   <result pre="Semin Immunol. (2017) 32:25–34. 10.1016/j.smim.2017.08.00128822617 37.ArvonenMBerntsonLPokkaTKarttunenTJVähäsaloPStollML. Gut microbiota-host interactions and" exact="juvenile idiopathic arthritis." post="Pediatr Rheumatol Online J. (2016) 14:44. 10.1186/s12969-016-0104-627448997 38.KinumakiASekizukaTHamadaHKatoKYamashitaAKurodaM. Characterization"/>
   <result pre="10.1098/rspb.2014.308526702035 45.QuinnRW. Comprehensive review of morbidity and mortality trends for" exact="rheumatic fever," post="streptococcal disease, and scarlet fever: the decline of rheumatic"/>
   <result pre="rheumatic fever, streptococcal disease, and scarlet fever: the decline of" exact="rheumatic fever." post="Rev Infect Dis. (1989) 11:928–53.2690288 46.KaplanELGastanaduyASHuweBB. The role of"/>
   <result pre="Revision of the Jones Criteria for the diagnosis of acute" exact="rheumatic fever" post="in the era of Doppler echocardiography: a scientific statement"/>
   <result pre="of Kawasaki disease. Medicine (Baltimore). (2017) 96:e7583. 10.1097/MD.000000000000758328723797 60.LeeKY. Pneumonia," exact="acute respiratory distress syndrome," post="and early immune-modulator therapy. Int J Mol Sci. (2017)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6537720\results\search\disease\results.xml">
   <result pre="Durham, NC 27710, USA; email: gregory.gray@duke.edu ppub: 2019-625611851191 Abstract Equine" exact="influenza" post="virus (EIV) is a common, highly contagious equid respiratory"/>
   <result pre="Equine influenza virus (EIV) is a common, highly contagious equid" exact="respiratory disease." post="Historically, EIV outbreaks have caused high levels of equine"/>
   <result pre="susceptible. In addition, equids are at risk from infection with" exact="avian influenza" post="viruses, which can increase mortality rates. EIV is spread"/>
   <result pre="In addition, equids are at risk from infection with avian" exact="influenza" post="viruses, which can increase mortality rates. EIV is spread"/>
   <result pre="cause substantial disease burden and subsequent economic distress. Keywords: Equine" exact="influenza" post="virus influenza A horses zoonoses H3N8 viruses Equine influenza"/>
   <result pre="disease burden and subsequent economic distress. Keywords: Equine influenza virus" exact="influenza" post="A horses zoonoses H3N8 viruses Equine influenza is a"/>
   <result pre="Equine influenza virus influenza A horses zoonoses H3N8 viruses Equine" exact="influenza" post="is a common, highly contagious respiratory disease of equids"/>
   <result pre="zoonoses H3N8 viruses Equine influenza is a common, highly contagious" exact="respiratory disease" post="of equids with a near-global distribution. Central Asia, Australia,"/>
   <result pre="near-global distribution. Central Asia, Australia, and Japan experienced large equine" exact="influenza" post="virus (EIV) outbreaks in 2007 (1,2). Serious outbreaks of"/>
   <result pre="Equine Influenza Viruses EIVs are believed to have originated from" exact="avian influenza" post="strains (7,8). Two subtypes, H7N7 and H3N8, historically have"/>
   <result pre="Influenza Viruses EIVs are believed to have originated from avian" exact="influenza" post="strains (7,8). Two subtypes, H7N7 and H3N8, historically have"/>
   <result pre="show EIV-like outbreaks preceded or, less commonly, followed several human" exact="influenza" post="outbreaks. Despite the possibility that these illnesses were caused"/>
   <result pre="of the largest assumed EIV outbreaks with smaller accompanying human" exact="influenza" post="outbreaks occurred in 1727, 1750, 1760, and 1872 (3)."/>
   <result pre="followed by similar human outbreaks 3 weeks later (12). Human" exact="influenza" post="epidemics without equine infections were more common during winter"/>
   <result pre="a glimpse into a likely association between human and equine" exact="respiratory disease," post="but their reliability is limited by the lack of"/>
   <result pre="could not reach the fire promptly (12,14). A mild human" exact="influenza" post="was reported in people working with horses during the"/>
   <result pre="in 2016, and 22 states in 2017 (8,17). Figure Equine" exact="influenza" post="distribution map 2006–2015, compiled from Expert Surveillance Panel on"/>
   <result pre="and Australia (25–27). In the early 2000s, a canine H3N8" exact="influenza" post="of equine origin was discovered in the United States,"/>
   <result pre="circulate with high transmission rates in dog shelters (25). Canine" exact="influenza" post="in Australia occurred simultaneously with the 2007 EIV outbreak"/>
   <result pre="2007 EIV outbreak in horses (26). During 2004–2006, surveillance for" exact="influenza" post="viruses in pigs in China discovered 2 H3N8 strains"/>
   <result pre="shedding with transmission to other cats (29). A strain of" exact="influenza" post="discovered in a camel in Mongolia was directly related"/>
   <result pre="of the time (31,32) raises concerns that novel, highly virulent" exact="avian influenza" post="viruses might adapt to horses and cause severe future"/>
   <result pre="the time (31,32) raises concerns that novel, highly virulent avian" exact="influenza" post="viruses might adapt to horses and cause severe future"/>
   <result pre="pathogenic disease in poultry that seems clinically similar to modern" exact="avian influenza" post="viruses (12). Although the connection of this avian disease"/>
   <result pre="disease in poultry that seems clinically similar to modern avian" exact="influenza" post="viruses (12). Although the connection of this avian disease"/>
   <result pre="could be a potential reservoir or amplifying host for future" exact="avian influenza" post="infections. Humans are also a potential host for EIV."/>
   <result pre="be a potential reservoir or amplifying host for future avian" exact="influenza" post="infections. Humans are also a potential host for EIV."/>
   <result pre="1896–1900 (36). The study was performed before the human H3" exact="influenza" post="virus was recorded and determined to have crossed from"/>
   <result pre="EIV, all at a low level, suggesting cross-reactivity with human" exact="influenza" post="strains (38). A similar study in Mongolia found only"/>
   <result pre="levels that could be explained by cross-reactivity with seasonal human" exact="influenza" post="virus infection or vaccine (39). However, a study in"/>
   <result pre="case was observed in Chile during 1973, but the human’s" exact="influenza" post="virus was not typed (41). Although experimental infection of"/>
   <result pre="results from a laboratory study that found enhanced aerosolizing of" exact="influenza" post="virus with colder and drier conditions (42). Further analysis"/>
   <result pre="1–2 km consistent with wind patterns (43). In addition, some" exact="avian influenza" post="virus strains persist in water and remain infectious for"/>
   <result pre="km consistent with wind patterns (43). In addition, some avian" exact="influenza" post="virus strains persist in water and remain infectious for"/>
   <result pre="seen since 2007 (8,11), OIE suggests omitting these from equine" exact="influenza" post="vaccines. The American Association of Equine Practitioners recommends EIV"/>
   <result pre="samples because horse owners seldom request a confirmatory diagnosis for" exact="influenza" post="(15). Surveillance is compounded by the failure of some"/>
   <result pre="in Harbin, China. Currently, no OIE reference laboratory for equine" exact="influenza" post="exists outside of Europe or North America, but OIE"/>
   <result pre="and elsewhere EIV may be circulating (http://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review/viewsummary?reportid=29135). Future Challenges Equine" exact="influenza" post="is a highly contagious virus with the potential to"/>
   <result pre="previously unexposed equine population (18). Furthermore, potential novel and virulent" exact="avian influenza" post="virus strains could cross into horses and rapidly spread"/>
   <result pre="unexposed equine population (18). Furthermore, potential novel and virulent avian" exact="influenza" post="virus strains could cross into horses and rapidly spread"/>
   <result pre="other nonhuman species (26,28,30). Historical review suggests the 1889 human" exact="influenza" post="pandemic might have been of equine origin, with equids"/>
   <result pre="epidemic, if not pandemic, threat. Appendix Timeline of major equine" exact="influenza" post="outbreaks in the 20th and 21st centuries. LINK Suggested"/>
   <result pre="A, Daramragchaa U, Chuluunbaatar M, Gonchigoo B, Gray GC. Equine" exact="influenza" post="virus—a neglected, reemergent disease threat. Emerg Infect Dis. 2019"/>
   <result pre="KydyrmanovA, KasymbekovY, KhanE, DaulbayevaK, AsanovaS, et al.Continuing evolution of equine" exact="influenza" post="virus in Central Asia, 2007-2012.Arch Virol. 2014;159:2321–7. 10.1007/s00705-014-2078-324748052 2."/>
   <result pre="KuribayashiS, SengeeS, BatchuluunD, et al.Antigenic and genetic analysis of H3N8" exact="influenza" post="viruses isolated from horses in Japan and Mongolia, and"/>
   <result pre="et al.Epidemiological and virological findings during multiple outbreaks of equine" exact="influenza" post="in South America in 2012.Influenza Other Respir Viruses. 2016;10:37–46."/>
   <result pre="2016;10:37–46. 10.1111/irv.1234926406274 5. PowellDG, WatkinsKL, LiPH, ShortridgeKF. Outbreak of equine" exact="influenza" post="among horses in Hong Kong during 1992.Vet Rec. 1995;136:531–6."/>
   <result pre="6. Patterson-KaneJC, CarrickJB, AxonJE, WilkieI, BeggAP. The pathology of bronchointerstitial" exact="pneumonia" post="in young foals associated with the first outbreak of"/>
   <result pre="in young foals associated with the first outbreak of equine" exact="influenza" post="in Australia.Equine Vet J. 2008;40:199–203. 10.2746/042516408X29221418321807 7. MadićJ, MartinovićS,"/>
   <result pre="NaglićT, HajsigD, CvetnićS. Serological evidence for the presence of A/equine-1" exact="influenza" post="virus in unvaccinated horses in Croatia.Vet Rec. 1996;138:68. 10.1136/vr.138.3.688629334"/>
   <result pre="9. SovinovaO, TumovaB, PouskaF, NemecJ. Isolation of a virus causing" exact="respiratory disease" post="in horses.Acta Virol. 1958;2:52–61.13533033 10. BryantNA, RashAS, WoodwardAL, MedcalfE,"/>
   <result pre="WoodwardAL, MedcalfE, HelwegenM, WohlfenderF, et al.Isolation and characterisation of equine" exact="influenza" post="viruses (H3N8) from Europe and North America from 2008"/>
   <result pre="al.Antigenic and genetic variations in European and North American equine" exact="influenza" post="virus strains (H3N8) isolated from 2006 to 2007.Vet Microbiol."/>
   <result pre="2007.Vet Microbiol. 2009;138:41–52. 10.1016/j.vetmic.2009.03.00419346084 12. MorensDM, TaubenbergerJK. Historical thoughts on" exact="influenza" post="viral ecosystems, or behold a pale horse, dead dogs,"/>
   <result pre="AndersonBD, DaramragchaaU, ChuluunbaatarM, GrayGC. A review of evidence that equine" exact="influenza" post="viruses are zoonotic.Pathogens. 2016;5:50. 10.3390/pathogens503005027420100 14. JudsonAB. History and"/>
   <result pre="1872–73.Public Health Pap Rep. 1873;1:88–109.19599890 15. CullinaneA, EltonD, MumfordJ. Equine" exact="influenza" post="- surveillance and control.Influenza Other Respir Viruses. 2010;4:339–44. 10.1111/j.1750-2659.2010.00176.x20958927"/>
   <result pre="TainshJ. Insights into the economic consequences of the 2007 equine" exact="influenza" post="outbreak in Australia.Aust Vet J. 2011;89(Suppl 1):151–8. 10.1111/j.1751-0813.2011.00777.x21711317 19."/>
   <result pre="on the spread of influenza: survival analysis of an equine" exact="influenza" post="(A/H3N8) outbreak.PLoS One. 2012;7:e35284. 10.1371/journal.pone.003528422536366 20. WatsonJ, DanielsP, KirklandP,"/>
   <result pre="WatsonJ, DanielsP, KirklandP, CarrollA, JeggoM. The 2007 outbreak of equine" exact="influenza" post="in Australia: lessons learned for international trade in horses.Rev"/>
   <result pre="ZayatB, WaltzekTB, JamiyanBO, et al.Isolation and characterization of H3N8 equine" exact="influenza" post="A virus associated with the 2011 epizootic in Mongolia.Influenza"/>
   <result pre="ZhaoL, LiH, et al.Isolation and genetic characterization of H3N8 equine" exact="influenza" post="virus from donkeys in China.Vet Microbiol. 2010;144:455–60. 10.1016/j.vetmic.2010.01.00620153940 23."/>
   <result pre="YinX, LuG, GuoW, QiT, MaJ, ZhuC, et al.Identification of equine" exact="influenza" post="virus infection in Asian wild horses (Equus przewalskii).Arch Virol."/>
   <result pre="Virol. 2014;159:1159–62. 10.1007/s00705-013-1908-z24212887 24. GilchristP, SergeantESG. Risk of an equine" exact="influenza" post="virus reservoir establishing in wild horses in New South"/>
   <result pre="CrawfordPC, DuboviEJ, CastlemanWL, StephensonI, GibbsEPJ, ChenL, et al.Transmission of equine" exact="influenza" post="virus to dogs.Science. 2005;310:482–5. 10.1126/science.111795016186182 26. CrispeE, FinlaisonDS, HurtAC,"/>
   <result pre="26. CrispeE, FinlaisonDS, HurtAC, KirklandPD. Infection of dogs with equine" exact="influenza" post="virus: evidence for transmission from horses during the Australian"/>
   <result pre="DalyJM, BlundenAS, MacraeS, MillerJ, BowmanSJ, KolodziejekJ, et al.Transmission of equine" exact="influenza" post="virus to English foxhounds.Emerg Infect Dis. 2008;14:461–4. 10.3201/eid1403.07064318325262 28."/>
   <result pre="ZhangA, GuoX, et al.Isolation and molecular characterization of equine H3N8" exact="influenza" post="viruses from pigs in China.Arch Virol. 2009;154:887–90. 10.1007/s00705-009-0381-119396578 29."/>
   <result pre="10.1007/s00705-009-0381-119396578 29. SuS, WangL, FuX, HeS, HongM, ZhouP, et al.Equine" exact="influenza" post="A(H3N8) virus infection in cats.Emerg Infect Dis. 2014;20:2096–9. 10.3201/eid2012.14086725417790"/>
   <result pre="10.3201/eid2012.14086725417790 30. YondonM, ZayatB, NelsonMI, HeilGL, AndersonBD, LinX, et al.Equine" exact="influenza" post="A(H3N8) virus isolated from Bactrian camel, Mongolia.Emerg Infect Dis."/>
   <result pre="KawaokaY, GormanO, ItoT, SaitoT, et al.Characterization of a new avian-like" exact="influenza" post="A virus from horses in China.Virology. 1992;188:245–55. 10.1016/0042-6822(92)90754-D1314452 32."/>
   <result pre="and molecular evidence for the presence of two H3N8 equine" exact="influenza" post="viruses in China in 1993-94.J Gen Virol. 1995;76:2009–14. 10.1099/0022-1317-76-8-20097636481"/>
   <result pre="33. Abdel-MoneimAS, Abdel-GhanyAE, ShanySA. Isolation and characterization of highly pathogenic" exact="avian influenza" post="virus subtype H5N1 from donkeys.J Biomed Sci. 2010;17:25. 10.1186/1423-0127-17-2520398268"/>
   <result pre="Abdel-MoneimAS, Abdel-GhanyAE, ShanySA. Isolation and characterization of highly pathogenic avian" exact="influenza" post="virus subtype H5N1 from donkeys.J Biomed Sci. 2010;17:25. 10.1186/1423-0127-17-2520398268"/>
   <result pre="34. KaselJA, CouchRB. Experimental infection in man and horses with" exact="influenza" post="A viruses.Bull World Health Organ. 1969;41:447–52.5309454 35. AlfordRH, KaselJA,"/>
   <result pre="AlfordRH, KaselJA, LehrichJR, KnightV. Human responses to experimental infection with" exact="influenza" post="A/Equi 2 virus.Am J Epidemiol. 1967;86:185–92. 10.1093/oxfordjournals.aje.a1207234951557 36. MasurelN,"/>
   <result pre="MasurelN, MulderJ. Studies on the content of antibodies for equine" exact="influenza" post="viruses in human sera.Bull World Health Organ. 1966;34:885–93.5296537 37."/>
   <result pre="SchellM, KatzJ, KawaokaY, NaeveC, GormanO, et al.Evolution of the H3" exact="influenza" post="virus hemagglutinin from human and nonhuman hosts.J Virol. 1992;66:1129–38.1731092"/>
   <result pre="HeilGL, WhiteSK, et al.Little evidence of human infection with equine" exact="influenza" post="during the 2007 epizootic, Queensland, Australia.J Clin Virol. 2014;59:100–3."/>
   <result pre="DarmaaB, UlziimaaD, TserennorovD, et al.Little evidence of avian or equine" exact="influenza" post="virus infection among a cohort of Mongolian adults with"/>
   <result pre="LarsonKRL, HeilGL, ChambersTM, CapuanoA, WhiteSK, GrayGC. Serological evidence of equine" exact="influenza" post="infections among persons with horse exposure, Iowa.J Clin Virol."/>
   <result pre="horse exposure, Iowa.J Clin Virol. 2015;67:78–83. 10.1016/j.jcv.2015.04.00925959164 41. BerríosP. [Equine" exact="influenza" post="in Chile (1963-1992): a possible human case][in Spanish]. Rev"/>
   <result pre="43. DavisJ, GarnerMG, EastIJ. Analysis of local spread of equine" exact="influenza" post="in the Park Ridge region of Queensland.Transbound Emerg Dis."/>
   <result pre="BrownJD, SwayneDE, CooperRJ, BurnsRE, StallknechtDE. Persistence of H5 and H7" exact="avian influenza" post="viruses in water.Avian Dis. 2007;51(Suppl):285–9. 10.1637/7636-042806R.117494568 45. ScholtensRG, SteeleJH,"/>
   <result pre="SwayneDE, CooperRJ, BurnsRE, StallknechtDE. Persistence of H5 and H7 avian" exact="influenza" post="viruses in water.Avian Dis. 2007;51(Suppl):285–9. 10.1637/7636-042806R.117494568 45. ScholtensRG, SteeleJH,"/>
   <result pre="responses and protective efficacy in ponies immunised with an equine" exact="influenza" post="ISCOM vaccine containing an ‘American lineage’ H3N8 virus.Vaccine. 2004;23:418–25."/>
   <result pre="virus.Vaccine. 2004;23:418–25. 10.1016/j.vaccine.2004.01.07415530689 47. BarqueroN, DalyJM, NewtonJR. Risk factors for" exact="influenza" post="infection in vaccinated racehorses: lessons from an outbreak in"/>
   <result pre="LinksI. Vaccination program in the response to the 2007 equine" exact="influenza" post="outbreak in Australia. Aust Vet J. 2011;89 Suppl 1(1):126."/>
   <result pre="1(1):126. 50. BinnsMM. Genetic and antigenic analysis of an equine" exact="influenza" post="H3 isolate from the 1989 epidemic.[Erratum in: Arch Vriol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6542110\results\search\disease\results.xml">
   <result pre="CentralLondon pmcid: 65421101863 doi: 10.1186/s12917-019-1863-3 : Research Article Genotyping bovine" exact="leukemia" post="virus in dairy cattle of Heilongjiang, northeastern China http://orcid.org/0000-0002-9548-7151YuChangqingycq_1926@126.com1WangXuefengwangxuefeng@caas.cn1ZhouYulongzhouyulong1980@163.com2WangYuyuiop6183@163.com1ZhangXianfengzhangxf@hvri.ac.cn1ZhengYonghuizhengyo@msu.edu13[1],"/>
   <result pre="available in this article, unless otherwise stated. Abstract Background Bovine" exact="leukemia" post="virus (BLV) causes enzootic bovine leukosis in cattle and"/>
   <result pre="supplementary material, which is available to authorized users. Keywords Bovine" exact="leukemia" post="virus Genotyping Cattle Enzootic bovine leukosis Funding http://dx.doi.org/10.13039/501100001809National Natural"/>
   <result pre="Funding http://dx.doi.org/10.13039/501100005046Natural Science Foundation of Heilongjiang Province H2016102ZhangXianfeng Background Bovine" exact="leukemia" post="virus (BLV) is closely related to human T-lymphotropic virus,"/>
   <result pre="longevity in dairy cattle [4–7]. Recently, a correlation between human" exact="breast cancer" post="and BLV infection was proposed [8–11], demonstrating that BLV"/>
   <result pre="in dairy cattle [4–7]. Recently, a correlation between human breast" exact="cancer" post="and BLV infection was proposed [8–11], demonstrating that BLV"/>
   <result pre="isolates of other genotypes. (PPTX 353 kb) Abbreviations BLV Bovine" exact="leukemia" post="virus env Envelope G Genotype ND Neutralizing domain nt"/>
   <result pre="advances in BLV researchViruses20157116080608810.3390/v711292926610551 2.AidaYMurakamiHTakahashiMTakeshimaSNMechanisms of pathogenesis induced by bovine" exact="leukemia" post="virus as a model for human T-cell leukemia virusFront"/>
   <result pre="by bovine leukemia virus as a model for human T-cell" exact="leukemia" post="virusFront Microbiol2013432810.3389/fmicb.2013.0032824265629 3.RodriguezSMFlorinsAGilletNde BrogniezASanchez-AlcarazMTBoxusMBoulangerFGutierrezGTronoKAlvarezIet al.Preventive and therapeutic strategies for"/>
   <result pre="virusFront Microbiol2013432810.3389/fmicb.2013.0032824265629 3.RodriguezSMFlorinsAGilletNde BrogniezASanchez-AlcarazMTBoxusMBoulangerFGutierrezGTronoKAlvarezIet al.Preventive and therapeutic strategies for bovine" exact="leukemia" post="virus: lessons for HTLVViruses2011371210124810.3390/v307121021994777 4.ErskineRJBartlettPCByremTMRenderCLFebvayCHousemanJTAssociation between bovine leukemia virus,"/>
   <result pre="for bovine leukemia virus: lessons for HTLVViruses2011371210124810.3390/v307121021994777 4.ErskineRJBartlettPCByremTMRenderCLFebvayCHousemanJTAssociation between bovine" exact="leukemia" post="virus, production, and population age in Michigan dairy herdsJ"/>
   <result pre="and population age in Michigan dairy herdsJ Dairy Sci201295272773410.3168/jds.2011-476022281337 5.YangYFanWMaoYYangZLuGZhangRZhangHSzetoCWangCBovine" exact="leukemia" post="virus infection in cattle of China: association with reduced"/>
   <result pre="scoreJ Dairy Sci20169953688369710.3168/jds.2015-1058026923050 6.DaYShanksRDStewartJALewinHAMilk and fat yields decline in bovine" exact="leukemia" post="virus-infected Holstein cattle with persistent lymphocytosisProc Natl Acad Sci"/>
   <result pre="Sci U S A199390146538654110.1073/pnas.90.14.65388341665 7.Della LiberaAMde SouzaFNBatistaCFSantosBPde AzevedoLFSanchezEMDinizSASilvaMXHaddadJPBlagitzMGEffects of bovine" exact="leukemia" post="virus infection on milk neutrophil function and the milk"/>
   <result pre="milk neutrophil function and the milk lymphocyte profileVet Res201546210.1186/s13567-014-0125-425595200 8.BuehringGCShenHMJensenHMChoiKYSunDNuovoGBovine" exact="leukemia" post="virus DNA in human breast tissueEmerg Infect Dis201420577278210.3201/eid2005.13129824750974 9.BuehringGCShenHMJensenHMJinDLHudesMBlockGExposure"/>
   <result pre="DNA in human breast tissueEmerg Infect Dis201420577278210.3201/eid2005.13129824750974 9.BuehringGCShenHMJensenHMJinDLHudesMBlockGExposure to bovine" exact="leukemia" post="virus is associated with breast cancer: a case-control studyPLoS"/>
   <result pre="cancer: a case-control studyPLoS One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine" exact="leukemia" post="virus and breast cancer in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949"/>
   <result pre="studyPLoS One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine leukemia virus and" exact="breast cancer" post="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked"/>
   <result pre="One2015109e013430410.1371/journal.pone.013430426332838 10.ZhangRJiangJSunWZhangJHuangKGuXYangYXuXShiYWangCLack of association between bovine leukemia virus and breast" exact="cancer" post="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked"/>
   <result pre="virus and breast cancer in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine" exact="leukemia" post="virus linked to breast cancer but not coinfection with"/>
   <result pre="in Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked to" exact="breast cancer" post="but not coinfection with human papillomavirus: case-control study of"/>
   <result pre="Chinese patientsBreast Cancer Res201618110110.1186/s13058-016-0763-827724949 11.BaltzellKAShenHMKrishnamurthySSisonJDNuovoGJBuehringGCBovine leukemia virus linked to breast" exact="cancer" post="but not coinfection with human papillomavirus: case-control study of"/>
   <result pre="case-control study of women in TexasCancer201812471342134910.1002/cncr.3116929266207 12.LairmoreMDAnimal models of bovine" exact="leukemia" post="virus and human T-lymphotrophic virus type-1: insights in transmission"/>
   <result pre="Sci U S A201311062306231110.1073/pnas.121384211023345446 14.PolatMTakeshimaSNAidaYEpidemiology and genetic diversity of bovine" exact="leukemia" post="virusVirol J201714120910.1186/s12985-017-0876-429096657 15.MamounRZAstierTGuillemainBDuplanJFBovine lymphosarcoma: processing of bovine leukaemia virus-coded"/>
   <result pre="Virol1983642791279510.1099/0022-1317-64-12-27916319563 16.DietzscholdBKaadenORFrenzelBSubunit and fine structure of the glycoprotein of bovine" exact="leukemia" post="virusAnn Rech Vet197894613617224755 17.CoulstonJNaifHBrandonRKumarSKhanSDanielRCLavinMFMolecular cloning and sequencing of an"/>
   <result pre="in argentine dairy cattleArch Virol2005150344345810.1007/s00705-004-0437-115592892 20.AsfawYTsudukuSKonishiMMurakamiKTsuboiTWuDSentsuiHDistribution and superinfection of bovine" exact="leukemia" post="virus genotypes in JapanArch Virol2005150349350510.1007/s00705-004-0433-515592894 21.CamargosMFPeredaAStancekDRochaMAdos ReisJKGreiser-WilkeILeiteRCMolecular characterization of"/>
   <result pre="of the env gene from Brazilian field isolates of bovine" exact="leukemia" post="virusVirus Genes200734334335010.1007/s11262-006-0011-x16917740 22.RodriguezSMGolembaMDCamposRHTronoKJonesLRBovine leukemia virus can be classified into"/>
   <result pre="from Brazilian field isolates of bovine leukemia virusVirus Genes200734334335010.1007/s11262-006-0011-x16917740 22.RodriguezSMGolembaMDCamposRHTronoKJonesLRBovine" exact="leukemia" post="virus can be classified into seven genotypes: evidence for"/>
   <result pre="of two novel cladesJ Gen Virol2009902788279710.1099/vir.0.011791-019587134 23.MoratorioGObalGDubraACorreaABianchiSBuschiazzoACristinaJPritschOPhylogenetic analysis of bovine" exact="leukemia" post="viruses isolated in South America reveals diversification in seven"/>
   <result pre="diversification in seven distinct genotypesArch Virol2010155448148910.1007/s00705-010-0606-320169372 24.MatsumuraKInoueEOsawaYOkazakiKMolecular epidemiology of bovine" exact="leukemia" post="virus associated with enzootic bovine leukosis in JapanVirus Res2011155134334810.1016/j.virusres.2010.11.00521095208"/>
   <result pre="in JapanVirus Res2011155134334810.1016/j.virusres.2010.11.00521095208 25.BalicDLojkicIPeriskicMBedekovicTJungicALemoNRoicBCacZBarbicLMadicJIdentification of a new genotype of bovine" exact="leukemia" post="virusArch Virol201215771281129010.1007/s00705-012-1300-422488472 26.AbabnehMMAl-RukibatRKHananehWMNasarATAl-ZghoulMBDetection and molecular characterization of bovine leukemia"/>
   <result pre="bovine leukemia virusArch Virol201215771281129010.1007/s00705-012-1300-422488472 26.AbabnehMMAl-RukibatRKHananehWMNasarATAl-ZghoulMBDetection and molecular characterization of bovine" exact="leukemia" post="viruses from JordanArch Virol2012157122343234810.1007/s00705-012-1447-z22914962 27.Rola-LuszczakMPlutaAOlechMDonnikIPetropavlovskiyMGerilovychAVinogradovaIChoudhuryBKuzmakJThe molecular characterization of bovine"/>
   <result pre="impact on phylogenyPLoS One201383e5870510.1371/journal.pone.005870523527009 28.PolatMOhnoATakeshimaSNKimJKikuyaMMatsumotoYMingalaCNOnumaMAidaYDetection and molecular characterization of bovine" exact="leukemia" post="virus in Philippine cattleArch Virol2015160128529610.1007/s00705-014-2280-325399399 29.LeeEKimEJJoungHKKimBHSongJYChoISLeeKKShinYKSequencing and phylogenetic analysis"/>
   <result pre="and phylogenetic analysis of the gp51 gene from Korean bovine" exact="leukemia" post="virus isolatesVirol J2015126410.1186/s12985-015-0286-425879943 30.OchirkhuuNKonnaiSOdbilegRNishimoriAOkagawaTMurataSOhashiKDetection of bovine leukemia virus and"/>
   <result pre="from Korean bovine leukemia virus isolatesVirol J2015126410.1186/s12985-015-0286-425879943 30.OchirkhuuNKonnaiSOdbilegRNishimoriAOkagawaTMurataSOhashiKDetection of bovine" exact="leukemia" post="virus and identification of its genotype in Mongolian cattleArch"/>
   <result pre="Virol2016161498599110.1007/s00705-015-2676-826711456 31.PolatMTakeshimaSNHosomichiKKimJMiyasakaTYamadaKAraingaMMurakamiTMatsumotoYde la Barra DiazVet al.A new genotype of bovine" exact="leukemia" post="virus in South America identified by NGS-based whole genome"/>
   <result pre="evolutionary genetic analysisRetrovirology201613410.1186/s12977-016-0239-z26754835 32.LeeEKimEJRatthanophartJVitoonpongRKimBHChoISSongJYLeeKKShinYKMolecular epidemiological and serological studies of bovine" exact="leukemia" post="virus (BLV) infection in Thailand cattleInfect Genet Evol20164124525410.1016/j.meegid.2016.04.01027090024 33.YangYKellyPJBaiJZhangRWangCFirst"/>
   <result pre="in Thailand cattleInfect Genet Evol20164124525410.1016/j.meegid.2016.04.01027090024 33.YangYKellyPJBaiJZhangRWangCFirst molecular characterization of bovine" exact="leukemia" post="virus infections in the CaribbeanPLoS One20161112e016837910.1371/journal.pone.016837927977761 34.PolatMMoeHHShimogiriTMoeKKTakeshimaSNAidaYThe molecular epidemiological"/>
   <result pre="in the CaribbeanPLoS One20161112e016837910.1371/journal.pone.016837927977761 34.PolatMMoeHHShimogiriTMoeKKTakeshimaSNAidaYThe molecular epidemiological study of bovine" exact="leukemia" post="virus infection in Myanmar cattleArch Virol2017162242543710.1007/s00705-016-3118-y27771791 35.GregoryLCarrillo GaetaNAraujoJMatsumiya ThomazelliLHarakawaRIkunoAAHiromi"/>
   <result pre="Paulo, BrazilJ Med Microbiol201766121790179710.1099/jmm.0.00063929120299 36.WangMWangYBalochARPanYXuFTianLZengQMolecular epidemiology and characterization of bovine" exact="leukemia" post="virus in domestic yaks (Bos grunniens) on the Qinghai-Tibet"/>
   <result pre="grunniens) on the Qinghai-Tibet plateau, ChinaArch Virol2018163365967010.1007/s00705-017-3658-929224130 37.JuliarenaMABarriosCNCerianiMCEstebanENHot topic: Bovine" exact="leukemia" post="virus (BLV)-infected cows with low proviral load are not"/>
   <result pre="analysis of envelope glycoproteins from diverse geographical isolates of bovine" exact="leukemia" post="virus identifies highly conserved peptide motifsRetrovirology2018151210.1186/s12977-017-0383-029310678 39.ChackerianBRudenseyLMOverbaughJSpecific N-linked and"/>
   <result pre="single envelope N-Linked glycosylation site enhances the pathogenicity of bovine" exact="leukemia" post="virusJ Virol201589178945895610.1128/JVI.00261-1526085161 42.RizzoGFortiKSerroniACagiolaMBaglivoSScocciaEDe GiuseppeASingle N-glycosylation site of bovine leukemia"/>
   <result pre="bovine leukemia virusJ Virol201589178945895610.1128/JVI.00261-1526085161 42.RizzoGFortiKSerroniACagiolaMBaglivoSScocciaEDe GiuseppeASingle N-glycosylation site of bovine" exact="leukemia" post="virus SU is involved in conformation and viral escapeVet"/>
   <result pre="is involved in conformation and viral escapeVet Microbiol2016197212610.1016/j.vetmic.2016.10.02427938679 43.GatotJSCallebautIVan LintCDemonteDKerkhofsPPortetelleDBurnyAWillemsLKettmannRBovine" exact="leukemia" post="virus SU protein interacts with zinc, and mutations within"/>
   <result pre="and infectivity in vivoJ Virol200276167956796710.1128/JVI.76.16.7956-7967.200212134000 44.ZhaoXBuehringGCNatural genetic variations in bovine" exact="leukemia" post="virus envelope gene: possible effects of selection and escapeVirology2007366115016510.1016/j.virol.2007.03.05817498765"/>
   <result pre="and escapeVirology2007366115016510.1016/j.virol.2007.03.05817498765 45.TakeshimaSNKitamura-MuramatsuYYuanYPolatMSaitoSAidaYBLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR assay for bovine" exact="leukemia" post="virus by reducing primer degeneracy and constructing an optimal"/>
   <result pre="samples from the same cattleVirus Res201521024825410.1016/j.virusres.2015.08.01326298004 47.JimbaMTakeshimaSNMatobaKEndohDAidaYBLV-CoCoMo-qPCR: Quantitation of bovine" exact="leukemia" post="virus proviral load using the CoCoMo algorithmRetrovirology201079110.1186/1742-4690-7-9121044304"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6542824\results\search\disease\results.xml">
   <result pre="view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract For" exact="dengue fever" post="and other seasonal epidemics we show how the stability"/>
   <result pre="assess λ*). To test its generality we examined records of" exact="influenza" post="incidence gathered from the World Health Organization database, where"/>
   <result pre="results that are consistent with the results of the country-level" exact="influenza" post="data, and slightly better for New York City. The"/>
   <result pre="in the severity of the diseases with possible under-reporting of" exact="influenza" post="in the inter-disease periods; (2) the fact that the"/>
   <result pre="(4) We also note that if novel strains of the" exact="influenza" post="virus are introduced too close to onset of an"/>
   <result pre="Shows the correlations between the eigenvalues 〈λ*〉 and the subsequent" exact="influenza" post="outbreak magnitudes in the 27 different countries having less"/>
   <result pre="robustness analysis is presented in Supplementary Fig. 4. Analysis of" exact="influenza" post="data The influenza analysis used time windows of length"/>
   <result pre="presented in Supplementary Fig. 4. Analysis of influenza data The" exact="influenza" post="analysis used time windows of length T = 30 weeks to"/>
   <result pre="capita in the year following the outbreak onsets. Although the" exact="influenza" post="database includes 79 different countries, only about half of"/>
   <result pre="Data of dengue incidence are from http://dengueforecasting.noaa.gov. The data of" exact="influenza" post="incidence are from http://www.pnas.org/content/suppl/2016/10/26/1607747113.DCSupplemental/pnas.1607747113.sd01.txt. Only studies with fewer than"/>
   <result pre="underlying seasonal patternsInt. J. Epidemiol.19821151410.1093/ije/11.1.57085179 15.EllnerSPet al.Noise and nonlinearity in" exact="measles" post="epidemics: combining mechanistic and statistical approaches to population modelingAm."/>
   <result pre="thailand: a longitudinal data analysisPLoS Med.20096e100016810.1371/journal.pmed.100016819918363 18.AxelsenJBYaariRGrenfellBTStoneLMultiannual forecasting of seasonal" exact="influenza" post="dynamics reveals climatic and evolutionary driversProc. Natl. Acad. Sci."/>
   <result pre="R. Soc. B: Biol. Sci.199033023525110.1098/rstb.1990.0195 23.LauerSAet al.Prospective forecasts of annual" exact="dengue hemorrhagic fever" post="incidence in thailand, 2010–2014Proc. Natl. Acad. Sci. USA2017115E2175E218210.1073/pnas.1714457115 24.DixonPAMilicichMJSugiharaGEpisodic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6544329\results\search\disease\results.xml">
   <result pre="Insects: Mosquitoes El Niño Southern Oscillation, overseas arrivals and imported" exact="chikungunya" post="cases in Australia: A time series analysis ENSO, overseas"/>
   <result pre="Australia: A time series analysis ENSO, overseas arrivals and imported" exact="chikungunya" post="in Australia HuangXiaodongConceptualizationData curationFormal analysisInvestigationMethodologyVisualizationWriting – original draft1HuWenbiaoConceptualizationFormal analysisFunding"/>
   <result pre="Since the National Notifiable Diseases Surveillance System [32] started reporting" exact="chikungunya" post="virus infection in 2008, imported cases to Australia have"/>
   <result pre="the Americas in 2014 [50], along with the first local" exact="chikungunya" post="outbreaks in June 2014 in Florida in the continental"/>
   <result pre="Australia originating in India that year. Bangladesh experienced a significant" exact="chikungunya" post="outbreak in 2017 [54], with Australia observing the largest"/>
   <result pre="MercierA, LepersC, HoyD, DuituturagaS, BenyonE, et al.Concurrent outbreaks of dengue," exact="chikungunya" post="and Zika virus infections–an unprecedented epidemic wave of mosquito-borne"/>
   <result pre="10.1056/NEJMp07801317314335 12ParolaP, de LamballerieX, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="2014;63:1137. 14RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="Lancet. 2007;370:1840–6. 15GouldEA, GallianP, LamballerieXd, NCharrelR. First cases of autochthonous" exact="dengue fever" post="and chikungunya fever in France: from bad dream to"/>
   <result pre="GallianP, LamballerieXd, NCharrelR. First cases of autochthonous dengue fever and" exact="chikungunya" post="fever in France: from bad dream to reality. Clinical"/>
   <result pre="new European invader Aedes (Finlaya) koreicus: a potential vector of" exact="chikungunya" post="virus. Pathog Glob Health. 2018;112(3):107–14. 10.1080/20477724.2018.146478029737236 17KraemerMU, SinkaME, DudaKA,"/>
   <result pre="PetersonAT. Climate change influences on global distributions of dengue and" exact="chikungunya" post="virus vectors. Philos Trans R Soc Lond B Biol"/>
   <result pre="10.1007/s00436-010-1767-420155369 26ViennetE, KnopeK, FaddyHM, WilliamsCR, HarleyD. Assessing the threat of" exact="chikungunya" post="virus emergence in Australia. Commun Dis Intell Q Rep."/>
   <result pre="BhimalaKR, KumaraswamyS, KadiriMR, et al.Temperature dependent transmission potential model for" exact="chikungunya" post="in India. Sci Total Environ. 2019;647:66–74. 10.1016/j.scitotenv.2018.07.46130077856 38YoshikawaMJ, KusriastutiR."/>
   <result pre="40KnopeKE, KuruczN, DoggettSL, MullerM, JohansenCA, FeldmanR, et al.Arboviral diseases and" exact="malaria" post="in Australia, 2012–13: Annual report of the National Arbovirus"/>
   <result pre="JansenS, LühkenR, HelmsM, PluskotaB, BeckerN, et al.Experimental risk assessment for" exact="chikungunya" post="virus transmission based on vector competence, distribution and temperature"/>
   <result pre="Branch NCfE, Zoonotic Infectious Diseases CDC. Notes from the field:" exact="chikungunya" post="virus spreads in the Americas—Caribbean and South America, 2013–2014."/>
   <result pre="mortality weekly report. 2014;63(22):500–1. .24898168 51KendrickK, StanekD, BlackmoreC. Transmission of" exact="chikungunya" post="virus in the continental United States-Florida, 2014. Centers for"/>
   <result pre="Emerging Infectious Diseases. 2013;19(9):1535–8. 10.3201/eid1909.130130 PMC3810919. 23965757 65Queensland Goverment. Queensland" exact="chikungunya" post="management plan 2014–2019. 2014 [cited 4 March 2019]. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6548069\results\search\disease\results.xml">
   <result pre="Zika en Colombia del 2008 al 2018Co-circulação dos vírus dengue," exact="chikungunya" post="e Zika na Colômbia, 2008–2018 Rico-MendozaAlejandro1AlexandraPorras-Ramírez1ChangAileen2EncinalesLiliana3LynchRebecca4[1], Grupo de Medicina"/>
   <result pre="Colombia’s Public Health Surveillance System (SIVIGILA). Results. In 2015, when" exact="chikungunya" post="was first detected, it had a higher incidence (1"/>
   <result pre="Saúde Pública da Colômbia (SIVIGILA). Resultados. Em 2015, quando o" exact="chikungunya" post="foi detectado pela primeira vez, sua incidência foi superior"/>
   <result pre="Este achado requer análise adicional. Keywords Zika virus dengue virus" exact="chikungunya" post="virus coinfection Colombia Palabras clave Virus Zika virus del"/>
   <result pre="coinfection Colombia Palabras clave Virus Zika virus del dengue virus" exact="chikungunya" post="coinfección; Colombia Palavras-chave Zika virus vírus da dengue vírus"/>
   <result pre="chikungunya coinfección; Colombia Palavras-chave Zika virus vírus da dengue vírus" exact="chikungunya" post="coinfecção Colômbia fig-count: table-count: equation-count: ref-count: In Latin America"/>
   <result pre="the Caribbean, the recent epidemics of mosquito-borne arboviruses, including the" exact="chikungunya" post="virus (CHIKV) and Zika virus (ZIKV), combined with the"/>
   <result pre="infection during pregnancy is associated with severe teratogenic effects, including" exact="microcephaly" post="(8-11). Co-circulation not only makes differential diagnoses more complicated"/>
   <result pre="weeks before the onset of symptoms and who presented with" exact="rash" post="and one or more of the following signs: fever"/>
   <result pre="more of the following signs: fever &amp;lt; 38.5 °C, nonpurulent" exact="conjunctivitis" post="or conjunctival hyperemia, arthralgia, myalgia, headache, or general discomfort."/>
   <result pre="aimed to describe the geographic distribution of Zika, dengue, and" exact="chikungunya" post="cases in Colombia based on the residence of people"/>
   <result pre="reported. In 2017, SIVIGILA was notified of 1 128 potential" exact="chikungunya" post="cases, of which 34 (3.0%; 95% CI: 2.1%–4.1%) were"/>
   <result pre="were suspected cases. Also in 2017, the national incidence of" exact="chikungunya" post="in urban populations was 4.0 cases per 100 000"/>
   <result pre="del Cauca (Figure 1). TABLE 2 Incidence of dengue (DENV)," exact="chikungunya" post="(CHIKV), and Zika (ZIKV), per 100 000 individuals in"/>
   <result pre="of Colombia with co-circulation of dengue (DENV), Zika (ZIKV), and" exact="chikungunya" post="(CHIKV), 2015 to 2018 DISCUSSION DENV, CHIKV, and ZIKV"/>
   <result pre="systematic review. PLOS Negl Trop Dis. 2015;9(3):e0003499. 2MattarSMirandaJPinzonHTiqueVBolanosAAponteJet al. Outbreak of" exact="chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="Tique V, Bolanos A, Aponte J, et al.  Outbreak of" exact="chikungunya" post="virus in the north Caribbean area of Colombia: clinical"/>
   <result pre="J Med. 2016 Jun 15. doi: 10.1056/NEJMoa1604037. 4RautCRaoNSinhaDHanumaiahHManjunathaMChikungunya, dengue, and" exact="malaria" post="co-infection after travel to Nigeria, IndiaEmerg Infect Dis201521590794. Raut"/>
   <result pre="N, Sinha D, Hanumaiah H, Manjunatha M. Chikungunya, dengue, and" exact="malaria" post="co-infection after travel to Nigeria, India. Emerg Infect Dis."/>
   <result pre="India. Emerg Infect Dis. 2015;21(5):907–9. 5FigueiredoMFigueiredoLEmerging alphaviruses in the Americas:" exact="chikungunya" post="and MayaroRev Soc Bra Med Trop201412476677835. Figueiredo M, Figueiredo"/>
   <result pre="Trop201412476677835. Figueiredo M, Figueiredo L. Emerging alphaviruses in the Americas:" exact="chikungunya" post="and Mayaro. Rev Soc Bra Med Trop. 2014 Dec;47(6):677–83."/>
   <result pre="Trop. 2014 Dec;47(6):677–83. 6CaronMPaupyCGrardGBecquartPMomboINsoBet al.Recent introduction and rapid dissemination of" exact="chikungunya" post="virus and dengue virus serotype 2 associated with human"/>
   <result pre="Nso B, et al. Recent introduction and rapid dissemination of" exact="chikungunya" post="virus and dengue virus serotype 2 associated with human"/>
   <result pre="Infect. 2017;6(1):1–6. 10SuwanmaneeSSurasombatpattanaPSoonthornworasiriNHamelRManeekanPMisséDet al.Monitoring arbovirus in Thailand: surveillance of dengue," exact="chikungunya" post="and zika virus, with a focus on coinfectionsActa Tropica2018188244503024831710."/>
   <result pre="D, et al. Monitoring arbovirus in Thailand: surveillance of dengue," exact="chikungunya" post="and zika virus, with a focus on coinfections. Acta"/>
   <result pre="Dis. 2016;14(3):177–9. 13CostaSBrancoMAquino JuniorJRodriguesZQueirozRAraujoAet al.Spatial analysis of probable cases of" exact="dengue fever," post="­chikungunya fever, and zika virus infections in Maranhao State,"/>
   <result pre="Araujo A, et al. Spatial analysis of probable cases of" exact="dengue fever," post="­chikungunya fever, and zika virus infections in Maranhao State,"/>
   <result pre="2 patients, New Caledonia, 2014. Emerg Infect Dis. 2015;21(2):381–2. 15Villamil-GómezWGonzález-CamargoORodriguez-AyubiJZapata-SerpaDRodriguez-MoralesADengue," exact="chikungunya" post="and Zika co-infection in a patient from ColombiaJ Infect"/>
   <result pre="W, González-Camargo O, Rodriguez-Ayubi J, Zapata-Serpa D, Rodriguez-Morales A. Dengue," exact="chikungunya" post="and Zika co-infection in a patient from Colombia. J"/>
   <result pre="chikun­gunya and dengue viruses. BMC Infect Dis. 2016;16:84. 18Mercado-ReyesMAcosta-ReyesJNavarro-LechugaECorchueloSRicoAParraEet al.Dengue," exact="chikungunya" post="and Zika virus coinfection: results of the national surveillance"/>
   <result pre="E, Corchuelo S, Rico A, Parra E, et al. Dengue," exact="chikungunya" post="and Zika virus coinfection: results of the national surveillance"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553602\results\search\disease\results.xml">
   <result pre="https://dx.doi.org/10.6084/m9.figshare.c.4444127. One contribution of 15 to a theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="approaches and important themes’. ppub: 2019-6-6epub: 2019-5-5pmc-release: 2019-5-53741775Theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="Nigeria. This article is part of the theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="This issue is linked with the subsequent theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: epidemic forecasting and"/>
   <result pre="as key in light of anticipated emergence of a novel" exact="infectious disease" post="in the future—the ‘Disease X’ as it was recently"/>
   <result pre="similarities with other common diseases seen in the region, i.e." exact="malaria" post="or typhoid fever [12,13]. On average, four out of"/>
   <result pre="other common diseases seen in the region, i.e. malaria or" exact="typhoid fever" post="[12,13]. On average, four out of five cases are"/>
   <result pre="has previously been used to demonstrate the causal link between" exact="influenza" post="transmission risk and humidity or temperature. The LF incidence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553608\results\search\disease\results.xml">
   <result pre="samantha.lycett@ed.ac.uk One contribution of 15 to a theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="available online at https://dx.doi.org/10.6084/m9.figshare.c.4441775. ppub: 2019-6-6epub: 2019-5-5pmc-release: 2019-5-53741775Theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="and source are credited.rstb20180257.pdf Abstract In 1918, a strain of" exact="influenza" post="A virus caused a human pandemic resulting in the"/>
   <result pre="know much more about the origins, evolution and epidemiology of" exact="influenza" post="epidemics. Here we review the history of avian influenza"/>
   <result pre="epidemiology of influenza epidemics. Here we review the history of" exact="avian influenza" post="viruses through the lens of their genetic makeup: from"/>
   <result pre="of influenza epidemics. Here we review the history of avian" exact="influenza" post="viruses through the lens of their genetic makeup: from"/>
   <result pre="zoonoses up to 2018. We describe the genesis of novel" exact="influenza" post="A virus strains by reassortment and evolution in wild"/>
   <result pre="migration in their long-range spread. The emergence of highly pathogenic" exact="avian influenza" post="viruses, and the zoonotic incursions of avian H5 and"/>
   <result pre="in their long-range spread. The emergence of highly pathogenic avian" exact="influenza" post="viruses, and the zoonotic incursions of avian H5 and"/>
   <result pre="of decades are also described. The threat of a new" exact="avian influenza" post="virus causing a human pandemic is still present today,"/>
   <result pre="decades are also described. The threat of a new avian" exact="influenza" post="virus causing a human pandemic is still present today,"/>
   <result pre="health. This article is part of the theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: approaches and important"/>
   <result pre="This issue is linked with the subsequent theme issue ‘Modelling" exact="infectious disease" post="outbreaks in humans, animals and plants: epidemic forecasting and"/>
   <result pre="outbreaks in humans, animals and plants: epidemic forecasting and control’." exact="avian influenza" post="virus epidemiology phylogenetics pandemic zoonotic Funding College of Medicine"/>
   <result pre="in humans, animals and plants: epidemic forecasting and control’. avian" exact="influenza" post="virus epidemiology phylogenetics pandemic zoonotic Funding College of Medicine"/>
   <result pre="single-stranded RNA viruses with segmented genomes. There are four main" exact="influenza" post="virus species: A, B, C and D. Type A"/>
   <result pre="more restricted host ranges. Influenza A viruses (IAV), including all" exact="avian influenza" post="viruses, possess eight separate genomic segments ranging in size"/>
   <result pre="restricted host ranges. Influenza A viruses (IAV), including all avian" exact="influenza" post="viruses, possess eight separate genomic segments ranging in size"/>
   <result pre="between 890 and 2341 nucleotides [1,2]. Like other RNA viruses," exact="influenza" post="viruses have a fast mutation rate, typically accumulating two"/>
   <result pre="Figure 1. PB2 phylogeny of a stratified sample of all" exact="influenza" post="subtypes. Tips in the circular neighbour-joining tree are coloured"/>
   <result pre="continents, H1N1, H1N2, H3N2 swine influenza, the H1N1 pandemic swine" exact="influenza" post="lineage in humans and swine, and the avian—Americas lineage"/>
   <result pre="swine, and the avian—Americas lineage with many subtypes. (c) Fowl" exact="plague" post="is avian influenza Severe non-bacterial outbreaks with high mortality"/>
   <result pre="the avian—Americas lineage with many subtypes. (c) Fowl plague is" exact="avian influenza" post="Severe non-bacterial outbreaks with high mortality rates in domestic"/>
   <result pre="avian—Americas lineage with many subtypes. (c) Fowl plague is avian" exact="influenza" post="Severe non-bacterial outbreaks with high mortality rates in domestic"/>
   <result pre="it was not until 1955 that Schafer determined that ‘fowl" exact="plague" post="virus’ (FPV) was indeed a type of IAV, with"/>
   <result pre="of IAV, with similar internal antigens to human and swine" exact="influenza" post="viruses [15]. Sequencing studies performed many years later resulted"/>
   <result pre="years later resulted in the identification of the highly pathogenic" exact="avian influenza" post="(HPAI) virus strains responsible for these outbreaks as H7"/>
   <result pre="later resulted in the identification of the highly pathogenic avian" exact="influenza" post="(HPAI) virus strains responsible for these outbreaks as H7"/>
   <result pre="However, this was reconsidered after the isolation of low pathogenic" exact="avian influenza" post="(LPAI) H5 and H7 strains from ducks in the"/>
   <result pre="this was reconsidered after the isolation of low pathogenic avian" exact="influenza" post="(LPAI) H5 and H7 strains from ducks in the"/>
   <result pre="low and high pathogenicity H5 viruses are shown. (d) Avian" exact="influenza" post="and human pandemics One hundred years ago, in 1918,"/>
   <result pre="in 1918, the ‘Spanish flu’ pandemic, caused by an H1N1" exact="influenza" post="virus is estimated to have contributed to the deaths"/>
   <result pre="no or little prior immunity. The relationship between fowl plague," exact="avian influenza" post="and human influenza was not apparent before the 1950s,"/>
   <result pre="or little prior immunity. The relationship between fowl plague, avian" exact="influenza" post="and human influenza was not apparent before the 1950s,"/>
   <result pre="immunity. The relationship between fowl plague, avian influenza and human" exact="influenza" post="was not apparent before the 1950s, but by 1967"/>
   <result pre="are considered in more detail later. 2. Global patterns of" exact="avian influenza" post="circulation Water fowl, especially Anseriformes (ducks, geese and swans)"/>
   <result pre="considered in more detail later. 2. Global patterns of avian" exact="influenza" post="circulation Water fowl, especially Anseriformes (ducks, geese and swans)"/>
   <result pre="analyses [67,68], and these techniques are particularly suitable for understanding" exact="avian influenza" post="systems since they make use of the fast-evolving viral"/>
   <result pre="[67,68], and these techniques are particularly suitable for understanding avian" exact="influenza" post="systems since they make use of the fast-evolving viral"/>
   <result pre="and across the Bering straits, which allows occasional transmission of" exact="influenza" post="viruses between North America and Eurasia. Flyways from http://wpe.wetlands.org/Iwhatfly."/>
   <result pre="between wild and domestic animals. 3. Rise of highly pathogenic" exact="avian influenza" post="As noted above (box 1), H5 and H7 avian"/>
   <result pre="wild and domestic animals. 3. Rise of highly pathogenic avian" exact="influenza" post="As noted above (box 1), H5 and H7 avian"/>
   <result pre="been raised about H5N1 as the source of the next" exact="influenza" post="pandemic [134,135], so its spread out of Asia was"/>
   <result pre="seasonal IAV, and now co-circulates alongside seasonal H3N2 IAV and" exact="influenza" post="B viruses in the human population. 5. Emergence of"/>
   <result pre="the industry, this is the most expensive recorded North American" exact="avian influenza" post="epidemic to date [182,183]. The control measures were successful,"/>
   <result pre="industry, this is the most expensive recorded North American avian" exact="influenza" post="epidemic to date [182,183]. The control measures were successful,"/>
   <result pre="brief history of bird flu, we have seen that current" exact="avian influenza" post="virus strains have been circulating and diversifying in wild"/>
   <result pre="history of bird flu, we have seen that current avian" exact="influenza" post="virus strains have been circulating and diversifying in wild"/>
   <result pre="of the disease. In some senses, the dynamics of human" exact="influenza" post="in humans and avian influenza in birds are similar—both"/>
   <result pre="some senses, the dynamics of human influenza in humans and" exact="avian influenza" post="in birds are similar—both can be thought of as"/>
   <result pre="senses, the dynamics of human influenza in humans and avian" exact="influenza" post="in birds are similar—both can be thought of as"/>
   <result pre="to keep outbreaks in these populations to a minimum. Ongoing" exact="avian influenza" post="virus spill-overs into human cases suggest that zoonotic bird"/>
   <result pre="keep outbreaks in these populations to a minimum. Ongoing avian" exact="influenza" post="virus spill-overs into human cases suggest that zoonotic bird"/>
   <result pre="in avian, human and other domestic animal populations, and control" exact="avian influenza" post="in domestic avian populations, then we can surely reduce"/>
   <result pre="avian, human and other domestic animal populations, and control avian" exact="influenza" post="in domestic avian populations, then we can surely reduce"/>
   <result pre="we can surely reduce the risks of a new human" exact="avian influenza" post="pandemic. Supplementary Material Supplementary Text LINK Supplementary Material Data"/>
   <result pre="can surely reduce the risks of a new human avian" exact="influenza" post="pandemic. Supplementary Material Supplementary Text LINK Supplementary Material Data"/>
   <result pre="Elsevier (10.1016/B978-0-12-384684-6.00136-1) 2WebsterRG, BeanWJ, GormanOT, ChambersTM, KawaokaY1992Evolution and ecology of" exact="influenza" post="A viruses. Microbiol. Rev.56, 152–179. (10.1111/j.1541-0420.2008.01180.x)1579108 3ChenR, HolmesEC2006Avian influenza"/>
   <result pre="of influenza A viruses. Microbiol. Rev.56, 152–179. (10.1111/j.1541-0420.2008.01180.x)1579108 3ChenR, HolmesEC2006Avian" exact="influenza" post="virus exhibits rapid evolutionary dynamics. Mol. Biol. Evol.23, 2336–2341."/>
   <result pre="TemkinaOA, EgorovVV, KlotchenkoSA, PlotnikovaMA, KiselevOI2014Molecular mechanisms enhancing the proteome of" exact="influenza" post="A viruses: an overview of recently discovered proteins. Virus"/>
   <result pre="proteins. Virus Res.185, 53–63. (10.1016/j.virusres.2014.03.015)24675275 5TongSet al.2012A distinct lineage of" exact="influenza" post="A virus from bats. Proc. Natl Acad. Sci. USA109,"/>
   <result pre="Sci. USA109, 4269–4274. (10.1073/pnas.1116200109)22371588 6TongSet al.2013New World bats harbor diverse" exact="influenza" post="A viruses. PLoS Pathog.9, e1003657 (10.1371/journal.ppat.1003657)24130481 7LemeyPet al.2014Unifying viral"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2. PLoS Pathog.10, e1003932 (10.1371/journal.ppat.1003932)24586153 8BaoY, BolotovP, DernovoyD, KiryutinB,"/>
   <result pre="e1003932 (10.1371/journal.ppat.1003932)24586153 8BaoY, BolotovP, DernovoyD, KiryutinB, ZaslavskyL, TatusovaT, OstellJ, LipmanD2008The" exact="influenza" post="virus resource at the National Center for Biotechnology Information."/>
   <result pre="Virol.82, 596–601. (10.1128/JVI.02005-07)17942553 9DuganVGet al.2008The evolutionary genetics and emergence of" exact="avian influenza" post="viruses in wild birds. PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL,"/>
   <result pre="596–601. (10.1128/JVI.02005-07)17942553 9DuganVGet al.2008The evolutionary genetics and emergence of avian" exact="influenza" post="viruses in wild birds. PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL,"/>
   <result pre="PLoS Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL, LycettSJ, Leigh BrownAJ2014Reassortment patterns of" exact="avian influenza" post="virus internal segments among different subtypes. BMC Evol. Biol.14,"/>
   <result pre="Pathog.4, e1000076 (10.1371/journal.ppat.1000076)18516303 10LuL, LycettSJ, Leigh BrownAJ2014Reassortment patterns of avian" exact="influenza" post="virus internal segments among different subtypes. BMC Evol. Biol.14,"/>
   <result pre="BMC Evol. Biol.14, 16 (10.1186/1471-2148-14-16)24456010 11BrownIH2000The epidemiology and evolution of" exact="influenza" post="viruses in pigs. Vet. Microbiol.74, 29–46. (10.1016/S0378-1135(00)00164-4)10799776 12LycettSJet al.2012Estimating"/>
   <result pre="29–46. (10.1016/S0378-1135(00)00164-4)10799776 12LycettSJet al.2012Estimating reassortment rates in co-circulating Eurasian swine" exact="influenza" post="viruses. J. Gen. Virol.93, 2326–2336. (10.1099/vir.0.044503-0)22971819 13AlexanderDJ, BrownIH2009History of"/>
   <result pre="J. Gen. Virol.93, 2326–2336. (10.1099/vir.0.044503-0)22971819 13AlexanderDJ, BrownIH2009History of highly pathogenic" exact="avian influenza." post="Rev. Sci. Tech.28, 19–38. (10.20506/rst.28.1.1856)19618616 14LupianiB, ReddySM2009The history of"/>
   <result pre="influenza. Rev. Sci. Tech.28, 19–38. (10.20506/rst.28.1.1856)19618616 14LupianiB, ReddySM2009The history of" exact="avian influenza." post="Comp. Immunol. Microbiol. Infect. Dis.32, 311–323. (10.1016/j.cimid.2008.01.004)18533261 15SchaferW1955Vergleichende sero-immunologische"/>
   <result pre="und klassischen Geflügelpest [Comparative sero-immunological studies on the viruses of" exact="influenza" post="and classical avian influenza]. Zeitschr. Naturforsch.10, 81–91 (in German)."/>
   <result pre="16RöhmC, HorimotoT, KawaokaY, SüssJ, WebsterRG1995Do hemagglutinin genes of highly pathogenic" exact="avian influenza" post="viruses constitute unique phylogenetic lineages?Virology209, 664–670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB,"/>
   <result pre="HorimotoT, KawaokaY, SüssJ, WebsterRG1995Do hemagglutinin genes of highly pathogenic avian" exact="influenza" post="viruses constitute unique phylogenetic lineages?Virology209, 664–670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB,"/>
   <result pre="viruses constitute unique phylogenetic lineages?Virology209, 664–670. (10.1006/viro.1995.1301)7778300 17PereiraHG, TumovaB, LawVG1965Avian" exact="influenza" post="A viruses. Bull. World Health Org.32, 855–860. 18PorterAG, BarberC,"/>
   <result pre="18PorterAG, BarberC, CareyNH, HallewellRA, ThrelfallG, EmtageJS1979Complete nucleotide sequence of an" exact="influenza" post="virus haemagglutinin gene from cloned DNA. Nature282, 471–477. (10.1038/282471a0)503226"/>
   <result pre="Nature282, 471–477. (10.1038/282471a0)503226 19BeckerWB1966The isolation and classification of tern virus:" exact="influenza" post="virus A/Tern/South Africa/1961. J. Hyg. (Lond).64, 309–320. (10.1017/S0022172400040596)5223681 20LangG,"/>
   <result pre="Hyg. (Lond).64, 309–320. (10.1017/S0022172400040596)5223681 20LangG, NarayanO, RouseBT, FergusonAE, ConnellMC1968A new" exact="influenza" post="A virus infection in turkeys II. A highly pathogenic"/>
   <result pre="772/66. Can. Vet. J9, 151.5690802 21BeardCW, HelferDH1972Isolation of two turkey" exact="influenza" post="viruses in Oregon. Avian Dis.16, 1133–1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review"/>
   <result pre="viruses in Oregon. Avian Dis.16, 1133–1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review of" exact="avian influenza" post="in different bird species. Vet. Microbiol.74, 3–13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An"/>
   <result pre="in Oregon. Avian Dis.16, 1133–1136. (10.2307/1588841)4629606 22AlexanderDJ2000A review of avian" exact="influenza" post="in different bird species. Vet. Microbiol.74, 3–13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An"/>
   <result pre="Vet. Microbiol.74, 3–13. (10.1016/S0378-1135(00)00160-7)10799774 23AlexanderDJ2007An overview of the epidemiology of" exact="avian influenza." post="Vaccine25, 5637–5644. (10.1016/j.vaccine.2006.10.051)17126960 24KraussSet al.2007Influenza in migratory birds and"/>
   <result pre="Health Code (2018). See http://www.oie.int/index.php?id=169&amp;amp;L=0&amp;amp;htmfile=chapitre_avian_influenza_viruses.htm. 26KlenkHD, RottR1988The molecular biology of" exact="influenza" post="virus pathogenicity. Adv. Virus Res.34, 247–281. (10.1016/S0065-3527(08)60520-5)3046255 27VeyM, OrlichM,"/>
   <result pre="(10.1016/S0065-3527(08)60520-5)3046255 27VeyM, OrlichM, AdlerS, KlenkHD, RottR, GartenW1992Hemagglutinin activation of pathogenic" exact="avian influenza" post="viruses of serotype H7 requires the protease recognition motif"/>
   <result pre="27VeyM, OrlichM, AdlerS, KlenkHD, RottR, GartenW1992Hemagglutinin activation of pathogenic avian" exact="influenza" post="viruses of serotype H7 requires the protease recognition motif"/>
   <result pre="recognition motif R-X-K/R-R. Virology188, 408–413. (10.1016/0042-6822(92)90775-K)1566583 28RottR1992The pathogenic determinant of" exact="influenza" post="virus. Vet. Microbiol.33, 303–310. (10.1016/0378-1135(92)90058-2)1481363 29LuczoJM, StambasJ, DurrPA, MichalskiWP,"/>
   <result pre="30JohnsonNPAS, MuellerJ2002Updating the accounts: global mortality of the 1918–1920 ‘Spanish’" exact="influenza" post="pandemic. Bull. Hist. Med.76, 105–115. (10.1353/bhm.2002.0022)11875246 31PereiraHG, TumovaB, WebsterRG1967Antigenic"/>
   <result pre="Bull. Hist. Med.76, 105–115. (10.1353/bhm.2002.0022)11875246 31PereiraHG, TumovaB, WebsterRG1967Antigenic relationship between" exact="influenza" post="A viruses of human and avian origins. Nature215, 982–983."/>
   <result pre="(10.1038/215982a0)6055434 32FangR, Min JouW, HuylebroeckD, DevosR, FiersW1981Complete structure of A/duck/Ukraine/63" exact="influenza" post="hemagglutinin gene: animal virus as progenitor of human H3"/>
   <result pre="animal virus as progenitor of human H3 Hong Kong 1968" exact="influenza" post="hemagglutinin. Cell25, 315–323. (10.1016/0092-8674(81)90049-0)6169439 33SchäferJR, KawaokaY, BeanWJ, SüssJ, SenneD,"/>
   <result pre="KawaokaY, BeanWJ, SüssJ, SenneD, WebsterRG1993Origin of the pandemic 1957 H2" exact="influenza" post="A virus and the persistence of its possible progenitors"/>
   <result pre="reservoir. Virology194, 781–788. (10.1006/viro.1993.1319)7684877 34SmithW, AndrewesCH, LaidlawPP1933A virus obtained from" exact="influenza" post="patients. Lancet222, 66–68. (10.1016/S0140-6736(00)78541-2) 35TaubenbergerJK, HultinJV, MorensDM2007Discovery and characterization"/>
   <result pre="(10.1016/S0140-6736(00)78541-2) 35TaubenbergerJK, HultinJV, MorensDM2007Discovery and characterization of the 1918 pandemic" exact="influenza" post="virus in historical context. Antivir. Ther.12, 581–591.17944266 36FanningTG, SlemonsRD,"/>
   <result pre="context. Antivir. Ther.12, 581–591.17944266 36FanningTG, SlemonsRD, ReidAH, JanczewskiTA, DeanJ, TaubenbergerJK20021917" exact="avian influenza" post="virus sequences suggest that the 1918 pandemic virus did"/>
   <result pre="Antivir. Ther.12, 581–591.17944266 36FanningTG, SlemonsRD, ReidAH, JanczewskiTA, DeanJ, TaubenbergerJK20021917 avian" exact="influenza" post="virus sequences suggest that the 1918 pandemic virus did"/>
   <result pre="7860–7862. (10.1128/JVI.76.15.7860-7862.2002)12097598 37ReidAH, FanningTG, SlemonsRD, JanczewskiTA, DeanJ, TaubenbergerJK2003Relationship of pre-1918" exact="avian influenza" post="HA and NP sequences to subsequent avian influenza strains."/>
   <result pre="(10.1128/JVI.76.15.7860-7862.2002)12097598 37ReidAH, FanningTG, SlemonsRD, JanczewskiTA, DeanJ, TaubenbergerJK2003Relationship of pre-1918 avian" exact="influenza" post="HA and NP sequences to subsequent avian influenza strains."/>
   <result pre="of pre-1918 avian influenza HA and NP sequences to subsequent" exact="avian influenza" post="strains. Avian Dis.47, 921–925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of"/>
   <result pre="pre-1918 avian influenza HA and NP sequences to subsequent avian" exact="influenza" post="strains. Avian Dis.47, 921–925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of"/>
   <result pre="Dis.47, 921–925. (10.1637/0005-2086-47.s3.921)14575087 38ReidAH, TaubenbergerJK2003The origin of the 1918 pandemic" exact="influenza" post="virus: a continuing enigma. J. Gen. Virol.84, 2285–2292. (10.1099/vir.0.19302-0)12917448"/>
   <result pre="(10.1099/vir.0.19302-0)12917448 39TaubenbergerJK, ReidAH, LourensRM, WangR, JinG, FanningTG2005Characterization of the 1918" exact="influenza" post="virus polymerase genes. Nature437, 889–893. (10.1038/nature04230)16208372 40WorobeyM, HanGZ, RambautA2014A"/>
   <result pre="RambautA2014A synchronized global sweep of the internal genes of modern" exact="avian influenza" post="virus. Nature508, 254–257. (10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of"/>
   <result pre="synchronized global sweep of the internal genes of modern avian" exact="influenza" post="virus. Nature508, 254–257. (10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of"/>
   <result pre="(10.1038/nature13016)24531761 41KawaokaY, KraussS, WebsterRG1989Avian-to-human transmission of the PB1 gene of" exact="influenza" post="A viruses in the 1957 and 1968 pandemics. J."/>
   <result pre="1968 pandemics. J. Virol.63, 4603–4608.2795713 42JosephUet al.2015Adaptation of pandemic H2N2" exact="influenza" post="A viruses in humans. J. Virol.89, 2442–2447. (10.1128/JVI.02590-14)25505070 43BeanWJ,"/>
   <result pre="43BeanWJ, SchellM, KatzJ, KawaokaY, NaeveC, GormanO, WebsterRG1992Evolution of the H3" exact="influenza" post="virus hemagglutinin from human and nonhuman hosts. J. Virol.66,"/>
   <result pre="44SmithGJDet al.2009Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemic. Nature459, 1122–1125. (10.1038/nature08182)19516283 45BhattSet al..2013The evolutionary dynamics"/>
   <result pre="A epidemic. Nature459, 1122–1125. (10.1038/nature08182)19516283 45BhattSet al..2013The evolutionary dynamics of" exact="influenza" post="A virus adaptation to mammalian hosts. Phil. Trans. R."/>
   <result pre="features and rapid viral diagnosis of human disease associated with" exact="avian influenza" post="A H5N1 virus. Lancet351, 467–471. (10.1016/S0140-6736(98)01182-9)9482437 47ShiW, ShiY, WuY,"/>
   <result pre="and rapid viral diagnosis of human disease associated with avian" exact="influenza" post="A H5N1 virus. Lancet351, 467–471. (10.1016/S0140-6736(98)01182-9)9482437 47ShiW, ShiY, WuY,"/>
   <result pre="WuY, LiuD, GaoGF2013Origin and molecular characterization of the human-infecting H6N1" exact="influenza" post="virus in Taiwan. Protein Cell4, 846–853. (10.1007/s13238-013-3083-0)24136722 48ParryJ2013H7N9 avian"/>
   <result pre="49ChenHet al.2014Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: a descriptive study. Lancet383, 714–721."/>
   <result pre="al.2014Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: a descriptive study. Lancet383, 714–721."/>
   <result pre="ChughtaiAA, AdamDC, MacIntyreCR2017An overview of the epidemiology and emergence of" exact="influenza" post="A infection in humans over time. Arch. Public Health75,"/>
   <result pre="humans over time. Arch. Public Health75, 15 (10.1186/s13690-017-0182-z)28352464 51FouchierRAMet al.2004Avian" exact="influenza" post="A virus (H7N7) associated with human conjunctivitis and a"/>
   <result pre="(10.1186/s13690-017-0182-z)28352464 51FouchierRAMet al.2004Avian influenza A virus (H7N7) associated with human" exact="conjunctivitis" post="and a fatal case of acute respiratory distress syndrome."/>
   <result pre="(H7N7) associated with human conjunctivitis and a fatal case of" exact="acute respiratory distress syndrome." post="Proc. Natl Acad. Sci. USA101, 1356–1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission"/>
   <result pre="Natl Acad. Sci. USA101, 1356–1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission of H7N7" exact="avian influenza" post="A virus to human beings during a large outbreak"/>
   <result pre="Acad. Sci. USA101, 1356–1361. (10.1073/pnas.0308352100)14745020 52KoopmansMet al.2004Transmission of H7N7 avian" exact="influenza" post="A virus to human beings during a large outbreak"/>
   <result pre="587–593. (10.1016/S0140-6736(04)15589-X)14987882 53OlsenB, MunsterVJ, WallenstenA, WaldenströmJ, OsterhausADME, FouchierRAM2006Global patterns of" exact="influenza" post="A virus in wild birds. Science312, 384–388. (10.1126/science.1122438)16627734 54EasterdayBC,"/>
   <result pre="Science312, 384–388. (10.1126/science.1122438)16627734 54EasterdayBC, TrainerDO, TůmováB, PereiraHG1968Evidence of infection with" exact="influenza" post="viruses in migratory waterfowl. Nature219, 523–524. (10.1038/219523a0)4299258 55DownieJC, LaverWG1973Isolation"/>
   <result pre="waterfowl. Nature219, 523–524. (10.1038/219523a0)4299258 55DownieJC, LaverWG1973Isolation of a type A" exact="influenza" post="virus from an Australian pelagic bird. Virology51, 259–269. (10.1016/0042-6822(73)90426-1)4632652"/>
   <result pre="WebsterRG, SchildGC, DowdleWR, LaverWG1973Characterization and ecology of a type A" exact="influenza" post="virus isolated from a shearwater. Bull. World Health Organ.49,"/>
   <result pre="a shearwater. Bull. World Health Organ.49, 559–566.4548383 57KuikenT2013Is low pathogenic" exact="avian influenza" post="virus virulent for wild waterbirds?Proc. R. Soc. B280, 20130990"/>
   <result pre="shearwater. Bull. World Health Organ.49, 559–566.4548383 57KuikenT2013Is low pathogenic avian" exact="influenza" post="virus virulent for wild waterbirds?Proc. R. Soc. B280, 20130990"/>
   <result pre="(10.1371/journal.pone.0008935)20126617 59RunstadlerJ, HillN, HusseinITM, PuryearW, KeoghM2013Connecting the study of wild" exact="influenza" post="with the potential for pandemic disease. Infect. Genet. Evol.17,"/>
   <result pre="StallknechtDE, SwayneDE2008Experimental infection of swans and geese with highly pathogenic" exact="avian influenza" post="virus (H5N1) of Asian lineage. Emerg. Infect. Dis.14, 136–142."/>
   <result pre="SwayneDE2008Experimental infection of swans and geese with highly pathogenic avian" exact="influenza" post="virus (H5N1) of Asian lineage. Emerg. Infect. Dis.14, 136–142."/>
   <result pre="and geographical distance are barriers to the gene flow of" exact="influenza" post="virus among North American birds. Ecol. Lett.15, 24–33. (10.1111/j.1461-0248.2011.01703.x)22008513"/>
   <result pre="24–33. (10.1111/j.1461-0248.2011.01703.x)22008513 62ScotchM, LamTT-Y, PabiloniaKL, AndersonT, BarochJ, KohlerD, DeLibertoTJ2014Diffusion of" exact="influenza" post="viruses among migratory birds with a focus on the"/>
   <result pre="southwest United States. Infect. Genet. Evol.26, 185–193. (10.1016/j.meegid.2014.05.029)24910106 63TianHet al.2015Avian" exact="influenza" post="H5N1 viral and bird migration networks in Asia. Proc."/>
   <result pre="Leigh BrownAJ2014Determining the phylogenetic and phylogeographic origin of highly pathogenic" exact="avian influenza" post="(H7N3) in Mexico. PLoS ONE9, e107330 (10.1371/journal.pone.0107330)25226523 65BahlJ, VijaykrishnaD,"/>
   <result pre="BrownAJ2014Determining the phylogenetic and phylogeographic origin of highly pathogenic avian" exact="influenza" post="(H7N3) in Mexico. PLoS ONE9, e107330 (10.1371/journal.pone.0107330)25226523 65BahlJ, VijaykrishnaD,"/>
   <result pre="65BahlJ, VijaykrishnaD, HolmesEC, SmithGJD, GuanY2009Gene flow and competitive exclusion of" exact="avian influenza" post="A virus in natural reservoir hosts. Virology390, 289–297. (10.1016/j.virol.2009.05.002)19501380"/>
   <result pre="VijaykrishnaD, HolmesEC, SmithGJD, GuanY2009Gene flow and competitive exclusion of avian" exact="influenza" post="A virus in natural reservoir hosts. Virology390, 289–297. (10.1016/j.virol.2009.05.002)19501380"/>
   <result pre="e1000520 (10.1371/journal.pcbi.1000520)19779555 68PybusOG, RambautA2009Evolutionary analysis of the dynamics of viral" exact="infectious disease." post="Nat. Rev. Genet.10, 540–550. (10.1038/nrg2583)19564871 69LycettSJet al.2016Role for migratory"/>
   <result pre="al.2016Role for migratory wild birds in the global spread of" exact="avian influenza" post="H5N8. Science354, 213–217. (10.1126/science.aaf8852)27738169 70HillSC, LeeY-J, SongB-M, KangH-M, LeeE-K,"/>
   <result pre="for migratory wild birds in the global spread of avian" exact="influenza" post="H5N8. Science354, 213–217. (10.1126/science.aaf8852)27738169 70HillSC, LeeY-J, SongB-M, KangH-M, LeeE-K,"/>
   <result pre="domestic duck density shape the epidemiology of highly pathogenic H5N8" exact="influenza" post="in the Republic of Korea. Infect. Genet. Evol.34, 267–277."/>
   <result pre="267–277. (10.1016/j.meegid.2015.06.014)26079277 71BahlJet al.2011Temporally structured metapopulation dynamics and persistence of" exact="influenza" post="A H3N2 virus in humans. Proc. Natl Acad. Sci."/>
   <result pre="76LuL, Leigh BrownAJ, LycettSJ2017Quantifying predictors for the spatial diffusion of" exact="avian influenza" post="virus in China. BMC Evol. Biol.17, 16 (10.1186/s12862-016-0845-3)28086751 77FariaNR,"/>
   <result pre="Leigh BrownAJ, LycettSJ2017Quantifying predictors for the spatial diffusion of avian" exact="influenza" post="virus in China. BMC Evol. Biol.17, 16 (10.1186/s12862-016-0845-3)28086751 77FariaNR,"/>
   <result pre="LemeyP2015Bayesian inference reveals host-specific contributions to the epidemic expansion of" exact="influenza" post="A H5N1. Mol. Biol. Evol.32, 3264–3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem"/>
   <result pre="Evol.32, 3264–3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem interactions underlie the spread of" exact="avian influenza" post="A viruses with pandemic potential. PLoS Pathog.12, e1005620 (10.1371/journal.ppat.1005620)27166585"/>
   <result pre="3264–3275. (10.1093/molbev/msv185)26341298 91BahlJet al.2016Ecosystem interactions underlie the spread of avian" exact="influenza" post="A viruses with pandemic potential. PLoS Pathog.12, e1005620 (10.1371/journal.ppat.1005620)27166585"/>
   <result pre="92KoehlerAV, PearceJM, FlintPL, FransonJC, IpHS2008Genetic evidence of intercontinental movement of" exact="avian influenza" post="in a migratory bird: the northern pintail (Anas acuta)."/>
   <result pre="PearceJM, FlintPL, FransonJC, IpHS2008Genetic evidence of intercontinental movement of avian" exact="influenza" post="in a migratory bird: the northern pintail (Anas acuta)."/>
   <result pre="6521–6524. (10.1128/JVI.00728-15)25855748 94CheonS-Het al.2018Genetic evidence for the intercontinental movement of" exact="avian influenza" post="viruses possessing North American-origin nonstructural gene allele B into"/>
   <result pre="(10.1128/JVI.00728-15)25855748 94CheonS-Het al.2018Genetic evidence for the intercontinental movement of avian" exact="influenza" post="viruses possessing North American-origin nonstructural gene allele B into"/>
   <result pre="Evol.66, 18–25. (10.1016/j.meegid.2018.09.001)30196122 95ChenHet al.2006Establishment of multiple sublineages of H5N1" exact="influenza" post="virus in Asia: implications for pandemic control. Proc. Natl"/>
   <result pre="USA103, 2845–2850. (10.1073/pnas.0511120103)16473931 96Gauthier-ClercM, LebarbenchonC, ThomasF2007Recent expansion of highly pathogenic" exact="avian influenza" post="H5N1: a critical review. Ibis149, 202–214. (10.1111/j.1474-919X.2007.00699.x) 97KilpatrickAM, ChmuraAA,"/>
   <result pre="2845–2850. (10.1073/pnas.0511120103)16473931 96Gauthier-ClercM, LebarbenchonC, ThomasF2007Recent expansion of highly pathogenic avian" exact="influenza" post="H5N1: a critical review. Ibis149, 202–214. (10.1111/j.1474-919X.2007.00699.x) 97KilpatrickAM, ChmuraAA,"/>
   <result pre="ChmuraAA, GibbonsDW, FleischerRC, MarraPP, DaszakP2006Predicting the global spread of H5N1" exact="avian influenza." post="Proc. Natl Acad. Sci. USA103, 19 368–19 373. (10.1073/pnas.0609227103)"/>
   <result pre="USA103, 19 368–19 373. (10.1073/pnas.0609227103) 98KraussSet al.2015Long-term surveillance of H7" exact="influenza" post="viruses in American wild aquatic birds: are the H7N3"/>
   <result pre="influenza viruses in American wild aquatic birds: are the H7N3" exact="influenza" post="viruses in wild birds the precursors of highly pathogenic"/>
   <result pre="domestic poultry?Emerg. Microbes Infect.4, e35 (10.1038/emi.2015.35)26954883 99MorrisRS, JacksonR2005Epidemiology of H5N1" exact="avian influenza" post="in Asia and implications for regional control. Rome, Italy:"/>
   <result pre="poultry?Emerg. Microbes Infect.4, e35 (10.1038/emi.2015.35)26954883 99MorrisRS, JacksonR2005Epidemiology of H5N1 avian" exact="influenza" post="in Asia and implications for regional control. Rome, Italy:"/>
   <result pre="regional control. Rome, Italy: FAO. See http://www.fao.org/docs/eims/upload/246974/aj122e00.pdf. 100CappelleJet al.2014Risks of" exact="avian influenza" post="transmission in areas of intensive free-ranging duck production with"/>
   <result pre="control. Rome, Italy: FAO. See http://www.fao.org/docs/eims/upload/246974/aj122e00.pdf. 100CappelleJet al.2014Risks of avian" exact="influenza" post="transmission in areas of intensive free-ranging duck production with"/>
   <result pre="ProsserDJ, GuoF, GilbertM2011Spatial distribution and risk factors of highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 in China. PLoS Pathog.7, e1001308 (10.1371/journal.ppat.1001308)21408202 102GilbertM,"/>
   <result pre="GuoF, GilbertM2011Spatial distribution and risk factors of highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 in China. PLoS Pathog.7, e1001308 (10.1371/journal.ppat.1001308)21408202 102GilbertM,"/>
   <result pre="PfeifferDU2012Risk factor modelling of the spatio-temporal patterns of highly pathogenic" exact="avian influenza" post="(HPAIV) H5N1: a review. Spat. Spatiotemp. Epidemiol.3, 173–183. (10.1016/j.sste.2012.01.002)"/>
   <result pre="factor modelling of the spatio-temporal patterns of highly pathogenic avian" exact="influenza" post="(HPAIV) H5N1: a review. Spat. Spatiotemp. Epidemiol.3, 173–183. (10.1016/j.sste.2012.01.002)"/>
   <result pre="e49528 (10.1371/journal.pone.0049528)23185352 104LamTT-Yet al.2013The genesis and source of the H7N9" exact="influenza" post="viruses causing human infections in China. Nature502, 241–244. (10.1038/nature12515)23965623"/>
   <result pre="China. Nature502, 241–244. (10.1038/nature12515)23965623 105MonneIet al.2014Emergence of a highly pathogenic" exact="avian influenza" post="virus from a low-pathogenic progenitor. J. Virol.88, 4375–4388. (10.1128/JVI.03181-13)24501401"/>
   <result pre="Nature502, 241–244. (10.1038/nature12515)23965623 105MonneIet al.2014Emergence of a highly pathogenic avian" exact="influenza" post="virus from a low-pathogenic progenitor. J. Virol.88, 4375–4388. (10.1128/JVI.03181-13)24501401"/>
   <result pre="progenitor. J. Virol.88, 4375–4388. (10.1128/JVI.03181-13)24501401 106SeekingsAHet al.2018Direct evidence of H7N7" exact="avian influenza" post="virus mutation from low to high virulence on a"/>
   <result pre="J. Virol.88, 4375–4388. (10.1128/JVI.03181-13)24501401 106SeekingsAHet al.2018Direct evidence of H7N7 avian" exact="influenza" post="virus mutation from low to high virulence on a"/>
   <result pre="and historical patterns in the emergences of novel highly pathogenic" exact="avian influenza" post="(HPAI) H5 and H7 viruses in poultry. Front. Vet."/>
   <result pre="historical patterns in the emergences of novel highly pathogenic avian" exact="influenza" post="(HPAI) H5 and H7 viruses in poultry. Front. Vet."/>
   <result pre="108BeanWJ, KawaokaY, WoodJM, PearsonJE, WebsterRG1985Characterization of virulent and avirulent A/chicken/Pennsylvania/83" exact="influenza" post="A viruses: potential role of defective interfering RNAs in"/>
   <result pre="molecular changes associated with emergence of a highly pathogenic H5N2" exact="influenza" post="virus in Mexico. Virology213, 223–230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS,"/>
   <result pre="virus in Mexico. Virology213, 223–230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS, AlexanderDJ2000H7N1" exact="avian influenza" post="in Italy (1999 to 2000) in intensively reared chickens"/>
   <result pre="in Mexico. Virology213, 223–230. (10.1006/viro.1995.1562)7483266 110CapuaI, MutinelliF, MarangonS, AlexanderDJ2000H7N1 avian" exact="influenza" post="in Italy (1999 to 2000) in intensively reared chickens"/>
   <result pre="BoumaA, ElbersARW, de JongMCM, NodelijkG, de KlerkF, KochG, van BovenM2004Avian" exact="influenza" post="A virus (H7N7) epidemic in The Netherlands in 2003:"/>
   <result pre="Avian Dis.51, 313–316. (10.1637/7627-042706R.1)17494573 113DuanLet al.2007Characterization of low-pathogenic H5 subtype" exact="influenza" post="viruses from Eurasia: implications for the origin of highly"/>
   <result pre="OsterhausAD, van BeekR, De JongJC, RimmelzwaanGF, SenneDA, KraussS, ShortridgeKF, WebsterRG1998Human" exact="influenza" post="A H5N1 virus related to a highly pathogenic avian"/>
   <result pre="WebsterRG1998Human influenza A H5N1 virus related to a highly pathogenic" exact="avian influenza" post="virus. Lancet351, 472–477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR,"/>
   <result pre="influenza A H5N1 virus related to a highly pathogenic avian" exact="influenza" post="virus. Lancet351, 472–477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR,"/>
   <result pre="Lancet351, 472–477. (10.1016/S0140-6736(97)11212-0)9482438 116ClaasECJ, de JongJC, van BeekR, RimmelzwaanGF, OsterhausADME1998Human" exact="influenza" post="virus A/HongKong/156/97 (H5N1) infection. Vaccine16, 977–978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization"/>
   <result pre="A/HongKong/156/97 (H5N1) infection. Vaccine16, 977–978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="(H5N1) infection. Vaccine16, 977–978. (10.1016/S0264-410X(98)00005-X)9682346 117SubbaraoKet al.1998Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="with a fatal respiratory illness. Science279, 393–396. (10.1126/science.279.5349.393)9430591 118ChanPKS2002Outbreak of" exact="avian influenza" post="A(H5N1) virus infection in Hong Kong in 1997. Clin."/>
   <result pre="a fatal respiratory illness. Science279, 393–396. (10.1126/science.279.5349.393)9430591 118ChanPKS2002Outbreak of avian" exact="influenza" post="A(H5N1) virus infection in Hong Kong in 1997. Clin."/>
   <result pre="Infect. Dis.34(Suppl. 2), S58–S64. (10.1086/338820)11938498 119ShortridgeKFet al.1998Characterization of avian H5N1" exact="influenza" post="viruses from poultry in Hong Kong. Virology252, 331–342. (10.1006/viro.1998.9488)9878612"/>
   <result pre="poultry in Hong Kong. Virology252, 331–342. (10.1006/viro.1998.9488)9878612 120ShortridgeKF1999Poultry and the" exact="influenza" post="H5N1 outbreak in Hong Kong, 1997: abridged chronology and"/>
   <result pre="S26–S29. (10.1016/S0264-410X(99)00102-4)10471177 121DuanLet al.2008The development and genetic diversity of H5N1" exact="influenza" post="virus in China, 1996–2006. Virology380, 243–254. (10.1016/j.virol.2008.07.038)18774155 122GuanY, PeirisJSM,"/>
   <result pre="DyrtingKC, KraussS, ZhangLJ, WebsterRG, ShortridgeKF2002Emergence of multiple genotypes of H5N1" exact="avian influenza" post="viruses in Hong Kong SAR. Proc. Natl Acad. Sci."/>
   <result pre="KraussS, ZhangLJ, WebsterRG, ShortridgeKF2002Emergence of multiple genotypes of H5N1 avian" exact="influenza" post="viruses in Hong Kong SAR. Proc. Natl Acad. Sci."/>
   <result pre="123LiKSet al.2004Genesis of a highly pathogenic and potentially pandemic H5N1" exact="influenza" post="virus in eastern Asia. Nature430, 209–213. (10.1038/nature02746)15241415 124collab: World"/>
   <result pre="World Health Organisation. 2018Cumulative number of confirmed human cases for" exact="avian influenza" post="A(H5N1) reported to WHO, 2003–2018. Geneva, Switzerland: WHO. See"/>
   <result pre="Health Organisation. 2018Cumulative number of confirmed human cases for avian" exact="influenza" post="A(H5N1) reported to WHO, 2003–2018. Geneva, Switzerland: WHO. See"/>
   <result pre="in migratory waterfowl. Nature436, 191–192. (10.1038/nature03974)16007072 127LiuJet al.2005Highly pathogenic H5N1" exact="influenza" post="virus infection in migratory birds. Science309, 1206 (10.1126/science.1115273)16000410 128ShinyaK,"/>
   <result pre="replicative efficiency, but not cell tropism, of Hong Kong H5N1" exact="influenza" post="A viruses in mice. Virology320, 258–266. (10.1016/j.virol.2003.11.030)15016548 129SalzbergSLet al.2007Genome"/>
   <result pre="258–266. (10.1016/j.virol.2003.11.030)15016548 129SalzbergSLet al.2007Genome analysis linking recent European and African" exact="influenza" post="(H5N1) viruses. Emerg. Infect. Dis.13, 713–718. (10.3201/eid1305.070013)17553249 130YingstSL, SaadMD,"/>
   <result pre="cats, northern Iraq. Emerg. Infect. Dis.12, 1295–1297. (10.3201/eid1208.060264)16972356 131MonneIet al.2008Reassortant" exact="avian influenza" post="virus (H5N1) in poultry, Nigeria, 2007. Emerg. Infect. Dis.14,"/>
   <result pre="northern Iraq. Emerg. Infect. Dis.12, 1295–1297. (10.3201/eid1208.060264)16972356 131MonneIet al.2008Reassortant avian" exact="influenza" post="virus (H5N1) in poultry, Nigeria, 2007. Emerg. Infect. Dis.14,"/>
   <result pre="Dis.14, 637–640. (10.3201/eid1404.071178)18394282 132HuangKet al.2012Establishment and lineage replacement of H6" exact="influenza" post="viruses in domestic ducks in southern China. J. Virol.86,"/>
   <result pre="and antigenic evolution and geographical spread of H5N1 highly pathogenic" exact="avian influenza" post="viruses in western Africa. J. Gen. Virol.88, 2297–2306. (10.1099/vir.0.82939-0)17622635"/>
   <result pre="antigenic evolution and geographical spread of H5N1 highly pathogenic avian" exact="influenza" post="viruses in western Africa. J. Gen. Virol.88, 2297–2306. (10.1099/vir.0.82939-0)17622635"/>
   <result pre="and perspective. mBio3, e00045-12 (10.1128/mBio.00045-12)22366820 137UngchusakKet al.2005Probable person-to-person transmission of" exact="avian influenza" post="A (H5N1). N. Engl. J. Med.352, 333–340. (10.1056/NEJMoa044021)15668219 138WangHet"/>
   <result pre="perspective. mBio3, e00045-12 (10.1128/mBio.00045-12)22366820 137UngchusakKet al.2005Probable person-to-person transmission of avian" exact="influenza" post="A (H5N1). N. Engl. J. Med.352, 333–340. (10.1056/NEJMoa044021)15668219 138WangHet"/>
   <result pre="333–340. (10.1056/NEJMoa044021)15668219 138WangHet al.2008Probable limited person-to-person transmission of highly pathogenic" exact="avian influenza" post="A (H5N1) virus in China. Lancet371, 1427–1434. (10.1016/S0140-6736(08)60493-6)18400288 139collab:"/>
   <result pre="(10.1056/NEJMoa044021)15668219 138WangHet al.2008Probable limited person-to-person transmission of highly pathogenic avian" exact="influenza" post="A (H5N1) virus in China. Lancet371, 1427–1434. (10.1016/S0140-6736(08)60493-6)18400288 139collab:"/>
   <result pre="A (H1N1) Virus Investigation Team. 2009Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humans. N. Engl. J. Med.360,"/>
   <result pre="Serology Working Group. 2013Estimating age-specific cumulative incidence for the 2009" exact="influenza" post="pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect."/>
   <result pre="Infect. Dis.12, 687–695. (10.1016/S1473-3099(12)70121-4)22738893 142LiuDet al.2013Origin and diversity of novel" exact="avian influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="Dis.12, 687–695. (10.1016/S1473-3099(12)70121-4)22738893 142LiuDet al.2013Origin and diversity of novel avian" exact="influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="1926–1932. (10.1016/S0140-6736(13)60938-1)23643111 143GuanY, ShortridgeKF, KraussS, ChinPS, DyrtingKC, EllisTM, WebsterRG, PeirisM2000H9N2" exact="influenza" post="viruses possessing H5N1-like internal genomes continue to circulate in"/>
   <result pre="WebbyRJ, WebsterRG, PeirisJS, PoonL, ButtC, LeungYHC, GuanY2004Continuing evolution of H9N2" exact="influenza" post="viruses in southeastern China. J. Virol.78, 8609–8614. (10.1128/JVI.78.16.8609-8614.2004)15280470 145ShiH,"/>
   <result pre="LuJ, LiuX2010Evaluation of transmission route and replication efficiency of H9N2" exact="avian influenza" post="virus. Avian Dis.54, 22–27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with"/>
   <result pre="LiuX2010Evaluation of transmission route and replication efficiency of H9N2 avian" exact="influenza" post="virus. Avian Dis.54, 22–27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with"/>
   <result pre="Dis.54, 22–27. (10.1637/8937-052809-Reg.1)20408394 146GaoRet al.2013Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N. Engl. J. Med.368, 1888–1897. (10.1056/NEJMoa1304459)23577628"/>
   <result pre="J. Med.368, 1888–1897. (10.1056/NEJMoa1304459)23577628 147ChenYet al.2013Human infections with the emerging" exact="avian influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="Med.368, 1888–1897. (10.1056/NEJMoa1304459)23577628 147ChenYet al.2013Human infections with the emerging avian" exact="influenza" post="A H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="2018. Rome, Italy: FAO. See http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html. 149MillmanAJet al.2015Detecting spread of" exact="avian influenza" post="A(H7N9) virus beyond China. Emerg. Infect. Dis.21, 741–749. (10.3201/eid2105.141756)25897654"/>
   <result pre="Rome, Italy: FAO. See http://www.fao.org/ag/againfo/programmes/en/empres/h7n9/situation_update.html. 149MillmanAJet al.2015Detecting spread of avian" exact="influenza" post="A(H7N9) virus beyond China. Emerg. Infect. Dis.21, 741–749. (10.3201/eid2105.141756)25897654"/>
   <result pre="LiuD, CuiJ, GaoGF, ZhouJ, LiuX2017Epidemiology, evolution, and pathogenesis of H7N9" exact="influenza" post="viruses in five epidemic waves since 2013 in China."/>
   <result pre="Costa-HurtadoM, SuarezDL2014Role of poultry in the spread of novel H7N9" exact="influenza" post="virus in China. J. Virol.88, 5381–5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9"/>
   <result pre="influenza virus in China. J. Virol.88, 5381–5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9" exact="avian influenza" post="virus is efficiently transmissible and induces an antibody response"/>
   <result pre="virus in China. J. Virol.88, 5381–5390. (10.1128/JVI.03689-13)24574407 152JiaoPet al.2018H7N9 avian" exact="influenza" post="virus is efficiently transmissible and induces an antibody response"/>
   <result pre="in chickens. Front. Immunol.9, 789 (10.3389/fimmu.2018.00789)29706970 153HerfstSet al.2012Airborne transmission of" exact="influenza" post="A/H5N1 virus between ferrets. Science336, 1534–1541. (10.1126/science.1213362)22723413 154ImaiMet al.2012Experimental"/>
   <result pre="between ferrets. Science336, 1534–1541. (10.1126/science.1213362)22723413 154ImaiMet al.2012Experimental adaptation of an" exact="influenza" post="H5 HA confers respiratory droplet transmission to a reassortant"/>
   <result pre="420–428. (10.1038/nature10831)22722205 155ZhuHet al.2013Infectivity, transmission, and pathology of human-isolated H7N9" exact="influenza" post="virus in ferrets and pigs. Science341, 183–186. (10.1126/science.1239844)23704376 156KucharskiAJ,"/>
   <result pre="pigs. Science341, 183–186. (10.1126/science.1239844)23704376 156KucharskiAJ, MillsHL, DonnellyCA, RileyS2015Transmission potential of" exact="influenza" post="A(H7N9) virus, China, 2013–2014. Emerg. Infect. Dis.21, 852–855. (10.3201/eid2105.141137)25897624"/>
   <result pre="of closure of live poultry markets on poultry-to-person transmission of" exact="avian influenza" post="A H7N9 virus: an ecological study. Lancet383, 541–548. (10.1016/S0140-6736(13)61904-2)24183056"/>
   <result pre="closure of live poultry markets on poultry-to-person transmission of avian" exact="influenza" post="A H7N9 virus: an ecological study. Lancet383, 541–548. (10.1016/S0140-6736(13)61904-2)24183056"/>
   <result pre="Lancet383, 541–548. (10.1016/S0140-6736(13)61904-2)24183056 158LamTT-Yet al.2015Dissemination, divergence and establishment of H7N9" exact="influenza" post="viruses in China. Nature522, 102–105. (10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic"/>
   <result pre="102–105. (10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic patterns and risk factors for" exact="avian influenza" post="A(H7N9) infections in humans, China. Emerg. Infect. Dis.24, 87–94."/>
   <result pre="(10.1038/nature14348)25762140 159ArtoisJet al.2018Changing geographic patterns and risk factors for avian" exact="influenza" post="A(H7N9) infections in humans, China. Emerg. Infect. Dis.24, 87–94."/>
   <result pre="(10.3201/eid2401.171393)29260681 160ZhouLet al.2017Preliminary epidemiology of human infections with highly pathogenic" exact="avian influenza" post="A(H7N9) virus, China, 2017. Emerg. Infect. Dis.23, 1355–1359. (10.3201/eid2308.170640)28580900"/>
   <result pre="160ZhouLet al.2017Preliminary epidemiology of human infections with highly pathogenic avian" exact="influenza" post="A(H7N9) virus, China, 2017. Emerg. Infect. Dis.23, 1355–1359. (10.3201/eid2308.170640)28580900"/>
   <result pre="and virological characteristics of the first detected human case of" exact="avian influenza" post="A(H5N6) virus. Infect. Genet. Evol.40, 236–242. (10.1016/j.meegid.2016.03.010)26973295 164collab: Ministry"/>
   <result pre="virological characteristics of the first detected human case of avian" exact="influenza" post="A(H5N6) virus. Infect. Genet. Evol.40, 236–242. (10.1016/j.meegid.2016.03.010)26973295 164collab: Ministry"/>
   <result pre="a good job of the autumn immunization of highly pathogenic" exact="avian influenza" post="in the whole country. Report no. 07B130303201700282 (in Chinese)."/>
   <result pre="good job of the autumn immunization of highly pathogenic avian" exact="influenza" post="in the whole country. Report no. 07B130303201700282 (in Chinese)."/>
   <result pre="China. See http://www.moa.gov.cn/govpublic/SYJ/201707/t20170711_5744436.htm. 165collab: Food and Agriculture Organisation. 2018Chinese-origin H7N9" exact="avian influenza" post="spread in poultry and human exposure – Qualitative risk"/>
   <result pre="See http://www.moa.gov.cn/govpublic/SYJ/201707/t20170711_5744436.htm. 165collab: Food and Agriculture Organisation. 2018Chinese-origin H7N9 avian" exact="influenza" post="spread in poultry and human exposure – Qualitative risk"/>
   <result pre="WHO/OIE/FAO H5N1 Evolution Working Group. 2012Continued evolution of highly pathogenic" exact="avian influenza" post="A (H5N1): updated nomenclature. Influenza Other Resp. Viruses6, 1–5."/>
   <result pre="H5N1 Evolution Working Group. 2012Continued evolution of highly pathogenic avian" exact="influenza" post="A (H5N1): updated nomenclature. Influenza Other Resp. Viruses6, 1–5."/>
   <result pre="1–5. (10.1111/j.1750-2659.2011.00298.x) 167SmithGJD, DonisRO2015Nomenclature updates resulting from the evolution of" exact="avian influenza" post="A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013–2014."/>
   <result pre="(10.1111/j.1750-2659.2011.00298.x) 167SmithGJD, DonisRO2015Nomenclature updates resulting from the evolution of avian" exact="influenza" post="A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013–2014."/>
   <result pre="Other Resp. Viruses9, 271–276. (10.1111/irv.12324) 168GuMet al.2011Novel reassortant highly pathogenic" exact="avian influenza" post="(H5N5) viruses in domestic ducks, China. Emerg. Infect. Dis.17,"/>
   <result pre="Resp. Viruses9, 271–276. (10.1111/irv.12324) 168GuMet al.2011Novel reassortant highly pathogenic avian" exact="influenza" post="(H5N5) viruses in domestic ducks, China. Emerg. Infect. Dis.17,"/>
   <result pre="Infect. Dis.17, 1060–1063. (10.3201/eid/1706.101406)21749770 169ZhaoGet al.2012Novel reassortant highly pathogenic H5N2" exact="avian influenza" post="viruses in poultry in China. PLoS ONE7, e46183 (10.1371/journal.pone.0046183)23049973"/>
   <result pre="Dis.17, 1060–1063. (10.3201/eid/1706.101406)21749770 169ZhaoGet al.2012Novel reassortant highly pathogenic H5N2 avian" exact="influenza" post="viruses in poultry in China. PLoS ONE7, e46183 (10.1371/journal.pone.0046183)23049973"/>
   <result pre="170ZhaoKet al.2013Characterization of three H5N5 and one H5N8 highly pathogenic" exact="avian influenza" post="viruses in China. Vet. Microbiol.163, 351–357. (10.1016/j.vetmic.2012.12.025)23375651 171ZouW, GuoX,"/>
   <result pre="al.2013Characterization of three H5N5 and one H5N8 highly pathogenic avian" exact="influenza" post="viruses in China. Vet. Microbiol.163, 351–357. (10.1016/j.vetmic.2012.12.025)23375651 171ZouW, GuoX,"/>
   <result pre="YangY, JinM2012Complete genome sequence of a novel natural recombinant H5N5" exact="influenza" post="virus from ducks in central China. J. Virol.86, 13878"/>
   <result pre="172LiuCG, LiuM, LiuF, LvR, LiuDF, QuLD, ZhangY2013Emerging multiple reassortant H5N5" exact="avian influenza" post="viruses in ducks, China, 2008. Vet. Microbiol.167, 296–306. (10.1016/j.vetmic.2013.09.004)24080350"/>
   <result pre="LiuM, LiuF, LvR, LiuDF, QuLD, ZhangY2013Emerging multiple reassortant H5N5 avian" exact="influenza" post="viruses in ducks, China, 2008. Vet. Microbiol.167, 296–306. (10.1016/j.vetmic.2013.09.004)24080350"/>
   <result pre="173WuH, PengX, XuL, JinC, ChengL, LuX, XieT, YaoH, WuN2014Novel reassortant" exact="influenza" post="A(H5N8) viruses in domestic ducks, eastern China. Emerg. Infect."/>
   <result pre="WuD, GaoX, PeiE, WangT, GaoY, XiaX2014A novel highly pathogenic H5N8" exact="avian influenza" post="virus isolated from a wild duck in China. Influenza"/>
   <result pre="GaoX, PeiE, WangT, GaoY, XiaX2014A novel highly pathogenic H5N8 avian" exact="influenza" post="virus isolated from a wild duck in China. Influenza"/>
   <result pre="YeJ, ZhaoZ, WuS, XuC, JiaoP, LiaoM2015New reassortant H5N8 highly pathogenic" exact="avian influenza" post="virus from waterfowl in southern China. Front. Microbiol.6, 1170"/>
   <result pre="ZhaoZ, WuS, XuC, JiaoP, LiaoM2015New reassortant H5N8 highly pathogenic avian" exact="influenza" post="virus from waterfowl in southern China. Front. Microbiol.6, 1170"/>
   <result pre="in southern China. Front. Microbiol.6, 1170 (10.3389/fmicb.2015.01170)26557113 176LeeY-Jet al.2014Novel reassortant" exact="influenza" post="A(H5N8) viruses, South Korea, 2014. Emerg. Infect. Dis.20, 1087–1089."/>
   <result pre="Korea, 2014. Emerg. Infect. Dis.20, 1087–1089. (10.3201/eid2006.140233)24856098 177JeongJet al.2014Highly pathogenic" exact="avian influenza" post="virus (H5N8) in domestic poultry and its relationship with"/>
   <result pre="2014. Emerg. Infect. Dis.20, 1087–1089. (10.3201/eid2006.140233)24856098 177JeongJet al.2014Highly pathogenic avian" exact="influenza" post="virus (H5N8) in domestic poultry and its relationship with"/>
   <result pre="2014. Vet. Microbiol.173, 249–257. (10.1016/j.vetmic.2014.08.002)25192767 178IpHSet al.2015Novel Eurasian highly pathogenic" exact="avian influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Vet. Microbiol.173, 249–257. (10.1016/j.vetmic.2014.08.002)25192767 178IpHSet al.2015Novel Eurasian highly pathogenic avian" exact="influenza" post="A H5 viruses in wild birds, Washington, USA, 2014."/>
   <result pre="Dis.21, 886–890. (10.3201/eid2105.142020)25898265 179BevinsSNet al.2016Widespread detection of highly pathogenic H5" exact="influenza" post="viruses in wild birds from the Pacific flyway of"/>
   <result pre="(10.1038/srep28980)27381241 180PasickJ, BerhaneY, JosephT, BowesV, HisanagaT, HandelK, AlexandersenS2015Reassortant highly pathogenic" exact="influenza" post="A H5N2 virus containing gene segments related to Eurasian"/>
   <result pre="TorchettiMK, HicksJ, KillianML, BahlJ, Pantin-JackwoodM, SwayneDE2018Transmission dynamics of highly pathogenic" exact="avian influenza" post="virus A(H5Nx) clade 2.3.4.4, North America, 2014–2015. Emerg. Infect."/>
   <result pre="HicksJ, KillianML, BahlJ, Pantin-JackwoodM, SwayneDE2018Transmission dynamics of highly pathogenic avian" exact="influenza" post="virus A(H5Nx) clade 2.3.4.4, North America, 2014–2015. Emerg. Infect."/>
   <result pre="APHIS. 2016Final report for the 2014–2015 outbreak of highly pathogenic" exact="avian influenza" post="(HPAI) in the United States. Washington, DC: United States"/>
   <result pre="2016Final report for the 2014–2015 outbreak of highly pathogenic avian" exact="influenza" post="(HPAI) in the United States. Washington, DC: United States"/>
   <result pre="See https://www.aphis.usda.gov/animal_health/emergency_management/downloads/hpai/2015-hpai-final-report.pdf. 183RamosS, MacLachlanM, MeltonA2017Impacts of the 2014–2015 highly pathogenic" exact="avian influenza" post="outbreak on the U.S. poultry sector. Livestock Dairy Poultry"/>
   <result pre="https://www.aphis.usda.gov/animal_health/emergency_management/downloads/hpai/2015-hpai-final-report.pdf. 183RamosS, MacLachlanM, MeltonA2017Impacts of the 2014–2015 highly pathogenic avian" exact="influenza" post="outbreak on the U.S. poultry sector. Livestock Dairy Poultry"/>
   <result pre="the apparent disappearance of Eurasian highly pathogenic H5 clade 2.3.4.4" exact="influenza" post="A viruses in North American waterfowl. Proc. Natl Acad."/>
   <result pre="A(H5N8) virus similar to strain in Korea causing highly pathogenic" exact="avian influenza" post="in Germany. Emerg. Infect. Dis.21, 860–863. (10.3201/eid2105.141897)25897703 186GlobigAet al.2017Epidemiological"/>
   <result pre="virus similar to strain in Korea causing highly pathogenic avian" exact="influenza" post="in Germany. Emerg. Infect. Dis.21, 860–863. (10.3201/eid2105.141897)25897703 186GlobigAet al.2017Epidemiological"/>
   <result pre="al.2017Epidemiological and molecular analysis of an outbreak of highly pathogenic" exact="avian influenza" post="H5N8 clade 2.3.4.4 in a German zoo: effective disease"/>
   <result pre="and molecular analysis of an outbreak of highly pathogenic avian" exact="influenza" post="H5N8 clade 2.3.4.4 in a German zoo: effective disease"/>
   <result pre="BouwstraR, VerdonckF, PenttinenP, HarderT2014Comparing introduction to Europe of highly pathogenic" exact="avian influenza" post="viruses A(H5N8) in 2014 and A(H5N1) in 2005. Eurosurveillance19,"/>
   <result pre="VerdonckF, PenttinenP, HarderT2014Comparing introduction to Europe of highly pathogenic avian" exact="influenza" post="viruses A(H5N8) in 2014 and A(H5N1) in 2005. Eurosurveillance19,"/>
   <result pre="(10.2807/1560-7917.es2014.19.50.20996)25597538 188VerhagenJHet al.2015Wild bird surveillance around outbreaks of highly pathogenic" exact="avian influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="188VerhagenJHet al.2015Wild bird surveillance around outbreaks of highly pathogenic avian" exact="influenza" post="A(H5N8) virus in the Netherlands, 2014, within the context"/>
   <result pre="21–32. (10.2807/1560-7917.ES2015.20.12.21069)25719964 189BouwstraR, HeutinkR, BossersA, HardersF, KochG, ElbersA2015Full-genome sequence of" exact="influenza" post="A(H5N8) virus in poultry linked to sequences of strains"/>
   <result pre="HardersF, van der SpekA, ElbersAR, BossersA2015Phylogenetic analysis of highly pathogenic" exact="avian influenza" post="A(H5N8) virus outbreak strains provides evidence for four separate"/>
   <result pre="van der SpekA, ElbersAR, BossersA2015Phylogenetic analysis of highly pathogenic avian" exact="influenza" post="A(H5N8) virus outbreak strains provides evidence for four separate"/>
   <result pre="November 2014. Eurosurveillance20, 21174 (10.2807/1560-7917.es2015.20.26.21174)26159311 191BriandF-Xet al.2017Emerging highly pathogenic H5" exact="avian influenza" post="viruses in France during winter 2015/16: phylogenetic analyses and"/>
   <result pre="2014. Eurosurveillance20, 21174 (10.2807/1560-7917.es2015.20.26.21174)26159311 191BriandF-Xet al.2017Emerging highly pathogenic H5 avian" exact="influenza" post="viruses in France during winter 2015/16: phylogenetic analyses and"/>
   <result pre="(10.2807/1560-7917.ES.2017.22.9.30473)28277218 192BriandFXet al.2018Emergence and multiple reassortments of French2015–2016highly pathogenic H5" exact="avian influenza" post="viruses. Infect. Genet. Evol.61, 208–214. (10.1016/j.meegid.2018.04.007) 193de VriesE, GuoH,"/>
   <result pre="192BriandFXet al.2018Emergence and multiple reassortments of French2015–2016highly pathogenic H5 avian" exact="influenza" post="viruses. Infect. Genet. Evol.61, 208–214. (10.1016/j.meegid.2018.04.007) 193de VriesE, GuoH,"/>
   <result pre="DaiM, RottierPJM, van KuppeveldFJM, de HaanCAM2015Rapid emergence of highly pathogenic" exact="avian influenza" post="subtypes from a subtype H5N1 hemagglutinin variant. Emerg. Infect."/>
   <result pre="RottierPJM, van KuppeveldFJM, de HaanCAM2015Rapid emergence of highly pathogenic avian" exact="influenza" post="subtypes from a subtype H5N1 hemagglutinin variant. Emerg. Infect."/>
   <result pre="842–846. (10.3201/eid2105.141927)25897518 194YangLet al.2017Genesis and dissemination of highly pathogenic H5N6" exact="avian influenza" post="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants"/>
   <result pre="(10.3201/eid2105.141927)25897518 194YangLet al.2017Genesis and dissemination of highly pathogenic H5N6 avian" exact="influenza" post="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants"/>
   <result pre="viruses. J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants of" exact="avian influenza" post="A (H5N6) virus in China. J. Gen. Virol.96, 975–981."/>
   <result pre="J. Virol.91, e02199-16 (10.1128/JVI.02199-16)28003485 195BiYet al.2015Two novel reassortants of avian" exact="influenza" post="A (H5N6) virus in China. J. Gen. Virol.96, 975–981."/>
   <result pre="Virol.96, 975–981. (10.1099/vir.0.000056)25604926 196BiYet al.2016Genesis, evolution and prevalence of H5N6" exact="avian influenza" post="viruses in China. Cell Host Microbe20, 810–821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet"/>
   <result pre="975–981. (10.1099/vir.0.000056)25604926 196BiYet al.2016Genesis, evolution and prevalence of H5N6 avian" exact="influenza" post="viruses in China. Cell Host Microbe20, 810–821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet"/>
   <result pre="Cell Host Microbe20, 810–821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet al.2016Diversity and evolution of" exact="avian influenza" post="viruses in live poultry markets, free-range poultry and wild"/>
   <result pre="Host Microbe20, 810–821. (10.1016/j.chom.2016.10.022)27916476 197ChenL-Jet al.2016Diversity and evolution of avian" exact="influenza" post="viruses in live poultry markets, free-range poultry and wild"/>
   <result pre="birds in China. J. Gen. Virol.97, 844–854. (10.1099/jgv.0.000399)26758561 198BiYet al.2016Novel" exact="avian influenza" post="A (H5N6) viruses isolated in migratory waterfowl before the"/>
   <result pre="in China. J. Gen. Virol.97, 844–854. (10.1099/jgv.0.000399)26758561 198BiYet al.2016Novel avian" exact="influenza" post="A (H5N6) viruses isolated in migratory waterfowl before the"/>
   <result pre="29888 (10.1038/srep29888)27431568 199PanMet al.2016Human infection with a novel, highly pathogenic" exact="avian influenza" post="A (H5N6) virus: virological and clinical findings. J. Infect.72,"/>
   <result pre="(10.1038/srep29888)27431568 199PanMet al.2016Human infection with a novel, highly pathogenic avian" exact="influenza" post="A (H5N6) virus: virological and clinical findings. J. Infect.72,"/>
   <result pre="52–59. (10.1016/j.jinf.2015.06.009)26143617 200YangZ-F, MokCKP, PeirisJSM, ZhongN-S2015Human infection with a novel" exact="avian influenza" post="A(H5N6) virus. N. Engl. J. Med.373, 487–489. (10.1056/NEJMc1502983) 201ZhangYet"/>
   <result pre="(10.1016/j.jinf.2015.06.009)26143617 200YangZ-F, MokCKP, PeirisJSM, ZhongN-S2015Human infection with a novel avian" exact="influenza" post="A(H5N6) virus. N. Engl. J. Med.373, 487–489. (10.1056/NEJMc1502983) 201ZhangYet"/>
   <result pre="Med.373, 487–489. (10.1056/NEJMc1502983) 201ZhangYet al.2017Human infections with novel reassortant H5N6" exact="avian influenza" post="viruses in China. Emerg. Microbes Infect.6, e50 (10.1038/emi.2017.38)28588293 202NguyenDTet"/>
   <result pre="487–489. (10.1056/NEJMc1502983) 201ZhangYet al.2017Human infections with novel reassortant H5N6 avian" exact="influenza" post="viruses in China. Emerg. Microbes Infect.6, e50 (10.1038/emi.2017.38)28588293 202NguyenDTet"/>
   <result pre="distribution, reassortment, and emergence of new subtypes of highly pathogenic" exact="avian influenza" post="A(H5) viruses collected from Vietnamese poultry from 2012 to"/>
   <result pre="reassortment, and emergence of new subtypes of highly pathogenic avian" exact="influenza" post="A(H5) viruses collected from Vietnamese poultry from 2012 to"/>
   <result pre="(10.1128/JVI.01708-16) 203ThanhHD, TranVT, NguyenDT, HungV-K, KimW2018Novel reassortant H5N6 highly pathogenic" exact="influenza" post="A viruses in Vietnamese quail outbreaks. Comp. Immunol. Microbiol."/>
   <result pre="Immunol. Microbiol. Infect. Dis.56, 45–57. (10.1016/j.cimid.2018.01.001)29406283 204WongFYKet al.2015Reassortant highly pathogenic" exact="influenza" post="A(H5N6) virus in Laos. Emerg. Infect. Dis.21, 511–516. (10.3201/eid2103.141488)25695754"/>
   <result pre="Dis.21, 511–516. (10.3201/eid2103.141488)25695754 205SiY-Jet al.2017Genetic characterisation of novel, highly pathogenic" exact="avian influenza" post="(HPAI) H5N6 viruses isolated in birds, South Korea, November"/>
   <result pre="511–516. (10.3201/eid2103.141488)25695754 205SiY-Jet al.2017Genetic characterisation of novel, highly pathogenic avian" exact="influenza" post="(HPAI) H5N6 viruses isolated in birds, South Korea, November"/>
   <result pre="206ZhangJet al.2018Genetic diversity and dissemination pathways of highly pathogenic H5N6" exact="avian influenza" post="viruses from birds in southwestern China along the East"/>
   <result pre="al.2018Genetic diversity and dissemination pathways of highly pathogenic H5N6 avian" exact="influenza" post="viruses from birds in southwestern China along the East"/>
   <result pre="flyway. J. Infect.76, 418–422. (10.1016/j.jinf.2017.11.009)29246638 207OkamatsuMet al.2017Characterization of highly pathogenic" exact="avian influenza" post="virus A(H5N6), Japan, November 2016. Emerg. Infect. Dis.23, 691–695."/>
   <result pre="J. Infect.76, 418–422. (10.1016/j.jinf.2017.11.009)29246638 207OkamatsuMet al.2017Characterization of highly pathogenic avian" exact="influenza" post="virus A(H5N6), Japan, November 2016. Emerg. Infect. Dis.23, 691–695."/>
   <result pre="691–695. (10.3201/eid2304.161957)28322695 208TakemaeNet al..2017Five distinct reassortants of H5N6 highly pathogenic" exact="avian influenza" post="A viruses affected Japan during the winter of 2016–2017."/>
   <result pre="(10.3201/eid2304.161957)28322695 208TakemaeNet al..2017Five distinct reassortants of H5N6 highly pathogenic avian" exact="influenza" post="A viruses affected Japan during the winter of 2016–2017."/>
   <result pre="8–20. (10.1016/j.virol.2017.08.035)28892736 209LeeH, LaoA2018Transmission dynamics and control strategies assessment of" exact="avian influenza" post="A (H5N6) in the Philippines. Infect. Dis. Model.3, 35–59."/>
   <result pre="(10.1016/j.virol.2017.08.035)28892736 209LeeH, LaoA2018Transmission dynamics and control strategies assessment of avian" exact="influenza" post="A (H5N6) in the Philippines. Infect. Dis. Model.3, 35–59."/>
   <result pre="SwayneDE, KurskayaO, SobolevI, KabilovM, AlekseevA, IrzaV, ShestopalovA2017Novel reassortant clade 2.3.4.4" exact="avian influenza" post="A(H5N8) virus in wild aquatic birds, Russia, 2016. Emerg."/>
   <result pre="KurskayaO, SobolevI, KabilovM, AlekseevA, IrzaV, ShestopalovA2017Novel reassortant clade 2.3.4.4 avian" exact="influenza" post="A(H5N8) virus in wild aquatic birds, Russia, 2016. Emerg."/>
   <result pre="359–360. (10.3201/eid2302.161252)27875109 211KleyheegEet al.2017Deaths among wild birds during highly pathogenic" exact="avian influenza" post="A(H5N8) virus outbreak, the Netherlands. Emerg. Infect. Dis.23, 2050–2054."/>
   <result pre="(10.3201/eid2302.161252)27875109 211KleyheegEet al.2017Deaths among wild birds during highly pathogenic avian" exact="influenza" post="A(H5N8) virus outbreak, the Netherlands. Emerg. Infect. Dis.23, 2050–2054."/>
   <result pre="Emerg. Infect. Dis.23, 2050–2054. (10.3201/eid2312.171086)29148372 212GrundCet al.2018A novel European H5N8" exact="influenza" post="A virus has increased virulence in ducks but low"/>
   <result pre="zoonotic potential. Emerg. Microbes Infect.7, 132 (10.1038/s41426-018-0130-1)30026505 213LiMet al.2017Highly pathogenic" exact="avian influenza" post="A(H5N8) virus in wild migratory birds, Qinghai Lake, China."/>
   <result pre="potential. Emerg. Microbes Infect.7, 132 (10.1038/s41426-018-0130-1)30026505 213LiMet al.2017Highly pathogenic avian" exact="influenza" post="A(H5N8) virus in wild migratory birds, Qinghai Lake, China."/>
   <result pre="Lake, China. Emerg. Infect. Dis.23, 637–641. (10.3201/eid2304.161866)28169827 214GlobigAet al.2017Highly pathogenic" exact="avian influenza" post="H5N8 clade 2.3.4.4b in Germany in 2016/2017. Front. Vet."/>
   <result pre="China. Emerg. Infect. Dis.23, 637–641. (10.3201/eid2304.161866)28169827 214GlobigAet al.2017Highly pathogenic avian" exact="influenza" post="H5N8 clade 2.3.4.4b in Germany in 2016/2017. Front. Vet."/>
   <result pre="240 (10.3389/fvets.2017.00240)29417053 215GhafouriSA, GhalyanchiLangeroudiA, MaghsoudlooH, FarahaniRKH, AbdollahiH, TehraniF, FallahMH2017Clade 2.3.4.4" exact="avian influenza" post="A (H5N8) outbreak in commercial poultry, Iran, 2016: the"/>
   <result pre="(10.3389/fvets.2017.00240)29417053 215GhafouriSA, GhalyanchiLangeroudiA, MaghsoudlooH, FarahaniRKH, AbdollahiH, TehraniF, FallahMH2017Clade 2.3.4.4 avian" exact="influenza" post="A (H5N8) outbreak in commercial poultry, Iran, 2016: the"/>
   <result pre="al.2017Outbreaks among wild birds and domestic poultry caused by reassorted" exact="influenza" post="A(H5N8) clade 2.3.4.4 viruses, Germany, 2016. Emerg. Infect. Dis.23,"/>
   <result pre="633 (10.3201/eid2304.161949)28055819 217PohlmannAet al.2018Swarm incursions of reassortants of highly pathogenic" exact="avian influenza" post="virus strains H5N8 and H5N5, clade 2.3.4.4b, Germany, winter"/>
   <result pre="(10.3201/eid2304.161949)28055819 217PohlmannAet al.2018Swarm incursions of reassortants of highly pathogenic avian" exact="influenza" post="virus strains H5N8 and H5N5, clade 2.3.4.4b, Germany, winter"/>
   <result pre="2016/17. Sci. Rep.8, 15 (10.1038/s41598-017-16936-8)29311555 218NagarajanSet al.2017Novel reassortant highly pathogenic" exact="avian influenza" post="(H5N8) virus in zoos, India. Emerg. Infect. Dis.23, 717–719."/>
   <result pre="Sci. Rep.8, 15 (10.1038/s41598-017-16936-8)29311555 218NagarajanSet al.2017Novel reassortant highly pathogenic avian" exact="influenza" post="(H5N8) virus in zoos, India. Emerg. Infect. Dis.23, 717–719."/>
   <result pre="219BeerensN, KochG, HeutinkR, HardersF, VriesDPE, HoC, BossersA, ElbersA2018Novel highly pathogenic" exact="avian influenza" post="A(H5N6) virus in the Netherlands, December 2017. Emerg. Infect."/>
   <result pre="KochG, HeutinkR, HardersF, VriesDPE, HoC, BossersA, ElbersA2018Novel highly pathogenic avian" exact="influenza" post="A(H5N6) virus in the Netherlands, December 2017. Emerg. Infect."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6553702\results\search\disease\results.xml">
   <result pre="showed atrophy and scarring due to germ-cell loss and inflammatory" exact="orchitis" post="(Fig 8). In addition, we observed that the damaged"/>
   <result pre="the ZIKV proliferative activity in neural progenitor cells that causes" exact="microcephaly" post="in mice; however, a recent report indicated that a"/>
   <result pre="recent report indicated that a confirmed congenital ZVD case with" exact="microcephaly" post="in Thailand was caused by infection with a Southeast"/>
   <result pre="single vector construct multi-pathogen vaccine protects against both Zika and" exact="chikungunya" post="viruses. Nature communications. 2018;9(1):123010.1038/s41467-018-03662-6 .29581442 31ShanC, MuruatoAE, JaggerBW, RichnerJ,"/>
   <result pre="NukuiY, KatoF, TakasakiT, KuraneI. A single mutation in the Japanese" exact="encephalitis" post="virus E protein (S123R) increases its growth rate in"/>
   <result pre="virus E protein (S123R) increases its growth rate in mouse" exact="neuroblastoma" post="cells and its pathogenicity in mice. Virology. 2010;396(2):298–304. 10.1016/j.virol.2009.10.035"/>
   <result pre="evolution. 2013;30(12):2725–9. 10.1093/molbev/mst197 .24132122 38YoshidaH, OkabeY, KawaneK, FukuyamaH, NagataS. Lethal" exact="anemia" post="caused by interferon-beta produced in mouse embryos carrying undigested"/>
   <result pre=".27303697 40GardnerJ, AnrakuI, LeTT, LarcherT, MajorL, RoquesP, et al.Chikungunya virus" exact="arthritis" post="in adult wild-type mice. Journal of virology. 2010;84(16):8021–32. 10.1128/JVI.02603-09"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6555921\results\search\disease\results.xml">
   <result pre="tree shrew is a promising model for the study of" exact="influenza" post="B virus infection YuanBing506638016@qq.com12YangChunguangyang_cg2140@163.com3XiaXueshanoliverxia2000@aliyun.com4ZaninMarkmark.zanin@gird.cn3WongSook-sansook-san.wong@gird.cn3YangFan64561651@qq.com5ChangJixiangchangjixiang233@163.com5MaiZhitongmzt7513@163.com3ZhaoJinzhaojin34@163.com3ZhangYunhuiyunhuizhang3188@126.com12LiRunfengomega_lee@163.com3ZhongNanshannanshan@vip.163.com3YangZifengjeffyah@163.com36[1], grid.414918.1Department of Respiration, the First"/>
   <result pre="Influenza B virus is a main causative pathogen of annual" exact="influenza" post="epidemics, however, research on influenza B virus in general"/>
   <result pre="main causative pathogen of annual influenza epidemics, however, research on" exact="influenza" post="B virus in general lags behind that on influenza"/>
   <result pre="on influenza B virus in general lags behind that on" exact="influenza" post="A viruses, one of the important reasons is studies"/>
   <result pre="A viruses, one of the important reasons is studies on" exact="influenza" post="B viruses in animal models are limited. Here we"/>
   <result pre="we investigated the tree shrew as a potential model for" exact="influenza" post="B virus studies. Methods Tree shrews and ferrets were"/>
   <result pre="ferrets were inoculated with either a Yamagata or Victoria lineage" exact="influenza" post="B virus. Symptoms including nasal discharge and weight loss"/>
   <result pre="including sneezing and rhinorrhea were evident in ferrets infected with" exact="influenza" post="B virus, tree shrews showed no significant respiratory symptoms,"/>
   <result pre="detected at 6DPI in tree shrews. Tree shrews infected with" exact="influenza" post="B virus showed similar seroconversion and respiratory tract pathology"/>
   <result pre="the tree shrew was sensitive to infection and disease by" exact="influenza" post="B virus. Conclusion The tree shrew to be a"/>
   <result pre="Conclusion The tree shrew to be a promising model for" exact="influenza" post="B virus research. Electronic supplementary material The online version"/>
   <result pre="ProvinceD-2017050YuanBing Highlights Ferrets, tree shrews and mice were infected by" exact="influenza" post="B virus strains of Yamagata or Victoria lineage isolated"/>
   <result pre="mortality in BALB/c mice. Viral replication and clinical signs of" exact="influenza" post="were similar between tree shrews and ferrets, although weight"/>
   <result pre="shrews are a useful alternative to ferrets for studies of" exact="influenza" post="B viruses, particularly considering their relatively small size, evolutionary"/>
   <result pre="viruses (IBVs) are one of the main causes of seasonal" exact="influenza" post="cases, accounting for up to 40% of total cases"/>
   <result pre="of total cases [1]. However, during the 2011/2012 and 2015/2016" exact="influenza" post="seasons in China, 53.7 and 52.2% of influenza notifications"/>
   <result pre="and 2015/2016 influenza seasons in China, 53.7 and 52.2% of" exact="influenza" post="notifications were due to IBV infections [2]. There are"/>
   <result pre="(Victoria) and B/Yamagata/16/1988-like (Yamagata). Generally, IBVs cause a less severe" exact="respiratory disease" post="compared to influenza A viruses (IAVs) [3]. However, IBVs"/>
   <result pre="Generally, IBVs cause a less severe respiratory disease compared to" exact="influenza" post="A viruses (IAVs) [3]. However, IBVs cause more complications"/>
   <result pre="to primates compared to ferrets, which are commonly used in" exact="influenza" post="virus research [10, 11]. Tree shrews are also smaller"/>
   <result pre="more cost-effective. Unlike mice, tree shrews display symptoms including fever," exact="rhinitis" post="and mild pneumonia post inoculation with IAVs, and show"/>
   <result pre="mice, tree shrews display symptoms including fever, rhinitis and mild" exact="pneumonia" post="post inoculation with IAVs, and show a distribution of"/>
   <result pre="the tree shrew to two animal models commonly used in" exact="influenza" post="research; ferrets and mice, using two strains of IBVs"/>
   <result pre="Fig. 2 Tree shrews show weight loss post inoculation with" exact="influenza" post="B viruses but ferrets do not. Tree shrews did"/>
   <result pre="up to 10% body weight loss (c) post inoculation with" exact="influenza" post="B viruses. Ferrets inoculated with B/Guangzhou/12/2016 showed a mean"/>
   <result pre="strain B/Guangzhou/0215/2012 (V0215) Fig. 3 Both Yamagata and Victoria lineage" exact="influenza" post="B viruses caused 100% mortality in BALB/c mice. Mice"/>
   <result pre="measured in tree shrews and ferrets 21 days post inoculation with" exact="influenza" post="B viruses Virus Number of animals seroconverted (mean and"/>
   <result pre="V0215 (Fig. 6). Fig. 4 Inoculation of tree shrews with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="tissues of the respiratory tracts of tree shrews inoculated with" exact="influenza" post="B virus. Statistically significant differences in fold expression levels"/>
   <result pre="B/Guangzhou/0215/2012 (V0215). **p &amp;lt; 0.01, *p &amp;lt; 0.05 Fig. 5 Inoculation of ferrets with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="in tissues of the respiratory tracts of ferrets inoculated with" exact="influenza" post="B virus. mRNA expression was detected via real-time PCR"/>
   <result pre="strain B/Guangzhou/0215/2012 (V0215) Fig. 6 Inoculation of BALB/c mice with" exact="influenza" post="B viruses causes inflammation in tissues of the respiratory"/>
   <result pre="in tissues of the respiratory tracts of mice inoculated with" exact="influenza" post="B virus. The Yamagata strain B/Guangzhou/12/2016 elicited greater increases"/>
   <result pre="respiratory tissues obtained from tree shrews inoculated by IBVs revealed" exact="rhinitis" post="and pneumonia in all animals, evident as submucosal hyperemia"/>
   <result pre="obtained from tree shrews inoculated by IBVs revealed rhinitis and" exact="pneumonia" post="in all animals, evident as submucosal hyperemia and focal"/>
   <result pre="inflammatory cells (Figs. 7, 8 and 9). Evidence of mild" exact="rhinitis" post="in six of nine tree shrews inoculated with V0215"/>
   <result pre="evident (Fig. 7). Two tree shrews showed evidence of moderate" exact="rhinitis" post="and one showed severe rhinitis. Tracheitis, characterized desquamated cilia"/>
   <result pre="mild cases, one moderate case and one severe case of" exact="pneumonia" post="were observed in seven tree shrews inoculated with V0215."/>
   <result pre="V0215. Two mild, three moderate and two severe cases of" exact="pneumonia" post="were observed in nine tree shrews inoculated with Y12."/>
   <result pre="of × 200 Histopathology of respiratory tissues obtained from ferrets revealed" exact="rhinitis" post="and pneumonia in both V0215 and Y12 inoculated ferrets"/>
   <result pre="Histopathology of respiratory tissues obtained from ferrets revealed rhinitis and" exact="pneumonia" post="in both V0215 and Y12 inoculated ferrets at 2,"/>
   <result pre="Y12 inoculated ferrets at 2, 4 and 6DPI. A mild" exact="tracheitis" post="characterized by few desquamated cilia was only evident in"/>
   <result pre="one Y12 inoculated ferret at 2DPI (Fig. 8). A moderate" exact="rhinitis" post="characterized by hyperemia and inflammatory cells in the submucosal"/>
   <result pre="in a V0215 inoculated ferret at 2DPI (Fig. 8a). Severe" exact="rhinitis" post="was also observed in a Y12 inoculated ferret at"/>
   <result pre="at 4 and 6DPI (Fig. 8g and m, respectively). Interstitial" exact="pneumonia" post="characterized by pulmonary interstitial thickening filled with inflammatory cells"/>
   <result pre="was observed in both V0215 and Y12 inoculated ferrets. Severe" exact="pneumonia" post="was also observed in a V0215 inoculated ferret at"/>
   <result pre="evidence of inflammation was mild (Fig. 8i and o). Moderate" exact="pneumonia" post="was observed in Y12 inoculated ferrets at 2, 4"/>
   <result pre="inoculated with V0215 or Y12. After inoculation with Y12, interstitial" exact="pneumonia" post="was observed in all but two mice (Fig. 9)."/>
   <result pre="five at 4DPI and four at 6DPI. Four mice showed" exact="pneumonia" post="of moderate severity; three at 2DPI and one at"/>
   <result pre="three at 2DPI and one at 6DPI. Two mice showed" exact="pneumonia" post="of mild severity at 2DPI. Of mice inoculated with"/>
   <result pre="in the respiratory tracts of these animals. Ferrets infected with" exact="influenza" post="B virus may have mild respiratory and systemic symptoms,"/>
   <result pre="we observed that the main symptoms in mice infected with" exact="influenza" post="virus include ruffled fur, arched back, shortness of breath"/>
   <result pre="mice infected with influenza virus include ruffled fur, arched back," exact="shortness" post="of breath and malaise. From the analogue comparison of"/>
   <result pre="the main pathogenic mechanism. Previously, it was considered that unadapted" exact="influenza" post="B virus could not be infected or replicated effectively"/>
   <result pre="effectively in laboratory animals such as mice [16, 17], because" exact="influenza" post="B virus exhibit a limited host range and lacked"/>
   <result pre="and mice were susceptible to two lineages of unadapted human" exact="influenza" post="B (V0215 and Y12). The results showed that the"/>
   <result pre="showed that the respiratory tract of these animals infected with" exact="influenza" post="B virus could replicate the virus effectively, which the"/>
   <result pre="period of respiratory viral shedding of tree shrews infected with" exact="influenza" post="B virus were similar to those of ferrets, and"/>
   <result pre="and similar to the respiratory viral shedding symptoms of human" exact="influenza" post="diseases,such as viral shedding time of duration and peak"/>
   <result pre="found differences in susceptibility of three animals to above two" exact="influenza" post="B viruses. There were no significant differences in titers"/>
   <result pre="respiratory tissues obtained from tree shrews inoculated by IBVs revealed" exact="rhinitis" post="and pneumonia in all animals. Because Y12 has longer"/>
   <result pre="obtained from tree shrews inoculated by IBVs revealed rhinitis and" exact="pneumonia" post="in all animals. Because Y12 has longer viral shedding"/>
   <result pre="by pathological examination. The antibody response of hosts infected with" exact="influenza" post="virus is an important immune and epidemic prevention mechanism."/>
   <result pre="is an important immune and epidemic prevention mechanism. Highly virulent" exact="influenza" post="virus strains produce higher antibody titers, which are related"/>
   <result pre="higher antibody titers, which are related to the severity of" exact="influenza" post="infection [24, 25]. A survey of serum antibodies against"/>
   <result pre="influenza infection [24, 25]. A survey of serum antibodies against" exact="influenza" post="viruses in Pennsylvania showed that the titers of antibodies"/>
   <result pre="cytokines and chemokines is the first line of defense against" exact="influenza" post="virus infection and the key factor of the immune"/>
   <result pre="infection and the key factor of the immune pathogenesis of" exact="influenza" post="virus infection in human and animal models [27]. Moderate"/>
   <result pre="[27]. Moderate inflammation can inhibit the replication and transmission of" exact="influenza" post="virus and prevent the development of disease, while excessive"/>
   <result pre="clinical severe pathological injury [28]. Especially in some highly pathogenic" exact="avian influenza" post="patients, excessive inflammation can promote the imbalance of immune"/>
   <result pre="severe pathological injury [28]. Especially in some highly pathogenic avian" exact="influenza" post="patients, excessive inflammation can promote the imbalance of immune"/>
   <result pre="termed a &quot;cytokine storm�?, leading to multiple organ dysfunction or" exact="acute respiratory distress syndrome" post="[29]. In this study, we detected six cytokines in"/>
   <result pre="suggesting that similar to human infection, tree shrews infected with" exact="influenza" post="can also form a feedback regulation mechanism between pro-inflammatory"/>
   <result pre="B/ Guangzhou/12/2016 We thank Dr. Feng Ye for gift of" exact="influenza" post="B virus B/Guangzhou/12/2016. Funding This work was supported by"/>
   <result pre="published maps and institutional affiliations. References References 1.BurnhamAJBaranovichTGovorkovaEANeuraminidase inhibitors for" exact="influenza" post="B virus infection: efficacy and resistanceAntivir Res2013100252053410.1016/j.antiviral.2013.08.02324013000 2.[Database] World"/>
   <result pre="infection: efficacy and resistanceAntivir Res2013100252053410.1016/j.antiviral.2013.08.02324013000 2.[Database] World Health Organization. Global" exact="influenza" post="surveillance and response system (GISRS). 2018. http://www.who.int/influenza/gisrs_laboratory/en/. 2018. 3.JacksonDElderfieldRABarclayWSMolecular"/>
   <result pre="and response system (GISRS). 2018. http://www.who.int/influenza/gisrs_laboratory/en/. 2018. 3.JacksonDElderfieldRABarclayWSMolecular studies of" exact="influenza" post="B virus in the reverse genetics eraJ Gen Virol20119211710.1099/vir.0.026187-020926635"/>
   <result pre="genetics eraJ Gen Virol20119211710.1099/vir.0.026187-020926635 4.MoonJHNaJYKimJHYumMKOhJWKimCRSeolIJNeurological and muscular manifestations associated with" exact="influenza" post="B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal influenza B"/>
   <result pre="associated with influenza B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal" exact="influenza" post="B myocarditis in a child and review of the"/>
   <result pre="influenza B infection in childrenPediatr Neurol20134929710110.1016/j.pediatrneurol.2013.04.00423859854 5.FrankH.WittekindC.LiebertU. G.SiekmeyerM.SiekmeyerW.SchusterV.KiessW.Lethal influenza B" exact="myocarditis" post="in a child and review of the literature for"/>
   <result pre="literature for pediatric age groupsInfection201038323123510.1007/s15010-010-0013-420358246 6.HaydenFGJenningsLRobsonRSchiffGJacksonHRanaBMcClellandGIpeDRobertsNWardPOral oseltamivir in human experimental" exact="influenza" post="B infectionAntivir Ther20005320521311075941 7.SatoMSaitoRSatoITanabeNShobugawaYSasakiALiDSuzukiYSakaiTOgumaTTsukadaHGejyoFSuzukiHEffectiveness of oseltamivir treatment among children"/>
   <result pre="B infectionAntivir Ther20005320521311075941 7.SatoMSaitoRSatoITanabeNShobugawaYSasakiALiDSuzukiYSakaiTOgumaTTsukadaHGejyoFSuzukiHEffectiveness of oseltamivir treatment among children with" exact="influenza" post="a or B virus infections during four successive winters"/>
   <result pre="JapanTohoku J Exp Med2008214211312010.1620/tjem.214.11318285668 8.SugayaNMitamuraKYamazakiMTamuraDIchikawaMKimuraKKawakamiCKisoMItoMHatakeyamaSKawaokaYLower clinical effectiveness of oseltamivir against" exact="influenza" post="B contrasted with influenza a infection in childrenClin Infect"/>
   <result pre="8.SugayaNMitamuraKYamazakiMTamuraDIchikawaMKimuraKKawakamiCKisoMItoMHatakeyamaSKawaokaYLower clinical effectiveness of oseltamivir against influenza B contrasted with" exact="influenza" post="a infection in childrenClin Infect Dis200744219720210.1086/50992517173216 9.Tsukiyama-KoharaKKoharaMTupaia belangeri as"/>
   <result pre="shrew provides a useful alternative model for the study of" exact="influenza" post="H1N1 virusVirol J20131011110.1186/1743-422X-10-11123575279 13.YangZFYangCGWangYTPanSHJiangHMLiRFGuanWDStudy on the selection of mouse"/>
   <result pre="13.YangZFYangCGWangYTPanSHJiangHMLiRFGuanWDStudy on the selection of mouse adaptation strain from clinical" exact="influenza" post="B virusJournal of the third military Medical University2014365446449 14.ReedLJMuenchHA"/>
   <result pre="fifty per cent endpointsAm J Epidemiol193827349349710.1093/oxfordjournals.aje.a118408 15.YangZWangYZhongSZhaoSZengXMoZQinSGuanWLiCZhongNIn vitro inhibition of" exact="influenza" post="virus infection by a crude extract from Isatis indigotica"/>
   <result pre="the prevention of viral attachmentMol Med Rep20125379379922179315 16.KimE-HParkS-JKwonH-IKimSMKimY-iSongM-SChoiE-JPascuaPNQChoiY-KMouse adaptation of" exact="influenza" post="B virus increases replication in the upper respiratory tract"/>
   <result pre="in the C-terminal domain of the matrix protein M1 of" exact="influenza" post="B virus confers mouse adaptation and virulenceVirology2005336231832610.1016/j.virol.2005.03.02815892972 18.KitanoMItohYKodamaMIshigakiHNakayamaMNagataTIshidaHTsuchiyaHToriiRBabaKEstablishment of"/>
   <result pre="adaptation and virulenceVirology2005336231832610.1016/j.virol.2005.03.02815892972 18.KitanoMItohYKodamaMIshigakiHNakayamaMNagataTIshidaHTsuchiyaHToriiRBabaKEstablishment of a cynomolgus macaque model of" exact="influenza" post="B virus infectionVirology2010407217818410.1016/j.virol.2010.08.00620822788 19.OsterhausARimmelzwaanGMartinaBBestebroerTFouchierRInfluenza B virus in sealsScience200028854681051105310.1126/science.288.5468.105110807575 20.CarratFVerguEFergusonNMLemaitreMCauchemezSLeachSValleronA-JTime"/>
   <result pre="studiesAm J Epidemiol2008167777578510.1093/aje/kwm37518230677 21.FritzRSHaydenFGCalfeeDPCassLMPengAWAlvordWGStroberWStrausSENasal cytokine and chemokine responses in experimental" exact="influenza" post="a virus infection: results of a placebo-controlled trial of"/>
   <result pre="Infect Dis1999180358659310.1086/31493810438343 22.BodewesRRimmelzwaanGFOsterhausADAnimal models for the preclinical evaluation of candidate" exact="influenza" post="vaccinesExpert Rev Vaccines201091597210.1586/erv.09.14820021306 23.RoweTBannerDFarooquiANgDCKelvinAARubinoSHuangSSHFangYKelvinDJIn vivo ribavirin activity against severe"/>
   <result pre="Rev Vaccines201091597210.1586/erv.09.14820021306 23.RoweTBannerDFarooquiANgDCKelvinAARubinoSHuangSSHFangYKelvinDJIn vivo ribavirin activity against severe pandemic H1N1" exact="influenza" post="a/Mexico/4108/2009J Gen Virol201091122898290610.1099/vir.0.024323-020797971 24.HuangSSBannerDFangYNgDCKanagasabaiTKelvinDJKelvinAAComparative analyses of pandemic H1N1 and"/>
   <result pre="24.HuangSSBannerDFangYNgDCKanagasabaiTKelvinDJKelvinAAComparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and" exact="influenza" post="B infections depict distinct clinical pictures in ferretsPLoS One2011611e2751210.1371/journal.pone.002751222110664"/>
   <result pre="prevention and treatment modalitiesAnn Pharmacother200943122001201110.1345/aph.1M55719920156 26.RossTMHairongLChiaBSHillEWeirbackHZimmerSPrevalence of antibodies against seasonal" exact="influenza" post="a and B viruses during the 2009-2010 and 2010-2011"/>
   <result pre="influenza a and B viruses during the 2009-2010 and 2010-2011" exact="influenza" post="seasons in residents of Pittsburgh, PA, USAPLoS Curr20113RRN126510.1371/currents.RRN126522037352 27.Nagaoka,"/>
   <result pre="and Tsukahara, H. (2017). Local and systemic immune responses to" exact="influenza" post="a virus infection in pneumonia and encephalitis mouse models."/>
   <result pre="and systemic immune responses to influenza a virus infection in" exact="pneumonia" post="and encephalitis mouse models. Dis Markers 2017, 2594231. 28.La"/>
   <result pre="immune responses to influenza a virus infection in pneumonia and" exact="encephalitis" post="mouse models. Dis Markers 2017, 2594231. 28.La GrutaNLKedzierskaKStambasJDohertyPCA question"/>
   <result pre="Markers 2017, 2594231. 28.La GrutaNLKedzierskaKStambasJDohertyPCA question of self-preservation: immunopathology in" exact="influenza" post="virus infectionImmunol Cell Biol2007852859210.1038/sj.icb.710002617213831 29.de JongMDSimmonsCPThanhTTHienVMSmithGJChauTNHoangDMChauNVKhanhTHDongVCQuiPTCamBVHa doQGuanYPeirisJSChinhNTHienTTFarrarJFatal outcome of"/>
   <result pre="virus infectionImmunol Cell Biol2007852859210.1038/sj.icb.710002617213831 29.de JongMDSimmonsCPThanhTTHienVMSmithGJChauTNHoangDMChauNVKhanhTHDongVCQuiPTCamBVHa doQGuanYPeirisJSChinhNTHienTTFarrarJFatal outcome of human" exact="influenza" post="a (H5N1) is associated with high viral load and"/>
   <result pre="response in the respiratory tract of ferrets following infection with" exact="influenza" post="a and B virusesJ Virol20159062838284810.1128/JVI.02797-1526719259 32.Garcia-RamirezRARamirez-VenegasAQuintana-CarrilloRCamarenaAEFalfan-ValenciaRMejia-ArangureJMTNF, IL6, and IL1B"/>
   <result pre="Virol20159062838284810.1128/JVI.02797-1526719259 32.Garcia-RamirezRARamirez-VenegasAQuintana-CarrilloRCamarenaAEFalfan-ValenciaRMejia-ArangureJMTNF, IL6, and IL1B polymorphisms are associated with severe" exact="influenza" post="a (H1N1) virus infection in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940"/>
   <result pre="infection in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940 33.ZhouJWangDGaoRZhaoBSongJQiXZhangYShiYYangLZhuWBaiTQinKLanYZouSGuoJDongJDongLWeiHLiXLuJLiuLZhaoXHuangWWenLBoHXinLChenYXuCPeiYYangYZhangXWangSFengZHanJYangWGaoGFWuGLiDWangYShuYBiological features of novel" exact="avian influenza" post="a (H7N9) virusNature2013499745950050310.1038/nature1237923823727 34.BlackwellTSChristmanJWSepsis and cytokines: current statusBr J"/>
   <result pre="in the Mexican populationPLoS One20151012e014483210.1371/journal.pone.014483226657940 33.ZhouJWangDGaoRZhaoBSongJQiXZhangYShiYYangLZhuWBaiTQinKLanYZouSGuoJDongJDongLWeiHLiXLuJLiuLZhaoXHuangWWenLBoHXinLChenYXuCPeiYYangYZhangXWangSFengZHanJYangWGaoGFWuGLiDWangYShuYBiological features of novel avian" exact="influenza" post="a (H7N9) virusNature2013499745950050310.1038/nature1237923823727 34.BlackwellTSChristmanJWSepsis and cytokines: current statusBr J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6555941\results\search\disease\results.xml">
   <result pre="and molecular details to our understanding regarding how ZIKV mediates" exact="suppression" post="of the IFN-I system and may provide a new"/>
   <result pre="which also includes several life-threatening human pathogens, such as Japanese" exact="encephalitis" post="virus (JEV), dengue virus (DENV), yellow fever virus (YFV)"/>
   <result pre="pathogens, such as Japanese encephalitis virus (JEV), dengue virus (DENV)," exact="yellow fever" post="virus (YFV) and West Nile virus (WNV) [1]. While"/>
   <result pre="an influenza-like illness, severe forms of ZIKV infection such as" exact="microcephaly" post="and other neurological abnormalities in newborns and Guillain–Barré syndrome,"/>
   <result pre="abnormalities in newborns and Guillain–Barré syndrome, meningoencephalitis, multi-organ failure or" exact="thrombocytopenia" post="in adults are seen in the clinic [1, 4]."/>
   <result pre="Our results revealed that, as shown in Fig. 3a, when" exact="influenza" post="(IVA)PB1-F2, a viral protein well recognized for its strong"/>
   <result pre="transfected with plasmids expressing Flag-tagged NS4A, Flag-tagged ZIKV prM or" exact="influenza" post="Flag-tagged PB1-F2 were stained with anti-Flag and anti-MAVS antibodies"/>
   <result pre="used as a negative control and the PB1-F2 protein of" exact="influenza" post="virus and DENV NS4A were used as a positive"/>
   <result pre="and found that expression of ZIKV NS4A, DENV NS4A or" exact="influenza" post="PB1-F2, but not ZIKV prM, markedly inhibited the activities"/>
   <result pre="world, as well as its link to severe complications, particularly" exact="microcephaly" post="in the newborns, have created a serious threat to"/>
   <result pre="of ZIKV and the associated severe diseases [1]. Mechanistically, aberrant" exact="suppression" post="of the antiviral property of IFNs might facilitate infection"/>
   <result pre="plasmid pFN10A (ACT) expressing the transcriptional activation domain of the" exact="herpes simplex" post="virus VP16 (VP16-AD) fused to RIG-I, MAVS, TBK1 or"/>
   <result pre="and table. Abbreviations ZIKV Zika virus IFN interferon JEV Japanese" exact="encephalitis" post="virus DENV dengue virus YFV yellow fever virus WNV"/>
   <result pre="IFN interferon JEV Japanese encephalitis virus DENV dengue virus YFV" exact="yellow fever" post="virus WNV West Nile virus IVA influenza PAMPs pathogen-associated"/>
   <result pre="virus YFV yellow fever virus WNV West Nile virus IVA" exact="influenza" post="PAMPs pathogen-associated molecular patterns PRRs pathogen recognition receptors RLRs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6557625\results\search\disease\results.xml">
   <result pre="ANP32B, or not to be, that is the question for" exact="influenza" post="virus BakerSteven Fhttps://orcid.org/0000-0001-8379-283X*MehleAndrewhttps://orcid.org/0000-0001-6060-4330amehle@wisc.edu*[], Department of Medical Microbiology and ImmunologyUniversity"/>
   <result pre="credited.elife-48084.pdf Abstract The evolutionary history of ANP32 proteins impacts how" exact="influenza" post="virus jumps from birds to mammals. influenza ANP32A ANP32B"/>
   <result pre="proteins impacts how influenza virus jumps from birds to mammals." exact="influenza" post="ANP32A ANP32B polymerase host specificity evolution Research organism Chicken"/>
   <result pre="2019. Species specific differences in use of ANP32 proteins by" exact="influenza" post="A virus. eLife8:e45066. doi: 10.7554/eLife.45066 Every year, the influenza"/>
   <result pre="by influenza A virus. eLife8:e45066. doi: 10.7554/eLife.45066 Every year, the" exact="influenza" post="A virus causes flu epidemics around the world, and"/>
   <result pre="produce new virions to infect more cells. Diverse populations of" exact="influenza" post="A viruses circulate in birds, their natural reservoir, before"/>
   <result pre="replicating, is less well understood. Looking into the ways that" exact="influenza" post="A virus infects new species, and how the hosts"/>
   <result pre="offers a glimpse into complex evolutionary processes in action. The" exact="influenza" post="polymerase is a complex formed of three proteins including"/>
   <result pre="Different species bear different ANP32 proteins. The polymerase of the" exact="influenza" post="A virus adapts to the ANP32 proteins that are"/>
   <result pre="In humans, ANP32A, 32B and 32E are present, and the" exact="influenza" post="virus can use either ANP32A or ANP32B to support"/>
   <result pre="In chicken, ANP32A, 32B and 32E are present, and the" exact="influenza" post="virus relies exclusively on ANP32A (red circle). Open circles"/>
   <result pre="ANP32 proteins and their potential role in the evolution of" exact="influenza" post="viruses. Now, in eLife, Barclay and colleagues at Imperial"/>
   <result pre="ANP32A and ANP32B have a redundant role in helping the" exact="influenza" post="virus to replicate in human cells. The double-knockout of"/>
   <result pre="chicken ANP32A. How ANP32 proteins support the activity of the" exact="influenza" post="polymerase also remains to be elucidated. In addition, it"/>
   <result pre="the current studies would predict to be non-functional for the" exact="influenza" post="virus. Instead, the mouse variant of ANP32B that has"/>
   <result pre="distant from rodents and which has no obvious history with" exact="influenza" post="virus. &quot;For who would bear the whips of scorn"/>
   <result pre="References References AlmondJW1977A single gene determines the host range of" exact="influenza" post="virusNature27061761810.1038/270617a0593388 BakerSFLedwithMPMehleA2018Differential splicing of ANP32A in birds alters its"/>
   <result pre="birds alters its ability to stimulate RNA synthesis by restricted" exact="influenza" post="polymeraseCell Reports242581258810.1016/j.celrep.2018.08.01230184493 DominguesPHaleBG2017Functional insights into ANP32A-dependent influenza A virus"/>
   <result pre="synthesis by restricted influenza polymeraseCell Reports242581258810.1016/j.celrep.2018.08.01230184493 DominguesPHaleBG2017Functional insights into ANP32A-dependent" exact="influenza" post="A virus polymerase host restrictionCell Reports202538254610.1016/j.celrep.2017.08.06128903035 LongJSGiotisESMoncorgéOFriseRMistryBJamesJMorissonMIqbalMVignalASkinnerMABarclayWS2016Species difference in"/>
   <result pre="virus polymerase host restrictionCell Reports202538254610.1016/j.celrep.2017.08.06128903035 LongJSGiotisESMoncorgéOFriseRMistryBJamesJMorissonMIqbalMVignalASkinnerMABarclayWS2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restrictionNature52910110410.1038/nature1647426738596 LongJSMistryBHaslamSMBarclayWS2019aHost and viral determinants"/>
   <result pre="A virus polymerase host restrictionNature52910110410.1038/nature1647426738596 LongJSMistryBHaslamSMBarclayWS2019aHost and viral determinants of" exact="influenza" post="A virus species specificityNature Reviews Microbiology17678110.1038/s41579-018-0115-z30487536 LongJSIdoko-AkohAMistryBGoldhillDStallerESchreyerJRossCGoodbournSSheltonHSkinnerMASangHMcGrewMJBarclayW2019bSpecies specific differences"/>
   <result pre="Microbiology17678110.1038/s41579-018-0115-z30487536 LongJSIdoko-AkohAMistryBGoldhillDStallerESchreyerJRossCGoodbournSSheltonHSkinnerMASangHMcGrewMJBarclayW2019bSpecies specific differences in use of ANP32 proteins by" exact="influenza" post="A viruseLife8e4506610.7554/eLife.4506631159925 SubbaraoEKLondonWMurphyBR1993A single amino acid in the PB2"/>
   <result pre="viruseLife8e4506610.7554/eLife.4506631159925 SubbaraoEKLondonWMurphyBR1993A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host rangeJournal of"/>
   <result pre="of Virology67176117648445709 SugiyamaKKawaguchiAOkuwakiMNagataK2015pp32 and APRIL are host cell-derived regulators of" exact="influenza" post="virus RNA synthesis from cRNAeLife4e0893910.7554/eLife.0893926512887 Te VelthuisAJFodorE2016Influenza virus RNA"/>
   <result pre="contribution and host range determination of ANP32A and ANP32B in" exact="influenza" post="A virus polymerase activityJournal of VirologyJVI.00174-1910.1128/JVI.00174-1930996088"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6559644\results\search\disease\results.xml">
   <result pre="and Life Sciences : Organisms : Viruses: Arboviruses Circulation of" exact="chikungunya" post="virus East/Central/South African lineage in Rio de Janeiro, Brazil"/>
   <result pre="original author and source are credited.pone.0217871.pdf Abstract The emergence of" exact="chikungunya" post="virus (CHIKV) has raised serious concerns due to the"/>
   <result pre="a later chronic condition, with persistent or relapse symptoms of" exact="arthropathy" post="[7]. As the majority of CHIKV infected patients are"/>
   <result pre="and establishment in the region. Thus, to better understand the" exact="chikungunya" post="outbreak in Rio de Janeiro, we generated 11 near-complete"/>
   <result pre="November 2015 [23, 24]. Fig 3 shows the number of" exact="chikungunya" post="cases weekly notified in the north-eastern region, the south-eastern"/>
   <result pre="the north-eastern and south-eastern regions of Brazil, 2015–2018. Number of" exact="chikungunya" post="fever cases by epidemiological week registered in the north-eastern"/>
   <result pre="the northeast region. Fig 3 also shows an increase in" exact="chikungunya" post="number of cases registered in Rio de Janeiro in"/>
   <result pre="Brazil has witnessed since 1928 [30]. By analyzing 64 new" exact="yellow fever" post="virus genomes the virus transmission pattern was revealed to"/>
   <result pre="mosquito-borne viruses. Supporting information S1 Fig Maximum likelihood phylogeny of" exact="chikungunya" post="virus. (TIF) LINK Click here for additional data file."/>
   <result pre="GreigJ, NgV, et al.A scoping review of published literature on" exact="chikungunya" post="virus. PLoS One. 2018;13(11):e020755410.1371/journal.pone.020755430496207 3collab: PAHO/WHO. Número de casos"/>
   <result pre="PLoS One. 2018;13(11):e020755410.1371/journal.pone.020755430496207 3collab: PAHO/WHO. Número de casos reportados de" exact="chikungunya" post="en países o territorios de las Américas 2017. Regional"/>
   <result pre="2017. 4Brasil. Boletim Epidemiológico—Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e doença aguda pelo vírus Zika até a Semana"/>
   <result pre="11SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyMC, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3(7):e26310.1371/journal.pmed.003026316700631"/>
   <result pre="(Maywood). 2011;236(8):909–14.21750019 13TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog."/>
   <result pre="10.3201/eid2310.17030728930031 18CunhaMDP, SantosCAD, NetoDFL, SchanoskiAS, PourSZ, PassosSD, et al.Outbreak of" exact="chikungunya" post="virus in a vulnerable population of Sergipe, Brazil-A molecular"/>
   <result pre="22Brasil. Boletim Epidemiológico. Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e febre pelo vírus Zika até a Semana Epidemiológica"/>
   <result pre="2. 23Brasil. Boletim Epidemiológico. Monitoramento dos casos dedengue, febre de" exact="chikungunya" post="efebre pelo vírus Zika até a SemanaEpidemiológica 47, 2015."/>
   <result pre="de JesusJ, AguiarRS, IaniFCM, et al.Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science. 2018;361(6405):894–9. 10.1126/science.aat711530139911 31QuickJ, GrubaughND, PullanST,"/>
   <result pre="43Brasil. Boletim Epidemiológico. Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e febre pelo vírus Zika até a Semana Epidemiológica"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560071\results\search\disease\results.xml">
   <result pre="vaccine candidates for WNV (Merino-Ramos et al., 2014), tick-borne virus" exact="encephalitis" post="(Heinz et al., 1995), Japanese encephalitis virus (Hunt et"/>
   <result pre="al., 2014), tick-borne virus encephalitis (Heinz et al., 1995), Japanese" exact="encephalitis" post="virus (Hunt et al., 2001), and Murray Valley encephalitis"/>
   <result pre="Japanese encephalitis virus (Hunt et al., 2001), and Murray Valley" exact="encephalitis" post="virus (Kroeger and McMinn, 2002) in the mouse model."/>
   <result pre="in the immediate defense of disseminated infection by West Nile" exact="encephalitis" post="virus. J. Virol.77, 2578–2586. 10.1128/JVI.77.4.2578-2586.2003, PMID: 12551996 DochertyD. E.LongR."/>
   <result pre="Recombinant and virion-derived soluble and particulate immunogens for vaccination against" exact="tick-borne encephalitis." post="Vaccine13, 1636–1642. 10.1016/0264-410X(95)00133-L, PMID: 8719513 HintonM. G.ReisenW. K.WheelerS. S.TownsendA."/>
   <result pre="R.CroppC. B.ChangG. J. (2001). A recombinant particulate antigen of Japanese" exact="encephalitis" post="virus produced in stably-transformed cells is an effective noninfectious"/>
   <result pre="311–322. 10.3201/eid0903.020628, PMID: 12643825 KroegerM. A.McMinnP. C. (2002). Murray Valley" exact="encephalitis" post="virus recombinant subviral particles protect mice from lethal challenge"/>
   <result pre="PMID: 16023273 SwayneD. E.BeckJ. R.SmithC. S.ShiehW. J.ZakiS. R. (2001). Fatal" exact="encephalitis" post="and myocarditis in young domestic geese (Anser anser domesticus)"/>
   <result pre="SwayneD. E.BeckJ. R.SmithC. S.ShiehW. J.ZakiS. R. (2001). Fatal encephalitis and" exact="myocarditis" post="in young domestic geese (Anser anser domesticus) caused by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6560413\results\search\disease\results.xml">
   <result pre="current knowledge for each of them and in comparison to" exact="chikungunya" post="virus. alphaviruses chikungunya virus Mayaro virus O’nyong’nyong virus Ross"/>
   <result pre="each of them and in comparison to chikungunya virus. alphaviruses" exact="chikungunya" post="virus Mayaro virus O’nyong’nyong virus Ross River virus 1."/>
   <result pre="rheumatic tropism. The latter, also called arthritogenic alphaviruses, notably include" exact="chikungunya" post="virus (CHIKV), now widely distributed, O’nyong’nyong virus (ONNV) located"/>
   <result pre="Description and Main Epidemics 2.1. Chikungunya Virus Robinson first described" exact="chikungunya" post="fever in 1955, after an epidemic of dengue-like fever"/>
   <result pre="which bends up�? describing this particular clinical manifestation. Three main" exact="chikungunya" post="virus genotypes, named after their original geographical distribution, are"/>
   <result pre="Asian genotypes (that include the Caribbean strains) [8,9]. Before 2000," exact="chikungunya" post="virus had been circulating mainly in Sub-Saharan Africa (Zimbabwe"/>
   <result pre="been reported. Since then, two worldwide epidemics occurred that pushed" exact="chikungunya" post="virus into the spotlight. The first epidemic, caused by"/>
   <result pre="described by Robinson [7]) with possible synovitis, and a delayed" exact="rash" post="that is often pruriginous while rarely bullous [128,163,164]. Less"/>
   <result pre="severe or lethal cases were questioned because of co-circulation with" exact="dengue fever" post="[19,129,165,166], it is now clearly established that CHIKV infection"/>
   <result pre="infection and is mostly located in the cervical region. Skin" exact="rash" post="is associated a few days later and is often"/>
   <result pre="(ranging between three and 21 days [75,169]). Fever polyarthralgia and" exact="rash" post="are, as is the case for the other rheumatic"/>
   <result pre="mentioned in case reports [72,170]. Severe forms of infection include" exact="glomerulonephritis" post="[158] and encephalitis [159,160,161], but to our knowledge, no"/>
   <result pre="reports [72,170]. Severe forms of infection include glomerulonephritis [158] and" exact="encephalitis" post="[159,160,161], but to our knowledge, no lethality has been"/>
   <result pre="it is important to differentiate chronic inflammatory rheumatism causing erosive" exact="arthritis" post="[131] and for which the differential diagnosis is rheumatoid"/>
   <result pre="erosive arthritis [131] and for which the differential diagnosis is" exact="rheumatoid arthritis," post="from musculoskeletal disorder. Indeed, whereas the latter is only"/>
   <result pre="in vitro and in vivo data suggest that post-RRV infection" exact="arthritis" post="may be erosive [182,183]. 5. Laboratory Features 5.1. Standard"/>
   <result pre="live-attenuated vaccines [205,206], recombinant virus vaccines (measles virus [207,208,209], vesicular" exact="stomatitis" post="virus [210,211]), inactivated vaccines [212,213], virus-like particles (VLPs) [214,215,216],"/>
   <result pre="Phase II clinical trials. The first one is a recombinant" exact="measles" post="virus encoding the CHIKV structural proteins. The first results"/>
   <result pre="after two injections (regardless of the individual’s immunological status against" exact="measles" post="virus) and excellent safety and tolerability [209]. The second"/>
   <result pre="to 10 million cases all together during the 21st Century," exact="chikungunya" post="virus is undoubtedly a re-emerged disease threatening both tropical"/>
   <result pre="virus is responsible. Indeed, despite some virus-specific trends such as" exact="lymphadenopathy" post="for ONNV, arthritogenic alphaviruses share very similar clinical manifestations"/>
   <result pre="interest. References References 1.SuhrbierA.Jaffar-BandjeeM.-C.GasqueP.Arthritogenic alphaviruses—An overviewNat. Rev. Rheumatol.2012842042910.1038/nrrheum.2012.6422565316 2.ChretienJ.-P.AnyambaA.BednoS.A.BreimanR.F.SangR.SergonK.PowersA.M.OnyangoC.O.SmallJ.TuckerC.J.et al.Drought-associated" exact="chikungunya" post="emergence along coastal east africaAm. J. Trop. Med. Hyg.20077640540710.4269/ajtmh.2007.76.40517360859"/>
   <result pre="territory, in 1952-1953Trans. R. Soc. Trop. Med. Hyg.195549283210.1016/0035-9203(55)90080-814373834 8.PowersA.M.TeshR.B.BraultA.C.WeaverS.C.Re-emergence of" exact="chikungunya" post="and O’nyong’nyong viruses: Evidence for distinct geographical lineages and"/>
   <result pre="the Chikungunya virusBull. World Health Organ.19734937404545155 14.FourieE.D.MorrisonJ.G.Rheumatoid arthritic syndrome after" exact="chikungunya" post="feverS. Afr. Med. J.197956130132494034 15.Muyembe-TamfumJ.J.PeyrefitteC.N.YogoleloR.Mathina BasisyaE.KoyangeD.PukutaE.MashakoM.TolouH.DurandJ.P.[Epidemic of Chikungunya virus"/>
   <result pre="of haemorrhagic fever in calcutta: Isolation of three strains of" exact="chikungunya" post="virusIndian J. Med. Res.19645267668314195507 21.MunasingheD.R.AmarasekeraP.J.FernandoC.F.O.An epidemic of dengue-like fever"/>
   <result pre="Trop. Med. Public Health20043540841515691147 27.LarasK.SukriN.C.LarasatiR.P.BangsM.J.KosimR.DjauziWandraT.MasterJ.KosasihH.HartatiS.et al.Tracking the re-emergence of epidemic" exact="chikungunya" post="virus in IndonesiaTrans. R. Soc. Trop. Med. Hyg.20059912814110.1016/j.trstmh.2004.03.01315693148 28.SimonF.TolouH.JeandelP.Chikungunya,"/>
   <result pre="Can DoAvailable online: https://www.nejm.org/doi/10.1056/NEJMp1407698?url_ver=Z39.88-2003&amp;amp;rfr_id=ori%3Arid%3Acrossref.org&amp;amp;rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov(accessed on 14 March 2019) 31.CassadouS.BoucauS.Petit-SinturelM.HucP.Leparc-GoffartI.LedransM.Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
   <result pre="Saint Martin island, October to December 2013Eurosurveillance2014192075210.2807/1560-7917.ES2014.19.13.2075224721536 32.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.C.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection with" exact="chikungunya" post="virus in Italy: An outbreak in a temperate regionLancet"/>
   <result pre="temperate regionLancet Lond. Engl.20073701840184610.1016/S0140-6736(07)61779-6 33.ManicaM.GuzzettaG.PolettiP.FilipponiF.SoliminiA.CaputoB.Della TorreA.RosàR.MerlerS.Transmission dynamics of the ongoing" exact="chikungunya" post="outbreak in Central Italy: From coastal areas to the"/>
   <result pre="of Rome, summer 2017Eurosurveillance20172217-0068510.2807/1560-7917.ES.2017.22.44.17-00685 34.VenturiG.Di LucaM.FortunaC.RemoliM.E.RiccardoF.SeveriniF.TomaL.Del MansoM.BenedettiE.CaporaliM.G.et al.Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017Eurosurveillance20172210.2807/1560-7917.ES.2017.22.39.17-0064629019306 35.AngeliniR.FinarelliA.C.AngeliniP.PoC.PetropulacosK.SilviG.MaciniP.FortunaC.VenturiG.MaguranoF.et"/>
   <result pre="September to October 2014Eurosurveillance20152010.2807/1560-7917.ES2015.20.17.21108 37.CalbaC.Guerbois-GallaM.FrankeF.JeanninC.Auzet-CaillaudM.GrardG.PigaglioL.DecoppetA.WeicherdingJ.SavaillM.-C.et al.Preliminary report of an autochthonous" exact="chikungunya" post="outbreak in France, July to September 2017Eurosurveillance20172210.2807/1560-7917.ES.2017.22.39.17-00647 38.HaddowA.J.DaviesC.W.WalkerA.J.O’nyong’nyong fever:"/>
   <result pre="January to March 2002Commun. Dis. Intell.200428261266 71.KnopeK.MullerM.KuruczN.DoggettS.FeldmanR.JohansenC.HobbyM.BennettS.LynchS.SlyA.et al.Arboviral diseases and" exact="malaria" post="in Australia, 2013-14: Annual report of the National Arbovirus"/>
   <result pre="THE COOK ISLANDSAm. J. Trop. Med. Hyg.1981301294130210.4269/ajtmh.1981.30.12947325286 76.HalsteadS.B.UdomsakdiS.Vertebrate hosts of" exact="chikungunya" post="virusBull. World Health Organ.1966358920604287 77.EastwoodG.SangR.C.GuerboisM.TarachaE.L.N.WeaverS.C.Enzootic Circulation of Chikungunya Virus"/>
   <result pre="Non-human Kenyan PrimatesAm. J. Trop. Med. Hyg.2017971399140410.4269/ajtmh.17-012629016323 78.WeinbrenM.HaddowA.WilliamsM.The occurrence of" exact="chikungunya" post="virus in Uganda I. Isolation from mosquitoesTrans. R. Soc."/>
   <result pre="epidemiologyTrans. R. Soc. Trop. Med. Hyg.195549335710.1016/0035-9203(55)90081-X14373835 83.SchuffeneckerI.ItemanI.MichaultA.MurriS.FrangeulL.VaneyM.-C.LavenirR.PardigonN.ReynesJ.-M.PettinelliF.et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreakPLoS Med.20063e26310.1371/journal.pmed.003026316700631 84.VazeilleM.MoutaillerS.CoudrierD.RousseauxC.KhunH.HuerreM.ThiriaJ.DehecqJ.-S.FontenilleD.SchuffeneckerI.et al.Two"/>
   <result pre="in the mosquito, Aedes albopictusPLoS ONE20072e116810.1371/journal.pone.000116818000540 85.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 86.KadingR.C.BorlandE.M.CranfieldM.PowersA.M.Prevalence"/>
   <result pre="DistrictAm. J. Trop. Med. Hyg.19996115816210.4269/ajtmh.1999.61.15810432073 90.VanlandinghamD.L.HongC.KlinglerK.TsetsarkinK.McElroyK.L.PowersA.M.LehaneM.J.HiggsS.Differential infectivities of O’nyong’nyong and" exact="chikungunya" post="virus isolates in Anopheles gambiae and Aedes aegypti mosquitoesAm."/>
   <result pre="albopictus from Houston, Texas, for dengue serotypes 1 to 4," exact="yellow fever" post="and Ross River virusesJ. Am. Mosq. Control Assoc.198734604652849638 114.MitchellC.J.GublerD.J.Vector"/>
   <result pre="2005 to 2007Transfusion2008481333134110.1111/j.1537-2995.2008.01646.x18298600 119.SimonF.JavelleE.CabieA.BouquillardE.TroisgrosO.GentileG.Leparc-GoffartI.HoenB.GandjbakhchF.Rene-CorailP.et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014Médecine Mal. Infect.20154524326310.1016/j.medmal.2015.05.007 120.AubryM.TeissierA.HuartM.MerceronS.VanhomwegenJ.MapotoekeM.Mariteragi-HelleT.RocheC.VialA.-L.TeururaiS.et"/>
   <result pre="French Polynesia, 2014–2015Emerg. Infect. Dis.20182455856110.3201/eid2403.17114929460745 121.YoonI.-K.AleraM.T.LagoC.B.Tac-AnI.A.VillaD.FernandezS.ThaisomboonsukB.KlungthongC.LevyJ.W.VelascoJ.M.et al.High rate of subclinical" exact="chikungunya" post="virus infection and association of neutralizing antibody with protection"/>
   <result pre="157 Adult PatientsClin. Infect. Dis.2007441401140710.1086/51753717479933 129.ThiruvengadamK.V.KalyanasundaramV.RajgopalJ.Clinical and pathological studies on" exact="chikungunya" post="fever in Madras cityIndian J. Med. Res.1965537297445830407 130.CouturierE.GuilleminF.MuraM.LéonL.VirionJ.-M.LetortM.-J.De ValkH.SimonF.VaillantV.Impaired"/>
   <result pre="cityIndian J. Med. Res.1965537297445830407 130.CouturierE.GuilleminF.MuraM.LéonL.VirionJ.-M.LetortM.-J.De ValkH.SimonF.VaillantV.Impaired quality of life after" exact="chikungunya" post="virus infection: A 2-year follow-up studyRheumatology2012511315132210.1093/rheumatology/kes01522427407 131.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.SudeepA.B.MuruganandamN.ChaitanyaI.K.GuruprasadD.R.Clinical progression of"/>
   <result pre="chikungunya virus infection: A 2-year follow-up studyRheumatology2012511315132210.1093/rheumatology/kes01522427407 131.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.SudeepA.B.MuruganandamN.ChaitanyaI.K.GuruprasadD.R.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
   <result pre="in American soldiers in VietnamAnn. Intern. Med.1967661129114310.7326/0003-4819-66-6-11295338939 137.VijayakumarK.P.AnishT.S.N.GeorgeB.LawrenceT.MuthukkuttyS.C.RamachandranR.Clinical profile of" exact="chikungunya" post="patients during the epidemic of 2007 in Kerala, IndiaJ."/>
   <result pre="2007 in Kerala, IndiaJ. Glob. Infect. Dis.2011322121887052 138.ZingmanM.A.PaulinoA.T.PayanoM.P.Clinical manifestations of" exact="chikungunya" post="among university professors and staff in Santo Domingo, the"/>
   <result pre="fever presenting with acute optic neuropathyBMJ Case Rep.20152015bcr201521008110.1136/bcr-2015-210081 154.MaitiC.R.MukherjeeA.K.BoseB.SahaG.L.Myopericarditis following" exact="chikungunya" post="virus infectionJ. Indian Med. Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis"/>
   <result pre="virus infectionJ. Indian Med. Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis and" exact="cardiomyopathy" post="following dengue and chikungunya fever—A follow-up studyAm. Heart J.19738518619410.1016/0002-8703(73)90459-64688831"/>
   <result pre="Assoc.197870256258712084 155.ObeyesekereI.HermonY.Arbovirus heart disease: Myocarditis and cardiomyopathy following dengue and" exact="chikungunya" post="fever—A follow-up studyAm. Heart J.19738518619410.1016/0002-8703(73)90459-64688831 156.DorléansF.HoenB.NajioullahF.Herrmann-StorckC.SchepersK.M.AbelS.LamauryI.FagourL.CésaireR.GuyomardS.et al.Outbreak of Chikungunya"/>
   <result pre="Ross River virus disease (epidemic polyarthritis)Clin. Nephrol.1988291491522834127 159.ScrimgeourE.M.AaskovJ.G.MatzL.R.Ross River virus" exact="arthritis" post="in Papua New GuineaTrans. R. Soc. Trop. Med. Hyg.19878183383410.1016/0035-9203(87)90045-92835834"/>
   <result pre="GuineaTrans. R. Soc. Trop. Med. Hyg.19878183383410.1016/0035-9203(87)90045-92835834 160.ScrimgeourE.M.Suspected Ross River virus" exact="encephalitis" post="in Papua New GuineaAust. N. Z. J. Med.19992955910.1111/j.1445-5994.1999.tb00759.x10868536 161.LucasR.E.QiaoM.A"/>
   <result pre="Papua New GuineaAust. N. Z. J. Med.19992955910.1111/j.1445-5994.1999.tb00759.x10868536 161.LucasR.E.QiaoM.A case of" exact="encephalitis" post="in central Australia due to Ross River virus?Aust. N."/>
   <result pre="Pediatr.2010169677210.1007/s00431-009-0986-019401826 164.GargT.SankeS.AhmedR.ChanderR.BasuS.Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of" exact="chikungunya" post="fever: A case seriesPediatr. Dermatol.20183539239610.1111/pde.1345029573443 165.JadhavM.NamboodripadM.CarmanR.H.CareyD.E.MyersR.M.Chikungunya disease in infants"/>
   <result pre="virologically proved casesIndian J. Med. Res.1965537647765830895 166.De RanitzC.M.MyersR.M.VarkeyM.J.IsaacZ.H.CareyD.E.Clinical impressions of" exact="chikungunya" post="in Vellore gained from study of adult patientsIndian J."/>
   <result pre="studyPLoS Negl. Trop. Dis.20137e213710.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de623556021 174.BouquillardÉ.CombeB.A report of 21 cases of" exact="rheumatoid arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint"/>
   <result pre="Negl. Trop. Dis.20137e213710.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de623556021 174.BouquillardÉ.CombeB.A report of 21 cases of rheumatoid" exact="arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint"/>
   <result pre="Region, 2006Emerg. Infect. Dis.20081441642210.3201/eid1403.07090618325256 185.AppassakijH.KhuntikijP.KemapunmanusM.WutthanarungsanR.SilpapojakulK.Viremic profiles in asymptomatic and symptomatic" exact="chikungunya" post="fever: A blood transfusion threat?Transfusion2013532567257410.1111/j.1537-2995.2012.03960.x23176378 186.Acosta-AmpudiaY.MonsalveD.M.RodríguezY.PachecoY.AnayaJ.-M.Ramírez-SantanaC.Mayaro: An emerging viral"/>
   <result pre="Kinetics of Zika and Chikungunya Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive" exact="arthritis" post="in a patient with chikungunya virus infection with persistent"/>
   <result pre="Viruses, BrazilEmerg. Infect. Dis.20192531131510.3201/eid2502.18016630666934 192.MalvyD.EzzedineK.Mamani-MatsudaM.AutranB.TolouH.ReceveurM.-C.PistoneT.RambertJ.MoynetD.MossalayiD.Destructive arthritis in a patient with" exact="chikungunya" post="virus infection with persistent specific IgM antibodiesBMC Infect. Dis.2009920010.1186/1471-2334-9-20020003320"/>
   <result pre="individual and community mitigation measures for prevention and control of" exact="chikungunya" post="virusPLoS ONE201914e021205410.1371/journal.pone.021205430811438 201.KuruczN.JacupsS.CarterJ.M.Determining Culex annulirostris larval densities and control"/>
   <result pre="Infect. Dis.2016214S488S49610.1093/infdis/jiw27127920179 205.EdelmanR.TacketC.O.WassermanS.S.BodisonS.A.PerryJ.A.PerryJ.G.Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218Am. J. Trop. Med. Hyg.20006268168510.4269/ajtmh.2000.62.68111304054 206.WangE.VolkovaE.AdamsA.P.ForresterN.XiaoS.-Y.FrolovI.WeaverS.C.Chimeric alphavirus"/>
   <result pre="Med. Hyg.20006268168510.4269/ajtmh.2000.62.68111304054 206.WangE.VolkovaE.AdamsA.P.ForresterN.XiaoS.-Y.FrolovI.WeaverS.C.Chimeric alphavirus vaccine candidates for chikungunyaVaccine2008265030503910.1016/j.vaccine.2008.07.05418692107 207.BrandlerS.RuffiéC.CombredetC.BraultJ.-B.NajburgV.PrevostM.-C.HabelA.TauberE.DesprèsP.TangyF.A recombinant" exact="measles" post="vaccine expressing chikungunya virus-like particles is strongly immunogenic and"/>
   <result pre="alphavirus vaccine candidates for chikungunyaVaccine2008265030503910.1016/j.vaccine.2008.07.05418692107 207.BrandlerS.RuffiéC.CombredetC.BraultJ.-B.NajburgV.PrevostM.-C.HabelA.TauberE.DesprèsP.TangyF.A recombinant measles vaccine expressing" exact="chikungunya" post="virus-like particles is strongly immunogenic and protects mice from"/>
   <result pre="is strongly immunogenic and protects mice from lethal challenge with" exact="chikungunya" post="virusVaccine2013313718372510.1016/j.vaccine.2013.05.08623742993 208.RamsauerK.SchwameisM.FirbasC.MüllnerM.PutnakR.J.ThomasS.J.DesprèsP.TauberE.JilmaB.TangyF.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based"/>
   <result pre="chikungunya virusVaccine2013313718372510.1016/j.vaccine.2013.05.08623742993 208.RamsauerK.SchwameisM.FirbasC.MüllnerM.PutnakR.J.ThomasS.J.DesprèsP.TauberE.JilmaB.TangyF.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: A randomised, double-blind, placebo-controlled, active-comparator, first-in-man trialLancet Infect."/>
   <result pre="trialLancet Infect. Dis.20151551952710.1016/S1473-3099(15)70043-525739878 209.ReisingerE.C.TschismarovR.BeublerE.WiedermannU.FirbasC.LoebermannM.PfeifferA.MuellnerM.TauberE.RamsauerK.Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: A double-blind, randomised, placebo-controlled and active-controlled"/>
   <result pre="virus-neutralizing antibodies in miceVirus Res.201216723624610.1016/j.virusres.2012.05.00422610133 221.ChangL.-J.DowdK.A.MendozaF.H.SaundersJ.G.SitarS.PlummerS.H.YamshchikovG.SarwarU.N.HuZ.EnamaM.E.et al.Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: A phase 1"/>
   <result pre="cross-sectional study in a Cambodian rural communityEmerg. Microbes Infect.201871310.1038/s41426-017-0010-029410416 225.PowersA.M.Licensed" exact="chikungunya" post="virus vaccine: A possibility?Lancet20183922660266110.1016/S0140-6736(18)32809-530409444 226.LangsjoenR.M.HallerS.L.RoyC.J.Vinet-OliphantH.BergrenN.A.ErasmusJ.H.LivengoodJ.A.PowellT.D.WeaverS.C.RossiS.L.Chikungunya Virus Strains Show Lineage-Specific"/>
   <result pre="227.PartidosC.D.PaykelJ.WegerJ.BorlandE.M.PowersA.M.SeymourR.WeaverS.C.StinchcombD.T.OsorioJ.E.Cross-protective immunity against O’nyong’nyong virus afforded by a novel recombinant" exact="chikungunya" post="vaccineVaccine2012304638464310.1016/j.vaccine.2012.04.09922583812 228.RobinsonD.M.ColeF.E.McManusA.T.PedersenC.E.Inactivated Mayaro vaccine produced in human diploid cell"/>
   <result pre="developmentPLoS Negl. Trop. Dis.201913e000691910.1371/journal.pntd.000691930653504 238.SuhrbierA.La LinnM.Clinical and pathologic aspects of" exact="arthritis" post="due to Ross River virus and other alphavirusesCurr. Opin."/>
   <result pre="alphavirusesCurr. Opin. Rheumatol.20041637437910.1097/01.bor.0000130537.76808.2615201600 239.PadmakumarB.JayanJ.B.MenonR.M.KrishnankuttyB.PayippallilR.NishaR.Comparative evaluation of four therapeutic regimes in" exact="chikungunya" post="arthritis: A prospective randomized parallel-group studyIndian J. Rheumatol.200949410110.1016/S0973-3698(10)60189-6 240.WolfS.TaylorA.ZaidA.FreitasJ.HerreroL.J.RaoS.SuhrbierA.ForwoodM.R.BucalaR.MahalingamS.Inhibition"/>
   <result pre="Loss Induced by Chikungunya Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 242.RulliN.E.GuglielmottiA.ManganoG.RolphM.S.ApicellaC.ZaidA.SuhrbierA.MahalingamS.Amelioration of alphavirus-induced" exact="arthritis" post="and myositis in a mouse model by treatment with"/>
   <result pre="by Chikungunya Virus InfectionJ. Virol.20158958159310.1128/JVI.02034-1425339772 242.RulliN.E.GuglielmottiA.ManganoG.RolphM.S.ApicellaC.ZaidA.SuhrbierA.MahalingamS.Amelioration of alphavirus-induced arthritis and" exact="myositis" post="in a mouse model by treatment with bindarit, an"/>
   <result pre="the antiviral screening platformsExpert Rev. Anti-Infect. Ther.20191712210.1080/14787210.2019.159559130449226 248.De LamballerieX.BoissonV.ReynierJ.-C.EnaultS.CharrelR.N.FlahaultA.RoquesP.Le GrandR.On" exact="chikungunya" post="acute infection and chloroquine treatmentVector Borne Zoonotic Dis.2008883783910.1089/vbz.2008.004918620511 249.RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.GrasG.LebonP.NgL.F.P.de"/>
   <result pre="260.MackenzieJ.S.LindsayM.D.A.SmithD.W.ImrieA.The ecology and epidemiology of Ross River and Murray Valley" exact="encephalitis" post="viruses in Western Australia: Examples of One Health in"/>
   <result pre="&amp;amp; evaluation of biotinylated DNA probe for clinical diagnosis of" exact="chikungunya" post="infection in patients’ acute phase serum &amp;amp; CSF samplesIndian"/>
   <result pre="CSF samplesIndian J. Med. Res.201313811712424056565 278.TuekprakhonA.PuipromO.SasakiT.MichielsJ.BartholomeeusenK.NakayamaE.E.MenoM.K.PhadungsombatJ.HuitsR.AriënK.K.et al.Broad-spectrum monoclonal antibodies against" exact="chikungunya" post="virus structural proteins: Promising candidates for antibody-based rapid diagnostic"/>
   <result pre="other general symptoms, and after a few days, a delayed" exact="rash" post="often appears. Lymphadenopathy is particularly frequent in ONNV infection."/>
   <result pre="(with cytolysis and increased creatinine kinase). Polyarthralgia with or without" exact="arthritis" post="and asthenia might be prolonged during the sub-acute phase"/>
   <result pre="as chronic symptoms, sometimes as post-infectious chronic inflammatory rheumatism mimicking" exact="rheumatoid arthritis." post="Indirect diagnosis by serology requires two blood samples separated"/>
   <result pre="since then. microorganisms-07-00133-t001_Table 1Table 1 Arthritogenic alphavirus general characteristics. CHIKV," exact="chikungunya" post="virus; ONNV, O’nyong’nyong virus; MAYV, Mayaro virus; RRV, Ross"/>
   <result pre="5/626 [125,146,147,148,149] Severe forms Meningo-encephalopathy [150,151], Guillain-Barré syndrome [152], acute" exact="optic neuropathy" post="[153], Myo-pericarditis [150,154,155], shock [150], neonatal infection [156,157] unknown"/>
   <result pre="[125,146,147,148,149] Severe forms Meningo-encephalopathy [150,151], Guillain-Barré syndrome [152], acute optic" exact="neuropathy" post="[153], Myo-pericarditis [150,154,155], shock [150], neonatal infection [156,157] unknown"/>
   <result pre="[150,154,155], shock [150], neonatal infection [156,157] unknown unknown Glomerulonephritis [158]," exact="encephalitis" post="[159,160,161]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6562360\results\search\disease\results.xml">
   <result pre="for many important viral pathogens, including HIV (11), RSV (12)," exact="influenza" post="(13), human DENV MBC derived antibodies were not fully"/>
   <result pre="develop severe dengue—referred to as dengue shock syndrome (DSS) or" exact="dengue hemorrhagic fever" post="(DHF)—which can further progress to organ failure and death."/>
   <result pre="which enabled them to isolate neutralizing mAbs against RSV and" exact="influenza" post="from human peripheral MBCs. Hybridoma technology is a well-established"/>
   <result pre="in humans that recognize RSV (52), Hepatitis C virus (54)," exact="influenza" post="(55), and DENV (56). Strengths and Limitations Immortalized B-cells"/>
   <result pre="13.WrammertJSmithKMillerJLangleyWAKokkoKLarsenCet al.. Rapid cloning of high-affinity human monoclonal antibodies against" exact="influenza" post="virus. Nature. (2008) 453:667–71. 10.1038/nature0689018449194 14.BeltramelloMWilliamsKLSimmonsCPMacagnoASimonelliLQuyenNTet al.. The human"/>
   <result pre="J Immunol Methods. (1983) 65:109–21. 10.1016/0022-1759(83)90308-36361139 37.SasakiSJaimesMCHolmesTHDekkerCLMahmoodKKembleGWet al.Comparison of the" exact="influenza" post="virus-specific effector and memory B-cell responses to immunization of"/>
   <result pre="immunization of children and adults with live attenuated or inactivated" exact="influenza" post="virus vaccines. J Virol. (2007) 81:215–28. 10.1128/JVI.01957-0617050593 38.AdamAWodaMKounlavouthSRothmanALJarmanRGCoxJHet al.."/>
   <result pre="55.EkiertDCFriesenRHBhabhaGKwaksTJongeneelenMYuWet al.. A highly conserved neutralizing epitope on group 2" exact="influenza" post="A viruses. Science. (2011) 333:843–50. 10.1126/science.120483921737702 56.NivarthiUKTuHADelacruzMJSwanstromJPatelBDurbinAPet al.. Longitudinal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563287\results\search\disease\results.xml">
   <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract The hemagglutinin (HA) and neuraminidase (NA) of" exact="influenza" post="A virus possess antagonistic activities on interaction with sialic"/>
   <result pre="and NA in relation to each other during virus entry." exact="influenza" post="A virus hemagglutinin neuraminidase virus entry 1. Introduction Influenza"/>
   <result pre="the recently identified type D [1,2]. Three main types of" exact="influenza" post="viruses (A, B and C) infect humans, with influenza"/>
   <result pre="of influenza viruses (A, B and C) infect humans, with" exact="influenza" post="A and B viruses usually cause annual epidemics, resulting"/>
   <result pre="can also result in occasional but devastating pandemics [3]. The" exact="influenza" post="A virus (IAV) and type B virus (IBV) genomes"/>
   <result pre="neuraminidase (NA) are the major surface glycoproteins [4]. In contrast," exact="influenza" post="C virus (ICV) and type D virus (IDV) carry"/>
   <result pre="SA of α-2,3 isomer predominates in the avian gut, where" exact="influenza" post="virus replicates in avian hosts, while the α-2,6 conformer"/>
   <result pre="replication in the human host [25,26]. Correspondingly, avian and human" exact="influenza" post="viruses are characterized by binding α-2,3 and α-2,6 isomers"/>
   <result pre="Although these NA containing SRBSs are predominantly from avian sources," exact="influenza" post="A (H7N9) virus containing SRBS in the N9 NA"/>
   <result pre="serve as a trap by presenting decoy receptors to which" exact="influenza" post="virus binds, followed by mucociliary clearance [65]. Previous studies"/>
   <result pre="the virion expressed HA [77]. When the NA genes from" exact="influenza" post="H9N2, H5N1 or A(H1N1) pdm09 virus was respectively expressed"/>
   <result pre="antiviral therapies mainly target NA, while recent approaches to new" exact="influenza" post="therapy include monoclonal antibodies targeting the HA [113,114]. Caution"/>
   <result pre="roles of HA and NA in the viral entry of" exact="influenza" post="viruses have implications in the basic biology of influenza"/>
   <result pre="of influenza viruses have implications in the basic biology of" exact="influenza" post="replication and pathogenesis and in the development of therapeutics"/>
   <result pre="online: http://www.who.int/mediacentre/factsheets/fs211/en/(accessed on 20 May 2019) 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a novel" exact="influenza" post="virus in cattle and swine: Proposal for a new"/>
   <result pre="3.TaubenbergerJ.K.MorensD.M.Pandemic influenza--including a risk assessment of H5N1Rev. Sci. Tech.20092818720210.20506/rst.28.1.187919618626 4.Resa-InfanteP.JorbaN.ColomaR.OrtinJ.The" exact="influenza" post="virus RNA synthesis machine: Advances in its structure and"/>
   <result pre="al.Genetic evolution and molecular selection of the he gene of" exact="influenza" post="C virusViruses20191116710.3390/v1102016730791465 6.SuS.FuX.LiG.KerlinF.VeitM.Novel influenza D virus: Epidemiology, pathology, evolution"/>
   <result pre="selection of the he gene of influenza C virusViruses20191116710.3390/v1102016730791465 6.SuS.FuX.LiG.KerlinF.VeitM.Novel" exact="influenza" post="D virus: Epidemiology, pathology, evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 7.RosenthalP.B.ZhangX.FormanowskiF.FitzW.WongC.H.Meier-EwertH.SkehelJ.J.WileyD.C.Structure"/>
   <result pre="evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 7.RosenthalP.B.ZhangX.FormanowskiF.FitzW.WongC.H.Meier-EwertH.SkehelJ.J.WileyD.C.Structure of the haemagglutinin-esterase-fusion glycoprotein of" exact="influenza" post="C virusNature1998396929610.1038/239749817207 8.HouserK.SubbaraoK.Influenza vaccines: Challenges and solutionsCell Host Microbe20151729530010.1016/j.chom.2015.02.01225766291"/>
   <result pre="Challenges and solutionsCell Host Microbe20151729530010.1016/j.chom.2015.02.01225766291 9.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="a virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 10.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et"/>
   <result pre="Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 10.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 11.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal influenza"/>
   <result pre="diverse influenza A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 11.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal" exact="influenza" post="with vaccines: Recommendations of the advisory committee on immunization"/>
   <result pre="of the advisory committee on immunization practices (ACIP)--UNITED states, 2014-15" exact="influenza" post="seasonMMWR Morb. Mortal. Wkly. Rep.20146369169725121712 12.MatrosovichM.HerrlerG.KlenkH.D.Sialic acid receptors of"/>
   <result pre="rafts play a major role in binding and endocytosis of" exact="influenza" post="A virusViruses20181065010.3390/v10110650 14.EdingerT.O.PohlM.O.StertzS.Entry of influenza A virus: Host factors"/>
   <result pre="in binding and endocytosis of influenza A virusViruses20181065010.3390/v10110650 14.EdingerT.O.PohlM.O.StertzS.Entry of" exact="influenza" post="A virus: Host factors and antiviral targetsJ. Gen. Virol.20149526327710.1099/vir.0.059477-024225499"/>
   <result pre="antiviral targetsJ. Gen. Virol.20149526327710.1099/vir.0.059477-024225499 15.RustM.J.LakadamyaliM.ZhangF.ZhuangX.Assembly of endocytic machinery around individual" exact="influenza" post="viruses during viral entryNat. Struct. Mol. Biol.20041156757310.1038/nsmb76915122347 16.SieczkarskiS.B.WhittakerG.R.Influenza virus"/>
   <result pre="absence of clathrin-mediated endocytosisJ. Virol.200276104551046410.1128/JVI.76.20.10455-10464.200212239322 17.De VriesE.TscherneD.M.WienholtsM.J.Cobos-JimenezV.ScholteF.Garcia-SastreA.RottierP.J.de HaanC.A.Dissection of the" exact="influenza" post="a virus endocytic routes reveals macropinocytosis as an alternative"/>
   <result pre="receptor bindingTrends Microbiol.201910.1016/j.tim.2019.03.001 21.WilsonI.A.SkehelJ.J.WileyD.C.Structure of the haemagglutinin membrane glycoprotein of" exact="influenza" post="virus at 3 a resolutionNature198128936637310.1038/289366a07464906 22.WeisW.BrownJ.H.CusackS.PaulsonJ.C.SkehelJ.J.WileyD.C.Structure of the influenza"/>
   <result pre="of influenza virus at 3 a resolutionNature198128936637310.1038/289366a07464906 22.WeisW.BrownJ.H.CusackS.PaulsonJ.C.SkehelJ.J.WileyD.C.Structure of the" exact="influenza" post="virus haemagglutinin complexed with its receptor, sialic acidNature198833342643110.1038/333426a03374584 23.LuoM.Influenza"/>
   <result pre="sialic acid receptors compatible with binding of avian and human" exact="influenza" post="virusesVirology200634627828610.1016/j.virol.2005.10.03516325879 27.BradleyK.C.JonesC.A.TompkinsS.M.TrippR.A.RussellR.J.GramerM.R.Heimburg-MolinaroJ.SmithD.F.CummingsR.D.SteinhauerD.A.Comparison of the receptor binding properties of contemporary"/>
   <result pre="28.ConnorR.J.KawaokaY.WebsterR.G.PaulsonJ.C.Receptor specificity in human, avian, and equine H2 and H3" exact="influenza" post="virus isolatesVirology1994205172310.1006/viro.1994.16157975212 29.IbricevicA.PekoszA.WalterM.J.NewbyC.BattaileJ.T.BrownE.G.HoltzmanM.J.BrodyS.L.Influenza virus receptor specificity and cell tropism"/>
   <result pre="30.GamblinS.J.HaireL.F.RussellR.J.StevensD.J.XiaoB.HaY.VasishtN.SteinhauerD.A.DanielsR.S.ElliotA.et al.The structure and receptor binding properties of the 1918" exact="influenza" post="hemagglutininScience20043031838184210.1126/science.109315514764886 31.MainesT.R.ChenL.M.Van HoevenN.TumpeyT.M.BlixtO.BelserJ.A.GustinK.M.PearceM.B.PappasC.StevensJ.et al.Effect of receptor binding domain mutations"/>
   <result pre="receptor binding domain mutations on receptor binding and transmissibility of" exact="avian influenza" post="H5N1 virusesVirology201141313914710.1016/j.virol.2011.02.01521397290 32.RussellR.J.StevensD.J.HaireL.F.GamblinS.J.SkehelJ.J.Avian and human receptor binding by hemagglutinins"/>
   <result pre="binding domain mutations on receptor binding and transmissibility of avian" exact="influenza" post="H5N1 virusesVirology201141313914710.1016/j.virol.2011.02.01521397290 32.RussellR.J.StevensD.J.HaireL.F.GamblinS.J.SkehelJ.J.Avian and human receptor binding by hemagglutinins"/>
   <result pre="H5N1 virusesVirology201141313914710.1016/j.virol.2011.02.01521397290 32.RussellR.J.StevensD.J.HaireL.F.GamblinS.J.SkehelJ.J.Avian and human receptor binding by hemagglutinins of" exact="influenza" post="A virusesGlycoconj. J.200623859210.1007/s10719-006-5440-116575525 33.StevensJ.BlixtO.GlaserL.TaubenbergerJ.K.PaleseP.PaulsonJ.C.WilsonI.A.Glycan microarray analysis of the hemagglutinins"/>
   <result pre="33.StevensJ.BlixtO.GlaserL.TaubenbergerJ.K.PaleseP.PaulsonJ.C.WilsonI.A.Glycan microarray analysis of the hemagglutinins from modern and pandemic" exact="influenza" post="viruses reveals different receptor specificitiesJ. Mol. Biol.20063551143115510.1016/j.jmb.2005.11.00216343533 34.SheltonH.Ayora-TalaveraG.RenJ.LoureiroS.PicklesR.J.BarclayW.S.JonesI.M.Receptor binding"/>
   <result pre="reveals different receptor specificitiesJ. Mol. Biol.20063551143115510.1016/j.jmb.2005.11.00216343533 34.SheltonH.Ayora-TalaveraG.RenJ.LoureiroS.PicklesR.J.BarclayW.S.JonesI.M.Receptor binding profiles of" exact="avian influenza" post="virus hemagglutinin subtypes on human cells as a predictor"/>
   <result pre="different receptor specificitiesJ. Mol. Biol.20063551143115510.1016/j.jmb.2005.11.00216343533 34.SheltonH.Ayora-TalaveraG.RenJ.LoureiroS.PicklesR.J.BarclayW.S.JonesI.M.Receptor binding profiles of avian" exact="influenza" post="virus hemagglutinin subtypes on human cells as a predictor"/>
   <result pre="Virol.2011851875188010.1128/JVI.01822-1021106732 35.YamadaS.SuzukiY.SuzukiT.LeM.Q.NidomC.A.Sakai-TagawaY.MuramotoY.ItoM.KisoM.HorimotoT.et al.Haemagglutinin mutations responsible for the binding of h5n1" exact="influenza" post="A viruses to human-type receptorsNature200644437838210.1038/nature0526417108965 36.YangZ.Y.WeiC.J.KongW.P.WuL.XuL.SmithD.F.NabelG.J.Immunization by avian H5"/>
   <result pre="influenza A viruses to human-type receptorsNature200644437838210.1038/nature0526417108965 36.YangZ.Y.WeiC.J.KongW.P.WuL.XuL.SmithD.F.NabelG.J.Immunization by avian H5" exact="influenza" post="hemagglutinin mutants with altered receptor binding specificityScience200731782582810.1126/science.113516517690300 37.StevensJ.BlixtO.TumpeyT.M.TaubenbergerJ.K.PaulsonJ.C.WilsonI.A.Structure and"/>
   <result pre="37.StevensJ.BlixtO.TumpeyT.M.TaubenbergerJ.K.PaulsonJ.C.WilsonI.A.Structure and receptor specificity of the hemagglutinin from an H5N1" exact="influenza" post="virusScience200631240441010.1126/science.112451316543414 38.MairC.M.LudwigK.HerrmannA.SiebenC.Receptor binding and ph stability—ow influenza A virus"/>
   <result pre="from an H5N1 influenza virusScience200631240441010.1126/science.112451316543414 38.MairC.M.LudwigK.HerrmannA.SiebenC.Receptor binding and ph stability—ow" exact="influenza" post="A virus hemagglutinin affects host-specific virus infectionBiochim. Biophys. Acta"/>
   <result pre="and pandemic riskTrends Microbiol.20182684185310.1016/j.tim.2018.03.00529681430 40.XuR.McBrideR.PaulsonJ.C.BaslerC.F.WilsonI.A.Structure, receptor binding, and antigenicity of" exact="influenza" post="virus hemagglutinins from the 1957 H2N2 pandemicJ. Virol.2010841715172110.1128/JVI.02162-0920007271 41.HaY.StevensD.J.SkehelJ.J.WileyD.C.X-ray"/>
   <result pre="potential H3 avian progenitor of the 1968 hong kong pandemic" exact="influenza" post="virusVirology200330920921810.1016/S0042-6822(03)00068-012758169 42.StevensJ.ChenL.M.CarneyP.J.GartenR.FoustA.LeJ.PokornyB.A.ManojkumarR.SilvermanJ.DevisR.et al.Receptor specificity of influenza a H3N2 viruses"/>
   <result pre="1968 hong kong pandemic influenza virusVirology200330920921810.1016/S0042-6822(03)00068-012758169 42.StevensJ.ChenL.M.CarneyP.J.GartenR.FoustA.LeJ.PokornyB.A.ManojkumarR.SilvermanJ.DevisR.et al.Receptor specificity of" exact="influenza" post="a H3N2 viruses isolated in mammalian cells and embryonated"/>
   <result pre="eggsJ. Virol.2010848287829910.1128/JVI.00058-1020519409 43.MainesT.R.JayaramanA.BelserJ.A.WadfordD.A.PappasC.ZengH.GustinK.M.PearceM.B.ViswanathanK.ShriverZ.H.et al.Transmission and pathogenesis of swine-origin 2009 a(H1N1)" exact="influenza" post="viruses in ferrets and miceScience200932548448710.1126/science.117723819574347 44.BradleyK.C.GallowayS.E.LasanajakY.SongX.Heimburg-MolinaroJ.YuH.ChenX.TalekarG.R.SmithD.F.CummingsR.D.et al.Analysis of influenza"/>
   <result pre="a(H1N1) influenza viruses in ferrets and miceScience200932548448710.1126/science.117723819574347 44.BradleyK.C.GallowayS.E.LasanajakY.SongX.Heimburg-MolinaroJ.YuH.ChenX.TalekarG.R.SmithD.F.CummingsR.D.et al.Analysis of" exact="influenza" post="virus hemagglutinin receptor binding mutants with limited receptor recognition"/>
   <result pre="in the membrane-insertion and &quot;stalk&quot; sequences in eight subtypes of" exact="influenza" post="type a virus neuraminidaseBiochemistry1982214001400710.1021/bi00260a0156896994 46.BarmanS.AdhikaryL.ChakrabartiA.K.BernasC.KawaokaY.NayakD.P.Role of transmembrane domain and"/>
   <result pre="of transmembrane domain and cytoplasmic tail amino acid sequences of" exact="influenza" post="A virus neuraminidase in raft association and virus buddingJ."/>
   <result pre="virus buddingJ. Virol.2004785258526910.1128/JVI.78.10.5258-5269.200415113907 47.MintaevR.R.AlexeevskiA.V.KordyukovaL.V.Co-evolution analysis to predict protein-protein interactions within" exact="influenza" post="virus envelopeJ. Bioinform. Comput. Biol.201412144100810.1142/S021972001441008X24712535 48.BarmanS.NayakD.P.Analysis of the transmembrane"/>
   <result pre="envelopeJ. Bioinform. Comput. Biol.201412144100810.1142/S021972001441008X24712535 48.BarmanS.NayakD.P.Analysis of the transmembrane domain of" exact="influenza" post="virus neuraminidase, a type ii transmembrane glycoprotein, for apical"/>
   <result pre="and additional glycosylation of the hemagglutinin influence the virulence of" exact="influenza" post="H5N1 viruses for miceJ. Virol.2009834704470810.1128/JVI.01987-0819225004 51.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic"/>
   <result pre="miceJ. Virol.2009834704470810.1128/JVI.01987-0819225004 51.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic and antigenic sites in" exact="influenza" post="virus neuraminidaseNature1983303414410.1038/303041a06188957 52.BurmeisterW.P.RuigrokR.W.CusackS.The 2.2 A resolution crystal structure of"/>
   <result pre="influenza virus neuraminidaseNature1983303414410.1038/303041a06188957 52.BurmeisterW.P.RuigrokR.W.CusackS.The 2.2 A resolution crystal structure of" exact="influenza" post="B neuraminidase and its complex with sialic acidEmbo J.199211495610.1002/j.1460-2075.1992.tb05026.x1740114"/>
   <result pre="its complex with sialic acidEmbo J.199211495610.1002/j.1460-2075.1992.tb05026.x1740114 53.GongJ.XuW.ZhangJ.Structure and functions of" exact="influenza" post="virus neuraminidaseCurr. Med. Chem.20071411312210.2174/09298670777931344417266572 54.VargheseJ.N.ColmanP.M.van DonkelaarA.BlickT.J.SahasrabudheA.McKimm-BreschkinJ.L.Structural evidence for a"/>
   <result pre="DonkelaarA.BlickT.J.SahasrabudheA.McKimm-BreschkinJ.L.Structural evidence for a second sialic acid binding site in" exact="avian influenza" post="virus neuraminidasesProc. Natl. Acad. Sci. USA199794118081181210.1073/pnas.94.22.118089342319 55.AirG.M.Influenza neuraminidaseInfluenza Other"/>
   <result pre="evidence for a second sialic acid binding site in avian" exact="influenza" post="virus neuraminidasesProc. Natl. Acad. Sci. USA199794118081181210.1073/pnas.94.22.118089342319 55.AirG.M.Influenza neuraminidaseInfluenza Other"/>
   <result pre="Acad. Sci. USA199794118081181210.1073/pnas.94.22.118089342319 55.AirG.M.Influenza neuraminidaseInfluenza Other Respir. Viruses2012624525610.1111/j.1750-2659.2011.00304.x22085243 56.SunX.LiQ.WuY.WangM.LiuY.QiJ.VavrickaC.J.GaoG.F.Structure of" exact="influenza" post="virus N7: The last piece of the neuraminidase &quot;jigsaw�?"/>
   <result pre="&quot;jigsaw�? puzzleJ. Virol.2014889197920710.1128/JVI.00805-1424899180 57.UhlendorffJ.MatrosovichT.KlenkH.D.MatrosovichM.Functional significance of the hemadsorption activity of" exact="influenza" post="virus neuraminidase and its alteration in pandemic virusesArch. Virol.200915494595710.1007/s00705-009-0393-x19458903"/>
   <result pre="resulting in reduced neuraminidase activity, preceded the emergence of H7N9" exact="influenza" post="A virusJ. Virol.20179110.1128/JVI.00049-17 59.BentonD.J.WhartonS.A.MartinS.R.McCauleyJ.W.Role of neuraminidase in influenza a(H7N9)"/>
   <result pre="of H7N9 influenza A virusJ. Virol.20179110.1128/JVI.00049-17 59.BentonD.J.WhartonS.A.MartinS.R.McCauleyJ.W.Role of neuraminidase in" exact="influenza" post="a(H7N9) virus receptor bindingJ. Virol.20179110.1128/JVI.02293-16 60.MohrP.G.DengY.M.McKimm-BreschkinJ.L.The neuraminidases of mdck"/>
   <result pre="virus receptor bindingJ. Virol.20179110.1128/JVI.02293-16 60.MohrP.G.DengY.M.McKimm-BreschkinJ.L.The neuraminidases of mdck grown human" exact="influenza" post="A (H3N2) viruses isolated since 1994 can demonstrate receptor"/>
   <result pre="demonstrate receptor bindingVirol. J.2015126710.1186/s12985-015-0295-325896455 61.LinY.P.GregoryV.CollinsP.KloessJ.WhartonS.CattleN.LackenbyA.DanielsR.HayA.Neuraminidase receptor binding variants of human" exact="influenza" post="A(H3N2) viruses resulting from substitution of aspartic acid 151"/>
   <result pre="role in virus attachment?J. Virol.2010846769678110.1128/JVI.00458-1020410266 62.MoglingR.RichardM.J.VlietS.V.BeekR.V.SchrauwenE.J.A.SpronkenM.I.RimmelzwaanG.F.FouchierR.A.M.Neuraminidase-mediated haemagglutination of recent human" exact="influenza" post="A(H3N2) viruses is determined by arginine 150 flanking the"/>
   <result pre="flanking the neuraminidase catalytic siteJ. Gen. Virol.2017981274128110.1099/jgv.0.00080928612701 63.GulatiS.SmithD.F.CummingsR.D.CouchR.B.GriesemerS.B.St GeorgeK.WebsterR.G.AirG.M.Human H3N2" exact="influenza" post="viruses isolated from 1968 to 2012 show varying preference"/>
   <result pre="disease or spreadPLoS ONE20138e6632510.1371/journal.pone.006632523805213 64.BurnetF.M.Mucins and mucoids in relation to" exact="influenza" post="virus action; inhibition of virus haemagglutination by glandular mucinsAust."/>
   <result pre="with neuraminidaseVirol. J.20131032110.1186/1743-422X-10-32124261589 67.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Neuraminidase is important for the initiation of" exact="influenza" post="virus infection in human airway epitheliumJ. Virol.200478126651266710.1128/JVI.78.22.12665-12667.200415507653 68.YangX.SteukersL.ForierK.XiongR.BraeckmansK.Van ReethK.NauwynckH.A"/>
   <result pre="airway epitheliumJ. Virol.200478126651266710.1128/JVI.78.22.12665-12667.200415507653 68.YangX.SteukersL.ForierK.XiongR.BraeckmansK.Van ReethK.NauwynckH.A beneficiary role for neuraminidase in" exact="influenza" post="virus penetration through the respiratory mucusPLoS ONE20149e11002610.1371/journal.pone.011002625333824 69.HoJ.W.HershkovitzO.PeirisM.ZilkaA.Bar-IlanA.NalB.ChuK.KudelkoM.KamY.W.AchdoutH.et al.H5-type"/>
   <result pre="influenza virus penetration through the respiratory mucusPLoS ONE20149e11002610.1371/journal.pone.011002625333824 69.HoJ.W.HershkovitzO.PeirisM.ZilkaA.Bar-IlanA.NalB.ChuK.KudelkoM.KamY.W.AchdoutH.et al.H5-type" exact="influenza" post="virus hemagglutinin is functionally recognized by the natural killer-activating"/>
   <result pre="natural killer-activating receptor NKP44J. Virol.2008822028203210.1128/JVI.02065-0718077718 70.AchdoutH.MeningherT.HirshS.GlasnerA.Bar-OnY.GurC.PorgadorA.MendelsonM.MandelboimM.MandelboimO.Killing of avian and swine" exact="influenza" post="virus by natural killer cellsJ. Virol.2010843993400110.1128/JVI.02289-0920130050 71.ArnonT.I.AchdoutH.LiebermanN.GazitR.Gonen-GrossT.KatzG.Bar-IlanA.BloushtainN.LevM.JosephA.et al.The mechanisms"/>
   <result pre="cellsNature20014091055106010.1038/3505911011234016 73.EierhoffT.HrinciusE.R.RescherU.LudwigS.EhrhardtC.The epidermal growth factor receptor (EGFR) promotes uptake of" exact="influenza" post="A viruses (IAV) into host cellsPLoS Pathog.20106e100109910.1371/journal.ppat.100109920844577 74.FujiokaY.NishideS.OseT.SuzukiT.KatoI.FukuharaH.FujiokaM.HoriuchiK.SatohA.O.NepalP.et al.A"/>
   <result pre="74.FujiokaY.NishideS.OseT.SuzukiT.KatoI.FukuharaH.FujiokaM.HoriuchiK.SatohA.O.NepalP.et al.A sialylated voltage-dependent ca(2+) channel binds hemagglutinin and mediates" exact="influenza" post="A virus entry into mammalian cellsCell Host Microbe201823809818.e510.1016/j.chom.2018.04.01529779930 75.SakaiT.NishimuraS.I.NaitoT.SaitoM.Influenza"/>
   <result pre="76.GuoH.RabouwH.SlompA.DaiM.van der VegtF.van LentJ.W.M.McBrideR.PaulsonJ.C.de GrootR.J.van KuppeveldF.J.M.et al.Kinetic analysis of the" exact="influenza" post="A virus ha/na balance reveals contribution of na to"/>
   <result pre="rolling on receptor-containing surfacesPLoS Pathog.201814e100723310.1371/journal.ppat.100723330102740 77.SuB.WurtzerS.Rameix-WeltiM.A.DwyerD.van der WerfS.NaffakhN.ClavelF.LabrosseB.Enhancement of the" exact="influenza" post="a hemagglutinin (HA)-mediated cell-cell fusion and virus entry by"/>
   <result pre="entry by the viral neuraminidase (NA)PLoS ONE20094e849510.1371/journal.pone.000849520041119 78.ChenQ.HuangS.ChenJ.ZhangS.ChenZ.Na proteins of" exact="influenza" post="A viruses H1N1/2009, H5N1, and H9N2 show differential effects"/>
   <result pre="ONE20138e5433410.1371/journal.pone.005433423349854 79.SuiZ.WenB.GaoZ.ChenQ.Fusion-related host proteins are actively regulated by na during" exact="influenza" post="infection as revealed by quantitative proteomics analysisPLoS ONE20149e10594710.1371/journal.pone.010594725153908 80.GaymardA.Le"/>
   <result pre="analysisPLoS ONE20149e10594710.1371/journal.pone.010594725153908 80.GaymardA.Le BriandN.FrobertE.LinaB.EscuretV.Functional balance between neuraminidase and haemagglutinin in" exact="influenza" post="virusesClin. Microbiol. Infect.20162297598310.1016/j.cmi.2016.07.00727424943 81.ThielenB.K.FriedlanderH.BistodeauS.ShuB.LynchB.MartinK.ByeE.Como-SabettiK.BoxrudD.StrainA.K.et al.Detection of influenza C viruses"/>
   <result pre="and haemagglutinin in influenza virusesClin. Microbiol. Infect.20162297598310.1016/j.cmi.2016.07.00727424943 81.ThielenB.K.FriedlanderH.BistodeauS.ShuB.LynchB.MartinK.ByeE.Como-SabettiK.BoxrudD.StrainA.K.et al.Detection of" exact="influenza" post="C viruses among outpatients and patients hospitalized for severe"/>
   <result pre="for severe acute respiratory infection, minnesota, 2013–2016Clin. Infect. Dis.2018661092109810.1093/cid/cix93129069373 82.AshaK.KumarB.Emerging" exact="influenza" post="D virus threat: What we know so far!J. Clin."/>
   <result pre="Med.2019810.3390/jcm802019230764577 83.StevensJ.BlixtO.PaulsonJ.C.WilsonI.A.Glycan microarray technologies: Tools to survey host specificity of" exact="influenza" post="virusesNat. Rev. Microbiol.2006485786410.1038/nrmicro153017013397 84.WetherallN.T.TrivediT.ZellerJ.Hodges-SavolaC.McKimm-BreschkinJ.L.ZambonM.HaydenF.G.Evaluation of neuraminidase enzyme assays using"/>
   <result pre="neuraminidase enzyme assays using different substrates to measure susceptibility of" exact="influenza" post="virus clinical isolates to neuraminidase inhibitors: Report of the"/>
   <result pre="neuraminidase inhibitor susceptibility networkJ. Clin. Microbiol.20034174275010.1128/JCM.41.2.742-750.200312574276 85.CohenM.FisherC.J.HuangM.L.LindsayL.L.PlancarteM.BoyceW.M.GodulaK.GagneuxP.Capture and characterization of" exact="influenza" post="A virus from primary samples using glycan bead arraysVirology201649312813510.1016/j.virol.2016.03.01127031581"/>
   <result pre="virus from primary samples using glycan bead arraysVirology201649312813510.1016/j.virol.2016.03.01127031581 86.VenkateshD.PoenM.J.BestebroerT.M.ScheuerR.D.VuongO.ChkhaidzeM.MachablishviliA.MamuchadzeJ.NinuaL.FedorovaN.B.et al.Avian" exact="influenza" post="viruses in wild birds: Virus evolution in a multihost"/>
   <result pre="evolution in a multihost ecosystemJ. Virol.20189210.1128/JVI.00433-1829769347 87.KaverinN.V.MatrosovichM.N.GambaryanA.S.RudnevaI.A.ShilovA.A.VarichN.L.MakarovaN.V.KropotkinaE.A.SinitsinB.V.Intergenic HA-NA interactions in" exact="influenza" post="A virus: Postreassortment substitutions of charged amino acid in"/>
   <result pre="acid in the hemagglutinin of different subtypesVirus Res.20006612312910.1016/S0168-1702(99)00131-810725545 88.AlexanderD.J.Report on" exact="avian influenza" post="in the eastern hemisphere during 1997–2002Avian Dis.20034779279710.1637/0005-2086-47.s3.79214575066 89.MunsterV.J.BaasC.LexmondP.WaldenstromJ.WallenstenA.FranssonT.RimmelzwaanG.F.BeyerW.E.SchuttenM.OlsenB.et al.Spatial,"/>
   <result pre="in the hemagglutinin of different subtypesVirus Res.20006612312910.1016/S0168-1702(99)00131-810725545 88.AlexanderD.J.Report on avian" exact="influenza" post="in the eastern hemisphere during 1997–2002Avian Dis.20034779279710.1637/0005-2086-47.s3.79214575066 89.MunsterV.J.BaasC.LexmondP.WaldenstromJ.WallenstenA.FranssonT.RimmelzwaanG.F.BeyerW.E.SchuttenM.OlsenB.et al.Spatial,"/>
   <result pre="Dis.20034779279710.1637/0005-2086-47.s3.79214575066 89.MunsterV.J.BaasC.LexmondP.WaldenstromJ.WallenstenA.FranssonT.RimmelzwaanG.F.BeyerW.E.SchuttenM.OlsenB.et al.Spatial, temporal, and species variation in prevalence of" exact="influenza" post="A viruses in wild migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 90.WagnerR.MatrosovichM.KlenkH.D.Functional balance"/>
   <result pre="migratory birdsPLoS Pathog.20073e6110.1371/journal.ppat.003006117500589 90.WagnerR.MatrosovichM.KlenkH.D.Functional balance between haemagglutinin and neuraminidase in" exact="influenza" post="virus infectionsRev. Med. Virol.20021215916610.1002/rmv.35211987141 91.FerrarisO.KesslerN.ValetteM.LinaB.Evolution of the susceptibility to"/>
   <result pre="Virol.20021215916610.1002/rmv.35211987141 91.FerrarisO.KesslerN.ValetteM.LinaB.Evolution of the susceptibility to antiviral drugs of a/H3N2" exact="influenza" post="viruses isolated in france from 2002 to 2005Vaccine2006246656665910.1016/j.vaccine.2006.05.05016797804 92.RichardM.ErnyA.CareB.TraversierA.BarthelemyM.HayA.LinY.P.FerrarisO.LinaB.Rescue"/>
   <result pre="in france from 2002 to 2005Vaccine2006246656665910.1016/j.vaccine.2006.05.05016797804 92.RichardM.ErnyA.CareB.TraversierA.BarthelemyM.HayA.LinY.P.FerrarisO.LinaB.Rescue of a H3N2" exact="influenza" post="virus containing a deficient neuraminidase protein by a hemagglutinin"/>
   <result pre="a hemagglutinin with a low receptor-binding affinityPLoS ONE20127e3388010.1371/journal.pone.003388022563453 93.HooperK.A.BloomJ.D.A mutant" exact="influenza" post="virus that uses an N1 neuraminidase as the receptor-binding"/>
   <result pre="N1 neuraminidase as the receptor-binding proteinJ. Virol.201387125311254010.1128/JVI.01889-1324027333 94.SauterN.K.BednarskiM.D.WurzburgB.A.HansonJ.E.WhitesidesG.M.SkehelJ.J.WileyD.C.Hemagglutinins from two" exact="influenza" post="virus variants bind to sialic acid derivatives with millimolar"/>
   <result pre="3′ terminal nucleotide sequences of the rna genome segments of" exact="influenza" post="virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 96.DesselbergerU.RacanielloV.R.ZazraJ.J.PaleseP.The 3′ and 5′-terminal sequences of"/>
   <result pre="influenza virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 96.DesselbergerU.RacanielloV.R.ZazraJ.J.PaleseP.The 3′ and 5′-terminal sequences of" exact="influenza" post="A, B and C virus rna segments are highly"/>
   <result pre="complementarityGene1980831532810.1016/0378-1119(80)90007-47358274 97.WangL.LeeC.W.Sequencing and mutational analysis of the non-coding regions of" exact="influenza" post="A virusVet. Microbiol.200913523924710.1016/j.vetmic.2008.09.06718986781 98.BergmannM.MusterT.Mutations in the nonconserved noncoding sequences"/>
   <result pre="virusVet. Microbiol.200913523924710.1016/j.vetmic.2008.09.06718986781 98.BergmannM.MusterT.Mutations in the nonconserved noncoding sequences of the" exact="influenza" post="A virus segments affect viral vRNA formationVirus Res.199644233110.1016/0168-1702(96)01335-48873410 99.ZhengH.PaleseP.Garcia-SastreA.Nonconserved"/>
   <result pre="99.ZhengH.PaleseP.Garcia-SastreA.Nonconserved nucleotides at the 3′ and 5′ ends of an" exact="influenza" post="A virus RNA play an important role in viral"/>
   <result pre="role in viral RNA replicationVirology199621724225110.1006/viro.1996.01118599209 100.GotoH.MuramotoY.NodaT.KawaokaY.The genome-packaging signal of the" exact="influenza" post="A virus genome comprises a genome incorporation signal and"/>
   <result pre="Virol.201387113161132210.1128/JVI.01301-1323926345 101.BenkarounJ.RobertsonG.J.WhitneyH.LangA.S.Analysis of the variability in the non-coding regions of" exact="influenza" post="A virusesVet. Sci.2018510.3390/vetsci503007630149635 102.WangJ.LiJ.ZhaoL.CaoM.DengT.Dual roles of the hemagglutinin segment-specific"/>
   <result pre="segment-specific noncoding nucleotides in the extended duplex region of the" exact="influenza" post="A virus RNA promoterJ. Virol.20179110.1128/JVI.01931-16 103.ZhaoL.PengY.ZhouK.CaoM.WangJ.WangX.JiangT.DengT.New insights into the"/>
   <result pre="noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of" exact="influenza" post="A virusesJ. Virol.201488114931150310.1128/JVI.01337-1425056889 104.ElsM.C.AirG.M.MurtiK.G.WebsterR.G.LaverW.G.An 18-amino acid deletion in an"/>
   <result pre="influenza A virusesJ. Virol.201488114931150310.1128/JVI.01337-1425056889 104.ElsM.C.AirG.M.MurtiK.G.WebsterR.G.LaverW.G.An 18-amino acid deletion in an" exact="influenza" post="neuraminidaseVirology198514224124710.1016/0042-6822(85)90332-04060573 105.CastrucciM.R.KawaokaY.Biologic importance of neuraminidase stalk length in influenza"/>
   <result pre="an influenza neuraminidaseVirology198514224124710.1016/0042-6822(85)90332-04060573 105.CastrucciM.R.KawaokaY.Biologic importance of neuraminidase stalk length in" exact="influenza" post="A virusJ. Virol.1993677597648419645 106.BaigentS.J.McCauleyJ.W.Glycosylation of haemagglutinin and stalk-length of"/>
   <result pre="and stalk-length of neuraminidase combine to regulate the growth of" exact="avian influenza" post="viruses in tissue cultureVirus Res.20017917718510.1016/S0168-1702(01)00272-611551658 107.HoffmannT.W.MunierS.LarcherT.SoubieuxD.LedevinM.EsnaultE.TourdesA.CrovilleG.GuerinJ.L.QuereP.et al.Length variations in"/>
   <result pre="stalk-length of neuraminidase combine to regulate the growth of avian" exact="influenza" post="viruses in tissue cultureVirus Res.20017917718510.1016/S0168-1702(01)00272-611551658 107.HoffmannT.W.MunierS.LarcherT.SoubieuxD.LedevinM.EsnaultE.TourdesA.CrovilleG.GuerinJ.L.QuereP.et al.Length variations in"/>
   <result pre="107.HoffmannT.W.MunierS.LarcherT.SoubieuxD.LedevinM.EsnaultE.TourdesA.CrovilleG.GuerinJ.L.QuereP.et al.Length variations in the NA stalk of an H7N1" exact="influenza" post="virus have opposite effects on viral excretion in chickens"/>
   <result pre="and ducksJ. Virol.20128658458810.1128/JVI.05474-1122013034 108.BlumenkrantzD.RobertsK.L.SheltonH.LycettS.BarclayW.S.The short stalk length of highly pathogenic" exact="avian influenza" post="H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus"/>
   <result pre="ducksJ. Virol.20128658458810.1128/JVI.05474-1122013034 108.BlumenkrantzD.RobertsK.L.SheltonH.LycettS.BarclayW.S.The short stalk length of highly pathogenic avian" exact="influenza" post="H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus"/>
   <result pre="hemagglutinin and the neuraminidase stalk length influence virulence of H9N2" exact="influenza" post="virus in chickens and miceJ. Virol.2013872963296810.1128/JVI.02688-1223269805 110.BiY.XiaoH.ChenQ.WuY.FuL.QuanC.WongG.LiuJ.HaywoodJ.LiuY.et al.Changes in"/>
   <result pre="of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of" exact="influenza" post="A virusesSci. Rep.201771092810.1038/s41598-017-11348-028883554 112.WasilewskiS.CalderL.J.GrantT.RosenthalP.B.Distribution of surface glycoproteins on influenza"/>
   <result pre="of influenza A virusesSci. Rep.201771092810.1038/s41598-017-11348-028883554 112.WasilewskiS.CalderL.J.GrantT.RosenthalP.B.Distribution of surface glycoproteins on" exact="influenza" post="A virus determined by electron cryotomographyVaccine2012307368737310.1016/j.vaccine.2012.09.08223063838 113.IsonM.G.Optimizing antiviral therapy"/>
   <result pre="therapy for influenza: Understanding the evidenceExpert Rev. Anti-Infect. Ther.20151341742510.1586/14787210.2015.101818325695406 114.NachbagauerR.KrammerF.Universal" exact="influenza" post="virus vaccines and therapeutic antibodiesClin. Microbiol. Infect.20172322222810.1016/j.cmi.2017.02.00928216325 Figure 1"/>
   <result pre="region and the cytoplasmic tail. Figure 2 Representative model for" exact="influenza" post="A virus moving on sialic acid (SA) decorated surface."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563321\results\search\disease\results.xml">
   <result pre="University Hospital, Germany) presented about co-infection between Staphylococcus aureus and" exact="influenza" post="virus. From the submitted abstracts, we selected talks by"/>
   <result pre="Nicole Kelly (University of Bern, Switzerland) on single-cell analysis of" exact="influenza" post="virus infection, Florian Erhard (University of Würzburg, Germany) on"/>
   <result pre="Mount Sinai, New York, USA) on in-depth transcriptomic analysis in" exact="influenza" post="A virus infection. Studying virus infections at the molecular"/>
   <result pre="disease of the respiratory tract and also the most common" exact="infectious disease." post="The classification of pneumonia into Hospital-Acquired Pneumonia (HAP), Community-Acquired"/>
   <result pre="and also the most common infectious disease. The classification of" exact="pneumonia" post="into Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP) and Ventilated-Acquired"/>
   <result pre="bacteria, viruses and fungi. Respiratory tract infections and in particular" exact="pneumonia" post="represent the most common cause of sepsis [5]. Long-time"/>
   <result pre="diseases characterized by mild to severe symptoms. The seasonal IV-associated" exact="bronchopneumonia" post="is one of these infectious diseases with the highest"/>
   <result pre="sudden increase of pathogenicity is the most striking problem of" exact="influenza" post="accompanied by bacterial co-infection. In a single-centre study conducted"/>
   <result pre="the first line of defence against invading respiratory pathogens, including" exact="influenza" post="viruses. Although several studies have now shown that both"/>
   <result pre="components and to examine how specific cell types respond to" exact="influenza" post="infection, we used single-cell RNA sequencing to acquire transcriptomes"/>
   <result pre="surfaces to prevent recognition by the human immune system. In" exact="cystic fibrosis," post="they can allow their hosts to cope with anaerobic"/>
   <result pre="leveraging pathogen genomics to reveal and control the spread of" exact="rabies" post="virus. From the submitted abstracts, we selected talks by"/>
   <result pre="United Kingdom) on parallel evolution and the emergence of highly-pathogenic" exact="avian influenza" post="A viruses, David Bauer (University of Oxford, United Kingdom)"/>
   <result pre="Kingdom) on parallel evolution and the emergence of highly-pathogenic avian" exact="influenza" post="A viruses, David Bauer (University of Oxford, United Kingdom)"/>
   <result pre="(University of Oxford, United Kingdom) on the structure of the" exact="influenza" post="A virus genome and Lu Lu (University of Edinburgh,"/>
   <result pre="in order to estimate spatial diffusion rates and routes. Using" exact="avian influenza" post="as an example of a widespread multi-species disease system,"/>
   <result pre="order to estimate spatial diffusion rates and routes. Using avian" exact="influenza" post="as an example of a widespread multi-species disease system,"/>
   <result pre="only cause mild to asymptomatic infections, known as Low Pathogenicity" exact="avian influenza" post="viruses (LP), High Pathogenicity avian influenza viruses (HP) can"/>
   <result pre="cause mild to asymptomatic infections, known as Low Pathogenicity avian" exact="influenza" post="viruses (LP), High Pathogenicity avian influenza viruses (HP) can"/>
   <result pre="known as Low Pathogenicity avian influenza viruses (LP), High Pathogenicity" exact="avian influenza" post="viruses (HP) can have an extremely high mortality rate"/>
   <result pre="as Low Pathogenicity avian influenza viruses (LP), High Pathogenicity avian" exact="influenza" post="viruses (HP) can have an extremely high mortality rate"/>
   <result pre="seasonal influenza-associated respiratory mortality: A modelling studyLancet (London, England)20183911285130010.1016/S0140-6736(17)33293-2 8.PapanicolaouG.A.Severe" exact="influenza" post="and S. aureus pneumonia: For whom the bell tolls?Virulence2013466666810.4161/viru.2695724165206"/>
   <result pre="9.KlemmC.BruchhagenC.van KrüchtenA.NiemannS.LöfflerB.PetersG.LudwigS.EhrhardtC.Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant" exact="influenza" post="virus and Staphylococcus aureus infectionSci. Rep.201774247310.1038/srep4247328195157 10.van KrüchtenA.WildenJ.J.NiemannS.PetersG.LöfflerB.LudwigS.EhrhardtC.Staphylococcus aureus"/>
   <result pre="aureus infectionSci. Rep.201774247310.1038/srep4247328195157 10.van KrüchtenA.WildenJ.J.NiemannS.PetersG.LöfflerB.LudwigS.EhrhardtC.Staphylococcus aureus triggers a shift from" exact="influenza" post="virus-induced apoptosis to necrotic cell deathFASEB J.2018322779279310.1096/fj.201701006R29401589 11.RussellA.B.TrapnellC.BloomJ.D.Extreme heterogeneity"/>
   <result pre="virus-induced apoptosis to necrotic cell deathFASEB J.2018322779279310.1096/fj.201701006R29401589 11.RussellA.B.TrapnellC.BloomJ.D.Extreme heterogeneity of" exact="influenza" post="virus infection in single cellseLife20187e3230310.7554/eLife.3230329451492 12.SteuermanY.CohenM.Peshes-YalozN.ValadarskyL.CohnO.DavidE.FrishbergA.MayoL.BacharachE.AmitI.et al.Dissection of Influenza"/>
   <result pre="14.JamesC.E.DaviesE.V.FothergillJ.L.WalshawM.J.BealeC.M.BrockhurstM.A.WinstanleyC.Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term" exact="cystic fibrosis" post="chronic lung infectionsISME J.201591391139810.1038/ismej.2014.22325461970 15.ShanJ.RamachandranA.ThankiA.M.VukusicF.B.I.BarylskiJ.ClokieM.R.J.Bacteriophages are more virulent to"/>
   <result pre="44.Krause-KyoraB.SusatJ.KeyF.M.KühnertD.BosseE.ImmelA.RinneC.KornellS.C.YepesD.FranzenburgS.et al.Neolithic and medieval virus genomes reveal complex evolution of" exact="hepatitis" post="BeLife20187e3666610.7554/eLife.3666629745896 45.MühlemannB.JonesT.C.DamgaardP.d.B.AllentoftM.E.ShevninaI.LogvinA.UsmanovaE.PanyushkinaI.P.BoldgivB.BazartserenT.et al.Ancient hepatitis B viruses from the Bronze"/>
   <result pre="virus genomes reveal complex evolution of hepatitis BeLife20187e3666610.7554/eLife.3666629745896 45.MühlemannB.JonesT.C.DamgaardP.d.B.AllentoftM.E.ShevninaI.LogvinA.UsmanovaE.PanyushkinaI.P.BoldgivB.BazartserenT.et al.Ancient" exact="hepatitis" post="B viruses from the Bronze Age to the Medieval"/>
   <result pre="from the Bronze Age to the Medieval periodNature201855741842310.1038/s41586-018-0097-z29743673 46.Bar-GalG.K.KimM.J.KleinA.ShinD.H.OhC.S.KimJ.W.KimT.H.KimS.B.GrantP.R.PappoO.et al.Tracing" exact="hepatitis" post="B virus to the 16th century in a Korean"/>
   <result pre="VirusesRole for migratory wild birds in the global spread of" exact="avian influenza" post="H5N8Science201635421321710.1126/science.aaf885227738169 59.LycettS.TanyaV.N.HallM.KingD.MazeriS.MiouletV.KnowlesN.WadsworthJ.Bachanek-BankowskaK.VictorN.N.et al.The evolution and phylodynamics of serotype A"/>
   <result pre="for migratory wild birds in the global spread of avian" exact="influenza" post="H5N8Science201635421321710.1126/science.aaf885227738169 59.LycettS.TanyaV.N.HallM.KingD.MazeriS.MiouletV.KnowlesN.WadsworthJ.Bachanek-BankowskaK.VictorN.N.et al.The evolution and phylodynamics of serotype A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563376\results\search\disease\results.xml">
   <result pre="available in this article, unless otherwise stated. Abstract Annual seasonal" exact="influenza" post="epidemics of variable severity result in significant morbidity and"/>
   <result pre="(U.S.) and worldwide. In temperate climate countries, including the U.S.," exact="influenza" post="activity peaks during the winter months. Annual influenza vaccination"/>
   <result pre="the U.S., influenza activity peaks during the winter months. Annual" exact="influenza" post="vaccination is recommended for all persons in the U.S."/>
   <result pre="(e.g. young children, elderly). Observational studies have reported effectiveness of" exact="influenza" post="vaccination to reduce the risks of severe disease requiring"/>
   <result pre="hospitalization, intensive care unit admission, and death. A diagnosis of" exact="influenza" post="should be considered in critically ill patients admitted with"/>
   <result pre="such as exacerbation of underlying chronic comorbidities, community-acquired pneumonia, and" exact="respiratory failure" post="during influenza season. Molecular tests are recommended for influenza"/>
   <result pre="of underlying chronic comorbidities, community-acquired pneumonia, and respiratory failure during" exact="influenza" post="season. Molecular tests are recommended for influenza testing of"/>
   <result pre="respiratory failure during influenza season. Molecular tests are recommended for" exact="influenza" post="testing of respiratory specimens in hospitalized patients. Antigen detection"/>
   <result pre="make clinical decisions, and respiratory specimens should be tested for" exact="influenza" post="by molecular assays. Because critically ill patients with lower"/>
   <result pre="ill patients with lower respiratory tract disease may have cleared" exact="influenza" post="virus in the upper respiratory tract, but have prolonged"/>
   <result pre="influenza virus in the upper respiratory tract, but have prolonged" exact="influenza" post="viral replication in the lower respiratory tract, an endotracheal"/>
   <result pre="purposes) should be tested by molecular assay for detection of" exact="influenza" post="viruses. Observational studies have reported that antiviral treatment of"/>
   <result pre="studies have reported that antiviral treatment of critically ill adult" exact="influenza" post="patients with a neuraminidase inhibitor is associated with survival"/>
   <result pre="unless clinically indicated for another reason, such as treatment of" exact="asthma" post="or COPD exacerbation, or septic shock. A number of"/>
   <result pre="Influenza Influenza vaccination Influenza testing Antiviral treatment Background Annual seasonal" exact="influenza" post="epidemics of variable severity result in significant morbidity and"/>
   <result pre="and worldwide [1–3]. In temperate climate countries, including the U.S.," exact="influenza" post="activity peaks during the winter months whereas in tropical"/>
   <result pre="activity peaks during the winter months whereas in tropical regions" exact="influenza" post="activity may be more variable [4–6]. Most persons with"/>
   <result pre="activity may be more variable [4–6]. Most persons with symptomatic" exact="influenza" post="virus infection have self-limited uncomplicated upper respiratory tract illness."/>
   <result pre="during 2010–2016, approximately 8.3% of the U.S. population experienced symptomatic" exact="influenza" post="each year [7]. However, complications may result in severe"/>
   <result pre="medical visits, 140,000–960,000 hospitalizations, and 12,000–79,000 deaths were associated with" exact="influenza" post="each year in the U.S. [8]. Another study estimated"/>
   <result pre="There are an estimated 291,000–646,000 respiratory deaths attributed to seasonal" exact="influenza" post="each year worldwide [2]. Here, we review strategies for"/>
   <result pre="Here, we review strategies for prevention, diagnosis, and treatment of" exact="influenza" post="virus infections in the ICU (Table 1). Table 1"/>
   <result pre="1). Table 1 Key points: care of patients with severe" exact="influenza" post="Key Points • There are an estimated 291,000–646,000 seasonal"/>
   <result pre="291,000–646,000 seasonal influenza-associated respiratory deaths every year worldwide. • Annual" exact="influenza" post="vaccination is the primary method of preventing influenza and"/>
   <result pre="• Annual influenza vaccination is the primary method of preventing" exact="influenza" post="and influenza-related complications, especially in high-risk persons. • Influenza"/>
   <result pre="patients, and should not be delayed while awaiting results of" exact="influenza" post="diagnostic tests. • Enterically administered oseltamivir is recommended for"/>
   <result pre="influenza diagnostic tests. • Enterically administered oseltamivir is recommended for" exact="influenza" post="patients except for those with contraindications (e.g., gastric stasis,"/>
   <result pre="be required to determine therapeutic endpoints in ventilated patients with" exact="influenza" post="• Corticosteroids are not recommended for the routine treatment"/>
   <result pre="• Corticosteroids are not recommended for the routine treatment of" exact="influenza" post="except when indicated for treatment of underlying medical conditions"/>
   <result pre="indicated for treatment of underlying medical conditions (e.g., COPD or" exact="asthma" post="exacerbation) or septic shock. Risk factors Influenza vaccination is"/>
   <result pre="Risk factors Influenza vaccination is the primary method for preventing" exact="influenza" post="and reducing the risk of severe outcomes. In the"/>
   <result pre="U.S., the Advisory Committee on Immunization Practices (ACIP) recommends annual" exact="influenza" post="vaccination for all persons aged 6 months and older and"/>
   <result pre="6 months and older and prioritizes those at higher risk for" exact="influenza" post="complications [10]. High-risk groups include adults aged &amp;gt; 65 years [11,"/>
   <result pre="who might be at risk for experiencing Reye syndrome with" exact="influenza" post="virus infection, and those who are extremely obese (BMI"/>
   <result pre="complications [10, 19–23]. Table 2 Groups at high risk for" exact="influenza" post="complications* Risk factors for severe influenza outcomes • Age"/>
   <result pre="at high risk for influenza complications* Risk factors for severe" exact="influenza" post="outcomes • Age &amp;lt; 5 years, especially those &amp;lt; 2 years • Age"/>
   <result pre="those &amp;lt; 2 years • Age &amp;gt; 65 years • Pregnant women • Extreme" exact="obesity" post="(BMI &amp;gt; 40 kg/m2) • Native Americans/Alaskan Natives (may also"/>
   <result pre="on Immunization Practices Many studies evaluated risk factors for severe" exact="influenza" post="during the 2009 H1N1 influenza pandemic. Adult ICU patients"/>
   <result pre="evaluated risk factors for severe influenza during the 2009 H1N1" exact="influenza" post="pandemic. Adult ICU patients with influenza A(H1N1)pdm09 virus infection"/>
   <result pre="during the 2009 H1N1 influenza pandemic. Adult ICU patients with" exact="influenza" post="A(H1N1)pdm09 virus infection were primarily non-elderly, were obese [24–28],"/>
   <result pre="[24–28], and had higher odds of death, invasive mechanical ventilation," exact="acute respiratory distress syndrome" post="(ARDS), septic shock, and multi-lobar pneumonia when compared with"/>
   <result pre="ventilation, acute respiratory distress syndrome (ARDS), septic shock, and multi-lobar" exact="pneumonia" post="when compared with seasonal influenza patients [24, 29]. In"/>
   <result pre="(ARDS), septic shock, and multi-lobar pneumonia when compared with seasonal" exact="influenza" post="patients [24, 29]. In children, independent risk factors for"/>
   <result pre="influenza patients [24, 29]. In children, independent risk factors for" exact="influenza" post="A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise,"/>
   <result pre="influenza A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise," exact="acute myocarditis" post="or encephalitis, and early presumed MRSA co-infection of the"/>
   <result pre="A(H1N1)pdm09-related mortality included chronic neurologic condition or immune compromise, acute" exact="myocarditis" post="or encephalitis, and early presumed MRSA co-infection of the"/>
   <result pre="Bacterial co-infection was identified in approximately one third of fatal" exact="influenza" post="A(H1N1)pdm09 cases in the largest autopsy case series [31]."/>
   <result pre="in the inter-pandemic period are also common in critically ill" exact="influenza" post="patients [32]. One study identified past or current tobacco"/>
   <result pre="study reported that mortality was higher in immunosuppressed patients with" exact="influenza" post="A(H1N1)pdm09 than in immunocompetent patients [34]. Severity of influenza"/>
   <result pre="with influenza A(H1N1)pdm09 than in immunocompetent patients [34]. Severity of" exact="influenza" post="seasons varies from year-to-year based on the predominant influenza"/>
   <result pre="of influenza seasons varies from year-to-year based on the predominant" exact="influenza" post="viruses, and between seasonal and pandemic influenza [35, 36]."/>
   <result pre="on the predominant influenza viruses, and between seasonal and pandemic" exact="influenza" post="[35, 36]. One study reported that patients with influenza"/>
   <result pre="pandemic influenza [35, 36]. One study reported that patients with" exact="influenza" post="A(H1N1)pdm09 had higher odds of severe disease than patients"/>
   <result pre="had higher odds of severe disease than patients with either" exact="influenza" post="A(H3N2) or influenza B virus infections [37]. However, influenza"/>
   <result pre="of severe disease than patients with either influenza A(H3N2) or" exact="influenza" post="B virus infections [37]. However, influenza B virus infection"/>
   <result pre="either influenza A(H3N2) or influenza B virus infections [37]. However," exact="influenza" post="B virus infection has been shown to increase the"/>
   <result pre="increase the odds of in-hospital mortality in children compared with" exact="influenza" post="A virus infection [38]. Prevention and vaccination Influenza vaccination"/>
   <result pre="&amp;gt; 6 months in the U.S. and should continue as long as" exact="influenza" post="viruses are circulating in the community. Previously unvaccinated children"/>
   <result pre="6 months through 8 years require two doses 1 month apart. Since" exact="influenza" post="vaccine effectiveness (VE) to prevent medically attended illness varies"/>
   <result pre="and immune function, some vaccinated individuals can become symptomatic with" exact="influenza" post="virus infection. However, several studies have reported influenza vaccine"/>
   <result pre="symptomatic with influenza virus infection. However, several studies have reported" exact="influenza" post="vaccine effectiveness in reducing illness severity, including reducing severe"/>
   <result pre="reduced a half-day in patients aged 50–64 years who had received" exact="influenza" post="vaccination compared with unvaccinated patients [41]. A study across"/>
   <result pre="[41]. A study across all age groups in Spain reported" exact="influenza" post="VE of 58% in reducing the risk of severe"/>
   <result pre="influenza VE of 58% in reducing the risk of severe" exact="influenza" post="requiring hospitalization [42]. A Southern Hemisphere study reported influenza"/>
   <result pre="severe influenza requiring hospitalization [42]. A Southern Hemisphere study reported" exact="influenza" post="VE of 82% in reducing influenza-associated ICU admissions among"/>
   <result pre="adults [43] while a study in Spain showed an adjusted" exact="influenza" post="VE of 23% in preventing ICU admission and death"/>
   <result pre="preventing ICU admission and death [44]. Despite the benefits of" exact="influenza" post="vaccination, there continues to be low vaccine coverage among"/>
   <result pre="high prevalence of high-risk comorbidities [45, 46]. In children, low" exact="influenza" post="vaccination coverage has also been reported among those admitted"/>
   <result pre="ICUs, even among those with underlying high-risk conditions [47]. Full" exact="influenza" post="vaccination was shown to result in a 74% reduction"/>
   <result pre="in pediatric ICU admissions compared to unvaccinated or partially vaccinated" exact="influenza" post="patients [47]. Furthermore, one study showed that influenza VE"/>
   <result pre="partially vaccinated influenza patients [47]. Furthermore, one study showed that" exact="influenza" post="VE was 65% in reducing the risk of mortality"/>
   <result pre="the U.S. [48]. These data further emphasize the benefits of" exact="influenza" post="vaccination in reducing severe influenza complications, especially in high-risk"/>
   <result pre="further emphasize the benefits of influenza vaccination in reducing severe" exact="influenza" post="complications, especially in high-risk persons. Diagnosis Persons with uncomplicated"/>
   <result pre="influenza complications, especially in high-risk persons. Diagnosis Persons with uncomplicated" exact="influenza" post="typically experience acute onset of respiratory symptoms (cough, rhinorrhea,"/>
   <result pre="rhinorrhea, congestion), myalgias, and headache with or without fever. During" exact="influenza" post="season, clinicians should also consider influenza when there is"/>
   <result pre="or without fever. During influenza season, clinicians should also consider" exact="influenza" post="when there is only fever present or in patients"/>
   <result pre="who are afebrile and have respiratory symptoms [49]. Complications of" exact="influenza" post="vary by age, underlying comorbidities or high-risk conditions such"/>
   <result pre="multi-organ failure, exacerbation of an underlying condition such as chronic" exact="lung disease" post="[50, 51], heart failure [52], or other extrapulmonary complications"/>
   <result pre="failure [52], or other extrapulmonary complications including stroke, encephalopathy, or" exact="encephalitis" post="[30, 49, 53]. Influenza testing is recommended for all"/>
   <result pre="with suspected influenza, including those admitted to the ICU during" exact="influenza" post="season with acute respiratory illness and community-acquired pneumonia, without"/>
   <result pre="alternative diagnosis. Furthermore, all individuals requiring critical care outside of" exact="influenza" post="season should be tested for influenza if there is"/>
   <result pre="critical care outside of influenza season should be tested for" exact="influenza" post="if there is a possible epidemiological link to an"/>
   <result pre="individual with recent influenza, such as travel to areas with" exact="influenza" post="activity or exposure to an institutional influenza outbreak. Special"/>
   <result pre="to areas with influenza activity or exposure to an institutional" exact="influenza" post="outbreak. Special consideration should be given to elderly and"/>
   <result pre="consideration should be given to elderly and immunocompromised patients, as" exact="influenza" post="virus infection may not present with typical acute respiratory"/>
   <result pre="of America (IDSA) 2018 Influenza Clinical Practice Guidelines also recommend" exact="influenza" post="testing for patients at high risk of complications such"/>
   <result pre="such as exacerbation of chronic cardiopulmonary disease [49]. Diagnosis of" exact="influenza" post="should be made as soon as possible in critically"/>
   <result pre="have reported an increase in mortality of ICU patients with" exact="influenza" post="A(H1N1)pdm09 virus infection when diagnosis was delayed [54], and"/>
   <result pre="was initiated within 6 h of admission [55]. Several kinds of" exact="influenza" post="diagnostic tests are available in clinical settings with variable"/>
   <result pre="the clinician to properly interpret their results. Most studies of" exact="influenza" post="diagnostic accuracy have been conducted on specimens from patients"/>
   <result pre="with uncomplicated influenza, and few have assessed the performance of" exact="influenza" post="tests in critically ill patients. The IDSA guidelines recommend"/>
   <result pre="tests in critically ill patients. The IDSA guidelines recommend molecular" exact="influenza" post="assays for testing respiratory specimens from all hospitalized patients"/>
   <result pre="for testing respiratory specimens from all hospitalized patients with suspected" exact="influenza" post="because of their high sensitivity, specificity, and time to"/>
   <result pre="results (15 min to several hours) [49]. The use of rapid" exact="influenza" post="molecular diagnostic testing can result in better outcomes for"/>
   <result pre="or throat NP or BAL/mini BAL Nasal or endotracheal Rapid" exact="influenza" post="diagnostic Test (RIDT) Antigen detection 10–15 min Low to moderate"/>
   <result pre="Some molecular assays also detect other respiratory pathogens #Patients with" exact="respiratory failure" post="and suspected influenza should have lower respiratory tract specimens"/>
   <result pre="detect other respiratory pathogens #Patients with respiratory failure and suspected" exact="influenza" post="should have lower respiratory tract specimens collected and tested,"/>
   <result pre="tested, including if upper respiratory tract specimens are negative for" exact="influenza" post="because a patient may have cleared influenza virus from"/>
   <result pre="are negative for influenza because a patient may have cleared" exact="influenza" post="virus from the upper respiratory tract and continue to"/>
   <result pre="virus from the upper respiratory tract and continue to have" exact="influenza" post="viral replication in the lower respiratory tract NP nasopharyngeal,"/>
   <result pre="recommended for diagnosis or clinical management of patients with suspected" exact="influenza" post="A recent meta-analysis reported that influenza antigen detection tests"/>
   <result pre="of patients with suspected influenza A recent meta-analysis reported that" exact="influenza" post="antigen detection tests that produce rapid results had very"/>
   <result pre="but sensitivities were highly variable compared with RT-PCR [58]. Rapid" exact="influenza" post="diagnostic tests (RIDTs) without an analyzer device had only"/>
   <result pre="device (digital immunoassays) had moderately high sensitivity (77–80%), and rapid" exact="influenza" post="molecular assays (nucleic acid detection) had high sensitivity (92–95%)"/>
   <result pre="high sensitivity (92–95%) [58]. Low sensitivity of RIDTs for detecting" exact="influenza" post="virus in ICU patients has been reported [59]. Recently,"/>
   <result pre="has been reported [59]. Recently, a systematic analysis of rapid" exact="influenza" post="molecular tests from 29 studies reported pooled sensitivity and"/>
   <result pre="97.4%, respectively [60]. Therefore, antigen detection assays, such as rapid" exact="influenza" post="diagnostic tests and immunofluorescence assays, are not recommended for"/>
   <result pre="immunofluorescence assays, are not recommended for hospitalized patients with suspected" exact="influenza" post="because of their lower sensitivities, unless molecular assays are"/>
   <result pre="unless molecular assays are not available [49]. Negative results for" exact="influenza" post="based on tests with low sensitivity (e.g., RIDTs, immunofluorescence"/>
   <result pre="up with reverse transcription polymerase chain reaction (RT-PCR) or other" exact="influenza" post="molecular assays to confirm results, and antiviral treatment should"/>
   <result pre="should continue until results are available. Preferred respiratory specimens for" exact="influenza" post="testing in hospitalized patients without lower respiratory tract disease"/>
   <result pre="tract specimens should be considered in hospitalized patients with suspected" exact="influenza" post="if upper respiratory tract specimens are negative and a"/>
   <result pre="31]. In hospitalized patients receiving invasive mechanical ventilation in whom" exact="influenza" post="is suspected, but not yet diagnosed, influenza testing should"/>
   <result pre="ventilation in whom influenza is suspected, but not yet diagnosed," exact="influenza" post="testing should be performed on endotracheal aspirate specimens instead"/>
   <result pre="the upper respiratory tract [61]. Molecular testing, including RT-PCR for" exact="influenza" post="viruses can also be performed on bronchoalveolar lavage (BAL)"/>
   <result pre="have very low diagnostic yield and are not recommended for" exact="influenza" post="testing [49]. Diagnostic test results on specimens collected from"/>
   <result pre="making even for patients with extra-pulmonary complications of influenza. Novel" exact="influenza" post="A viruses are typically of animal origin, differ antigenically"/>
   <result pre="animal origin, differ antigenically and genetically from currently circulating seasonal" exact="influenza" post="A viruses (including H1N1pdm09 and H3N2 subtypes) and have"/>
   <result pre="H3N2 subtypes) and have infected at least one person. Novel" exact="influenza" post="A viruses can cause a wide clinical spectrum of"/>
   <result pre="and multi-organ failure [62] and human infection with a novel" exact="influenza" post="A virus is of public health concern. In the"/>
   <result pre="health concern. In the U.S., human infection with a novel" exact="influenza" post="A virus is nationally reportable to the Centers for"/>
   <result pre="Health Organization. A major concern is the risk of novel" exact="influenza" post="A virus transmission among humans; depending upon the prevalence"/>
   <result pre="upon the prevalence of pre-existing immunity in the population, novel" exact="influenza" post="A viruses may have pandemic potential. Patients suspected with"/>
   <result pre="A viruses may have pandemic potential. Patients suspected with novel" exact="influenza" post="A virus infection should be investigated for a possible"/>
   <result pre="close contact to an individual with suspected or confirmed novel" exact="influenza" post="A virus infection. Novel influenza A virus infection cannot"/>
   <result pre="with suspected or confirmed novel influenza A virus infection. Novel" exact="influenza" post="A virus infection cannot be distinguished from seasonal influenza"/>
   <result pre="Novel influenza A virus infection cannot be distinguished from seasonal" exact="influenza" post="A virus infection by clinical findings or testing at"/>
   <result pre="RT-PCR at public health laboratories [63]. Cases of suspected novel" exact="influenza" post="A virus infections should be discussed with appropriate local"/>
   <result pre="to coordinate the testing of appropriate respiratory specimens. Treatment of" exact="influenza" post="Treatment of severe influenza presents multiple challenges. The mainstay"/>
   <result pre="of appropriate respiratory specimens. Treatment of influenza Treatment of severe" exact="influenza" post="presents multiple challenges. The mainstay of therapy for patients"/>
   <result pre="presents multiple challenges. The mainstay of therapy for patients with" exact="influenza" post="is initiation of antiviral medication as soon as possible"/>
   <result pre="rimantadine) (Table 4). NAIs and baloxavir have activity against both" exact="influenza" post="A and B viruses. Adamantanes only have activity against"/>
   <result pre="influenza A and B viruses. Adamantanes only have activity against" exact="influenza" post="A viruses and are not recommended for treatment of"/>
   <result pre="influenza A viruses and are not recommended for treatment of" exact="influenza" post="due to widespread resistance among currently circulating strains of"/>
   <result pre="due to widespread resistance among currently circulating strains of seasonal" exact="influenza" post="A viruses. Notably, FDA-approved antiviral medications for treatment of"/>
   <result pre="influenza A viruses. Notably, FDA-approved antiviral medications for treatment of" exact="influenza" post="are approved for early treatment of uncomplicated influenza in"/>
   <result pre="treatment of influenza are approved for early treatment of uncomplicated" exact="influenza" post="in outpatients based upon randomized placebo-controlled clinical trials conducted"/>
   <result pre="of randomized placebo-controlled clinical trials of early oseltamivir treatment of" exact="influenza" post="in pediatric and adult outpatients have reported clinical benefit"/>
   <result pre="duration of illness and risk for some complications associated with" exact="influenza" post="[65, 66]. Table 4 Antiviral treatment Antiviral agents and"/>
   <result pre="A phase III clinical trial of baloxavir treatment of hospitalized" exact="influenza" post="patients is ongoing: https://clinicaltrials.gov/ct2/show/NCT03684044 No completed randomized, placebo-controlled trials"/>
   <result pre="placebo-controlled trials of antiviral treatment have been conducted in hospitalized" exact="influenza" post="patients to establish the efficacy of oseltamivir or other"/>
   <result pre="treatment (&amp;gt; 48 h), and a 69% reduction in mortality risk between" exact="influenza" post="patients receiving early NAI treatment and those who did"/>
   <result pre="underpowered because death is less common in hospitalized children with" exact="influenza" post="than in adults. Although studies have shown the greatest"/>
   <result pre="median duration of ICU hospitalization in severely ill patients with" exact="influenza" post="A(H3N2), but not A(H1N1pdm09) or B virus infection in"/>
   <result pre="reported delays in initiation of oseltamivir treatment prescribed to hospitalized" exact="influenza" post="patients and suggested empiric administration of oseltamivir treatment in"/>
   <result pre="for patients being admitted with lower respiratory tract disease during" exact="influenza" post="season [79]. Overall, based upon available observational data to"/>
   <result pre="of therapy with neuraminidase inhibitors are limited in critically ill" exact="influenza" post="patients. Enterically administered oseltamivir is the preferred treatment for"/>
   <result pre="patients and the risk of bronchospasm in patients with underlying" exact="lung disease." post="Studies indicate that oseltamivir administered orally or via oro/naso-gastric"/>
   <result pre="not provide additional clinical benefit in obese adults, including extreme" exact="obesity" post="(BMI &amp;gt; 40) [93, 94]. Duration of therapy can be"/>
   <result pre="Duration of therapy can be difficult to define, as prolonged" exact="influenza" post="viral replication and shedding from the both upper and"/>
   <result pre="also help reduce the pro-inflammatory dysregulated cytokine response triggered by" exact="influenza" post="virus infection and reduce nosocomial influenza virus transmission to"/>
   <result pre="cytokine response triggered by influenza virus infection and reduce nosocomial" exact="influenza" post="virus transmission to healthcare personnel in the ICU. Consultation"/>
   <result pre="should be considered for ICU patients with evidence of persistent" exact="influenza" post="viral replication after NAI treatment, particularly in severely immunocompromised"/>
   <result pre="enteric oseltamivir [101]. Notably, a randomized trial conducted in three" exact="influenza" post="seasons found similar clinical outcomes between IV peramivir and"/>
   <result pre="outcomes between IV peramivir and enteric oseltamivir in hospitalized adult" exact="influenza" post="patients [102]; a separate trial did not identify significant"/>
   <result pre="clinical benefit between enteric oseltamivir and intravenous peramivir in hospitalized" exact="influenza" post="patients [104]. In 2018, a novel antiviral agent, baloxavir"/>
   <result pre="agent, baloxavir marboxil, was FDA-approved for early treatment of uncomplicated" exact="influenza" post="in outpatients aged ≥ 12 years old. Baloxavir acts via inhibition"/>
   <result pre="outpatients aged ≥ 12 years old. Baloxavir acts via inhibition of the" exact="influenza" post="virus cap-dependent endonuclease, a different mechanism than the neuraminidase"/>
   <result pre="different mechanism than the neuraminidase inhibitors, and can treat NAI-resistant" exact="influenza" post="virus infections. Randomized controlled trials of single-dose oral baloxavir"/>
   <result pre="or in combination with an NAI for treatment of hospitalized" exact="influenza" post="patients is unclear. Specifically, optimal dosing, duration of therapy,"/>
   <result pre="have yet to be determined for baloxavir treatment of hospitalized" exact="influenza" post="patients. In the outpatient RCT, patients treated with single-dose"/>
   <result pre="RCT, patients treated with single-dose baloxavir showed significant reduction in" exact="influenza" post="viral levels in the upper respiratory tract at 24 h"/>
   <result pre="oseltamivir [105]. However, it is unknown whether this reduction in" exact="influenza" post="viral shedding correlates with reduced transmissibility. A potential concern"/>
   <result pre="baloxavir in combination with oseltamivir versus oseltamivir monotherapy in hospitalized" exact="influenza" post="patients is currently enrolling participants [107]. There are no"/>
   <result pre="no completed randomized clinical trials of adjunctive corticosteroid treatment in" exact="influenza" post="patients. A trial of corticosteroid therapy was planned during"/>
   <result pre="tripled the risk of developing critical illness or death from" exact="influenza" post="A(H1N1)pdm09 virus infection [109]. A re-analysis of prospectively collected"/>
   <result pre="infection [109]. A re-analysis of prospectively collected data on 1846" exact="influenza" post="patients admitted with primary influenza pneumonia to 148 ICUs"/>
   <result pre="prospectively collected data on 1846 influenza patients admitted with primary" exact="influenza" post="pneumonia to 148 ICUs in Spain during 2009–2014 using"/>
   <result pre="collected data on 1846 influenza patients admitted with primary influenza" exact="pneumonia" post="to 148 ICUs in Spain during 2009–2014 using propensity"/>
   <result pre="observational studies have concluded that that corticosteroid treatment of hospitalized" exact="influenza" post="patients does not result in better outcomes and may"/>
   <result pre="have also reported potential association between corticosteroid treatment and adverse" exact="influenza" post="outcomes [30, 114, 115]. A recent Cochrane review of"/>
   <result pre="suggested increased mortality when adjunctive corticosteroid therapy is used for" exact="influenza" post="patients; however, the available evidence was of low quality"/>
   <result pre="studies have reported that corticosteroid treatment is associated with prolonged" exact="influenza" post="viral shedding in hospitalized patients [117–119], including in sporadic"/>
   <result pre="in hospitalized patients [117–119], including in sporadic human infections with" exact="avian influenza" post="A(H7N9) virus in China [120], and increased rates of"/>
   <result pre="hospitalized patients [117–119], including in sporadic human infections with avian" exact="influenza" post="A(H7N9) virus in China [120], and increased rates of"/>
   <result pre="not well understood. One observational study of hospitalized patients with" exact="viral pneumonia" post="due to avian influenza A(H7N9) virus infection in China"/>
   <result pre="well understood. One observational study of hospitalized patients with viral" exact="pneumonia" post="due to avian influenza A(H7N9) virus infection in China"/>
   <result pre="observational study of hospitalized patients with viral pneumonia due to" exact="avian influenza" post="A(H7N9) virus infection in China reported that high-dose, but"/>
   <result pre="study of hospitalized patients with viral pneumonia due to avian" exact="influenza" post="A(H7N9) virus infection in China reported that high-dose, but"/>
   <result pre="unless clinically indicated for another reason, such as treatment of" exact="asthma" post="or COPD exacerbation or septic shock [49]. Further studies"/>
   <result pre="benefit or harms associated with corticosteroid treatment of critically ill" exact="influenza" post="patients. Although neuraminidase inhibitors (oseltamivir) are currently recommended for"/>
   <result pre="neuraminidase inhibitors (oseltamivir) are currently recommended for antiviral treatment of" exact="influenza" post="in hospitalized patients based on observational studies, including in"/>
   <result pre="are a number of novel strategies and products for treating" exact="influenza" post="in various stages of development. One approach under investigation"/>
   <result pre="therapy, which combines amantadine, ribavirin, and oseltamivir for treatment of" exact="influenza" post="in critically ill and high-risk patients. Unfortunately, studies to"/>
   <result pre="of monoclonal and polyclonal antibodies, targeted against a variety of" exact="influenza" post="viral proteins, are also in development [130–133]. Similarly, convalescent"/>
   <result pre="interest is the modification of the host antiviral response to" exact="influenza" post="virus infection. There are ongoing preclinical and clinical studies"/>
   <result pre="at risk for severe complications of influenza. A diagnosis of" exact="influenza" post="should be considered in critically ill patients admitted with"/>
   <result pre="such as exacerbation of underlying chronic comorbidities, community-acquired pneumonia, and" exact="respiratory failure" post="during influenza season. Influenza molecular assays are recommended for"/>
   <result pre="of underlying chronic comorbidities, community-acquired pneumonia, and respiratory failure during" exact="influenza" post="season. Influenza molecular assays are recommended for testing upper"/>
   <result pre="ill patients with lower respiratory tract disease may have cleared" exact="influenza" post="virus in the upper respiratory tract, but have prolonged"/>
   <result pre="influenza virus in the upper respiratory tract, but have prolonged" exact="influenza" post="viral replication in the lower respiratory tract, an endotracheal"/>
   <result pre="is recommended as soon as possible for patients with suspected" exact="influenza" post="without waiting for testing results. Corticosteroids should not be"/>
   <result pre="results. Corticosteroids should not be routinely administered for treatment of" exact="influenza" post="and should only be given for other indications (e.g.,"/>
   <result pre="should only be given for other indications (e.g., exacerbation of" exact="asthma" post="or chronic obstructive pulmonary disease, or septic shock), because"/>
   <result pre="be given for other indications (e.g., exacerbation of asthma or" exact="chronic obstructive pulmonary disease," post="or septic shock), because of the risk for prolongation"/>
   <result pre="or septic shock), because of the risk for prolongation of" exact="influenza" post="viral shedding and ventilator-associated pneumonia in critically ill influenza"/>
   <result pre="the risk for prolongation of influenza viral shedding and ventilator-associated" exact="pneumonia" post="in critically ill influenza patients with respiratory failure. Future"/>
   <result pre="of influenza viral shedding and ventilator-associated pneumonia in critically ill" exact="influenza" post="patients with respiratory failure. Future directions for treatment of"/>
   <result pre="shedding and ventilator-associated pneumonia in critically ill influenza patients with" exact="respiratory failure." post="Future directions for treatment of influenza in critically ill"/>
   <result pre="influenza patients with respiratory failure. Future directions for treatment of" exact="influenza" post="in critically ill patients include novel antiviral compounds, combination"/>
   <result pre="the U.S. CDC’s Advisory Committee on Immunization Practices recommendations for" exact="influenza" post="vaccination. This may also apply to indigenous people from"/>
   <result pre="and institutional affiliations. References References 1.JacksonMLPhillipsCHBenoitJet al.Burden of medically attended" exact="influenza" post="infection and cases averted by vaccination - United States,"/>
   <result pre="cases averted by vaccination - United States, 2013/14 through 2015/16" exact="influenza" post="seasonsVaccine201836446747210.1016/j.vaccine.2017.12.01429249545 2.IulianoADRoguskiKMChangHHet al.Estimates of global seasonal influenza-associated respiratory mortality:"/>
   <result pre="and subtropics - when to vaccinate?PLoS One2016114e015300310.1371/journal.pone.015300327119988 5.TinocoYOAzziz-BaumgartnerEUyekiTMet al.Burden of" exact="influenza" post="in 4 ecologically distinct regions of Peru: household active"/>
   <result pre="of a community cohort, 2009-2015Clin Infect Dis20176591532154110.1093/cid/cix56529020267 6.YangWCummingsMJBakamutumahoBet al.Dynamics of" exact="influenza" post="in tropical Africa: temperature, humidity, and co-circulating (sub)typesInfluenza Other"/>
   <result pre="and co-circulating (sub)typesInfluenza Other Respir Viruses201812444645610.1111/irv.1255629573157 7.TokarsJIOlsenSJReedCSeasonal incidence of symptomatic" exact="influenza" post="in the United StatesClin Infect Dis201866101511151810.1093/cid/cix106029206909 8.Centers for Disease"/>
   <result pre="Available at: https://www.cdc.gov/flu/about/burden/index.html. Accessed 24 Apr 2019. 9.ReedCChavesSSDaily KirleyPet al.Estimating" exact="influenza" post="disease burden from population-based surveillance data in the United"/>
   <result pre="in the United StatesPLoS One2015103e011836910.1371/journal.pone.011836925738736 10.GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the advisory committee on immunization"/>
   <result pre="recommendations of the advisory committee on immunization practices-United States, 2018-19" exact="influenza" post="seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and influenza associated hospitalization"/>
   <result pre="on immunization practices-United States, 2018-19 influenza seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess" exact="pneumonia" post="and influenza associated hospitalization during influenza epidemics in the"/>
   <result pre="practices-United States, 2018-19 influenza seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and" exact="influenza" post="associated hospitalization during influenza epidemics in the United States,"/>
   <result pre="seasonMMWR Recomm Rep201867312010.15585/mmwr.rr6703a130141464 11.BarkerWHExcess pneumonia and influenza associated hospitalization during" exact="influenza" post="epidemics in the United States, 1970-78Am J Public Health198676776176510.2105/AJPH.76.7.7613717461"/>
   <result pre="States, 1970-78Am J Public Health198676776176510.2105/AJPH.76.7.7613717461 12.BarkerWHMulloolyJPImpact of epidemic type A" exact="influenza" post="in a defined adult populationAm J Epidemiol1980112679881110.1093/oxfordjournals.aje.a1130527457471 13.PoehlingKAEdwardsKMGriffinMRet al.The"/>
   <result pre="a defined adult populationAm J Epidemiol1980112679881110.1093/oxfordjournals.aje.a1130527457471 13.PoehlingKAEdwardsKMGriffinMRet al.The burden of" exact="influenza" post="in young children, 2004-2009Pediatrics2013131220721610.1542/peds.2012-125523296444 14.PoehlingKAEdwardsKMWeinbergGAet al.The underrecognized burden of"/>
   <result pre="influenza in young children, 2004-2009Pediatrics2013131220721610.1542/peds.2012-125523296444 14.PoehlingKAEdwardsKMWeinbergGAet al.The underrecognized burden of" exact="influenza" post="in young childrenN Engl J Med20063551314010.1056/NEJMoa05486916822994 15.SistonAMRasmussenSAHoneinMAet al.Pandemic 2009"/>
   <result pre="influenza in young childrenN Engl J Med20063551314010.1056/NEJMoa05486916822994 15.SistonAMRasmussenSAHoneinMAet al.Pandemic 2009" exact="influenza" post="A(H1N1) virus illness among pregnant women in the United"/>
   <result pre="StatesJAMA2010303151517152510.1001/jama.2010.47920407061 16.MertzDGeraciJWinkupJGessnerBDOrtizJRLoebMPregnancy as a risk factor for severe outcomes from" exact="influenza" post="virus infection: a systematic review and meta-analysis of observational"/>
   <result pre="and meta-analysis of observational studiesVaccine201735452152810.1016/j.vaccine.2016.12.01228024955 17.LouieJKAcostaMJamiesonDJHoneinMAcollab: Group CPHNWSevere 2009 H1N1" exact="influenza" post="in pregnant and postpartum women in CaliforniaN Engl J"/>
   <result pre="and postpartum women in CaliforniaN Engl J Med20103621273510.1056/NEJMoa091044420032319 18.LouieJKJamiesonDJRasmussenSA2009 Pandemic" exact="influenza" post="a (H1N1) virus infection in postpartum women in CaliforniaAm"/>
   <result pre="among adultsVaccine200725584685510.1016/j.vaccine.2006.09.04117074423 22.MertzDKimTHJohnstoneJet al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysisBMJ2013347f506110.1136/bmj.f506123974637 23.Van KerkhoveMDVandemaeleKAShindeVet al.Risk factors"/>
   <result pre="meta-analysisBMJ2013347f506110.1136/bmj.f506123974637 23.Van KerkhoveMDVandemaeleKAShindeVet al.Risk factors for severe outcomes following 2009" exact="influenza" post="A (H1N1) infection: a global pooled analysisPLoS Med201187e100105310.1371/journal.pmed.100105321750667 24.RelloJRodriguezAIbanezPet"/>
   <result pre="pooled analysisPLoS Med201187e100105310.1371/journal.pmed.100105321750667 24.RelloJRodriguezAIbanezPet al.Intensive care adult patients with severe" exact="respiratory failure" post="caused by influenza A (H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet"/>
   <result pre="al.Intensive care adult patients with severe respiratory failure caused by" exact="influenza" post="A (H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet al.Critical illness from"/>
   <result pre="(H1N1)v in SpainCrit Care2009135R14810.1186/cc804419747383 25.RiceTWRubinsonLUyekiTMet al.Critical illness from 2009 pandemic" exact="influenza" post="A virus and bacterial coinfection in the United StatesCrit"/>
   <result pre="StatesCrit Care Med20124051487149810.1097/CCM.0b013e3182416f2322511131 26.WebbSAPettiläVSeppeltIet al.Critical care services and 2009 H1N1" exact="influenza" post="in Australia and New ZealandN Engl J Med2009361201925193410.1056/NEJMoa090848119815860 27.Domínguez-CheritGLapinskySEMaciasAEet"/>
   <result pre="ZealandN Engl J Med2009361201925193410.1056/NEJMoa090848119815860 27.Domínguez-CheritGLapinskySEMaciasAEet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) in MexicoJAMA2009302171880188710.1001/jama.2009.153619822626 28.KumarAZarychanskiRPintoRet al.Critically ill patients with 2009"/>
   <result pre="influenza A(H1N1) in MexicoJAMA2009302171880188710.1001/jama.2009.153619822626 28.KumarAZarychanskiRPintoRet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) infection in CanadaJAMA2009302171872187910.1001/jama.2009.149619822627 29.MincholeEFigueredoALOmeñacaMet al.Seasonal influenza a H1N1pdm09"/>
   <result pre="patients with 2009 influenza A(H1N1) infection in CanadaJAMA2009302171872187910.1001/jama.2009.149619822627 29.MincholeEFigueredoALOmeñacaMet al.Seasonal" exact="influenza" post="a H1N1pdm09 virus and severe outcomes: a reason for"/>
   <result pre="People PLoS One20161111e016571110.1371/journal.pone.016571127832114 30.RandolphAGVaughnFSullivanRet al.Critically ill children during the 2009-2010" exact="influenza" post="pandemic in the United StatesPediatrics20111286e1450e145810.1542/peds.2011-077422065262 31.ShiehWJBlauDMDenisonAMet al.2009 pandemic influenza"/>
   <result pre="2009-2010 influenza pandemic in the United StatesPediatrics20111286e1450e145810.1542/peds.2011-077422065262 31.ShiehWJBlauDMDenisonAMet al.2009 pandemic" exact="influenza" post="A (H1N1): pathology and pathogenesis of 100 fatal cases"/>
   <result pre="and treatment-related risk factors for mortality among immunosuppressed patients with" exact="influenza" post="A (H1N1) virus admitted to the intensive care unitJ"/>
   <result pre="al.Complications among adults hospitalized with influenza: a comparison of seasonal" exact="influenza" post="and the 2009 H1N1 pandemicClin Infect Dis201459216617410.1093/cid/ciu28524785230 36.AyscuePMurrayEUyekiTet al.Influenza-associated"/>
   <result pre="2014MMWR Morb Mortal Wkly Rep201463714314724553197 37.ChavesSSAragonDBennettNet al.Patients hospitalized with laboratory-confirmed" exact="influenza" post="during the 2010-2011 influenza season: exploring disease severity by"/>
   <result pre="Rep201463714314724553197 37.ChavesSSAragonDBennettNet al.Patients hospitalized with laboratory-confirmed influenza during the 2010-2011" exact="influenza" post="season: exploring disease severity by virus type and subtypeJ"/>
   <result pre="in children, FluSurv-NET, 2011–2017Open Forum Infectious Dis20185suppl_1S748S7S910.1093/ofid/ofy210.2146 39.CasadoIDomínguezAToledoDet al.Effect of" exact="influenza" post="vaccination on the prognosis of hospitalized influenza patientsExpert Rev"/>
   <result pre="39.CasadoIDomínguezAToledoDet al.Effect of influenza vaccination on the prognosis of hospitalized" exact="influenza" post="patientsExpert Rev Vaccines201615342543210.1586/14760584.2016.113432826690376 40.ArriolaCGargSAndersonEJet al.Influenza vaccination modifies disease severity"/>
   <result pre="among community-dwelling adults hospitalized with influenzaClin Infect Dis20176581289129710.1093/cid/cix46828525597 41.ArriolaCSAndersonEJBaumbachJet al.Does" exact="influenza" post="vaccination modify influenza severity? Data on older adults hospitalized"/>
   <result pre="hospitalized with influenzaClin Infect Dis20176581289129710.1093/cid/cix46828525597 41.ArriolaCSAndersonEJBaumbachJet al.Does influenza vaccination modify" exact="influenza" post="severity? Data on older adults hospitalized with influenza during"/>
   <result pre="vaccination modify influenza severity? Data on older adults hospitalized with" exact="influenza" post="during the 2012-2013 season in the United StatesJ Infect"/>
   <result pre="Catalonia. Influenza vaccine effectiveness in reducing severe outcomes over six" exact="influenza" post="seasons, a case-case analysis, Spain, 2010/11 to 2015/16. Euro"/>
   <result pre="2018;23(43). 10.2807/1560-7917.ES.2018.23.43.1700732. 45.CataniaJQueLGGovertJAHollingsworthJWWolfeCRHigh intensive care unit admission rate for 2013-2014" exact="influenza" post="is associated with a low rate of vaccinationAm J"/>
   <result pre="vaccinationAm J Respir Crit Care Med2014189448548710.1164/rccm.201401-0066LE24512430 46.TaylorGAbdesselamKPeludeLet al.Epidemiological features of" exact="influenza" post="in Canadian adult intensive care unit patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet"/>
   <result pre="Canadian adult intensive care unit patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet al.Effectiveness of" exact="influenza" post="vaccine against life-threatening RT-PCR-confirmed influenza illness in US children,"/>
   <result pre="patientsEpidemiol Infect2016144474175010.1017/S095026881500211326384310 47.FerdinandsJMOlshoLEAganAAet al.Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed" exact="influenza" post="illness in US children, 2010-2012J Infect Dis2014210567468310.1093/infdis/jiu18524676207 48.FlanneryBrendanReynoldsSue B.BlantonLeneeSantibanezTammy"/>
   <result pre="frequently present as the infecting agent in acute exacerbations of" exact="chronic obstructive pulmonary disease" post="in patients presenting to hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in"/>
   <result pre="in patients presenting to hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in severe" exact="asthma" post="exacerbations and critical asthma syndromeClin Rev Allergy Immunol201548110411310.1007/s12016-014-8435-x24984968 52.PanhwarMuhammad"/>
   <result pre="hospitalIntern Med J201646101160116510.1111/imj.1321327515577 51.SandrockCENorrisAInfection in severe asthma exacerbations and critical" exact="asthma" post="syndromeClin Rev Allergy Immunol201548110411310.1007/s12016-014-8435-x24984968 52.PanhwarMuhammad S.KalraAnkurGuptaTanushKolteDhavalKheraSahilBhattDeepak L.GinwallaMahazarinEffect of Influenza"/>
   <result pre="burden of influenza: a review of the extra-pulmonary complications of" exact="influenza" post="infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014 54.Alvarez-LermaFMarin-CorralJVilaCet al.Delay in diagnosis of"/>
   <result pre="influenza infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014 54.Alvarez-LermaFMarin-CorralJVilaCet al.Delay in diagnosis of" exact="influenza" post="A (H1N1)pdm09 virus infection in critically ill patients and"/>
   <result pre="58.MerckxJWaliRSchillerIet al.Diagnostic accuracy of novel and traditional rapid tests for" exact="influenza" post="infection compared with reverse transcriptase polymerase chain reaction: a"/>
   <result pre="review and meta-analysisAnn Intern Med2017167639440910.7326/M17-084828869986 59.BlythCCIredellJRDwyerDERapid-test sensitivity for novel swine-origin" exact="influenza" post="A (H1N1) virus in humansN Engl J Med200936125249310.1056/NEJMc090904919923563 60.Vos"/>
   <result pre="molecular assays, RT-PCR, and other molecular assays for diagnosis of" exact="influenza" post="virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm. Accessed 24 Apr 2019."/>
   <result pre="virus infection. Available at: https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm. Accessed 24 Apr 2019. 62.UyekiTMKatzJMJerniganDBNovel" exact="influenza" post="A viruses and pandemic threatsLancet2017389100852172217410.1016/S0140-6736(17)31274-628589883 63.UyekiTMInfluenzaAnn Intern Med20171675ITC33ITC4810.7326/AITC20170905028869984 64.Centers"/>
   <result pre="Available at: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm. Accessed 24 Apr 2019. 65.DobsonJWhitleyRJPocockSMontoASOseltamivir treatment for" exact="influenza" post="in adults: a meta-analysis of randomised controlled trialsLancet201538599791729173710.1016/S0140-6736(14)62449-125640810 66.MaloshREMartinETHeikkinenTBrooksWAWhitleyRJMontoASEfficacy"/>
   <result pre="early treatment with oseltamivir in hospitalized patients with documented 2009" exact="influenza" post="A (H1N1): retrospective cohort studyJ Antimicrob Chemother20116651150510.1093/jac/dkr08921393197 68.CoffinSELeckermanKKerenRHallMLocalioRZaoutisTEOseltamivir shortens"/>
   <result pre="treatment on outcomes of public health importance during the 2009-2010" exact="influenza" post="a(H1N1) pandemic: a systematic review and meta-analysis in hospitalized"/>
   <result pre="inhibitors in reducing mortality in patients admitted to hospital with" exact="influenza" post="A H1N1pdm09 virus infection: a meta-analysis of individual participant"/>
   <result pre="al.Effectiveness of antiviral treatment in preventing death in severe hospitalised" exact="influenza" post="cases over six seasonsEpidemiol Infect2018146779980810.1017/S095026881800066329606178 74.RodriguezADiazEMartin-LoechesIet al.Impact of early"/>
   <result pre="treatment on outcome in critically ill patients with 2009 pandemic" exact="influenza" post="AJ Antimicrob Chemother20116651140114910.1093/jac/dkq51121385717 75.DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors"/>
   <result pre="AJ Antimicrob Chemother20116651140114910.1093/jac/dkq51121385717 75.DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors for" exact="influenza" post="treatment, prophylaxis, and outbreak control: a systematic review of"/>
   <result pre="77.LouieJKYangSAcostaMet al.Treatment with neuraminidase inhibitors for critically ill patients with" exact="influenza" post="A (H1N1)pdm09Clin Infect Dis20125591198120410.1093/cid/cis63622843781 78.Lytras T, Mouratidou E, Andreopoulou"/>
   <result pre="intervention study on higher-dose oseltamivir treatment in adults hospitalized with" exact="influenza" post="a and B infectionsClin Infect Dis201357111511151910.1093/cid/cit59724046309 89.NoelZRBastinMLTMontgomeryAAFlanneryAHComparison of high-dose"/>
   <result pre="randomized study of standard versus double dose oseltamivir for treating" exact="influenza" post="in the communityAntivir Ther201520768969810.3851/IMP280724912485 93.PaiMPLodiseTPJrOseltamivir and oseltamivir carboxylate pharmacokinetics"/>
   <result pre="is not necessaryAntimicrob Agents Chemother201155125640564510.1128/AAC.00422-1121930881 94.Thorne-HumphreyLMGoralskiKBSlayterKLet al.Oseltamivir pharmacokinetics in morbid" exact="obesity" post="(OPTIMO trial)J Antimicrob Chemother20116692083209110.1093/jac/dkr25721700623 95.collab: To KKHungIFLiIWet al.Delayed clearance"/>
   <result pre="marked cytokine activation in severe cases of pandemic H1N1 2009" exact="influenza" post="virus infectionClin Infect Dis201050685085910.1086/65058120136415 96.LeeNChanPKWongCKet al.Viral clearance and inflammatory"/>
   <result pre="and inflammatory response patterns in adults hospitalized for pandemic 2009" exact="influenza" post="A(H1N1) virus pneumoniaAntivir Ther201116223724710.3851/IMP172221447873 97.IsonMGde JongMDGilliganKJet al.End points for"/>
   <result pre="A(H1N1) virus pneumoniaAntivir Ther201116223724710.3851/IMP172221447873 97.IsonMGde JongMDGilliganKJet al.End points for testing" exact="influenza" post="antiviral treatments for patients at high risk of severe"/>
   <result pre="two placebo-controlled trialsAntivir Ther201520770971910.3851/IMP287425318121 100.IsonMGFraizJHellerBet al.Intravenous peramivir for treatment of" exact="influenza" post="in hospitalized patientsAntivir Ther201419434936110.3851/IMP268023985625 101.LeeJParkJHJwaHKimYHComparison of efficacy of intravenous"/>
   <result pre="peramivir compared with oral oseltamivir for the treatment of seasonal" exact="influenza" post="in hospitalized adultsAntivir Ther201318565166110.3851/IMP244223111657 103.de JongMDIsonMGMontoASet al.Evaluation of intravenous"/>
   <result pre="Ther201318565166110.3851/IMP244223111657 103.de JongMDIsonMGMontoASet al.Evaluation of intravenous peramivir for treatment of" exact="influenza" post="in hospitalized patientsClin Infect Dis20145912e172e18510.1093/cid/ciu63225115871 104.NakamuraSMiyazakiTIzumikawaKet al.Efficacy and safety"/>
   <result pre="intravenous peramivir compared with oseltamivir in high-risk patients infected with" exact="influenza" post="A and B viruses: a multicenter randomized controlled studyOpen"/>
   <result pre="controlled studyOpen Forum Infect Dis201743ofx12910.1093/ofid/ofx12928761899 105.HaydenFGSugayaNHirotsuNet al.Baloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescentsN Engl J Med20183791091392310.1056/NEJMoa171619730184455 106.OmotoSSperanziniVHashimotoTet al.Characterization"/>
   <result pre="in adults and adolescentsN Engl J Med20183791091392310.1056/NEJMoa171619730184455 106.OmotoSSperanziniVHashimotoTet al.Characterization of" exact="influenza" post="virus variants induced by treatment with the endonuclease inhibitor"/>
   <result pre="a randomized trial for pandemic critical illness: the 2009 H1N1" exact="influenza" post="pandemicIntensive Care Med2012381293910.1007/s00134-011-2409-822120766 109.HanKMaHAnXet al.Early use of glucocorticoids was"/>
   <result pre="Dis201153432633310.1093/cid/cir39821810744 110.MorenoGRodriguezAReyesLFet al.Corticosteroid treatment in critically ill patients with severe" exact="influenza" post="pneumonia: a propensity score matching studyIntensive Care Med20184491470148210.1007/s00134-018-5332-430074052 111.RodrigoCLeonardi-BeeJNguyen-Van-TamJSLimWSEffect"/>
   <result pre="Dis2015212218319410.1093/infdis/jiu64525406333 112.YangJWFanLCMiaoXYet al.Corticosteroids for the treatment of human infection with" exact="influenza" post="virus: a systematic review and meta-analysisClin Microbiol Infect2015211095696310.1016/j.cmi.2015.06.02226123860 113.NiYNChenGSunJLiangBMLiangZAThe"/>
   <result pre="Infect2015211095696310.1016/j.cmi.2015.06.02226123860 113.NiYNChenGSunJLiangBMLiangZAThe effect of corticosteroids on mortality of patients with" exact="influenza" post="pneumonia: a systematic review and meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group"/>
   <result pre="review and meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group R-SAHNvREarly corticosteroids in severe" exact="influenza" post="a/H1N1 pneumonia and acute respiratory distress syndromeAm J Respir"/>
   <result pre="meta-analysisCrit Care20192319910.1186/s13054-019-2395-830917856 114.Brun-BuissonCRichardJCMercatAThiebautACBrochardLcollab: Group R-SAHNvREarly corticosteroids in severe influenza a/H1N1" exact="pneumonia" post="and acute respiratory distress syndromeAm J Respir Crit Care"/>
   <result pre="Med201118391200120610.1164/rccm.201101-0135OC21471082 115.KimSHHongSBYunSCet al.Corticosteroid treatment in critically ill patients with pandemic" exact="influenza" post="A/H1N1 2009 infection: analytic strategy using propensity scoresAm J"/>
   <result pre="Database Syst Rev20192CD01040630798570 117.LeeNCockramCSChanPKHuiDSChoiKWSungJJAntiviral treatment for patients hospitalized with severe" exact="influenza" post="infection may affect clinical outcomesClin Infect Dis20084681323132410.1086/53347718444878 118.GiannellaMAlonsoMGarcia de"/>
   <result pre="Infect Dis20084681323132410.1086/53347718444878 118.GiannellaMAlonsoMGarcia de ViedmaDet al.Prolonged viral shedding in pandemic" exact="influenza" post="a(H1N1): clinical significance and viral load analysis in hospitalized"/>
   <result pre="120.WangYGuoQYanZet al.Factors associated with prolonged viral shedding in patients with" exact="avian influenza" post="A(H7N9) virus infectionJ Infect Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection"/>
   <result pre="al.Factors associated with prolonged viral shedding in patients with avian" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection"/>
   <result pre="Dis2018217111708171710.1093/infdis/jiy11529648602 121.LeeNLeoYSCaoBet al.Neuraminidase inhibitors, superinfection and corticosteroids affect survival of" exact="influenza" post="patientsEur Respir J20154561642165210.1183/09031936.0016971425573405 122.Martin-LoechesILisboaTRhodesAet al.Use of early corticosteroid therapy"/>
   <result pre="on ICU admission in patients affected by severe pandemic (H1N1)v" exact="influenza" post="A infectionIntensive Care Med201137227228310.1007/s00134-010-2078-z21107529 123.DelaneyJWPintoRLongJet al.The influence of corticosteroid"/>
   <result pre="123.DelaneyJWPintoRLongJet al.The influence of corticosteroid treatment on the outcome of" exact="influenza" post="A(H1N1pdm09)-related critical illnessCrit Care2016207510.1186/s13054-016-1230-827036638 124.CaoBGaoHZhouBet al.Adjuvant corticosteroid treatment in"/>
   <result pre="critical illnessCrit Care2016207510.1186/s13054-016-1230-827036638 124.CaoBGaoHZhouBet al.Adjuvant corticosteroid treatment in adults with" exact="influenza" post="A (H7N9) viral pneumoniaCrit Care Med2016446e318e32810.1097/CCM.000000000000161626934144 125.BeigelJHBaoYBeelerJet al.Oseltamivir, amantadine,"/>
   <result pre="Dis201717121255126510.1016/S1473-3099(17)30476-028958678 126.SeoSEnglundJANguyenJTet al.Combination therapy with amantadine, oseltamivir and ribavirin for" exact="influenza" post="A infection: safety and pharmacokineticsAntivir Ther201318337738610.3851/IMP247523264438 127.KimWYYoung SuhGHuhJWet al.Triple-combination"/>
   <result pre="pharmacokineticsAntivir Ther201318337738610.3851/IMP247523264438 127.KimWYYoung SuhGHuhJWet al.Triple-combination antiviral drug for pandemic H1N1" exact="influenza" post="virus infection in critically ill patients on mechanical ventilationAntimicrob"/>
   <result pre="efficacy and safety study of favipiravir for treatment of uncomplicated" exact="influenza" post="in adults - T705US316. ClinicalTrialsgov [Internet]. November 11, 2015"/>
   <result pre="Oseltamivir (Tamiflu®) compared with Oseltamivir alone in hospitalized adults with" exact="influenza" post="a infection requiring oxygen support. ClinicalTrialsgov [internet]. August 28,"/>
   <result pre="in combination with oseltamivir versus oseltamivir in participants with severe" exact="influenza" post="a infection. ClinicalTrialsgov [internet]. June 18, 2018 ed2018BethesdaNational Library"/>
   <result pre="al.Convalescent plasma treatment reduced mortality in patients with severe pandemic" exact="influenza" post="A (H1N1) 2009 virus infectionClin Infect Dis201152444745610.1093/cid/ciq10621248066 136.HungIFNcollab: To"/>
   <result pre="multicenter double-blind randomized controlled trial for patients with severe 2009" exact="influenza" post="A(H1N1) infectionChest2013144246447310.1378/chest.12-290723450336 137.HungIA randomized controlled trial on the treatment"/>
   <result pre="infectionChest2013144246447310.1378/chest.12-290723450336 137.HungIA randomized controlled trial on the treatment of severe" exact="influenza" post="a infection. ClinicalTrialsgov [internet]. July 25, 2017 ed2017BethesdaNational Library"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563504\results\search\disease\results.xml">
   <result pre="human and animal health worldwide. Understanding the control mechanisms of" exact="influenza" post="infection and dynamics is crucial and could result in"/>
   <result pre="a new approach to understanding the overall structure of twelve" exact="influenza" post="A virus infection models and their relationship to each"/>
   <result pre="helpful in model development and model integration, also beyond the" exact="influenza" post="area. chemical organization theory influenza A virus dynamics modeling"/>
   <result pre="model integration, also beyond the influenza area. chemical organization theory" exact="influenza" post="A virus dynamics modeling complex networks analysis 1. Introduction"/>
   <result pre="modeling complex networks analysis 1. Introduction Influenza is an infectious" exact="respiratory disease," post="annually infecting 5–15% of the human population and causing"/>
   <result pre="of epidemics is caused by the continuous alteration of seasonal" exact="influenza" post="viruses, which enables them to efficiently escape the immune"/>
   <result pre="major burden of disease in humans is caused by seasonal" exact="influenza" post="A (IAV) and influenza B viruses, causing symptoms varying"/>
   <result pre="in humans is caused by seasonal influenza A (IAV) and" exact="influenza" post="B viruses, causing symptoms varying from mild respiratory disease"/>
   <result pre="(IAV) and influenza B viruses, causing symptoms varying from mild" exact="respiratory disease" post="characterized by fever, sore throat, headache and muscle pain"/>
   <result pre="and muscle pain to severe and in some cases lethal" exact="pneumonia" post="and secondary bacterial infections [3]. The long-term spread of"/>
   <result pre="pneumonia and secondary bacterial infections [3]. The long-term spread of" exact="influenza" post="viruses in the human population and the acute nature"/>
   <result pre="viruses in the human population and the acute nature of" exact="influenza" post="virus epidemics is driven by the global movement of"/>
   <result pre="movement of these viruses. Differences in seasonal epidemics caused by" exact="influenza" post="viruses are mainly driven by differences in the rates"/>
   <result pre="the rates of virus evolution. The single-stranded RNA segments of" exact="influenza" post="viruses, which are located inside the virus particle (or"/>
   <result pre="have been developed to provide insight into within-host dynamics of" exact="influenza" post="A virus infections (for reviews, see [4,5,6,7,8]). These models"/>
   <result pre="Figure 1. By applying the method to twelve models of" exact="influenza" post="A virus infection, we found different types of model"/>
   <result pre="illustrate our method, we follow a basic ODE model of" exact="influenza" post="dynamics, namely the target cell limited model by Baccam"/>
   <result pre="The organization O 2 B represents an organism without any" exact="influenza" post="A virus infection. Note that there is no organization"/>
   <result pre="present now the full analysis for eleven additional more detailed" exact="influenza" post="models of IAV dynamics, with up to 15 variables"/>
   <result pre="References References 1.StöhrK.Influenza—WHO caresLancet Infect. Dis.2002251710.1016/S1473-3099(02)00366-312206966 2.PetrovaV.N.RussellC.A.The evolution of seasonal" exact="influenza" post="virusesNat. Rev. Microbiol.201816476010.1038/nrmicro.2017.11829081496 3.KrammerF.SmithG.J.FouchierR.A.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Prim.2018410.1038/s41572-018-0002-y29955068 4.SmithA.M.PerelsonA.S.Influenza"/>
   <result pre="Rev. Syst. Biol. Med.2011342944510.1002/wsbm.12921197654 5.BeaucheminC.A.HandelA.A review of mathematical models of" exact="influenza" post="A infections within a host or cell culture: Lessons"/>
   <result pre="and challenges aheadBMC Public Health201111Suppl. 1S710.1186/1471-2458-11-S1-S721356136 6.DobrovolnyH.M.ReddyM.B.KamalM.A.RaynerC.R.BeaucheminC.A.Assessing mathematical models of" exact="influenza" post="infections using features of the immune responsePLoS ONE20138e5708810.1371/journal.pone.005708823468916 7.BoianelliA.NguyenV.K.EbensenT.SchulzeK.WilkE.SharmaN.Stegemann-KoniszewskiS.BruderD.ToapantaF.R.GuzmanC.A.et"/>
   <result pre="for Influenza ResearchViruses201575274530410.3390/v710287526473911 8.HandelA.LiaoL.E.BeaucheminC.A.Progress and trends in mathematical modelling of" exact="influenza" post="A virus infectionsCurr. Opin. Syst. Biol.201812303610.1016/j.coisb.2018.08.009 9.LeeH.Y.TophamD.J.ParkS.Y.HollenbaughJ.TreanorJ.MosmannT.R.JinX.WardB.M.MiaoH.Holden-WiltseJ.et al.Simulation and"/>
   <result pre="9.LeeH.Y.TophamD.J.ParkS.Y.HollenbaughJ.TreanorJ.MosmannT.R.JinX.WardB.M.MiaoH.Holden-WiltseJ.et al.Simulation and prediction of the adaptive immune response to" exact="influenza" post="A virus infectionJ. Virol.2009837151716510.1128/JVI.00098-0919439465 10.DittrichP.Speroni di FenizioP.Chemical Organization TheoryBull."/>
   <result pre="Limit Sets in Chemical Reaction SystemsAdv. Complex Syst.201114779610.1142/S0219525911002895 13.BaccamP.BeaucheminC.MackenC.A.HaydenF.G.PerelsonA.S.Kinetics of" exact="influenza" post="A virus infection in humansJ. Virol.2006807590759910.1128/JVI.01623-0516840338 14.MiaoH.HollenbaughJ.A.ZandM.S.Holden-WiltseJ.MosmannT.R.PerelsonA.S.WuH.TophamD.J.Quantifying the early"/>
   <result pre="response and adaptive immune response kinetics in mice infected with" exact="influenza" post="A virusJ. Virol.2010846687669810.1128/JVI.00266-1020410284 15.SmithA.M.SmithA.P.A Critical, Nonlinear Threshold Dictates Bacterial"/>
   <result pre="dependence supports biphasic viral decayFront. Microbiol.20189155410.3389/fmicb.2018.0155430042759 23.PawelekK.A.HuynhG.T.QuinlivanM.CullinaneA.RongL.PerelsonA.S.Modeling within-host dynamics of" exact="influenza" post="virus infection including immune responsesPLoS Comput. Biol.20128e100258810.1371/journal.pcbi.100258822761567 24.HandelA.LonginiI.M.Jr.AntiaR.Towards a"/>
   <result pre="Biol.20128e100258810.1371/journal.pcbi.100258822761567 24.HandelA.LonginiI.M.Jr.AntiaR.Towards a quantitative understanding of the within-host dynamics of" exact="influenza" post="A infectionsJ. R. Soc. Interface20097354710.1098/rsif.2009.006719474085 25.HandelA.LonginiI.M.Jr.AntiaR.Neuraminidase inhibitor resistance in"/>
   <result pre="generation and spreadPLoS Comput. Biol.20073e24010.1371/journal.pcbi.003024018069885 26.Hernandez-VargasA.E.Meyer-HermannM.Innate immune system dynamics to" exact="influenza" post="virusIFAC Proc. Vol.20124526026510.3182/20120829-3-HU-2029.00029 27.CaoP.YanA.W.HeffernanJ.M.PetrieS.MossR.G.CarolanL.A.GuarnacciaT.A.KelsoA.BarrI.G.McVernonJ.et al.Innate Immunity and the Inter-exposure"/>
   <result pre="and Explain Observed Viral HierarchiesPLoS Comput. Biol.201511e100433410.1371/journal.pcbi.100433426284917 28.SaenzR.A.QuinlivanM.EltonD.MacraeS.BlundenA.S.MumfordJ.A.DalyJ.M.DigardP.CullinaneA.GrenfellB.T.et al.Dynamics of" exact="influenza" post="virus infection and pathologyJ. Virol.2010843974398310.1128/JVI.02078-0920130053 29.HanciogluB.SwigonD.ClermontG.A dynamical model of"/>
   <result pre="pathologyJ. Virol.2010843974398310.1128/JVI.02078-0920130053 29.HanciogluB.SwigonD.ClermontG.A dynamical model of human immune response to" exact="influenza" post="A virus infectionJ. Theor. Biol.2007246708610.1016/j.jtbi.2006.12.01517266989 30.BocharovG.A.RomanyukhaA.A.Mathematical model of antiviral"/>
   <result pre="Influenza A virus infectionJ. Theor. Biol.199416732336010.1006/jtbi.1994.10747516024 31.CaoP.McCawJ.The mechanisms for within-host" exact="influenza" post="virus control affect model-based assessment and prediction of antiviral"/>
   <result pre="infected cells ( E P * ) and free infectious" exact="influenza" post="viruses ( V ). Figure 4 The Baccam II"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6563844\results\search\disease\results.xml">
   <result pre="comply with these terms. Abstract The high genetic variability of" exact="influenza" post="A viruses poses a continual challenge to seasonal and"/>
   <result pre="was observed. In addition to identifying dextromethorphan as a potential" exact="influenza" post="treatment option, our study illustrates the feasibility of a"/>
   <result pre="bioinformatics-driven rational approach for repurposing approved drugs against infectious diseases." exact="influenza" post="A virus drug repurposing antiviral (H1N1 and H3N2) activity"/>
   <result pre="glycoproteins. Based on the antigenic properties of these viral glycoproteins," exact="influenza" post="A viruses are classified into different subtypes. To date,"/>
   <result pre="(3, 4). With the exception of bat-associated subtypes (4), all" exact="influenza" post="A virus subtypes can be found in wild aquatic"/>
   <result pre="without causing severe disease (8). Even though the production of" exact="influenza" post="vaccines is well established, and the regulatory process allows"/>
   <result pre="play an important role in reducing disease severity during seasonal" exact="influenza" post="epidemics. Two classes of approved drugs against influenza A"/>
   <result pre="during seasonal influenza epidemics. Two classes of approved drugs against" exact="influenza" post="A virus infections have been available for years: adamantane-based"/>
   <result pre="of widespread use, and at this time, all circulating human" exact="influenza" post="A viruses are adamantane-resistant (12), and the number of"/>
   <result pre="inhibitor, has been licensed in Japan for the treatment of" exact="influenza" post="virus infections (14), and favipiravir, an inhibitor of the"/>
   <result pre="list of promising candidate proteins and pathways involved in the" exact="influenza" post="virus life cycle (18–21). Watanabe et al. previously described"/>
   <result pre="fetal calf serum (FCS), and 1% L-glutamine at 37°C. The" exact="influenza" post="A virus strains H1N1 A/Puerto Rico/8/34 (PR8, (23), H3N2"/>
   <result pre="the experiment was repeated including additional drug concentrations and different" exact="influenza" post="A strains. For the calculation of the 50% effective"/>
   <result pre="(mustela putorius furo, bred in-house) without antibodies against circulating seasonal" exact="influenza" post="A virus strains were treated orally every 8 h"/>
   <result pre="Influenza Virus Life Cycle Whole genome siRNA screens using different" exact="influenza" post="A virus strains and cell lines have yielded a"/>
   <result pre="a list of cellular proteins that are required in the" exact="influenza" post="virus life cycle (22). While it is in most"/>
   <result pre="that modulate their expression levels or activity may also inhibit" exact="influenza" post="virus. Therefore, we computationally searched for FDA-approved drugs annotated"/>
   <result pre="updated host factor network generated by a meta-analysis of available" exact="influenza" post="virus siRNA screen data sets (Figure 1). This bioinformatics"/>
   <result pre="(Table 1). Figure 1 Identification of candidate drugs. Network of" exact="influenza" post="host factors with drug targets highlighted. From the network"/>
   <result pre="DrugBank flat file version 3.0 (27). Table 1 Inhibition of" exact="influenza" post="A virus replication by licensed drugs with Drug ID"/>
   <result pre="Compounds Inhibit Influenza A Virus Replication To identify candidates with" exact="influenza" post="virus inhibitory activity, cells were pre-treated with the respective"/>
   <result pre="of the endosome, which may explain its inhibitory effect on" exact="influenza" post="A viruses (32). Naltrexone, a competitive opioid receptor agonist"/>
   <result pre="6-phosphogluconate dehydrogenase (PGD) in vitro (37), which is upregulated in" exact="influenza" post="A virus-infected cells (38). To determine whether the antiviral"/>
   <result pre="potential candidates extended to circulating seasonal H3N2 and pandemic H1N1" exact="influenza" post="strains, A/Victoria/36/2011 (H3N2), and A/Mexico/InDRE4487/2009 (H1N1pdm09) were included in"/>
   <result pre="cells were pretreated for 8 h and infected with the" exact="influenza" post="strains A/Puerto Rico/8/34 (PR8) (A), A/Mexico/InDRE4487/2009 (H1N1pdm09) (B), or"/>
   <result pre="index (SI) of the different compounds against H1N1 and H3N2" exact="influenza" post="A viruses. PR8 pH1N1 H3N2 CC50 (μM) EC50 (μM)"/>
   <result pre="different strains and even different virus families (16, 45). For" exact="influenza" post="virus, several whole genome siRNA screens have been published"/>
   <result pre="years (18–21), allowing the cross-matching of host proteins required for" exact="influenza" post="replication with known cellular drug targets. Using this approach,"/>
   <result pre="reduction of clinical signs, supporting its further consideration as an" exact="influenza" post="treatment option. High-throughput siRNA screens have opened a new"/>
   <result pre="for drug repurposing (46). This is of special relevance for" exact="infectious disease" post="targets with lesser market potential, as the development of"/>
   <result pre="subject of ongoing studies. Ferrets closely mimic the course of" exact="influenza" post="disease seen in humans (44, 60). Seasonal and pandemic"/>
   <result pre="disease seen in humans (44, 60). Seasonal and pandemic 2009" exact="influenza" post="viruses thus cause a mild to moderate disease of"/>
   <result pre="drugs are frequently used as over the counter remedies for" exact="influenza" post="and influenza-like respiratory infections, a more detailed evaluation of"/>
   <result pre="century. Emerg Infect Dis. (2006) 12:9–14. 10.3201/eid1201.05125416494710 2.OsterhausABrooksABrobergEMacIntyreRCapuaI. Why should" exact="influenza" post="be a public health priority. Vaccine. (2015) 33:7022–5. 10.1016/j.vaccine.2015.08.04926319062"/>
   <result pre="PA: Lippincott Williams &amp;amp; Wilkins (2013). p. 1151–85. 4.MehleA. Unusual" exact="influenza" post="A viruses in bats. Viruses. (2014) 6:3438–49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission"/>
   <result pre="A viruses in bats. Viruses. (2014) 6:3438–49. 10.3390/v609343825256392 5.NeumannGKawaokaYTransmission of" exact="influenza" post="A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic"/>
   <result pre="influenza A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic" exact="avian influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482"/>
   <result pre="A viruses. Virology. (2015) 479–80:234–246. 10.1016/j.virol.2015.03.009 6.KalthoffDGlobigABeerM. Highly pathogenic avian" exact="influenza" post="as a zoonotic agent. Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482"/>
   <result pre="Vet Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from" exact="avian influenza" post="viruses. Avian Dis. (2005) 49:317–27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
   <result pre="Microbiol. (2010) 140:237–45. 10.1016/j.vetmic.2009.08.02219782482 7.PerdueMLSwayneDE. Public health risk from avian" exact="influenza" post="viruses. Avian Dis. (2005) 49:317–27. 10.1637/7390-060305R.116252482 8.WuHWangXXueMXueMWuCLuQet al.. Spatial"/>
   <result pre="al.. Spatial characteristics and the epidemiology of human infections with" exact="avian influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
   <result pre="Spatial characteristics and the epidemiology of human infections with avian" exact="influenza" post="A(H7N9) virus in five waves from 2013 to 2017"/>
   <result pre="Zhejiang Province, China. PLoS One. (2017) 12:e0180763. 10.1371/journal.pone.018076328750032 9.NafzigerANPrattDS. Seasonal" exact="influenza" post="vaccination and technologies. J Clin Pharmacol. (2014) 54:719–31. 10.1002/jcph.29924691877"/>
   <result pre="6:187–98. 10.2147/IDR.S3660124277988 12.DeydeVMXuXBrightRAShawMSmithCBet al.. Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis."/>
   <result pre="10.1086/51893617570112 13.GubarevaLVBesselaarTGDanielsRSFryAGregoryVHuangWet al.. Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2015–2016. Antiviral Res. (2017) 146:12–20."/>
   <result pre="10.1038/nrmicro303623728212 18.BrassALHuangICBenitaYJohnSPKrishnanMNFeeleyEMet al.. The IFITM proteins mediate cellular resistance to" exact="influenza" post="A H1N1 virus, West Nile virus, and dengue virus."/>
   <result pre="al.. Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature. (2010) 463:818–22. 10.1038/nature0876020081832 20.KönigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human"/>
   <result pre="(2010) 463:818–22. 10.1038/nature0876020081832 20.KönigRStertzSZhouYInoueAHoffmannHHBhattacharyyaSet al.. Human host factors required for" exact="influenza" post="virus replication. Nature. (2010) 463:813–7. 10.1038/nature0869920027183 21.ShapiraSDGat-ViksIShumBODricotAde GraceMMWuLet al.."/>
   <result pre="Cell. (2009) 139:1255–67. 10.1016/j.cell.2009.12.01820064372 22.WatanabeTWatanabeSKawaokaY. Cellular networks involved in the" exact="influenza" post="virus life cycle. Cell Host Microbe. (2010) 7:427–39. 10.1016/j.chom.2010.05.00820542247"/>
   <result pre="Cell Host Microbe. (2010) 7:427–39. 10.1016/j.chom.2010.05.00820542247 23.SvitekNRuddPAObojesKPilletSvon MesslingV. Severe seasonal" exact="influenza" post="in ferrets correlates with reduced interferon and increased IL-6"/>
   <result pre="28.SleemanKMishinVPDeydeVMFurutaYKlimovAIGubarevaLV. In vitro antiviral activity of favipiravir (T-705) against drug-resistant" exact="influenza" post="and 2009 A(H1N1) viruses. Antimicrobial Agents Chemother. (2010) 54:2517–24."/>
   <result pre="32.YamauchiYBoukariHBanerjeeISbalzariniIFHorvathPHeleniusA. Histone deacetylase 8 is required for centrosome cohesion and" exact="influenza" post="A virus entry. PLoS Pathog. (2011) 7:e1002316. 10.1371/journal.ppat.100231622046129 33.SuTPSuTCNakamuraYTsaiSY."/>
   <result pre="Enzyme Inhib Med Chem. (2010) 25:871–5. 10.3109/1475636090348958121054237 38.JankeRGenzelYWetzelMReichlU. Effect of" exact="influenza" post="virus infection on key metabolic enzyme activities in MDCK"/>
   <result pre="al.. Mast cell-induced lung injury in mice infected with H5N1" exact="influenza" post="virus. J Virol. (2012) 86:3347–56. 10.1128/JVI.06053-1122238293 40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet"/>
   <result pre="40.LiuSL Li YHShiGYTangSHJiangSJHuangCWLiuPYet al.. Dextromethorphan reduces oxidative stress and inhibits" exact="atherosclerosis" post="and neointima formation in mice. Cardiovasc Res. (2009) 82:161–9."/>
   <result pre="Effects of double combinations of amantadine, oseltamivir, and ribavirin on" exact="influenza" post="A (H5N1) virus infections in cell culture and in"/>
   <result pre="effects of dextromethorphan. PLoS ONE.9:e89985. 10.1371/journal.pone.008998524587167 43.BouvierNM. Animal models for" exact="influenza" post="virus transmission studies: a historical perspective. Curr Opin Virol."/>
   <result pre="10.1016/j.cell.2007.08.03617981125 58.OchiaiHKurokawaMNiwayamaS. Influence of trifluoperazine on the late stage of" exact="influenza" post="virus infection in MDCK cells. Antiviral Res. (1991) 15:149–60."/>
   <result pre="(1991) 15:149–60. 10.1016/0166-3542(91)90032-M1859203 59.FujiokaYTsudaMNanboAHattoriTSasakiJSasakiTet al.. A Ca(2+)-dependent signalling circuit regulates" exact="influenza" post="A virus internalization and infection. Nat Commun. (2013) 4:2763."/>
   <result pre="10.1038/ncomms376324434940 60.BelserJAKatzJMTumpeyTM. The ferret as a model organism to study" exact="influenza" post="A virus infection. Dis Model Mech. (2011) 4:575–9. 10.1242/dmm.00782321810904"/>
   <result pre="Characterization in vitro and in vivo of pandemic (H1N1) 2009" exact="influenza" post="viruses isolated from patients. J Virol. (2012) 86:9361–8. 10.1128/JVI.01214-1222718834"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6564047\results\search\disease\results.xml">
   <result pre=": Gene amplification: RNA amplification Field diagnosis and genotyping of" exact="chikungunya" post="virus using a dried reverse transcription loop-mediated isothermal amplification"/>
   <result pre="amplification (LAMP) assay and MinION sequencing Diagnosis and genotyping of" exact="chikungunya" post="by MinION HayashidaKyokoConceptualizationInvestigationWriting – original draftWriting – review &amp;amp;"/>
   <result pre="author and source are credited.pntd.0007480.pdf Abstract Detection and sequencing of" exact="chikungunya" post="virus (CHIKV) genome was performed using a combination of"/>
   <result pre="several outbreaks in the world. As the clinical symptoms of" exact="chikungunya" post="is similar to other mosquito-borne febrile diseases, the definitive"/>
   <result pre="the present work, a simple dried format LAMP test for" exact="chikungunya" post="diagnosis was developed which can be directly amplified from"/>
   <result pre="DRA007513. Introduction Chikungunya is a mosquito-borne febrile disease caused by" exact="chikungunya" post="virus (CHIKV), which is a positive strand RNA virus"/>
   <result pre="the genus Alphavirus. In the last decade, serious outbreaks of" exact="chikungunya" post="have been reported. These appeared to have started on"/>
   <result pre="as temperate Mediterranean areas of Europe [5–7]. Since late 2013," exact="chikungunya" post="outbreaks have been also reported in the Caribbean, United"/>
   <result pre="mosquito vectors and mammalian hosts. Since the clinical features of" exact="chikungunya" post="are similar to other mosquito-borne febrile diseases, including Dengue"/>
   <result pre="clinical signs is difficult in endemic regions. Definitive diagnosis of" exact="chikungunya" post="is based on serology, virus isolation, or genome detection"/>
   <result pre="equipment is required. Notably as most of the newly emerging" exact="infectious disease" post="outbreaks have been reported in the remote areas with"/>
   <result pre="Laboratory using both RNA and serum samples of patients with" exact="chikungunya" post="collected and kept at the Fiocruz. RNA and serum"/>
   <result pre="1). 10.1371/journal.pntd.0007480.t001Table 1 RT-LAMP results using RNA and serum from" exact="chikungunya" post="patient and endemic healthy control in Rio de Janeiro,"/>
   <result pre="healthy N.D. N.D. N.D. RNA and serum samples from 33" exact="chikungunya" post="patients and 4 endemic healthy control patients were examined"/>
   <result pre="of the qRT-PCR Ct value. N.D.: not detected. Genotyping of" exact="chikungunya" post="virus by CHIKV-CZC-LAMP and MinION The amplified products by"/>
   <result pre="sequence data, demonstrating the proof-of-concept of our analysis. For the" exact="chikungunya" post="patient samples from Rio de Janeiro, the obtained sequences"/>
   <result pre="system will also be useful for diagnosis not only of" exact="chikungunya" post="but also other established and newly emerging infections of"/>
   <result pre="Feira de Santana, respectively [9–11]. In 2016, an outbreak of" exact="chikungunya" post="was reported in Rio de Janeiro, and ECSA genotype"/>
   <result pre="our CHIK-CZC-LAMP combined with MinION portable sequencer using samples from" exact="chikungunya" post="patients in Rio de Janeiro, to determine if on-site"/>
   <result pre="resource-limited region was possible. The sequence data obtained from the" exact="chikungunya" post="samples revealed that those were the ECSA genotype, which"/>
   <result pre="pathogen lineages will be required for a better understanding of" exact="chikungunya" post="epidemics. Many lineages from diverse geographical areas have potential"/>
   <result pre="serum samples from 16 CHIKV serology positive patients during recent" exact="chikungunya" post="outbreaks in Rio de Janeiro, Brazil. In combination with"/>
   <result pre="3MavalankarD, ShastriP, BandyopadhyayT, ParmarJ, RamaniKV. Increased mortality rate associated with" exact="chikungunya" post="epidemic, Ahmedabad, India. Emerg Infect Dis. 2008;14:412–5. 10.3201/eid1403.07072018325255 4RianthavornP,"/>
   <result pre="2008;14:412–5. 10.3201/eid1403.07072018325255 4RianthavornP, PrianantathavornK, WuttirattanakowitN, TheamboonlersA, PoovorawanY. An outbreak of" exact="chikungunya" post="in southern Thailand from 2008 to 2009 caused by"/>
   <result pre="10.3201/eid1705.10187321529410 6RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliA, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
   <result pre="20(17). pii: 21108. 8WahidB, AliA, RafiqueS, IdreesM. Global expansion of" exact="chikungunya" post="virus: mapping the 64-year history. Int J Infect Dis."/>
   <result pre="2015;13:10210.1186/s12916-015-0348-x25976325 12ParolaP, de LamballerieX, JourdanJ, RoveryC, VaillantV, MinodierP, et al.Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
   <result pre="13SchuffeneckerI, ItemanI, MichaultA, MurriS, FrangeulL, VaneyM-C, et al.Genome microevolution of" exact="chikungunya" post="viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e26310.1371/journal.pmed.003026316700631"/>
   <result pre="PLoS Med. 2006;3:e26310.1371/journal.pmed.003026316700631 14LanciottiRS, ValadereAM. Transcontinental movement of Asian genotype" exact="chikungunya" post="virus. Emerg Infect Dis.2014;20:1400–2. 10.3201/eid2008.14026825076384 15TeixeiraMG, AndradeAMS, Costa M"/>
   <result pre="Costa M daCN, CastroJ-NSM, OliveiraFLS, GoesCSB, et al.East/Central/South African genotype" exact="chikungunya" post="virus, Brazil, 2014. Emerg Infect Dis. 2015;21:906–7. 10.3201/eid2105.14172725898939 16SouzaTMA,"/>
   <result pre="SimuunzaM, NdebeJ, ChotaA, et al.Direct detection of falciparum and non-falciparum" exact="malaria" post="DNA from a drop of blood with high sensitivity"/>
   <result pre="WileyMR. et al.First report of naturally infected Aedes aegypti with" exact="chikungunya" post="virus genotype ECSA in the Americas. PLoS Negl Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6572267\results\search\disease\results.xml">
   <result pre="has experienced several arbovirus outbreaks in recent years, among which" exact="yellow fever" post="stands out. The state of Minas Gerais faced outbreaks"/>
   <result pre="out. The state of Minas Gerais faced outbreaks of sylvatic" exact="yellow fever" post="in 2017 and 2018, with 1002 confirmed cases and"/>
   <result pre="work presents the results of survey efforts to detect the" exact="yellow fever" post="virus in mosquitoes from two conservation areas in the"/>
   <result pre="was extracted from the mosquitoes for real-time PCR analysis for" exact="yellow fever," post="chikungunya, mayaro, Zika and dengue viruses. The yellow fever"/>
   <result pre="for yellow fever, chikungunya, mayaro, Zika and dengue viruses. The" exact="yellow fever" post="infection rate was 8.2% for Hg. janthinomys (13 mosquitoes),"/>
   <result pre="janthinomys (13 mosquitoes), which is the main vector of sylvatic" exact="yellow fever" post="in Brazil. In addition to surveying the mosquito fauna"/>
   <result pre="monitoring the circulation of viruses near large urban centers. arboviruses" exact="yellow fever" post="mosquitoes 1. Introduction Yellow fever (YF) is a severe"/>
   <result pre="lethality (20–50% among symptomatic cases) [1] and is caused by" exact="yellow fever" post="virus (YFV), an arbovirus of the family Flaviviridae. The"/>
   <result pre="(Linnaeus, 1972), however there have been no reports of urban" exact="yellow fever" post="in Brazil since 1942 [5,6]. On the African continent,"/>
   <result pre="2017–2018, including Zika, for which there were 3308 confirmed cases," exact="chikungunya" post="with 61,625 confirmed cases and dengue with 145,137 confirmed"/>
   <result pre="Minas Gerais, Brazil, and to evaluate the viral presence of" exact="yellow fever" post="virus (YFV), dengue virus (DENV), chikungunya virus (CHIKV), Zika"/>
   <result pre="viral presence of yellow fever virus (YFV), dengue virus (DENV)," exact="chikungunya" post="virus (CHIKV), Zika virus (ZIKV) and mayaro virus (MAYV)."/>
   <result pre="to block local transmission at that moment of epidemics. Several" exact="yellow fever" post="vaccination campaigns were promoted and an example of this"/>
   <result pre="a previous outbreak in the South region, the trajectory of" exact="yellow fever" post="virus circulation was estimated as 600 km in six"/>
   <result pre="SantosA.A.C.de MelloI.S.SantosM.P.RibeiroI.P.Ferreira-de-BritoA.de MirandaR.M.de CastroM.G.RibeiroM.S.et al.Genomic and structural features of the" exact="yellow fever" post="virus from the 2016-2017 Brazilian outbreakJ. Gen. Virol.20189953654810.1099/jgv.0.00103329469689 11.Monitoramento"/>
   <result pre="outbreakJ. Gen. Virol.20189953654810.1099/jgv.0.00103329469689 11.Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e doença aguda pelo vírus Zika até a Semana"/>
   <result pre="of an artificial diet for Wolbachia-infected Aedes aegyptiSci. Rep.2017711110.1038/s41598-017-16045-628127051 17.DomingoC.PatelP.YillahJ.WeidmannM.MéndezJ.A.NakounéE.R.NiedrigM.Advanced" exact="yellow fever" post="virus genome detection in point-of-care facilities and reference laboratoriesJ."/>
   <result pre="Med. Hyg.20118575075710.4269/ajtmh.2011.11-035921976583 23.FigueiredoL.B.CecílioA.B.FerreiraG.P.DrumondB.P.de OliveiraJ.G.BonjardimC.A.FerreiraP.C.P.KroonE.G.Dengue virus 3 genotype 1 associated with" exact="dengue fever" post="and dengue hemorrhagic fever, BrazilEmerg. Infect. Dis.20081431431610.3201/eid1402.07027818258129 24.NevesD.P.da SilvaJ.E.Aspectos"/>
   <result pre="OliveiraJ.G.BonjardimC.A.FerreiraP.C.P.KroonE.G.Dengue virus 3 genotype 1 associated with dengue fever and" exact="dengue hemorrhagic fever," post="BrazilEmerg. Infect. Dis.20081431431610.3201/eid1402.07027818258129 24.NevesD.P.da SilvaJ.E.Aspectos da biologia dos culicinae"/>
   <result pre="RosaJ.F.S.New entomological and virological data on the vectors of sylvatic" exact="yellow fever" post="in BrazilArthropod-Borne Virus Inf. Exch.19932122 26.GoenagaS.FabbriC.DueñasJ.C.R.GardenalC.N.RossiG.C.CalderonG.MoralesM.A.GarciaJ.B.EnriaD.A.LevisS.Isolation of Yellow Fever"/>
   <result pre="Brazil, 2008Emerg. Infect. Dis.2010161918192421122222 29.de SouzaR.P.PetrellaS.CoimbraT.L.M.MaedaA.Y.RoccoI.M.BisordiI.SilveiraV.R.PereiraL.E.SuzukiA.dos Santos SilvaS.J.et al.Isolation of" exact="yellow fever" post="virus (YFV) from naturally infected Haemagogus (Conopostegus) leucocelaenus (Diptera,"/>
   <result pre="Haemagogus (Haemagogus) janthinomys in Eastern AmazoniaVector-Borne Zoonotic Dis.20022475010.1089/15303660276026077912656130 36.MartinsR.M.MaiaM.D.L.S.FariasR.H.G.CamachoL.A.B.FreireM.S.GallerR.YamamuraA.M.Y.AlmeidaL.F.C.LimaS.M.B.NogueiraR.M.R.et al.17DD" exact="yellow fever" post="vaccine: A double blind, randomized clinical trial of immunogenicity"/>
   <result pre="of monkeys, mosquitoes, and humans in the occurrence of a" exact="yellow fever" post="outbreak in a fragmented landscape in south Brazil: Protecting"/>
   <result pre="studiesAm. J. Trop. Med. Hyg.1950s1-3010.4269/ajtmh.1950.s1-30.301 44.PinheiroF.P.Travassos da RosaA.P.A.MoraesM.A.P.An epidemic of" exact="yellow fever" post="in central Brazil, 1972-1973. II. Ecological studiesAm. J. Trop."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6572372\results\search\disease\results.xml">
   <result pre="risk factors 1. Introduction Since 2013, the two emerging arboviruses," exact="chikungunya" post="virus (CHIKV) and Zika virus (ZIKV), transmitted by the"/>
   <result pre="lower fevers and milder peripheral symptoms, such as rash, nonpurulent" exact="conjunctivitis" post="and oedema [10,11]. However, in the Americas, ZIKV infections"/>
   <result pre="a fever (&amp;gt;38 °C), sudden onset of severe arthralgia or" exact="arthritis" post="and rash, not explained by other medical conditions, and"/>
   <result pre="interest. Abbreviations CAR conditional autoregressive models DENV dengue virus CHIKV" exact="chikungunya" post="virus DANE National Administrative Department of Statistics DIC deviance"/>
   <result pre="standardised incidence rate ZIKV Zika virus References References 1.CassadouS.BoucauS.Petit-SinturelM.HucP.Leparc-GoffartI.LedransM.Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
   <result pre="Aedes aegypti as a main contributor of fast dispersal of" exact="chikungunya" post="outbreaks in Latin AmericaAntivir. Res.2015124304226518229 3.HalsteadS.B.Reappearance of chikungunya, formerly"/>
   <result pre="Colombia, 2014Trans. R. Soc. Trop. Med. Hyg.201510979380210.1093/trstmh/trv09426626342 7.CuevasE.L.Preliminary report of" exact="microcephaly" post="potentially associated with Zika virus infection during pregnancy—Colombia, January–November"/>
   <result pre="9.HuaC.CombeB.Chikungunya virus-associated diseaseCurr. Rheumatol. Rep.2017196910.1007/s11926-017-0694-028983760 10.Beltrán-SilvaS.L.Chacón-HernándezS.S.Moreno-PalaciosE.Pereyra-MolinaJ.A.Clinical and differential diagnosis: Dengue," exact="chikungunya" post="and ZikaRevista Médica del Hospital General de México201881146153 11.Paniz-MondolfiA.E.Rodriguez-MoralesA.J.BlohmG.MarquezM.Villamil-GomezW.E.ChikDenMaZika"/>
   <result pre="dengue: The impact of international travelMed. Clin. N. Am.2008921377139010.1016/j.mcna.2008.07.00219061757 20.KhormiH.M.KumarL.Modeling" exact="dengue fever" post="risk based on socioeconomic parameters, nationality and age groups:"/>
   <result pre="based case studySci. Total Environ.20114094713471910.1016/j.scitotenv.2011.08.02821906782 21.SissokoD.MoendandzeA.MalvyD.GiryC.EzzedineK.SoletJ.L.PierreV.Seroprevalence and risk factors of" exact="chikungunya" post="virus infection in Mayotte, Indian Ocean, 2005–2006: A population-based"/>
   <result pre="A population-based surveyPLoS ONE20083e306610.1371/journal.pone.000306618725980 22.PerkinsT.A.MetcalfC.J.E.GrenfellB.T.TatemA.J.Estimating drivers of autochthonous transmission of" exact="chikungunya" post="virus in its invasion of the AmericasPLoS Curr.2015710.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc 23.BogochI.I.BradyO.J.KraemerM.U.GermanM.CreatoreM.I.KulkarniM.A.BrownsteinJ.S.MekaruS.R.HayS.I.GrootE.Anticipating"/>
   <result pre="Publica2013291522153210.1590/S0102-311X201300120000524005918 35.DelmelleE.HagenlocherM.KienbergerS.CasasI.A spatial model of socioeconomic and environmental determinants of" exact="dengue fever" post="in Cali, ColombiaActa Trop.201616416917610.1016/j.actatropica.2016.08.02827619189 36.CamposM.C.DombrowskiJ.G.PhelanJ.MarinhoC.R.HibberdM.ClarkT.G.CampinoS.Zika might not be acting"/>
   <result pre="investigate potential co-acting risk factors for an unusual pattern of" exact="microcephaly" post="in BrazilPLoS ONE201813e020145210.1371/journal.pone.020145230110370 37.HsuehY.LeeJ.BeltzL.Spatio-temporal patterns of dengue fever cases"/>
   <result pre="unusual pattern of microcephaly in BrazilPLoS ONE201813e020145210.1371/journal.pone.020145230110370 37.HsuehY.LeeJ.BeltzL.Spatio-temporal patterns of" exact="dengue fever" post="cases in Kaoshiung City, Taiwan, 2003–2008Appl. Geogr.20123458759410.1016/j.apgeog.2012.03.003 38.Reyes-CastroP.A.HarrisR.B.BrownH.E.ChristophersonG.L.ErnstK.C.Spatio-temporal and"/>
   <result pre="prevention and controlAnn. Acad. Med. Singap.20083753818695764 42.HagenlocherM.DelmelleE.CasasI.KienbergerS.Assessing socioeconomic vulnerability to" exact="dengue fever" post="in Cali, Colombia: Statistical vs expert-based modelingInt. J. Health"/>
   <result pre="space, and behaviors shape the spread of infectious diseases using" exact="chikungunya" post="as a case studyProc. Natl. Acad. Sci.2016113134201342510.1073/pnas.161139111327821727 44.VezzaniD.Artificial container-breeding"/>
   <result pre="information value based analysis of physical and climatic factors affecting" exact="dengue fever" post="and dengue haemorrhagic fever incidenceInt. J. Health Geogr.200541310.1186/1476-072X-4-1315943863 47.CheongY.L.LeitãoP.J.LakesT.Assessment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6585104\results\search\disease\results.xml">
   <result pre=": Debate Why all blood donations should be tested for" exact="hepatitis" post="E virus (HEV) http://orcid.org/0000-0003-3244-6085DennerJoachimDennerJ@rki.de1PischkeSvens.pischke@uke.de2SteinmannEikeeike.steinmann@ruhr-uni-bochum.de3BlümelJohannesJohannes.Bluemel@pei.de4GlebeDieterDieter.Glebe@viro.med.uni-giessen.de5[1], 0000 0001 0940 3744grid.13652.33Robert Koch"/>
   <result pre="article, unless otherwise stated. Abstract Background Hepatitis E is a" exact="liver disease" post="caused by a small RNA virus known as hepatitis"/>
   <result pre="liver disease caused by a small RNA virus known as" exact="hepatitis" post="E virus (HEV). Four major genotypes infect humans, of"/>
   <result pre="against human immunodeficiency virus 1 (HIV-1) and HIV-2, against human" exact="hepatitis" post="C virus (HCV), against human hepatitis B core antigen"/>
   <result pre="and HIV-2, against human hepatitis C virus (HCV), against human" exact="hepatitis" post="B core antigen (HBcAg), as well as for human"/>
   <result pre="hepatitis B core antigen (HBcAg), as well as for human" exact="hepatitis" post="B surface antigen (HBsAg) and for the genomes of"/>
   <result pre="West Nile virus (WNV), human T cell lymphotropic virus (HTLV)," exact="rabies" post="virus as well as of parasites (mainly malaria) and"/>
   <result pre="[41], the rate of HEV-positive donations was 1:4525 [42] and" exact="hepatitis" post="E viraemia was found at a relatively high rate"/>
   <result pre="in rare cases a mild anicteric illness and a moderate" exact="hepatitis" post="were reported. In some cases an acute hepatitis by"/>
   <result pre="a moderate hepatitis were reported. In some cases an acute" exact="hepatitis" post="by red blood cell transfusion was described in immunocompetent"/>
   <result pre="was described in immunocompetent subjects [53]. In a patient with" exact="thrombotic thrombocytopenic purpura" post="(TTP), an acute HEV infection by cryosupernatant plasma triggered"/>
   <result pre="in immunocompetent subjects [53]. In a patient with thrombotic thrombocytopenic" exact="purpura" post="(TTP), an acute HEV infection by cryosupernatant plasma triggered"/>
   <result pre="also observed in an immunocompetent patient with a history of" exact="systemic lupus erythematosus" post="[55]. Neurological manifestations caused by HEV infections have been"/>
   <result pre="observed in an immunocompetent patient with a history of systemic" exact="lupus erythematosus" post="[55]. Neurological manifestations caused by HEV infections have been"/>
   <result pre="are still not well analysed [56]. In patients with underlying" exact="liver disease," post="a severe hepatitis occurs [19]. HEV may be an"/>
   <result pre="analysed [56]. In patients with underlying liver disease, a severe" exact="hepatitis" post="occurs [19]. HEV may be an immunosuppressive virus. There"/>
   <result pre="47]. In one case, HEV transmission was associated with fatal" exact="hepatitis" post="in a Japanese cancer patient [62]. However, it is"/>
   <result pre="HEV transmission was associated with fatal hepatitis in a Japanese" exact="cancer" post="patient [62]. However, it is obvious that the risk"/>
   <result pre="Cancer patients under chemotherapy, HIV infected individuals, and patients with" exact="rheumatoid arthritis" post="and other rheumatic diseases under immunosuppressive treatment should also"/>
   <result pre="patients under chemotherapy, HIV infected individuals, and patients with rheumatoid" exact="arthritis" post="and other rheumatic diseases under immunosuppressive treatment should also"/>
   <result pre="included. The fatal outcome of a transfusion-transmitted infection of a" exact="cancer" post="patient in Japan [62] underlines that the risk-group should"/>
   <result pre="J, Waldvogel S, Wiengand T, Züger M, Gowland P. Current" exact="hepatitis" post="E virus seroprevalence in Swiss blood donors and apparent"/>
   <result pre="Nishiyama T, Primadharsini PP, Okamoto H. Characterization of the quasi-enveloped" exact="hepatitis" post="E virus particles released by the cellular Exosomal pathway."/>
   <result pre="released by the cellular Exosomal pathway. J Virol. 2017;(22):91. 8.WooPCLauSKTengJLCaoKYWerneryUSchountzTChiuTHTsangAKWongPCWongEYYuenKYNew" exact="hepatitis" post="E virus genotype in Bactrian camels, Xinjiang, China, 2013Emerg"/>
   <result pre="Bactrian camels, Xinjiang, China, 2013Emerg Infect Dis201622122219222110.3201/eid2212.16097927869607 9.PavioNDoceulVBagdassarianEJohneRRecent knowledge on" exact="hepatitis" post="E virus in Suidae reservoirs and transmission routes to"/>
   <result pre="and two reference ELISAsJ Virol Methods2013190111610.1016/j.jviromet.2013.03.01023523888 13.LeeGHTanBHTeoECLimSGDanYYWeeAAwPPZhuYHibberdMLTanCKPurdyMATeoCGChronic infection with camelid" exact="hepatitis" post="E virus in a liver transplant recipient who regularly"/>
   <result pre="consumes camel meat and MilkGastroenterology.2016150235535710.1053/j.gastro.2015.10.04826551551 14.YangYShiRSheRMaoJZhaoYDuFLiuCLiuJChengMZhuRLiWWangXSoomroMHFatal disease associated with swine" exact="hepatitis" post="E virus and porcine circovirus 2 co-infection in four"/>
   <result pre="in the context of xenotransplantation: detection and vertical transmission of" exact="hepatitis" post="E virusPLoS One20151010e013989310.1371/journal.pone.013989326466154 16.SchielkeASachsKLierzMAppelBJansenAJohneRDetection of hepatitis E virus in"/>
   <result pre="and vertical transmission of hepatitis E virusPLoS One20151010e013989310.1371/journal.pone.013989326466154 16.SchielkeASachsKLierzMAppelBJansenAJohneRDetection of" exact="hepatitis" post="E virus in wild boars of rural and urban"/>
   <result pre="genome characterization of an endemic strainVirol J200965810.1186/1743-422X-6-5819442307 17.WidénFSundqvistLMatyi-TothAMetreveliGBelákSHallgrenGNorderHMolecular epidemiology of" exact="hepatitis" post="E virus in humans, pigs and wild boars in"/>
   <result pre="humans, pigs and wild boars in SwedenEpidemiol Infect2011139336137110.1017/S095026881000134220546635 18.KrumbholzAMohnULangeJMotzMWenzelJJJilgWWaltherMStraubeEWutzlerPZellRPrevalence of" exact="hepatitis" post="E virus-specific antibodies in humans with occupational exposure to"/>
   <result pre="Hepatitis E: Two Sides of the Same CoinViruses201681129910.3390/v8110299 20.SommerkornFMSchauerBSchreinerTFickenscherHKrumbholzAPerformance of" exact="hepatitis" post="E virus (HEV)-antibody tests: a comparative analysis based on"/>
   <result pre="SauxJCChevéJOllivierJLe PenduJLe GuyaderFSBioaccumulation efficiency, tissue distribution, and environmental occurrence of" exact="hepatitis" post="E virus in bivalve shellfish from FranceAppl Environ Microbiol201480144269427610.1128/AEM.00978-1424795382"/>
   <result pre="from FranceAppl Environ Microbiol201480144269427610.1128/AEM.00978-1424795382 22.O'HaraZCrossanCCraftJScobieLFirst report of the presence of" exact="hepatitis" post="E virus in Scottish-harvested shellfish purchased at retail levelFood"/>
   <result pre="M, Stark K. Case-control study on risk factors for acute" exact="hepatitis" post="E in Germany, 2012 to 2014. Euro Surveill. 2018;23(19)."/>
   <result pre="2018;23(19). 25.WenzelJJPreissJSchemmererMHuberBJilgWTest performance characteristics of anti-HEV IgG assays strongly influence" exact="hepatitis" post="E seroprevalence estimatesJ Infect Dis2013207349750010.1093/infdis/jis68823148290 26.VollmerTDiekmannJJohneREberhardtMKnabbeCDreierJNovel approach for detection"/>
   <result pre="E seroprevalence estimatesJ Infect Dis2013207349750010.1093/infdis/jis68823148290 26.VollmerTDiekmannJJohneREberhardtMKnabbeCDreierJNovel approach for detection of" exact="hepatitis" post="E virus infection in German blood donorsJ Clin Microbiol20125082708271310.1128/JCM.01119-1222675127"/>
   <result pre="in German blood donorsJ Clin Microbiol20125082708271310.1128/JCM.01119-1222675127 27.MansuyJMGallianPDimeglioCSauneKArnaudCPelletierBMorelPLegrandDTiberghienPIzopetJA nationwide survey of" exact="hepatitis" post="E viral infection in French blood donorsHepatology.20166341145115410.1002/hep.2843627008201 28.GallianPLhommeSPiquetYSaunéKAbravanelFAssalATiberghienPIzopetJHepatitis E"/>
   <result pre="virus infections in blood donorsFrance Emerg Infect Dis201420111914191710.3201/eid2011.14051625340881 29.GallianPCouchouronADupontIFabraCPiquetYDjoudiRAssalATiberghienPComparison of" exact="hepatitis" post="E virus nucleic acid test screening platforms and RNA"/>
   <result pre="screening platforms and RNA prevalence in French blood donorsTransfusion.201757122322410.1111/trf.1388928097700 30.SlotEHogemaBRiezebos-BrilmanAKokTMolierMZaaijerHSilent" exact="hepatitis" post="E virus infection in Dutch blood donors, 2011 to"/>
   <result pre="infection in Dutch blood donors, 2011 to 2012Eurosurveillance201318312055010.2807/1560-7917.ES2013.18.31.2055023929229 31.ZaaijerHLNo artefact," exact="hepatitis" post="E is emergingHepatology20156265410.1002/hep.27611 32.BealeMATettmarKSzypulskaRTedderRSIjaz S. is there evidence of"/>
   <result pre="E is emergingHepatology20156265410.1002/hep.27611 32.BealeMATettmarKSzypulskaRTedderRSIjaz S. is there evidence of recent" exact="hepatitis" post="E virus infection in English and north welsh blood"/>
   <result pre="virus in Scottish blood donorsVox Sang2013105428328910.1111/vox.1205623763589 35.HarritshøjLHHolmDKSaekmoseSGJensenBAHogemaBMFischerTKMidgleySEKrogJSErikstrupCUllumHLow transfusion transmission of" exact="hepatitis" post="E among 25,637 single-donation, nucleic acid-tested blood donorsTransfusion.20165692225223210.1111/trf.1370027385646 36.SauledaSOngEBesMJanssenACoryRBabizkiMShinTLindquistAHoangAVangLPironMCasamitjanaNKoppelmanMDanzigLLinnenJMSeroprevalence"/>
   <result pre="E among 25,637 single-donation, nucleic acid-tested blood donorsTransfusion.20165692225223210.1111/trf.1370027385646 36.SauledaSOngEBesMJanssenACoryRBabizkiMShinTLindquistAHoangAVangLPironMCasamitjanaNKoppelmanMDanzigLLinnenJMSeroprevalence of" exact="hepatitis" post="E virus (HEV) and detection of HEV RNA with"/>
   <result pre="in blood donors, FranceEmerg Infect Dis2011171223091210.3201/eid1712.11037122172156 38.HogemaBMMolierMSlotEZaaijerHLPast and present of" exact="hepatitis" post="E in the NetherlandsTransfusion.201454123092309610.1111/trf.1273324889277 39.ChristensenPBEngleREHjortCHomburgKMVachWGeorgsenJPurcellRHTime trend of the prevalence"/>
   <result pre="E in the NetherlandsTransfusion.201454123092309610.1111/trf.1273324889277 39.ChristensenPBEngleREHjortCHomburgKMVachWGeorgsenJPurcellRHTime trend of the prevalence of" exact="hepatitis" post="E antibodies among farmers and blood donors: a potential"/>
   <result pre="Dis20084781026103110.1086/59197018781880 40.HogemaBMMolierMSjerpsMde WaalMvan SwietenPvan de LaarTMolenaar-de BackerMZaaijerHLIncidence and duration of" exact="hepatitis" post="E virus infection in Dutch blood donorsTransfusion.201656372272810.1111/trf.1340226559806 41.JuhlDBaylisSABlümelJGörgSHennigHSeroprevalence and"/>
   <result pre="virus infection in Dutch blood donorsTransfusion.201656372272810.1111/trf.1340226559806 41.JuhlDBaylisSABlümelJGörgSHennigHSeroprevalence and incidence of" exact="hepatitis" post="E virus infection in German blood donorsTransfusion.2014541495610.1111/trf.1212123441647 42.BaylisSAGärtnerTNickSOvemyrJBlümelJOccurrence of"/>
   <result pre="hepatitis E virus infection in German blood donorsTransfusion.2014541495610.1111/trf.1212123441647 42.BaylisSAGärtnerTNickSOvemyrJBlümelJOccurrence of" exact="hepatitis" post="E virus RNA in plasma donations from Sweden, Germany"/>
   <result pre="systematic review and meta-analysis. Liver Int. 2018 Apr 16. 44.BoxallEHerbornAKochethuGPrattGAdamsDIjazSTeoCGTransfusion-transmitted" exact="hepatitis" post="E in a 'nonhyperendemic' countryTransfus Med2006162798310.1111/j.1365-3148.2006.00652.x16623913 45.WesthölterDHillerJDenzerUPolywkaSAyukFRybczynskiMHorvatitsTGundlachSBlöckerJSchulze Zur WieschJFischerNAddoMMPeineSGökeBLohseAWLütgehetmannMPischkeSHEV-positive"/>
   <result pre="represent a relevant infection risk for immunosuppressed recipientsJ Hepatol2018691364210.1016/j.jhep.2018.02.03129551705 46.DreierJKnabbeCVollmerTTransfusion-transmitted" exact="hepatitis" post="E: NAT screening of blood donations and infectious doseFront"/>
   <result pre="or blood-that is the questionTransfusion.201757226727210.1111/trf.1397628194857 48.SatakeMMatsubayashiKHoshiYTairaRFuruiYKokudoNAkamatsuNYoshizumiTOhkohchiNOkamotoHMiyoshiMTamuraAFuseKTadokoroKUnique clinical courses of transfusion-transmitted" exact="hepatitis" post="E in patients with immunosuppressionTransfusion.201757228028810.1111/trf.1399428144952 49.SchlosserBSteinANeuhausRPahlSRamezBKrügerDHBergTHofmannJLiver transplant from a"/>
   <result pre="transplant from a donor with occult HEV infection induced chronic" exact="hepatitis" post="and cirrhosis in the recipientJ Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus"/>
   <result pre="a donor with occult HEV infection induced chronic hepatitis and" exact="cirrhosis" post="in the recipientJ Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus infection as"/>
   <result pre="Hepatol201256250050210.1016/j.jhep.2011.06.02121798217 50.PischkeSSuneethaPVBaechleinCBarg-HockHHeimAKamarNSchlueJStrassburgCPLehnerFRaupachRBremerBMagerstedtPCornbergMSeehusenFBaumgaertnerWKlempnauerJIzopetJMannsMPGrummerBWedemeyerHHepatitis E virus infection as a cause of graft" exact="hepatitis" post="in liver transplant recipientsLiver Transpl2010161748210.1002/lt.2195819866448 51.PischkeSGreerMHardtkeSBremerBGisaALehmannPHaverichAWelteTMannsMPWedemeyerHGottliebJHepatitis E study group."/>
   <result pre="Transpl2010161748210.1002/lt.2195819866448 51.PischkeSGreerMHardtkeSBremerBGisaALehmannPHaverichAWelteTMannsMPWedemeyerHGottliebJHepatitis E study group. Course and treatment of chronic" exact="hepatitis" post="E virus infection in lung transplant recipientsTranspl Infect Dis201416233333910.1111/tid.1218324438577"/>
   <result pre="lung transplant recipientsTranspl Infect Dis201416233333910.1111/tid.1218324438577 52.AnkcornMJIjazSPohJElsharkawyAMSmitECrambRRaviSMartinKTedderRNeubergerJToward systematic screening for persistent" exact="hepatitis" post="E virus infections in transplant patientsTransplantation.201810271139114710.1097/TP.000000000000209729953421 53.Riveiro-BarcielaMSauledaSQuerJSalvadorFGregoriJPirónMRodríguez-FríasFButiMRed blood cell"/>
   <result pre="virus infections in transplant patientsTransplantation.201810271139114710.1097/TP.000000000000209729953421 53.Riveiro-BarcielaMSauledaSQuerJSalvadorFGregoriJPirónMRodríguez-FríasFButiMRed blood cell transfusion-transmitted acute" exact="hepatitis" post="E in an immunocompetent subject in Europe: a case"/>
   <result pre="an immunocompetent subject in Europe: a case reportTransfusion.201757224424710.1111/trf.1387627785789 54.Riveiro-BarcielaMBesMQuerJValcarcelDPirizSGregoriJLlorensMSalcedoMTPironMEstebanRButiMSauledaSThrombotic thrombocytopenic" exact="purpura" post="relapse induced by acute hepatitis E transmitted by cryosupernatant"/>
   <result pre="a case reportTransfusion.201757224424710.1111/trf.1387627785789 54.Riveiro-BarcielaMBesMQuerJValcarcelDPirizSGregoriJLlorensMSalcedoMTPironMEstebanRButiMSauledaSThrombotic thrombocytopenic purpura relapse induced by acute" exact="hepatitis" post="E transmitted by cryosupernatant plasma and successfully controlled with"/>
   <result pre="transmitted by cryosupernatant plasma and successfully controlled with ribavirinTransfusion.201858112501250510.1111/trf.1483130284732 55.GrewalPKamiliSMotamedDChronic" exact="hepatitis" post="E in an immunocompetent patient: a case reportHepatology.201459134734810.1002/hep.2663623913727 56.DaltonHRKamarNvan"/>
   <result pre="virus and neurological injuryNat Rev Neurol2016122778510.1038/nrneurol.2015.23426711839 57.CaoDCaoQMSubramaniamSYugoDMHeffronCLRogersAJKenneySPTianDMatzingerSROverendCCatanzaroNLeRoithTWangHPiñeyroPLindstromNClark-DeenerSYuanLMengXJPig model mimicking chronic" exact="hepatitis" post="E virus infection in immunocompromised patients to assess immune"/>
   <result pre="TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant" exact="hepatitis" post="eIntervirology.2009522788510.1159/00021486219401616 59.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPWangYJAiXHuYMTangQYaoXYanQXianYLWuTLiYMMiaoJNgMHShihJWXiaNSEfficacy and safety of a recombinant hepatitis E"/>
   <result pre="and fulminant hepatitis eIntervirology.2009522788510.1159/00021486219401616 59.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPWangYJAiXHuYMTangQYaoXYanQXianYLWuTLiYMMiaoJNgMHShihJWXiaNSEfficacy and safety of a recombinant" exact="hepatitis" post="E vaccine in healthy adults: a large-scale, randomised, double-blind"/>
   <result pre="2019. 63.de VosASJanssenMPZaaijerHLHogemaBMCost-effectiveness of the screening of blood donations for" exact="hepatitis" post="E virus in the NetherlandsTransfusion.201757225826610.1111/trf.1397828144956 64.KampCBlümelJBaylisSABekeredjian-DingIChudyMHeidenMHenselerOKeller-StanislawskiBde VosASFunkMBImpact of hepatitis"/>
   <result pre="for hepatitis E virus in the NetherlandsTransfusion.201757225826610.1111/trf.1397828144956 64.KampCBlümelJBaylisSABekeredjian-DingIChudyMHeidenMHenselerOKeller-StanislawskiBde VosASFunkMBImpact of" exact="hepatitis" post="E virus testing on the safety of blood components"/>
   <result pre="Platelet Transfusion in an Immunocompetent Trauma PatientEmerging Infectious Diseases201723114614710.3201/eid2301.16092327983485 67.GrewalPKamiliSMotamedDChronic" exact="hepatitis" post="E in an immunocompetent patient: a case reportHepatology, Hepatology201459134734810.1002/hep.2663623913727"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6586808\results\search\disease\results.xml">
   <result pre="infection is often asymptomatic, or associated with mild respiratory or" exact="gastrointestinal disease" post="in children. However some types, in particular human parechovirus"/>
   <result pre="LC133458.1 2014 Case V3 V7140151 Faeces 16/05/2017 399 VIC Irritable," exact="gastroenteritis" post="1 N MK604056 HPeV1 Strain 131170176, Japan LC318432.1 2017"/>
   <result pre="KY556666.1 2015 Case V5 V7169416 CSF 29/08/2017 17 VIC Sepsis-like," exact="meningitis" post="3 Y MK604058 Australian recombinant HPeV3 FEC10 KY556666.1 2015"/>
   <result pre="the 2 HPeV1 cases (W14 and W17) had less severe" exact="gastroenteritis" post="or fever respectively. Phylogenetic analysis Recombination, selection and phylogenetic"/>
   <result pre="a range of clinical presentations including irritability, fever, rash, gastroenteritis," exact="meningitis" post="and sepsis-like syndrome. These samples likely represented the most"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6591850\results\search\disease\results.xml">
   <result pre="and respiratory syncytial virus, BrazilEmerg Infect Dis20099121626162810.3201/eid0912.030522 7.PeirisJSMTangWHChanKHKhongPLGuanYLauYLet al.Children with" exact="respiratory disease" post="associated with metapneumovirus in Hong KongEmerg Infect Dis20039662863310.3201/eid0906.03000912781000 8.Guerrero-PlataACasolaASuarezGYuXSpetchLPeeplesMEet"/>
   <result pre="individualsPLoS One2011611910.1371/journal.pone.0016314 17.HeldLHöhleMHofmannMA statistical framework for the analysis of multivariate" exact="infectious disease" post="surveillance countsStat Modelling20055318719910.1191/1471082X05st098oa 18.O’HaraRBKotzeDJDo not log-transform count dataMethods Ecol"/>
   <result pre="a non-linear random effects model for multivariate time series of" exact="infectious disease" post="countsStat Med201130101118113621484849 23.PaulMMeyerSThe function hhh4 in the R -package"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6593267\results\search\disease\results.xml">
   <result pre="significantly advantage for detection of the true etiology of a" exact="respiratory disease." post="Furthermore, knowledge of which virus is the cause of"/>
   <result pre="Furthermore, knowledge of which virus is the cause of a" exact="respiratory disease" post="is not useful from a therapeutic point of view"/>
   <result pre="is not useful from a therapeutic point of view unless" exact="influenza" post="virus or respiratory syncytial virus are the infecting agents"/>
   <result pre="are warranted. multiplex platforms PCR respiratory pathogens respiratory tract infection" exact="influenza" post="respiratory syncytial virus Funding Horizon 202010.13039/501100007601 fig-count: table-count: equation-count:"/>
   <result pre="viruses, mainly respiratory syncytial virus (RSV) (Griffiths et al., 2017)," exact="influenza" post="virus (IV) (Antonova et al., 2012), and rhinovirus (RV)"/>
   <result pre="are the cause, Streptococcus pyogenes is a common cause of" exact="pharyngitis" post="(Paradise, 1992), and Streptococcus pneumoniae is a typical cause"/>
   <result pre="capacity to cause upper and lower RTIs and to trigger" exact="asthma" post="and chronic obstructive pulmonary disease exacerbations (Esposito et al.,"/>
   <result pre="cause upper and lower RTIs and to trigger asthma and" exact="chronic obstructive pulmonary disease" post="exacerbations (Esposito et al., 2012b; Parker et al., 2014;"/>
   <result pre="for those agents that are frequently asymptomatically carried. Although certain" exact="influenza" post="patients can shed the virus up to 8 days,"/>
   <result pre="currently available on these diagnostic platforms. Presently, only drugs against" exact="influenza" post="virus, RSV and atypical bacteria are licensed. Furthermore, it"/>
   <result pre="al., 2018) is not recommended for all the cases of" exact="influenza" post="because influenza is frequently a mild disease, and the"/>
   <result pre="is not recommended for all the cases of influenza because" exact="influenza" post="is frequently a mild disease, and the advantage of"/>
   <result pre="is a drug licensed for the treatment of cytomegalovirus (CMV)" exact="retinitis" post="in HIV-infected patients, has been used to treat ADV"/>
   <result pre="considered as a potential solution to treat mild-to-moderate cases of" exact="respiratory disease" post="in otherwise healthy children (Ganapathi et al., 2016). Can"/>
   <result pre="risk of transmission and potential nosocomial clusters of RSV and" exact="influenza" post="virus on hemato-oncological wards (Baier et al., 2018). On"/>
   <result pre="and untested children was not significant. The knowledge that a" exact="bronchiolitis" post="case was associated with the detection of RSV in"/>
   <result pre="et al. (2003) showed that children with a positive rapid" exact="influenza" post="test were significantly less likely than those with a"/>
   <result pre="Cantais et al. (2018), who showed that the diagnosis of" exact="influenza" post="was followed by a 47.9% reduction in blood puncture,"/>
   <result pre="improve the judgement of clinicians. However, the diagnosis of a" exact="viral disease" post="by a laboratory test can be interpreted as a"/>
   <result pre="References References AntonovaE. N.RycroftC. E.AmbroseC. S.HeikkinenT.PrincipiN. (2012). Burden of paediatric" exact="influenza" post="in Western Europe: a systematic review. BMC Public Health12:968."/>
   <result pre="2019). BlockS. L.HammerschlagM. R.HedrickJ.TylerR.SmithA.RoblinP.et al.. (1997). Chlamydia pneumoniae in acute" exact="otitis media." post="Pediatr. Infect. Dis. J.16, 858–862. 10.1097/00006454-199709000-000089306480 BrancheA. R.FalseyA. R."/>
   <result pre="248–253. 10.1016/j.pec.2014.01.01024569180 CantaisA.MoryO.PlatA.BourmaudA.GiraudA.CostilleM.et al.. (2018). Impact of bedside diagnosis of" exact="influenza" post="in the paediatric emergency ward. Clin. Microbiol. Infect. 10.1016/j.cmi.2018.11.019"/>
   <result pre="human rhinovirus isolates collected from otherwise healthy children with community-acquired" exact="pneumonia" post="during five successive years. PLoS ONE8:e80614. 10.1371/journal.pone.008061424260436 DoanQ.EnarsonP.KissoonN.KlassenT. P.JohnsonD."/>
   <result pre="Infect. Dis.31, 1637–1645. 10.1007/s10096-011-1487-422124536 EspositoS.MarchisioP.MorelliP.CrovariP.PrincipiN. (2003). Effect of a rapid" exact="influenza" post="diagnosis. Arch. Dis. Child.88, 525–526. 10.1136/adc.88.6.52512765923 EspositoS.PrincipiN. (2012). Unsolved"/>
   <result pre="Seegene Allplex Respiratory Panel 1 kit for the detection of" exact="influenza" post="virus and human respiratory syncytial virus. J. Clin. Virol.105,"/>
   <result pre="G.SugayaN.HirotsuN.LeeN.de JongM. D.HurtA. C.et al.. (2018). Baloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescents. N. Engl. J. Med.379, 913–923."/>
   <result pre="(2017). Viral shedding and transmission potential of asymptomatic and paucisymptomatic" exact="influenza" post="virus infections in the community. Clin. Infect. Dis.64, 736–742."/>
   <result pre="Front. Microbiol.9:3101. 10.3389/fmicb.2018.0310130619180 ParadiseJ. L. (1992). Etiology and management of" exact="pharyngitis" post="and pharyngotonsillitis in children: a current review. Ann. Otol."/>
   <result pre="PrincipiN.PirallaA.ZampieroA.BianchiniS.UmbrelloG.ScalaA.et al.. (2015a). Bocavirus infection in otherwise healthy children with" exact="respiratory disease." post="PLoS ONE10:e0135640. 10.1371/journal.pone.013564026267139 PrincipiN.ZampieroA.GambinoM.ScalaA.SenatoreL.LeliiM.et al.. (2015b). Prospective evaluation of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6594658\results\search\disease\results.xml">
   <result pre="their global reach. Author summary When novel infectious diseases like" exact="chikungunya" post="or Zika emerge and threaten global spread, public health"/>
   <result pre="wide range of possible epidemic outcomes, from terminal importations to" exact="stuttering" post="chains of transmission to full blown epidemics [4, 9–11]."/>
   <result pre="S1 File). Results In the face of a novel emerging" exact="infectious disease" post="threat, public health officials must borrow information from related"/>
   <result pre="used to assess disease transmission risk during elimination efforts, including" exact="malaria" post="in non-endemic regions [48]. The key innovation is that,"/>
   <result pre="method for continuously updating transmission risk estimates for populations experiencing" exact="infectious disease" post="importations, with or without secondary transmission. As we demonstrated"/>
   <result pre="of R(0) and transmission heterogeneity from the size distribution of" exact="stuttering" post="chains. PLoS Comput Biol. 2013;9(5):e100299310.1371/journal.pcbi.100299323658504 14BlumbergS, Lloyd-SmithJO. Comparing methods"/>
   <result pre="the impact of temperature on transmission of Zika, dengue and" exact="chikungunya" post="using mechanistic models. PLOS Neglected Tropical Diseases. 2017;11:e000556810.1371/journal.pntd.000556828448507 24TeslaB,"/>
   <result pre="NovotnyJ, NtshalintshaliN, KuneneS, CauchemezS. Public health. Measuring the path toward" exact="malaria" post="elimination. Science. 2014;344(6189):1230–1232. 10.1126/science.125144924926005"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6595446\results\search\disease\results.xml">
   <result pre="aegypti and Aedes albopictus, of dengue virus (DENV), resulting in" exact="dengue fever" post="now being considered a global burden. More than half"/>
   <result pre="20,000 deaths per 50 million to 100 million cases of" exact="dengue fever" post="annually (6). Indeed, the prevalence of dengue fever poses"/>
   <result pre="cases of dengue fever annually (6). Indeed, the prevalence of" exact="dengue fever" post="poses a serious threat to human health and greatly"/>
   <result pre="and greatly impacts the economy. The annual global cost of" exact="dengue fever" post="(direct and indirect) has been estimated to be $8.9"/>
   <result pre="infection (with another serotype) will develop into a severe disease," exact="dengue hemorrhagic fever" post="or dengue shock syndrome (10–13). In some tropical regions,"/>
   <result pre="17). Definitive methods used in laboratories for the diagnosis of" exact="dengue fever" post="include viral isolation, viral RNA detection, IgM/IgG antibody detection,"/>
   <result pre="28°C until cytopathic effects were observed. As a control, Japanese" exact="encephalitis" post="virus (JEV) strain SA14-14-2 was propagated in BHK-21 cells,"/>
   <result pre="serotypes with no mutual cross-reactivity and no cross-reactivity with Japanese" exact="encephalitis" post="virus or Zika virus (determined using supernatants of Vero"/>
   <result pre="there was no cross-reactivity with the NS1 proteins of Japanese" exact="encephalitis" post="virus or Zika virus derived from the supernatant from"/>
   <result pre="sera infected with viruses other than DENV, such as Japanese" exact="encephalitis" post="virus, Zika virus, or West Nile virus. At present,"/>
   <result pre="Centers for Disease Control of Taiwan confirmed 15,732 cases of" exact="dengue fever" post="in 2014 and 43,784 cases in 2015 (largely in"/>
   <result pre="of deaths than in any other previous outbreak resulted from" exact="dengue hemorrhagic fever" post="and dengue shock syndrome during the 2015 epidemic (47)."/>
   <result pre="NS1 early in dengue illness correlate with the development of" exact="dengue hemorrhagic fever." post="J Infect Dis186:1165–1168. doi:10.1086/343813.12355369 28.DussartP, LabeauB, LagathuG, LouisP, NunesMRT,"/>
   <result pre="YehTM, HuangJH, LiuCC, HalsteadSB2005Association between sex, nutritional status, severity of" exact="dengue hemorrhagic fever," post="and immune status in infants with dengue hemorrhagic fever."/>
   <result pre="of dengue hemorrhagic fever, and immune status in infants with" exact="dengue hemorrhagic fever." post="Am J Trop Med Hyg72:370–374.15827272 50.AppannaR, PonnampalavanarS, Lum Chai"/>
   <result pre="Chai SeeL, SekaranSD2010Susceptible and protective HLA class 1 alleles against" exact="dengue fever" post="and dengue hemorrhagic fever patients in a Malaysian population."/>
   <result pre="and protective HLA class 1 alleles against dengue fever and" exact="dengue hemorrhagic fever" post="patients in a Malaysian population. PLoS One5:e13029. doi:10.1371/journal.pone.0013029.20927388 51.GuzmanMG,"/>
   <result pre="of third or fourth dengue infections resulting in admissions and" exact="dengue hemorrhagic fever," post="and serotype sequences. Am J Trop Med Hyg77:910–913. doi:10.4269/ajtmh.2007.77.910.17984352"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6595505\results\search\disease\results.xml">
   <result pre="transgenic individuals were present in the environment. competence risk transgenic" exact="malaria" post="arbovirus Funding Bill &amp;amp; Melinda Gates Foundation10.13039/100000865 Open Philanthropy"/>
   <result pre="NIAID10.13039/100000060 NIH10.13039/100000002 page-count: Considerable progress is being made in reducing" exact="malaria" post="transmission using entomological methods, primarily long-lasting insecticide-treated bednets and"/>
   <result pre="most optimistic expected outcomes of existing interventions and elimination of" exact="malaria" post="(Brown and Rogerson 2016). In addition to the potential"/>
   <result pre="and drug resistance present, the shortfall in effort needed for" exact="malaria" post="elimination means that unless novel, less expensive and more"/>
   <result pre="unless novel, less expensive and more effective interventions are developed," exact="malaria" post="elimination will remain an aspiration rather than a reality"/>
   <result pre="al. 2011, Gantz et al. 2015), major vectors of human" exact="malaria" post="parasites in Africa and Asia, respectively. A potentially powerful"/>
   <result pre="respectively. A potentially powerful and economical method of introducing population" exact="suppression" post="and antipathogen effectors into populations is via ‘gene drive’"/>
   <result pre="epidemics of a severe febrile, arthralgic syndrome often confused with" exact="dengue fever." post="O’nyong-nyong (ONNV) is one of the few viruses pathogenic"/>
   <result pre="TEP1 that is known to affect A. gambiae susceptibility to" exact="malaria" post="parasites is also recruited to eliminate sperm in males"/>
   <result pre="2009Methylparaben in Anopheles gambiae s.l. sugar meals increases longevity and" exact="malaria" post="oocyst abundance but is not a preferred diet. J."/>
   <result pre="Biol. 13: 625–635.15606811 BrownG., and RogersonS.. 2016Malaria: global challenges for" exact="malaria" post="eradication. Microbiol. Aust. 37: 34–38. BurtA2014Heritable strategies for controlling"/>
   <result pre="sex ratio distortion system for the control of the human" exact="malaria" post="mosquito. Nature Comm. 5: 1–8. GantzV. M., JasinskieneN., TatarenkovaO.,"/>
   <result pre="2015Highly efficient Cas9-mediated gene drive for population modification of the" exact="malaria" post="vector mosquito Anopheles stephensi. Proc. Natl. Acad. Sci. USA."/>
   <result pre="al.2016A CRISPR-Cas9 gene drive system targeting female reproduction in the" exact="malaria" post="mosquito vector Anopheles gambiae. Nat. Biotechnol. 34: 78–83.26641531 IsaacsA."/>
   <result pre="LongC. A.. 2013Qualification of standard membrane-feeding assay with Plasmodium falciparum" exact="malaria" post="and potential improvements for future assays. PLoS One8: e57909.23483940"/>
   <result pre="Q.. 2016bBenchmarking vector arthropod culture: an example using the African" exact="malaria" post="mosquito, Anopheles gambiae (Diptera: Culicidae). Malar. J. 15: 262.27160438"/>
   <result pre="Anopheles gambiae. PLoS Genet. 4: e1000291.19057670 collab: World Health Organization2015World" exact="malaria" post="report 2015. World Health Organization, Geneva."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6608929\results\search\disease\results.xml">
   <result pre="the foreseeable future. Despite successes such as the eradication of" exact="smallpox" post="and reductions in the prevalence of falciparum malaria, there"/>
   <result pre="often the primary vector of the dengue, chikungunya, Zika, and" exact="yellow fever" post="viruses. Variation in dengue transmission risk, for instance, is"/>
   <result pre="References 1HeesterbeekH, AndersonR, AndreasenV, BansalS, De AngelisD, DyeC, et al.Modeling" exact="infectious disease" post="dynamics in the complex landscape of global health. Science."/>
   <result pre="the impact of temperature on transmission of Zika, dengue, and" exact="chikungunya" post="using mechanistic models. PLoS Negl Trop Dis. 2017;11:e000556810.1371/journal.pntd.000556828448507 4NationsUnited."/>
   <result pre="GalvaniA, MeyersL. Effects of heterogeneous and clustered contact patterns on" exact="infectious disease" post="dynamics. PloS Computational Biology. 2011;7:e100204210.1371/journal.pcbi.100204221673864 13SmithD, DushoffJ, McKenzieF. The"/>
   <result pre="Assessing the role of spatial heterogeneity and human movement in" exact="malaria" post="dynamics and control. Journal of Theoretical Biology. 2012;303:1–14. 10.1016/j.jtbi.2012.02.01022525434"/>
   <result pre="LeeJ, LevisP, FeldmanM, JonesJ. A high-resolution human contact network for" exact="infectious disease" post="transmission. Proceedings of the National Academy of Sciences. 2010;107:22020–5."/>
   <result pre="Dzul-ManzanillaF, Gomez-DantesH, Pavia-RuzN, HladishT, LenhartA, et al.Spatio-temporal coherence of dengue," exact="chikungunya" post="and ZIka outbreaks in Merida, Mexico. PLoS Negl Trop"/>
   <result pre="OuedraogoA, et al.Mathematical models of human mobility of relevance to" exact="malaria" post="transmission in Africa. Scientific Reports. 2018;8:771310.1038/s41598-018-26023-129769582 46PerkinsT, Paz-SoldanV, StoddardS,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6609753\results\search\disease\results.xml">
   <result pre="is properly cited. Abstract Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics and pandemics. A well-organized surveillance"/>
   <result pre="the epidemiologic features of influenza. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
   <result pre="related to influenza. This article discusses the general aspects of" exact="influenza" post="surveillance systems and the future direction of the national"/>
   <result pre="influenza surveillance systems and the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza Human Sentinel surveillance Population"/>
   <result pre="Population surveillance Korea Introduction Influenza is a very important respiratory" exact="infectious disease" post="that causes seasonal epidemics globally and annually among people"/>
   <result pre="but also causes pandemics every 10 to 40 years. Thus," exact="influenza" post="is considered as one of the most important among"/>
   <result pre="surveillance system is necessary to monitor and respond effectively to" exact="influenza" post="epidemics. An influenza surveillance system is useful for identifying"/>
   <result pre="necessary to monitor and respond effectively to influenza epidemics. An" exact="influenza" post="surveillance system is useful for identifying influenza epidemics, the"/>
   <result pre="influenza epidemics. An influenza surveillance system is useful for identifying" exact="influenza" post="epidemics, the nature of the virus, and the burden"/>
   <result pre="of disease, as well as determining the policies aimed at" exact="influenza" post="epidemic control, vaccine selection, and the development of guidelines"/>
   <result pre="development of guidelines for the use of antiviral drugs. An" exact="influenza" post="surveillance system can also be used to monitor influenza"/>
   <result pre="An influenza surveillance system can also be used to monitor" exact="influenza" post="pandemics and new respiratory infectious diseases. Korea currently operates"/>
   <result pre="and new respiratory infectious diseases. Korea currently operates a national" exact="influenza" post="surveillance system based on the clinical sentinel surveillance system,"/>
   <result pre="pieces of information related to influenza. This article reviews the" exact="influenza" post="surveillance system characteristics, foreign surveillance systems, including those of"/>
   <result pre="Health Organization (WHO) and the United States (US), and the" exact="influenza" post="surveillance system of Korea. It further discusses the future"/>
   <result pre="Korea. It further discusses the future direction of the national" exact="influenza" post="surveillance system of Korea. Influenza surveillance systems in general"/>
   <result pre="or passive or active surveillance systems [4]. In countries operating" exact="influenza" post="surveillance systems, the most common form is active sentinel"/>
   <result pre="and laboratory data [5678]. There are two major forms of" exact="influenza" post="surveillance systems: clinical sentinel surveillance and virologic sentinel surveillance"/>
   <result pre="[9]. A clinical sentinel surveillance system is used to identify" exact="influenza" post="outbreaks and epidemics, establish a vaccination plan, initiate antiviral"/>
   <result pre="other indicators can be used that represent the burden of" exact="influenza" post="in the community such as absenteeism, or that show"/>
   <result pre="community such as absenteeism, or that show the severity of" exact="influenza" post="or burden from the healthcare perspective such as emergency"/>
   <result pre="OPD-based surveillance systems are used to determine the occurrence of" exact="influenza" post="epidemics by monitoring the ratio of the number of"/>
   <result pre="distribution and population characteristics among OPD clinics that directly treat" exact="influenza" post="patients. The selected sites report the information of patients"/>
   <result pre="participating sites, virologic surveillance data, geographical and demographic characteristics, and" exact="influenza" post="vaccination rate. The hospitalization-based surveillance system contributes to the"/>
   <result pre="contributes to the understanding of the severity and burden of" exact="influenza" post="by monitoring cases of severe acute respiratory illness (SARI),"/>
   <result pre="progression than other respiratory viruses. The main anticipated effect of" exact="influenza" post="vaccination is to reduce the burden of influenza. Therefore,"/>
   <result pre="determine the appropriateness and evaluate the effectiveness of policies for" exact="influenza" post="control. Data collected through both surveillance systems can be"/>
   <result pre="collected through both surveillance systems can be used to assess" exact="influenza" post="vaccine effectiveness. However, a procedure for increasing the accuracy"/>
   <result pre="vaccine effectiveness. However, a procedure for increasing the accuracy of" exact="influenza" post="vaccination history is required to evaluate the influenza vaccine"/>
   <result pre="accuracy of influenza vaccination history is required to evaluate the" exact="influenza" post="vaccine effectiveness accurately. In addition, a sufficient number of"/>
   <result pre="the vaccine effect by virus type/subtypes and age groups. Foreign" exact="influenza" post="surveillance systems 1. World Health Organization The WHO discussion"/>
   <result pre="Health Organization The WHO discussion on the operation of the" exact="influenza" post="network began in 1951 at a conference held in"/>
   <result pre="Pandemic Influenza Preparedness Framework was adopted, which involved sharing of" exact="influenza" post="virus characteristics and other benefits of vaccines, and its"/>
   <result pre="and Response System (GISRS). The GISRS consists of 144 national" exact="influenza" post="centers, 6 WHO collaborating centers (CCs), 4 essential regulatory"/>
   <result pre="13 H5 reference laboratories (H5RefLabs) as of 2019 [11]. National" exact="influenza" post="centers collect virus specimens, and ship representative clinical specimens"/>
   <result pre="antigenic and genetic analysis. The WHO recommends the composition of" exact="influenza" post="vaccines based on the results of the analysis. WHO"/>
   <result pre="the six WHO CCs is responsible for surveillance, epidemiology, and" exact="influenza" post="prevention. Essential regulatory laboratories have the critical function of"/>
   <result pre="critical function of connecting surveillance and risk assessment activities with" exact="influenza" post="vaccine response. H5RefLabs were established in 2004, in response"/>
   <result pre="2004, in response to the public health needs arising from" exact="avian influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
   <result pre="in response to the public health needs arising from avian" exact="influenza" post="A/H5N1 infection in humans and influenza pandemic preparedness. H5RefLabs"/>
   <result pre="needs arising from avian influenza A/H5N1 infection in humans and" exact="influenza" post="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or"/>
   <result pre="in humans and influenza pandemic preparedness. H5RefLabs collect and analyze" exact="influenza" post="A/H5N1 or other influenza subtypes that can potentially cause"/>
   <result pre="pandemic preparedness. H5RefLabs collect and analyze influenza A/H5N1 or other" exact="influenza" post="subtypes that can potentially cause human infections. The data"/>
   <result pre="database and presented via FluNet, a global web-based tool for" exact="influenza" post="virologic surveillance first launched in 1997. The virologic data"/>
   <result pre="[12]. Thus, in many countries, data on the burden of" exact="influenza" post="are being prepared [13141516]. 2. United States The US"/>
   <result pre="five categories of information from eight different data sources on" exact="influenza" post="activity year-round: virologic surveillance, outpatient illness surveillance, summary of"/>
   <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the percentage of positive test results"/>
   <result pre="test results, and the percentage of positive test results by" exact="influenza" post="virus type. Public health laboratories also report other kinds"/>
   <result pre="weekly total number of specimens tested, the number of positive" exact="influenza" post="test results, and the number by influenza virus type,"/>
   <result pre="number of positive influenza test results, and the number by" exact="influenza" post="virus type, subtype, and influenza B lineage. Outpatient illness"/>
   <result pre="results, and the number by influenza virus type, subtype, and" exact="influenza" post="B lineage. Outpatient illness surveillance. Information on outpatient visits"/>
   <result pre="departments report the estimated level of the geographic spread of" exact="influenza" post="activity in their states each week through the State"/>
   <result pre="each week through the State and Territorial Epidemiologists Reports. The" exact="influenza" post="activity is classified at five levels: no activity, sporadic,"/>
   <result pre="Influenza. Each state reports on the weekly geographic spread of" exact="influenza" post="activity through the State and Territorial Epidemiologists Reports. Influenza"/>
   <result pre="Influenza Hospitalization Surveillance Network monitors laboratory-confirmed influenza-associated hospitalization. During the" exact="influenza" post="season, data are collected from cases with laboratory-confirmed influenza."/>
   <result pre="mortality surveillance system. The National Center for Health Statistics collects" exact="pneumonia" post="and influenza mortality data from each state based on"/>
   <result pre="system. The National Center for Health Statistics collects pneumonia and" exact="influenza" post="mortality data from each state based on ICD-10 codes."/>
   <result pre="from each state based on ICD-10 codes. The seasonal baseline" exact="pneumonia" post="and influenza mortality rate is estimated using a periodic"/>
   <result pre="state based on ICD-10 codes. The seasonal baseline pneumonia and" exact="influenza" post="mortality rate is estimated using a periodic regression model."/>
   <result pre="2004, deaths among children younger than 18 years with laboratory-confirmed" exact="influenza" post="have been added as a nationally notifiable condition. In"/>
   <result pre="been operating a vaccine effectiveness surveillance [18]. Surveillance for monitoring" exact="influenza" post="vaccine effectiveness is managed separately by the US Flu"/>
   <result pre="At the participating sites, respiratory specimens are collected for isolating" exact="influenza" post="viruses together with demographic and medical information, including underlying"/>
   <result pre="together with demographic and medical information, including underlying diseases and" exact="influenza" post="vaccination history. The two networks assess and report influenza"/>
   <result pre="and influenza vaccination history. The two networks assess and report" exact="influenza" post="vaccine effectiveness separately during each season [1920]. The US"/>
   <result pre="each season [1920]. The US CDC calculates and reports the" exact="influenza" post="disease burden using the Influenza surveillance data, and the"/>
   <result pre="aim of the EISN is to contribute to reducing the" exact="influenza" post="burden in Europe. The EISN originated in the European"/>
   <result pre="member states in Europe. Each member state has a separate" exact="influenza" post="surveillance system and case definition for the surveillance. The"/>
   <result pre="influenza-positive cases from intensive care units. 4. Japan The national" exact="influenza" post="surveillance system of Japan is affiliated to the National"/>
   <result pre="sentinel surveillance systems for various kinds of infectious diseases including" exact="influenza" post="[23]. The sentinel outpatient surveillance system has been applied"/>
   <result pre="[23]. The sentinel outpatient surveillance system has been applied to" exact="influenza" post="surveillance. Sentinel sites were designated according to the geographic"/>
   <result pre="with ILI every week. Virologic surveillance, consisting of testing for" exact="influenza" post="virus and the analysis of viral antigenicity, is incorporated"/>
   <result pre="for hospitalization surveillance. Japan has monitored the incidence of influenza-associated" exact="encephalopathy" post="since the late 1990s. Japan has a surveillance system"/>
   <result pre="school closures. The law of Japan states that children with" exact="influenza" post="infection should stay home for at least 6 days"/>
   <result pre="the school can be closed to stop the transmission of" exact="influenza" post="depending on the size of influenza outbreaks. In addition"/>
   <result pre="stop the transmission of influenza depending on the size of" exact="influenza" post="outbreaks. In addition to the surveillance system operated by"/>
   <result pre="is organized by volunteer clinicians who report the number of" exact="influenza" post="patients diagnosed at their clinics through the ML-Influenza Database."/>
   <result pre="diagnosed at their clinics through the ML-Influenza Database. The current" exact="influenza" post="surveillance system of Korea The influenza surveillance system of"/>
   <result pre="ML-Influenza Database. The current influenza surveillance system of Korea The" exact="influenza" post="surveillance system of Korea was initiated in October 1997"/>
   <result pre="since 2000 to the Korea Influenza Surveillance Scheme. Currently, the" exact="influenza" post="surveillance system operated by the Korea CDC consists of"/>
   <result pre="surveillance (Korea Influenza and Respiratory Virus Surveillance System [KINRESS]), and" exact="influenza" post="hospitalization and mortality surveillance systems [24]. Clinical sentinel surveillance."/>
   <result pre="of the following year. The data are used to identify" exact="influenza" post="epidemics in Korea. Laboratory sentinel surveillance. KINRESS is operated"/>
   <result pre="reexamination of unidentified specimens. Based on these results, the circulating" exact="influenza" post="viruses in Korea are identified, and the characteristics of"/>
   <result pre="patients diagnosed with influenza. Medical histories are also collected, including" exact="influenza" post="vaccination history, underlying medical condition, travel history, and the"/>
   <result pre="have been used to analyze the clinical course of severe" exact="influenza" post="[2627], influenza disease burden [28], characteristics of influenza viruses"/>
   <result pre="used to analyze the clinical course of severe influenza [2627]," exact="influenza" post="disease burden [28], characteristics of influenza viruses that caused"/>
   <result pre="of severe influenza [2627], influenza disease burden [28], characteristics of" exact="influenza" post="viruses that caused severe clinical course [29], influenza vaccine"/>
   <result pre="characteristics of influenza viruses that caused severe clinical course [29]," exact="influenza" post="vaccine effectiveness, and so on. In addition to surveillance"/>
   <result pre="addition to surveillance for severe influenza, there is surveillance for" exact="avian influenza" post="viruses that can cause human infection such as A/H7N9"/>
   <result pre="to surveillance for severe influenza, there is surveillance for avian" exact="influenza" post="viruses that can cause human infection such as A/H7N9"/>
   <result pre="to be operated at nine hospitals. The future direction of" exact="influenza" post="surveillance systems in Korea Influenza comprises not only a"/>
   <result pre="part of the government budget has been used to target" exact="influenza" post="vaccination. Influenza vaccination among the elderly has been included"/>
   <result pre="immunization program from the 2019–2020 season. Considering the impact of" exact="influenza" post="and the continuous change in the characteristics of influenza"/>
   <result pre="of influenza and the continuous change in the characteristics of" exact="influenza" post="viruses, a proper surveillance system is essential in Korea."/>
   <result pre="a proper surveillance system is essential in Korea. The national" exact="influenza" post="surveillance system currently operated by the government has played"/>
   <result pre="by the government has played an important role in identifying" exact="influenza" post="epidemic patterns and virus characteristics in Korea. However, it"/>
   <result pre="KCDC provides a limited understanding of the characteristics of serious" exact="influenza" post="and its disease burden. The hospitalization and mortality surveillance"/>
   <result pre="difficult to identify the characteristics of viruses associated with severe" exact="influenza" post="because specimens are not collected. If it is not"/>
   <result pre="of influenza. In the US, when assessing the burden of" exact="influenza" post="illness, the spectrum of influenza from mild to dead"/>
   <result pre="when assessing the burden of influenza illness, the spectrum of" exact="influenza" post="from mild to dead is estimated based on hospitalized"/>
   <result pre="Another limitation is the difficulty in assessing the effectiveness of" exact="influenza" post="vaccines. Although information regarding influenza vaccination history has been"/>
   <result pre="in assessing the effectiveness of influenza vaccines. Although information regarding" exact="influenza" post="vaccination history has been collected, the reliability of the"/>
   <result pre="outpatients and inpatients. An example is the surveillance system for" exact="influenza" post="vaccine effectiveness in the US. The assessment of the"/>
   <result pre="effectiveness in the US. The assessment of the burden of" exact="influenza" post="and the evaluation of the vaccine effectiveness is very"/>
   <result pre="cannot fulfill every purpose. To meet the unmet need of" exact="influenza" post="surveillance in Korea, therefore, it does not simply suffice"/>
   <result pre="simply suffice to adjust the data collected from the existing" exact="influenza" post="surveillance system. The national influenza surveillance system currently operated"/>
   <result pre="data collected from the existing influenza surveillance system. The national" exact="influenza" post="surveillance system currently operated in Korea is relatively well-organized"/>
   <result pre="However, more needs to be done to better cope with" exact="influenza" post="considering the influenza situation of Korea and foreign surveillance"/>
   <result pre="to be done to better cope with influenza considering the" exact="influenza" post="situation of Korea and foreign surveillance systems. A better"/>
   <result pre="support proper policy making and produce enough scientific evidence regarding" exact="influenza" post="control. Conflict of Interest: No conflicts of interest. References"/>
   <result pre="Economic Area countries, 2009 to 2013Euro Surveill2018231700454 2GrossPAHermogenesAWSacksHSLauJLevandowskiRAThe efficacy of" exact="influenza" post="vaccine in elderly persons. A meta-analysis and review of"/>
   <result pre="literatureAnn Intern Med19951235185277661497 3DollMKWintersNBoikosCKraicer-MelamedHGoreGQuachCSafety and effectiveness of neuraminidase inhibitors for" exact="influenza" post="treatment, prophylaxis, and outbreak control: a systematic review of"/>
   <result pre="Med Public Health20074025926417693727 5SanicasMForleoEPozziGDiopDA review of the surveillance systems of" exact="influenza" post="in selected countries in the tropical regionPan Afr Med"/>
   <result pre="in the tropical regionPan Afr Med J20141912125745529 6ThommesEWKruseMKohliMSharmaRNoorduynSGReview of seasonal" exact="influenza" post="in Canada: Burden of disease and the cost-effectiveness of"/>
   <result pre="Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated" exact="influenza" post="vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of influenza surveillance systems in"/>
   <result pre="cost-effectiveness of quadrivalent inactivated influenza vaccinesHum Vaccin Immunother20171386787627858509 7SambalaEZNdwandweDEImaanLMWiysongeCSEvaluation of" exact="influenza" post="surveillance systems in sub-Saharan Africa: a systematic review protocolBMJ"/>
   <result pre="sub-Saharan Africa: a systematic review protocolBMJ Open20199e023335 8YangPDuanWLvMShiWPengXWangXLuYLiangHSealeHPangXWangQReview of an" exact="influenza" post="surveillance system, Beijing, People's Republic of ChinaEmerg Infect Dis2009151603160819861053"/>
   <result pre="9KimWJNohJYParkMSSongJYShinOAhnDHWieSHLeeJSJangJCheongHJChunBCChoiYKChoiWSInfluenzaSeoulTransgovernmental Enterprise for Pandemic Influenza in Korea2016 10ZieglerTMamahitACoxNJ65 years of" exact="influenza" post="surveillance by a World Health Organization-coordinated global networkInfluenza Other"/>
   <result pre="Organization-coordinated global networkInfluenza Other Respir Viruses201812558565 11collab: World Heaith OrganizationGlobal" exact="influenza" post="surveillance and response system (GISRS)Accessed 22 April 2019Available at:"/>
   <result pre="12ChaiyakunaprukNKotirumSNewallATLambachPHutubessyRCWRationale and opportunities in estimating the economic burden of seasonal" exact="influenza" post="across countries using a standardized WHO tool and manualInfluenza"/>
   <result pre="Viruses201812132129143498 13OlivaJDelgado-SanzCLarrauriAcollab: Spanish Influenza Surveillance SystemEstimating the burden of seasonal" exact="influenza" post="in Spain from surveillance of mild and severe influenza"/>
   <result pre="seasonal influenza in Spain from surveillance of mild and severe" exact="influenza" post="disease, 2010-2016Influenza Other Respir Viruses20181216117028960828 14SchanzerDLSabouiMLeeLNwosuABancejCBurden of influenza, respiratory"/>
   <result pre="respiratory inpatients, Canada, 2003-2014Influenza Other Respir Viruses20181211312129243369 15SimmermanJMUyekiTMThe burden of" exact="influenza" post="in East and South-East Asia: a review of the"/>
   <result pre="Infect Dis2018241173117729912681 17collab: Centers for Disease Control and PreventionOverview of" exact="influenza" post="surveillance in the United StatesAccessed 22 April 2019Available at:"/>
   <result pre="2019Available at: https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm 19TreanorJJTalbotHKOhmitSEColemanLAThompsonMGChengPYPetrieJGLofthusGMeeceJKWilliamsJVBermanLBreese HallCMontoASGriffinMRBelongiaEShayDKcollab: US Flu-VE NetworkEffectiveness of seasonal" exact="influenza" post="vaccines in the United States during a season with"/>
   <result pre="three vaccine strainsClin Infect Dis20125595195922843783 20FerdinandsJMGaglaniMMartinETMiddletonDMontoASMurthyKSilveiraFPTalbotHKZimmermanRAlyanakEStricklandCSpencerSFryAMcollab: HAIVEN Study InvestigatorsPrevention of" exact="influenza" post="hospitalization among adults in the US, 2015-16: Results from"/>
   <result pre="ahead of print 21RolfesMAFoppaIMGargSFlanneryBBrammerLSingletonJABurnsEJerniganDOlsenSJBreseeJReedCAnnual estimates of the burden of seasonal" exact="influenza" post="in the United States: a tool for strengthening influenza"/>
   <result pre="seasonal influenza in the United States: a tool for strengthening" exact="influenza" post="surveillance and preparednessInfluenza Other Respir Viruses20181213213729446233 22collab: European Centre"/>
   <result pre="Respir Viruses20181213213729446233 22collab: European Centre for Disease Prevention and ControlEuropean" exact="influenza" post="surveillance network (EISN)Accessed 2 April 2019Available at: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eisn 23ZaraketHSaitoRJapanese"/>
   <result pre="24collab: Korea Centers for Disease Control and Prevention (KCDC)2018-2019 season" exact="influenza" post="management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based influenza morbidity and mortality surveillance system"/>
   <result pre="Disease Control and Prevention (KCDC)2018-2019 season influenza management guidelineOsongKCDC2018 25SeoYBSongJYCheongHJChoYDWieSHJeongHWKimWJHospital-based" exact="influenza" post="morbidity and mortality surveillance system for influenza-like illnesses: a"/>
   <result pre="mortality surveillance system for influenza-like illnesses: a comparison with national" exact="influenza" post="surveillance systemsInfluenza Other Respir Viruses20148172024020512 26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes"/>
   <result pre="26HongKWCheongHJChoiWSLeeJWieSHBaekJHKimHYJeongHWKimWJClinical courses and outcomes of hospitalized adult patients with seasonal" exact="influenza" post="in Korea, 2011-2012: Hospital-based Influenza Morbidity &amp;amp; Mortality (HIMM)"/>
   <result pre="27KangSHCheongHJSongJYNohJYJeonJHChoiMJLeeJSeoYBLeeJSWieSHJeongHWKimYKParkKHKimSWJeongEJLeeSHChoiWSKimWJAnalysis of risk factors for severe acute respiratory infection and" exact="pneumonia" post="and among adult patients with acute respiratory illness during"/>
   <result pre="and among adult patients with acute respiratory illness during 2011-2014" exact="influenza" post="seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal"/>
   <result pre="influenza seasons in KoreaInfect Chemother20164829430127883375 28ChoiWSCowlingBJNohJYSongJYWieSHLeeJSSeoYBLeeJJeongHWKimYKKimSWParkKHLeeSHCheongHJKimWJDisease burden of 2013-2014 seasonal" exact="influenza" post="in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of"/>
   <result pre="influenza in adults in KoreaPLoS One201712e017201228278158 29LeeHSNohJYSongJYCheongHJChoiWSJeongHWWieSHKimWJMolecular genetic characteristics of" exact="influenza" post="A virus clinically isolated during 2011-2016 influenza seasons in"/>
   <result pre="genetic characteristics of influenza A virus clinically isolated during 2011-2016" exact="influenza" post="seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity"/>
   <result pre="during 2011-2016 influenza seasons in KoreaInfluenza Other Respir Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based" exact="influenza" post="morbidity and mortality (HIMM) surveillance for A/H7N9 influenza virus"/>
   <result pre="Viruses20181249750729489060 30SongJYNohJYLeeJWooHJLeeJSWieSHKimYKJeongHWKimSWLeeSHParkKHKangSHKeeSYKimTHChooEJLeeHSChoiWSCheongHJKimWJHospital-based influenza morbidity and mortality (HIMM) surveillance for A/H7N9" exact="influenza" post="virus infection in returning travelersJ Korean Med Sci201833e4929359537 31collab:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6610691\results\search\disease\results.xml">
   <result pre="nervous system cerebrospinal fluid children dengue virus flavivirus Saint Louis" exact="encephalitis" post="virus Zika virus Introduction Aseptic meningoencephalitis is an important"/>
   <result pre="virus flavivirus Saint Louis encephalitis virus Zika virus Introduction Aseptic" exact="meningoencephalitis" post="is an important cause of mortality and morbidity in"/>
   <result pre="of children in the USA whereas in Asia the Japanese" exact="encephalitis" post="virus is found most often [2], [3]. Japanese encephalitis"/>
   <result pre="Japanese encephalitis virus is found most often [2], [3]. Japanese" exact="encephalitis" post="virus, and some representatives of the Flavivirus genus (family"/>
   <result pre="neurotropic viruses, including West Nile virus (WNV) and Saint Louis" exact="encephalitis" post="virus (SLEV) [4]. However, in recent years, other members"/>
   <result pre="Brazilian Ministry of Health [16] reported 7237 notified cases of" exact="meningitis" post="probably caused by viruses. Our group investigated 299 cases"/>
   <result pre="viruses. Our group investigated 299 cases of children with suspected" exact="meningoencephalitis" post="from 2014 to 2018 in Minas Gerais State, Brazil"/>
   <result pre="DENV RNA was found in CSF samples from children with" exact="meningoencephalitis" post="tested during the 2014/2015 epidemic in Minas Gerais State,"/>
   <result pre="these patients was an 11-year-old girl with a diagnosis of" exact="encephalitis" post="and positive serum IgM [20]. In Espírito Santo State,"/>
   <result pre="Viral diagnosis CNS manifestation State References Dengue virus 1 serological" exact="encephalitis" post="Rio de Janeiro Soares et al. 2006 [20] 1"/>
   <result pre="Rio de Janeiro Soares et al. 2006 [20] 1 serological" exact="acute disseminated encephalomyelitis" post="Rondônia Miranda de Sousa et al. 2006 [22] 2"/>
   <result pre="Janeiro Soares et al. 2006 [20] 1 serological acute disseminated" exact="encephalomyelitis" post="Rondônia Miranda de Sousa et al. 2006 [22] 2"/>
   <result pre="Rondônia Miranda de Sousa et al. 2006 [22] 2 PCR" exact="encephalitis" post="Espírito Santo Domingues et al. 2007 [21] 3 serological"/>
   <result pre="encephalitis Espírito Santo Domingues et al. 2007 [21] 3 serological" exact="meningitis" post="Ceará Araujo et al. 2012 [19] 7 PCR and"/>
   <result pre="Ceará Araujo et al. 2012 [19] 7 PCR and serological" exact="meningoencephalitis" post="Minas Gerais Marinho et al. 2017 [17] 5 PCR"/>
   <result pre="Gerais Marinho et al. 2017 [17] 5 PCR and serological" exact="meningitis" post="Minas Gerais De Oliveira et al. 2017 [18] 5"/>
   <result pre="et al. 2017 [18] 5 PCR and serological Encephalitis and" exact="meningitis" post="Amazonas Bastos et al. 2018 [23] Saint Louis encephalitis"/>
   <result pre="and meningitis Amazonas Bastos et al. 2018 [23] Saint Louis" exact="encephalitis" post="virus 3 PCR meningoencephalitis São Paulo Mondini et al."/>
   <result pre="et al. 2018 [23] Saint Louis encephalitis virus 3 PCR" exact="meningoencephalitis" post="São Paulo Mondini et al. 2007 [32] Zika virus"/>
   <result pre="Paulo Mondini et al. 2007 [32] Zika virus 1 PCR" exact="encephalitis" post="— Silva Vieira et al. 2018 [26] A case"/>
   <result pre="Silva Vieira et al. 2018 [26] A case of post-infection" exact="acute disseminated encephalomyelitis" post="was reported in a child by de Miranda de"/>
   <result pre="et al. 2018 [26] A case of post-infection acute disseminated" exact="encephalomyelitis" post="was reported in a child by de Miranda de"/>
   <result pre="anti-dengue IgM antibodies in the serum and CSF, indicating that" exact="neuromyelitis optica" post="may be caused by DENV. Recently a study carried"/>
   <result pre="with meningitis/encephalitis. All children presented cytological CSF characteristic of viral" exact="meningoencephalitis" post="[23]. Zika virus The circulation of ZIKV has been"/>
   <result pre="[4], [6], [25]. In Brazil, only a single case of" exact="encephalitis" post="has been described in an 8-year-old child with ZIKV"/>
   <result pre="(unpublished data), 3% of CSF samples from children with suspected" exact="meningoencephalitis" post="were ZIKV positive by PCR. Although studies have primarily"/>
   <result pre="suggest that the virus is an important causative agent of" exact="meningoencephalitis" post="in paediatric patients. Saint Louis encephalitis virus Saint Louis"/>
   <result pre="important causative agent of meningoencephalitis in paediatric patients. Saint Louis" exact="encephalitis" post="virus Saint Louis encephalitis virus was first isolated in"/>
   <result pre="meningoencephalitis in paediatric patients. Saint Louis encephalitis virus Saint Louis" exact="encephalitis" post="virus was first isolated in 1933 during a major"/>
   <result pre="as the main targets for flavivirus infection such as Japanese" exact="encephalitis" post="virus in CNS in mice model and they described"/>
   <result pre="be similar in both children and adults [11], [23], with" exact="rash" post="observed in approximately 50% of patients, particularly children [11]."/>
   <result pre="children were seizures or tonic-clonic seizures, convulsions [5], [14], [26];" exact="meningitis" post="signs with acute onset of fever, headache, vomiting, nuchal"/>
   <result pre="with acute onset of fever, headache, vomiting, nuchal rigidity [19];" exact="encephalitis" post="signs of cerebral involvement with altered consciousness or cognition"/>
   <result pre="flavivirus. Soares et al.[20] had 57% of the cases of" exact="meningitis" post="caused by DENV with normal chemocytological CSF. Other studies"/>
   <result pre="system infections in hospitalised Cambodian childrenBMC Infect Dis17201780629284418 3HasbunR.WoottonS.H.RosenthalN.Balada-LlasatJ.M.ChungJ.DuffS.Epidemiology of" exact="meningitis" post="and encephalitis in infants and children in the United"/>
   <result pre="in hospitalised Cambodian childrenBMC Infect Dis17201780629284418 3HasbunR.WoottonS.H.RosenthalN.Balada-LlasatJ.M.ChungJ.DuffS.Epidemiology of meningitis and" exact="encephalitis" post="in infants and children in the United States, 2011–2014Pediatr"/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: a case studyLancet Infect Dis16201665366026897108 13O'LearyD.R.KuhnS.KnissK.L.HinckleyA.F.RasmussenS.A.PapeW.J.Birth outcomes"/>
   <result pre="serotypes in childrenBrazil Emerg Infect Dis23201711511827983492 18de OliveiraD.B.CandianiT.M.Franco-LuizA.P.M.AlmeidaG.M.F.AbrahãoJ.S.RiosM.Etiological agents of" exact="viral meningitis" post="in children from a dengue-endemic area, Southeast region of"/>
   <result pre="in childrenBrazil Emerg Infect Dis23201711511827983492 18de OliveiraD.B.CandianiT.M.Franco-LuizA.P.M.AlmeidaG.M.F.AbrahãoJ.S.RiosM.Etiological agents of viral" exact="meningitis" post="in children from a dengue-endemic area, Southeast region of"/>
   <result pre="in a Brazilian childRev Soc Bras Med Trop51201839039229972576 27RoccoI.M.SantosC.L.BisordiI.PetrellaS.M.PereiraL.E.SouzaR.P.St. Louis" exact="encephalitis" post="virus: first isolation from a human in São Paulo"/>
   <result pre="BrazilRev Inst Med Trop Sao Paulo47200528128516302112 28CauseyO.R.ShopeR.E.TheilerM.Isolation of St. Louis" exact="encephalitis" post="virus from arthropods in Para, BrazilAm J Trop Med"/>
   <result pre="of the Pantanal, BrazilPLoS Negl Trop Dis82014e2706 31SilvaJ.R.RomeiroM.F.SouzaW.M.MunhozT.D.BorgesG.P.SoaresO.A.A Saint Louis" exact="encephalitis" post="and Rocio virus serosurvey in Brazilian horsesRev Soc Bras"/>
   <result pre="serosurvey in Brazilian horsesRev Soc Bras Med Trop47201441441725229279 32MondiniA.CardealI.L.LázaroE.NunesS.H.MoreiraC.C.RahalP.Saint Louis" exact="encephalitis" post="virus, BrazilEmerg Infect Dis13200717617817370543 33PetersenL.R.BraultA.C.NasciR.S.West Nile virus: review of"/>
   <result pre="nervous system and neuroinflammation precede blood–brain barrier disruption during Japanese" exact="encephalitis" post="virus infectionJ Virol8920155602561425762733 35RamosC.SánchezG.PandoR.H.BaqueraJ.HernándezD.MotaJ.Dengue virus in the brain of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6611972\results\search\disease\results.xml">
   <result pre="in FP and whose ability to transmit dengue, zika and" exact="chikungunya" post="viruses is well known. In addition, we discuss the"/>
   <result pre="risk for new emergences. Keywords Aedes aegypti Aedes polynesiensis arboviruses" exact="chikungunya" post="virus Culex annulirostris dengue virus French Polynesia mosquito vectors"/>
   <result pre="mentioned in old written works [1]. Zika virus (ZIKV) and" exact="chikungunya" post="virus (CHIKV) were introduced in 2013 and 2014, respectively,"/>
   <result pre="strains of mosquitoes were developed by manipulating Wolbachia to induce" exact="infertility" post="between a Wolbachia-infected male mosquito and an uninfected female"/>
   <result pre="C. annulirostris, C. sitiens and C. quinquefasciatus may transmit Japanese" exact="encephalitis" post="virus [51] and, with A. vexans, West Nile virus"/>
   <result pre="Nile virus [43], [52]. Aedes aegypti is a vector of" exact="yellow fever" post="virus [53]. Consequently, these arboviruses are a risk for"/>
   <result pre="Aedes aegypti and Aedes polynesiensis populations from French Polynesia for" exact="chikungunya" post="virusPLoS Negl Trop Dis102016e0004694 7RichardV.ViallonJ.Cao-LormeauV.M.Use of centrifugal filter devices"/>
   <result pre="strains to oral and parenteral infection with dengue and Japanese" exact="encephalitis" post="virusesAm J Trop Med Hyg3419856036152860816 11CalvezE.MoussonL.VazeilleM.O'ConnorO.Cao-LormeauV.M.Mathieu-DaudeF.Zika virus outbreak in"/>
   <result pre="River virus vectors at Maroochy Shire, AustraliaJ Med Entomol37200014615215218919 32MillerB.R.MonathT.P.TabachnickW.J.EzikeV.I.Epidemic" exact="yellow fever" post="caused by an incompetent mosquito vectorTrop Med Parasitol4019893963992623418 33MitchellC.J.GublerD.J.Vector"/>
   <result pre="51OliveiraA.R.S.StratheE.EtcheverryL.CohnstaedtL.W.McVeyD.S.PiaggioJ.Assessment of data on vector and host competence for Japanese" exact="encephalitis" post="virus: a systematic review of the literaturePrev Vet Med1542018718929685447"/>
   <result pre="Res Public Health1020133735375223965926 53KlittingR.GouldE.A.PaupyC.de LamballerieX.What does the future hold for" exact="yellow fever" post="virus? (I)Genes62018"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6612077\results\search\disease\results.xml">
   <result pre="pathogenicity with other family members such as dengue virus (DENV)," exact="yellow fever" post="virus (YFV), West Nile virus (WNV) and Japanese encephalitis"/>
   <result pre="yellow fever virus (YFV), West Nile virus (WNV) and Japanese" exact="encephalitis" post="virus (JEV) [2]. Approximately 80% of Zika infections are"/>
   <result pre="non-specific clinical symptoms such as mild fever, rash, arthralgia, myalgia," exact="conjunctivitis" post="and headache [5]. Nevertheless, sometimes ZIKV infection can lead"/>
   <result pre="complications, such as Guillain-Barre Syndrome in adults [6, 7] and" exact="microcephaly" post="in neonates [8]. ZIKV is transmitted to humans mainly"/>
   <result pre="been a challenging aspect in the control and prevention of" exact="infectious disease," post="for their ability to spread virus and high mobility"/>
   <result pre="Rep201771582910.1038/s41598-017-05013-928724972 5.PetersenLRJamiesonDJPowersAMHoneinMAZika VirusN Engl J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome," exact="acute disseminated encephalomyelitis" post="and encephalitis associated with Zika virus infection in Brazil:"/>
   <result pre="VirusN Engl J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome, acute disseminated" exact="encephalomyelitis" post="and encephalitis associated with Zika virus infection in Brazil:"/>
   <result pre="J Med2016374161552156310.1056/NEJMra160211327028561 6.BritoFMAntunesDBCMoreiraAde MoraisMMHenriques-SouzaAet al.Guillain-Barre syndrome, acute disseminated encephalomyelitis and" exact="encephalitis" post="associated with Zika virus infection in Brazil: detection of"/>
   <result pre="the Australian blood supply?Aust N Z J Public Health201842110410510.1111/1753-6405.1269728749569 16.KielyPWoodEMGambhirMChengACMcQuiltenZKSeedCREmerging" exact="infectious disease" post="agents and blood safety in Australia: spotlight on Zika"/>
   <result pre="United States in 2002N Engl J Med2003349131236124510.1056/NEJMoa03096914500806 35.Transfusion-related transmission of" exact="yellow fever" post="vaccine virus--California, 2009. MMWR Morb Mortal Wkly Rep, 2010."/>
   <result pre="virus in sera of Brazilian blood donorsTransfusion20125281667167110.1111/j.1537-2995.2012.03729.x22670858 40.GallianPLeparc-GoffartIRichardPMaireFFlusinODjoudiRet al.Epidemiology of" exact="chikungunya" post="virus outbreaks in Guadeloupe and Martinique, 2014: an observational"/>
   <result pre="global epidemiology: to screen or not to screen?Transfusion20125281634163910.1111/j.1537-2995.2012.03747.x22882092 42.StramerSLHollingerFBKatzLMKleinmanSMetzelPSet al.Emerging" exact="infectious disease" post="agents and their potential threat to transfusion safetyTransfusion200949Suppl 21S29S10.1111/j.1537-2995.2009.02279.x19686562"/>
   <result pre="in red blood cells using amustaline and glutathioneTransfusion201757122888289610.1111/trf.1431828921542 50.LaughhunnAHuangYSVanlandinghamDLLanteriMCStassinopoulosAInactivation of" exact="chikungunya" post="virus in blood components treated with amotosalen/ultraviolet a light"/>
   <result pre="Pharmacol Ther201746977377910.1111/apt.1431928892184 53.FordACMarwahaALimAMoayyediPSystematic review and meta-analysis of the prevalence of" exact="irritable bowel syndrome" post="in individuals with dyspepsiaClin Gastroenterol Hepatol20108540140910.1016/j.cgh.2009.07.02019631762"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6614477\results\search\disease\results.xml">
   <result pre="family Flaviviridae, similar to dengue, West Nile, Japanese encephalitis, and" exact="yellow fever" post="viruses1. ZIKV was first identified in a sentinel rhesus"/>
   <result pre="for both viral and bacterial diseases. Notably, during the 1918" exact="influenza" post="pandemic, serum from recovered patients was used successfully to"/>
   <result pre="role of convalescent serum therapy expanded to many infections beyond" exact="influenza" post="during the first half of the 20th century with"/>
   <result pre="severity) m1 m2 m3 m4 m5 m6 m7 m8 Nonsuppurative" exact="encephalitis" post="Ctl ++ ++ ++ ++ +++ +++ +++ N/A"/>
   <result pre="0 0 0 + + + + 0/+ (0.50) Nonsuppurative" exact="meningitis" post="Ctl + ++ ++ ++ ++ ++ ++ N/A"/>
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: a case studyLancet Infect Dis20161665366010.1016/S1473-3099(16)00095-526897108 7.MlakarJet al.Zika"/>
   <result pre="Confirmed CasesClin Infect Dis2017641302130810.1093/cid/cix16628329257 37.LukeTCKilbaneEMJacksonJLHoffmanSLMeta-analysis: convalescent blood products for Spanish" exact="influenza" post="pneumonia: a future H5N1 treatment?Ann Intern Med200614559960910.7326/0003-4819-145-8-200610170-0013916940336 38.JanewayCAUse of"/>
   <result pre="based on clinical diagnosesJ Am Med Assoc19531511272128513034471 40.AlexanderHEet al.Hemophilus influenzae" exact="meningitis" post="treated with streptomycinJ Am Med Assoc194613243444010.1001/jama.1946.0287043001400520999674 41.CasadevallAScharffMDSerum therapy revisited:"/>
   <result pre="convalescent serum to pregnant mice prevents Zika virus infection and" exact="microcephaly" post="in offspringCell Res20172715816010.1038/cr.2016.14427922617 67.DowdKAet al.Broadly Neutralizing Activity of Zika"/>
   <result pre="Single Viral SerotypeCell Rep2016161485149110.1016/j.celrep.2016.07.04927481466 68.KammanadimintiSet al.Combination therapy with antibiotics and" exact="anthrax" post="immune globulin intravenous (AIGIV) is potentially more effective than"/>
   <result pre="transferred antibodyJ Infect Dis197914052753310.1093/infdis/140.4.527117061 72.TamuraMWebsterRGEnnisFASubtype cross-reactive, infection-enhancing antibody responses to" exact="influenza" post="A virusesJ Virol199468349935048189489 73.SauterPHoberDMechanisms and results of the antibody-dependent"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6620336\results\search\disease\results.xml">
   <result pre="high morbidity2. It causes a febrile illness accompanied by maculopapular" exact="rash" post="and severe joint pain that can last for months"/>
   <result pre="number of emerging arboviruses such as dengue virus, Venezuelan equine" exact="encephalitis" post="virus, CHIKV, and Zika, which have caused severe public"/>
   <result pre="authors declare no competing interests. References References 1.AnWGeNCaoYSunJJinXRecent progress on" exact="chikungunya" post="virus researchVirologica Sinica20173244145310.1007/s12250-017-4072-x29188427 2.TsetsarkinKAChenRWeaverSCInterspecies transmission and chikungunya virus emergenceCurrent"/>
   <result pre="1.AnWGeNCaoYSunJJinXRecent progress on chikungunya virus researchVirologica Sinica20173244145310.1007/s12250-017-4072-x29188427 2.TsetsarkinKAChenRWeaverSCInterspecies transmission and" exact="chikungunya" post="virus emergenceCurrent opinion in virology20161614315010.1016/j.coviro.2016.02.00726986235 3.Pan American Health Organization,"/>
   <result pre="Academy of Sciences20171399617710.1111/nyas.1330628187236 7.SahadeoNSDet al.Understanding the evolution and spread of" exact="chikungunya" post="virus in the Americas using complete genome sequencesVirus evolution20173vex01010.1093/ve/vex01028480053"/>
   <result pre="extension and terminal adenylyltransferase activitiesAntiviral research2017143384710.1016/j.antiviral.2017.04.00128390873 9.SchwartzOAlbertMLBiology and pathogenesis of" exact="chikungunya" post="virusNature reviews. Microbiology2010849150010.1038/nrmicro236820551973 10.YangSFinkDHulseAPrattRDRegulatory considerations in development of vaccines"/>
   <result pre="Chikungunya Virus E2 ProteinPLoS neglected tropical diseases201711e000531810.1371/journal.pntd.000531828114368 13.MendezNOviedo-PastranaMMattarSCaicedo-CastroIArrietaGZika virus disease," exact="microcephaly" post="and Guillain-Barre syndrome in Colombia: epidemiological situation during 21"/>
   <result pre="of infection in developing countries201591126113210.3855/jidc.667026517488 21.VolkSMet al.Genome-scale phylogenetic analyses of" exact="chikungunya" post="virus reveal independent emergences of recent epidemics and various"/>
   <result pre="migratorio Julio del 2014. http://migracioncolombia.gov.co/index.php/es/?option = com_content&amp;amp;view = article&amp;amp;id = 718 (2014). 29.CarreraJPet al.Unusual pattern of" exact="chikungunya" post="virus epidemic in the Americas, the Panamanian experiencePLoS neglected"/>
   <result pre="36.TsetsarkinKAet al.Epistatic roles of E2 glycoprotein mutations in adaption of" exact="chikungunya" post="virus to Aedes albopictus and Ae. aegypti mosquitoesPloS one20094e683510.1371/journal.pone.000683519718263"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6624372\results\search\disease\results.xml">
   <result pre="Population density and water balance influence the global occurrence of" exact="hepatitis" post="E epidemics CarratalàAnnaanna.carratala@epfl.ch1http://orcid.org/0000-0002-1184-7501JoostStéphane2[1], 0000000121839049grid.5333.6Environmental Chemistry Laboratory (LCE), School of"/>
   <result pre="visit http://creativecommons.org/licenses/by/4.0/. Abstract In developing countries, the waterborne transmission of" exact="hepatitis" post="E virus (HEV), caused by HEV genotypes 1 (HEV-1)"/>
   <result pre="viruses in the near future. Subject terms Ecological modelling Viral" exact="hepatitis" post="Introduction Hepatitis E virus (HEV) is recognized as one"/>
   <result pre="recognized as one of the most important agents of acute" exact="viral hepatitis" post="worldwide1. According to estimates of the World Health Organization"/>
   <result pre="as one of the most important agents of acute viral" exact="hepatitis" post="worldwide1. According to estimates of the World Health Organization"/>
   <result pre="have instead been identified as causative agents in sporadic acute" exact="hepatitis" post="E cases in the United States, Europe, China and"/>
   <result pre="in Mexico in 198632. Figure 1 Outbreaks caused worldwide by" exact="hepatitis" post="E virus (HEV-1 or HEV-2) due to the consumption"/>
   <result pre="refugee camps. Table 1 General summary of the dataset of" exact="hepatitis" post="E waterborne outbreaks (1980–2017) compiled in this study, per"/>
   <result pre="in Asia than in Africa. Models of spatial suitability for" exact="hepatitis" post="E virus outbreaks General model The combination of variables"/>
   <result pre="general model of the ecological suitability for the occurrence of" exact="hepatitis" post="E waterborne outbreaks obtained by the Maxent method. This"/>
   <result pre="environmental variables selected on the basis of current knowledge on" exact="hepatitis" post="E virus. This model predicts a high ecological suitability"/>
   <result pre="from countries with very high suitability for the occurrence of" exact="hepatitis" post="E outbreaks such as India, Indonesia, Pakistan or Bangladesh,"/>
   <result pre="40%39, thus migration fluxes may contribute to the occurrence of" exact="hepatitis" post="E viruses in Saudi Arabia, where some areas are"/>
   <result pre="and environmental suitability for the occurrence of waterborne outbreaks of" exact="hepatitis" post="E virus (genotypes 1 and 2). Specifically, our results"/>
   <result pre="a step forward for anticipating and preventing the occurrence of" exact="hepatitis" post="E epidemics due to the contamination of drinking and"/>
   <result pre="work was compiled using literature records of waterborne outbreaks of" exact="hepatitis" post="E available in the PubMed database and in WHO"/>
   <result pre="use the term &quot;waterborne HEV�? to refer to outbreaks of" exact="hepatitis" post="E caused by either genotype 1 and 2. The"/>
   <result pre="density is beneficial for the onset of waterborne outbreaks of" exact="hepatitis" post="E, and that population density has increased in many"/>
   <result pre="population density data, environmental data and our complete dataset of" exact="hepatitis" post="E outbreaks (general model), (ii) a model using environmental"/>
   <result pre="a model using environmental data and our complete dataset of" exact="hepatitis" post="E outbreaks (environmental model), (iii) models using population density"/>
   <result pre="of drinking water on attack and fatality rates in a" exact="hepatitis" post="E epidemic in SomaliaAm J Trop Med Hyg1994514667410.4269/ajtmh.1994.51.4667943574 4.SailajaBet"/>
   <result pre="in SomaliaAm J Trop Med Hyg1994514667410.4269/ajtmh.1994.51.4667943574 4.SailajaBet al.Outbreak of waterborne" exact="hepatitis" post="E in Hyderabad, India, 2005Epidemiol Infect20091372344010.1017/S095026880800095218606027 5.GreenAThe omitted epidemic-hepatitis"/>
   <result pre="the family HepeviridaeJ Gen Virol20149522233210.1099/vir.0.068429-024989172 7.OkamotoHGenetic variability and evolution of" exact="hepatitis" post="E virusVirus Res.20071272162810.1016/j.virusres.2007.02.00217363102 8.Purcell, R. H. &amp;amp; Emerson, S."/>
   <result pre="&amp;amp; Wilkins, Philadelphia, PA, 2001). 9.Gupta, N. et al. Acute" exact="hepatitis" post="E in India appears to be caused exclusively by"/>
   <result pre="in India appears to be caused exclusively by genotype 1" exact="hepatitis" post="E virus (2018). 10.SpinaAet al.A large outbreak of Hepatitis"/>
   <result pre="11.HuangCCet al.Molecular cloning and sequencing of the mexico isolate of" exact="hepatitis" post="E virus (HEV)Virology1992191550810.1016/0042-6822(92)90230-M1448913 12.BuissonYet al.Identification of a novel hepatitis"/>
   <result pre="of hepatitis E virus (HEV)Virology1992191550810.1016/0042-6822(92)90230-M1448913 12.BuissonYet al.Identification of a novel" exact="hepatitis" post="E virus in NigeriaJ Gen Virol200081903910.1099/0022-1317-81-4-90310725415 13.MailaHTBowyerSMSwanepoelRIdentification of a"/>
   <result pre="in NigeriaJ Gen Virol200081903910.1099/0022-1317-81-4-90310725415 13.MailaHTBowyerSMSwanepoelRIdentification of a new strain of" exact="hepatitis" post="E virus from an outbreak in Namibia in 1995J"/>
   <result pre="in Namibia in 1995J Gen Virol200485899510.1099/vir.0.19587-014718623 14.NicandEet al.Genetic heterogeneity of" exact="hepatitis" post="E virus in Darfur, Sudan, and neighboring ChadJ Med"/>
   <result pre="in Darfur, Sudan, and neighboring ChadJ Med Virol2005775192110.1002/jmv.2048716254969 15.IppaguntaSKNaikSSharmaBAggarwalRPresence of" exact="hepatitis" post="E virus in sewage in Northern India: frequency and"/>
   <result pre="viruses in two settlements based in Eastern Chad: Analysis of" exact="hepatitis" post="E virus, hepatitis A virus and human adenovirus in"/>
   <result pre="settlements based in Eastern Chad: Analysis of hepatitis E virus," exact="hepatitis" post="A virus and human adenovirus in water sourcesJ Water"/>
   <result pre="in Mexico, 1986–1987JAMA J Am Med Assoc19902633281510.1001/jama.1990.03440240071018 33.NaikSRAggarwalRSalunkePNMehrotraNNA large waterborne" exact="viral hepatitis" post="E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne"/>
   <result pre="Mexico, 1986–1987JAMA J Am Med Assoc19902633281510.1001/jama.1990.03440240071018 33.NaikSRAggarwalRSalunkePNMehrotraNNA large waterborne viral" exact="hepatitis" post="E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne"/>
   <result pre="hepatitis E epidemic in Kanpur, IndiaIndian J Pediatr19936064364310.1007/BF02821726 34.RabMAet al.Water-borne" exact="hepatitis" post="E virus epidemic in Islamabad, Pakistan: A common source"/>
   <result pre="syndrome in northern Uganda, 2010–2012Am J Trop Med Hyg201592411410.4269/ajtmh.14-019625448237 36.JohargyAKMahomedMFKhanMMKabrahSAnti" exact="hepatitis" post="E virus seropositivity in a group of male blood"/>
   <result pre="in Makkah, Saudi ArabiaJ Pak Med Assoc201363185923894892 37.AbdelaalMet al.Epidemiology of" exact="hepatitis" post="E virus in male blood donors in Jeddah, Saudi"/>
   <result pre="donors in Jeddah, Saudi ArabiaIr J Med Sci199816794610.1007/BF029379469638024 38.ArifMQattanIal-FalehFRamiaSEpidemiology of" exact="hepatitis" post="E virus (HEV) infection in Saudi ArabiaAnn Trop Med"/>
   <result pre="ArabiaAnn Trop Med Parasitol199488163810.1080/00034983.1994.118128548067812 39.ArankalleVAet al.Age-specific prevalence of antibodies to" exact="hepatitis" post="A and E viruses in pune, india, 1982 and"/>
   <result pre="and 1992J Infect Dis19951714475010.1093/infdis/171.2.4477844387 40.CorwinALet al.The unique riverine ecology of" exact="hepatitis" post="E virus transmission in South-East AsiaTrans R Soc Trop"/>
   <result pre="ONE201495e9854610.1371/journal.pone.009854624874010 44.KaurMet al.Hepatitis E virus: A leading cause of waterborne" exact="viral hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians20179121410.4103/0974-2727.19963628367028 45.PonsWendyYoungIanTruongJeniferJones-BittonAndriaMcEwenScottPintarKatarinaPapadopoulosAndrewA"/>
   <result pre="44.KaurMet al.Hepatitis E virus: A leading cause of waterborne viral" exact="hepatitis" post="in Northwest Districts of Punjab, IndiaJ Lab Physicians20179121410.4103/0974-2727.19963628367028 45.PonsWendyYoungIanTruongJeniferJones-BittonAndriaMcEwenScottPintarKatarinaPapadopoulosAndrewA"/>
   <result pre="in Canada and the United StatesPLOS ONE20151010e014164610.1371/journal.pone.014164626513152 46.HuangWet al.Cross-protection of" exact="hepatitis" post="E virus genotypes 1 and 4 in rhesus macaquesJ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6624375\results\search\disease\results.xml">
   <result pre="Hepatitis C virus (HCV) is a major cause of chronic" exact="liver disease," post="cirrhosis, and hepatocellular carcinoma, giving rise to a major"/>
   <result pre="is a major cause of chronic liver disease, cirrhosis, and" exact="hepatocellular carcinoma," post="giving rise to a major public health issue on"/>
   <result pre="The authors declare no competing interests. References References 1.AlterMJEpidemiology of" exact="hepatitis" post="C virus infectionWorld J Gastroenterol2007132436244110.3748/wjg.v13.i17.243617552026 2.SimmondsPGenetic diversity and evolution"/>
   <result pre="C virus infectionWorld J Gastroenterol2007132436244110.3748/wjg.v13.i17.243617552026 2.SimmondsPGenetic diversity and evolution of" exact="hepatitis" post="C virus–15 years onJ Gen Virol2004853173318810.1099/vir.0.80401-015483230 3.SmithDet al.Expanded Classification"/>
   <result pre="Updated Criteria and Genotype Assignment Web ResourceHepatology20145931832710.1002/hep.2674424115039 4.ShepardCFinelliLAlterMGlobal epidemiology of" exact="hepatitis" post="C virus infectionLancet Infectious Diseases2005555856710.1016/S1473-3099(05)70216-416122679 5.MessinaJet al.Global Distribution and"/>
   <result pre="of Hepatitis C Virus GenotypesHepatology201561778710.1002/hep.2725925069599 6.KalininaONorderHMukomolovSMagniusLOA natural intergenotypic recombinant of" exact="hepatitis" post="C virus identified in St. PetersburgJ Virol2002764034404310.1128/JVI.76.8.4034-4043.200211907242 7.MagiorkinisGkikasMagiorkinisEmmanouilParaskevisDimitriosHoSimon Y."/>
   <result pre="1a and 1b: A Phylodynamic and Phylogeographic AnalysisPLoS Medicine2009612e100019810.1371/journal.pmed.100019820041120 8.PybusOGCochraneAHolmesECSimmondsPThe" exact="hepatitis" post="C virus epidemic among injecting drug usersInfect Genet Evol2005513113910.1016/j.meegid.2004.08.00115639745"/>
   <result pre="from 1991 to 2006World J Gastroenterol2008141237124310.3748/wjg.14.123718300350 10.MoriceYet al.Molecular epidemiology of" exact="hepatitis" post="C virus subtype 3a in injecting drug usersJ Med"/>
   <result pre="therapy programs in CyprusJournal of Medical Virology20108226327010.1002/jmv.2169020029809 14.DemetriouVLKostrikisLGMolecular epidemiology of" exact="hepatitis" post="C infection in Cyprus within the general population and"/>
   <result pre="infectionNat Rev Gastroenterol Hepatol20131055356210.1038/nrgastro.2013.10723817321 24.PybusOGet al.The epidemic behavior of the" exact="hepatitis" post="C virusScience20012922323232510.1126/science.105832111423661 25.BukhJThe history of hepatitis C virus (HCV):"/>
   <result pre="epidemic behavior of the hepatitis C virusScience20012922323232510.1126/science.105832111423661 25.BukhJThe history of" exact="hepatitis" post="C virus (HCV): Basic research reveals unique features in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6627469\results\search\disease\results.xml">
   <result pre="evaluated as inhibitors of the adhesion protein HA of the" exact="influenza" post="A virus (IAV). HA relies on multivalency for strong"/>
   <result pre="cross the animal–human species barrier. Prophylactic and therapeutic options against" exact="influenza" post="are limited. Several approaches are being used, the most"/>
   <result pre="Schematic tripodal ligand design for the chelation type inhibition of" exact="influenza" post="virus A hemagglutinin protein. These scaffolds were extended with"/>
   <result pre="Fouchier (Erasmus Medical Center, The Netherlands) for generously providing recombinant" exact="influenza" post="viruses WU95 and VI75. Abbreviations Used CCR2 CC chemokine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6627559\results\search\disease\results.xml">
   <result pre="biologically active compounds that target proteins or genes of the" exact="influenza" post="virus and host components that are necessary for replication"/>
   <result pre="metabolites as potential agents for the prevention and therapy of" exact="influenza" post="infection. Materials and methods: The sources of scientific literature"/>
   <result pre="humanity. Recently developed drugs are quite effective against currently circulating" exact="influenza" post="virus strains, but their use can lead to the"/>
   <result pre="clinical studies about the effectiveness of these compounds in combating" exact="influenza" post="infection and explains the necessity of their use as"/>
   <result pre="a serious medical and social problem for humanity. This acute" exact="infectious disease" post="is caused by an enveloped ribonucleic acid (RNA) containing"/>
   <result pre="[4]. In Russia, every seventh person is involved in the" exact="influenza" post="virus’ annual epidemic [5]. When a new antigenic variant"/>
   <result pre="age groups of the population [6]. The 2009 pandemic of" exact="influenza" post="A (H1N1)pdm09 was accompanied by wide coverage of the"/>
   <result pre="people with no significant previous pathology, including pregnant women. The" exact="influenza" post="virus can cause disease not only in humans but"/>
   <result pre="horses) [9]. In recent years, cases of human infection with" exact="avian influenza" post="viruses of the H5N1, H7N7, and H7N9 subtypes have"/>
   <result pre="[9]. In recent years, cases of human infection with avian" exact="influenza" post="viruses of the H5N1, H7N7, and H7N9 subtypes have"/>
   <result pre="controlled. Recently developed drugs are quite effective against currently circulating" exact="influenza" post="virus strains, but their use can lead to the"/>
   <result pre="studies demonstrating the excellent effectiveness of these compounds in combating" exact="influenza" post="infection and explain the need to use them as"/>
   <result pre="researchers working on the problem of prevention and therapy of" exact="influenza" post="to coordinate their efforts for the creation of standard"/>
   <result pre="the viral genome occur (Figure 1). The binding of the" exact="influenza" post="virus with cell sial-containing receptors creates surface glycoproteins, i.e.,"/>
   <result pre="Due to a short life cycle, the evolution of the" exact="influenza" post="virus is fast. As a result, the rapid appearance"/>
   <result pre="capsid encloses the genome of the virus. Three types of" exact="influenza" post="virus (genera) have been described: A, B, and C"/>
   <result pre="in humans. Hemagglutinin and neuraminidase carry antigenic determinants of the" exact="influenza" post="virus and determine its subtype (H5N1, H3N2, H1N1, etc.)."/>
   <result pre="assessing the post-infectious or post-vaccination humoral immune response to the" exact="influenza" post="virus [21]. However, the value of HA is not"/>
   <result pre="the unification of viral and cellular membranes. The NA of" exact="influenza" post="destroys sialic acid-based cell receptors on infected cell surfaces"/>
   <result pre="of the virus through mucin during a natural infection. In" exact="influenza" post="A viruses, there are nine subtypes of NA, but"/>
   <result pre="but weaker than antibodies against HA [26]. The nucleoprotein of" exact="influenza" post="virus (NP) is the main antigen recognized by cytotoxic"/>
   <result pre="T lymphocytes. Amino acid sequences 260–283 of the nucleoprotein of" exact="influenza" post="A virus induce the T cell response. The NP"/>
   <result pre="A virus induce the T cell response. The NP of" exact="influenza" post="virus is a major factor in the cycle of"/>
   <result pre="the cycle of viral infection when switching the synthesis of" exact="influenza" post="virus RNA from transcription mode to replication mode [25]."/>
   <result pre="mode [25]. Protein M1 is the matrix protein of the" exact="influenza" post="virus; it covers the lipid membrane. It is in"/>
   <result pre="of new virus particles [28]. Membrane protein M2 is an" exact="influenza" post="virus surface protein that participates in the creation of"/>
   <result pre="epithelium of the respiratory tract are main targets of the" exact="influenza" post="virus. For infection, the virus must overcome the factors"/>
   <result pre="the recognition of conservative molecules characteristic of pathogenic microorganisms. The" exact="influenza" post="virus stimulates the TLR responses of innate and adaptive"/>
   <result pre="mechanisms of the action of marine sulphated polysaccharides on the" exact="influenza" post="virus and its targets in the body. 4. Recent"/>
   <result pre="drugs continue [35,36]. Currently, for the prevention and treatment of" exact="influenza" post="infection, a number of drugs are available with different"/>
   <result pre="act on two stages of the life cycle of the" exact="influenza" post="virus: stripping the virus and releasing virus particles from"/>
   <result pre="into the cell. As a result, the fusion of the" exact="influenza" post="virus with the vacuole membrane is prevented, which makes"/>
   <result pre="of the cell. Thus, rimantadine becomes an obstacle between the" exact="influenza" post="virus and the genome of the host. Along with"/>
   <result pre="gastrointestinal tract and the nervous system [38]. In addition, many" exact="influenza" post="A viruses (for example, H3N2, H1N1) quickly became resistant"/>
   <result pre="decade, a number of drugs with direct action on the" exact="influenza" post="virus (direct-acting antivirals, DAA) have appeared [39]. These include"/>
   <result pre="but are carried out by the host mechanisms. These include" exact="toxic shock syndrome," post="hyperproduction of proinflammatory cytokines, cellular tissue infiltration, haemorrhagic syndrome,"/>
   <result pre="etc. Although modern drugs are quite effective against currently circulating" exact="influenza" post="virus strains, their use often leads to the selection"/>
   <result pre="Drugs aimed at various viruses or impairing different stages of" exact="influenza" post="virus replication will represent a serious means of fighting"/>
   <result pre="and polyethylene sulphates) have antiviral activity not only against the" exact="influenza" post="virus but also against many other viruses, such as"/>
   <result pre="also against many other viruses, such as those that cause" exact="hepatitis" post="C, tick-borne encephalitis, haemorrhagic fever with renal syndrome, dengue"/>
   <result pre="many other viruses, such as those that cause hepatitis C," exact="tick-borne encephalitis," post="haemorrhagic fever with renal syndrome, dengue fever, and AIDS."/>
   <result pre="cause hepatitis C, tick-borne encephalitis, haemorrhagic fever with renal syndrome," exact="dengue fever," post="and AIDS. It is known that, in the human"/>
   <result pre="appeared that presents the effectiveness of fucoidans and carrageenans in" exact="influenza" post="infection, as well as acute viral &quot;colds�?. 5.1. Carrageenans"/>
   <result pre="have attracted the attention of researchers investigating the problem of" exact="influenza" post="and other acute respiratory viral infections, particularly in terms"/>
   <result pre="and also inhibit the formation of a syncytium, induced by" exact="influenza" post="A viruses. A. Leibbrand et al. [37] carried out"/>
   <result pre="out an investigation showing the effectiveness of carrageenan against human" exact="influenza" post="A viruses. The authors determined the sensitivity of the"/>
   <result pre="A viruses. The authors determined the sensitivity of the H1N1" exact="influenza" post="virus strains, as well as the pandemic H3N2 strain,"/>
   <result pre="the same authors investigated the effect of carrageenans on an" exact="influenza" post="virus-infected primary cell culture of the human epithelium from"/>
   <result pre="However, local administration has a pronounced effect, for example, with" exact="influenza" post="infection and other viral diseases of the respiratory system."/>
   <result pre="viral infection may complicate underlying diseases in the form of" exact="asthma" post="[59,60]. In this regard, a decrease in the intensity"/>
   <result pre="weight of 1–3 kDa effectively dose-dependently inhibited the replication of" exact="influenza" post="A (H1N1) virus in MDCK cells (selectivity index &amp;gt;25.0)."/>
   <result pre="survival rate of mice infected with a lethal dose of" exact="influenza" post="virus and reduced the viral load in the lungs"/>
   <result pre="low molecular weight oligosaccharides of carrageenan in the treatment of" exact="influenza" post="as an alternative strategy to combat this infection. Shao"/>
   <result pre="the molecular mechanisms of cell protection using k-carrageenan against SW731" exact="influenza" post="virus penetration. The authors showed that the polysaccharide specifically"/>
   <result pre="the polysaccharide specifically and effectively inhibited the reproduction of the" exact="influenza" post="virus. The MDCK cells were infected with various strains"/>
   <result pre="The MDCK cells were infected with various strains of the" exact="influenza" post="virus, after which they were treated with carrageenan at"/>
   <result pre="viruses (homologous MDCK) was recorded. The remaining experimental strains of" exact="influenza" post="virus (PR8, WSN, ZB07, and H1N1) were insensitive to"/>
   <result pre="prevented the development of the extra- and intracellular stages of" exact="influenza" post="virus replication. To determine the stage of reproduction of"/>
   <result pre="that not only extracellular, but also some intracellular stages of" exact="influenza" post="virus replication were affected by k-carrageenan. The titer of"/>
   <result pre="influenza virus replication were affected by k-carrageenan. The titer of" exact="influenza" post="virus SW731 was decreased in cases where the virus"/>
   <result pre="The same authors showed that carrageenan does not inactivate the" exact="influenza" post="virus, since no differences were found between the pre-treatment"/>
   <result pre="authors have proposed the use of carrageenan against the H1N1/2009" exact="influenza" post="virus and other viruses containing HA/H1N1/2009. The carrageenan used"/>
   <result pre="it was shown that the antiviral activity (IC50 against the" exact="influenza" post="virus at doses 0.19–0.48 µg/mL) of the galactan is"/>
   <result pre="suggested using hybrid carrageenan (ı/κ/ν-carrageenan) as a potential inhibitor of" exact="influenza" post="A virus. In this study, the authors obtained three"/>
   <result pre="580, and 510 kDa, respectively. Antiviral activity against the H1N1" exact="influenza" post="virus was highest when used the hybrid polysaccharide (276.5"/>
   <result pre="used the hybrid polysaccharide (276.5 μg/mL), and the H1N1 virus" exact="suppression" post="index was 52% using a polysaccharide dose of 250"/>
   <result pre="from 1 to 18 years) with respiratory viral infections, including" exact="influenza" post="B. Intranasal spray was used three times a day"/>
   <result pre="did not alleviate symptoms in children with acute symptoms of" exact="common cold," post="but significantly reduced viral load in nasal secretions that"/>
   <result pre="in both children and adults. The treatment of patients with" exact="influenza" post="by carrageenan gel was shown to significantly facilitate respiratory"/>
   <result pre="separately exhibited different antiviral activity against different strains of the" exact="influenza" post="virus. Since the mechanism of action of these agents"/>
   <result pre="μg/mL zanamivir and 533 μg/mL carrageenan). The effectiveness of the" exact="suppression" post="of the replication by both substances depended on the"/>
   <result pre="H7N7, respectively. Thus, zanamivir and carrageenan target different strains of" exact="influenza" post="virus to varying degrees and, therefore, they can provide"/>
   <result pre="used simultaneously. Mice infected with a lethal dose of the" exact="influenza" post="virus that received the placebo dies, as did the"/>
   <result pre="caused by a wide variety of respiratory viruses, including the" exact="influenza" post="virus. The authors combined this vasoconstrictor and ı-carrageenan in"/>
   <result pre="prolonged oral ingestion [70]. Among the many study associated with" exact="influenza" post="infection, we did not find reports of adverse side"/>
   <result pre="for intranasal administration as a preventive and therapeutic agent for" exact="influenza" post="and ARIs is permitted. Apparently, attention should be paid"/>
   <result pre="the nasal cavity against respiratory viruses, including various strains of" exact="influenza" post="virus. At an early stage of viral infection carrageenans"/>
   <result pre="stage of viral infection carrageenans are directly associated with the" exact="influenza" post="virus, preventing its adsorption, penetration, and replication. At the"/>
   <result pre="[78] to establish that in mice, infected in vivo with" exact="avian influenza" post="A viruses (subtypes H5N3 and H7N2), the level of"/>
   <result pre="to establish that in mice, infected in vivo with avian" exact="influenza" post="A viruses (subtypes H5N3 and H7N2), the level of"/>
   <result pre="immunocompetent and immunocompromised mice infected with a lethal dose of" exact="influenza" post="virus. The use of this polysaccharides reduced virus replication,"/>
   <result pre="fucoidan, because in this case there was no recurrence of" exact="influenza" post="virus reproduction, as is sometimes the case when treating"/>
   <result pre="recommended by the authors as a new treatment strategy for" exact="influenza" post="infection. The fucoidan from the brown alga Kjelmaniella crassifolia"/>
   <result pre="treated with oseltamivir alone, 90% of the mice survived. All" exact="influenza" post="viruses used in the experiment were sensitive to treatment"/>
   <result pre="to block the processes of penetration and the release of" exact="influenza" post="A virus from cells. The investigated fucoidan is a"/>
   <result pre="drops. Using SPEV cell culture sensitive to the reproduction of" exact="influenza" post="A (H5N1), Makarenkova et al. [80] investigated the in"/>
   <result pre="fucoidan from the brown seaweed Laminaria japonica against the H5N1" exact="influenza" post="virus. The results showed that the fucoidan did not"/>
   <result pre="not protect the cell culture against cytopathogenic effects of the" exact="influenza" post="A virus at 48 and 72 h after infection."/>
   <result pre="introduced resulted in a decrease in the titer of the" exact="influenza" post="virus by 2.3–3.3 log units. With simultaneous introduction of"/>
   <result pre="influenza virus by 2.3–3.3 log units. With simultaneous introduction of" exact="influenza" post="A virus and fucoidan into the cell culture, the"/>
   <result pre="The in vitro antiviral effects were evaluated against the H9N2" exact="influenza" post="virus. In the hemagglutination test, the most active were"/>
   <result pre="SQP. Under the action of these polysaccharides, the titer of" exact="influenza" post="B virus decreased significantly. GFP was the most active"/>
   <result pre="the presence of fucose in these preparations. The more pronounced" exact="suppression" post="of the replication of the influenza virus by the"/>
   <result pre="preparations. The more pronounced suppression of the replication of the" exact="influenza" post="virus by the GFP polysaccharide was explained by the"/>
   <result pre="vaccination, as well as to suppress the replication of the" exact="influenza" post="virus. In another study [81], as a result of"/>
   <result pre="were isolated from green algae. The interaction between the H5N1" exact="influenza" post="virus and fucoidan were investigated by Bobrovnitsky [86]. For"/>
   <result pre="this evidence, fucoidans have not only a direct effect on" exact="influenza" post="viruses but also affect the processes of viral attachment"/>
   <result pre="to prevent bacterial complications, which often aggravates the course of" exact="influenza" post="infection. 6. Lectins Lectins are widespread carbohydrate-binding proteins and"/>
   <result pre="nanomolar levels, these lectins have potential antiviral activity against the" exact="influenza" post="virus due to the recognition of HM-glucans in the"/>
   <result pre="the composition of the glycoproteins of the spikes of the" exact="influenza" post="virus. Mu et al. [97] isolated lectin HRL40 from"/>
   <result pre="nM) the infectious process in NCI-H292 cells caused by the" exact="influenza" post="A/H3N2/Udom/72 virus. Additionally, a lectin with anti-influenza activity was"/>
   <result pre="and designated as KAA-2, effectively inhibited the entry of the" exact="influenza" post="virus into cells. The carbohydrate-binding profile of this lectin"/>
   <result pre="glycans. The authors tested this lectin against various strains of" exact="influenza" post="virus, including the pandemic variant H1N1-2009. With the immunofluorescent"/>
   <result pre="lectin KAA-2 was directly associated with the HA of the" exact="influenza" post="virus. It was proposed the use of this lectin"/>
   <result pre="use of this lectin as a future means of preventing" exact="influenza" post="infection. In the study by Sato et al. [99],"/>
   <result pre="on MDCK cells using different strains (clinical isolates) of the" exact="influenza" post="virus (H1N1-2009, A/Oita/ou1P3-3/09). The best results in terms of"/>
   <result pre="virus (H1N1-2009, A/Oita/ou1P3-3/09). The best results in terms of inhibiting" exact="influenza" post="infection were obtained with the HM-binding lectin ESA-2. The"/>
   <result pre="HM-glycans, suggesting that ESA-2 binds to the HA of the" exact="influenza" post="virus through HM-glycans. The lectin inhibited the penetration of"/>
   <result pre="this experiment). Sensitivity to lectin depended on the strain of" exact="influenza" post="virus. The most susceptible were strains A/Philippines/2/82 (EC50 17.2"/>
   <result pre="to be an effective selective inhibitor of the NA of" exact="influenza" post="virus (72% at a dose of 30 µg/mL). By"/>
   <result pre="diecol. The inhibitory activities of these components were assessed against" exact="influenza" post="viruses from NA group 1 (A/Bervig_Mission/1/18[H1N1]), A/PR/8/34[H1N1]) and group"/>
   <result pre="4.5 and 14.7 mmol, respectively); diecol inhibited the NA of" exact="influenza" post="virus strains of group 2 more effectively. All derivatives"/>
   <result pre="also investigated as candidate adjuvants for the next generation of" exact="influenza" post="vaccines. The main direction of improvement for anti-influenza vaccines"/>
   <result pre="to various antigens and vaccine strains of infectious agents, including" exact="influenza" post="virus [104,108]. The results of our experimental studies also"/>
   <result pre="manifested as an increase in the immunogenicity of the inactivated" exact="influenza" post="virus A/California/7/09 H1N1pdm09. At the same time, the effect"/>
   <result pre="promising application of fucoidan as an adjuvant in vaccines of" exact="influenza" post="[109]. Of significant interest are the results of a"/>
   <result pre="mg/day orally for 4 weeks. Subsequent immunization with the trivalent" exact="influenza" post="vaccine led to the identification of higher antibody titers"/>
   <result pre="safe and effective adjuvants in the composition of next generation" exact="influenza" post="vaccines. Fucoidans may form a new molecular basis for"/>
   <result pre="molecular basis for the creation of immune adjuvants, including for" exact="influenza" post="vaccines, due to their high biocompatibility, lack of toxicity,"/>
   <result pre="red, and green algae have such properties in relation to" exact="influenza" post="infection (Figure 2). The pharmaceutical market currently offers a"/>
   <result pre="to exert a virucidal effect, that prevent the penetration of" exact="influenza" post="viruses into cells and suppress the replication of viral"/>
   <result pre="to reduce itPulmonologiya201626389397(In Russian)10.18093/0869-0189-2016-26-4-389-397 7.AriasC.F.Escalera-ZamudioM.Soto-Del Rio MdeL.Cobian-GuemesA.G.IsaP.LopezS.Molecular anatomy of 2009" exact="influenza" post="virus A (H1N1)Arch. Med. Res.20094064365410.1016/j.arcmed.2009.10.00720304251 8.GillJ.R.ShengZ.M.ElyS.F.GuineeD.G.BeasleyM.B.SuhJ.DeshpandeC.MolluraD.J.MorensD.M.BrayM.et al.Pulmonary pathologic findings"/>
   <result pre="Med. Res.20094064365410.1016/j.arcmed.2009.10.00720304251 8.GillJ.R.ShengZ.M.ElyS.F.GuineeD.G.BeasleyM.B.SuhJ.DeshpandeC.MolluraD.J.MorensD.M.BrayM.et al.Pulmonary pathologic findings of fatal 2009 pandemic" exact="influenza" post="A/H1N1 viral infectionsArch. Pathol. Lab. Med.201013423524320121613 9.BilichenkoT.N.Influence of year"/>
   <result pre="control strategies, drug stockpiles, and vaccine development during outbreaks of" exact="avian influenza" post="A H5N1, H1N1, and H7N9 among humansBiosci. Trends20137647610.5582/bst.2013.v7.2.6423612075 11.MedinaR.A.Garcia-SastreA.Influenza"/>
   <result pre="strategies, drug stockpiles, and vaccine development during outbreaks of avian" exact="influenza" post="A H5N1, H1N1, and H7N9 among humansBiosci. Trends20137647610.5582/bst.2013.v7.2.6423612075 11.MedinaR.A.Garcia-SastreA.Influenza"/>
   <result pre="22 June 2019) 16.NobusawaE.SatoK.Comparison of the mutation rates of human" exact="influenza" post="A and B virusesJ. Virol.2006803675367810.1128/JVI.80.7.3675-3678.200616537638 17.SmithD.B.InglisS.C.The mutation rate and"/>
   <result pre="(Pt 11)2729274010.1099/0022-1317-68-11-27293316486 18.DrakeJ.W.CharlesworthB.CharlesworthD.CrowJ.F.Rates of spontaneous mutationGenetics1998148166716869560386 19.HayA.J.GregoryV.DouglasA.R.LinY.P.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. Lond. B Biol. Sci.20013561861187010.1098/rstb.2001.099911779385 20.TateM.D.JobE.R.DengY.M.GunalanV.Maurer-StrohS.ReadingP.C.Playing"/>
   <result pre="Biol. Sci.20013561861187010.1098/rstb.2001.099911779385 20.TateM.D.JobE.R.DengY.M.GunalanV.Maurer-StrohS.ReadingP.C.Playing hide and seek: How glycosylation of the" exact="influenza" post="virus hemagglutinin can modulate the immune response to infectionViruses201461294131610.3390/v603129424638204"/>
   <result pre="21.TsvetkovV.V.GolobokovG.S.Neuraminidase inhibitors - the gold standard for antiviral therapy for" exact="influenza" post="AMed. Adv.201742530(In Russian)10.21518/2079-701X-2017-4-25-30 22.KovalevN.A.KrasochkoP.A.Viruses and Prions in the Pathology"/>
   <result pre="Pneumonia2017Available online: https://www.monographies.ru/ru/book/view?id=686(accessed on 22 June 2019) 24.KaverinN.V.RudnevaI.A.TimofeevaT.A.Antigenic structure of" exact="influenza" post="A hemagglutininVopr. Virol.20121148158 25.DeshevaY.A.SmolonoginaT.A.RudenkoL.G.Biological and protective properties of serum"/>
   <result pre="hemagglutininVopr. Virol.20121148158 25.DeshevaY.A.SmolonoginaT.A.RudenkoL.G.Biological and protective properties of serum antibodies to" exact="influenza" post="neuraminidase virusMed. Acad. J.2015153544(In Russian) 26.GlezenW.P.Emerging infections: Pandemic influenzaEpidemiol."/>
   <result pre="2019) 31.LeeN.WongC.K.HuiD.S.LeeS.K.WongR.Y.NgaiK.L.ChanM.C.ChuY.J.HoA.W.LuiG.C.et al.Role of human Toll-like receptors in naturally occurring" exact="influenza" post="A infectionsInfluenza Other Respir. Viruses2013766667510.1111/irv.1210923552014 32.LondriganS.L.TateM.D.BrooksA.G.ReadingP.C.Cell-surface receptors on macrophages"/>
   <result pre="on macrophages and dendritic cells for attachment and entry of" exact="influenza" post="virusJ. Leukoc. Biol.2012929710610.1189/jlb.101149222124137 33.LeeS.M.KokK.H.JaumeM.CheungT.K.YipT.F.LaiJ.C.GuanY.WebsterR.G.JinD.Y.PeirisJ.S.Toll-like receptor 10 is involved in"/>
   <result pre="10 is involved in induction of innate immune responses to" exact="influenza" post="virus infectionProc. Natl. Acad. Sci. USA20141113793379810.1073/pnas.132426611124567377 34.WeberM.GawanbachtA.HabjanM.RangA.BornerC.SchmidtA.M.VeitingerS.JacobR.DevignotS.KochsG.et al.Incoming RNA"/>
   <result pre="trialLancet Respir. Med.2017513514610.1016/S2213-2600(16)30435-028094141 37.LeibbrandtA.MeierC.Konig-SchusterM.WeinmullnerR.KalthoffD.PflugfelderB.GrafP.Frank-GehrkeB.BeerM.FazekasT.et al.Iota-carrageenan is a potent inhibitor of" exact="influenza" post="A virus infectionPLoS ONE20105e1432010.1371/journal.pone.001432021179403 38.JeffersonT.JonesM.DoshiP.Del MarC.Neuraminidase inhibitors for preventing"/>
   <result pre="virus infectionPLoS ONE20105e1432010.1371/journal.pone.001432021179403 38.JeffersonT.JonesM.DoshiP.Del MarC.Neuraminidase inhibitors for preventing and treating" exact="influenza" post="in healthy adults: systematic review and meta-analysisBMJ2009339b510610.1136/bmj.b510619995812 39.NelsonM.I.SimonsenL.ViboudC.MillerM.A.HolmesE.C.The origin"/>
   <result pre="meta-analysisBMJ2009339b510610.1136/bmj.b510619995812 39.NelsonM.I.SimonsenL.ViboudC.MillerM.A.HolmesE.C.The origin and global emergence of adamantane resistant A/H3N2" exact="influenza" post="virusesVirology200938827027810.1016/j.virol.2009.03.02619394063 40.SologubT.V.TokinI.I.Tactics of flu patients at the present stageEffect."/>
   <result pre="down-regulation of airway hyperresponsiveness in a mouse model of bronchial" exact="asthma" post="with prolonged antigen exposureClin. Exp. Allergy20093929029810.1111/j.1365-2222.2008.03131.x19032358 59.RohdeG.Drug targets in"/>
   <result pre="Microbiol. Rev.201023749810.1128/CMR.00032-0920065326 61.WangW.ZhangP.HaoC.ZhangX.E.CuiZ.Q.GuanH.S.In vitro inhibitory effect of carrageenan oligosaccharide on" exact="influenza" post="A H1N1 virusAntivir. Res.20119223724610.1016/j.antiviral.2011.08.01021867732 62.WangW.WuJ.ZhangX.HaoC.ZhaoX.JiaoG.ShanX.TaiW.YuG.Inhibition of influenza A virus"/>
   <result pre="carrageenan oligosaccharide on influenza A H1N1 virusAntivir. Res.20119223724610.1016/j.antiviral.2011.08.01021867732 62.WangW.WuJ.ZhangX.HaoC.ZhaoX.JiaoG.ShanX.TaiW.YuG.Inhibition of" exact="influenza" post="A virus infection by fucoidan targeting viral neuraminidase and"/>
   <result pre="Pandemic 2009 H1N1 Influenza VirusPLoS ONE201510e012657725969984 64.KimM.YimJ.H.KimS.Y.KimH.S.LeeW.G.KimS.J.KangP.S.LeeC.K.In vitro inhibition of" exact="influenza" post="A virus infection by marine microalga-derived sulfated polysaccharide p-KG03Antivir."/>
   <result pre="iota-carrageenan for the symptomatic relief of nasal congestion caused by" exact="rhinitis" post="and sinusitisInt. J. Gen. Med.20181127528310.2147/IJGM.S16712330013382 70.Gubina-VakyulykG.I.GorbachT.V.TkachenkoA.S.TkachenkoM.O.Damage and regeneration of"/>
   <result pre="compoundsCarbohydr. Polym.20151151910.1016/j.carbpol.2014.07.01625439860 78.SynytsyaA.BlehaR.PohlR.HayashiK.YoshinagaK.NakanoT.HayashiT.Mekabu fucoidan: structural complexity and defensive effects against" exact="avian influenza" post="A virusesCarbohydr. Polym.201411163364410.1016/j.carbpol.2014.05.03225037398 79.HayashiK.LeeJ.B.NakanoT.HayashiT.Anti-influenza A virus characteristics of a"/>
   <result pre="Polym.20151151910.1016/j.carbpol.2014.07.01625439860 78.SynytsyaA.BlehaR.PohlR.HayashiK.YoshinagaK.NakanoT.HayashiT.Mekabu fucoidan: structural complexity and defensive effects against avian" exact="influenza" post="A virusesCarbohydr. Polym.201411163364410.1016/j.carbpol.2014.05.03225037398 79.HayashiK.LeeJ.B.NakanoT.HayashiT.Anti-influenza A virus characteristics of a"/>
   <result pre="of sulfated polysaccharide from the brown algae Laminaria japonica against" exact="avian influenza" post="A (H5N1) virus infection in the cultured cellsProbl. Virol.201014145(In"/>
   <result pre="sulfated polysaccharide from the brown algae Laminaria japonica against avian" exact="influenza" post="A (H5N1) virus infection in the cultured cellsProbl. Virol.201014145(In"/>
   <result pre="82.SongL.ChenX.LiuX.ZhangF.HuL.YueY.LiK.LiP.Characterization and comparison of the structural features, immunomodulatory and anti-avian" exact="influenza" post="virus activities conferred by three algal sulfated polysaccharidesMar. Drugs201614410.3390/md14010004"/>
   <result pre="lectin (KAA-2) from the red alga Kappaphycus alvarezii potently inhibits" exact="influenza" post="virus infection in a strain-independent mannerBiochem. Biophys. Res. Commun.201140529129610.1016/j.bbrc.2011.01.03121219864"/>
   <result pre="women with fucoidan from seaweed increases immune responses to seasonal" exact="influenza" post="vaccinationJ. Nutr.20131431794179810.3945/jn.113.17903624005608 Figure 1 The life cycle of influenza"/>
   <result pre="seasonal influenza vaccinationJ. Nutr.20131431794179810.3945/jn.113.17903624005608 Figure 1 The life cycle of" exact="influenza" post="virus. Figure 2 Antiviral activity of algae metabolites. marinedrugs-17-00373-t001_Table"/>
   <result pre="Effects Oseltamivir (Tamiflu) Competitive and selective inhibitor of neuraminidase of" exact="influenza" post="viruses A and B The gastrointestinal tract can be"/>
   <result pre="tract); generalized pain Zanamivir (Relenza) Selective inhibitor of neuraminidase of" exact="influenza" post="viruses A, inhibitor of replication and release of new"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6629154\results\search\disease\results.xml">
   <result pre="Sciences : Zoology: Animal Phylogenetics PB2 mutations arising during H9N2" exact="influenza" post="evolution in the Middle East confer enhanced replication and"/>
   <result pre="replication and growth in mammals Expanded host range of H9N2" exact="influenza" post="virus during evolution in nature AraiYasuhaConceptualizationData curationFormal analysisFunding acquisitionInvestigationWriting"/>
   <result pre="provided the original author and source are credited.ppat.1007919.pdf Abstract Avian" exact="influenza" post="virus H9N2 has been endemic in birds in the"/>
   <result pre="the current outbreaks. Author summary The G1-like clade of H9N2" exact="influenza" post="viruses can undergo genetic reassortment with other influenza virus"/>
   <result pre="of H9N2 influenza viruses can undergo genetic reassortment with other" exact="influenza" post="virus subtypes to produce novel zoonotic viruses, such as"/>
   <result pre="and H5N8 viruses. Since 1998, the G1-like subclade of H9N2" exact="influenza" post="virus has been widely circulating in birds in Central"/>
   <result pre="gene pool in these areas would enable reassortment with other" exact="influenza" post="viruses. This study indicated the need for studies of"/>
   <result pre="within the manuscript and its Supporting Information files. Introduction The" exact="avian influenza" post="(AI) virus H9N2 subtype was first identified in South"/>
   <result pre="the manuscript and its Supporting Information files. Introduction The avian" exact="influenza" post="(AI) virus H9N2 subtype was first identified in South"/>
   <result pre="to higher polymerase activity in human cells than other zoonotic" exact="influenza" post="viruses In our previous study, we found that a"/>
   <result pre="activity in human cells. Fig 1 Polymerase activity of zoonotic" exact="avian influenza" post="viruses in human cells. Viral polymerase activity was measured"/>
   <result pre="in human cells. Fig 1 Polymerase activity of zoonotic avian" exact="influenza" post="viruses in human cells. Viral polymerase activity was measured"/>
   <result pre="assays in human 293T cells. (A) Polymerase activity of zoonotic" exact="avian influenza" post="viruses at 33°C. The data are expressed relative to"/>
   <result pre="in human 293T cells. (A) Polymerase activity of zoonotic avian" exact="influenza" post="viruses at 33°C. The data are expressed relative to"/>
   <result pre="genotype EG/2013-wt and G1(3P+NP)E627V/E543D/A655V/K526R viruses induced notably more severe bronchitis," exact="bronchiolitis" post="and localized bronchointerstitial pneumonia, characterized by occasional foci of"/>
   <result pre="EG/2013V627E and G1(3P+NP)E627V viruses caused minimal to mild bronchitis or" exact="bronchiolitis" post="in infected mice, indicating an intermediate phenotype. The degree"/>
   <result pre="mutations on the structure of the G1-A/B polymerase complex The" exact="influenza" post="virus polymerase complex is intrinsically flexible and can adopt"/>
   <result pre="in different functional states, as described elsewhere [25]. Discussion The" exact="influenza" post="virus H9N2 G1-like clade continues to evolve and expand"/>
   <result pre="[28]. Regional clustering has led to the establishment of distinct" exact="influenza" post="virus G1-like subclades (A-D), with subclade A and B"/>
   <result pre="and a large gene pool to enable reassortment with other" exact="influenza" post="viruses. However, the biological properties of the H9N2 virus"/>
   <result pre="accumulation of adaptive mutations distinct from those observed in other" exact="avian influenza" post="virus lineages. Selective pressure in the Middle East may"/>
   <result pre="of adaptive mutations distinct from those observed in other avian" exact="influenza" post="virus lineages. Selective pressure in the Middle East may"/>
   <result pre="to be involved in host species specificity mediated by the" exact="influenza" post="virus PB2-627 domain [25, 38–40]. It is also possible"/>
   <result pre="mortality and severe weight loss of mice infected with these" exact="influenza" post="virus adaptation mutations was in agreement with our in"/>
   <result pre="turbinates. This indicated that increased replication fitness contributed to high" exact="influenza" post="virus virulence in mice. However, several studies reported that"/>
   <result pre="influenza virus virulence in mice. However, several studies reported that" exact="influenza" post="A virus polymerase can produce additional viral RNA products,"/>
   <result pre="a co-infection and reassortment with a seasonal human or swine" exact="influenza" post="virus in the upper airway. The G1-A/B reassortant has"/>
   <result pre="public health risk. In conclusion, this study showed that the" exact="influenza" post="virus G1-A/B reassortant, that has been prevalent in Egypt,"/>
   <result pre="G1/1997 mutants were modeled using published crystal structures of the" exact="influenza" post="virus polymerase complexes (PDB: 4WSB and 5D98, respectively). MOE"/>
   <result pre="WangS, YinY, ZhangG, CarterRA, WangJ, et al.Evolution of the H9N2" exact="influenza" post="genotype that facilitated the genesis of the novel H7N9"/>
   <result pre="Avian Influenza Viruses in Egypt. Viruses. 2018;10(3):E12110.3390/v1003012129522492 3SunY, LiuJ. H9N2" exact="influenza" post="virus in China: a cause of concern. Protein Cell."/>
   <result pre="LiQ, HuangJ, ZhaoM, GuX, et al.Enzootic genotype S of H9N2" exact="avian influenza" post="viruses donates internal genes to emerging zoonotic influenza viruses"/>
   <result pre="HuangJ, ZhaoM, GuX, et al.Enzootic genotype S of H9N2 avian" exact="influenza" post="viruses donates internal genes to emerging zoonotic influenza viruses"/>
   <result pre="H9N2 avian influenza viruses donates internal genes to emerging zoonotic" exact="influenza" post="viruses in China. Vet Microbiol. 2014;174(3–4):309–15. 10.1016/j.vetmic.2014.09.029 .25457363 5GuanY,"/>
   <result pre="10.1016/j.vetmic.2014.09.029 .25457363 5GuanY, ShortridgeKF, KraussS, WebsterRG. Molecular characterization of H9N2" exact="influenza" post="viruses: were they the donors of the &quot;internal&quot; genes"/>
   <result pre="GaoGF. Poultry carrying H9N2 act as incubators for novel human" exact="avian influenza" post="viruses. Lancet. 2014;383(9920):86910.1016/S0140-6736(14)60386-X .24581684 7FusaroA, MonneI, SalviatoA, ValastroV, SchivoA,"/>
   <result pre="Poultry carrying H9N2 act as incubators for novel human avian" exact="influenza" post="viruses. Lancet. 2014;383(9920):86910.1016/S0140-6736(14)60386-X .24581684 7FusaroA, MonneI, SalviatoA, ValastroV, SchivoA,"/>
   <result pre="2011;85(16):8413–21. 10.1128/JVI.00219-1121680519 8AamirUB, WerneryU, IlyushinaN, WebsterRG. Characterization of avian H9N2" exact="influenza" post="viruses from United Arab Emirates 2000 to 2003. Virology."/>
   <result pre="10.1016/j.virol.2006.10.03717157891 9DavidsonI, FusaroA, HeidariA, MonneI, CattoliG. Molecular evolution of H9N2" exact="avian influenza" post="viruses in Israel. Virus Genes. 2014;48(3):457–63. 10.1007/s11262-014-1037-0 .24469467 10HosseiniH,"/>
   <result pre="9DavidsonI, FusaroA, HeidariA, MonneI, CattoliG. Molecular evolution of H9N2 avian" exact="influenza" post="viruses in Israel. Virus Genes. 2014;48(3):457–63. 10.1007/s11262-014-1037-0 .24469467 10HosseiniH,"/>
   <result pre="Fallah MehrabadiMH, SediqianMS, ShayeganmehrA, GhafouriSA, et al.Phylogenetic analysis of H9N2" exact="avian influenza" post="viruses in Afghanistan (2016–2017). Arch Virol. 2017;162(10):3161–5. 10.1007/s00705-017-3474-2 .28674864"/>
   <result pre="MehrabadiMH, SediqianMS, ShayeganmehrA, GhafouriSA, et al.Phylogenetic analysis of H9N2 avian" exact="influenza" post="viruses in Afghanistan (2016–2017). Arch Virol. 2017;162(10):3161–5. 10.1007/s00705-017-3474-2 .28674864"/>
   <result pre="11KayaliG, KandeilA, El-SheshenyR, KayedAS, GomaaMM, MaatouqAM, et al.Active surveillance for" exact="avian influenza" post="virus, Egypt, 2010–2012. Emerg Infect Dis. 2014;20(4):542–51. 10.3201/eid2004.13129524655395 12MonneI,"/>
   <result pre="KandeilA, El-SheshenyR, KayedAS, GomaaMM, MaatouqAM, et al.Active surveillance for avian" exact="influenza" post="virus, Egypt, 2010–2012. Emerg Infect Dis. 2014;20(4):542–51. 10.3201/eid2004.13129524655395 12MonneI,"/>
   <result pre="2014;20(4):542–51. 10.3201/eid2004.13129524655395 12MonneI, HusseinHA, FusaroA, ValastroV, HamoudMM, KhalefaRA, et al.H9N2" exact="influenza" post="A virus circulates in H5N1 endemically infected poultry population"/>
   <result pre="Maurer-StrohS, et al.Evolutionary trajectories and diagnostic challenges of potentially zoonotic" exact="avian influenza" post="viruses H5N1 and H9N2 co-circulating in Egypt. Infect Genet"/>
   <result pre="et al.Evolutionary trajectories and diagnostic challenges of potentially zoonotic avian" exact="influenza" post="viruses H5N1 and H9N2 co-circulating in Egypt. Infect Genet"/>
   <result pre="WatanabeT, YamayoshiS, Iwatsuki-HorimotoK, et al.Risk assessment of recent Egyptian H5N1" exact="influenza" post="viruses. Sci Rep. 2016;6:3838810.1038/srep3838827922116 15WatanabeY, IbrahimMS, EllakanyHF, KawashitaN, MizuikeR,"/>
   <result pre="et al.Acquisition of human-type receptor binding specificity by new H5N1" exact="influenza" post="virus sublineages during their emergence in birds in Egypt."/>
   <result pre="AraiY, DaidojiT, KawashitaN, IbrahimMS, El-Gendy EelD, et al.Characterization of H5N1" exact="influenza" post="virus variants with hemagglutinin mutations isolated from patients. MBio."/>
   <result pre="2015;6(2):e00081–15. 10.1128/mBio.00081-1525852160 18ChrzastekK, LeeDH, GharaibehS, ZsakA, KapczynskiDR. Characterization of H9N2" exact="avian influenza" post="viruses from the Middle East demonstrates heterogeneity at amino"/>
   <result pre="10.1128/mBio.00081-1525852160 18ChrzastekK, LeeDH, GharaibehS, ZsakA, KapczynskiDR. Characterization of H9N2 avian" exact="influenza" post="viruses from the Middle East demonstrates heterogeneity at amino"/>
   <result pre="Insights into genetic diversity and biological propensities of potentially zoonotic" exact="avian influenza" post="H9N2 viruses circulating in Egypt. Virology. 2017;511:165–74. 10.1016/j.virol.2017.08.028 .28863277"/>
   <result pre="into genetic diversity and biological propensities of potentially zoonotic avian" exact="influenza" post="H9N2 viruses circulating in Egypt. Virology. 2017;511:165–74. 10.1016/j.virol.2017.08.028 .28863277"/>
   <result pre="EllakanyHF, Abd El-HamidHS, IkutaK. Genetic diversification of H5N1 highly pathogenic" exact="avian influenza" post="A virus during replication in wild ducks. J Gen"/>
   <result pre="Abd El-HamidHS, IkutaK. Genetic diversification of H5N1 highly pathogenic avian" exact="influenza" post="A virus during replication in wild ducks. J Gen"/>
   <result pre="DuanL, CheungCL, et al.The genesis and source of the H7N9" exact="influenza" post="viruses causing human infections in China. Nature. 2013;502(7470):241–4. 10.1038/nature1251523965623"/>
   <result pre="mammalian-adapting mutations in the polymerase complex of an avian H5N1" exact="influenza" post="virus. Nat Commun. 2015;6:749110.1038/ncomms849126082035 24SugiyamaK, KawaguchiA, OkuwakiM, NagataK. pp32"/>
   <result pre="OkuwakiM, NagataK. pp32 and APRIL are host cell-derived regulators of" exact="influenza" post="virus RNA synthesis from cRNA. ELife. 2015;4:e0893910.7554/eLife.0893926512887 25Te VelthuisAJ,"/>
   <result pre="RamboRP, et al.Crystal structure of the RNA-dependent RNA polymerase from" exact="influenza" post="C virus. Nature. 2015;527(7576):114–7. 10.1038/nature1552526503046 28WatanabeY, IbrahimMS, IkutaK. Evolution"/>
   <result pre="2013;14(2):117–22. 10.1038/embor.2012.21223306655 29SediriH, ThieleS, SchwalmF, GabrielG, KlenkHD. PB2 subunit of" exact="avian influenza" post="virus subtype H9N2: a pandemic risk factor. J Gen"/>
   <result pre="10.1038/embor.2012.21223306655 29SediriH, ThieleS, SchwalmF, GabrielG, KlenkHD. PB2 subunit of avian" exact="influenza" post="virus subtype H9N2: a pandemic risk factor. J Gen"/>
   <result pre="host range and mammalian-associated genetic changes in a duck H9N2" exact="influenza" post="virus following adaptation in quail and chickens. PLoS One."/>
   <result pre="31HattaM, HattaY, KimJH, WatanabeS, ShinyaK, NguyenT, et al.Growth of H5N1" exact="influenza" post="A viruses in the upper respiratory tracts of mice."/>
   <result pre="MurphyBR. A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host range. J"/>
   <result pre="a PB2-E627K substitution confers a virulent phenotype to an H9N2" exact="avian influenza" post="virus during adoption in mice. Arch Virol. 2015;160(5):1267–77. 10.1007/s00705-015-2383-5"/>
   <result pre="PB2-E627K substitution confers a virulent phenotype to an H9N2 avian" exact="influenza" post="virus during adoption in mice. Arch Virol. 2015;160(5):1267–77. 10.1007/s00705-015-2383-5"/>
   <result pre="amino acid substitutions are involved in the adaptation of H9N2" exact="avian influenza" post="virus to mice. Vet Microbiol. 2009;138(1–2):85–91. 10.1016/j.vetmic.2009.03.010 .19342184 35SongW,"/>
   <result pre="acid substitutions are involved in the adaptation of H9N2 avian" exact="influenza" post="virus to mice. Vet Microbiol. 2009;138(1–2):85–91. 10.1016/j.vetmic.2009.03.010 .19342184 35SongW,"/>
   <result pre="in viral protein PB2 enhances the effects of E627K on" exact="influenza" post="virus replication. Nat Commun. 2014;5:550910.1038/ncomms650925409547 36NeumannG, MackenCA, KarasinAI, FouchierRA,"/>
   <result pre="Nat Commun. 2014;5:550910.1038/ncomms650925409547 36NeumannG, MackenCA, KarasinAI, FouchierRA, KawaokaY. Egyptian H5N1" exact="influenza" post="viruses-cause for concern?PLoS Pathog. 2012;8(11):e100293210.1371/journal.ppat.100293223166487 37SohYS, MonclaLH, EguiaR, BedfordT,"/>
   <result pre="MonclaLH, EguiaR, BedfordT, BloomJD. Comprehensive mapping of adaptation of the" exact="avian influenza" post="polymerase protein PB2 to humans. ELife. 2019;8:e4507910.7554/eLife.4507931038123 38LongJS, MistryB,"/>
   <result pre="EguiaR, BedfordT, BloomJD. Comprehensive mapping of adaptation of the avian" exact="influenza" post="polymerase protein PB2 to humans. ELife. 2019;8:e4507910.7554/eLife.4507931038123 38LongJS, MistryB,"/>
   <result pre="2019;8:e4507910.7554/eLife.4507931038123 38LongJS, MistryB, HaslamSM, BarclayWS. Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat Rev Microbiol. 2019;17(2):67–81. 10.1038/s41579-018-0115-z"/>
   <result pre="MoncorgeO, FriseR, MistryB, JamesJ, et al.Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature. 2016;529(7584):101–4. 10.1038/nature1647426738596 41Te"/>
   <result pre="et al.Mini viral RNAs act as innate immune agonists during" exact="influenza" post="virus infection. Nat Microbiol. 2018;3(11):1234–42. 10.1038/s41564-018-0240-530224800 42WanH, PerezDR. Amino"/>
   <result pre="42WanH, PerezDR. Amino acid 226 in the hemagglutinin of H9N2" exact="influenza" post="viruses determines cell tropism and replication in human airway"/>
   <result pre="WebbyRJ, et al.Evidence of infection with avian, human, and swine" exact="influenza" post="viruses in pigs in Cairo, Egypt. Arch Virol. 2018;163(2):359–64."/>
   <result pre=".29075888 44GomaaMR, KayedAS, ElabdMA, ZeidDA, ZakiSA, El RifayAS, et al.Avian" exact="influenza" post="A(H5N1) and A(H9N2) seroprevalence and risk factors for infection"/>
   <result pre="2015;211(9):1399–407. 10.1093/infdis/jiu52925355942 45KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR. Compatibility of H9N2" exact="avian influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="10.1093/infdis/jiu52925355942 45KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR. Compatibility of H9N2 avian" exact="influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009" exact="influenza" post="viruses. Proc Natl Acad Sci USA. 2011;108(10):4164–9. 10.1073/pnas.101910910821368167 47AraiY,"/>
   <result pre="polymerase gene mutations for human adaptation occurring in Asian H5N1" exact="influenza" post="virus clinical isolates. Sci Rep. 2018;8(1):1306610.1038/s41598-018-31397-3 .30166556 48WatanabeY, AraiY,"/>
   <result pre="FujiiK, GotoH, WatanabeS, NodaT, et al.Strand-specific real-time RT-PCR for distinguishing" exact="influenza" post="vRNA, cRNA, and mRNA. J Virol Methods. 2011;173(1):1–6. 10.1016/j.jviromet.2010.12.01421185869"/>
   <result pre="of polymerase gene mutations that affect viral replication in H5N1" exact="influenza" post="viruses isolated from pigeons. J Gen Virol. 2017;98(1):6–17. 10.1099/jgv.0.000674"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6629778\results\search\disease\results.xml">
   <result pre="al., 2001; Mostashari et al., 2001). Mortality due to WNV" exact="encephalitis" post="ranges between 10 and 17% and increases with age"/>
   <result pre="Americas. After its arrival in 2015, an increased incidence of" exact="microcephaly" post="in newborns and Guillain-Barré syndrome (GBS) in adults infected"/>
   <result pre="other flaviviruses able to cause neurological diseases (such as Japanese" exact="encephalitis" post="and tick-borne encephalitis virus), and due to the size"/>
   <result pre="able to cause neurological diseases (such as Japanese encephalitis and" exact="tick-borne encephalitis" post="virus), and due to the size of the review"/>
   <result pre="to cause neurological diseases (such as Japanese encephalitis and tick-borne" exact="encephalitis" post="virus), and due to the size of the review"/>
   <result pre="continues its steady expansion and constitutes the most common mosquito-borne" exact="viral disease" post="worldwide. WNV is the most widespread flavivirus causing neurological"/>
   <result pre="in the Americas is responsible for thousands of cases of" exact="microcephaly" post="in newborns and Guillain-Barre syndrome in adults. Different strategies"/>
   <result pre="WNV infection can lead to severe neurological problems. These include" exact="aseptic meningitis," post="febrile convulsions in children, encephalitis, and myelitis (Turtle et"/>
   <result pre="These include aseptic meningitis, febrile convulsions in children, encephalitis, and" exact="myelitis" post="(Turtle et al., 2012). Thus, models of the brain"/>
   <result pre="mainly been studied in monolayer cultures of various brain cell-type" exact="cancer" post="cell lines, such as neuro-2a (de Borba et al.,"/>
   <result pre="to be a novel tool for drug screening development for" exact="cancer" post="(Weeber et al., 2017), intestinal diseases (Liu et al.,"/>
   <result pre="screening approach was recently utilized to elucidate that ZIKV-elicited congenital" exact="microcephaly" post="may act through dysregulation of the retinoic acid response"/>
   <result pre="role of both viral and human microRNA in congenital ZIKV" exact="microcephaly" post="(Pylro et al., 2016). In addition to studies focused"/>
   <result pre="infection and pathogenesis. However, in vitro models that rely on" exact="cancer" post="cell lines or monolayer cultures are limited in human"/>
   <result pre="comparative analysis of the relative efficacy of vector-control strategies against" exact="dengue fever." post="Bull. Math. Biol.76, 697–717. 10.1007/s11538-014-9939-524619807 AmannaI. J.SlifkaM. K. (2014)."/>
   <result pre="pathologic study of a DENV2 clinical isolate capable of inducing" exact="encephalitis" post="and hematological disturbances in immunocompetent mice. PLoS ONE7:e44984. 10.1371/journal.pone.004498423028722"/>
   <result pre="leucocyte antigen-DR on peripheral blood monocytes during mild and severe" exact="dengue fever." post="Immunology130, 202–216. 10.1111/j.1365-2567.2009.03224.x20113369 BalasubramanianA.TeramotoT.KulkarniA. A.BhattacharjeeA. K.PadmanabhanR. (2017). Antiviral activities"/>
   <result pre="GoodfellowF. T.TeslaB.SimchickG.ZhaoQ.HodgeT.BrindleyM. A.et al.. (2016). Zika virus induced mortality and" exact="microcephaly" post="in chicken embryos. Stem Cells Dev.25, 1691–1697. 10.1089/scd.2016.023127627457 GrebenyukS.RangaA."/>
   <result pre="Front. Bioeng. Biotechnol.7:39. 10.3389/fbioe.2019.0003930941347 GuirakhooF.KitchenerS.MorrisonD.ForratR.McCarthyK.NicholsR.et al. (2006). Live attenuated chimeric" exact="yellow fever" post="dengue type 2 (ChimeriVax™-DEN2) vaccine: Phase I clinical trial"/>
   <result pre="Phase I clinical trial for safety and immunogenicity: effect of" exact="yellow fever" post="pre-immunity in induction of cross neutralizing antibody responses to"/>
   <result pre="First Isolation of West Nile virus from a patient with" exact="encephalitis" post="in the United States. Emerging Infect. Dis.8, 1367–1371. 10.3201/eid0812.02053212498649"/>
   <result pre="MarianiJ.CoppolaG.ZhangP.AbyzovA.ProviniL.TomasiniL.et al.. (2015). FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in" exact="autism" post="spectrum disorders. Cell162, 375–390. 10.1016/j.cell.2015.06.03426186191 MartinJ. E.PiersonT. C.HubkaS.RuckerS.GordonI. J.EnamaM."/>
   <result pre="S. (2003). Infection and injury of neurons by West Nile" exact="encephalitis" post="virus. J. Virol.77, 13203–13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP. N.ShiP."/>
   <result pre="endpoints of CELADEN: a randomized, placebo-controlled trial of celgosivir in" exact="dengue fever" post="patients. PLoS Negl. Trop. Dis.10:e0004851. 10.1371/journal.pntd.000485127509020 TalaveraD.CastilloA. M.DominguezM. C.GutierrezA."/>
   <result pre="Immunother.13, 1059–1072. 10.1080/21645515.2016.126177028281864 TsaiT. F.PopoviciF.CernescuC.CampbellG. L.NedelcuN. I. (1998). West Nile" exact="encephalitis" post="epidemic in southeastern Romania. Lancet352, 767–771. 10.1016/S0140-6736(98)03538-79737281 TsaiY. T.ChangS."/>
   <result pre="WeeberF.OoftS. N.DijkstraK. K.VoestE. E. (2017). Tumor organoids as a pre-clinical" exact="cancer" post="model for drug discovery. Cell Chem. Biol.24, 1092–1100. 10.1016/j.chembiol.2017.06.01228757181"/>
   <result pre="Modeling the Effects of augmentation strategies on the control of" exact="dengue fever" post="with an impulsive differential equation. Bull. Math. Biol.78, 1968–2010."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6630566\results\search\disease\results.xml">
   <result pre="have spread efficiently from person to person to cause an" exact="influenza" post="pandemic. The ability to infect a different species, replicate"/>
   <result pre="avian IAV to infect and spread in humans are discussed." exact="influenza" post="species barrier cross-species infection zoonoses animal–human interface 1. Introduction"/>
   <result pre="interface 1. Introduction Much of what we know about pandemic" exact="influenza" post="viruses is based on analysis of the four influenza"/>
   <result pre="pandemic influenza viruses is based on analysis of the four" exact="influenza" post="A viruses (IAVs) that caused influenza pandemics in the"/>
   <result pre="analysis of the four influenza A viruses (IAVs) that caused" exact="influenza" post="pandemics in the last 100 years: the 1918 H1N1,"/>
   <result pre="infected by relatively few IAV subtypes. For example, classical swine" exact="influenza" post="(which refers to H1N1 virus infection in pigs), H1N1pdm09"/>
   <result pre="viruses infect pigs, H3 and H7 subtypes have caused equine" exact="influenza" post="and sustained epidemics in humans have only been caused"/>
   <result pre="segments of negative-sense, single-stranded RNA. The enormous genetic diversity of" exact="influenza" post="viruses in nature is a result of an error-prone"/>
   <result pre="fatal, multi-system infection in poultry that is called highly pathogenic" exact="avian influenza" post="(HPAI). Avian IAVs that lack the MCBS are referred"/>
   <result pre="multi-system infection in poultry that is called highly pathogenic avian" exact="influenza" post="(HPAI). Avian IAVs that lack the MCBS are referred"/>
   <result pre="that lack the MCBS are referred to as low pathogenicity" exact="avian influenza" post="(LPAI) viruses [14]. Highly pathogenic avian H5N1, H7N7 and,"/>
   <result pre="lack the MCBS are referred to as low pathogenicity avian" exact="influenza" post="(LPAI) viruses [14]. Highly pathogenic avian H5N1, H7N7 and,"/>
   <result pre="Furthermore, erroneous polymerase activity during viral RNA replication of some" exact="influenza" post="viruses can lead to the production of short aberrant"/>
   <result pre="IAVs have infected and become established in pigs [22], so" exact="influenza" post="in swine today is caused by a variety of"/>
   <result pre="Consequence of Interspecies Transmission Influenza pandemics occur when a novel" exact="influenza" post="A virus, to which a significant proportion of the"/>
   <result pre="IAVs in humans is referred to as antigenic shift. Novel" exact="influenza" post="viruses are introduced from an animal reservoir. If the"/>
   <result pre="a pandemic threat. The 1957 H2N2 and 1968 H3N2 pandemic" exact="influenza" post="viruses were genetic reassortants that derived three [HA, NA"/>
   <result pre="or two (HA and PB1) gene segments, respectively, from an" exact="avian influenza" post="virus and the remaining gene segments from the previously"/>
   <result pre="two (HA and PB1) gene segments, respectively, from an avian" exact="influenza" post="virus and the remaining gene segments from the previously"/>
   <result pre="and the remaining gene segments from the previously circulating human" exact="influenza" post="virus [27,28]. The host in which these reassortment events"/>
   <result pre="to infected poultry. Compared to the four viruses that caused" exact="influenza" post="pandemics, with very rare exceptions in close contacts, these"/>
   <result pre="the Species Barrier The molecular determinants of the transmissibility of" exact="influenza" post="viruses are not well understood. Epidemiologically successful IAVs, e.g.,"/>
   <result pre="not well understood. Epidemiologically successful IAVs, e.g., seasonal and pandemic" exact="influenza" post="viruses, transmit efficiently from person to person while those"/>
   <result pre="animal by a mesh (airborne transmission) are assessed. While seasonal" exact="influenza" post="A viruses transmit by contact and airborne transmission, avian"/>
   <result pre="the ferret, a site that was overlooked in all previous" exact="influenza" post="research [42]. We found that the soft palate of"/>
   <result pre="economic consequences of a pandemic and the certainty that another" exact="influenza" post="pandemic will occur are so great that the public"/>
   <result pre="most effective approach to prevent and treat influenza. However, pandemic" exact="influenza" post="vaccines pose several challenges [43,44,45]; currently licensed vaccines take"/>
   <result pre="highly strain-specific immunity. There are active efforts to develop universal" exact="influenza" post="vaccines that will provide protection against a broad range"/>
   <result pre="and spread efficiently from person to person to cause an" exact="influenza" post="pandemic. The global impact of influenza pandemics drives scientific"/>
   <result pre="person to cause an influenza pandemic. The global impact of" exact="influenza" post="pandemics drives scientific efforts to understand the barriers to"/>
   <result pre="declares no conflict of interest. References References 1.MostafaA.AbdelwhabE.M.MettenleiterT.C.PleschkaS.Zoonotic potential of" exact="influenza" post="a viruses: A comprehensive overviewViruses20181049710.3390/v1009049730217093 2.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage"/>
   <result pre="a viruses: A comprehensive overviewViruses20181049710.3390/v1009049730217093 2.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="a virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 3.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et"/>
   <result pre="Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 3.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="a virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 4.ZhangY.Z.WuW.C.ShiM.HolmesE.C.The diversity, evolution and origins of"/>
   <result pre="of vertebrate rna virusesCurr. Opin. Virol.20183191610.1016/j.coviro.2018.07.01730114593 5.YoonS.W.WebbyR.J.WebsterR.G.Evolution and ecology of" exact="influenza" post="a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and avian influenza"/>
   <result pre="ecology of influenza a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and" exact="avian influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="of influenza a virusesCurr. Top. Microbiol. Immunol.201438535937524990620 6.MatrosovichM.N.MatrosovichT.Y.GrayT.RobertsN.A.KlenkH.D.Human and avian" exact="influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="avian h5n1 virus hemagglutininNat. Biotechnol.20082610711310.1038/nbt137518176555 8.RogersG.N.PaulsonJ.C.DanielsR.S.SkehelJ.J.WilsonI.A.WileyD.C.Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificityNature1983304767810.1038/304076a06191220 9.ShinyaK.EbinaM.YamadaS.OnoM.KasaiN.KawaokaY.Avian flu: Influenza virus"/>
   <result pre="al.Glycomic analysis of human respiratory tract tissues and correlation with" exact="influenza" post="virus infectionPLoS Pathog.20139e100322310.1371/journal.ppat.100322323516363 12.Stieneke GroberA.VeyM.AnglikerH.ShawE.ThomasG.RobertsC.KlenkH.D.GartenW.Influenza virus hemagglutinin with multibasic"/>
   <result pre="by furin, a subtilisin-like endoproteaseEMBO J.1992112407241410.1002/j.1460-2075.1992.tb05305.x1628614 13.VeyM.OrlichM.AdlerS.KlenkH.D.RottR.GartenW.Hemagglutinin activation of pathogenic" exact="avian influenza" post="viruses of serotype h7 requires the protease recognition motif"/>
   <result pre="furin, a subtilisin-like endoproteaseEMBO J.1992112407241410.1002/j.1460-2075.1992.tb05305.x1628614 13.VeyM.OrlichM.AdlerS.KlenkH.D.RottR.GartenW.Hemagglutinin activation of pathogenic avian" exact="influenza" post="viruses of serotype h7 requires the protease recognition motif"/>
   <result pre="Microbiol.2005359160010.1038/nrmicro120816064053 15.SubbaraoE.K.LondonW.MurphyB.R.A single amino acid in the pb2 gene of" exact="influenza" post="a virus is a determinant of host rangeJ. Virol.199367176117648445709"/>
   <result pre="host rangeJ. Virol.199367176117648445709 16.LiZ.ChenH.JiaoP.DengG.TianG.LiY.HoffmannE.WebsterR.G.MatsuokaY.YuK.Molecular basis of replication of duck h5n1" exact="influenza" post="viruses in a mammalian mouse modelJ. Virol.200579120581206410.1128/JVI.79.18.12058-12064.200516140781 17.MehleA.DoudnaJ.A.Adaptive strategies"/>
   <result pre="in a mammalian mouse modelJ. Virol.200579120581206410.1128/JVI.79.18.12058-12064.200516140781 17.MehleA.DoudnaJ.A.Adaptive strategies of the" exact="influenza" post="virus polymerase for replication in humansProc. Natl. Acad. Sci."/>
   <result pre="humansProc. Natl. Acad. Sci. USA2009106213122131610.1073/pnas.091191510619995968 18.LongJ.S.MistryB.HaslamS.M.BarclayW.S.Host and viral determinants of" exact="influenza" post="a virus species specificityNat. Rev. Microbiol.201917678110.1038/s41579-018-0115-z30487536 19.LongJ.S.GiotisE.S.MoncorgeO.FriseR.MistryB.JamesJ.MorissonM.IqbalM.VignalA.SkinnerM.A.et al.Species difference"/>
   <result pre="species specificityNat. Rev. Microbiol.201917678110.1038/s41579-018-0115-z30487536 19.LongJ.S.GiotisE.S.MoncorgeO.FriseR.MistryB.JamesJ.MorissonM.IqbalM.VignalA.SkinnerM.A.et al.Species difference in anp32a underlies" exact="influenza" post="a virus polymerase host restrictionNature201652910110410.1038/nature1647426738596 20.GabrielG.KlingelK.OtteA.ThieleS.HudjetzB.Arman-KalcekG.SauterM.ShmidtT.RotherF.BaumgarteS.et al.Differential use of"/>
   <result pre="of importin-alpha isoforms governs cell tropism and host adaptation of" exact="influenza" post="virusNat. Commun.2011215610.1038/ncomms115821245837 21.Te VelthuisA.J.W.LongJ.C.BauerD.L.V.FanR.L.Y.YenH.L.SharpsJ.SiegersJ.Y.KillipM.J.FrenchH.Oliva-MartinM.J.et al.Mini viral rnas act as"/>
   <result pre="VelthuisA.J.W.LongJ.C.BauerD.L.V.FanR.L.Y.YenH.L.SharpsJ.SiegersJ.Y.KillipM.J.FrenchH.Oliva-MartinM.J.et al.Mini viral rnas act as innate immune agonists during" exact="influenza" post="virus infectionNat. Microbiol.201831234124210.1038/s41564-018-0240-530224800 22.NelsonM.I.VincentA.L.Reverse zoonosis of influenza to swine:"/>
   <result pre="immune agonists during influenza virus infectionNat. Microbiol.201831234124210.1038/s41564-018-0240-530224800 22.NelsonM.I.VincentA.L.Reverse zoonosis of" exact="influenza" post="to swine: New perspectives on the human-animal interfaceTrends Microbiol.20152314215310.1016/j.tim.2014.12.00225564096"/>
   <result pre="New perspectives on the human-animal interfaceTrends Microbiol.20152314215310.1016/j.tim.2014.12.00225564096 23.VincentA.AwadaL.BrownI.ChenH.ClaesF.DauphinG.DonisR.CulhaneM.HamiltonK.LewisN.et al.Review of" exact="influenza" post="a virus in swine worldwide: A call for increased"/>
   <result pre="researchZoonoses Public Health20146141710.1111/zph.1204923556412 24.ChenY.TrovaoN.S.WangG.ZhaoW.HeP.ZhouH.MoY.WeiZ.OuyangK.HuangW.et al.Emergence and evolution of novel reassortant" exact="influenza" post="a viruses in canines in southern ChinamBio20189e00909e0091810.1128/mBio.00909-1829871917 25.CrawfordP.C.DuboviE.J.CastlemanW.L.StephensonI.GibbsE.P.ChenL.SmithC.HillR.C.FerroP.PompeyJ.et al.Transmission"/>
   <result pre="viruses in canines in southern ChinamBio20189e00909e0091810.1128/mBio.00909-1829871917 25.CrawfordP.C.DuboviE.J.CastlemanW.L.StephensonI.GibbsE.P.ChenL.SmithC.HillR.C.FerroP.PompeyJ.et al.Transmission of equine" exact="influenza" post="virus to dogsScience200531048248510.1126/science.111795016186182 26.SongD.S.LeeJ.Y.OhJ.S.LyooK.S.YoonK.J.ParkY.H.ParkB.K.Isolation of h3n2 swine influenza virus"/>
   <result pre="of equine influenza virus to dogsScience200531048248510.1126/science.111795016186182 26.SongD.S.LeeJ.Y.OhJ.S.LyooK.S.YoonK.J.ParkY.H.ParkB.K.Isolation of h3n2 swine" exact="influenza" post="virus in south koreaJ. Vet. Diagn. Invest.200315303410.1177/10406387030150010712580292 27.KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission"/>
   <result pre="Vet. Diagn. Invest.200315303410.1177/10406387030150010712580292 27.KawaokaY.KraussS.WebsterR.G.Avian-to-human transmission of the pb1 gene of" exact="influenza" post="a viruses in the 1957 and 1968 pandemicsJ. Virol.198963460346082795713"/>
   <result pre="and 1968 pandemicsJ. Virol.198963460346082795713 28.SchaferJ.R.KawaokaY.BeanW.J.SussJ.SenneD.WebsterR.G.Origin of the pandemic 1957 h2" exact="influenza" post="a virus and the persistence of its possible progenitors"/>
   <result pre="its possible progenitors in the avian reservoirVirology199319478178810.1006/viro.1993.13197684877 29.ScholtissekC.Molecular evolution of" exact="influenza" post="virusesVirus Genes19951120921510.1007/BF017286608828147 30.ReidA.H.TaubenbergerJ.K.FanningT.G.Evidence of an absence: The genetic origins"/>
   <result pre="of an absence: The genetic origins of the 1918 pandemic" exact="influenza" post="virusNat. Rev. Microbiol.2004290991410.1038/nrmicro102715494747 31.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza"/>
   <result pre="pandemic influenza virusNat. Rev. Microbiol.2004290991410.1038/nrmicro102715494747 31.SmithG.J.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 32.WorobeyM.HanG.Z.RambautA.A synchronized global sweep"/>
   <result pre="32.WorobeyM.HanG.Z.RambautA.A synchronized global sweep of the internal genes of modern" exact="avian influenza" post="virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of influenza at the human-animal interface,"/>
   <result pre="synchronized global sweep of the internal genes of modern avian" exact="influenza" post="virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of influenza at the human-animal interface,"/>
   <result pre="internal genes of modern avian influenza virusNature201450825425710.1038/nature1301624531761 33.HammondA.FitznerJ.CollinsL.OngS.K.VandemaeleK.Human cases of" exact="influenza" post="at the human-animal interface, January 2015–April 2017Wkly. Epidemiol. Rec.201733460475"/>
   <result pre="Rec.201733460475 34.MainesT.R.ChenL.M.MatsuokaY.ChenH.RoweT.OrtinJ.FalconA.NguyenT.H.Mai leQ.SedyaningsihE.R.et al.Lack of transmission of h5n1 avian-human reassortant" exact="influenza" post="viruses in a ferret modelProc. Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383"/>
   <result pre="Natl. Acad. Sci. USA2006103121211212610.1073/pnas.060513410316880383 35.WanH.SorrellE.M.SongH.HossainM.J.Ramirez-NietoG.MonneI.StevensJ.CattoliG.CapuaI.ChenL.M.et al.Replication and transmission of h9n2" exact="influenza" post="viruses in ferrets: Evaluation of pandemic potentialPLoS ONE20083e292310.1371/journal.pone.000292318698430 36.Van"/>
   <result pre="ha and polymerase subunit pb2 proteins confer transmission of an" exact="avian influenza" post="virus through the airProc. Natl. Acad. Sci. USA20091063366337110.1073/pnas.081317210619211790 37.LakdawalaS.S.LamirandeE.W.SuguitanA.L.Jr.WangW.SantosC.P.VogelL.MatsuokaY.LindsleyW.G.JinH.SubbaraoK.Eurasian-origin"/>
   <result pre="and polymerase subunit pb2 proteins confer transmission of an avian" exact="influenza" post="virus through the airProc. Natl. Acad. Sci. USA20091063366337110.1073/pnas.081317210619211790 37.LakdawalaS.S.LamirandeE.W.SuguitanA.L.Jr.WangW.SantosC.P.VogelL.MatsuokaY.LindsleyW.G.JinH.SubbaraoK.Eurasian-origin"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic h1n1" exact="influenza" post="virusPLoS Pathog.20117e100244310.1371/journal.ppat.100244322241979 38.YenH.L.LiangC.H.WuC.Y.ForrestH.L.FergusonA.ChoyK.T.JonesJ.WongD.D.CheungP.P.HsuC.H.et al.Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of"/>
   <result pre="38.YenH.L.LiangC.H.WuC.Y.ForrestH.L.FergusonA.ChoyK.T.JonesJ.WongD.D.CheungP.P.HsuC.H.et al.Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic h1n1" exact="influenza" post="virus in ferretsProc. Natl. Acad. Sci. USA2011108142641426910.1073/pnas.111100010821825167 39.ImaiM.WatanabeT.HattaM.DasS.C.OzawaM.ShinyaK.ZhongG.HansonA.KatsuraH.WatanabeS.et al.Experimental"/>
   <result pre="ferretsProc. Natl. Acad. Sci. USA2011108142641426910.1073/pnas.111100010821825167 39.ImaiM.WatanabeT.HattaM.DasS.C.OzawaM.ShinyaK.ZhongG.HansonA.KatsuraH.WatanabeS.et al.Experimental adaptation of an" exact="influenza" post="h5 ha confers respiratory droplet transmission to a reassortant"/>
   <result pre="h5 ha/h1n1 virus in ferretsNature201248642042810.1038/nature1083122722205 40.HerfstS.SchrauwenE.J.LinsterM.ChutinimitkulS.de WitE.MunsterV.J.SorrellE.M.BestebroerT.M.BurkeD.F.SmithD.J.et al.Airborne transmission of" exact="influenza" post="a/h5n1 virus between ferretsScience20123361534154110.1126/science.121336222723413 41.MatrosovichM.TuzikovA.BovinN.GambaryanA.KlimovA.CastrucciM.R.DonatelliI.KawaokaY.Early alterations of the receptor-binding"/>
   <result pre="alterations of the receptor-binding properties of h1, h2, and h3" exact="avian influenza" post="virus hemagglutinins after their introduction into mammalsJ. Virol.2000748502851210.1128/JVI.74.18.8502-8512.200010954551 42.LakdawalaS.S.JayaramanA.HalpinR.A.LamirandeE.W.ShihA.R.StockwellT.B.LinX.SimenauerA.HansonC.T.VogelL.et"/>
   <result pre="of the receptor-binding properties of h1, h2, and h3 avian" exact="influenza" post="virus hemagglutinins after their introduction into mammalsJ. Virol.2000748502851210.1128/JVI.74.18.8502-8512.200010954551 42.LakdawalaS.S.JayaramanA.HalpinR.A.LamirandeE.W.ShihA.R.StockwellT.B.LinX.SimenauerA.HansonC.T.VogelL.et"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature201552612212510.1038/nature1537926416728 43.BazM.LukeC.J.ChengX.JinH.SubbaraoK.H5n1 vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 44.CzakoR.SubbaraoK.Refining the approach"/>
   <result pre="vaccines in humansVirus Res.2013178789810.1016/j.virusres.2013.05.00623726847 44.CzakoR.SubbaraoK.Refining the approach to vaccines against" exact="influenza" post="a viruses with pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to"/>
   <result pre="with pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to developing vaccines against" exact="avian influenza" post="virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of influenza vaccines: Status"/>
   <result pre="pandemic potentialFuture Virol.2015101033104710.2217/fvl.15.6926587050 45.SubbaraoK.JosephT.Scientific barriers to developing vaccines against avian" exact="influenza" post="virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of influenza vaccines: Status"/>
   <result pre="vaccines against avian influenza virusesNature Rev.2007726727810.1038/nri205417363960 46.FoxA.QuinnK.M.SubbaraoK.Extending the breadth of" exact="influenza" post="vaccines: Status and prospects for a universal vaccineDrugs2018781297130810.1007/s40265-018-0958-730088204"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6630949\results\search\disease\results.xml">
   <result pre="health burden worldwide. Vaccination is the best way to prevent" exact="influenza" post="virus infections. However, conventional vaccines are only effective for"/>
   <result pre="a short period of time due to the propensity of" exact="influenza" post="viruses to undergo antigenic drift and antigenic shift. The"/>
   <result pre="have been discovered that may serve as means to suppress" exact="influenza" post="viral infection and allow the process of natural immunity"/>
   <result pre="approach assumes a robust tool that could aid control of" exact="influenza" post="viruses. In this review, we comment on some improvements"/>
   <result pre="viruses. In this review, we comment on some improvements in" exact="influenza" post="management and promising vaccine development platforms with an emphasis"/>
   <result pre="coupled with the use of antivirals in the management of" exact="influenza" post="infection. Influenza virus vaccines passive immunization immunotherapeutics 1. Introduction"/>
   <result pre="nearly a million morbidities and half-a-million mortalities. Four types of" exact="influenza" post="viruses (i.e., A, B, C, and D) have been"/>
   <result pre="humans) and D (isolated from cattle) are less common; typically," exact="influenza" post="virus C is associated with less severe illness [1,2]."/>
   <result pre="associated with less severe illness [1,2]. On the other hand," exact="influenza" post="viruses A (infecting avian and mammals including human) and"/>
   <result pre="humans and seals) account for the annual global burden of" exact="influenza" post="[3,4]. The persistence of influenza viruses A and B"/>
   <result pre="the annual global burden of influenza [3,4]. The persistence of" exact="influenza" post="viruses A and B has been attributed to their"/>
   <result pre="ability to evolve rapidly. Antigenic variabilities are also common with" exact="influenza" post="viruses A and B, and these are partly as"/>
   <result pre="by Fergusson et al. revealed that antigenic drifts in seasonal" exact="influenza" post="viruses (H3, H1, and B) were estimated at fixation"/>
   <result pre="supports the idea that antigenic drifts occur more frequently in" exact="influenza" post="A viruses than influenza B viruses. In addition, high"/>
   <result pre="antigenic drifts occur more frequently in influenza A viruses than" exact="influenza" post="B viruses. In addition, high mutation rates cause a"/>
   <result pre="rates cause a tremendous impact in efficacy of the seasonal" exact="influenza" post="vaccines which comprise forecasted strains [9]. For instance, gain"/>
   <result pre="the same study, the authors further observed that the 1968" exact="influenza" post="epidemic strain (A/VIC/3/75) that had N63 (known glycosylation site),"/>
   <result pre="in potential cause of vaccine failure. Antigenic shift also allows" exact="influenza" post="viruses to escape pre-existing immunity [11]. This mechanism is"/>
   <result pre="reliant on the ability of the eight genomic fragments of" exact="influenza" post="viruses to reassort with genomes of other influenza viral"/>
   <result pre="fragments of influenza viruses to reassort with genomes of other" exact="influenza" post="viral subtypes. It occurs when two or more of"/>
   <result pre="viral subtypes or strains [11,12]. Thus, antigenic shifts (principally underlying" exact="influenza" post="A virus pandemics) and antigenic drifts (underlying vaccine mismatches"/>
   <result pre="virus pandemics) and antigenic drifts (underlying vaccine mismatches against seasonal" exact="influenza" post="A and B viruses) and a wide host-range (for"/>
   <result pre="influenza A and B viruses) and a wide host-range (for" exact="influenza" post="A viruses) all contribute to the recurring cases of"/>
   <result pre="influenza A viruses) all contribute to the recurring cases of" exact="influenza" post="all year round [13,14]. Furthermore, antigenic drifts and shifts"/>
   <result pre="immediate need for highly efficacious intervention. We review here vital" exact="influenza" post="management strategies, novel vaccine and antiviral development approaches with"/>
   <result pre="prospects. 2. Current Influenza Vaccines Three types of vaccines against" exact="influenza" post="are currently used worldwide including inactivated influenza vaccine (IIV),"/>
   <result pre="of vaccines against influenza are currently used worldwide including inactivated" exact="influenza" post="vaccine (IIV), live-attenuated influenza vaccine (LAIV) and influenza virus"/>
   <result pre="are currently used worldwide including inactivated influenza vaccine (IIV), live-attenuated" exact="influenza" post="vaccine (LAIV) and influenza virus subunit vaccine: each of"/>
   <result pre="including inactivated influenza vaccine (IIV), live-attenuated influenza vaccine (LAIV) and" exact="influenza" post="virus subunit vaccine: each of which has its own"/>
   <result pre="in the nasopharynx elicit immune response that epitomizes a natural" exact="influenza" post="infection. For this reason, LAIV has shown some superiority"/>
   <result pre="about 0.7 μg/ mL [24,25,26]. The development of the subunit" exact="influenza" post="vaccines, which often comprise of influenza virus HA that"/>
   <result pre="development of the subunit influenza vaccines, which often comprise of" exact="influenza" post="virus HA that have been purified following protein expression"/>
   <result pre="Besides, the subunit vaccine also offers desirable protection against seasonal" exact="influenza" post="viruses; but its downside being higher dosage requirement at"/>
   <result pre="both the LAIV and IIV are cocktails of circulating seasonal" exact="influenza" post="viruses. Mainly three viruses, i.e., A (H1N1) pdm09, A"/>
   <result pre="i.e., A (H1N1) pdm09, A (H3N2), and the pre-determined dominant" exact="influenza" post="B lineage (whether Yamagata or Victoria) are the constituents"/>
   <result pre="Yamagata or Victoria) are the constituents of the seasonal trivalent" exact="influenza" post="vaccines (TIV). Subunit vaccines are also formulated as TIV,"/>
   <result pre="[29]. However, it became necessary to feature both lineages of" exact="influenza" post="B viruses based on the current global epidemiology of"/>
   <result pre="influenza B viruses based on the current global epidemiology of" exact="influenza" post="as recommended by Ambrose and Levin in 2012. This"/>
   <result pre="Levin in 2012. This resulted in the advancement of quadrivalent" exact="influenza" post="vaccines (QIV) containing the pre-determined representatives of both Yamagata"/>
   <result pre="(QIV) containing the pre-determined representatives of both Yamagata and Victoria" exact="influenza" post="B virus lineages, in addition to the two pre-determined"/>
   <result pre="virus lineages, in addition to the two pre-determined circulating seasonal" exact="influenza" post="A subtypes [30]. This approach of vaccine preparation thus"/>
   <result pre="a constant reformulation to maintain desirable efficacy limits during an" exact="influenza" post="season [30,31]. 3. Use of the Seasonal Influenza Vaccines"/>
   <result pre="with influenza, the US CDC advocates the use of seasonal" exact="influenza" post="vaccines in all persons &amp;gt;6 months prior to the"/>
   <result pre="other hand, the WHO extends recommendations for the use of" exact="influenza" post="vaccination in the persons categorized as high-risk, which comprises"/>
   <result pre="Africa and Asia, there are either limited or no established" exact="influenza" post="vaccination policies. Thus, restricted availability of influenza vaccines makes"/>
   <result pre="or no established influenza vaccination policies. Thus, restricted availability of" exact="influenza" post="vaccines makes vaccinations quite uncommon to these populations. Perhaps,"/>
   <result pre="acquiring vaccines annually or still, the reduced efficacy of the" exact="influenza" post="vaccines, as have been critically assessed by Xu et"/>
   <result pre="been made for twice-dose vaccination due to frequencies of seasonal" exact="influenza" post="occurrences, all year round [34]. Although poor vaccine coverage"/>
   <result pre="Duque et al., upon investigation on the availability of seasonal" exact="influenza" post="vaccines, there are still no clearly underpinned core reasons"/>
   <result pre="clearly underpinned core reasons [35]. Therefore, the improved efficacy of" exact="influenza" post="vaccines would also contribute to enhanced vaccine coverage in"/>
   <result pre="in Africa and Asia. 4. Novel Influenza Vaccine Platforms Rapid" exact="influenza" post="virus evolution and yearly vaccine reformulations make the stockpiling"/>
   <result pre="but without their complete set of genetic materials. A typical" exact="influenza" post="VLP has the HA, NA, and the matrix protein"/>
   <result pre="a range of viruses including human papilloma virus (HPV) and" exact="hepatitis" post="B virus (HBV) or hepatitis E virus (HEV) as"/>
   <result pre="human papilloma virus (HPV) and hepatitis B virus (HBV) or" exact="hepatitis" post="E virus (HEV) as discussed by Zhao et al."/>
   <result pre="these examples have completely different &quot;biologies�? when compared with the" exact="influenza" post="virus, rapid advances and need for a new vaccine"/>
   <result pre="a new vaccine platform are generating some promising data for" exact="influenza" post="VLPs. For instance, to overcome challenges raised by rapid"/>
   <result pre="influenza VLPs. For instance, to overcome challenges raised by rapid" exact="influenza" post="evolution Gao et al. attempted to generate VLPs with"/>
   <result pre="which increased murine mucosal immunity to both drifted and homologous" exact="influenza" post="A (H3N2) viruses, as well as the longevity of"/>
   <result pre="a platform for improved formulation of multivalent (containing heterologous epitopes)" exact="influenza" post="vaccine. 6. Computationally Optimized Broadly Reactive Antigen Vaccines (COBRA)"/>
   <result pre="was fitter in eggs, is good news for generation of" exact="influenza" post="vaccines in eggs [48]. Alternatively, replication-incompetent viruses can be"/>
   <result pre="trivalent vaccine which revealed protection of vaccinees against the seasonal" exact="influenza" post="viruses [49,50]. This platform has also paved way for"/>
   <result pre="has also paved way for the generation of single-cycle replicating" exact="influenza" post="viruses as vaccine candidates and have shown similar or"/>
   <result pre="protection than the conventional LAIV [51,52,53]. The main reasons synthetic" exact="influenza" post="vaccines remain promising is due to their ability to"/>
   <result pre="children during a pandemic revealed a cross-reactivity pattern to historical" exact="influenza" post="A (H1N1) isolates [57]. A conserved epitope situated on"/>
   <result pre="epitope in a murine challenge against diverse strains of the" exact="influenza" post="A (H1N1) [57]. Another universal vaccine candidate currently undergoing"/>
   <result pre="HA; three, to NP and one, to M1) of several" exact="influenza" post="virus strains, and this vaccine has been shown to"/>
   <result pre="(APCs) to efficiently involve the T-cell arm of immunity to" exact="influenza" post="virus clearance. One of the examples is the work"/>
   <result pre="of Fonteneau and colleagues who showed that after exposure to" exact="influenza" post="virus, dendritic cells (DCs) (both CD11c+ DCs and plasmacytoid"/>
   <result pre="10. Nanoparticle-Based Influenza Vaccines Continued efforts to develop a universal" exact="influenza" post="vaccine has driven the use of self-assembling monomeric ion-carrier"/>
   <result pre="vaccines displaying multivalent HA from 8 diverse strains of H1N1" exact="influenza" post="A viruses, were shown to induce broadly protective antibodies"/>
   <result pre="affording protection of mice challenged with virulent strain of an" exact="influenza" post="virus [63,64]. Intranasal administration of polylactic-co-glycolic acid (PLGA) nanoparticle"/>
   <result pre="[63,64]. Intranasal administration of polylactic-co-glycolic acid (PLGA) nanoparticle conjugated to" exact="influenza" post="A (H1N1) conserved peptides as a vaccine were also"/>
   <result pre="in mice that were immunized prior to challenge with specific" exact="influenza" post="A viruses [67]. Though a promising influenza vaccine platform,"/>
   <result pre="challenge with specific influenza A viruses [67]. Though a promising" exact="influenza" post="vaccine platform, high-throughput nanoparticle-based vaccines approaches that will facilitate"/>
   <result pre="nanoparticle-based vaccines approaches that will facilitate replacement of the seasonal" exact="influenza" post="vaccines are still to be developed [68]. 11. Viral-Vectored"/>
   <result pre="the humoral and cellular immunity [69]. Use of the modified" exact="vaccinia virus" post="Ankara (MVA) as a vector, incorporating influenza NP and"/>
   <result pre="the modified vaccinia virus Ankara (MVA) as a vector, incorporating" exact="influenza" post="NP and M1 proteins, has shown potent induction of"/>
   <result pre="NP and M1 proteins, has shown potent induction of both" exact="influenza" post="virus-specific humoral and cell-mediated responses leading to the phase"/>
   <result pre="to the phase II clinical trial [70,71]. An Adenovirus vectored" exact="influenza" post="vaccine has equally shown a strong induction of influenza"/>
   <result pre="vectored influenza vaccine has equally shown a strong induction of" exact="influenza" post="virus HA-stalk cross-reactive antibodies in mice [72]. Recently, Lingel"/>
   <result pre="mice [72]. Recently, Lingel et al. expressed multivalent adenovirus vectored" exact="influenza" post="virus vaccine (that comprise the consensus sequences of divergent"/>
   <result pre="administration in mice conferred protection of mice in a lethal" exact="influenza" post="virus challenge experiment [73]. This provides an avenue for"/>
   <result pre="baculovirus, Newcastle disease virus, pox virus, parainfluenza virus and vesicular" exact="stomatitis" post="virus, are other vectors that have also been proposed"/>
   <result pre="vaccines [74]. 12. Current Influenza Managing Antivirals Management of ongoing" exact="influenza" post="infection currently requires the use of antiviral drugs. Two"/>
   <result pre="antiviral drugs. Two drug classes approved for the control of" exact="influenza" post="infections include the adamantanes (Amantadines and Rimantadines) and NA"/>
   <result pre="is otherwise responsible for newly generated virion dissemination [75,76,77,78]. However," exact="influenza" post="viruses resistant to both the adamantanes and neuraminidase inhibitors"/>
   <result pre="Additionally, lack of data suggesting antiviral efficacy against highly pathogenic" exact="avian influenza" post="viruses (HPAI), i.e., H5N1 remains an important issue in"/>
   <result pre="lack of data suggesting antiviral efficacy against highly pathogenic avian" exact="influenza" post="viruses (HPAI), i.e., H5N1 remains an important issue in"/>
   <result pre="is imperative to note that there are still NA inhibitor-sensitive" exact="influenza" post="A viruses in circulation, and this drug class can"/>
   <result pre="Management Therapies 13.1. Next-Generation Antivirals Against Influenza The burden of" exact="influenza" post="requires identification of a novel compounds that have the"/>
   <result pre="the airways [89]. This inhibits the initial attachment of the" exact="influenza" post="virus HA that recognizes Neu5Ac in the α(2, 3)-"/>
   <result pre="shown to inhibit H1N1pdm09, H3N2, and H5N1 viruses [91,92,93]. Besides" exact="influenza" post="viruses, other sialic acid-dependent viruses such as human metapneumovirus"/>
   <result pre="These metabolites have been shown to inhibit the maturation of" exact="influenza" post="HA by blocking the trafficking and insertion of HA"/>
   <result pre="a licensed anthelminthic drug that has been repurposed to ameliorate" exact="influenza" post="due to its broad range of protection efficiency against"/>
   <result pre="influenza due to its broad range of protection efficiency against" exact="influenza" post="viruses in a phase II b/III clinical trial [95]."/>
   <result pre="b/III clinical trial [95]. The antiviral, JNJ-63623872 (Pimodivir) is non-nucleoside" exact="influenza" post="virus PB2 inhibitor, which binds a conserved domain on"/>
   <result pre="binds a conserved domain on the polymerase subunit, PB2 of" exact="influenza" post="A viruses and thereby inhibiting host cap-snatching (a perquisite"/>
   <result pre="pre-approval trial (of Pimodivir) for the treatment of patients with" exact="influenza" post="virus A (H7N9) infection, has been allowed. In 2002,"/>
   <result pre="was shown to have a selective index over 2000 for" exact="influenza" post="viruses, with no detectable cytotoxicity in vitro [101]. Trials"/>
   <result pre="[101]. Trials of T-705 in mice confirmed both selectivity to" exact="influenza" post="viruses and protection as an anti-influenza virus therapeutic agent."/>
   <result pre="noro- and flavi-viruses [106,107,108,109]. In summary, T-705 is effective against" exact="influenza" post="viruses in group 1 such as H1N1pdm09, H5N1 and"/>
   <result pre="H1N1pdm09 virus strain [111] Efficacy of T-705 for treatment of" exact="influenza" post="has thus warranted its advancement through phase III and"/>
   <result pre="shown to act as a selective cap-dependent endonuclease inhibitor of" exact="influenza" post="viruses’ (both A and B) polymerase subunit PA. The"/>
   <result pre="phase I trial [113]. The overall optimal performance against uncomplicated" exact="influenza" post="among adults and adolescents, was shown during phase II"/>
   <result pre="the US as Xofluxa, for the treatment of acute uncomplicated" exact="influenza" post="among ≥12 years [115]. Arbidol (Umifenovir) is another influenza-limiting"/>
   <result pre="originally developed in Russia and was found to potently inhibit" exact="influenza" post="virus fusion with susceptible cell membranes, followed by interferon"/>
   <result pre="interferon induction [118]. Like other broad-spectrum antivirals discussed earlier, besides" exact="influenza" post="viruses, Arbidol has been shown to efficiently suppress other"/>
   <result pre="and the flaviviruses (Zika virus, West Nile virus and Tick-borne" exact="encephalitis" post="virus) [119,120,121]. Currently, phase III trial of the Arbidol"/>
   <result pre="of 2017, Ingavirin has been approved for the treatment of" exact="influenza" post="and other viral causes of acute respiratory illness, in"/>
   <result pre="Management of Influenza The need for new strategies to control" exact="influenza" post="infections has led to the investigations of antibody therapy"/>
   <result pre="virus infections [125,126]. The feasibility of immunotherapy for rapidly evolving" exact="influenza" post="was attained upon the discovery of broadly neutralizing antibody"/>
   <result pre="as well as C179 was later found to neutralize only" exact="influenza" post="A viruses with group 1 HA. Similarly, another potential"/>
   <result pre="anti-H5N1 antibody could protect mice against a lethal challenge of" exact="influenza" post="H5N1 [133]. Such an example shows that use of"/>
   <result pre="Such an example shows that use of passive immunotherapy during" exact="influenza" post="outbreaks could complement the use of available antivirals that"/>
   <result pre="[136]. Wohlbold et al. also realized the importance of the" exact="influenza" post="HA stalk as a good vaccine target when they"/>
   <result pre="immunized with three tandem copies of M2e, fused with the" exact="hepatitis" post="B virus (HBV) core fusion protein) to show Fc-dependent"/>
   <result pre="for RSV with the commercial immunotherapy palivizumab, antibody-based therapies with" exact="influenza" post="antibodies could aid most susceptible populations including infants, which"/>
   <result pre="in mice (who received the construct intramuscularly) during a pathogenic" exact="influenza" post="virus (H1, H2, and H5) challenge [144]. Their experiments"/>
   <result pre="immuno-prophylaxis and -therapeutics have more prospects in effective intermediation of" exact="influenza" post="outbreaks and production of specific influenza vaccines, noting that"/>
   <result pre="in effective intermediation of influenza outbreaks and production of specific" exact="influenza" post="vaccines, noting that the broadly-reacting antibodies have the capacity"/>
   <result pre="antibody-dependent cell lysis (ADCL) are well-studied in the context of" exact="influenza" post="viruses. ADCC, which mainly involves destruction of infected cells"/>
   <result pre="has been observed for murine antibodies weakly interacting with cognate" exact="influenza" post="M2e [147]. Similarly, virus replication in mice was shown"/>
   <result pre="infected mice that either received anti-influenza serum before or after" exact="influenza" post="infection, when neutrophils were retained and not inhibited by"/>
   <result pre="ADCL is another mechanism that could augment the killing of" exact="influenza" post="viruses as observed by Terajima et al., realizing that"/>
   <result pre="emphasize the therapeutic capacity of novel monoclonal antibodies in combating" exact="influenza" post="infection, and speculate that, in addition to the use"/>
   <result pre="to the use of effective antivirals, passive immunotherapy against both" exact="influenza" post="A and B viruses might be the way forward"/>
   <result pre="A and B viruses might be the way forward for" exact="influenza" post="virus management amongst all classes (be it high- or"/>
   <result pre="influenza. Acknowledgments The authors are thankful to The Pirbright Institute’s" exact="avian influenza" post="research team (Jean-Remy Sadeyen, Pengxiang Chang, Sushant Bhat, Joshua"/>
   <result pre="Acknowledgments The authors are thankful to The Pirbright Institute’s avian" exact="influenza" post="research team (Jean-Remy Sadeyen, Pengxiang Chang, Sushant Bhat, Joshua"/>
   <result pre="Epidemiology, pathology, evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 2.KimuraH.AbikoC.PengG.MurakiY.SugawaraK.HongoS.KitameF.MizutaK.NumazakiY.SuzukiH.et al.Interspecies transmission of" exact="influenza" post="C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of"/>
   <result pre="influenza C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of" exact="avian influenza" post="A viruses in mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in"/>
   <result pre="C virus between humans and pigsVirus Res.199748717910.1016/S0168-1702(96)01427-X9140195 3.HinshawV.S.WebsterR.G.EasterdayB.C.BeanW.J.Jr.Replication of avian" exact="influenza" post="A viruses in mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in"/>
   <result pre="mammalsInfect. Immun.1981343543617309229 4.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 5.GerhardW.WebsterR.G.Antigenic drift in" exact="influenza" post="A viruses. I. Selection and characterization of antigenic variants"/>
   <result pre="I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1)" exact="influenza" post="virus with monoclonal antibodiesJ. Exp. Med.197814838339210.1084/jem.148.2.383359746 6.YewdellJ.W.WebsterR.G.GerhardW.U.Antigenic variation in"/>
   <result pre="Exp. Med.197814838339210.1084/jem.148.2.383359746 6.YewdellJ.W.WebsterR.G.GerhardW.U.Antigenic variation in three distinct determinants of an" exact="influenza" post="type A haemagglutinin moleculeNature197927924624810.1038/279246a086955 7.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et al.Hemagglutinin Receptor Binding Avidity"/>
   <result pre="Influenza A Virus Antigenic DriftScience200932673473610.1126/science.117825819900932 8.FergusonN.M.GalvaniA.P.BushR.M.Ecological and immunological determinants of" exact="influenza" post="evolutionNature200342242843310.1038/nature0150912660783 9.CarratF.FlahaultA.Influenza vaccine: The challenge of antigenic driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 10.SkehelJ.J.StevensD.J.DanielsR.S.DouglasA.R.KnossowM.WilsonI.A.WileyD.C.A"/>
   <result pre="driftVaccine2007256852686210.1016/j.vaccine.2007.07.02717719149 10.SkehelJ.J.StevensD.J.DanielsR.S.DouglasA.R.KnossowM.WilsonI.A.WileyD.C.A carbohydrate side chain on hemagglutinins of Hong Kong" exact="influenza" post="viruses inhibits recognition by a monoclonal antibodyProc. Natl. Acad."/>
   <result pre="and H3 strains elucidates antigenic shift and drift in human" exact="influenza" post="virusNature198028730130610.1038/287301a07421990 13.DonatelliI.CastrucciM.R.De MarcoM.A.DeloguM.WebsterR.G.Human–Animal Interface: The Case for Influenza Interspecies"/>
   <result pre="and Inactivated Influenza Vaccine in AdultsClin. Vaccine Immunol.201724e00414-1610.1128/CVI.00414-1627847366 17.ShinjohM.SugayaN.YamaguchiY.IibuchiN.KamimakiI.GotoA.KobayashiH.KobayashiY.ShibataM.TamaokaS.et al.Inactivated" exact="influenza" post="vaccine effectiveness and an analysis of repeated vaccination for"/>
   <result pre="for children during the 2016/17 seasonVaccine2018365510551810.1016/j.vaccine.2018.07.06530093289 18.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 19.BeyerW.E.P.PalacheA.M.de"/>
   <result pre="A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 19.BeyerW.E.P.PalacheA.M.de JongJ.C.OsterhausA.D.M.E.Cold-adapted live" exact="influenza" post="vaccine versus inactivated vaccine: Systemic vaccine reactions, local and"/>
   <result pre="al.Comparison of the safety, vaccine virus shedding, and immunogenicity of" exact="influenza" post="virus vaccine, trivalent, types A and B, live cold-adapted,"/>
   <result pre="childrenN. Engl. J. Med.19983381405141210.1056/NEJM1998051433820029580647 22.KeitelW.A.CouchR.B.CateT.R.MaassabH.F.Variability in infectivity of cold-adapted recombinant" exact="influenza" post="virus vaccines in humansJ. Infect. Dis.199416947710.1093/infdis/169.2.4778106789 23.GalazkaA.M.LauerB.A.HendersonR.H.KejaJ.Indications and Contraindications"/>
   <result pre="to vaccines practice parameter 2012 updateJ. Allergy Clin. Immunol.2012130254310.1016/j.jaci.2012.04.00322608573 25.OwensG.MacGinnitieA.Higher-ovalbumin-content" exact="influenza" post="vaccines are well tolerated in children with egg allergyJ."/>
   <result pre="children with egg allergyJ. Allergy Clin. Immunol.201112726426510.1016/j.jaci.2010.10.00521094520 26.LiJ.T.RankM.A.SquillaceD.L.KitaH.Ovalbumin content of" exact="influenza" post="vaccinesJ. Allergy Clin. Immunol.20101251412141310.1016/j.jaci.2010.03.00920451987 27.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.collab: Centers for Disease Control"/>
   <result pre="J. Transplant.20141429062913 28.StephensonI.NicholsonK.G.GluckR.MischlerR.NewmanR.W.PalacheA.M.VerlanderN.Q.WarburtonF.WoodJ.M.ZambonM.C.Safety and antigenicity of whole virus and subunit" exact="influenza" post="A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: Phase I"/>
   <result pre="healthy adults: Phase I randomised trialLancet20033621959196610.1016/S0140-6736(03)15014-314683655 29.GiezemanK.M.NautaJ.de BruijnI.A.PalacheA.M.Trivalent inactivated subunit" exact="influenza" post="vaccine Influvac (R): 25-Year experience of safety and immunogenicityVaccine2009272414241710.1016/j.vaccine.2009.02.00819368782"/>
   <result pre="25-Year experience of safety and immunogenicityVaccine2009272414241710.1016/j.vaccine.2009.02.00819368782 30.AmbroseC.S.LevinM.J.The rationale for quadrivalent" exact="influenza" post="vaccinesHum. Vaccines Immunother.20128818810.4161/hv.8.1.17623 31.KumarA.MeldgaardT.S.BertholetS.Novel Platforms for the Development of"/>
   <result pre="Vaccines Immunother.20128818810.4161/hv.8.1.17623 31.KumarA.MeldgaardT.S.BertholetS.Novel Platforms for the Development of a Universal" exact="influenza" post="vaccineFront. Immunol.2018960010.3389/fimmu.2018.0060029628926 32.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of influenza with"/>
   <result pre="a Universal influenza vaccineFront. Immunol.2018960010.3389/fimmu.2018.0060029628926 32.FioreA.E.UyekiT.M.BroderK.FinelliL.EulerG.L.SingletonJ.A.IskanderJ.K.WortleyP.M.ShayD.K.BreseeJ.S.et al.Prevention and control of" exact="influenza" post="with vaccines: Recommendations of the Advisory Committee on Immunization"/>
   <result pre="in tropical and subtropical areasLancet Respir. Med.2017592092210.1016/S2213-2600(17)30377-629066091 35.DuqueJ.McMorrowM.L.CohenA.L.Influenza vaccines and" exact="influenza" post="antiviral drugs in Africa: Are they available and do"/>
   <result pre="from three H5N1 clades protects chickens from H5N1 and H5N8" exact="influenza" post="virusesVaccine2016341575158110.1016/j.vaccine.2016.02.01126868083 41.WangB.-Z.QuanF.-S.KangS.-M.BozjaJ.SkountzouI.CompansR.W.Incorporation of membrane-anchored flagellin into influenza virus-like particles"/>
   <result pre="H5N1 and H5N8 influenza virusesVaccine2016341575158110.1016/j.vaccine.2016.02.01126868083 41.WangB.-Z.QuanF.-S.KangS.-M.BozjaJ.SkountzouI.CompansR.W.Incorporation of membrane-anchored flagellin into" exact="influenza" post="virus-like particles enhances the breadth of immune responsesJ. Virol.200882118131182310.1128/JVI.01076-0818786995"/>
   <result pre="the breadth of immune responsesJ. Virol.200882118131182310.1128/JVI.01076-0818786995 42.MohanT.BermanZ.LuoY.WangC.WangS.CompansR.W.WangB.Z.Chimeric virus-like particles containing" exact="influenza" post="HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against"/>
   <result pre="viral challengeJ. Virol.2012861029310230110.1128/JVI.01131-1222787224 50.MosslerC.GroissF.WolztM.WolschekM.SeipeltJ.MusterT.Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 51.BazM.BoonnakK.PaskelM.SantosC.PowellT.TownsendA.SubbaraoK.Nonreplicating influenza A virus vaccines"/>
   <result pre="of a replication-deficient trivalent influenza virus vaccine lacking NS1Vaccine2013316194620010.1016/j.vaccine.2013.10.06124183981 51.BazM.BoonnakK.PaskelM.SantosC.PowellT.TownsendA.SubbaraoK.Nonreplicating" exact="influenza" post="A virus vaccines confer broad protection against lethal challengeMBio20156e01487-1510.1128/mBio.01487-1526489862"/>
   <result pre="Induced by a Single-Cycle Influenza VaccineJ. Immunol.20182004068407710.4049/jimmunol.180014229703861 53.NachbagauerR.LiuW.C.ChoiA.WohlboldT.J.AtlasT.RajendranM.SolórzanoA.Berlanda-ScorzaF.García-SastreA.PaleseP.et al.A universal" exact="influenza" post="virus vaccine candidate confers protection against pandemic H1N1 infection"/>
   <result pre="in preclinical ferret studiesNpj Vaccines201722610.1038/s41541-017-0026-429263881 54.ImpagliazzoA.MilderF.KuipersH.WagnerM.V.ZhuX.Y.HoffmanR.M.B.van MeersbergenR.HuizinghJ.WanningenP.VerspuijJ.et al.A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogenScience20153491301130610.1126/science.aac726326303961 55.CorreiaB.E.BatesJ.T.LoomisR.J.BaneyxG.CarricoC.JardineJ.G.RupertP.CorrentiC.KalyuzhniyO.VittalV.et al.Proof"/>
   <result pre="57.ThompsonC.P.LourencoJ.WaltersA.A.ObolskiU.EdmansM.PalmerD.S.KooblallK.CarnellG.W.O’ConnorD.BowdenT.A.et al.A naturally protective epitope of limited variability as an" exact="influenza" post="vaccine targetNat. Commun.20189385910.1038/s41467-018-06228-830242149 58.AtsmonJ.Kate-IlovitzE.ShaikevichD.SingerY.VolokhovI.HaimK.Y.Ben-YedidiaT.Safety and immunogenicity of multimeric-001—A novel"/>
   <result pre="vaccine targetNat. Commun.20189385910.1038/s41467-018-06228-830242149 58.AtsmonJ.Kate-IlovitzE.ShaikevichD.SingerY.VolokhovI.HaimK.Y.Ben-YedidiaT.Safety and immunogenicity of multimeric-001—A novel universal" exact="influenza" post="vaccineJ. Clin. Immunol.20123259560310.1007/s10875-011-9632-522318394 59.FonteneauJ.-F.GillietM.LarssonM.DasilvaI.MünzC.LiuY.-J.BhardwajN.Activation of influenza virus–specific CD4+ and"/>
   <result pre="of multimeric-001—A novel universal influenza vaccineJ. Clin. Immunol.20123259560310.1007/s10875-011-9632-522318394 59.FonteneauJ.-F.GillietM.LarssonM.DasilvaI.MünzC.LiuY.-J.BhardwajN.Activation of" exact="influenza" post="virus–specific CD4+ and CD8+ T cells: A new role"/>
   <result pre="role for plasmacytoid dendritic cells in adaptive immunityBlood20031013520352610.1182/blood-2002-10-306312511409 60.Abdel-MotalU.M.GuayH.M.WigglesworthK.WelshR.M.GaliliU.Immunogenicity of" exact="influenza" post="virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting"/>
   <result pre="APC surface molecules influences the immune response phenotypePLoS ONE20138e8000810.1371/journal.pone.008000824244595 62.KanekiyoM.WeiC.J.YassineH.M.McTamneyP.M.BoyingtonJ.C.WhittleJ.R.RaoS.S.KongW.P.WangL.NabelG.J.Self-assembling" exact="influenza" post="nanoparticle vaccines elicit broadly neutralizing H1N1 antibodiesNature201349910210610.1038/nature1220223698367 63.DengL.ChoK.J.FiersW.SaelensX.M2e-Based Universal"/>
   <result pre="antibodiesNature201349910210610.1038/nature1220223698367 63.DengL.ChoK.J.FiersW.SaelensX.M2e-Based Universal Influenza A VaccinesVaccines2015310513610.3390/vaccines301010526344949 64.TaoW.Q.GillH.S.M2e-immobilized gold nanoparticles as" exact="influenza" post="A vaccine: Role of soluble M2e and longevity of"/>
   <result pre="Sci. USA20161134133414210.1073/pnas.1600299113 67.DengL.MohanT.ChangT.Z.GonzalezG.X.WangY.KwonY.M.KangS.M.CompansR.W.ChampionJ.A.WangB.Z.Double-layered protein nanoparticles induce broad protection against divergent" exact="influenza" post="A virusesNat. Commun.20182435910.1038/s41467-017-02725-429367723 68.HardingA.T.HeatonN.S.Efforts to Improve the Seasonal Influenza"/>
   <result pre="al.Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic" exact="influenza" post="A vaccine, MVA-NP+M1Clin. Infect. Dis.2011521710.1093/cid/ciq01521148512 71.AntrobusR.D.BerthoudT.K.MullarkeyC.E.HoschlerK.CoughlanL.ZambonM.HillA.V.GilbertS.C.Coadministration of seasonal influenza"/>
   <result pre="heterosubtypic influenza A vaccine, MVA-NP+M1Clin. Infect. Dis.2011521710.1093/cid/ciq01521148512 71.AntrobusR.D.BerthoudT.K.MullarkeyC.E.HoschlerK.CoughlanL.ZambonM.HillA.V.GilbertS.C.Coadministration of seasonal" exact="influenza" post="vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated"/>
   <result pre="of an Adenoviral Vectored Multivalent Centralized Influenza VaccineSci. Rep.201771491210.1038/s41598-017-14891-y29097763 74.TrippR.A.TompkinsS.M.Virus-vectored" exact="influenza" post="virus vaccinesViruses201463055307910.3390/v608305525105278 75.GubarevaL.V.KaiserL.HaydenF.G.Influenza virus neuraminidase inhibitorsLancet200035582783510.1016/S0140-6736(99)11433-810711940 76.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DeGradoW.F.A functionally defined"/>
   <result pre="76.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DeGradoW.F.A functionally defined model for the M2 proton channel of" exact="influenza" post="A virus suggests a mechanism for its ion selectivityProc."/>
   <result pre="ion channel activityCell19926951752810.1016/0092-8674(92)90452-I1374685 78.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchönA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.Identification of the functional core of the" exact="influenza" post="A virus A/M2 proton-selective ion channelProc. Natl. Acad. Sci."/>
   <result pre="Natl. Acad. Sci. USA2009106122831228810.1073/pnas.090572610619590009 79.Van VorisL.P.BettsR.F.HaydenF.G.ChristmasW.A.DouglasR.G.Jr.Successful treatment of naturally occurring" exact="influenza" post="A/USSR/77 H1N1JAMA19812451128123110.1001/jama.1981.033103600200167007668 80.BeanW.J.ThrelkeldS.C.WebsterR.G.Biologic potential of amantadine-resistant influenza A virus"/>
   <result pre="of naturally occurring influenza A/USSR/77 H1N1JAMA19812451128123110.1001/jama.1981.033103600200167007668 80.BeanW.J.ThrelkeldS.C.WebsterR.G.Biologic potential of amantadine-resistant" exact="influenza" post="A virus in an avian modelJ. Infect. Dis.19891591050105610.1093/infdis/159.6.10502723453 81.DeydeV.M.XuX.Y.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance"/>
   <result pre="avian modelJ. Infect. Dis.19891591050105610.1093/infdis/159.6.10502723453 81.DeydeV.M.XuX.Y.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 82.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug"/>
   <result pre="and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 82.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug resistance in" exact="influenza" post="A virus: The epidemiology and managementInfect. Drug Resist.20171012113410.2147/IDR.S10547328458567 83.McKimm-BreschkinJ.L.Neuraminidase"/>
   <result pre="84.Rameix-WeltiM.A.EnoufV.CuvelierF.JeanninP.van der WerfS.Enzymatic properties of the neuraminidase of seasonal H1N1" exact="influenza" post="viruses provide insights for the emergence of natural resistance"/>
   <result pre="Virol.20094425526110.1016/j.jcv.2009.01.01019272835 86.SamsonM.PizzornoA.AbedY.BoivinG.Influenza virus resistance to neuraminidase inhibitorsAntivir. Res.20139817418510.1016/j.antiviral.2013.03.01423523943 87.NoahD.L.NoahJ.W.Adapting global" exact="influenza" post="management strategies to address emerging virusesAm. J. Physiol.-Lung Cell."/>
   <result pre="Physiol.-Lung Cell. Mol. Physiol.201330510811710.1152/ajplung.00105.201323709619 88.NguyenH.T.NguyenT.MishinV.P.SleemanK.BalishA.JonesJ.CreangaA.MarjukiH.UyekiT.M.NguyenD.H.et al.Antiviral susceptibility of highly pathogenic" exact="avian influenza" post="A(H5N1) viruses isolated from poultry, Vietnam, 2009–2011Emerg. Infect. Dis.2013191963197110.3201/eid1912.13070524274711"/>
   <result pre="Cell. Mol. Physiol.201330510811710.1152/ajplung.00105.201323709619 88.NguyenH.T.NguyenT.MishinV.P.SleemanK.BalishA.JonesJ.CreangaA.MarjukiH.UyekiT.M.NguyenD.H.et al.Antiviral susceptibility of highly pathogenic avian" exact="influenza" post="A(H5N1) viruses isolated from poultry, Vietnam, 2009–2011Emerg. Infect. Dis.2013191963197110.3201/eid1912.13070524274711"/>
   <result pre="89.MalakhovM.P.AschenbrennerL.M.SmeeD.F.WanderseeM.K.SidwellR.W.GubarevaL.V.MishinV.P.HaydenF.G.KimD.H.IngA.et al.Sialidase fusion protein as a novel broad-spectrum inhibitor of" exact="influenza" post="virus infectionAntimicrob. Agents Chemother.2006501470147910.1128/AAC.50.4.1470-1479.200616569867 90.BaumL.G.PaulsonJ.C.Sialyloligosaccharides of the respiratory epithelium"/>
   <result pre="90.BaumL.G.PaulsonJ.C.Sialyloligosaccharides of the respiratory epithelium in the selection of human" exact="influenza" post="virus receptor specificityActa Histochem. Suppl.19904035382091044 91.BelserJ.A.LuX.SzretterK.J.JinX.AschenbrennerL.M.LeeA.HawleyS.KimD.H.MalakhovM.P.YuM.et al.DAS181, a novel"/>
   <result pre="al.DAS181, a novel sialidase fusion protein, protects mice from lethal" exact="avian influenza" post="H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1"/>
   <result pre="a novel sialidase fusion protein, protects mice from lethal avian" exact="influenza" post="H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1"/>
   <result pre="influenza H5N1 virus infectionJ. Infect. Dis.20071961493149910.1086/52260918008229 92.ChanR.W.ChanM.C.WongA.C.KaramanskaR.DellA.HaslamS.M.SihoeA.D.ChuiW.H.Triana-BaltzerG.LiQ.et al.DAS181 inhibits H5N1" exact="influenza" post="virus infection of human lung tissuesAntimicrob. Agents Chemother.2009533935394110.1128/AAC.00389-0919596886 93.Triana-BaltzerG.B.BabizkiM.ChanM.C.WongA.C.AschenbrennerL.M.CampbellE.R.LiQ.X.ChanR.W.PeirisJ.S.NichollsJ.M.et"/>
   <result pre="al.DAS181, a sialidase fusion protein, protects human airway epithelium against" exact="influenza" post="virus infection: An in vitro pharmacodynamic analysisJ. Antimicrob. Chemother.20106527528410.1093/jac/dkp42119942616"/>
   <result pre="activity of VX-787, a first-in-class, orally bioavailable inhibitor of the" exact="influenza" post="virus polymerase PB2 subunitAntimicrob. Agents Chemother.2015591569158210.1128/AAC.04623-1425547360 98.SmeeD.F.BarnardD.L.JonesS.M.Activities of JNJ63623872"/>
   <result pre="PB2 subunitAntimicrob. Agents Chemother.2015591569158210.1128/AAC.04623-1425547360 98.SmeeD.F.BarnardD.L.JonesS.M.Activities of JNJ63623872 and oseltamivir against" exact="influenza" post="A H1N1pdm and H3N2 virus infections in miceAntivir. Res.2016136455010.1016/j.antiviral.2016.10.00927771390"/>
   <result pre="H1N1pdm and H3N2 virus infections in miceAntivir. Res.2016136455010.1016/j.antiviral.2016.10.00927771390 99.FuY.GaelingsL.SoderholmS.BelanovS.NandaniaJ.NymanT.A.MatikainenS.AndersS.VelagapudiV.KainovD.E.JNJ872 inhibits" exact="influenza" post="A virus replication without altering cellular antiviral responsesAntivir. Res.2016133233110.1016/j.antiviral.2016.07.00827451344"/>
   <result pre="RNA viral infectionsAntivir. Res.2009829510210.1016/j.antiviral.2009.02.19819428599 102.FurutaY.TakahashiK.Kuno-MaekawaM.SangawaH.UeharaS.KozakiK.NomuraN.EgawaH.ShirakiK.Mechanism of action of T-705 against" exact="influenza" post="virusAntimicrob. Agents Chemother.20054998198610.1128/AAC.49.3.981-986.200515728892 103.BaranovichT.WongS.S.ArmstrongJ.MarjukiH.WebbyR.J.WebsterR.G.GovorkovaE.A.T-705 (favipiravir) induces lethal mutagenesis in"/>
   <result pre="influenza virusAntimicrob. Agents Chemother.20054998198610.1128/AAC.49.3.981-986.200515728892 103.BaranovichT.WongS.S.ArmstrongJ.MarjukiH.WebbyR.J.WebsterR.G.GovorkovaE.A.T-705 (favipiravir) induces lethal mutagenesis in" exact="influenza" post="A H1N1 viruses in vitroJ. Virol.2013873741375110.1128/JVI.02346-1223325689 104.JinZ.SmithL.K.RajwanshiV.K.KimB.DevalJ.The ambiguous base-pairing"/>
   <result pre="and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-triphosphate towards" exact="influenza" post="A virus polymerasePLoS ONE20138e6834710.1371/journal.pone.006834723874596 105.NaesensL.GuddatL.W.KeoughD.T.van KuilenburgA.B.MeijerJ.Vande VoordeJ.BalzariniJ.Role of human"/>
   <result pre="Adults and AdolescentsN. Engl. J. Med.201837991392310.1056/NEJMoa171619730184455 115.O’HanlonR.ShawM.L.Baloxavir marboxil: The new" exact="influenza" post="drug on the marketCurr. Opin. Virol.201935141810.1016/j.coviro.2019.01.00630852344 116.GagarinovaV.M.Ignat’evaG.S.SinitskaiaL.V.IvanovaA.M.RodinaM.A.Tur’evaA.V.The new chemical"/>
   <result pre="Virol.201935141810.1016/j.coviro.2019.01.00630852344 116.GagarinovaV.M.Ignat’evaG.S.SinitskaiaL.V.IvanovaA.M.RodinaM.A.Tur’evaA.V.The new chemical preparation arbidol: Its prophylactic efficacy during" exact="influenza" post="epidemicsZh Mikrobiol. Epidemiol. Immunobiol.199354043 117.BoriskinY.S.LenevaI.A.PecheurE.I.PolyakS.J.Arbidol: A broad-spectrum antiviral compound"/>
   <result pre="FlavivirusesViruses20181018410.3390/v10040184 122.LoginovaS.BorisevichS.V.MaksimovV.A.BondarevV.P.Nebol’sinV.E.Therapeutic efficacy of Ingavirin, a new domestic formulation against" exact="influenza" post="A virus (H3N2)Antibiot Khimioter200853273019227120 123.GalegovG.A.AndronovaV.L.Nebol’sinV.E.Antiviral effect of Ingavirin against"/>
   <result pre="A virus (H3N2)Antibiot Khimioter200853273019227120 123.GalegovG.A.AndronovaV.L.Nebol’sinV.E.Antiviral effect of Ingavirin against seasonal" exact="influenza" post="virus A/H1N1 in MDCK cell cultureAntibiot Khimioter2009541922 124.ZarubaevV.V.BeliaevskaiaS.V.SirotkinA.K.AnfimovP.M.Nebol’sinV.E.KiselevO.I.ReĭkhartD.V.In vitro"/>
   <result pre="vivo effects of ingavirin on the ultrastructure and infectivity of" exact="influenza" post="virusVopr. Virusol.201156212522171473 125.SimoesE.A.GroothuisJ.R.Carbonell-EstranyX.RiegerC.H.MitchellI.FredrickL.M.KimpenJ.L.collab: Palivizumab Long-Term Respiratory Outcomes Study GroupPalivizumab"/>
   <result pre="broadly neutralizing stem antibody in complex with a pandemic H2" exact="influenza" post="virus hemagglutininJ. Virol.2013877149715410.1128/JVI.02975-1223552413 129.ThrosbyM.van den BrinkE.JongeneelenM.PoonL.L.M.AlardP.CornelissenL.BakkerA.CoxF.van DeventerE.GuanY.et al.Heterosubtypic Neutralizing"/>
   <result pre="Acute Uncomplicated InfluenzaAntimicrob. Agents Chemother.201862e00694-1810.1128/AAC.00694-1830150460 132.PappasL.FoglieriniM.PiccoliL.KallewaardN.L.TurriniF.SilacciC.Fernandez-RoadriguezB.AgaticG.Giacchetto-SasselliI.PellicciottaG.et al.Rapid development of broadly" exact="influenza" post="neutralizing antibodies through redundant mutationsNature201451641842210.1038/nature1376425296253 133.LuJ.GuoZ.PanX.WangG.ZhangD.LiY.TanB.OuyangL.YuX.Passive immunotherapy for influenza"/>
   <result pre="broadly influenza neutralizing antibodies through redundant mutationsNature201451641842210.1038/nature1376425296253 133.LuJ.GuoZ.PanX.WangG.ZhangD.LiY.TanB.OuyangL.YuX.Passive immunotherapy for" exact="influenza" post="A H5N1 virus infection with equine hyperimmune globulin F"/>
   <result pre="neutralizing antibodies are produced by individuals immunized with a seasonal" exact="influenza" post="vaccineJ. Clin. Investig.20101201663167310.1172/JCI4190220389023 136.MargineI.KrammerF.HaiR.HeatonN.TanG.AndrewsS.RunstadlerJ.A.WilsonP.C.AlbrechtR.A.Garcia-SastreA.et al.Hemagglutinin stalk-based universal vaccine constructs"/>
   <result pre="136.MargineI.KrammerF.HaiR.HeatonN.TanG.AndrewsS.RunstadlerJ.A.WilsonP.C.AlbrechtR.A.Garcia-SastreA.et al.Hemagglutinin stalk-based universal vaccine constructs protect against group 2" exact="influenza" post="A virusesJ. Virol.201310.1128/JVI.01715-1323903831 137.NachbagauerR.MillerM.S.HaiR.RyderA.B.RoseJ.K.PaleseP.García-SastreA.KrammerF.AlbrechtR.A.Hemagglutinin stalk immunity reduces influenza virus"/>
   <result pre="group 2 influenza A virusesJ. Virol.201310.1128/JVI.01715-1323903831 137.NachbagauerR.MillerM.S.HaiR.RyderA.B.RoseJ.K.PaleseP.García-SastreA.KrammerF.AlbrechtR.A.Hemagglutinin stalk immunity reduces" exact="influenza" post="virus replication and transmission in ferretsJ. Virol.2016903268327310.1128/JVI.02481-15 138.WohlboldT.J.NachbagauerR.MargineI.TanG.S.HirshA.KrammerF.Vaccination with"/>
   <result pre="with soluble headless hemagglutinin protects mice from challenge with divergent" exact="influenza" post="virusesVaccine2015333314332110.1016/j.vaccine.2015.05.03826026378 139.El BakkouriK.DescampsF.De FiletteM.SmetA.FestjensE.BirkettA.Van RooijenN.VerbeekS.FiersW.SaelensX.Universal vaccine based on ectodomain"/>
   <result pre="RooijenN.VerbeekS.FiersW.SaelensX.Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protectionJ. Immunol.20111861022103110.4049/jimmunol.090214721169548"/>
   <result pre="Fc receptors and alveolar macrophages mediate protectionJ. Immunol.20111861022103110.4049/jimmunol.090214721169548 140.WilsonJ.R.BelserJ.A.DaSilvaJ.GuoZ.SunX.GansebomS.BaiY.StarkT.J.ChangJ.CarneyP.et al.An" exact="influenza" post="A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from"/>
   <result pre="virus disease in nonhuman primates with ZMappNature2014514475310.1038/nature1377725171469 144.BalazsA.B.BloomJ.D.HongC.M.RaoD.S.BaltimoreD.Broad protection against" exact="influenza" post="infection by vectored immunoprophylaxis in miceNat. Biotechnol.20133164765210.1038/nbt.261823728362 145.BerryC.M.PenhaleW.J.SangsterM.Y.Passive broad-spectrum"/>
   <result pre="influenza infection by vectored immunoprophylaxis in miceNat. Biotechnol.20133164765210.1038/nbt.261823728362 145.BerryC.M.PenhaleW.J.SangsterM.Y.Passive broad-spectrum" exact="influenza" post="immunoprophylaxisInfluenza. Res. Treat.2014201426759410.1155/2014/26759425328697 146.ZhouB.ZhongN.GuanY.Treatment with convalescent plasma for influenza"/>
   <result pre="broad-spectrum influenza immunoprophylaxisInfluenza. Res. Treat.2014201426759410.1155/2014/26759425328697 146.ZhouB.ZhongN.GuanY.Treatment with convalescent plasma for" exact="influenza" post="A (H5N1) infectionN. Engl. J. Med.20073571450145110.1056/NEJMc07035917914053 147.JegerlehnerA.SchmitzN.StorniT.BachmannM.F.Influenza A vaccine"/>
   <result pre="in both protection against and recovery from pulmonary infection with" exact="influenza" post="virus in miceJ. Virol.2008822772278310.1128/JVI.01210-0718184718 149.TerajimaM.CoM.D.T.CruzJ.EnnisF.A.High Antibody-Dependent Cellular Cytotoxicity Antibody"/>
   <result pre="150.YuX.TsibaneT.McGrawP.A.HouseF.S.KeeferC.J.HicarM.D.TumpeyT.M.PappasC.PerroneL.A.MartinezO.et al.Neutralizing antibodies derived from the B cells of 1918" exact="influenza" post="pandemic survivorsNature200845553210.1038/nature0723118716625 151.KrammerF.García-SastreA.PaleseP.Is it possible to develop a &quot;universal�?"/>
   <result pre="influenza pandemic survivorsNature200845553210.1038/nature0723118716625 151.KrammerF.García-SastreA.PaleseP.Is it possible to develop a &quot;universal�?" exact="influenza" post="virus vaccine? Toward a universal influenza virus vaccine: Potential"/>
   <result pre="to develop a &quot;universal�? influenza virus vaccine? Toward a universal" exact="influenza" post="virus vaccine: Potential target antigens and critical aspects for"/>
   <result pre="antibody-dependent cell lysis (ADCL). vaccines-07-00053-t001_Table 1Table 1 Summary of novel" exact="influenza" post="virus vaccine platforms. Vaccines Design References Virus-like particle vaccines"/>
   <result pre="inhibition III completed USA JNJ-63623872 (Pimodivir) Small molecule inhibitor of" exact="influenza" post="A virus PB2 III recruiting Belgium T705 (Favipiravir) RNA-dependent"/>
   <result pre="from the clinicaltrials.gov. 1 Approved for treatment of acute uncomplicated" exact="influenza" post="among ≥12 years vaccines-07-00053-t003_Table 3Table 3 Antibodies undergoing clinical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631137\results\search\disease\results.xml">
   <result pre="traditional design of effective vaccines for rapidly-evolving pathogens, such as" exact="influenza" post="A virus, has failed to provide broad spectrum and"/>
   <result pre="demonstrated the potential to facilitate the design of a universal" exact="influenza" post="vaccine. However, few studies have integrated computational optimization in"/>
   <result pre="T-cell epitopes. Interactions between virus-host-environment determine the evolvability of the" exact="influenza" post="population. We propose that with the development of novel"/>
   <result pre="will be crucial for the development of a long-lasting universal" exact="influenza" post="vaccine. Taken together, computational approaches are powerful and promising"/>
   <result pre="powerful and promising tools for the development of a universal" exact="influenza" post="vaccine with durable and broad protection. Universal influenza vaccine"/>
   <result pre="a universal influenza vaccine with durable and broad protection. Universal" exact="influenza" post="vaccine computational design interactions of virus-host-environment 1. Introduction In"/>
   <result pre="lasting protection for human populations. This is particularly true for" exact="influenza" post="viruses, a single-stranded, negative sense RNA virus. One of"/>
   <result pre="One of the important weapons being developed to effectively prevent" exact="influenza" post="virus infection is a vaccine that can provide durable"/>
   <result pre="those that may cause potential pandemics, that is, a universal" exact="influenza" post="vaccine [1]. The National Institute of Allergy and Infectious"/>
   <result pre="and Infectious Diseases (NIAID) has defined the criteria for universal" exact="influenza" post="vaccine, which includes (1) being at least 75% effective"/>
   <result pre="which includes (1) being at least 75% effective against symptomatic" exact="influenza" post="infection; (2) protecting against group I and group II"/>
   <result pre="influenza infection; (2) protecting against group I and group II" exact="influenza" post="A viruses (influenza B would be a secondary target);"/>
   <result pre="design novel broadly-reactive vaccine candidates, which have been used for" exact="influenza" post="and other pathogens [2]. These new approaches have revealed"/>
   <result pre="the genomic era can aid in achieving goals of universal" exact="influenza" post="vaccine design. However, it has found limited applications in"/>
   <result pre="briefly summarize the currently applied approaches of seasonal and universal" exact="influenza" post="vaccine design and their disadvantages (part 2), gather information"/>
   <result pre="necessary resources and efforts needed for computational approaches of universal" exact="influenza" post="vaccine candidates (part 4). We will explore the important"/>
   <result pre="computational advances that could help in restructuring the existing seasonal" exact="influenza" post="vaccine design and contribute to the development of universal"/>
   <result pre="influenza vaccine design and contribute to the development of universal" exact="influenza" post="vaccine. 2. Current Approach for Influenza Vaccine Design 2.1."/>
   <result pre="for Seasonal Vaccine Design To prevent infections from circulating seasonal" exact="influenza" post="viruses, the annually administered influenza virus vaccines contain H1N1"/>
   <result pre="prevent infections from circulating seasonal influenza viruses, the annually administered" exact="influenza" post="virus vaccines contain H1N1 (phylogenetic group 1 hemagglutinin), H3N2"/>
   <result pre="group 1 hemagglutinin), H3N2 (phylogenetic group 2 hemagglutinin) and two" exact="influenza" post="B virus components (Victoria-like and Yamagata-like) [7]. The vaccine"/>
   <result pre="components (Victoria-like and Yamagata-like) [7]. The vaccine candidates from natural" exact="influenza" post="virus strains are recommended by the World Health Organization"/>
   <result pre="of vaccine strains to make recommendation on the components of" exact="influenza" post="vaccine [8]. The evaluations are mainly based on viral"/>
   <result pre="at least 6-8 months to produce sufficient global supplies of" exact="influenza" post="vaccine via current vaccine production technologies with egg-based, cell-based"/>
   <result pre="vaccine [9,10]. For a comprehensive review of traditional approaches for" exact="influenza" post="vaccine selection, design, development and challenges refer to this"/>
   <result pre="by Wong and Webby [11]. Influenza vaccines selected from natural" exact="influenza" post="virus strains predominantly elicit specific antibodies against the globular"/>
   <result pre="annual vaccines, demonstrating severely low and unstable immune protection from" exact="influenza" post="infection [18]. Predictive models of viral evolution to forecast"/>
   <result pre="[18]. Predictive models of viral evolution to forecast dominant circulating" exact="influenza" post="viral strains in the upcoming influenza seasons through the"/>
   <result pre="to forecast dominant circulating influenza viral strains in the upcoming" exact="influenza" post="seasons through the analysis of genetic and epidemiological data"/>
   <result pre="seasons through the analysis of genetic and epidemiological data from" exact="influenza" post="surveillance system have been developed to make quantitative predictions"/>
   <result pre="viral evolution and aim to improve the selection of seasonal" exact="influenza" post="vaccine candidates [10,19]. This framework has demonstrated potential to"/>
   <result pre="has demonstrated potential to integrate multiple data sources to improve" exact="influenza" post="vaccine design. 2.2. Universal Influenza Vaccine Design Seasonal vaccines"/>
   <result pre="vaccines offer a little or no protection to emerging zoonotic" exact="influenza" post="viruses with pandemic potential, as many species, especially wild"/>
   <result pre="are recognized as the natural reservoir of all subtypes of" exact="influenza" post="A viruses and have the potential to occur spillover"/>
   <result pre="have the potential to elicit broadly protective antibodies against seasonal" exact="influenza" post="strain. M2-based universal vaccine design focuses on the conserved"/>
   <result pre="domain [25]. While the stalk domain is conserved across multiple" exact="influenza" post="subtypes, it is shielded by the immune-dominant head domain."/>
   <result pre="and protective vaccines for hypervariable and rapidly-evolving viral pathogens, including" exact="influenza" post="viruses [30,31]. The reasons for this failure include inherent"/>
   <result pre="vaccine design often ignores the underlying processes of the global" exact="influenza" post="meta-population which generates diversity that allows the viral populations"/>
   <result pre="fit the needs of universal vaccine design for highly diverse" exact="influenza" post="virus in several promising aspects [38,39]: (1) being able"/>
   <result pre="assessment and prediction. Computational approaches to identify candidates for universal" exact="influenza" post="vaccine design have been used with a variety of"/>
   <result pre="both, to tackle with the high degree of variability in" exact="influenza" post="viruses by boosting the immunity from the conserved or"/>
   <result pre="severity. Particularly, memory CD4+ T-cells can provide substantial protection against" exact="influenza" post="infection through direct effector mechanisms as well as indirect"/>
   <result pre="[72,73,74,75,76,77,78]. Taken together, these studies suggest that an epitope-based universal" exact="influenza" post="vaccine can be developed by selecting the well-conserved and"/>
   <result pre="be developed by selecting the well-conserved and immunodominant epitopes across" exact="influenza" post="subtypes using the immunomics approach. A major challenge in"/>
   <result pre="in Clinical Development There are currently three promising epitope-based universal" exact="influenza" post="vaccines, FP-01.1, Flu-v and Multimeric-001 (M-001) are at different"/>
   <result pre="(PB1 and PB2) and have high level conservancy across H1-H9" exact="influenza" post="A subtypes with wider population coverage. The phase I"/>
   <result pre="epitopes derived from NP, matrix proteins (M1 and M2) from" exact="influenza" post="A and NP from influenza B viruses and are"/>
   <result pre="proteins (M1 and M2) from influenza A and NP from" exact="influenza" post="B viruses and are conserved across most influenza viruses"/>
   <result pre="NP from influenza B viruses and are conserved across most" exact="influenza" post="viruses with high population coverage [81,82]. The phase II"/>
   <result pre="and also induced antibody response [83]. Multimeric-001 (M-001), a universal" exact="influenza" post="epitope-based vaccine, is currently at the pivotal phase III"/>
   <result pre="conserved and common epitopes from NP, M1, and HA of" exact="influenza" post="A and B viruses to activate both humoral and"/>
   <result pre="system to provide multi-strain protection from the seasonal and pandemic" exact="influenza" post="viruses [85]. The predicted population coverage of these selected"/>
   <result pre="approaches to prevent infections from remerging or emerging highly evolving" exact="influenza" post="viruses. 3.2.3. Computational Approaches that Incorporate Host Immunological Factors"/>
   <result pre="[89,94]. These technologies and bioinformatics tools can be applied to" exact="influenza" post="virus vaccine design with creating library of antibody repertoire"/>
   <result pre="generated consensus sequences for NA protein of H1N1 and several" exact="influenza" post="proteins of H5N1, including HA, NA and matrix protein"/>
   <result pre="rounds of consensus generation. Within each phylogenetic subclade of the" exact="influenza" post="virus subtype, the primary consensus with the most common"/>
   <result pre="immune targets. Phylogenetic evolutionary models have been used to infer" exact="influenza" post="viral evolutionary history for decades with molecular data, including"/>
   <result pre="[44] developed an ancestral sequence reconstruction method for highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 surface proteins HA and NA. Based on"/>
   <result pre="developed an ancestral sequence reconstruction method for highly pathogenic avian" exact="influenza" post="(HPAI) H5N1 surface proteins HA and NA. Based on"/>
   <result pre="of these viruses. These ancestral sequences were synthesized into attenuated" exact="influenza" post="viruses that could replicate. Their cross-reactive protection against H5N1"/>
   <result pre="vaccine design, the computational approach is promising. Precise estimation of" exact="influenza" post="virus evolution including protein structural and its functional information"/>
   <result pre="heritable phenotype [123]. The zoonotic nature and complicated ecology of" exact="influenza" post="viruses make evolvability more difficult to quantify and predict."/>
   <result pre="and potentially interact to shape viral phylogenies�? [124,125]. Dynamics of" exact="influenza" post="virus infections and transmissions at individual-level (such as viral"/>
   <result pre="experimental testing can be integrated together to improve prediction on" exact="influenza" post="virus evolvability. For example, experimental studies designed to assess"/>
   <result pre="which can improve the prediction of viral evolvability for natural" exact="influenza" post="virus strains [127]. The potential predictors and consequent mutations"/>
   <result pre="enhance our understanding on viral characteristics, potential immune escape, or" exact="influenza" post="antiviral drug resistance [128]. Challenges for this area are"/>
   <result pre="ameliorate the output from computational modeling [19,129,130]. Compared to other" exact="infectious disease" post="sampling, influenza viruses have already established an excellent global"/>
   <result pre="from computational modeling [19,129,130]. Compared to other infectious disease sampling," exact="influenza" post="viruses have already established an excellent global network of"/>
   <result pre="a large amount of genetic data has been available for" exact="influenza" post="research. However, three main limitations exist in current surveillance:"/>
   <result pre="the unequal sampling in zoonotic hosts is more severe. Human" exact="influenza" post="outbreaks have been well monitored and sampled [129]. However,"/>
   <result pre="can provide an initial rationalization and optimal sample size for" exact="avian influenza" post="virus surveillance [129,133,134]. The affiliated sequence meta-data records have"/>
   <result pre="provide an initial rationalization and optimal sample size for avian" exact="influenza" post="virus surveillance [129,133,134]. The affiliated sequence meta-data records have"/>
   <result pre="access database platforms have facilitated the accessibility and sharing of" exact="influenza" post="sequence data to the science community. Despite the availability"/>
   <result pre="have been using the traditional approaches to design and develop" exact="influenza" post="vaccines. The rapid genetic changes and antigenic drift of"/>
   <result pre="influenza vaccines. The rapid genetic changes and antigenic drift of" exact="influenza" post="virus populations result in short-term protection necessitating continual vaccine"/>
   <result pre="the interactions of host- pathogen-environment that produced important insights into" exact="influenza" post="disease dynamics across biological scales. Integrating these computational and"/>
   <result pre="can facilitate the development of a broadly cross-reactive, evolutionarily-resistant universal" exact="influenza" post="vaccine. Acknowledgments We thank Lambodhar Damodaran and Jiani Chen"/>
   <result pre="DiseasesJ. Infect. Dis.201821834735410.1093/infdis/jiy10329506129 2.RappuoliR.AderemA.A 2020 vision for vaccines against HIV," exact="tuberculosis" post="and malariaNature201147346346910.1038/nature1012421614073 3.MedinaR.A.StertzS.ManicassamyB.ZimmermannP.SunX.AlbrechtR.A.Uusi-KerttulaH.ZagordiO.BelsheR.B.FreyS.E.et al.Glycosylations in the Globular Head of"/>
   <result pre="the Promise of Applied Evolutionary BiologyTrends Microbiol.20182610211810.1016/j.tim.2017.09.00429097090 11.WongS.-S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 12.AndersonC.S.OrtegaS.ChavesF.A.ClarkA.M.YangH.TophamD.J.DeDiegoM.L.Natural and directed antigenic drift of"/>
   <result pre="Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 12.AndersonC.S.OrtegaS.ChavesF.A.ClarkA.M.YangH.TophamD.J.DeDiegoM.L.Natural and directed antigenic drift of the H1" exact="influenza" post="virus hemagglutinin stalk domainSci. Rep.201771461410.1038/s41598-017-14931-729097696 13.Berlanda ScorzaF.TsvetnitskyV.DonnellyJ.J.Universal influenza vaccines:"/>
   <result pre="the H1 influenza virus hemagglutinin stalk domainSci. Rep.201771461410.1038/s41598-017-14931-729097696 13.Berlanda ScorzaF.TsvetnitskyV.DonnellyJ.J.Universal" exact="influenza" post="vaccines: Shifting to better vaccinesVaccine2016342926293310.1016/j.vaccine.2016.03.08527038130 14.SkowronskiD.M.JanjuaN.Z.De SerresG.SabaiducS.EshaghiA.DickinsonJ.A.FonsecaK.WinterA.L.GubbayJ.B.KrajdenM.et al.Low 2012–13"/>
   <result pre="Not Antigenic Drift in Circulating VirusesPLoS ONE20149e9215310.1371/journal.pone.009215324667168 15.ZostS.J.ParkhouseK.GuminaM.E.KimK.Diaz PerezS.WilsonP.C.TreanorJ.J.SantA.J.CobeyS.HensleyS.E.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="16.WuN.C.ZostS.J.ThompsonA.J.OyenD.NycholatC.M.McBrideR.PaulsonJ.C.HensleyS.E.WilsonI.A.A structural explanation for the low effectiveness of the seasonal" exact="influenza" post="H3N2 vaccinePLoS Pathog.201713e100668210.1371/journal.ppat.100668229059230 17.PaulesC.I.SullivanS.G.SubbaraoK.FauciA.S.Chasing Seasonal Influenza—The Need for a"/>
   <result pre="Prediction for Human Influenza VirusesTrends Microbiol.20182611913110.1016/j.tim.2017.09.00129032900 20.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of" exact="influenza" post="A virusesMicrobiol. Rev.1992561521791579108 21.GuanY.VijaykrishnaD.BahlJ.ZhuH.WangJ.SmithG.J.D.The emergence of pandemic influenza virusesProtein"/>
   <result pre="ecology of influenza A virusesMicrobiol. Rev.1992561521791579108 21.GuanY.VijaykrishnaD.BahlJ.ZhuH.WangJ.SmithG.J.D.The emergence of pandemic" exact="influenza" post="virusesProtein Cell2010191310.1007/s13238-010-0008-z21203993 22.SmithG.J.D.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic influenza virusesProc."/>
   <result pre="of pandemic influenza virusesProtein Cell2010191310.1007/s13238-010-0008-z21203993 22.SmithG.J.D.BahlJ.VijaykrishnaD.ZhangJ.PoonL.L.ChenH.WebsterR.G.PeirisJ.S.GuanY.Dating the emergence of pandemic" exact="influenza" post="virusesProc. Natl. Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 23.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential"/>
   <result pre="Acad. Sci. USA2009106117091171210.1073/pnas.090499110619597152 23.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 24.ZhangH.WangL.CompansR.W.WangB.-Z.Universal Influenza Vaccines, a Dream to Be Realized"/>
   <result pre="Be Realized SoonViruses20146197410.3390/v605197424784572 25.JangY.H.SeongB.L.Options and obstacles for designing a universal" exact="influenza" post="vaccineViruses201463159318010.3390/v608315925196381 26.KirchenbaumG.A.RossT.M.Eliciting broadly protective antibody responses against influenzaCurr. Opin."/>
   <result pre="protective antibody responses against influenzaCurr. Opin. Immunol.201428717610.1016/j.coi.2014.02.00524632083 27.SauttoG.A.KirchenbaumG.A.RossT.M.Towards a universal" exact="influenza" post="vaccine: Different approaches for one goalVirol. J.2018151710.1186/s12985-017-0918-y29370862 28.CarterD.M.DarbyC.A.LefoleyB.C.CrevarC.J.AlefantisT.OomenR.AndersonS.F.StrugnellT.Cortés-GarciaG.VogelT.U.Design and"/>
   <result pre="Hemagglutinin Vaccine for H1N1 Influenza VirusesJ. Virol.2016904720473410.1128/JVI.03152-1526912624 29.JobE.R.YsenbaertT.SmetA.ChristopoulouI.StrugnellT.OlooE.O.OomenR.P.KleanthousH.VogelT.U.SaelensX.Broadened immunity against" exact="influenza" post="by vaccination with computationally designed influenza virus N1 neuraminidase"/>
   <result pre="Virol.2016904720473410.1128/JVI.03152-1526912624 29.JobE.R.YsenbaertT.SmetA.ChristopoulouI.StrugnellT.OlooE.O.OomenR.P.KleanthousH.VogelT.U.SaelensX.Broadened immunity against influenza by vaccination with computationally designed" exact="influenza" post="virus N1 neuraminidase constructsNPJ Vaccines201835510.1038/s41541-018-0093-130510776 30.HeL.ZhuJ.Computational tools for epitope"/>
   <result pre="particle vaccinesClin. Vaccine Immunol.20121912813910.1128/CVI.05533-1122190399 35.ShuY.McCauleyJ.GISAID: Global initiative on sharing all" exact="influenza" post="data––From vision to realityEurosurveillance2017223049410.2807/1560-7917.ES.2017.22.13.3049428382917 36.NCBI Influenza virus databaseAvailable online:"/>
   <result pre="databaseAvailable online: https://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go=database(accessed on 28 April 2019) 37.collab: WHOFluID—A global" exact="influenza" post="epidemiological data sharing platformWHO2017Available online: https://www.who.int/influenza/surveillance_monitoring/fluid/en/(accessed on 5 March"/>
   <result pre="40.NabelG.J.FauciA.S.Induction of unnatural immunity: Prospects for a broadly protective universal" exact="influenza" post="vaccineNat. Med.2010161389139110.1038/nm1210-138921135852 41.GilesB.M.RossT.M.A computationally optimized broadly reactive antigen (COBRA)"/>
   <result pre="from H5N1 InfectionJ. Infect. Dis.20122051562157010.1093/infdis/jis23222448011 44.DucatezM.F.BahlJ.GriffinY.Stigger-RosserE.FranksJ.BarmanS.VijaykrishnaD.WebbA.GuanY.WebsterR.G.Feasibility of reconstructed ancestral H5N1" exact="influenza" post="viruses for cross-clade protective vaccine developmentProc. Natl. Acad. Sci."/>
   <result pre="epitope-based diagnostics and vaccinesBMC Bioinformatics2006715310.1186/1471-2105-7-15316545123 65.Molero-AbrahamM.LafuenteE.M.FlowerD.R.RecheP.A.Selection of conserved epitopes from" exact="hepatitis" post="C virus for pan-populational stimulation of T-cell responsesClin. Dev."/>
   <result pre="cross-reactive and virus-specific T-cell populations after immunization with serologically distinct" exact="influenza" post="A virusesJ. Exp. Med.197714555756810.1084/jem.145.3.557233901 70.KreijtzJ.H.BodewesR.van AmerongenG.KuikenT.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Primary influenza A virus"/>
   <result pre="with serologically distinct influenza A virusesJ. Exp. Med.197714555756810.1084/jem.145.3.557233901 70.KreijtzJ.H.BodewesR.van AmerongenG.KuikenT.FouchierR.A.OsterhausA.D.RimmelzwaanG.F.Primary" exact="influenza" post="A virus infection induces cross-protective immunity against a lethal"/>
   <result pre="a heterosubtypic virus strain in miceVaccine20072561262010.1016/j.vaccine.2006.08.03617005299 71.ZweerinkH.J.CourtneidgeS.A.SkehelJ.J.CrumptonM.J.AskonasB.A.Cytotoxic T cells kill" exact="influenza" post="virus infected cells but do not distinguish between serologically"/>
   <result pre="cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic" exact="influenza" post="virusesInfluenza Other Respi. Viruses2010424925810.1111/j.1750-2659.2010.00161.x20716156 73.DuvvuriV.R.DuvvuriB.JamnikV.GubbayJ.B.WuJ.WuG.E.T cell memory to evolutionarily"/>
   <result pre="74.De GrootA.S.ArditoM.McClaineE.M.MoiseL.MartinW.D.Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin" exact="influenza" post="A (H1N1) virus with epitopes in 2008–2009 conventional influenza"/>
   <result pre="swine-origin influenza A (H1N1) virus with epitopes in 2008–2009 conventional" exact="influenza" post="vaccineVaccine2009275740574710.1016/j.vaccine.2009.07.04019660593 75.GeX.TanV.BollykyP.L.StandiferN.E.JamesE.A.KwokW.W.Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell"/>
   <result pre="Influenza A VirusJ. Virol.2010843312331910.1128/JVI.02226-0920071564 76.GreenbaumJ.A.KotturiM.F.KimY.OseroffC.VaughanK.SalimiN.VitaR.PonomarenkoJ.ScheuermannR.H.SetteA.et al.Pre-existing immunity against swine-origin H1N1" exact="influenza" post="viruses in the general human populationProc. Natl. Acad. Sci."/>
   <result pre="al.Preexisting influenza-specific CD4+ T cells correlate with disease protection against" exact="influenza" post="challenge in humansNat. Med.2012187428010.1038/nm.261222286307 79.ClinicalTrials.gov Identifier:NCT01265914 A Study to"/>
   <result pre="safety of different doses and formulations of a broad spectrum" exact="influenza" post="vaccine (FLU-v) developed by SEEK: Study protocol for a"/>
   <result pre="https://clinicaltrials.gov/ct2/show/NCT03450915?term=epitope&amp;amp;cond=Influenza&amp;amp;rank=6(accessed on 20 February 2019) 85.GottliebT.Ben-YedidiaT.Epitope-based approaches to a universal" exact="influenza" post="vaccineJ. Autoimmun.201454152010.1016/j.jaut.2014.07.00525172355 86.AtsmonJ.CaracoY.Ziv-SeferS.ShaikevichD.AbramovE.VolokhovI.BruzilS.HaimaK.Y.GottliebT.Ben-YedidiaT.Priming by a novel universal influenza vaccine"/>
   <result pre="a universal influenza vaccineJ. Autoimmun.201454152010.1016/j.jaut.2014.07.00525172355 86.AtsmonJ.CaracoY.Ziv-SeferS.ShaikevichD.AbramovE.VolokhovI.BruzilS.HaimaK.Y.GottliebT.Ben-YedidiaT.Priming by a novel universal" exact="influenza" post="vaccine (Multimeric-001)—A gateway for improving immune response in the"/>
   <result pre="108.BaeleG.SuchardM.A.RambautA.LemeyP.Emerging Concepts of Data Integration in Pathogen PhylodynamicsSyst. Biol.201766e47e6510.1093/sysbio/syw05428173504 109.KirkpatrickE.QiuX.WilsonP.C.BahlJ.KrammerF.The" exact="influenza" post="virus hemagglutinin head evolves faster than the stalk domainSci."/>
   <result pre="evolutionary models improve phylogenetic reconstruction for emerging, seasonal, and pandemic" exact="influenza" post="virusesbioRxiv201710.1101/228692 111.KleinmanC.L.RodrigueN.LartillotN.PhilippeH.Statistical Potentials for Improved Structurally Constrained Evolutionary ModelsMol."/>
   <result pre="VirusPLOS Pathog.201612e100585610.1371/journal.ppat.100585627571422 127.ThyagarajanB.BloomJ.D.The inherent mutational tolerance and antigenic evolvability of" exact="influenza" post="hemagglutininElife2014310.7554/eLife.03300 128.BloomJ.D.GongL.I.BaltimoreD.Permissive Secondary Mutations Enable the Evolution of Influenza"/>
   <result pre="Computational identification of selective sweeps to monitor the adaptation of" exact="influenza" post="A virusesSci. Rep.2018837310.1038/s41598-017-18791-z29321538 131.AmpofoW.K.Azziz-BaumgartnerE.BashirU.CoxN.J.FasceR.GiovanniM.GrohmannG.HuangS.KatzJ.MironenkoA.et al.Strengthening the influenza vaccine virus"/>
   <result pre="the adaptation of influenza A virusesSci. Rep.2018837310.1038/s41598-017-18791-z29321538 131.AmpofoW.K.Azziz-BaumgartnerE.BashirU.CoxN.J.FasceR.GiovanniM.GrohmannG.HuangS.KatzJ.MironenkoA.et al.Strengthening the" exact="influenza" post="vaccine virus selection and development processVaccine2015334368438210.1016/j.vaccine.2015.06.09026148877 132.collab: Institute of"/>
   <result pre="Academies Press (US)Washington, DC, USA2010 133.HoyeB.J.MunsterV.J.NishiuraH.KlaassenM.FouchierR.A.Surveillance of wild birds for" exact="avian influenza" post="virusEmerg. Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.García-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics"/>
   <result pre="Press (US)Washington, DC, USA2010 133.HoyeB.J.MunsterV.J.NishiuraH.KlaassenM.FouchierR.A.Surveillance of wild birds for avian" exact="influenza" post="virusEmerg. Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.García-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics"/>
   <result pre="Infect. Dis.2010161827183410.3201/eid1612.10058921122209 134.SquiresR.B.NoronhaJ.HuntV.García-SastreA.MackenC.BaumgarthN.SuarezD.PickettB.E.ZhangY.LarsenC.N.Influenza research database: An integrated bioinformatics resource for" exact="influenza" post="research and surveillanceInfluenza Other Respi. Viruses2012640441610.1111/j.1750-2659.2011.00331.x22260278 135.GunnarssonG.Latorre-MargalefN.HobsonK.A.Van WilgenburgS.L.ElmbergJ.OlsenB.FouchierR.A.M.WaldenströmJ.Disease dynamics"/>
   <result pre="bird migration––Linking mallards Anas platyrhynchos and subtype diversity of the" exact="influenza" post="A virus in time and spacePLoS ONE20127e3567910.1371/journal.pone.003567922536424 136.ElbeS.Buckland-MerrettG.Data, disease"/>
   <result pre="are modeled to understand the susceptibility and immune response to" exact="influenza" post="viruses by studying the host immunogenetics, for example, the"/>
   <result pre="ecological determinants that affect viral evolution and host immunity to" exact="influenza" post="virus. In order to generate critical components for vaccine"/>
   <result pre="high-quality information and broad-reactive components for a universal vaccine of" exact="influenza" post="viruses. Figure 2 Framework for computational influenza universal vaccine"/>
   <result pre="universal vaccine of influenza viruses. Figure 2 Framework for computational" exact="influenza" post="universal vaccine design. (A) Model-free consensus-based optimized approach. Consensus"/>
   <result pre="domains. Based on the evolutionary relationship among different subtypes of" exact="influenza" post="A virus, common ancestral sequences of head and stalk"/>
   <result pre="sequences of head and stalk domains can be generated within" exact="influenza" post="A virus Group 1 (H1, H2, H5, H6, H7,"/>
   <result pre="approaches should be used for all the gene segments of" exact="influenza" post="viruses to generate a full profile of viral immunogenicity."/>
   <result pre="viral immunogenicity. vaccines-07-00045-t001_Table 1Table 1 Summary and examples of computational" exact="influenza" post="universal vaccine design. Approach Conceptual Design Evidence-Level Advantages Disadvantages"/>
   <result pre="the same subtype;(3) Neutralize the receptor binding sites to prevent" exact="influenza" post="disease with a clear path towards clinical proof of"/>
   <result pre="2B Pre-clinical (1) Induce broad cross-reactive protection within highly diverse" exact="influenza" post="subtype(2) Account for sampling bias and the variability of"/>
   <result pre="Table 2 for details vaccines-07-00045-t002_Table 2Table 2 Promising epitope-based universal" exact="influenza" post="vaccines at clinical trials. Vaccine Company Projects Clinical Phase"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631207\results\search\disease\results.xml">
   <result pre="or in vitro against viral replication and and/or ZIKV-induced neurotoxicity." exact="microcephaly" post="arbovirus flavivirus drug development neurodevelopment therapy drug screening pregnancy"/>
   <result pre="neurodevelopment therapy drug screening pregnancy Food and Drug Administration (FDA)" exact="encephalitis" post="1. Introduction Zika virus (ZIKV) has been known since"/>
   <result pre="reported in newborn babies exposed to ZIKV in uterus, being" exact="microcephaly" post="the most severe outcome. Infants who develop ZIKV-induced microcephaly"/>
   <result pre="being microcephaly the most severe outcome. Infants who develop ZIKV-induced" exact="microcephaly" post="show recurrent seizures [3], and severely compromised neuropsychomotor development"/>
   <result pre="Extensive research has focused on unraveling the mechanisms of congenital" exact="microcephaly" post="induced by ZIKV [6,7,8]. However, increasing evidence from clinical"/>
   <result pre="dystonic movement, and impaired fine motor skills [9,10,11]. Post-natal onset" exact="microcephaly" post="was also reported, and studies suggest that 60% of"/>
   <result pre="show that ZIKV infection in adult patients may result in" exact="encephalitis" post="[18,19,20], encephalomyelitis [18,20], acute myelitis [18,19], chronic inflammatory demyelinating"/>
   <result pre="ZIKV infection in adult patients may result in encephalitis [18,19,20]," exact="encephalomyelitis" post="[18,20], acute myelitis [18,19], chronic inflammatory demyelinating polyneuropathy [21],"/>
   <result pre="adult patients may result in encephalitis [18,19,20], encephalomyelitis [18,20], acute" exact="myelitis" post="[18,19], chronic inflammatory demyelinating polyneuropathy [21], and Guillain-Barre syndrome"/>
   <result pre="may result in encephalitis [18,19,20], encephalomyelitis [18,20], acute myelitis [18,19]," exact="chronic inflammatory demyelinating polyneuropathy" post="[21], and Guillain-Barre syndrome [19,22,23] (Figure 1B). Episodes of"/>
   <result pre="encephalitis [18,19,20], encephalomyelitis [18,20], acute myelitis [18,19], chronic inflammatory demyelinating" exact="polyneuropathy" post="[21], and Guillain-Barre syndrome [19,22,23] (Figure 1B). Episodes of"/>
   <result pre="northeast of Brazil, epidemiological studies showed that higher incidence of" exact="microcephaly" post="was observed in districts with lower developmental index, higher"/>
   <result pre="potential of sofosbuvir (SFB), an antiviral prodrug clinically used against" exact="hepatitis" post="C virus (HCV), to inhibit ZIKV replication [100,101]. Later,"/>
   <result pre="American ZIKV strains in different in vitro models: placental and" exact="neuroblastoma" post="cell lines, human fetal-derived neuronal stem cells, induced-pluripotent neural"/>
   <result pre="cause excitotoxicity in the brain and contribute to further aggravate" exact="neurodegeneration" post="[94]. Based on such assumption, Costa and colleagues showed"/>
   <result pre="development (Balasubramanian, 2017). AQ has been used for treatment of" exact="malaria" post="in pediatric settings, but serious adverse effects were shown"/>
   <result pre="function of viral RNA polymerase of several viruses such as" exact="measles" post="and rabies [131]. One specific adenosine analog, NITD008, has"/>
   <result pre="viral RNA polymerase of several viruses such as measles and" exact="rabies" post="[131]. One specific adenosine analog, NITD008, has been proven"/>
   <result pre="action is BCX4430 (Galidesivir), which showed strong antiviral activity against" exact="yellow fever" post="and several others viruses in previous studies, and was"/>
   <result pre="(RIB) is a nucleoside analogue used for the treatment of" exact="hepatitis" post="C. In an early report, RIB was able to"/>
   <result pre="of Zika virus from amniotic fl uid of fetuses with" exact="microcephaly" post="in Brazil: A case studyLancet Infect Dis20161665366010.1016/S1473-3099(16)00095-526897108 36.YuanL.HuangX.-Y.LiuZ.-Y.ZhangF.ZhuX.-L.YuJ.-Y.JiX.XuY.-P.LiG.LiC.et al.A"/>
   <result pre="distributed among human populations?PLoS Biol.201816e200659210.1371/journal.pbio.200659230142150 75.de OliveiraW.K.de FrançaG.V.A.CarmoE.H.DuncanB.B.de Souza KuchenbeckerR.SchmidtM.I.Infection-related" exact="microcephaly" post="after the 2015 and 2016 Zika virus outbreaks in"/>
   <result pre="Prevents Neuronal Death Induced by Zika Virus InfectionMBio20178e00350-1710.1128/mBio.00350-1728442607 95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues" exact="microcephaly" post="in a humanized in vitro model of Zika infection"/>
   <result pre="agent, demonstrates antitumor activity by blocking multiple signaling pathways of" exact="cancer" post="stem cellsChin. J. Cancer20123117818410.5732/cjc.011.1029022237038 126.collab: BayerYomesan (Package Insert)BayerLeverkusen, Germany1988"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631456\results\search\disease\results.xml">
   <result pre="66314564232 doi: 10.1186/s12879-019-4232-8 : Research Article An outbreak of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 8 in primary school,"/>
   <result pre="article, unless otherwise stated. Abstract Background Two outbreaks of epidemic" exact="keratoconjunctivitis" post="(EKC) occurred successively with an interval of 5 days"/>
   <result pre="was constructed by MEGA 7.0. Results A total of 331" exact="acute conjunctivitis" post="cases, including probable cases of EKC, were reported in"/>
   <result pre="constructed by MEGA 7.0. Results A total of 331 acute" exact="conjunctivitis" post="cases, including probable cases of EKC, were reported in"/>
   <result pre="China; therefore, it is necessary to monitor the pathogens causing" exact="acute conjunctivitis" post="in this area. Keywords Human adenovirus 8 Epidemic Keratoconjunctivitis"/>
   <result pre="therefore, it is necessary to monitor the pathogens causing acute" exact="conjunctivitis" post="in this area. Keywords Human adenovirus 8 Epidemic Keratoconjunctivitis"/>
   <result pre="of Yunnan Province Disease Control and Prevention2017ZX10104001-005-002XuWen Background Acute infectious" exact="conjunctivitis" post="is a very common disease that is usually caused"/>
   <result pre="bacteria; it has high incidence rates. Outbreaks of acute infectious" exact="conjunctivitis" post="can occur in schools, military camps and hospitals where"/>
   <result pre="economic and social burdens [1, 2]. In recent years, viral" exact="conjunctivitis" post="has been the most common form, followed by bacterial"/>
   <result pre="viral conjunctivitis has been the most common form, followed by" exact="bacterial conjunctivitis" post="[3, 4]; adenoviruses are one of the main causes"/>
   <result pre="conjunctivitis has been the most common form, followed by bacterial" exact="conjunctivitis" post="[3, 4]; adenoviruses are one of the main causes"/>
   <result pre="42, 48, 53, 54, 56, and 64 are associated with" exact="acute conjunctivitis." post="Of these, HAdV-8, − 19 and − 37 cause a severe form"/>
   <result pre="these, HAdV-8, − 19 and − 37 cause a severe form of epidemic" exact="keratoconjunctivitis" post="(EKC) [5, 7–9, 13–17]. In addition, EKC [18–20] is"/>
   <result pre="manifestations of the patients, and the risk factors associated with" exact="acute conjunctivitis" post="transmission within the schools; and provided infection control recommendations."/>
   <result pre="of the patients, and the risk factors associated with acute" exact="conjunctivitis" post="transmission within the schools; and provided infection control recommendations."/>
   <result pre="Autonomous Prefecture. Outbreak information In May 2018, two outbreaks of" exact="acute conjunctivitis" post="occurred in Weixi County Ethnic Primary School and Yongchun"/>
   <result pre="Prefecture. Outbreak information In May 2018, two outbreaks of acute" exact="conjunctivitis" post="occurred in Weixi County Ethnic Primary School and Yongchun"/>
   <result pre="previous studies. These variables included the number of individuals with" exact="acute conjunctivitis" post="in their family, in the same class and in"/>
   <result pre="studies. These variables included the number of individuals with acute" exact="conjunctivitis" post="in their family, in the same class and in"/>
   <result pre="45 days, respectively. A total of 331 cases of acute haemorrhagic" exact="conjunctivitis" post="(AHC) were reported; 171 cases (attack rate 30.59%, 171/559,"/>
   <result pre="and 78 cases were interviewed. Logistic regression analysis showed that" exact="acute conjunctivitis" post="occurrence within the family; contact with a patient’s eyes"/>
   <result pre="78 cases were interviewed. Logistic regression analysis showed that acute" exact="conjunctivitis" post="occurrence within the family; contact with a patient’s eyes"/>
   <result pre="an incubation period (IP) approximately 6 days; these characteristics fit HAdV" exact="conjunctivitis" post="very well. The pathogen causing the outbreaks was determined"/>
   <result pre="have occurred or been reported. Previous studies have shown that" exact="acute conjunctivitis" post="is most common in summer [4]. The clinical manifestations,"/>
   <result pre="occurred or been reported. Previous studies have shown that acute" exact="conjunctivitis" post="is most common in summer [4]. The clinical manifestations,"/>
   <result pre="39–41]. Conjunctival hyperaemia and increased secretion are common features of" exact="acute conjunctivitis," post="while watery secretions are more characteristic of viral conjunctivitis"/>
   <result pre="acute conjunctivitis, while watery secretions are more characteristic of viral" exact="conjunctivitis" post="[4]. These characteristics are of great significance for laboratory"/>
   <result pre="of an outbreak. In China, AHC is the only notifiable" exact="acute conjunctivitis" post="disease. Due to the lack of an aetiological diagnosis,"/>
   <result pre="an outbreak. In China, AHC is the only notifiable acute" exact="conjunctivitis" post="disease. Due to the lack of an aetiological diagnosis,"/>
   <result pre="lack of an aetiological diagnosis, clinically suspected cases of viral" exact="conjunctivitis" post="are more likely to be reported as clinically diagnosed"/>
   <result pre="surveillance is necessary in areas with a high incidence of" exact="acute conjunctivitis." post="Abbreviations CDC Center for Disease Control and Prevention EKC"/>
   <result pre="Abbreviations CDC Center for Disease Control and Prevention EKC Epidemic" exact="keratoconjunctivitis" post="HAdV Human adenoviruses HAdv-8 Human adenovirus type 8 NGS"/>
   <result pre="assistance with the collection and transportation of conjunctival swabs from" exact="acute conjunctivitis" post="patients and for clinically diagnosing the patients. Authors’ contributions"/>
   <result pre="with the collection and transportation of conjunctival swabs from acute" exact="conjunctivitis" post="patients and for clinically diagnosing the patients. Authors’ contributions"/>
   <result pre="References 1.SmithAFWaycasterCEstimate of the direct and indirect annual cost of" exact="bacterial conjunctivitis" post="in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of conjunctivitis outbreak,"/>
   <result pre="1.SmithAFWaycasterCEstimate of the direct and indirect annual cost of bacterial" exact="conjunctivitis" post="in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of conjunctivitis outbreak,"/>
   <result pre="of bacterial conjunctivitis in the United StatesBMC Ophthalmol200991310.1186/1471-2415-9-1319939250 2.FilleulLPagesFWanGCBrottetEVilainPCosts of" exact="conjunctivitis" post="outbreak, Reunion Island, FranceEmerg Infect Dis201824116817010.3201/eid2401.17091629260662 3.FarokhfarAAhmadzadehAAHeidariGMASheikhrezaeeMCommon causes of"/>
   <result pre="4.AzariAABarneyNPConjunctivitis: a systematic review of diagnosis and treatmentJAMA2013310161721172910.1001/jama.2013.28031824150468 5.LiJLuXJiangBDuYYangYQianHLiuBLinCJiaLChenLet al.Adenovirus-associated" exact="acute conjunctivitis" post="in Beijing, China, 2011-2013BMC Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological"/>
   <result pre="a systematic review of diagnosis and treatmentJAMA2013310161721172910.1001/jama.2013.28031824150468 5.LiJLuXJiangBDuYYangYQianHLiuBLinCJiaLChenLet al.Adenovirus-associated acute" exact="conjunctivitis" post="in Beijing, China, 2011-2013BMC Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological"/>
   <result pre="Infect Dis201818113510.1186/s12879-018-3014-z29558885 6.BalasopoulouAKappaokkinosPPagoulatosDPlotasPMakriOEGeorgakopoulosCDVantarakisAAlpha molecular epidemiological analysis of adenoviruses from excess" exact="conjunctivitis" post="casesBMC Ophthalmol20171715110.1186/s12886-017-0447-x28438142 7.GhebremedhinBHuman adenovirus: viral pathogen with increasing importanceEur"/>
   <result pre="analysis of a novel intertypic recombinant human adenovirus causing epidemic" exact="keratoconjunctivitis" post="in JapanJ Clin Microbiol201149248449010.1128/JCM.01044-1021147954 9.TabbaraKFOmarNHammoudaEAkanumaMOhguchiTArigaTTagawaYKitaichiNIshidaSAokiKet al.Molecular epidemiology of adenoviral"/>
   <result pre="keratoconjunctivitis in JapanJ Clin Microbiol201149248449010.1128/JCM.01044-1021147954 9.TabbaraKFOmarNHammoudaEAkanumaMOhguchiTArigaTTagawaYKitaichiNIshidaSAokiKet al.Molecular epidemiology of adenoviral" exact="keratoconjunctivitis" post="in Saudi ArabiaMol Vis2010162132213621139691 10.PintoRDLiraRPArietaCECastroRSBononSHThe prevalence of adenoviral conjunctivitis"/>
   <result pre="adenoviral keratoconjunctivitis in Saudi ArabiaMol Vis2010162132213621139691 10.PintoRDLiraRPArietaCECastroRSBononSHThe prevalence of adenoviral" exact="conjunctivitis" post="at the clinical Hospital of the State University of"/>
   <result pre="University of Campinas, BrazilClinics (Sao Paulo)2015701174875010.6061/clinics/2015(11)0626602522 11.MaranhaoAGSoaresCCAlbuquerqueMCSantosNMolecular epidemiology of adenovirus" exact="conjunctivitis" post="in Rio de Janeiro, Brazil, between 2004 and 2007Rev"/>
   <result pre="for prevention and treatmentDtsch Arztebl Int20111082747548021814523 15.HuangGYaoWYuWMaoLSunHYaoWTianJWangLBoZZhuZet al.Outbreak of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 56, China, 2012PLoS One2014910e11078110.1371/journal.pone.011078125343525"/>
   <result pre="adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of" exact="keratoconjunctivitis" post="occurred in Pune, Maharashtra, Western IndiaJ Med Virol201688122100210510.1002/jmv.2456527152842 17.RobinsonCMShariatiFZaitshikJGillaspyAFDyerDWChodoshJHuman"/>
   <result pre="17.RobinsonCMShariatiFZaitshikJGillaspyAFDyerDWChodoshJHuman adenovirus type 19: genomic and bioinformatics analysis of a" exact="keratoconjunctivitis" post="isolateVirus Res2009139112212610.1016/j.virusres.2008.10.00119000724 18.UemuraTMigitaHUenoTTsukahara-KawamuraTSaekiYFujimotoTUchioEClinical and virological analysis of epidemic keratoconjunctivitis"/>
   <result pre="a keratoconjunctivitis isolateVirus Res2009139112212610.1016/j.virusres.2008.10.00119000724 18.UemuraTMigitaHUenoTTsukahara-KawamuraTSaekiYFujimotoTUchioEClinical and virological analysis of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus type 54 in a regional ophthalmic"/>
   <result pre="acute hemorrhagic conjunctivitisMed Mal Infect201040421221810.1016/j.medmal.2009.09.00619836177 20.ZhangLZhaoNHuangXJinXGengXChanTCLiuSMolecular epidemiology of acute hemorrhagic" exact="conjunctivitis" post="caused by coxsackie a type 24 variant in China,"/>
   <result pre="a type 24 variant in China, 2004-2014Sci Rep201774520210.1038/srep4520228332617 21.MaitreyiRSDarLMuthukumarAVajpayeeMXessIVajpayeeRBSethPBroorSAcute hemorrhagic" exact="conjunctivitis" post="due to enterovirus 70 in IndiaEmerg Infect Dis19995226726910.3201/eid0502.99021210221880 22.ShulmanLMManorYAzarRHandsherRVonsoverAMendelsonERothmanSHassinDHalmutTAbramovitzBet"/>
   <result pre="outbreak of hemorrhagic conjunctivitisJ Clin Microbiol1997358214521499230400 23.LeiZZhuZWangBMeiHLiHGaDJieGChiMZhangSMaCet al.Outbreaks of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type 8 in the Tibet"/>
   <result pre="of China in 2016PLoS One2017129e18504810.1371/journal.pone.0185048 24.BurrSESillahAJoofHBaileyRLHollandMJAn outbreak of acute haemorrhagic" exact="conjunctivitis" post="associated with coxsackievirus A24 variant in the Gambia, West"/>
   <result pre="identified based on phylogenetic analysis during an outbreak of acute" exact="keratoconjunctivitis" post="in ChennaiIndian J Med Res2012136226026422960893 27.ReillySDhillonBJNkanzaKMD'SouzaAMTaylorNHobbsSJFrekeARoomeAPAdenovirus type 8 keratoconjunctivitis--an"/>
   <result pre="(Lond)198696355757510.1017/S00221724000663653016080 28.GreggMBField epidemiology19964459 29.YeZWRuanFZhangXBXiaoSJInvestigation of an outbreak of acute hemorrhagic" exact="conjunctivitis" post="and analysis of risk factors in primary schoolPract Prev"/>
   <result pre="factors in primary schoolPract Prev Med2013201214671468 30.ZhuZZhangYXuSYuPTianXWangLLiuZTangLMaoNJiYet al.Outbreak of acute" exact="respiratory disease" post="in China caused by B2 species of adenovirus type"/>
   <result pre="of adenovirus type 11J Clin Microbiol200947369770310.1128/JCM.01769-0819109466 31.RichmondSBurmanRCrosdaleECropperLLongsonDEnochBEDoddCLA large outbreak of" exact="keratoconjunctivitis" post="due to adenovirus type 8J Hyg (Lond)198493228529110.1017/S00221724000648106094666 32.VineyKAKehoePJDoyleBSheppeardVRoberts-WitteveenARSemirliHMcPhieKADwyerDEMcAnultyJMAn outbreak"/>
   <result pre="to adenovirus type 8J Hyg (Lond)198493228529110.1017/S00221724000648106094666 32.VineyKAKehoePJDoyleBSheppeardVRoberts-WitteveenARSemirliHMcPhieKADwyerDEMcAnultyJMAn outbreak of epidemic" exact="keratoconjunctivitis" post="in a regional ophthalmology clinic in New South WalesEpidemiol"/>
   <result pre="ophthalmology clinic in New South WalesEpidemiol Infect200813691197120610.1017/S095026880700984318047749 33.MelendezCPFlorentinoMMMartinezILLopezHMOutbreak of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus in medical residentsMol Vis20091555756219365589 34.DoyleTJKingDCobbJMillerDJohnsonBAn outbreak"/>
   <result pre="by adenovirus in medical residentsMol Vis20091555756219365589 34.DoyleTJKingDCobbJMillerDJohnsonBAn outbreak of epidemic" exact="keratoconjunctivitis" post="at an outpatient ophthalmology clinicInfect Dis Rep201022e1710.4081/idr.2010.e1724470897 35.AkiyoshiKSugaTFukuiKTaniguchiKOkabeNFujimotoTOutbreak of"/>
   <result pre="at an outpatient ophthalmology clinicInfect Dis Rep201022e1710.4081/idr.2010.e1724470897 35.AkiyoshiKSugaTFukuiKTaniguchiKOkabeNFujimotoTOutbreak of epidemic" exact="keratoconjunctivitis" post="caused by adenovirus type 54 in a nursery school"/>
   <result pre="Kobe City, Japan in 2008Jpn J Infect Dis201164435335521788718 36.KingDJohnsonBMillerDLandonEMDevriesAFullerSAdenovirus-associated epidemic" exact="keratoconjunctivitis" post="outbreaks--four states, 2008-2010MMWR Morb Mortal Wkly Rep2013623263764123945769 37.LeeYCChenNHuangITYangHHHuangCTChenLKSheuMMHuman adenovirus"/>
   <result pre="2008-2010MMWR Morb Mortal Wkly Rep2013623263764123945769 37.LeeYCChenNHuangITYangHHHuangCTChenLKSheuMMHuman adenovirus type 8 epidemic" exact="keratoconjunctivitis" post="with large corneal epithelial full-layer detachment: an endemic outbreak"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631698\results\search\disease\results.xml">
   <result pre="the development of the neurogenic disease known as acute flaccid" exact="myelitis" post="(AFM), mostly in children, seriously endangering public health. Hitherto,"/>
   <result pre="infection and virus–host interactions, and its relationship to acute flaccid" exact="myelitis" post="(AFM), in order to broaden our understanding of the"/>
   <result pre="development of effective antiviral agents. Enterovirus D68 (EV-D68) acute flaccid" exact="myelitis" post="(AFM) immune antagonism infection mechanism genomic characteristics infection mechanism"/>
   <result pre="the throat swab samples taken from four Californian children with" exact="pneumonia" post="and bronchiolitis in 1962 [1], giving rise to four"/>
   <result pre="swab samples taken from four Californian children with pneumonia and" exact="bronchiolitis" post="in 1962 [1], giving rise to four distinct virus"/>
   <result pre="was found to have a temporal association with a polio-like" exact="neurological disorder" post="known as acute flaccid myelitis (AFM), with symptoms such"/>
   <result pre="association with a polio-like neurological disorder known as acute flaccid" exact="myelitis" post="(AFM), with symptoms such as dysneuria and muscle weakness,"/>
   <result pre="[6]. This phenomenon suggests a potential for EV-D68 to induce" exact="nervous system disease" post="[7], arousing widespread concern among health authorities and the"/>
   <result pre="by telaprevir, an FDA-approved drug used for the treatment of" exact="hepatitis" post="C virus infection [12]. The 3C protease contributes to"/>
   <result pre="strains, which were associated with the neurovirulence of acute flaccid" exact="myelitis" post="(AFM) in American strains [7,22]. Moreover, through comparative analyses"/>
   <result pre="of transforming growth factor β-activated kinase 1(TAK1), leading to the" exact="suppression" post="of NF-κB activation, a host response crucial for toll-like"/>
   <result pre="infection, and DAS 181, being developed for the treatment of" exact="influenza" post="and parainfluenza infections, are thought to have the potential"/>
   <result pre="to have an association with acute flaccid paralysis (AFP), a" exact="neurological disorder." post="In some cases, it can produce symptoms of acute"/>
   <result pre="al.A novel outbreak enterovirus D68 strain associated with acute flaccid" exact="myelitis" post="cases in the USA (2012–14): A retrospective cohort studyLancet"/>
   <result pre="associated with paralysis during the 2014 outbreakVirus Evolut.201621 24.EspositoS.ChidiniG.CinnanteC.NapolitanoL.GianniniA.TerranovaL.NiestersH.PrincipiN.CalderiniE.Acute flaccid" exact="myelitis" post="associated with enterovirus-D68 infection in an otherwise healthy childVirol."/>
   <result pre="serotype with rhinovirus and enterovirus featuresJ. Clin. Microbiol.2002404218422310.1128/JCM.40.11.4218-4223.200212409401 27.KrautkrämerE.ZeierM.Hantavirus causing" exact="hemorrhagic fever with renal syndrome" post="enters from the apical surface and requires decay-accelerating factor"/>
   <result pre="of State and Territorial EpidemiologistsNotes from the field: Acute flaccid" exact="myelitis" post="among persons aged ≤21 years—United States, August 1-November 13,"/>
   <result pre="July-October, 2017 and 2018MMWR20196827728010.15585/mmwr.mm6812a130921299 60.PérezG.RosanovaM.T.FreireM.C.PazM.I.RuvinskyS.RugiloC.RuggieriV.CisternaD.MartirenS.LemaC.et al.Unusual increase of cases of" exact="myelitis" post="in a pediatric hospital in ArgentinaArch. Argent. Pediatr201711536436928737865 61.KreuterJ.D.BarnesA.McCarthyJ.E.SchwartzmanJ.D.ObersteM.S.RhodesC.H.ModlinJ.F.WrightP.F.A"/>
   <result pre="and optimal growth temperaturePLoS Pathog.201814e100696210.1371/journal.ppat.100696229630666 65.HixonA.M.YuG.LeserJ.S.YagiS.ClarkeP.ChiuC.Y.TylerK.L.A mouse model of paralytic" exact="myelitis" post="caused by enterovirus D68PLoS Pathog.201713e100619910.1371/journal.ppat.100619928231269 66.HixonA.M.ClarkeP.TylerK.L.Evaluating Treatment Efficacy in"/>
   <result pre="neonatal mouse model of Enterovirus D68 infection induces both interstitial" exact="pneumonia" post="and acute flaccid myelitisAntiviral Res.201916110811510.1016/j.antiviral.2018.11.01330503887 68.GahmbergC.G.TianL.NingL.Nyman-HuttunenH.ICAM-5—A novel two-facetted adhesion"/>
   <result pre="genome. Figure 2 Phylogenetic tree of EV-D68 including acute flaccid" exact="myelitis" post="(AFM)-related strains. A maximum likelihood phylogenetic tree of EV-D68"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6631769\results\search\disease\results.xml">
   <result pre="caused by human-to-human or animal-to-human transmissible viral pathogens. Annually, seasonal" exact="influenza" post="epidemics attack human populations leading to 290–650 thousand deaths/year"/>
   <result pre="fusion protein of the H1-type haemagglutinin (HA) of the pandemic" exact="influenza" post="A virus (H1N1) strain from 2009 (H1N1pdm09) and the"/>
   <result pre="reliable approach to protect against two different viral infections. OMVs" exact="influenza" post="vaccine MERS-CoV H1N1pdm 1. Introduction Acute respiratory infections are"/>
   <result pre="millions of human deaths worldwide each year [3]. Annually, seasonal" exact="influenza" post="epidemics attack 10–20% of the human population leading to"/>
   <result pre="world is confronted every 10–40 years with antigenically distinct pandemic" exact="influenza" post="virus strains of wide geographical distribution and considerable human-to-human"/>
   <result pre="recent years, the world has been challenged with newly emerging" exact="influenza" post="A virus (IAV) infections, which have the potential to"/>
   <result pre="the human population within limited epidemics. For instance, highly pathogenic" exact="avian influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
   <result pre="human population within limited epidemics. For instance, highly pathogenic avian" exact="influenza" post="viruses (HPAIV) of the H5N1-subtype and low pathogenic avian"/>
   <result pre="avian influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic" exact="avian influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
   <result pre="influenza viruses (HPAIV) of the H5N1-subtype and low pathogenic avian" exact="influenza" post="viruses (LPAIV) of the H7N9-, H10N8- and H6N1-subtypes [6,7,8,9]"/>
   <result pre="caused global pandemic outbreaks, such as the 2009 swine-origin H1N1" exact="influenza" post="virus (H1N1pdm09) [10,11]. In 2012, a novel Middle East"/>
   <result pre="viral HA1 protein was achieved using rabbit monoclonal antibodies recognizing" exact="influenza" post="A virus hemagglutinin (Abcam), diluted 1:1000 in blocking buffer."/>
   <result pre="weight (2 μg/g). An infectious dose of 105.5 TCID50 of" exact="influenza" post="virus A/California/04/2009 (H1N1) wild type, was administered intra-nasally to"/>
   <result pre="were performed according to Egyptian regulations for the propagation of" exact="influenza" post="viruses. All experiments involving low pathogenic and highly pathogenic"/>
   <result pre="influenza viruses. All experiments involving low pathogenic and highly pathogenic" exact="avian influenza" post="A viruses were performed in biosafety level 2 and"/>
   <result pre="viruses. All experiments involving low pathogenic and highly pathogenic avian" exact="influenza" post="A viruses were performed in biosafety level 2 and"/>
   <result pre="humoral and cellular neutralizing antibody (nAb) immune responses [26,27,28,29,30,31]. Traditionally," exact="influenza" post="vaccines are produced by generating a natural or recombinant"/>
   <result pre="address additional vaccines needed to combat seasonal H1N1, H3N2 and" exact="influenza" post="B viruses. OMVs had been introduced as a part"/>
   <result pre="responses in animal models from diverse microorganisms such as N." exact="meningitis" post="B, Vibrio cholera, Salmonella Typhimurium, Pseudomonas aeruginosa, Gallibacterium anatis,"/>
   <result pre="Gallibacterium anatis, Acinetobacter baumannii, Chlamydia trachomatis, Shigella spp., and Mycobacterium" exact="tuberculosis" post="[35,36,37,38,39,40,41]. LPS in the outer surface of OMVs acts"/>
   <result pre="the immunogenicity and produce antiviral innate immune responses against various" exact="influenza" post="virus infections via activation of macrophages [42,43,44]. Despite that"/>
   <result pre="OMVs-H1/RBD produced high levels of a neutralizing Abs titer against" exact="influenza" post="H1N1 virus at 8 weeks post immunization. Stimulated neutralizing"/>
   <result pre="stable chimeric fusion protein of H1-type HA of the pandemic" exact="influenza" post="A virus (H1N1) strain and RBD of MERS-CoV induces"/>
   <result pre="flu infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an" exact="avian influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
   <result pre="infects humans for the first timeBMJ2013346f215110.1136/bmj.f215123558347 7.BahgatM.M.KutkatM.A.NasraaM.H.MostafaA.WebbyR.BahgatI.M.AliM.A.Characterization of an avian" exact="influenza" post="virus H5N1 Egyptian isolateJ. Virol. Methods.200915924425010.1016/j.jviromet.2009.04.00819406157 8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and"/>
   <result pre="8.ChenH.YuanH.GaoR.ZhangJ.WangD.XiongY.FanG.YangF.LiX.ZhouJ.et al.Clinical and epidemiological characteristics of a fatal case of" exact="avian influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
   <result pre="al.Clinical and epidemiological characteristics of a fatal case of avian" exact="influenza" post="A H10N8 virus infection: A descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and"/>
   <result pre="descriptive studyLancet201438371472110.1016/S0140-6736(14)60111-224507376 9.ShiW.ShiY.WuY.LiuD.GaoG.F.Origin and molecular characterization of the human-infecting H6N1" exact="influenza" post="virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic influenza"/>
   <result pre="H6N1 influenza virus in TaiwanProtein Cell2013484685310.1007/s13238-013-3083-024136722 10.LesslerJ.ReichN.G.CummingsD.A.NairH.P.JordanH.T.ThompsonN.Outbreak of 2009 pandemic" exact="influenza" post="A (H1N1) at a New York City schoolN. Engl."/>
   <result pre="Engl. J. Med.20093612628263610.1056/NEJMoa090608920042754 11.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 12.Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Available online: https://www.who.int/emergencies/mers-cov/en/(accessed"/>
   <result pre="ThreatViruses2018109310.3390/v10020093 14.MostafaA.PleschkaS.Influenza H3N2 Vaccines: Recent ChallengesTrends Microbiol.201710.1016/j.tim.2017.12.00329268980 15.ZostS.J.ParkhouseK.GuminaM.E.KimK.Diaz PerezS.WilsonP.C.TreanorJ.J.SantA.J.CobeyS.HensleyS.E.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="16.WuN.C.ZostS.J.ThompsonA.J.OyenD.NycholatC.M.McBrideR.PaulsonJ.C.HensleyS.E.WilsonI.A.A structural explanation for the low effectiveness of the seasonal" exact="influenza" post="H3N2 vaccinePLoS Pathogens201713e100668210.1371/journal.ppat.100668229059230 17.GerritzenM.J.H.MartensD.E.WijffelsR.H.van der PolL.StorkM.Bioengineering bacterial outer membrane"/>
   <result pre="lumenJ. Extracell Vesicles2014310.3402/jev.v3.24015 21.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.Improved dual promotor-driven reverse genetics system for" exact="influenza" post="virusesJ. Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia"/>
   <result pre="Virol. Methods201319360361010.1016/j.jviromet.2013.07.02123886561 22.BommakantiG.CitronM.P.HeplerR.W.CallahanC.HeideckerG.J.NajarT.A.LuX.JoyceJ.G.ShiverJ.W.CasimiroD.R.et al.Design of an HA2-based Escherichia coli expressed" exact="influenza" post="immunogen that protects mice from pathogenic challengeProc. Natl. Acad."/>
   <result pre="coronavirus: A comprehensive reviewFront. Med.20161012013610.1007/s11684-016-0430-626791756 32.MostafaA.KanraiP.ZiebuhrJ.PleschkaS.The PB1 segment of an" exact="influenza" post="A virus H1N1 2009pdm isolate enhances the replication efficiency"/>
   <result pre="virus H1N1 2009pdm isolate enhances the replication efficiency of specific" exact="influenza" post="vaccine strains in cell culture and embryonated eggsJ. Gen."/>
   <result pre="the conserved hemagglutinin stalk domain and its prospects for universal" exact="influenza" post="vaccine developmentBiomed. Res. Int.201410.1155/2014/546274 34.LynchM.Evolution of the mutation rateTrends"/>
   <result pre="using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria" exact="meningitis" post="BImmunobiology201810.1016/j.imbio.2018.07.02130055864 40.PerssonG.PorsS.E.ThofnerI.C.N.BojesenA.M.Vaccination with outer membrane vesicles and the fimbrial"/>
   <result pre="Immunology20189250110.3389/fimmu.2018.0250130459769 50.RappazzoC.G.WatkinsH.C.GuarinoC.M.ChauA.LopezJ.L.DeLisaM.P.LeiferC.A.WhittakerG.R.PutnamD.Recombinant m2e outer membrane vesicle vaccines protect against lethal" exact="influenza" post="a challenge in balb/c miceVaccine2016341252125810.1016/j.vaccine.2016.01.02826827663 51.WatkinsH.C.RappazzoC.G.HigginsJ.S.SunX.BrockN.ChauA.MisraA.CannizzoJ.P.B.KingM.R.MainesT.R.et al.Safe Recombinant Outer"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6632129\results\search\disease\results.xml">
   <result pre="1392 confirmed cases [3] (https://dass.gouv.nc/votre-sante/documents-rapports-etudes) (Figure 1B). Despite repeated introductions," exact="chikungunya" post="virus (CHIKV) has not caused major outbreaks in NC,"/>
   <result pre="no conflict of interest. References References 1.RothA.MercierA.LepersC.Concurrent outbreaks of dengue," exact="chikungunya" post="and zika virus infections—An unprecedented epidemic wave of mosquito-borne"/>
   <result pre="vectorsPLoS Negl. Trop. Dis.201812e000663710.1371/journal.pntd.000663730016372 8.TeurlaiM.MenkesC.E.CavareroV.Socio-economic and climate factors associated with" exact="dengue fever" post="spatial heterogeneity: A worked example in New CaledoniaPLoS Negl."/>
   <result pre="1000 inhabitants per month are indicated for dengue, Zika and" exact="chikungunya" post="(http://www.institutpasteur.nc/wp-content/uploads/2016/12/)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6635310\results\search\disease\results.xml">
   <result pre="viral diseases specially water born infections, such as diarrheal diseases," exact="hepatitis" post="A and E, air-borne infections and vector borne diseases"/>
   <result pre="and E, air-borne infections and vector borne diseases such as" exact="yellow fever," post="west Nile fever (WNF) and dengue fever (5, 6)."/>
   <result pre="diseases such as yellow fever, west Nile fever (WNF) and" exact="dengue fever" post="(5, 6). This review explains the viral infections during"/>
   <result pre="and history of viruses’ circulation. In early spring in Iran," exact="influenza" post="viruses and respiratory syncytial virus circulations were reported in"/>
   <result pre="sewage systems, poor hygiene, overcrowding and unhealthy drinking water, viral" exact="gastroenteritis" post="may occur. After hurricane Katrina, outbreaks of norovirus gastroenteritis"/>
   <result pre="viral gastroenteritis may occur. After hurricane Katrina, outbreaks of norovirus" exact="gastroenteritis" post="were reported (12). There was an outbreak of norovirus"/>
   <result pre="water or food, is the main route for transmission of" exact="hepatitis" post="A and E, as reported in India and Sudan"/>
   <result pre="(16, 17). Shears et al. reported the increased number of" exact="hepatitis" post="A infections after Khartoum floods in 1988 (18). In"/>
   <result pre="Khartoum floods in 1988 (18). In Italy the number of" exact="hepatitis" post="A cases was increased in Liguria, Piemonte and Lombardia"/>
   <result pre="with non-affected counties (20). There was not any report of" exact="gastrointestinal disease" post="outbreak after different floods in Iran, but in general"/>
   <result pre="after different floods in Iran, but in general outbreaks of" exact="hepatitis" post="A and E and enteroviruses might happen in areas"/>
   <result pre="Mosquito borne diseases. After flooding, mosquito borne diseases for example" exact="dengue fever," post="especially in endemic areas, can increase. Standing water after"/>
   <result pre="In the flooding in northern Peru in 2017, outbreaks of" exact="chikungunya" post="and dengue fever with more than 19000 suspected cases"/>
   <result pre="flooding in northern Peru in 2017, outbreaks of chikungunya and" exact="dengue fever" post="with more than 19000 suspected cases of dengue fever"/>
   <result pre="and dengue fever with more than 19000 suspected cases of" exact="dengue fever" post="were reported (21). Outbreaks of WNF after flooding occurred"/>
   <result pre="flood in Punjab/Pakistan in 2010, 21204 people were reported with" exact="dengue fever" post="(23, 24). Again in 2011–2013 dengue infections were reported"/>
   <result pre="in Karachi, 700, 858, 630 and 2700 deaths related to" exact="dengue fever" post="were identified in 2010, 2011, 2012 and 2013 respectively"/>
   <result pre="Iran (37). The species A. albopictus is well-known for transmitting" exact="chikungunya" post="and dengue viruses. In another research, Aedes unilineatus was"/>
   <result pre="[Online] Available from: http://www.who.int/hac/crises/pak/sitreps/16august2010/en/index.html 9.JavidNMoradiATabarraeiABazouriMasoudClinical and epidemiological profile of pandemic" exact="influenza" post="a H1N1, H3N2, and type B in the southeast"/>
   <result pre="Iran. Arch Pediatr Infect Dis2013; 1:118–121. 11.HajikhezriZMakvndiMSamarbaf-zadehARNeisiNAhmadiK.Relative frequency of seasonal" exact="influenza" post="A and B in Khuzestan province by reverse transcription-polymerase"/>
   <result pre="1998, and 2004. Am J Trop Med Hyg2006; 74:1067–1073.16760521 16.McCarthyMCHeJHyamsKCel-TiganiAKhalidIOCarlM.Acute" exact="hepatitis" post="E infection during the 1988 floods in Khartoum, Sudan."/>
   <result pre="Trans R Soc Trop Med Hyg1994; 88:177.8036664 17.PalSJuyalDSharmaMKotianSNegiVSharmaN.An outbreak of" exact="hepatitis" post="A virus among children in a flood rescue camp:"/>
   <result pre="35:677–680.16248864 33.SharififardMAlaviSMSalmanzadehSSafdariFKamaliA.Epidemiological survey of crimean-Congo Hemorrhagic fever (CCHF), a fatal" exact="infectious disease" post="in Khuzestan province, southwest Iran, during 1999–2015. Jundishapur J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6641468\results\search\disease\results.xml">
   <result pre=": Mathematics : Statistics : Statistical Methods: Forecasting Seasonality of" exact="influenza" post="and its association with meteorological parameters in two cities"/>
   <result pre="two cities of Pakistan: A time series analysis Association of" exact="influenza" post="seasonality with meteorological parameters http://orcid.org/0000-0002-4107-6154NisarNadiaConceptualizationData curationFormal analysisInvestigationMethodologySoftwareValidationVisualizationWriting – original"/>
   <result pre="which are yet to be fully ascertained. Temperate zones show" exact="influenza" post="epidemic during the winter months. The tropical and subtropical"/>
   <result pre="winter months. The tropical and subtropical regions show more diverse" exact="influenza" post="outbreak patterns. This study explores the seasonality of influenza"/>
   <result pre="diverse influenza outbreak patterns. This study explores the seasonality of" exact="influenza" post="activity and predicts influenza peak based on historical surveillance"/>
   <result pre="This study explores the seasonality of influenza activity and predicts" exact="influenza" post="peak based on historical surveillance time series data in"/>
   <result pre="Methods This is a descriptive study of routinely collected monthly" exact="influenza" post="sentinel surveillance data and meteorological data from 2012–16 in"/>
   <result pre="(North) and Multan (Central). Results Mean number of cases of" exact="influenza" post="and levels of precipitation were higher in Islamabad compared"/>
   <result pre="levels were similar in both the cities. The number of" exact="influenza" post="cases rose with decrease in precipitation and temperature in"/>
   <result pre="be said about humidity. The relationship between meteorological parameters and" exact="influenza" post="incidence was not pronounced in case of Multan. The"/>
   <result pre="a significant peak during the month of January. Conclusion The" exact="influenza" post="surveillance system gave a better understanding of the disease"/>
   <result pre="better understanding of the disease trend and could accurately forecast" exact="influenza" post="activity in Pakistan. Funding http://dx.doi.org/10.13039/100000030Centers for Disease Control and"/>
   <result pre="paper and Supporting Information files. Introduction Influenza is a communicable" exact="respiratory disease" post="caused by the influenza virus. The disease severity may"/>
   <result pre="Introduction Influenza is a communicable respiratory disease caused by the" exact="influenza" post="virus. The disease severity may range from mild to"/>
   <result pre="illness and 290,000–650,000 deaths worldwide in 2017 due to seasonal" exact="influenza" post="epidemics [1]. Influenza is known to have a specific"/>
   <result pre="be fully ascertained [2]. Studies report that temperate zones show" exact="influenza" post="epidemic during the winter months of November-March in northern"/>
   <result pre="hemisphere [3,4]. The tropical and subtropical regions show more diverse" exact="influenza" post="outbreak patterns. Annual epidemics occur in the tropical locations"/>
   <result pre="while biannual incidence is the norm in some regions, and" exact="influenza" post="activity occurs throughout the year in other countries [3]."/>
   <result pre="countries [3]. There is limited understanding about the epidemiology of" exact="influenza" post="and the characteristics of seasonal influenza in the tropical"/>
   <result pre="about the epidemiology of influenza and the characteristics of seasonal" exact="influenza" post="in the tropical region where there is influenza activity"/>
   <result pre="of seasonal influenza in the tropical region where there is" exact="influenza" post="activity all throughout the year.[5,6] A number of theories"/>
   <result pre="this [8]. In tropical and subtropical regions the upsurge of" exact="influenza" post="has been coupled with precipitation (rain). Epidemics also occur"/>
   <result pre="sub-tropical and tropical regions no significant relation between rainfall and" exact="influenza" post="activity has been observed [9]. There are three mediating"/>
   <result pre="There are three mediating mechanisms that might help in explaining" exact="influenza" post="activity and epidemics: 1) Contact rate, 2) Viral survival"/>
   <result pre="is possible that the seasonal factors that govern activity of" exact="influenza" post="virus in temperate zones do not impact influenza virus"/>
   <result pre="activity of influenza virus in temperate zones do not impact" exact="influenza" post="virus very strongly in the tropics. [3] Pakistan is"/>
   <result pre="in the southern region. The country had a robust laboratory-based" exact="influenza" post="sentinel surveillance system in eight sites from 2009–2016. This"/>
   <result pre="the relationship between meteorological parameters (humidity, precipitation and temperature) and" exact="influenza" post="activity in two major cities of Pakistan, Islamabad and"/>
   <result pre="pandemic period. We also sought to explore the seasonality of" exact="influenza" post="activity and predict influenza peak based on historical surveillance"/>
   <result pre="sought to explore the seasonality of influenza activity and predict" exact="influenza" post="peak based on historical surveillance time series data. Materials"/>
   <result pre="design This is a descriptive study of routinely collected monthly" exact="influenza" post="sentinel surveillance and meteorological data from 2012–16 in two"/>
   <result pre="scanty rainfall. Influenza surveillance system In 2008, a sentinel laboratory-based" exact="influenza" post="surveillance network was established in collaboration with the US-Centers"/>
   <result pre="the first sentinel site under the network [16]. Seven more" exact="influenza" post="surveillance sentinel sites in high load tertiary hospitals across"/>
   <result pre="of onset and requiring hospital admission[17]. Study variables Data on" exact="influenza" post="cases and positivity were obtained from the surveillance database"/>
   <result pre="the surveillance database during 2012–16. Surveillance data during the pandemic" exact="influenza" post="seasons (2009–2011) were excluded to understand the characteristics of"/>
   <result pre="seasons (2009–2011) were excluded to understand the characteristics of seasonal" exact="influenza" post="only. Monthly data on three weather parameters namely temperature,"/>
   <result pre="to present the monthly trend in the number of confirmed" exact="influenza" post="cases and its relationship with other meteorological parameters for"/>
   <result pre="the strength and direction of association between meteorological parameters and" exact="influenza" post="cases and test positivity at monthly intervals. Fitting a"/>
   <result pre="smoothing models to describe autocorrelations in the data and forecast" exact="influenza" post="activity for the next 12 months [18]. Expert modeler"/>
   <result pre="of the meteorological parameters (precipitation, humidity and temperature) and the" exact="influenza" post="activity in Islamabad and Multan. The mean number of"/>
   <result pre="in Islamabad and Multan. The mean number of cases of" exact="influenza" post="and levels of precipitation were much higher in Islamabad"/>
   <result pre="1 Meteorological parameters (humidity, precipitation and temperature) and number of" exact="influenza" post="cases in two cities of Pakistan, 2012–16. Characteristics Mean"/>
   <result pre="19 24 50 Fig 1 shows that the number of" exact="influenza" post="cases rose with decrease in precipitation and temperature in"/>
   <result pre="be said about humidity. The relationship between meteorological parameters and" exact="influenza" post="incidence was not pronounced in case of Multan (Fig"/>
   <result pre="of Multan (Fig 2). Fig 1 Precipitation, humidity, temperature and" exact="influenza" post="cases in Islamabad during 2012–16. Fig 2 Precipitation, humidity,"/>
   <result pre="in Islamabad during 2012–16. Fig 2 Precipitation, humidity, temperature and" exact="influenza" post="cases in Multan during 2012–16. Overall, temperature (r ="/>
   <result pre="However, no significant correlation was found between meteorological parameters and" exact="influenza" post="cases in Multan. (Table 2). 10.1371/journal.pone.0219376.t002Table 2 Correlation of"/>
   <result pre="Multan. (Table 2). 10.1371/journal.pone.0219376.t002Table 2 Correlation of meteorological parameters with" exact="influenza" post="test positivity and number of cases of influenza in"/>
   <result pre="parameters with influenza test positivity and number of cases of" exact="influenza" post="in two cities of Pakistan, 2012–16. Overall (n ="/>
   <result pre="Fig 3 also shows the relationship between meteorological parameters and" exact="influenza" post="cases in each month. An increase in cases of"/>
   <result pre="influenza cases in each month. An increase in cases of" exact="influenza" post="is seen with a fall in temperature and precipitation."/>
   <result pre="3 Association of precipitation, humidity and temperature with number of" exact="influenza" post="cases in Islamabad and Multan during 2012–16. Exponential smoothing"/>
   <result pre="of Multan whereas simple seasonal model fitted well with the" exact="influenza" post="surveillance data for Islamabad. The Ljung-Box (modified Box-Pierce) test"/>
   <result pre="outliers in the data.(Table 3). 10.1371/journal.pone.0219376.t003Table 3 Model statistics for" exact="influenza" post="surveillance data in two cities of Pakistan, 2012–16. Model"/>
   <result pre="15 0.960 Winter’s additive Fig 4 shows the trend of" exact="influenza" post="cases during the period 2012–16 in Islamabad. It shows"/>
   <result pre="peaks during the months of July-September. Fig 4 Forecasting of" exact="influenza" post="in Islamabad using exponential smoothing model. The blue line"/>
   <result pre="smoothing model. The blue line represents the observed values of" exact="influenza" post="incidence from 2012 to 2016, and the red line"/>
   <result pre="curve of 2017. Fig 5 shows the seasonal trend of" exact="influenza" post="cases during 2012–16 in Multan showing regular seasonal peaks"/>
   <result pre="seen in both the sequence charts. Fig 5 Forecasting of" exact="influenza" post="in Multan using exponential smoothing model. The blue line"/>
   <result pre="smoothing model. The blue line represents the observed values of" exact="influenza" post="incidence from 2012 to 2016, and the red line"/>
   <result pre="47%). The socio-demographic and clinical details of patients tested for" exact="influenza" post="are given in Table 4. 10.1371/journal.pone.0219376.t004Table 4 Socio-demographic and"/>
   <result pre="10.1371/journal.pone.0219376.t004Table 4 Socio-demographic and clinical characteristics of patients tested for" exact="influenza" post="in two cities of Pakistan, 2012–16. Characteristics Islamabad Multan"/>
   <result pre="Severe Acute Respiratory Illness Of those tested, 1101 cases of" exact="influenza" post="were reported from Islamabad (n = 961) and Multan"/>
   <result pre="was the predominant strain (41.9%, n = 403) followed by" exact="influenza" post="A/H3N2 (273, 28%) in Islamabad. Multan also followed the"/>
   <result pre="and reported highest number of A/H1N1pdm09 (60, 44%) followed by" exact="influenza" post="B (28, 20%) (Table 5). 10.1371/journal.pone.0219376.t005Table 5 Socio-demographic and"/>
   <result pre="(Table 5). 10.1371/journal.pone.0219376.t005Table 5 Socio-demographic and clinical characteristics of confirmed" exact="influenza" post="cases in two cities of Pakistan, 2012–16. Characteristics Islamabad"/>
   <result pre="Acute Respiratory Illness Fig 6 shows that the cases of" exact="influenza" post="peaked during the months of December, January and February"/>
   <result pre="and October in 2012. Fig 6 Weekly incidence curve of" exact="influenza" post="in two cities of Pakistan, 2012–16. Discussion This study"/>
   <result pre="Discussion This study highlights the relationship between meteorological parameters and" exact="influenza" post="activity in two major cities of Pakistan in the"/>
   <result pre="of Pakistan in the post-2011 pandemic period and also predicts" exact="influenza" post="activity based on historical surveillance time series data. Time"/>
   <result pre="system. This study used the exponential smoothing model to forecast" exact="influenza" post="incidence, contributing to an early warning system that can"/>
   <result pre="public awareness, and tackle the situation effectively. The association between" exact="influenza" post="activity and climatic factors was assessed for 78 geographical"/>
   <result pre="for 78 geographical locations around the globe. At high latitudes," exact="influenza" post="peaks coincided with months of lower temperature and lower"/>
   <result pre="with months of lower temperature and lower humidity.In contrast, peak" exact="influenza" post="activity in localities within 10° of the equator correlated"/>
   <result pre="of this study[20–23]. The study had some interesting findings. First," exact="influenza" post="activity, in terms of number of cases and test"/>
   <result pre="elsewhere, no significant correlation was found between humidity levels and" exact="influenza" post="activity [26]. However, amulti-site influenza study from India reported"/>
   <result pre="found between humidity levels and influenza activity [26]. However, amulti-site" exact="influenza" post="study from India reported a positive correlation between relative"/>
   <result pre="from India reported a positive correlation between relative humidity and" exact="influenza" post="positive cases by multivariate analysis[27]. Another study from Thailand"/>
   <result pre="Thailand showed that only maximum relative humidity correlated with suspected" exact="influenza" post="cases in the southern region, whereas all parameters including"/>
   <result pre="including maximum, minimum, and average relative humidity correlated with suspected" exact="influenza" post="cases in the central region[28]. Third, the study forecasted"/>
   <result pre="effectively. The study has some significant strong points. First, the" exact="influenza" post="surveillance data were part of a US-CDC supported laboratory"/>
   <result pre="the country with high patient influx. Confirmation of diagnosis of" exact="influenza" post="was done using real time RT-PCR which is the"/>
   <result pre="the gold standard test. Second, five-year historical data (2008–17) on" exact="influenza" post="surveillance in two major cities of the country allows"/>
   <result pre="study had some limitations as well. First, the cases of" exact="influenza" post="presented in this study were reported from hospital-based sentinel"/>
   <result pre="time. This might be explained by antigenic drift of the" exact="influenza" post="virus and many unknown factors that affect disease transmission."/>
   <result pre="Third, we could only infer associations, but not causality, between" exact="influenza" post="activity and various meteorological parameters. As a result, the"/>
   <result pre="factors not considered in this study. Conclusion In conclusion, the" exact="influenza" post="surveillance system gave a better understanding of the disease"/>
   <result pre="better understanding of the disease trend and could accurately forecast" exact="influenza" post="activity in Pakistan. Exponential smoothing model was the best"/>
   <result pre="smoothing model was the best fit statistical model for predicting" exact="influenza" post="cases. This information will be useful for public health"/>
   <result pre="in effectively implementing preventive and control measures for the seasonal" exact="influenza" post="outbreaks or epidemics. Supporting information S1 File Climate SPSS"/>
   <result pre="Available: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) 2FoxSJ, MillerJC, MeyersLA. Seasonality in risk of pandemic" exact="influenza" post="emergence. 2017; 10.1371/journal.pcbi.1005749 3LowenAC, SteelJ. Roles of Humidity and"/>
   <result pre="2014;88: 7692–7695. 10.1128/JVI.03544-1324789791 4TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ. Global" exact="influenza" post="seasonality: Reconciling patterns across temperate and tropical regions. Environ"/>
   <result pre="439–445. 10.1289/ehp.100238321097384 5CainiS, El-Guerche SéblainC, CiblakMA, PagetJ. Epidemiology of seasonal" exact="influenza" post="in the Middle East and North Africa regions, 2010–2016:"/>
   <result pre="in the Middle East and North Africa regions, 2010–2016: Circulating" exact="influenza" post="A and B viruses and spatial timing of epidemics."/>
   <result pre="et al.Decline in temperature and humidity increases the occurrence of" exact="influenza" post="in cold climate. Environ Heal. BioMed Central; 2014;13: 2210.1186/1476-069X-13-2224678699"/>
   <result pre="KatayamaK, SanoK. Absolute humidity as a deterministic factor affecting seasonal" exact="influenza" post="epidemics in Japan. Tohoku J Exp Med. 2011;224: 251–6."/>
   <result pre="251–6. Available: http://www.ncbi.nlm.nih.gov/pubmed/2170585021705850 21TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ. Global" exact="influenza" post="seasonality: Reconciling patterns across temperate and tropical regions. Environmental"/>
   <result pre="Shaping Influenza Seasonality. 2014;88: 1410.1128/JVI.03544-1324789791 24ShamanJ, KohnM. Absolute humidity modulates" exact="influenza" post="survival, transmission, and seasonality. 2009;106. 25LowenAC, SteelJ, MubarekaS, PaleseP."/>
   <result pre="27JalgaonkarS V., KantL, ChadhaMS, MishraAC, BroorS, AbrahamAM, et al.Multisite virological" exact="influenza" post="surveillance in India: 2004–2008. Influenza Other Respi Viruses. 2011;6:"/>
   <result pre="Limited; 2015;2015: 43649510.1155/2015/43649526664492 29ChanPKS, MokHY, LeeTC, ChuIMT, LamW-Y, SungJJY. Seasonal" exact="influenza" post="activity in Hong Kong and its association with meteorological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6642581\results\search\disease\results.xml">
   <result pre="critical extracellular matrix. Approximately 30–40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be &amp;lt; 5 years old, &amp;gt; 65 years old,"/>
   <result pre="old, Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking, and are immunocompromised. Influenza can"/>
   <result pre="to bacterial sepsis and ARDS. Viral infections presenting concurrently with" exact="bacterial pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial" exact="pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="(ICU) admission. Influenza A is the predominant viral etiology of" exact="acute respiratory distress syndrome" post="(ARDS) in adults. Risk factors independently associated with ARDS"/>
   <result pre="old, pregnancy, and obesity, while protective factors are female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="B viruses. In the ICU, particularly during the winter season," exact="influenza" post="should be suspected not only in patients with typical"/>
   <result pre="Influenza Epidemiology Pneumonia Sepsis ARDS Complications Background The pathophysiology of" exact="influenza" post="virus infection Human influenza virus infection replicates primarily in"/>
   <result pre="ARDS Complications Background The pathophysiology of influenza virus infection Human" exact="influenza" post="virus infection replicates primarily in the respiratory epithelium. Other"/>
   <result pre="The ferret has traditionally been used as a model of" exact="influenza" post="transmission as most human influenza viruses do not need"/>
   <result pre="used as a model of influenza transmission as most human" exact="influenza" post="viruses do not need any adaptation to infect and"/>
   <result pre="have identified the soft palate as a major source of" exact="influenza" post="viruses that are transmitted between individuals. Notably, the soft"/>
   <result pre="preferred by the hemagglutinin proteins currently found in circulating human" exact="influenza" post="viruses [2]. This enrichment also occurs in the soft"/>
   <result pre="the soft palate of humans [3]. The primary mechanism of" exact="influenza" post="pathophysiology is a result of lung inflammation and compromise"/>
   <result pre="respiratory distress [4]. Some associations have also been observed between" exact="influenza" post="virus infection and cardiac sequelae, including increased risk of"/>
   <result pre="including increased risk of myocardial disease in the weeks following" exact="influenza" post="virus infection. The mechanisms of this, beyond a general"/>
   <result pre="Amplification of inflammation and local and systemic cytokine production How" exact="influenza" post="triggers ARDS Influenza virus infects respiratory epithelial cells that"/>
   <result pre="and allowing viral exposure to endothelial cells. Early interactions between" exact="influenza" post="virus, the alveolar macrophages that are resident in the"/>
   <result pre="damage and improved survival in a mouse model of severe" exact="influenza" post="virus infection and in a model of influenza-pneumococcal coinfection"/>
   <result pre="targeting NLRP3 (a key component of inflammasome signaling) downstream of" exact="influenza" post="has had positive effects on recovery in animal models"/>
   <result pre="NET structures have been observed in humans suffering from severe" exact="influenza" post="disease. In one study of severe H7N9 and H1N1pdm09"/>
   <result pre="promote recovery implicates host metabolism in the etiology of severe" exact="influenza" post="disease, given the central role mTOR plays in nutrient"/>
   <result pre="noted in local and systemic analyses of severe cases of" exact="influenza" post="[25] and metabolic interventions have been shown to alter"/>
   <result pre="context. For example, in mouse models of bacterial sepsis or" exact="influenza" post="virus infection, glucose restriction had opposing effects, protecting against"/>
   <result pre="immunity and potentially increased viral pathogenesis. The mechanisms relating to" exact="obesity" post="to susceptibility are likely complex and multi-factorial, including increased"/>
   <result pre="increased inflammation and decreased wound healing in obese individuals. Additionally," exact="obesity" post="dampens some features of adaptive immunity that may delay"/>
   <result pre="increase susceptibility to initial infection [29–31]. Influenza clinical progression to" exact="pneumonia" post="and ARDS Approximately 30–40% of the hospitalized patients with"/>
   <result pre="and ARDS Approximately 30–40% of the hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be young (&amp;lt; 5 years old), old"/>
   <result pre="old), Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking; and are more commonly immunocompromised."/>
   <result pre="develop severe Influenza complications [32–35]. Nonetheless, unlike seasonal epidemics of" exact="influenza" post="virus infection that display these classic risk factors, pandemics"/>
   <result pre="2009 H1N1 were associated with a higher rate of hospitalized" exact="respiratory failure" post="in previously healthy and young adults [36, 37]. More"/>
   <result pre="risk factors independently associated with ARDS in patients diagnosed with" exact="influenza" post="are age between 36 and 55 years old, pregnancy, and"/>
   <result pre="obesity, while protective factors associated with ARDS were female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="new risk factor for the development of ARDS during the" exact="influenza" post="season is the performance of cardiac surgery [43]. The"/>
   <result pre="the performance of cardiac surgery [43]. The challenge of diagnosing" exact="pneumonia" post="and ARDS in patients with positive laboratory results for"/>
   <result pre="pneumonia and ARDS in patients with positive laboratory results for" exact="influenza" post="relates to the temporality of the clinical events. Influenza"/>
   <result pre="the clinical events. Influenza virus infection alone can cause severe" exact="pneumonia" post="and ARDS, but it can also act in conjunction"/>
   <result pre="with a bacterial infection (discussed below). It can precede a" exact="pneumonia" post="episode caused by a secondary bacterial infection, most commonly"/>
   <result pre="pneumoniae, or can be followed by an episode of nosocomial" exact="pneumonia" post="[44]. Clinicians commonly fail to clinically diagnose influenza in"/>
   <result pre="of nosocomial pneumonia [44]. Clinicians commonly fail to clinically diagnose" exact="influenza" post="in up to two-thirds of patients whom have confirmed"/>
   <result pre="influenza in up to two-thirds of patients whom have confirmed" exact="influenza" post="virus infection [45]. In the case of severe pneumonia"/>
   <result pre="confirmed influenza virus infection [45]. In the case of severe" exact="pneumonia" post="or ARDS, the only reliable clue that influenza is"/>
   <result pre="of severe pneumonia or ARDS, the only reliable clue that" exact="influenza" post="is a possible causal agent is the presentation during"/>
   <result pre="of the epidemic because the symptomatology alone cannot distinguish severe" exact="influenza" post="from other viral or bacterial respiratory infections. Primary influenza"/>
   <result pre="severe influenza from other viral or bacterial respiratory infections. Primary" exact="influenza" post="pneumonia shows persistence and/or subsequent worsening of respiratory symptoms,"/>
   <result pre="influenza from other viral or bacterial respiratory infections. Primary influenza" exact="pneumonia" post="shows persistence and/or subsequent worsening of respiratory symptoms, while"/>
   <result pre="shows persistence and/or subsequent worsening of respiratory symptoms, while secondary" exact="bacterial pneumonia" post="occurs 1–3 weeks as a &quot;relapse�? after the initial Influenza"/>
   <result pre="persistence and/or subsequent worsening of respiratory symptoms, while secondary bacterial" exact="pneumonia" post="occurs 1–3 weeks as a &quot;relapse�? after the initial Influenza"/>
   <result pre="etiology [46]. Influenza presenting as sepsis The immune response to" exact="influenza" post="shares many common pathways with the response to bacteria,"/>
   <result pre="to bacteria, thus it should not be surprising that an" exact="influenza" post="virus infection can have a very similar clinical presentation"/>
   <result pre="receptors for Gram-positive and Gram-negative bacteria, are also related to" exact="influenza" post="pathogenicity [49–51]. The inflammatory response also varies according to"/>
   <result pre="to tissue edema and organ failure have been observed with" exact="influenza" post="virus infections [55, 56]. Analogous to the influenza virus"/>
   <result pre="observed with influenza virus infections [55, 56]. Analogous to the" exact="influenza" post="virus predisposition to secondary bacterial pneumonia, influenza virus increases"/>
   <result pre="[55, 56]. Analogous to the influenza virus predisposition to secondary" exact="bacterial pneumonia," post="influenza virus increases by 6-fold the progression to secondary"/>
   <result pre="Analogous to the influenza virus predisposition to secondary bacterial pneumonia," exact="influenza" post="virus increases by 6-fold the progression to secondary bacterial"/>
   <result pre="Asia found that 4% of all sepsis were caused by" exact="influenza" post="viruses [61]. In the recent 2017 winter season with"/>
   <result pre="than expected, which the authors attributed in part to the" exact="influenza" post="virus season [38]. Role of viral-bacterial co-infections and their"/>
   <result pre="for over a century, including the period of the 1918" exact="influenza" post="pandemic; however, until just a few years ago, the"/>
   <result pre="these viral-bacterial infections also affect 10–20% of patients with hospital-acquired" exact="pneumonia" post="(HAP) [44, 68–70]. In a large cohort study with"/>
   <result pre="The mechanism of increased susceptibility to bacterial co-infection after an" exact="influenza" post="virus infection has been a focus of many studies."/>
   <result pre="many studies. The lung immune environment is substantially altered after" exact="influenza" post="virus infection, with early depletion of alveolar macrophages [79]."/>
   <result pre="can allow a window of opportunity for bacteria [80]. Similarly," exact="influenza" post="virus infection induces systemic glucocorticoids that can dampen inflammation"/>
   <result pre="bacterial growth, as was shown in a mouse model of" exact="influenza" post="virus-Listeria co-infection [81]. Blocking the glucocorticoid response actually led"/>
   <result pre="actually led to death from the inflammation associated with the" exact="influenza" post="virus infection, demonstrating the balance between tolerance and pathogen"/>
   <result pre="host [81]. Other less common severe complications of Influenza Acute" exact="myositis" post="accompanied by rhabdomyolysis may rarely happen, most commonly in"/>
   <result pre="elevation of serum creatinine phosphokinase and myoglobinuria [82]. Myocarditis and" exact="pericarditis" post="have also been rarely described in clinical cases, but"/>
   <result pre="autopsy studies [83, 84]. Central nervous system complications associated with" exact="influenza" post="include encephalitis, acute disseminated encephalomyelitis, transverse myelitis, aseptic meningitis,"/>
   <result pre="84]. Central nervous system complications associated with influenza include encephalitis," exact="acute disseminated encephalomyelitis," post="transverse myelitis, aseptic meningitis, and Guillain-Barre syndrome [85–87] (Table"/>
   <result pre="associated with influenza include encephalitis, acute disseminated encephalomyelitis, transverse myelitis," exact="aseptic meningitis," post="and Guillain-Barre syndrome [85–87] (Table 2). Table 2 Severe"/>
   <result pre="meningitis, and Guillain-Barre syndrome [85–87] (Table 2). Table 2 Severe" exact="influenza" post="complications Severe influenza complications Influenza pneumonia Secondary bacterial pneumonia"/>
   <result pre="syndrome [85–87] (Table 2). Table 2 Severe influenza complications Severe" exact="influenza" post="complications Influenza pneumonia Secondary bacterial pneumonia ARDS Influenza sepsis"/>
   <result pre="2). Table 2 Severe influenza complications Severe influenza complications Influenza" exact="pneumonia" post="Secondary bacterial pneumonia ARDS Influenza sepsis Secondary bacterial sepsis"/>
   <result pre="2 Severe influenza complications Severe influenza complications Influenza pneumonia Secondary" exact="bacterial pneumonia" post="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis"/>
   <result pre="Severe influenza complications Severe influenza complications Influenza pneumonia Secondary bacterial" exact="pneumonia" post="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis"/>
   <result pre="ARDS Influenza sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis Acute" exact="myocarditis" post="Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis"/>
   <result pre="sepsis Secondary bacterial sepsis Myositis and rhabdomyolysis Acute myocarditis Acute" exact="pericarditis" post="Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis Aseptic meningitis"/>
   <result pre="bacterial sepsis Myositis and rhabdomyolysis Acute myocarditis Acute pericarditis Acute" exact="encephalitis" post="Acute disseminated encephalomyelitis Transverse myelitis Aseptic meningitis Guillain-Barre syndrome"/>
   <result pre="and rhabdomyolysis Acute myocarditis Acute pericarditis Acute encephalitis Acute disseminated" exact="encephalomyelitis" post="Transverse myelitis Aseptic meningitis Guillain-Barre syndrome Conclusions Influenza virus"/>
   <result pre="Acute myocarditis Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse" exact="myelitis" post="Aseptic meningitis Guillain-Barre syndrome Conclusions Influenza virus affects the"/>
   <result pre="Acute pericarditis Acute encephalitis Acute disseminated encephalomyelitis Transverse myelitis Aseptic" exact="meningitis" post="Guillain-Barre syndrome Conclusions Influenza virus affects the respiratory tract"/>
   <result pre="critical extracellular matrix. Approximately 30–40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. These patients who develop"/>
   <result pre="influenza are diagnosed with acute pneumonia. These patients who develop" exact="pneumonia" post="are more likely to be &amp;lt; 5 years old, &amp;gt; 65 years old,"/>
   <result pre="old, Caucasian, and nursing home residents; have chronic lung or" exact="heart disease" post="and history of smoking; and are immunocompromised. Influenza can"/>
   <result pre="to bacterial sepsis and ARDS. Viral infections presenting concurrently with" exact="bacterial pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="bacterial sepsis and ARDS. Viral infections presenting concurrently with bacterial" exact="pneumonia" post="are now known to occur with a frequency of"/>
   <result pre="admission. Influenza A virus is the predominant viral etiology of" exact="acute respiratory distress syndrome" post="(ARDS) in adults. Risk factors independently associated with ARDS"/>
   <result pre="old, pregnancy, and obesity, while protective factors are female sex," exact="influenza" post="vaccination, and infections with Influenza A (H3N2) or Influenza"/>
   <result pre="immune system response. Approximately 30–40% of hospitalized patients with laboratory-confirmed" exact="influenza" post="are diagnosed with acute pneumonia. Coinfections with other viruses"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="virusesNature.2015526757112212510.1038/nature1537926416728 3.NichollsJMBourneAJChenHGuanYPeirisJSSialic acid receptor detection in the human respiratory"/>
   <result pre="for widespread distribution of potential binding sites for human and" exact="avian influenza" post="virusesRespir Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients"/>
   <result pre="widespread distribution of potential binding sites for human and avian" exact="influenza" post="virusesRespir Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients"/>
   <result pre="Res200787310.1186/1465-9921-8-7317961210 4.ZangrilloABiondi-ZoccaiGLandoniGFratiGPatronitiNPesentiAet al.Extracorporeal membrane oxygenation (ECMO) in patients with H1N1" exact="influenza" post="infection: a systematic review and meta-analysis including 8 studies"/>
   <result pre="heart failure prognosis?Heart Fail Rev201722332933610.1007/s10741-017-9614-728508293 6.KwongJCSchwartzKLCampitelliMAAcute myocardial infarction after laboratory-confirmed" exact="influenza" post="infectionN Engl J Med2018378262540254129949484 7.SandersCJVogelPMcClarenJLBajracharyaRDohertyPCThomasPGCompromised respiratory function in lethal"/>
   <result pre="influenza infectionN Engl J Med2018378262540254129949484 7.SandersCJVogelPMcClarenJLBajracharyaRDohertyPCThomasPGCompromised respiratory function in lethal" exact="influenza" post="infection is characterized by the depletion of type I"/>
   <result pre="J Physiol Lung Cell Mol Physiol20133047L481L48810.1152/ajplung.00343.201223355384 8.CardaniABoultonAKimTSBracialeTJAlveolar macrophages prevent lethal" exact="influenza" post="pneumonia by inhibiting infection of type-1 alveolar epithelial cellsPLoS"/>
   <result pre="Physiol Lung Cell Mol Physiol20133047L481L48810.1152/ajplung.00343.201223355384 8.CardaniABoultonAKimTSBracialeTJAlveolar macrophages prevent lethal influenza" exact="pneumonia" post="by inhibiting infection of type-1 alveolar epithelial cellsPLoS Pathog2017131e100614010.1371/journal.ppat.100614028085958"/>
   <result pre="9.TeijaroJRWalshKBCahalanSFremgenDMRobertsEScottFet al.Endothelial cells are central orchestrators of cytokine amplification during" exact="influenza" post="virus infectionCell.2011146698099110.1016/j.cell.2011.08.01521925319 10.BoydDFThomasPGTowards integrating extracellular matrix and immunological pathwaysCytokine.201798798610.1016/j.cyto.2017.03.00428325629"/>
   <result pre="AR, et al. Matrix metalloproteinase-9 deficiency protects mice from severe" exact="influenza" post="A viral infection. JCI Insight. 2018;3(24). 10.1172/jci.insight.99022. 16.AllenICScullMAMooreCBHollEKMcElvania-TeKippeETaxmanDJet al.The"/>
   <result pre="16.AllenICScullMAMooreCBHollEKMcElvania-TeKippeETaxmanDJet al.The NLRP3 inflammasome mediates in vivo innate immunity to" exact="influenza" post="A virus through recognition of viral RNAImmunity.200930455656510.1016/j.immuni.2009.02.00519362020 17.ThomasPGDashPAldridgeJRJrEllebedyAHReynoldsCFunkAJet al.The"/>
   <result pre="intracellular sensor NLRP3 mediates key innate and healing responses to" exact="influenza" post="A virus via the regulation of caspase-1Immunity.200930456657510.1016/j.immuni.2009.02.00619362023 18.RenRWuSCaiJYangYRenXFengYet al.The"/>
   <result pre="A virus via the regulation of caspase-1Immunity.200930456657510.1016/j.immuni.2009.02.00619362023 18.RenRWuSCaiJYangYRenXFengYet al.The H7N9" exact="influenza" post="A virus infection results in lethal inflammation in the"/>
   <result pre="19.TateMDOngJDDowlingJKMcAuleyJLRobertsonABLatzEet al.Reassessing the role of the NLRP3 inflammasome during pathogenic" exact="influenza" post="A virus infection via temporal inhibitionSci Rep201662791210.1038/srep2791227283237 20.TavaresLPGarciaCCMachadoMGQueiroz-JuniorCMBarthelemyATrotteinFet al.CXCR1/2"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitisAm J Pathol2011179119921010.1016/j.ajpath.2011.03.01321703402 22.ZhuLLiuLZhangYPuLLiuJLiXet al.High level of neutrophil extracellular"/>
   <result pre="sirolimus, and steroids improves outcomes in patients with severe H1N1" exact="pneumonia" post="and acute respiratory failureCrit Care Med201442231332110.1097/CCM.0b013e3182a2727d24105455 25.SunXSongLFengSLiLYuHWangQet al.Fatty acid"/>
   <result pre="in bacterial and viral inflammationCell.201616661512152510.1016/j.cell.2016.07.02627610573 27.SmallwoodHSDuanSMorfouaceMRezinciucSShulkinBLShelatAet al.Targeting metabolic reprogramming by" exact="influenza" post="infection for therapeutic interventionCell Rep20171981640165310.1016/j.celrep.2017.04.03928538182 28.ThaiMThakerSKFengJDuYHuHTing WuTet al.MYC-induced reprogramming"/>
   <result pre="optimal virus replicationNat Commun20156887310.1038/ncomms987326561297 29.MaierHELopezRSanchezNNgSGreshLOjedaSet al.Obesity increases the duration of" exact="influenza" post="a virus shedding in adultsJ Infect Dis201821891378138210.1093/infdis/jiy37030085119 30.O'BrienKBVogelPDuanSGovorkovaEAWebbyRJMcCullersJAet al.Impaired"/>
   <result pre="Dis201821891378138210.1093/infdis/jiy37030085119 30.O'BrienKBVogelPDuanSGovorkovaEAWebbyRJMcCullersJAet al.Impaired wound healing predisposes obese mice to severe" exact="influenza" post="virus infectionJ Infect Dis2012205225226110.1093/infdis/jir72922147799 31.PaichHASheridanPAHandyJKarlssonEASchultz-CherrySHudgensMGet al.Overweight and obese adult"/>
   <result pre="humans have a defective cellular immune response to pandemic H1N1" exact="influenza" post="A virusObesity (Silver Spring)201321112377238610.1002/oby.2038323512822 32.CasalinoEAntoniolSFidouhNChoquetCLucetJCDuvalXet al.Influenza virus infections among"/>
   <result pre="cohort studyChest.2016149252653410.1378/chest.14-276826203671 34.GargSJainSDawoodFSJhungMPerezAD'MelloTet al.Pneumonia among adults hospitalized with laboratory-confirmed seasonal" exact="influenza" post="virus infection-United States, 2005-2008BMC Infect Dis20151536910.1186/s12879-015-1004-y26307108 35.UyekiTimothy MBernsteinHenry HBradleyJohn"/>
   <result pre="al.Factors associated with death or hospitalization due to pandemic 2009" exact="influenza" post="A(H1N1) infection in CaliforniaJAMA.2009302171896190210.1001/jama.2009.158319887665 37.collab: Writing Committee of the"/>
   <result pre="Writing Committee of the WHOCoCAoPIBautistaEChotpitayasunondhTGaoZHarperSAShawMet al.Clinical aspects of pandemic 2009" exact="influenza" post="A (H1N1) virus infectionN Engl J Med2010362181708171910.1056/NEJMra100044920445182 38.BurrellAHucksonSPilcherDVcollab: AnzicsICU"/>
   <result pre="infectionN Engl J Med2010362181708171910.1056/NEJMra100044920445182 38.BurrellAHucksonSPilcherDVcollab: AnzicsICU admissions for Sepsis or" exact="pneumonia" post="in Australia and New Zealand in 2017N Engl J"/>
   <result pre="New Zealand in 2017N Engl J Med2018378222138213910.1056/NEJMc171717829847767 39.IkeJDKempkerJAKramerMRMartinGSThe association between" exact="acute respiratory distress syndrome" post="hospital case volume and mortality in a U.S. cohort,"/>
   <result pre="2002-2011Crit Care Med201846576477310.1097/CCM.000000000000301529394181 40.SchoutenLRVeltkampFBosAPvan WoenselJBSerpa NetoASchultzMJet al.Incidence and mortality of" exact="acute respiratory distress syndrome" post="in children: a systematic review and meta-analysisCrit Care Med201644481982926509320"/>
   <result pre="H, Yann LS, Daniel L-B. Intensive care unit surveillance of" exact="influenza" post="infection in France: the 2009/10 pandemic and the three"/>
   <result pre="subsequent seasons. Euro Surveill. 2015;20(46). 42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with" exact="avian influenza" post="A (H7N9) and influenza a (H1N1) complicated by acute"/>
   <result pre="seasons. Euro Surveill. 2015;20(46). 42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with avian" exact="influenza" post="A (H7N9) and influenza a (H1N1) complicated by acute"/>
   <result pre="42.LiHWengHLanCZhangHWangXPanJet al.Comparison of patients with avian influenza A (H7N9) and" exact="influenza" post="a (H1N1) complicated by acute respiratory distress syndromeMedicine (Baltimore)20189712e019410.1097/MD.000000000001019429561442"/>
   <result pre="Med2018378877277310.1056/NEJMc171272729466160 44.ZhouFLiHGuLLiuMXueCXCaoBet al.Risk factors for nosocomial infection among hospitalised severe" exact="influenza" post="A(H1N1)pdm09 patientsRespir Med2018134869110.1016/j.rmed.2017.11.01729413513 45.DugasAFValsamakisAAtreyaMRThindKAlarcon ManchegoPFaisalAet al.Clinical diagnosis of influenza"/>
   <result pre="severe influenza A(H1N1)pdm09 patientsRespir Med2018134869110.1016/j.rmed.2017.11.01729413513 45.DugasAFValsamakisAAtreyaMRThindKAlarcon ManchegoPFaisalAet al.Clinical diagnosis of" exact="influenza" post="in the EDAm J Emerg Med201533677077510.1016/j.ajem.2015.03.00825827595 46.van AstenLLuna PinzonAde"/>
   <result pre="Emerg Med201533677077510.1016/j.ajem.2015.03.00825827595 46.van AstenLLuna PinzonAde LangeDWde JongeEDijkstraFMarbusSet al.Estimating severity of" exact="influenza" post="epidemics from severe acute respiratory infections (SARI) in intensive"/>
   <result pre="review of mechanisms and methodsAntivir Res201293121510.1016/j.antiviral.2011.10.01922068147 48.FlorescuDFKalilACThe complex link between" exact="influenza" post="and severe sepsisVirulence.20145113714210.4161/viru.2710324253109 49.ImaiYKubaKNeelyGGYaghubian-MalhamiRPerkmannTvan LooGet al.Identification of oxidative stress"/>
   <result pre="Immunol201031293910.1038/mi.2009.12019865078 51.ShireyKALaiWScottAJLipskyMMistryPPletnevaLMet al.The TLR4 antagonist Eritoran protects mice from lethal" exact="influenza" post="infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic avian influenza viruses inhibit effective immune"/>
   <result pre="antagonist Eritoran protects mice from lethal influenza infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic" exact="avian influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJ"/>
   <result pre="Eritoran protects mice from lethal influenza infectionNature.2013497745049850210.1038/nature1211823636320 52.FriesenhagenJBoergelingYHrinciusELudwigSRothJViemannDHighly pathogenic avian" exact="influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJ"/>
   <result pre="Biol2012921112010.1189/jlb.091147922442495 53.CheungCYPoonLLLauASLukWLauYLShortridgeKFet al.Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009" exact="influenza" post="virusesJ Gen Virol201192Pt 61428143410.1099/vir.0.030346-021367984 55.WangSLeTQKuriharaNChidaJCisseYYanoMet al.Influenza virus-cytokine-protease cycle in"/>
   <result pre="as a therapeutic target in severe influenzaAntivir Res201399211311810.1016/j.antiviral.2013.05.00323685311 57.JainSBenoitSRSkarbinskiJBramleyAMFinelliLPandemic InfluenzaAVHITInfluenza-associated" exact="pneumonia" post="among hospitalized patients with 2009 pandemic influenza A (H1N1)"/>
   <result pre="Res201399211311810.1016/j.antiviral.2013.05.00323685311 57.JainSBenoitSRSkarbinskiJBramleyAMFinelliLPandemic InfluenzaAVHITInfluenza-associated pneumonia among hospitalized patients with 2009 pandemic" exact="influenza" post="A (H1N1) virus--United States, 2009Clin Infect Dis20125491221122910.1093/cid/cis19722437239 58.KumarAZarychanskiRPintoRCookDJMarshallJLacroixJet al.Critically"/>
   <result pre="States, 2009Clin Infect Dis20125491221122910.1093/cid/cis19722437239 58.KumarAZarychanskiRPintoRCookDJMarshallJLacroixJet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) infection in CanadaJAMA.2009302171872187910.1001/jama.2009.149619822627 59.Dominguez-CheritGLapinskySEMaciasAEPintoREspinosa-PerezLde la TorreAet al.Critically ill"/>
   <result pre="in CanadaJAMA.2009302171872187910.1001/jama.2009.149619822627 59.Dominguez-CheritGLapinskySEMaciasAEPintoREspinosa-PerezLde la TorreAet al.Critically ill patients with 2009" exact="influenza" post="A(H1N1) in MexicoJAMA.2009302171880188710.1001/jama.2009.153619822626 60.FariasJAFernandezAMonteverdeEVidalNAriasPMontesMJet al.Critically ill infants and children"/>
   <result pre="A(H1N1) in MexicoJAMA.2009302171880188710.1001/jama.2009.153619822626 60.FariasJAFernandezAMonteverdeEVidalNAriasPMontesMJet al.Critically ill infants and children with" exact="influenza" post="A (H1N1) in pediatric intensive care units in ArgentinaIntensive"/>
   <result pre="Forum Infect Dis201632ofw07110.1093/ofid/ofw07127191004 68.LoubetPVoiriotGHouhou-FidouhNNeuvilleMBouadmaLLescureFXet al.Impact of respiratory viruses in hospital-acquired" exact="pneumonia" post="in the intensive care unit: a single-center retrospective studyJ"/>
   <result pre="influenzaIntensive Care Med2017431485810.1007/s00134-016-4578-y27709265 75.RandolphAGVaughnFSullivanRRubinsonLThompsonBTYoonGet al.Critically ill children during the 2009-2010" exact="influenza" post="pandemic in the United StatesPediatrics.20111286e1450e145810.1542/peds.2011-077422065262 76.RiceTWRubinsonLUyekiTMVaughnFLJohnBBMillerRR3rdet al.Critical illness from"/>
   <result pre="in the United StatesPediatrics.20111286e1450e145810.1542/peds.2011-077422065262 76.RiceTWRubinsonLUyekiTMVaughnFLJohnBBMillerRR3rdet al.Critical illness from 2009 pandemic" exact="influenza" post="A virus and bacterial coinfection in the United StatesCrit"/>
   <result pre="in the United StatesCrit Care Med20124051487149810.1097/CCM.0b013e3182416f2322511131 77.RozencwajgSBrechotNSchmidtMHekimianGLebretonGBessetSet al.Co-infection with influenza-associated" exact="acute respiratory distress syndrome" post="requiring extracorporeal membrane oxygenationInt J Antimicrob Agents201851342743310.1016/j.ijantimicag.2017.11.00529174419 78.RandolphAGXuRNovakTNewhamsMMBubeck WardenburgJWeissSLet"/>
   <result pre="influenza-related critical illnessClin Infect Dis201968336537210.1093/cid/ciy49529893805 79.GhoneimHEThomasPGMcCullersJADepletion of alveolar macrophages during" exact="influenza" post="infection facilitates bacterial superinfectionsJ Immunol201319131250125910.4049/jimmunol.130001423804714 80.GouldingJGodleeAVekariaSHiltyMSnelgroveRHussellTLowering the threshold of"/>
   <result pre="Microbe20107210311410.1016/j.chom.2010.01.01020159617 82.DellKMSchulmanSLRhabdomyolysis and acute renal failure in a child with" exact="influenza" post="a infectionPediatr Nephrol199711336336510.1007/s0046700502999203195 83.MamasMAFraserDNeysesLCardiovascular manifestations associated with influenza virus"/>
   <result pre="child with influenza a infectionPediatr Nephrol199711336336510.1007/s0046700502999203195 83.MamasMAFraserDNeysesLCardiovascular manifestations associated with" exact="influenza" post="virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and bacterial"/>
   <result pre="with influenza virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and" exact="bacterial pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
   <result pre="influenza virus infectionInt J Cardiol2008130330430910.1016/j.ijcard.2008.04.04418625525 84.PaddockCDLiuLDenisonAMBartlettJHHolmanRCDeleon-CarnesMet al.Myocardial injury and bacterial" exact="pneumonia" post="contribute to the pathogenesis of fatal influenza B virus"/>
   <result pre="injury and bacterial pneumonia contribute to the pathogenesis of fatal" exact="influenza" post="B virus infectionJ Infect Dis2012205689590510.1093/infdis/jir86122291193 85.GoenkaAMichaelBDLedgerEHartIJAbsoudMChowGet al.Neurological manifestations of"/>
   <result pre="influenza B virus infectionJ Infect Dis2012205689590510.1093/infdis/jir86122291193 85.GoenkaAMichaelBDLedgerEHartIJAbsoudMChowGet al.Neurological manifestations of" exact="influenza" post="infection in children and adults: results of a National"/>
   <result pre="Surveillance StudyClin Infect Dis201458677578410.1093/cid/cit92224352349 86.OkunoHYahataYTanaka-TayaKAraiSSatohHMorinoSet al.Characteristics and outcomes of Influenza-associated" exact="encephalopathy" post="cases among children and adults in Japan, 2010-2015Clin Infect"/>
   <result pre="burden of influenza: a review of the extra-pulmonary complications of" exact="influenza" post="infectionInfluenza Other Respir Viruses201711537239310.1111/irv.1247028745014"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6646355\results\search\disease\results.xml">
   <result pre="linked to several neurological disorders, such as Guillain-Barre Syndrome10,11 and" exact="microcephaly" post="in infants born to mothers who were infected with"/>
   <result pre="potential countermeasures, thereby helping to decrease the potentiality of this" exact="infectious disease" post="to become a pandemic. The primary objective of this"/>
   <result pre="suspected cases if they were presented to health practitioners with" exact="rash" post="and/or mild fever and at least two of the"/>
   <result pre="following characteristics: acute onset of generalized macular or papular rash," exact="arthritis" post="or arthralgia, or nonpurulent conjunctivitis. Out of the total"/>
   <result pre="19 (2014). 12.Schuler-FacciniLet al.Possible association between Zika virus infection and" exact="microcephaly" post="- Brazil, 2015MMWR Morb. Mortal. Wkly. Rep.201665596210.15585/mmwr.mm6503e226820244 13.MlakarJet al.Zika"/>
   <result pre="optimal control theory perspectivesJournal of Computational and Applied Mathematics201630714316110.1016/j.cam.2016.02.051 15.MutuaJMWangFBVaidyaNKModeling" exact="malaria" post="and typhoid fever co-infection dynamicsMath. Biosci.201526412814410.1016/j.mbs.2015.03.01425865934 16.Keeling, M. J."/>
   <result pre="theory perspectivesJournal of Computational and Applied Mathematics201630714316110.1016/j.cam.2016.02.051 15.MutuaJMWangFBVaidyaNKModeling malaria and" exact="typhoid fever" post="co-infection dynamicsMath. Biosci.201526412814410.1016/j.mbs.2015.03.01425865934 16.Keeling, M. J. &amp;amp; Rohani, P."/>
   <result pre="Oxford, 1992). 18.VaidyaNKet al.Modelling the epidemic spread of an H1N1" exact="influenza" post="outbreak in a rural university townEpidemiol. Infect.20151431610162010.1017/s095026881400256825323631 19.AkbariSVaidyaNKWahlLMThe time"/>
   <result pre="disease transmissionMath. Biosci.2002180294810.1016/S0025-5564(02)00108-612387915 32.ChitnisNHymanJMCushingJMDetermining important parameters in the spread of" exact="malaria" post="through the sensitivity analysis of a mathematical modelBull. Math."/>
   <result pre="and SIR models for dengue transmissionMath. Biosci.201310.1016/j.mbs.2013.10.00724427785 38.ManoreCAHickmannKSXuSWearingHJHymanJMComparing dengue and" exact="chikungunya" post="emergence and endemic transmission in A. aegypti and A."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6648004\results\search\disease\results.xml">
   <result pre="presents the most recent scientific evidence of kidney involvement in" exact="yellow fever," post="since AKI plays an important role in the mortality"/>
   <result pre="required to provide a better clinical control for patients with" exact="yellow fever." post="Yellow fever Acute kidney injury Epidemics Pathophysiology fig-count: table-count:"/>
   <result pre="virion production7 , 9 . A meticulous study of the" exact="yellow fever" post="virus genome is essential to establish genetic differences between"/>
   <result pre="of the mosquito since 1942. However, the enzootic cycle (sylvatic" exact="yellow fever" post="cycle involving non-human primates) occurs in the Amazon basin"/>
   <result pre="the last two years, there has been a recrudescence of" exact="yellow fever" post="(YF) in some countries in Africa and South America11"/>
   <result pre="rate, ranging from 25% to 50%13 - 15 . The" exact="yellow fever" post="virus is one of the most critical arboviruses. Annually,"/>
   <result pre="renal and myocardial lesions. In more severe cases, internal hemorrhage," exact="kidney failure," post="shock, coma or even death can occur11 . In"/>
   <result pre="this hypothesis. Currently, specific antiviral treatment is not available for" exact="yellow fever" post="(YF). Prevention and vaccination are the key control-factors in"/>
   <result pre="At the beginning of the 21th century, new cases of" exact="yellow fever" post="outside the rainforest environment have become a matter of"/>
   <result pre="have been reported. Since 2015, Brazil has faced significant sylvatic" exact="yellow fever" post="outbreaks in the four States of the Southeast region,"/>
   <result pre="more than 20 years20 . Furthermore, in 2016, an unconnected" exact="yellow fever" post="outbreak took place in Uganda (Africa), and some occasional"/>
   <result pre="on, and, more recently, Nigeria has been facing an active" exact="yellow fever" post="outbreak25 - 27 . Historical aspects and epidemiology There"/>
   <result pre="by an infected vector ( A. aegypti ), as the" exact="yellow fever" post="was very unusual on sailing ships3 , 28 ,"/>
   <result pre="some specific regions. Besides, the epizootic cycle may overlap sporadic" exact="yellow fever" post="outbreaks in non-immunized populations that live in or close"/>
   <result pre="Brazilian Ministry of Health and the WHO32 , 33 ," exact="yellow fever" post="is a seasonal disease that mostly occurs during the"/>
   <result pre="Figure 1 . Figure 1 Distribution of confirmed cases of" exact="yellow fever" post="in Brazil in the seasonal monitoring period. Adapted from"/>
   <result pre="Brazilian Ministry of Health published in February 2018 that 1,080" exact="yellow fever" post="cases were notified between July 2017 and January 2018,"/>
   <result pre="shown in Table 1 . Table 1 Distribution of reported" exact="yellow fever" post="cases in Brazil, from July the 1st 2017 to"/>
   <result pre="Saúde32. The Brazilian Amazon basin is an epidemic area for" exact="yellow fever." post="However, sporadic outbreaks may occur outside this region, as"/>
   <result pre="outside this region, as shown in 2016, when thousands of" exact="yellow fever" post="cases in humans were reported (more than 1,900) in"/>
   <result pre="1,900) in Southeastern Brazil10 . According to the revised 2010" exact="yellow fever" post="map, Brazil is one of the 11 South American"/>
   <result pre="can be infected, providing a new endemic area for sylvatic" exact="yellow fever." post="Therefore, the YFV moves forward through the forest areas,"/>
   <result pre="circulation34 , and the displacement of asymptomatic patients infected with" exact="yellow fever" post="virus has implications for the global dissemination of yellow"/>
   <result pre="yellow fever virus has implications for the global dissemination of" exact="yellow fever," post="it is imperative that travelers are vaccinated, due the"/>
   <result pre="imperative that travelers are vaccinated, due the high risk of" exact="yellow fever" post="transmission23 , 25 , 33 . Yellow fever was"/>
   <result pre="from the WHO25 , 33 , 34 reports, show the" exact="yellow fever" post="geographic distribution worldwide ( Figure 2 ). Figure 2"/>
   <result pre="( Figure 2 ). Figure 2 Areas at risk of" exact="yellow fever" post="transmission. Adapted from the World Health Organization34. Pathogenesis and"/>
   <result pre="urban vector. A. aegypti is responsible for the dissemination of" exact="yellow fever" post="in the urban environment. Therefore, the human-human transmission can"/>
   <result pre="clinical disease in humans is broad, and the severity of" exact="yellow fever" post="can cause symptoms ranging from inapparent infection to severe"/>
   <result pre="appear, and, according to Maciel et al .36 , disseminated" exact="mycosis" post="(severe infection in yellow fever patients) can mimic bacterial"/>
   <result pre="Maciel et al .36 , disseminated mycosis (severe infection in" exact="yellow fever" post="patients) can mimic bacterial sepsis. Diagnosis and diagnostic methods"/>
   <result pre="Diagnosis and diagnostic methods One of the greatest challenges in" exact="yellow fever" post="is the diagnosis of disease, because symptoms can be"/>
   <result pre="early stages of YF, the differential diagnosis is imperative, because" exact="yellow fever" post="can be easily mistaken for other hemorrhagic diseases, such"/>
   <result pre="be easily mistaken for other hemorrhagic diseases, such as leptospirosis," exact="dengue fever," post="malaria and viral hepatitis2 . Another important point is"/>
   <result pre="mistaken for other hemorrhagic diseases, such as leptospirosis, dengue fever," exact="malaria" post="and viral hepatitis2 . Another important point is that"/>
   <result pre="areas of other tropical diseases, such as zika, dengue and" exact="chikungunya" post="infections1 , 5 . Additionally, the quick identification of"/>
   <result pre="5 . Additionally, the quick identification of zika, dengue and" exact="chikungunya" post="viruses can indirectly help to control and prevent yellow"/>
   <result pre="and chikungunya viruses can indirectly help to control and prevent" exact="yellow fever," post="since the preventive measures to control the vector of"/>
   <result pre="POC can be a great monitoring and diagnostic tool for" exact="yellow fever" post="as well, because it can help to attain a"/>
   <result pre="outbreaks. Other hemorrhagic diseases that constitute the differential diagnosis of" exact="yellow fever" post="have been studied in search of bioactive molecules and"/>
   <result pre="and appear in inflammatory reactions, they are not specific for" exact="yellow fever." post="Attaining a correct diagnosis is essential, especially if there"/>
   <result pre="diagnosis is essential, especially if there are concomitant infections, because" exact="yellow fever" post="can quickly evolve to the severe forms of the"/>
   <result pre="disease or even death4 , 41 . Kidney injury in" exact="yellow fever" post="One of the targets for viral replication are kidney"/>
   <result pre="cylinders has some similarities with some classic histopathological findings of" exact="yellow fever" post="in humans30 . Maciel et al .36 described in"/>
   <result pre="the autopsy of patients affected by the severe form of" exact="yellow fever" post="virus infection, which was associated to disseminated mycoses. In"/>
   <result pre="according to the study by Maciel et al .36 ," exact="interstitial nephritis" post="was identified, associated with tubular necrosis and interlobular thrombosis"/>
   <result pre="to the study by Maciel et al .36 , interstitial" exact="nephritis" post="was identified, associated with tubular necrosis and interlobular thrombosis"/>
   <result pre="ischemic necrosis of the adrenal gland. The autopsy of another" exact="yellow fever" post="patient showed that there was preservation of the parenchymal"/>
   <result pre="face of the right kidney. The microscopic analysis revealed multiple" exact="interstitial nephritis" post="foci, combined with fibrosis and tubular necrosis. Thrombosis and"/>
   <result pre="of the right kidney. The microscopic analysis revealed multiple interstitial" exact="nephritis" post="foci, combined with fibrosis and tubular necrosis. Thrombosis and"/>
   <result pre="in the kidneys of animals that needed euthanasia. Surprisingly, the" exact="yellow fever" post="virus antigen was not detected in kidney tissues, which"/>
   <result pre="site. As discussed by Engelmann et al .42 , the" exact="yellow fever" post="disease follows the same pattern in monkeys as described"/>
   <result pre="even if the patient is normovolemic, which may evolve to" exact="anuria" post="and acute tubular necrosis (ATN). At this stage, there"/>
   <result pre="the patient is normovolemic, which may evolve to anuria and" exact="acute tubular necrosis" post="(ATN). At this stage, there is a high rate"/>
   <result pre="al .42 , these observations provide new information on the" exact="yellow fever" post="pathogenesis, suggesting that the kidney and the lymphoid tissue"/>
   <result pre="and chromium-EDTA45 , 46 , they are not helpful in" exact="yellow fever," post="because of the appalling disease severity and progression. According"/>
   <result pre="About 20 to 50% of death cases involving liver and" exact="kidney failure" post="due to YFV is a significant high rate that"/>
   <result pre="are not adequately applied and are overlooked. Treatment To date," exact="yellow fever" post="treatment consists of intensive support by providing hydration, blood"/>
   <result pre="antiviral inhibitor of the RNA-directed RNA polymerase (NS5B) enzyme of" exact="hepatitis" post="C virus, which is essential for viral replication. This"/>
   <result pre="for viral replication. This molecule incorporates into the RNA of" exact="hepatitis" post="C virus and inhibits its replication. This drug is"/>
   <result pre="to treat diseases such as dengue and malaria49 . Nanotechnology" exact="aids" post="in drug delivery, using biological organisms or nanoparticles (that"/>
   <result pre="on vector control measures14 , 37 . In 1927, the" exact="yellow fever" post="virus strain Asibi isolated from a patient in Ghana"/>
   <result pre="and since then The Oswald Cruz Foundation has produced the" exact="yellow fever" post="17DD (YF-17D) vaccine. To produce the 17DD vaccine, a"/>
   <result pre="vaccine. To produce the 17DD vaccine, a sample of the" exact="yellow fever" post="virus is inoculated into pathogens-free embryonated chicken eggs, as"/>
   <result pre="vaccination calendar, campaigns and providing vaccination coverage to travelers visiting" exact="yellow fever" post="risk zones. In addition to vaccination, vector control is"/>
   <result pre="and is also classified as a preventive action. Nevertheless, the" exact="yellow fever" post="virus can also be transmitted between humans by the"/>
   <result pre="Aedes mosquito, the urban vector, resulting in urban epidemics. Therefore," exact="yellow fever" post="surveillance that includes humans, animals (other primate hosts) and"/>
   <result pre="20 . Between 2008 and 2009, the transmission of wild" exact="yellow fever" post="occurred in Sao Paulo and Rio Grande do Sul"/>
   <result pre="are very effective against many viruses55 . CONCLUSION As a" exact="viral disease" post="with a huge impact, constituting a global public health"/>
   <result pre="of the disease may occur27 . Other aspects that make" exact="yellow fever" post="a challenging disease are its similarity with other hemorrhagic"/>
   <result pre="and preventive measures3 , 4 , 27 . Even though" exact="yellow fever" post="is a disease that has spread along the years"/>
   <result pre="is a scarcity of studies on the kidney involvement in" exact="yellow fever." post="The kidney is a very complex organ and its"/>
   <result pre="variety of histological findings related to kidney damage, such as" exact="interstitial nephritis," post="tubular necrosis, interlobular thrombosis in kidney vessels, hemorrhage and"/>
   <result pre="necrosis21 , 30 , 36 , 42 . Although the" exact="yellow fever" post="virus cannot be completely eradicated due to the existence"/>
   <result pre="not contain viral genetic material56 . Therefore, the spread of" exact="yellow fever" post="disease can be controlled. However, once the disease is"/>
   <result pre="we suggest that more studies on the kidney involvement in" exact="yellow fever" post="and the early diagnosis of kidney damage should be"/>
   <result pre="of YF sequelae. References REFERENCES 1MansuyJMLhommeSCazabatMPasquierCMartin-BlondelGIzopetJDetection of Zika, dengue and" exact="chikungunya" post="viruses using single-reaction multiplex real-time RT-PCRDiagn Microbiol Infect Dis20189228428730029808"/>
   <result pre="using single-reaction multiplex real-time RT-PCRDiagn Microbiol Infect Dis20189228428730029808 2DomingoCPatelPYillahJWeidmannMMéndezJANakounéERet al.Advanced" exact="yellow fever" post="virus genome detection in point-of-care facilities and reference laboratoriesJ"/>
   <result pre="facilities and reference laboratoriesJ Clin Microbiol2012504054406023052311 3HigueraARamírezJDMolecular epidemiology of dengue," exact="yellow fever," post="Zika and Chikungunya arboviruses: an updateActa Trop20191909911130444971 4StockNKEscadafalCAchaziKCisséMNiedrigMDevelopment and"/>
   <result pre="polymerase chain reaction assay for simultaneous detection of Zika, dengue," exact="yellow fever," post="and chikungunya viruses in a single tubeJ Med Virol2018901681168629979812"/>
   <result pre="assay for simultaneous detection of Zika, dengue, yellow fever, and" exact="chikungunya" post="viruses in a single tubeJ Med Virol2018901681168629979812 6AubryFNougairèdeAGouldEALamballerieXFlavivirus reverse"/>
   <result pre="a historical perspectiveAntiviral Res2015114678525512228 7BozzaccoLYiZAndreoUConklinCRLiMMRiceCMMacDonaldMRChaperone-assisted protein folding is critical for" exact="yellow fever" post="virus NS3/4A cleavage and replicationJ Virol2016903212322826739057 8KlittingRFischerCDrexlerJFGouldEARoizDPaupyCLamballerieXWhat does the"/>
   <result pre="cleavage and replicationJ Virol2016903212322826739057 8KlittingRFischerCDrexlerJFGouldEARoizDPaupyCLamballerieXWhat does the future hold for" exact="yellow fever" post="virus? (II)GenesBasel20189size: E425pages 9Fernandez-GarciaMDMeertensLChazalMHafirassouMLDejarnacOZamborliniAet al.Vaccine and wild-type strains of"/>
   <result pre="fever virus? (II)GenesBasel20189size: E425pages 9Fernandez-GarciaMDMeertensLChazalMHafirassouMLDejarnacOZamborliniAet al.Vaccine and wild-type strains of" exact="yellow fever" post="virus engage distinct entry mechanisms and differentially stimulate antiviral"/>
   <result pre="differentially stimulate antiviral immune responsesMBio20167e01956-1526861019 10RezendeIMSacchettoLMunhoz de MelloEAlvesPAIaniFCAdelinoTEet al.Persistence of" exact="yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
   <result pre="detection, prevention and therapyAntiviral Res2015115487025545072 15PestanaCPLawson-FerreiraRLessa-AquinoCLealMLFreireMSHommaAet al.Sanger-based sequencing technology for" exact="yellow fever" post="vaccine genetic quality controlJ Virol Methods2018260828730009851 16DouamFSoto AlbrechtYEHrebikovaGSadiminEDavidsonCKotenkoSVet al.Type"/>
   <result pre="al.Type III interferon-mediated signaling is critical for controlling live attenuated" exact="yellow fever" post="virus infection in vivoMBio20178e00819-1728811340 17SaavedraMEarly-life disease exposure and occupational"/>
   <result pre="vivoMBio20178e00819-1728811340 17SaavedraMEarly-life disease exposure and occupational status: the impact of" exact="yellow fever" post="during the 19thcenturyExplor Econ Hist2017646281 18MansoPPDias de OliveiraBCCarvalho de"/>
   <result pre="OliveiraBCCarvalho de SequeiraPRodrigues Maia de SouzaYSantos FerroJMSilvaIJet al.Kinetic study of" exact="yellow fever" post="17DD viral infection in Gallus gallus domesticus embryosPLoS One201611e015504127158977"/>
   <result pre="Dis20148size: e2740pages 20ShearerFMLongbottomJBrowneAJPigottDMBradyOJKraemerMUet al.Existing and potential infection risk zones of" exact="yellow fever" post="worldwide: a modelling analysisLancet Glob Health20186e270e27829398634 21CavalcanteKRTauilPLRisk of re-emergence"/>
   <result pre="a modelling analysisLancet Glob Health20186e270e27829398634 21CavalcanteKRTauilPLRisk of re-emergence of urban" exact="yellow fever" post="in BrazilEpidemiol Serv Saúde20172661762028977185 22SelemaneIEpidemiological monitoring of the last"/>
   <result pre="BrazilEpidemiol Serv Saúde20172661762028977185 22SelemaneIEpidemiological monitoring of the last outbreak of" exact="yellow fever" post="in Brazil: an outlook from PortugalTravel Med Infect Dis201928465130583006"/>
   <result pre="spread and challenges for immunisationMem Inst Oswaldo Cruz2018113e18027830427974 24MirDDelatorreEBonaldoMLourenço-de-OliveiraRVicenteACBelloGPhylodynamics of" exact="yellow fever" post="virus in the Americas: new insights into the origin"/>
   <result pre="vaccines and biologicals: yellow fevercited 2019 Jun 24https://www.who.int/immunization/diseases/yellow_fever/en/ 26ShearerFMMoyesCLPigottDMBradyOJMarinhoFDeshpandeAet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="to 2016: an adjusted retrospective analysisLancet Infect Dis2017171209121728822780 27IngelbeenBWeregemereNANoelHTshapendaGPMossokoMNsioJet al.Urban" exact="yellow fever" post="outbreak-Democratic Republic of the Congo, 2016: towards more rapid"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virusInfect Genet Evol20131929231123523817 29ChippauxJPChippauxAYellow fever in Africa and the"/>
   <result pre="Venom Anim Toxins Incl Trop Dis201824size: 20pages 30FernandesNCCunhaMSGuerraJMRéssioRACirqueiraCSIgleziasSDet al.Outbreak of" exact="yellow fever" post="among nonhuman primates, Espirito Santo, Brazil, 2017Emerg Infect Dis2017232038204129148378"/>
   <result pre="Santo, Brazil, 2017Emerg Infect Dis2017232038204129148378 31TretyakovaINickolsBHidajatRJokinenJLukashevichISPushkoPPlasmid DNA initiates replication of" exact="yellow fever" post="vaccine in vitro and elicits virus-specificVirology2014-2835 32collab: Brasilcollab: Ministério"/>
   <result pre="2019 Jun 24http://portalms.saude.gov.br/noticias/agencia-saude/42422-ministerio-da-saude-atualiza-casos-de-febre-amarela-30-jan 33collab: World Health OrganizationVaccines and vaccination against" exact="yellow fever." post="WHO Position Paper – June 2013Wkly Epidemiol Rec20138826928323909008 34collab:"/>
   <result pre="fever: a current threatcited 2019 Jun 24https://www.who.int/csr/disease/yellowfev/impact1/en/ 35KlittingRRothLReyFALamballerieXMolecular determinants of" exact="yellow fever" post="virus pathogenicity in Syrian golden hamsters: one mutation away"/>
   <result pre="one mutation away from virulenceEmerg Microb Infect20187size: 51pages 36MacielGVTavaresMCPereiraLSSilvaGLOliveiraNRPaulinoEJúnioret al.Disseminated" exact="mycosis" post="in a patient with yellow feverAutops Case Rep20188e201803830123781 37EscadafalCFayeOSallAAFayeOWeidmannMStrohmeierOet"/>
   <result pre="Case Rep20188e201803830123781 37EscadafalCFayeOSallAAFayeOWeidmannMStrohmeierOet al.Rapid molecular assays for the detection of" exact="yellow fever" post="virus in low-resource settingsPLoS Negl Trop Dis20148e273024603874 38IbrahimFThioTHFaisalTNeumanMThe application"/>
   <result pre="41PriyaSPSakinahSSharmilahKHamatRASekawiZHiguchiAet al.Leptospirosis: molecular trial path and immunopathogenesis correlated with dengue," exact="malaria" post="and mimetic hemorrhagic infectionsActa Trop201717620622328823908 42EngelmannFJossetLGirkeTParkBBarronADewaneJet al.Pathophysiologic and transcriptomic"/>
   <result pre="hemorrhagic infectionsActa Trop201717620622328823908 42EngelmannFJossetLGirkeTParkBBarronADewaneJet al.Pathophysiologic and transcriptomic analyses of viscerotropic" exact="yellow fever" post="in a rhesus macaque modelPLoS Negl Trop Dis20148size: e3295pages"/>
   <result pre="HoelzLBastosMMet al.Beyond members of the Flaviviridae family, sofosbuvir also inhibits" exact="chikungunya" post="virus replicationAntimicrob Agents Chemother201963e01389-1830455237 49IslanGADuránMCacicedoMLNakazatoGKobayashiRKMartinezDSet al.Nanopharmaceuticals as a solution"/>
   <result pre="da febre amarela no BrasilRev Pan-Amaz Saude201121126 51LindseyNPHoriuchiKAFultonCPanellaAJKosoyOIVelezJOet al.Persistence of" exact="yellow fever" post="virus-specific neutralizing antibodies after vaccination among US travellersJ Travel"/>
   <result pre="among US travellersJ Travel Med201825tay108 52LindseyNPSchroederBAMillerERBraunMMHinckleyAFMaranoNet al.Adverse event reports following" exact="yellow fever" post="vaccinationVaccine2008266077608218809449 53DouamFPlossAYellow fever virus: knowledge gaps impeding the fight"/>
   <result pre="gaps impeding the fight against an old foeTrends Microbiol20182691392829933925 54VanniceKWilder-SmithAHombachJFractional-dose" exact="yellow fever" post="vaccination: advancing the evidence baseN Engl J Med201837960360529995585 55DixitRHerzJDaltonRBooyRBenefits"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6653809\results\search\disease\results.xml">
   <result pre="to sylvatic maintenance cycles in South America, as did the" exact="yellow fever" post="virus (YFV) in the past. All these viruses are"/>
   <result pre="an urban cycle as a spill-back from the sylvatic cycle." exact="yellow fever" post="arbovirus sylvatic cycle arbovirus infecting non-human primates arboviruses in"/>
   <result pre="in South America. This group of viruses also includes the" exact="yellow fever" post="virus (YFV), which switched to a sylvatic maintenance cycle"/>
   <result pre="around 10% of the infected individuals, YFV can cause severe" exact="hepatitis" post="and hemorrhagic fever (Vasconcelos, 2003). All 4 DENV are"/>
   <result pre="patients, especially women over 45 years of age, develop an" exact="arthropathy" post="that chronifies with great impact on the quality of"/>
   <result pre="of primates transmitted by Haemagogus mosquitoes that reside in treetops," exact="stroke" post="Manaus, a city with 2 million inhabitants, producing dozens"/>
   <result pre="caused outbreaks of acute febrile illness, including some cases of" exact="meningitis" post="in Manaus city (Mourão et al., 2012). These data"/>
   <result pre="an urban arbovirus that became sylvatic in South America. Today," exact="yellow fever" post="has shown to be a zoonosis of non-human primates"/>
   <result pre="the largest epidemic in the past 60 years. Epizootics of" exact="yellow fever" post="in primates have advanced through gallery forests, mostly along"/>
   <result pre="January 2016 to June 2017, transmitted in a sylvatic cycle," exact="yellow fever" post="caused 3,140 cases with 410 deaths, mostly in the"/>
   <result pre="Ministry of Health, 2018). In 2018–2019, this ongoing epizootic of" exact="yellow fever" post="bypassed the São Paulo metropolitan area and moved toward"/>
   <result pre="outbreak (Figure 2). Non-human American primates are highly susceptible to" exact="yellow fever," post="and many animals, namely howler monkeys (Alouatta), die as"/>
   <result pre="is estimated that 90% of the howler monkeys died from" exact="yellow fever" post="in 2016–2017 (Lopes, 2017). The death of primates is"/>
   <result pre="The death of primates is a precocious detectable sign of" exact="yellow fever" post="epizootics, and the surveillance of primate deaths in Brazil"/>
   <result pre="Brazil became an important tool to prevent cases of human" exact="yellow fever" post="with the rapid vaccination of inhabitants in the target"/>
   <result pre="the mapping of ecological corridors and the progression rate of" exact="yellow fever" post="among primates in São Paulo State in 2017–2018. Public"/>
   <result pre="before the arrival of the epizootic (Fioravanti, 2018). During the" exact="yellow fever" post="epizootic in southeastern Brazil, and in addition to taking"/>
   <result pre="an effective protector that avoids cases and also re-urbanization of" exact="yellow fever," post="the 17DD vaccine. This vaccine, containing live attenuated virus,"/>
   <result pre="or more of the population to impair urban outbreaks of" exact="yellow fever" post="(Shearer et al., 2017). This sudden outbreak began in"/>
   <result pre="et al., 2017). This sudden outbreak began in 2015 and" exact="stroke" post="a community of the Brazilian Southeast that was poorly"/>
   <result pre="against the issue, approximately 20,000,000 people were quickly vaccinated against" exact="yellow fever" post="in 2017–2018. Similar to YFV, sylvatic cycles may occur"/>
   <result pre="T. M.Freitas-JuniorL. H. (2018). Evaluation of broad-spectrum antiviral compounds against" exact="chikungunya" post="infection using a phenotypic screening strategy. F1000Research7:173010.12688/f1000research.16498.1 collab: Brazilian"/>
   <result pre="vivo. PLoS Negl. Trop. Dis.13:e0007072. 10.1371/journal.pntd.000707230699122 FriersonJ. G. (2010). The" exact="yellow fever" post="vaccine: a history. Yale J. Biol. Med. 83, 77–85.20589188"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virus. Infect. Genet. Evol.19, 292–311. 10.1016/j.meegid.2013.03.00823523817 KunoG.Gwong-JenJ.TsuchiyaC. K. R.KarabatsosN.CroppB."/>
   <result pre="Em. com. br. gerais. Lourenço-de-OliveiraR.FaillouxA. B. (2017). High risk for" exact="chikungunya" post="virus to initiate an enzootic sylvatic cycle in the"/>
   <result pre="(2018). Evidence for multiple sylvatic transmission cycles during the 2016-2017" exact="yellow fever" post="virus outbreak, Brazil. Clin Microbiol Infect.24:1019.e1–019.e4. 10.1016/j.cmi.2018.01.02629427798 MourãoM. P."/>
   <result pre="Med.13:102. 10.1186/s12916-015-0348-x25976325 ShearerF. M.MoyesC. L.PigottD. M.BradyO. J.MarinhoF.DeshpandeA.et al. (2017). Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6656825\results\search\disease\results.xml">
   <result pre="10.1186/s13613-019-0559-y : Research Human metapneumovirus as cause of severe community-acquired" exact="pneumonia" post="in adults: insights from a ten-year molecular and epidemiological"/>
   <result pre="human metapneumovirus in critically ill adult patients with severe community-acquired" exact="pneumonia" post="(CAP) and the role of biomarkers identifying bacterial coinfection"/>
   <result pre="metapneumovirus showed group B predominance (60.7%). All patients had acute" exact="respiratory failure." post="Median APACHE II and SOFA score were 13 and"/>
   <result pre="material, which is available to authorized users. Keywords Severe community-acquired" exact="pneumonia" post="Human metapneumovirus Acute respiratory distress syndrome Biomarkers Background Human"/>
   <result pre="in 2–4% of adult patients admitted due to a community-acquired" exact="pneumonia" post="(CAP) [8, 9] and has been associated with asthma"/>
   <result pre="community-acquired pneumonia (CAP) [8, 9] and has been associated with" exact="asthma" post="and chronic obstructive pulmonary disease exacerbation [10–12]. The same"/>
   <result pre="(CAP) [8, 9] and has been associated with asthma and" exact="chronic obstructive pulmonary disease" post="exacerbation [10–12]. The same as with other common respiratory"/>
   <result pre="with non-severe pneumonia, whereas risk factors like immunosuppression, specific comorbidities—chronic" exact="lung disease," post="heart disease, blood disorders— elderly and living in long-term"/>
   <result pre="pneumonia, whereas risk factors like immunosuppression, specific comorbidities—chronic lung disease," exact="heart disease," post="blood disorders— elderly and living in long-term care facilities"/>
   <result pre="care facilities are associated with a higher risk of severe" exact="viral pneumonia" post="[13, 14]. Nevertheless, recent studies suggest that hMPV infection"/>
   <result pre="facilities are associated with a higher risk of severe viral" exact="pneumonia" post="[13, 14]. Nevertheless, recent studies suggest that hMPV infection"/>
   <result pre="critical illness, also in previously healthy patients [15–18]. Severe community-acquired" exact="pneumonia" post="(SCAP) is a known infectious complication of respiratory viruses"/>
   <result pre="describe the clinical and epidemiological characteristics of adults with severe" exact="pneumonia" post="caused by hMPV who required intensive care unit (ICU)"/>
   <result pre="turned the standard of care in the ICU after 2009" exact="influenza" post="pandemic. To be included, cases meet two of the"/>
   <result pre="of the following three criteria upon admission: (a) severe acute" exact="respiratory failure" post="(paO2/FiO2 &amp;lt; 250), (b) multilobar radiological involvement or (c) systolic arterial"/>
   <result pre="following the Berlin criteria [21]. Exclusion criteria: subjects with nosocomial" exact="pneumonia" post="or admitted due to non-respiratory infection (non-severe coincidental infection)"/>
   <result pre="due to non-respiratory infection (non-severe coincidental infection) and patients with" exact="pneumonia" post="during the preceding 2 months (persistence of viral RNA"/>
   <result pre="16 (57.1%) in March–April. HMPV circulated every year later than" exact="influenza" post="virus, being the epidemic peak of both infections separated"/>
   <result pre="infections in patients admitted to ICU occurred out of the" exact="influenza" post="epidemic period (Table 1). Fig. 1 Cases of severe"/>
   <result pre="epidemic period (Table 1). Fig. 1 Cases of severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection, hospitalized in the Intensive"/>
   <result pre="Sebastián, North of Spain) Table 1 Annual epidemic peaks of" exact="influenza" post="virus and human metapneumovirus infections, and temporal distribution of"/>
   <result pre="and temporal distribution of isolates in patients with severe community-acquired" exact="pneumonia" post="due to human metapneumovirus infection (Gipuzkoa, Spain, 2008–2017) Year"/>
   <result pre="February (n = 1) March (n = 2) hMPV human metapneumovirus, SCAP severe community-acquired" exact="pneumonia" post="Genotyping of hMPV was performed in 27 cases, being"/>
   <result pre="(67% genotype B). At ICU admission, all patients had acute" exact="respiratory failure" post="and received empiric antibiotic therapy. Median APACHE II score"/>
   <result pre="patients (67.9%) had major comorbidities such as immune compromise (n = 7)," exact="asthma" post="(n = 3) or chronic respiratory disease (n = 3) (Table 2). Seven"/>
   <result pre="comorbidities such as immune compromise (n = 7), asthma (n = 3) or chronic" exact="respiratory disease" post="(n = 3) (Table 2). Seven patients (none died) had coinfection"/>
   <result pre="(32.1) 4 5 Lymphopenia/mm3 (&amp;lt; 1000) 23 (82.1) 6 17 COPD" exact="chronic obstructive pulmonary disease" post="Predominant radiologic pattern in patients with hMPV infection and"/>
   <result pre="mechanical ventilation (median 5.5 days [IQR 5–14.2]) due to acute" exact="respiratory failure" post="and four were tracheostomized due to prolonged mechanical ventilation."/>
   <result pre="All of them underwent invasive mechanical ventilation due to acute" exact="respiratory failure" post="(one had coinfection with hPIV3). The main clinical and"/>
   <result pre="2: Table S2). The majority of the patients (83.3%) had" exact="lymphocytopenia" post="(&amp;lt; 1000/mL) at admission (Table 2). Four patients (average age"/>
   <result pre="immunocompromised, died during the ICU stay due to complications of" exact="respiratory failure." post="Among survivors, ICU and hospital median stay were 6.5"/>
   <result pre="study gives new insights on the molecular epidemiology of hMPV" exact="pneumonia" post="admitted to the ICU over 10 years. HMPV was"/>
   <result pre="65 years without comorbidities. HMPV CAP often presented as acute" exact="respiratory failure" post="with bilateral opacities and half of ICU subjects underwent"/>
   <result pre="implement hMPV diagnosis tests in subjects with CAP developing acute" exact="respiratory failure." post="Two out of three patients of this study had"/>
   <result pre="patients with hMPV infection acquired in the community and acute" exact="respiratory failure" post="who required ICU admission [15–17]. In a large prospective"/>
   <result pre="of this study had major comorbidities at admission, mainly chronic" exact="respiratory failure" post="and immunosuppression, being those patients and the elderly the"/>
   <result pre="with CAP, helping physicians to early discrimination between viral or" exact="bacterial pneumonia" post="and antimicrobial stewardship [29]. Three different genotypes of hMPV"/>
   <result pre="CAP, helping physicians to early discrimination between viral or bacterial" exact="pneumonia" post="and antimicrobial stewardship [29]. Three different genotypes of hMPV"/>
   <result pre="not be investigated for viral etiology. However, from the 2009" exact="influenza" post="pandemics, nasopharyngeal swab samples with respiratory viral detection are"/>
   <result pre="conclusion, our study confirms that hMPV, a respiratory virus causing" exact="bronchiolitis" post="and pneumonia in children, was associated with severe CAP"/>
   <result pre="study confirms that hMPV, a respiratory virus causing bronchiolitis and" exact="pneumonia" post="in children, was associated with severe CAP requiring ICU"/>
   <result pre="specifically hMPV) should be ruled out when complicated with acute" exact="respiratory failure." post="While one out of four patients showed pneumococcal coinfection,"/>
   <result pre="to the Intensive Care Unit due to a severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection (Guipuzcoa, Basque Country, Spain,"/>
   <result pre="to the Intensive Care Unit due to a severe community-acquired" exact="pneumonia" post="associated with human metapneumovirus infection (Guipuzcoa, Basque Country, Spain,"/>
   <result pre="human metapneumovirus infection (Guipuzcoa, Basque Country, Spain, 2007–2017). Abbreviations ARDS" exact="acute respiratory distress syndrome" post="APACHE II acute physiology and chronic health evaluation II"/>
   <result pre="II acute physiology and chronic health evaluation II CAP community-acquired" exact="pneumonia" post="COPD chronic obstructive pulmonary disease CRP C-reactive protein hMPV"/>
   <result pre="physiology and chronic health evaluation II CAP community-acquired pneumonia COPD" exact="chronic obstructive pulmonary disease" post="CRP C-reactive protein hMPV human metapneumovirus ICU intensive care"/>
   <result pre="SAPS III simplified acute physiology score III SCAP severe community-acquired" exact="pneumonia" post="SOFA sequential organ failure assessment Publisher's Note Springer Nature"/>
   <result pre="review of respiratory viral pathogens identified in adults with community-acquired" exact="pneumonia" post="in EuropeJ Clin Virol201795263510.1016/j.jcv.2017.07.01928837859 9.JainSSelfWHWunderinkRGet al.Community-acquired pneumonia requiring hospitalization"/>
   <result pre="adults with community-acquired pneumonia in EuropeJ Clin Virol201795263510.1016/j.jcv.2017.07.01928837859 9.JainSSelfWHWunderinkRGet al.Community-acquired" exact="pneumonia" post="requiring hospitalization among U.S. adultsN Engl J Med2015373541542710.1056/NEJMoa150024526172429 10.WalshEEPetersonDRFalseyARHuman"/>
   <result pre="11.WilliamsJVCroweJEJrEnriquezRet al.Human metapneumovirus infection plays an etiologic role in acute" exact="asthma" post="exacerbations requiring hospitalization in adultsJ Infect Dis200519271149115310.1086/44439216136455 12.HamelinMECôtéSLaforgeJet al.Human"/>
   <result pre="Infect Dis200519271149115310.1086/44439216136455 12.HamelinMECôtéSLaforgeJet al.Human metapneumovirus infection in adults with community-acquired" exact="pneumonia" post="and exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158"/>
   <result pre="and exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158 13.GattarelloSRelloJSevere" exact="viral pneumonia" post="in adults: what is important for the ICU physician?Hosp"/>
   <result pre="exacerbation of chronic obstructive pulmonary diseaseClin Infect Dis200541449850210.1086/43198116028158 13.GattarelloSRelloJSevere viral" exact="pneumonia" post="in adults: what is important for the ICU physician?Hosp"/>
   <result pre="casesAnn Intensive Care.2012213010.1186/2110-5820-2-3022812412 17.ChoiSHHongSBKoGBLeeYet al.Viral infection in patients with severe" exact="pneumonia" post="requiring intensive care unit admissionAm J Respir Crit Care"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6657620\results\search\disease\results.xml">
   <result pre="permitted which does not comply with these terms. Abstract The" exact="influenza" post="A virus infection continues to be a threat to"/>
   <result pre="Abs that play a protective role during infection or vaccination." exact="influenza" post="A virus neutralizing antibodies non-neutralizing antibidies influenza proteins protective"/>
   <result pre="infection or vaccination. influenza A virus neutralizing antibodies non-neutralizing antibidies" exact="influenza" post="proteins protective antibodies Funding Consejo Nacional de Ciencia y"/>
   <result pre="y Tecnología10.13039/501100003141 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The" exact="influenza" post="proteins are recognized as foreign by the immune system,"/>
   <result pre="This mechanism makes it necessary the annual revision of seasonal" exact="influenza" post="vaccines. On the contrary, the antigenic shift occurs rarely,"/>
   <result pre="Virus Vaccines Currently, there are three types of licensed human" exact="influenza" post="vaccines: trivalent/quadrivalent inactivated vaccines (TIV/QIV) live attenuated vaccines (LAIV)"/>
   <result pre="are non-adjuvanted inactivated vaccines composed of three or four circulating" exact="influenza" post="virus strains (H1N1, H3N2, B; or two B strains"/>
   <result pre="in the nasal cavities. Flublok is a trivalent recombinant hemmaglutinin" exact="influenza" post="vaccine, licensed by the FDA (US Food and Drug"/>
   <result pre="in 2013, that contains HA antigens derived from the three" exact="influenza" post="virus strains recommended by the World Health Organization (WHO)"/>
   <result pre="Mouse Model The first Abs that participate in clearing an" exact="influenza" post="infection are the so-called natural Abs, which are polyreactive"/>
   <result pre="the antigens (11). The role of natural Abs in the" exact="influenza" post="infection was addressed by Baumgarth et al., who showed"/>
   <result pre="serum from wild-type to IgM KO (−/−) mice infected with" exact="influenza" post="reduced the mortality in comparison to the controls (12)."/>
   <result pre="major promotors of center germinal formation (15, 16). Once the" exact="influenza" post="antigens reach the draining lymph nodes, two types of"/>
   <result pre="responses. Antibodies Against IAV External Proteins HA-Specific Antibodies HA from" exact="influenza" post="viruses is a spike-shaped protein that extends from the"/>
   <result pre="original antigenic sin Most of the classical neutralizing Abs against" exact="influenza" post="are directed to the conformational epitopes on HA, particularly"/>
   <result pre="the hierarchy of immunodominance for the HA of a post-2009" exact="influenza" post="pandemic strain, A/Michigan/45/2015 (H1N1) in several species including humans:"/>
   <result pre="vaccination usually are strain-specific, and they will hardly neutralize subsequent" exact="influenza" post="virus strains (homosubtypic protection). This is explained by the"/>
   <result pre="(antigenic drift) makes it necessary the annual reformulation of seasonal" exact="influenza" post="vaccines. Only specific Abs for the head of HA"/>
   <result pre="by Thomas Francis to describe the fact that in humans," exact="influenza" post="virus infections in childhood leaves an immunological imprint that"/>
   <result pre="with an OAS phenotype were effective in neutralizing antigenically different" exact="influenza" post="virus strains in vivo, indicating that OAS-Abs are an"/>
   <result pre="HCDR3. In this report, CH65 neutralized 30 out of 36" exact="influenza" post="H1N1 strains in vitro (44). Other receptor-binding site mAb"/>
   <result pre="and is capable to neutralize group 1 and group 2" exact="influenza" post="virus strains (45). Furthermore, anti-head broadly neutralizing mAbs whose"/>
   <result pre="group 1 (CR6261), group 2 (CR8020), and both groups of" exact="influenza" post="viruses (FI6) (49–51), have been described in humans. Unfortunately,"/>
   <result pre="al. analyzed the cross-reactivity pattern of anti-HA Abs after an" exact="influenza" post="infection in patients diagnosed with pH1N1/2009 or seasonal H3N2,"/>
   <result pre="HA globular domain prevails with the subsequent encounters with the" exact="influenza" post="virus (60). This observation echoes the dilemma of producing"/>
   <result pre="it is possible that consecutive challenges with seasonal strains of" exact="influenza" post="will move the balance in favor of anti-head Abs."/>
   <result pre="the second most abundant glycoprotein on the surface of the" exact="influenza" post="virion. It is a homotetramer with a mushroom-like form,"/>
   <result pre="a short cytoplasmic N-terminal domain that is 100% homologous among" exact="influenza" post="strains, a transmembrane hydrophobic domain, and a stem-shaped C-terminal"/>
   <result pre="due to the central role that HA has played in" exact="influenza" post="research. However, for the last 50 years, important data"/>
   <result pre="gathered suggesting that anti-NA Abs can offer protection against the" exact="influenza" post="infection. In 1968, Schulman et al. demonstrated that Abs"/>
   <result pre="that anti-NA Abs were also present in humans after an" exact="influenza" post="infection (64). Later, Murphy et al. investigated the role"/>
   <result pre="variable levels of anti-NA Abs. These subjects were infected with" exact="influenza" post="virus A/NT/60/68 (H3N2), and the authors observed that the"/>
   <result pre="directly proportional to age, and their reactivity are highest against" exact="influenza" post="virus strains that more likely circulated during their childhood"/>
   <result pre="nasal secretions are independent predictors of immunity and protection to" exact="influenza" post="in samples taken pre and post pandemic of 2009"/>
   <result pre="and 21.2%, respectively. They also reported that after the 2007–2008" exact="influenza" post="season, NAI levels in subjects with confirmed infection rose"/>
   <result pre="with different recombinant NA resulted in reduction of mortality against" exact="influenza" post="virus challenges with heterologous (not heterosubtypic) strains. This protection"/>
   <result pre="of a &quot;universal vaccine,�? because it is highly conserved among" exact="influenza" post="strains, and because the capacity of anti-M2e Abs to"/>
   <result pre="this, such as coupling M2e to carrier proteins —like the" exact="hepatitis" post="B virus core protein (HBc) (102)— or to flagellin"/>
   <result pre="symptoms compared to group that received placebo, when challenged with" exact="influenza" post="virus A/Wisconsin/67/2005 (H3N2) (110). Also, several phase I and"/>
   <result pre="recently a phase I clinical trial started to evaluate a" exact="hepatitis" post="B core-M2e-based vaccine in Russia (NCT03789539) (113). Antibodies Against"/>
   <result pre="at least the anti-NP Abs can weakly help to clear" exact="influenza" post="infection (117, 118). The aa sequence of NP is"/>
   <result pre="NP is conserved up to 90%, among various strains of" exact="influenza" post="and heterosubtypic immunity (HSI) induced by this protein has"/>
   <result pre="shown that NP can be expressed on the surface of" exact="influenza" post="virus-infected cells (123–125), however evidence for Fc-mediated effector functions"/>
   <result pre="in human sera higher titers of NP-specific ADCC-Abs reactive to" exact="avian influenza" post="strain H7N9, as compared with HA- or NA-specific ADCC-Abs"/>
   <result pre="human sera higher titers of NP-specific ADCC-Abs reactive to avian" exact="influenza" post="strain H7N9, as compared with HA- or NA-specific ADCC-Abs"/>
   <result pre="Abs correlated with ADCC-Abs reactive to NP in the seasonal" exact="influenza" post="viruses (H1N1 and H3N2), suggesting that they could be"/>
   <result pre="received artificial IC consisting of a NP-specific mAb and the" exact="influenza" post="virus, the CTL response was restored, along with an"/>
   <result pre="experimental infected mice (114). A summary of protective Abs against" exact="influenza" post="virus and their mechanisms of protection is shown in"/>
   <result pre="respectively. Table 1 Mechanisms of action of protective antibodies against" exact="influenza" post="virus proteins in mouse and humans. Antibodies against Mechanism"/>
   <result pre="neutralizing and non-neutralizing Abs specific for different proteins of the" exact="influenza" post="virus. (A) Abs that neutralize the infection (B) Abs"/>
   <result pre="Nat Rev Microbiol. (2011) 9:590–603. 10.1038/nrmicro261321747392 3.YasudaJNakadaSKatoAToyodaTIshihamaA. Molecular assembly of" exact="influenza" post="virus: association of the NS2 protein with virion matrix."/>
   <result pre="novel interaction between the NS1 protein derived from the 1918" exact="influenza" post="virus and RIG-I. Structure. (2015) 23:2001–10. 10.1016/j.str.2015.08.00726365801 6.KlemmCBoergelingYLudwigSEhrhardtC. Immunomodulatory"/>
   <result pre="RIG-I. Structure. (2015) 23:2001–10. 10.1016/j.str.2015.08.00726365801 6.KlemmCBoergelingYLudwigSEhrhardtC. Immunomodulatory nonstructural proteins of" exact="influenza" post="A viruses. Trends Microbiol. (2018) 26:624-636. 10.1016/j.tim.2017.12.00629373257 7.ChenWCalvoPAMalideDGibbsJSchubertUBacikIet al.."/>
   <result pre="viruses. Trends Microbiol. (2018) 26:624-636. 10.1016/j.tim.2017.12.00629373257 7.ChenWCalvoPAMalideDGibbsJSchubertUBacikIet al.. A novel" exact="influenza" post="A virus mitochondrial protein that induces cell death. Nat"/>
   <result pre="Nat Immunol. (2006) 7:449–55. 10.1038/ni134316622432 9.CoxMMPatriarcaPATreanorJ. FluBlok, a recombinant hemagglutinin" exact="influenza" post="vaccine. Influenza Other Respir Viruses. (2008) 2:211–9. 10.1111/j.1750-2659.2008.00053.19453397 10.WongSSWebbyRJ."/>
   <result pre="Other Respir Viruses. (2008) 2:211–9. 10.1111/j.1750-2659.2008.00053.19453397 10.WongSSWebbyRJ. Traditional and new" exact="influenza" post="vaccines. Clin Microbiol Rev. (2013) 26:476–92. 10.1128/CMR.00097-1223824369 11.ChoiYSBaumgarthN. Dual"/>
   <result pre="10.1128/CMR.00097-1223824369 11.ChoiYSBaumgarthN. Dual role for B-1a cells in immunity to" exact="influenza" post="virus infection. J Exp Med. (2008) 205:3053–64. 10.1084/jem.2008097919075288 12.BaumgarthNHermanOCJagerGCBrownLEHerzenbergLAChenJ."/>
   <result pre="M antibodies are nonredundant components of the protective response to" exact="influenza" post="virus infection. J Exp Med. (2000) 192:271–80. 10.1084/jem.192.2.27110899913 13.BaumgarthN."/>
   <result pre="255:82–94. 10.1111/imr.1209423947349 14.JayasekeraJPMosemanEACarrollMC. Natural antibody and complement mediate neutralization of" exact="influenza" post="virus in the absence of prior immunity. J Virol."/>
   <result pre="J Virol. (2007) 81:3487–94. 10.1128/JVI.02128-0617202212 15.ChiuCEllebedyAHWrammertJAhmedR. B cell responses to" exact="influenza" post="infection and vaccination. Curr Top Microbiol Immunol. (2015) 386:381–98."/>
   <result pre="al.. CD4 T cell-independent antibody response promotes resolution of primary" exact="influenza" post="infection and helps to prevent reinfection. J Immunol. (2005)"/>
   <result pre="J Exp Med. (2000) 192:813–21. 10.1084/jem.192.6.81310993912 20.WangTTParidesMKPaleseP. Seroevidence for H5N1" exact="influenza" post="infections in humans: meta-analysis. Science. (2012) 335:1463. 10.1126/science.121888822362880 21.GaoRCaoBHuYFengZWangDHuWet"/>
   <result pre="335:1463. 10.1126/science.121888822362880 21.GaoRCaoBHuYFengZWangDHuWet al.. Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N Engl J Med. (2013) 368:1888–97."/>
   <result pre="Med. (2013) 368:1888–97. 10.1056/NEJMoa130445923577628 22.CatonAJBrownleeGGYewdellJWGerhardW. The antigenic structure of the" exact="influenza" post="virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. (1982) 31(2 Pt"/>
   <result pre="Pt 1):417–27. 10.1016/0092-8674(82)90135-06186384 23.LubeckMDGerhardW. Topological mapping antigenic sites on the" exact="influenza" post="A/PR/8/34 virus hemagglutinin using monoclonal antibodies. Virology. (1981) 113:64–72."/>
   <result pre="Annu Rev Microbiol. (1981) 35:185–206. 10.1146/annurev.mi.35.100181.0011536170247 25.GerhardWYewdellJFrankelMEWebsterR. Antigenic structure of" exact="influenza" post="virus haemagglutinin defined by hybridoma antibodies. Nature. (1981) 290:713–7."/>
   <result pre="viruses. Nat Immunol. (2017)18:456-463. 10.1038/ni.368028192417 27.LiuSTHBehzadiMASunWFreynAWLiuWCBroeckerFet al.. Antigenic sites in" exact="influenza" post="H1 hemagglutinin display species-specific immunodominance. J Clin Invest. (2018)"/>
   <result pre="antigenic site B in the hemagglutinin of the current H3N2" exact="influenza" post="virus in humans and mice. J Virol. (2018) 92:e01100-18."/>
   <result pre="29.SunWKangDSZhengALiuSTHBroeckerFSimonVet al.. Antibody responses toward the major antigenic sites of" exact="influenza" post="B virus hemagglutinin in mice, ferrets, and humans. J"/>
   <result pre="Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8" exact="influenza" post="virus infection in mice. J Virol. (2016) 90:851–61. 10.1128/JVI.02275-1526512088"/>
   <result pre="J Exp Med. (1966) 124:331–45. 10.1084/jem.124.3.3315922742 35.CobeySHensleySE. Immune history and" exact="influenza" post="virus susceptibility. Curr Opin Virol. (2017) 22:105–111. 10.1016/j.coviro.2016.12.00428088686 36.NdifonW."/>
   <result pre="Structural basis of preexisting immunity to the 2009 H1N1 pandemic" exact="influenza" post="virus. Science. (2010) 328:357–60. 10.1126/science.118643020339031 38.HancockKVeguillaVLuXZhongWButlerENSunHet al.. Cross-reactive antibody"/>
   <result pre="38.HancockKVeguillaVLuXZhongWButlerENSunHet al.. Cross-reactive antibody responses to the 2009 pandemic H1N1" exact="influenza" post="virus. N Engl J Med. (2009) 361:1945–52. 10.1056/NEJMoa090645319745214 39.KrauseJCTumpeyTMHuffmanCJMcGrawPAPearceMBTsibaneTet"/>
   <result pre="occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic" exact="influenza" post="A (H1N1) viruses. J Virol. (2010) 84:3127–30. 10.1128/JVI.02184-0920042511 40.LindermanSLHensleySE."/>
   <result pre="sin' properties are valuable components of secondary immune responses to" exact="influenza" post="viruses. PLoS Pathog. (2016) 12:e1005806. 10.1371/journal.ppat.100580627537358 41.WrammertJSmithKMillerJLangleyWAKokkoKLarsenCet al.. Rapid"/>
   <result pre="41.WrammertJSmithKMillerJLangleyWAKokkoKLarsenCet al.. Rapid cloning of high-affinity human monoclonal antibodies against" exact="influenza" post="virus. Nature. (2008) 453:667–71. 10.1038/nature0689018449194 42.O'DonnellCDet al.Humans and ferrets"/>
   <result pre="(2008) 453:667–71. 10.1038/nature0689018449194 42.O'DonnellCDet al.Humans and ferrets with prior H1N1" exact="influenza" post="virus infections do not exhibit evidence of original antigenic"/>
   <result pre="sin after infection or vaccination with the 2009 pandemic H1N1" exact="influenza" post="virus. Clin Vaccine Immunol. (2014) 21:737–46. 10.1128/CVI.00790-1324648486 43.YoshidaRIgarashiMOzakiHKishidaNTomabechiDKidaHet al.."/>
   <result pre="antibody directed against antigenic site B of the hemagglutinin of" exact="influenza" post="A viruses. PLoS Pathog. (2009) 5:e1000350. 10.1371/journal.ppat.100035019300497 44.WhittleJRZhangRKhuranaSKingLRManischewitzJGoldingHet al.."/>
   <result pre="Broadly neutralizing human antibody that recognizes the receptor-binding pocket of" exact="influenza" post="virus hemagglutinin. Proc Natl Acad Sci USA. (2011) 108:14216–21."/>
   <result pre="Acad Sci USA. (2011) 108:14216–21. 10.1073/pnas.111149710821825125 45.EkiertDCKashyapAKSteelJRubrumABhabhaGKhayatRet al.. Cross-neutralization of" exact="influenza" post="A viruses mediated by a single antibody loop. Nature."/>
   <result pre="Naturally occurring antibodies in humans can neutralize a variety of" exact="influenza" post="virus strains, including H3, H1, H2, and H5. J"/>
   <result pre="monoclonal antibody directed against a novel conserved epitope on the" exact="influenza" post="virus H3 hemagglutinin globular head. J Virol. (2014) 88:6743–50."/>
   <result pre="48.OkunoYIsegawaYSasaoFUedaS. A common neutralizing epitope conserved between the hemagglutinins of" exact="influenza" post="A virus H1 and H2 strains. J Virol. (1993)"/>
   <result pre="plasma cells that binds to group 1 and group 2" exact="influenza" post="A hemagglutinins. Science. (2011) 333:850–6. 10.1126/science.120566921798894 50.EkiertDCFriesenRHBhabhaGKwaksTJongeneelenMYuWet al.. A"/>
   <result pre="50.EkiertDCFriesenRHBhabhaGKwaksTJongeneelenMYuWet al.. A highly conserved neutralizing epitope on group 2" exact="influenza" post="A viruses. Science. (2011) 333:843–50. 10.1126/science.120483921737702 51.EkiertDCBhabhaGElsligerMAFriesenRHJongeneelenMThrosbyMet al.. Antibody"/>
   <result pre="333:843–50. 10.1126/science.120483921737702 51.EkiertDCBhabhaGElsligerMAFriesenRHJongeneelenMThrosbyMet al.. Antibody recognition of a highly conserved" exact="influenza" post="virus epitope. Science. (2009) 324:246–51. 10.1126/science.117149119251591 52.EkiertDCWilsonIA. Broadly neutralizing"/>
   <result pre="epitope. Science. (2009) 324:246–51. 10.1126/science.117149119251591 52.EkiertDCWilsonIA. Broadly neutralizing antibodies against" exact="influenza" post="virus and prospects for universal therapies. Curr Opin Virol."/>
   <result pre="Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against" exact="influenza" post="A viruses. PLoS Pathog. (2014) 10:e1004103. 10.1371/journal.ppat.100410324788925 54.AvnirYWatsonCTGlanvilleJPetersonECTallaricoASBennettASet al.IGHV1-69"/>
   <result pre="A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits" exact="influenza" post="A virus particle release. EBioMedicine. (2017) 17:182–91. 10.1016/j.ebiom.2017.03.00728286060 56.PalesePWangTT."/>
   <result pre="virus particle release. EBioMedicine. (2017) 17:182–91. 10.1016/j.ebiom.2017.03.00728286060 56.PalesePWangTT. Why do" exact="influenza" post="virus subtypes die out? A hypothesis. MBio. (2011) 2:5."/>
   <result pre="2:5. 10.1128/mBio.00150-1121878571 57.NachbagauerRChoiAHirshAMargineIIidaSBarreraAet al.Defining the antibody cross-reactome directed against the" exact="influenza" post="virus surface glycoproteins. Nat Immunol. (2017)8:464-473. 10.1038/ni.3684 58.Cortina-CeballosBGodoy-LozanoEETéllez-SosaJOvilla-MuñozMSámano-SánchezHAguilar-SalgadoAet al.."/>
   <result pre="cell repertoire reveals unique effects of immunization with a new" exact="influenza" post="virus strain. Genome Med. (2015) 7:124. 10.1186/s13073-015-0239-y26608341 59.LiGMChiuCWrammertJMcCauslandMAndrewsSFZhengNYet al.."/>
   <result pre="strain. Genome Med. (2015) 7:124. 10.1186/s13073-015-0239-y26608341 59.LiGMChiuCWrammertJMcCauslandMAndrewsSFZhengNYet al.. Pandemic H1N1" exact="influenza" post="vaccine induces a recall response in humans that favors"/>
   <result pre="Med. (2015) 7:316ra192. 10.1126/scitranslmed.aad052226631631 61.ChaiNSwemLRReicheltMChen-HarrisHLuisEParkSet al.. Two escape mechanisms of" exact="influenza" post="A virus to a broadly neutralizing stalk-binding antibody. PLoS"/>
   <result pre="63.SchulmanJLKhakpourMKilbourneED. Protective effects of specific immunity to viral neuraminidase on" exact="influenza" post="virus infection of mice. J Virol. (1968) 2:778–86.5701819 64.KilbourneEDChristensonWNSandeM."/>
   <result pre="J Virol. (1968) 2:778–86.5701819 64.KilbourneEDChristensonWNSandeM. Antibody response in man to" exact="influenza" post="virus neuraminidase following influenza. J Virol. (1968) 2:761–2.5723531 65.MurphyBRKaselJAChanockRM."/>
   <result pre="2:761–2.5723531 65.MurphyBRKaselJAChanockRM. Association of serum anti-neuraminidase antibody with resistance to" exact="influenza" post="in man. N Engl J Med. (1972) 286:1329–32. 10.1056/NEJM1972062228625025027388"/>
   <result pre="of antibody production against neuraminidase to the protection afforded by" exact="influenza" post="vaccines. Rev Med Virol. (2012) 22:267–79. 10.1002/rmv.171322438243 68.EichelbergerMCWanH. Influenza"/>
   <result pre="Immunol, 2015. 386: p. 275-99. 10.1007/82_2014_39825033754 69.MarcelinGBlandHMNegovetichNJSandbulteMREllebedyAHWebbADet al.. Inactivated seasonal" exact="influenza" post="vaccines increase serum antibodies to the neuraminidase of pandemic"/>
   <result pre="influenza vaccines increase serum antibodies to the neuraminidase of pandemic" exact="influenza" post="A(H1N1) 2009 virus in an age-dependent manner. J Infect"/>
   <result pre="influenza. Lancet. (1973) 1:623–5. 10.1016/S0140-6736(73)92196-X4121842 71.CoxRJ. Correlates of protection to" exact="influenza" post="virus where do we go from here?Hum Vaccin Immunother."/>
   <result pre="antihemagglutinin and antineuraminidase antibodies as correlates of protection in an" exact="influenza" post="A/H1N1 virus healthy human challenge model. MBio. (2016) 7:e00417–16."/>
   <result pre="al.. Antibody correlates and predictors of immunity to naturally occurring" exact="influenza" post="in humans and the importance of antibody to the"/>
   <result pre="J Infect Dis. (2013) 207:974–81. 10.1093/infdis/jis93523307936 74.MontoASPetrieJGCrossRTJohnsonELiuMZhongWet al.. Antibody to" exact="influenza" post="virus neuraminidase: an independent correlate of protection. J Infect"/>
   <result pre="recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against" exact="influenza" post="virus infection in mice. MBio. (2015) 6:e0255610.1128/mBio.02556-1425759506 76.SandbulteMRJimenezGSBoonACSmithLRTreanorJJWebbyRJ. Cross-reactive"/>
   <result pre="(2007) 4:e59. 10.1371/journal.pmed.004005917298168 77.Gillim-RossLSubbaraoK. Can immunity induced by the human" exact="influenza" post="virus N1 neuraminidase provide some protection from avian influenza"/>
   <result pre="the human influenza virus N1 neuraminidase provide some protection from" exact="avian influenza" post="H5N1 viruses?PLoS Med. (2007) 4:e91. 10.1371/journal.pmed.004009117298170 78.GérentesLKesslerNAymardM. Difficulties in"/>
   <result pre="human influenza virus N1 neuraminidase provide some protection from avian" exact="influenza" post="H5N1 viruses?PLoS Med. (2007) 4:e91. 10.1371/journal.pmed.004009117298170 78.GérentesLKesslerNAymardM. Difficulties in"/>
   <result pre="4:e91. 10.1371/journal.pmed.004009117298170 78.GérentesLKesslerNAymardM. Difficulties in standardizing the neuraminidase content of" exact="influenza" post="vaccines. Dev Biol Stand. (1999) 98:189–96; discussion 197.10494973 79.Getie-KebtieMSultanaIEichelbergerMAltermanM."/>
   <result pre="79.Getie-KebtieMSultanaIEichelbergerMAltermanM. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in" exact="influenza" post="virus preparations and vaccines. Influenza Other Respir Viruses. (2013)"/>
   <result pre="Influenza Other Respir Viruses. (2013) 7:521–30. 10.1111/irv.1200122943763 80.JohanssonBEKilbourneED. Dissociation of" exact="influenza" post="virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition."/>
   <result pre="their intravirionic antigenic competition. J Virol. (1993) 67:5721–3.8371337 81.JohanssonBEBucherDJKilbourneED. Purified" exact="influenza" post="virus hemagglutinin and neuraminidase are equivalent in stimulation of"/>
   <result pre="82.KrammerFFouchierRAMEichelbergerMCWebbyRJShaw-SalibaKWanHet al.. NAction! how can neuraminidase-based immunity contribute to better" exact="influenza" post="virus vaccines?MBio. (2018) 9:2. 10.1128/mBio.02332-1729615508 83.DiLilloDJPalesePWilsonPCRavetchJV. Broadly neutralizing anti-influenza"/>
   <result pre="neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against" exact="influenza" post="virus in vivo. Nat Med. (2014) 20:143–51. 10.1038/nm.344324412922 85.JegaskandaSLaurieKLAmarasenaTHWinnallWRKramskiMDe"/>
   <result pre="RoseRet al.. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic" exact="influenza" post="A virus subtype H1N1. J Infect Dis. (2013) 208:1051–61."/>
   <result pre="Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal" exact="influenza" post="A viruses that are directed toward the nucleoprotein. J"/>
   <result pre="High antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9" exact="avian influenza" post="A viruses in healthy US adults and older children."/>
   <result pre="antibody-dependent cellular cytotoxicity antibody titers to H5N1 and H7N9 avian" exact="influenza" post="A viruses in healthy US adults and older children."/>
   <result pre="212:1052–60. 10.1093/infdis/jiv18125795791 89.JegaskandaSReadingPCKentSJ. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal" exact="influenza" post="vaccine. J Immunol. (2014) 193:469–75. 10.4049/jimmunol.140043224994909 90.Ana-Sosa-BatizFVandervenHJegaskandaSJohnstonARockmanSLaurieKet al.. Influenza-specific"/>
   <result pre="manner. MBio. (2016) 7:5. 10.1128/mBio.01624-1627703076 92.TerajimaMCruzJCoMDLeeJHKaurKWrammertJet al.. Complement-dependent lysis of" exact="influenza" post="a virus-infected cells by broadly cross-reactive human monoclonal antibodies."/>
   <result pre="Structure of the extracellular domain of matrix protein 2 of" exact="influenza" post="A virus in complex with a protective monoclonal antibody."/>
   <result pre="monoclonal antibody. J Virol. (2015) 89:3700–11. 10.1128/JVI.02576-1425609808 94.DengLChoKJFiersWSaelensX. M2e-based universal" exact="influenza" post="A vaccines. Vaccines. (2015) 3:105–36. 10.3390/vaccines301010526344949 95.ZebedeeSLLambRA. Influenza A"/>
   <result pre="96.TreanorJJTierneyELZebedeeSLLambRAMurphyBR. Passively transferred monoclonal antibody to the M2 protein inhibits" exact="influenza" post="A virus replication in mice. J Virol. (1990) 64:1375–7.2304147"/>
   <result pre="antibodies but plays a critical role in conferring protection after" exact="influenza" post="M2 vaccination. Immunology. (2014) 143:300–9. 10.1111/imm.1231024773389 98.El BakkouriKDescampsFDe FiletteMSmetAFestjensEBirkettAet"/>
   <result pre="Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protection. J"/>
   <result pre="al.. Therapeutic potential of a fully human monoclonal antibody against" exact="influenza" post="A virus M2 protein. Antiviral Res. (2008) 80:168–77. 10.1016/j.antiviral.2008.06.00218598723"/>
   <result pre="M2 protein. Antiviral Res. (2008) 80:168–77. 10.1016/j.antiviral.2008.06.00218598723 102.NeirynckSDerooTSaelensXVanlandschootPJouWMFiersW. A universal" exact="influenza" post="A vaccine based on the extracellular domain of the"/>
   <result pre="10.1038/1348410502819 103.TurleyCBRuppREJohnsonCTaylorDNWolfsonJTusseyLet al.. Safety and immunogenicity of a recombinant M2e-flagellin" exact="influenza" post="vaccine (STF2.4xM2e) in healthy adults. Vaccine. (2011) 29:5145–52. 10.1016/j.vaccine.2011.05.04121624416"/>
   <result pre="to gold nanoparticles confers protection against H1N1, H3N2 and H5N1" exact="influenza" post="A viruses. Antiviral Res. (2017) 141:62–72. 10.1016/j.antiviral.2017.01.02128161578 105.GaoXWangWLiYZhangSDuanYXingLet al.."/>
   <result pre="10.1016/j.antiviral.2013.01.01023416215 106.TompkinsSMZhaoZSLoCYMisplonJALiuTYeZet al.. Matrix protein 2 vaccination and protection against" exact="influenza" post="viruses, including subtype H5N1. Emerg Infect Dis. (2007) 13:426–35."/>
   <result pre="Dis. (2007) 13:426–35. 10.3201/eid1303.06112517552096 107.KimYJKoEJKimMCLeeYNKimKHJungYJet al.. Roles of antibodies to" exact="influenza" post="A virus hemagglutinin, neuraminidase, and M2e in conferring cross"/>
   <result pre="to matrix protein 2 following natural infection with 2009 pandemic" exact="influenza" post="A(H1N1) virus in humans. J Infect Dis. (2014) 209:986–94.24325965"/>
   <result pre="(accesed November 13, 2017). 113.TsybalovaLMStepanovaLAKuprianovVVBlokhinaEAPotapchukMVKorotkovAVet al.. Development of a candidate" exact="influenza" post="vaccine based on virus-like particles displaying influenza M2e peptide"/>
   <result pre="of a candidate influenza vaccine based on virus-like particles displaying" exact="influenza" post="M2e peptide into the immunodominant region of hepatitis B"/>
   <result pre="particles displaying influenza M2e peptide into the immunodominant region of" exact="hepatitis" post="B core antigen: Broad protective efficacy of particles carrying"/>
   <result pre="al.. Antibodies to PB1-F2 protein are induced in response to" exact="influenza" post="A virus infection. Arch Virol. (2009) 154:1599–604. 10.1007/s00705-009-0479-519672555 115.KhuranaSChungKYCoyleEMMeijerAGoldingH."/>
   <result pre="antibody response in humans following exposure to highly pathogenic H7N7" exact="avian influenza" post="virus: evidence for Anti-PA-X antibodies. J Virol. (2016) 90:9383–93."/>
   <result pre="response in humans following exposure to highly pathogenic H7N7 avian" exact="influenza" post="virus: evidence for Anti-PA-X antibodies. J Virol. (2016) 90:9383–93."/>
   <result pre="antibody dependent natural killer cell activation by antibodies to internal" exact="influenza" post="virus proteins. EBioMedicine. (2016) 8:277–90. 10.1016/j.ebiom.2016.04.02927428437 117.LaMereMWLamHTMoquinAHaynesLLundFERandallTDet al.. Contributions"/>
   <result pre="117.LaMereMWLamHTMoquinAHaynesLLundFERandallTDet al.. Contributions of antinucleoprotein IgG to heterosubtypic immunity against" exact="influenza" post="virus. J Immunol. (2011) 186:4331–9. 10.4049/jimmunol.100305721357542 118.CarragherDMKaminskiDAMoquinAHartsonLRandallTD. A novel"/>
   <result pre="role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to" exact="influenza" post="virus. J Immunol. (2008) 181:4168–76. 10.4049/jimmunol.181.6.416818768874 119.ShuLLBeanWJWebsterRG. Analysis of"/>
   <result pre="119.ShuLLBeanWJWebsterRG. Analysis of the evolution and variation of the human" exact="influenza" post="A virus nucleoprotein gene from 1933 to 1990. J"/>
   <result pre="122.Rangel-MorenoJCarragherDMMisraRSKusserKHartsonLMoquinAet al.. B cells promote resistance to heterosubtypic strains of" exact="influenza" post="via multiple mechanisms. J Immunol. (2008) 180:454–63. 10.4049/jimmunol.180.1.45418097047 123.YewdellJWFrankEGerhardW."/>
   <result pre="multiple mechanisms. J Immunol. (2008) 180:454–63. 10.4049/jimmunol.180.1.45418097047 123.YewdellJWFrankEGerhardW. Expression of" exact="influenza" post="A virus internal antigens on the surface of infected"/>
   <result pre="immunological significance of a human monoclonal antibody directed to the" exact="influenza" post="a virus nucleoprotein. Clin Vaccine Immunol. (2013) 20:1333–7. 10.1128/CVI.00339-1323761662"/>
   <result pre="10.1128/CVI.00339-1323761662 125.VirelizierJLAllisonACOxfordJSSchildGC. Early presence of ribonucleoprotein antigen on surface of" exact="influenza" post="virus-infected cells. Nature. (1977) 266:52–4. 10.1038/266052a0840296 126.LeónBBallesteros-TatoARandallTDLundFE. Prolonged antigen"/>
   <result pre="Rectification of age-associated deficiency in cytotoxic T cell response to" exact="influenza" post="A virus by immunization with immune complexes. J Immunol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6658116\results\search\disease\results.xml">
   <result pre="Nile virus (WNV) has been responsible for the largest human" exact="encephalitis" post="epidemics in the continental United States. Avians and Culex"/>
   <result pre="in 1999, West Nile virus (WNV) has caused large human" exact="encephalitis" post="epidemics in the United States resulting in 48,183 reported"/>
   <result pre="is closely related to other human pathogens such as Japanese" exact="encephalitis" post="(JEV), Saint Louis encephalitis and Murray Valley encephalitis viruses"/>
   <result pre="other human pathogens such as Japanese encephalitis (JEV), Saint Louis" exact="encephalitis" post="and Murray Valley encephalitis viruses within the Japanese encephalitis"/>
   <result pre="as Japanese encephalitis (JEV), Saint Louis encephalitis and Murray Valley" exact="encephalitis" post="viruses within the Japanese encephalitis virus (JEV) serocomplex[5, 6]."/>
   <result pre="Louis encephalitis and Murray Valley encephalitis viruses within the Japanese" exact="encephalitis" post="virus (JEV) serocomplex[5, 6]. The natural reservoir/amplification hosts of"/>
   <result pre="been exposed to WNV or another endemic flavivirus, St. Louis" exact="encephalitis" post="virus (SLEV), birds were bled prior to inoculation and"/>
   <result pre="viruses cannot be discounted as in vitro studies with recombinant" exact="rabies" post="virus glycoproteins have shown that differential glycosylation efficiencies of"/>
   <result pre="Other flaviviruses such as Yellow fever virus and St. Louis" exact="encephalitis" post="viruses do not encode a glycosylated E protein[10, 47,"/>
   <result pre="Trop Med. 1940;s1-20(4):471–92. 2HubalekZ, HalouzkaJ. West Nile fever—a reemerging mosquito-borne" exact="viral disease" post="in Europe. Emerg Infect Dis. 1999;5(5):643–50. 10.3201/eid0505.99050510511520 3MarfinAA, PetersenLR,"/>
   <result pre="of the West Nile virus responsible for an outbreak of" exact="encephalitis" post="in the northeastern United States. Science. 1999;286(5448):2333–7. 10.1126/science.286.5448.233310600742 13BinH,"/>
   <result pre="differential oral infection phenotypes of West Nile and St. Louis" exact="encephalitis" post="viruses in Culex spp. mosquitoes. Am J Trop Med"/>
   <result pre="and biological characterization of a non-glycosylated isolate of St Louis" exact="encephalitis" post="virus. J Gen Virol. 1993;74(12):2653–60. 10.1099/0022-1317-74-12-26537506301 49FallG, DialloM, LoucoubarC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6659212\results\search\disease\results.xml">
   <result pre="experimentally found to be potential vectors of arboviruses such as" exact="chikungunya" post="virus (CHIKV) [5] and Rift Valley fever phlebovirus (RVFV)"/>
   <result pre="been associated with severe clinical manifestations and congenital malformations including" exact="microcephaly" post="[11] and Guillain-Barré syndrome [12]. ZIKV was isolated for"/>
   <result pre="transmission rate TE transmission efficiency MEB midgut escape barrier CHIKV" exact="chikungunya" post="virus DENV dengue virus RVFV Rift Valley fever phlebovirus"/>
   <result pre="and February 2014Euro Surveill2014192075110.2807/1560-7917.ES2014.19.13.2075124721538 11.CauchemezSBesnardMBompardPDubTGuillemette-ArturPEyrolle-GuignotDet al.Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013–15: a retrospective studyLancet20163872125213210.1016/S0140-6736(16)00651-626993883 12.Cao-LormeauV-MBlakeAMonsSLastèreSRocheCVanhomwegenJet al.Guillain-Barré"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6661876\results\search\disease\results.xml">
   <result pre="epidemiological characteristics, detection methods, pathogenesis, treatment and prophylactic measures of" exact="influenza" post="in China. It will be helpful for us to"/>
   <result pre="us to understand the current situation of influenza. Key words" exact="influenza" post="epidemiology H7N9 page-count: Introduction Influenza (Flu) is a kind"/>
   <result pre="(Flu) is a kind of acute respiratory infection caused by" exact="influenza" post="virus (IVs). Influenza A Virus (IAV), Influenza B Virus"/>
   <result pre="the epidemiological characteristics, detection methods, pathogenesis, prevention and treatment of" exact="influenza" post="in China. Epidemiology of common influenza viruses H7N9 In"/>
   <result pre="prevention and treatment of influenza in China. Epidemiology of common" exact="influenza" post="viruses H7N9 In 2013, human cases of new H7N9"/>
   <result pre="influenza viruses H7N9 In 2013, human cases of new H7N9" exact="avian influenza" post="infection were first reported in Shanghai and Anhui.[2] Then"/>
   <result pre="viruses H7N9 In 2013, human cases of new H7N9 avian" exact="influenza" post="infection were first reported in Shanghai and Anhui.[2] Then"/>
   <result pre="with H7N9.[3] Since the first human infection case with H7N9" exact="avian influenza" post="virus (AIVs) was identified in March 2013, five viral"/>
   <result pre="H7N9.[3] Since the first human infection case with H7N9 avian" exact="influenza" post="virus (AIVs) was identified in March 2013, five viral"/>
   <result pre="As of March 2, 2018, the World Health Organization (WHO)" exact="influenza" post="surveillance reported a total of 1567 laboratory confirmed cases"/>
   <result pre="of 1567 laboratory confirmed cases of human infection with H7N9" exact="avian influenza," post="of which 615 died and the cumulative mortality rate"/>
   <result pre="live poultry markets, culling poultry, and establishing the platform for" exact="influenza" post="research and early-warning and standard bioinformatics analyses for monitoring"/>
   <result pre="al.[6] performed large-scale surveillance and evaluated the vaccine to H5/H7" exact="influenza" post="virus in laboratories and farmed poultry in September 2017."/>
   <result pre="showed that this bivalent H5/H7 inactivated vaccine had controlled H7" exact="influenza" post="viruses efficiently. The obvious decreased prevalence of the H7N9"/>
   <result pre="During October 2017 to 2018 winter, H1N1 became the main" exact="influenza" post="virus type in mainland China once again. According to"/>
   <result pre="Center for Disease Control and Prevention (CDC), the number of" exact="influenza" post="epidemics in the Chinese mainland in 2017 was 456,718,"/>
   <result pre="456,718, with an incidence rate of 33.1/100,000. The intensity of" exact="influenza" post="activity caused by H1N1 was higher than recent years."/>
   <result pre="The popular dominant viruses were mainly the Yamagata strain of" exact="influenza" post="B and influenza A (including H3N2 and H1N1). There"/>
   <result pre="viruses were mainly the Yamagata strain of influenza B and" exact="influenza" post="A (including H3N2 and H1N1). There were differences in"/>
   <result pre="30, 2013, the first case of human infection with H10N8" exact="avian influenza" post="virus was discovered in Nanchang City, China’s Jiangxi Province.[8]"/>
   <result pre="2013, the first case of human infection with H10N8 avian" exact="influenza" post="virus was discovered in Nanchang City, China’s Jiangxi Province.[8]"/>
   <result pre="patient was a 73-year-old woman, who was diagnosed with severe" exact="pneumonia" post="accompanied by high blood pressure, heart disease, myasthenia gravis"/>
   <result pre="was diagnosed with severe pneumonia accompanied by high blood pressure," exact="heart disease," post="myasthenia gravis and other underlying diseases, with a low"/>
   <result pre="with severe pneumonia accompanied by high blood pressure, heart disease," exact="myasthenia gravis" post="and other underlying diseases, with a low immunity level."/>
   <result pre="that the risk of human infection and transmission of H10N8" exact="avian influenza" post="virus through personal contact was low. In February 2014,"/>
   <result pre="the risk of human infection and transmission of H10N8 avian" exact="influenza" post="virus through personal contact was low. In February 2014,"/>
   <result pre="from Hunan Province was the first person diagnosed with H5N6" exact="influenza" post="virus infection in China.[9] In the following two years,"/>
   <result pre="China. Influenza virus detection method The main detection methods of" exact="influenza" post="virus mainly include viral nucleic acid detection, viral antigen"/>
   <result pre="isolation culture and serological detection. The most common method is" exact="influenza" post="virus nucleic acid, which is always detected by multiple"/>
   <result pre="Biochip technique Rapid identification of infections with specific subtypes of" exact="influenza" post="virus is critical for treatment and pandemic control. Wang"/>
   <result pre="(human H1N1, human H3N2, avian H5N1 and avian H7N9) of" exact="influenza" post="viruses in circulation in China. PCR products were analyzed"/>
   <result pre="a rapid, reliable and inexpensive detection and differentiation of human-infecting" exact="influenza" post="viruses. Gene Sequencing In recent years, the sequencing of"/>
   <result pre="al[11] used NGS technology in clinical specimens to investigate an" exact="influenza" post="outbreak in hospitals. Nasopharyngeal swabs from patients were collected"/>
   <result pre="factor storms, leading to systemic inflammatory reactions, which can cause" exact="acute respiratory distress syndrome" post="(ARDS), shock and multiple organ failure. During viral replication"/>
   <result pre="that, in patients infected with H1N1, the level of circulating" exact="influenza" post="specific CD4+ but not CD8+T cells is positively correlated"/>
   <result pre="play an important role in the prevention and treatment of" exact="influenza" post="in the future. Treatments Current Antiviral Drugs At present,"/>
   <result pre="sites on the NA molecule to inhibit the release of" exact="influenza" post="virus progeny from the cell surface. Three FDA-approved NAIs"/>
   <result pre="resistance to adamantanes; therefore, they are no longer recommended for" exact="influenza" post="treatment. NAIs are still the main antiviral drugs.[18] Zou"/>
   <result pre="on design and structural characterization of potent peptidic inhibitors against" exact="influenza" post="HA. The peptide design was based on complementarity determining"/>
   <result pre="CR9114. The optimized peptides exhibit nanomolar affinity and neutralization against" exact="influenza" post="A viruses including H1N1 and H5N1. These peptidic compounds"/>
   <result pre="accelerate development of novel small molecule and peptide-based therapeutics against" exact="influenza" post="virus. A small molecule prodrug – Baloxavir marboxil In"/>
   <result pre="currently a new drug that can inhibit the proliferation of" exact="influenza" post="virus. Recently, Koshimichi et al.[22] published a phase III"/>
   <result pre="U.S. FDA approved it for the treatment of uncomplicated acute" exact="influenza" post="patients aged 12 years and older, who have been"/>
   <result pre="the past 20 years. Corticosteroids The application of corticosteroids in" exact="influenza" post="virus pneumonia has always been controversial. A multicenter, retrospective"/>
   <result pre="20 years. Corticosteroids The application of corticosteroids in influenza virus" exact="pneumonia" post="has always been controversial. A multicenter, retrospective study about"/>
   <result pre="mortality than late administration. More patients receiving steroids had acquired" exact="pneumonia" post="and a trend to a longer duration of ventilation.[23]"/>
   <result pre="group was more likely to have superinfection such as secondary" exact="bacterial pneumonia" post="or invasive fungal infection, and had more prolonged intensive"/>
   <result pre="was more likely to have superinfection such as secondary bacterial" exact="pneumonia" post="or invasive fungal infection, and had more prolonged intensive"/>
   <result pre="the timing, dosage, and course of corticosteroids in patients with" exact="influenza" post="virus pneumonia are still the focus of controversy. Extracorporeal"/>
   <result pre="dosage, and course of corticosteroids in patients with influenza virus" exact="pneumonia" post="are still the focus of controversy. Extracorporeal membrane oxygenation"/>
   <result pre="of patients. ECMO was the breakthrough treatment for the severe" exact="avian influenza" post="A (H1N1) outbreak of 2009 and reduced mortality from"/>
   <result pre="patients. ECMO was the breakthrough treatment for the severe avian" exact="influenza" post="A (H1N1) outbreak of 2009 and reduced mortality from"/>
   <result pre="is effective at improving oxygenation and ventilation of patients with" exact="avian influenza" post="A (H7N9) induced severe ARDS. Early initiation of ECMO"/>
   <result pre="effective at improving oxygenation and ventilation of patients with avian" exact="influenza" post="A (H7N9) induced severe ARDS. Early initiation of ECMO"/>
   <result pre="Chinese medicine also plays an important role in fighting against" exact="influenza" post="virus. Chinese herbal medicines are commonly used for anti-influenza"/>
   <result pre="and tonic drugs. The main ways of Chinese medicine against" exact="influenza" post="virus are as follows: (1) Banlangen, Honeysuckle, Forsythia, Guanzhong"/>
   <result pre="killing the virus, inhibiting the adsorption, infection and replication of" exact="influenza" post="virus. Among them, baicalin[30] and silybin inhibit the virus"/>
   <result pre="word, combination of traditional Chinese medicine and Western medicine against" exact="influenza" post="virus is a direction worth exploring. Prevention Isolation of"/>
   <result pre="prevent IVA. Wu et al.[33] compared the detection frequency of" exact="avian influenza" post="H7 subtypes at live poultry markets in Guangdong Province,"/>
   <result pre="IVA. Wu et al.[33] compared the detection frequency of avian" exact="influenza" post="H7 subtypes at live poultry markets in Guangdong Province,"/>
   <result pre="centuryEur J Immunol2009392946–5419790188 2GaoRCaoBHuYFengZWangDHuWet alHuman infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusN Engl J Med20133681888–9723577628 3BaoCJCuiLBZhouMHHongLGaoGFWangHLive animal markets"/>
   <result pre="A (H7N9) virusN Engl J Med20133681888–9723577628 3BaoCJCuiLBZhouMHHongLGaoGFWangHLive animal markets and" exact="influenza" post="A (H7N9) virus infectionN Engl J Med20133682337–923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology"/>
   <result pre="A (H7N9) virus infectionN Engl J Med20133682337–923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="(H7N9) virus infectionN Engl J Med20133682337–923697471 4WangXJiangHWuPUyekiTMFengLLaiSet alEpidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="Infect Dis201717822–3228583578 5WeiXCuiJWhy were so few people infected with H7N9" exact="influenza" post="A viruses in China from late 017 to 2018?Sci"/>
   <result pre="7ZhuHLeeACYLiCMakWWNChenYYChanKHet alLow population serum microneutralization antibody titer against the predominating" exact="influenza" post="A(H3N2) N121K virus during the severe influenza summer peak"/>
   <result pre="against the predominating influenza A(H3N2) N121K virus during the severe" exact="influenza" post="summer peak of Hong Kong in 2017Emerg Microbes Infect"/>
   <result pre="2018;723 8WanJZhangJTaoWJiangGZhouWPanJet alA report of first fatal case of H10N8" exact="avian influenza" post="virus pneumonia in the worldZhonghua Wei Zhong Bing Ji"/>
   <result pre="8WanJZhangJTaoWJiangGZhouWPanJet alA report of first fatal case of H10N8 avian" exact="influenza" post="virus pneumonia in the worldZhonghua Wei Zhong Bing Ji"/>
   <result pre="report of first fatal case of H10N8 avian influenza virus" exact="pneumonia" post="in the worldZhonghua Wei Zhong Bing Ji Jiu Yi"/>
   <result pre="and virological characteristics of the first detected human case of" exact="avian influenza" post="A(H5N6) virusInfect Genet Evol201640236–4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of"/>
   <result pre="virological characteristics of the first detected human case of avian" exact="influenza" post="A(H5N6) virusInfect Genet Evol201640236–4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of"/>
   <result pre="A(H5N6) virusInfect Genet Evol201640236–4226973295 10WangYQuJBaQDongJZhangLZhangHet alDetection and typing of human-infecting" exact="influenza" post="viruses in China by using a multiplex DNA biochip"/>
   <result pre="using a multiplex DNA biochip assayJ Virol Methods2016234178–8527150046 11SeongMWChoSIParkHSeoSHLeeSJKimECet alGenotyping" exact="influenza" post="virus by next-generation deep sequencing in clinical specimensAnn Lab"/>
   <result pre="next-generation deep sequencing in clinical specimensAnn Lab Med201636255–826915615 12LiHCaoBPandemic and" exact="avian influenza" post="A viruses in humans: epidemiology, virology, clinical characteristics, and"/>
   <result pre="deep sequencing in clinical specimensAnn Lab Med201636255–826915615 12LiHCaoBPandemic and avian" exact="influenza" post="A viruses in humans: epidemiology, virology, clinical characteristics, and"/>
   <result pre="alHigh levels of virus-specific CD4+ T cells predict severe pandemic" exact="influenza" post="A virus infectionAm J Respir Crit Care Med20121861292–723087026 15XueCWenMBaoLLiHLiFLiuMet"/>
   <result pre="Respir Crit Care Med20121861292–723087026 15XueCWenMBaoLLiHLiFLiuMet alVγ4+γδT cells aggravate severe H1N1" exact="influenza" post="virus infection-induced acute pulmonary immunopathological injury via secreting interleukin-17AFront"/>
   <result pre="of therapeutics in clinical development for respiratory syncytial virus and" exact="influenza" post="in childrenClin Ther2018401268–8130077340 17WangYGuoQYanZZhouDZhangWZhouSet alFactors associated with prolonged viral"/>
   <result pre="17WangYGuoQYanZZhouDZhangWZhouSet alFactors associated with prolonged viral shedding in patients with" exact="avian influenza" post="A(H7N9) virus infectionJ Infect Dis20182171708–1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of"/>
   <result pre="alFactors associated with prolonged viral shedding in patients with avian" exact="influenza" post="A(H7N9) virus infectionJ Infect Dis20182171708–1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of"/>
   <result pre="A(H7N9) virus infectionJ Infect Dis20182171708–1729648602 18GrohskopfLASokolowLZBroderKRWalterEBFryAMJerniganDBPrevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the advisory committee on immunization"/>
   <result pre="recommendations of the advisory committee on immunization practices-united states, 2018-19" exact="influenza" post="seasonMMWR Recomm Rep2018671–20 19ZouXGuoQZhangWChenHBaiWLuBet alDynamic variation and reversion in"/>
   <result pre="germline-like human monoclonal antibody targets a ph-sensitive epitope on H7N9" exact="influenza" post="hemagglutininCell Host Microbe201722471–8328966056 21KadamRUJuraszekJBrandenburgBBuyckCSchepensWBGKesteleynBet alPotent peptidic fusion inhibitors of"/>
   <result pre="influenza hemagglutininCell Host Microbe201722471–8328966056 21KadamRUJuraszekJBrandenburgBBuyckCSchepensWBGKesteleynBet alPotent peptidic fusion inhibitors of" exact="influenza" post="virusScience2017358496–50228971971 22KoshimichiHIshibashiTKawaguchiNSatoCKawasakiAWajimaTSafety, tolerability, and pharmacokinetics of the novel anti-influenza"/>
   <result pre="study findingsClin Drug Investig2018381189–96 23HaydenFGSugayaNHirotsuNLeeNdeJong MDHurtACet alBaloxavir marboxil for uncomplicated" exact="influenza" post="in adults and adolescentsN Engl J Med2018379913–2330184455 24Brun-BuissonCRichardJCMercatAThiébautACBrochardL; REVA-SRLF"/>
   <result pre="J Med2018379913–2330184455 24Brun-BuissonCRichardJCMercatAThiébautACBrochardL; REVA-SRLF A/H1N1v2009Registry Group. Early corticosteroids in severe" exact="influenza" post="A/H1N1 pneumonia and acute respiratory distress syndromeAm J Respir"/>
   <result pre="24Brun-BuissonCRichardJCMercatAThiébautACBrochardL; REVA-SRLF A/H1N1v2009Registry Group. Early corticosteroids in severe influenza A/H1N1" exact="pneumonia" post="and acute respiratory distress syndromeAm J Respir Crit Care"/>
   <result pre="Med20111831200–6 25KimSHHongSBYunSCChoiWIAhnJJLeeYJet alCorticosteroid treatment in critically ill patients with pandemic" exact="influenza" post="A/H1N1 2009 infection: analytic strategy using propensity scoresAm J"/>
   <result pre="therapy on ICU admission in patients affected by severe pandemic(H1N1)v" exact="influenza" post="A infectionIntensive Care Med201137272–8321107529 27CaoBGaoHZhouBDengXHuCDengCet alAdjuvant corticosteroid treatment in"/>
   <result pre="infectionIntensive Care Med201137272–8321107529 27CaoBGaoHZhouBDengXHuCDengCet alAdjuvant corticosteroid treatment in adults with" exact="influenza" post="A (H7N9) viral pneumoniaCrit Care Med201644e318–e32826934144 28LiHYangSGGuLZhangYYanXXLiangZAet alEffect of"/>
   <result pre="low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with" exact="influenza" post="A(H1N1) pdm09 viral pneumoniaInfluenza Other Respir Viruses201711345–5428464462 29HuangLZhangWYangYWuWLuWXueHet alApplication"/>
   <result pre="29HuangLZhangWYangYWuWLuWXueHet alApplication of extracorporeal membrane oxygenation in patients with severe" exact="acute respiratory distress syndrome" post="induced by avian influenza A (H7N9) viral pneumonia: national"/>
   <result pre="in patients with severe acute respiratory distress syndrome induced by" exact="avian influenza" post="A (H7N9) viral pneumonia: national data from the Chinese"/>
   <result pre="patients with severe acute respiratory distress syndrome induced by avian" exact="influenza" post="A (H7N9) viral pneumonia: national data from the Chinese"/>
   <result pre="multicentre collaborationBMC Infect Dis2018182329310581 30ZhuHYHanLShiXLWangBLHuangHWangXet alBaicalin inhibits autophagy induced by" exact="influenza" post="A virus H3N2Antiviral Res201511362–7025446340 31ZhouZLiXLiuJDongLChenQLiuJet alHoneysuckle-encoded atypical microRNA2911 directly"/>
   <result pre="A virus H3N2Antiviral Res201511362–7025446340 31ZhouZLiXLiuJDongLChenQLiuJet alHoneysuckle-encoded atypical microRNA2911 directly targets" exact="influenza" post="A virusesCell Res20152539–4925287280 32ChenHWChengJXLiuMTKingKPengJYZhangXQet alInhibitory and combinatorial effect of"/>
   <result pre="alInhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on" exact="influenza" post="virusesAntiviral Res201399371–8223820269 33WuJKeCLauEHYSongYChengKLZouLet alInfluenza H5/H7 virus vaccination in poultry"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6663013\results\search\disease\results.xml">
   <result pre="Life Sciences : Genetics: Microbial Genetics Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 Severe cases of seasonal influenza"/>
   <result pre="seasonal influenza in Russia in 2017-2018 Severe cases of seasonal" exact="influenza" post="in Russia in 2017-2018 http://orcid.org/0000-0001-8865-8592KolosovaNatalia P.ConceptualizationFormal analysisInvestigationMethodologyValidationVisualizationWriting – original"/>
   <result pre="the original author and source are credited.pone.0220401.pdf Abstract The 2017–2018" exact="influenza" post="epidemic season in Russia was characterized by a relatively"/>
   <result pre="and mortality. We evaluated herd immunity prior to the 2017–2018" exact="influenza" post="season in hemagglutination inhibition assay, and performed characterization of"/>
   <result pre="influenza season in hemagglutination inhibition assay, and performed characterization of" exact="influenza" post="viruses isolated from severe or fatal influenza cases and"/>
   <result pre="performed characterization of influenza viruses isolated from severe or fatal" exact="influenza" post="cases and from influenza cases in people vaccinated in"/>
   <result pre="viruses isolated from severe or fatal influenza cases and from" exact="influenza" post="cases in people vaccinated in the fall of 2017."/>
   <result pre="the fall of 2017. During the 2017–2018 epidemic season, 87" exact="influenza" post="A and B viruses were isolated and viruses of"/>
   <result pre="and B viruses were isolated and viruses of the 75" exact="influenza" post="cases, including selected viral isolates and viruses analyzed directly"/>
   <result pre="hemagglutinin gene of A(H1N1)pdm09 for epidemiological surveillance. One strain of" exact="influenza" post="virus A(H1N1)pdm09 was resistant to oseltamivir and had the"/>
   <result pre="the presence of protective antibody titers against vaccine strains of" exact="influenza" post="A and influenza B/Victoria-like, respectively. Mass vaccination of the"/>
   <result pre="protective antibody titers against vaccine strains of influenza A and" exact="influenza" post="B/Victoria-like, respectively. Mass vaccination of the population had evidently"/>
   <result pre="reduced the severity of the flu epidemic during the 2017–2018" exact="influenza" post="epidemic season in Russia. Funding This work was supported"/>
   <result pre="and its Supporting Information files. Introduction Influenza is an infectious" exact="respiratory disease" post="caused by influenza viruses type A, B, C and"/>
   <result pre="files. Introduction Influenza is an infectious respiratory disease caused by" exact="influenza" post="viruses type A, B, C and D. The disease"/>
   <result pre="An emergence in the human population of a variant of" exact="influenza" post="A virus with new antigenic properties may cause a"/>
   <result pre="mortality [3]. Thereby, monitoring population immunity and severe cases of" exact="influenza" post="is an essential activity carried out within the framework"/>
   <result pre="studying the population humoral immunity and the epidemic situation of" exact="influenza" post="in Russia since 2009 [4–8]. This study continues our"/>
   <result pre="continues our work on annual evaluation of herd immunity to" exact="influenza" post="just before the influenza epidemic seasons in Russia and"/>
   <result pre="annual evaluation of herd immunity to influenza just before the" exact="influenza" post="epidemic seasons in Russia and analyses of circulating influenza"/>
   <result pre="the influenza epidemic seasons in Russia and analyses of circulating" exact="influenza" post="viruses in Russia, with a focus on the influenza"/>
   <result pre="circulating influenza viruses in Russia, with a focus on the" exact="influenza" post="viruses which cause severe illness, including cases with lethal"/>
   <result pre="with lethal outcome. The epidemic rise in the incidence of" exact="influenza" post="in Russia began during the 6th to 7th weeks"/>
   <result pre="In contrast to Western countries, the epidemic rise in the" exact="influenza" post="disease incidence was smooth, and throughout the epidemic, the"/>
   <result pre="2017–2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
   <result pre="purpose of this study was to assess population immunity to" exact="influenza" post="viruses before the 2017–2018 Russian epidemic season and to"/>
   <result pre="viruses before the 2017–2018 Russian epidemic season and to characterize" exact="influenza" post="viruses from clinical material from cases of severe influenza"/>
   <result pre="characterize influenza viruses from clinical material from cases of severe" exact="influenza" post="disease, autopsy material from influenza disease cases with lethal"/>
   <result pre="material from cases of severe influenza disease, autopsy material from" exact="influenza" post="disease cases with lethal outcome, and clinical material from"/>
   <result pre="[6]. The A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2) and B/Brisbane/60/2008 (Victoria lineage)" exact="influenza" post="viruses were kindly provided by the WHO Collaborating Center"/>
   <result pre="the Russian Federation. PCR-based diagnostics of the original material for" exact="influenza" post="virus RNA was conducted in local laboratories, and then"/>
   <result pre="of cells [12]. Diagnostic real-time PCR for detecting RNA of" exact="influenza" post="A virus and influenza B virus was performed using"/>
   <result pre="real-time PCR for detecting RNA of influenza A virus and" exact="influenza" post="B virus was performed using RNA isolated with the"/>
   <result pre="Rights Protection and Human Wellbeing (Moscow, Russia). Serological analysis of" exact="influenza" post="viruses Serological typing/subtyping of isolated influenza virus strains and"/>
   <result pre="Russia). Serological analysis of influenza viruses Serological typing/subtyping of isolated" exact="influenza" post="virus strains and studying their antigenic features were carried"/>
   <result pre="A/Michigan/45/2015 A(H1N1)pdm09, A/HongKong/4801/2014 A(H3N2), B/Brisbane/60/2008 (Victoria lineage), B/Phuket/3073/2013 (Yamagata lineage)" exact="influenza" post="viruses were used for serological typing of influenza virus"/>
   <result pre="(Yamagata lineage) influenza viruses were used for serological typing of" exact="influenza" post="virus isolates. All reference sera were kindly furnished by"/>
   <result pre="Influenza in Atlanta, US. Sensitivity to anti-neuraminidase drugs Susceptibility of" exact="influenza" post="viruses to neuraminidase inhibitors oseltamivir and zanamivir was tested"/>
   <result pre="the protocol recommended by the WHO [13]. Sequence analysis of" exact="influenza" post="viruses Sequencing was carried out at the FBRI SRC"/>
   <result pre="Results Investigation of herd immunity To assess herd immunity to" exact="influenza" post="A and B viruses, 3728 serum samples collected in"/>
   <result pre="the results obtained in the HI tests with the seasonal" exact="influenza" post="vaccine strains for 2017–2018. Fig 1 Seropositivity for influenza"/>
   <result pre="seasonal influenza vaccine strains for 2017–2018. Fig 1 Seropositivity for" exact="influenza" post="vaccine viruses in the studied groups of people from"/>
   <result pre="(1:40 and above) in HI tests with vaccine strains of" exact="influenza" post="A virus subtypes A(H1N1)pdm09 and A(H3N2) (Fig 1). The"/>
   <result pre="A(H3N2) (Fig 1). The proportion of seropositive individuals for the" exact="influenza" post="B virus of the Victoria genetic lineage was slightly"/>
   <result pre="seropositive individuals in 2016, versus 33% in 2017) to the" exact="influenza" post="A(H1N1)pdm09 virus, while the proportion of seropositive individuals to"/>
   <result pre="strains in circulation during the 2016–2017 season. Characterization of seasonal" exact="influenza" post="viruses In the epidemic season of 2017–2018, the SRC"/>
   <result pre="primary samples were received that were positive for RNA of" exact="influenza" post="A and B viruses, including 90 samples of autopsy"/>
   <result pre="with severe disease and 136 samples from patients vaccinated against" exact="influenza" post="in the fall of 2017 (Table 1). 10.1371/journal.pone.0220401.t001Table 1"/>
   <result pre="1). 10.1371/journal.pone.0220401.t001Table 1 Data on patients with cases of severe" exact="influenza" post="disease, cases of influenza disease with fatal outcome, and"/>
   <result pre="on patients with cases of severe influenza disease, cases of" exact="influenza" post="disease with fatal outcome, and patients vaccinated in the"/>
   <result pre="2017. Group Fatal cases (number) Severe cases (number) Vaccinated against" exact="influenza" post="in the fall of 2017 (number of infected) Sex"/>
   <result pre="70 3 Pregnant women 1 146 12 People vaccinated against" exact="influenza" post="in the fall of 2017 4 132 136 Total"/>
   <result pre="136 Total 90 757 136 During the monitoring of seasonal" exact="influenza" post="virus in the territory of the Russian Federation in"/>
   <result pre="Russian Federation in the 2017–2018 epidemic season, 87 strains of" exact="influenza" post="A and B viruses were isolated: 47 strains of"/>
   <result pre="strains of A(H1N1)pdm09, 13 strains of A(H3N2), 25 strains of" exact="influenza" post="B virus of the Yamagata lineage and 2 strains"/>
   <result pre="B virus of the Yamagata lineage and 2 strains of" exact="influenza" post="B virus of the Victoria lineage. Influenza viruses from"/>
   <result pre="clinical material (S1, S3 and S5 Tables). Antigenic analysis of" exact="influenza" post="viruses The antigenic properties of all strains of influenza"/>
   <result pre="of influenza viruses The antigenic properties of all strains of" exact="influenza" post="A(H1N1)pdm09 virus (including 17 isolates from lethal cases of"/>
   <result pre="disease) were similar to the A/Michigan/45/2015 vaccine strain, strains of" exact="influenza" post="B/Yamagata-like virus (3 of which were isolated from lethal"/>
   <result pre="similar to the B/Phuket/3073/2013 vaccine strain, and two strains of" exact="influenza" post="B/Victoria-like virus were similar to the B/Brisbane/60/2008 vaccine strain."/>
   <result pre="egg adaptive changes decreased vaccine effectiveness [19]. Genetic analysis of" exact="influenza" post="viruses Influenza viruses from 75 selected cases (original specimen"/>
   <result pre="(S1 Table), 26 viruses of A(H3N2) subtype (S3 Table), 18" exact="influenza" post="B/Yamagata-like viruses and 2 influenza B/Victoria-like viruses (S5 Table)."/>
   <result pre="A(H3N2) subtype (S3 Table), 18 influenza B/Yamagata-like viruses and 2" exact="influenza" post="B/Victoria-like viruses (S5 Table). The complete nucleotide sequences of"/>
   <result pre="complete nucleotide sequences of the hemagglutinin (HA) gene for 70" exact="influenza" post="viruses were determined and were used to perform a"/>
   <result pre="analysis. The results of the phylogenetic analysis showed that the" exact="influenza" post="A(H1N1)pdm09 viruses from 26 cases grouped in clade 6B.1"/>
   <result pre="from 26 cases grouped in clade 6B.1 (S1 Fig), 25" exact="influenza" post="A(H3N2) viruses grouped in clade 3C.2a (of which 11"/>
   <result pre="of complete genomes (or partially sequenced genomes) of 29 selected" exact="influenza" post="viruses A(H1N1)pdm09 showed a close genetic similarity with the"/>
   <result pre="A(H1N1)pdm09 cases comprised 65% of all studied and diagnostically confirmed" exact="influenza" post="lethal cases in Russia, with H3N2 and influenza type"/>
   <result pre="diagnostically confirmed influenza lethal cases in Russia, with H3N2 and" exact="influenza" post="type B being 15% and 20%, respectively, according to"/>
   <result pre="of the HA gene of 29 selected cases of A(H1N1)pdm09" exact="influenza" post="revealed in the major virus variant the presence of"/>
   <result pre="criteria of the WHO expert working group on surveillance of" exact="influenza" post="antiviral susceptibility) [20, 21]. No mutations associated with resistance"/>
   <result pre="antiviral susceptibility) [20, 21]. No mutations associated with resistance of" exact="influenza" post="A(H1N1)pdm09 viruses to the NA inhibitor zanamivir were identified."/>
   <result pre="the NA inhibitor zanamivir were identified. Genetic analysis of A(H3N2)" exact="influenza" post="virus was performed for 26 selected cases, including 2"/>
   <result pre="of amino acid substitutions in the HA of the studied" exact="influenza" post="A(H3N2) viruses in comparison with the A/Hong Kong/4801/2014 vaccine"/>
   <result pre="with the vaccine strain. The majority of the fatal of" exact="influenza" post="B/Yamagata-like viruses were associated with the presence of the"/>
   <result pre="influenza B/Yamagata-like viruses were associated with the presence of the" exact="influenza" post="illness risk group factors established by the WHO (age"/>
   <result pre="genetically similar to the B/Brisbane/60/2008 vaccine strain. No variants of" exact="influenza" post="B/Victoria-like viruses with a deletion in the HA gene"/>
   <result pre="amino acid positions in the protein) were found. Analysis of" exact="influenza" post="cases in vaccinated individuals Of the 136 cases in"/>
   <result pre="those that recovered from influenza, 63 cases were diagnosed with" exact="influenza" post="virus B, 41 with A(H3N2) virus, 25 with A(H1N1)pdm09"/>
   <result pre="with A(H3N2) virus, 25 with A(H1N1)pdm09 virus and 3 with" exact="influenza" post="A virus that was not subtyped. There were only"/>
   <result pre="B/Yamagata-like virus. One of the A(H1N1)pdm09 viruses from a lethal" exact="influenza" post="case in a vaccinated individual, A/Irkutsk/1727/2018, was genetically analyzed."/>
   <result pre="the presence of serious chronic diseases, which are considered as" exact="influenza" post="risk factors by the WHO [26]. The second lethal"/>
   <result pre="risk factors by the WHO [26]. The second lethal A(H1N1)pdm09" exact="influenza" post="case in a vaccinated individual was associated with the"/>
   <result pre="the presence of serious chronic diseases, one of which was" exact="chronic obstructive pulmonary disease" post="(COPD). Analysis of sensitivity to anti-neuraminidase drugs In the"/>
   <result pre="seasonal influenza, sensitivity to oseltamivir and zanamivir of 87 isolated" exact="influenza" post="viruses A and B was analyzed. According to the"/>
   <result pre="the phenotypic study, all isolated isolates of A(H3N2) and B" exact="influenza" post="viruses were sensitive to anti-neuraminidase drugs oseltamivir and zanamivir."/>
   <result pre="Discussion In this study the assessment of population immunity to" exact="influenza" post="viruses before the 2017–2018 Russian epidemic season was performed"/>
   <result pre="Russian epidemic season was performed and a representative set of" exact="influenza" post="viruses, which circulated in Russia during the 2017–2018 epidemic"/>
   <result pre="Russia during the 2017–2018 epidemic season, from cases of severe" exact="influenza" post="disease, including cases with lethal outcome, and clinical material"/>
   <result pre="at the beginning of the epidemic period, one of the" exact="influenza" post="A virus subtypes (A(H1N1)pdm09 and A(H3N2), respectively) prevailed in"/>
   <result pre="(A(H1N1)pdm09 and A(H3N2), respectively) prevailed in the northern hemisphere and" exact="influenza" post="B viruses became prevalent at the end of the"/>
   <result pre="the epidemic season, joint circulation of type A and B" exact="influenza" post="strains was observed [6, 8]. The United States were"/>
   <result pre="The United States were characterized by a significant prevalence of" exact="influenza" post="A viruses (71.2%) over influenza B viruses (28.8%); of"/>
   <result pre="by a significant prevalence of influenza A viruses (71.2%) over" exact="influenza" post="B viruses (28.8%); of the influenza A viruses, 84.9%"/>
   <result pre="A viruses (71.2%) over influenza B viruses (28.8%); of the" exact="influenza" post="A viruses, 84.9% belonged to the A(H3N2) subtype and"/>
   <result pre="A(H3N2) subtype and 15.1% belonged to the A(H1N1)pdm09 subtype. Among" exact="influenza" post="B viruses, viruses of the B/Yamagata genetic lineage prevailed"/>
   <result pre="was observed with occurrences of a slightly higher prevalence of" exact="influenza" post="A virus (Canada, 57%), or influenza B virus (Europe,"/>
   <result pre="slightly higher prevalence of influenza A virus (Canada, 57%), or" exact="influenza" post="B virus (Europe, 56%). Different countries in Europe demonstrated"/>
   <result pre="in Europe demonstrated the predominance of a particular subtype of" exact="influenza" post="A virus (A(H3N2) in the UK, A(H1N1)pdm09 in France,"/>
   <result pre="proportions of both subtypes were approximately equal [9]. In China," exact="influenza" post="viruses of A and B type circulated in approximately"/>
   <result pre="to 4th weeks of 2018), A(H1N1)pdm09 strains significantly prevailed among" exact="influenza" post="A viruses [4TN]. Most of the influenza A(H1N1)pdm09 viruses"/>
   <result pre="significantly prevailed among influenza A viruses [4TN]. Most of the" exact="influenza" post="A(H1N1)pdm09 viruses studied in North America and Europe were"/>
   <result pre="recommendation of the WHO [29]. In Russia, none of the" exact="influenza" post="virus subtypes was dominant in the 2017–2018 epidemic season:"/>
   <result pre="27]. Analysis revealed an increase in the proportion of A(H1N1)pdm09" exact="influenza" post="virus detected in lethal influenza cases (65%) compared to"/>
   <result pre="in the proportion of A(H1N1)pdm09 influenza virus detected in lethal" exact="influenza" post="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2)"/>
   <result pre="cases (65%) compared to equal proportions of A(H1N1)pdm09, A(H3N2) and" exact="influenza" post="B viruses in all influenza cases. A similar increased"/>
   <result pre="proportions of A(H1N1)pdm09, A(H3N2) and influenza B viruses in all" exact="influenza" post="cases. A similar increased proportion of A(H1N1)pdm09 compared with"/>
   <result pre="virus isolates from the 19 studied lethal cases of A(H1N1)pdm09" exact="influenza" post="(Table 2, S1 and S2 Tables). It is known"/>
   <result pre="tract, which can lead to an increased risk of developing" exact="viral pneumonia." post="Some researchers suggest that increased virulence and lethality of"/>
   <result pre="Some researchers suggest that increased virulence and lethality of A(H1N1)pdm09" exact="influenza" post="virus may be caused by the presence of D222G/N"/>
   <result pre="accumulate as a result of selection from a mixture of" exact="influenza" post="virus variants (quasi-species) in the lower parts of the"/>
   <result pre="receptors in allantoic cells [35, 36, 37]. Cultivation of human" exact="influenza" post="viruses on MDCK cells has proved to be a"/>
   <result pre="stability and are used as the standard cell line for" exact="influenza" post="virus propagation [34]. MDCK cells have both 2,6- and"/>
   <result pre="those cell types. In previously reported genetic stability studies of" exact="influenza" post="virus propagation on MDCK cells, it was shown that"/>
   <result pre="evaluate the significance of the observed genetic changes of seasonal" exact="influenza" post="viruses in studies that employ virus isolation using MDCK"/>
   <result pre="epidemiological analysis and prognosis. Among the 87 analyzed isolates of" exact="influenza" post="A and B viruses, only one A(H1N1)pdm09 strain isolated"/>
   <result pre="only one A(H1N1)pdm09 strain isolated from a lethal case of" exact="influenza" post="was resistant to oseltamivir while remaining susceptible to zanamivir;"/>
   <result pre="season of 2017–2018, however, no more than 1% of the" exact="influenza" post="viruses analyzed in the Northern Hemisphere were characterized by"/>
   <result pre="decrease in sensitivity to NA inhibitors [27]. This class of" exact="influenza" post="drugs is still highly effective and specific for the"/>
   <result pre="is still highly effective and specific for the treatment of" exact="influenza" post="and is recommended for use at an early stage"/>
   <result pre="the population with protective antibody titers was 24%-47% against the" exact="influenza" post="vaccine strains prior to the 2017–2018 epidemic season and"/>
   <result pre="VB &quot;Vector�?, Rospotrebnadzor received clinical samples from 136 cases of" exact="influenza" post="among individuals vaccinated in the fall of 2017, 60%"/>
   <result pre="the fall of 2017, 60% of which included cases of" exact="influenza" post="disease among children under the age of 18 years"/>
   <result pre="the 2017–2018 season. The epidemic rise in the incidence of" exact="influenza" post="began during the 6th to 7th weeks of 2018,"/>
   <result pre="The proportion of patients with severe acute respiratory infection of" exact="influenza" post="etiology placed in the intensive care unit (2.3%) was"/>
   <result pre="trivalent vaccine recommended by the WHO for use in the" exact="influenza" post="season of 2018–2019, 2 components were simultaneously replaced: A(H3N2)"/>
   <result pre="instead of B/Brisbane/60/2008 strain) [27]. A new variant of B/Victoria-like" exact="influenza" post="virus, which has a deletion in the HA gene,"/>
   <result pre="prior to the 2017–2018 epidemic season. The rise of the" exact="influenza" post="epidemic began during the 6th to 7th weeks of"/>
   <result pre="2017–2018 epidemic season in Russia was characterized by a low" exact="influenza" post="disease incidence in persons vaccinated in the fall of"/>
   <result pre="next generation sequencing of the original clinical material and isolated" exact="influenza" post="strains of A(H1N1)pdm09 viruses revealed major or minor viral"/>
   <result pre="the 87 analyzed viral isolates only one strain of A(H1N1)pdm09" exact="influenza" post="virus was resistant to oseltamivir and had the H275Y"/>
   <result pre="inhibitor drugs at the first manifestation of clinical signs of" exact="influenza" post="disease are effective means of population protection against influenza."/>
   <result pre="information S1 Fig The phylogenetic tree for HA of A(H1N1)pdm09" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S2 Fig The phylogenetic tree for HA of A(H3N2)" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S3 Fig The phylogenetic tree for HA of B/Yamagata-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="file. S4 Fig The phylogenetic tree for HA of B/Victoria-like" exact="influenza" post="viruses analyzed in this study. (DOC) LINK Click here"/>
   <result pre="Click here for additional data file. S5 Table Type B" exact="influenza" post="virus cases characteristics. (DOC) LINK Click here for additional"/>
   <result pre="additional data file. S6 Table Case characteristics and properties of" exact="influenza" post="viruses isolated and characterized in the 2017–2018 epidemic season."/>
   <result pre="10.1016/j.meegid.2011.05.00221600305 5IlyichevaT, SobolevI, SusloparovI, KurskayaO, DurymanovA, SharshovK, et al.Monitoring of" exact="influenza" post="viruses in Western Siberia in 2008–2012. Infection, Genetics and"/>
   <result pre="KolosovaN, GoncharovaN, SvyatchenkoS, PetrovaO, BondarA, MikheevV, RyzhikovAFatal cases of seasonal" exact="influenza" post="in Russia in 2015–2016. PLoS One2016; 11(10):e016533210.1371/journal.pone.016533227776172 7IlyichevaT, AbdurashitovM,"/>
   <result pre="GoncharovaN, KolosovaN, MikheevV, RyzhikovA. Herd immunity and fatal cases of" exact="influenza" post="among the population exposed to poultry and wild birds"/>
   <result pre="2016; 88(1):35–44. 10.1002/jmv.2430126105790 8IlyichevaTN., DurymanovAG., SvyatchenkoSV, et al.Humoral immunity to" exact="influenza" post="in an at-risk population and severe influenza cases in"/>
   <result pre="al.Humoral immunity to influenza in an at-risk population and severe" exact="influenza" post="cases in Russia in 2016–2017. Arch Virol. 2018; 163:"/>
   <result pre="from http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic" exact="avian influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381–1385."/>
   <result pre="http://www.influenza.spb.ru/en/influenza_surveillance_system_in_russia/who_national_influenza_centre. 11MarchenkoVY, SusloparovIM, KomissarovAB, et al.Reintroduction of highly pathogenic avian" exact="influenza" post="A/H5N8 virus of clade 2.3.4.4. in Russia. Arch.Virol. 2017;162(5):1381–1385."/>
   <result pre="method for full genome sequencing of multiple subtypes of human" exact="influenza" post="A viruses. J Clin Virol. 2015;68:43–48. 10.1016/j.jcv.2015.04.01926071334 16HoffmannE, StechJ,"/>
   <result pre="PerezDR. Universal primer set for the full-length amplification of all" exact="influenza" post="A viruses. Arch. Virol. 2001;146:2275–2289. 10.1007/s00705017000211811679 17Li H, 2013."/>
   <result pre="10.1093/molbev/mst19724132122 19BarrIG, DonisRO, KatzJM, McCauleyJW, OdagiriT, TrusheimH, et al.Cell culture-derived" exact="influenza" post="vaccines in the severe 2017–2018 epidemic season: a step"/>
   <result pre="in the severe 2017–2018 epidemic season: a step towards improved" exact="influenza" post="vaccine effectiveness. NPJ Vaccines. 2018109;3:4410.1038/s41541-018-0079-z30323955 20collab: WHOMeetings of the"/>
   <result pre="20collab: WHOMeetings of the WHO working group on surveillance of" exact="influenza" post="antiviral susceptibility—Geneva, November 2011 and June 2012. Wkly. Epidemiol."/>
   <result pre="GregoryV, GubarevaLV, et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors and status of novel antivirals,"/>
   <result pre="HsuSZ, KuoCY, HuangHY, HuangTY, WangHC, et al.An epidemic surge of" exact="influenza" post="A(H3N2) virus at the end of the 2016–2017 season"/>
   <result pre="24ZostSJ, ParkhouseK, GuminaME, KimK, Diaz PerezS, WilsonPC, et al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="BarrIG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1)" exact="influenza" post="viruses. Antimicrob Agents Chemother. 2009;53(10):4433–4440. 10.1128/AAC.00334-0919651908 26Geneva: World Health"/>
   <result pre="Mortal Wkly Rep. 201868;67(22):634–642. 10.15585/mmwr.mm6722a429879098 28BlantonL, AlabiN, MustaquimD, et al.Update:" exact="influenza" post="activity in the United States during the 2016–17 season"/>
   <result pre="States during the 2016–17 season and composition of the 2017–18" exact="influenza" post="vaccine. MMWR Morb Mortal Wkly Rep2017;66:668–76. 10.15585/mmwr.mm6625a328662019 29BlumbergEAMMWR: Prevention"/>
   <result pre="Am J Transplant. 201811;18(11):282910.1111/ajt.1514030372600 30SelkovaEP, GrenkovaTA, GudovaNV, OganesyanAS. Results on" exact="influenza" post="and acute respiratory viral infection in the 2017–2018 epidemic"/>
   <result pre="SnackenR, MelidouA, IonescuS, PenttinenP. The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
   <result pre="GiombiniE, BartoliniB, AbbateI, et al.Detection of haemagglutinin D222 polymorphisms in" exact="influenza" post="A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. Clin Microbiol Infect. 2013;19(7):668–73."/>
   <result pre="33BaldantiF, CampaniniG, PirallaA, RovidaF, BraschiA, MojoliF, et al.Severe outcome of" exact="influenza" post="A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin:"/>
   <result pre="LaurieKL. MDCK-SIAT1 cells show improved isolation rates for recent human" exact="influenza" post="viruses compared to conventional MDCK cells. J Clin Microbiol."/>
   <result pre="linkages in the chicken egg amnion and allantois influence human" exact="influenza" post="virus receptor specificity and variant selection. J. Virol. 71:3357–3362."/>
   <result pre="JiaLiu, ZiLi, YuelongShu, DayanWang. Mutations associated with egg adaptation of" exact="influenza" post="A(H1N1)pdm09 virus in laboratory based surveillance in China, 2009–2016,"/>
   <result pre="MajorD, RobertsonEW, WoodJM. Sequence analysis of the haemagglutinin (HA) of" exact="influenza" post="A (H1N1) viruses present in clinical material and comparison"/>
   <result pre="J Gen Virol. 1991;72:2671–77; 10.1099/0022-1317-72-11-2671 .1940864 38ChowellG, MillerMA, ViboudC. Seasonal" exact="influenza" post="in the United States, France, and Australia: transmission and"/>
   <result pre="inhibition antibody titers as a correlate of protection for inactivated" exact="influenza" post="vaccines in children. Pediatr Infect Dis J. 201112;30(12):1081–5. 10.1097/INF.0b013e318236766221983214"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6664529\results\search\disease\results.xml">
   <result pre="66645294306 doi: 10.1186/s12879-019-4306-7 : Case Report Successful management of refractory" exact="respiratory failure" post="caused by avian influenza H7N9 and secondary organizing pneumonia:"/>
   <result pre="Case Report Successful management of refractory respiratory failure caused by" exact="avian influenza" post="H7N9 and secondary organizing pneumonia: a case report and"/>
   <result pre="Report Successful management of refractory respiratory failure caused by avian" exact="influenza" post="H7N9 and secondary organizing pneumonia: a case report and"/>
   <result pre="available in this article, unless otherwise stated. Abstract Backgroud Organizing" exact="pneumonia" post="(OP) is a rare complication of influenza infection that"/>
   <result pre="Abstract Backgroud Organizing pneumonia (OP) is a rare complication of" exact="influenza" post="infection that has substantial morbidity. We report the first"/>
   <result pre="morbidity. We report the first case of OP associated with" exact="avian influenza" post="H7N9 infection that had significant improvement with corticosteroid treatment."/>
   <result pre="We report the first case of OP associated with avian" exact="influenza" post="H7N9 infection that had significant improvement with corticosteroid treatment."/>
   <result pre="A 35-year-old male admitted to intensive care unit because of" exact="respiratory failure." post="He was diagnosed as severe pneumonia caused by avian"/>
   <result pre="unit because of respiratory failure. He was diagnosed as severe" exact="pneumonia" post="caused by avian influenza H7N9 viral infection. After initial"/>
   <result pre="respiratory failure. He was diagnosed as severe pneumonia caused by" exact="avian influenza" post="H7N9 viral infection. After initial clinical improvement supported by"/>
   <result pre="failure. He was diagnosed as severe pneumonia caused by avian" exact="influenza" post="H7N9 viral infection. After initial clinical improvement supported by"/>
   <result pre="was the first case of successful management of refractory severe" exact="respiratory failure" post="caused by avian influenza H7N9 infection complicated with OP."/>
   <result pre="of successful management of refractory severe respiratory failure caused by" exact="avian influenza" post="H7N9 infection complicated with OP. Refractory hypoxia with clinical"/>
   <result pre="successful management of refractory severe respiratory failure caused by avian" exact="influenza" post="H7N9 infection complicated with OP. Refractory hypoxia with clinical"/>
   <result pre="considered among patients at the second or third week of" exact="influenza" post="H7N9 infection, especially in patients with clinical condition deteriorated"/>
   <result pre="especially in patients with clinical condition deteriorated after the primary" exact="influenza" post="pneumonia was controlled. And a steroid dose of methylprednisolone"/>
   <result pre="in patients with clinical condition deteriorated after the primary influenza" exact="pneumonia" post="was controlled. And a steroid dose of methylprednisolone 1.5 mg/kg"/>
   <result pre="1.5 mg/kg may be suggested for treatment of OP associated with" exact="avian influenza" post="H7N9 infection. Keywords Organizing pneumonia Avian influenza H7N9 Respiratory"/>
   <result pre="may be suggested for treatment of OP associated with avian" exact="influenza" post="H7N9 infection. Keywords Organizing pneumonia Avian influenza H7N9 Respiratory"/>
   <result pre="of OP associated with avian influenza H7N9 infection. Keywords Organizing" exact="pneumonia" post="Avian influenza H7N9 Respiratory failure Background Human infected with"/>
   <result pre="associated with avian influenza H7N9 infection. Keywords Organizing pneumonia Avian" exact="influenza" post="H7N9 Respiratory failure Background Human infected with avian influenza"/>
   <result pre="pneumonia Avian influenza H7N9 Respiratory failure Background Human infected with" exact="avian influenza" post="A H7N9 virus were first confirmed on March 30th,"/>
   <result pre="Avian influenza H7N9 Respiratory failure Background Human infected with avian" exact="influenza" post="A H7N9 virus were first confirmed on March 30th,"/>
   <result pre="2013 in China [1, 2], with high incidence of severe" exact="respiratory failure," post="high intensive care unit (ICU) admission and mortality. The"/>
   <result pre="care unit (ICU) admission and mortality. The development of organizing" exact="pneumonia" post="(OP) has been reported in patients with influenza A,"/>
   <result pre="of organizing pneumonia (OP) has been reported in patients with" exact="influenza" post="A, H1N1 and influenza B, and a high incidence"/>
   <result pre="has been reported in patients with influenza A, H1N1 and" exact="influenza" post="B, and a high incidence of more than 10%"/>
   <result pre="a high incidence of more than 10% of OP in" exact="influenza" post="A H1N1 was reported in one case series [3–5]."/>
   <result pre="report, we describe the first case of OP associated with" exact="avian influenza" post="H7N9 infection. Case presentation A 35 year-old male, non-smoker, with"/>
   <result pre="we describe the first case of OP associated with avian" exact="influenza" post="H7N9 infection. Case presentation A 35 year-old male, non-smoker, with"/>
   <result pre="two days. And his condition deteriorated with dyspnea and severe" exact="respiratory failure," post="and the blood gas analysis showed PaO2 was 58 mmHg"/>
   <result pre="culture for bacteria and the microscopic examination for bacteria and" exact="tuberculosis" post="were done at ICU admission. The nucleic acid polymerase"/>
   <result pre="ICU admission. The nucleic acid polymerase chain reaction (PCR) for" exact="influenza" post="H7N9 virus of sputum specimen turned out to be"/>
   <result pre="aggravating consolidation on new areas (Fig. 1), compatible with organizing" exact="pneumonia" post="(OP). Considering no underlying cause of OP existed other"/>
   <result pre="existed other than virus infection, therefore, OP associated with H7N9" exact="influenza" post="virus infection was suspected. Methylprednisolone 80 mg (1 mg/kg) daily was"/>
   <result pre="fever to 40 °C, refractory hypoxemia (PaO2:FiO2 = 65) and a mild" exact="leukopenia" post="(WBC was 11.92 × 109/L). the patient was reintubated and supported"/>
   <result pre="of consolidation especially in the lower lobe. As the patient’s" exact="respiratory failure" post="and condition did not improve after 5 days of daily"/>
   <result pre="infection showed gradually improvement, with mild interlobular septal thickening, traction" exact="bronchiectasis" post="and consolidation in chest CT on the ninth month"/>
   <result pre="published cases and the current case of OP associated with" exact="influenza" post="virus infection were reviewed [3–10]. With available information, the"/>
   <result pre="The other one case was OP complicated with co-infection of" exact="influenza" post="B and Streptococcus. Respiratory failure associated with OP was"/>
   <result pre="67%(8/12) of cases, with release of primary opacity associated with" exact="influenza" post="infection in some cases. Autopsy were applied at about"/>
   <result pre="OP in our case. Table 1 Cas series reported organizing" exact="pneumonia" post="associated with influenza viral infection Citation Age Gender Virus"/>
   <result pre="case. Table 1 Cas series reported organizing pneumonia associated with" exact="influenza" post="viral infection Citation Age Gender Virus type Manifestation HRCT"/>
   <result pre="Respiratory failure Not examined 12 days Autopsy OP, DAD, hemorrhage and" exact="bronchiolitis" post="NR Dead 24 F H1N1 Respiratory failure Consolidation and"/>
   <result pre="3d improvement 36 M H1N1 Fever, increased inflammatory parameters, and" exact="respiratory failure" post="Consolidation and loss of global lung volume Over 3 weeks"/>
   <result pre="fibrosis and residual dyspnea This case 35 M H7N9 Fever," exact="respiratory failure" post="Consolidation and GGO 39 days OLB OP, hemorrhage and edema"/>
   <result pre="C/R improvement Discussion and conclusions Since the cases infected with" exact="avian influenza" post="H7N9 virus were first confirmed in 2013 in China"/>
   <result pre="improvement Discussion and conclusions Since the cases infected with avian" exact="influenza" post="H7N9 virus were first confirmed in 2013 in China"/>
   <result pre="exposure to disease onset was five days, then, 6.8 days to" exact="acute respiratory distress syndrome" post="(ARDS). In dead cases, the median time from disease"/>
   <result pre="patients required mechanical ventilation and 21% need ECMO for severe" exact="respiratory failure" post="[1, 2]. However, refractory severe respiratory failure caused by"/>
   <result pre="ECMO for severe respiratory failure [1, 2]. However, refractory severe" exact="respiratory failure" post="caused by OP secondary to avian influenza H7N9 virus"/>
   <result pre="However, refractory severe respiratory failure caused by OP secondary to" exact="avian influenza" post="H7N9 virus infection was first reported in this case."/>
   <result pre="refractory severe respiratory failure caused by OP secondary to avian" exact="influenza" post="H7N9 virus infection was first reported in this case."/>
   <result pre="obliterans organizing pneumonia�? (BOOP) [14]. Now, for avoiding confusion with" exact="bronchiolitis" post="obliterans (BO), the term organizing pneumonia (OP) is preferred"/>
   <result pre="for avoiding confusion with bronchiolitis obliterans (BO), the term organizing" exact="pneumonia" post="(OP) is preferred [15]. In fact, OP is an"/>
   <result pre="injuries. It can be with idiopathic nature, namely cryptogenic organizing" exact="pneumonia" post="(COP), or be associated with different clinical settings, such"/>
   <result pre="fungus or parasite), drugs (antibiotics, antiepileptics, immunomodulators), connective tissue disease," exact="vasculitis" post="or lung/marrow transplantation. Considering symptomatology, physical signs, laboratory and"/>
   <result pre="have higher mortality [16]. OP has been linked to multiple" exact="influenza" post="viral infections including influenza A and B, but this"/>
   <result pre="OP has been linked to multiple influenza viral infections including" exact="influenza" post="A and B, but this is the first report"/>
   <result pre="A and B, but this is the first report of" exact="avian influenza" post="H7N9-associated OP with relapse occurrence and severe respiratory failure."/>
   <result pre="and B, but this is the first report of avian" exact="influenza" post="H7N9-associated OP with relapse occurrence and severe respiratory failure."/>
   <result pre="of avian influenza H7N9-associated OP with relapse occurrence and severe" exact="respiratory failure." post="The main clinical features of our avian influenza H7N9-associated"/>
   <result pre="and severe respiratory failure. The main clinical features of our" exact="avian influenza" post="H7N9-associated OP is similar to the cases of influenza"/>
   <result pre="severe respiratory failure. The main clinical features of our avian" exact="influenza" post="H7N9-associated OP is similar to the cases of influenza"/>
   <result pre="avian influenza H7N9-associated OP is similar to the cases of" exact="influenza" post="A cases. In these cases reported, OP onset mostly"/>
   <result pre="of primary virus infection; And the OP is complicated with" exact="respiratory failure," post="and no evidence of other pathogen was found; And"/>
   <result pre="TBLB or OLB at the third week. In cases with" exact="influenza" post="associated OP, other than common findings of OP, diffuse"/>
   <result pre="OP, diffuse alveolar damage (DAD), alveolar hemorrhage and edema and" exact="bronchiolitis" post="can also be found, showing the lung injury of"/>
   <result pre="a main manifestation of OP, and had a relapse of" exact="respiratory failure" post="associated with OP. A differential diagnosis of OP should"/>
   <result pre="to third week after the primary infection among patients with" exact="influenza" post="H7N9 infection. Furthermore, there was no clear evidence of"/>
   <result pre="by the nosocomial infection which was frequently complicated with severe" exact="influenza" post="pneumonia. The majority of patients with OP show rapid"/>
   <result pre="may relapse in tapering period. For the current patient with" exact="avian influenza" post="H7N9-associated OP, methylprednisolone 80 mg (1 mg/kg) daily was applied for"/>
   <result pre="relapse in tapering period. For the current patient with avian" exact="influenza" post="H7N9-associated OP, methylprednisolone 80 mg (1 mg/kg) daily was applied for"/>
   <result pre="to the relapsing of OP before final diagnosis. Therefore, Post" exact="avian influenza" post="H7N9 infection OP may responsive to a brief course"/>
   <result pre="the relapsing of OP before final diagnosis. Therefore, Post avian" exact="influenza" post="H7N9 infection OP may responsive to a brief course"/>
   <result pre="knowledge, this was the first case of OP associated with" exact="avian influenza" post="H7N9 infection. With clinical manifestation and radiological findings compatible"/>
   <result pre="this was the first case of OP associated with avian" exact="influenza" post="H7N9 infection. With clinical manifestation and radiological findings compatible"/>
   <result pre="OP, a differential diagnosis should be considered among patients with" exact="influenza" post="H7N9 infection at the second or third week after"/>
   <result pre="in patients with clinical condition deteriorated after controlling of primary" exact="influenza" post="pneumonia. And a steroid dose of methylprednisolone 1.5 mg/kg maybe"/>
   <result pre="methylprednisolone 1.5 mg/kg maybe suggested for treatment of OP associated with" exact="avian influenza" post="H7N9 infection. Our case provide clinical insight into refractory"/>
   <result pre="1.5 mg/kg maybe suggested for treatment of OP associated with avian" exact="influenza" post="H7N9 infection. Our case provide clinical insight into refractory"/>
   <result pre="influenza H7N9 infection. Our case provide clinical insight into refractory" exact="respiratory failure" post="with lung involvement due to avian influenza H7N9. OP"/>
   <result pre="insight into refractory respiratory failure with lung involvement due to" exact="avian influenza" post="H7N9. OP should be considered on the differential diagnosis"/>
   <result pre="into refractory respiratory failure with lung involvement due to avian" exact="influenza" post="H7N9. OP should be considered on the differential diagnosis"/>
   <result pre="considered on the differential diagnosis of patients with fever and" exact="respiratory failure" post="after severe influenza A H7N9 infection, where steroids might"/>
   <result pre="diagnosis of patients with fever and respiratory failure after severe" exact="influenza" post="A H7N9 infection, where steroids might be useful. Abbreviations"/>
   <result pre="ICU Intensive care unit OLB Open lung biopsy OP Organizing" exact="pneumonia" post="Publisher’s Note Springer Nature remains neutral with regard to"/>
   <result pre="interests. References References 1.GaoRCaoBHuYFengZWangDHuWChenJJieZQiuHXuKet al.Human infection with a novel avian-origin" exact="influenza" post="a (H7N9) virusN Engl J Med2013368201888189710.1056/NEJMoa130445923577628 2.ChenYLiangWYangSWuNGaoHShengJYaoHWoJFangQCuiDet al.Human infections"/>
   <result pre="virusN Engl J Med2013368201888189710.1056/NEJMoa130445923577628 2.ChenYLiangWYangSWuNGaoHShengJYaoHWoJFangQCuiDet al.Human infections with the emerging" exact="avian influenza" post="a H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="Engl J Med2013368201888189710.1056/NEJMoa130445923577628 2.ChenYLiangWYangSWuNGaoHShengJYaoHWoJFangQCuiDet al.Human infections with the emerging avian" exact="influenza" post="a H7N9 virus from wet market poultry: clinical analysis"/>
   <result pre="J, Luengo C, Tobar E, Romero C, Galvez LR. Organizing" exact="pneumonia" post="in patients with severe respiratory failure due to novel"/>
   <result pre="Romero C, Galvez LR. Organizing pneumonia in patients with severe" exact="respiratory failure" post="due to novel a (H1N1) influenza. BMJ Case Rep."/>
   <result pre="novel a (H1N1) influenza. BMJ Case Rep. 2010;2010. 4.StaudRRamosLGInfluenza A-associated" exact="bronchiolitis" post="obliterans organizing pneumonia mimicking Wegener's granulomatosisRheumatol Int200120312512810.1007/s00296000009511354560 5.KwokWCLamSHWongMPIpMSLamDCInfluenza B/streptococcal"/>
   <result pre="influenza. BMJ Case Rep. 2010;2010. 4.StaudRRamosLGInfluenza A-associated bronchiolitis obliterans organizing" exact="pneumonia" post="mimicking Wegener's granulomatosisRheumatol Int200120312512810.1007/s00296000009511354560 5.KwokWCLamSHWongMPIpMSLamDCInfluenza B/streptococcal co-infection complicated by"/>
   <result pre="complicated by organizing pneumoniaRespirol Case Rep201645e0017027516886 6.FujitaJBandohSYamaguchiMHigaFTateyamaMChest CT findings of" exact="influenza" post="virus-associated pneumonia in 12 adult patientsInfluenza Other Respir Viruses200715–618318710.1111/j.1750-2659.2008.00034.x19453425"/>
   <result pre="organizing pneumoniaRespirol Case Rep201645e0017027516886 6.FujitaJBandohSYamaguchiMHigaFTateyamaMChest CT findings of influenza virus-associated" exact="pneumonia" post="in 12 adult patientsInfluenza Other Respir Viruses200715–618318710.1111/j.1750-2659.2008.00034.x19453425 7.FujitaJOhtsukiYHigaHAzumaMYoshinouchiTHaranagaSHigaFTateyamaMClinicopathological findings"/>
   <result pre="Other Respir Viruses200715–618318710.1111/j.1750-2659.2008.00034.x19453425 7.FujitaJOhtsukiYHigaHAzumaMYoshinouchiTHaranagaSHigaFTateyamaMClinicopathological findings of four cases of pure" exact="influenza" post="virus a pneumoniaIntern Med201453121333134210.2169/internalmedicine.53.117424930653 8.MarchioriEZanettiGFontesCASantosMLValiantePMManoCMTeixeiraGHHochheggerBInfluenza a (H1N1) virus-associated pneumonia:"/>
   <result pre="Influenza A (H1N1) organising pneumonia. BMJ Case Rep. 2010;2010. 10.Gomez-GomezAMartinez-MartinezRGotwayMBOrganizing" exact="pneumonia" post="associated with swine-origin influenza a H1N1 2009 viral infectionAJR"/>
   <result pre="pneumonia. BMJ Case Rep. 2010;2010. 10.Gomez-GomezAMartinez-MartinezRGotwayMBOrganizing pneumonia associated with swine-origin" exact="influenza" post="a H1N1 2009 viral infectionAJR Am J Roentgenol20111961W103W10410.2214/AJR.10.468921178022 11.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet"/>
   <result pre="Am J Roentgenol20111961W103W10410.2214/AJR.10.468921178022 11.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection with" exact="avian influenza" post="a(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="J Roentgenol20111961W103W10410.2214/AJR.10.468921178022 11.ZhouLRenRYangLBaoCWuJWangDLiCXiangNWangYLiDet al.Sudden increase in human infection with avian" exact="influenza" post="a(H7N9) virus in China, September-December 2016Western Pac Surveill Response"/>
   <result pre="Surveill Response J20178161410.5365/wpsar.2017.8.1.001 12.GaoHNLuHZCaoBDuBShangHGanJHLuSHYangYDFangQShenYZet al.Clinical findings in 111 cases of" exact="influenza" post="a (H7N9) virus infectionN Engl J Med2013368242277228510.1056/NEJMoa130558423697469 13.DavisonAGHeardBEMcAllisterWATurner-WarwickMECryptogenic organizing"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6667926\results\search\disease\results.xml">
   <result pre="IFN response can reduce the peak viral load during an" exact="influenza" post="infection and explain the viral load plateau observed after"/>
   <result pre="spread spatially. For a wide variety of viral infections, including" exact="influenza" post="infection (22), HIV infection (29), mosquito borne viral infection,"/>
   <result pre="cell can infect is reduced. For many other viruses, e.g.," exact="influenza" post="virus (22, 24) and HCV (23, 32), spatial viral"/>
   <result pre="example, imaging of liver biopsy from patients chronically infected with" exact="hepatitis" post="C virus (HCV) showed that HCV infected cells form"/>
   <result pre="another study (33), to understand the evolutionary trade-off of viral" exact="suppression" post="of the IFN response, Domingo-Calap et al. compared the"/>
   <result pre="compared the spread of a wild-type strain of the vesicular" exact="stomatitis" post="virus to a mutant strain that stimulates stronger IFN"/>
   <result pre="Similar patterns of foci of infection are also observed for" exact="influenza" post="virus (22). Further work is warranted to consider network"/>
   <result pre="pathology and death in nonhuman primates infected by highly pathogenic" exact="influenza" post="virus. Proc Natl Acad Sci USA. (2009) 106:3455–60. 10.1073/pnas.081323410619218453"/>
   <result pre="11:e1005345. 10.1371/journal.ppat.100534526720415 7.DuYXinLShiYZhangTHWuNCDaiLet al.. Genome-wide identification of interferon-sensitive mutations enables" exact="influenza" post="vaccine design. Science. (2018) 359:290–6. 10.1126/science.aan880629348231 8.IyerSSBibollet-RucheFSherrill-MixSLearnGHPlenderleithLSmithAGet al.. Resistance"/>
   <result pre="9.Hirai-YukiAHensleyLMcgivernDRGonzalez-LopezODasAFengHet al.. MAVS-dependent host species range and pathogenicity of human" exact="hepatitis" post="A virus. Science. (2016) 353:1541–5. 10.1126/science.aaf832527633528 10.TakeuchiOAkiraS. Pattern recognition"/>
   <result pre="response. Nature. (2011) 472:481–5. 10.1038/nature0990721478870 12.McnabFMayer-BarberKSherAWackAO'garraA. Type I interferons in" exact="infectious disease." post="Nat Rev Immunol. (2015) 15:87–103. 10.1038/nri378725614319 13.BaccamPBeaucheminCMackenCAHaydenFGPerelsonAS. Kinetics of"/>
   <result pre="disease. Nat Rev Immunol. (2015) 15:87–103. 10.1038/nri378725614319 13.BaccamPBeaucheminCMackenCAHaydenFGPerelsonAS. Kinetics of" exact="influenza" post="A virus infection in humans. J Virol. (2006) 80:7590–9."/>
   <result pre="Soc Interface. (2006) 3:699–709. 10.1098/rsif.2006.013616971338 15.PawelekKAHuynhGTQuinlivanMCullinaneARongLPerelsonAS. Modeling within-host dynamics of" exact="influenza" post="virus infection including immune responses. PLoS Comput Biol. (2012)"/>
   <result pre="Natl Acad Sci USA. (2009) 106:6872–7. 10.1073/pnas.081076210619332788 22.MatrosovichMNMatrosovichTYGrayTRobertsNAKlenkHD. Human and" exact="avian influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="Acad Sci USA. (2009) 106:6872–7. 10.1073/pnas.081076210619332788 22.MatrosovichMNMatrosovichTYGrayTRobertsNAKlenkHD. Human and avian" exact="influenza" post="viruses target different cell types in cultures of human"/>
   <result pre="Sci USA. (2004) 101:4620–4. 10.1073/pnas.030800110115070767 23.WielandSMakowskaZCampanaBCalabreseDDillMTChungJet al.. Simultaneous detection of" exact="hepatitis" post="C virus and interferon stimulated gene expression in infected"/>
   <result pre="of human airway epithelium by human and avian strains of" exact="influenza" post="a virus. J Virol. (2006) 80:8060–8. 10.1128/JVI.00384-0616873262 27.NichollsJMChanRWRussellRJAirGMPeirisJM. Evolving"/>
   <result pre="virus. J Virol. (2006) 80:8060–8. 10.1128/JVI.00384-0616873262 27.NichollsJMChanRWRussellRJAirGMPeirisJM. Evolving complexities of" exact="influenza" post="virus and its receptors. Trends Microbiol. (2008) 16:149–57. 10.1016/j.tim.2008.01.00818375125"/>
   <result pre="16:149–57. 10.1016/j.tim.2008.01.00818375125 28.De GraafMFouchierRA. Role of receptor binding specificity in" exact="influenza" post="A virus transmission and pathogenesis. EMBO J. (2014) 33:823–41."/>
   <result pre="(2005) 2:295–307. 10.1098/rsif.2005.005116849187 36.MeyersLContact network epidemiology: Bond percolation applied to" exact="infectious disease" post="prediction and control. B Am Math Soc. (2007) 44:63–86."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669529\results\search\disease\results.xml">
   <result pre="the genus Morbillivirus within the family Paramyxoviridae, which also includes" exact="measles" post="virus (measles morbillivirus—MeV), phocine distemper virus (phocine morbillivirus—PDV), peste"/>
   <result pre="Domestic Dogs and Wildlife Canine distemper is a worldwide distributed" exact="viral disease" post="that is highly contagious and has high morbidity and"/>
   <result pre="gastroenteritis, hyperkeratosis of the plantar pads and snout, and tooth" exact="enamel hypoplasia" post="in puppies [26] In addition, seizures, myoclonia with hyperesthesia,"/>
   <result pre="in viremia in peripheral blood mononuclear cells and mild transient" exact="leukopenia" post="and lymphopenia, however no clinical signs of disease were"/>
   <result pre="have shown high neuropathogenicity potential in those animals with severe" exact="encephalitis" post="[32,111,112,113]. Thus, the ability of the virus to adapt"/>
   <result pre="was made to establish a possible association between CDV with" exact="multiple sclerosis" post="by finding CDV antibodies in patients with multiple sclerosis"/>
   <result pre="with multiple sclerosis by finding CDV antibodies in patients with" exact="multiple sclerosis" post="[118]. It is well known that experimental MeV vaccination"/>
   <result pre="All of these cases showed evidence of nervous symptomatology and" exact="respiratory disease" post="with fatal outcomes [129]. The mutations association studies of"/>
   <result pre="protein expressionJ. Virol.200882105101051810.1128/JVI.01419-0818753197 6.WolfeN.D.DunavanC.P.DiamondJ.Origins of major human infectious diseasesNature200744727928310.1038/nature0577517507975 7.SchuhmannK.M.PfallerC.K.ConzelmannK.K.The" exact="measles" post="virus V protein binds to p65 (Rela) to suppress"/>
   <result pre="marker PVRL4 (nectin 4) is an epithelial cell receptor for" exact="measles" post="virusPLoS Pathog.20117e100224010.1371/journal.ppat.100224021901103 15.SchultzR.D.ThielB.MukhtarE.SharpP.LarsonL.J.Age and long-term protective immunity in dogs"/>
   <result pre="of canine distemper virusVirol. J.2019163010.1186/s12985-019-1136-630845967 102.LinL.T.RichardsonC.D.The host cell receptors for" exact="measles" post="virus and their interaction with the viral hemagglutinin (h)"/>
   <result pre="cell-to-cell spreadVirology2014454–45510911710.1016/j.virol.2014.02.01424725937 108.NoyceR.S.RichardsonC.D.Nectin 4 is the epithelial cell receptor for" exact="measles" post="virusTrends Microbiol.20122042943910.1016/j.tim.2012.05.00622721863 109.PratakpiriyaW.Ping TehA.P.RadtanakatikanonA.PiraratN.Thi LanN.TakedaM.TechangamsuwanS.YamaguchiR.Expression of canine distemper virus"/>
   <result pre="119.De VriesP.UytdehaagF.G.OsterhausA.D.Canine distemper virus (CDV) immune-stimulating complexes (iscoms), but not" exact="measles" post="virus iscoms, protect dogs against CDV infectionJ. Gen. Virol1988692071208310.1099/0022-1317-69-8-20713404123"/>
   <result pre="virus induce incomplete immunity to canine distemperArch. Virol.198482738210.1007/BF013093696497659 121.BakerJ.A.SheffyB.E.RobsonD.S.GilmartinJ.Response to" exact="measles" post="virus by puppies with maternally transferred distemper antibodiesCornell Vet.1966565885946008347"/>
   <result pre="viruses studied with monoclonal antibodiesJ. Gen. Virol.1986671381139210.1099/0022-1317-67-7-13812425047 124.RouxelR.N.SvitekN.von MesslingV.A chimeric" exact="measles" post="virus with canine distemper envelope protects ferrets from lethal"/>
   <result pre="J. Paleopathol.20192426627810.1016/j.ijpp.2018.12.00730743216 142.BeatyS.M.LeeB.Constraints on the genetic and antigenic variability of" exact="measles" post="virusViruses2016810910.3390/v804010927110809 143.YuanC.LiuW.WangY.HouJ.ZhangL.WangG.Homologous recombination is a force in the evolution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669537\results\search\disease\results.xml">
   <result pre="an ecological niche and could be a potential source of" exact="viral disease." post="The identification of SiMSiV and RhGMV in all regions"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669682\results\search\disease\results.xml">
   <result pre="infection in humans, ZIKV may cause disease in adults, including" exact="meningoencephalitis" post="[6], myelitis [7], thrombocytopenia [8], and Guillain–Barré syndrome [9,10]."/>
   <result pre="humans, ZIKV may cause disease in adults, including meningoencephalitis [6]," exact="myelitis" post="[7], thrombocytopenia [8], and Guillain–Barré syndrome [9,10]. It is"/>
   <result pre="may cause disease in adults, including meningoencephalitis [6], myelitis [7]," exact="thrombocytopenia" post="[8], and Guillain–Barré syndrome [9,10]. It is now established"/>
   <result pre="of a potent anti-ZIKV factor. Similar to earlier findings for" exact="hepatitis" post="C virus (HCV), this factor is dominant in the"/>
   <result pre="BrouckerT.Brun-BuissonC.Leparc-GoffartI.et al.Zika Virus Associated with MeningoencephalitisN. Engl. J. Med.20163741595159610.1056/NEJMc160296426958738 7.MécharlesS.HerrmannC.PoullainP.TranT.-H.DeschampsN.MathonG.LandaisA.BreurecS.LannuzelA.Acute" exact="myelitis" post="due to Zika virus infectionLancet2016387148110.1016/S0140-6736(16)00644-926946926 8.KarimiO.GoorhuisA.SchinkelJ.CodringtonJ.VredenS.G.S.VermaatJ.S.StijnisC.GrobuschM.P.Thrombocytopenia and subcutaneous bleedings"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6669691\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Reporter" exact="influenza" post="A viruses (IAVs) carrying fluorescent or luminescent genes provide"/>
   <result pre="co-circulates with H1N1 among humans causing annual epidemics, a reporter" exact="influenza" post="A subtype H3N2 virus would be highly valuable. In"/>
   <result pre="(Gluc) gene. Using reverse genetics, NY-r19-Gluc, a replication competent reassortant" exact="influenza" post="A subtype H3N2 virus expressing reporter Gluc was successfully"/>
   <result pre="therapeutic antibodies as well as the evaluation of novel vaccines." exact="influenza" post="A virus subtype H3N2 reassortant reporter virus 1. Introduction"/>
   <result pre="A virus subtype H3N2 reassortant reporter virus 1. Introduction The" exact="influenza" post="A virus (IAV) is a major cause of respiratory"/>
   <result pre="Currently, IAV subtypes H1N1 and H3N2 as well as two" exact="influenza" post="B virus strains of Yamagata and Victoria lineages co-circulate"/>
   <result pre="the similarity between different groups is only 40–44% [10]. Seasonal" exact="influenza" post="vaccines are prepared in advance according to the recommendations"/>
   <result pre="containing two IAV strains (H1N1 and H3N2) and one (trivalent" exact="influenza" post="vaccine) or two (quadrivalent influenza vaccine) influenza B virus"/>
   <result pre="and H3N2) and one (trivalent influenza vaccine) or two (quadrivalent" exact="influenza" post="vaccine) influenza B virus (IBV) strains. These vaccines usually"/>
   <result pre="and one (trivalent influenza vaccine) or two (quadrivalent influenza vaccine)" exact="influenza" post="B virus (IBV) strains. These vaccines usually become less"/>
   <result pre="match the circulating strain(s), particularly in the context of an" exact="influenza" post="pandemic [12]. Several compounds have been shown to block"/>
   <result pre="Here we report the successful generation of a reporter reassortant" exact="influenza" post="A subtype H3N2 virus carrying the Gaussia luciferase (Gluc)"/>
   <result pre="to NS1 Loses the Reporter Gene Rapidly Previously, a reporter" exact="influenza" post="A subtype H1N1 virus PR8-Gluc was successfully generated by"/>
   <result pre="a similar strategy was initially employed to generate the reporter" exact="influenza" post="A subtype H3N2 virus, NY-Gluc (Figure 1a). However, as"/>
   <result pre="Carrying PR8/NS-Gluc Segment Induces CPE Alteration To generate the reporter" exact="influenza" post="A subtype H3N2 virus, another strategy was explored based"/>
   <result pre="reassortant NY-r19-Gluc virus is a good candidate as a reporter" exact="influenza" post="A subtype H3N2 virus for further characterization and application."/>
   <result pre="cells (Figure 4d). Collectively, these data demonstrate that the reporter" exact="influenza" post="A subtype H3N2 virus NY-r19-Gluc is replication-competent, and viral"/>
   <result pre="open reading frame that was successfully used to construct reporter" exact="influenza" post="A subtype H1N1 viruses [28,45] failed to generate a"/>
   <result pre="A subtype H1N1 viruses [28,45] failed to generate a reporter" exact="influenza" post="A subtype H3N2 virus (Figure 1). This is not"/>
   <result pre="protein was also explored in this study, and a reporter" exact="influenza" post="A subtype H3N2 virus NY-r18-Gluc was successfully rescued. This"/>
   <result pre="tool. Using a third strategy, we successfully generated a reporter" exact="influenza" post="subtype H3N2 virus NY-r19-Gluc, which is a 6:2 genetic"/>
   <result pre="or vaccines against IAVs. In summary, a stable replication-competent reassortant" exact="influenza" post="A subtype H3N2 virus carrying a Gluc gene was"/>
   <result pre="New York, NY, USA) for generously providing the plasmids for" exact="influenza" post="reverse genetics. Author Contributions Conceptualization, L.R. and R.D.; Data"/>
   <result pre="Challenges and solutionsCell Host Microbe20151729530010.1016/j.chom.2015.02.01225766291 4.TongS.LiY.RivaillerP.ConrardyC.CastilloD.A.ChenL.M.RecuencoS.EllisonJ.A.DavisC.T.YorkI.A.et al.A distinct lineage of" exact="influenza" post="A virus from batsProc. Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 5.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et"/>
   <result pre="Natl. Acad. Sci. USA20121094269427410.1073/pnas.111620010922371588 5.TongS.ZhuX.LiY.ShiM.ZhangJ.BourgeoisM.YangH.ChenX.RecuencoS.GomezJ.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 6.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal influenza"/>
   <result pre="diverse influenza A virusesPLoS Pathog.20139e100365710.1371/journal.ppat.100365724130481 6.GrohskopfL.A.OlsenS.J.SokolowL.Z.BreseeJ.S.CoxN.J.BroderK.R.KarronR.A.WalterE.B.Prevention and control of seasonal" exact="influenza" post="with vaccines: recommendations of the Advisory Committee on Immunization"/>
   <result pre="Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15" exact="influenza" post="seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an"/>
   <result pre="influenza seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an" exact="avian influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="seasonMmwr. Morb. Mortal. Wkly. Rep.20146369169725121712 7.SubbaraoK.KlimovA.KatzJ.RegneryH.LimW.HallH.PerdueM.SwayneD.BenderC.HuangJ.et al.Characterization of an avian" exact="influenza" post="A (H5N1) virus isolated from a child with a"/>
   <result pre="fatal respiratory illnessScience199827939339610.1126/science.279.5349.3939430591 8.GaoR.CaoB.HuY.FengZ.WangD.HuW.ChenJ.JieZ.QiuH.XuK.et al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virusNew Engl. J. Med.20133681888189710.1056/NEJMoa130445923577628 9.YangJ.LiM.ShenX.LiuS.Influenza A virus"/>
   <result pre="Broad Protection against the Influenza A VirusViruses20191140510.3390/v11050405 11.RussellR.J.GamblinS.J.HaireL.F.StevensD.J.XiaoB.HaY.SkehelJ.J.H1 and H7" exact="influenza" post="haemagglutinin structures extend a structural classification of haemagglutinin subtypesVirology200432528729610.1016/j.virol.2004.04.04015246268"/>
   <result pre="structural classification of haemagglutinin subtypesVirology200432528729610.1016/j.virol.2004.04.04015246268 12.VemulaS.V.SayedahmedE.E.SambharaS.MittalS.K.Vaccine approaches conferring cross-protection against" exact="influenza" post="virusesExpert Rev. Vaccines2017161141115410.1080/14760584.2017.137939628925296 13.PlotchS.J.O’HaraB.MorinJ.PalantO.LaRocqueJ.BloomJ.D.LangS.A.Jr.DiGrandiM.J.BradleyM.NilakantanR.et al.Inhibition of influenza A virus"/>
   <result pre="conferring cross-protection against influenza virusesExpert Rev. Vaccines2017161141115410.1080/14760584.2017.137939628925296 13.PlotchS.J.O’HaraB.MorinJ.PalantO.LaRocqueJ.BloomJ.D.LangS.A.Jr.DiGrandiM.J.BradleyM.NilakantanR.et al.Inhibition of" exact="influenza" post="A virus replication by compounds interfering with the fusogenic"/>
   <result pre="of stachyflin derivativesJ. Antibiot.20025516517110.7164/antibiotics.55.16512002998 15.LuoG.ColonnoR.KrystalM.Characterization of a hemagglutinin-specific inhibitor of" exact="influenza" post="A virusVirology1996226667610.1006/viro.1996.06288941323 16.LuoG.TorriA.HarteW.E.DanetzS.CianciC.TileyL.DayS.MullaneyD.YuK.L.OuelletC.et al.Molecular mechanism underlying the action of"/>
   <result pre="mechanism underlying the action of a novel fusion inhibitor of" exact="influenza" post="A virusJ. Virol.199771406240709094684 17.StaschkeK.A.HatchS.D.TangJ.C.HornbackW.J.MunroeJ.E.ColacinoJ.M.MuesingM.A.Inhibition of influenza virus hemagglutinin-mediated membrane"/>
   <result pre="novel fusion inhibitor of influenza A virusJ. Virol.199771406240709094684 17.StaschkeK.A.HatchS.D.TangJ.C.HornbackW.J.MunroeJ.E.ColacinoJ.M.MuesingM.A.Inhibition of" exact="influenza" post="virus hemagglutinin-mediated membrane fusion by a compound related to"/>
   <result pre="by a compound related to podocarpic acidVirology199824826427410.1006/viro.1998.92739721235 18.ZhuL.LiY.LiS.LiH.QiuZ.LeeC.LuH.LinX.ZhaoR.ChenL.et al.Inhibition of" exact="influenza" post="A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral"/>
   <result pre="Chemical GeneticsJ. Virol.2015902690270110.1128/JVI.02326-1526676787 21.BodianD.L.YamasakiR.B.BuswellR.L.StearnsJ.F.WhiteJ.M.KuntzI.D.Inhibition of the fusion-inducing conformational change of" exact="influenza" post="hemagglutinin by benzoquinones and hydroquinonesBiochemistry1993322967297810.1021/bi00063a0078457561 22.RussellR.J.KerryP.S.StevensD.J.SteinhauerD.A.MartinS.R.GamblinS.J.SkehelJ.J.Structure of influenza hemagglutinin"/>
   <result pre="change of influenza hemagglutinin by benzoquinones and hydroquinonesBiochemistry1993322967297810.1021/bi00063a0078457561 22.RussellR.J.KerryP.S.StevensD.J.SteinhauerD.A.MartinS.R.GamblinS.J.SkehelJ.J.Structure of" exact="influenza" post="hemagglutinin in complex with an inhibitor of membrane fusionProc."/>
   <result pre="of an inducer of the low-pH conformational change in the" exact="influenza" post="virus hemagglutinin: irreversible inhibition of infectivityJ. Virol.199771880888209343241 24.BoriskinY.S.LenevaI.A.PecheurE.I.PolyakS.J.Arbidol: A"/>
   <result pre="compound that blocks viral fusionCurr. Med. Chem.200815997100510.2174/09298670878404965818393857 25.SuttonT.C.ObadanA.LavigneJ.ChenH.LiW.PerezD.R.Genome rearrangement of" exact="influenza" post="virus for anti-viral drug screeningVirus Res.2014189142310.1016/j.virusres.2014.05.00324833536 26.EckertN.WrenschF.GartnerS.PalanisamyN.GoedeckeU.JagerN.PohlmannS.WinklerM.Influenza A virus"/>
   <result pre="Influenza A Viruses Expressing Reporter GenesViruses2016817910.3390/v8070179 30.FukuyamaS.KatsuraH.ZhaoD.OzawaM.AndoT.ShoemakerJ.E.IshikawaI.YamadaS.NeumannG.WatanabeS.et al.Multi-spectral fluorescent reporter" exact="influenza" post="viruses (Color-flu) as powerful tools for in vivo studiesNat."/>
   <result pre="Vivo ApplicationsPLoS ONE201510e013388810.1371/journal.pone.013388826241861 32.PerezJ.T.Garcia-SastreA.ManicassamyB.Insertion of a GFP reporter gene in" exact="influenza" post="virusCurr. Protoc. Microbiol.201310.1002/9780471729259.mc15g04s2923686828 33.ZhaoX.WangL.CuiQ.LiP.WangY.ZhangY.YangY.RongL.DuR.A Mechanism Underlying Attenuation of Recombinant"/>
   <result pre="genes contribute to the high virulence of the human H5N1" exact="influenza" post="virus isolate A/Vietnam/1203/04J. Exp. Med.200620368969710.1084/jem.2005193816533883 35.FriedeM.MullerS.BriandJ.P.PlaueS.FernandesI.FrischB.SchuberF.Van RegenmortelM.H.Selective induction of"/>
   <result pre="isolate A/Vietnam/1203/04J. Exp. Med.200620368969710.1084/jem.2005193816533883 35.FriedeM.MullerS.BriandJ.P.PlaueS.FernandesI.FrischB.SchuberF.Van RegenmortelM.H.Selective induction of protection against" exact="influenza" post="virus infection in mice by a lipid-peptide conjugate delivered"/>
   <result pre="in mice by a lipid-peptide conjugate delivered in liposomesVaccine19941279179710.1016/0264-410X(94)90287-97975857 36.WraithD.C.VesseyA.E.AskonasB.A.Purified" exact="influenza" post="virus nucleoprotein protects mice from lethal infectionJ. Gen. Virol.198768"/>
   <result pre="synthetic peptides corresponding to B- and T-cell recognition sites of" exact="influenza" post="A hemagglutininVaccine19951392793210.1016/0264-410X(95)00014-R7483766 38.SaelensX.VanlandschootP.MartinetW.MarasM.NeirynckS.ContrerasR.FiersW.JouW.M.Protection of mice against a lethal influenza"/>
   <result pre="of influenza A hemagglutininVaccine19951392793210.1016/0264-410X(95)00014-R7483766 38.SaelensX.VanlandschootP.MartinetW.MarasM.NeirynckS.ContrerasR.FiersW.JouW.M.Protection of mice against a lethal" exact="influenza" post="virus challenge after immunization with yeast-derived secreted influenza virus"/>
   <result pre="a lethal influenza virus challenge after immunization with yeast-derived secreted" exact="influenza" post="virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal influenza virus"/>
   <result pre="yeast-derived secreted influenza virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal" exact="influenza" post="virus encephalitis by intranasally primed CD8+ memory T cellsJ."/>
   <result pre="influenza virus hemagglutininEur. J. Biochem.199926016617510.1046/j.1432-1327.1999.00150.x10091596 39.StevensonP.G.HawkeS.BanghamC.R.Protection against lethal influenza virus" exact="encephalitis" post="by intranasally primed CD8+ memory T cellsJ. Immunol. (Baltimore,"/>
   <result pre="cellsJ. Immunol. (Baltimore, Md.: 1950)199615730653073 40.MitchellJ.A.GreenT.D.BrightR.A.RossT.M.Induction of heterosubtypic immunity to" exact="influenza" post="A virus using a DNA vaccine expressing hemagglutinin-C3d fusion"/>
   <result pre="using a DNA vaccine expressing hemagglutinin-C3d fusion proteinsVaccine20032190291410.1016/S0264-410X(02)00539-X12547601 41.QuanF.S.SteinhauerD.HuangC.RossT.M.CompansR.W.KangS.M.A bivalent" exact="influenza" post="VLP vaccine confers complete inhibition of virus replication in"/>
   <result pre="capacity of a cyclic peptide corresponding to site A of" exact="influenza" post="virus haemagglutininVaccine1990830831410.1016/0264-410X(90)90086-22396470 43.ThangavelR.R.BouvierN.M.Animal models for influenza virus pathogenesis, transmission,"/>
   <result pre="to site A of influenza virus haemagglutininVaccine1990830831410.1016/0264-410X(90)90086-22396470 43.ThangavelR.R.BouvierN.M.Animal models for" exact="influenza" post="virus pathogenesis, transmission, and immunologyJ. Immunol. Methods2014410607910.1016/j.jim.2014.03.02324709389 44.FalzaranoD.GrosethA.HoenenT.Development and"/>
   <result pre="challenges and perspectivesAntivir. Res.2014103788710.1016/j.antiviral.2014.01.00324462694 45.ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProc."/>
   <result pre="a GFP reporter virusProc. Natl. Acad. Sci. USA2010107115311153610.1073/pnas.091499410720534532 46.AntanasijevicA.ChengH.WardropD.J.RongL.CaffreyM.Inhibition of" exact="influenza" post="H7 hemagglutinin-mediated entryPLoS ONE20138e7636310.1371/journal.pone.007636324194835 47.WangY.DingY.YangC.LiR.DuQ.HaoY.LiZ.JiangH.ZhaoJ.ChenQ.et al.Inhibition of the infectivity"/>
   <result pre="ONE20138e7636310.1371/journal.pone.007636324194835 47.WangY.DingY.YangC.LiR.DuQ.HaoY.LiZ.JiangH.ZhaoJ.ChenQ.et al.Inhibition of the infectivity and inflammatory response of" exact="influenza" post="virus by Arbidol hydrochloride in vitro and in vivo"/>
   <result pre="vivo (mice and ferret)Biomed. Pharmacother.20179139340110.1016/j.biopha.2017.04.09128475918 Figure 1 Generation of reporter" exact="influenza" post="A subtype H3N2 virus by fusing Gluc gene to"/>
   <result pre="(a) Engineering of Gluc reporter gene in the genome of" exact="influenza" post="A NY (H3N2) virus. The porcine teschovirus–1 2A (PTV-1"/>
   <result pre="(p.i.) luciferase assays were performed. Figure 2 Generation of reporter" exact="influenza" post="A subtype H3N2 virus by using segment PR8/NS-Gluc, which"/>
   <result pre="syncytia induced by NY-r18-Gluc infection. Figure 3 Generation of reporter" exact="influenza" post="A subtype H3N2 virus encoding the HA and NA"/>
   <result pre="canine kidney (MDCK) cells were infected with A/NY-r19–Gluc, A/NY-r19, and" exact="influenza" post="A virus (IAV) NY at a multiplicity of infection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6670050\results\search\disease\results.xml">
   <result pre="applicable. basic reproduction number Bayesian model dengue force of infection" exact="infectious disease" post="seroprevalence vector control Funding National Environment Agency10.13039/501100001358 National Medical"/>
   <result pre="infections averted�? has been widely applied in the evaluation of" exact="malaria" post="disease control efforts in Africa (36) and the dengue"/>
   <result pre="by the request that donors with recent (diagnosed) dengue or" exact="chikungunya" post="virus infection defer their donation for 6 months (48),"/>
   <result pre="Sci Rep. 2016;6:22592.26940650 20HapuarachchiHC, KooC, RajarethinamJ, et al.Epidemic resurgence of" exact="dengue fever" post="in Singapore in 2013–2014: a virological and entomological perspective."/>
   <result pre="et al.Reconstructing historical changes in the force of infection of" exact="dengue fever" post="in Singapore: implications for surveillance and control. Bull World"/>
   <result pre="in dengue transmission may act to increase the incidence of" exact="dengue hemorrhagic fever." post="Proc Natl Acad Sci U S A. 2008;105(6):2238–2243.18250338 32Rodríguez-BarraquerI,"/>
   <result pre="Trop Dis. 2012;6(6):e1679.22745839 36BhattS, WeissDJ, CameronE, et al.The effect of" exact="malaria" post="control on Plasmodium falciparum in Africa between 2000 and"/>
   <result pre="Surveill Response J. 2011;2(2):24–29. 41RoweEK, LeoYS, WongJG, et al.Challenges in" exact="dengue fever" post="in the elderly: atypical presentation and risk of severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6676504\results\search\disease\results.xml">
   <result pre="the crucial components of protective immunity? dengue flavivirus pathogenesis immunity" exact="dengue fever" post="severe dengue vaccines epidemiology Funding The author(s) declared that"/>
   <result pre="the expanding scientific literature. Studies on dengue as an arthropod-borne" exact="viral disease" post="contribute to three areas of research: (a) one on"/>
   <result pre="1 and 3 infections result in high rates of classic" exact="dengue fever" post="but dengue 2 and 4 infections cause milder disease"/>
   <result pre="ways 40– 43. The most notable genetic effect is the" exact="suppression" post="of severe disease accompanying a second heterotypic dengue infection"/>
   <result pre="first infecting DENV type. A subset of severe dengue cases," exact="hemophagocytic lymphohistiocytosis" post="(HLH), is increasingly recognized. HLH, a rare and potentially"/>
   <result pre="2008 to 2013. Cases were often infants, who frequently had" exact="influenza" post="co-infections and were satisfactorily treated with steroids 47. There"/>
   <result pre="(21 years old or older) with acute laboratory-confirmed dengue with" exact="thrombocytopenia" post="(not more than 20,000 platelets per microliter) but no"/>
   <result pre="patients who may progress to shock syndrome. A low echocardiographic" exact="stroke" post="volume index and reduced left ventricular function plus high"/>
   <result pre="decline of platelet counts successfully predicted shock 57. Epidemiology During" exact="yellow fever" post="epidemics, it was well understood that multiple cases occurred"/>
   <result pre="is not spread significantly by sick individuals. Those who developed" exact="dengue fever" post="spent more time at home, visited fewer locations, and"/>
   <result pre="Chittagong, where a number of recent outbreaks of dengue and" exact="chikungunya" post="have occurred, had a high prevalence of dengue antibodies,"/>
   <result pre="emergence of epidemic severe dengue throughout India. The reason why" exact="yellow fever" post="continues to be a major health problem in the"/>
   <result pre="fateful event that occurred centuries ago: the stable introduction of" exact="yellow fever" post="virus into a complex zoonotic cycle 71. All four"/>
   <result pre="activate platelets in vitro via Toll-like-receptor 4 (TLR4), and produce" exact="thrombocytopenia" post="in TLR4 knockout and normal mice 90– 93. In"/>
   <result pre="chimera of structural genes of the four DENVs with the" exact="yellow fever" post="vaccine non-structural genome. This vaccine was tested for vaccine"/>
   <result pre="II.Am J Trop Med Hyg.1952;1(1):30–50. 10.4269/ajtmh.1952.1.3014903434 11NimmannityaSHalsteadSBCohenSNet al.: Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962-1964. I. Observations"/>
   <result pre="virus infections.Front Immunol.2014;5:280. 10.3389/fimmu.2014.0028024966859 13HalsteadSB: Observations related to pathogensis of" exact="dengue hemorrhagic fever." post="VI. Hypotheses and discussion.Yale J Biol Med.1970;42:350–62. 5419208 14HalsteadSBLanNTMyintTTet"/>
   <result pre="of third or fourth dengue infections resulting in admissions and" exact="dengue hemorrhagic fever," post="and serotype sequences.Am J Trop Med Hyg.2007;77(5):910–3. 10.4269/ajtmh.2007.77.91017984352 F1000"/>
   <result pre="2001–2002.Int J Infect Dis.2012;16(3):e198–e203. 10.1016/j.ijid.2011.09.02622277259 32HubertBHalsteadSB: Dengue 1 virus and" exact="dengue hemorrhagic fever," post="French Polynesia, 2001.Emerg Infect Dis.2009;15(8):1265–70. 10.3201/eid1508.08150019751589 33GambleJBethellDDayNPet al.: Age-related"/>
   <result pre="association test indicate two distinct pathogenic pathways involved in classical" exact="dengue fever" post="and dengue shock syndrome.PLoS Negl Trop Dis.2018;12(2):e0006202. 10.1371/journal.pntd.000620229447178 F1000"/>
   <result pre="Borne Zoonotic Dis.2019. 10.1089/vbz.2018.240830964397 73HalsteadSBNimmannityaSCohenSN: Observations related to pathogenesis of" exact="dengue hemorrhagic fever." post="IV. Relation of disease severity to antibody response and"/>
   <result pre="recovered.Yale J Biol Med.1970;42(5):311–28. 5419206 74AyeKSCharngkaewKWinNet al.: Pathologic highlights of" exact="dengue hemorrhagic fever" post="in 13 autopsy cases from Myanmar.Hum Pathol.2014;45(6):1221–33. 10.1016/j.humpath.2014.01.02224767772 75HalsteadSB:"/>
   <result pre="Sci.2018;25(1):77. 10.1186/s12929-018-0482-930409217 87SchlesingerJJBrandrissMWWalshEE: Protection of mice against dengue 2 virus" exact="encephalitis" post="by immunization with the dengue 2 virus non-structural glycoprotein"/>
   <result pre="protein 1 activates platelets via Toll-like receptor 4, leading to" exact="thrombocytopenia" post="and hemorrhage.PLoS Pathog.2019;15(4):e1007625. 10.1371/journal.ppat.100762531009511 94ModhiranNWattersonDMullerDAet al.: Dengue virus NS1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6676611\results\search\disease\results.xml">
   <result pre="the hospitalized patients, there were more patients hospitalized with bronchopneumonia/or" exact="pneumonia" post="in the 2011 epidemic (10.6% vs 5.1%, p &amp;lt; 0.001), while"/>
   <result pre="severe and lead to long term respiratory sequelae, such as" exact="bronchiolitis" post="obliterans or bronchiectasis [3]. HAdVs were an important cause"/>
   <result pre="to long term respiratory sequelae, such as bronchiolitis obliterans or" exact="bronchiectasis" post="[3]. HAdVs were an important cause of acute respiratory"/>
   <result pre="and HAdV7 was related to post-infectious pulmonary sequelae, such as" exact="bronchiolitis" post="obliterans [9–11]. Molecular genotyping of HAdV was used to"/>
   <result pre="the demographics, clinical characteristics, and risk factors of hospitalization and" exact="pneumonia" post="in patients between the 2011 and 2014 epidemics. Methods"/>
   <result pre="containing Madin-Darby canine kidney cells, Vero cells, A549 cells or" exact="rhabdomyosarcoma" post="cells within 24 h of collection. Cells were incubated at"/>
   <result pre="However, patients with severe definite bacterial infection, including bacteremia and" exact="urinary tract infection" post="were excluded from this cohort. Fifty-three adult patients were"/>
   <result pre="while there was a significantly higher percentage of bronchiolitis/bronchopneumonia (p &amp;lt; 0.001)," exact="pneumonia" post="(p &amp;lt; 0.001) and acute gastroenterocolitis (p = 0.016) among hospitalized patients. A"/>
   <result pre="a significantly higher percentage of hospitalized patients had cough and" exact="diarrhea" post="compared with non-hospitalized patients (both p &amp;lt; 0.05). Laboratory values showed"/>
   <result pre="a significantly high percentage of hospitalized patients had bronchiolitis/bronchopneumonia and" exact="pneumonia" post="(both p &amp;lt; 0.001). A higher percentage of hospitalized patients had"/>
   <result pre="higher proportion of patients were hospitalized with the diagnosis of" exact="pneumonia" post="in the 2011 epidemic than in the 2014 epidemic"/>
   <result pre="was significantly increased in patients with co-infections (OR = 5.944, p = 0.011), bronchiolitis/" exact="bronchopneumonia" post="(OR = 2.505, p = 0.024), underlying disease (OR = 18.187, p &amp;lt; 0.001), diarrhea (OR = 2.056, p = 0.037),"/>
   <result pre="(OR = 5.944, p = 0.011), bronchiolitis/ bronchopneumonia (OR = 2.505, p = 0.024), underlying disease (OR = 18.187, p &amp;lt; 0.001)," exact="diarrhea" post="(OR = 2.056, p = 0.037), vomiting (OR = 2.413, p = 0.003), increased WBC counts (OR = 1.00006,"/>
   <result pre="P &amp;lt; 0.05 Comparison of difference between patients with and without HAdV" exact="pneumonia" post="Diagnosis of radiologically-conformed alveolar pneumonia was according to World"/>
   <result pre="patients with and without HAdV pneumonia Diagnosis of radiologically-conformed alveolar" exact="pneumonia" post="was according to World Health Organization (WHO) criteria [20]."/>
   <result pre="such an opacity�?. There were 29 patients diagnosed with HAdV" exact="pneumonia" post="in the two epidemics. We compared the demographics and"/>
   <result pre="between these two groups. However, a significantly higher percentage of" exact="pneumonia" post="patients had co-infections compared to non-pneumonia patients (p = 0.012). Among"/>
   <result pre="infection (75%) was more predominant than bacterial infection in the" exact="pneumonia" post="group. Pneumonia patients had significantly higher mean WBC counts"/>
   <result pre="patients. There was no significant difference in genotype distribution between" exact="pneumonia" post="patients and non-pneumonia patients. Table 4 Comparison of demographics"/>
   <result pre="Table 4 Comparison of demographics and clinical characteristics between the" exact="pneumonia" post="and non-pneumonia patients in 2011 and 2014 epidemics Variables"/>
   <result pre="the demographics, clinical characteristics, and risk factors of hospitalization and" exact="pneumonia" post="in patients from the 2011 and 2014 adenovirus epidemics"/>
   <result pre="be other important emergent genotypes in immunocompetent adults with severe" exact="pneumonia" post="in China, we did not identify any HAdV55 or"/>
   <result pre="that infection with HAdV7 was more likely to be associated" exact="pneumonia" post="[11, 17]. On the contrary, we found that the"/>
   <result pre="epidemic (21.0% vs. 16.7%), but had a lower rate of" exact="pneumonia" post="(1.6% vs. 3.3%). Also, when we pooled these two"/>
   <result pre="associated with pneumonia. HAdV4 caused an epidemic outbreak of acute" exact="respiratory disease" post="(ARD) in military recruits in United States and may"/>
   <result pre="recruits in United States and may also result in severe" exact="pneumonia" post="[28, 29]. HAdV1 was also reported to cause severe"/>
   <result pre="pneumonia [28, 29]. HAdV1 was also reported to cause severe" exact="pneumonia" post="in immunocompetent patients in French intensive care unit [30]."/>
   <result pre="were not associated with severe lower respiratory tract infection (four" exact="pneumonia" post="cases caused by HAdV1; one pneumonia case caused by"/>
   <result pre="respiratory tract infection (four pneumonia cases caused by HAdV1; one" exact="pneumonia" post="case caused by HAdV4). It is therefore possible that"/>
   <result pre="risk factor for severe HAdV infection. The neurological disease, chronic" exact="lung disease," post="and airway anomalies were reported to be related to"/>
   <result pre="and airway anomalies were reported to be related to HAdV" exact="pneumonia" post="[19, 21]. Neurological disease was particularly associated with severe"/>
   <result pre="pneumonia [19, 21]. Neurological disease was particularly associated with severe" exact="pneumonia" post="caused by HAdV3 and 7 during the 2011 epidemic"/>
   <result pre="leukocytosis (WBC &amp;gt; 15,000/mm3) was more common in HAdV2 infection, whereas" exact="leukopenia" post="(WBC &amp;lt; 5000/mm3) was more common in HAdV7 infection [27]. Leukocytosis"/>
   <result pre="seems to occur in the early course of infection, whereas" exact="leukopenia" post="and thrombocytopenia were shown to correlate with progression [17,"/>
   <result pre="occur in the early course of infection, whereas leukopenia and" exact="thrombocytopenia" post="were shown to correlate with progression [17, 32]. This"/>
   <result pre="major laboratory finding in HAdV infection, while other studies reported" exact="leukopenia" post="[17, 19, 21]. In our study, we demonstrated that"/>
   <result pre="values compared to children infected with other genotypes [15]. HAdV" exact="pneumonia" post="is the most common manifestation of severe HAdV infection"/>
   <result pre="less 5% of all HAdV infection [35]. In our analysis," exact="pneumonia" post="patients had higher WBC counts and CRP levels than"/>
   <result pre="[40, 41]. Since 2006, there are the outbreaks and severe" exact="respiratory disease" post="worldwide, which were caused by HAdV14p1 and HAdV55 of"/>
   <result pre="lower respiratory tract infections ANC Absolute neutrophil count ARD Acute" exact="respiratory disease" post="ARIs Acute respiratory infections CRP C-Reactive protein HAdV Human"/>
   <result pre="and transmission characteristics of human adenovirus type 7 caused acute" exact="respiratory disease" post="outbreak in military trainees in East ChinaAm J Transl"/>
   <result pre="One201389e7520810.1371/journal.pone.007520824073254 17.LaiCYLeeCJLuCYLeePIShaoPLWuETet al.Adenovirus serotype 3 and 7 infection with acute" exact="respiratory failure" post="in children in Taiwan, 2010-2011PLoS One201381e5361410.1371/journal.pone.005361423326469 18.LinYCLuPLLinKHChuPYWangCFLinJHet al.Molecular epidemiology"/>
   <result pre="Dis201218111825183210.3201/eid1811.12062923092602 20.Organization WH. Revised WHO classification and treatment of childhood" exact="pneumonia" post="at health facilities. https://apps.who.int/iris/bitstream/handle/10665/137319/9789241507813_eng.pdf;jsessionid=DC643EB627A159361843B225BF79BF8E?sequence=1. 21.ChengJLPengCCChiuNCWengLCChiuYYChangLet al.Risk factor analysis and"/>
   <result pre="24.ZhaoSWanCKeCSetoJDehghanSZouLet al.Re-emergent human adenovirus genome type 7d caused an acute" exact="respiratory disease" post="outbreak in southern China after a twenty-one year absenceSci"/>
   <result pre="China after a twenty-one year absenceSci Rep20144736510.1038/srep0736525482188 25.GuLLiuZLiXQuJGuanWLiuYet al.Severe community-acquired" exact="pneumonia" post="caused by adenovirus type 11 in immunocompetent adults in"/>
   <result pre="in immunocompetent adults in BeijingJ Clin Virol201254429530110.1016/j.jcv.2012.04.01822608839 26.TanDZhuHFuYTongFYaoDWallineJet al.Severe community-acquired" exact="pneumonia" post="caused by human adenovirus in immunocompetent adults: a multicenter"/>
   <result pre="case reportJ Clin Virol201681788110.1016/j.jcv.2016.06.00527354307 30.CassirNHraiechSNougairedeAZandottiCFournierPPapazianLOutbreak of adenovirus type 1 severe" exact="pneumonia" post="in a French intensive care unit, September–October 2012Eurosurveillance201419392091410.2807/1560-7917.ES2014.19.39.2091425306980 31.GrayGCMcCarthyTLebeckMGSchnurrDPRussellKLKajonAEet"/>
   <result pre="adenovirus infectionSwiss Med Wkly200213225–2634535012422291 35.ChenSPHuangYCChiuCHWongKSHuangYLHuangCGet al.Clinical features of radiologically confirmed" exact="pneumonia" post="due to adenovirus in childrenJ Clin Virol201356171210.1016/j.jcv.2012.08.02123021965 36.ChenSTianXVaccine development"/>
   <result pre="43.KajonAELuXErdmanDDLouieJSchnurrDGeorgeKSet al.Molecular epidemiology and brief history of emerging adenovirus 14-associated" exact="respiratory disease" post="in the United StatesJ Infect Dis201020219310310.1086/65308320500088 44.LuQBTongYGWoYWangHYLiuEMGrayGCet al.Epidemiology of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6679168\results\search\disease\results.xml">
   <result pre="contagious virus that causes seasonal epidemics and unpredictable pandemics. Four" exact="influenza" post="virus types have been identified to date: A, B,"/>
   <result pre="humans. Influenza A and B viruses are responsible for seasonal" exact="influenza" post="epidemics in humans and are responsible for up to"/>
   <result pre="flu infections annually. The M2 protein is present in all" exact="influenza" post="types and belongs to the class of viroporins, i.e.,"/>
   <result pre="ion channels that increase membrane permeability in virus-infected cells. In" exact="influenza" post="A and B, AM2 and BM2 are predominantly proton"/>
   <result pre="some permeability to monovalent cations. By contrast, M2 proteins in" exact="influenza" post="C and D, CM2 and DM2, appear to be"/>
   <result pre="The present review summarizes the biochemical and structural aspects of" exact="influenza" post="viroporins and discusses the most relevant aspects of function,"/>
   <result pre="relevant aspects of function, inhibition, and interaction with the host." exact="influenza" post="virus matrix protein 2 (M2) viroporins ion channel inhibition"/>
   <result pre="segmented, negative-sense RNA viruses belonging to the Orthomyxoviridae family. Four" exact="influenza" post="virus types have been identified to date, classified based"/>
   <result pre="bovine and canine species [4]. The main reservoir of the" exact="influenza" post="A viruses are aquatic birds [5]. The seasonal flu"/>
   <result pre="viruses are aquatic birds [5]. The seasonal flu caused by" exact="influenza" post="A virus (IAV) in humans is a very contagious"/>
   <result pre="are caused by the sporadic transmission of avian or swan" exact="influenza" post="viruses to humans, as pre-immunity to these new strains"/>
   <result pre="still capable of causing serious outbreaks, is responsible for seasonal" exact="influenza" post="epidemics among humans [9,10], and accounts for half of"/>
   <result pre="epidemics among humans [9,10], and accounts for half of the" exact="influenza" post="diseases in recent years (www.cdc.gov). Types B (IBV) and"/>
   <result pre="to BM2 [60]. 3. CM2 and DM2 3.1. CM2 The" exact="influenza" post="C virus M2 protein (CM2) was first reported by"/>
   <result pre="is encoded by RNA segment 6 (M gene) of the" exact="influenza" post="C virus [20], which produces a p42 protein precursor,"/>
   <result pre="could partially restore the infectious virus production of an M2-deficient" exact="influenza" post="A virus [103], which suggests that CM2 can alter"/>
   <result pre="probably plays a role in the uncoating process of the" exact="influenza" post="C virus. The glycoprotein HEF of the influenza C"/>
   <result pre="of the influenza C virus. The glycoprotein HEF of the" exact="influenza" post="C virus has the ability to cause low pH-dependent"/>
   <result pre="impaired packaging and uncoating in virus-like particles (VLPs) and recombinant" exact="influenza" post="viruses [109]. 3.2. DM2 A new type of influenza"/>
   <result pre="recombinant influenza viruses [109]. 3.2. DM2 A new type of" exact="influenza" post="virus, known as type D, has recently been identified"/>
   <result pre="remains to be elucidated. The main features of viroporins in" exact="influenza" post="are summarized in Table 1. 4. Other Influenza Viroporins"/>
   <result pre="variants of AM2 [131,132,133,134]. Indeed, more than 95% of circulating" exact="influenza" post="A viruses carry the S31N mutation in their M2"/>
   <result pre="Cu(II) inhibition. Therefore, Cu(II) complexes may also be toxic to" exact="influenza" post="B viruses. 6. M2-Mediated Disruption of Ion Homeostasis The"/>
   <result pre="NLRP3 inflammasome in influenza-infected cells [142]. AM2 also contributes to" exact="influenza" post="pathogenesis by downregulating the expression and function of two"/>
   <result pre="channels, the amiloride-sensitive epithelial sodium channels (ENaC) [143] and the" exact="cystic fibrosis" post="transmembrane conductance regulator (CFTR) chloride channels [144]. These are"/>
   <result pre="impairment in their activity is associated with detrimental consequences, including" exact="pulmonary edema" post="and rhinorrhea (see [147]). AM2 has been found to"/>
   <result pre="some of these protein–protein interactions involving M2, and how the" exact="influenza" post="virus may exploit these host cell factors to its"/>
   <result pre="and have been reported to exhibit inhibitory effects on the" exact="influenza" post="virus [165]. This action of cardiac glycosides on viral"/>
   <result pre="ouabain, digoxin and lanatoside C, which express antiviral activity against" exact="influenza" post="[166,167]. The β1 auxiliary subunit of the Na+/K+ ATPase,"/>
   <result pre="and a stable ATP1B1-knockdown cell line was able to suppress" exact="influenza" post="virus A/WSN/33 replication [167]. Using deletion mutations, the authors"/>
   <result pre="identified as binders to M2 in all of four independent" exact="influenza" post="interactome screening campaigns [171,179,180,181]. It would be interesting to"/>
   <result pre="TRAPP complex subunits may cooperate in the modulation of the" exact="influenza" post="life cycle. Finally, the host factor Golgi-specific brefeldin A-resistant"/>
   <result pre="the process. 8. Conclusions In summary, most information available for" exact="influenza" post="viroporins is centered around AM2, followed by BM2. For"/>
   <result pre="authors declare no conflict of interest. References References 1.RitcheyM.B.PaleseP.KilbourneE.D.RNAs of" exact="influenza" post="A, B, and C virusesJ. Virol.197618738744944790 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a"/>
   <result pre="A, B, and C virusesJ. Virol.197618738744944790 2.HauseB.M.CollinE.A.LiuR.HuangB.ShengZ.LuW.WangD.NelsonE.A.LiF.Characterization of a novel" exact="influenza" post="virus in cattle and swine: Proposal for a new"/>
   <result pre="in the Orthomyxoviridae familyMBio2014510.1128/mBio.00031-1424595369 3.HauseB.M.DucatezM.CollinE.A.RanZ.LiuR.ShengZ.ArmienA.KaplanB.ChakravartyS.HoppeA.D.et al.Isolation of a novel swine" exact="influenza" post="virus from Oklahoma in 2011 which is distantly related"/>
   <result pre="from Oklahoma in 2011 which is distantly related to human" exact="influenza" post="C virusesPLoS Pathog.20139e100317610.1371/journal.ppat.100317623408893 4.ParrishC.R.MurciaP.R.HolmesE.C.Influenza virus reservoirs and intermediate hosts:"/>
   <result pre="reservoirs and intermediate hosts: Dogs, horses, and new possibilities for" exact="influenza" post="virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 5.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of"/>
   <result pre="influenza virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 5.WebsterR.G.BeanW.J.GormanO.T.ChambersT.M.KawaokaY.Evolution and ecology of" exact="influenza" post="A virusesMicrobiol. Rev.1992561521791579108 6.HayA.J.GregoryV.DouglasA.R.YiP.L.The evolution of human influenza virusesPhilos."/>
   <result pre="ecology of influenza A virusesMicrobiol. Rev.1992561521791579108 6.HayA.J.GregoryV.DouglasA.R.YiP.L.The evolution of human" exact="influenza" post="virusesPhilos. Trans. R. Soc. B Biol. Sci.20013561861187010.1098/rstb.2001.0999 7.NeumannG.NodaT.KawaokaY.Emergence and"/>
   <result pre="B Biol. Sci.20013561861187010.1098/rstb.2001.0999 7.NeumannG.NodaT.KawaokaY.Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virusNature200945993193910.1038/nature0815719525932 8.MolinariN.A.M.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal influenza in the"/>
   <result pre="of swine-origin H1N1 influenza virusNature200945993193910.1038/nature0815719525932 8.MolinariN.A.M.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the US: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 9.WebsterR.G.MontoA.S.BracialeT.J.LambR.A.Textbook"/>
   <result pre="Wiley &amp;amp; Sons, Ltd.Hoboken, NJ, USA2013 10.KoutsakosM.NguyenT.H.BarclayW.S.KedzierskaK.Knowns and unknowns of" exact="influenza" post="B virusesFuture Microbiol.20161111913510.2217/fmb.15.12026684590 11.RanZ.ShenH.LangY.KolbE.A.TuranN.ZhuL.MaJ.BawaB.LiuQ.LiuH.et al.Domestic pigs are susceptible to"/>
   <result pre="virusesFuture Microbiol.20161111913510.2217/fmb.15.12026684590 11.RanZ.ShenH.LangY.KolbE.A.TuranN.ZhuL.MaJ.BawaB.LiuQ.LiuH.et al.Domestic pigs are susceptible to infection with" exact="influenza" post="B virusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 12.OsterhausA.D.M.E.RimmelzwaanG.F.MartinaB.E.E.BestebroerT.M.FouchierR.A.M.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 13.FergusonL.OlivierA.K.GenovaS.EppersonW.B.SmithD.R.SchneiderL.BartonK.McCuanK.WebbyR.J.WanX.F.Pathogenesis"/>
   <result pre="B virusesJ. Virol.2015894818482610.1128/JVI.00059-1525673727 12.OsterhausA.D.M.E.RimmelzwaanG.F.MartinaB.E.E.BestebroerT.M.FouchierR.A.M.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 13.FergusonL.OlivierA.K.GenovaS.EppersonW.B.SmithD.R.SchneiderL.BartonK.McCuanK.WebbyR.J.WanX.F.Pathogenesis of" exact="influenza" post="D virus in cattleJ. Virol.2016905636564210.1128/JVI.03122-1527030270 14.PaleseP.ShawM.L.Orthomyxoviridae: The viruses and"/>
   <result pre="Virol.198862276227722455818 16.SkehelJ.J.WileyD.C.Receptor binding and membrane fusion in virus entry: The" exact="influenza" post="hemagglutininAnnu. Rev. Biochem.20006953156910.1146/annurev.biochem.69.1.53110966468 17.KunduA.AvalosR.T.SandersonC.M.NayakD.P.Transmembrane domain of influenza virus neuraminidase,"/>
   <result pre="virus entry: The influenza hemagglutininAnnu. Rev. Biochem.20006953156910.1146/annurev.biochem.69.1.53110966468 17.KunduA.AvalosR.T.SandersonC.M.NayakD.P.Transmembrane domain of" exact="influenza" post="virus neuraminidase, a type II protein, possesses an apical"/>
   <result pre="MDCK cellsJ. Virol.199670650865158709291 18.SakaguchiT.TuQ.A.PintoL.H.LambR.A.The active oligomeric state of the minimalistic" exact="influenza" post="virus M-2 ion channel is a tetramerProc. Natl. Acad."/>
   <result pre="WilkinsPhiladelphia, PA, USA2013 20.MurakiY.HongoS.The molecular virology and reverse genetics of" exact="influenza" post="C virusJpn. J. Infect. Dis.20106315716520495266 21.Castano-RodriguezC.HonrubiaJ.M.Gutierrez-AlvarezJ.DeDiegoM.L.Nieto-TorresJ.L.Jimenez-GuardenoJ.M.Regla-NavaJ.A.Fernandez-DelgadoR.Verdia-BaguenaC.Queralt-MartinM.et al.Role of Severe"/>
   <result pre="on the infected-cell surfaceCell19854062763310.1016/0092-8674(85)90211-93882238 26.LambR.A.ChoppinP.W.The gene structure and replication of" exact="influenza" post="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 27.SugrueR.J.HayA.J.Structural characteristics of the M2 protein"/>
   <result pre="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 27.SugrueR.J.HayA.J.Structural characteristics of the M2 protein of" exact="influenza" post="a viruses: Evidence that it forms a tetrameric channelVirology199118061762410.1016/0042-6822(91)90075-M1989386"/>
   <result pre="channelVirology199118061762410.1016/0042-6822(91)90075-M1989386 28.HullJ.D.GilmoreR.LambR.A.Integration of a small integral membrane protein, M2, of" exact="influenza" post="virus into the endoplasmic reticulum: Analysis of the internal"/>
   <result pre="with an ectoplasmic NH2 terminusJ. Cell Biol.19881061489149810.1083/jcb.106.5.14892836432 29.HeleniusA.Unpacking the incoming" exact="influenza" post="virusCell19926957757810.1016/0092-8674(92)90219-31375129 30.MartinK.HeleniusA.Transport of incoming influenza virus nucleocapsids into the"/>
   <result pre="Cell Biol.19881061489149810.1083/jcb.106.5.14892836432 29.HeleniusA.Unpacking the incoming influenza virusCell19926957757810.1016/0092-8674(92)90219-31375129 30.MartinK.HeleniusA.Transport of incoming" exact="influenza" post="virus nucleocapsids into the nucleusJ. Virol.19916523224410.1016/0962-8924(92)90130-F1985199 31.TakeuchiK.LambR.A.Influenza virus M2"/>
   <result pre="protein ion channel activity stabilizes the native form of fowl" exact="plague" post="virus hemagglutinin during intracellular transportJ. Virol.1994689119197507186 32.CiamporF.BayleyP.M.NermutM.V.HirstE.M.A.SugrueR.J.HayA.J.Evidence that the"/>
   <result pre="intracellular transportJ. Virol.1994689119197507186 32.CiamporF.BayleyP.M.NermutM.V.HirstE.M.A.SugrueR.J.HayA.J.Evidence that the amantadine-induced, M2-mediated conversion of" exact="influenza" post="A virus hemagglutinin to the low pH conformation occurs"/>
   <result pre="conformation occurs in an acidic trans golgi compartmentVirology1992188142410.1016/0042-6822(92)90730-D1566569 33.GrambasS.HayA.J.Maturation of" exact="influenza" post="a virus hemagglutinin-Estimates of the pH encountered during transport"/>
   <result pre="regulation by the M2 proteinVirology1992190111810.1016/0042-6822(92)91187-Y1529523 34.SugrueR.J.BahadurG.ZambonM.C.Hall-SmithM.DouglasA.R.HayA.J.Specific structural alteration of the" exact="influenza" post="haemagglutinin by amantadineEMBO J.199093469347610.1002/j.1460-2075.1990.tb07555.x2209554 35.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchönA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.et al.Identification of the functional"/>
   <result pre="amantadineEMBO J.199093469347610.1002/j.1460-2075.1990.tb07555.x2209554 35.MaC.PolishchukA.L.OhigashiY.StoufferA.L.SchönA.MagavernE.JingX.LearJ.D.FreireE.LambR.A.et al.Identification of the functional core of the" exact="influenza" post="A virus A/M2 proton-selective ion channelProc. Natl. Acad. Sci."/>
   <result pre="36.PintoL.H.DieckmannG.R.GandhiC.S.PapworthC.G.BramanJ.ShaughnessyM.A.LearJ.D.LambR.A.DegradoW.F.A functionally defined model for the M2 proton channel of" exact="influenza" post="A virus suggests a mechanism for its ion selectivityProc."/>
   <result pre="ion selectivityProc. Natl. Acad. Sci. USA199794113011130610.1073/pnas.94.21.113019326604 37.TangY.ZaitsevaF.LambR.A.PintoL.H.The gate of the" exact="influenza" post="virus M2 proton channel is formed by a single"/>
   <result pre="single tryptophan residueJ. Biol. Chem.2002277398803988610.1074/jbc.M20658220012183461 38.PintoL.H.LambR.A.The M2 proton channels of" exact="influenza" post="A and B virusesJ. Biol. Chem.20062818997900010.1074/jbc.R50002020016407184 39.HattaM.GotoH.KawaokaY.Influenza B virus"/>
   <result pre="the cell surfaceVirology200330671710.1016/S0042-6822(02)00083-112620792 42.WangJ.PielakR.M.McClintockM.A.ChouJ.J.Solution structure and functional analysis of the" exact="influenza" post="B proton channelNat. Struct. Mol. Biol.2009161267127110.1038/nsmb.170719898475 43.MaC.WangJ.Functional studies reveal"/>
   <result pre="similarities and differences between AM2 and BM2 proton channels from" exact="influenza" post="virusesBiochim. Biophys. Acta Biomembr.2018186027228010.1016/j.bbamem.2017.10.02629106970 44.OdagiriT.HongJ.OharaY.The BM2 protein of influenza"/>
   <result pre="from influenza virusesBiochim. Biophys. Acta Biomembr.2018186027228010.1016/j.bbamem.2017.10.02629106970 44.OdagiriT.HongJ.OharaY.The BM2 protein of" exact="influenza" post="B virus is synthesized in the late phase of"/>
   <result pre="virions as a subviral componentJ. Gen. Virol.1999802573258110.1099/0022-1317-80-10-257310573149 45.SugrueR.J.BelsheR.B.HayA.J.Palmitoylation of the" exact="influenza" post="a virus M2 proteinVirology1990179515610.1016/0042-6822(90)90272-S2219738 46.HolsingerL.J.AlamsR.Influenza virus M2 integral membrane"/>
   <result pre="formation of disulfide bondsVirology1991183324310.1016/0042-6822(91)90115-R2053285 47.ThomasJ.M.StevensM.P.PercyN.BarclayW.S.Phosphorylation of the M2 protein of" exact="influenza" post="A virus is not essential for virus viabilityVirology1998252546410.1006/viro.1998.93849875317 48.HutchinsonE.C.DenhamE.M.ThomasB.TrudgianD.C.HesterS.S.RidlovaG.YorkA.TurrellL.FodorE.Mapping"/>
   <result pre="is not essential for virus viabilityVirology1998252546410.1006/viro.1998.93849875317 48.HutchinsonE.C.DenhamE.M.ThomasB.TrudgianD.C.HesterS.S.RidlovaG.YorkA.TurrellL.FodorE.Mapping the phosphoproteome of" exact="influenza" post="A and B viruses by mass spectrometryPLoS Pathog.20128e100299310.1371/journal.ppat.100299323144613 49.ParkE.K.CastrucciM.R.PortnerA.KawaokaY.The"/>
   <result pre="Pathog.20128e100299310.1371/journal.ppat.100299323144613 49.ParkE.K.CastrucciM.R.PortnerA.KawaokaY.The M2 ectodomain is important for its incorporation into" exact="influenza" post="A virionsJ. Virol.199872244924559499106 50.AcharyaR.CarnevaleV.FiorinG.LevineB.G.PolishchukA.L.BalannikV.SamishI.LambR.A.PintoL.H.DeGradoW.F.et al.Structure and mechanism of proton"/>
   <result pre="transport through the transmembrane tetrameric M2 protein bundle of the" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA2010107150751508010.1073/pnas.100707110720689043 51.ThomastonJ.L.PolizziN.F.KonstantinidiA.WangJ.KolocourisA.DegradoW.F.Inhibitors of the"/>
   <result pre="Soc.2018140152191522610.1021/jacs.8b0674130165017 52.SchnellJ.R.ChouJ.J.Structure and mechanism of the M2 proton channel of" exact="influenza" post="A virusNature200845159159510.1038/nature0653118235503 53.WangJ.WuY.MaC.FiorinG.WangJ.PintoL.H.LambR.A.KleinM.L.DeGradoW.F.Structure and inhibition of the drug-resistant S31N"/>
   <result pre="the drug-resistant S31N mutant of the M2 ion channel of" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20131101315132010.1073/pnas.121652611023302696 54.HuF.Schmidt-RohrK.HongM.NMR detection of"/>
   <result pre="channelJ. Am. Chem. Soc.20121343703371310.1021/ja208118521974716 55.SharmaM.YiM.DongH.QinH.PetersonE.BusathD.D.ZhouH.X.CrossT.A.Insight into the mechanism of the" exact="influenza" post="A proton channel from a structure in a lipid"/>
   <result pre="a lipid bilayerScience201033050951210.1126/science.119175020966252 56.CadyS.D.Schmidt-RohrK.WangJ.SotoC.S.DegradoW.F.HongM.Structure of the amantadine binding site of" exact="influenza" post="M2 proton channels in lipid bilayersNature201046368969210.1038/nature0872220130653 57.LiangR.LiH.SwansonJ.M.VothG.A.Multiscale simulation reveals"/>
   <result pre="simulation reveals a multifaceted mechanism of proton permeation through the" exact="influenza" post="A M2 proton channelProc. Natl. Acad. Sci. USA20141119396940110.1073/pnas.140199711124979779 58.HuJ.FuR.NishimuraK.ZhangL.ZhouH.X.BusathD.D.VijayvergiyaV.CrossT.A.Histidines,"/>
   <result pre="Sci. USA20141119396940110.1073/pnas.140199711124979779 58.HuJ.FuR.NishimuraK.ZhangL.ZhouH.X.BusathD.D.VijayvergiyaV.CrossT.A.Histidines, heart of the hydrogen ion channel from" exact="influenza" post="A virus: Toward an understanding of conductance and proton"/>
   <result pre="stabilizes the Trp41 gate of the M2 proton channel of" exact="influenza" post="a virusStructure2013212033204110.1016/j.str.2013.08.02924139991 61.PielakR.M.ChouJ.J.Kinetic analysis of the M2 proton conduction"/>
   <result pre="virusStructure2013212033204110.1016/j.str.2013.08.02924139991 61.PielakR.M.ChouJ.J.Kinetic analysis of the M2 proton conduction of the" exact="influenza" post="virusJ. Am. Chem. Soc.2010132176951769710.1021/ja108458u21090748 62.OkadaA.MiuraT.TakeuchiH.Protonation of histidine and histidine-tryptophan"/>
   <result pre="interaction in the activation of the M2 ion channel from" exact="influenza" post="A virusBiochemistry2001406053606010.1021/bi002844111352741 63.ColvinM.T.AndreasL.B.ChouJ.J.GriffinR.G.Proton association constants of his 37 in"/>
   <result pre="65.StoufferA.L.AcharyaR.SalomD.LevineA.S.Di CostanzoL.SotoC.S.TereshkoV.NandaV.StayrookS.DeGradoW.F.Structural basis for the function and inhibition of an" exact="influenza" post="virus proton channelNature200845159659910.1038/nature0652818235504 66.ThomastonJ.L.Alfonso-PrietoM.WoldeyesR.A.FraserJ.S.KleinM.L.FiorinG.DeGradoW.F.High-resolution structures of the M2 channel"/>
   <result pre="virus proton channelNature200845159659910.1038/nature0652818235504 66.ThomastonJ.L.Alfonso-PrietoM.WoldeyesR.A.FraserJ.S.KleinM.L.FiorinG.DeGradoW.F.High-resolution structures of the M2 channel from" exact="influenza" post="A virus reveal dynamic pathways for proton stabilization and"/>
   <result pre="Natl. Acad. Sci. USA2015112142601426510.1073/pnas.151849311226578770 67.ThomastonJ.L.DeGradoW.F.Crystal structure of the drug-resistant S31N" exact="influenza" post="M2 proton channelProtein Sci.20161551155410.1002/pro.293727082171 68.ThomastonJ.L.WoldeyesR.A.NakaneT.YamashitaA.TanakaT.KoiwaiK.BrewsterA.S.BaradB.A.ChenY.LemminT.et al.XFEL structures of the"/>
   <result pre="influenza M2 proton channelProtein Sci.20161551155410.1002/pro.293727082171 68.ThomastonJ.L.WoldeyesR.A.NakaneT.YamashitaA.TanakaT.KoiwaiK.BrewsterA.S.BaradB.A.ChenY.LemminT.et al.XFEL structures of the" exact="influenza" post="M2 proton channel: Room temperature water networks and insights"/>
   <result pre="69.AgmonN.The Grotthuss mechanismChem. Phys. Lett.199524445646210.1016/0009-2614(95)00905-J 70.LiangR.SwansonJ.M.J.MadsenJ.J.HongM.DeGradoW.F.VothG.A.Acid activation mechanism of the" exact="influenza" post="A M2 proton channelProc. Natl. Acad. Sci. USA2016113E6955E696410.1073/pnas.161547111327791184 71.LinT.SchroederC.Definitive"/>
   <result pre="attoampere unitary current to the M2 ion channel protein of" exact="influenza" post="A virusJ. Virol.2001753647365610.1128/JVI.75.8.3647-3656.200111264354 72.ChizhmakovI.V.OgdenD.C.GeraghtyF.M.HayhurstA.SkinnerA.BetakovaT.HayA.J.Differences in conductance of M2 proton"/>
   <result pre="Virol.2001753647365610.1128/JVI.75.8.3647-3656.200111264354 72.ChizhmakovI.V.OgdenD.C.GeraghtyF.M.HayhurstA.SkinnerA.BetakovaT.HayA.J.Differences in conductance of M2 proton channels of two" exact="influenza" post="viruses at low and high pHJ. Physiol.200354642743810.1113/jphysiol.2002.02891012527729 73.MouldJ.A.LiH.C.DudlakC.S.LearJ.D.PekoszA.LambR.A.PintoL.H.Mechanism for"/>
   <result pre="73.MouldJ.A.LiH.C.DudlakC.S.LearJ.D.PekoszA.LambR.A.PintoL.H.Mechanism for proton conduction of the M2 ion channel of" exact="influenza" post="A virusJ. Biol. Chem.20002758592859910.1074/jbc.275.12.859210722698 74.MoffatJ.C.VijayvergiyaV.GaoP.F.CrossT.A.WoodburyD.J.BusathD.D.Proton transport through influenza A"/>
   <result pre="channel of influenza A virusJ. Biol. Chem.20002758592859910.1074/jbc.275.12.859210722698 74.MoffatJ.C.VijayvergiyaV.GaoP.F.CrossT.A.WoodburyD.J.BusathD.D.Proton transport through" exact="influenza" post="A virus M2 protein reconstituted in vesiclesBiophys. J.20089443444510.1529/biophysj.107.10908217827230 75.DecourseyT.E.Voltage-gated"/>
   <result pre="transfer pathwaysPhysiol. Rev.20038347557910.1152/physrev.00028.200212663866 76.HuF.LuoW.HongM.Mechanisms of proton conduction and gating in" exact="influenza" post="M2 proton channels from solid-state NMRScience201033050550810.1126/science.119171420966251 77.WilliamsJ.K.ZhangY.Schmidt-RohrK.HongM.PH-dependent conformation, dynamics,"/>
   <result pre="and aromatic interaction of the gating tryptophan residue of the" exact="influenza" post="M2 proton channel from solid-state NMRBiophys. J.20131041698170810.1016/j.bpj.2013.02.05423601317 78.DiFrancescoM.L.HansenU.P.ThielG.MoroniA.SchroederI.Effect of"/>
   <result pre="reveals structural characteristics of the proton transport cycle in the" exact="influenza" post="A protein M2 in cell-free membrane patches of Xenopus"/>
   <result pre="oocytesPLoS ONE2014910.1371/journal.pone.0107406 79.ZhouH.X.A theory for the proton transport of the" exact="influenza" post="virus M2 protein: Extensive test against conductance dataBiophys. J.201110091292110.1016/j.bpj.2011.01.00221320435"/>
   <result pre="of the hydration status of the tryptophan gate in the" exact="influenza" post="A M2 proton channelPCCP201618289392895010.1039/C6CP03426H27725984 81.LinC.W.MensaB.Barniol-XicotaM.DeGradoW.F.GaiF.Activation pH and Gating Dynamics"/>
   <result pre="characterization of conformational plasticity within the transmembrane domain of the" exact="influenza" post="A M2 proton channelBiochim. Biophys. Acta200717683162317010.1016/j.bbamem.2007.08.02517936720 84.YiM.CrossT.A.ZhouH.X.Conformational heterogeneity of"/>
   <result pre="suggest a conduction mechanism for the M2 proton channel from" exact="influenza" post="A virusProc. Natl. Acad. Sci. USA20091061069107410.1073/pnas.081172010619144924 86.WeiC.PohorilleA.M2 Proton Channel:"/>
   <result pre="the pore-lining residues of the BM2 ion channel protein of" exact="influenza" post="B virusJ. Biol. Chem.2008283159211593110.1074/jbc.M71030220018408016 89.WilliamsJ.K.TietzeD.LeeM.WangJ.HongM.Solid-State NMR Investigation of the"/>
   <result pre="Chem. Soc.20161388143815510.1021/jacs.6b0314227286559 90.WilliamsJ.K.ShcherbakovA.A.WangJ.HongM.Protonation equilibria and pore-opening structure of the dual-histidine" exact="influenza" post="B virus M2 transmembrane proton channel from solid-state NMRJ."/>
   <result pre="NMRJ. Biol. Chem.2017292178761788410.1074/jbc.M117.81399828893910 91.HongoS.SugawaraK.NishimuraH.MurakiY.KitameF.NakamuraK.Identification of a second protein encoded by" exact="influenza" post="C virus RNA segment 6J. Gen. Virol.1994753503351010.1099/0022-1317-75-12-35037996141 92.HongoS.IshiiK.MoriK.TakashitaE.MurakiY.MatsuzakiY.SugawaraK.Detection of"/>
   <result pre="(P42) by signal peptidase cleavageJ. Virol.19997346509847305 95.PekoszA.LambR.A.The CM2 protein of" exact="influenza" post="C virus is an oligomeric integral membrane glycoprotein structurally"/>
   <result pre="virus is an oligomeric integral membrane glycoprotein structurally analogous to" exact="influenza" post="A virus M2 and influenza B virus NB proteinsVirology199723743945110.1006/viro.1997.87889356355"/>
   <result pre="membrane glycoprotein structurally analogous to influenza A virus M2 and" exact="influenza" post="B virus NB proteinsVirology199723743945110.1006/viro.1997.87889356355 96.HongoS.SugawaraK.MurakiY.KitameF.NakamuraK.Characterization of a second protein"/>
   <result pre="a second protein (CM2) encoded by RNA segment 6 of" exact="influenza" post="C virusJ. Virol.199771278627929060633 97.MurakiY.OkuwaT.HimedaT.HongoS.OharaY.Effect of Cysteine Mutations in the"/>
   <result pre="CM2 on the Influenza C Virus ReplicationPLoS ONE2013810.1371/journal.pone.006051023593230 98.TadaY.HongoS.MurakiY.MatsuzakiY.SugawaraK.KitameF.NakamuraK.Phosphorylation of" exact="influenza" post="C virus CM2 proteinVirus Res.199858657210.1016/S0168-1702(98)00103-89879763 99.KukolA.ArkinI.T.Structure of the Influenza"/>
   <result pre="searchingJ. Biol. Chem.20002754225422910.1074/jbc.275.6.422510660588 100.MurakiY.WashiokaH.SugawaraK.MatsuzakiY.TakashitaE.HongoS.Identification of an amino acid residue on" exact="influenza" post="C virus M1 protein responsible for formation of the"/>
   <result pre="transmembrane helix-helix interactionsBiophys. J.2001812681269210.1016/S0006-3495(01)75911-511606281 102.BetakovaT.HayA.J.Evidence that the CM2 protein of" exact="influenza" post="C virus can modify the pH of the exocytic"/>
   <result pre="of the exocytic pathway of transfected cellsJ. Gen. Virol.2007882291229610.1099/vir.0.82785-017622634 103.StewartS.M.PekoszA.The" exact="influenza" post="C virus CM2 protein can alter intracellular pH, and:"/>
   <result pre="and: Its transmembrane domain can substitute for that of the" exact="influenza" post="a virus M2 protein and support infectious virus productionJ."/>
   <result pre="virus productionJ. Virol.2012861277128110.1128/JVI.05681-1121917958 104.OhuchiM.OhuchiR.MifuneK.Demonstration of hemolytic and fusion activities of" exact="influenza" post="C virusJ. Virol.198242107610797097857 105.ChizhmakovI.V.GeraghtyF.M.OgdenD.C.HayhurstA.AntoniouM.HayA.J.Selective proton permeability and pH regulation"/>
   <result pre="virusJ. Virol.198242107610797097857 105.ChizhmakovI.V.GeraghtyF.M.OgdenD.C.HayhurstA.AntoniouM.HayA.J.Selective proton permeability and pH regulation of the" exact="influenza" post="virus M2 channel expressed in mouse erythroleukaemia cellsJ. Physiol.199649432933610.1113/jphysiol.1996.sp0214958841994"/>
   <result pre="Physiol.199649432933610.1113/jphysiol.1996.sp0214958841994 106.MouldJ.A.DruryJ.E.FringS.M.KauppU.B.PekoszA.LambR.A.PintoL.H.Permeation and activation of the M2 ion channel of" exact="influenza" post="A virusJ. Biol. Chem.2000275310383105010.1074/jbc.M00366320010913133 107.BetákováT.KollerováE.pH modulating activity of ion"/>
   <result pre="virusJ. Biol. Chem.2000275310383105010.1074/jbc.M00366320010913133 107.BetákováT.KollerováE.pH modulating activity of ion channels of" exact="influenza" post="A, B, and C virusesActa Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of influenza"/>
   <result pre="of influenza A, B, and C virusesActa Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of" exact="influenza" post="C viruses, distinct from that of influenza A and"/>
   <result pre="Virol.20065018719317131938 108.ZhirnovO.P.GrigorievV.B.Disassembly of influenza C viruses, distinct from that of" exact="influenza" post="A and B viruses requires neutral-alkaline pHVirology199420028429110.1006/viro.1994.11888128628 109.FurukawaT.MurakiY.NodaT.TakashitaE.ShoR.SugawaraK.MatsuzakiY.ShimotaiY.HongoS.Role of"/>
   <result pre="requires neutral-alkaline pHVirology199420028429110.1006/viro.1994.11888128628 109.FurukawaT.MurakiY.NodaT.TakashitaE.ShoR.SugawaraK.MatsuzakiY.ShimotaiY.HongoS.Role of the CM2 protein in the" exact="influenza" post="C virus replication cycleJ. Virol.2011851322132910.1128/JVI.01367-1021106743 110.KesingerE.LiuJ.JensenA.ChiaC.P.DemersA.MoriyamaH.Influenza D virus M2"/>
   <result pre="ion channel activity in Xenopus laevis oocytesPLoS ONE201813e019922710.1371/journal.pone.019922729927982 111.HenkelM.MitznerD.HenkleinP.Meyer-AlmesF.J.MoroniA.DiFrancescoM.L.HenkesL.M.KreimM.KastS.M.SchubertU.et al.Proapoptotic" exact="influenza" post="A virus protein PB1-F2 forms a nonselective ion channelPLoS"/>
   <result pre="PB1-F2 forms a nonselective ion channelPLoS ONE2010510.1371/journal.pone.0011112 112.ChenW.CalvoP.A.MalideD.GibbsJ.SchubertU.BacikI.BastaS.O’NeillR.SchickliJ.PaleseP.et al.A novel" exact="influenza" post="A virus mitochondrial protein that induces cell deathNat. Med.200171306131210.1038/nm1201-130611726970"/>
   <result pre="and deletions in a bicistronic mRNA on the synthesis of" exact="influenza" post="B virus NB and NA glycoproteinsJ. Virol.19896328352908923 117.DemersA.RanZ.DengQ.WangD.EdmanB.LuW.LiF.Palmitoylation is"/>
   <result pre="NA glycoproteinsJ. Virol.19896328352908923 117.DemersA.RanZ.DengQ.WangD.EdmanB.LuW.LiF.Palmitoylation is required for intracellular trafficking of" exact="influenza" post="B virus NB protein and efficient influenza B virus"/>
   <result pre="intracellular trafficking of influenza B virus NB protein and efficient" exact="influenza" post="B virus growth in vitroJ. Gen. Virol.2014951211122010.1099/vir.0.063511-024671751 118.SunstromN.A.PremkumarL.S.PremkumarA.EwartG.CoxG.B.GageP.W.Ion channels"/>
   <result pre="in vitroJ. Gen. Virol.2014951211122010.1099/vir.0.063511-024671751 118.SunstromN.A.PremkumarL.S.PremkumarA.EwartG.CoxG.B.GageP.W.Ion channels formed by NB, an" exact="influenza" post="B virus proteinJ. Membr. Biol.199615012713210.1007/s0023299000378661776 119.PremkumarA.EwartG.D.CoxG.B.GageP.W.An amino-acid substitution in"/>
   <result pre="protein affects ion-channel gatingJ. Membr. Biol.200419713514310.1007/s00232-004-0648-015042345 120.HattaM.KawaokaY.The NB protein of" exact="influenza" post="B virus is not necessary for virus replication in"/>
   <result pre="Virus EntryMed. Res. Rev.20143430133910.1002/med.2128923801557 126.DeydeV.M.XuX.BrightR.A.ShawM.SmithC.B.ZhangY.ShuY.GubarevaL.V.CoxN.J.KlimovA.I.Surveillance of resistance to adamantanes among" exact="influenza" post="A(H3N2) and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 127.BrightR.A.ShayD.K.ShuB.CoxN.J.KlimovA.I.Adamantane"/>
   <result pre="and A(H1N1) viruses isolated worldwideJ. Infect. Dis.200719624925710.1086/51893617570112 127.BrightR.A.ShayD.K.ShuB.CoxN.J.KlimovA.I.Adamantane resistance among" exact="influenza" post="A viruses isolated early during the 2005-2006 influenza season"/>
   <result pre="resistance among influenza A viruses isolated early during the 2005-2006" exact="influenza" post="season in the United StatesJAMA200629589189410.1001/jama.295.8.joc6002016456087 128.BrightR.A.MedinaM.J.XuX.Perez-OronozG.WallisT.R.DavisX.M.PovinelliL.CoxN.J.KlimovA.I.Incidence of adamantane resistance"/>
   <result pre="season in the United StatesJAMA200629589189410.1001/jama.295.8.joc6002016456087 128.BrightR.A.MedinaM.J.XuX.Perez-OronozG.WallisT.R.DavisX.M.PovinelliL.CoxN.J.KlimovA.I.Incidence of adamantane resistance among" exact="influenza" post="A (H3N2) viruses isolated worldwide from 1994 to 2005:"/>
   <result pre="from 1994 to 2005: A cause for concernLancet20053661175118110.1016/S0140-6736(05)67338-216198766 129.HaydenF.G.De JongM.D.Emerging" exact="influenza" post="antiviral resistance threatsJ. Infect. Dis.201120361010.1093/infdis/jiq01221148489 130.FioreA.E.FryA.ShayD.GubarevaL.BreseeJ.S.UyekiT.M.collab: Centers for Disease"/>
   <result pre="vitro and in vivo antiviral activities against amantadine-sensitive and -resistant" exact="influenza" post="A virusesAntivir. Res.2017140455410.1016/j.antiviral.2017.01.00628087313 135.DongG.PengC.LuoJ.WangC.HanL.WuB.JiG.HeH.Adamantane-resistant influenza a viruses in the"/>
   <result pre="activities against amantadine-sensitive and -resistant influenza A virusesAntivir. Res.2017140455410.1016/j.antiviral.2017.01.00628087313 135.DongG.PengC.LuoJ.WangC.HanL.WuB.JiG.HeH.Adamantane-resistant" exact="influenza" post="a viruses in the world (1902-2013): Frequency and distribution"/>
   <result pre="Today2012171111112010.1016/j.drudis.2012.06.00222704956 137.GuR.X.LiuL.A.WeiD.Q.Structural and energetic analysis of drug inhibition of the" exact="influenza" post="A M2 proton channelTrends Pharmacol. Sci.20133457158010.1016/j.tips.2013.08.00324011996 138.ToJ.SuryaW.TorresJ.Targeting the Channel"/>
   <result pre="Biol.2016104307355 139.GandhiC.S.ShuckK.LearJ.D.DieckmannG.R.DeGradoW.F.LambR.A.PintoL.H.Cu(II) inhibition of the proton translocation machinery of the" exact="influenza" post="A virus M 2 proteinJ. Biol. Chem.19992745474548210.1074/jbc.274.9.547410026160 140.SuY.HuF.HongM.Paramagnetic Cu(II)"/>
   <result pre="probing membrane protein structure and function: Inhibition mechanism of the" exact="influenza" post="M2 proton channelJ. Am. Chem. Soc.20121348693870210.1021/ja302632822519936 141.GordonN.A.McGuireK.L.WallentineS.K.MohlG.A.LynchJ.D.HarrisonR.G.BusathD.D.Divalent copper complexes"/>
   <result pre="M2 proton channelJ. Am. Chem. Soc.20121348693870210.1021/ja302632822519936 141.GordonN.A.McGuireK.L.WallentineS.K.MohlG.A.LynchJ.D.HarrisonR.G.BusathD.D.Divalent copper complexes as" exact="influenza" post="A M2 inhibitorsAntivir. Res.201714710010610.1016/j.antiviral.2017.10.00929032206 142.IchinoheT.PangI.K.IwasakiA.Influenza virus activates inflammasomes via"/>
   <result pre="Host Microbe2009636738010.1016/j.chom.2009.09.00519837376 150.BourmakinaS.V.García-SastreA.Reverse genetics studies on the filamentous morphology of" exact="influenza" post="a virusJ. Gen. Virol.20038451752710.1099/vir.0.18803-012604801 151.BealeR.WiseH.StuartA.RavenhillB.J.DigardP.RandowF.A LC3-interacting motif in the"/>
   <result pre="influenza a virusJ. Gen. Virol.20038451752710.1099/vir.0.18803-012604801 151.BealeR.WiseH.StuartA.RavenhillB.J.DigardP.RandowF.A LC3-interacting motif in the" exact="influenza" post="A virus M2 protein is required to subvert autophagy"/>
   <result pre="Hsp40 to inhibit PKR activationPLoS ONE2011610.1371/journal.pone.002021521698289 155.GuanZ.LiuD.MiS.ZhangJ.YeQ.WangM.GaoG.F.YanJ.Interaction of Hsp40 with" exact="influenza" post="virus M2 protein: Implications for PKR signaling pathwayProtein Cell2010194495510.1007/s13238-010-0115-x21204021"/>
   <result pre="the viral M2 proteinBiochem. J.201747471573010.1042/BCJ2016086128087685 158.MaH.KienF.ManièreM.ZhangY.LagardeN.TseK.S.PoonL.L.M.NalB.Human annexin A6 interacts with" exact="influenza" post="a virus protein M2 and negatively modulates infectionJ. Virol.2012861789180110.1128/JVI.06003-1122114333"/>
   <result pre="Chem.20172925070508810.1074/jbc.M117.77611228130444 160.RudickM.AndersonR.G.W.Multiple functions of caveolin-1J. Biol. Chem.2002277412954129812189159 161.SunL.HemgårdG.V.SusantoS.A.WirthM.Caveolin-1 influences human" exact="influenza" post="A virus (H1N1) multiplication in cell cultureVirol. J.2010710.1186/1743-422X-7-108 162.CouetJ.LiS.OkamotoT.IkezuT.LisantiM.P.Identification"/>
   <result pre="minireviewInt. J. Mol. Sci.201819215410.3390/ijms1908215430042322 164.ChanM.C.W.KuokD.I.T.LeungC.Y.H.HuiK.P.Y.ValkenburgS.A.LauE.H.Y.NichollsJ.M.FangX.GuanY.LeeJ.W.et al.Human mesenchymal stromal cells reduce" exact="influenza" post="A H5N1-associated acute lung injury in vitro and in"/>
   <result pre="vitro and in vivoProc. Natl. Acad. Sci. USA20161133621362610.1073/pnas.160191111326976597 165.HoffmannH.H.PaleseP.ShawM.L.Modulation of" exact="influenza" post="virus replication by alteration of sodium ion transport and"/>
   <result pre="ebola virusViruses2016827710.3390/v811027727801778 167.MiS.F.LiY.YanJ.H.GaoG.F.Na+/K+-ATPase β1 subunit interacts with M2 proteins of" exact="influenza" post="A and B viruses and affects the virus replicationSci."/>
   <result pre="168.DomsR.W.LambR.A.RoseJ.K.HeleniusA.Folding and assembly of viral membrane proteinsVirology199319354556210.1006/viro.1993.11648460475 169.HugheyP.G.CompansR.W.ZebedeeS.L.LambR.A.Expression of the" exact="influenza" post="A virus M2 protein Is restricted to apical surfaces"/>
   <result pre="Virus BuddingCell Host Microbe20151872373510.1016/j.chom.2015.11.00226651948 172.BruceE.A.DigardP.StuartA.D.The Rab11 pathway is required for" exact="influenza" post="A virus budding and filament formationJ. Virol.2010845848585910.1128/JVI.00307-1020357086 173.ChenW.FengY.ChenD.Wandinger-NessA.Rab11 is"/>
   <result pre="ESCRT-Independent Membrane ScissionCell201014290291310.1016/j.cell.2010.08.02920850012 177.ZhuP.LiangL.ShaoX.LuoW.JiangS.ZhaoQ.SunN.ZhaoY.LiJ.WangJ.et al.Host cellular protein TRAPPC6AΔ interacts with" exact="influenza" post="A virus M2 protein and regulates viral propagation by"/>
   <result pre="Proteostasis Limits Influenza Virus, HIV, and Dengue Virus InfectionImmunity201644465810.1016/j.immuni.2015.12.01726789921 180.WangL.FuB.LiW.PatilG.LiuL.DorfM.E.LiS.Comparative" exact="influenza" post="protein interactomes identify the role of plakophilin 2 in"/>
   <result pre="viroporins in influenza. Influenza A M2 (AM2; strain A/Udorn/1972 H3N2)," exact="influenza" post="B M2 (BM2; strain B/Taiwan/70061/2006), influenza C M2 (CM2;"/>
   <result pre="(AM2; strain A/Udorn/1972 H3N2), influenza B M2 (BM2; strain B/Taiwan/70061/2006)," exact="influenza" post="C M2 (CM2; strain C/Ann Arbor/1/1950) and influenza D"/>
   <result pre="strain B/Taiwan/70061/2006), influenza C M2 (CM2; strain C/Ann Arbor/1/1950) and" exact="influenza" post="D M2 (DM2; strain D/swine/Oklahoma/1334/2011). The predicted transmembrane regions"/>
   <result pre="conformation. Scheme adapted from [70]. cells-08-00654-t001_Table 1Table 1 Properties of" exact="influenza" post="viroporins. PB1-F2 and NB are much less studied compared"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6681032\results\search\disease\results.xml">
   <result pre="5′-monophosphate analog called EdAP (5). EdAP exhibited potent inhibition against" exact="influenza" post="virus multiplication in Madin–Darby canine kidney (MDCK) cells transfected"/>
   <result pre="this DNA-type nucleic acid analog (5) inhibited the multiplication of" exact="influenza" post="A virus, although influenza virus is an RNA virus"/>
   <result pre="analog (5) inhibited the multiplication of influenza A virus, although" exact="influenza" post="virus is an RNA virus that does not generate"/>
   <result pre="an RNA virus that does not generate DNA. 4′-ethynyl-2′-deoxyadenosine 5′-monophosphate" exact="influenza" post="anti-influenza activity 1. Introduction Influenza caused by influenza A"/>
   <result pre="4′-ethynyl-2′-deoxyadenosine 5′-monophosphate influenza anti-influenza activity 1. Introduction Influenza caused by" exact="influenza" post="A virus is an infectious respiratory disease, which is"/>
   <result pre="Introduction Influenza caused by influenza A virus is an infectious" exact="respiratory disease," post="which is responsible for seasonal epidemics and periodic global"/>
   <result pre="medicine has been frequently reported to limit treatment efficiency. The" exact="influenza" post="A virus is a negative-sense single-strand RNA virus with"/>
   <result pre="antiviral compound. The inhibitors should work against several subtypes of" exact="influenza" post="A viruses and be tolerated by a drug-resistant mutant"/>
   <result pre="a drug-resistant mutant because it is highly conserved in all" exact="influenza" post="subtypes and is essential to the viral life cycle."/>
   <result pre="5′-monophosphate analog called EdAP (5) as a potent inhibitor of" exact="influenza" post="A virus. Interestingly, this DNA-type nucleic acid analog inhibited"/>
   <result pre="Interestingly, this DNA-type nucleic acid analog inhibited the multiplication of" exact="influenza" post="A virus, although influenza A virus is an RNA"/>
   <result pre="acid analog inhibited the multiplication of influenza A virus, although" exact="influenza" post="A virus is an RNA virus that does not"/>
   <result pre="on our hypothesis that EFdA analogs may work against the" exact="influenza" post="virus [25]. The adenosine derivatives of compounds 1–3 were"/>
   <result pre="3). Consequently, compound 5 significantly inhibited the growth of the" exact="influenza" post="virus, with an IC50 of 3.8 μM, whereas no"/>
   <result pre="inhibition level of 5 was around a 79% decrease of" exact="influenza" post="virus-produced NPs. This level is comparable to that of"/>
   <result pre="MD. 3.2.2. Virus As described previously [38], the number of" exact="influenza" post="A/Narita/1/09 H1N1pdm viruses were increased in MDCK–SIAT1 cells containing"/>
   <result pre="inhibitor-containing MEM medium on the cells was replaced with the" exact="influenza" post="virus-inhibitor mixture. After incubation at 37 °C in a"/>
   <result pre="(4E6) and secondary β-galactosidase-conjugated antimouse IgG antibody. The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in the permeabilized cells in each"/>
   <result pre="only the virus was used to express the number of" exact="influenza" post="virus-produced NPs in each well. Then, a graph was"/>
   <result pre="was generated by plotting the percentage of relative numbers of" exact="influenza" post="virus-produced NPs against the logarithm of the inhibitor concentrations."/>
   <result pre="50% in comparison to the control (IC50) was obtained. The" exact="influenza" post="virus-produced NPs in the permeabilized cells in each well"/>
   <result pre="developed EdAP, a new 4′-ethynyl-2′-deoxyadenosine 5′-monophosphate analog, as a potent" exact="influenza" post="A inhibitor with an IC50 of 3.8 μM. EdAP"/>
   <result pre="References References 1.Global Influenza Strategy 2019–2030World Health OrganizationGeneva, Switzerland2019 2.StevaertA.NaesensL.The" exact="influenza" post="virus polymerase complex: An update on its structure, functions,"/>
   <result pre="23.StoddartC.A.GalkinaS.A.JoshiP.KosikovaG.MorenoM.E.RiveraJ.M.SloanB.ReeveA.B.SarafianosS.G.Murphey-CorbM.et al.Oral administration of the nucleoside EFdA (4′-ethynyl-2-fluoro-2′-deoxyadenosine) provides rapid" exact="suppression" post="of HIV viremia in humanized mice and favorable pharmacokinetic"/>
   <result pre="Chem.2000434516452510.1021/jm000209n11087576 26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and" exact="avian influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
   <result pre="26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and avian" exact="influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
   <result pre="apricot fruit juice concentrate show multiple inhibitory effects on pandemic" exact="influenza" post="A (H1N1) virusFood Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and"/>
   <result pre="Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and highly specific inhibitor against" exact="influenza" post="viral N1-N9 neuraminidases: Insight into neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056"/>
   <result pre="neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056 40.SriwilaijaroenN.SuzukiK.TakashitaE.HiramatsuH.KanieO.SuzukiY.6SLN-lipo PGA specifically catches (coats) human" exact="influenza" post="virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic"/>
   <result pre="(coats) human influenza virus and synergizes neuraminidase-targeting drugs for human" exact="influenza" post="therapeutic potentialJ. Antimicrob. Chemother.2015702797280910.1093/jac/dkv19326169554 Figures, Scheme and Table Figure"/>
   <result pre="1 Synthesis of EdAP (5). Figure 3 Inhibition of the" exact="influenza" post="virus growth in the MDCK–SIAT1 cells by EdAP (5)."/>
   <result pre="MDCK–SIAT1 cells by EdAP (5). Upper panel: The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in cells decreased with an increase"/>
   <result pre="indicated. Lower panel: The reduction in the relative numbers of" exact="influenza" post="virus-produced NPs in cells was a function of EdAP"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6687121\results\search\disease\results.xml">
   <result pre="author and source are credited.pone.0220391.pdf Abstract Background The number of" exact="dengue fever" post="(DF) cases and the number of dengue outbreaks have"/>
   <result pre="and its Supporting Information files. Introduction Dengue is an arthropod-borne" exact="viral disease" post="that results in a broad spectrum of clinical symptoms"/>
   <result pre="broad spectrum of clinical symptoms ranging from mild fever to" exact="dengue hemorrhagic fever" post="(DHF), which can lead to dengue shock syndrome (DSS)"/>
   <result pre="[6]. Despite being considered an imported disease in mainland China," exact="dengue fever" post="(DF) cases and the number of dengue outbreaks have"/>
   <result pre="the effectiveness of control measures for many infectious diseases, including" exact="chikungunya" post="fever[12], Ebola[13], hemorrhagic conjunctivitis[14], shigellosis[15], influenza[16] and norovirus[17]. For"/>
   <result pre="to 5%. Despite the fact that dengue is a mosquito-borne" exact="viral disease" post="and the inapparent infection can also transmit it, we"/>
   <result pre="studies and may provide more accurate simulations. Finally, owing to" exact="hypersensitivity" post="to the number of cases for one parameter, the"/>
   <result pre="References 1PangXJ, ZhangRD, ChengG. Progress towards understanding the pathogenesis of" exact="dengue hemorrhagic fever." post="VIROLOGICA SINICA. 2016;32,110.1007/s12250-016-3855-9 .27853992 2Maria GGuzman,EvaHarris. Dengue. Lancet. 2015;385,453–65."/>
   <result pre="A model for evaluation of key measures for control of" exact="chikungunya" post="fever outbreak in China. Chin J Epidemiol. 2015;36,1253–1257.(in Chinese)"/>
   <result pre="Dynamic modelling of strategies for the control of acute haemorrhagic" exact="conjunctivitis" post="outbreaks in schools in Changsha,China (2004–2015). Epidemiol. Infect.2017;145, 368–378."/>
   <result pre="10.1016/j.mbs.2009.10.005 .19861133 25NewtonE, ReiterP. A model of the transmission of" exact="dengue fever" post="with an evaluation of the impact of ultra-low volume"/>
   <result pre="XieZ, HuGQ. Evaluating the effects of common control measures for" exact="influenza" post="A (H1N1) outbreak at school in China: A modeling"/>
   <result pre="2017;12,e018452710.1371/journal.pone.0184527 .28886143 36ManoreCA, HickmannKS, XuS, WearingHJ, HymanJM. Comparing dengue and" exact="chikungunya" post="emergence and endemic transmission in A. aegypti and A."/>
   <result pre="LiuRC, ZhangXX, XieZ, ChenSL. Simulation of key interventions for seasonal" exact="influenza" post="outbreak control at school in Changsha, China. Journal of"/>
   <result pre="ZhuYS, XiaY, ZhangYT, HuangXD, HuangJW,et al.Dynamic spatiotemporal analysis of indigenous" exact="dengue fever" post="at street-level in Guangzhou city, China. PLoS Negl Trop"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6688121\results\search\disease\results.xml">
   <result pre="need to be obtained within days. visualization phylogenetics phylogenomics phylodynamics" exact="infectious disease" post="epidemiology evolution fig-count: table-count: equation-count: ref-count: page-count: word-count: 1."/>
   <result pre="and continuously updated pipelines that accommodate increasing data flow during" exact="infectious disease" post="outbreaks (19) (see further sections for more information and"/>
   <result pre="in nature, driven by the intrinsic objective to better understand" exact="viral disease" post="epidemiology. Due to the increasing complexity and interactivity of"/>
   <result pre="Finally, visualization and accompanying interpretation are a critical component of" exact="infectious disease" post="epidemiological and evolutionary analyses. Indeed, many researchers use visualization"/>
   <result pre="or more phylogenetic trees, for example when inferred from different" exact="influenza" post="proteins (PB1, PB2, PA, HA, NP, NA, M1, and"/>
   <result pre="on the output of a Bayesian phylodynamic analysis of a" exact="rabies" post="virus (RABV) data set consisting of time-stamped genetic data"/>
   <result pre="of spatio-temporal histories have become broadly and increasingly applied in" exact="viral disease" post="investigations. The incorporation of geographical and phylogenetic uncertainty into"/>
   <result pre="time by integrating viral phenotypic information into phylogenetic trees of" exact="influenza" post="viruses, thereby providing additional insights into the rate of"/>
   <result pre="evolutionary phenomena such as recombination (e.g., HIV-1) and hybridization (e.g.," exact="influenza" post="virus) events (30, 32, 87). Tanglegrams and related visualization"/>
   <result pre="the selection of the virus strain composition of the seasonal" exact="influenza" post="vaccine is informed by analyses and visualizations of circulating"/>
   <result pre="has substantially grown as an elementary discipline for investigations of" exact="infectious disease" post="epidemiology and evolution. An extensive array of software and"/>
   <result pre="References References 1.RifeBDMavianCChenXCiccozziMSalemiMMinJet al.. Phylodynamic applications in 21st century global" exact="infectious disease" post="research. Glob Health Res Policy. (2017) 2:13. 10.1186/s41256-017-0034-y29202081 2.DellicourSBaeleGDudasGFariaNRPybusOGSuchardMAet"/>
   <result pre="10.1126/science.125673925278604 4.FariaNRKraemerMUGHillSCGoes de JesusJAguiarRSIaniFCMet al.. Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science. (2018) 361:894–9. 10.1126/science.aat711530139911 5.DudasGCarvalhoLMBedfordTTatemAJBaeleGFariaNRet al.."/>
   <result pre="epidemic. Nature. (2017) 544:309–15. 10.1038/nature2204028405027 6.RussellCAKassonPMDonisRORileySDunbarJRambautAet al.Science Forum: improving pandemic" exact="influenza" post="risk assessment. eLife. (2014) 3:e0388310.7554/eLife.0388325321142 7.GermanDGrabowskiMKBeyrerC. Enhanced use of"/>
   <result pre="Genom. (2016) 2:e000093. 10.1099/mgen.0.00009328348833 47.NeherRABedfordT. nextflu: real-time tracking of seasonal" exact="influenza" post="virus evolution in humans. Bioinformatics. (2015) 31:3546–8. 10.1093/bioinformatics/btv38126115986 48.YuGLamTTZhuHGuanY."/>
   <result pre="10.1093/ve/vey01629942656 52.StreickerDTurmelleAVonhofMKuzminIMcCrackenGFRupprechtC. Host phylogeny constrains cross-species emergence and establishment of" exact="rabies" post="virus in bats. Science. (2010) 329:676–9. 10.1126/science.118883620689015 53.LemeyPRambautADrummondAJSuchardMA. Bayesian"/>
   <result pre="plot reveals temporal changes of epidemic spread in HIV and" exact="hepatitis" post="C virus (HCV). Proc Natl Acad Sci USA. (2013)"/>
   <result pre="70.NeherRABedfordTDanielsRSRussellCAShraimanBI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal" exact="influenza" post="viruses. Proc Natl Acad Sci USA. (2016) 113:E1701–1709. 10.1073/pnas.152557811326951657"/>
   <result pre="71.SmithDJLapedesASde JongJCBestebroerTMRimmelzwaanGFOsterhausADet al.. Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science. (2004) 305:371–6. 10.1126/science.109721115218094 72.KatzelnickLCFonvilleJMGromowskiGDBustos ArriagaJGreenAJamesSLet al.Dengue viruses"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2. PLoS Pathog. (2014) 10:e1003932. 10.1371/journal.ppat.100393224586153 74.MininVNSuchardMA. Counting labeled"/>
   <result pre="75.BedfordTCobeySBeerliPPascualM. Global migration dynamics underlie evolution and persistence of human" exact="influenza" post="A (H3N2). PLoS Pathog. (2010) 6:e1000918. 10.1371/journal.ppat.100091820523898 76.SuYCBahlJJosephUButtKMPeckHAKoayESet al.."/>
   <result pre="PLoS Pathog. (2010) 6:e1000918. 10.1371/journal.ppat.100091820523898 76.SuYCBahlJJosephUButtKMPeckHAKoayESet al.. Phylodynamics of H1N1/2009" exact="influenza" post="reveals the transition from host adaptation to immune-driven selection."/>
   <result pre="10.1371/journal.pcbi.100461326717515 81.YpmaRJvan BallegooijenWMWallingaJ. Relating phylogenetic trees to transmission trees of" exact="infectious disease" post="outbreaks. Genetics. (2013) 195:1055–62. 10.1534/genetics.113.15485624037268 82.MollentzeNNelLHTownsendSle RouxKHampsonKHaydonDTet al.. A"/>
   <result pre="10.1098/rspb.2013.325124619442 83.KlinkenbergDBackerJADidelotXColijnCWallingaJ. Simultaneous inference of phylogenetic and transmission trees in" exact="infectious disease" post="outbreaks. PLoS Comput Biol. (2017) 13:e1005495. 10.1371/journal.pcbi.100549528545083 84.DudasGBedfordTLycettSRambautA. Reassortment"/>
   <result pre="outbreaks. PLoS Comput Biol. (2017) 13:e1005495. 10.1371/journal.pcbi.100549528545083 84.DudasGBedfordTLycettSRambautA. Reassortment between" exact="influenza" post="B lineages and the emergence of a coadapted PB1-PB2-HA"/>
   <result pre="variants in the non-structural proteins 5A and 5B of the" exact="hepatitis" post="C virus. Virus Evol. (2018) 4:vex041. 10.1093/ve/vex04129362671 97.MagiorkinisGMagiorkinisEParaskevisDHoSYShapiroBPybusOGet al.."/>
   <result pre="Evol. (2018) 4:vex041. 10.1093/ve/vex04129362671 97.MagiorkinisGMagiorkinisEParaskevisDHoSYShapiroBPybusOGet al.. The global spread of" exact="hepatitis" post="C virus 1a and 1b: a phylodynamic and phylogeographic"/>
   <result pre="10.1089/aid.2015.009526651266 100.NelsonMISimonsenLViboudCMillerMAHolmesEC. Phylogenetic analysis reveals the global migration of seasonal" exact="influenza" post="A viruses. PLoS Pathog. (2007) 3:1220–28. 10.1371/journal.ppat.003013117941707 101.FourmentMDarlingAEHolmesEC. The"/>
   <result pre="101.FourmentMDarlingAEHolmesEC. The impact of migratory flyways on the spread of" exact="avian influenza" post="virus in North America. BMC Evol Biol. (2017) 17:118."/>
   <result pre="The impact of migratory flyways on the spread of avian" exact="influenza" post="virus in North America. BMC Evol Biol. (2017) 17:118."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689137\results\search\disease\results.xml">
   <result pre="&amp;lt;100 cells/mm3, it will allow for retinal diseases such as" exact="retinitis" post="and retinal microangiopathy.1 AIDS is pandemic composed of multiple"/>
   <result pre="HIV infection, established through clinical and laboratory criteria by an" exact="infectious disease" post="specialist at the UFRJ Hospital. Patients with factors that"/>
   <result pre="were excluded. These include the diagnosis of glaucoma, active uveitis," exact="retinal detachment," post="use of antiglaucomatous eye drops, previous surgery on the"/>
   <result pre="three groups, regarding sex (P=0.962), race (P=0.967), family history of" exact="glaucoma" post="(P=0.608), comorbidities (P=0.058) and form of virus acquisition (P=0.801)."/>
   <result pre="7 (7.0) 1 (1.1) 0 (0.0) Absent family history of" exact="glaucoma" post="(%) 100 (100.0) 91 (100.0) 8 (100.0) 0.608 BUT"/>
   <result pre="left eye; VL, viral load; SAH, systemic arterial hypertension; DM," exact="diabetes mellitus;" post="BUT, breakup time film; BIO, biomicroscopy; DO, optic disc."/>
   <result pre="humor of patients with AIDS and ocular manifestations including CMV" exact="retinitis" post="and HIV retinopathy. They observed a decrease in the"/>
   <result pre="also being investigated. Cidofovir is a medication known to cause" exact="ocular hypotension." post="Through a cohort, they showed that IOP reduced after"/>
   <result pre="to CMV patients without the use of the medication. Previous" exact="uveitis" post="was a common finding in patients taking cidofovir.13 In"/>
   <result pre="Am J Ophthalmol. 1996;122(1):91–96. doi:10.1016/S0002-9394(14)71968-38659603 13.AklerME, JohnsonDW, BurmanWJ, JohnsonSC. Anterior" exact="uveitis" post="and hypotony after intravenous cidofovir for the treatment of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689504\results\search\disease\results.xml">
   <result pre=": Original Article Transient expression of hemagglutinin antigen from canine" exact="influenza" post="virus H3N2 in Nicotiana benthamiana and Lactuca sativa https://orcid.org/0000-0001-9241-0100MaharjanPuna"/>
   <result pre="provided the original work is properly cited. Abstract Purpose Canine" exact="influenza" post="virus (CIV), H3N2, carries potentiality for zoonotic transmission and"/>
   <result pre="DNA sequences of the HA gene from Korean CIV strain" exact="influenza" post="A/canine/Korea/S3001/2015 (H3N2) for cloning into a geminiviral expression vectors"/>
   <result pre="as an instant host system for the transient expression of" exact="influenza" post="antigen at the time of emergency. The geminiviral vector"/>
   <result pre="of complex-glycosylated and basal-glycosylated rHA in lettuce and tobacco. Canine" exact="influenza" post="H3N2 Lactuca sativa Nicotiana benthamiana Plant-made vaccine Viral vector"/>
   <result pre="Canine influenza, a dog flu, is caused by two different" exact="influenza" post="A viruses; equine-originated canine influenza virus (CIV) H3N8 and"/>
   <result pre="is caused by two different influenza A viruses; equine-originated canine" exact="influenza" post="virus (CIV) H3N8 and the avian-originated CIV H3N2 virus"/>
   <result pre="and fact of the quick and constant mutation in the" exact="influenza" post="virus genome, CIV H3N2 may possibly lead to human"/>
   <result pre="cold chain distribution. The advancement of the transgenic lettuce produced" exact="hepatitis" post="B surface antigen vaccine into a clinical trial (phase"/>
   <result pre="phases of a clinical trial. For example, Nicotiana benthamiana-produced human" exact="influenza" post="virus-like particles (VLP) quadrivalent (phase III), human influenza H1N1"/>
   <result pre="benthamiana-produced human influenza virus-like particles (VLP) quadrivalent (phase III), human" exact="influenza" post="H1N1 (phase I), tobacco produced Ebola vaccine (phase II),"/>
   <result pre="the various strain and subtype of human (H1N1, H3N2) and" exact="avian influenza" post="(H5N1) have been expressed transiently in N. benthamiana and"/>
   <result pre="various strain and subtype of human (H1N1, H3N2) and avian" exact="influenza" post="(H5N1) have been expressed transiently in N. benthamiana and"/>
   <result pre="trial [15161718]. However, there is no report on the canine" exact="influenza" post="vaccine antigen expressed in plant. In this study, we"/>
   <result pre="In this study, we investigated whether HA from Korean canine" exact="influenza" post="strain A/canine/Korea/S3001/2015H3N2 can be expressed in N. benthamiana and"/>
   <result pre="buffer (https://advansta.com). The membrane was probed with a rabbit polyclonal" exact="influenza" post="A H3N2-HA antibody (PA5-34930, Thermo Fisher, Waltham, MA, USA)"/>
   <result pre="cloning, we optimized the viral specific codon of HA from" exact="influenza" post="A/canine/Korea/S3001/2015 (H3N2) towards the usage of preferred codon in"/>
   <result pre="to express the vaccine candidate protein against the human infectious" exact="viral disease" post="in the lettuce, there is only a few report"/>
   <result pre="there is only a few report on transient expression of" exact="influenza" post="vaccine candidate in lettuce [22232425]. Geminiviral vector system has"/>
   <result pre="studies suggest the importance of considering the glycosylation aspect for" exact="influenza" post="vaccine design. During 2016–2017 influenza season, human H3N2 vaccine"/>
   <result pre="considering the glycosylation aspect for influenza vaccine design. During 2016–2017" exact="influenza" post="season, human H3N2 vaccine used at that time was"/>
   <result pre="of this study is to accomplish the transient expression of" exact="influenza" post="HA antigen from A/canine/Korea/S3001/2015/H3N2 strain in the plant that"/>
   <result pre="that commercially available lettuce head can be used to produce" exact="influenza" post="antigen when geminiviral vector system was employed (Figs. 1,"/>
   <result pre="carries a great value for the quick response to the" exact="influenza" post="outbreak and pandemic owing to the rapid production of"/>
   <result pre="influenza outbreak and pandemic owing to the rapid production of" exact="influenza" post="vaccine reducing the time required for the preparation of"/>
   <result pre="be the relevant system to cope with seasonal and pandemic" exact="influenza" post="since influenza HA vaccine with variable glycosylation pattern could"/>
   <result pre="relevant system to cope with seasonal and pandemic influenza since" exact="influenza" post="HA vaccine with variable glycosylation pattern could be produced"/>
   <result pre="embrace a great value for the prompt response to novel" exact="influenza" post="strain outbreak [3435]. In conclusion, we successfully produced complex-glycosylated"/>
   <result pre="that may help alleviate the situation at the time of" exact="influenza" post="epidemic. We would like to thank Hugh S. Mason"/>
   <result pre="to this article was reported. References 1CrawfordPCDuboviEJCastlemanWLet al.Transmission of equine" exact="influenza" post="virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of avian influenza virus"/>
   <result pre="al.Transmission of equine influenza virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of" exact="avian influenza" post="virus (H3N2) to dogsEmerg Infect Dis20081474174618439355 3collab: Center for"/>
   <result pre="of equine influenza virus to dogsScience200531048248516186182 2SongDKangBLeeCet al.Transmission of avian" exact="influenza" post="virus (H3N2) to dogsEmerg Infect Dis20081474174618439355 3collab: Center for"/>
   <result pre="3collab: Center for Disease Control and PreventionKey facts about canine" exact="influenza" post="(dog flu)Atlanta, GACenter for Disease Control and Prevention2019 4SongDSAnDJMoonHJet"/>
   <result pre="Disease Control and Prevention2019 4SongDSAnDJMoonHJet al.Interspecies transmission of the canine" exact="influenza" post="H3N2 virus to domestic cats in South Korea, 2010J"/>
   <result pre="Gen Virol201192Pt 102350235521715595 5KimHSongDMoonHet al.Inter- and intraspecies transmission of canine" exact="influenza" post="virus (H3N2) in dogs, cats, and ferretsInfluenza Other Respir"/>
   <result pre="al.Comparative analysis of virulence of a novel, avian-origin H3N2 canine" exact="influenza" post="virus in various host speciesVirus Res201519513514025218482 7SohrabSSSuhailMKamalMAHusenAAzharEIRecent development and"/>
   <result pre="vaccinesCurr Drug Metab20171883184128699508 8PilletSAubinETrepanierSet al.A plant-derived quadrivalent virus like particle" exact="influenza" post="vaccine induces cross-reactive antibody and T cell response in"/>
   <result pre="Biopharmaceautical2019 12SkehelJJWileyDCReceptor binding and membrane fusion in virus entry: the" exact="influenza" post="hemagglutininAnnu Rev Biochem20006953156910966468 13GrgacicEVAndersonDAVirus-like particles: passport to immune recognitionMethods200640606516997714"/>
   <result pre="15CummingsJFGuerreroMLMoonJEet al.Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based" exact="influenza" post="vaccine derived from influenza A (H1N1)pdm09 virus: a Phase"/>
   <result pre="of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from" exact="influenza" post="A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in"/>
   <result pre="adultsVaccine2014322251225924126211 16ChichesterJAJonesRMGreenBJet al.Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based" exact="influenza" post="vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a"/>
   <result pre="plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1)" exact="influenza" post="virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study"/>
   <result pre="healthy adultsViruses201243227324423202523 17ShojiYFarranceCEBautistaJet al.A plant-based system for rapid production of" exact="influenza" post="vaccine antigensInfluenza Other Respir Viruses2012620421021974811 18LandryNPilletSFavreDet al.Influenza virus-like particle"/>
   <result pre="benthamiana elicit durable, poly-functional and cross-reactive T cell responses to" exact="influenza" post="HA antigensClin Immunol201415416417725128897 19DiamosAGRosenthalSHMasonHS5′ and 3′ untranslated regions strongly"/>
   <result pre="DNA replicon systemBiotechnol Bioeng201010691720047189 22KapustaJModelskaAFiglerowiczMet al.A plant-derived edible vaccine against" exact="hepatitis" post="B virusFASEB J1999131796179910506582 23PniewskiTKapustaJBociagPet al.Low-dose oral immunization with lyophilized"/>
   <result pre="al.Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing" exact="hepatitis" post="B surface antigen for prototype plant-derived vaccine tablet formulationJ"/>
   <result pre="system generating orally immunogenic Norwalk virus-like particlesVaccine2008261846185418325641 27ZostSJParkhouseKGuminaMEet al.Contemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="strainsProc Natl Acad Sci U S A2017114125781258329109276 28AnYParsonsLMJankowskaEMelnykDJoshiMCipolloJFN-glycosylation of seasonal" exact="influenza" post="vaccine hemagglutinins: implication for potency testing and immune processingJ"/>
   <result pre="al.Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic" exact="avian influenza" post="virus H5N1 challenge infectionJ Virol201084120021201020810729 31PhoolcharoenWDyeJMKilbourneJet al.A nonreplicating subunit"/>
   <result pre="with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian" exact="influenza" post="virus H5N1 challenge infectionJ Virol201084120021201020810729 31PhoolcharoenWDyeJMKilbourneJet al.A nonreplicating subunit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6689664\results\search\disease\results.xml">
   <result pre="prevalence and distribution of the main viral causes of equine" exact="encephalitis" post="and discusses their impact and potential approaches to limit"/>
   <result pre="vector vaccination mathematical modeling fig-count: table-count: ref-count: page-count: Introduction Viral" exact="encephalitis" post="is one of the most common infections of the"/>
   <result pre="This review focuses on the main neurotropic viruses that cause" exact="encephalitis" post="in equids and not viruses that can cause other"/>
   <result pre="diseases such as equine herpes myeloencephalopathy. Other viruses that cause" exact="encephalitis" post="in horses less frequently or affecting a smaller region"/>
   <result pre="Kunjin Australia Birds Equids Human Y Y 92 St. Louis" exact="encephalitis" post="North America Birds Equids Human Y Y 93 Usutu"/>
   <result pre="Lagomorphs Rodents Skunks DogsBirds Equids Human Y Y 95 Tick-borne" exact="encephalitis" post="AsiaEurope FinlandRussia Small rodents Equids HumanPrimatesDogsRuminants Y Y 96–98"/>
   <result pre="continent.3 The most common equine encephalitic viruses are Eastern equine" exact="encephalitis" post="(EEE), Western equine encephalitis (WEE), and Venezuelan equine encephalitis"/>
   <result pre="equine encephalitic viruses are Eastern equine encephalitis (EEE), Western equine" exact="encephalitis" post="(WEE), and Venezuelan equine encephalitis (VEE). Collectively known as"/>
   <result pre="equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan equine" exact="encephalitis" post="(VEE). Collectively known as the equine encephalitides, they are"/>
   <result pre="a fatal human case in 2009 associated with WEE virus" exact="encephalitis" post="in a child led to a seroprevalence survey in"/>
   <result pre="the epizootic strains 1-AB and 1-AC of VEE virus produce" exact="encephalomyelitis" post="in horses, with a fatality rate close to 90%.19,20"/>
   <result pre="contains the largest number of viral species that may cause" exact="encephalitis" post="in horses. All are zoonotic and transmitted by mosquitoes"/>
   <result pre="The most significant are West Nile virus (WNV) and Japanese" exact="encephalitis" post="virus (JEV).1 West Nile virus West Nile virus is"/>
   <result pre="endemic in northern Australia but has caused recent outbreaks of" exact="encephalitis" post="in horses in the southeast probably because of enhanced"/>
   <result pre="PRNT, plaque reduction neutralization test; VNT, virus neutralization test. Japanese" exact="encephalitis" post="virus Japanese encephalitis virus most commonly circulates amongst birds"/>
   <result pre="neutralization test; VNT, virus neutralization test. Japanese encephalitis virus Japanese" exact="encephalitis" post="virus most commonly circulates amongst birds and mosquitoes.30 Pigs"/>
   <result pre="order (Rhabdoviridae, Orthobornaviridae, and Paramyxoviridae) include viruses that can produce" exact="encephalitis" post="in animals and humans.36 Rabies virus Rabies virus, a"/>
   <result pre="in 2017.39 Nevertheless, in some African countries, large numbers of" exact="rabies" post="cases occur in equids, including donkeys, and there may"/>
   <result pre="pathogen in the genus Orthobornavirus (family Bornaviridae) that causes mononuclear" exact="encephalomyelitis" post="in horses.41 This disease is endemic in certain areas"/>
   <result pre="reports of confirmed human BoDV-1 infection including a recent fatal" exact="encephalitis" post="case,54 but it is unclear whether these represent interspecies"/>
   <result pre="domestic pigs and people but can occasionally affect horses producing" exact="encephalitis" post="and meningitis.59 Prevention and control The majority of equine"/>
   <result pre="detection of pathogens.64 Early identification of the virus causing equine" exact="encephalitis" post="will improve the effectiveness of many disease control measures."/>
   <result pre="currently available for many of the viruses that cause equine" exact="encephalitis" post="(Table 3). An equine vaccine for JEV is notably"/>
   <result pre="for use in horses to protect against viruses that cause" exact="encephalitis" post="Virus Vaccine type Eastern equine encephalitis Inactivated whole virus"/>
   <result pre="against viruses that cause encephalitis Virus Vaccine type Eastern equine" exact="encephalitis" post="Inactivated whole virus Western equine encephalitis Inactivated whole virus"/>
   <result pre="Vaccine type Eastern equine encephalitis Inactivated whole virus Western equine" exact="encephalitis" post="Inactivated whole virus Venezuelan equine encephalitis (VEE) Inactivated whole"/>
   <result pre="whole virus Western equine encephalitis Inactivated whole virus Venezuelan equine" exact="encephalitis" post="(VEE) Inactivated whole virusA conditionally available modified live virus"/>
   <result pre="theoretical idea.66 Vaccination has led to the global eradication of" exact="smallpox" post="and rinderpest virus. However, herd immunity and disease eradication"/>
   <result pre="example, where poisoning of bats has been used to control" exact="rabies" post="in South America. At the equine premises level, exposure"/>
   <result pre="vector of equine encephalitic viruses, ticks (eg, Powassan virus74 and" exact="louping ill" post="virus) and midges (eg, African horse sickness viruses) can"/>
   <result pre="this work. References References 1.LongMT. West nile virus and equine" exact="encephalitis" post="viruses. Vet Clin North Am Equine Pract. 2014;30:523–542. doi:10.1016/j.cveq.2014.08.00125441112"/>
   <result pre="PowersAM, Villarreal ChavezCL, et al. Genetic and antigenic diversity among" exact="eastern equine encephalitis" post="viruses from North, Central, and South America. Am J"/>
   <result pre="ChavezCL, et al. Genetic and antigenic diversity among eastern equine" exact="encephalitis" post="viruses from North, Central, and South America. Am J"/>
   <result pre="LedermannJP, Saxton-ShawKD, et al. The first outbreak of Eastern equine" exact="encephalitis" post="in Vermont: outbreak description and phylogenetic relationships of the"/>
   <result pre="LindsayLR, DrebotM, MichelP. Characterizing areas of potential human exposure to" exact="eastern equine encephalitis" post="virus using serological and clinical data from horses. Epidemiol"/>
   <result pre="MichelP. Characterizing areas of potential human exposure to eastern equine" exact="encephalitis" post="virus using serological and clinical data from horses. Epidemiol"/>
   <result pre="Infect. 2017;145:667–677. doi:10.1017/S095026881700066827903326 8.RocheleauJ-P, ArsenaultJ, LindsayLR, et al. Eastern equine" exact="encephalitis" post="virus: high seroprevalence in horses from Southern Quebec, Canada,"/>
   <result pre="Emerg Dis. 2015;64:990–993. doi:10.1111/tbed.1238226608567 10.AguilarPV, RobichRM, TurellMJ, et al. Endemic" exact="eastern equine encephalitis" post="in the Amazon region of Peru. Am J Trop"/>
   <result pre="2015;64:990–993. doi:10.1111/tbed.1238226608567 10.AguilarPV, RobichRM, TurellMJ, et al. Endemic eastern equine" exact="encephalitis" post="in the Amazon region of Peru. Am J Trop"/>
   <result pre="Hyg. 2007;76:293–298. doi:10.4269/ajtmh.2007.76.29317297038 11.CarreraJ-P, ForresterN, WangE, et al. Eastern equine" exact="encephalitis" post="in Latin America. New Engl J Med. 2013;369:732–744. doi:10.1056/NEJMoa121262823964935"/>
   <result pre="doi:10.1056/NEJMoa121262823964935 12.de Novaes OliveiraR, IamamotoK, SilvaMLCR, et al. Eastern equine" exact="encephalitis" post="cases among horses in Brazil between 2005 and 2009."/>
   <result pre="Virol. 2014;159:2615–2620. doi:10.1007/s00705-014-2121-424862186 13.SilvaMLCR, GalizaGJN, DantasAFM, et al. Outbreaks of" exact="eastern equine encephalitis" post="in northeastern Brazil. J Vet Diagn Invest. 2011;23:570–575. doi:10.1177/104063871140341421908293"/>
   <result pre="doi:10.1007/s00705-014-2121-424862186 13.SilvaMLCR, GalizaGJN, DantasAFM, et al. Outbreaks of eastern equine" exact="encephalitis" post="in northeastern Brazil. J Vet Diagn Invest. 2011;23:570–575. doi:10.1177/104063871140341421908293"/>
   <result pre="2015;110:125–133. doi:10.1590/0074-0276014038325742272 15.NegiSS, BraunWA, AugusteAJ, BergrenNA, ForresterNL, WeaverSC. Western equine" exact="encephalitis" post="virus: evolutionary analysis of a declining alphavirus based on"/>
   <result pre="al. Continued evidence of decline in the enzootic activity of" exact="western equine encephalitis" post="virus in Colorado. J Med Entomol. 2018;1987:1–5. 19.Estrada-FrancoJG, CarraraA-S,"/>
   <result pre="evidence of decline in the enzootic activity of western equine" exact="encephalitis" post="virus in Colorado. J Med Entomol. 2018;1987:1–5. 19.Estrada-FrancoJG, CarraraA-S,"/>
   <result pre="AronsonJF, WeaverSC, GonzalezD. Equine amplification and virulence of subtype IE" exact="venezuelan equine encephalitis" post="viruses isolated during the 1993 and 1996 Mexican Epizootics."/>
   <result pre="GonzalezD. Equine amplification and virulence of subtype IE venezuelan equine" exact="encephalitis" post="viruses isolated during the 1993 and 1996 Mexican Epizootics."/>
   <result pre="WertheimJO, DuganVG, et al. Evolution and spread of Venezuelan equine" exact="encephalitis" post="complex alphavirus in the Americas. PLoS Negl Trop Dis."/>
   <result pre="Dis. 2017;11:1–19. doi:10.1371/journal.pntd.0005693 21.Navarro-LopezR, ClementsT, FreierJE, et al. Venezuelan equine" exact="encephalitis" post="virus, Southern Mexico. Emerg Infect Dis. 2012;10:2113–2121. 22.AdamsAP, Navarro-LopezR,"/>
   <result pre="Infect Dis. 2012;10:2113–2121. 22.AdamsAP, Navarro-LopezR, Ramirez-AguilarFJ, et al. Venezuelan equine" exact="encephalitis" post="virus activity in the Gulf Coast region of Mexico,"/>
   <result pre="ArshadSS, SelvarajahGT, et al. Prevalence and risk factors of Japanese" exact="encephalitis" post="virus (JEV) in livestock and companion animal in high-risk"/>
   <result pre="Health Prod. 2018;50:741–752. doi:10.1007/s11250-017-1490-629243139 31.RicklinME, Garcia-NicolasO, BrechbuhlD, et al. Japanese" exact="encephalitis" post="virus tropism in experimentally infected pigs. Vet Res. 2016;47:34."/>
   <result pre="Vet Res. 2016;47:34. doi:10.1186/s13567-016-0319-z26911997 32.MansfieldKL, Hernandez-TrianaLM, BanyardAC, FooksAR, JohnsonN. Japanese" exact="encephalitis" post="virus infection, diagnosis and control in domestic animals. Vet"/>
   <result pre="SinghBK, VirmaniN, KumarS, SinghRK. Isolation and genetic characterization of Japanese" exact="encephalitis" post="virus from equines in India. J Vet Sci. 2012;13:111–118."/>
   <result pre="Med Assoc. 2018;253:1555–1568. doi:10.2460/javma.253.8.98030668262 40.JemberuWT, MollaW, AlmawG, AlemuS. Incidence of" exact="rabies" post="in humans and domestic animals and people’s awareness in"/>
   <result pre="Vet Res. 2002;33:127–138. doi:10.1051/vetres:200200211944803 54.KornK, CorasR, BobingerT, et al. Fatal" exact="encephalitis" post="associated with Borna disease virus 1. New Engl J"/>
   <result pre="et al. Vaccination of dogs in an African city interrupts" exact="rabies" post="transmission and reduces human exposure. Sci Transl Med. 2017;9:eaaf6984."/>
   <result pre="exposure. Sci Transl Med. 2017;9:eaaf6984. doi:10.1126/scitranslmed.aaf698429263230 68.CurtisC. Insecticide-treated nets against" exact="malaria" post="vectors and polystyrene beads against Culex larvae. Trends Parasitol."/>
   <result pre="applications. Proc Biol Sci. 2004;271:501–507. doi:10.1098/rspb.2003.260815129960 74.KeaneDP, LittlePB. Equine viral" exact="encephalomyelitis" post="in Canada: a review of known and potential causes."/>
   <result pre="80.KelenPV, DownsJA, UnnaschT, StarkL. A risk index model for predicting" exact="eastern equine encephalitis" post="virus transmission to horses in Florida. Appl Geog. 2014;48:79–86."/>
   <result pre="UnnaschT, StarkL. A risk index model for predicting eastern equine" exact="encephalitis" post="virus transmission to horses in Florida. Appl Geog. 2014;48:79–86."/>
   <result pre="of geographic information technology in determining risk of eastern equine" exact="encephalomyelitis" post="virus transmission. AMCA. 2000;16:28–35. 82.ZouL, MillerSN, SchmidtmannET. A GIS"/>
   <result pre="to experimental infection with Murray Valley encephalitis, Kunjin and Japanese" exact="encephalitis" post="viruses. Austr J Exp Biol Med Sci. 1983;61:655–664. doi:10.1038/icb.1983.62"/>
   <result pre="doi:10.1038/icb.1983.62 93.WhiteGS, SymmesK, SunP, et al. Reemergence of St. Louis" exact="encephalitis" post="virus, California, 2015. Emerg Infect Dis. 2016;22:2185–2188. doi:10.3201/eid2212.16080527869600 94.HydeJ,"/>
   <result pre="PéterO, VoordouwMJ. Goats as sentinel hosts for the detection of" exact="tick-borne encephalitis" post="risk areas in the Canton of Valais, Switzerland. BMC"/>
   <result pre="VoordouwMJ. Goats as sentinel hosts for the detection of tick-borne" exact="encephalitis" post="risk areas in the Canton of Valais, Switzerland. BMC"/>
   <result pre="Res. 2017;13:1–13. doi:10.1186/s12917-016-0931-128049469 97.RushtonJO, LecollinetS, HubálekZ, SvobodováP, LussyH, NowotnyN. Tick-borne" exact="encephalitis" post="virus in horses, Austria, 2011. Emerg Infect Dis. 2013;19:635–637."/>
   <result pre="Infect Dis. 2013;19:635–637. doi:10.3201/eid1904.12145023631894 98.YoshiiK, SongJY, ParkSB, YangJ, SchmittHJ. Tick-borne" exact="encephalitis" post="in Japan, Republic of Korea and China. Emerg Microbes"/>
   <result pre="2005;157:711–713. doi:10.1136/vr.157.22.71116311385 110.BouzalasIG, DiakakisN, ChaintoutisSC, et al. Emergence of equine" exact="west nile encephalitis" post="in central Macedonia, Greece, 2010. Transbound Emerg Dis. 2016;63:e219–e227."/>
   <result pre="110.BouzalasIG, DiakakisN, ChaintoutisSC, et al. Emergence of equine west nile" exact="encephalitis" post="in central Macedonia, Greece, 2010. Transbound Emerg Dis. 2016;63:e219–e227."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6690514\results\search\disease\results.xml">
   <result pre="Analysis Techniques: Amino Acid Analysis Evolutionary dynamics of the H7N9" exact="avian influenza" post="virus based on large-scale sequence analysis Evolutionary dynamics of"/>
   <result pre="Techniques: Amino Acid Analysis Evolutionary dynamics of the H7N9 avian" exact="influenza" post="virus based on large-scale sequence analysis Evolutionary dynamics of"/>
   <result pre="are credited.pone.0220249.pdf Abstract Since 2013, epidemics caused by novel H7N9" exact="avian influenza" post="A viruses (AIVs) have become a considerable public health"/>
   <result pre="credited.pone.0220249.pdf Abstract Since 2013, epidemics caused by novel H7N9 avian" exact="influenza" post="A viruses (AIVs) have become a considerable public health"/>
   <result pre="of the virus can circulate in avian species [2]. Occasionally," exact="avian influenza" post="A viruses (AIVs) can be transmitted from avian species"/>
   <result pre="the virus can circulate in avian species [2]. Occasionally, avian" exact="influenza" post="A viruses (AIVs) can be transmitted from avian species"/>
   <result pre="severe human infections and deaths [5]. Subsequent outbreaks of H7N9" exact="influenza" post="in humans have occurred in the winter and spring"/>
   <result pre="AIV as a triple-reassortant virus of H7, N9, and H9N2" exact="influenza" post="viruses. Phylogenetic characteristics, variations involving key amino acids, virulence,"/>
   <result pre="for the efficient growth of IAVs. NA also contributes to" exact="influenza" post="virus species specificity and determines the virulence and drug"/>
   <result pre="early warning signs of an H7N9 epidemic. We used relevant" exact="influenza" post="virus bioinformatics databases to investigate the evolutionary dynamics of"/>
   <result pre="H7N9 AIVs are much higher than any previous H7 subtype" exact="influenza" post="[15,16]. Compared with early H7, the HA of the"/>
   <result pre="H7N9 vaccines have been widely used to prevent and control" exact="avian influenza" post="in poultry farms [8,36], the immune pressure among poultry"/>
   <result pre="vaccines have been widely used to prevent and control avian" exact="influenza" post="in poultry farms [8,36], the immune pressure among poultry"/>
   <result pre="manuscript. References References 1SchrauwenEJ, FouchierRA. Host adaptation and transmission of" exact="influenza" post="A viruses in mammals. Emerg Microbes Infect. 2014; 3(2):e910.1038/emi.2014.9"/>
   <result pre="LiY, ShiM, ZhangJ, BourgeoisM, et al.New world bats harbor diverse" exact="influenza" post="A viruses. PLoS Pathog. 2013; 9(10): e100365710.1371/journal.ppat.1003657 .24130481 3MaW,"/>
   <result pre="RichtJA. The role of swine in the generation of novel" exact="influenza" post="viruses. Zoonoses Public Health. 2009; 56(6–7): 326–37. 10.1111/j.1863-2378.2008.01217.x .19486316"/>
   <result pre=".19486316 4WebsterRG, BeanWJ, GormanOT, ChambersTM, KawaokaY. Evolution and ecology of" exact="influenza" post="A viruses. Microbiol Rev. 1992; 56(1): 152–79. .1579108 5GaoR,"/>
   <result pre="FengZ, WangD, HuW, et al.Human infection with a novel avian-origin" exact="influenza" post="A (H7N9) virus. N Engl J Med. 2013; 368(20):"/>
   <result pre=".28734617 7WangX, JiangH, WuP, UyekiTM, FengL, LaiS, et al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="7WangX, JiangH, WuP, UyekiTM, FengL, LaiS, et al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="GuM, LiR, et al.Recombinant baculovirus vaccine expressing hemagglutinin of H7N9" exact="avian influenza" post="virus confers full protection against lethal highly pathogenic H7N9"/>
   <result pre="LiR, et al.Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian" exact="influenza" post="virus confers full protection against lethal highly pathogenic H7N9"/>
   <result pre="ShiY, WangD, XiaoH, LiW, et al.Origin and diversity of novel" exact="avian influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="WangD, XiaoH, LiW, et al.Origin and diversity of novel avian" exact="influenza" post="A H7N9 viruses causing human infection: phylogenetic, structural, and"/>
   <result pre="García-SastreA, TumpeyTM, et al.A single amino acid substitution in 1918" exact="influenza" post="virus hemagglutinin changes receptor binding specificity. J Virol. 2005;"/>
   <result pre="10.1128/JVI.79.17.11533-11536.2005 .16103207 13OshanskyCM, PickensJA, BradleyKC, JonesLP, Saavedra-EbnerGM, BarberJP, et al.Avian" exact="influenza" post="viruses infect primary human bronchial epithelial cells unconstrained by"/>
   <result pre="KawaokaY. Host range restriction and pathogenicity in the context of" exact="influenza" post="pandemic. Emerg Infect Dis. 2006; 12(6): 881–6. 10.3201/eid1206.051336 .16707041"/>
   <result pre="10.3201/eid1206.051336 .16707041 15WebbyRJ, YangZ. The changing landscape of A H7N9" exact="influenza" post="virus infections in China. Lancet Infect Dis. 2017; 17(8):"/>
   <result pre="acid substitutions involved in the adaption of three avian-origin H7N9" exact="influenza" post="viruses in mice. Virol J. 2019; 16(1): 310.1186/s12985-018-1109-1 .30621708"/>
   <result pre="KraussS, YenHL, GuanY, PeirisM, et al.Lethality to ferrets of H5N1" exact="influenza" post="viruses isolated from humans and poultry in 2004. J"/>
   <result pre="JiangS. Genomic signature and protein sequence analysis of a novel" exact="influenza" post="A (H7N9) virus that causes an outbreak in humans"/>
   <result pre="monoclonal neutralizing antibody that targets a unique conserved epitope on" exact="influenza" post="HA. Nat Commun. 2018; 9(1): 266910.1038/s41467-018-04704-9 .29991715 20XuH, ZhangW,"/>
   <result pre="sites screening on HA sequence that affect the virulence of" exact="influenza" post="A H5N1 for mammalian species. Fudan Univ J Med"/>
   <result pre="et al.A carbohydrate side chain on hemagglutinins of Hong Kong" exact="influenza" post="viruses inhibits recognition by a monoclonal antibody. Proc Natl"/>
   <result pre="the hemagglutinin (HA) cleavage site sequence of H5 and H7" exact="avian influenza" post="viruses: amino acid sequence at the HA cleavage site"/>
   <result pre="hemagglutinin (HA) cleavage site sequence of H5 and H7 avian" exact="influenza" post="viruses: amino acid sequence at the HA cleavage site"/>
   <result pre="PaulsonJC, DanielsRS, SkehelJJ, WilsonIA, WileyDC. Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificity. Nature. 1983; 304(5921): 76–8."/>
   <result pre="sequences and receptor-binding properties among 13 serotypes of hemagglutinins of" exact="influenza" post="A viruses. Virology. 1991; 182(2): 475–85. 10.1016/0042-6822(91)90588-3 .2024485 25ObenauerJC,"/>
   <result pre="DensonJ, MehtaPK, SuX, MukatiraS, FinkelsteinDB, et al.Large-scale sequence analysis of" exact="avian influenza" post="isolates. Science. 2006; 311(5767): 1576–80. 10.1126/science.1121586 .16439620 26ZhangWT, JiangQW."/>
   <result pre="MehtaPK, SuX, MukatiraS, FinkelsteinDB, et al.Large-scale sequence analysis of avian" exact="influenza" post="isolates. Science. 2006; 311(5767): 1576–80. 10.1126/science.1121586 .16439620 26ZhangWT, JiangQW."/>
   <result pre="26ZhangWT, JiangQW. Phylogenetic analysis for H3A1 strain of all human" exact="influenza" post="A virus. Zhonghua Liu Xing Bing Xue Za Zhi."/>
   <result pre="HA gene of pandemic (2009) and seasonal human and swine" exact="influenza" post="A H1 subtype viruses. Virology. 2010; 405(2): 314–21. 10.1016/j.virol.2010.06.018"/>
   <result pre="LiX, ZhangY, GuoJ, LiM, et al.Selection pressure analysis of H3N2" exact="influenza" post="virus from China between 1992 and 2012. Zhonghua Shi"/>
   <result pre="XieD. Evolution and adaptation of hemagglutinin gene of human H5N1" exact="influenza" post="virus. Virus Genes. 2012; 44(3): 450–8. 10.1007/s11262-012-0717-x .22286608 30SchrauwenEJ,"/>
   <result pre="de GraafM, HerfstS, RimmelzwaanGF, OsterhausAD, FouchierRA. Determinants of virulence of" exact="influenza" post="A virus. Eur J Clin Microbiol Infect Dis. 2014;"/>
   <result pre="32FangS, WangX, DongF, JinT, LiuG, LuX, et al.Genomic characterization of" exact="influenza" post="A (H7N9) viruses isolated in Shenzhen, Southern China, during"/>
   <result pre="SchimanskiL, DongT, et al.Structure-function analysis of neutralizing antibodies to H7N9" exact="influenza" post="from naturally infected humans. Nat Microbiol. 2019; 4(2): 306–15."/>
   <result pre="CuiLB, TangFY, et al.Probable person to person transmission of novel" exact="avian influenza" post="A (H7N9) virus in Eastern China, 2013: epidemiological investigation."/>
   <result pre="TangFY, et al.Probable person to person transmission of novel avian" exact="influenza" post="A (H7N9) virus in Eastern China, 2013: epidemiological investigation."/>
   <result pre="PengH, TaoQ, ZhaoX, TangH, TangZ, et al.Serologic assay for avian-origin" exact="influenza" post="A (H7N9) virus in adults of Shanghai, Guangzhou and"/>
   <result pre="SkehelJJ. Structural identification of the antibody-binding sites of Hong Kong" exact="influenza" post="haemagglutinin and their involvement in antigenic variation. Nature. 1981;"/>
   <result pre="activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of" exact="influenza" post="virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother. 2001;"/>
   <result pre="2001; 45(12): 3403–8. 10.1128/AAC.45.12.3403-3408.2001 .11709315 39MuñozET, DeemMW. Epitope analysis for" exact="influenza" post="vaccine design. Vaccine. 2005; 23(9): 1144–8. 10.1016/j.vaccine.2004.08.028 .15629357 40YangH,"/>
   <result pre="receptor complexes of the hemagglutinin from a highly pathogenic H7N7" exact="influenza" post="virus. J Virol. 2012; 86(16): 8645–52. 10.1128/JVI.00281-12 .22674977 41WuY,"/>
   <result pre="et al.Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9" exact="influenza" post="viruses. Cell Res. 2013; 23(12): 1347–55. 10.1038/cr.2013.144 .24165891 42BertoniM,"/>
   <result pre="CoxNJ. Positive selection on the H3 hemagglutinin gene of human" exact="influenza" post="virus A. Mol Biol Evol. 1999; 16(11): 1457–65. 10.1093/oxfordjournals.molbev.a026057"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6692539\results\search\disease\results.xml">
   <result pre="Commentary, Meeting Report How to assess the effectiveness of nasal" exact="influenza" post="vaccines? Role and measurement of sIgA in mucosal secretions"/>
   <result pre="of mucosal immunity. Mucosally delivered vaccines, such as live attenuated" exact="influenza" post="vaccine (LAIV), are able to mimic natural infection without"/>
   <result pre="the advantages and limitations of their use. enzyme�?linked immunosorbent assay" exact="influenza" post="vaccines influenza virus mucosal immunity secretory IgAs fig-count: table-count:"/>
   <result pre="and limitations of their use. enzyme�?linked immunosorbent assay influenza vaccines" exact="influenza" post="virus mucosal immunity secretory IgAs fig-count: table-count: page-count: word-count:"/>
   <result pre="TrombettaC, ManiniI, MontomoliE. How to assess the effectiveness of nasal" exact="influenza" post="vaccines? Role and measurement of sIgA in mucosal secretions."/>
   <result pre="disease with high morbidity and mortality which is caused by" exact="influenza" post="viruses of types A and B.1, 2 Seasonal influenza"/>
   <result pre="by influenza viruses of types A and B.1, 2 Seasonal" exact="influenza" post="epidemics are estimated to result in 3�?5 million cases"/>
   <result pre="IgG antibodies.3 Figure 1 Simplified scheme of immune responses following" exact="influenza" post="virus infection of the upper respiratory tract with focus"/>
   <result pre="to the mucus by diffusion and provide protection against homologous" exact="influenza" post="viruses. dIgA are actively transcytosed across epithelial cells via"/>
   <result pre="cells via pIgR and provide protection against homologous and heterologous" exact="influenza" post="viruses. dIgA can bind to newly synthesized viral proteins"/>
   <result pre="immunity, also the cell�?mediated immune (CMI) response is activated after" exact="influenza" post="infection. Unlike humoral response, capable of neutralizing activity, CMI"/>
   <result pre="of antigen�?presenting cells (APCs), such as dendritic cells (DCs) and" exact="influenza" post="antigens, induce the differentiation of naïve B cells into"/>
   <result pre="after infection. sIgA have a pivotal role in protecting against" exact="influenza" post="infection of the upper respiratory mucosal surfaces, since they"/>
   <result pre="infection which support its additional important role in protection against" exact="influenza" post="virus re�?infections.18 Along with IgA, IgM antibodies are also"/>
   <result pre="in mice which has shown that IgM antibodies can neutralize" exact="influenza" post="viruses in the presence of complement just as well"/>
   <result pre="as well as IgG antibodies.19 2.4 IgA immune responses upon" exact="influenza" post="virus infection of the mucosa of the upper respiratory"/>
   <result pre="pIgA.29 3 IgA IMMUNE RESPONSE UPON INFLUENZA VACCINATION Conventional inactivated" exact="influenza" post="vaccines (IIVs), generally delivered through subcutaneous or intramuscular injection,"/>
   <result pre="the most efficient, valuable, and low�?cost tools to effectively reduce" exact="influenza" post="virus infections and subsequently morbidity and mortality.35 This parental"/>
   <result pre="wide cross�?protection activity. This represents a limit for conventional inactivated" exact="influenza" post="vaccines in conferring full protection against infection.36 While natural"/>
   <result pre="heterosubtypic responses, the immunity induced by parenterally application of inactivated" exact="influenza" post="vaccines is generally virus subtype�?specific.37 In pre�?immunized subjects, the"/>
   <result pre="antibodies could be elicited by intranasal vaccination with live attenuated" exact="influenza" post="vaccines (LAIV). Live attenuated influenza vaccines is administered as"/>
   <result pre="intranasal vaccination with live attenuated influenza vaccines (LAIV). Live attenuated" exact="influenza" post="vaccines is administered as a nasal spray and contains"/>
   <result pre="a nasal spray and contains a cold�?adapted (ca) live attenuated" exact="influenza" post="virus which, in contrast to wild�?type viruses, is able"/>
   <result pre="onwards, the use of Russian LAIV for the prophylaxis of" exact="influenza" post="has been widely extended to all age groups including"/>
   <result pre="IgA from the respiratory tract of mice immunized with live" exact="influenza" post="virus has been seen to provide protection in naive"/>
   <result pre="studies conducted on different age cohorts throughout the world.49 After" exact="influenza" post="LAIV administration, as well as natural infection, sIgA are"/>
   <result pre="vaccine strains or in children with underlying diseases such as" exact="asthma" post="have shown a higher efficiency in comparison to IIV,"/>
   <result pre="was provided by Q�?LAIV compared to IIV toward a drifted" exact="influenza" post="B strain. Data obtained from the US reported an"/>
   <result pre="reported an apparent lack of LAIV effectiveness in the 2015/2016" exact="influenza" post="season, especially toward A/H1N1 vaccine component. Such results have"/>
   <result pre="64 but without causing the signs and symptoms associated with" exact="influenza" post="illness.49 Nowadays, intranasal vaccination against influenza is mainly made"/>
   <result pre="and symptoms associated with influenza illness.49 Nowadays, intranasal vaccination against" exact="influenza" post="is mainly made up through ca LAIVs. However, other"/>
   <result pre="include the following: intranasal vaccinations using inactivated whole or split" exact="influenza" post="vaccines,65, 66 sublingual administration of adjuvanted influenza vaccines,67 and"/>
   <result pre="whole or split influenza vaccines,65, 66 sublingual administration of adjuvanted" exact="influenza" post="vaccines,67 and novel types of LAIVs, for example, formulated"/>
   <result pre="IgA CONTENT IN TEST SAMPLES According to the type of" exact="influenza" post="vaccine used and the route of administration, specific compartments"/>
   <result pre="which are still considered as the gold standard in assessing" exact="influenza" post="vaccine immunogenicity, is generally lower after intranasal vaccination than"/>
   <result pre="couple of laboratory tests that can be used to assess" exact="influenza" post="antibody levels, the enzyme�?linked immunosorbent assay (ELISA) is the"/>
   <result pre="different classes of antibodies that are able to bind to" exact="influenza" post="virions or purified HA proteins.70 Many different protocols and"/>
   <result pre="based on the same principle. Generally, HA protein or whole" exact="influenza" post="virus is pre�?adsorbed to the wells of an ELISA"/>
   <result pre="described elsewhere.73 In brief, ELISA plates are coated with an" exact="influenza" post="antigen (preferably purified HA) and a capture antibody (anti�?human"/>
   <result pre="protein content in the samples (Figure 2). The determination of" exact="influenza" post="HA�?specific IgA with respect to total protein generally proves"/>
   <result pre="will be added to the coated plate together with the" exact="influenza" post="antigen, and the background signal will be used to"/>
   <result pre="been shown in a previous pediatric study with LAIV that" exact="influenza" post="virus–specific salivary IgA levels correlated with serum HI responses,76"/>
   <result pre="approach to evaluate the immunogenicity of LAIVs, IIVs, or recombinant" exact="influenza" post="vaccines (eg rHA) in inducing selective anti�?influenza antibodies with"/>
   <result pre="influenza vaccines (eg rHA) in inducing selective anti�?influenza antibodies with" exact="influenza" post="virus–neutralizing potential. Beside classical ELISA�?based and NT assays specific"/>
   <result pre="virus–neutralizing potential. Beside classical ELISA�?based and NT assays specific anti�?HA" exact="influenza" post="antibodies, there are newer assays with increased precision and"/>
   <result pre="the simultaneous detection of antibodies against the Newcastle disease and" exact="avian influenza" post="virus and have shown that the Luminex XMAP�?based assay"/>
   <result pre="simultaneous detection of antibodies against the Newcastle disease and avian" exact="influenza" post="virus and have shown that the Luminex XMAP�?based assay"/>
   <result pre="assay has been up to 1024 times more sensitive for" exact="avian influenza" post="virus antibody detection compared to the conventional ELISA assay."/>
   <result pre="has been up to 1024 times more sensitive for avian" exact="influenza" post="virus antibody detection compared to the conventional ELISA assay."/>
   <result pre="6 CONCLUSIONS Influenza vaccines elicit protective immunity before a new" exact="influenza" post="virus variant is able to spread; they therefore constitute"/>
   <result pre="a primary protection tool. Although the main protective effectors against" exact="influenza" post="virus infection are CTLs, IgG, and IgA located in"/>
   <result pre="distribution. For these reasons, its expanded use could increase the" exact="influenza" post="vaccination coverage globally. Furthermore, it may represent a favorable"/>
   <result pre="recent years to develop novel intranasally administered vaccines to promote" exact="influenza" post="virus�?specific sIgA,30, 88 which, as has been widely reported,"/>
   <result pre="of vaccine efficacy or effectiveness in the field, as currently" exact="influenza" post="vaccine efficacy is traditionally assessed by means of serological"/>
   <result pre="measurement of sIgA in mucosal secretions for the evaluation of" exact="influenza" post="vaccine efficacy or effectiveness and, in addition, also of"/>
   <result pre="process. References REFERENCES 1GlezenWP. Serious morbidity and mortality associated with" exact="influenza" post="epidemics. Epidemiol Rev. 1982;4:25�?44.6754408 2https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal).Accessed 20 August 2018. 3BrandtzagP,"/>
   <result pre="ClementsML. The systemic and mucosal immune response of humans to" exact="influenza" post="virus. Curr Topics Microbial Immun. 1989;146:107�?116. 6ItoR, OzakiYA, YoshikawaT,"/>
   <result pre="of the respiratory tract of vaccinated mice in preventing lethal" exact="influenza" post="pneumonia. Vaccine. 2003;21:2362�?2371.12744867 7SunJ, BracialeTJ. Role of T cell"/>
   <result pre="7SunJ, BracialeTJ. Role of T cell immunity in recovery from" exact="influenza" post="virus infection. Curr Opin Virol. 2013;3:425�?429.23721865 8DohertyPC, KelsoA. Towards"/>
   <result pre="Curr Opin Virol. 2013;3:425�?429.23721865 8DohertyPC, KelsoA. Towards a broadly protective" exact="influenza" post="vaccine. J Clin Invest. 2008;118:3273�?3275.18802488 9WoofJM, MesteckyJ. Mucosal immunoglobulins."/>
   <result pre="neutralizing antibody levels in nasal washings from men infected with" exact="influenza" post="virus. JAMA. 1970;211:1157�?1161.5466966 12WrightPF, MurphyBR, KervinaM, LawrenceEM, PhelanMA, KarzonDT."/>
   <result pre="KervinaM, LawrenceEM, PhelanMA, KarzonDT. Secretory immunological response after intranasal inactivated" exact="influenza" post="A virus vaccinations: evidence for immunoglobulin A memory. Infect"/>
   <result pre="1983;40:1092�?1095.6852914 13BrokstadKA, CoxRJ, ErikssonJC, OlofssonJ, JonssonR, DavidssonA. High prevalence of" exact="influenza" post="specific antibody secreting cells in nasal mucosa. Scand J"/>
   <result pre="antigen�?specific nasal secretory IgA levels and serum IgG levels after" exact="influenza" post="infection in adults. Influenza Other Respir Viruses. 2012;6:369�?403. 15van"/>
   <result pre="2012;6:369�?403. 15van RietE, AinaiA, SuzukiT, HasegawaH. Mucosal IgA responses in" exact="influenza" post="virus infections; thoughts for vaccine design. Vaccine. 2012;30:5893�?5900.22835738 16KokTW,"/>
   <result pre="CostabileM, TannockGA, LiP. Colocalization of intracellular specific IgA (icIgA) with" exact="influenza" post="virus in patients' nasopharyngeal aspirate cells. J Virol Methods."/>
   <result pre="cells. J Virol Methods. 2018;252:8�?14.29102516 17TamuraS, KurataT. Defense mechanisms against" exact="influenza" post="virus infection in the respiratory tract mucosa. Jpn J"/>
   <result pre="Comparison of the immune response to inactivated and live, attenuated" exact="influenza" post="vaccines. Scand J Immunol. 2004;59:1�?15.14723616 19SkountzouI, SatyabhamaL, StavropoulouA, et"/>
   <result pre="the quaternary structure of human secretory IgA to neutralization of" exact="influenza" post="virus. Proc Natl Acad Sci USA. 2015;112:7809�?7814.26056267 26MazanecMB, KaetzelCS,"/>
   <result pre="WrightPF. Role of IgA versus IgG in the control of" exact="influenza" post="viral infection in the murine respiratory tract. J Immunol."/>
   <result pre="virus neutralization on human upper respiratory mucosa after intranasal inactivated" exact="influenza" post="vaccine administration. Hum Vaccin Immunother. 2018;14(6):1351–1361.29425074 29RenegarKB, JacksonGD, MesteckyJ."/>
   <result pre="antibody. PLoS Pathog. 2019;15:e1007427.30605488 32TaylorHP, DimmockNJ. Mechanism of neutralization of" exact="influenza" post="virus by secretory IgA is different from that of"/>
   <result pre="or IgG. J Exp Med. 1985;161:198�?209.2981953 33ArmstrongSJ, DimmockNJ. Neutralization of" exact="influenza" post="virus by low concentrations of hemagglutinin�?specific polymeric immunoglobulin A"/>
   <result pre="characteristics of secretory IgA antibodies elicited by mucosal vaccines against" exact="influenza" post="virus. Vaccine. 2017;35:5297�?5302.28780981 35GianchecchiE, TrombettaC, PiccirellaS, MontomoliE. Evaluating influenza"/>
   <result pre="against influenza virus. Vaccine. 2017;35:5297�?5302.28780981 35GianchecchiE, TrombettaC, PiccirellaS, MontomoliE. Evaluating" exact="influenza" post="vaccines: progress and perspectives. Future Virology. 2016;11:379�?393. 36TamuraS. Studies"/>
   <result pre="Virology. 2016;11:379�?393. 36TamuraS. Studies on the usefulness of intranasal inactivated" exact="influenza" post="vaccines. Vaccine. 2010;28:6393�?6397.20493820 37MorokuttiA, MusterT, FerkoB. Intranasal vaccination with"/>
   <result pre="Vaccine. 2010;28:6393�?6397.20493820 37MorokuttiA, MusterT, FerkoB. Intranasal vaccination with a replication�?deficient" exact="influenza" post="virus induces heterosubtypic neutralising mucosal IgA antibodies in humans."/>
   <result pre="MinuseE, AndersonG. Laboratory and clinical characteristics of attenuated strains of" exact="influenza" post="virus. Bull World Health Organ. 1969;41:589�?594.5309481 39SlepushkinAN, DukovaVS, KalegaevaVA,"/>
   <result pre="KaganAN, TemriukEE. Results of studying the effectiveness of a live" exact="influenza" post="vaccine for peroral use on preschool and schoolchildren. Zh"/>
   <result pre="40RudenkoL, YeolekarL, KiselevaI, Isakova�?SivakI. Development and approval of live attenuated" exact="influenza" post="vaccines based on Russian master donor viruses: Process challenges"/>
   <result pre="al. Rationale for vaccination with trivalent or quadrivalent live attenuated" exact="influenza" post="vaccines: protective vaccine efficacy in the ferret model. PLoS"/>
   <result pre="the ferret model. PLoS ONE. 2018;13(12):e0208028.30507951 42CarterNJ, CurranMP. Live attenuated" exact="influenza" post="vaccine (FluMist®; Fluenz™): a review of its use in"/>
   <result pre="a review of its use in the prevention of seasonal" exact="influenza" post="in children and adults. Drugs. 2011;71:1591�?1622.21861544 43TamuraS�?I, FunatoH, HirabayashiY,"/>
   <result pre="adults. Drugs. 2011;71:1591�?1622.21861544 43TamuraS�?I, FunatoH, HirabayashiY, et al. Cross�?protection against" exact="influenza" post="A virus infection by passively transferred respiratory tract IgA"/>
   <result pre="J Immunol. 1991;21:1337�?1344.1646112 44AsahiY, YoshikawaT, WatanabeI, et al. Protection against" exact="influenza" post="virus infection in polymeric Ig receptor knockout mice immunized"/>
   <result pre="2002;168:2930�?2938.11884464 45NguyenHH, van GinkelFW, VuHL, McGheeJR, MesteckyJ. Heterosubtypic immunity to" exact="influenza" post="A virus infection requires B cells but not CD8+"/>
   <result pre="Dis. 2001;183:368�?376.11133367 46RenegarKB, SmallPAJr. Passive transfer of local immunity to" exact="influenza" post="virus infection by IgA antibody. J Immunol. 1991;146:1972�?1978.2005388 47RenegarKB,"/>
   <result pre="antibodies in lungs of mice after intragastric administration of inactivated" exact="influenza" post="virus vaccines. J Gen Virol. 1988;69:2779�?2784.3183627 49RappuoliR, Del GiudiceG."/>
   <result pre="al. Evaluation of trivalent, live, cold�?adapted (CAIV�?T) and inactivated (TIV)" exact="influenza" post="vaccines in prevention of virus infection and illness following"/>
   <result pre="virus infection and illness following challenge of adults with wild�?type" exact="influenza" post="A (H1N1), A (H3N2), and B viruses. Vaccine. 1999;18:899�?906.10580204"/>
   <result pre="al. Efficacy of vaccination with live attenuated, cold�?adapted, trivalent, intranasal" exact="influenza" post="virus vaccine against a variant (A/Sydney) not contained in"/>
   <result pre="VertruyenA, ArísteguiJ, et al. Superior relative efficacy of live attenuated" exact="influenza" post="vaccine compared with inactivated influenza vaccine in young children"/>
   <result pre="relative efficacy of live attenuated influenza vaccine compared with inactivated" exact="influenza" post="vaccine in young children with recurrent respiratory tract infections."/>
   <result pre="Comparison of the efficacy and safety of live attenuated cold�?adapted" exact="influenza" post="vaccine, trivalent, with trivalent inactivated influenza virus vaccine in"/>
   <result pre="of live attenuated cold�?adapted influenza vaccine, trivalent, with trivalent inactivated" exact="influenza" post="virus vaccine in children and adolescents with asthma. Pediatr"/>
   <result pre="2006;25:860�?869.17006278 54McLeanHQ, CaspardH, GriffinMR, et al. Effectiveness of live attenuated" exact="influenza" post="vaccine and inactivated influenza vaccine in children during the"/>
   <result pre="et al. Effectiveness of live attenuated influenza vaccine and inactivated" exact="influenza" post="vaccine in children during the 2014–2015 season. Vaccine. 2017;35:2685�?2693.28408121"/>
   <result pre="2017;35:2685�?2693.28408121 55JeffersonT, Di PietrantonjC, RivettiA, et al. Vaccines for preventing" exact="influenza" post="in healthy adults. Cochrane Database Syst Rev. 2010;(7): CD001269."/>
   <result pre="Cochrane Database Syst Rev. 2014;3:CD001269. 56PebodyR, McMenaminJ, NohynekH. Live attenuated" exact="influenza" post="vaccine (LAIV): recent effectiveness results from the USA and"/>
   <result pre="Child. 2018;103:101�?105.28855230 57PebodyR, WarburtonF, EllisJ, et al. Effectiveness of seasonal" exact="influenza" post="vaccine for adults and children in preventing laboratory�?confirmed influenza"/>
   <result pre="seasonal influenza vaccine for adults and children in preventing laboratory�?confirmed" exact="influenza" post="in primary care in the United Kingdom: 2015/16 end�?of�?season"/>
   <result pre="SundmanJ, JokinenJ. Effectiveness of the live attenuated and the inactivated" exact="influenza" post="vaccine in two�?year�?olds – A nationwide cohort study Finland,"/>
   <result pre="influenza vaccine in two�?year�?olds – A nationwide cohort study Finland," exact="influenza" post="season 2015/16. Euro Surveill. 2016;21, 1�?8. 59MohnK g�?i, BredholtG,"/>
   <result pre="al. Longevity of B�?cell and T�?cell responses after live attenuated" exact="influenza" post="vaccination in children. J Infect Dis. 2015;211:1541�?1549.25425696 60SridharS, BrokstadKA,"/>
   <result pre="BrokstadKA, CoxRJ. Influenza vaccination strategies: comparing inactivated and live attenuated" exact="influenza" post="vaccines. Vaccines. 2015;3(2):373�?389.26343192 61WagnerDK, ClementsML, ReimerCB, SnyderM, NelsonDL, MurphyBR."/>
   <result pre="immunoglobulin G antibody responses after administration of live and inactivated" exact="influenza" post="A vaccine indicates that nasal wash immunoglobulin G is"/>
   <result pre="for distinct immune responses to trivalent inactivated and live attenuated" exact="influenza" post="vaccines. J Cell Physiol. 2019;234:5196�?5202.30203415 63BeyerWE, PalacheAM, de JongJC,"/>
   <result pre="Cell Physiol. 2019;234:5196�?5202.30203415 63BeyerWE, PalacheAM, de JongJC, OsterhausAD. Cold�?adapted live" exact="influenza" post="vaccine versus inactivated vaccine: systemic vaccine reactions, local and"/>
   <result pre="FerkoB, ByunY�?H, et al. Sublingual immunization with a live attenuated" exact="influenza" post="a virus lacking the nonstructural protein 1 induces broad"/>
   <result pre="virus vaccine induces a broad spectrum of heterosubtypic immunity against" exact="influenza" post="A virus infection in mice. Vaccine. 2003;21:3212�?3218.12804850 66CoxRJ, HovdenA�?O,"/>
   <result pre="and protective efficacy of vaccination with inactivated split and whole" exact="influenza" post="virus vaccines in BALB/c mice. Vaccine. 2006;10(24):6585�?6587. 67GalloriniS, TacconeM,"/>
   <result pre="67GalloriniS, TacconeM, BonciA, et al. Sublingual immunization with a subunit" exact="influenza" post="vaccine elicits comparable systemic immune response as intramuscular immunization,"/>
   <result pre="WolschekM, SeipeltJ, MusterT. Phase I/II trial of a replication�?deficient trivalent" exact="influenza" post="virus vaccine lacking NS1. Vaccine. 2013;31:6194�?6200.24183981 69CoxJR, BrokstadKA, OgraP."/>
   <result pre="Comparison of the Immune response to inactivated and live, attenuated" exact="influenza" post="vaccine. Scand J Immunol. 2003;59:1�?15. 70KatzJM, HancockK, XuX. Serologic"/>
   <result pre="Scand J Immunol. 2003;59:1�?15. 70KatzJM, HancockK, XuX. Serologic assays for" exact="influenza" post="surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect"/>
   <result pre="71MurphyBR, PhelanMA, NelsonDL. Hemagglutinin�?specific enzyme�?linked immunosorbent assay for antibodies to" exact="influenza" post="A and B. J Clin Virol. 1981;43:241�?243. 72El�?MadhunAS, CoxRJ,"/>
   <result pre="priming on the IgG and IgA subclass responses after parenteral" exact="influenza" post="vaccination. J Infect Dis. 1999;180:1356�?1360.10479172 73ManentiA, TeteSM, MohonG, et"/>
   <result pre="IgG subclass and IgA responses in children and adults after" exact="influenza" post="vaccination. Vaccine. 2017;35:191�?198.27789145 74AinaiA, TamuraS�?I, SuzukiT, et al. Intranasal"/>
   <result pre="TamuraS�?I, SuzukiT, et al. Intranasal vaccination with an inactivated whole" exact="influenza" post="virus vaccine induces strong antibody responses in serum and"/>
   <result pre="Eng J. 2010;4:271�?278.21625379 76MohnK�?I, BrokstadKA, PathiranaRD, et al. Live attenuated" exact="influenza" post="vaccine in children induces B�?cell responses in tonsils. J"/>
   <result pre="2016;214:722�?731.27247344 77MohnKG�?I, SmithI, SjursenH, CoxJC. Immune responses after live attenuated" exact="influenza" post="vaccination. Hum Vacc Immunother. 2018;14:571�?578. 78HowardKM, SabarthN, Savidis�?DachoH, et"/>
   <result pre="SteinC, et al. Localized mucosal response to intranasal live attenuated" exact="influenza" post="vaccine in adults. J Infect Dis. 2013;207:115�?124.23087433 80GriffinSM, ConverseRR,"/>
   <result pre="the simultaneous detection of antibodies to Newcastle disease virus and" exact="avian influenza" post="virus. Poult Sci. 2019;98:1494�?1499.30476286 82SindoniD, La FauciV, SqueriR, et"/>
   <result pre="simultaneous detection of antibodies to Newcastle disease virus and avian" exact="influenza" post="virus. Poult Sci. 2019;98:1494�?1499.30476286 82SindoniD, La FauciV, SqueriR, et"/>
   <result pre="Comparison between a conventional subunit vaccine and the MF59�?adjuvanted subunit" exact="influenza" post="vaccine in the elderly: an evaluation of the safety,"/>
   <result pre="Hyg. 2009;50:121�?126.20099444 83SqueriR, RisoR, FacciolàA, et al. Management of two" exact="influenza" post="vaccination campaign in health care workers of a university"/>
   <result pre="Italy. Ann Ig. 2017;29:223�?231.28383614 84AdaGL, JonesPD. The immune response to" exact="influenza" post="infection. Curr Top Microbiol Immunol. 1986;128:1�?54.3533447 85BelzGT, WodarzD, DiazG,"/>
   <result pre="Top Microbiol Immunol. 1986;128:1�?54.3533447 85BelzGT, WodarzD, DiazG, NowakMA, DohertyPC. Compromised" exact="influenza" post="virus�?specific CD8(+)�?T�?cell memory in CD4(+)�?T�?cell�?deficient mice. J Virol. 2002;76:12388�?12393.12414983"/>
   <result pre="2005;5(12):905�?916.16239901 88MoldoveanuZ, ClementsML, PrinceSJ, MurphyBR, MesteckyJ. Human immune responses to" exact="influenza" post="virus vaccines administered by systemic or mucosal routes. Vaccine."/>
   <result pre="ManiniI, GianchecchiE. Immunogenicity and safety of the new inactivated quadrivalent" exact="influenza" post="vaccine Vaxigrip Tetra: preliminary results in children &amp;gt; months"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6694824\results\search\disease\results.xml">
   <result pre="Long JS, Barclay WS. 2019. ANP32 proteins are essential for" exact="influenza" post="virus replication in human cells. J Virol 93:e00217-19. https://doi.org/10.1128/JVI.00217-19."/>
   <result pre="is the etiological agent behind some of the most devastating" exact="infectious disease" post="pandemics to date, and influenza outbreaks still pose a"/>
   <result pre="of the most devastating infectious disease pandemics to date, and" exact="influenza" post="outbreaks still pose a major threat to public health."/>
   <result pre="against viral proteins, including the polymerase, but RNA viruses like" exact="influenza" post="tend to become resistant to such drugs very rapidly."/>
   <result pre="that the human proteins ANP32A and ANP32B are essential for" exact="influenza" post="A and B virus replication, such that in their"/>
   <result pre="intervention. Abstract ABSTRACT ANP32 proteins have been implicated in supporting" exact="influenza" post="virus replication, but most of the work to date"/>
   <result pre="the ability of avian Anp32 proteins to overcome restriction of" exact="avian influenza" post="polymerases in human cells. Using a CRISPR approach, we"/>
   <result pre="ability of avian Anp32 proteins to overcome restriction of avian" exact="influenza" post="polymerases in human cells. Using a CRISPR approach, we"/>
   <result pre="ANP32B are functionally redundant but essential host factors for mammalian-adapted" exact="influenza" post="A virus (IAV) and influenza B virus (IBV) replication"/>
   <result pre="essential host factors for mammalian-adapted influenza A virus (IAV) and" exact="influenza" post="B virus (IBV) replication in human cells. When both"/>
   <result pre="human cells. When both proteins are absent from human cells," exact="influenza" post="polymerases are unable to replicate the viral genome, and"/>
   <result pre="approach has identified a pair of essential host factors for" exact="influenza" post="virus replication and can be harnessed to inform future"/>
   <result pre="is the etiological agent behind some of the most devastating" exact="infectious disease" post="pandemics to date, and influenza outbreaks still pose a"/>
   <result pre="of the most devastating infectious disease pandemics to date, and" exact="influenza" post="outbreaks still pose a major threat to public health."/>
   <result pre="against viral proteins, including the polymerase, but RNA viruses like" exact="influenza" post="tend to become resistant to such drugs very rapidly."/>
   <result pre="that the human proteins ANP32A and ANP32B are essential for" exact="influenza" post="A and B virus replication, such that in their"/>
   <result pre="inform future intervention. KEYWORDS ANP32 ANP32A ANP32B CRISPR host factor" exact="influenza" post="polymerase replication virus Funding Imperial College President's Scholarship StallerEcco"/>
   <result pre="emergence of pandemic viruses from birds, the natural reservoir of" exact="influenza" post="viruses. The most notorious of these events, in 1918,"/>
   <result pre="(2). In order to mitigate the impact of the next" exact="influenza" post="pandemic and reduce the seasonal burden, new approaches to"/>
   <result pre="pandemic and reduce the seasonal burden, new approaches to thwart" exact="influenza" post="virus are required. A first step toward novel treatment"/>
   <result pre="replication of its genome and production of new virions. The" exact="influenza" post="genome is made up of eight segments of single-stranded"/>
   <result pre="at the C terminus. ANP32 proteins have been associated with" exact="influenza" post="A polymerase function. A nuclear fraction containing ANP32A and"/>
   <result pre="has been suggested to account for host range restriction of" exact="avian influenza" post="strains in mammalian cells, and much of the work"/>
   <result pre="been suggested to account for host range restriction of avian" exact="influenza" post="strains in mammalian cells, and much of the work"/>
   <result pre="experimental platform in which to investigate the interplay between different" exact="influenza" post="virus polymerases and mammalian ANP32 proteins. We find that"/>
   <result pre="and ANP32B proteins are thus functionally redundant but essential for" exact="influenza" post="virus replication. We further show that this redundancy is"/>
   <result pre="of the host proteins as key for the support of" exact="influenza" post="polymerase activity and a target for future interventions. RESULTS"/>
   <result pre="1 Human cells lacking ANP32A and ANP32B do not support" exact="influenza" post="virus polymerase activity. (a) Schematic showing location of CRISPR"/>
   <result pre="and double ANP32-knockout cells with reconstituted polymerases from three different" exact="influenza" post="A viruses—a seasonal H3N2 virus (A/Victoria/3/75), an avian H5N1"/>
   <result pre="and a 2009 pandemic H1N1 virus (A/England/195/2009)—as well as an" exact="influenza" post="B virus (B/Florida/04/2006). Surprisingly, absence of ANP32A in human"/>
   <result pre="ANP32A in human cells did not result in loss of" exact="influenza" post="polymerase activity; in fact, activity increased for some polymerase"/>
   <result pre="suggest functionally redundant roles for ANP32A and ANP32B in supporting" exact="influenza" post="virus polymerase activity in human cells. In order to"/>
   <result pre="PB1, PB2-627K, PA-green fluorescent protein (GFP), and NP, with an" exact="influenza" post="minigenome encoding blue fluorescent protein (BFP) as a reporter."/>
   <result pre="that ANP32A and ANP32B proteins are essential but redundant for" exact="influenza" post="A and B polymerase activity in human cells. Intriguingly,"/>
   <result pre="that lack expression of ANP32 proteins, we preexpressed an inactive" exact="influenza" post="polymerase complex (to stabilize any cRNA generated) for 20 h"/>
   <result pre="to ask whether Anp32 proteins from nonhuman species relevant to" exact="influenza" post="virology were capable of supporting polymerase function. We carried"/>
   <result pre="factor for some polymerase constellations, we hypothesized that in mice," exact="influenza" post="virus might rely solely on MusB to support its"/>
   <result pre="ANP32A and ANP32B are functionally redundant in their support for" exact="influenza" post="virus polymerase in human cells and that the RdRp"/>
   <result pre="of ANP32A might liberate the preferred ANP32B for recruitment by" exact="influenza" post="virus RdRp. Alternatively, ANP32A and ANP32B, being very similar"/>
   <result pre="ANP32B being functionally superior in humans to ANP32A for supporting" exact="influenza" post="polymerase. However, these differences were not so readily apparent"/>
   <result pre="MusA, but IBV polymerase can, albeit inefficiently. The ability of" exact="influenza" post="A virus to replicate in mice is explained by"/>
   <result pre="cells, it is the Anp32A orthologue that is utilized by" exact="avian influenza" post="polymerase, whereas chAnp32B does not support replication; this difference"/>
   <result pre="it is the Anp32A orthologue that is utilized by avian" exact="influenza" post="polymerase, whereas chAnp32B does not support replication; this difference"/>
   <result pre="recurring issue with such drugs is the ease with which" exact="influenza" post="virus evolves resistance to them, be it in a"/>
   <result pre="on the host protein without compromising its cellular functions. As" exact="influenza" post="virus replication is completely abrogated in their absence, ANP32"/>
   <result pre="at least 3 repeats. Minigenome assay. In order to measure" exact="influenza" post="virus polymerase activity, pCAGGS expression plasmids encoding PB1 (0.04 μg),"/>
   <result pre="encodes a minigenome containing a firefly reporter flanked by either" exact="influenza" post="A or B promoter sequences, or, in Fig. 2e,"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling study. Lancet Infect"/>
   <result pre="Infect Dis12:687–695. doi:10.1016/S1473-3099(12)70121-4.22738893 3.HsuMT, ParvinJD, GuptaS, KrystalM, PaleseP1987Genomic RNAs of" exact="influenza" post="viruses are held in a circular conformation in virions"/>
   <result pre="S A84:8140–8144. doi:10.1073/pnas.84.22.8140.2446318 4.MoellerA, KirchdoerferRN, PotterCS, CarragherB, WilsonIA2012Organization of the" exact="influenza" post="virus replication machinery. Science338:1631–1634. doi:10.1126/science.1227270.23180774 5.ArranzR, ColomaR, ChichonFJ, ConesaJJ,"/>
   <result pre="ColomaR, ChichonFJ, ConesaJJ, CarrascosaJL, ValpuestaJM, OrtinJ, Martin-BenitoJ2012The structure of native" exact="influenza" post="virion ribonucleoproteins. Science338:1634–1637. doi:10.1126/science.1228172.23180776 6.PflugA, GuilligayD, ReichS, CusackS2014Structure of"/>
   <result pre="influenza virion ribonucleoproteins. Science338:1634–1637. doi:10.1126/science.1228172.23180776 6.PflugA, GuilligayD, ReichS, CusackS2014Structure of" exact="influenza" post="A polymerase bound to the viral RNA promoter. Nature516:355–360."/>
   <result pre="LukarskaM, Resa-InfanteP, ReichS, CusackS2017Structural insights into RNA synthesis by the" exact="influenza" post="virus transcription-replication machine. Virus Res234:103–117. doi:10.1016/j.virusres.2017.01.013.28115197 9.ReillyPT, YuY, HamicheA,"/>
   <result pre="KornbluthS2006Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in" exact="breast cancer" post="cells. Cancer Res66:2210–2218. doi:10.1158/0008-5472.CAN-05-3923.16489023 14.MunemasaY, SuzukiT, AizawaK, MiyamotoS, ImaiY,"/>
   <result pre="sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast" exact="cancer" post="cells. Cancer Res66:2210–2218. doi:10.1158/0008-5472.CAN-05-3923.16489023 14.MunemasaY, SuzukiT, AizawaK, MiyamotoS, ImaiY,"/>
   <result pre="KawaguchiA, OkuwakiM, NagataK2015Pp32 and APRIL are host cell-derived regulators of" exact="influenza" post="virus RNA synthesis from cRNA. Elife4:e08939. doi:10.7554/eLife.08939.26512887 18.LongJS, GiotisES,"/>
   <result pre="JamesJ, MorissonM, IqbalM, VignalA, SkinnerMA, BarclayWS2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529:101–104. doi:10.1038/nature16474.26738596 19.BakerSF, LedwithMP,"/>
   <result pre="birds alters its ability to stimulate RNA synthesis by restricted" exact="influenza" post="polymerase. Cell Rep24:2581–2588.e4. doi:10.1016/j.celrep.2018.08.012.30184493 20.DominguesP, HaleBG2017Functional insights into ANP32A-dependent"/>
   <result pre="influenza polymerase. Cell Rep24:2581–2588.e4. doi:10.1016/j.celrep.2018.08.012.30184493 20.DominguesP, HaleBG2017Functional insights into ANP32A-dependent" exact="influenza" post="A virus polymerase host restriction. Cell Rep20:2538–2546. doi:10.1016/j.celrep.2017.08.061.28903035 21.WatanabeT,"/>
   <result pre="22.Bradel-TrethewayBG, MattiacioJL, KrasnoselskyA, StevensonC, PurdyD, DewhurstS, KatzeMG2011Comprehensive proteomic analysis of" exact="influenza" post="virus polymerase complex reveals a novel association with mitochondrial"/>
   <result pre="Virol85:8569–8581. doi:10.1128/JVI.00496-11.21715506 23.LongJS, MistryB, HaslamSM, BarclayWS2019Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat Rev Microbiol17:67–81. doi:10.1038/s41579-018-0115-z.30487536 24.EssletzbichlerP,"/>
   <result pre="doi:10.1038/nbt.3437.26780180 29.JorbaN, ColomaR, OrtinJ2009Genetic trans-complementation establishes a new model for" exact="influenza" post="virus RNA transcription and replication. PloS Pathog5:e1000462. doi:10.1371/journal.ppat.1000462.19478885 30.YorkA,"/>
   <result pre="contribution and host range determination of ANP32A and ANP32B in" exact="influenza" post="A virus polymerase activity. J Virol93 doi:10.1128/jvi.00174-19:JVI.00174-19. 32.KarlasA, MachuyN,"/>
   <result pre="RudelT, MeyerTF2010Genome-wide RNAi screen identifies human host factors crucial for" exact="influenza" post="virus replication. Nature463:818–822. doi:10.1038/nature08760.20081832 33.HanJ, PerezJT, ChenC, LiY, BenitezA,"/>
   <result pre="AndradeJ, tenOeverB, ManicassamyB2018Genome-wide CRISPR/Cas9 screen identifies host factors essential for" exact="influenza" post="virus replication. Cell Rep23:596–607. doi:10.1016/j.celrep.2018.03.045.29642015 34.LongJS, Idoko-AkohA, MistryB, GoldhillD,"/>
   <result pre="McGrewMJ, BarclayW2019Species specific differences in use of ANP32 proteins by" exact="influenza" post="A virus. Elife8:e45066. doi:10.7554/eLife.45066.31159925 35.BloomJD, GongLI, BaltimoreD2010Permissive secondary mutations"/>
   <result pre="doi:10.7554/eLife.45066.31159925 35.BloomJD, GongLI, BaltimoreD2010Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistance. Science328:1272–1275. doi:10.1126/science.1187816.20522774 36.BrightRA, ShayDK, ShuB, CoxNJ, KlimovAI2006Adamantane"/>
   <result pre="resistance. Science328:1272–1275. doi:10.1126/science.1187816.20522774 36.BrightRA, ShayDK, ShuB, CoxNJ, KlimovAI2006Adamantane resistance among" exact="influenza" post="A viruses isolated early during the 2005–2006 influenza season"/>
   <result pre="resistance among influenza A viruses isolated early during the 2005–2006" exact="influenza" post="season in the United States. Jama295:891–894. doi:10.1001/jama.295.8.joc60020.16456087 37.TakashitaE, MoritaH,"/>
   <result pre="MoritaH, OgawaR, NakamuraK, FujisakiS, ShirakuraM, KuwaharaT, KishidaN, WatanabeS, OdagiriT2018Susceptibility of" exact="influenza" post="viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil."/>
   <result pre="effect of the PB2 mutation 627K on highly pathogenic H5N1" exact="avian influenza" post="virus is dependent on the virus lineage. J Virol87:9983–9996."/>
   <result pre="of the PB2 mutation 627K on highly pathogenic H5N1 avian" exact="influenza" post="virus is dependent on the virus lineage. J Virol87:9983–9996."/>
   <result pre="J Virol87:9983–9996. doi:10.1128/JVI.01399-13.23843645 39.MoncorgeO, LongJS, CauldwellAV, ZhouH, LycettSJ, BarclayWS2013Investigation of" exact="influenza" post="virus polymerase activity in pig cells. J Virol87:384–394. doi:10.1128/JVI.01633-12.23077313"/>
   <result pre="CadmanA, ZurcherT, BarclayWS2002A reverse genetics approach for recovery of recombinant" exact="influenza" post="B viruses entirely from cDNA. J Virol76:11744–11747. doi:10.1128/jvi.76.22.11744-11747.2002.12388735 41.BystrykhLV2012Generalized"/>
   <result pre="WatanabeT, FujiiK, GotoH, WatanabeS, NodaT, KawaokaY2011Strand-specific real-time RT-PCR for distinguishing" exact="influenza" post="vRNA, cRNA, and mRNA. J Virol Methods173:1–6. doi:10.1016/j.jviromet.2010.12.014.21185869 44.KnyazC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695095\results\search\disease\results.xml">
   <result pre="Gene Expression Dysregulation of M segment gene expression contributes to" exact="influenza" post="A virus host restriction Regulation of influenza A virus"/>
   <result pre="expression contributes to influenza A virus host restriction Regulation of" exact="influenza" post="A virus gene expression as a host range determinant"/>
   <result pre="are credited.ppat.1007892.pdf Abstract The M segment of the 2009 pandemic" exact="influenza" post="A virus (IAV) has been implicated in its emergence"/>
   <result pre="cells with avian IAVs, and which is overcome in human-adapted" exact="influenza" post="A lineages. Critically, the mechanism leading to this host-restricted"/>
   <result pre="changes in the M segment of pH1N1 and H3N2 human" exact="influenza" post="A lineages. Fig 2 pH1N1 M segment confers higher"/>
   <result pre="kinetics than the PR8 NL09 M virus. Fig 3 pH1N1" exact="influenza" post="A virus M segment confers efficient replication and transmission"/>
   <result pre="cells have been previously reported for the avian IAV, fowl" exact="plague" post="virus [20,21]. We therefore hypothesized that the high expression"/>
   <result pre="segment mRNAs and gene products. (A) The M segment of" exact="influenza" post="virus is template for synthesis of mRNA7 (encoding M1),"/>
   <result pre="peptide from a short open reading frame). (B) Pandemic H1N1" exact="influenza" post="virus M1 and M2 proteins differ from the avian"/>
   <result pre="differ by 8.3% at the nucleotide level. (C) Seasonal H3N2" exact="influenza" post="virus strain A/Panama/2007/99 M1 and M2 proteins differ from"/>
   <result pre="differ by 9% at the nucleotide level. (D) Seasonal H3N2" exact="influenza" post="virus strain A/Bethesda/55/15 M1 and M2 proteins differ from"/>
   <result pre="LINK Click here for additional data file. S3 Fig pH1N1" exact="influenza" post="virus M segment increases kinetics of replication of PR8-based"/>
   <result pre="Fig Schematic depicting chimeric M Segment RNAs. (A) Pandemic H1N1" exact="influenza" post="virus M1 and M2 proteins differ from the avian"/>
   <result pre="1PattersonKD, PyleGF (1991) The geography and mortality of the 1918" exact="influenza" post="pandemic. Bull Hist Med65: 4–21. 2021692 2ViboudC, SimonsenL, FuentesR,"/>
   <result pre="et al. (2005) Multinational impact of the 1968 Hong Kong" exact="influenza" post="pandemic: evidence for a smoldering pandemic. J Infect Dis192:"/>
   <result pre="ThompsonWW, WortleyPM, et al. (2007) The annual impact of seasonal" exact="influenza" post="in the US: measuring disease burden and costs. Vaccine25:"/>
   <result pre="5086–5096. 10.1016/j.vaccine.2007.03.04617544181 5ReperantLA, KuikenT, OsterhausAD (2012) Adaptive pathways of zoonotic" exact="influenza" post="viruses: from exposure to establishment in humans. Vaccine30: 4419–4434."/>
   <result pre="Vol. 4:105–121. 10.1146/annurev-virology-101416-04172628548881 7SteelJ, LowenAC, MubarekaS, PaleseP (2009) Transmission of" exact="influenza" post="virus in a mammalian host is increased by PB2"/>
   <result pre="(1993) A single amino acid in the PB2 gene of" exact="influenza" post="A virus is a determinant of host range. J"/>
   <result pre="FriseR, MistryB, et al. (2016) Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529: 101–104. 10.1038/nature1647426738596 11RogersGN,"/>
   <result pre="10.1038/nature1647426738596 11RogersGN, PaulsonJC (1983) Receptor determinants of human and animal" exact="influenza" post="virus isolates: differences in receptor specificity of the H3"/>
   <result pre="361–373. 6868370 12TannerWD, TothDJ, GundlapalliAV (2015) The pandemic potential of" exact="avian influenza" post="A(H7N9) virus: a review. Epidemiol Infect143: 3359–3374. 10.1017/S095026881500157026205078 13CapuaI,"/>
   <result pre="6868370 12TannerWD, TothDJ, GundlapalliAV (2015) The pandemic potential of avian" exact="influenza" post="A(H7N9) virus: a review. Epidemiol Infect143: 3359–3374. 10.1017/S095026881500157026205078 13CapuaI,"/>
   <result pre="review. Epidemiol Infect143: 3359–3374. 10.1017/S095026881500157026205078 13CapuaI, MunozO (2013) Emergence of" exact="influenza" post="viruses with zoonotic potential: open issues which need to"/>
   <result pre="7–12. 10.1016/j.vetmic.2013.01.04423567150 14CauldwellAV, LongJS, MoncorgeO, BarclayWS (2014) Viral determinants of" exact="influenza" post="A host range. J Gen Virol. 95: 1193–1210. 10.1099/vir.0.062836-024584475"/>
   <result pre="RNA and protein synthesis in a permissive and an abortive" exact="influenza" post="virus infection In: MahyBWJ, BarryRD, editors. Negative Strand Viruses"/>
   <result pre="(1978) Macromolecular syntheses during abortive infection of KB cells by" exact="influenza" post="virus In: MahyBWJ, BarryRD, editors. Negative Strand Viruses and"/>
   <result pre="Press pp. 475–482. 17LohmeyerJ, TalensLT, KlenkHD (1979) Biosynthesis of the" exact="influenza" post="virus envelope in abortive infection. J Gen Virol42: 73–88."/>
   <result pre="Sequences of mRNAs derived from genome RNA segment 7 of" exact="influenza" post="virus: colinear and interrupted mRNAs code for overlapping proteins."/>
   <result pre="a second protein (M2) encoded by RNA segment 7 of" exact="influenza" post="virus. Virology112: 729–737. 7257188 20InglisSC, BrownCM (1984) Differences in"/>
   <result pre="of virus mRNA splicing during permissive or abortive infection with" exact="influenza" post="A (fowl plague) virus. J Gen Virol65 (Pt 1):"/>
   <result pre="21LauSC, ScholtissekC (1995) Abortive infection of Vero cells by an" exact="influenza" post="A virus (FPV). Virology212: 225–231. 10.1006/viro.1995.14737676635 22BogdanowB, EichelbaumK, SadewasserA,"/>
   <result pre="SadewasserA, WangX, HusicI, et al. (2018) The dynamic proteome of" exact="influenza" post="A virus infection identifies M segment splicing as a"/>
   <result pre="(2018) Adaptive evolution during the establishment of European avian-like H1N1" exact="influenza" post="A virus in swine. Evol Appl11: 534–546. 10.1111/eva.1253629636804 24CampbellPJ,"/>
   <result pre="et al. (2014) The M segment of the 2009 pandemic" exact="influenza" post="virus confers increased NA activity, filamentous morphology and efficient"/>
   <result pre="et al. (2014) Residue 41 of the Eurasian avian-like swine" exact="influenza" post="a virus matrix protein modulates virion filament length and"/>
   <result pre="(2011) The M segment of the 2009 new pandemic H1N1" exact="influenza" post="virus is critical for its high transmission efficiency in"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1" exact="influenza" post="virus. PLoS Pathog7: e100244310.1371/journal.ppat.1002443 29RossmanJS, LambRA (2011) Influenza virus"/>
   <result pre="Garcia-SastreA (2003) Reverse genetics studies on the filamentous morphology of" exact="influenza" post="A virus. J Gen Virol84: 517–527. 10.1099/vir.0.18803-012604801 32EllemanCJ, BarclayWS"/>
   <result pre="(2004) The M1 matrix protein controls the filamentous phenotype of" exact="influenza" post="A virus. Virology321: 144–153. 10.1016/j.virol.2003.12.00915033573 33StaufferS, FengY, NebiogluF, HeiligR,"/>
   <result pre="a high K+ concentration is required for efficient uncoating of" exact="influenza" post="A virus cores after penetration. J Virol88: 13029–13046. 10.1128/JVI.01430-1425165113"/>
   <result pre="penetration. J Virol88: 13029–13046. 10.1128/JVI.01430-1425165113 34O'NeillRE, TalonJ, PaleseP (1998) The" exact="influenza" post="virus NEP (NS2 protein) mediates the nuclear export of"/>
   <result pre="(2003) Crystal structure of the M1 protein-binding domain of the" exact="influenza" post="A virus nuclear export protein (NEP/NS2). EMBO J22: 4646–4655."/>
   <result pre="VreedeF, et al. (2014) The nuclear export protein of H5N1" exact="influenza" post="A viruses recruits Matrix 1 (M1) protein to the"/>
   <result pre="10.1074/jbc.M114.56917824891509 37WatanabeK, HandaH, MizumotoK, NagataK (1996) Mechanism for inhibition of" exact="influenza" post="virus RNA polymerase activity by matrix protein. J Virol70:"/>
   <result pre="39AliA, AvalosRT, PonimaskinE, NayakDP (2000) Influenza virus assembly: effect of" exact="influenza" post="virus glycoproteins on the membrane association of M1 protein."/>
   <result pre="of transmembrane domain and cytoplasmic tail amino acid sequences of" exact="influenza" post="a virus neuraminidase in raft association and virus budding."/>
   <result pre="Ion selectivity and activation of the M2 ion channel of" exact="influenza" post="virus. Biophys J70: 1335–1346. 10.1016/S0006-3495(96)79690-X8785289 42GrambasS, HayAJ (1992) Maturation"/>
   <result pre="virus. Biophys J70: 1335–1346. 10.1016/S0006-3495(96)79690-X8785289 42GrambasS, HayAJ (1992) Maturation of" exact="influenza" post="A virus hemagglutinin—estimates of the pH encountered during transport"/>
   <result pre="HayAJ (1992) Regulation of pH by the M2 protein of" exact="influenza" post="A viruses. Virus Res22: 247–258. 1626420 44TakeuchiK, LambRA (1994)"/>
   <result pre="protein ion channel activity stabilizes the native form of fowl" exact="plague" post="virus hemagglutinin during intracellular transport. J Virol68: 911–919. 7507186"/>
   <result pre="RavenhillBJ, DigardP, et al. (2014) A LC3-interacting motif in the" exact="influenza" post="A virus M2 protein is required to subvert autophagy"/>
   <result pre="AlbrechtR, DengjelJ, TorossiT, et al. (2009) Matrix protein 2 of" exact="influenza" post="A virus blocks autophagosome fusion with lysosomes. Cell Host"/>
   <result pre="WhelanSP, WertzGW (1997) cis-Acting signals involved in termination of vesicular" exact="stomatitis" post="virus mRNA synthesis include the conserved AUAC and the"/>
   <result pre="WhelanSP, WertzGW (1997) Role of the intergenic dinucleotide in vesicular" exact="stomatitis" post="virus RNA transcription. J Virol71: 1794–1801. 9032308 52PaganI, HolmesEC,"/>
   <result pre="53AbrahamG, BanerjeeAK (1976) Sequential transcription of the genes of vesicular" exact="stomatitis" post="virus. Proc Natl Acad Sci U S A73: 1504–1508."/>
   <result pre="(2006) The guinea pig as a transmission model for human" exact="influenza" post="viruses. Proc Natl Acad Sci U S A103: 9988–9992."/>
   <result pre="and unspliced RNAs encoded by virion RNA segment 7 of" exact="influenza" post="virus. Nucleic Acids Res9: 2727–2740. 10.1093/nar/9.12.27276169001 57FujitaN, ItohT, OmoriH,"/>
   <result pre="61SkehelJJ, HayAJ, ArmstrongJA (1978) On the mechanism of inhibition of" exact="influenza" post="virus replication by amantadine hydrochloride. J Gen Virol38: 97–110."/>
   <result pre="M-gene segment can substantially increase replication efficiency of NS1 deletion" exact="influenza" post="A virus in MDCK cells. J Virol86: 12341–12350. 10.1128/JVI.01725-1222951840"/>
   <result pre="of a conserved hairpin in the M gene segment of" exact="influenza" post="A virus shows its role in virus replication. RNA"/>
   <result pre="64ShihSR, KrugRM (1996) Novel exploitation of a nuclear function by" exact="influenza" post="virus: the cellular SF2/ASF splicing factor controls the amount"/>
   <result pre="al. (2018) Co-regulatory activity of hnRNP K and NS1-BP in" exact="influenza" post="and human mRNA splicing. Nat Commun9: 240710.1038/s41467-018-04779-429921878 66RenY, LiC,"/>
   <result pre="(1998) Selective perturbation of apical membrane traffic by expression of" exact="influenza" post="M2, an acid-activated ion channel, in polarized madin-darby canine"/>
   <result pre="network pH but not lysosome pH by dose-dependent expression of" exact="influenza" post="M2 protein. J Biol Chem274: 9854–9860. 10.1074/jbc.274.14.985410092677 74BurleighLM, CalderLJ,"/>
   <result pre="75RobertsPC, LambRA, CompansRW (1998) The M1 and M2 proteins of" exact="influenza" post="A virus are important determinants in filamentous particle formation."/>
   <result pre="76FodorE, DevenishL, EngelhardtOG, PaleseP, BrownleeGG, et al. (1999) Rescue of" exact="influenza" post="A virus from recombinant DNA. J Virol73: 9679–9682. 10516084"/>
   <result pre="ZamarinD, Garcia-SastreA, CullinaneA, ChambersT, et al. (2005) Attenuation of equine" exact="influenza" post="viruses through truncations of the NS1 protein. J Virol79:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695175\results\search\disease\results.xml">
   <result pre="13HapuarachchiHC, KooC, RajarethinamJ, ChongCS, LinC, YapG, et al.Epidemic resurgence of" exact="dengue fever" post="in Singapore in 2013–2014: A virological and entomological perspective."/>
   <result pre="ShimonoT, LamaningaoP, DarcyAW, MishimaN, et al.Co-circulation of the dengue with" exact="chikungunya" post="virus during the 2013 outbreak in the southern part"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6695206\results\search\disease\results.xml">
   <result pre="Birds NS2B/NS3 mutations enhance the infectivity of genotype I Japanese" exact="encephalitis" post="virus in amplifying hosts NS2B/NS3 mutations and hosts responsible"/>
   <result pre="mutations and hosts responsible for the genotype replacement of Japanese" exact="encephalitis" post="virus http://orcid.org/0000-0003-1866-0800FanYi-ChinConceptualizationFormal analysisInvestigationValidationWriting – original draft12¤LiangJian-JongMethodology3ChenJo-MeiFormal analysisInvestigation1LinJen-WeiInvestigation1ChenYi-YingInvestigation1SuKuan-HsuanMethodology4LinChang-ChiMethodology5TuWu-ChunMethodologyResources6ChiouMing-TangMethodologyResources4http://orcid.org/0000-0002-0857-9008OuShan-ChiaMethodologyResources1http://orcid.org/0000-0001-9959-6585ChangGwong-Jen J.ConceptualizationResourcesWriting –"/>
   <result pre="has replaced genotype III (GIII) virus as the dominant Japanese" exact="encephalitis" post="virus (JEV) in the epidemic area of Asia. The"/>
   <result pre="within the manuscript and its Supporting Information files. Introduction Japanese" exact="encephalitis" post="virus (JEV), a mosquito-borne flavivirus, has a single-stranded, positive-sense"/>
   <result pre="3’ terminal sequence was generated by a ribozyme sequence of" exact="hepatitis" post="delta virus (HDVr) incorporated right after the 3’UTR of"/>
   <result pre="NiH, BeasleyDW, EkkelenkampM, CardosaMJ, BarrettAD. Origin and evolution of Japanese" exact="encephalitis" post="virus in southeast Asia. Journal of virology. 2003;77(5):3091–8. Epub"/>
   <result pre="10.1128/JVI.77.5.3091-3098.200312584335 3SchererWF, MoyerJT, IzumiT, GresserI, McCJ. Ecologic studies of Japanese" exact="encephalitis" post="virus in Japan. VI. Swine infection. The American journal"/>
   <result pre="10.4269/ajtmh.1959.8.698 .14442656 4SchererWF, KitaokaM, OkunoT, OgataT. Ecologic studies of Japanese" exact="encephalitis" post="virus in Japan. VII. Human infection. The American journal"/>
   <result pre="1959/11/01. 10.4269/ajtmh.1959.8.707 .14442655 5SchererWF, BuescherEL, McCH. Ecologic studies of Japanese" exact="encephalitis" post="virus in Japan. V. Avian factors. The American journal"/>
   <result pre="6BuescherEL, SchererWF, RosenbergMZ, GresserI, HardyJL, BullockHR. Ecologic studies of Japanese" exact="encephalitis" post="virus in Japan. II. Mosquito infection. The American journal"/>
   <result pre="Epub 1959/11/01. 10.4269/ajtmh.1959.8.651 .13805722 7BuescherEL, SchererWF. Ecologic studies of Japanese" exact="encephalitis" post="virus in Japan. IX. Epidemiologic correlations and conclusions. The"/>
   <result pre="den HurkAF, RitchieSA, MackenzieJS. Ecology and geographical expansion of Japanese" exact="encephalitis" post="virus. Annual review of entomology. 2009;54:17–35. Epub 2008/12/11. 10.1146/annurev.ento.54.110807.090510"/>
   <result pre="MukhopadhyaySK, ChakrabartiS, ChatterjeeS. Molecular evidence for the occurrence of Japanese" exact="encephalitis" post="virus genotype I and III infection associated with acute"/>
   <result pre="encephalitis virus genotype I and III infection associated with acute" exact="encephalitis" post="in patients of West Bengal, India, 2010. Virology journal."/>
   <result pre="FuSH, LiuHZ, ZhangHL, et al.Emergence of genotype I of Japanese" exact="encephalitis" post="virus as the dominant genotype in Asia. Journal of"/>
   <result pre="LinTH, TengHJ, SuCL, TsaiKH, LuLC, et al.Molecular epidemiology of Japanese" exact="encephalitis" post="virus, Taiwan. Emerging infectious diseases. 2010;16(5):876–8. Epub 2010/04/23. 10.3201/eid1605.09105520409392"/>
   <result pre="13NitatpattanaN, Dubot-PeresA, GouilhMA, SourisM, BarbazanP, YoksanS, et al.Change in Japanese" exact="encephalitis" post="virus distribution, Thailand. Emerging infectious diseases. 2008;14(11):1762–5. Epub 2008/11/04."/>
   <result pre="Carmen ParquetM, CuongVD, MaSP, HasebeF, InoueS, et al.Shift in Japanese" exact="encephalitis" post="virus (JEV) genotype circulating in northern Vietnam: implications for"/>
   <result pre="TadanoM, OnoT, OgawaM. Short report: a major genotype of Japanese" exact="encephalitis" post="virus currently circulating in Japan. The American journal of"/>
   <result pre="Epub 2003/09/19. .13677370 16SchuhAJ, WardMJ, BrownAJ, BarrettAD. Phylogeography of Japanese" exact="encephalitis" post="virus: genotype is associated with climate. PLoS neglected tropical"/>
   <result pre="2013;7(8):e2411 Epub 2013/09/07. 10.1371/journal.pntd.000241124009790 17DoLP, BuiTM, PhanNT. Mechanism of Japanese" exact="encephalitis" post="virus genotypes replacement based on human, porcine and mosquito-originated"/>
   <result pre="BowenR. North American birds as potential amplifying hosts of Japanese" exact="encephalitis" post="virus. The American journal of tropical medicine and hygiene."/>
   <result pre="FangW, et al.Comparison of genotypes I and III in Japanese" exact="encephalitis" post="virus reveals distinct differences in their genetic and host"/>
   <result pre="shock protein 70 is associated with replicase complex of Japanese" exact="encephalitis" post="virus and positively regulates viral genome replication. PloS one."/>
   <result pre="one. 2013;8(9):e7518810.1371/journal.pone.007518824086464 24RicklinME, Garcia-NicolasO, BrechbuhlD, PythonS, ZumkehrB, PosthausH, et al.Japanese" exact="encephalitis" post="virus tropism in experimentally infected pigs. Veterinary research. 2016;47:3410.1186/s13567-016-0319-z26911997"/>
   <result pre="research. 2016;47:3410.1186/s13567-016-0319-z26911997 25CletonNB, Bosco-LauthA, PageMJ, BowenRA. Age-related susceptibility to Japanese" exact="encephalitis" post="virus in domestic ducklings and chicks. The American journal"/>
   <result pre="LaurentD, CrabolY, MeyC, et al.Isolation and full-genome sequences of Japanese" exact="encephalitis" post="virus genotype I strains from Cambodian human patients, mosquitoes"/>
   <result pre="10.1038/nature22365 .28514450 30TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS pathogens."/>
   <result pre="neglected tropical diseases. 2016;10(10):e000503810.1371/journal.pntd.0005038 .27706157 35MoritaK. Molecular epidemiology of Japanese" exact="encephalitis" post="in East Asia. Vaccine. 2009;27(50):7131–2. 10.1016/j.vaccine.2009.09.051 .19799848 36XiaoC, LiC,"/>
   <result pre="DiD, CappelleJ, LiuL, WangX, et al.Differential replication efficiencies between Japanese" exact="encephalitis" post="virus genotype I and III in avian cultured cells"/>
   <result pre="of Culex tritaeniorhynchus on the pattern of transmission of Japanese" exact="encephalitis" post="virus. Journal of medical entomology. 1976;13(3):275–84. 10.1093/jmedent/13.3.275 .1011230 38Garcia-NicolasO,"/>
   <result pre="America. 2018;115(27):E6310–E8. 10.1073/pnas.180340611529915078 45LiangJJ, LiaoCL, LiaoJT, LeeYL, LinYL. A Japanese" exact="encephalitis" post="virus vaccine candidate strain is attenuated by decreasing its"/>
   <result pre="FitzgeraldME, WasikBR, HouL, ZhaoH, et al.Temperature-dependent innate defense against the" exact="common cold" post="virus limits viral replication at warm temperature in mouse"/>
   <result pre="ChenWJ. Mutations in the NS3 gene and 3'-NCR of Japanese" exact="encephalitis" post="virus isolated from an unconventional ecosystem and implications for"/>
   <result pre="10.1006/viro.2001.1033 .11601924 56ChenYY, FanYC, TuWC, ChangRY, ShihCC, LuIH, et al.Japanese" exact="encephalitis" post="virus genotype replacement, Taiwan, 2009–2010. Emerging infectious diseases. 2011;17(12):2354–6."/>
   <result pre="CrabtreeMB, GuirakhooF, MonathTP, MillerBR. Growth characteristics of the chimeric Japanese" exact="encephalitis" post="virus vaccine candidate, ChimeriVax-JE (YF/JE SA14—14—2), in Culex tritaeniorhynchus,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6698327\results\search\disease\results.xml">
   <result pre="CentralLondon pmcid: 6698327808 doi: 10.1186/s12199-019-0808-6 : Research Article Seroprevalence of" exact="influenza" post="A virus in pigs and low risk of acute"/>
   <result pre="exposure to pigs, occurrence of acute respiratory illness (ARI), and" exact="influenza" post="A virus infection. Methods The study was conducted in"/>
   <result pre="130 human NP/OP swabs tested, four (3.1%) were positive for" exact="influenza" post="A virus, one pig worker, and three among non-pig"/>
   <result pre="4462 swabs collected from pig and poultry tested positive for" exact="influenza" post="A virus by RT-PCR, 265 of 4273 (6.2%) of"/>
   <result pre="for potential confounders. Conclusions Our findings demonstrate moderate seropositivity for" exact="influenza" post="A virus among pigs, suggesting the circulation of swine"/>
   <result pre="influenza A virus among pigs, suggesting the circulation of swine" exact="influenza" post="virus and a potential for interspecies transmission. Keywords Acute"/>
   <result pre="inherent ability to allow replication of swine, avian, and human" exact="influenza" post="viruses and potential to have mixed infections [2–4]. For"/>
   <result pre="potential to have mixed infections [2–4]. For example, the 2009" exact="influenza" post="A H1N1 pandemic virus that was associated with 150,000–570,000"/>
   <result pre="deaths globally was the product of re-assortment of circulating human" exact="influenza" post="and avian influenza strains with pigs suspected as the"/>
   <result pre="was the product of re-assortment of circulating human influenza and" exact="avian influenza" post="strains with pigs suspected as the mixing vessel [5]."/>
   <result pre="the product of re-assortment of circulating human influenza and avian" exact="influenza" post="strains with pigs suspected as the mixing vessel [5]."/>
   <result pre="pigs suspected as the mixing vessel [5]. Pig-to-human and human-to-pig" exact="influenza" post="(reverse zoonosis) virus transmission events have been documented in"/>
   <result pre="infections are mild or subclinical [12, 13]. Reverse zoonosis of" exact="influenza" post="virus is considered an important source of swine influenza"/>
   <result pre="of influenza virus is considered an important source of swine" exact="influenza" post="virus (SIV) diversity which reduces the efficacy of vaccines"/>
   <result pre="of vaccines to SIV in pigs [14]. The transmission of" exact="influenza" post="viruses between pigs and humans is not only associated"/>
   <result pre="study in pigs from a Kenyan slaughterhouse revealed an overall" exact="influenza" post="A seroprevalence of 15%, including &amp;gt; 12% seroprevalence of"/>
   <result pre="15%, including &amp;gt; 12% seroprevalence of the pandemic 2009 H1N1" exact="influenza" post="virus, suggesting transmission of influenza viruses from humans to"/>
   <result pre="of the pandemic 2009 H1N1 influenza virus, suggesting transmission of" exact="influenza" post="viruses from humans to pigs [17]. The growing demand"/>
   <result pre="in such livestock production systems may be exposed to swine" exact="influenza" post="viruses, no studies on the occupational exposure risks to"/>
   <result pre="influenza viruses, no studies on the occupational exposure risks to" exact="influenza" post="viruses have been documented in the country. Here, we"/>
   <result pre="occupational exposure to pigs and the occurrence of ARI and" exact="influenza" post="A virus infection. We monitored ARI among the humans"/>
   <result pre="among the humans to determine its utility in detection of" exact="influenza" post="virus infections among pig workers. We also assessed the"/>
   <result pre="also assessed the farming practices associated with high risks of" exact="influenza" post="virus transmission among pig keepers. Methods Study area The"/>
   <result pre="the human component of the study were the prevalence of" exact="influenza" post="A virus infection and the number of ARI episodes"/>
   <result pre="the animal study, the primary outcome was the detection of" exact="influenza" post="A virus infection and seroprevalence of influenza A virus."/>
   <result pre="the detection of influenza A virus infection and seroprevalence of" exact="influenza" post="A virus. A minimum sample size of 392 pigs"/>
   <result pre="°C until testing. Animal serum was tested for antibodies against" exact="influenza" post="A viruses using the IDEXX® ELISA (FlockChek AI MultiS-Screen"/>
   <result pre="polymerase chain reaction (RT-PCR) using CDC primers and probes for" exact="influenza" post="A and influenza B viruses [22, 23]. The RNA"/>
   <result pre="(RT-PCR) using CDC primers and probes for influenza A and" exact="influenza" post="B viruses [22, 23]. The RNA was extracted using"/>
   <result pre="used to validate the test assay. Subtyping was attempted for" exact="influenza" post="A positive swabs for seasonal human influenza, avian, and"/>
   <result pre="A positive swabs for seasonal human influenza, avian, and swine" exact="influenza" post="[24]. Animal nasal and OP swabs were screened for"/>
   <result pre="influenza [24]. Animal nasal and OP swabs were screened for" exact="influenza" post="A virus by RT-PCR using the CDC protocol for"/>
   <result pre="influenza A virus by RT-PCR using the CDC protocol for" exact="influenza" post="A virus detection that targets the matrix gene [23]."/>
   <result pre="40 years old and 54.1% were farmers (Table 1). Human" exact="influenza" post="vaccination in the previous 12 months was reported by"/>
   <result pre="has some missing data. SD standard deviation Human and animal" exact="influenza" post="A virus results A total of 130 swab samples"/>
   <result pre="from non-pig workers. Four (3%) human swabs tested positive for" exact="influenza" post="A by RT-PCR: one from a pig worker and"/>
   <result pre="(0.9%) from turkey. None of the swabs was positive for" exact="influenza" post="A virus by RT-PCR. A total of 4273 serum"/>
   <result pre="Overall, 265 (6.2%) of the animal sera were positive for" exact="influenza" post="A virus by ELISA, including 230 of 1990 (11.6%)"/>
   <result pre="of 2283 (1.5%) poultry sera. Among poultry, the seropositivity for" exact="influenza" post="A was 3.3% for geese, 2.9% for ducks, 1.4%"/>
   <result pre="To assess risky practices associated with the transmission of the" exact="influenza" post="virus at the human-animal interface, we restricted the analyses"/>
   <result pre="study documents a human-animal environment in Kiambu County with robust" exact="influenza" post="virus circulation, demonstrated by &amp;gt; 6% seropositivity of the"/>
   <result pre="found 3% of humans with acute respiratory illness positive for" exact="influenza" post="A virus by RT-PCR. These findings agree with other"/>
   <result pre="with other studies, including a Kenyan study that reported 15%" exact="influenza" post="virus prevalence among pigs and other studies elsewhere in"/>
   <result pre="elsewhere in Africa and Asia reporting as high as 67%" exact="influenza" post="virus seroprevalence among swine in live markets [28–31]. Since"/>
   <result pre="virus seroprevalence among swine in live markets [28–31]. Since swine" exact="influenza" post="vaccination was not practiced by the farmers in our"/>
   <result pre="seropositivity suggests exposure to circulating virus. The 1.4–3.3% prevalence of" exact="influenza" post="virus among the poultry species (chicken, ducks, and geese)"/>
   <result pre="the finding that Kiambu County is an environment of animal" exact="influenza" post="virus circulation. Our finding of 3% influenza positive ARI"/>
   <result pre="environment of animal influenza virus circulation. Our finding of 3%" exact="influenza" post="positive ARI human cases is lower than a community"/>
   <result pre="lower than a community study in Romania that reported 13%" exact="influenza" post="A virus positive samples among ARI cases by PCR"/>
   <result pre="time per participant was about 3 months and seasonality of" exact="influenza" post="could account for the relatively low number of positive"/>
   <result pre="the general population would likely miss potential zoonotic events. Zoonotic" exact="influenza" post="events are likely to first appear among those working"/>
   <result pre="young adults. With the reported levels of exposure to swine" exact="influenza" post="among pigs in our study, including the pig workers"/>
   <result pre="pigs in our study, including the pig workers in the" exact="influenza" post="surveillance could enhance efforts to detect early zoonotic influenza"/>
   <result pre="the influenza surveillance could enhance efforts to detect early zoonotic" exact="influenza" post="events. Focused surveillance in an occupationally exposed group offers"/>
   <result pre="a potentially cost-effective mechanism to monitor trends of influenza, including" exact="influenza" post="zoonotic events. A number of innovative and affordable approaches"/>
   <result pre="poor usage of personal protective equipment are risk factors for" exact="influenza" post="transmission [29, 31]. These transmission-promoting practices could be due"/>
   <result pre="those retained, they could have had different experiences on ARI," exact="influenza" post="A positivity and farming practices. Although the study period"/>
   <result pre="testing would allow for sampling to account for seasonality of" exact="influenza" post="infections as well as subclinical cases. Another limitation is"/>
   <result pre="able to conduct hemagglutination inhibition (HI) tests to determine the" exact="influenza" post="A virus strains circulating among pigs. However, a study"/>
   <result pre="Kenya in 2012 [38] reported 72% of seropositive pigs had" exact="influenza" post="virus (A/H1N1/pdm09) by HI, findings that could reflect the"/>
   <result pre="influenza virus (A/H1N1/pdm09) by HI, findings that could reflect the" exact="influenza" post="virus strains among pigs in our study. Conclusion Our"/>
   <result pre="study. Conclusion Our study documents moderate seropositivity among pigs for" exact="influenza" post="A virus, suggesting circulation of swine influenza virus and"/>
   <result pre="among pigs for influenza A virus, suggesting circulation of swine" exact="influenza" post="virus and therefore a potential for interspecies transmission. Swine"/>
   <result pre="be a better approach to quantify the risk of zoonotic" exact="influenza" post="infection, focused syndromic surveillance in this population offers an"/>
   <result pre="reverse transcriptase polymerase chain reaction SD Standard deviation SIV Swine" exact="influenza" post="viruses VTM Virus transport media Publisher’s Note Springer Nature"/>
   <result pre="eds pp Philadelphia Lippincott Williams Wilkins200115331579 2.Van ReethKAvian and swine" exact="influenza" post="viruses: our current understanding of the zoonotic riskVet Res"/>
   <result pre="England20073824326010.1051/vetres:2006062 3.ItoTCouceiroJNKelmSBaumLGKraussSCastrucciMRet al.Molecular basis for the generation in pigs of" exact="influenza" post="A viruses with pandemic potentialJ Virol United States19987273677373 4.AlexanderDJBrownIHRecent"/>
   <result pre="with pandemic potentialJ Virol United States19987273677373 4.AlexanderDJBrownIHRecent zoonoses caused by" exact="influenza" post="A virusesRev Sci Tech France20001919722510.20506/rst.19.1.1220 5.DawoodFSIulianoADReedCMeltzerMIShayDKChengP-Yet al.Estimated global mortality"/>
   <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling studyLancet Infect Dis"/>
   <result pre="Virus InfectionsEmerging Infectious Diseases200713121871187810.3201/eid1312.06132318258038 7.GregoryV.BennettM.ThomasY.KaiserL.WunderliW.MatterH.HayA.LinY. P.Human infection by a swine" exact="influenza" post="A (H1N1) virus in SwitzerlandArchives of Virology2003148479380210.1007/s00705-002-0953-912664301 8.MyersKPOlsenCWGrayGCCases of"/>
   <result pre="A (H1N1) virus in SwitzerlandArchives of Virology2003148479380210.1007/s00705-002-0953-912664301 8.MyersKPOlsenCWGrayGCCases of swine" exact="influenza" post="in humans: a review of the literatureClin Infect Dis2007441084108810.1086/51281317366454"/>
   <result pre="of the literatureClin Infect Dis2007441084108810.1086/51281317366454 9.RithSNetrabukkanaPSornSMumfordEMeyCHollDet al.Serologic evidence of human" exact="influenza" post="virus infections in swine populations, CambodiaInfluenza Other Respi Viruses"/>
   <result pre="Viruses England2013727127910.1111/j.1750-2659.2012.00382.x 10.MaMAndersonBDWangTChenYZhangDGrayGCet al.Serological evidence and risk factors for swine" exact="influenza" post="infections among Chinese swine workers in Guangdong ProvincePLoS One"/>
   <result pre="Pollinger JP, Cattoli G, Terregino C, et al. Pandemic A/H1N1/2009" exact="influenza" post="virus in Swine, Cameroon, 2010. Vet Microbiol. 2012. 12.GathererDThe"/>
   <result pre="in Swine, Cameroon, 2010. Vet Microbiol. 2012. 12.GathererDThe 2009 H1N1" exact="influenza" post="outbreak in its historical contextJ Clin Virol Netherlands20094517417810.1016/j.jcv.2009.06.004 13.EmbreeJPandemic"/>
   <result pre="in its historical contextJ Clin Virol Netherlands20094517417810.1016/j.jcv.2009.06.004 13.EmbreeJPandemic 2009 (A)H1N1" exact="influenza" post="(swine flu) - the Manitoba experienceBiochem Cell Biol Canada20108858959310.1139/O10-025"/>
   <result pre="Cell Biol Canada20108858959310.1139/O10-025 14.Nelson MI, Vincent AL. Reverse zoonosis of" exact="influenza" post="to swine: new perspectives on the human-animal interface. Trends"/>
   <result pre="15.BeaudoinAGramerMGrayGCCapuanoASetterquistSBenderJSerologic survey of swine workers for exposure to H2N3 swine" exact="influenza" post="A. Influenza Other Respi Viruses2010Oxford, UKBlackwell Publishing Ltd163170 16.Lopez-RoblesGMontalvo-CorralMCaire-JuveraGAyora-TalaveraGHernandezJSeroprevalence"/>
   <result pre="Viruses2010Oxford, UKBlackwell Publishing Ltd163170 16.Lopez-RoblesGMontalvo-CorralMCaire-JuveraGAyora-TalaveraGHernandezJSeroprevalence and risk factors for swine" exact="influenza" post="zoonotic transmission in swine workers from northwestern MexicoTransbound Emerg"/>
   <result pre="workers from northwestern MexicoTransbound Emerg Dis Germany20125918318810.1111/j.1865-1682.2011.01250.x 17.Munyua PM. Pandemic" exact="influenza" post="virus in pigs raised in small holder farms in"/>
   <result pre="Nations (FAO)Pig sector Kenya. Rome2012 19.KrumbholzAndiLangeJeannetteDürrwaldRalfHoyerHeikeBengschStefanWutzlerPeterZellRolandPrevalence of antibodies to swine" exact="influenza" post="viruses in humans with occupational exposure to pigs, Thuringia,"/>
   <result pre="in epidemiologic studiesStatistical Methods in Medical Research19954431133710.1177/0962280295004004048745129 21.MunyuaPMGithinjiJWWaibociLWNjagiLMArungaGMwasiLet al.Detection of" exact="influenza" post="A virus in live bird markets in Kenya, 2009–2011Blackwell"/>
   <result pre="of a real-time reverse transcriptase PCR assay for type A" exact="influenza" post="virus and the avian H5 and H7 hemagglutinin subtypes."/>
   <result pre="CE, Harrower B, Gould AR, et al. Detection of novel" exact="influenza" post="A(H1N1) virus by real-time RT-PCR. J Clin Virol. 2009."/>
   <result pre="assays for the detection and differentiation of North American swine" exact="influenza" post="viruses. J Vet Diagnostic Investig. 2004. 25.R Core Team."/>
   <result pre="CG, Lim YS, et al. Seroprevalence and risk factors for" exact="influenza" post="A viruses in pigs in Peninsular Malaysia. Zoonoses Public"/>
   <result pre="E, Peyre M, Peiris M, Cowling BJ. Epidemiological features of" exact="influenza" post="circulation in swine populations: a systematic review and meta-analysis."/>
   <result pre="Martín M, et al. Seroprevalence and risk factors of swine" exact="influenza" post="in Spain. Vet Microbiol. 2011. 32.AwosanyaEJOgundipeGBabalobiOOmilabuSPrevalence and correlates of"/>
   <result pre="33.ComanAMafteiDNKruegerWSHeilGLCherechesRMSirlincanEet al.A prospective study of Romanian agriculture workers for zoonotic" exact="influenza" post="infectionsPLoS One [Internet]. Public Library of Science20149e9824810.1371/journal.pone.0098248 34.Chowdhury R,"/>
   <result pre="Arunga G, Fields B, et al. Identification and characterization of" exact="influenza" post="A viruses in selected domestic animals in Kenya, 2010-2012."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6701881\results\search\disease\results.xml">
   <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil a case studyLancet Infect Dis201616665366026897108 4RussoFBBeltrão-BragaPCBThe impact"/>
   <result pre="125 amino acidsBiochim Biophys Acta20151848123150315726403837 28ElazarMLiuPRiceCMGlennJSAn N-terminal amphipathic helix in" exact="hepatitis" post="C virus (HCV) NS4B mediates membrane association, correct localization"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6702286\results\search\disease\results.xml">
   <result pre="these terms. Abstract Rift Valley Fever is an important zoonotic" exact="viral disease" post="of livestock occurring across much of Africa causing acute"/>
   <result pre="word-count: Introduction Rift Valley Fever (RVF) is a mosquito-borne zoonotic" exact="viral disease" post="of ruminants, caused by a Phlebovirus in the Bunyaviridae"/>
   <result pre="This survey was part of a larger study of bovine" exact="tuberculosis" post="and liver fluke and the sample size was based"/>
   <result pre="The smaller chloropeth maps show the mean estimated prevalence of" exact="rift valley fever" post="seroprevalence for each site by Division (NWR) or sub-Division"/>
   <result pre="age group as one would expect for a vector borne" exact="infectious disease" post="(Figures 5 and 6). Figure 5 Bayesian mean and"/>
   <result pre="screening of febriles illnesses should be considered by hospitals where" exact="malaria" post="has been ruled out. Data Availability The datasets generated"/>
   <result pre="(2009) 234:883–93. 10.2460/javma.234.7.88319335238 11.ChevalierVRakotondrafaraTJourdanMHeraudJMAndriamanivoHRDurandBet al.. An unexpected recurrent transmission of" exact="rift valley fever" post="virus in cattle in a temperate and mountainous area"/>
   <result pre="online at: https://www.wto.org/english/tratop_e/tpr_e/s285-00_e.pdf (accessed January 10, 2019). 17.BronsvoortBMDTanyaVNKitchingRPNfonCHammanSMMorganKL. Foot and" exact="mouth disease" post="and livestock husbandry practices in the Adamawa Province of"/>
   <result pre="Health Prod. (2003) 35:491–507. 10.1023/A:102730252530114690088 18.NfonCKMarszalPZhangSWeingartlHM. Innate immune response to" exact="rift valley fever" post="virus in goats. PLoS Negl Trop Dis. (2012) 6:e1623."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6706471\results\search\disease\results.xml">
   <result pre="Myerburg MM, Marr LC, Lakdawala SS. 2019. Environmental persistence of" exact="influenza" post="viruses is dependent upon virus type and host origin."/>
   <result pre="Creative Commons Attribution 4.0 International license.mSphere.00552-19.pdf The rapid spread of" exact="influenza" post="viruses (IV) from person to person during seasonal epidemics"/>
   <result pre="spread of IV in our environment. Abstract ABSTRACT Highly transmissible" exact="influenza" post="viruses (IV) must remain stable and infectious under a"/>
   <result pre="stationary droplets under a range of RH conditions. H3N2 and" exact="influenza" post="B virus (IBV) isolates are resistant to RH-dependent decay"/>
   <result pre="longevities of H1N1, H3N2, and IBV in droplets. Surprisingly, low-pathogenicity" exact="avian influenza" post="H6N1 and H9N2 viruses, which cause sporadic infections in"/>
   <result pre="of H1N1, H3N2, and IBV in droplets. Surprisingly, low-pathogenicity avian" exact="influenza" post="H6N1 and H9N2 viruses, which cause sporadic infections in"/>
   <result pre="virus type and host origin. IMPORTANCE The rapid spread of" exact="influenza" post="viruses (IV) from person to person during seasonal epidemics"/>
   <result pre="and spread of IV in our environment. KEYWORDS aerosols droplets" exact="influenza" post="virus persistence relative humidity Funding Tsinghua Education Foundation of"/>
   <result pre="(NIH)https://doi.org/10.13039/100000002 UL1-TR-001857 fig-count: table-count: equation-count: ref-count: page-count: word-count: INTRODUCTION Seasonal" exact="influenza" post="viruses (IV) cause yearly infection cycles that tend to"/>
   <result pre="the risk of transmission under different environmental conditions during an" exact="influenza" post="epidemic. Recurring epidemics are driven by cocirculation of human-pathogenic"/>
   <result pre="driven by cocirculation of human-pathogenic seasonal H1N1 and H3N2 subtype" exact="influenza" post="A viruses (IAV) and influenza B viruses (IBV), which"/>
   <result pre="seasonal H1N1 and H3N2 subtype influenza A viruses (IAV) and" exact="influenza" post="B viruses (IBV), which persist in the population despite"/>
   <result pre="(22). The impact of the environment on the seasonality of" exact="influenza" post="viruses in temperate climates is still poorly understood. One"/>
   <result pre="IV that are poorly transmissible in the human population. Low-pathogenicity" exact="avian influenza" post="(LPAI) viruses, including H6N1 and H9N2, have caused sporadic"/>
   <result pre="that are poorly transmissible in the human population. Low-pathogenicity avian" exact="influenza" post="(LPAI) viruses, including H6N1 and H9N2, have caused sporadic"/>
   <result pre="IBV is sensitive to RH-mediated decay in stationary droplets. Seasonal" exact="influenza" post="infections are caused by IAV subtypes H1N1 and H3N2"/>
   <result pre="we tested the stability of MDCK cell-propagated and HBE cell-propagated" exact="avian influenza" post="virus H6N1 (avH6N1) and avH9N2 strains in large droplets"/>
   <result pre="tested the stability of MDCK cell-propagated and HBE cell-propagated avian" exact="influenza" post="virus H6N1 (avH6N1) and avH9N2 strains in large droplets"/>
   <result pre="type (wt) (item number FR-458) and A/Brisbane/59/2007 (H1N1) FR-1 and" exact="influenza" post="B virus B/Texas/02/2013 (Victoria lineage, cell-derived, FR-1302) were obtained"/>
   <result pre="and Research, Food and Drug Administration (Silver Spring, MD). LPAI" exact="influenza" post="A viruses A/shorebird/DE Bay/230/2009 (H6N1) NR-45155 and A/shorebird/DE/127/2003 (H9N2)"/>
   <result pre="number UL1-TR-001857. References REFERENCES 1.TameriusJ, NelsonMI, ZhouSZ, ViboudC, MillerMA, AlonsoWJ2011Global" exact="influenza" post="seasonality: reconciling patterns across temperate and tropical regions. Environ"/>
   <result pre="doi:10.1073/pnas.1607747113.27799563 4.HemmesJH, KoolSM, WinklerKC1962Virus survival as a seasonal factor in" exact="influenza" post="and poliomyelitis. Antonie Van Leeuwenhoek28:221. doi:10.1007/BF02538737.13953681 5.MarrLC, TangJW, Van"/>
   <result pre="MullekomJ, LakdawalaSS2019Mechanistic insights into the effect of humidity on airborne" exact="influenza" post="virus survival, transmission and incidence. J R Soc Interface16:20180298."/>
   <result pre="TumpeyTM, MainesTR2015Environmental conditions affect exhalation of H3N2 seasonal and variant" exact="influenza" post="viruses and respiratory droplet transmission in ferrets. PLoS One10:e0125874."/>
   <result pre="tests with four viruses. J Hyg (Lond)59:479–486. doi:10.1017/s0022172400039176.13904777 10.HoodAM1963Infectivity of" exact="influenza" post="virus aerosols. J Hyg (Lond)61:331. doi:10.1017/s0022172400039619.14066589 11.NotiJD, BlachereFM, McMillenCM,"/>
   <result pre="LindsleyWG, KashonML, SlaughterDR, BeezholdDH2013High humidity leads to loss of infectious" exact="influenza" post="virus from simulated coughs. PLoS One8:e57485. doi:10.1371/journal.pone.0057485.23460865 12.SchafferFL, SoergelME,"/>
   <result pre="simulated coughs. PLoS One8:e57485. doi:10.1371/journal.pone.0057485.23460865 12.SchafferFL, SoergelME, StraubeDC1976Survival of airborne" exact="influenza" post="virus: effects of propagating host, relative humidity, and composition"/>
   <result pre="infections. III. Certain aspects of the behavior of type A" exact="influenza" post="virus as an air-borne cloud. J Infect Dis87:128–132. doi:10.1093/infdis/87.2.128.14774528"/>
   <result pre="J Infect Dis87:128–132. doi:10.1093/infdis/87.2.128.14774528 14.YangW, ElankumaranS, MarrLC2012Relationship between humidity and" exact="influenza" post="A viability in droplets and implications for influenza’s seasonality."/>
   <result pre="17.NturibiE, BhagwatAR, CoburnS, MyerburgMM, LakdawalaSS1292017, posting date. Intracellular colocalization of" exact="influenza" post="viral RNA and Rab11A is dependent upon microtubule filaments."/>
   <result pre="microtubule filaments. J Virol doi:10.1128/JVI.01179-17. 18.PetrovaVN, RussellCA2018The evolution of seasonal" exact="influenza" post="viruses. Nat Rev Microbiol16:60. doi:10.1038/nrmicro.2017.146.29109554 19.BarrIG, McCauleyJ, CoxN, DanielsR,"/>
   <result pre="Composition for 2009-2010. 2010Epidemiological, antigenic and genetic characteristics of seasonal" exact="influenza" post="A(H1N1), A(H3N2) and B influenza viruses: basis for the"/>
   <result pre="and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: basis for the WHO recommendation on the composition"/>
   <result pre="viruses: basis for the WHO recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 Northern Hemisphere season."/>
   <result pre="ViboudC, KoelleK, FerrariMJ, BhartiN, GrenfellBT2007Global patterns in seasonal activity of" exact="influenza" post="A/H3N2, A/H1N1, and B from 1997 to 2005: viral"/>
   <result pre="doi:10.1371/journal.pone.0001296.18074020 21.GoldsteinE, CobeyS, TakahashiS, MillerJC, LipsitchM2011Predicting the epidemic sizes of" exact="influenza" post="A/H1N1, A/H3N2, and B: a statistical method. PLoS Med8:e1001051."/>
   <result pre="LevyJ, UyekiTM, LeungGM, PeirisJS, ChotpitayasunondhT, NishiuraH, SimmermanJM2014Modes of transmission of" exact="influenza" post="B virus in households. PLoS One9:e108850. doi:10.1371/journal.pone.0108850.25268241 23.YuanRY, LiangLJ,"/>
   <result pre="WuJ, KangYF, SongYC, ZouLR, ZhangX, NiHZ, KeCW2017Human infection with an" exact="avian influenza" post="A/H9N2 virus in Guangdong in 2016. J Infect74:422–425. doi:10.1016/j.jinf.2017.01.003.28109675"/>
   <result pre="KangYF, SongYC, ZouLR, ZhangX, NiHZ, KeCW2017Human infection with an avian" exact="influenza" post="A/H9N2 virus in Guangdong in 2016. J Infect74:422–425. doi:10.1016/j.jinf.2017.01.003.28109675"/>
   <result pre="HuSX, ZhouSY, TangYL, XiangXY, LiFC, LiWC, GaoLD2015Human infection with an" exact="avian influenza" post="A (H9N2) virus in the middle region of China."/>
   <result pre="ZhouSY, TangYL, XiangXY, LiFC, LiWC, GaoLD2015Human infection with an avian" exact="influenza" post="A (H9N2) virus in the middle region of China."/>
   <result pre="LimW, WebsterRG, YuenKY, PeirisJSM, GuanY2005Human infection with an avian H9N2" exact="influenza" post="A virus in Hong Kong in 2003. J Clin"/>
   <result pre="LinMC, ChungWC, LiaoCH, LeeMS, HuangWT, ChenPJ, LiuMT, ChangFY2013Human infection with" exact="avian influenza" post="A H6N1 virus: an epidemiological analysis. Lancet Respir Med1:771–778."/>
   <result pre="ChungWC, LiaoCH, LeeMS, HuangWT, ChenPJ, LiuMT, ChangFY2013Human infection with avian" exact="influenza" post="A H6N1 virus: an epidemiological analysis. Lancet Respir Med1:771–778."/>
   <result pre="HerfstS, MurciaPR, RocheB, WilkeCO, RussellCA11112016, posting date. Viral factors in" exact="influenza" post="pandemic risk assessment. Elife doi:10.7554/eLife.18491. 28.DriskellEA, PickensJA, Humberd-SmithJ, GordyJT,"/>
   <result pre="PickensJA, Humberd-SmithJ, GordyJT, BradleyKC, SteinhauerDA, BerghausRD, StallknechtDE, HowerthEW, TompkinsSM2012Low pathogenic" exact="avian influenza" post="isolates from wild birds replicate and transmit via contact"/>
   <result pre="Humberd-SmithJ, GordyJT, BradleyKC, SteinhauerDA, BerghausRD, StallknechtDE, HowerthEW, TompkinsSM2012Low pathogenic avian" exact="influenza" post="isolates from wild birds replicate and transmit via contact"/>
   <result pre="PaulsonJC, BrockwellC, WebbyR, BlancoJ, Al-NatourMQ, PerezDR2008Replication and transmission of H9N2" exact="influenza" post="viruses in ferrets: evaluation of pandemic potential. PLoS One3:e2923."/>
   <result pre="PLoS One3:e2923. doi:10.1371/journal.pone.0002923.18698430 30.KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR2011Compatibility of H9N2" exact="avian influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="One3:e2923. doi:10.1371/journal.pone.0002923.18698430 30.KimbleJB, SorrellE, ShaoH, MartinPL, PerezDR2011Compatibility of H9N2 avian" exact="influenza" post="surface genes and 2009 pandemic H1N1 internal genes for"/>
   <result pre="the 20th century. Emerg Infect Dis12:9–14. doi:10.3201/eid1201.051254.16494710 32.NeumannG, KawaokaY2015Transmission of" exact="influenza" post="A viruses. Virology479–480:234–246. doi:10.1016/j.virol.2015.03.009. 33.FlemingDM, DurnallH, WarburtonF, EllisJS, ZambonMC2016Is"/>
   <result pre="Virology479–480:234–246. doi:10.1016/j.virol.2015.03.009. 33.FlemingDM, DurnallH, WarburtonF, EllisJS, ZambonMC2016Is the onset of" exact="influenza" post="in the community age-related?Epidemiol Infect144:2295–2305. doi:10.1017/S0950268816000510.27350234 34.RogersGN, PaulsonJC1983Receptor determinants"/>
   <result pre="age-related?Epidemiol Infect144:2295–2305. doi:10.1017/S0950268816000510.27350234 34.RogersGN, PaulsonJC1983Receptor determinants of human and animal" exact="influenza" post="virus isolates: differences in receptor specificity of the H3"/>
   <result pre="35.RogersGN, PaulsonJC, DanielsRS, SkehelJJ, WilsonIA, WileyDC1983Single amino acid substitutions in" exact="influenza" post="haemagglutinin change receptor binding specificity. Nature304:76–78. doi:10.1038/304076a0.6191220 36.LakdawalaSS, JayaramanA,"/>
   <result pre="soft palate is an important site of adaptation for transmissible" exact="influenza" post="viruses. Nature526:122. doi:10.1038/nature15379.26416728 37.BeanB, MooreBM, SternerB, PetersonLR, GerdingDN, BalfourHHJr.1982Survival"/>
   <result pre="viruses. Nature526:122. doi:10.1038/nature15379.26416728 37.BeanB, MooreBM, SternerB, PetersonLR, GerdingDN, BalfourHHJr.1982Survival of" exact="influenza" post="viruses on environmental surfaces. J Infect Dis146:47–51. doi:10.1093/infdis/146.1.47.6282993 38.ThomasY,"/>
   <result pre="doi:10.1093/infdis/146.1.47.6282993 38.ThomasY, VogelG, WunderliW, SuterP, WitschiM, KochD, TapparelC, KaiserL2008Survival of" exact="influenza" post="virus on banknotes. Appl Environ Microbiol74:3002–3007. doi:10.1128/AEM.00076-08.18359825 39.Pulit-PenalozaJA, BelserJA,"/>
   <result pre="banknotes. Appl Environ Microbiol74:3002–3007. doi:10.1128/AEM.00076-08.18359825 39.Pulit-PenalozaJA, BelserJA, TumpeyTM, MainesTR2019Swine-origin H1" exact="influenza" post="viruses isolated from humans exhibit sustained infectivity in an"/>
   <result pre="transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1" exact="influenza" post="virus. PLoS Pathog7:e1002443. doi:10.1371/journal.ppat.1002443.22241979 42.O’DonnellCD, VogelL, MatsuokaY, JinH, SubbaraoK2014The"/>
   <result pre="and thermal stability of the hemagglutinin of pandemic live attenuated" exact="influenza" post="virus vaccines. J Virol88:12374–12384. doi:10.1128/JVI.01107-14.25122789 43.RussierM, YangG, RehgJE, WongSS,"/>
   <result pre="FabrizioTP, BarmanS, KraussS, WebsterRG, WebbyRJ, RussellCJ2016Molecular requirements for a pandemic" exact="influenza" post="virus: an acid-stable hemagglutinin protein. Proc Natl Acad Sci"/>
   <result pre="WebbyRJ, PeirisM2011Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1" exact="influenza" post="virus in ferrets. Proc Natl Acad Sci U S"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6708098\results\search\disease\results.xml">
   <result pre="viruses were rhinovirus (7.2%), respiratory syncytial virus A (7.2%) and" exact="influenza" post="B virus (6%). Conclusion: This study was an important"/>
   <result pre="Our results indicated that rhinovirus, respiratory syncytial virus A and" exact="influenza" post="B virus are important viral pathogens causing respiratory infection"/>
   <result pre="known�? in this topic: Some previous studies reported that adenoviruses," exact="influenza" post="viruses, human rhinoviruses, and coronaviruses are the predominant viruses"/>
   <result pre="Human rhinovirus (7.2%), human respiratory syncytial virus A (7.2%), and" exact="influenza" post="B virus (6%) were the most frequently detected respiratory"/>
   <result pre="detected respiratory viruses in our study, followed by bocavirus (3%)," exact="influenza" post="A H1N1 (2.2%), influenza A H3N2 (1.5%), human respiratory"/>
   <result pre="our study, followed by bocavirus (3%), influenza A H1N1 (2.2%)," exact="influenza" post="A H3N2 (1.5%), human respiratory syncytial virus B (1.5%),"/>
   <result pre="viral transmission to newer cohorts (3). The higher vulnerability to" exact="respiratory disease" post="epidemics observed in military trainees has been attributed to"/>
   <result pre="and insomnia (4, 5). Numerous previous studies reported that adenoviruses," exact="influenza" post="A and B, human rhinoviruses, and coronaviruses are the"/>
   <result pre="predominant viruses detected in the military population. Outbreaks of adenovirus-associated" exact="respiratory disease" post="have been reported globally in the military environments (3,"/>
   <result pre="days prior to the onset of illness (8). Outbreaks of" exact="influenza" post="viruses A and B have also been associated with"/>
   <result pre="have also been associated with much morbidity and mortality, especially" exact="influenza" post="A (H1N1) pdm09 virus infection (9-13). It has been"/>
   <result pre="40 years) are amongst the major risk factors for acquiring" exact="influenza" post="infections (14). Human rhinoviruses are the most important causative"/>
   <result pre="Human rhinoviruses are the most important causative agents of the" exact="common cold" post="and associated with more complicated upper respiratory tract infections"/>
   <result pre="this study. Exclusion criteria were a prior history of chronic" exact="respiratory disease" post="such as asthma and chronic obstructive pulmonary disease (COPD),"/>
   <result pre="were a prior history of chronic respiratory disease such as" exact="asthma" post="and chronic obstructive pulmonary disease (COPD), recent antiviral therapy,"/>
   <result pre="prior history of chronic respiratory disease such as asthma and" exact="chronic obstructive pulmonary disease" post="(COPD), recent antiviral therapy, and military personnel. Those trainees"/>
   <result pre="(n=29; 7.2%), human respiratory syncytial virus A (n=29; 7.2%), and" exact="influenza" post="B virus (n=24; 6%) were the most frequently detected"/>
   <result pre="respiratory viruses in our study, followed by bocavirus (n=12; 3%)," exact="influenza" post="A H1N1 (n=9; 2.2%), influenza A H3N2 (n=6; 1.5%),"/>
   <result pre="followed by bocavirus (n=12; 3%), influenza A H1N1 (n=9; 2.2%)," exact="influenza" post="A H3N2 (n=6; 1.5%), human respiratory syncytial virus B"/>
   <result pre="1.5%), and human coronavirus 229E (n=3; 0.7%). Other viruses including" exact="influenza" post="C virus, human parainfluenza viruses, metapneumovirus, and echovirus have"/>
   <result pre="patients with respiratory syncytial viruses A and B, followed by" exact="influenza" post="B (n=2; 25%) and coronavirus 229E (n=1; 12.5%). Sore"/>
   <result pre="rhinovirus infection. The most cases of myalgia were seen in" exact="influenza" post="B (n=5; 62.5%) and influenza A H1N1 (n=3; 37.5%)"/>
   <result pre="of myalgia were seen in influenza B (n=5; 62.5%) and" exact="influenza" post="A H1N1 (n=3; 37.5%) infections, respectively (Table 1). Fig."/>
   <result pre="According to our results, rhinovirus, respiratory syncytial virus A, and" exact="influenza" post="B virus have been responsible for ~66% of viral"/>
   <result pre="infections among military trainees. Previous studies have shown that adenoviruses," exact="influenza" post="A and B viruses, human coronaviruses, rhinoviruses, and at"/>
   <result pre="British military recruits receiving basic training with respiratory symptoms, adenovirus," exact="influenza" post="viruses and respiratory syncytial virus were found in 35%,"/>
   <result pre="19% and 14%, respectively (33). It is notable that among" exact="influenza" post="viruses, influenza B was more associated with symptomatic infections,"/>
   <result pre="14%, respectively (33). It is notable that among influenza viruses," exact="influenza" post="B was more associated with symptomatic infections, which was"/>
   <result pre="and the most commonly detected viruses among FRI cases were" exact="influenza" post="A H1N1(13%), influenza B (13%), and coxsackievirus (9%). The"/>
   <result pre="commonly detected viruses among FRI cases were influenza A H1N1(13%)," exact="influenza" post="B (13%), and coxsackievirus (9%). The low prevalence of"/>
   <result pre="in compared with other viral infections. Our study revealed that" exact="influenza" post="viruses (particularly influenza B) also have an important role"/>
   <result pre="other viral infections. Our study revealed that influenza viruses (particularly" exact="influenza" post="B) also have an important role in causing respiratory"/>
   <result pre="military trainees. It may be explained by the fact that" exact="influenza" post="infection tends to occur in the winter, while adenovirus"/>
   <result pre="a military recruit settingJ Infect Dis200619478778516960774 8TateJEBunningMLLottLLuXSuJMetzgarDet al.Outbreak of severe" exact="respiratory disease" post="associated with emergent human adenovirus serotype 14 at a"/>
   <result pre="training facility in 2007J Infect Dis20091991014192619351260 9DuronSMayetALienhardFHaus-CheymolRVerretCVédySet al.The French Military" exact="influenza" post="surveillance system (MISS): overview of epidemiological and virological results"/>
   <result pre="system (MISS): overview of epidemiological and virological results during four" exact="influenza" post="seasons--2008-2012Swiss Med Wkly2013143w1384824089257 10MayetADuronSNivoixPHaus-CheymolRLigierCGacheKet al.Novel influenza A (H1N1) outbreak"/>
   <result pre="virological results during four influenza seasons--2008-2012Swiss Med Wkly2013143w1384824089257 10MayetADuronSNivoixPHaus-CheymolRLigierCGacheKet al.Novel" exact="influenza" post="A (H1N1) outbreak among French armed forces in 2009:"/>
   <result pre="2009: results of Military Influenza Surveillance SystemPublic health2011125849450021767855 11LiuPYWangLCLinYHTsaiCAShiZYOutbreak of" exact="influenza" post="A and B among military recruits: evidence from viral"/>
   <result pre="chain reactionJ Microbiol Immunol Infect20094221142119597642 12YapJTanCHCookARLohJPTambyahPATanBHet al.Differing clinical characteristics between" exact="influenza" post="strains among young healthy adults in the tropicsBMC Infect"/>
   <result pre="and clinical characteristicsBMC Infect Dis201414120424735158 14TarabboMLapaDCastillettiCTommaselliPGuarducciRLucàGet al.Retrospective investigation of an" exact="influenza" post="A/H1N1pdm outbreak in an Italian military ship cruising in"/>
   <result pre="Acute Respiratory Disease During 2010-2012 in Shiraz, IranArch Pediatr201422e15930 38BaratiMNoorbakhshSTabatabaeiATajFETalebi-TaherMAdenovirus," exact="influenza" post="virus A, B and respiratory syncitial virus infection in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6708702\results\search\disease\results.xml">
   <result pre="doi: 10.1097/CM9.0000000000000376 : Correspondence First outbreak of human infection with" exact="avian influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017 WangJing1JiangLi-Na1NingChuan-Yi2YangYi-Ping3ChenMin1ZhangChao1HeWei-Tao1TanYi1"/>
   <result pre="10.1097/CM9.0000000000000376 : Correspondence First outbreak of human infection with avian" exact="influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017 WangJing1JiangLi-Na1NingChuan-Yi2YangYi-Ping3ChenMin1ZhangChao1HeWei-Tao1TanYi1"/>
   <result pre="Content is available in the text To the Editor: Since" exact="avian influenza" post="A(H7N9) was first identified in Shanghai, China, in March"/>
   <result pre="is available in the text To the Editor: Since avian" exact="influenza" post="A(H7N9) was first identified in Shanghai, China, in March"/>
   <result pre="4.09% of cases (31/758) were infected with the highly pathogenic" exact="avian influenza" post="(HPAI) A(H7N9). This indicated that the pathotype of the"/>
   <result pre="of cases (31/758) were infected with the highly pathogenic avian" exact="influenza" post="(HPAI) A(H7N9). This indicated that the pathotype of the"/>
   <result pre="the pathotype of the A(H7N9) had switched from low pathogenic" exact="avian influenza" post="(LPAI) to HPAI. Guangxi is located in southwest China,"/>
   <result pre="pathotype of the A(H7N9) had switched from low pathogenic avian" exact="influenza" post="(LPAI) to HPAI. Guangxi is located in southwest China,"/>
   <result pre="of cases is also explored. The collection of data from" exact="influenza" post="A(H7N9) cases was decided to be a part of"/>
   <result pre="in the laboratory to test for A(H7N9). Active surveillance on" exact="avian influenza" post="was increased from February 2017 until the outbreak was"/>
   <result pre="the laboratory to test for A(H7N9). Active surveillance on avian" exact="influenza" post="was increased from February 2017 until the outbreak was"/>
   <result pre="and drinking water of poultry, were collected and tested for" exact="avian influenza" post="virus by the local CDC. Fisher exact test was"/>
   <result pre="drinking water of poultry, were collected and tested for avian" exact="influenza" post="virus by the local CDC. Fisher exact test was"/>
   <result pre="1]. We found a steep increase in the number of" exact="avian influenza" post="A(H7N9) cases between February 10 and March 21, 2017."/>
   <result pre="We found a steep increase in the number of avian" exact="influenza" post="A(H7N9) cases between February 10 and March 21, 2017."/>
   <result pre="this study, we described the prevalence of human infection with" exact="influenza" post="A(H7N9) in Guangxi during 2016 to 2017 season and"/>
   <result pre="which could lead to an increase in the risk of" exact="avian influenza" post="infection. This difference was mainly due to the fact"/>
   <result pre="could lead to an increase in the risk of avian" exact="influenza" post="infection. This difference was mainly due to the fact"/>
   <result pre="active environmental surveillance are critical in preventing and controlling future" exact="influenza" post="A(H7N9) epidemics. Underlying chronic conditions and delayed treatment accelerate"/>
   <result pre="He WT, Tan Y. First outbreak of human infection with" exact="avian influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017. Chin"/>
   <result pre="WT, Tan Y. First outbreak of human infection with avian" exact="influenza" post="A(H7N9) virus in Guangxi, China, 2016 to 2017. Chin"/>
   <result pre="Organization, 2017Available from: https://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1Accessed June 3, 2019. 2.WangXJiangHWuPUyekiTMFengLLaiSet al.Epidemiology of" exact="avian influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="2017Available from: https://www.who.int/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_10_30_2017.pdf?ua=1Accessed June 3, 2019. 2.WangXJiangHWuPUyekiTMFengLLaiSet al.Epidemiology of avian" exact="influenza" post="A H7N9 virus in human beings across five epidemics"/>
   <result pre="doi: 10.1016/S1473-3099(17)30323-7.28583578 3.KangMLauEHYGuanWYangYSongTCowlingBJet al.Epidemiology of human infections with highly pathogenic" exact="avian influenza" post="A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill2017;"/>
   <result pre="10.1016/S1473-3099(17)30323-7.28583578 3.KangMLauEHYGuanWYangYSongTCowlingBJet al.Epidemiology of human infections with highly pathogenic avian" exact="influenza" post="A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill2017;"/>
   <result pre="Euro Surveill2017; 22:30568doi: 10.2807/1560-7917.ES.2017.22.27.30568. 4.SunXBelserJAPappasCPulit-PenalozaJABrockNZengHet al.Risk assessment of fifth-wave H7N9" exact="influenza" post="A viruses in mammalian models. J Virol2018; 93:e01740–e1818. doi:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6709294\results\search\disease\results.xml">
   <result pre="commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0medi-98-e16401.pdf Abstract Abstract Viral" exact="hepatitis" post="is caused by different etiological agents with distinct epidemiological,"/>
   <result pre="factors pertaining to STIs. This article aims to present the" exact="hepatitis" post="B (hepatitis B surface antigen - HBsAg) and C"/>
   <result pre="and blood testing for syphilis, human immunodeficiency virus (HIV), and" exact="hepatitis" post="B and C. In total 38,247 conscripts were enrolled;"/>
   <result pre="Region (0.49%) and in the Central-west Region (0.65%), respectively. Regarding" exact="hepatitis" post="B vaccination, 23.5% (n = 8412) of the individuals reported being"/>
   <result pre="with steady partners. Our data suggest a low prevalence of" exact="hepatitis" post="B virus (HBV) and hepatitis C virus (HCV) infections"/>
   <result pre="suggest a low prevalence of hepatitis B virus (HBV) and" exact="hepatitis" post="C virus (HCV) infections among Brazilian young men, and"/>
   <result pre="HCV infections. To achieve the World Health Organization's goal of" exact="viral hepatitis" post="elimination, access to hepatitis information, testing, and surveillance need"/>
   <result pre="infections. To achieve the World Health Organization's goal of viral" exact="hepatitis" post="elimination, access to hepatitis information, testing, and surveillance need"/>
   <result pre="World Health Organization's goal of viral hepatitis elimination, access to" exact="hepatitis" post="information, testing, and surveillance need to be improved. Keywords"/>
   <result pre="and surveillance need to be improved. Keywords army Brazil conscripts" exact="hepatitis" post="prevalence sexual behavior young men 1 Introduction Viral hepatitis"/>
   <result pre="conscripts hepatitis prevalence sexual behavior young men 1 Introduction Viral" exact="hepatitis" post="is an infectious disease caused by different etiological agents"/>
   <result pre="sexual behavior young men 1 Introduction Viral hepatitis is an" exact="infectious disease" post="caused by different etiological agents that present distinct epidemiological,"/>
   <result pre="2015, an estimated 257 million people were living with chronic" exact="hepatitis" post="B virus (HBV) infection, and 71 million people with"/>
   <result pre="B virus (HBV) infection, and 71 million people with chronic" exact="hepatitis" post="C virus (HCV) infection.[1] From 1999 to 2017, 218,257"/>
   <result pre="cases have been reported in Brazil.[2] Worldwide, mortality due to" exact="hepatitis" post="B and C was comparable to that due to"/>
   <result pre="hepatitis B and C was comparable to that due to" exact="tuberculosis" post="and higher than that due to HIV.[1] In Brazil,"/>
   <result pre="to HCV infection are the leading cause of deaths among" exact="viral hepatitis" post="patients; the number of deaths due to this etiology"/>
   <result pre="HCV infection are the leading cause of deaths among viral" exact="hepatitis" post="patients; the number of deaths due to this etiology"/>
   <result pre="related to HBV have been reported.[2] The major modes of" exact="viral hepatitis" post="transmission include either mucous membrane contact or percutaneous exposure"/>
   <result pre="to HBV have been reported.[2] The major modes of viral" exact="hepatitis" post="transmission include either mucous membrane contact or percutaneous exposure"/>
   <result pre="use has become proportionately more important as a vector for" exact="viral hepatitis" post="transmission.[3,4] HCV and HBV infections can lead to chronic"/>
   <result pre="has become proportionately more important as a vector for viral" exact="hepatitis" post="transmission.[3,4] HCV and HBV infections can lead to chronic"/>
   <result pre="can lead to chronic hepatitis, cirrhosis, and the development of" exact="hepatocellular carcinoma" post="if patients are not diagnosed and do not receive"/>
   <result pre="direct-acting antivirals.[1] In both cases, an efficient response to the" exact="hepatitis" post="epidemics, especially the hepatitis C epidemic, requires a well-structured"/>
   <result pre="cases, an efficient response to the hepatitis epidemics, especially the" exact="hepatitis" post="C epidemic, requires a well-structured public health policy. For"/>
   <result pre="and risk factors pertaining to STIs. Assessment of knowledge about" exact="viral hepatitis" post="was included in the 6th edition of the serosurvey"/>
   <result pre="risk factors pertaining to STIs. Assessment of knowledge about viral" exact="hepatitis" post="was included in the 6th edition of the serosurvey"/>
   <result pre="in the overall population. This article aims to present the" exact="hepatitis" post="B (hepatitis B surface antigen - HBsAg) and C"/>
   <result pre="questionnaire and provided blood samples for Human Immunodeficiency Virus (HIV)," exact="hepatitis" post="B and C, and syphilis infection testing. The questionnaire"/>
   <result pre="for Human Immunodeficiency Virus (HIV), hepatitis B and C, and" exact="syphilis" post="infection testing. The questionnaire contained 74 questions and included"/>
   <result pre="ON, Canada). Specimens obtained from recruited conscripts were tested for" exact="hepatitis" post="B and C using the Elecsys HBsAg II (Roche"/>
   <result pre="be positive for anti-HCV and HBsAg by the manufacturer. All" exact="hepatitis" post="tests were performed according to the manufacturer's instructions by"/>
   <result pre="standard deviations (SD). P values &amp;lt; .05 were considered statistically significant. The" exact="hepatitis" post="B and C prevalence rates were expressed with a"/>
   <result pre="simultaneously HBsAg and anti-HCV positive. Table 1 Estimated seroprevalence of" exact="hepatitis" post="B surface antigen and anti-hepatitis C virus antibodies among"/>
   <result pre="any partner. Table 2 Risk factors associated with a positive" exact="hepatitis" post="B surface antigen and anti-hepatitis C virus antibody test"/>
   <result pre="C virus antibody test result among Brazilian conscripts, 2016. Regarding" exact="hepatitis" post="B vaccination, 23.5% (n = 8,412) of the individuals reported being"/>
   <result pre="as part of the public health system. 3.4 Knowledge about" exact="hepatitis" post="transmission Table 3 presents the results of the questions"/>
   <result pre="the results of the questions which verified the knowledge about" exact="hepatitis" post="transmission according to the serological status for hepatitis B"/>
   <result pre="knowledge about hepatitis transmission according to the serological status for" exact="hepatitis" post="B and C. In the anti-HCV positive group, it"/>
   <result pre="group, it is noteworthy that most of conscripts answered that" exact="hepatitis" post="cannot be transmitted by sexual relations (n = 69, 0.47%, P = .038),"/>
   <result pre="in the HBsAg-positive group, most of the conscripts answered that" exact="hepatitis" post="cannot be transmitted when receiving dental care, endoscopy, or"/>
   <result pre="hemodialysis (n = 68, 0.25%, P = .026). Table 3 Association between knowledge about" exact="hepatitis" post="transmission and a positive hepatitis B surface antigen and"/>
   <result pre="3 Association between knowledge about hepatitis transmission and a positive" exact="hepatitis" post="B surface antigen and anti-hepatitis C virus antibody test"/>
   <result pre="Brazilian conscripts, 2016. 4 Discussion Since 2003, all cases of" exact="viral hepatitis" post="detected in Brazil are subject to compulsory notification on"/>
   <result pre="conscripts, 2016. 4 Discussion Since 2003, all cases of viral" exact="hepatitis" post="detected in Brazil are subject to compulsory notification on"/>
   <result pre="(WHO, 2016). The goal of the strategy is to eliminate" exact="viral hepatitis" post="as a major public health challenge by 2030.[10] Brazil"/>
   <result pre="2016). The goal of the strategy is to eliminate viral" exact="hepatitis" post="as a major public health challenge by 2030.[10] Brazil"/>
   <result pre="goals. One of the action plans involves estimating cases of" exact="hepatitis" post="at the national level, based on epidemiological data.[2] The"/>
   <result pre="army male conscripts at the national level. The WHO classifies" exact="hepatitis" post="endemicity according to the prevalence of the HBsAg, and"/>
   <result pre="or present infection, respectively.[3,4] Currently, Brazil has intermediate to low" exact="hepatitis" post="endemicity depending on the region, state, and city.[11] We"/>
   <result pre="a systematic review performed by Schweitzer et al showed a" exact="hepatitis" post="B seroprevalence rate of 0.65% for both sexes in"/>
   <result pre="risk factors assessed in our study are well-described predictors[3,4] for" exact="viral hepatitis," post="we did not observe such association among Brazilian conscripts."/>
   <result pre="number of sexual partners and positivity of serologic markers of" exact="hepatitis" post="B and other STIs has often been reported in"/>
   <result pre="of transmission of these infections in 2017.[2] Sexual transmission of" exact="viral hepatitis" post="B plays a major role in the spread of"/>
   <result pre="transmission of these infections in 2017.[2] Sexual transmission of viral" exact="hepatitis" post="B plays a major role in the spread of"/>
   <result pre="B plays a major role in the spread of the" exact="hepatitis" post="B epidemic, whereas sexual transmission of viral hepatitis C,"/>
   <result pre="spread of the hepatitis B epidemic, whereas sexual transmission of" exact="viral hepatitis" post="C, although possible, is much less common. Special attention"/>
   <result pre="of the hepatitis B epidemic, whereas sexual transmission of viral" exact="hepatitis" post="C, although possible, is much less common. Special attention"/>
   <result pre="populations such as men who have not been vaccinated against" exact="hepatitis" post="B virus and heterosexual persons with multiple sexual partners."/>
   <result pre="correctly using male and female condoms, offer powerful protection against" exact="viral hepatitis" post="B and C and a wide range of other"/>
   <result pre="using male and female condoms, offer powerful protection against viral" exact="hepatitis" post="B and C and a wide range of other"/>
   <result pre="currently available safe and effective vaccines. The main objective of" exact="hepatitis" post="B immunization strategies is to prevent chronic infection and"/>
   <result pre="is to prevent chronic infection and its consequences, including liver" exact="cirrhosis" post="and hepatocellular carcinoma. According to the WHO, the complete"/>
   <result pre="prevent chronic infection and its consequences, including liver cirrhosis and" exact="hepatocellular carcinoma." post="According to the WHO, the complete vaccine series induces"/>
   <result pre="n = 10,388) of the conscripts self-reported that they have received the" exact="hepatitis" post="B vaccine. In Brazil, hepatitis B vaccination was incorporated"/>
   <result pre="that they have received the hepatitis B vaccine. In Brazil," exact="hepatitis" post="B vaccination was incorporated into the national immunization program"/>
   <result pre="expected that a higher proportion of participants had reported receiving" exact="hepatitis" post="B vaccination; however, due to the young age at"/>
   <result pre="is approximately 55% to 60%, based on serological evidence of" exact="hepatitis" post="B immunization (anti-HBs titers above 10 UI/L and a negative"/>
   <result pre="anti-hepatitis B core antigen (anti-HBc) status).[18] Other studies reported that" exact="hepatitis" post="B vaccination coverage among military personnel in the Southeast"/>
   <result pre="South regions of Brazil is between 57% and 70%.[13,19] Regarding" exact="hepatitis" post="C, as there is no vaccine currently available, primary"/>
   <result pre="studies have already demonstrated a low level of knowledge about" exact="viral hepatitis," post="suggesting the need for strategies to increase access to"/>
   <result pre="as awareness campaigns targeted towards this population.[22,23] Early diagnosis of" exact="hepatitis" post="infections is critical for effective treatment and care. The"/>
   <result pre="HCV infections. In order to achieve the goal of eliminating" exact="viral hepatitis," post="efforts to improve access to HCV and HBV information,"/>
   <result pre="of Health Surveillance, Ministry of Health of Brazil, HBV =" exact="hepatitis" post="B virus, HCV = hepatitis C virus, HIV ="/>
   <result pre="Health of Brazil, HBV = hepatitis B virus, HCV =" exact="hepatitis" post="C virus, HIV = human immunodeficiency virus, MSM= men"/>
   <result pre="at: https://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2018/en/[Acessed May 14, 2019]. [5]MastEEAlterMJMargolisHSStrategies to prevent and control" exact="hepatitis" post="B and C virus infections: a global perspective. Vaccine1999;17:1730–3.10194830"/>
   <result pre="a nationwide cross-sectional survey of prevalence and epidemiological patterns of" exact="hepatitis" post="A, B and C infection in Brazil. Cad Saude"/>
   <result pre="Available at: https://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/[Acessed December 12, 2018]. [11]PereiraVRZBWolfJMLuzCAet al.Risk factors for" exact="hepatitis" post="B transmission in south Brazil. Mem Inst Oswaldo Cruz2017;112:544–50.28767979"/>
   <result pre="Inst Oswaldo Cruz2017;112:544–50.28767979 [12]SchweitzerAHornJMikolajczykRTet al.Estimations of worldwide prevalence of chronic" exact="hepatitis" post="B virus infection: a systematic review of data published"/>
   <result pre="published between 1965 and 2013. Lancet2015;386:1546–55.26231459 [13]VillarLMdo ÓKMRScalioniLPet al.Prevalence of" exact="hepatitis" post="B and C virus infections among military personnel. Braz"/>
   <result pre="cross-sectional study. BMC Infect Dis2013;13:60.23374914 [15]XimenesRAAFigueiredoGMCardosoMRAet al.Population-based multicentric survey of" exact="hepatitis" post="B infection and risk factors in the North, South,"/>
   <result pre="Hyg2015;93:1341–8.26503280 [16]collab: World Health Organization. Global health sector strategy on" exact="viral hepatitis" post="2016–2021. Glob Hepat Program Dep HIV/AIDS. 2016; (June):56. Available"/>
   <result pre="[16]collab: World Health Organization. Global health sector strategy on viral" exact="hepatitis" post="2016–2021. Glob Hepat Program Dep HIV/AIDS. 2016; (June):56. Available"/>
   <result pre="Saúde; 2013. Available at: http://bvsms.saude.gov.br/bvs/publicacoes/programa_nacional_imunizacoes_pni40.pdf[Acessed January 7, 2019]. [18]SoutoFJDDistribution of" exact="hepatitis" post="B infection in Brazil: the epidemiological situation at the"/>
   <result pre="https://www.who.int/hiv/pub/hepatitis/Framework/en/[Acessed January 8, 2019]. [22]CruzHMBarbosaJRBaima ColaresJKet al.Cross-sectional study to determine" exact="viral hepatitis" post="knowledge in different urban populations in Brazil. World J"/>
   <result pre="January 8, 2019]. [22]CruzHMBarbosaJRBaima ColaresJKet al.Cross-sectional study to determine viral" exact="hepatitis" post="knowledge in different urban populations in Brazil. World J"/>
   <result pre="populations in Brazil. World J Hepatol2018;10:867–76.30533187 [23]de OliveiraSBSabidóMPascomARPet al.State of" exact="viral hepatitis" post="knowledge and testing uptake in Brazil: findings from the"/>
   <result pre="in Brazil. World J Hepatol2018;10:867–76.30533187 [23]de OliveiraSBSabidóMPascomARPet al.State of viral" exact="hepatitis" post="knowledge and testing uptake in Brazil: findings from the"/>
   <result pre="http://www.aids.gov.br/pt-br/pub/2015/manualtecnicopara-o-diagnostico-das-hepatites-virais[Accessed January 17, 2019]. [25]LaiKKYJinMYuanSet al.Improved reflexive testing algorithm for" exact="hepatitis" post="C infection using signal-to-cutoff ratios of a hepatitis C"/>
   <result pre="algorithm for hepatitis C infection using signal-to-cutoff ratios of a" exact="hepatitis" post="C virus antibody assay. Clin Chem2011;57:1050–6.21566071 [26]Granados-GarcíaVContrerasAMGarcía-PeñaCet al.Cost-effectiveness analysis"/>
   <result pre="of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for" exact="hepatitis" post="C virus infection. J Infect Dev Ctries2016;10:1031–4.27694738"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6710328\results\search\disease\results.xml">
   <result pre="pillars in the development of virology, comprising poliovirus, rhinovirus, and" exact="hepatitis" post="A virus. Picornavirus infectious particles use the fecal–oral or"/>
   <result pre="the fecal–oral route (Yin-Murphy and Almond, 1996). RVs cause the" exact="common cold," post="the most prevalent infectious disease worldwide, resulting in uncountable"/>
   <result pre="Almond, 1996). RVs cause the common cold, the most prevalent" exact="infectious disease" post="worldwide, resulting in uncountable lost days from school and"/>
   <result pre="also have been proposed to be decoy particles for the" exact="hepatitis" post="B virus (Rydell et al., 2017). Several picornavirus procapsids"/>
   <result pre="receptor engagement in the evolution of a pandemic acute hemorrhagic" exact="conjunctivitis" post="virus. Proc. Natl. Acad. Sci. U.S.A.115, 397–402. 10.1073/pnas.171328411529284752 BaltimoreD."/>
   <result pre="Sci. U.S.A.114, 8017–8022. 10.1073/pnas.170736911428696310 DrysdaleS. B.MejiasA.RamiloO. (2017). Rhinovirus—not just the" exact="common cold." post="J. Infect.74(Suppl. 1), S41–S46. 10.1016/S0163-4453(17)30190-128646961 EggersH. J. (1999). Milestones"/>
   <result pre="Infect.74(Suppl. 1), S41–S46. 10.1016/S0163-4453(17)30190-128646961 EggersH. J. (1999). Milestones in early" exact="poliomyelitis" post="research (1840 to 1949). J. Virol.73, 4533–4535. 10233910 EggersH."/>
   <result pre="F.WellerT. H.RobbinsF. C. (1949). Cultivation of the Lansing strain of" exact="poliomyelitis" post="virus in cultures of various human embryonic tissues. Science109,"/>
   <result pre="Allergy Clin. Immunol.126, 120–126. 10.1016/j.jaci.2010.04.01620541246 KirkegaardK. (2017). Unconventional secretion of" exact="hepatitis" post="A virus. Proc. Natl. Acad. Sci. U. S.A. 114,"/>
   <result pre="J. Virol.86, 13062–13069. 10.1128/JVI.01033-1223015694 LiJ.WangJ.XuC.YinQ.HuM.SunZ.et al.. (2017). Hand, foot, and" exact="mouth disease" post="in Mainland China before it was listed as category"/>
   <result pre="Chem.291, 13999–14011. 10.1074/jbc.M116.72659627137934 McKinneyR. E.KatzS. L.WilfertC. M. (1987). Chronic enteroviral" exact="meningoencephalitis" post="in agammaglobulinemic patients. Clin. Infect. Dis.9, 334–356. 10.1093/clinids/9.2.3343296100 McLeishN."/>
   <result pre="G.ArnoldE.EricksonJ. W.FrankenbergerE. A.GriffithJ. P.HechtH.-J.et al.. (1985). Structure of a human" exact="common cold" post="virus and functional relationship to other picornaviruses. Nature317, 145–153."/>
   <result pre="subviral particles reduces the neutralizing effect of anti-HBs antibodies on" exact="hepatitis" post="B viral particles in vitro. Virology509, 67–70. 10.1016/j.virol.2017.05.01728605637 SabinA."/>
   <result pre="of monoclonal antibodies to identify four neutralization immunogens on a" exact="common cold" post="picornavirus, human rhinovirus 14. J. Virol.57, 246–257. 2416951 ShinglerK."/>
   <result pre="canyon. Nature383, 350–354. 10.1038/383350a08848050 StapletonJ. T. (1992). Passive immunization against" exact="hepatitis" post="A. Vaccine10, S45–S47. 10.1016/0264-410X(92)90541-Q1335658 StapletonJ. T.LemonS. M. (1987). Neutralization"/>
   <result pre="Neutralization escape mutants define a dominant immunogenic neutralization site on" exact="hepatitis" post="A virus. J. Virol.61, 491–498. 2433464 StauntonD. E.MerluzziV. J.RothleinR.BartonR.MarlinS."/>
   <result pre="population. Nature439, 344–348. 10.1038/nature0438816327776 WangX.ZhuL.DangM.HuZ.GaoQ.YuanS.et al.. (2017). Potent neutralization of" exact="hepatitis" post="A virus reveals a receptor mimic mechanism and the"/>
   <result pre="al.. (2015). Phylogenetic analysis of the major causative agents of" exact="hand, foot and mouth disease" post="in Suzhou city, Jiangsu province, China, in 2012–2013. Emerg."/>
   <result pre="analysis of the major causative agents of hand, foot and" exact="mouth disease" post="in Suzhou city, Jiangsu province, China, in 2012–2013. Emerg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711296\results\search\disease\results.xml">
   <result pre="that serve as endemic hosts, resistant hosts or hosts supporting" exact="stuttering" post="chains of transmission [13,14]. Bats may also be critical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711302\results\search\disease\results.xml">
   <result pre="recent epidemics (e.g. Ebola virus [5]) and pandemics (e.g. H1N1" exact="influenza" post="virus [6]); however, we emphasize the general methods and"/>
   <result pre="spatial and temporal resolution. The authors use case studies of" exact="brucellosis" post="in the Greater Yellowstone Ecosystem [13] and of avian"/>
   <result pre="of brucellosis in the Greater Yellowstone Ecosystem [13] and of" exact="avian influenza" post="virus in China and North America [14] to emphasize"/>
   <result pre="brucellosis in the Greater Yellowstone Ecosystem [13] and of avian" exact="influenza" post="virus in China and North America [14] to emphasize"/>
   <result pre="cross-species transmission [9]. The authors focus their case study on" exact="yellow fever," post="a mosquito-borne viral disease of historical importance in South"/>
   <result pre="authors focus their case study on yellow fever, a mosquito-borne" exact="viral disease" post="of historical importance in South America that persists in"/>
   <result pre="and immunological data from Brazil across 16 years to predict" exact="yellow fever" post="spillover in humans. The authors show that a mechanistic"/>
   <result pre="at some spatial and temporal resolution (e.g., spatio-temporal counts of" exact="yellow fever" post="spillovers [15]). The authors show how modelling cross-species transmission"/>
   <result pre="the host in the environment [9]. For pathogens such as" exact="avian influenza" post="virus, persistence in the environment (e.g. ponds) can also"/>
   <result pre="host in the environment [9]. For pathogens such as avian" exact="influenza" post="virus, persistence in the environment (e.g. ponds) can also"/>
   <result pre="reservoirs. Although no gold standard for capturing, isolating and identifying" exact="avian influenza" post="virus diversity from the environment exists, environmental metagenomics and"/>
   <result pre="Although no gold standard for capturing, isolating and identifying avian" exact="influenza" post="virus diversity from the environment exists, environmental metagenomics and"/>
   <result pre="to highlight challenges and opportunities arising at the intersection of" exact="infectious disease" post="ecology, microbial risk assessment and virology. Lunn et al."/>
   <result pre="to cause epidemics or pandemics in the new host species:" exact="influenza" post="A viruses [43], human immunodeficiency virus [44] and canine"/>
   <result pre="at the human-wildlife-environment interface. In The connections between ecology and" exact="infectious disease" post="(ed. HurstCJ), pp. 267–298. Cham, Switzerland: Springer International Publishing."/>
   <result pre="(10.3201/eid2206.160021)27070842 6NeumannG, NodaT, KawaokaY2009Emergence and pandemic potential of swine-origin H1N1" exact="influenza" post="virus. Nature459, 931–939. (10.1038/nature08157)19525932 7CassirerEFet al.2018Pneumonia in bighorn sheep:"/>
   <result pre="MerkleJA, GudeJA, CrossPC2019Modeling elk-to-livestock transmission risk to predict hotspots of" exact="brucellosis" post="spillover. J. Wildl. Manage.83, 817–829. (10.1002/jwmg.21645) 9PlowrightRK, ParrishCR, McCallumH,"/>
   <result pre="DobsonAP, EdwardsWH, HamlinKL, LuikartG, MiddletonAD, ScurlockBM, WhitePJ2010Probable causes of increasing" exact="brucellosis" post="in free-ranging elk of the Greater Yellowstone Ecosystem. Ecol."/>
   <result pre="Yellowstone Ecosystem. Ecol. Appl.20, 278–288. (10.1890/08-2062.1)20349847 14LiuJet al.2005Highly pathogenic H5N1" exact="influenza" post="virus infection in migratory birds. Science309, 1206 (10.1126/science.1115273)16000410 15ChildsML,"/>
   <result pre="NovaN, ColvinJ, MordecaiEA2019Mosquito and primate ecology predict human risk of" exact="yellow fever" post="virus spillover in Brazil. Phil. Trans. R. Soc. B374,"/>
   <result pre="Soc. B374, 20180335 (10.1098/rstb.2018.0335)31401964 16FariaNRet al.2018Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science361, 894–899. (10.1126/science.aat7115)30139911 17WashburneAD, CrowleyDE, BeckerDJ,"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virus. Infect. Genet. Evol.19, 292–311. (10.1016/j.meegid.2013.03.008)23523817 21PlowrightRK, PeelAJ, StreickerDG,"/>
   <result pre="26BrebanR, DrakeJM, StallknechtDE, RohaniP2009The role of environmental transmission in recurrent" exact="avian influenza" post="epidemics. PLoS Comput. Biol.5, e1000346 (10.1371/journal.pcbi.1000346)19360126 27RocheB, DrakeJM, BrownJ,"/>
   <result pre="DrakeJM, StallknechtDE, RohaniP2009The role of environmental transmission in recurrent avian" exact="influenza" post="epidemics. PLoS Comput. Biol.5, e1000346 (10.1371/journal.pcbi.1000346)19360126 27RocheB, DrakeJM, BrownJ,"/>
   <result pre="RohaniP2014Adaptive evolution and environmental durability jointly structure phylodynamic patterns in" exact="avian influenza" post="viruses. PLoS Biol.12, e1001931 (10.1371/journal.pbio.1001931)25116957 28PepinKM, HopkenMW, ShrinerSA, SpackmanE,"/>
   <result pre="evolution and environmental durability jointly structure phylodynamic patterns in avian" exact="influenza" post="viruses. PLoS Biol.12, e1001931 (10.1371/journal.pbio.1001931)25116957 28PepinKM, HopkenMW, ShrinerSA, SpackmanE,"/>
   <result pre="RileyS, Lloyd-SmithJO, PiaggioAJ2019Improving risk assessment of the emergence of novel" exact="influenza" post="A viruses by incorporating environmental surveillance. Phil. Trans. R."/>
   <result pre="20180346 (10.1098/rstb.2018.0346)31401963 29KellerMWet al.2018Direct RNA sequencing of the coding complete" exact="influenza" post="A virus genome. Sci. Rep.8, 14408 (10.1038/s41598-018-32615-8)30258076 30RosarioK, NilssonC,"/>
   <result pre="20190017 (10.1098/rstb.2019.0017)31401954 43LongJS, MistryB, HaslamSM, BarclayWS2019Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat. Rev. Microbiol.17, 67–81. (10.1038/s41579-018-0115-z)30487536"/>
   <result pre="R. Soc. B374, 20180342 (10.1098/rstb.2018.0342)31401951 61SokolowSHet al.2015Reduced transmission of human" exact="schistosomiasis" post="after restoration of a native river prawn that preys"/>
   <result pre="CoxJ, DrakeleyCJ, FergusonHM, KaoRR2019Predictive analysis across spatial scales links zoonotic" exact="malaria" post="to deforestation. Proc. R. Soc. B286, 20182351 (10.1098/rspb.2018.2351)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711306\results\search\disease\results.xml">
   <result pre="Research Article Mosquito and primate ecology predict human risk of" exact="yellow fever" post="virus spillover in Brazil Yellow fever spillover in Brazil"/>
   <result pre="spillover is an important public health goal. In the Americas," exact="yellow fever" post="in humans primarily occurs following spillover from non-human primates"/>
   <result pre="primarily occurs following spillover from non-human primates via mosquitoes. Predicting" exact="yellow fever" post="spillover can improve public health responses through vector control"/>
   <result pre="mechanistic model of pathogen spillover to predict human risk for" exact="yellow fever" post="in Brazil. This environmental risk model, based on the"/>
   <result pre="of mosquito vectors and non-human primate hosts, distinguished municipality-months with" exact="yellow fever" post="spillover from 2001 to 2016 with high accuracy (AUC"/>
   <result pre="accuracy, suggesting the potential to improve preventive action to reduce" exact="yellow fever" post="spillover and avert onward epidemics in humans. This article"/>
   <result pre="pathogen spillover’. Brazil disease ecology mosquito pathogen spillover vector-borne disease" exact="yellow fever" post="Funding Lindsay Family E-IPER Fellowship Hellman Foundationhttp://dx.doi.org/10.13039/100010336 Stanford University"/>
   <result pre="respiratory syndrome (SARS), influenza, Plasmodium knowlesi and other primate malarias," exact="yellow fever" post="and leptospirosis—arise from spillover of pathogens from wildlife or"/>
   <result pre="cycle between humans and Aedes aegypti mosquitoes [9]. Spillover of" exact="yellow fever" post="requires the virus to be transmitted locally, mosquito vectors"/>
   <result pre="immune dynamics to align in space and time. In humans," exact="yellow fever" post="is the most severe vector-borne virus circulating in the"/>
   <result pre="severe cases of 47% [13]. While no urban transmission of" exact="yellow fever" post="has occurred in the Americas since 1997 [14] and"/>
   <result pre="most recently in areas previously believed to be free of" exact="yellow fever." post="Prior statistical models have found climate and weather (including"/>
   <result pre="to be predictive of the spatial and spatio-temporal distribution of" exact="yellow fever" post="[6,8]. We build on previous efforts by incorporating a"/>
   <result pre="mechanistic understanding of how ecological and human population factors affect" exact="yellow fever" post="transmission and spillover. A mechanistic model allows known relationships"/>
   <result pre="to identify other regions where conditions are also suitable for" exact="yellow fever" post="spillover. We use a mechanistic model encapsulating sylvatic yellow"/>
   <result pre="yellow fever spillover. We use a mechanistic model encapsulating sylvatic" exact="yellow fever" post="ecology to predict the spatial and temporal distribution of"/>
   <result pre="fever ecology to predict the spatial and temporal distribution of" exact="yellow fever" post="spillover in Brazil, and we test the model on"/>
   <result pre="spillover in Brazil, and we test the model on human" exact="yellow fever" post="case data using a receiver operating characteristic curve and"/>
   <result pre="transmission—together termed environmental risk—predict geographical, seasonal and interannual variation in" exact="yellow fever" post="virus spillover into humans? (2) Are human population size"/>
   <result pre="predict spillover in other parts of Brazil predict the recent" exact="yellow fever" post="outbreak in the Southeast region of Brazil in 2016–2018,"/>
   <result pre="Methods Our goals were (1) to construct mechanistic estimates of" exact="yellow fever" post="spillover risk over space and time, (2) to test"/>
   <result pre="to test these mechanistic risk models against observed cases of" exact="yellow fever" post="spillover to humans and (3) to statistically test for"/>
   <result pre="Methods: Spillover model (§2a)). We then predicted monthly risk of" exact="yellow fever" post="spillover from the component submodels for each 1 km"/>
   <result pre="covariates to identify the traits of municipalities and months when" exact="yellow fever" post="spillover occurred using the available human case data from"/>
   <result pre="a mechanistic spillover model to predict four risk metrics of" exact="yellow fever" post="in humans: periodic disease risk, environmental disease risk, immunological"/>
   <result pre="mosquito that took an infectious blood meal becomes infectious with" exact="yellow fever" post="virus given a temperature T ( x , t"/>
   <result pre="data (see Methods: Phenomenological primate dynamics (§2c)). We hypothesized that" exact="yellow fever" post="spillover could be limited by environmental conditions, human susceptibility,"/>
   <result pre="compare their relative importance, we defined four metrics of model-predicted" exact="yellow fever" post="spillover risk. First, we approximated environmental risk (equation (2.1),"/>
   <result pre="estimated proportion of the human population that is susceptible to" exact="yellow fever" post="(figure 2i), using previously estimated vaccine coverage rates [18]."/>
   <result pre="dynamics and susceptibility have been suggested as important constraints on" exact="yellow fever" post="spillover [19], which remain poorly characterized. In the absence"/>
   <result pre="This is the only mechanistic submodel that uses the human" exact="yellow fever" post="spillover data directly—all other submodels are independent of human"/>
   <result pre="infection data. For this submodel, we used human cases of" exact="yellow fever" post="reported by month of first symptoms and municipality of"/>
   <result pre="as one in which at least one human case of" exact="yellow fever" post="occurred. As an estimate of reservoir infection dynamics, we"/>
   <result pre="model predictions for spillover risk with observed human cases of" exact="yellow fever" post="spillover using a statistical model. We limited the comparison"/>
   <result pre="means and maxima for all four risk metrics with human" exact="yellow fever" post="data for model evaluation in the following three ways."/>
   <result pre="and estimated vaccine coverage, we regressed the number of reported" exact="yellow fever" post="cases given that spillover occurred, and calculated Spearman's rank"/>
   <result pre="relationship to environmental and human population covariates. As predictors of" exact="yellow fever" post="spillover in the boosted regression tree, we included the"/>
   <result pre="response variable is the binary indicator of whether or not" exact="yellow fever" post="spillover occurred in a municipality-month (see Methods: Model–data comparison"/>
   <result pre="[126], which has previously been shown to be predictive of" exact="yellow fever" post="spillover [8]. We also included vaccine coverage and human"/>
   <result pre="and virus ecology compose an estimate of environmental risk of" exact="yellow fever" post="spillover (electronic supplementary material, file S2). The environmental risk"/>
   <result pre="file S2). The environmental risk model strongly predicted episodes of" exact="yellow fever" post="spillover into humans (AUC = 0.72) and adding phenomenological"/>
   <result pre="in the spatial distribution of spillover; regions known to experience" exact="yellow fever" post="spillover are likely to have high vaccination rates, while"/>
   <result pre="spillovers are shown (red points), defined as municipality-months with human" exact="yellow fever" post="cases. Red points show the date of spillover (x-axis)"/>
   <result pre="and humans, and vector dispersal, survival, infectiousness and seasonal abundance—predicts" exact="yellow fever" post="spillover into humans with high accuracy (AUC = 0.72;"/>
   <result pre="land cover information alone, including phenomenologically modelled variation in primate" exact="yellow fever" post="infection prevalence improved predictions of year-to-year variation in spillover"/>
   <result pre="regions of Brazil and find Southeast Brazil seasonally suitable for" exact="yellow fever" post="spillover. Our mechanistic model further illustrates that this differing"/>
   <result pre="by rainfall. Given the importance of vaccination campaigns in limiting" exact="yellow fever" post="outbreaks, we expected that the number of susceptible (unvaccinated)"/>
   <result pre="susceptible (unvaccinated) people would be an important positive predictor of" exact="yellow fever" post="spillover occurrence, yet mechanistic population-scaled risk performed worse at"/>
   <result pre="a significant predictor of the number of human cases of" exact="yellow fever" post="given that spillover occurred (electronic supplementary material, table S5)."/>
   <result pre="in Brazil are used to detect non-human primate cases of" exact="yellow fever" post="as an advanced warning system [134]. While this advanced"/>
   <result pre="surveillance data, could help to indicate when primate cases of" exact="yellow fever" post="are likely, to provide additional time for public health"/>
   <result pre="significant and potentially very fruitful gap in our understanding of" exact="yellow fever" post="transmission and spillover. Vector–human contact rates are another important"/>
   <result pre="[136]. The wealth of existing knowledge about the ecology of" exact="yellow fever" post="virus and its sylvatic reservoir hosts and vectors allowed"/>
   <result pre="Americas and presently in other regions such as sub-Saharan Africa," exact="yellow fever" post="regularly has entered urban transmission cycles that lead to"/>
   <result pre="other flaviviruses, to ask intriguing questions such as: What prevents" exact="yellow fever" post="from entering urban transmission cycles in the Americas, where"/>
   <result pre="recently in Africa and not in South America? What prevents" exact="yellow fever" post="circulation and spillover in Southeast Asia, where sylvatic vectors"/>
   <result pre="VilcaLM, UrionaS, SchneiderMC2017Geographic patterns and environmental factors associated with human" exact="yellow fever" post="presence in the Americas. PLoS Negl. Trop. Dis.11, e5897"/>
   <result pre="Dis.23, 415–422. (10.3201/eid2303.160101)28221131 8KaulRB, EvansMV, MurdockCC, DrakeJM2018Spatio-temporal spillover risk of" exact="yellow fever" post="in Brazil. Parasit. Vectors11, 488 (10.1186/s13071-018-3063-6)30157908 9MonathTP, VasconcelosPFC2015Yellow fever."/>
   <result pre="J. Med.376, 1397–1399. (10.1056/NEJMp1002530)28273000 11FariaNRet al.2018Genomic and epidemiological monitoring of" exact="yellow fever" post="virus transmission potential. Science361, 894–899. (10.1126/science.aat7115)30139911 12HanleyKA, MonathTP, WeaverSC,"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virus. Infect. Genet. Evol.19, 292–311. (10.1016/j.meegid.2013.03.008)23523817 13JohanssonMA, VasconcelosPFC, StaplesJE2014The"/>
   <result pre="(10.1016/j.meegid.2013.03.008)23523817 13JohanssonMA, VasconcelosPFC, StaplesJE2014The whole iceberg: estimating the incidence of" exact="yellow fever" post="virus infection from the number of severe cases. Trans."/>
   <result pre="Res. Commun.492, 541–547. (10.1016/j.bbrc.2017.05.050)28499872 15de SouzaRPet al.2010Detection of a new" exact="yellow fever" post="virus lineage within the South American genotype I in"/>
   <result pre="(10.1002/jmv.21606)19950229 16collab: Pan American Health Organization/World Health Organization. 2018Epidemiological update:" exact="yellow fever" post="(7 December 2018). See https://bit.ly/2Qhwucf. 17WashburneAD, CrowleyDE, BeckerDJ, ManloveKR,"/>
   <result pre="spillover. Phil. Trans. R. Soc. B374, 20180331 (10.1098/rstb.2018.0331)31401950 18ShearerFMet al.2017Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
   <result pre="in Brazil. Virol. J.7, 152 (10.1186/1743-422X-7-152)20624314 48de SouzaRPet al.2011Isolation of" exact="yellow fever" post="virus (YFV) from naturally infected Haemagogus (Conopostegus) leucocelaenus (Diptera,"/>
   <result pre="News121, 393–396. (10.3157/021.121.0414) 51FernandezZ, RichartzR, Da RosaAT, SoccolVT.2000Identification of the" exact="encephalitis" post="equine virus, Brazil. Rev. Saude Publica34, 232–235. (10.1590/S0034-89102000000300004)10920444 52ForattiniOP,"/>
   <result pre="National Park, Brazil, with an emphasis on potential vectors of" exact="yellow fever." post="Rev. Soc. Bras. Med. Trop.46, 566–574. (10.1590/0037-8682-0136-2013)24142367 57MangudoC, AparicioJP,"/>
   <result pre="IgG4 for Culicidae mosquito blood meal identification from an epizootic" exact="yellow fever" post="area in Brazil. J. Venom. Anim. Toxins Incl. Trop."/>
   <result pre="(Diptera: Culicidae) mosquito eggs with emphasis on sylvan vectors of" exact="yellow fever" post="virus. Mem. Inst. Oswaldo Cruz109, 114–117. (10.1590/0074-0276130168)24626304 62Méndez-LópezMR, AttouiH,"/>
   <result pre="64MucciLFet al.2016Haemagogus leucocelaenus and other mosquitoes potentially associated with sylvatic" exact="yellow fever" post="in Cantareira State Park in the São Paulo Metropolitan"/>
   <result pre="preference for oviposition of mosquito (Diptera: Culicidae) vectors of sylvatic" exact="yellow fever" post="virus near the hydroelectric reservoir of Simplicío, Minas Gerais,"/>
   <result pre="behavior of Haemagogus leucocelaenus (Diptera: Culicidae), a vector of wild" exact="yellow fever" post="in Brazil. Rev. Inst. Med. Trop. Sao Paulo59, e60"/>
   <result pre="dynamics of Haemagogus janthinomys (Diptera: Culicidae), a vector of sylvatic" exact="yellow fever." post="Entomol. News121, 45–52. (10.3157/021.121.0109) 84AlencarJ, de MelloCF, BarbosaLS, Gil-SantanaHR,"/>
   <result pre="(10.3157/021.121.0109) 84AlencarJ, de MelloCF, BarbosaLS, Gil-SantanaHR, MaiaDA, MarcondesCB, SilvaJS2016Diversity of" exact="yellow fever" post="mosquito vectors in the Atlantic forest of Rio de"/>
   <result pre="Pernambuco, including the first report of Haemagogus janthinomys (Diptera: Culicidae)," exact="yellow fever" post="vector and 14 other species (Diptera: Culicidae). Rev. Soc."/>
   <result pre="epidemiologic findings. Emerg. Infect. Dis.7, 565–569. (10.3201/eid0707.017738)11485676 90VasconcelosPFCet al.2003Isolations of" exact="yellow fever" post="virus from Haemagogus leucocelaenus in Rio Grande do Sul"/>
   <result pre="variations in rainfall: prevalence of Haemagogus and incidence of jungle" exact="yellow fever" post="in Brazil and Colombia. Trans. R. Soc. Trop. Med."/>
   <result pre="(10.1093/jmedent/27.6.1041)1980705 99ChadeeDD, TikasinghES, GaneshR1992Seasonality, biting cycle and parity of the" exact="yellow fever" post="vector mosquito Haemagogus janthinomys in Trinidad. Med. Vet. Entomol.6,"/>
   <result pre="the impact of temperature on transmission of Zika, dengue, and" exact="chikungunya" post="using mechanistic models. PLoS Negl. Trop. Dis.11, e0005568 (10.1371/journal.pntd.0005568)28448507"/>
   <result pre="Trop. Dis.11, e0005568 (10.1371/journal.pntd.0005568)28448507 108JohanssonMA, Arana-VizcarrondoN, BiggerstaffBJ, StaplesJE2010Incubation periods of" exact="yellow fever" post="virus. Am. J. Trop. Med. Hyg.83, 183–188. (10.4269/ajtmh.2010.09-0782)20595499 109ChanM,"/>
   <result pre="(10.1371/journal.pone.0050972)23226436 110KummHW, WaddellMB1948Haemagogus capricornii Lutz as a laboratory vector of" exact="yellow fever." post="Am. J. Trop. Med. Hyg.s1-28, 247–252. (10.4269/ajtmh.1948.s1-28.247) 111Roca-GarcíaM, BatesM1946The"/>
   <result pre="Hyg.s1-28, 247–252. (10.4269/ajtmh.1948.s1-28.247) 111Roca-GarcíaM, BatesM1946The development of the virus of" exact="yellow fever" post="in Haemagogus mosquitoes. Am. J. Trop. Med. Hyg.s1-26, 585–605."/>
   <result pre="Trop. Med. Hyg.s1-26, 585–605. (10.4269/ajtmh.1946.s1-26.585) 112AndersonCR, Osorno-MesaE1946The laboratory transmission of" exact="yellow fever" post="virus by Haemagogus splendens. Am. J. Trop. Med. Hyg.26,"/>
   <result pre="Med. Hyg.26, 613–618. (10.4269/ajtmh.1946.s1-26.613)21003269 113WaddellMB, TaylorRM1945Studies on cyclic passage of" exact="yellow fever" post="virus in South American mammals and mosquitoes: marmosets (Callithrix"/>
   <result pre="(10.4269/ajtmh.1945.s1-25.225) 114Roca-GarciaM, BatesM1945Laboratory studies of the saimiri-Haemagogus cycle of jungle" exact="yellow fever." post="Am. J. Trop. Med. Hyg.s1-25, 203–216. (10.4269/ajtmh.1945.s1-25.203) 115GalindoP, TrapidoH,"/>
   <result pre="Med. Hyg.s1-25, 203–216. (10.4269/ajtmh.1945.s1-25.203) 115GalindoP, TrapidoH, de RodanicheE.1956Experimental transmission of" exact="yellow fever" post="by Central American species of Haemagogus and Sabethes chloropterus."/>
   <result pre="South American Aëdes and Haemagogus mosquitoes as laboratory vectors of" exact="yellow fever." post="Am. J. Trop. Med. Hyg.29, 567–575. (10.4269/ajtmh.1949.s1-29.567)18153054 117WaddellMB, TaylorRM1947Studies"/>
   <result pre="Hyg.29, 567–575. (10.4269/ajtmh.1949.s1-29.567)18153054 117WaddellMB, TaylorRM1947Studies on the cyclic passage of" exact="yellow fever" post="virus in South American mammals and Mosquitoes III. Further"/>
   <result pre="of dispersal distances of Culex erraticus in a focus of" exact="eastern equine encephalitis" post="virus in the southeastern United States. J. Med. Entomol.47,"/>
   <result pre="distances of Culex erraticus in a focus of eastern equine" exact="encephalitis" post="virus in the southeastern United States. J. Med. Entomol.47,"/>
   <result pre="18 October 2018). 122CamaraFP, GomesALBB, CarvalhoLMF, CastelloLGV2011Dynamic behavior of sylvatic" exact="yellow fever" post="in Brazil (1954-2008). Rev. Soc. Bras. Med. Trop.44, 297–299."/>
   <result pre="(10.1098/rspb.2018.1076) 133PaaijmansKP, BlanfordS, BellAS, BlanfordJI, ReadAF, ThomasMB2010Influence of climate on" exact="malaria" post="transmission depends on daily temperature variation. Proc. Natl Acad."/>
   <result pre="Acad. Sci. USA107, 15 135–15 139. (10.1073/pnas.1006422107) 134AlmeidaMABet al.2014Surveillance for" exact="yellow fever" post="virus in non-human primates in southern Brazil, 2001–2011: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711314\results\search\disease\results.xml">
   <result pre="of viruses that have gained efficient onward transmission after spillover:" exact="influenza" post="A viruses that are respiratory transmitted, HIV, a retrovirus,"/>
   <result pre="integrative approaches to understanding pathogen spillover’. epidemic emergence virus HIV" exact="influenza" post="parvovirus host range Funding U.S. Department of Defensehttp://dx.doi.org/10.13039/100000005 National"/>
   <result pre="East Respiratory Syndrome (MERS) coronaviruses, Nipah virus, Hendra virus and" exact="avian influenza" post="A viruses (IAV). In addition to emergence in humans,"/>
   <result pre="Respiratory Syndrome (MERS) coronaviruses, Nipah virus, Hendra virus and avian" exact="influenza" post="A viruses (IAV). In addition to emergence in humans,"/>
   <result pre="transmissible virus of mammals. Across these known examples of animal" exact="influenza" post="viruses overcoming host-specific differences to cause epidemics in humans,"/>
   <result pre="host adaptation [40]. (e) Particle release and host-to-host transmission of" exact="influenza" post="A virus Many IAVs cause severe infections of new"/>
   <result pre="disaggregate and release efficiently. The processes underlying the transmission of" exact="influenza" post="viruses are still not well understood, but likely require"/>
   <result pre="all regions of the world, with some dogs developing severe" exact="gastroenteritis" post="with profuse bloody diarrhoea, while neonatal puppies developed a"/>
   <result pre="challenge. Emerg. Infect. Dis.8, 1468–1473. (10.3201/eid0812.010317)12498665 8NelsonMI, VincentAL2015Reverse zoonosis of" exact="influenza" post="to swine: new perspectives on the human–animal interface. Trends"/>
   <result pre="Infect. Dis.17, 711–713. (10.3201/eid1704.100883)21470468 10MenaIet al.2016Origins of the 2009 H1N1" exact="influenza" post="pandemic in swine in Mexico. Elife5, e16777 (10.7554/eLife.16777)27350259 11LongJS,"/>
   <result pre="e16777 (10.7554/eLife.16777)27350259 11LongJS, MistryB, HaslamSM, BarclayWS2018Host and viral determinants of" exact="influenza" post="A virus species specificity. Nat. Rev. Microbiol.17, 67–81. (10.1038/s41579-018-0115-z)"/>
   <result pre="evolution of Zika virus. Nat. Ecol. Evol.3, 561–569. (10.1038/s41559-019-0836-z)30886369 19HumphreysM2018The" exact="influenza" post="of 1918: evolutionary perspectives in a historical context. Evol."/>
   <result pre="context. Evol. Med. Public Health2018, 219–229. (10.1093/emph/eoy024)30410762 20BarclayW, OpenshawP2018The 1918" exact="influenza" post="pandemic: one hundred years of progress, but where now?Lancet"/>
   <result pre="Respir. Med.6, 588–589. (10.1016/S2213-2600(18)30272-8)29941354 21YoonS-W, WebbyRJ, WebsterRG2014Evolution and ecology of" exact="influenza" post="A viruses. Curr. Top. Microbiol. Immunol.385, 359–375. (10.1007/82_2014_396)24990620 22VincentAet"/>
   <result pre="viruses. Curr. Top. Microbiol. Immunol.385, 359–375. (10.1007/82_2014_396)24990620 22VincentAet al.2014Review of" exact="influenza" post="A virus in swine worldwide: a call for increased"/>
   <result pre="4–17. (10.1111/zph.12049)23556412 23HaywardJJ, DuboviEJ, ScarlettJM, JaneczkoS, HolmesEC, ParrishCR2010Microevolution of canine" exact="influenza" post="virus in shelters and its molecular epidemiology in the"/>
   <result pre="States. J. Virol.84, 12 636–12 645. (10.1128/JVI.01350-10) 24PuryearWBet al.2016Prevalence of" exact="influenza" post="A virus in live-captured North Atlantic gray seals: a"/>
   <result pre="Infect.5, e81 (10.1038/emi.2016.77)27485496 25HeWet al.2018Emergence and adaptation of H3N2 canine" exact="influenza" post="virus from avian influenza virus: an overlooked role of"/>
   <result pre="25HeWet al.2018Emergence and adaptation of H3N2 canine influenza virus from" exact="avian influenza" post="virus: an overlooked role of dogs in interspecies transmission."/>
   <result pre="al.2018Emergence and adaptation of H3N2 canine influenza virus from avian" exact="influenza" post="virus: an overlooked role of dogs in interspecies transmission."/>
   <result pre="Dis.66, 842–851. (10.1111/tbed.13093) 26CiminskiK, ThamamongoodT, ZimmerG, SchwemmleM2017Novel insights into bat" exact="influenza" post="A viruses. J. Gen. Virol.98, 2393–2400. (10.1099/jgv.0.000927)28906230 27ParrishCR, KawaokaY2005The"/>
   <result pre="the acquisition of new host ranges by canine parvovirus and" exact="influenza" post="A viruses. Annu. Rev. Microbiol.59, 553–586. (10.1146/annurev.micro.59.030804.121059)16153179 28ChristmanMC, KedwaiiA,"/>
   <result pre="retrospective. Infect. Genet. Evol.11, 803–811. (10.1016/j.meegid.2011.02.021)21382522 29LipsitchMet al.2016Viral factors in" exact="influenza" post="pandemic risk assessment. Elife5, e18491 (10.7554/eLife.18491)27834632 30WilksS, de GraafM,"/>
   <result pre="Elife5, e18491 (10.7554/eLife.18491)27834632 30WilksS, de GraafM, SmithDJ, BurkeDF.2012A review of" exact="influenza" post="haemagglutinin receptor binding as it relates to pandemic properties."/>
   <result pre="4369–4376. (10.1016/j.vaccine.2012.02.076)22682293 31de GraafM, FouchierRAM2014Role of receptor binding specificity in" exact="influenza" post="A virus transmission and pathogenesis. EMBO J.33, 823–841. (10.1002/embj.201387442)24668228"/>
   <result pre="K193T mutation. J. Virol.92, e02016-17 (10.1128/JVI.02016-17)29491160 34BoivinS, HartDJ2011Interaction of the" exact="influenza" post="A virus polymerase PB2 C-terminal region with importin alpha"/>
   <result pre="10 439–10 448. (10.1074/jbc.M110.182964) 35LongJSet al.2016Species difference in ANP32A underlies" exact="influenza" post="A virus polymerase host restriction. Nature529, 101–104. (10.1038/nature16474)26738596 36LakdawalaSS,"/>
   <result pre="(10.1038/nature16474)26738596 36LakdawalaSS, FodorE, SubbaraoK2016Moving on out: transport and packaging of" exact="influenza" post="viral RNA into virions. Annu. Rev. Virol.3, 411–427. (10.1146/annurev-virology-110615-042345)27741407"/>
   <result pre="38NogalesA, Martinez-SobridoL, TophamDJ, DeDiegoML2018Modulation of innate immune responses by the" exact="influenza" post="A NS1 and PA-X proteins. Viruses10, 708 (10.3390/v10120708) 39PepinKM,"/>
   <result pre="Nat. Rev. Microbiol.8, 802–813. (10.1038/nrmicro2440)20938453 40ChauchéCet al.2018Mammalian adaptation of an" exact="avian influenza" post="A virus involves stepwise changes in NS1. J. Virol.92,"/>
   <result pre="Rev. Microbiol.8, 802–813. (10.1038/nrmicro2440)20938453 40ChauchéCet al.2018Mammalian adaptation of an avian" exact="influenza" post="A virus involves stepwise changes in NS1. J. Virol.92,"/>
   <result pre="in hemagglutinin subunits HA1 and HA2 affecting hemagglutinin stability and" exact="influenza" post="virus infectivity. J. Virol.89, 10 602–10 611. (10.1128/JVI.00939-15) 43HolmesKK,"/>
   <result pre="BiY, GaoGF2015MERS, SARS, and Ebola: the role of super-spreaders in" exact="infectious disease." post="Cell Host Microbe18, 398–401. (10.1016/j.chom.2015.09.013)26468744 68PeckKM, LauringAS2018Complexities of viral"/>
   <result pre="rates. J. Virol.92, e01031-17 (10.1128/JVI.01031-17)29720522 69LyonsDM, LauringAS2018Mutation and epistasis in" exact="influenza" post="virus evolution. Viruses10, 407 (10.3390/v10080407) 70PoirierEZ, VignuzziM2017Virus population dynamics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6711507\results\search\disease\results.xml">
   <result pre="other individuals in the community. As a best case, the" exact="infectious disease" post="may even be eliminated if the number of infected"/>
   <result pre="a partly vaccinated population can prevent the spread of an" exact="infectious disease," post="and thereby protect unvaccinated persons. In addition, the possibility"/>
   <result pre="we will illustrate methodological issues in disease transmission modeling using" exact="dengue fever" post="as an exemplary infectious disease. Dengue is a mosquito-borne"/>
   <result pre="in disease transmission modeling using dengue fever as an exemplary" exact="infectious disease." post="Dengue is a mosquito-borne tropical infectious disease caused by"/>
   <result pre="as an exemplary infectious disease. Dengue is a mosquito-borne tropical" exact="infectious disease" post="caused by the dengue virus. The dengue virus is"/>
   <result pre="focus on infectious diseases and the case example of a" exact="dengue fever" post="epidemic. Dynamic (compared to static) In transmission models, the"/>
   <result pre="incubation period. The symptoms range from an asymptomatic disease to" exact="dengue fever" post="(DF), severe hemorrhagic fever (DHF), and to life-threatening septic"/>
   <result pre="period (mosquitoes) 8–12 days (random) McBride et al. [30] DF:" exact="dengue fever," post="DHF: hemorrhagic fever, DSS: septic shock The provided datasets"/>
   <result pre="PoungsombatS, et al.Temporal patterns and a disease forecasting model of" exact="dengue hemorrhagic fever" post="in Jakarta based on 10 years of surveillance data."/>
   <result pre="World Health Organization. 1972;46(2):211–26. Epub 1972/01/01. .4537483 50GublerDJ. Dengue and" exact="dengue hemorrhagic fever." post="Clinical microbiology reviews. 1998;11:480–96. 9665979 51EddyDM, HollingworthW, CaroJJ, TsevatJ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6712034\results\search\disease\results.xml">
   <result pre="for the detection and identification of emerging agents, such as" exact="monkeypox" post="virus17,18, pandemic influenza viruses19, hemorrhagic fever viruses20, rhabdoviruses21. Several"/>
   <result pre="and identification of emerging agents, such as monkeypox virus17,18, pandemic" exact="influenza" post="viruses19, hemorrhagic fever viruses20, rhabdoviruses21. Several steps of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6714416\results\search\disease\results.xml">
   <result pre="exist till date. Recent ZIKV outbreaks and increase association of" exact="microcephaly" post="with congenital ZIKV and neurological complications (Guillain-Barré syndrome) has"/>
   <result pre="diagnosis, preventive aspects, and management protocol. K EYWORDS: Guillain-Barré syndrome" exact="microcephaly" post="pregnancy public health menace zika virus I NTRODUCTION Zika"/>
   <result pre="of ZIKV from a surveillant macaque in the course of" exact="yellow fever" post="surveillance in Uganda's Zika forests, thus, deriving the name"/>
   <result pre="geographic regions[35]Adaptable to both urban and sylvatic habitats[36]Alleged linkage for" exact="yellow fever" post="virus in Brazil[37] N ONMOSQUITO T RANSMISSION Although mosquitoes"/>
   <result pre="has attracted significant attention due to an alarming increase in" exact="microcephaly" post="cases in congenital ZIKV-infected newborns. Isolation of ZIKV RNA"/>
   <result pre="febrile sentinel monkey acquired this virus during the surveillance of" exact="yellow fever" post="virus in Zika forests of Uganda.[54344] The first human"/>
   <result pre="confirmed ZIKV infected patients presented maculo-papular exanthema (rash), bilateral nonpurulent" exact="conjunctivitis" post="and arthralgia over the 13 weeks duration of the"/>
   <result pre="the third reported epidemic of ZIKV.[4849] The first incidence of" exact="microcephaly" post="with ZIKV was documented in October 2015 in Brazil."/>
   <result pre="the WHO in February 2016 due to alleged linkage with" exact="microcephaly" post="and varied neurologic complications.[50] Data till February 2, 2017,"/>
   <result pre="South America &amp;gt;1.5 million cases October 2015 First incidence of" exact="microcephaly" post="with ZIKV February 2016 WHO declared ZIKV a public"/>
   <result pre="macular or maculopapular exanthema (seen in 90% of cases). The" exact="rash" post="has a characteristic centrifugal pattern (extends from the trunk"/>
   <result pre="and persist for a period of 4–5 days.[315657] The typical" exact="rash" post="of ZIKV is usually seen within the 1st or"/>
   <result pre="the symptoms sets in. This is in contrast to the" exact="rash" post="in dengue and Chikungunya, which usually appears after 4"/>
   <result pre="and joint pain as compared to severe intense myalgia of" exact="chikungunya" post="infection.[31] Localized or generalized lymphadenopathy may also be seen"/>
   <result pre="to severe intense myalgia of chikungunya infection.[31] Localized or generalized" exact="lymphadenopathy" post="may also be seen in a few cases of"/>
   <result pre="to two or more of the following features: Fever Nonpurulent" exact="conjunctivitis" post="and pruritus Arthralgia of multiple joints (polyarthralgia) Periarticular edema."/>
   <result pre="Unusual Blood dyscrasias (shock and thrombocytopenia) +++ +/_ +/_ Non-purulent" exact="conjunctivitis" post="+ +++ ++ Peripheral edema _ + _ lymphadenopathy"/>
   <result pre="Non-purulent conjunctivitis + +++ ++ Peripheral edema _ + _" exact="lymphadenopathy" post="++ + ++ Neurological complications Encephalitis Guillain-Barré syndrome and"/>
   <result pre="lymphadenopathy ++ + ++ Neurological complications Encephalitis Guillain-Barré syndrome and" exact="encephalitis" post="Guillain-Barré syndrome and encephalitis (especially in neonates) Course of"/>
   <result pre="Neurological complications Encephalitis Guillain-Barré syndrome and encephalitis Guillain-Barré syndrome and" exact="encephalitis" post="(especially in neonates) Course of disease Mostly, dengue infection"/>
   <result pre="other causes of chronic rheumatism predispose patients to chronicity of" exact="chikungunya" post="infection Hospitalization Secondary dengue infection often requires hospitalization and"/>
   <result pre="cases are managed on an outpatient basis Patients with severe" exact="chikungunya" post="fever requiring hospitalization tend to be older and have"/>
   <result pre="probable association. Thereafter, a total of 2366 confirmed cases of" exact="microcephaly" post="associated with ZIKV infection have been noted in Brazil.[68]"/>
   <result pre="the infectious symptoms in the mother. Various proposed mechanisms for" exact="microcephaly" post="in ZIKV infection are: (1) Increased occurrence of microcephaly"/>
   <result pre="for microcephaly in ZIKV infection are: (1) Increased occurrence of" exact="microcephaly" post="cases associated with ZIKV epidemics (2) 2 Documented cases"/>
   <result pre="amniotic fluid.[70] N EUROLOGICAL C OMPLICATIONS GBS refers to a" exact="polyneuropathy" post="of acute onset. More than two-thirds of the reported"/>
   <result pre="ZIKV evaluation is suggested in following cases: (1) infants with" exact="microcephaly" post="or intracranial calcifications born to women who traveled to"/>
   <result pre="ZIKV should be immediately referred to an expert gynecologist or" exact="infectious disease" post="specialist. Review of fetal ultrasounds to monitor fetal growth"/>
   <result pre="HIV-infected patient in Rio De Janeiro, BrazilJ Clin Virol2016741326615388 19GautretPSimonFDengue," exact="chikungunya" post="and Zika and mass gatherings: What happened in Brazil,"/>
   <result pre="Trop Med Hyg19691841154976739 28Akoua-KoffiCDiarrassoubaSBéniéVBNgbichiJMBozouaTBossonAet al.Investigation surrounding a fatal case of" exact="yellow fever" post="in Côte D'ivoire in 1999Bull Soc Pathol Exot2001942273011681215 29FagbamiAZika"/>
   <result pre="of Communicable DiseasesSurveillance protocol and response to the occurrence of" exact="microcephaly" post="related to Zika virus infection2015BrasíliaMinistry of Health55 46HancockWTMarfelMBelMZika virus,"/>
   <result pre="2007Emerg Infect Dis2008141232918680646 54MardekianSKRobertsALDiagnostic options and challenges for dengue and" exact="chikungunya" post="virusesBiomed Res Int2015201583437126509163 55LopesNNozawaCLinharesRECGeneral features and epidemiology of emerging"/>
   <result pre="literaturePLoS One201611e015637627244249 60De OliveiraWKCortez-EscalanteJDe OliveiraWTCarmoGMHenriqueCMCoelhoGEet al.Increase in reported prevalence of" exact="microcephaly" post="in infants born to women living in areas with"/>
   <result pre="Health Organization201722 69De CarvalhoNSDe CarvalhoBFFugaçaCADórisBBiscaiaESZika virus infection during pregnancy and" exact="microcephaly" post="occurrence: A review of literature and Brazilian dataBraz J"/>
   <result pre="Immunol20177713 81SatoHNakadaHYamaguchiRImotoSMiyanoSKamiMet al.When should we intervene to control the 2009" exact="influenza" post="A (H1N1) pandemic?Euro Surveill201015pii: 19455 82Scalia TombaGWallingaJA simple explanation"/>
   <result pre="clinical trialsLancet20183915526229217376 87MillerBRMitchellCJGenetic selection of a flavivirus-refractory strain of the" exact="yellow fever" post="mosquito Aedes aegyptiAm J Trop Med Hyg1991453994071659238 88MeghaniZBoëteCGenetically engineered"/>
   <result pre="outbreak – United states, 2016MMWR Morb Mortal Wkly Rep20166530326796813 94JamiesonDJRasmussenSAUyekiTMWeinbaumCPandemic" exact="influenza" post="and pregnancy revisited: Lessons learned from 2009 pandemic influenza"/>
   <result pre="94JamiesonDJRasmussenSAUyekiTMWeinbaumCPandemic influenza and pregnancy revisited: Lessons learned from 2009 pandemic" exact="influenza" post="A (H1N1)Am J Obstet Gynecol2011204S1321640228 95LiRDingJDingGFanXHeYWangXet al.Zika virus infections,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6716807\results\search\disease\results.xml">
   <result pre="and patterns of subgroup persistence identified through surveillance of pediatric" exact="pneumonia" post="hospital admissions in coastal Kenya, 2007–2016 http://orcid.org/0000-0002-8020-0787OketchJohn W.+254 715"/>
   <result pre="nasal samples from children &amp;lt; 5 years of age admitted with syndromic" exact="pneumonia" post="between 2007 and 2016 to Kilifi County Hospital, coastal"/>
   <result pre="on HMPV in Africa, which bears a high burden of" exact="pneumonia" post="morbidity and mortality [26, 27]. In this study, we"/>
   <result pre="surface F and G gene nucleotide sequences collected through paediatric" exact="pneumonia" post="surveillance at the Kilifi County Hospital in rural coastal"/>
   <result pre="aimed at understanding the epidemiology and disease burden of RSV-associated" exact="pneumonia" post="cases [29]. KCH, located in coastal Kenya, is a"/>
   <result pre="presented with modified WHO defined syndromic severe or very severe" exact="pneumonia" post="as previously described [29]. During the period between 2007"/>
   <result pre="and cases positives per year from 2007 to 16 amongst" exact="pneumonia" post="paediatric admissions to Kilifi County Hospital, Kenya Year Admissionsa"/>
   <result pre="5 years of age; b. Cases of severe or very severe" exact="pneumonia" post="amongst the admissions [29]; c. Samples eligible for testing"/>
   <result pre="the admissions [29]; c. Samples eligible for testing from the" exact="pneumonia" post="admissions included only residents from within the Kilifi Health"/>
   <result pre="cases identified monthly from surveillance of severe and very severe" exact="pneumonia" post="cases aged under 5 years admitted to Kilifi County Hospital,"/>
   <result pre="under 5 years admitted to Kilifi County Hospital, Kenya 2007–2016. Number" exact="pneumonia" post="cases and number tested are shown on the secondary"/>
   <result pre="the primary Y axis. Samples eligible for testing from the" exact="pneumonia" post="admissions included only residents from within the Kilifi Health"/>
   <result pre="not observe a statistically significant association between HMPV subgroup and" exact="pneumonia" post="severity ( p-value = 0.264) (Table 3). Table 3 Association between"/>
   <result pre="current dataset. There is also some evidence that reduction in" exact="bacterial pneumonia" post="(e.g. S. pneumoniae), as has been seen in this"/>
   <result pre="dataset. There is also some evidence that reduction in bacterial" exact="pneumonia" post="(e.g. S. pneumoniae), as has been seen in this"/>
   <result pre="over this study period [52], results in a reduction in" exact="viral pneumonia" post="[53, 54]. Future investigations will be necessary to give"/>
   <result pre="this study period [52], results in a reduction in viral" exact="pneumonia" post="[53, 54]. Future investigations will be necessary to give"/>
   <result pre="change over time. In addition, the proportion of very severe" exact="pneumonia" post="cases was high among sampled eligibles compared to unsampled"/>
   <result pre="Stockholm, Sweden, 2002-2006J Med Virol2008809161168 26.Green RJ, Kolberg JM. Neonatal" exact="pneumonia" post="in sub-Saharan Africa. Pneumonia . 2016;0–1. 27.LiuLJohnsonHLCousensSPerinJScottSLawnJEet al.Global, regional,"/>
   <result pre="Infect Dis201616130127316548 29.NokesDJNgamaMBettAAbwaoJMunywokiPEnglishMet al.Incidence and severity of respiratory syncytial virus" exact="pneumonia" post="in rural Kenyan children identified through hospital surveillanceClin Infect"/>
   <result pre="Journal of Epidemiology 2012;(April): 41(3):650–7. 31.BerkleyJAMunywokiPNgamaMAbwaoJBettALassauniéreRet al.Viral etiology of severe" exact="pneumonia" post="among Kenyan young infants and childrenJama.2010303202051205720501927 32.HammittLLKazunguSWelchSBettAOnyangoCOGunsonRNet al.Added value"/>
   <result pre="of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed" exact="pneumonia" post="and clinically-defined pneumonia in Kenyan children : an interrupted"/>
   <result pre="conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined" exact="pneumonia" post="in Kenyan children : an interrupted time-series analysisLancet Global"/>
   <result pre="54.FathimaPBlythCCLehmannDLimFJAbdallaTDe KlerkNet al.The impact of pneumococcal vaccination on bacterial and" exact="viral pneumonia" post="in Western Australian children: record linkage cohort study of"/>
   <result pre="KlerkNet al.The impact of pneumococcal vaccination on bacterial and viral" exact="pneumonia" post="in Western Australian children: record linkage cohort study of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6718459\results\search\disease\results.xml">
   <result pre="which vaccines are not yet available. Some of them are" exact="hepatitis" post="C virus (HCV), dengue virus, respiratory syncytial virus, cytomegalovirus,"/>
   <result pre="clinical outcomes: asymptomatic (most common) or mildly symptomatic illness, uncomplicated" exact="dengue fever," post="or more severe disease including plasma leakage, hemorrhage, and"/>
   <result pre="for premembrane (prM) and envelope (E) proteins of the attenuated" exact="yellow fever" post="virus (YFV) 17D vaccine strain for the prM and"/>
   <result pre="partially-attenuated strains of DENV-2 or DENV-3 (29). However, it provokes" exact="rash" post="in more than 60% of those vaccinated (30). The"/>
   <result pre="responses. Viral vectors usually include adenovirus, vaccinia, fowlpox, and vesicular" exact="stomatitis" post="virus (33, 34). It has been proposed that strategies"/>
   <result pre="models against various diseases such as HIV, malaria, and even" exact="cancer" post="(35). In the specific case of malaria control the"/>
   <result pre="malaria, and even cancer (35). In the specific case of" exact="malaria" post="control the studies conducted by Li and coworkers were"/>
   <result pre="pioneers demonstrating that the immunization of mice with a recombinant" exact="vaccinia virus," post="after priming with an influenza virus expressing the same"/>
   <result pre="mice with a recombinant vaccinia virus, after priming with an" exact="influenza" post="virus expressing the same CS protein of the parasite,"/>
   <result pre="parasite can be induced by a single immunization with a" exact="vaccinia virus" post="presenting the CS protein a second dose with the"/>
   <result pre="Rodríguez and colleagues when evaluated the effectiveness of several recombinant" exact="influenza" post="and vaccinia viruses to induce a malaria-specific immune response"/>
   <result pre="studies indicate that complementary prime-boost immunization strategies that use recombinant" exact="vaccinia virus" post="and bacterial plasmids could be useful for the control"/>
   <result pre="the HCV genotype 1a and later boosted with a modified" exact="vaccinia virus" post="Ankara expressing the proteins NS3/4/5B from genotype 1b. This"/>
   <result pre="However, the intracellular bacteria Mycobacterium bovis (M. bovis), which produces" exact="tuberculosis" post="(TB), is able to resist most antibody-mediated antibacterial effects"/>
   <result pre="Intramuscularly 2 doses Prime: plasmid encodingE protein from DENV-2 Boost:" exact="vaccinia virus" post="expressingE protein from DENV-2 Highest levels of E-specific IgG"/>
   <result pre="DENV-2 Highest levels of E-specific IgG in groups immunized with" exact="vaccinia virus," post="but short duration High production of cytokines by CD4+"/>
   <result pre="expressingE protein from DENV-2 Vaccinia DNA Vaccinia/DNA 2 doses Prime:" exact="vaccinia virus" post="expressingE protein from DENV-2 Boost: plasmid encodingE protein from"/>
   <result pre="encodingE protein from DENV-2 Vaccinia Adenovirus Vaccinia/adenovirus 2 doses Prime:" exact="vaccinia virus" post="expressingE protein from DENV-2 Boost: adenovirus expressingE protein from"/>
   <result pre="Adenovirus/vaccinia 2 doses Prime: adenovirus expressingE protein from DENV-2 Boost:" exact="vaccinia virus" post="expressingE protein from DENV-2 2011 Infective virus Recombinant protein"/>
   <result pre="by replacing the prM and E genes from the 17D" exact="yellow fever" post="vaccine virus by those from DENV-2). BALB/c mice were"/>
   <result pre="candidates: a DNA plasmid, a recombinant adenovirus and a recombinant" exact="vaccinia virus." post="All constructions included the E protein from DENV-2 as"/>
   <result pre="sera of anti-E-specific IgG were observed in mice boosted with" exact="vaccinia virus." post="However, when vaccinia virus was used for priming the"/>
   <result pre="were observed in mice boosted with vaccinia virus. However, when" exact="vaccinia virus" post="was used for priming the levels of anti-E antibodies"/>
   <result pre="in vivo CTL killing activity, the group primed with the" exact="vaccinia virus" post="and boosted with the DNA plasmid showed the highest"/>
   <result pre="immunogenicity of a dengue vaccine candidate based on a pediatric" exact="measles" post="vaccine expressing dengue antigens. The vaccine antigen was obtained"/>
   <result pre="from DENV-1. This recombinant construct (EDIII-ectoM) was expressed in a" exact="measles" post="vector (MV). The recombinant MV-EDIII-ectoM induced in MV-susceptible mice,"/>
   <result pre="a monovalent dengue vaccine from DENV-1 or DENV-2 or the" exact="yellow fever" post="vaccine were boosted with Dengvaxia®. The results showed that"/>
   <result pre="was lower than those measured in the group receiving the" exact="yellow fever" post="vaccine and in the naïve group. These results suggest"/>
   <result pre="J Immunol. (2003) 170:2599–604. 10.4049/jimmunol.170.5.259912594287 36.LiSRodriguezMRodriguezDRodriguezJREstebanMPalesePet al.. Priming with recombinant" exact="influenza" post="virus followed by administration of recombinant vaccinia virus induces"/>
   <result pre="Priming with recombinant influenza virus followed by administration of recombinant" exact="vaccinia virus" post="induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl"/>
   <result pre="(1993) 90:5214–8. 10.1073/pnas.90.11.52147685119 37.RodriguezMLiSMurataKRodriguezDRodriguezJRBacikIet al.. Influenza and vaccinia viruses expressing" exact="malaria" post="CD8+ T and B cell epitopes. Comparison of their"/>
   <result pre="Immunol. (1994) 153:4636–48. 7525709 38.AleshinSETimofeevAVKhoretonenkoMVZakharovaLGPashvykinaGVStephensonJRet al.. Combined prime-boost vaccination against" exact="tick-borne encephalitis" post="(TBE) using a recombinant vaccinia virus and a bacterial"/>
   <result pre="(1994) 153:4636–48. 7525709 38.AleshinSETimofeevAVKhoretonenkoMVZakharovaLGPashvykinaGVStephensonJRet al.. Combined prime-boost vaccination against tick-borne" exact="encephalitis" post="(TBE) using a recombinant vaccinia virus and a bacterial"/>
   <result pre="Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant" exact="vaccinia virus" post="and a bacterial plasmid both expressing TBE virus non-structural"/>
   <result pre="prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for" exact="hepatitis" post="C virus. J Infect Dis. (2013) 208:1008–19. 10.1093/infdis/jit26723776192 40.SaeediAGhaemiATabarraeiAMoradiAGorjiASemnaniSet"/>
   <result pre="(2013) 208:1008–19. 10.1093/infdis/jit26723776192 40.SaeediAGhaemiATabarraeiAMoradiAGorjiASemnaniSet al.. Enhanced cell immune responses to" exact="hepatitis" post="C virus core by novel heterologous DNA prime/lambda nanoparticles"/>
   <result pre="(2003) 77:8729–35. 10.1128/JVI.77.16.8729-8735.200312885892 45.RodriguesLCDiwanVKWheelerJG. Protective effect of BCG against tuberculous" exact="meningitis" post="and miliary tuberculosis: a meta-analysis. Int J Epidemiol. (1993)"/>
   <result pre="and PPE protein boost provides potent protection against acute Mycobacterium" exact="tuberculosis" post="infection in mice. Microb Pathog. (2016) 93:1–7. 10.1016/j.micpath.2016.01.00626792673 48.SterneJARodriguesLCGuedesIN."/>
   <result pre="combined BCG and killed Mycobacterium leprae vaccine for prevention of" exact="leprosy" post="and tuberculosis in Malawi. Lancet. (1996) 348:17–24. 10.1016/S0140-6736(96)02166-68691924 50.DalmiaNRamsayAJ."/>
   <result pre="and killed Mycobacterium leprae vaccine for prevention of leprosy and" exact="tuberculosis" post="in Malawi. Lancet. (1996) 348:17–24. 10.1016/S0140-6736(96)02166-68691924 50.DalmiaNRamsayAJ. Prime-boost approaches"/>
   <result pre="in Malawi. Lancet. (1996) 348:17–24. 10.1016/S0140-6736(96)02166-68691924 50.DalmiaNRamsayAJ. Prime-boost approaches to" exact="tuberculosis" post="vaccine development. Exp Rev Vaccines. (2012) 11:1221–33. 10.1586/erv.12.9423176655 51.DunachieSJHillAV."/>
   <result pre="Exp Rev Vaccines. (2012) 11:1221–33. 10.1586/erv.12.9423176655 51.DunachieSJHillAV. Prime-boost strategies for" exact="malaria" post="vaccine development. J Exp Biol. (2003) 206:3771–9. 10.1242/jeb.0064214506212 52.OertliMNobenMEnglerDBSemperRPReuterSMaxeinerJet"/>
   <result pre="(2007) 7:10. 10.1186/1472-6750-7-1017302980 68.ChenLEwingDSubramanianHBlockKRaynerJAltersonKDet al.. A heterologous DNA prime-Venezuelan equine" exact="encephalitis" post="virus replicon particle boost dengue vaccine regimen affords complete"/>
   <result pre="cynomolgus macaques. J Virol. (2007) 81:11634–9. 10.1128/JVI.00996-0717715224 69.BrandlerSLucas-HouraniMMorisAFrenkielMPCombredetCFevrierMet al.. Pediatric" exact="measles" post="vaccine expressing a dengue antigen induces durable serotype-specific neutralizing"/>
   <result pre="ONE. (2013) 8:e58357. 10.1371/journal.pone.005835723472186 84.QiaoMShawDForratRWartel-TramALangJ. Priming effect of dengue and" exact="yellow fever" post="vaccination on the immunogenicity, infectivity, and safety of a"/>
   <result pre="indicates that a single dose of the national institute of" exact="allergy" post="and infectious diseases tetravalent dengue vaccine induces a robust"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6720359\results\search\disease\results.xml">
   <result pre="provided the original work is properly cited. Abstract Background Yearly" exact="influenza" post="epidemics have considerable effects on public health worldwide. The"/>
   <result pre="epidemics have considerable effects on public health worldwide. The 2017-2018" exact="influenza" post="season in Italy was of greater severity than previous"/>
   <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in Southern Italy and the molecular characteristics of"/>
   <result pre="from week 46/2017 to week 17/2018 were tested to identify" exact="influenza" post="A viruses (IAV) and influenza B viruses (IBV). Sequencing"/>
   <result pre="17/2018 were tested to identify influenza A viruses (IAV) and" exact="influenza" post="B viruses (IBV). Sequencing and phylogenetic analysis of haemagglutinin"/>
   <result pre="Intensive-care unit (ICU) admission was required in 50 cases of" exact="acute respiratory distress syndrome" post="(ARDS). Among the &amp;gt;64-year age group, 18 out of"/>
   <result pre="14 of these (77.8%) were B/Yamagata lineage. Conclusions The 2017-2018" exact="influenza" post="season was one of the most severe in a"/>
   <result pre="suggests that further data on the effectiveness of the available" exact="influenza" post="vaccines are needed to determine the best way to"/>
   <result pre="protect the elderly against both IBV lineages. 1. Introduction Yearly" exact="influenza" post="epidemics have severe effects on public health worldwide. Influenza"/>
   <result pre="in children [2]. Every year, 3–5 million cases of severe" exact="influenza" post="and around 290,000–650,000 influenza-related deaths occur [3]. Vaccination is"/>
   <result pre="occur [3]. Vaccination is the most effective way to prevent" exact="influenza" post="virus infection and its complications. However, because of antigenic"/>
   <result pre="and its complications. However, because of antigenic drift in seasonal" exact="influenza" post="viruses, the composition of the vaccines must be changed"/>
   <result pre="In Italy, the recommendations for the use of the available" exact="influenza" post="vaccines are reported yearly in a document of the"/>
   <result pre="a document of the Ministry of Health. For the 2017-2018" exact="influenza" post="season, for the northern hemisphere, the recommended vaccine formulation"/>
   <result pre="acute respiratory infections (ARIs) to the national focal point for" exact="influenza" post="surveillance [6]. From week 40 of one year to"/>
   <result pre="(epidemiological surveillance) and collect respiratory specimens to identify the circulating" exact="influenza" post="strains (virological surveillance) [7]. In Italy, the estimated incidence"/>
   <result pre="strains (virological surveillance) [7]. In Italy, the estimated incidence of" exact="influenza" post="in the 2017-2018 season was &amp;gt;8.5 million [8], which"/>
   <result pre="in the week 02/2018 [8]. Some 60% of all laboratory-confirmed" exact="influenza" post="cases were caused by influenza B virus (IBV) [9]."/>
   <result pre="Some 60% of all laboratory-confirmed influenza cases were caused by" exact="influenza" post="B virus (IBV) [9]. No recent data are available"/>
   <result pre="[9]. No recent data are available on the epidemiology of" exact="influenza" post="and on the circulation of influenza viruses during recent"/>
   <result pre="on the epidemiology of influenza and on the circulation of" exact="influenza" post="viruses during recent seasons in Southern Italy. The aim"/>
   <result pre="The aim of this study was to describe the 2017-2018" exact="influenza" post="season in the Apulia region (Southern Italy), along with"/>
   <result pre="&amp;gt;4 million people. According to the national protocol, the regional" exact="influenza" post="surveillance system surveys about 2% of the general population"/>
   <result pre="least one of three respiratory symptoms (cough, sore throat, and" exact="shortness" post="of breath) [10]. For epidemiological purposes, the number of"/>
   <result pre="sign or symptom of acute respiratory illness (cough, sore throat," exact="shortness" post="of breath, and coryza) [10], and from patients admitted"/>
   <result pre="admitted to all intensive-care units (ICUs) of the region with" exact="acute respiratory distress syndrome" post="(ARDS), during the influenza season. All the samples were"/>
   <result pre="the region with acute respiratory distress syndrome (ARDS), during the" exact="influenza" post="season. All the samples were analysed at the Laboratory"/>
   <result pre="(Anyplex RV16 Detection; Seegene, Seoul, Republic of Korea). Subtyping of" exact="influenza" post="A virus (IAV) was performed with a commercial real-time"/>
   <result pre="from patients with SARI, and 14 from ICU-ARDS), 36 were" exact="influenza" post="A/H1N1pdm09 (five from individuals with ILIs, 10 from patients"/>
   <result pre="patients with SARI, and 21 from ICU-ARDS), and two were" exact="influenza" post="A/H3N2 (one from a patient with SARI and one"/>
   <result pre="that already deposited. 3. Results In Apulia, during the 2017-2018" exact="influenza" post="season, the first two sporadic cases were identified in"/>
   <result pre="week 9/2018. A total of 2,175 patients was tested for" exact="influenza" post="viruses, and 565 (26.0%) were positive. IBV strains were"/>
   <result pre="50 individuals, 8 of whom were vaccinated for the 2017-2018" exact="influenza" post="season, and all but 3 of whom had comorbidities."/>
   <result pre="age group, in which 12 of the 50 individuals with" exact="influenza" post="(24.0%) had ICU-ARDS, whereas no children &amp;lt;15 years old"/>
   <result pre="3 shows the distribution of the number of cases of" exact="influenza" post="by age group and type of virus identified for"/>
   <result pre="the 15–49-year and 50–64-year age groups was mostly associated with" exact="influenza" post="A/H1N1pdm09 infection, whereas among the 65–74-year and &amp;gt;74-year age"/>
   <result pre="IBV infection was significantly more frequent in patients with severe" exact="influenza" post="(ICU-ARDS and SARI cases) compared to sentinel patients (ILI"/>
   <result pre="more frequent in ILI cases compared to patients with severe" exact="influenza" post="(p&amp;lt;0.0001), whereas no significant difference was found for the"/>
   <result pre="genes of the 35 IBV strains characterised during the 2017-2018" exact="influenza" post="season (Figure 4) showed that all of the B/Yamagata"/>
   <result pre="season in the northern hemisphere). 4. Discussion The monitoring of" exact="influenza" post="epidemiology and disease and the characterisation of circulating strain"/>
   <result pre="provide data to public-health authorities to facilitate the management of" exact="influenza" post="epidemics and the planning of control measures. In Apulia,"/>
   <result pre="In Apulia, as in the rest of Italy, the 2017-2018" exact="influenza" post="season had one of the greatest impacts on public"/>
   <result pre="fell, and infection with A/H1N1pdm09 became predominant. The proportion of" exact="influenza" post="infections resulting from IBV was higher in Apulia than"/>
   <result pre="Italy as a whole (71.0% versus 60.0%) [9]. The 2017-2018" exact="influenza" post="season was characterised by an IBV lineage mismatch with"/>
   <result pre="the lineage mismatch contributed to the severe impact of the" exact="influenza" post="epidemic. Notably, all of the characterised B/Yamagata strains belonged"/>
   <result pre="the impact of IBV in the elderly in the 2017-2018" exact="influenza" post="season, the Italian Ministry of Health has also recommended,"/>
   <result pre="at low risk (without multiple comorbidities) [24]. The use of" exact="influenza" post="vaccines in those &amp;gt;64 years old is under debate"/>
   <result pre="[30–34]. Further evidence of the relative effectiveness of the different" exact="influenza" post="vaccines in the elderly is needed for definitive recommendations"/>
   <result pre="In conclusion, our data provide information on the most recent" exact="influenza" post="season and on the molecular epidemiology of the circulating"/>
   <result pre="influenza season and on the molecular epidemiology of the circulating" exact="influenza" post="viruses in Apulia, a densely populated region of Italy."/>
   <result pre="virological surveillance remain an essential tool for monitoring of the" exact="influenza" post="season and the characteristics of circulating viruses, to identify"/>
   <result pre="and Jolanda Prisco for invaluable help in collecting data on" exact="influenza" post="cases and on ICU-ARDS. Abbreviations ARDS: Acute respiratory distress"/>
   <result pre="respiratory distress syndrome ARI: Acute respiratory infection aTIV: Adjuvanted trivalent" exact="influenza" post="vaccine IAV: Influenza A virus IBV: Influenza B virus"/>
   <result pre="IBV: Influenza B virus ILI: Influenza-like illness ICU-ARDS: Case of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
   <result pre="with ARDS requiring admission to an intensive-care unit QIV: Quadrivalent" exact="influenza" post="vaccine SARI: Severe acute respiratory infection TIV: Trivalent influenza"/>
   <result pre="Quadrivalent influenza vaccine SARI: Severe acute respiratory infection TIV: Trivalent" exact="influenza" post="vaccine. Data Availability The data that support the findings"/>
   <result pre="Fact Sheets Influenza (Seasonal). http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) 4Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2017&amp;amp;codLeg=60180&amp;amp;parte=1%20&amp;amp;serie=null 5World Health"/>
   <result pre="– Operating protocol for epidemiological and virological surveillance - 2017-2018" exact="influenza" post="season. http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&amp;amp;id=2649 8InfluNet - Epidemiological report, week 17/2018. http://www.salute.gov.it/portale/temi/documenti/epidemiologica/Influnet_2018_17.pdf"/>
   <result pre="Health Organization (WHO). WHO information for the molecular detection of" exact="influenza" post="viruses. July 2017. https://www.who.int/influenza/gisrs_laboratory/WHO_information_for_the_molecular_detection_of_influenza_viruses_20171023_Final.pdf?ua=1 12VegaT.LozanoJ. E.MeerhoffT.et al.Influenza surveillance in"/>
   <result pre="HemagglutininJournal of Virology20088263011302010.1128/JVI.02477-0718184701 15World Health Organization (WHO). Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017- 2018 northern"/>
   <result pre="virus vaccines for use in the 2017- 2018 northern hemisphere" exact="influenza" post="season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18 influenza seasonal"/>
   <result pre="northern hemisphere influenza season. March 2017. https://www.who.int/influenza/vaccines/virus/recommendations/201703_recommendation.pdf?ua=1 16RondyM.KisslingE.EmborgH.et al.Interim 2017/18" exact="influenza" post="seasonal vaccine effectiveness: combined results from five European studiesEurosurveillance201823910.2807/1560-7917.ES.2018.23.9.18-00086"/>
   <result pre="of D222G amino acid substitution in the haemagglutinin of pandemic" exact="influenza" post="A (H1N1) 2009 viruses. Wkly Epidemiol Rec. 2010 Jan"/>
   <result pre="Epidemiol Rec. 2010 Jan 22;85(4):21-2 19RykkvinR.KilanderA.DudmanS. G.HungnesO.Within-patient emergence of the" exact="influenza" post="A(H1N1)pdm09 HA1 222G variant and clear association with severe"/>
   <result pre="virus receptors in the human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated" exact="influenza" post="surveillance report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health."/>
   <result pre="human airwayNature2006440708343543610.1038/440435a16554799 22Flu News Italy. Integrated influenza surveillance report, 2017/2018" exact="influenza" post="season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for influenza prevention"/>
   <result pre="report, 2017/2018 influenza season. http://www.salute.gov.it/portale/influenza/documenti/flunews/FluNews_2018_13.pdf 23Ministry of Health. Recommendations for" exact="influenza" post="prevention and control, 2018-2019 season, Italy. http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2018&amp;amp;codLeg=64381&amp;amp;parte=1%20&amp;amp;serie=null 24Apulia region."/>
   <result pre="region. Nota n. 4571, 16.10.2017. &quot;Ministry of Health, Recommendations for" exact="influenza" post="prevention and control, 2017-2018 season, Italy. Notification.�? https://www.sanita.puglia.it/documents/36044/41587901/Circolare+regionale/62a1ca12-38de-4dde-9944-e97f04a84dea 25BarbieriM.CapriS.WaureC."/>
   <result pre="D. E.BoccaliniS.PanattoD.Age- and risk-related appropriateness of the use of available" exact="influenza" post="vaccines in the Italian elderly population is advantageous: Results"/>
   <result pre="Hygiene2017584E279E28729707658 26MenniniF. S.BiniC.MarcellusiA.RinaldiA.FrancoE.Cost-effectiveness of switching from trivalent to quadrivalent inactivated" exact="influenza" post="vaccines for the at-risk population in ItalyHuman Vaccines &amp;amp;"/>
   <result pre="&amp;amp; Immunotherapeutics20181481867187310.1080/21645515.2018.146936829708843 27MontomoliE.TorelliA.ManiniI.GianchecchiE.Immunogenicity and safety of the new inactivated quadrivalent" exact="influenza" post="vaccine vaxigrip tetra: Preliminary results in children ≥6 months"/>
   <result pre="months and older adultsVaccines201861 28CapriS.BarbieriM.de WaureC.BoccaliniS.PanattoD.Cost-effectiveness analysis of different seasonal" exact="influenza" post="vaccines in the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079"/>
   <result pre="the elderly Italian populationHuman Vaccines &amp;amp; Immunotherapeutics20181461331134110.1080/21645515.2018.143879229425079 29de WaureC.BoccaliniS.BonanniP.et al.Adjuvanted" exact="influenza" post="vaccine for the Italian elderly in the 2018/19 season:"/>
   <result pre="during 2016–2017 seasonClinical Infectious Diseases2018 31CastillaJ.NavascuésA.CasadoI.et al.Interim effectiveness of trivalent" exact="influenza" post="vaccine in a season dominated by lineage mismatched influenza"/>
   <result pre="trivalent influenza vaccine in a season dominated by lineage mismatched" exact="influenza" post="B, northern Spain, 2017/18Eurosurveillance201823710.2807/1560-7917.ES.2018.23.7.18-00057 32CamilloniB.NeriM.LepriE.IorioA. M.Cross-reactive antibodies in middle-aged"/>
   <result pre="antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent" exact="influenza" post="vaccine against B viruses of the B/Victoria or B/Yamagata"/>
   <result pre="33RayR.Dos SantosG.BuckP. O.et al.A review of the value of quadrivalent" exact="influenza" post="vaccines and their potential contribution to influenza controlHuman Vaccines"/>
   <result pre="value of quadrivalent influenza vaccines and their potential contribution to" exact="influenza" post="controlHuman Vaccines &amp;amp; Immunotherapeutics20171371640165210.1080/21645515.2017.131337528532276 34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness"/>
   <result pre="34SkowronskiD. M.ChambersC.De SerresG.et al.Vaccine effectiveness against lineage matched and mismatched" exact="influenza" post="B viruses across 8 seasons in Canada, 2010-11 to"/>
   <result pre="1 Distribution of samples according to type or subtype of" exact="influenza" post="virus identified and incidence of influenza-like illness (ILI) in"/>
   <result pre="in each week of surveillance in Apulia in the 2017-2018" exact="influenza" post="season. Figure 2 Distribution of influenza-positive cases by age"/>
   <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 3 Distribution of the number of cases"/>
   <result pre="season. Figure 3 Distribution of the number of cases of" exact="influenza" post="infection with ARDS requiring admission to an intensive-care unit"/>
   <result pre="and type of virus identified, in Apulia in the 2017-2018" exact="influenza" post="season. Figure 4 Phylogenetic analysis of the haemagglutinin (HA)"/>
   <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
   <result pre="influenza-like illness; SARI, severe acute respiratory illness; ICU-ARDS, cases with" exact="acute respiratory distress syndrome" post="requiring admission to an intensive-care unit) and, if vaccinated,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6720821\results\search\disease\results.xml">
   <result pre="recent use of mathematical epidemiological SIR or SEIR models in" exact="plague" post="research. This use of S(E)IR models is highly problematic,"/>
   <result pre="in that such models are used to &quot;prove�? that historical" exact="plague" post="was a (1) Filoviridae disease and (2) a bacterial"/>
   <result pre="historical plague was a (1) Filoviridae disease and (2) a" exact="bacterial disease" post="caused by Yersinia pestis which was transmitted by human"/>
   <result pre="fleas). They purportedly consistently disprove (4) the conventional view that" exact="plague" post="is/was a rat-and-rat-flea-borne disease. For these reasons, the focus"/>
   <result pre="historical epidemiological data. An important or predominant vectorial role in" exact="plague" post="epidemics for human fleas and lice requires that several"/>
   <result pre="not considered by advocates of the human ectoparasite hypothesis of" exact="plague" post="transmission: (1) the prevalence and levels of human plague"/>
   <result pre="of plague transmission: (1) the prevalence and levels of human" exact="plague" post="bacteraemia (human plague cases as sources of infection of"/>
   <result pre="(1) the prevalence and levels of human plague bacteraemia (human" exact="plague" post="cases as sources of infection of feeding human ectoparasites);"/>
   <result pre="human fleas and lice; (3) the consequent number of ingested" exact="plague" post="bacteria; (4) the lethal dose of bacteria for 50%"/>
   <result pre="human ectoparasite hypothesis. The view of the standard works on" exact="plague" post="has been corroborated, that bubonic plague, historical and modern,"/>
   <result pre="of the standard works on plague has been corroborated, that" exact="bubonic plague," post="historical and modern, is/was a rat-and-rat-flea-borne disease caused by"/>
   <result pre="as a mechanism of transmission of LDs to humans in" exact="plague" post="epidemics and removed this solution to the problem of"/>
   <result pre="the erroneous use of them, in this case on historical" exact="plague" post="epidemics. The S(E)IR models are good for their intended"/>
   <result pre="of tenability). This has clearly been the case in historical" exact="plague" post="research with significance also for the understanding of modern"/>
   <result pre="plague research with significance also for the understanding of modern" exact="bubonic plague." post="However, models are in methodological principle analogues and can,"/>
   <result pre="epidemic spread. Relating to the theory of early-phase transmission of" exact="plague" post="by fleas, B. J. Hinnebusch (Chief of the Plague"/>
   <result pre="high flea burden and not in the case of human" exact="plague" post="[3, 4]. Epidemiological mathematical models produce the outcome of"/>
   <result pre="identity and epidemiological dynamics of the Black Death and historical" exact="plague" post="epidemics. 2. Basic Structures of the Reed–Frost Mathematical Epidemiological"/>
   <result pre="the Black Death and the subsequent epidemics of the second" exact="plague" post="pandemic. The model's name refers to two scholars at"/>
   <result pre="lasting immunity on survivors. This is also the case with" exact="bubonic plague," post="and survivors generally acquire only weak and brief immunity"/>
   <result pre="This is reflected in the numerous cases of survivors of" exact="plague" post="disease who fall ill by plague again and also"/>
   <result pre="cases of survivors of plague disease who fall ill by" exact="plague" post="again and also three times in the same epidemic"/>
   <result pre="sources [12]. This was also noted in connection with modern" exact="bubonic plague" post="in India, China, and Vietnam, [13, 14]; Langen and"/>
   <result pre="[12]. This was also noted in connection with modern bubonic" exact="plague" post="in India, China, and Vietnam, [13, 14]; Langen and"/>
   <result pre="[13, 14]; Langen and Liechtenstein state on the experience with" exact="plague" post="epidemics in Java: &quot;reinfection with plague may occur within"/>
   <result pre="on the experience with plague epidemics in Java: &quot;reinfection with" exact="plague" post="may occur within a few months; surviving an attack"/>
   <result pre="a very limited immunity�? [15]. This shows, for starters, that" exact="bubonic plague" post="cannot be modelled by SIR models including the Reed–Frost"/>
   <result pre="very limited immunity�? [15]. This shows, for starters, that bubonic" exact="plague" post="cannot be modelled by SIR models including the Reed–Frost"/>
   <result pre="the Reed–Frost version of the model because it is a" exact="bacterial disease" post="and because it does not confer lasting immunity. The"/>
   <result pre="only to simple situations as illustrated by an outbreak of" exact="measles" post="in a closed group�? [16], and the latter is"/>
   <result pre="applied on epidemics that were or were suspected of being" exact="bubonic plague," post="which are by wide consensus transmitted and disseminated by"/>
   <result pre="and/or (4) have animal reservoirs, as in the case of" exact="bubonic plague." post="Furthermore, (5) people in historical society did not, by"/>
   <result pre="level of exposure to infection. The social scenes of historical" exact="plague" post="epidemics were never &quot;simple situations�? as all historians know."/>
   <result pre="and Duncan used the Reed–Frost model to analyse various historical" exact="plague" post="epidemics, and it consistently confirmed the revolutionary theory that"/>
   <result pre="epidemics, and it consistently confirmed the revolutionary theory that historical" exact="plague" post="had to be a Filoviridae disease, (a variant of)"/>
   <result pre="or Marburg disease [5]. According to the Reed–Frost model, historical" exact="plague" post="epidemics allegedly exhibited a pattern of spread formed by"/>
   <result pre="the second pandemic or in the countries where the third" exact="plague" post="pandemic spread. Scott and Duncan performed these analyses without"/>
   <result pre="let it suffice to point out that (1) epidemics of" exact="bubonic plague" post="in general do not conform to the pattern of"/>
   <result pre="it suffice to point out that (1) epidemics of bubonic" exact="plague" post="in general do not conform to the pattern of"/>
   <result pre="case with bubo(es), a defining feature of modern and historical" exact="plague" post="[11] (although rare cases of enlarged lymph nodes have"/>
   <result pre="expected) [29]. In a treatise designed to show that historical" exact="plague" post="cannot have been bubonic plague but was a Filoviridae"/>
   <result pre="treatise designed to show that historical plague cannot have been" exact="bubonic plague" post="but was a Filoviridae disease, Scott and Duncan tacitly"/>
   <result pre="designed to show that historical plague cannot have been bubonic" exact="plague" post="but was a Filoviridae disease, Scott and Duncan tacitly"/>
   <result pre="due to bacterial infection or transmitted by insects, such as" exact="bubonic plague." post="As such the whole treatise is based on a"/>
   <result pre="Reed–Frost model cannot be used to &quot;represent,�? i.e., to model" exact="bubonic plague" post="for several sufficient conditions, because it is a bacterial"/>
   <result pre="model cannot be used to &quot;represent,�? i.e., to model bubonic" exact="plague" post="for several sufficient conditions, because it is a bacterial"/>
   <result pre="bubonic plague for several sufficient conditions, because it is a" exact="bacterial disease" post="with an animal reservoir and transmitted by insects, means"/>
   <result pre="used when a central issue is whether or not historical" exact="plague" post="was bubonic plague, a crucial condition also ignored by"/>
   <result pre="a central issue is whether or not historical plague was" exact="bubonic plague," post="a crucial condition also ignored by Scott and Duncan."/>
   <result pre="1992 doctoral thesis on the Black Death and subsequent late-medieval" exact="plague" post="epidemics in the Scandinavian countries (and to my 2004"/>
   <result pre="of the Black Death conformed to the conventional view of" exact="bubonic plague" post="as rat-and-rat-flea-borne [28], as presented in all standard works"/>
   <result pre="the Black Death conformed to the conventional view of bubonic" exact="plague" post="as rat-and-rat-flea-borne [28], as presented in all standard works"/>
   <result pre="assert repeatedly that, according to evidence produced in India, modern" exact="bubonic plague" post="was &quot;a rural disease hitting harder in the small"/>
   <result pre="repeatedly that, according to evidence produced in India, modern bubonic" exact="plague" post="was &quot;a rural disease hitting harder in the small"/>
   <result pre="Death was a different disease from the modern epidemics of" exact="bubonic plague" post="in India. This is at variance with the central"/>
   <result pre="was a different disease from the modern epidemics of bubonic" exact="plague" post="in India. This is at variance with the central"/>
   <result pre="important pioneering observation of a unique and defining feature of" exact="bubonic plague" post="that modern bubonic plague in India and the Black"/>
   <result pre="pioneering observation of a unique and defining feature of bubonic" exact="plague" post="that modern bubonic plague in India and the Black"/>
   <result pre="a unique and defining feature of bubonic plague that modern" exact="bubonic plague" post="in India and the Black Death in Europe had"/>
   <result pre="unique and defining feature of bubonic plague that modern bubonic" exact="plague" post="in India and the Black Death in Europe had"/>
   <result pre="that the Black Death had similar epidemiological properties as modern" exact="plague" post="in India and was bubonic plague. Hankin was not"/>
   <result pre="similar epidemiological properties as modern plague in India and was" exact="bubonic plague." post="Hankin was not alone in making these peculiar observations."/>
   <result pre="the Black Death in England and found a similar corroboration:" exact="bubonic plague" post="in India in the early 1900s and the Black"/>
   <result pre="Black Death in England and found a similar corroboration: bubonic" exact="plague" post="in India in the early 1900s and the Black"/>
   <result pre="cities, and this was a unique and defining feature of" exact="bubonic plague" post="[38]. In their book and collateral articles, G. Christakos"/>
   <result pre="and this was a unique and defining feature of bubonic" exact="plague" post="[38]. In their book and collateral articles, G. Christakos"/>
   <result pre="the Black Death. In this book, this defining feature of" exact="bubonic plague" post="is presented in a chapter containing both modern and"/>
   <result pre="Black Death. In this book, this defining feature of bubonic" exact="plague" post="is presented in a chapter containing both modern and"/>
   <result pre="directly from person to person, such as, for instance, rat-and-rat-flea-based" exact="bubonic plague," post="can exhibit a different pattern. In the case of"/>
   <result pre="provides a basic explanation for why, in the case of" exact="bubonic plague," post="the severity of impact on human populations declines with"/>
   <result pre="lived in the countryside. Christakos et al.'s focus on urban" exact="plague" post="is misplaced. One point remains to be explained: the"/>
   <result pre="underpinned unique pattern of mortality according to settlement size for" exact="bubonic plague," post="namely, the inverse correlation according to population density, it"/>
   <result pre="population density, it also constitutes evidence that modern and historical" exact="plague" post="at least predominantly were the same disease, namely, rat-and-rat-flea-borne"/>
   <result pre="plague at least predominantly were the same disease, namely, rat-and-rat-flea-borne" exact="bubonic plague." post="On p. 206, in Chapter V(D, f) on &quot;Some"/>
   <result pre="showing the main features of the &quot;Propagation of the modern" exact="bubonic plague" post="in India (adapted from Plague Research Commission, 1912).�? In"/>
   <result pre="the main features of the &quot;Propagation of the modern bubonic" exact="plague" post="in India (adapted from Plague Research Commission, 1912).�? In"/>
   <result pre="report LI, which do not relate to the spread of" exact="plague" post="in India. This is not a misprint or scribe's"/>
   <result pre="Hankin and Greenwood compared their studies of the spread of" exact="plague" post="in India with the spread of the Black Death"/>
   <result pre="England and concluded that the pattern of spread of these" exact="plague" post="epidemics was similar. This apparently spurious map and reference"/>
   <result pre="need for construed support. All assertions to the effect that" exact="plague" post="in India or China spread according to a different"/>
   <result pre="on epidemiological studies by IPRC [12] or on the Chinese" exact="plague" post="research team based in Shanghai [41] or on the"/>
   <result pre="based in Shanghai [41] or on the standard works on" exact="plague" post="synthesizing (also) this plague research [11, 12, 23–25]. 5.1."/>
   <result pre="or on the standard works on plague synthesizing (also) this" exact="plague" post="research [11, 12, 23–25]. 5.1. The Burial Register of"/>
   <result pre="of Plague Epidemics Another defining feature of modern and historical" exact="bubonic plague" post="formed by the rat-and-rat-flea-borne epidemiology can be demonstrated also"/>
   <result pre="Plague Epidemics Another defining feature of modern and historical bubonic" exact="plague" post="formed by the rat-and-rat-flea-borne epidemiology can be demonstrated also"/>
   <result pre="cases. Instead, it is concordant with another defining feature of" exact="bubonic plague," post="the latency period, the &quot;silent�? period between the first"/>
   <result pre="continuity by day in early August. In the case of" exact="bubonic plague," post="the first deaths would reflect the arrival of one"/>
   <result pre="and time of incubation, indicating 25 June as the day" exact="plague" post="contagion arrived. If this infective flea or another flea"/>
   <result pre="period, is a characteristic feature and defining feature of rat-based-rat-flea-borne" exact="bubonic plague" post="[12]. In this case, the latency period is followed"/>
   <result pre="is a characteristic feature and defining feature of rat-based-rat-flea-borne bubonic" exact="plague" post="[12]. In this case, the latency period is followed"/>
   <result pre="the slow and &quot;sputtering�? development of the endemic phase of" exact="bubonic plague," post="reflecting the early epizootic phase in the rat colonies"/>
   <result pre="instance, whether the form of the epidemic could conform to" exact="bubonic plague," post="which could not be performed by model, only by"/>
   <result pre="epidemiological evidence supporting the notion that the disease was ordinary" exact="bubonic plague." post="The slowly developing early epidemic phase in August with"/>
   <result pre="lice. Without alternative empirical-based explanation, this usual epidemic pattern of" exact="bubonic plague" post="invalidates their model-based hypothesis (see below). The inverse correlation"/>
   <result pre="Without alternative empirical-based explanation, this usual epidemic pattern of bubonic" exact="plague" post="invalidates their model-based hypothesis (see below). The inverse correlation"/>
   <result pre="and the latency period are two defining features of rat-and-rat-flea-borne" exact="bubonic plague" post="that can be identified by the individualized study of"/>
   <result pre="the latency period are two defining features of rat-and-rat-flea-borne bubonic" exact="plague" post="that can be identified by the individualized study of"/>
   <result pre="J. G. Dijkstra, which reveals the specific pattern of rat-and-rat-flea-borne" exact="bubonic plague" post="[47, 48]. 5.2. Clinical Features as Evidence The Filoviridae"/>
   <result pre="G. Dijkstra, which reveals the specific pattern of rat-and-rat-flea-borne bubonic" exact="plague" post="[47, 48]. 5.2. Clinical Features as Evidence The Filoviridae"/>
   <result pre="refer to any known case. In contrast, human cases of" exact="bubonic plague" post="normally exhibit buboes both in modern and historical plague,"/>
   <result pre="to any known case. In contrast, human cases of bubonic" exact="plague" post="normally exhibit buboes both in modern and historical plague,"/>
   <result pre="system. Buboes are described as a normal clinical feature of" exact="plague" post="in connection with the siege of Kaffa from where"/>
   <result pre="arriving with goods from Genoa. Recently, a paleobiological study of" exact="plague" post="graves from the Black Death near Genoa identified Y."/>
   <result pre="bodily locations, beginning with Guy de Chauliac's clinical description of" exact="plague" post="cases in Avignon [50]. From Avignon, the spread of"/>
   <result pre="Death which identified persons who had been miraculously healed from" exact="plague" post="disease by intercessory prayer to St. Remi, the city's"/>
   <result pre="on normalcy and locations of buboes is consistent with modern" exact="bubonic plague," post="only with bubonic plague and is, thus, a defining"/>
   <result pre="of buboes is consistent with modern bubonic plague, only with" exact="bubonic plague" post="and is, thus, a defining feature of bubonic plague"/>
   <result pre="buboes is consistent with modern bubonic plague, only with bubonic" exact="plague" post="and is, thus, a defining feature of bubonic plague"/>
   <result pre="with bubonic plague and is, thus, a defining feature of" exact="bubonic plague" post="[12, 52]. Dubois sums up the two central aspects"/>
   <result pre="bubonic plague and is, thus, a defining feature of bubonic" exact="plague" post="[12, 52]. Dubois sums up the two central aspects"/>
   <result pre="It is characterized by two features: (1) &quot;almost everywhere, the" exact="plague" post="has shown the bubonic form with secondary manifestations�?; (2)"/>
   <result pre="the spring�? [52]. These features are defining features of rat-and-rat-flea-borne" exact="bubonic plague" post="[12]. There are other clinical features which could be"/>
   <result pre="spring�? [52]. These features are defining features of rat-and-rat-flea-borne bubonic" exact="plague" post="[12]. There are other clinical features which could be"/>
   <result pre="that they had proved with the Reed–Frost model that historical" exact="plague" post="had a very long incubation period of 32–34 days with"/>
   <result pre="during the 5 days of illness. In all, historical cases of" exact="plague" post="disease purportedly lasted 37–39 days of which the diseased were"/>
   <result pre="that Black Death was a different kind of epidemic than" exact="bubonic plague." post="No damaging hard evidence has been found against the"/>
   <result pre="(SIR) model, and apparent scholarly distance to modern research on" exact="bubonic plague" post="and Filoviridae disease. They are incompatible with a full-scale"/>
   <result pre="model, and apparent scholarly distance to modern research on bubonic" exact="plague" post="and Filoviridae disease. They are incompatible with a full-scale"/>
   <result pre="containing, inter alia, 12 studies of biological material obtained in" exact="plague" post="graves or pits which with probability or certainty related"/>
   <result pre="of 45 biomolecular studies of skeletal material obtained in putative" exact="plague" post="graves or burial pits in 40 different localities and"/>
   <result pre="allegedly produced strong evidence that the Black Death and historical" exact="plague" post="was not bubonic plague caused by transmission of the"/>
   <result pre="evidence that the Black Death and historical plague was not" exact="bubonic plague" post="caused by transmission of the bacterium Y. pestis by"/>
   <result pre="that the Black Death and historical plague was not bubonic" exact="plague" post="caused by transmission of the bacterium Y. pestis by"/>
   <result pre="synthesis of the paleobiological studies of biological material from historical" exact="plague" post="graves was presented and in 2016 an updated version"/>
   <result pre="an updated version [12, 54]. These syntheses showed that paleobiological" exact="plague" post="studies had become so numerous, covered such a wide"/>
   <result pre="were so consistent in their identification of Yersinia pestis, the" exact="plague" post="bacterium, that alternative microbiological theories were excluded. The new"/>
   <result pre="scientific discipline had definitely confirmed the results of conventional historical" exact="plague" post="studies [28, 54–56]. Nonetheless, a few years later, it"/>
   <result pre="adapted for their use and used to prove that historical" exact="plague" post="was a Filoviridae disease, had become an alternative by"/>
   <result pre="thesis for the degree of Master of Science called Modelling" exact="plague" post="transmission in Medieval European cities [7] at CEES of"/>
   <result pre="Christakos found between pre-plague city size and the duration of" exact="plague" post="epidemics during the Black Death [30] formed the basis"/>
   <result pre="model, according to Christakos et al., allegedly invalidated that historical" exact="plague" post="could have been bubonic plague. Instead, it allegedly proved"/>
   <result pre="et al., allegedly invalidated that historical plague could have been" exact="bubonic plague." post="Instead, it allegedly proved that the Black Death and"/>
   <result pre="Instead, it allegedly proved that the Black Death and later" exact="plague" post="epidemics of the second pandemic were an entirely different"/>
   <result pre="entirely different conclusion, namely, that the Black Death and later" exact="plague" post="epidemics of the second pandemic were not a Filoviridae"/>
   <result pre="by direct infection of contaminated living cells but was indeed" exact="bubonic plague," post="caused by the bacterium Y. pestis and (purportedly) transmitted"/>
   <result pre="instance, in her statement that it contains a dataset of" exact="plague" post="outbreaks in 53 cities that purportedly, without (superfluous) support"/>
   <result pre="examples of SIR models with presentations of mortality data from" exact="plague" post="epidemics based on purported correct historical information. However, these"/>
   <result pre="includes also the reuse of Christakos et al.'s model of" exact="plague" post="deaths in Givry by month, purportedly with an entirely"/>
   <result pre="to the number of deaths per week for the 1905-06" exact="plague" post="epidemic in Bombay.�? However, Dean uses Christakos et al.'s"/>
   <result pre="with the human ectoparasite theory but easily compatible with rat-based-flea-borne" exact="bubonic plague" post="and as such a defining feature of this modality"/>
   <result pre="the human ectoparasite theory but easily compatible with rat-based-flea-borne bubonic" exact="plague" post="and as such a defining feature of this modality"/>
   <result pre="that, in Mumbai, &quot;plague in man is a reflection of" exact="plague" post="in rats�? and insert this crucial condition together with"/>
   <result pre="a substantial number of studies, in relation to, e.g., the" exact="plague" post="epidemics in the East Devon town of Colyton in"/>
   <result pre="1665-66, in studies of five streets in Bristol in the" exact="plague" post="epidemics of 1575 and 1603, and in the district"/>
   <result pre="In the latter study, the patterns of spread of the" exact="plague" post="epidemics of 1617 and 1624, according to individualized burials"/>
   <result pre="pattern of local distribution of deaths caused by the (&quot;Spanish�?)" exact="influenza" post="epidemic in the same and quite unchanged district in"/>
   <result pre="the disparate and highly distinct patterns of spread of rat-and-rat-flea-borne" exact="plague" post="and spread of flu by interhuman cross infection with"/>
   <result pre="this very best approach produced conclusive epidemiological evidence that the" exact="plague" post="epidemics were rat-and-rat-flea-borne bubonic plague. The presumption or hypothesis"/>
   <result pre="produced conclusive epidemiological evidence that the plague epidemics were rat-and-rat-flea-borne" exact="bubonic plague." post="The presumption or hypothesis that infectious or contagious diseases"/>
   <result pre="Whittles and Didelot published a new study of the 1665-66" exact="plague" post="epidemic in the village/township of Eyam using a SEIR"/>
   <result pre="by Christakos et al. and supported their finding that historical" exact="plague" post="was a Filoviridae Ebola or Marburg disease (see above)."/>
   <result pre="problems and the fallacious implications for the epidemiological study of" exact="plague" post="epidemics when it is clear, among other things, that"/>
   <result pre="plague epidemics when it is clear, among other things, that" exact="plague" post="is a bacterial disease transmitted by hematophagous insects as"/>
   <result pre="it is clear, among other things, that plague is a" exact="bacterial disease" post="transmitted by hematophagous insects as intermediary agents and with"/>
   <result pre="enough new susceptible people.�? As pointed out earlier, survival of" exact="bubonic plague" post="confers only a brief and weak immunity, as is"/>
   <result pre="new susceptible people.�? As pointed out earlier, survival of bubonic" exact="plague" post="confers only a brief and weak immunity, as is"/>
   <result pre="that historical sources record many cases where a person contracts" exact="plague" post="twice and also three times in the same epidemic"/>
   <result pre="which seemingly eliminates immunity as an issue. However, in historical" exact="plague" post="epidemics as well as in modern plague in early"/>
   <result pre="However, in historical plague epidemics as well as in modern" exact="plague" post="in early developing countries roughly around a hundred years"/>
   <result pre="the huge amount of accumulated medical and historical data on" exact="bubonic plague" post="which is needed for adequate empirical testing of the"/>
   <result pre="huge amount of accumulated medical and historical data on bubonic" exact="plague" post="which is needed for adequate empirical testing of the"/>
   <result pre="not consult any of the outstanding medical standard works on" exact="bubonic plague" post="for empirical data, in this case on the duration"/>
   <result pre="consult any of the outstanding medical standard works on bubonic" exact="plague" post="for empirical data, in this case on the duration"/>
   <result pre="cf. 59] is unwarranted and shows unfamiliarity with primary empirical" exact="plague" post="research [11]. As other recent users of S(E)IR models"/>
   <result pre="have had to consider the results of paleobiological studies of" exact="plague" post="victims of the past, Whittle and Didelot accept that"/>
   <result pre="the past, Whittle and Didelot accept that the epidemic is" exact="bubonic plague" post="but also conclude emphatically that their model engenders &quot;conclusive"/>
   <result pre="past, Whittle and Didelot accept that the epidemic is bubonic" exact="plague" post="but also conclude emphatically that their model engenders &quot;conclusive"/>
   <result pre="that interhuman transmission played a predominant role also in the" exact="plague" post="epidemic at Eyam. This should according to methodological principles"/>
   <result pre="should include the prevalence and levels of bacteraemia in human" exact="plague" post="cases which would determine the possible prevalence and level"/>
   <result pre="Didelot do not really relate to the question of human" exact="plague" post="bacteraemia. As for the necessary condition of a viable"/>
   <result pre="As mentioned above, this hypothesis has been invalidated for human" exact="plague" post="and may be significant only in highly susceptible rodent"/>
   <result pre="demographic epidemiological analysis in the article. Previous studies of the" exact="plague" post="epidemic in Eyam are entered in References, but Whittles"/>
   <result pre="not mention that, over a generation ago, Bradley studied the" exact="plague" post="epidemic in Eyam on the basis of a professional"/>
   <result pre="that the epidemiological analysis shows the characteristic features of rat-based-rat-flea-borne" exact="bubonic plague" post="[64]. 10.3. Demographic Analysis of the Epidemic in Eyam"/>
   <result pre="the epidemiological analysis shows the characteristic features of rat-based-rat-flea-borne bubonic" exact="plague" post="[64]. 10.3. Demographic Analysis of the Epidemic in Eyam"/>
   <result pre="information in the burial register in temporal perspective. The first" exact="plague" post="victim was interred on 7 September after 3 days of"/>
   <result pre="have been infected on about 30 August, and the second" exact="plague" post="burial occurred on 22 September, 15 days later. This period"/>
   <result pre="assumption. Instead, the period of delay fits nicely with rat-and-rat-flea-borne" exact="plague" post="where the flea causing the first infection or another"/>
   <result pre="Death epidemic in Givry, the 23 days elapsing between the first" exact="plague" post="case and the second represent proof of the initial"/>
   <result pre="proof of the initial phase of an epidemic of rat-and-rat-flea-borne" exact="bubonic plague." post="The Indian Plague Research Commission (IPRC) early established that"/>
   <result pre="spring months are incompatible with notions of interhuman transmission of" exact="plague" post="because it includes too long intervals without spread of"/>
   <result pre="spread of infection and new victims. There is, e.g., no" exact="plague" post="burial between 1 and 15 and 28 of January"/>
   <result pre="disappearance of the epidemic are also not compatible with louse-borne" exact="plague" post="which Whittles and Didelot, like Dean and Dean et"/>
   <result pre="Dean and Dean et al., include as important agents of" exact="plague" post="transmission [8]. Wintry weather should strengthen human-to-human cross infection"/>
   <result pre="the main reasons louse-borne rickettsial epidemic diseases, such as exanthematic" exact="typhus" post="and quintan fever (trench fever), display strong powers of"/>
   <result pre="tenable, which they evidently are not. The steep fall in" exact="plague" post="cases with the advent of cold weather should acutely"/>
   <result pre="cold weather should acutely raise the questions of whether human" exact="plague" post="cases actually functioned as sources of potential lethal doses"/>
   <result pre="and fleas. All advocates of the human ectoparasite theory of" exact="plague" post="transmission have in common that they avoid raising this"/>
   <result pre="It is not correct that this seasonal pattern of a" exact="plague" post="epidemic, the sharp decline with cold weather followed by"/>
   <result pre="a unique case [8]. This is the typical feature of" exact="plague" post="epidemics that break out in the autumn and do"/>
   <result pre="[12]. This argument is evidence of deficient knowledge of historical" exact="plague" post="epidemics. As fur fleas, rat fleas enjoy a comfortable"/>
   <result pre="Whittles and Didelot, but that the prevalence and levels of" exact="plague" post="bacteraemia in rats sharply decline when temperatures fall below"/>
   <result pre="about 10°C. For this reason, the rates and levels of" exact="plague" post="infection acquired by feeding rat fleas fall steeply, and"/>
   <result pre="extinguished) [26, 68, 69]. For this reason, the transseasonality of" exact="bubonic plague" post="is also a unique and defining feature of rat-based-rat-flea-borne"/>
   <result pre="[26, 68, 69]. For this reason, the transseasonality of bubonic" exact="plague" post="is also a unique and defining feature of rat-based-rat-flea-borne"/>
   <result pre="plague is also a unique and defining feature of rat-based-rat-flea-borne" exact="bubonic plague" post="[12]. 11. The Functions of Human Plague Cases as"/>
   <result pre="is also a unique and defining feature of rat-based-rat-flea-borne bubonic" exact="plague" post="[12]. 11. The Functions of Human Plague Cases as"/>
   <result pre="human fleas and lice were the predominant vectors of the" exact="plague" post="epidemics of the past, for instance, Dean, Whittles and"/>
   <result pre="and human fleas have been found to be infected by" exact="plague" post="bacteria after having fed on human plague patients with"/>
   <result pre="be infected by plague bacteria after having fed on human" exact="plague" post="patients with bacteraemia, i.e., with plague bacteria in the"/>
   <result pre="having fed on human plague patients with bacteraemia, i.e., with" exact="plague" post="bacteria in the blood stream. Evidently, this does not"/>
   <result pre="[71], a former leader of the French research effort on" exact="plague" post="in Madagascar in the capacity of director of the"/>
   <result pre="ants, beetles, and cockroaches which have ingested bloody cough from" exact="pneumonic plague" post="patients or other plague material become infected but no"/>
   <result pre="beetles, and cockroaches which have ingested bloody cough from pneumonic" exact="plague" post="patients or other plague material become infected but no"/>
   <result pre="have ingested bloody cough from pneumonic plague patients or other" exact="plague" post="material become infected but no one has argued that"/>
   <result pre="one has argued that they function as (significant) vectors of" exact="plague" post="contagion [11, 40]. The fact that insects feeding on"/>
   <result pre="and cannot serve as evidence of a vectorial capacity for" exact="plague" post="disease or transmission of lethal doses. 11.2. Are Human"/>
   <result pre="relation to LD A significant or central vectorial role in" exact="plague" post="epidemics for human fleas and lice are dependent on"/>
   <result pre="are not considered by proponents of human ectoparasite hypotheses of" exact="plague" post="transmission: (1) the prevalence and levels of human plague"/>
   <result pre="of plague transmission: (1) the prevalence and levels of human" exact="plague" post="bacteraemia; (2) the general size of blood meals ingested"/>
   <result pre="human fleas and lice; (3) the consequent number of ingested" exact="plague" post="bacteria; (4) the lethal dose (LD) of plague bacteria"/>
   <result pre="of ingested plague bacteria; (4) the lethal dose (LD) of" exact="plague" post="bacteria for human beings, normally expressed as the number"/>
   <result pre="on these matters in the discussion. Mass studies of human" exact="plague" post="bacteraemia were performed on patients in Mumbai's plague hospitals"/>
   <result pre="of human plague bacteraemia were performed on patients in Mumbai's" exact="plague" post="hospitals around 1900 and several quite large studies by"/>
   <result pre="physicians during the Vietnam War when there were quite big" exact="plague" post="epidemics with 4,500–5,600 recorded cases in the three peak"/>
   <result pre="that, respectively, not more than 45% and 30% of human" exact="plague" post="cases developed plague bacteraemia, or conversely that 70–55% did"/>
   <result pre="more than 45% and 30% of human plague cases developed" exact="plague" post="bacteraemia, or conversely that 70–55% did not and could"/>
   <result pre="272. These studies showed that the huge majority of bacteraemic" exact="plague" post="patients developed only slight levels of bacteraemia and that"/>
   <result pre="must ingest blood containing on the average ∼2440 or ∼5560" exact="plague" post="bacteria/mL, respectively, in order to become infected by 1"/>
   <result pre="plague bacteria/mL, respectively, in order to become infected by 1" exact="plague" post="bacterium, which represents the infection-level divisors or gauges. According"/>
   <result pre="individual measurements of human septicaemia, at least 90% of all" exact="plague" post="patients will not infect a feeding female flea, which"/>
   <result pre="takes by far the largest blood meals, with a single" exact="plague" post="bacterium during the course of plague disease [54]. When"/>
   <result pre="meals, with a single plague bacterium during the course of" exact="plague" post="disease [54]. When fleas ingest sufficiently contaminated blood, bacteria"/>
   <result pre="least 97% of feeding fleas which have fed on human" exact="plague" post="diseased will for all practical purposes be infection free"/>
   <result pre="line of reasoning can be developed further. Among the 272" exact="plague" post="patients who were individually examined for (level of) bacteraemia,"/>
   <result pre="of bacteraemia. By very far, the highest level of human" exact="plague" post="bacteraemia on record is a unique or extreme outlier"/>
   <result pre="statistical outliers, who constitute 2.9% of all individually examined human" exact="plague" post="cases for (level of) bacteraemia, probably represent the normal"/>
   <result pre="implies that 99.6% of all fleas which feed on human" exact="plague" post="cases for all practical purposes will be infection free"/>
   <result pre="meal. This is concordant with the fact that transmission of" exact="plague" post="by human fleas is not observed in large-scale laboratory"/>
   <result pre="laboratory experiments [81]. IPRC noted that Pulex irritans could transmit" exact="plague" post="to healthy guinea pigs if fed on extremely bacteraemic"/>
   <result pre="not known, the mechanism of transmission of lethal doses of" exact="plague" post="bacteria to the guinea pigs was not observed and"/>
   <result pre="remain uncertain [82]. Guinea pigs are, however, exceptionally susceptible to" exact="plague" post="infection, studies show that infection by 1 plague bacterium"/>
   <result pre="susceptible to plague infection, studies show that infection by 1" exact="plague" post="bacterium killed two-thirds of guinea pigs, i.e., LD63 = 1 [10]."/>
   <result pre="[10]. This means that the transmission of lethal doses of" exact="plague" post="infection to these guinea pigs probably occurred by the"/>
   <result pre="parts still soiled with blood containing one or a few" exact="plague" post="bacteria, which would be without significance for human beings."/>
   <result pre="This observation is concordant with the fact that transmission of" exact="bubonic plague" post="by human ectoparasites never has been observed during bubonic"/>
   <result pre="observation is concordant with the fact that transmission of bubonic" exact="plague" post="by human ectoparasites never has been observed during bubonic"/>
   <result pre="bubonic plague by human ectoparasites never has been observed during" exact="bubonic plague" post="epidemics. Plague experiments cannot be performed on human beings"/>
   <result pre="plague by human ectoparasites never has been observed during bubonic" exact="plague" post="epidemics. Plague experiments cannot be performed on human beings"/>
   <result pre="case. 90% of black rats survived primary inoculation with 5,550" exact="plague" post="bacteria, corresponding to LD10, LD50 must be significantly higher."/>
   <result pre="of a species of highly susceptible ground squirrels was 6,070" exact="plague" post="bacteria [54], which arguably could be usable as a"/>
   <result pre="at least 2.7 × 106 or 7.2 × 107 bacteria/mL to ingest this number of" exact="plague" post="bacteria. By a huge margin, this requirement is met"/>
   <result pre="of bacteraemia of 4 × 106 or 0.4% of all 272 human" exact="plague" post="cases individually examined for level of plague bacteraemia. This"/>
   <result pre="all 272 human plague cases individually examined for level of" exact="plague" post="bacteraemia. This evidence also explains that no concrete case"/>
   <result pre="explains that no concrete case of interhuman cross infection of" exact="bubonic plague" post="was observed in the big plague epidemics in India,"/>
   <result pre="that no concrete case of interhuman cross infection of bubonic" exact="plague" post="was observed in the big plague epidemics in India,"/>
   <result pre="cross infection of bubonic plague was observed in the big" exact="plague" post="epidemics in India, China, Java, and Madagascar or in"/>
   <result pre="in Egypt and Vietnam, according to the huge syntheses of" exact="plague" post="studies given in the standard works on plague. This"/>
   <result pre="to advocate an important vectorial role for this ectoparasite in" exact="plague" post="epidemics. Dean and Dean et al. refer for evidence"/>
   <result pre="human lice have also been found to be infected by" exact="plague" post="bacteria after having fed on human plague patients with"/>
   <result pre="be infected by plague bacteria after having fed on human" exact="plague" post="patients with bacteraemia. However, as pointed out, this does"/>
   <result pre="this does not constitute evidence of ingestion of LDs of" exact="plague" post="bacteria or of subsequent development of LDs in the"/>
   <result pre="that each μL of blood contains on the average 1" exact="plague" post="bacterium. This implies that a batch of lice with"/>
   <result pre="in the past 24 hours would altogether be infected by 23" exact="plague" post="bacteria when feeding on a person with a level"/>
   <result pre="level measured only in one of 271 individually studied human" exact="plague" post="cases, albeit with large margins. Also as an approximate"/>
   <result pre="which, in the light of the presented data on human" exact="plague" post="bacteraemia, puts in perspective claims that lice can play"/>
   <result pre="lice can play an important part in the transmission of" exact="bubonic plague," post="a negligible part would be more accurate, as maintained"/>
   <result pre="Blanc and Baltazard neglected to examine the group of 90" exact="plague" post="cases constituting their research material with respect to prevalence"/>
   <result pre="it seems, they withdrew blood from 2 of the 90" exact="plague" post="cases (nos. 4 and 24), who were examined by"/>
   <result pre="the basic and crucial premises of their hypothesis that human" exact="plague" post="cases quite generally develop bacteraemia and at sufficient levels"/>
   <result pre="and ∼15,200 Y. pestis/mL in order to take in 1" exact="plague" post="bacterium, which is the infection gauge or infection-level divisor"/>
   <result pre="lice, respectively. This means that 3 of the 272 human" exact="plague" post="cases examined for level of bacteraemia would infect feeding"/>
   <result pre="inaccurate measurements would infect the feeding female lice with 0–&amp;gt;∼160" exact="plague" post="bacteria, 7 cases with ∼160–240 bacteria, and only the"/>
   <result pre="for all practical purposes, will not ingest lethal doses of" exact="plague" post="by feeding on human plague cases and by vast"/>
   <result pre="not ingest lethal doses of plague by feeding on human" exact="plague" post="cases and by vast margins. Because lice feed 3"/>
   <result pre="to preserve virulence during the passage through the hindgut. Defecated" exact="plague" post="bacteria have strongly reduced virulence. Also, &quot;the faeces do"/>
   <result pre="or highly restricted results with respect to possible transmission of" exact="plague" post="bacteria by rubbing faeces into bite wounds or scarified"/>
   <result pre="scarified skin on guinea pigs which are extremely susceptible to" exact="plague" post="infection, according to the lice-typhus model [80, 85, 87],"/>
   <result pre="the very high and stable virulence and also size of" exact="plague" post="bacteria [33]. This stands out in contrast to Rickettsia"/>
   <result pre="through tiny bite wounds has only one-sixth the size of" exact="plague" post="bacteria [54]. This is the reason that human plague"/>
   <result pre="of plague bacteria [54]. This is the reason that human" exact="plague" post="cases normally develop buboes because the contagion is deposited"/>
   <result pre="drained to lymph nodes which swell upon infection. Only human" exact="plague" post="cases who develop secondary bacteraemic plague by leakage of"/>
   <result pre="upon infection. Only human plague cases who develop secondary bacteraemic" exact="plague" post="by leakage of bacteria into the blood stream from"/>
   <result pre="by toxins also display petechia. In contrast, cases of exanthematic" exact="typhus" post="rarely develop buboes while petechia are a regular feature,"/>
   <result pre="Baltazard's poster with considerations on experience with a few rural" exact="plague" post="cases in Morocco in 1941 is mentioned in the"/>
   <result pre="the discussion of the possible role of human lice in" exact="plague" post="transmission. The negative results of fine studies on the"/>
   <result pre="90]. In addition, advocates of an important vectorial role in" exact="plague" post="epidemics for human lice also refer to a more"/>
   <result pre="were fed on rabbits inoculated with 109 cfu (colony-forming units) of" exact="plague" post="bacteria without relating to the questions whether transmission of"/>
   <result pre="the questions whether transmission of such a huge load of" exact="plague" post="bacteria occurs in nature, the usual size of infections"/>
   <result pre="rabbits, and the relative incidence of possible consequent transmission of" exact="plague" post="by lice. Another matter is the relevance of the"/>
   <result pre="without a real consideration of the experiments' relationship with human" exact="plague" post="bacteraemia which would be the source of infection in"/>
   <result pre="plague bacteraemia which would be the source of infection in" exact="plague" post="epidemics, only in a highly selective and unrepresentative manner."/>
   <result pre="the fact that the LD63 of guinea pigs is 1" exact="plague" post="bacterium; when fleas were introduced, the epizootic, once started,"/>
   <result pre="[92]. The IPRC also studied the prevalence and level of" exact="plague" post="bacteraemia in black rats [93], data which also could"/>
   <result pre="epidemic plague. Houhamdi et al. used bacterial strains of the" exact="plague" post="&quot;biovar Orientalis�? [91], which has been shown not be"/>
   <result pre="for invalidation of the paper. The prevalence and levels of" exact="plague" post="bacteraemia among black rats are hugely different from human"/>
   <result pre="plague bacteraemia among black rats are hugely different from human" exact="plague" post="bacteraemia: rats (and guinea pigs) generally develop nearly 1000"/>
   <result pre="bacteraemia and are comparable, which only a minority of human" exact="plague" post="cases does. In reality, therefore, the real difference is"/>
   <result pre="infection of feeding fleas and lice in comparison with human" exact="plague" post="cases. A large proportion of plague-diseased rats will infect"/>
   <result pre="of plague-diseased rats will infect feeding fleas with numbers of" exact="plague" post="bacteria conducive to formation of blockage/biofilm [93], which is"/>
   <result pre="role for human fleas and/or lice in the transmission of" exact="bubonic plague," post="also for a tiny role. There are also other"/>
   <result pre="role for human fleas or lice in the epidemiology of" exact="plague" post="[54]. This explains that not any of the authors"/>
   <result pre="who also have in common a life-long combat of big" exact="plague" post="epidemics in various early developing countries, in the field"/>
   <result pre="do not attempt to explain how hypothesized lethal doses of" exact="plague" post="bacteria from a preceding feed should be transmitted against"/>
   <result pre="early-phase transmission has been invalidated as a significant factor in" exact="plague" post="epidemics. Taken together, this leaves them without substantiating evidence"/>
   <result pre="leaves them without substantiating evidence on the presumption on human" exact="plague" post="bacteraemia as sufficient source of lethal bacterial doses and"/>
   <result pre="bacterial doses and without a functional means of transmission of" exact="plague" post="infection. This means not only that the analysed use"/>
   <result pre="that human ectoparasites could play an important role in the" exact="plague" post="epidemics of the past. Dean states, e.g., that &quot;With"/>
   <result pre="that &quot;Mathematical modelling can provide strong insight into mechanisms of" exact="plague" post="transmission for past epidemics,�? which indicates a clear empirical"/>
   <result pre="demographers, to test the epidemiological and microbiological character of the" exact="plague" post="epidemic in Colyton (Devon, England) in 1645-46 on the"/>
   <result pre="convincing grounds that it displayed the characteristic features of rat-based-rat-flea-borne" exact="bubonic plague" post="[54, 58]. 13. Conclusions: The Uses and Limits of"/>
   <result pre="grounds that it displayed the characteristic features of rat-based-rat-flea-borne bubonic" exact="plague" post="[54, 58]. 13. Conclusions: The Uses and Limits of"/>
   <result pre="the dynamics of spread of the Black Death and subsequent" exact="plague" post="epidemics of the Second Plague Pandemic (1346-c. 1690). Using"/>
   <result pre="identified two entirely different diseases, also different from the rat-and-rat-flea-borne" exact="bubonic plague" post="presented in the standard works on plague: historical plague"/>
   <result pre="two entirely different diseases, also different from the rat-and-rat-flea-borne bubonic" exact="plague" post="presented in the standard works on plague: historical plague"/>
   <result pre="bubonic plague presented in the standard works on plague: historical" exact="plague" post="(1) was a Filoviridae disease (e.g., Ebola disease); (2)"/>
   <result pre="(1) was a Filoviridae disease (e.g., Ebola disease); (2) a" exact="bacterial disease" post="caused by the bacterium Yersinia pestis transmitted by inter-human"/>
   <result pre="to &quot;prove�? or corroborate incompatible theories, in casu that historical" exact="plague" post="was two entirely different diseases, something must be fundamentally"/>
   <result pre="means that these models will malfunction if the studied historical" exact="plague" post="epidemics were bacterial, e.g., caused by Y. pestis, and/or"/>
   <result pre="of the use of these models with respect to historical" exact="plague" post="epidemics can be empirically tested: (1) Paleobiological studies consistently"/>
   <result pre="be empirically tested: (1) Paleobiological studies consistently show that historical" exact="plague" post="was caused by the conventional plague bacterium Y. pestis"/>
   <result pre="consistently show that historical plague was caused by the conventional" exact="plague" post="bacterium Y. pestis [54, Ch. 1.5; 12, Ch. 10]."/>
   <result pre="Studies of the prevalence and levels of bacteraemia in human" exact="plague" post="cases show that they cannot serve as sources of"/>
   <result pre="ectoparasites that can enable them to transmit lethal doses of" exact="plague" post="except in exceedingly rare cases, irrespective of the hypothesis"/>
   <result pre="show that human fleas normally hardly have vector capacity for" exact="plague" post="infection and potentially can transmit plague only exceedingly rarely."/>
   <result pre="have vector capacity for plague infection and potentially can transmit" exact="plague" post="only exceedingly rarely. (4) The proposed role of ETP"/>
   <result pre="evidence which can explain that all scholarly studies of historical" exact="plague" post="epidemics by use of mathematical epidemiological S(E)IR models have"/>
   <result pre="to identify the microbial agent and epidemiological dynamics of the" exact="plague" post="epidemics of the past and indicate completely different diseases"/>
   <result pre="that plague-infected black rats have a prevalence and levels of" exact="plague" post="bacteraemia that make them extremely good sources for heavy"/>
   <result pre="fleas that can enable them to transmit lethal doses of" exact="plague" post="bacteria. (6) Laboratory studies show that the black-rat flea"/>
   <result pre="of lethal doses of plague. (7) The historical study of" exact="plague" post="epidemics, for instance, the complete history of the Black"/>
   <result pre="display the characteristic patterns of seasonality and spread of rat-and-rat-flea-borne" exact="plague" post="of Y. pestis [12, 28, 54]. This is in"/>
   <result pre="This is in complete concordance with the standard works on" exact="plague" post="and also the historical views provided by diachronic historical"/>
   <result pre="models in this article shows why they malfunction in historical" exact="plague" post="studies and confirmed the limitations in the range of"/>
   <result pre="use of mathematical S(E)IR models in the study of historical" exact="plague" post="epidemics is also analysed on the basis of the"/>
   <result pre="Epidemic Modelling: The Case of Black Death2005Berlin, GermanySpringer 7DeanK. R.Modeling" exact="plague" post="transmission in medieval European cities2015Oslo, NorwayCEES, University of OsloM.S."/>
   <result pre="University of OsloM.S. thesis 8WhittlesL. K.DidelotX.Epidemiological analysis of the Eyam" exact="plague" post="outbreak of 1665-1666Proceedings of the Royal Society B: Biological"/>
   <result pre="Biological Sciences201628318301910.1098/rspb.2016.0618 9DeanK. R.KrauerF.WalløeL.et al.Human ectoparasites and the spread of" exact="plague" post="in Europe during the second pandemicProceedings of the National"/>
   <result pre="the spatiotemporal modelling and comparative analysis of Black Death and" exact="bubonic plague" post="epidemicsPublic Health2007121970072010.1016/j.puhe.2006.12.01117544041 35https://dictionary.cambridge.org/dictionary/english/village,town,city,metropolis,urban 36BurnetF. M.WhiteD. O.Natural History of Infectious"/>
   <result pre="spatiotemporal modelling and comparative analysis of Black Death and bubonic" exact="plague" post="epidemicsPublic Health2007121970072010.1016/j.puhe.2006.12.01117544041 35https://dictionary.cambridge.org/dictionary/english/village,town,city,metropolis,urban 36BurnetF. M.WhiteD. O.Natural History of Infectious"/>
   <result pre="Research CommissionReports on Plague Investigations in India XLVGreenwoodM.Statistical investigation of" exact="plague" post="in the Punjab, third report: on some of the"/>
   <result pre="the prevalence of plagueJournal of Hygiene1911116215620474479 39BenedictowO. J.Morbidity in historical" exact="plague" post="epidemicsPopulation Studies198741340143110.1080/003247203100014297611612345 40PollitzerR.MeyerK. F.MayJ. M.The ecology of plagueStudies in"/>
   <result pre="Journal of Medicine20153721404710.1056/NEJMoa141124925372658 45collab: Indian Plague Research Commission Reports on" exact="plague" post="investigations in India, XXIIThe epidemiological observations made by the"/>
   <result pre="spread of the Black Death in Italy: first evidence of" exact="plague" post="victims from 14th-century Liguria (Northern Italy)Anthropological Science20171251152410.1537/ase.161011 50JoubertL.Chirurgia Magna"/>
   <result pre="famous of all English plagues: a detailed analysis of the" exact="plague" post="at Eyam 1665-6The Plague Reconsidered1977Derbyshire, UKLocal Population Studies, Matlock6394"/>
   <result pre="17 Jahrhundert, insbesondere in der Stadt Uelzen1954Uelzen, GermanyBecker Verlag 61The" exact="plague" post="reconsidered: a new look at its origins and effects"/>
   <result pre="case of Nonantola (Northern Italy) in 1630Population Studies201873110111810.1080/00324728.2018.145779429770727 64ColemanM. P.A" exact="plague" post="epidemic in voluntary quarantineInternational Journal of Epidemiology198615337938510.1093/ije/15.3.3793533810 65ShrewsburyJ. F."/>
   <result pre="on Plague Investigations in India, XXOn the seasonal prevalence of" exact="plague" post="in IndiaJournal of Hygiene19088226630110.1017/s002217240000331420474359 69SealS. C.Epidemiological studies of plague"/>
   <result pre="of plague in IndiaJournal of Hygiene19088226630110.1017/s002217240000331420474359 69SealS. C.Epidemiological studies of" exact="plague" post="in IndiaBulletin of the World Health Organization1969232-3283292 70BlancG.BaltazardM.Rôle de"/>
   <result pre="and inoculation tests for infectionPublic Health Reports (1896–1970)193954321467148110.2307/4582984 81BurroughsA. L.Sylvatic" exact="plague" post="studies: the vector efficiency of nine species of fleas"/>
   <result pre="Plague Investigations in India, XVFurther observations on the transmission of" exact="plague" post="by fleas, with special reference to the fate of"/>
   <result pre="by fleas, with special reference to the fate of the" exact="plague" post="bacillus in the body of the rat flea (P."/>
   <result pre="LXIIBacotA. W.MartinC. J.Observations on the mechanism of the transmission of" exact="plague" post="by fleasJournal of Hygiene, Plague Supplement III191414423439 87HinnebuschB. J.ChouikhaI.SunY.-C.Ecological"/>
   <result pre="Yersinia pestis hemin storage (hms) locus in the transmission of" exact="plague" post="by fleasScience1996273527336737010.1126/science.273.5273.3678662526 89LorangeE. A.RaceB. L.SebbaneF.Joseph HinnebuschB.Poor vector competence of"/>
   <result pre="Investigations in India, I Part threeExperiments upon the transmission of" exact="plague" post="by fleasJournal of Hygiene1906645046720474277 93collab: Indian Plague Research Commission,"/>
   <result pre="Reports on Plague Investigations in India, VIIIOn the number of" exact="plague" post="bacilli in the blood, urine, and faeces respectively of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6721381\results\search\disease\results.xml">
   <result pre="Hemorrhagic fever with renal syndrome (HFRS) is an emerging zoonotic" exact="infectious disease" post="caused by hantaviruses which circulate worldwide. So far, it"/>
   <result pre="Hemorrhagic fever with renal syndrome (HFRS) is an emerging zoonotic" exact="infectious disease" post="caused by hantaviruses which circulate worldwide posing the ongoing"/>
   <result pre="Thus, more attention need to be paid cause this zoonotic" exact="infectious disease" post="has killed too many people and made severe adverse"/>
   <result pre="Virol20088061033104110.1002/jmv.2114918428127 13.LiQCaiYWeiYHanXHanZZhangYQiSXuYGenovariation study of hantavirus in main endemic areas of" exact="hemorrhagic fever with renal syndrome" post="in Hebei Province, ChinaPLoS One2016117e015973110.1371/journal.pone.015973127442527 14.YangWLiZLanYWangJMaJJinLSunQLvWLaiSLiaoYet al.A nationwide web-based"/>
   <result pre="datasetsMol Biol Evol20163371870187410.1093/molbev/msw05427004904 23.LiQZhaoWWeiYHanXHanZZhangYQiSXuYAnalysis of incidence and related factors of" exact="hemorrhagic fever with renal syndrome" post="in Hebei Province, ChinaPLoS One201497e10134810.1371/journal.pone.010134825000390 24.KrugerDHSchonrichGKlempaBHuman pathogenic hantaviruses and"/>
   <result pre="pathogenic hantaviruses and prevention of infectionHum Vaccin20117668569310.4161/hv.7.6.1519721508676 25.ChenHXQiuFXDongBJJiSZLiYTWangYWangHMZuoGFTaoXXGaoSYEpidemiological studies on" exact="hemorrhagic fever with renal syndrome" post="in ChinaJ Infect Dis1986154339439810.1093/infdis/154.3.3942874178 26.ChenHXQiuFXEpidemiologic surveillance on the hemorrhagic"/>
   <result pre="renal syndrome in ChinaJ Infect Dis1986154339439810.1093/infdis/154.3.3942874178 26.ChenHXQiuFXEpidemiologic surveillance on the" exact="hemorrhagic fever with renal syndrome" post="in ChinaChin Med J1993106118578637908258 27.TianHYuPCazellesBXuLTanHYangJHuangSXuBCaiJMaCet al.Interannual cycles of Hantaan"/>
   <result pre="citiesProc Natl Acad Sci U S A2018115184707471210.1073/pnas.171276711529666240 32.HanSSKimSChoiYKimSKimYSAir pollution and" exact="hemorrhagic fever with renal syndrome" post="in South Korea: an ecological correlation studyBMC Public Health20131334710.1186/1471-2458-13-34723587219"/>
   <result pre="studyBMC Public Health20131334710.1186/1471-2458-13-34723587219 33.JiangFWangLWangSZhuLDongLZhangZHaoBYangFLiuWDengYet al.Meteorological factors affect the epidemiology of" exact="hemorrhagic fever with renal syndrome" post="via altering the breeding and hantavirus-carrying states of rodents"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6722215\results\search\disease\results.xml">
   <result pre="which does not comply with these terms. distemper evolution morbillivirus" exact="measles" post="zoonotic disease Funding Departamento Administrativo de Ciencia, Tecnología e"/>
   <result pre="had become common in Europe (Walker et al., 2015). Multiple" exact="measles" post="epidemics, therefore, devastated the indigenous American populations (Walker et"/>
   <result pre="maternal immunity, and the vaccine has been useful against clinical" exact="measles" post="disease in non-human primates (Christe et al., 2019). Hence,"/>
   <result pre="J. Virol.92:e01248–18. 10.1128/JVI.01248-1830232185 BakerJ. A.SheffyB. E.RobsonD. S.GilmartinJ. (1966). Response to" exact="measles" post="virus by puppies with maternally transferred distemper antibodies. Cornell"/>
   <result pre="Med. Vet.29, 35−41. 15376360 BrownA. L.MccarthyR. E. (1974). Relationship between" exact="measles" post="and canine distemper viruses determined by delayed type hypersensitivity"/>
   <result pre="between measles and canine distemper viruses determined by delayed type" exact="hypersensitivity" post="reactions in dogs. Nature248, 344–345. 10.1038/248344a04819642 BrownA. L.VitamvasJ. A.MerryD."/>
   <result pre="from related veterinary viruses and need for continued vaccination post" exact="measles" post="eradication. Hum. Vaccin. Immunother.14, 229–233. 10.1080/21645515.2017.140367729173050 De VriesR. D.DuprexW."/>
   <result pre="virus. Mem. Inst. Oswaldo Cruz113:e170385. 10.1590/0074-0276017038529768530 FuruseY.SuzukiA.OshitaniH. (2010). Origin of" exact="measles" post="virus: divergence from rinderpest virus between the 11th and"/>
   <result pre="and 12th centuries. Virol. J.7:52. 10.1186/1743-422X-7-5220202190 GoniN.IriarteA.ComasV.SonoraM.MorenoP.MoratorioG.et al.. (2012). Pandemic" exact="influenza" post="A virus codon usage revisited: biases, adaptation and implications"/>
   <result pre="B.OvsyannikovaI. G.WhitakerJ. A.PolandG. A. (2015). Variability in humoral immunity to" exact="measles" post="vaccine: new developments. Trends Mol. Med.21, 789–801. 10.1016/j.molmed.2015.10.00526602762 HolzmannH.HengelH.TenbuschM.DoerrH."/>
   <result pre="marker PVRL4 (nectin 4) is an epithelial cell receptor for" exact="measles" post="virus. PLoS Pathog.7:e1002240. 10.1371/journal.ppat.100224021901103 OhishiK.SuzukiR.MaedaT.TsudaM.AbeE.YoshidaT.et al.. (2014). Recent host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6723535\results\search\disease\results.xml">
   <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Aseptic" exact="meningitis" post="is a common viral infection associated with human enteroviruses."/>
   <result pre="characterize the enteroviruses associated with outbreaks and sporadic cases of" exact="aseptic meningitis" post="that occurred in different regions of Brazil between 2013"/>
   <result pre="the enteroviruses associated with outbreaks and sporadic cases of aseptic" exact="meningitis" post="that occurred in different regions of Brazil between 2013"/>
   <result pre="children ≤ 15 years old. The temporal distribution of all" exact="aseptic meningitis" post="and EV-positive cases showed an obvious seasonal pattern during"/>
   <result pre="≤ 15 years old. The temporal distribution of all aseptic" exact="meningitis" post="and EV-positive cases showed an obvious seasonal pattern during"/>
   <result pre="have provided valuable information about the enteroviral etiology of the" exact="aseptic meningitis" post="cases in Brazil pointing to the importance of enterovirus"/>
   <result pre="provided valuable information about the enteroviral etiology of the aseptic" exact="meningitis" post="cases in Brazil pointing to the importance of enterovirus"/>
   <result pre="pointing to the importance of enterovirus surveillance in neurological diseases." exact="aseptic meningitis" post="enterovirus echovirus-30 echovirus-6 1. Introduction Human enteroviruses (EV) are"/>
   <result pre="to the importance of enterovirus surveillance in neurological diseases. aseptic" exact="meningitis" post="enterovirus echovirus-30 echovirus-6 1. Introduction Human enteroviruses (EV) are"/>
   <result pre="associated with a broad spectrum of clinical presentations such as" exact="hand, foot, and mouth disease," post="acute myalgia, herpangina, conjunctivitis, upper and lower respiratory disease"/>
   <result pre="broad spectrum of clinical presentations such as hand, foot, and" exact="mouth disease," post="acute myalgia, herpangina, conjunctivitis, upper and lower respiratory disease"/>
   <result pre="and mouth disease, acute myalgia, herpangina, conjunctivitis, upper and lower" exact="respiratory disease" post="and severe syndromes of the central nervous system (CNS)"/>
   <result pre="CNS, it is worth mentioning encephalitis, acute flaccid paralysis, paralytic" exact="myelitis" post="and aseptic meningitis [1]. Aseptic meningitis is defined as"/>
   <result pre="is worth mentioning encephalitis, acute flaccid paralysis, paralytic myelitis and" exact="aseptic meningitis" post="[1]. Aseptic meningitis is defined as a non-bacterial acute"/>
   <result pre="worth mentioning encephalitis, acute flaccid paralysis, paralytic myelitis and aseptic" exact="meningitis" post="[1]. Aseptic meningitis is defined as a non-bacterial acute"/>
   <result pre="acute flaccid paralysis, paralytic myelitis and aseptic meningitis [1]. Aseptic" exact="meningitis" post="is defined as a non-bacterial acute infectious disease of"/>
   <result pre="meningitis [1]. Aseptic meningitis is defined as a non-bacterial acute" exact="infectious disease" post="of the tissue that covers the brain and spinal"/>
   <result pre="most common viral infection of the CNS. The majority of" exact="aseptic meningitis" post="cases are caused by non-polio enteroviruses, although other infectious"/>
   <result pre="common viral infection of the CNS. The majority of aseptic" exact="meningitis" post="cases are caused by non-polio enteroviruses, although other infectious"/>
   <result pre="of the meninges [3]. The common symptoms in patients with" exact="viral meningitis" post="can vary with age and underlying immune state, but"/>
   <result pre="the meninges [3]. The common symptoms in patients with viral" exact="meningitis" post="can vary with age and underlying immune state, but"/>
   <result pre="limited number of investigations on EV that are associated with" exact="aseptic meningitis" post="outbreaks have been reported, such as those related to"/>
   <result pre="number of investigations on EV that are associated with aseptic" exact="meningitis" post="outbreaks have been reported, such as those related to"/>
   <result pre="be necessary to understand the distribution of EV serotypes causing" exact="aseptic meningitis" post="besides their clinical features. The present work aimed to"/>
   <result pre="necessary to understand the distribution of EV serotypes causing aseptic" exact="meningitis" post="besides their clinical features. The present work aimed to"/>
   <result pre="work aimed to identify and characterize the EV associated with" exact="aseptic meningitis" post="outbreaks or sporadic cases in different geographic areas of"/>
   <result pre="aimed to identify and characterize the EV associated with aseptic" exact="meningitis" post="outbreaks or sporadic cases in different geographic areas of"/>
   <result pre="and all laboratorial data obtained from the analysis of 2659" exact="aseptic meningitis" post="suspected cases during this period were included in the"/>
   <result pre="all laboratorial data obtained from the analysis of 2659 aseptic" exact="meningitis" post="suspected cases during this period were included in the"/>
   <result pre="specimens (2532/2659) with sufficient volume were used to inoculate human" exact="rhabdomyosarcoma" post="(RD) and human cervix carcinoma (Hep2C) cell lines as"/>
   <result pre="(RT-PCR) for EV. To identify the EV serotypes associated with" exact="aseptic meningitis," post="viral RNA was extracted from 140 μL of the"/>
   <result pre="Results 3.1. Epidemiological Analysis A total of 2659 cases of" exact="aseptic meningitis" post="were reported from 2013 to 2017 in four geographic"/>
   <result pre="3.1. Epidemiological Analysis A total of 2659 cases of aseptic" exact="meningitis" post="were reported from 2013 to 2017 in four geographic"/>
   <result pre="gender ratio (male/female) was 1.4:1, indicating a higher prevalence of" exact="aseptic meningitis" post="in male children (Table 1). Regarding the EV-positive patients,"/>
   <result pre="ratio (male/female) was 1.4:1, indicating a higher prevalence of aseptic" exact="meningitis" post="in male children (Table 1). Regarding the EV-positive patients,"/>
   <result pre="to 2.2) (Table 1). In general, the age distribution of" exact="aseptic meningitis" post="cases ranged from 1 month to 92 years old"/>
   <result pre="2.2) (Table 1). In general, the age distribution of aseptic" exact="meningitis" post="cases ranged from 1 month to 92 years old"/>
   <result pre="the specimens sent for enterovirus investigation. The monthly distributions of" exact="aseptic meningitis" post="cases are illustrated in Figure 1. Although the number"/>
   <result pre="specimens sent for enterovirus investigation. The monthly distributions of aseptic" exact="meningitis" post="cases are illustrated in Figure 1. Although the number"/>
   <result pre="acids identities and similarity, respectively. 4. Discussion Numerous studies about" exact="aseptic meningitis" post="have been conducted over the last few years and"/>
   <result pre="identities and similarity, respectively. 4. Discussion Numerous studies about aseptic" exact="meningitis" post="have been conducted over the last few years and"/>
   <result pre="this study, we evaluated the epidemiological and virological features of" exact="aseptic meningitis" post="outbreaks/sporadic cases caused by EV from 2013 to 2017"/>
   <result pre="study, we evaluated the epidemiological and virological features of aseptic" exact="meningitis" post="outbreaks/sporadic cases caused by EV from 2013 to 2017"/>
   <result pre="to studies performed in other countries [19,20]. A predominance of" exact="aseptic meningitis" post="among males was observed in this work with an"/>
   <result pre="studies performed in other countries [19,20]. A predominance of aseptic" exact="meningitis" post="among males was observed in this work with an"/>
   <result pre="age of six years old [21,22,23]. Regarding the distribution of" exact="aseptic meningitis" post="cases reported in different geographic areas of Brazil, we"/>
   <result pre="of six years old [21,22,23]. Regarding the distribution of aseptic" exact="meningitis" post="cases reported in different geographic areas of Brazil, we"/>
   <result pre="for more than 80% (2174/2659) of these cases. However, although" exact="aseptic meningitis" post="is a notifiable disease in Brazil many regions do"/>
   <result pre="more than 80% (2174/2659) of these cases. However, although aseptic" exact="meningitis" post="is a notifiable disease in Brazil many regions do"/>
   <result pre="of cases per region. Regarding the seasonal distribution of the" exact="aseptic meningitis" post="cases, some studies in temperate climates have shown that"/>
   <result pre="cases per region. Regarding the seasonal distribution of the aseptic" exact="meningitis" post="cases, some studies in temperate climates have shown that"/>
   <result pre="also occurred in other seasons. Conversely, other studies reported that" exact="aseptic meningitis" post="cases in the southern hemisphere countries occurred more frequently"/>
   <result pre="occurred in other seasons. Conversely, other studies reported that aseptic" exact="meningitis" post="cases in the southern hemisphere countries occurred more frequently"/>
   <result pre="E-6 were considered the major enteroviruses causing epidemics/sporadic cases of" exact="aseptic meningitis" post="around of the world as well as a high"/>
   <result pre="were considered the major enteroviruses causing epidemics/sporadic cases of aseptic" exact="meningitis" post="around of the world as well as a high"/>
   <result pre="we found that E-30 was the main pathogen associated with" exact="aseptic meningitis" post="(102/295; 34.6% of the EV-positive patients) followed by E-6"/>
   <result pre="found that E-30 was the main pathogen associated with aseptic" exact="meningitis" post="(102/295; 34.6% of the EV-positive patients) followed by E-6"/>
   <result pre="shown, these two enteroviruses were commonly observed in co-circulation in" exact="aseptic meningitis" post="cases, enabling the occurrence of the co-infection, which may"/>
   <result pre="these two enteroviruses were commonly observed in co-circulation in aseptic" exact="meningitis" post="cases, enabling the occurrence of the co-infection, which may"/>
   <result pre="of Brazil, E-30 was first described to be involved with" exact="aseptic meningitis" post="outbreaks in Southern Brazil between 1998 and 2003 [27]."/>
   <result pre="Brazil, E-30 was first described to be involved with aseptic" exact="meningitis" post="outbreaks in Southern Brazil between 1998 and 2003 [27]."/>
   <result pre="with E-30 strains from Argentina and USA. Information about E-6-causing" exact="aseptic meningitis" post="in Brazil is scarce. Dos Santos et al. reported"/>
   <result pre="E-30 strains from Argentina and USA. Information about E-6-causing aseptic" exact="meningitis" post="in Brazil is scarce. Dos Santos et al. reported"/>
   <result pre="Santos et al. reported a low incidence of E-6 in" exact="aseptic meningitis" post="outbreaks/sporadic cases in Brazil between 1998 and 2003 [27]."/>
   <result pre="et al. reported a low incidence of E-6 in aseptic" exact="meningitis" post="outbreaks/sporadic cases in Brazil between 1998 and 2003 [27]."/>
   <result pre="a previous study demonstrated the involvement of E-6 in an" exact="aseptic meningitis" post="outbreak that occurred in the São Paulo state in"/>
   <result pre="previous study demonstrated the involvement of E-6 in an aseptic" exact="meningitis" post="outbreak that occurred in the São Paulo state in"/>
   <result pre="In fact, we identified the increasing occurrence of E-6 in" exact="aseptic meningitis" post="cases in Brazil. In the last years, the number"/>
   <result pre="fact, we identified the increasing occurrence of E-6 in aseptic" exact="meningitis" post="cases in Brazil. In the last years, the number"/>
   <result pre="detection rate. Furthermore, E-6 was the main EV involved in" exact="aseptic meningitis" post="cases identified across 2015 and 2016. Phylogenetic analysis revealed"/>
   <result pre="rate. Furthermore, E-6 was the main EV involved in aseptic" exact="meningitis" post="cases identified across 2015 and 2016. Phylogenetic analysis revealed"/>
   <result pre="agents. Overall, the enteroviral etiology and epidemiologic characteristics involved in" exact="aseptic meningitis" post="in Brazil is similar to that observed around the"/>
   <result pre="Overall, the enteroviral etiology and epidemiologic characteristics involved in aseptic" exact="meningitis" post="in Brazil is similar to that observed around the"/>
   <result pre="the world. E-30 and E-6 are predominant serotypes involved in" exact="aseptic meningitis" post="cases. The Brazilian vast territory associated with recurrent E-6/E-30"/>
   <result pre="world. E-30 and E-6 are predominant serotypes involved in aseptic" exact="meningitis" post="cases. The Brazilian vast territory associated with recurrent E-6/E-30"/>
   <result pre="these viruses showed the importance of enterovirus surveillance in the" exact="aseptic meningitis" post="context. Acknowledgments We would like to acknowledge the collaboration"/>
   <result pre="viruses showed the importance of enterovirus surveillance in the aseptic" exact="meningitis" post="context. Acknowledgments We would like to acknowledge the collaboration"/>
   <result pre="SantosG.P.da CostaE.V.TavaresF.N.da CostaL.J.da SilvaE.E.Genetic diversity of Echovirus 30 involved in" exact="aseptic meningitis" post="cases in Brazil (1998–2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus"/>
   <result pre="CostaE.V.TavaresF.N.da CostaL.J.da SilvaE.E.Genetic diversity of Echovirus 30 involved in aseptic" exact="meningitis" post="cases in Brazil (1998–2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus"/>
   <result pre="cases in Brazil (1998–2008)J. Med. Virol.2011832164217110.1002/jmv.2223522012725 5.KmetzschC.I.BalkieE.M.MonteiroA.CostaE.V.dos SantosG.P.da SilvaE.E.Echovirus 13" exact="aseptic meningitis," post="BrazilEmerg. Infect. Dis.2006121289129010.3201/eid1708.05131716977690 6.SousaI.P.Jr.BurlandyF.M.OliveiraS.S.NunesA.M.SousaC.da SilvaE.M.SouzaJ.G.A.de PaulaV.A.OliveiraI.C.M.TavaresF.N.et al.Acute flaccid paralysis"/>
   <result pre="Encephalitis in the United States, 2011–2014Clin. Infect. Dis.20176535936310.1093/cid/cix31928419350 19.KimH.J.KangB.HwangS.HongJ.KimK.CheonD.S.Epidemics of" exact="viral meningitis" post="caused by echovirus 6 and 30 in Korea in"/>
   <result pre="in the United States, 2011–2014Clin. Infect. Dis.20176535936310.1093/cid/cix31928419350 19.KimH.J.KangB.HwangS.HongJ.KimK.CheonD.S.Epidemics of viral" exact="meningitis" post="caused by echovirus 6 and 30 in Korea in"/>
   <result pre="J.201293810.1186/1743-422X-9-3822336050 20.ChenP.LinbX.LiubG.WangbS.SongbL.TaoZ.XuaA.Analysis of enterovirus types in patients with symptoms of" exact="aseptic meningitis" post="in 2014 in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human"/>
   <result pre="20.ChenP.LinbX.LiubG.WangbS.SongbL.TaoZ.XuaA.Analysis of enterovirus types in patients with symptoms of aseptic" exact="meningitis" post="in 2014 in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human"/>
   <result pre="in Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human enteroviruses associated with" exact="aseptic meningitis" post="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of"/>
   <result pre="Shandong, ChinaVirology201851619620110.1016/j.virol.2018.01.02229407377 21.ZhuY.ZhouX.LiuJ.XiaL.PanY.ChenJ.LuoN.YinJ.MaS.Molecular identification of human enteroviruses associated with aseptic" exact="meningitis" post="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of"/>
   <result pre="meningitis in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of" exact="aseptic meningitis" post="caused by a distinct lineage of coxsackievirus B5 in"/>
   <result pre="in Yunnan province, Southwest ChinaSpringerPlus20165151510.1186/s40064-016-3194-127652088 22.LiuN.JiaL.YinJ.WuZ.WangZ.LiP.HaoR.WangL.WangY.QiuS.et al.An outbreak of aseptic" exact="meningitis" post="caused by a distinct lineage of coxsackievirus B5 in"/>
   <result pre="2007–2013J. Med. Virol.2014861609161310.1002/jmv.2388524474149 26.SmutsH.CronjeS.ThomasJ.BrinkD.KorsmanS.HardieD.Molecular characterization of an outbreak of enterovirus-associated" exact="meningitis" post="in Mossel Bay, South Africa, December 2015–January 2016BMC Infect."/>
   <result pre="1998–2003J. Med. Virol.2006789810410.1002/jmv.2050916299728 28.Pinto JuniorV.L.RebeloM.C.CostaE.V.SilvaE.E.BóiaM.N.Description of a widespread outbreak of" exact="aseptic meningitis" post="due to echovirus 30 in Rio de Janeiro state,"/>
   <result pre="Med. Virol.2006789810410.1002/jmv.2050916299728 28.Pinto JuniorV.L.RebeloM.C.CostaE.V.SilvaE.E.BóiaM.N.Description of a widespread outbreak of aseptic" exact="meningitis" post="due to echovirus 30 in Rio de Janeiro state,"/>
   <result pre="Janeiro state, BrazilBraz. J. Infect. Dis.20091336737010.1590/S1413-8670200900050001120428638 29.LuchsA.RussoD.H.CilliA.CostaF.F.MorilloS.G.MachadoB.C.PelliniA.C.CarmonaR.C.C.TimenetskyM.C.Echovirus 6 associated to" exact="aseptic meningitis" post="outbreak, in São Joaquim da Barra, São Paulo, BrazilBraz."/>
   <result pre="state, BrazilBraz. J. Infect. Dis.20091336737010.1590/S1413-8670200900050001120428638 29.LuchsA.RussoD.H.CilliA.CostaF.F.MorilloS.G.MachadoB.C.PelliniA.C.CarmonaR.C.C.TimenetskyM.C.Echovirus 6 associated to aseptic" exact="meningitis" post="outbreak, in São Joaquim da Barra, São Paulo, BrazilBraz."/>
   <result pre="Enterovirus and EV71-Specific PrimersJ. Clin. Microbiol.2002402823282710.1128/JCM.40.8.2823-2827.200212149336 33.SousaI.P.Jr.BurlandyF.M.CostaE.V.TavaresF.N.da SilvaE.E.Enteroviruses associated with" exact="hand, foot, and mouth disease" post="in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic"/>
   <result pre="PrimersJ. Clin. Microbiol.2002402823282710.1128/JCM.40.8.2823-2827.200212149336 33.SousaI.P.Jr.BurlandyF.M.CostaE.V.TavaresF.N.da SilvaE.E.Enteroviruses associated with hand, foot, and" exact="mouth disease" post="in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic"/>
   <result pre="mouth disease in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of" exact="aseptic meningitis" post="cases in Brazil from 2013 to 2017 for all"/>
   <result pre="disease in BrazilJ. Infect.20187744845410.1016/j.jinf.2018.08.012 Figure 1 Seasonal distribution of aseptic" exact="meningitis" post="cases in Brazil from 2013 to 2017 for all"/>
   <result pre="Proportion of enterovirus detection based on cell culture isolation in" exact="aseptic meningitis" post="patients. Figure 3 Enterovirus serotypes detected between 2013 and"/>
   <result pre="of enterovirus detection based on cell culture isolation in aseptic" exact="meningitis" post="patients. Figure 3 Enterovirus serotypes detected between 2013 and"/>
   <result pre="Figure 3 Enterovirus serotypes detected between 2013 and 2017 from" exact="aseptic meningitis" post="patients. (A). Enterovirus serotypes identified per year (2013–2017). (B)."/>
   <result pre="3 Enterovirus serotypes detected between 2013 and 2017 from aseptic" exact="meningitis" post="patients. (A). Enterovirus serotypes identified per year (2013–2017). (B)."/>
   <result pre="and 867 bp in length, respectively) of Brazilian isolates causing" exact="meningitis" post="and other sequences available at the GenBank database. (A)"/>
   <result pre="as a color scale. viruses-11-00690-t001_Table 1Table 1 Demographic features of" exact="aseptic meningitis" post="patients in Brazil, 2013–2017. Variable Year (All Patients/EV-Positive) Year"/>
   <result pre="a color scale. viruses-11-00690-t001_Table 1Table 1 Demographic features of aseptic" exact="meningitis" post="patients in Brazil, 2013–2017. Variable Year (All Patients/EV-Positive) Year"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6724274\results\search\disease\results.xml">
   <result pre="tract infections are common during early childhood. How they impact" exact="cystic fibrosis" post="lung disease history in young children is poorly known."/>
   <result pre="are common during early childhood. How they impact cystic fibrosis" exact="lung disease" post="history in young children is poorly known. The principal"/>
   <result pre="study was to determinate respiratory tract infections frequency in this" exact="cystic fibrosis" post="young population. Secondary outcomes were nature of viral agents"/>
   <result pre="conducted a prospective cohort study of 25 children affected by" exact="cystic fibrosis" post="and aged less than 2 years. Nasal samplings were taken"/>
   <result pre="tested by a combination of five duplex RT-PCRs or PCRs:" exact="influenza" post="A and B, respiratory syncytial virus (RSV), metapneumovirus (MPV),"/>
   <result pre="mild severity. Conclusions Respiratory tract infections in young children with" exact="cystic fibrosis" post="were of mild severity, rarely requiring hospitalization. Unsurprisingly, RV/EV"/>
   <result pre="improvement in patient care over the last few years, CF-related" exact="lung disease" post="remains the main cause of morbidity-mortality in these patients."/>
   <result pre="tested by a combination of five duplex RT-PCRs or PCRs:" exact="influenza" post="A and B, respiratory syncytial virus (RSV), metapneumovirus (MPV),"/>
   <result pre="None received palivizumab and 22 patients (88%) were vaccinated against" exact="influenza" post="virus. Sixty percent had commensal flora at inclusion. Table"/>
   <result pre="were RV/EV (27/44; 61%), RSV (6/44; 14%), adenovirus (6/44; 14%)," exact="influenza" post="(4/44; 9%), bocavirus (3/44; 7%), parainfluenzae (2/44; 5%) and"/>
   <result pre="with adenovirus (n = 2), RSV (n = 1), bocavirus (n = 1); bocavirus associated with" exact="influenza" post="(n = 1), adenovirus (n = 1) and adenovirus associated with RSV (n = 3)"/>
   <result pre="(n = 2), bocavirus (n = 2), coronavirus (n = 1); bocavirus associated with adenovirus (n = 1)," exact="influenza" post="(n = 1), cytomegalovirus (n = 1) For the six patients presenting a"/>
   <result pre="adenoviruses and metapneumovirus. However, a smaller proportion of RSV and" exact="influenza" post="but a higher proportion of bocavirus and coronavirus were"/>
   <result pre="EwijkBEWilbrinkBet al.Frequency and duration of rhinovirus infections in children with" exact="cystic fibrosis" post="and healthy controls: a longitudinal cohort studyPediatr Infect Dis"/>
   <result pre="10.EtheringtonCNaseerRConwaySPet al.The role of respiratory viruses in adult patients with" exact="cystic fibrosis" post="receiving intravenous antibiotics for a pulmonary exacerbationJ Cyst Fibros2014131495510.1016/j.jcf.2013.06.00423891398"/>
   <result pre="14.HoekRAPaatsMSPasSDet al.Incidence of viral respiratory pathogens causing exacerbations in adult" exact="cystic fibrosis" post="patientsScand J Infect Dis2013451656910.3109/00365548.2012.70894222992129 15.WarkPAToozeMCheeseLWhiteheadBet al.Viral infections trigger exacerbations"/>
   <result pre="patientsScand J Infect Dis2013451656910.3109/00365548.2012.70894222992129 15.WarkPAToozeMCheeseLWhiteheadBet al.Viral infections trigger exacerbations of" exact="cystic fibrosis" post="in adults and childrenEur Respir J201240251051210.1183/09031936.0020231122855475 16.AbmanSHOgleJWButler-SimonNet al.Role of"/>
   <result pre="fibrosisPediatr Infect Dis J201736654554810.1097/INF.000000000000150128005688 22.BuchsCDalphinMLSanchezSet al.Palivizumab prophylaxis in infants with" exact="cystic fibrosis" post="does not delay first isolation of Pseudomonas aeruginosa or"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6724460\results\search\disease\results.xml">
   <result pre="por Aedes aegyptiRev Bras Malariol Doenças Trop196921(4)7293110.5123/S1679-497420070002000065397213 6TauilPL[Critical aspects of" exact="yellow fever" post="control in Brazil]. Rev Saude Publica. 2010;44(3):555-8. Apud Franco"/>
   <result pre="12collab: Secretaria da Saúde do Estado do CearáBoletim epidemiológico dengue," exact="chikungunya" post="e zika. Coordenadoria de Promoção e Proteção è Saúde"/>
   <result pre="Hyg201593(1)182310.4269/ajtmh.13-066326013373 17SacramentoRHde Melo BragaDNSacramentoFFde Carvalho AraújoFMLimaAAde Lima PompeuMMet al.Death by" exact="dengue fever" post="in a Brazilian child: a case reportBMC Res Notes2014785510.1186/1756-0500-7-85525428248"/>
   <result pre="forecastsLancet Infect Dis201414(7)6192610.1016/S1473-3099(14)70781-924841859 20VasconcelosPFde MenezesDBMeloLPPessoETRodriguesSGda RosaESet al.A large epidemic of" exact="dengue fever" post="with dengue hemorrhagic cases in Ceará State, Brazil, 1994Rev"/>
   <result pre="JúniorGBDiógenesSSSilvaHFDengue and aplastic anemia-a rare associationTravel Med Infect Dis20097(2)1182010.1016/j.tmaid.2009.01.00119237145 25AragãoREBarreiraIMLimaLNRabeloLPPereiraFB[Bilateral" exact="optic neuritis" post="after dengue viral infection: case report]Arq Bras Oftalmol201073(2)175810.1590/S0004-2749201000020001520549049 26PonteHJPucciFHMoreira"/>
   <result pre="manifestations in patients admitted to a reference hospital with presumptive" exact="dengue fever" post="diagnosisRev Dor201112(2)104710.1590/S1806-00132011000200005 27LimaDMSabino-Santos JuniorGOliveiraACFontesRMColaresJKAraújoFMet al.Hantavirus infection in suspected dengue"/>
   <result pre="nervous system manifestations, BrazilEmerg Infect Dis201218(4)677910.3201/eid1804.11152222469335 31MacedoRNRochaFARolimDBVilarDCAraújoFMVieiraNNet al.Severe coinfection of" exact="melioidosis" post="and dengue fever in Northeastern Brazil: first case reportRev"/>
   <result pre="manifestations, BrazilEmerg Infect Dis201218(4)677910.3201/eid1804.11152222469335 31MacedoRNRochaFARolimDBVilarDCAraújoFMVieiraNNet al.Severe coinfection of melioidosis and" exact="dengue fever" post="in Northeastern Brazil: first case reportRev Soc Bras Med"/>
   <result pre="first case reportRev Soc Bras Med Trop201245(1)132310.1590/S0037-8682201200010002822370846 32TorresAFBragaDNMunizFMendonçaCOliveiraDNde SouzaETet al.Lymphocytic" exact="myocarditis" post="at autopsy in patients with dengue feverBraz J Infect"/>
   <result pre="BrazilMem Inst Oswaldo Cruz2014109(1)93810.1590/0074-027614038424626308 34TeixeiraMGPaixãoESCosta MdaCCunhaRVPamplonaLDiasJPet al.Arterial hypertension and skin" exact="allergy" post="are risk factors for progression from dengue to dengue"/>
   <result pre="Soc Bras Med Trop201548(6)783510.1590/0037-8682-0205-201526676509 38de Melo BezerraLFFontesRMGomesAMda SilvaDAColaresJKLimaDMSerological evidence of" exact="leptospirosis" post="in patients with a clinical suspicion of dengue in"/>
   <result pre="Publica200925Suppl 1S1253610.1590/S0102-311X200900130001219287857 63HeukelbachJde OliveiraFAKerr-PontesLRFeldmeierHRisk factors associated with an outbreak of" exact="dengue fever" post="in a favela in Fortaleza, north-east BrazilTrop Med Int"/>
   <result pre="Results Reference 1995 Descriptive To evaluate the cases of hemorrhagic" exact="dengue fever" post="in the city of Fortaleza in 1994. Of the"/>
   <result pre="was documented. 23 2009 Descriptive To report a case of" exact="aplastic anemia" post="induced by dengue virus infection. Dengue can induce aplastic"/>
   <result pre="documented. 23 2009 Descriptive To report a case of aplastic" exact="anemia" post="induced by dengue virus infection. Dengue can induce aplastic"/>
   <result pre="aplastic anemia induced by dengue virus infection. Dengue can induce" exact="aplastic anemia" post="by directly invading the bone marrow. This rare complication"/>
   <result pre="anemia induced by dengue virus infection. Dengue can induce aplastic" exact="anemia" post="by directly invading the bone marrow. This rare complication"/>
   <result pre="induce complete remission. 24 2010 Descriptive To report cases of" exact="optic neuritis" post="after dengue virus infection. Two cases of bilateral neuritis"/>
   <result pre="2012 Retrospective To correlate laboratory tests during the progression of" exact="dengue fever" post="with symptoms to predict the severity of the disease."/>
   <result pre="predict the severity of the disease. In patients with CD," exact="thrombocytopenia" post="and elevated transaminase levels were observed; in those with"/>
   <result pre="elevated transaminase levels were observed; in those with DHF, the" exact="thrombocytopenia" post="and elevated transaminase levels were similar to those in"/>
   <result pre="To evaluate the prevalence of dengue in patients with suspected" exact="viral meningitis." post="Dengue should be suspected in patients in endemic areas"/>
   <result pre="diagnoses in endemic disease areas. 31 2013 Retrospective To report" exact="myocarditis" post="due to dengue, which is rarely diagnosed. Myocarditis caused"/>
   <result pre="dengue who may benefit from therapy to prevent death from" exact="heart disease." post="32 2013 Retrospective To describe the clinical spectrum of"/>
   <result pre="obvious. 15 2014 Descriptive To report the first case of" exact="dengue fever" post="in an indigenous child who died. With positive immunohistochemical"/>
   <result pre="none died. 35 2015 Descriptive To diagnose possible cases of" exact="leptospirosis" post="in dengue-negative patients in samples from 2008, 2010, and"/>
   <result pre="that 20% of dengue cases may actually be cases of" exact="leptospirosis" post="in endemic disease areas. 36 2015 Descriptive To identify"/>
   <result pre="transplantation in endemic disease areas. 37 2015 Descriptive To investigate" exact="leptospirosis" post="in patients with clinical suspicion of dengue. Of the"/>
   <result pre="thus prevent death. 39 Notes: DENV: dengue virus, CD: classic" exact="dengue fever," post="SD: severe dengue, DHF: dengue hemorrhagic fever, CSF: cerebrospinal"/>
   <result pre="dengue virus, CD: classic dengue fever, SD: severe dengue, DHF:" exact="dengue hemorrhagic fever," post="CSF: cerebrospinal fluid, CNS: central nervous system, IgM: immunoglobulin"/>
   <result pre="A. aegypti and A. albopictus To compare the incidence of" exact="dengue fever" post="in relation to the rainfall in the city of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6727498\results\search\disease\results.xml">
   <result pre="spectrum, with the exception of a lower incidence of Kaposi’s" exact="sarcoma" post="in HIV-2 infected individuals [13, 14]. Interestingly, studies have"/>
   <result pre="HIV-2-specific T-cells from LTNPs in the French cohort showed potent" exact="suppression" post="of viral replication, in many cases exceeding the suppressive"/>
   <result pre="cure’ has emerged, or lately ‘relapse-free remission’ to define sustained" exact="suppression" post="of virus without the need for ART. This means"/>
   <result pre="prospective open cohort studyLancet HIV20186e25e3110.1016/S2352-3018(18)30254-6 13.AriyoshiKSchim van der LoeffMCookPWhitbyDCorrahTJaffarSet al.Kaposi’s" exact="sarcoma" post="in the Gambia, West Africa is less frequent in"/>
   <result pre="dually infected patientsJ Acquir Immune Defic Syndr201672325425810.1097/QAI.000000000000093926825178 129.WejseCFurtadoACamaraCLuneborg-NielsenMSodemannMGerstoftJet al.Impact of" exact="tuberculosis" post="treatment on CD4 cell count, HIV RNA, and p24"/>
   <result pre="with sub-subtype A3J Infect Dis2014209572172810.1093/infdis/jit41623935204 142.LindmanJLManssonFBiagueADa SilvaZJAnderssonSNorrgrenHDeclining prevalence rates of" exact="syphilis" post="among police officers in Guinea-Bissau, West Africa, 1990–2010Sex Transm"/>
   <result pre="Guinea-BissauEnviron Int201036767568210.1016/j.envint.2010.04.02020537392 145.NorrgrenHBambaSDa SilvaZJKoivulaTAnderssonSHigher mortality in HIV-2/HTLV-1 co-infected patients with" exact="pulmonary tuberculosis" post="in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patientsInt"/>
   <result pre="Int201036767568210.1016/j.envint.2010.04.02020537392 145.NorrgrenHBambaSDa SilvaZJKoivulaTAnderssonSHigher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary" exact="tuberculosis" post="in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patientsInt"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6728053\results\search\disease\results.xml">
   <result pre="coastal Mombasa compared to Kisumu. Author summary Dengue is a" exact="viral disease" post="of global public health significance owing to rapid spread"/>
   <result pre="insecticide-treated cows, as has been suggested for Anopheles mosquitoes in" exact="malaria" post="control [43]. As a limitation, data on the density"/>
   <result pre="10AghaSB, TchouassiDP, BastosADS, SangR. Assessment of risk of dengue and" exact="yellow fever" post="virus transmission in three major Kenyan cities based on"/>
   <result pre="Negl Trop Dis. 2017;11(8):e000585810.1371/journal.pntd.000585828817563 11AghaSB, TchouassiDP, BastosADS, SangR. Dengue and" exact="yellow fever" post="virus vectors: seasonal abundance, diversity and resting preferences in"/>
   <result pre="Dis. 2015;9(4):e000373310.1371/journal.pntd.000373325923210 19JohnsonBK, OchengD, GichogoA, OkiroM, LibondoD, KinyanjuiP, et al.Epidemic" exact="dengue fever" post="caused by dengue type 2 virus in Kenya: preliminary"/>
   <result pre="of Aedes aegypti from three distinct cities in Kenya for" exact="chikungunya" post="virus. PLoS Negl Trop Dis. 2017;11(8):e000586010.1371/journal.pntd.000586028820881 26PaupyC, Le GoffG,"/>
   <result pre="imperial, and San Joaquin Valleys of California for St. Louis" exact="encephalitis" post="virus. Am J Trop Med Hyg. 1983;32(2):305–11. 10.4269/ajtmh.1983.32.3056301301 32TurellMJ."/>
   <result pre="et al.Seroprevalence of infections with dengue, Rift Valley fever and" exact="chikungunya" post="viruses in Kenya, 2007. PLoS One. 2015;10(7):e013264510.1371/journal.pone.013264526177451 36CarringtonLB, SeifertSN,"/>
   <result pre="ValeGA, TorrSJ, FillingerU. Exploring the potential of using cattle for" exact="malaria" post="vector surveillance and control: a pilot study in western"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6729038\results\search\disease\results.xml">
   <result pre="threats to Europe, such as West Nile virus, Toscana virus," exact="measles" post="and enteroviruses [1, 2]. The epidemiology of community-acquired CNS"/>
   <result pre="the burden of the two most common etiological agents for" exact="bacterial meningitis" post="in adults and older children, Streptococcus pneumoniae and Neisseria"/>
   <result pre="burden of the two most common etiological agents for bacterial" exact="meningitis" post="in adults and older children, Streptococcus pneumoniae and Neisseria"/>
   <result pre="type B (Hib) is also becoming a rare cause of" exact="meningitis" post="in Europe [5]. However, reports of serotype replacement and"/>
   <result pre="to be tailored to regions and travel [3, 5]. Neonatal" exact="meningitis" post="is associated with high morbidity and higher incidence compared"/>
   <result pre="virus (VZV) and arthropod-borne viruses (arboviruses) [11]. The epidemiology of" exact="encephalitis" post="is constantly evolving [11], and emerging infectious diseases may"/>
   <result pre="the emergence of Toscana virus as a leading cause of" exact="aseptic meningitis" post="in regions in southern Europe during the summer [13,"/>
   <result pre="emergence of Toscana virus as a leading cause of aseptic" exact="meningitis" post="in regions in southern Europe during the summer [13,"/>
   <result pre="of systematic reviews (ID: CRD42014014212). The protocol was informed by" exact="infectious disease" post="specialists and systematic reviewers. Search strategy One reviewer conducted"/>
   <result pre="22 June 2017. Search terms: (&quot;Central Nervous System Infections�?[Mesh]) OR" exact="meningitis" post="[Title/Abstract]) OR meningoencephalitis [Title/Abstract]) OR encephalitis [Title/Abstract])) AND (guideline"/>
   <result pre="Search terms: (&quot;Central Nervous System Infections�?[Mesh]) OR meningitis [Title/Abstract]) OR" exact="meningoencephalitis" post="[Title/Abstract]) OR encephalitis [Title/Abstract])) AND (guideline [Title]) OR guidelines"/>
   <result pre="Nervous System Infections�?[Mesh]) OR meningitis [Title/Abstract]) OR meningoencephalitis [Title/Abstract]) OR" exact="encephalitis" post="[Title/Abstract])) AND (guideline [Title]) OR guidelines [Title]) OR guidance"/>
   <result pre="(n = 1) (Fig. 2). Ten focused on viral encephalitis/meningoencephalitis, 14 on" exact="bacterial meningitis" post="and two on both (Additional file 2). Fig. 1"/>
   <result pre="(Fig. 2). Ten focused on viral encephalitis/meningoencephalitis, 14 on bacterial" exact="meningitis" post="and two on both (Additional file 2). Fig. 1"/>
   <result pre="changes to personality or behaviour as signs and symptoms of" exact="encephalitis" post="in both children and adults. It was noted that"/>
   <result pre="ALOC altered level of consciousness, AMS altered mental status Bacterial" exact="meningitis" post="Nine CMGs covering bacterial CNS meningitis presented symptoms at"/>
   <result pre="altered mental status Bacterial meningitis Nine CMGs covering bacterial CNS" exact="meningitis" post="presented symptoms at presentation in adults [2, 5, 23,"/>
   <result pre="feeding were most commonly described, followed by bulging fontanelle, petechial" exact="rash" post="and lethargy. It was also highlighted by several CMGs"/>
   <result pre="[5]. It was also highlighted that the classic signs of" exact="meningitis" post="are not always present in adults either [23]. Therefore,"/>
   <result pre="meningitis are not always present in adults either [23]. Therefore," exact="bacterial meningitis" post="cannot be ruled out based on the absence of"/>
   <result pre="are not always present in adults either [23]. Therefore, bacterial" exact="meningitis" post="cannot be ruled out based on the absence of"/>
   <result pre="bacterial aetiologies. CT should not delay antibiotic treatment for suspected" exact="bacterial meningitis" post="Abbreviations: IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="aetiologies. CT should not delay antibiotic treatment for suspected bacterial" exact="meningitis" post="Abbreviations: IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="seizures or consciousness disorder ^^If LP contraindicated Viral encephalitis/meningoencephalitis, Bacterial" exact="meningitis" post="Bacterial meningitis All CMGs covering bacterial CNS infections recommended"/>
   <result pre="consciousness disorder ^^If LP contraindicated Viral encephalitis/meningoencephalitis, Bacterial meningitis Bacterial" exact="meningitis" post="All CMGs covering bacterial CNS infections recommended urgent LP"/>
   <result pre="(Table 3), since a positive CSF culture is confirmative of" exact="bacterial meningitis" post="and enables in vitro testing of antimicrobial susceptibility to"/>
   <result pre="3), since a positive CSF culture is confirmative of bacterial" exact="meningitis" post="and enables in vitro testing of antimicrobial susceptibility to"/>
   <result pre="depending on season or exposure, arboviruses. Testing for influenza, mumps," exact="measles" post="and rubella were also recommended, especially during an on-going"/>
   <result pre="season or exposure, arboviruses. Testing for influenza, mumps, measles and" exact="rubella" post="were also recommended, especially during an on-going epidemic [30]."/>
   <result pre="CMV, EBV, JCV, Dengue virus, respiratory viruses, RSV, HIV, adenovirus," exact="influenza" post="A and B, rotavirus, Coxsackie B5, non-typed enterovirus, Parainfluenza"/>
   <result pre="on epidemiological and clinical features. IDSA* Neonates: HSV 2, CMV," exact="rubella" post="virus, L. monocytogenes, T. pallidum, Toxoplasma gondii Infants and"/>
   <result pre="monocytogenes, T. pallidum, Toxoplasma gondii Infants and Children: Eastern equine" exact="encephalitis" post="virus, Japanese encephalitis virus, Murray Valley encephalitis virus, influenza"/>
   <result pre="Toxoplasma gondii Infants and Children: Eastern equine encephalitis virus, Japanese" exact="encephalitis" post="virus, Murray Valley encephalitis virus, influenza virus, La Crosse"/>
   <result pre="Children: Eastern equine encephalitis virus, Japanese encephalitis virus, Murray Valley" exact="encephalitis" post="virus, influenza virus, La Crosse virus Unspecified: HSV, WNV,"/>
   <result pre="equine encephalitis virus, Japanese encephalitis virus, Murray Valley encephalitis virus," exact="influenza" post="virus, La Crosse virus Unspecified: HSV, WNV, TBEV, A."/>
   <result pre="Unspecified: HSV, WNV, TBEV, A. phagocytophilum, B.burgdorferi Elderly: Eastern equine" exact="encephalitis" post="virus, St. Louis encephalitis virus, WNV, sporadic Creutzfeldt-Jakob Disease,"/>
   <result pre="A. phagocytophilum, B.burgdorferi Elderly: Eastern equine encephalitis virus, St. Louis" exact="encephalitis" post="virus, WNV, sporadic Creutzfeldt-Jakob Disease, L. monocytogenes Person-to-person transmission:"/>
   <result pre="sporadic Creutzfeldt-Jakob Disease, L. monocytogenes Person-to-person transmission: VZV, Venezuelan equine" exact="encephalitis" post="virus (rare), poliovirus, non-polio enteroviruses, measles virus, mumps virus,"/>
   <result pre="transmission: VZV, Venezuelan equine encephalitis virus (rare), poliovirus, non-polio enteroviruses," exact="measles" post="virus, mumps virus, rubella virus, EBV, HHV 6, B"/>
   <result pre="Venezuelan equine encephalitis virus (rare), poliovirus, non-polio enteroviruses, measles virus," exact="mumps" post="virus, rubella virus, EBV, HHV 6, B virus, WNV"/>
   <result pre="encephalitis virus (rare), poliovirus, non-polio enteroviruses, measles virus, mumps virus," exact="rubella" post="virus, EBV, HHV 6, B virus, WNV (transfusion transplantation,"/>
   <result pre="B virus, WNV (transfusion transplantation, breast feeding), HIV, Nipah virus," exact="rabies" post="virus (transplantation), influenza virus, M. pneumoniae, Mycobacterium tuberculosis, T."/>
   <result pre="(transfusion transplantation, breast feeding), HIV, Nipah virus, rabies virus (transplantation)," exact="influenza" post="virus, M. pneumoniae, Mycobacterium tuberculosis, T. pallidum. Others based"/>
   <result pre="and adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus (&amp;lt; 3 years), HHV-6 (&amp;lt; 3 years)," exact="mumps" post="(if epidemic), Influenza A, B (if epidemic), HIV, Others"/>
   <result pre="and risk factors BIA/ABN Adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus," exact="measles" post="virus, mumps virus, TBEV (eastern Europe), WNV (southern Europe),"/>
   <result pre="factors BIA/ABN Adults: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, measles virus," exact="mumps" post="virus, TBEV (eastern Europe), WNV (southern Europe), HIV, EBV"/>
   <result pre="(eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised)" exact="influenza" post="virus (rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis"/>
   <result pre="(rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis virus (rare)," exact="rubella" post="virus (rare) Others based on epidemiological and clinical features."/>
   <result pre="features. BIA/ABN/BPAIIG Children: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, HHV 6/7," exact="measles" post="virus, mumps virus, rotavirus, HIV, TBEV (eastern Europe), WNV"/>
   <result pre="Children: HSV-1, HSV-2, VZV, enteroviruses, parechovirus, HHV 6/7, measles virus," exact="mumps" post="virus, rotavirus, HIV, TBEV (eastern Europe), WNV (southern Europe),"/>
   <result pre="(eastern Europe), WNV (southern Europe), HIV, EBV (immunocompromised), CMV (immunocompromised)" exact="influenza" post="virus (rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis"/>
   <result pre="(rare), adenovirus (rare), Erythrovirus B19 (rare), lymphocytic choreomeningitis virus (rare)," exact="rubella" post="virus (rare) Others based on epidemiological and clinical features."/>
   <result pre="epidemiological and clinical features. AEPED* Congenital: Lymphocytic Choriomeningitis virus, CMV," exact="measles" post="virus, T. gondii, T. pallidum, Neonates (&amp;lt; 1 month): HSV, enteroviruses,"/>
   <result pre="HSV, VZV, HIV, enterovirus, L. monocytogenes (higher risk &amp;gt; 65 years), M." exact="tuberculosis" post="(higher risk &amp;gt; 75 years) NNF* Unspecified: HSV-1, HSV-2, VZV, EBV,"/>
   <result pre="A, measles, mumps, rubella, HIV, Hepatitis E, Japanese B, WNV," exact="rabies" post="virus, TBE, Eastern equine encephalitis, S. pneumoniae, B. burgdorferi,"/>
   <result pre="B. burgdorferi, M. pneumoniae, Chlamydia trachomatis, L. monocytogenes, M. tuberculosis," exact="cerebral malaria," post="Cystericosis. Others based on immune status. PHE: ME* Unspecified:"/>
   <result pre="CMV Cytomegalovirus, EBV Epstein-Barr virus, RSV respiratory syncytial virus, TBEV" exact="tick-borne encephalitis" post="virus, WNV West Nile virus, JEV Japanese encephalitis virus,"/>
   <result pre="Cytomegalovirus, EBV Epstein-Barr virus, RSV respiratory syncytial virus, TBEV tick-borne" exact="encephalitis" post="virus, WNV West Nile virus, JEV Japanese encephalitis virus,"/>
   <result pre="TBEV tick-borne encephalitis virus, WNV West Nile virus, JEV Japanese" exact="encephalitis" post="virus, IEC International Encephalitis Consortium, EFNS European Federation of"/>
   <result pre="differential diagnostic recommendations ^Differential diagnostic recommendations not clearly defined Bacterial" exact="meningitis" post="There was consensus on the initial differential diagnostics for"/>
   <result pre="for adults and older children presenting with syndromes suggestive of" exact="bacterial meningitis" post="(Table 5). Besides two CMGs which only focused on"/>
   <result pre="adults and older children presenting with syndromes suggestive of bacterial" exact="meningitis" post="(Table 5). Besides two CMGs which only focused on"/>
   <result pre="25, 36, 39]. Table 5 Differential diagnostic recommendations for suspected" exact="bacterial meningitis" post="Pathogen Age group EFNSEurope ESCMIDEurope DSIDenmark SPILFFrance DGN: BM^Germany"/>
   <result pre="36, 39]. Table 5 Differential diagnostic recommendations for suspected bacterial" exact="meningitis" post="Pathogen Age group EFNSEurope ESCMIDEurope DSIDenmark SPILFFrance DGN: BM^Germany"/>
   <result pre="not presented in the table The different epidemiology for neonatal" exact="meningitis" post="was reflected in the eight CMGs providing recommendations for"/>
   <result pre="diagnostic results. Table 6 Empirical treatment recommendations for suspected viral" exact="encephalitis" post="and meningoencephalitis The table shows the CMGs that included"/>
   <result pre="Table 6 Empirical treatment recommendations for suspected viral encephalitis and" exact="meningoencephalitis" post="The table shows the CMGs that included recommendations for"/>
   <result pre="empirical treatment recommendations should be reviewed pending diagnostic results Bacterial" exact="meningitis" post="All 15 CMGs covering treatment recommended urgent administration of"/>
   <result pre="treatment recommended urgent administration of antibiotics on clinical suspicion of" exact="bacterial meningitis" post="(Table 7). Thirty-three percent (n = 5/15) specified a time-frame for"/>
   <result pre="recommended urgent administration of antibiotics on clinical suspicion of bacterial" exact="meningitis" post="(Table 7). Thirty-three percent (n = 5/15) specified a time-frame for"/>
   <result pre="timing of antimicrobial administration to clinical outcome in patients with" exact="bacterial meningitis," post="but since it is a neurologic emergency, appropriate therapy"/>
   <result pre="all age-groups [38]. Table 7 Empirical treatment recommendations for suspected" exact="bacterial meningitis" post="Initial treatment recommendations*  CMG 3rd-generation cephalosporin (ceftriaxone^ or cefotaxime)"/>
   <result pre="age-groups [38]. Table 7 Empirical treatment recommendations for suspected bacterial" exact="meningitis" post="Initial treatment recommendations*  CMG 3rd-generation cephalosporin (ceftriaxone^ or cefotaxime)"/>
   <result pre="corticosteroids in infants is controversial and only recommended for Hib" exact="meningitis" post="[44]. It was highlighted that corticosteroids can reduce inflammation"/>
   <result pre="infections and antimicrobial resistance. The most recent Europe-wide CMG on" exact="bacterial meningitis" post="was published in 2016 [5], whilst the most recent"/>
   <result pre="and antimicrobial resistance. The most recent Europe-wide CMG on bacterial" exact="meningitis" post="was published in 2016 [5], whilst the most recent"/>
   <result pre="a general consensus on diagnostic methods, but wider variations in" exact="infectious disease" post="differential diagnostics recommendations, especially for paediatric and elderly populations."/>
   <result pre="the need for urgent I.V. antibiotics on clinical suspicion of" exact="bacterial meningitis." post="However, only about half recommended pre-hospital antibiotics when presenting"/>
   <result pre="of America IEC International Encephalitis Consortium I.V. Intravenous JEV Japanese" exact="encephalitis" post="virus LP Lumbar puncture MeSH Medical subject headings MHSSE"/>
   <result pre="SPILF Société de Pathologie Infectieuse de Langue Française TBEV Tick-borne" exact="encephalitis" post="virus TRIP Turning research into practice UK United Kingdom"/>
   <result pre="specialist societies guideline on the diagnosis and management of acute" exact="meningitis" post="and meningococcal sepsis in immunocompetent adultsJ Infect201672440543810.1016/j.jinf.2016.01.00726845731 3.van EttekovenCNvan"/>
   <result pre="and challengesClin Microbiol Infect201723960160610.1016/j.cmi.2017.04.01928478238 4.McIntyrePBO'BrienKLGreenwoodBvan de BeekDEffect of vaccines on" exact="bacterial meningitis" post="worldwideLancet201238098541703171110.1016/S0140-6736(12)61187-823141619 5.van de BeekD.CabellosC.DzupovaO.EspositoS.KleinM.KloekA.T.LeibS.L.MourvillierB.OstergaardC.PaglianoP.PfisterH.W.ReadR.C.SipahiO. ResatBrouwerM.C.ESCMID guideline: diagnosis and treatment"/>
   <result pre="challengesClin Microbiol Infect201723960160610.1016/j.cmi.2017.04.01928478238 4.McIntyrePBO'BrienKLGreenwoodBvan de BeekDEffect of vaccines on bacterial" exact="meningitis" post="worldwideLancet201238098541703171110.1016/S0140-6736(12)61187-823141619 5.van de BeekD.CabellosC.DzupovaO.EspositoS.KleinM.KloekA.T.LeibS.L.MourvillierB.OstergaardC.PaglianoP.PfisterH.W.ReadR.C.SipahiO. ResatBrouwerM.C.ESCMID guideline: diagnosis and treatment"/>
   <result pre="and treatment of acute bacterial meningitisClinical Microbiology and Infection201622S37S6210.1016/j.cmi.2016.01.00727062097 6.KuLCBoggessKACohen-WolkowiezMBacterial" exact="meningitis" post="in the infantClin Perinatol2015421294510.1016/j.clp.2014.10.00425677995 7.TunkelARGlaserCABlochKCSejvarJJMarraCMRoosKLet al.The management of encephalitis:"/>
   <result pre="Diseases Society of AmericaClin Infect Dis20084730332710.1086/58974718582201 8.GlaserCAGilliamSSchnurrDForghaniBHonarmandSKhetsurianiNet al.In search of" exact="encephalitis" post="etiologies: diagnostic challenges in the California encephalitis project, 1998-2000Clin"/>
   <result pre="al.In search of encephalitis etiologies: diagnostic challenges in the California" exact="encephalitis" post="project, 1998-2000Clin Infect Dis200336673174210.1086/36784112627357 9.GranerodJAmbroseHEDaviesNWClewleyJPWalshALMorganDet al.Causes of encephalitis and"/>
   <result pre="the California encephalitis project, 1998-2000Clin Infect Dis200336673174210.1086/36784112627357 9.GranerodJAmbroseHEDaviesNWClewleyJPWalshALMorganDet al.Causes of" exact="encephalitis" post="and differences in their clinical presentations in England: a"/>
   <result pre="algorithms, and priorities in encephalitis: consensus statement of the international" exact="encephalitis" post="consortiumClin Infect Dis2013571114112810.1093/cid/cit45823861361 11.BoucherAHerrmannJLMorandPBuzeleRCrabolYStahlJPet al.Epidemiology of infectious encephalitis causes"/>
   <result pre="the international encephalitis consortiumClin Infect Dis2013571114112810.1093/cid/cit45823861361 11.BoucherAHerrmannJLMorandPBuzeleRCrabolYStahlJPet al.Epidemiology of infectious" exact="encephalitis" post="causes in 2016Med Mal Infect201747322123510.1016/j.medmal.2017.02.00328341533 12.MaillesAStahlJPBlochKCUpdate and new insights"/>
   <result pre="disease 2013 [cited 2018 March]. 22.SolomonTMichaelBDSmithPESandersonFDaviesNWSHartIJet al.Management of suspected viral" exact="encephalitis" post="in adults - Association of British Neurologists and British"/>
   <result pre="UK2015 [cited 2019 Feb]. 25.PHE. UK standards for microbiology investigations:" exact="meningoencephalitis" post="UK: PHE; 2014. Available from: www.gov.uk/government/uploads/system/uploads/attachment_data/file/344105/S_5i1.pdf. [cited 2018 March]"/>
   <result pre="[cited 2018 March] 26.StahlJ.P.AzouviP.BruneelF.De BrouckerT.DuvalX.FantinB.GirardN.HerrmannJ.L.HonnoratJ.LecuitM.MaillesA.Martinez-AlmoynaL.MorandP.PirothL.TattevinP.Guidelines on the management of infectious" exact="encephalitis" post="in adultsMédecine et Maladies Infectieuses201747317919410.1016/j.medmal.2017.01.00528412044 27.Navarro Gómez M, González"/>
   <result pre="AEPED; 2011 [cited 2018 March]. 28.KneenRMichaelBDMensonEMehtaBEastonAHemingwayCet al.Management of suspected viral" exact="encephalitis" post="in children - Association of British Neurologists and British"/>
   <result pre="al.Guidelines for the early clinical and public health management of" exact="bacterial meningitis" post="(including meningococcal disease)2015 36.ChaudhuriAMartinPMKennedyPGEAndrew SeatonRPortegiesPBojarMet al.EFNS guideline on the"/>
   <result pre="for the early clinical and public health management of bacterial" exact="meningitis" post="(including meningococcal disease)2015 36.ChaudhuriAMartinPMKennedyPGEAndrew SeatonRPortegiesPBojarMet al.EFNS guideline on the"/>
   <result pre="bacterial meningitis: report of an EFNS task force on acute" exact="bacterial meningitis" post="in older children and adultsEur J Neurol20081564965910.1111/j.1468-1331.2008.02193.x18582342 37.PfisterHAmbulant erworbene"/>
   <result pre="meningitis: report of an EFNS task force on acute bacterial" exact="meningitis" post="in older children and adultsEur J Neurol20081564965910.1111/j.1468-1331.2008.02193.x18582342 37.PfisterHAmbulant erworbene"/>
   <result pre="manual2016175179 39.LebechAHansenBBrandtCvon LüttichauHBodilsenJWieseLet al.Rekommandationer for initial behandling af akut bakteriel" exact="meningitis" post="hos voksne2018DenmarkDansk Selskab for Infektionsmedicin 40.ArtigaoFLopezRCastillo Martin delFMeningitis bacteriana2011SpainProtocolos"/>
   <result pre="of diagnostic accuracyJ Infect20177411910.1016/j.jinf.2016.09.00727746160 42.McGillFGriffithsMJBonnettLJGerettiAMMichaelBDBeechingNJet al.Incidence, aetiology, and sequelae of" exact="viral meningitis" post="in UK adults: a multicentre prospective observational cohort studyLancet"/>
   <result pre="diagnostic accuracyJ Infect20177411910.1016/j.jinf.2016.09.00727746160 42.McGillFGriffithsMJBonnettLJGerettiAMMichaelBDBeechingNJet al.Incidence, aetiology, and sequelae of viral" exact="meningitis" post="in UK adults: a multicentre prospective observational cohort studyLancet"/>
   <result pre="multicentre prospective observational cohort studyLancet Infect Dis2018189992100310.1016/S1473-3099(18)30245-730153934 43.BrouwerMCvan de BeekDViral" exact="meningitis" post="in the UK: time to speed upLancet Infect Dis201818993093110.1016/S1473-3099(18)30287-130153931"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731212\results\search\disease\results.xml">
   <result pre="Article Epidemiological and clinical characteristics of children hospitalized due to" exact="influenza" post="A and B in the south of Europe, 2010–2016"/>
   <result pre="epidemiological and clinical characteristics of children hospitalized due to confirmed" exact="influenza" post="in influenza surveillance sentinel hospitals in Catalonia. Retrospective descriptive"/>
   <result pre="clinical characteristics of children hospitalized due to confirmed influenza in" exact="influenza" post="surveillance sentinel hospitals in Catalonia. Retrospective descriptive study conducted"/>
   <result pre="sentinel hospitals in Catalonia. Retrospective descriptive study conducted in six" exact="influenza" post="seasons (2010–2011 to 2015–2016) in persons aged 0–17 years"/>
   <result pre="to 2015–2016) in persons aged 0–17 years diagnosed with laboratory-confirmed" exact="influenza" post="requiring hospitalization. 291 cases were notified to the health"/>
   <result pre="notified to the health authorities: 79.4% were due to the" exact="influenza" post="A virus and 20.6% to the B virus. The"/>
   <result pre="were aged &amp;lt;1 year. 62.2% of cases had pneumonia, 26.8%" exact="acute respiratory distress syndrome" post="and 11.7% bacterial pneumonia. 5.8% of cases were vaccinated"/>
   <result pre="cases had pneumonia, 26.8% acute respiratory distress syndrome and 11.7%" exact="bacterial pneumonia." post="5.8% of cases were vaccinated and 21.3% required intensive"/>
   <result pre="were aged &amp;lt;2 years. There were 3 deaths, all with" exact="influenza" post="A infection. Influenza A cases were younger than influenza"/>
   <result pre="with influenza A infection. Influenza A cases were younger than" exact="influenza" post="B cases (OR 3.22; 95% CI: 1.73–6.00). Conclusion: Children"/>
   <result pre="Grant number 2017 SGR 1342). Introduction Influenza, an acute viral" exact="infectious disease" post="that primarily affects the upper respiratory tract, is caused"/>
   <result pre="primarily affects the upper respiratory tract, is caused by the" exact="influenza" post="virus, which belongs to the Orthomyxoviridae family. There are"/>
   <result pre="belongs to the Orthomyxoviridae family. There are three types of" exact="influenza" post="viruses, which commonly infect humans: A, B and C."/>
   <result pre="first two are responsible for annual seasonal epidemics. Type A" exact="influenza" post="viruses are divided into subtypes depending on the composition"/>
   <result pre="proteins on the virus surface. There are several subtypes of" exact="influenza" post="A but, currently, the viruses that circulate and affect"/>
   <result pre="(H1N1) pdm09 was first identified in 2009, in the first" exact="influenza" post="pandemic of the 21st century, and since then has"/>
   <result pre="estimated that between 3 and 5 million people have serious" exact="influenza" post="with complications and hospital admission annually and approximately 250,000–500,000"/>
   <result pre="reports suggest that children may more easily introduce and transmit" exact="influenza" post="in the community1,5,6. A surveillance program of influenza and"/>
   <result pre="and transmit influenza in the community1,5,6. A surveillance program of" exact="influenza" post="and other acute respiratory infections (PIDIRAC) was initiated in"/>
   <result pre="2005–2006 season, the PIDIRAC has formed part of the Spanish" exact="influenza" post="surveillance sentinel system, coordinated by the National Center for"/>
   <result pre="European Center for Disease Control (ECDC) which is responsible for" exact="influenza" post="surveillance in Europe. As a result of the 2009"/>
   <result pre="2010–2011 season, the surveillance of severe hospitalized cases of confirmed" exact="influenza" post="was introduced, using a sentinel hospital system that at"/>
   <result pre="geographically distributed throughout all Catalan health care regions. In Catalonia" exact="influenza" post="vaccination is not recommended in childhood except if they"/>
   <result pre="of complications. The aim is to determine the activity of" exact="influenza" post="viruses and the severity of hospitalized cases9. Various studies"/>
   <result pre="of hospitalized cases9. Various studies have analysed the distribution of" exact="influenza" post="in the general population, vaccine effectiveness and hygienic preventive"/>
   <result pre="epidemiological and clinical characteristics of children hospitalized due to confirmed" exact="influenza" post="A or B virus infection in the sentinel hospitals"/>
   <result pre="Methods We carried out a retrospective descriptive study in six" exact="influenza" post="seasons (2010–2011 to 2015–2016) in children and adolescents aged"/>
   <result pre="and adolescents aged 0–17 years hospitalized due to severe acute" exact="influenza" post="virus infection. The surveillance system of severe hospitalized influenza"/>
   <result pre="acute influenza virus infection. The surveillance system of severe hospitalized" exact="influenza" post="in Catalonia, a region in the northeast of Spain"/>
   <result pre="on who was a case. A hospitalized case of severe" exact="influenza" post="was defined as a case of laboratory-confirmed influenza virus"/>
   <result pre="of severe influenza was defined as a case of laboratory-confirmed" exact="influenza" post="virus infection that required hospitalization due to pneumonia, acute"/>
   <result pre="laboratory-confirmed influenza virus infection that required hospitalization due to pneumonia," exact="acute respiratory distress syndrome," post="septic shock, multiorgan failure or any other serious condition,"/>
   <result pre="variables studied were: sex, age, pre-existing chronic disease (asthma, chronic" exact="respiratory disease," post="obesity, diabetes, kidney disease, immunodeficiency, cardiovascular disease, liver disease),"/>
   <result pre="disease (asthma, chronic respiratory disease, obesity, diabetes, kidney disease, immunodeficiency," exact="cardiovascular disease," post="liver disease), date of symptom onset and date of"/>
   <result pre="onset and date of hospital admission, ICU admission, complications (pneumonia," exact="acute respiratory distress syndrome," post="multiorgan failure and septic shock), antiviral treatment received, seasonal"/>
   <result pre="syndrome, multiorgan failure and septic shock), antiviral treatment received, seasonal" exact="influenza" post="vaccination status and viral type/subtype (A H1N1 pdm09, A"/>
   <result pre="was performed to identify factors associated with the type of" exact="influenza" post="virus (A or B). Associations between clinical and epidemiological"/>
   <result pre="(A or B). Associations between clinical and epidemiological characteristics and" exact="influenza" post="type were determined by calculating the odds ratio (OR)"/>
   <result pre="adjusting by the population of each season. The differences between" exact="influenza" post="A subtypes and influenza B were assessed using the"/>
   <result pre="of each season. The differences between influenza A subtypes and" exact="influenza" post="B were assessed using the Chi-square test. The statistical"/>
   <result pre="receive, treat and temporarily store personal data on cases of" exact="infectious disease." post="Therefore, all study activities formed part of public surveillance"/>
   <result pre="by any of the authors. Results During the six seasonal" exact="influenza" post="seasons between 2010–2011 and 2015–2016, 291 confirmed cases of"/>
   <result pre="influenza seasons between 2010–2011 and 2015–2016, 291 confirmed cases of" exact="influenza" post="requiring hospitalization were reported to the General Subdirectorate of"/>
   <result pre="hospitalized in the six seasons. There was a predominance of" exact="influenza" post="A(H1N1)pdm09 subtype in cases hospitalized in the 2010–2011 and"/>
   <result pre="December, January and February. In seasons with a predominance of" exact="influenza" post="B viruses (season 2012–13 and 2015–16), there was co-circulation"/>
   <result pre="B viruses (season 2012–13 and 2015–16), there was co-circulation with" exact="influenza" post="A(H1N1) pdm09 subtype. Figure 1 Weekly hospitalizations due to"/>
   <result pre="influenza A(H1N1) pdm09 subtype. Figure 1 Weekly hospitalizations due to" exact="influenza" post="in children aged &amp;lt;18 years according to season and"/>
   <result pre="2015–2016. Of the 291 hospitalized cases, 79% tested positive for" exact="influenza" post="A virus and 21% for influenza B. The most"/>
   <result pre="79% tested positive for influenza A virus and 21% for" exact="influenza" post="B. The most frequent subtypes were H1N1 pdm09 (57.8%)"/>
   <result pre="was 3.3 years (±SD 4), 16.8% had chronic disease, including" exact="asthma" post="(28.6%), cardiovascular disease (26.5%), immunosuppressive disease (20.4%) and chronic"/>
   <result pre="years (±SD 4), 16.8% had chronic disease, including asthma (28.6%)," exact="cardiovascular disease" post="(26.5%), immunosuppressive disease (20.4%) and chronic respiratory disease (14.3%)."/>
   <result pre="asthma (28.6%), cardiovascular disease (26.5%), immunosuppressive disease (20.4%) and chronic" exact="respiratory disease" post="(14.3%). The mean length of hospital stay was 9.2"/>
   <result pre="was 5.2 days (±SD 4.2). The most frequent complications were" exact="pneumonia" post="(62.2%), acute respiratory distress syndrome (26.8%) and bacterial pneumonia"/>
   <result pre="days (±SD 4.2). The most frequent complications were pneumonia (62.2%)," exact="acute respiratory distress syndrome" post="(26.8%) and bacterial pneumonia (11.7%). ICU admission was required"/>
   <result pre="complications were pneumonia (62.2%), acute respiratory distress syndrome (26.8%) and" exact="bacterial pneumonia" post="(11.7%). ICU admission was required in 21.3% of cases"/>
   <result pre="were pneumonia (62.2%), acute respiratory distress syndrome (26.8%) and bacterial" exact="pneumonia" post="(11.7%). ICU admission was required in 21.3% of cases"/>
   <result pre="ICU admission was required in 21.3% of cases (21.7% of" exact="influenza" post="A cases and 19.7% of influenza B cases), with"/>
   <result pre="of cases (21.7% of influenza A cases and 19.7% of" exact="influenza" post="B cases), with a mean length of stay of"/>
   <result pre="The clinical and epidemiological differences of cases hospitalized due to" exact="influenza" post="type A and B are shown in Table 1."/>
   <result pre="A and B are shown in Table 1. Cases of" exact="influenza" post="A were significantly younger (OR 3.22; 95% CI: 1.73–6.00):"/>
   <result pre="younger (OR 3.22; 95% CI: 1.73–6.00): 62.6% of cases of" exact="influenza" post="A were aged &amp;lt;2 years, while 63.9% of cases"/>
   <result pre="A were aged &amp;lt;2 years, while 63.9% of cases of" exact="influenza" post="B were aged 3–17 years. No differences were found"/>
   <result pre="0.57–1.92). Differences in the mean hospital stay were not significant:" exact="influenza" post="A 9.89 days (±SD18.37) vs. influenza B 8.49 days"/>
   <result pre="stay were not significant: influenza A 9.89 days (±SD18.37) vs." exact="influenza" post="B 8.49 days (±SD9.08). There were no significant differences"/>
   <result pre="epidemiological characteristics of children aged &amp;lt;18 years hospitalized due to" exact="influenza" post="type A or B virus. Catalonia, seasons 2010–2011 to"/>
   <result pre="shown only as a descriptive variable. Ω: In clinical conditions," exact="asthma" post="and other risk factors, the denominator data is written"/>
   <result pre="questionnaires. Table 2 shows cases requiring ICU admission: 80.6% had" exact="influenza" post="A virus infection (60% due to subtype A (H1N1)"/>
   <result pre="(60% due to subtype A (H1N1) pdm09) and 19.4% had" exact="influenza" post="B virus infection. In children with pre-existing chronic disease,"/>
   <result pre="virus infection. In children with pre-existing chronic disease, 16% had" exact="influenza" post="A infection and 33.3% influenza B: 30.6% were aged"/>
   <result pre="pre-existing chronic disease, 16% had influenza A infection and 33.3%" exact="influenza" post="B: 30.6% were aged &amp;lt;1 year. Table 2 Characteristics"/>
   <result pre="years with ICU admission according to type and subtype of" exact="influenza" post="virus. Catalonia, seasons 2010–2011 to 2015–2016. Influenza A Influenza"/>
   <result pre="to the ICU, 61.3%, 41.9%, 17.7% and 6.4% had pneumonia," exact="acute respiratory distress syndrome," post="bacterial coinfection or multiorgan failure, respectively: 81.6% of cases"/>
   <result pre="multiorgan failure, respectively: 81.6% of cases of pneumonia, 90.9% of" exact="bacterial pneumonia" post="and 84.6% of acute respiratory distress syndrome occurred in"/>
   <result pre="failure, respectively: 81.6% of cases of pneumonia, 90.9% of bacterial" exact="pneumonia" post="and 84.6% of acute respiratory distress syndrome occurred in"/>
   <result pre="cases of pneumonia, 90.9% of bacterial pneumonia and 84.6% of" exact="acute respiratory distress syndrome" post="occurred in influenza A cases. In more than half"/>
   <result pre="pneumonia and 84.6% of acute respiratory distress syndrome occurred in" exact="influenza" post="A cases. In more than half of all influenza"/>
   <result pre="in influenza A cases. In more than half of all" exact="influenza" post="A cases, the cause was the H1N1 subtype. All"/>
   <result pre="was the H1N1 subtype. All cases presenting multiorgan failure had" exact="influenza" post="A and, of these, 75% were due to subtype"/>
   <result pre="to subtype A (H1N1) pdm09. The mean ICU stay for" exact="influenza" post="A (H1N1) pdm09 and B were longer (12.3 days"/>
   <result pre="(±SD 9.7) and 15.1 days (±SD 15.6), respectively) than for" exact="influenza" post="A (H3N2) (8.3 days ± SD 2.4), although the differences were"/>
   <result pre="year, 1 year and 8 years, respectively), all infected by" exact="influenza" post="type A (two H1N1 pdm09 and one A without"/>
   <result pre="One death occurred without presenting complications; another occurred after presenting" exact="pneumonia" post="with acute respiratory distress syndrome, bacterial pneumonia and multiorgan"/>
   <result pre="occurred without presenting complications; another occurred after presenting pneumonia with" exact="acute respiratory distress syndrome," post="bacterial pneumonia and multiorgan failure; the third death presented"/>
   <result pre="another occurred after presenting pneumonia with acute respiratory distress syndrome," exact="bacterial pneumonia" post="and multiorgan failure; the third death presented bacterial pneumonia."/>
   <result pre="occurred after presenting pneumonia with acute respiratory distress syndrome, bacterial" exact="pneumonia" post="and multiorgan failure; the third death presented bacterial pneumonia."/>
   <result pre="syndrome, bacterial pneumonia and multiorgan failure; the third death presented" exact="bacterial pneumonia." post="None had received the influenza vaccine. Discussion Our results"/>
   <result pre="the third death presented bacterial pneumonia. None had received the" exact="influenza" post="vaccine. Discussion Our results show the clinical and epidemiological"/>
   <result pre="persons aged 0–17 years hospitalized with severe conditions due to" exact="influenza" post="A and B in the post-pandemic seasons between 2010–2011"/>
   <result pre="and 2015–2016 in Catalonia. Four-fifths of cases were infected by" exact="influenza" post="A and 20% by influenza B. Although not significant,"/>
   <result pre="of cases were infected by influenza A and 20% by" exact="influenza" post="B. Although not significant, hospitalization due to influenza was"/>
   <result pre="20% by influenza B. Although not significant, hospitalization due to" exact="influenza" post="was more frequent in males than in females, as"/>
   <result pre="that differences in sex and morbidity and mortality due to" exact="influenza" post="may be related to endocrine-immunological interactions and behavioural and"/>
   <result pre="a significant differential factor when we analysed virus subtypes. The" exact="influenza" post="A (H1N1) pdm09 subtype was more frequent and aggressive"/>
   <result pre="frequent and aggressive in children aged &amp;lt;2 years (63.1%), while" exact="influenza" post="B was more frequent in children aged 3–11 years"/>
   <result pre="had chronic disease. Although not significant, 24.6% of cases of" exact="influenza" post="B had pre-existing chronic disease compared with 14.8% of"/>
   <result pre="had pre-existing chronic disease compared with 14.8% of cases of" exact="influenza" post="A. This is in line with other studies, such"/>
   <result pre="that by Mancinelli et al.1 who found that children with" exact="cancer" post="were more susceptible to influenza B, and the study"/>
   <result pre="who found that children with cancer were more susceptible to" exact="influenza" post="B, and the study by Acar et al.21 which"/>
   <result pre="B, and the study by Acar et al.21 which found" exact="influenza" post="B infection is more frequent in children with pulmonary,"/>
   <result pre="admission. Of these, more than three-quarters were infected with the" exact="influenza" post="A virus, with the H1N1 pdm09 subtype being found"/>
   <result pre="other published studies1,21–23. This suggests disease severity is associated with" exact="influenza" post="A infection, as in our study, in which the"/>
   <result pre="our study, in which the three deaths were caused by" exact="influenza" post="A, and two by subtype H1N1 pdm09. The percentage"/>
   <result pre="The percentage of cases requiring ICU admission were similar in" exact="influenza" post="A and influenza B cases (21.7% and 19.7%, respectively)."/>
   <result pre="cases requiring ICU admission were similar in influenza A and" exact="influenza" post="B cases (21.7% and 19.7%, respectively). The study by"/>
   <result pre="The study by Tran et al.24 obtained similar percentages between" exact="influenza" post="A and influenza B cases (12.7% and 12.6%, respectively);"/>
   <result pre="Tran et al.24 obtained similar percentages between influenza A and" exact="influenza" post="B cases (12.7% and 12.6%, respectively); however, these percentages"/>
   <result pre="in our study severe hospitalized children were included. Pneumonia and" exact="acute respiratory distress syndrome" post="were the most frequent complications, as observed in other"/>
   <result pre="A small percentage of hospitalized cases were vaccinated against seasonal" exact="influenza" post="and only one in four children with pre-existing chronic"/>
   <result pre="et al. described a vaccination coverage of &amp;lt;50%26, even though" exact="influenza" post="vaccination is included in the routine vaccination schedule: before"/>
   <result pre="was &amp;lt;6% in children. Children have a higher incidence of" exact="influenza" post="and a higher hospitalization rate than adults27 and are"/>
   <result pre="such as Austria, Finland, Latvia and Slovakia have introduced routine" exact="influenza" post="vaccination for all children from 6–7 months, while in"/>
   <result pre="influenza29–31. The United States, Canada and Japan have also included" exact="influenza" post="vaccination from 6 months of age32–34. Sugaya et al."/>
   <result pre="months of age32–34. Sugaya et al. evaluated the inclusion of" exact="influenza" post="vaccination in the 2013–2016 seasons in children aged 6"/>
   <result pre="a vaccine effectiveness (VE) in disease prevention of 51% for" exact="influenza" post="A and 32% for influenza B; the VE in"/>
   <result pre="disease prevention of 51% for influenza A and 32% for" exact="influenza" post="B; the VE in preventing hospitalizations was 52% for"/>
   <result pre="influenza B; the VE in preventing hospitalizations was 52% for" exact="influenza" post="A and 28% for influenza B35. Currently, vaccination of"/>
   <result pre="preventing hospitalizations was 52% for influenza A and 28% for" exact="influenza" post="B35. Currently, vaccination of people aged &amp;lt;60 years with"/>
   <result pre="aged &amp;lt;60 years with a high risk of complications from" exact="influenza" post="is recommended in Catalonia36, but this does not include"/>
   <result pre="there seem to be no studies supporting the administration of" exact="influenza" post="vaccine or antiviral treatment in children aged &amp;lt;6 months,"/>
   <result pre="the clinical and epidemiological characteristics of children hospitalized due to" exact="influenza" post="in Catalonia, and the differences observed according to the"/>
   <result pre="interests. References References 1.MancinelliLet al.Clinical features of children hospitalized with" exact="influenza" post="A and B infections during the 2012–2013 influenza season"/>
   <result pre="hospitalized with influenza A and B infections during the 2012–2013" exact="influenza" post="season in ItalyBMC Infect. Dis.201616610.1186/s12879-015-1333-x26743673 2.IulianoADet al.Estimates of global"/>
   <result pre="influenza-associated respiratory mortality: a modelling studyLancet.20183911285130010.1016/S0140-6736(17)33293-229248255 3.HongKWet al.Clinical manifestations of" exact="influenza" post="A and B in children and adults at a"/>
   <result pre="in Hong KongVaccine.2012301895190010.1016/j.vaccine.2011.12.02722222872 6.MoolasartVManosuthiWRisk factors for hospitalization among children with" exact="influenza" post="B infectionSoutheast Asian J. Trop. Med. Public Health.20144562262924974646 7.Departament"/>
   <result pre="la grip. Available from: http://canalsalut.gencat.cat/ca/salut-a-z/g/grip/recursos-per-a-professionals/ (2018). 10.AntónAet al.Virological surveillance of" exact="influenza" post="and other respiratory viruses during six consecutive seasons from"/>
   <result pre="al.Effectiveness of hand hygiene and provision of information in preventing" exact="influenza" post="cases requiring hospitalizationPrev. Med.20125443443910.1016/j.ypmed.2012.04.00922548868 13.DomínguezAGodoyPTornerNThe effectiveness of influenza vaccination"/>
   <result pre="in preventing influenza cases requiring hospitalizationPrev. Med.20125443443910.1016/j.ypmed.2012.04.00922548868 13.DomínguezAGodoyPTornerNThe effectiveness of" exact="influenza" post="vaccination in different groupsExpert Rev. Vac.20161575176410.1586/14760584.2016.1142878 14.Observatori del Sistema"/>
   <result pre="Catalunya. Available from: http://observatorisalut.gencat.cat/web/.content/minisite/observatorisalut/ossc_central_resultats/informes/fitxers_estatics/Central_resultats_hospitals_dades_2016.pdf (2017). 15.QuachCPiché-WalkerLPlattRMooreDRisk factors associated with severe" exact="influenza" post="infections in childhood: implication for vaccine strategyPediatrics.2003112e197e20110.1542/peds.112.3.e19712949312 16.World Health"/>
   <result pre="influenza-associated hospitalizations in Hong KongAm. J. Epidemiol.201518233534410.1093/aje/kwv06826219977 18.ChoiWIRhoBHLeeMYMale predominance of" exact="pneumonia" post="and hospitalization in pandemic influenza A (H1N1) 2009 infectionBMC"/>
   <result pre="J. Epidemiol.201518233534410.1093/aje/kwv06826219977 18.ChoiWIRhoBHLeeMYMale predominance of pneumonia and hospitalization in pandemic" exact="influenza" post="A (H1N1) 2009 infectionBMC Res. Notes.2011435110.1186/1756-0500-4-35121906395 19.KleinSLHodgsonARobisonDPMechanisms of sex"/>
   <result pre="(H1N1) 2009 infectionBMC Res. Notes.2011435110.1186/1756-0500-4-35121906395 19.KleinSLHodgsonARobisonDPMechanisms of sex disparities in" exact="influenza" post="pathogenesisJ. Leukoc. Biol.201292677310.1189/jlb.081142722131346 20.KareagaNAet al.Características clínicas de los niños"/>
   <result pre="infección por virus InfluenzaAn. Pediatr. (Barc).20056251210.1157/1307017415642235 21.AcarMet al.Clinical differences of" exact="influenza" post="subspecies among hospitalized childrenTurk. Arch. Pediatr.201752152210.5152/TurkPediatriArs.2017.4695 22.KusznierzGet al.Impact of"/>
   <result pre="influenza subspecies among hospitalized childrenTurk. Arch. Pediatr.201752152210.5152/TurkPediatriArs.2017.4695 22.KusznierzGet al.Impact of" exact="influenza" post="in the post-pandemic phase: Clinical features in hospitalized patients"/>
   <result pre="in the post-pandemic phase: Clinical features in hospitalized patients with" exact="influenza" post="A (H1N1) pdm09 and H3N2 viruses, during 2013 in"/>
   <result pre="ArgentinaJ. Med. Virol.2017891186119110.1002/jmv.2475828004402 23.StrengAPrifertCWeissbrichBLieseJGContinued high incidence of children with severe" exact="influenza" post="A(H1N1)pdm09 admitted to paediatric intensive care units in Germany"/>
   <result pre="intensive care units in Germany during the first three post-pandemic" exact="influenza" post="seasons, 2010/11-2012/13BMC Infect Dis.20151857310.1186/s12879-015-1293-1 24.TranDet al.Hospitalization for influenza A"/>
   <result pre="three post-pandemic influenza seasons, 2010/11-2012/13BMC Infect Dis.20151857310.1186/s12879-015-1293-1 24.TranDet al.Hospitalization for" exact="influenza" post="A versus BPediatrics.2016138e2015464310.1542/peds.2015-464327535144 25.MachablishviliATsereteliDZkhashviliKKarseladzeIImnadzePClinical and epidemiological characterization of influenza"/>
   <result pre="for influenza A versus BPediatrics.2016138e2015464310.1542/peds.2015-464327535144 25.MachablishviliATsereteliDZkhashviliKKarseladzeIImnadzePClinical and epidemiological characterization of" exact="influenza" post="A/H1N1pdm and b among hospitalized children, Georgia, season 2010–2011Georgian"/>
   <result pre="pediatría, ¿sí o no?An. Pediatr. (Barc).201379261e1261e1110.1016/j.anpedi.2013.03.00523623850 28.LimJKet al.The association between" exact="influenza" post="treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed"/>
   <result pre="primary school-age children against influenza: experiences of a live attenuated" exact="influenza" post="vaccine programme, England, 2015/16. Euro Surveill. 23 (2018). 31.ECDC."/>
   <result pre="2015/16. Euro Surveill. 23 (2018). 31.ECDC. Vaccine schedules for seasonal" exact="influenza" post="in all countries of the European Union Available from:"/>
   <result pre="Available from: https://ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccination-schedule. 32.CDC. Influenza vaccines — United States, 2017–18" exact="influenza" post="season. Available from: https://www.cdc.gov/flu/protect/vaccine/vaccines.htm. 33.Public Health Agency of Canada."/>
   <result pre="2015-2016. Available from: https://static1.squarespace.com/static/5111f3d0e4b0e580c19f5405/t/57e9b1b1be6594b5b5cd6243/1474933169756/FluFlyerEng16-17.pdf (2015). 35.SugayaNet al.Three-season effectiveness of inactivated" exact="influenza" post="vaccine in preventing influenza illness and hospitalization in children"/>
   <result pre="(2015). 35.SugayaNet al.Three-season effectiveness of inactivated influenza vaccine in preventing" exact="influenza" post="illness and hospitalization in children in Japan, 2013-2016Vaccine.2018361063107110.1016/j.vaccine.2018.01.02429361343 36.Agència"/>
   <result pre="for Disease Prevention and Control. ECDC scientific advice on seasonal" exact="influenza" post="vaccination of children and pregnant women. Stockholm: ECDC. Available"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731519\results\search\disease\results.xml">
   <result pre="italic;} EpidemicsEpidemicsEpidemics1755-43651878-0067Elsevier pmcid: 6731519S1755-4365(18)30105-1 doi: 10.1016/j.epidem.2019.100346100346 : Article Phylogeography of" exact="rubella" post="virus in Asia: Vaccination and demography shape synchronous outbreaks"/>
   <result pre="the CC BY license (http://creativecommons.org/licenses/by/4.0/). Highlights •Metapopulation dynamics contribute to" exact="rubella" post="persistence in East/Southeast Asia. •Circulation patterns differ between rubella"/>
   <result pre="to rubella persistence in East/Southeast Asia. •Circulation patterns differ between" exact="rubella" post="viral genotypes 1E and 2B. •China serves as a"/>
   <result pre="Asia. •Taiwan may act as an important sentinel for regional" exact="rubella" post="activity. Abstract Rubella virus causes mild disease in children"/>
   <result pre="early stages of pregnancy, it can cause spontaneous abortion, congenital" exact="rubella" post="syndrome (CRS) and associated birth defects. Despite the availability"/>
   <result pre="associated birth defects. Despite the availability of an effective vaccine," exact="rubella" post="virus continues to circulate endemically in several regions of"/>
   <result pre="is therefore important to understand how the regional persistence of" exact="rubella" post="is affected both by dynamics occurring across countries and"/>
   <result pre="from countries in E/SE Asia to explore the phylogeography of" exact="rubella" post="virus in this region. Our results underline that metapopulation"/>
   <result pre="region. Our results underline that metapopulation dynamics are key for" exact="rubella" post="persistence and highlight the source-sink population structure of the"/>
   <result pre="still estimates that over 100,000 babies/year are born with congenital" exact="rubella" post="syndrome worldwide (Vynnycky et al., 2016; World Health Organization,"/>
   <result pre="knowledge, just a single study has addressed global diffusion of" exact="rubella" post="(Cloete, 2014); findings indicated that infection tends to flow"/>
   <result pre="of vaccination coverage. While countries such as Japan introduced the" exact="rubella" post="vaccine to adolescent school girls as early as 1977"/>
   <result pre="outbreak, suggesting a degree of regional synchronization. Our understanding of" exact="rubella" post="persistence will be strengthened by characterizing the extent to"/>
   <result pre="with waning immunity, or complex cross-immunity (e.g. influenza), but as" exact="rubella" post="infection and vaccination are completely immunizing, estimation of the"/>
   <result pre="birth cohorts. Characterizing susceptible dynamics will improve our understanding of" exact="rubella" post="persistence and may contribute to optimizing public health intervention"/>
   <result pre="one serotype exists, the CDC has identified two groups of" exact="rubella" post="viruses consisting of ten and three genotypes, respectively (World"/>
   <result pre="we aimed to assess the importance of metapopulation dynamics to" exact="rubella" post="persistence in E/SE Asia. We used publicly available genetic"/>
   <result pre="additionally estimated country-specific susceptibility profiles to link temporal trends in" exact="rubella" post="incidence and susceptible population size with the timing of"/>
   <result pre="that did not map to the 739bp window used for" exact="rubella" post="genotype identification (World Health Organization, 2005) were discarded. For"/>
   <result pre="dependent fashion (Bjørnstad et al., 2002). Estimated coverage achieved in" exact="rubella" post="vaccination programs, timing and age range of supplementary immunization"/>
   <result pre="that occur at intervals of 2–4 years), and time-series of" exact="rubella" post="incidence are publicly available from the World Health Organization"/>
   <result pre="to 2015 (supplementary Fig. 7). Fig. 2 Circulation patterns of" exact="rubella" post="virus in Asia. Circulation maps of a) genotype 1E"/>
   <result pre="this period; according to the World Health Organization, reporting of" exact="rubella" post="cases in many countries did not start until 2005"/>
   <result pre="a vaccination coverage threshold of 80% (1-1/R0 for R0˜5). That" exact="rubella" post="continues to circulate in many of these countries suggests"/>
   <result pre="the importance of metapopulation processes in the epidemic dynamics of" exact="rubella" post="in this region. Demographic reconstruction of the viral effective"/>
   <result pre="coincides with the period in which several Asian countries experienced" exact="rubella" post="epidemics (supplementary Fig. 1a). Broad concordance between peaks in"/>
   <result pre="To understand whether metapopulation dynamics contribute to the persistence of" exact="rubella" post="across neighboring countries that vary in their level of"/>
   <result pre="evidence. Our analysis indicates that circulation patterns may differ between" exact="rubella" post="virus genotypes 1E and 2B. As no evidence of"/>
   <result pre="1E, Taiwan likely acts as an important indicator for regional" exact="rubella" post="activity across East and Southeast Asia. In line with"/>
   <result pre="to E/SE Asia. While other studies have looked at global" exact="rubella" post="circulation, our study focuses on regional spread in an"/>
   <result pre="a poor measure for the connections that are relevant to" exact="rubella" post="spread. Our finding that viral persistence is maintained through"/>
   <result pre="the limited relevance of imports from India for re-introduction of" exact="rubella" post="in E/SE Asia will become increasingly important as the"/>
   <result pre="E/SE Asia will become increasingly important as the region approaches" exact="rubella" post="elimination. Given the introduction of rubella-containing vaccine to all"/>
   <result pre="metric indicating successful control. It remains to be seen how" exact="rubella" post="dynamics throughout the region will affect Japan as it"/>
   <result pre="by its large population size, relatively recent introduction of routine" exact="rubella" post="vaccination, and prevalence of travel connections, our finding of"/>
   <result pre="and characterization, there are multiple factors that predispose Taiwan to" exact="rubella" post="importations. Past serological studies show that seronegativity is higher"/>
   <result pre="2007) and until 2002, Taiwan did not require proof of" exact="rubella" post="vaccination upon immigration (Lin et al., 2010; Taiwan Centers"/>
   <result pre="immigrants now come from nations in Southeast Asia, where endemic" exact="rubella" post="transmission is still widespread and vaccination has only recently"/>
   <result pre="its strong geopolitical ties to China, a clear source of" exact="rubella" post="infection, makes Taiwan an ideal sentinel for the identification"/>
   <result pre="effective population size of both genotypes is striking given that" exact="rubella" post="virus immunity is completely cross-protective. Previous work has shown"/>
   <result pre="two consecutive years of viral population growth during any single" exact="rubella" post="epidemic in a given location, closely synchronized outbreaks across"/>
   <result pre="major pulse driver, akin to that of London for pre-vaccination" exact="measles" post="epidemics in the United Kingdom (Grenfell et al., 2001)."/>
   <result pre="cities are above the critical community size for maintaining persistent" exact="rubella" post="circulation (Metcalf et al., 2013) and that high international"/>
   <result pre="exceeds that from countries in Southeast and South Asia, where" exact="rubella" post="is often not a notifiable disease. Further, even in"/>
   <result pre="lack access to vaccination, will further refine our understanding of" exact="rubella" post="circulation and persistence. Literature on the historical genotypic characterization"/>
   <result pre="and persistence. Literature on the historical genotypic characterization of global" exact="rubella" post="viruses indicates that many subtypes and lineages have gone"/>
   <result pre="in countries with minimal available data. Our results suggest that" exact="rubella" post="lineages are not confined to specific countries and therefore"/>
   <result pre="BAB; OPP1094793). References References AbernathyE.S.Status of global virologic surveillance for" exact="rubella" post="virusesJ. Infect. Dis.2042011S524S53221666209 AndersonR.M.MayR.M.Infectious Diseases of Humans: Dynamics and"/>
   <result pre="using a time series SIR modelEcol. Monogr.722002169184 ChengW.-Y.WangH.-C.LiuM.-T.WuH.-S.Molecular surveillance of" exact="rubella" post="viruses in Taiwan from 2005 to 2011J. Med. Virol.85201374575323417619"/>
   <result pre="Population Ages, Japan Quietly Turns to Immigration2017https://www.migrationpolicy.org/article/its-population-ages-japan-quietly-turns-immigration DewanP.GuptaP.Burden of congenital" exact="rubella" post="syndrome (CRS) in India: a systematic reviewIndian Pediatr.49201237739922700664 DrummondA.J.SuchardM.A.XieD.RambautA.Bayesian"/>
   <result pre="in continuous-time Markov chainsCan. J. Stat.362008355368 FigueiredoC.A.OliveiraM.I.CurtiS.P.AfonsoA.M.S.Yu ALFrugiGualbertoF.DurigonE.L.Phylogenetic analysis of" exact="rubella" post="virus strains during an outbreak in São Paulo, 2007-2008J."/>
   <result pre="26 October 2017). GongL.I.SuchardM.A.BloomJ.D.Stability-mediated epistasis constrains the evolution of an" exact="influenza" post="proteinElife22013e00631 GrenfellB.T.BjørnstadO.N.KappeyJ.Travelling waves and spatial hierarchies in measles epidemicsNature414200171672311742391"/>
   <result pre="of an influenza proteinElife22013e00631 GrenfellB.T.BjørnstadO.N.KappeyJ.Travelling waves and spatial hierarchies in" exact="measles" post="epidemicsNature414200171672311742391 GrenfellB.T.PybusO.G.GogJ.R.WoodJ.L.N.DalyJ.M.MumfordJ.A.HolmesE.C.Unifying the epidemiological and evolutionary dynamics of pathogensScience3032004327"/>
   <result pre="molecular clock of mitochondrial DNAJ. Mol. Evol.2219851601743934395 IcenogleJ.P.FreyT.K.AbernathyE.ReefS.E.SchnurrD.StewartJ.A.Genetic analysis of" exact="rubella" post="viruses found in the United States between 1966 and"/>
   <result pre="the United States between 1966 and 2004: evidence that indigenous" exact="rubella" post="viruses have been eliminatedClin. Infect. Dis.432006S133S14016998772 KearseM.Geneious2012 KinoshitaR.NishiuraH.Assessing herd"/>
   <result pre="have been eliminatedClin. Infect. Dis.432006S133S14016998772 KearseM.Geneious2012 KinoshitaR.NishiuraH.Assessing herd immunity against" exact="rubella" post="in Japan: a retrospective seroepidemiological analysis of age-dependent transmission"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2PLoS Pathog.102014e1003932 LesslerJ.MetcalfC.J.E.Balancing evidence and uncertainty when considering rubella"/>
   <result pre="human influenza H3N2PLoS Pathog.102014e1003932 LesslerJ.MetcalfC.J.E.Balancing evidence and uncertainty when considering" exact="rubella" post="vaccine introductionPLoS One82013 LesslerJ.MetcalfC.J.E.GraisR.F.LuqueroF.J.CummingsD.A.T.GrenfellB.T.Measuring the performance of vaccination programs"/>
   <result pre="in AsiaAm. J. Trop. Med. Hyg.822010404420064993 Martínez-TorresA.O.MosqueraM.M.De OryF.González-PraetoriusA.EchevarríaJ.E.Genetic characterization of" exact="rubella" post="virus strains detected in Spain, 1998-2014PLoS One112016e0162403 MetcalfC.J.E.BjørnstadO.N.FerrariM.J.KlepacP.BhartiN.Lopez-GatellH.GrenfellB.T.The epidemiology"/>
   <result pre="virus strains detected in Spain, 1998-2014PLoS One112016e0162403 MetcalfC.J.E.BjørnstadO.N.FerrariM.J.KlepacP.BhartiN.Lopez-GatellH.GrenfellB.T.The epidemiology of" exact="rubella" post="in Mexico: seasonality, stochasticity and regional variationEpidemiol. Infect.13920111029103820843389 MetcalfC.J.E.MunaycoC.V.ChowellG.GrenfellB.T.BjørnstadO.N.Rubella"/>
   <result pre="and importance of spatial coupling to the risk of congenital" exact="rubella" post="syndrome in PeruJ. R. Soc. Interface8201136937620659931 MetcalfC.J.E.Implications of spatially"/>
   <result pre="of spatially heterogeneous vaccination coverage for the risk of congenital" exact="rubella" post="syndrome in South AfricaJ. R. Soc. Interface10201320120756 MininV.N.SuchardM.A.Counting labeled"/>
   <result pre="coalescent-based inference of population dynamicsMol. Biol. Evol.2520081459147118408232 MiramboM.M.MajigoM.AboudS.GroßU.MshanaS.E.Serological makers of" exact="rubella" post="infection in Africa in the pre vaccination era: a"/>
   <result pre="the pre vaccination era: a systematic reviewBMC Res. Notes8201571626602892 MuldersM.N.Global" exact="measles" post="and rubella laboratory network support for elimination goals, 2010–2015MMWR"/>
   <result pre="vaccination era: a systematic reviewBMC Res. Notes8201571626602892 MuldersM.N.Global measles and" exact="rubella" post="laboratory network support for elimination goals, 2010–2015MMWR Morb. Mortal."/>
   <result pre="Inf. Source2009118 PhamV.H.VanNguyen T.NguyenT.T.T.DangL.D.HoangN.H.VanNguyen T.AbeK.Rubella epidemic in Vietnam: Characteristic of" exact="rubella" post="virus genes from pregnant women and their fetuses/newborns with"/>
   <result pre="virus genes from pregnant women and their fetuses/newborns with congenital" exact="rubella" post="syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of rubella and rubella"/>
   <result pre="fetuses/newborns with congenital rubella syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of" exact="rubella" post="and rubella vaccination leading to eliminationClin. Infect. Dis.432006S164S16816998777 Pons-salortM.ParkerE.Pk.GrasslyN.C.The"/>
   <result pre="congenital rubella syndromeJ. Clin. Virol.57201315215623481444 PlotkinS.A.The history of rubella and" exact="rubella" post="vaccination leading to eliminationClin. Infect. Dis.432006S164S16816998777 Pons-salortM.ParkerE.Pk.GrasslyN.C.The epidemiology of"/>
   <result pre="outstanding questionsCurr. Opin. Infect. Dis.28201547948726203854 RivaillerP.AbernathyE.IcenogleJ.Genetic diversity of currently circulating" exact="rubella" post="viruses: a need to define more precise viral groupsJ."/>
   <result pre="precise viral groupsJ. Gen. Virol.2017 RussellC.A.The global circulation of seasonal" exact="influenza" post="A (H3N2) virusesScience (80-.)3202008340346 ShihC.T.ChangY.C.WangH.L.LinC.C.Comparing the rubella seronegativity in"/>
   <result pre="circulation of seasonal influenza A (H3N2) virusesScience (80-.)3202008340346 ShihC.T.ChangY.C.WangH.L.LinC.C.Comparing the" exact="rubella" post="seronegativity in pregnant women who received one dose of"/>
   <result pre="rubella seronegativity in pregnant women who received one dose of" exact="rubella" post="vaccine at different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of"/>
   <result pre="rubella vaccine at different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of" exact="rubella" post="and congenital rubella syndrome in the 2012-2013 epidemics in"/>
   <result pre="different ages in TaiwanVaccine3420164787479127544587 SugishitaY.ShimataniN.KatowS.TakahashiT.HoriN.Epidemiological characteristics of rubella and congenital" exact="rubella" post="syndrome in the 2012-2013 epidemics in Tokyo, JapanJpn. J."/>
   <result pre="on 25 October 2017). TakahashiS.MetcalfC.J.E.FerrariM.J.MossW.J.TrueloveS.A.TatemA.J.GrenfellB.T.LesslerJ.Reduced vaccination and the risk of" exact="measles" post="and other childhood infections post-EbolaScience34720151240124225766232 TakahashiS.MetcalfC.J.E.FerrariM.J.TatemA.J.LesslerJ.The geography of measles"/>
   <result pre="of measles and other childhood infections post-EbolaScience34720151240124225766232 TakahashiS.MetcalfC.J.E.FerrariM.J.TatemA.J.LesslerJ.The geography of" exact="measles" post="vaccination in the African Great Lakes regionNat. Commun.820171558528541287 Tanaka-TayaKeikoSatohHiroshiAraiSatoruYamagishiTakuyaYahataYuichiroNakashimaKazutoshiSugawaraTamieOhkusaYasushiMatsuiTamanoSaitoTakehitoKanouKazuhikoShimadaTomoeKinoshitaHitomiYamashitaKazuyoYasuiYoshinoriYukiK.O.Nationwide"/>
   <result pre="measles vaccination in the African Great Lakes regionNat. Commun.820171558528541287 Tanaka-TayaKeikoSatohHiroshiAraiSatoruYamagishiTakuyaYahataYuichiroNakashimaKazutoshiSugawaraTamieOhkusaYasushiMatsuiTamanoSaitoTakehitoKanouKazuhikoShimadaTomoeKinoshitaHitomiYamashitaKazuyoYasuiYoshinoriYukiK.O.Nationwide" exact="rubella" post="epidemic - Japan, 2013MMWR Morb. Mortal. Wkly. Rep.62201345746223760185 TeradaK.Rubella"/>
   <result pre="- Japan, 2013MMWR Morb. Mortal. Wkly. Rep.62201345746223760185 TeradaK.Rubella and congenital" exact="rubella" post="syndrome in Japan: epidemiological problemsJpn. J. Infect. Dis.562003818712944671 ThaoN.T.T.Evolution"/>
   <result pre="ASEAN Stud.320156892 United NationsInternational Migration Report 2015(doi:ST/ESA/SER.A/384)2016 Vauloup-FellousC.HübschenJ.M.AbernathyE.S.IcenogleJ.GaidotN.DubreuilP.Parent-du-ChâteletI.Grangeot-KerosL.MullerC.P.Phylogenetic analysis of" exact="rubella" post="viruses involved in congenital rubella infections in France between"/>
   <result pre="Report 2015(doi:ST/ESA/SER.A/384)2016 Vauloup-FellousC.HübschenJ.M.AbernathyE.S.IcenogleJ.GaidotN.DubreuilP.Parent-du-ChâteletI.Grangeot-KerosL.MullerC.P.Phylogenetic analysis of rubella viruses involved in congenital" exact="rubella" post="infections in France between 1995 and 2009J. Clin. Microbiol.4820102530253520463161"/>
   <result pre="immunisation coverage data to estimate the global burden of congenital" exact="rubella" post="syndrome, 1996-2010 : a systematic reviewPLoS One112016e0149160 WangI.J.HuangL.M.ChenH.H.HwangK.C.ChenC.J.Seroprevalence of"/>
   <result pre="rubella syndrome, 1996-2010 : a systematic reviewPLoS One112016e0149160 WangI.J.HuangL.M.ChenH.H.HwangK.C.ChenC.J.Seroprevalence of" exact="rubella" post="infection after national immunization program in Taiwan: vaccination status"/>
   <result pre="Interface13201620151101- WesolowskiA.Multinational patterns of seasonal asymmetry in human movement influence" exact="infectious disease" post="dynamicsNat. Commun.82017206929234011 WinterA.K.PramanikS.LesslerJ.FerrariM.GrenfellB.T.MetcalfC.J.E.Rubella Vaccination in India: Identifying broad consequences"/>
   <result pre="Health OrganizationStandardization of the nomenclature for genetic characteristics of wild-type" exact="rubella" post="virusesWkly. Epidemiol. Rec.80200512613215850226 World Health OrganizationRubella vaccines: WHO position"/>
   <result pre="methodsJ. Mol. Evol.3919943063147932792 ZhuZ.Emergence and continuous evolution of genotype 1E" exact="rubella" post="viruses in ChinaJ. Clin. Microbiol.50201235336322162559 ZhuZ.Evolutionary analysis of rubella"/>
   <result pre="1E rubella viruses in ChinaJ. Clin. Microbiol.50201235336322162559 ZhuZ.Evolutionary analysis of" exact="rubella" post="viruses in mainland China during 2010–2012: endemic circulation of"/>
   <result pre="of genotype 2BSci. Rep.52015799925613734 ZhuZ.Analysis of complete genomes of the" exact="rubella" post="virus genotypes 1E and 2B which circulated in China,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6731520\results\search\disease\results.xml">
   <result pre="of the British salmonid aquaculture industry from the perspective of" exact="infectious disease" post="control. We combine for the first time live fish"/>
   <result pre="an estimated one third of salmon mortality was attributed to" exact="infectious disease" post="(Kilburn et al., 2012). Finfish diseases can have severe"/>
   <result pre="diseases can be maintained in wild populations with examples in" exact="parasitic disease" post="or sustained via vertical transmission. However, most evidence points"/>
   <result pre="excluded here, although this background risk could be incorporated in" exact="infectious disease" post="simulation models and this would be relevant for the"/>
   <result pre="a detailed multi-layer network mapping of the potential routes of" exact="infectious disease" post="transmission. These layers are live fish movement, transmission along"/>
   <result pre="position in connecting sub-components of the network. More generally in" exact="infectious disease" post="transmission, &quot;super-spreaders�? are often identified (Woolhouse et al., 1997),"/>
   <result pre="the potential effectiveness of control measures requires dynamic simulation of" exact="infectious disease" post="transmission on this network. In conclusion, the contact structure"/>
   <result pre="infectionJ. Aquat. Anim. Health1632004109115 DentJ.E.The potential spread of highly pathogenic" exact="avian influenza" post="virus via dynamic contacts between poultry premises in Great"/>
   <result pre="Aquat. Anim. Health1632004109115 DentJ.E.The potential spread of highly pathogenic avian" exact="influenza" post="virus via dynamic contacts between poultry premises in Great"/>
   <result pre="Western ScotlandAquaculture36836920128994 KiveläM.Multilayer networksJ. Complex Netw.232014203271 LøvdalT.EngerØ.Detection of infectious salmon" exact="anemia" post="virus in sea water by nested RT-PCRDis. Aquat. Org.49200212312812078980"/>
   <result pre="Health.2016 MardonesF.O.Farm-level reproduction number during an epidemic of infectious salmon" exact="anemia" post="virus in southern Chile in 2007-2009Prev. Vet. Med.1023201117518421840073 MardonesF.O.The"/>
   <result pre="role of fish movements and the spread of infectious salmon" exact="anemia" post="virus (ISAV) in Chile, 2007–2009Prev. Vet. Med.11412014374624485704 MunroL.A.GregoryA.Application of"/>
   <result pre="20162017The Scottish GovernmentEdinburgh MurrayA.G.SmithR.J.StaggR.M.Shipping and the spread of infectious salmon" exact="anemia" post="in Scottish aquacultureEmerg. Infect. Dis.8120021511749740 MurrayA.G.Epidemiology of Renibacterium salmoninarum"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6734352\results\search\disease\results.xml">
   <result pre="CentralLondon pmcid: 6734352563 doi: 10.1186/s12929-019-0563-4 : Research Inhibition of H1N1" exact="influenza" post="virus infection by zinc oxide nanoparticles: another emerging application"/>
   <result pre="oxide nanoparticles (ZnO-NPs) and PEGylated zinc oxide nanoparticles against H1N1" exact="influenza" post="virus. Methods The nanoparticles were characterized using the inductively"/>
   <result pre="an indirect immunofluorescence assay was also performed. Results Post-exposure of" exact="influenza" post="virus with PEGylated ZnO-NPs and bare ZnO-NPs at the"/>
   <result pre="be a novel, effective, and promising antiviral agent against H1N1" exact="influenza" post="virus infection, and future studies can be designed to"/>
   <result pre="of these nanoparticles. Keywords Antiviral activity Zinc oxide nanoparticle H1N1" exact="influenza" post="Polyethylene glycol Funding iran university of medical sciences9321540003MonavariSeyed Hamidreza"/>
   <result pre="recent estimates reported by the World Health Organization (WHO), seasonal" exact="influenza" post="epidemics lead to about 3–5 million cases of severe"/>
   <result pre="the viral nucleoprotein and major matrix protein, of which only" exact="influenza" post="A and B viruses are the major culprit in"/>
   <result pre="there are only two classes of drugs available against different" exact="influenza" post="A strains and subtypes licensed by the U.S. Food"/>
   <result pre="effects of ZnO-NPs and ZnO-PEG-NPs on the replication of H1N1" exact="influenza" post="virus, which are amongst the most challenging viruses that"/>
   <result pre="dissolved in DMEM and used as a standard drug against" exact="influenza" post="at different concentrations. Polyethylene glycol (PEG) 6000 was also"/>
   <result pre="evaluate direct effects of ZnO and ZnO-PEG nanoparticles on H1N1" exact="influenza" post="particles, equal volumes of the viral suspensions (100 TCID50/ml)"/>
   <result pre="of total progeny virus. Quantitative Real-Time PCR assay To determine" exact="influenza" post="viral load, a quantitative system using Real-Time PCR assay"/>
   <result pre="kit contains primers and probe designed for detection of all" exact="influenza" post="A subtypes. The assay was performed using the Rotor-Gene"/>
   <result pre="ZnO-PEG-NPs did not lead to any reduction of the H1N1" exact="influenza" post="virus titer. Meanwhile, virucidal activity was not observed at"/>
   <result pre="nanoparticles, suggesting that nanoparticles could not act directly against the" exact="influenza" post="virus particle resulting in viral inactivation. The striking finding"/>
   <result pre="in a significant decrease in viral titer. Post-exposure of H1N1" exact="influenza" post="virus with PEGylated ZnO-NPs at the concentrations of 75,"/>
   <result pre="ZnO-PEG-NPs, polyethylene glycol, and oseltamivir on the titer of H1N1" exact="influenza" post="virus by TCID50 assay. * Statistically significant (p &amp;lt; 0.0001). Error"/>
   <result pre="level The antiviral activities of ZnO-NPs and ZnO-PEG-NPs against H1N1" exact="influenza" post="virus were further confirmed by quantitative Real-Time PCR. It"/>
   <result pre="94.6%, respectively. The inhibition rates were calculated based on the" exact="influenza" post="viral loads. It is obvious that the anti-influenza activity"/>
   <result pre="52.2% (Fig. 6). It is notable that the production of" exact="influenza" post="virus was completely inhibited by oseltamivir at the concentration"/>
   <result pre="6 The inhibitory rates of the four compounds against H1N1" exact="influenza" post="virus determined by Real-Time PCR assay regarding to the"/>
   <result pre="study the inhibitory impact of nanoparticles on the expression of" exact="influenza" post="virus antigens on the MDCK-SIAT1 cells surface, an indirect"/>
   <result pre="of 75 μg/mL. Fig. 7 Immunofluorescence staining for detection of H1N1" exact="influenza" post="virus antigens in the MDCK-SIAT1 cells. (a) Cell control,"/>
   <result pre="(d) 200 μg/ml ZnO-PEG-NPs at 24 h post infection Discussion The H1N1" exact="influenza" post="virus is a significant global public health threat with"/>
   <result pre="cause worldwide epidemics and pandemics. The current antiviral drugs against" exact="influenza" post="are weakened due to their significant adverse effects and"/>
   <result pre="a key role in enhancement of antiviral activity against H1N1" exact="influenza" post="virus and reduction of cell cytotoxicity on MDCK-SIAT1 cells."/>
   <result pre="that PEGylated ZnO-NP was associated with higher antiviral activity against" exact="herpes simplex" post="virus type 1 (HSV-1) and lower cytotoxicity on Vero"/>
   <result pre="for assessment of cytotoxicity of ZnO-NPs and ZnO-PEG-NPs on MCF-7" exact="breast cancer" post="cells, and they demonstrated the higher cytotoxicity for bare"/>
   <result pre="assessment of cytotoxicity of ZnO-NPs and ZnO-PEG-NPs on MCF-7 breast" exact="cancer" post="cells, and they demonstrated the higher cytotoxicity for bare"/>
   <result pre="the nanoparticles have inhibitory activities to suppress the proliferation of" exact="influenza" post="virus when added 1 h after infection. As shown in"/>
   <result pre="not result in any decrease in the titer of H1N1" exact="influenza" post="virus. These findings indicate that the nanoparticles do not"/>
   <result pre="not occupied specific receptors involved in attachment and entry of" exact="influenza" post="particles into the host cells. These experimental results show"/>
   <result pre="with the some stages in the life cycle of the" exact="influenza" post="virus which occur after viral adsorption and internalization by"/>
   <result pre="revealed that inhibitory potential of ZnO-NPs and ZnO-PEG-NPs against H1N1" exact="influenza" post="virus was only documented in post-exposure antiviral assay, antiviral"/>
   <result pre="cellular uptake of nanoparticles [22, 23]. On the other hand," exact="influenza" post="viruses carry out their transcription and replication entirely inside"/>
   <result pre="its maximal non-cytotoxic concentration (200 μg/ml) had slightly antiviral activity on" exact="influenza" post="virus (with inhibition rate of 13.5%). As an explanation,"/>
   <result pre="conducted to investigate the inhibitory effects of various nanostructures on" exact="influenza" post="virus infection. In the most recent work, Kumar et"/>
   <result pre="against PR8-H1N1strain, and they proposed the IO-NPs as the potent" exact="influenza" post="virus inhibitor with 8 fold decrease in viral RNA"/>
   <result pre="nanoparticles (SeNPs) and zanamivir modified selenium nanoparticles (Se@ZNV) against H1N1" exact="influenza" post="virus investigated, and their results indicated that Se@ZNV has"/>
   <result pre="capabilities of SeNPs and oseltamivir surface-modified SeNPs (Se@OTV) against H1N1" exact="influenza" post="virus [28]. Their findings showed that Se@OTV is associated"/>
   <result pre="with higher antiviral activity and has less toxicity. Interference with" exact="influenza" post="virus life cycle by inhibition of hemagglutinin and neuraminidase"/>
   <result pre="as a possible mechanism. During the last stage of the" exact="influenza" post="virus replication cycle, newly assembled viral particles should be"/>
   <result pre="this cleavage step, and interfere with the release of progeny" exact="influenza" post="virus from infected host cells and subsequently, prevent the"/>
   <result pre="research which examined the inhibitory effects of ZnO-NPs on H1N1" exact="influenza" post="virus. The results showed that PEGylated ZnO-NPs have a"/>
   <result pre="can be effective in enhancement of antiviral activity against H1N1" exact="influenza" post="virus and reduction of cell cytotoxicity on MDCK-SIAT1 cells."/>
   <result pre="experiments also demonstrated that the nanoparticles have inhibitory properties against" exact="influenza" post="virus only after viral entry into the host cells."/>
   <result pre="microscope (TEM), as well as to examine the pattern of" exact="influenza" post="virus gene expression in the presence of the nanoparticles."/>
   <result pre="test with hemagglutination inhibition test to evaluate neutralizing antibody against" exact="influenza" post="virus (H1N1)Iran J Public Health20174612169029259944 2.World Health Organization. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)."/>
   <result pre="Organization. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 6 Nov 2018. 3.KeshavarzMTavakoliAMozaffari NejadASMokhtari-AzadTRezaeiFA review of" exact="influenza" post="vaccination among different population groups in IranJ Clin Diagn"/>
   <result pre="population groups in IranJ Clin Diagn Res2018126 4.MoghoofeiMMonavariSHMostafaeiSHadifarSGhasemiABabaeiFet al.Prevalence of" exact="influenza" post="a infection in the M iddle-E ast: a systematic"/>
   <result pre="systematic review and meta-analysisClin Respir J20181251787180110.1111/crj.1275829316311 5.ChaisriUChaicumpaWEvolution of therapeutic antibodies," exact="influenza" post="virus biology, influenza, and influenza immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet"/>
   <result pre="J20181251787180110.1111/crj.1275829316311 5.ChaisriUChaicumpaWEvolution of therapeutic antibodies, influenza virus biology, influenza, and" exact="influenza" post="immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet al.Expression of the influenza M2"/>
   <result pre="influenza, and influenza immunotherapyBiomed Res Int20182018974754910.1155/2018/974754929998138 6.EsghaeiMMonavariSHRTavassoti-KheiriMShamsi-ShahrabadiMHeydarchiBFarahmandBet al.Expression of the" exact="influenza" post="M2 protein in three different eukaryotic cell linesJ Virol"/>
   <result pre="different eukaryotic cell linesJ Virol Methods2012179116116510.1016/j.jviromet.2011.10.01622079618 7.Toledo-RuedaWRosas-MurrietaNHMuñoz-MedinaJEGonzález-BonillaCRReyes-LeyvaJSantos-LópezGAntiviral resistance markers in" exact="influenza" post="virus sequences in Mexico, 2000–2017Infect Drug Resist201811175110.2147/IDR.S15315430349332 8.DingYCaoZCaoLDingGWangZXiaoWAntiviral activity"/>
   <result pre="Mexico, 2000–2017Infect Drug Resist201811175110.2147/IDR.S15315430349332 8.DingYCaoZCaoLDingGWangZXiaoWAntiviral activity of chlorogenic acid against" exact="influenza" post="a (H1N1/H3N2) virus and its inhibition of neuraminidaseSci Rep201774572310.1038/srep4572328393840"/>
   <result pre="amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant" exact="influenza" post="a virusesPLoS One201271e3100610.1371/journal.pone.003100622292088 10.Tavakoli A, Hashemzadeh MS. Inhibition of"/>
   <result pre="influenza a virusesPLoS One201271e3100610.1371/journal.pone.003100622292088 10.Tavakoli A, Hashemzadeh MS. Inhibition of" exact="herpes simplex" post="virus type 1 by copper oxide nanoparticles. J Virol"/>
   <result pre="12.MukherjeeSPatraCRBiologically synthesized metal nanoparticles: recent advancement and future perspectives in" exact="cancer" post="theranosticsFuture Sci OA201733FSO20310.4155/fsoa-2017-003528884002 13.JainNBhargavaARathiMDilipRVPanwarJRemoval of protein capping enhances the"/>
   <result pre="glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against" exact="herpes simplex" post="virus type 1Nanomedicine.201813212675269010.2217/nnm-2018-008930346253 17.ReedLJMuenchHA simple method of estimating fifty"/>
   <result pre="activity of peanut (Arachis hypogaea L.) skin extract against human" exact="influenza" post="virusesJ Med Food201821877778410.1089/jmf.2017.412129847745 21.MonavariSHThe inhibitory effect of acyclovir loaded"/>
   <result pre="Med Food201821877778410.1089/jmf.2017.412129847745 21.MonavariSHThe inhibitory effect of acyclovir loaded nano-niosomes against" exact="herpes simplex" post="virus type-1 in cell cultureMed J Islam Repub Iran2014289925664300"/>
   <result pre="deliveryPharm Res201532103248326010.1007/s11095-015-1701-726002743 24.AkarsuHIwatsuki-HorimotoKNodaTKawakamiEKatsuraHBaudinFet al.Structure-based design of NS2 mutants for attenuated" exact="influenza" post="a virus vaccinesVirus Res2011155124024810.1016/j.virusres.2010.10.01420970464 25.RosaSConnollyCSchettinoGButterworthKTPriseKMBiological mechanisms of gold nanoparticle"/>
   <result pre="Nanotechnol201781210.1186/s12645-017-0026-028217176 26.KumarRNayakMSahooGCPandeyKSarkarMCAnsariYet al.Iron oxide nanoparticles based antiviral activity of H1N1" exact="influenza" post="a virusJ Infect Chemother201925532532910.1016/j.jiac.2018.12.00630770182 27.LinZLiYGuoMXiaoMWangCZhaoMet al.Inhibition of H1N1 influenza"/>
   <result pre="H1N1 influenza a virusJ Infect Chemother201925532532910.1016/j.jiac.2018.12.00630770182 27.LinZLiYGuoMXiaoMWangCZhaoMet al.Inhibition of H1N1" exact="influenza" post="virus by selenium nanoparticles loaded with zanamivir through p38"/>
   <result pre="al.Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1" exact="influenza" post="virusInt J Nanomedicine201712573310.2147/IJN.S14093928848350 29.MittalNMedhiBThe bird flu: a new emerging"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6739551\results\search\disease\results.xml">
   <result pre="et al.17), Dengue virus (according to Drosten et al.18) and" exact="yellow fever" post="virus (using in-house primers) were amplified in discrete RT-PCRs"/>
   <result pre="in Table 1. Separate reaction mixtures for Lassa, Dengue and" exact="yellow fever" post="viruses were prepared and cycled as described in the"/>
   <result pre="Goettingen, Germany). TABLE 1 Primers used for Lassa, Dengue and" exact="yellow fever" post="investigation, Lagos, Nigeria, March 2018. Virus Primer name Primer"/>
   <result pre="chain reaction amplification and Agarose gel analysis of the Lassa," exact="yellow fever" post="and Dengue viruses Among the 70 samples, 5 (7.1%)"/>
   <result pre="band sizes (~405 bp) and (~75 bp) were detected for" exact="yellow fever" post="or Dengue18 viruses (Figures 2 and 3). FIGURE 1"/>
   <result pre="FIGURE 3 Reverse transcription polymerase chain reaction detection of the" exact="yellow fever" post="virus, Lagos, Nigeria, March 2018. The gel lanes represent"/>
   <result pre="(-VE CTRL) while a tissue culture inactivated sample of 17D" exact="yellow fever" post="strain from the Virology Unit Laboratory of the Bernhard"/>
   <result pre="hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and" exact="yellow fever" post="virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002;40(7):2323–2330."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6742212\results\search\disease\results.xml">
   <result pre="of severe cases or chikungunya-related deaths [5, 6]. Particularly, the" exact="chikungunya" post="outbreak in Reunion Island revealed unknown characteristics of the"/>
   <result pre="in Ahmedabad, India [8], and Mauritius [9] during the 2005–2006" exact="chikungunya" post="epidemics. These findings were published at least 4 years"/>
   <result pre="region, and the Pan American Health Organization (PAHO) reported 631" exact="chikungunya" post="deaths among 2.5 million cases [10]. This number of"/>
   <result pre="Martinique), an excess mortality of more than 14,000 deaths during" exact="chikungunya" post="epidemics has been estimated for the years 2014 to"/>
   <result pre="[12]. In addition, some aspects of the clinical course of" exact="chikungunya" post="contribute to death underreporting, such as (i) the fatal"/>
   <result pre="to death underreporting, such as (i) the fatal association of" exact="chikungunya" post="with the decompensation of comorbidities leads to death certificates"/>
   <result pre="city in Brazil (capital of Ceará state) that had a" exact="chikungunya" post="epidemic in 2016–2017 (80,000 cases), recording the highest number"/>
   <result pre="by one of the studies that investigated excess mortality during" exact="chikungunya" post="epidemics [12]. It also reported a median time between"/>
   <result pre="be related to different pathophysiological processes. On the one hand," exact="chikungunya" post="deaths caused primarily by acute CHIKV infection with direct"/>
   <result pre="eventually culminate in nosocomial infections [5, 16]. Fig 1 Confirmed" exact="chikungunya" post="cases (N = 80,153), case fatality rates (per 1,000"/>
   <result pre="= 80,153), case fatality rates (per 1,000 cases), and confirmed" exact="chikungunya" post="deaths (N = 169) by age groups and interval"/>
   <result pre="to emerging threats. In 2008, a Death Investigation Committee (including" exact="infectious disease" post="specialists, virologists, and pathologists) was created by the state"/>
   <result pre="of patients in a timeline format between the onset of" exact="chikungunya" post="symptoms and the death in order to try to"/>
   <result pre="the underreporting of deaths due to dengue, Zika virus, and" exact="chikungunya" post="in Fortaleza [17]. Unfortunately, very few municipalities/localities in Brazil"/>
   <result pre="to elucidate arboviruses deaths. What should be done to prevent" exact="chikungunya" post="fatality? Despite the need for further studies to establish"/>
   <result pre="causal link between CHIKV and mortality, current evidence suggest that" exact="chikungunya" post="may be the vector-borne disease associated with the highest"/>
   <result pre="lethality of the disease. Currently, most clinical protocols to manage" exact="chikungunya" post="cases are focused on acute or chronic joint pain"/>
   <result pre="imperative that international agencies formally recognize the high lethality of" exact="chikungunya" post="in specific groups in order to reorient disease surveillance."/>
   <result pre="order to reorient disease surveillance. Although usually a benign disease," exact="chikungunya" post="does not always have a self-limited clinical course. CHIKV"/>
   <result pre="of preexisting medical conditions leading to a fatal outcome. Current" exact="chikungunya" post="clinical protocols should be reviewed with the ultimate aim"/>
   <result pre="and in Brazil [3, 18]. However, contrary to dengue protocols," exact="chikungunya" post="management guidelines are not yet targeted to avoid fatal"/>
   <result pre="scant histopathological data and knowledge gaps in the pathophysiology of" exact="chikungunya" post="limit the comprehensiveness of the risk classification, available knowledge"/>
   <result pre="of new epidemics, it is critical that new protocols of" exact="chikungunya" post="management be devised, with a particular attention to mortality"/>
   <result pre="BouquillardE, TroisgrosO, GentileG, et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014. Médecine et Maladies"/>
   <result pre="10.1016/j.medmal.2015.05.00726119684 4QueyriauxB, SimonF, GrandadamM, MichelR, TolouH, BoutinJP. Clinical burden of" exact="chikungunya" post="virus infection. The Lancet Infectious diseases. 2008;8(1):2–3. Epub 2007/12/25."/>
   <result pre="SoletJL, SissokoD, BalleydierE, LarrieuS, FilleulL, et al.A major epidemic of" exact="chikungunya" post="virus infection on Reunion Island, France, 2005–2006. The American"/>
   <result pre="8MavalankarD, ShastriP, BandyopadhyayT, ParmarJ, RamaniKV. Increased mortality rate associated with" exact="chikungunya" post="epidemic, Ahmedabad, India. Emerging infectious diseases. 2008;14(3):412–5. Epub 2008/03/08."/>
   <result pre="and Martinique, islands of the French West Indies, during the" exact="chikungunya" post="epidemic of 2014. Epidemiology and infection. 2018;146(16):2059–65. Epub 2018/08/29."/>
   <result pre="Alarcon-ElbalPM, Paulino-RamirezR, DonalisioMR. Excess mortality profile during the Asian genotype" exact="chikungunya" post="epidemic in the Dominican Republic, 2014. Transactions of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6742362\results\search\disease\results.xml">
   <result pre="Biology : Population Metrics: Age Distribution The epidemiological signature of" exact="influenza" post="B virus and its B/Victoria and B/Yamagata lineages in"/>
   <result pre="B/Victoria and B/Yamagata lineages in the 21st century Epidemiology of" exact="influenza" post="B virus and its lineages http://orcid.org/0000-0002-2262-1102CainiSaverioConceptualizationData curationFormal analysisInvestigationMethodologyVisualizationWriting –"/>
   <result pre="the epidemiological characteristics, pattern of circulation, and geographical distribution of" exact="influenza" post="B viruses and its lineages using data from the"/>
   <result pre="the Global Influenza B Study. We included over 1.8 million" exact="influenza" post="cases occurred in thirty-one countries during 2000–2018. We calculated"/>
   <result pre="during 2000–2018. We calculated the proportion of cases caused by" exact="influenza" post="B and its lineages; determined the timing of influenza"/>
   <result pre="by influenza B and its lineages; determined the timing of" exact="influenza" post="A and B epidemics; compared the age distribution of"/>
   <result pre="lineage-level mismatch for the trivalent vaccine. The median proportion of" exact="influenza" post="cases caused by influenza B virus was 23.4%, with"/>
   <result pre="trivalent vaccine. The median proportion of influenza cases caused by" exact="influenza" post="B virus was 23.4%, with a tendency (borderline statistical"/>
   <result pre="type in about one every seven seasons. In temperate countries," exact="influenza" post="B epidemics occurred on average three weeks later than"/>
   <result pre="influenza B epidemics occurred on average three weeks later than" exact="influenza" post="A epidemics; no consistent pattern emerged in the tropics."/>
   <result pre="tropics. The two B lineages caused a comparable proportion of" exact="influenza" post="B cases globally, however the B/Yamagata was more frequent"/>
   <result pre="tropics. The type B virus caused a substantial proportion of" exact="influenza" post="infections globally in the 21st century, and its two"/>
   <result pre="on populations globally [1]. The impact of seasonal and pandemic" exact="influenza" post="on population health in high-income countries has been described"/>
   <result pre="in high-income countries has been described extensively [2]. In Europe," exact="influenza" post="ranks first among infectious diseases in terms of burden,"/>
   <result pre="has been accumulating that the burden of disease associated with" exact="influenza" post="is high in low- and middle-income countries as well"/>
   <result pre="middle-income countries as well [4]. Type A viruses cause most" exact="influenza" post="cases and are responsible for pandemics, but influenza B"/>
   <result pre="cause most influenza cases and are responsible for pandemics, but" exact="influenza" post="B is an important cause of morbidity and mortality"/>
   <result pre="co-circulated globally in the 21st century [8–9]. The mainstay of" exact="influenza" post="prevention is vaccination, aimed primarily at individuals who are"/>
   <result pre="ensure adequate immunity against influenza; thus, investigating the timing of" exact="influenza" post="epidemics and the patterns of circulation of the different"/>
   <result pre="influenza epidemics and the patterns of circulation of the different" exact="influenza" post="virus types, subtypes and lineages is of great importance"/>
   <result pre="importance from a public health perspective [11]. Until 2012, trivalent" exact="influenza" post="vaccines (TIV) were available that contained only one type"/>
   <result pre="vaccines (TIV) were available that contained only one type B" exact="influenza" post="virus, belonging to either the B/Victoria or B/Yamagata lineage."/>
   <result pre="the mismatched lineage [12], and substantial health impact [13]. Quadrivalent" exact="influenza" post="vaccine (QIV), containing one B/Victoria and one B/Yamagata virus"/>
   <result pre="describe the epidemiology, clinical characteristics and burden of disease of" exact="influenza" post="B in more depth, and to compare the cost-effectiveness"/>
   <result pre="settings and populations. Despite significant advances in our understanding of" exact="influenza" post="B [14], important knowledge gaps persist, in particular concerning"/>
   <result pre="for instance in order to evaluate the cost-effectiveness of alternative" exact="influenza" post="prevention strategies and thus enable more appropriate public health"/>
   <result pre="Here, we conducted a global analysis of the epidemiology of" exact="influenza" post="B virus and its lineages using the database of"/>
   <result pre="detail elsewhere [14,23–24]. The GIBS database encompasses epidemiological and virological" exact="influenza" post="surveillance data from thirty-one countries around the world (Fig"/>
   <result pre="population centre [25]. Participating countries were required to make available" exact="influenza" post="surveillance data for as many consecutive years as possible"/>
   <result pre="(from 2000 onwards). Data include the weekly number of laboratory-confirmed" exact="influenza" post="cases broken down by virus type (A, B), type"/>
   <result pre="age groups) was also available. In most participating countries, the" exact="influenza" post="surveillance system covers the whole national territory, and a"/>
   <result pre="system covers the whole national territory, and a sample of" exact="influenza" post="virus positive specimens or virus isolates is routinely sent"/>
   <result pre="The GIBS database was initially assembled in 2013–14 by merging" exact="influenza" post="surveillance data up to as late as December 2013"/>
   <result pre="20 weeks of reported data and at least 100 laboratory-confirmed" exact="influenza" post="cases. In each season, we calculated the percentage of"/>
   <result pre="influenza cases. In each season, we calculated the percentage of" exact="influenza" post="cases that were due to influenza B. We then"/>
   <result pre="calculated the percentage of influenza cases that were due to" exact="influenza" post="B. We then determined the percentage of cases that"/>
   <result pre="country) the subset of seasons with 50 or more characterized" exact="influenza" post="B viruses. The non-parametric Kruskal-Wallis test was applied to"/>
   <result pre="Kruskal-Wallis test was applied to compare the median proportion of" exact="influenza" post="A and B cases (over all influenza cases) and"/>
   <result pre="median proportion of influenza A and B cases (over all" exact="influenza" post="cases) and B/Victoria and B/Yamagata cases (over all cases"/>
   <result pre="and B/Victoria and B/Yamagata cases (over all cases with characterized" exact="influenza" post="B viruses) between countries based on their latitude (Northern"/>
   <result pre="[25]. We compared the timing of the primary peak of" exact="influenza" post="A and B epidemics in each country using the"/>
   <result pre="hemisphere countries) because of the markedly atypical timing of the" exact="influenza" post="A(H1N1)pdm09 pandemics. Time series were first standardized by dividing"/>
   <result pre="series were first standardized by dividing the weekly number of" exact="influenza" post="cases by the maximum weekly number (per country by"/>
   <result pre="in each country. We aimed to evaluated the frequency of" exact="influenza" post="B lineage-level vaccine mismatch, which was defined as a"/>
   <result pre="mismatch between the lineage that caused the majority (&amp;gt;50%) of" exact="influenza" post="B cases in a given season and country, and"/>
   <result pre="and the lineage included in the trivalent vaccine. Information on" exact="influenza" post="vaccine formulation was retrieved from the WHO website [27]."/>
   <result pre="belt. While the WHO issues recommendations on the composition of" exact="influenza" post="vaccines to be used in tropical countries [28], these"/>
   <result pre="the resulting increase in the number of cases with characterized" exact="influenza" post="B viruses made it possible to compare the age"/>
   <result pre="viruses made it possible to compare the age distribution of" exact="influenza" post="B/Victoria and B/Yamagata cases in a similar way to"/>
   <result pre="a similar way to what had been done previously for" exact="influenza" post="B vs. A (and its subtypes) [14,24]. This analysis"/>
   <result pre="for at least 50 B/Victoria and at least 50 B/Yamagata" exact="influenza" post="cases over all seasons available. The virus-lineage-specific age distribution"/>
   <result pre="cases over all seasons available. The virus-lineage-specific age distribution of" exact="influenza" post="B cases was visualized, separately in each country, using"/>
   <result pre="Wilcoxon rank sum test to compare the median age of" exact="influenza" post="B cases by virus lineage. Statistical analyses were conducted"/>
   <result pre="the Global Influenza B Study encompassed a total of 1.820.301" exact="influenza" post="cases between 2000 and 2018, of which 419,167 (23.0%)"/>
   <result pre="with USA and Australia contributing 54.1% and 25.3% of all" exact="influenza" post="cases to the database, respectively. Information on age was"/>
   <result pre="remaining countries, information on age was available for most (95.0%)" exact="influenza" post="cases. After applying our exclusion criteria, 299 seasons with"/>
   <result pre="our exclusion criteria, 299 seasons with 100 or more reported" exact="influenza" post="cases overall were included in the analysis, of which"/>
   <result pre="to eighteen (for New Zealand). The number of overall and" exact="influenza" post="B cases in each country and season included in"/>
   <result pre="country and season included in the analysis, the proportion of" exact="influenza" post="B cases of which the virus was characterized, and"/>
   <result pre="and B/Yamagata lineages, are provided in S1 Table. Frequency of" exact="influenza" post="B Influenza B virus caused a median 23.4% (interquartile"/>
   <result pre="caused a median 23.4% (interquartile range [IQR] 9.3–38.9%) of reported" exact="influenza" post="cases in a season. More specifically, the proportion of"/>
   <result pre="influenza cases in a season. More specifically, the proportion of" exact="influenza" post="cases caused by the B virus type was &amp;lt;20%"/>
   <result pre="and above 50% in 45 seasons (15.1%). The proportion of" exact="influenza" post="B cases over all influenza cases reported in the"/>
   <result pre="seasons (15.1%). The proportion of influenza B cases over all" exact="influenza" post="cases reported in the season varied geographically (Fig 2):"/>
   <result pre="(22.2%, IQR 9.1–34.5%) hemispheres. The proportion of seasons in which" exact="influenza" post="B cases constituted between 20 and 50% or more"/>
   <result pre="20 and 50% or more than 50% of all reported" exact="influenza" post="cases did not significantly differ (p = 0.275) between"/>
   <result pre="two hemispheres (39.9% and 14.3%, respectively). Fig 2 Distribution of" exact="influenza" post="seasons by proportion of influenza B cases and geographical"/>
   <result pre="respectively). Fig 2 Distribution of influenza seasons by proportion of" exact="influenza" post="B cases and geographical area (Inter-tropical belt, Northern hemisphere,"/>
   <result pre="75th percentiles. The Global Influenza B Study, 2000–2018. Timing of" exact="influenza" post="A and B epidemics In countries of the Southern"/>
   <result pre="A and B epidemics In countries of the Southern hemisphere," exact="influenza" post="A epidemics typically peaked in July-September, on average 1.1"/>
   <result pre="typically peaked in July-September, on average 1.1 month earlier than" exact="influenza" post="B (August-September) (Table 1). Influenza epidemics also peaked in"/>
   <result pre="in the winter months of Northern hemisphere countries, earlier for" exact="influenza" post="A (January-February, except Ukraine, in March) than for influenza"/>
   <result pre="for influenza A (January-February, except Ukraine, in March) than for" exact="influenza" post="B (February-March, except England, in January), with an average"/>
   <result pre="countries among those situated in the Northern hemisphere), where both" exact="influenza" post="A and B epidemics typically peaked in August. There"/>
   <result pre="(0.3 months earlier on average) for the primary peak of" exact="influenza" post="A and B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of"/>
   <result pre="B epidemics. 10.1371/journal.pone.0222381.t001Table 1 Typical timing of the peak of" exact="influenza" post="A and B epidemics according to countries’ latitude. The"/>
   <result pre="Global Influenza B Study, 2000–2018. Country Latitude Typical timing of" exact="influenza" post="peak A B Southern hemisphere New Zealand 41.8 S"/>
   <result pre="where the virus lineage was determined for 50 or more" exact="influenza" post="B cases (out of a total 299 seasons, 28.1%)"/>
   <result pre="B/Yamagata lineage viruses caused a similar range of proportions of" exact="influenza" post="B cases. More precisely, the median proportion of influenza"/>
   <result pre="of influenza B cases. More precisely, the median proportion of" exact="influenza" post="B cases reported in a season that were caused"/>
   <result pre="5.3–89.6%). The range of the proportion of B/Victoria over all" exact="influenza" post="B cases was 0%-100%, meaning that there were seasons"/>
   <result pre="was 0%-100%, meaning that there were seasons in which all" exact="influenza" post="B cases were caused by either virus lineage. Co-circulation"/>
   <result pre="84 seasons, both lineages accounted for at least 20% of" exact="influenza" post="B cases, while the B/Victoria and B/Yamagata lineages caused"/>
   <result pre="the B/Victoria and B/Yamagata lineages caused over 80% of all" exact="influenza" post="B cases in 27 (32.1%) and 30 (35.8%) seasons,"/>
   <result pre="(35.8%) seasons, respectively. The proportion of either lineage over all" exact="influenza" post="B cases varied according to the age structure of"/>
   <result pre="the countries’ latitude as well (Fig 3). The proportion of" exact="influenza" post="B cases caused by the B/Victoria lineage in a"/>
   <result pre="a median age below 30 years (median proportion over all" exact="influenza" post="B cases = 67.0%) compared to countries with a"/>
   <result pre="(36.2%). Likewise, the median proportion of B/Victoria over all characterized" exact="influenza" post="B cases in a season was higher in countries"/>
   <result pre="Southern hemisphere (43.8%) (p-value = 0.048). Fig 3 Proportion of" exact="influenza" post="B cases in a season that were caused by"/>
   <result pre="Influenza B Study, 2000–2018. Age distribution of B/Victoria and B/Yamagata" exact="influenza" post="cases In Table 2, we compared the median age"/>
   <result pre="cases In Table 2, we compared the median age of" exact="influenza" post="B cases according to virus lineage. In Australia, B/Victoria"/>
   <result pre="and in Ukraine (p-value 0.082). 10.1371/journal.pone.0222381.t002Table 2 Age distribution of" exact="influenza" post="B/Victoria and B/Yamagata patients by country (sorted by median"/>
   <result pre="B Study, 2000–2018. Country (a) Median age general population No." exact="influenza" post="B cases Median age (IQR) Victoria Yamagata Victoria Yamagata"/>
   <result pre="was available for ≥50 B Victoria and ≥50 B Yamagata" exact="influenza" post="cases. (b) Wilcoxon rank-sum test for comparison of medians"/>
   <result pre="of B/Victoria and B/Yamagata cases (S1 File). In most countries," exact="influenza" post="B/Victoria cases tended to be distributed according to their"/>
   <result pre="peaking at above 50 years of age. Frequency of lineage-level" exact="influenza" post="B trivalent vaccine mismatches The proportion of influenza B"/>
   <result pre="of lineage-level influenza B trivalent vaccine mismatches The proportion of" exact="influenza" post="B lineage-level vaccine mismatch was 54.2% in countries in"/>
   <result pre="composition for the Southern hemisphere. Discussion Our analysis found that" exact="influenza" post="B virus was responsible for nearly one fourth of"/>
   <result pre="B virus was responsible for nearly one fourth of all" exact="influenza" post="cases in an average season between 2000 and 2018."/>
   <result pre="in an average season between 2000 and 2018. More specifically," exact="influenza" post="B virus accounted for over 20% of all influenza"/>
   <result pre="specifically, influenza B virus accounted for over 20% of all" exact="influenza" post="cases in more than half of the seasons, and"/>
   <result pre="seven seasons. This proportion varied geographically, as the proportion of" exact="influenza" post="B over all influenza cases tended to be higher"/>
   <result pre="varied geographically, as the proportion of influenza B over all" exact="influenza" post="cases tended to be higher on average in tropical"/>
   <result pre="epidemics tended to peak on average three weeks later than" exact="influenza" post="A epidemics during the winter period in temperate countries"/>
   <result pre="is consistent with previous country reports [21,30,32–34]. The timing of" exact="influenza" post="A and B epidemics was different in tropical countries"/>
   <result pre="weather conditions that are most favourable to the occurrence of" exact="influenza" post="epidemics (e.g. cold-dry) last for only a limited number"/>
   <result pre="area (i.e. anywhere around the world seasons occurred where all" exact="influenza" post="B cases were caused by either the B/Victoria or"/>
   <result pre="faced when trying to predict which lineage will cause most" exact="influenza" post="B cases next season. This helps explain the very"/>
   <result pre="that whilst the two lineages caused a comparable proportion of" exact="influenza" post="B cases globally during the study period, their distribution"/>
   <result pre="&quot;cold-dry�? and &quot;humid-rainy�? environmental conditions that drive the occurrence of" exact="influenza" post="epidemics in temperate and tropical countries, respectively [38]. This"/>
   <result pre="be supported by the available evidence, which suggests instead that" exact="influenza" post="viruses of different types and subtypes (e.g. A(H3N2), A(H1N1)pdm09,"/>
   <result pre="that differ greatly under many aspects, including the type of" exact="influenza" post="surveillance system) that B/Yamagata cases are on average older"/>
   <result pre="patients. Importantly, our findings support earlier work showing that each" exact="influenza" post="A subtype (H3N2, pre-2009-pandemic H1N1, and H1N1pdm09) tends to"/>
   <result pre="viruses [41]. Finally, antigenic original sin (i.e. preferential response to" exact="influenza" post="B viruses encountered in the past [42]) may also"/>
   <result pre="These findings have important implications for assessing the impact of" exact="influenza" post="B viruses in a population each season. Knowing early"/>
   <result pre="season. Knowing early in the season (through surveillance activities) which" exact="influenza" post="B lineage virus is circulating will allow one to"/>
   <result pre="was a lineage-level vaccine mismatch) and a high burden of" exact="influenza" post="B was observed in many European countries [43]. We"/>
   <result pre="B was observed in many European countries [43]. We analyzed" exact="influenza" post="surveillance data from around the world to determine the"/>
   <result pre="data from around the world to determine the epidemiology of" exact="influenza" post="B virus and its lineages in the 21st century."/>
   <result pre="lineages, thus achieving a better understanding of the epidemiology of" exact="influenza" post="B globally. The most important limitation of our study"/>
   <result pre="included, number of years with data and average number of" exact="influenza" post="cases reported per year, proportion of influenza B viruses"/>
   <result pre="average number of influenza cases reported per year, proportion of" exact="influenza" post="B viruses that were characterized availability of information on"/>
   <result pre="intensity of surveillance activities, and the coverage of each country’s" exact="influenza" post="surveillance system. Throughout this paper, we have used statistical"/>
   <result pre="of analysis for the comparison of the frequency of B" exact="influenza" post="across countries, the standardization offered by the EPIPOI software"/>
   <result pre="the EPIPOI software in the analysis of temporal patterns of" exact="influenza" post="epidemics, and the use of medians to compare the"/>
   <result pre="the use of medians to compare the age distribution of" exact="influenza" post="cases between countries. However, we acknowledge that these sources"/>
   <result pre="quantify precisely, and a further improvement in the harmonization of" exact="influenza" post="surveillance data remains desirable as it would allow researchers"/>
   <result pre="study provides important new information that describes the epidemiology of" exact="influenza" post="B viruses and its lineages during the start of"/>
   <result pre="during the start of the 21st century. We showed that" exact="influenza" post="B virus caused nearly one fourth (on average) of"/>
   <result pre="B virus caused nearly one fourth (on average) of all" exact="influenza" post="cases occurring annually in the world during 2000–2018, and"/>
   <result pre="both lineages accounted each for a comparable proportion of all" exact="influenza" post="B cases globally. We also observed that cases infected"/>
   <result pre="our knowledge of the epidemiology and pattern of circulation of" exact="influenza" post="B virus, these findings will help inform health policy"/>
   <result pre="policy decisions aiming to reduce disease burden associated with seasonal" exact="influenza" post="locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed"/>
   <result pre="influenza locally, regionally and globally. Supporting information S1 Table Laboratory-confirmed" exact="influenza" post="cases reported in each country and season, and proportion"/>
   <result pre="country and season, and proportion of those caused by the" exact="influenza" post="B virus type (overall and by lineage). The Global"/>
   <result pre="year for other countries. (b) Seasons with fewer than 100" exact="influenza" post="cases were not included. (c) Number of influenza B"/>
   <result pre="than 100 influenza cases were not included. (c) Number of" exact="influenza" post="B cases in each season, and proportion of influenza"/>
   <result pre="of influenza B cases in each season, and proportion of" exact="influenza" post="B over all influenza cases in the same season."/>
   <result pre="in each season, and proportion of influenza B over all" exact="influenza" post="cases in the same season. (d) Number of influenza"/>
   <result pre="all influenza cases in the same season. (d) Number of" exact="influenza" post="B cases for which the virus lineage was characterized,"/>
   <result pre="which the virus lineage was characterized, and proportion over all" exact="influenza" post="B cases in the same season. (e) Number of"/>
   <result pre="influenza B cases in the same season. (e) Number of" exact="influenza" post="B cases caused by viruses belonging to the Victoria"/>
   <result pre="the Victoria and Yamagata lineages, and proportion over all characterized" exact="influenza" post="B viruses in the same season. Not reported in"/>
   <result pre="season. Not reported in seasons with fewer than 50 characterized" exact="influenza" post="B cases. (DOCX) LINK Click here for additional data"/>
   <result pre="for additional data file. S1 File Age distribution of laboratory-confirmed" exact="influenza" post="patients infected with type B viruses belonging to the"/>
   <result pre="exact age for ≥50 B Victoria and ≥50 B Yamagata" exact="influenza" post="for the whole study period cases were included. Countries"/>
   <result pre="FlanneryB, BrammerL, SingletonJAet al.Annual estimates of the burden of seasonal" exact="influenza" post="in the United States: A tool for strengthening influenza"/>
   <result pre="seasonal influenza in the United States: A tool for strengthening" exact="influenza" post="surveillance and preparedness. Influenza Other Respir Viruses. 2018;12(1):132–137. 10.1111/irv.1248629446233"/>
   <result pre="4LeeVJ, HoZJM, GohEH, CampbellH, CohenC, CozzaV, et al.Advances in measuring" exact="influenza" post="burden of disease. Influenza Other Respir Viruses. 2018;12(1):3–9. 10.1111/irv.1253329460425"/>
   <result pre="10.1111/irv.1253329460425 5Paul GlezenW, SchmierJK, KuehnCM, RyanKJ, OxfordJ. The burden of" exact="influenza" post="B: a structured literature review. Am J Public Health."/>
   <result pre="RotaJS, KendalAP, NeromeK. Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983. Virology. 1990;175(1):59–68. 10.1016/0042-6822(90)90186-u2309452 8PaivaTM,"/>
   <result pre="BenegaMA, SilvaDB, SantosKC, CruzAS, HortenciMF, et al.Evolutionary pattern of reemerging" exact="influenza" post="B/Victoria lineage viruses in São Paulo, Brazil, 1996–2012: Implications"/>
   <result pre="LeePI, KimWJ, BuchyP, et al.Literature review of the epidemiology of" exact="influenza" post="B disease in 15 countries in the Asia-Pacific region."/>
   <result pre="ScienceM, KusterSP, et al.Populations at risk for severe or complicated" exact="influenza" post="illness: systematic review and meta-analysis. BMJ. 2013;347:f506110.1136/bmj.f506123974637 11CainiS, SchellevisF,"/>
   <result pre="SchellevisF, El-Guerche SéblainC, PagetJ. Important changes in the timing of" exact="influenza" post="epidemics in the WHO European Region over the past"/>
   <result pre="Surveill. 2018;23(1). 12TriccoAC, ChitA, SoobiahC, HallettD, MeierG, ChenMH, et al.Comparing" exact="influenza" post="vaccine efficacy against mismatched and matched strains: a systematic"/>
   <result pre="and meta-analysis. BMC Med. 2013;11:15310.1186/1741-7015-11-15323800265 13HeikkinenT, IkonenN, ZieglerT. Impact of" exact="influenza" post="B lineage-level mismatch between trivalent seasonal influenza vaccines and"/>
   <result pre="ZieglerT. Impact of influenza B lineage-level mismatch between trivalent seasonal" exact="influenza" post="vaccines and circulating viruses, 1999–2012. Clin Infect Dis. 2014;59(11):1519–24."/>
   <result pre="CiblakMA, KusznierzG, OwenR, WangchukS, et al.Epidemiological and virological characteristics of" exact="influenza" post="B: results of the Global Influenza B Study. Influenza"/>
   <result pre="al.A systematic review of the health economic consequences of quadrivalent" exact="influenza" post="vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249–265. 10.1080/14737167.2017.134314528613092 16So�?anM,"/>
   <result pre="A comparison of the demographic and clinical characteristics of laboratory-confirmed" exact="influenza" post="B Yamagata and Victoria lineage infection. J Clin Virol."/>
   <result pre="17LeTT, PhamTH, PhamTH, Nguyen leKH, NguyenCT, HoangVM, et al.Circulation of" exact="influenza" post="B lineages in northern Viet Nam, 2007–2014. Western Pac"/>
   <result pre="18XuC, ChanKH, TsangTK, FangVJ, FungRO, IpDK, et al.Comparative epidemiology of" exact="influenza" post="B Yamagata- and Victoria-lineage viruses in households. Am J"/>
   <result pre="Epidemiol. 2015;182(8):705–13. 10.1093/aje/kwv11026400854 19BarrIG, VijaykrishnaD, SullivanSG. Differential age susceptibility to" exact="influenza" post="B/Victoria lineage viruses in the 2015 Australian influenza season."/>
   <result pre="susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian" exact="influenza" post="season. Euro Surveill. 2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS,"/>
   <result pre="2016;21(4). 20SelekaM, TreurnichtFK, TempiaS, HellfersceeO, MtshaliS, CohenAL, et al.Epidemiology of" exact="influenza" post="B/Yamagata and B/Victoria lineages in South Africa, 2005–2014. PLoS"/>
   <result pre="2005–2014. PLoS One. 2017;12(5):e017765510.1371/journal.pone.017765528542324 21MoaAM, MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of" exact="influenza" post="B in Australia: 2001–2014 influenza seasons. Influenza Other Respir"/>
   <result pre="MuscatelloDJ, TurnerRM, MacIntyreCR. Epidemiology of influenza B in Australia: 2001–2014" exact="influenza" post="seasons. Influenza Other Respir Viruses. 2017;11(2):102–109. 10.1111/irv.1243227650482 22LapinsckiB, PereiraLA,"/>
   <result pre="22LapinsckiB, PereiraLA, NogueiraMB, VidalLR, RiedigerI, DeburMC, et al.Molecular epidemiology of" exact="influenza" post="B virus and implications in immunization strategy, Southern Brazil."/>
   <result pre="23CainiS, AndradeW, BadurS, BalmasedaA, BarakatA, BellaA, et al.Temporal patterns of" exact="influenza" post="A and B in tropical and temperate countries: what"/>
   <result pre="in tropical and temperate countries: what are the lessons for" exact="influenza" post="vaccination?PLoS One. 2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK,"/>
   <result pre="2016;11(3):e015231010.1371/journal.pone.015231027031105 24CainiS, SpreeuwenbergP, KusznierzGF, RudiJM, OwenR, PenningtonK, et al.Distribution of" exact="influenza" post="virus types by age using case-based global surveillance data"/>
   <result pre="Health. 2012;12(1):982.23153033 27World Health Organization. Recommendations on the composition of" exact="influenza" post="virus vaccines. http://www.who.int/influenza/vaccines/virus/recommendations/en/ Cited 18 June 2018 28World Health"/>
   <result pre="18 June 2018 29HirveS, LambachP, PagetJ, VandemaeleK, FitznerJ, ZhangW. Seasonal" exact="influenza" post="vaccine policy, use and effectiveness in the tropics and"/>
   <result pre="2016;10(4):254–67. 10.1111/irv.1237426842617 30MosnierA, CainiS, DaviaudI, BensoussanJL, Stoll-KellerF, BuiTT, et al.Ten" exact="influenza" post="seasons in France: distribution and timing of influenza A"/>
   <result pre="et al.Ten influenza seasons in France: distribution and timing of" exact="influenza" post="A and B circulation, 2003–2013. BMC Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794"/>
   <result pre="Infect Dis. 2015;15:35710.1186/s12879-015-1056-z26289794 31BarrosEN, CintraO, RossettoE, FreitasL, ColindresR. Patterns of" exact="influenza" post="B circulation in Brazil and its relevance to seasonal"/>
   <result pre="YangP, QianH, ShiW, WuS, et al.Epidemiological and phylogenetic characteristics of" exact="influenza" post="B infection in severe acute respiratory infection cases in"/>
   <result pre="van GinkelA, SuijkerbuijkA, van der HoekW, et al.Early occurrence of" exact="influenza" post="A epidemics coincided with changes in occurrence of other"/>
   <result pre="10.1111/irv.1234826369646 34CainiS, AlonsoWJ, SéblainCE, SchellevisF, PagetJ. The spatiotemporal characteristics of" exact="influenza" post="A and B in the WHO European Region: can"/>
   <result pre="and B in the WHO European Region: can one define" exact="influenza" post="transmission zones in Europe?Euro Surveill. 2017;22(35). 35LaurieKL, GuarnacciaTA, CarolanLA,"/>
   <result pre="infections and viral hierarchy are determinants of viral interference following" exact="influenza" post="virus infection in a ferret model. J Infect Dis."/>
   <result pre="10.1093/infdis/jiv26025943206 36BelsheRB, CoelinghK, AmbroseCS, WooJC, WuX. Efficacy of live attenuated" exact="influenza" post="vaccine in children against influenza B viruses by lineage"/>
   <result pre="WuX. Efficacy of live attenuated influenza vaccine in children against" exact="influenza" post="B viruses by lineage and antigenic similarity. Vaccine. 2010;28(9):2149–56."/>
   <result pre="NguyenTP, MoyesJ, CohenC, et al.The cost-effectiveness of trivalent and quadrivalent" exact="influenza" post="vaccination in communities in South Africa, Vietnam and Australia."/>
   <result pre="ShamanJ, AlonsoWJ, Bloom-FeshbachK, UejioCK, ComrieA, et al.Environmental predictors of seasonal" exact="influenza" post="epidemics across temperate and tropical climates. PLoS Pathog. 2013;9(3):e100319410.1371/journal.ppat.100319423505366"/>
   <result pre="2013;9(3):e100319410.1371/journal.ppat.100319423505366 39LowenAC, SteelJ. Roles of humidity and temperature in shaping" exact="influenza" post="seasonality. J Virol. 2014;88(14):7692–5. 10.1128/JVI.03544-1324789791 40VijaykrishnaD, HolmesEC, JosephU, FourmentM,"/>
   <result pre="JosephU, FourmentM, SuYC, HalpinR, et al.The contrasting phylodynamics of human" exact="influenza" post="B viruses. Elife. 2015;4:e0505510.7554/eLife.0505525594904 41NyirendaM, OmoriR, TessmerHL, ArimuraH, ItoK."/>
   <result pre="OmoriR, TessmerHL, ArimuraH, ItoK. Estimating the lineage dynamics of human" exact="influenza" post="B viruses. PLoS One. 2016;11(11):e016610710.1371/journal.pone.016610727829058 42SkowronskiDM, HottesTS, De SerresG,"/>
   <result pre="MelidouA, IonescuS, Penttinen; collab: The European Influenza Surveillance Network. Dominant" exact="influenza" post="A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6743175\results\search\disease\results.xml">
   <result pre="typing of human rhinovirus of adults hospitalized for exacerbation of" exact="asthma" post="and chronic obstructive pulmonary disease KoFanny Wai-san1ChanPaul Kay-sheung2ChanRenee W."/>
   <result pre="human rhinovirus of adults hospitalized for exacerbation of asthma and" exact="chronic obstructive pulmonary disease" post="KoFanny Wai-san1ChanPaul Kay-sheung2ChanRenee W. Y.3ChanKa-Pang1IpApril1KwokAngela2NgaiJenny Chun-li1NgSo-Shan1OnChan Tat1http://orcid.org/0000-0003-4382-2445HuiDavid Shu-cheongdschui@cuhk.edu.hk1[1], 0000"/>
   <result pre="this article, unless otherwise stated. Abstract Background Acute exacerbations of" exact="chronic obstructive pulmonary disease" post="(AECOPD) and asthma are associated with a variety of"/>
   <result pre="Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and" exact="asthma" post="are associated with a variety of precipitating factors including"/>
   <result pre="multiplex polymerase chain reaction of patients hospitalized with AECOPD and" exact="asthma" post="exacerbations. In addition, infective etiologies were assessed for association"/>
   <result pre="outcome of the patients. Methods Adults admitted with AECOPD and" exact="asthma" post="exacerbations between August 2016 and July 2017 were recruited."/>
   <result pre="Results Altogether 402 patients with AECOPD, 80 stable COPD, 100" exact="asthma" post="exacerbation and 21 stable asthma subjects were recruited. Among"/>
   <result pre="AECOPD, 80 stable COPD, 100 asthma exacerbation and 21 stable" exact="asthma" post="subjects were recruited. Among those admitted for AECOPD and"/>
   <result pre="asthma subjects were recruited. Among those admitted for AECOPD and" exact="asthma" post="exacerbations, 141(35.1%) and 45(45.0%) respectively had pathogens identified in"/>
   <result pre="identified in the NPA specimens. The commonest virus identified was" exact="influenza" post="A followed by HRV. HRV typing identified HRV-A and"/>
   <result pre="readmission rates and mortality except that identification of pathogens in" exact="asthma" post="exacerbation was associated with a lower rate of readmissions"/>
   <result pre="60 days. Conclusions Many respiratory viruses were associated with AECOPD and" exact="asthma" post="exacerbation. HRV-A and HRV-C were the more common HRV"/>
   <result pre="of pathogens in NPA was associated with less readmissions for" exact="asthma" post="patients at 30 and 60 days. Trial registration ClinicalTrials.gov NCT02866357."/>
   <result pre="Health Bureau, HKSAR Government 13140671 Summary at a glance For" exact="asthma" post="and COPD exacerbations, identification of pathogens in nasopharyngeal aspirate"/>
   <result pre="not affect clinical outcomes except that identification of pathogens in" exact="asthma" post="exacerbation was associated with a lower rate of readmissions"/>
   <result pre="between 22 and 60% in patients with AECOPD [6]. For" exact="asthma" post="exacerbation, a previous study from the United Kingdom found"/>
   <result pre="that upper respiratory viral infections were associated with 80–85% of" exact="asthma" post="exacerbations in children aged 9–11 years [7]. There are limited"/>
   <result pre="9–11 years [7]. There are limited data on viral aetiologies for" exact="asthma" post="exacerbation in adults. A recent study in Australia found"/>
   <result pre="aetiologies were identified in 32, 5 and 7% respectively of" exact="asthma" post="exacerbations with hospital admissions [8]. HRVs are a major"/>
   <result pre="admissions [8]. HRVs are a major trigger of AECOPD and" exact="asthma" post="exacerbations and may pose a significant problem for disease"/>
   <result pre="respiratory viruses, HRV infection preceded as many as 50% of" exact="asthma" post="exacerbations in children [11]. Over 100 types of HRVs"/>
   <result pre="the subtypes of HRV that is related to adults with" exact="asthma" post="exacerbations [14]. Furthermore it is unknown that if certain"/>
   <result pre="the typing of HRV) in relation to acute exacerbations of" exact="asthma" post="and COPD. The secondary aim was to assess if"/>
   <result pre="hospitalization, 30 and 60-day readmissions and mortality. Methods Subjects with" exact="asthma" post="exacerbation or AECOPD who were admitted to the Prince"/>
   <result pre="for at least two consecutive days [16, 17]. Patients with" exact="asthma" post="exacerbations were subjects aged ≥18 years, who had background asthma"/>
   <result pre="with asthma exacerbations were subjects aged ≥18 years, who had background" exact="asthma" post="(with a consistent history, prior documented evidence of variable"/>
   <result pre="wheeze or cough for at least 2 consecutive days. Control" exact="asthma" post="and COPD subjects were recruited from the respiratory clinic"/>
   <result pre="COPD subjects should have an FEV1/FVC ratio of &amp;lt; 70%. For" exact="asthma" post="patients, they should have a clinical diagnosis of asthma"/>
   <result pre="For asthma patients, they should have a clinical diagnosis of" exact="asthma" post="(as above). These subjects should have no exacerbation of"/>
   <result pre="asthma (as above). These subjects should have no exacerbation of" exact="asthma" post="or COPD for 6 weeks prior to the assessment. Patients"/>
   <result pre="of lung resection or other significant pulmonary diseases such as" exact="pulmonary fibrosis," post="active infection such as pulmonary tuberculosis and having short"/>
   <result pre="pulmonary diseases such as pulmonary fibrosis, active infection such as" exact="pulmonary tuberculosis" post="and having short life expectancies including subjects with terminal"/>
   <result pre="diseases such as pulmonary fibrosis, active infection such as pulmonary" exact="tuberculosis" post="and having short life expectancies including subjects with terminal"/>
   <result pre="from the patients within 1–2 days of hospitalization for exacerbation of" exact="asthma" post="and COPD. This study was approved by the Joint"/>
   <result pre="22 respiratory pathogens (coronavirus 229E, HKU1, NL63, OC43, human metapneumovirus," exact="influenza" post="A (including H1 and H3), influenza A H1N1pdm09, influenza"/>
   <result pre="NL63, OC43, human metapneumovirus, influenza A (including H1 and H3)," exact="influenza" post="A H1N1pdm09, influenza B, parainfluenza 1, 2, 3 &amp;amp;"/>
   <result pre="metapneumovirus, influenza A (including H1 and H3), influenza A H1N1pdm09," exact="influenza" post="B, parainfluenza 1, 2, 3 &amp;amp; 4, rhinovirus/enterovirus, RSV-A"/>
   <result pre="baseline assessment for up to 2 months. For control COPD and" exact="asthma" post="patients, we identified patients from the out-patient clinic and"/>
   <result pre="aimed at recruiting 400 episodes of AECOPD, 100 episodes of" exact="asthma" post="exacerbation and 1/5 the number of exacerbation of subjects"/>
   <result pre="to the prevalence of different viruses found in AECOPD and" exact="asthma" post="patients and comparisons with the control subjects were done"/>
   <result pre="recruited 402 patients with AECOPD, 80 stable COPD, 100 with" exact="asthma" post="exacerbation, and 21 with stable asthma subjects for this"/>
   <result pre="stable COPD, 100 with asthma exacerbation, and 21 with stable" exact="asthma" post="subjects for this study. The characteristics of the COPD"/>
   <result pre="subjects for this study. The characteristics of the COPD and" exact="asthma" post="subjects are shown in Table 1. The exacerbation and"/>
   <result pre="and inhaler therapies. Table 1 Characteristics of the COPD and" exact="asthma" post="patients Subjects with acute exacerbation of COPD (n = 402)"/>
   <result pre="(n = 80) p-value(compared acute exacerbation and stable COPD) Subjects with" exact="asthma" post="exacerbation of (n = 100) Control asthma (n = 21) p-value(compared"/>
   <result pre="stable COPD) Subjects with asthma exacerbation of (n = 100) Control" exact="asthma" post="(n = 21) p-value(compared acute and stable asthma) Gender (Male)"/>
   <result pre="75 (93.8%) &amp;lt; 0.001* 30 (30.0%) 4 (19.0%) 0.23 Comorbidities  Old" exact="tuberculosis" post="67 (16.6%) 9 (11.3%) 0.22 4 (4.0%) 0 (0.0%)"/>
   <result pre="(8.9%) 4 (5.0%) 0.24 9 (9.0%) 0 (0.0%) 0.35  Ischaemic" exact="heart disease" post="38 (9.4%) 5 (6.2%) 0.35 7 (7.0%) 1 (4.7%)"/>
   <result pre="Additional file 1: Figure S1. Only the AECOPD group and" exact="asthma" post="exacerbation group (not control subjects), had influenza A identified"/>
   <result pre="AECOPD group and asthma exacerbation group (not control subjects), had" exact="influenza" post="A identified by RTPCR in the NPA. For those"/>
   <result pre="by RTPCR in the NPA. For those with AECOPD and" exact="asthma" post="exacerbation subjects, 5 out of the 50 (10.0%) and"/>
   <result pre="had the H1N1pdm09 strain identified respectively. The rest of the" exact="influenza" post="A belonged to the H3N2 strain. Fig. 1 NPA"/>
   <result pre="with those without isolation of pathogens. Among 100 subjects with" exact="asthma" post="exacerbation, 45(45.0%) had pathogens detected. 5(5.0%) subjects had co-infections"/>
   <result pre="co-infections with more than 1 pathogen studied. Among the 21" exact="asthma" post="control subjects, only 1(4.8%) subject had parainfluenza virus detected."/>
   <result pre="had parainfluenza virus detected. The prevalence of microorganisms identified in" exact="asthma" post="(exacerbated asthma and stable) patients is shown in Fig."/>
   <result pre="virus detected. The prevalence of microorganisms identified in asthma (exacerbated" exact="asthma" post="and stable) patients is shown in Fig. 2. The"/>
   <result pre="file 1: Figure S2. Fig. 2 NPA results of the" exact="asthma" post="cases. a: Patients with acute exacerbation of asthma and"/>
   <result pre="of the asthma cases. a: Patients with acute exacerbation of" exact="asthma" post="and stable asthma with or without microorganisms detected in"/>
   <result pre="cases. a: Patients with acute exacerbation of asthma and stable" exact="asthma" post="with or without microorganisms detected in the NPA. b:"/>
   <result pre="M pneumoniae = Mycoplasma pneumoniae; HRVs = Human rhinovirus; RSV = Respiratory syncytial virus Subjects with" exact="asthma" post="exacerbations with detection of pathogens in the NPA had"/>
   <result pre="in the NPA vs those without microorganisms identified for both" exact="asthma" post="and COPD exacerbations. Results are shown in Table 2."/>
   <result pre="unit, NIV non-invasive ventilation Comparison of subjects with and without" exact="influenza" post="vaccination found that the rate of influenza-related exacerbations appeared"/>
   <result pre="of influenza-related exacerbations appeared to be higher in those with" exact="influenza" post="vaccination but that did not reach statistical significance. Results"/>
   <result pre="shown in Table 3. Table 3 Subjects with and without" exact="influenza" post="vaccination and rate of admission for exacerbations with influenza"/>
   <result pre="without influenza vaccination and rate of admission for exacerbations with" exact="influenza" post="A or B isolated in the NPA among subjects"/>
   <result pre="B isolated in the NPA among subjects with COPD and" exact="asthma" post="AECOPD (n = 402) Asthma exacerbation (n = 100) With flu"/>
   <result pre="B identified in NPA among the subjects with or without" exact="influenza" post="vaccination in the COPD* and asthma# acute exacerbation subjects:*p"/>
   <result pre="detected in 26, 11 and 1 subjects respectively with AECOPD," exact="asthma" post="exacerbations and stable COPD. No subject in stable asthma"/>
   <result pre="AECOPD, asthma exacerbations and stable COPD. No subject in stable" exact="asthma" post="group had HRV identified in the NPA. The subtypes"/>
   <result pre="identified in the subjects AECOPD Stable COPD Asthma exacerbation Stable" exact="asthma" post="HRV_A HRV_A1 HRV_A7 HRV_A21 HRV_A33 HRV_A33 HRV_A36 HRV_A36 HRV_A43"/>
   <result pre="between the various types of HRV in both AECOPD and" exact="asthma" post="exacerbations with hospital LOS, readmission and mortality. The results"/>
   <result pre="relationships of HRV types and clinical outcomes of AECOPD and" exact="asthma" post="exacerbation are shown in Additional file 1: Tables S1"/>
   <result pre="detection of respiratory pathogens of adults hospitalized for AECOPD and" exact="asthma" post="exacerbations, this study has found that the rates of"/>
   <result pre="rates were much lower among the corresponding control COPD and" exact="asthma" post="subjects, which were 11.2 and 4.8% respectively. HRV typing"/>
   <result pre="the more common HRV that were associated with AECOPD and" exact="asthma" post="exacerbations with a wide variety of genotypes. Detection of"/>
   <result pre="the hospital LOS, readmissions and mortality except that patients with" exact="asthma" post="exacerbation, identification of pathogens was associated with a lower"/>
   <result pre="our previous study 10 years ago (35.1 vs 22%) [1], and" exact="influenza" post="A viruses remained the most common pathogen identified. Most"/>
   <result pre="commonest virus identified [6]. In contrast, relatively few studies reported" exact="influenza" post="A as the most frequently found virus [20, 21]."/>
   <result pre="as the most frequently found virus [20, 21]. Among the" exact="asthma" post="subjects, 45.0% had pathogens detected in this study. Most"/>
   <result pre="of the previous studies on detection of respiratory pathogens in" exact="asthma" post="exacerbations were conducted in children [22]. A Korean study"/>
   <result pre="in children [22]. A Korean study found that in adult" exact="asthma" post="subjects with acute exacerbation, 26.3% had viruses identified in"/>
   <result pre="HRV being the commonest organisms identified [24]. Adult subjects with" exact="asthma" post="exacerbation thus appeared to have a lower rate of"/>
   <result pre="identified in the NPA were observed in this study with" exact="influenza" post="viruses reaching the peak in November to February and"/>
   <result pre="July for AECOPD. A similar pattern was observed for adult" exact="asthma" post="exacerbation with influenza virus detection which peaked in November"/>
   <result pre="A similar pattern was observed for adult asthma exacerbation with" exact="influenza" post="virus detection which peaked in November and June to"/>
   <result pre="June to July. This pattern was in phase with the" exact="influenza" post="seasonal patterns in Hong Kong [25]. A study of"/>
   <result pre="of airway diseases in the UK were related to childhood" exact="asthma" post="with a seasonal increase of HRV infections in September"/>
   <result pre="Spring [26]. Similar patterns were noted for adult COPD and" exact="asthma" post="exacerbation patients in this study. For children, HRV-A and"/>
   <result pre="For children, HRV-A and HRV-C are more frequently associated with" exact="asthma" post="exacerbations. A cross-sectional study of subjects aged &amp;lt; 18 years in"/>
   <result pre="Hong Kong between October 2008 and March 2009 found that" exact="asthma" post="exacerbation was strongly associated with HRV and specifically HRV-C"/>
   <result pre="with HRV and specifically HRV-C infections [13]. Similar observation for" exact="asthma" post="children in other parts of the world was observed"/>
   <result pre="those requiring hospitalization [30, 31]. In contrast, our adults with" exact="asthma" post="exacerbation had HRV-A being isolated from the NPA more"/>
   <result pre="that HRV-A or HRV-C had a potential role in precipitating" exact="asthma" post="attacks among Japanese adult patients, with a broad genetic"/>
   <result pre="generally have not typed the HRV. Those with history of" exact="influenza" post="vaccination appeared to have a higher rate of identification"/>
   <result pre="vaccination appeared to have a higher rate of identification of" exact="influenza" post="viruses in the NPA than those without vaccination for"/>
   <result pre="the NPA than those without vaccination for both AECOPD and" exact="asthma" post="exacerbation though this did not reach statistical significance. A"/>
   <result pre="suggested that protective serum antibody titres in COPD patients after" exact="influenza" post="vaccination was lower than control subjects [32]. Overall the"/>
   <result pre="lower than control subjects [32]. Overall the mortality benefit of" exact="influenza" post="vaccine in COPD is suggested by some studies but"/>
   <result pre="Another systemic review indicated a favorable benefit-risk ratio for seasonal" exact="influenza" post="vaccination in patients with COPD [34]. For persons with"/>
   <result pre="For persons with asthma, a recent systematic review observed that" exact="influenza" post="vaccination might be effective in both reducing influenza infection"/>
   <result pre="observed that influenza vaccination might be effective in both reducing" exact="influenza" post="infection and asthma attacks [35]. However, another Cochrane review"/>
   <result pre="vaccination might be effective in both reducing influenza infection and" exact="asthma" post="attacks [35]. However, another Cochrane review has expressed uncertainty"/>
   <result pre="review has expressed uncertainty of the degree of protection that" exact="influenza" post="vaccination might confer against asthma exacerbations that are related"/>
   <result pre="the degree of protection that influenza vaccination might confer against" exact="asthma" post="exacerbations that are related to influenza infection [36]. During"/>
   <result pre="vaccination might confer against asthma exacerbations that are related to" exact="influenza" post="infection [36]. During the study period from August 2016"/>
   <result pre="During the study period from August 2016 to July 2017," exact="influenza" post="A(H3N2) was the main circulating strain causing the Summer"/>
   <result pre="sites and distances in addition to egg adaptation especially for" exact="influenza" post="A(H3N2) virus [38]. A previous systematic review found substantial"/>
   <result pre="virus [38]. A previous systematic review found substantial variations in" exact="influenza" post="vaccine effectiveness across types and subtypes of influenza with"/>
   <result pre="variations in influenza vaccine effectiveness across types and subtypes of" exact="influenza" post="with substantially lower protection against H3N2 [39]. Examination of"/>
   <result pre="influenza with substantially lower protection against H3N2 [39]. Examination of" exact="influenza" post="vaccine effectiveness by serology is beyond the scope of"/>
   <result pre="due to current or previous infection or vaccination by measuring" exact="influenza" post="antibody based on haemagglutinin inhibition. While identification of pathogens"/>
   <result pre="lower rate of readmissions for asthma, exacerbations of COPD and" exact="asthma" post="might also be due to other acute and transient"/>
   <result pre="were other factors that might be associated with AECOPD and" exact="asthma" post="exacerbations, e.g. air pollution, weather changes, allergic sensitization, etc."/>
   <result pre="viral and atypical pathogens that were associated with AECOPD and" exact="asthma" post="exacerbations in hospitalized patients. HRV typing suggested that HRV-A"/>
   <result pre="more common HRV subtypes that were associated with AECOPD and" exact="asthma" post="exacerbations with a wide variety of genotypes. Presence of"/>
   <result pre="mortality except that patients who had infective aetiology identified during" exact="asthma" post="exacerbation had lower rates of readmissions at 30 and"/>
   <result pre="cases in different months. Figure S2. NPA results of the" exact="asthma" post="exacerbation cases in different months. (DOCX 145 kb) Abbreviations"/>
   <result pre="competing interests. References References 1.KoFWIpMChanPKChanMCChanMCToKWNgSSChauSSTangJWHuiDSViral etiology of acute exacerbations of" exact="chronic obstructive pulmonary disease" post="in Hong KongChest200713290090817573516 2.KoFWIpMChanPKFokJPChanMCNgaiJCChanDPHuiDSA 1-year prospective study of the"/>
   <result pre="2018). 4.KoFWTamWWongTWChanDPTungAHLaiCKHuiDSTemporal relationship between air pollutants and hospital admissions for" exact="chronic obstructive pulmonary disease" post="in Hong KongThorax20076278078517311838 5.KoFWTamWWongTWLaiCKWongGWLeungTFNgSSHuiDSEffects of air pollution on asthma"/>
   <result pre="pulmonary disease in Hong KongThorax20076278078517311838 5.KoFWTamWWongTWLaiCKWongGWLeungTFNgSSHuiDSEffects of air pollution on" exact="asthma" post="hospitalization rates in different age groups in Hong KongClin"/>
   <result pre="al.Community study of role of viral infections in exacerbations of" exact="asthma" post="in 9-11 year old childrenBMJ1995310122512297767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection"/>
   <result pre="9-11 year old childrenBMJ1995310122512297767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection in acute" exact="asthma" post="and chronic obstructive pulmonary disease increases the risk of"/>
   <result pre="old childrenBMJ1995310122512297767192 8.WarkPAToozeMPowellHParsonsKViral and bacterial infection in acute asthma and" exact="chronic obstructive pulmonary disease" post="increases the risk of readmissionRespirology201318996100223600594 9.JohnstonNWJohnstonSLDuncanJMGreeneJMKebadzeTKeithPKRoyMWasermanSSearsMRThe September epidemic of"/>
   <result pre="disease increases the risk of readmissionRespirology201318996100223600594 9.JohnstonNWJohnstonSLDuncanJMGreeneJMKebadzeTKeithPKRoyMWasermanSSearsMRThe September epidemic of" exact="asthma" post="exacerbations in children: a search for etiologyJ Allergy Clin"/>
   <result pre="J20001667768311106212 11.ThumerelleCDeschildreABouquillonCSantosCSardetAScalbertMDelbecqueLDebrayPDewildeATurckDLeclercFRole of viruses and atypical bacteria in exacerbations of" exact="asthma" post="in hospitalized children: a prospective study in the Nord-pas"/>
   <result pre="in the development of therapeutic agents for viral exacerbations of" exact="asthma" post="and chronic obstructive pulmonary diseasePulm Pharmacol Ther201430C3243 13.MakRKTseLYLamWYWongGWChanPKLeungTFClinical spectrum"/>
   <result pre="14.JarttiTGernJERole of viral infections in the development and exacerbation of" exact="asthma" post="in childrenJ Allergy Clin Immunol201714089590628987219 15.Global Initiative for Chronic"/>
   <result pre="Strategy for the diagnosis, management, and prevention of chronic obstructive" exact="lung disease." post="Updated 2018. 2018:http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf (last assessed date 20 Feb 2018)."/>
   <result pre="To MYYeungACWongYSWongGWChanPKMultiplex molecular detection of respiratory pathogens in children with" exact="asthma" post="exacerbationChest201013734835419749009 25.Center for Health Protection. Department of Health. The"/>
   <result pre="Erbas B. The role of human rhinovirus (HRV) species on" exact="asthma" post="exacerbation severity in children and adolescents. The Journal of"/>
   <result pre="asthma exacerbation severity in children and adolescents. The Journal of" exact="asthma" post=": official journal of the Association for the Care"/>
   <result pre="SpainPediatr Infect Dis J20102971772020305581 29.KhetsurianiNLuXTeagueWGKazerouniNAndersonLJErdmanDDNovel human rhinoviruses and exacerbation of" exact="asthma" post="in childrenEmerg Infect Dis2008141793179618976575 30.CoxDWBizzintinoJFerrariGKhooSKZhangGWhelanSLeeWMBochkovYAGeelhoedGCGoldblattJGernJELaingIALe SouefPNHuman rhinovirus species C"/>
   <result pre="on viral replication and cytokine productionJ Allergy Clin Immunol201413433234124636084 32.EaganTMHardieJAJul-LarsenAGrydelandTBBakkePSCoxRJSelf-reported" exact="influenza" post="vaccination and protective serum antibody titers in a cohort"/>
   <result pre="understanding immunogenicity, efficacy and effectivenessTher Adv Respir Dis20161034936727193567 34.Bekkat-BerkaniRWilkinsonTBuchyPDos SantosGStefanidisDDevasterJMMeyerNSeasonal" exact="influenza" post="vaccination in patients with COPD: a systematic literature reviewBMC"/>
   <result pre="a systematic literature reviewBMC pulmonary medicine2017177928468650 35.VasileiouESheikhAButlerCEl FerkhKvon WissmannBMcMenaminJRitchieLSchwarzeJPapadopoulosNGJohnstonSLTianLSimpsonCREffectiveness of" exact="influenza" post="vaccines in asthma: a systematic review and meta-analysisClinical infectious"/>
   <result pre="Society of America2017651388139528591866 36.Cates CJ, Rowe BH. Vaccines for preventing" exact="influenza" post="in people with asthma. The Cochrane database of systematic"/>
   <result pre="(Last access date 24 Aug 2018). 2018;15:1–7. 38.ZostSJParkhouseKGuminaMEKimKDiaz PerezSWilsonPCTreanorJJSantAJCobeySHensleySEContemporary H3N2" exact="influenza" post="viruses have a glycosylation site that alters binding of"/>
   <result pre="egg-adapted vaccine strainsProc Natl Acad Sci U S A2017114125781258329109276 39.BelongiaEASimpsonMDKingJPSundaramMEKelleyNSOsterholmMTMcLeanHQVariable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6745427\results\search\disease\results.xml">
   <result pre="competence and the public health threat of dengue, MERS-CoV, and" exact="influenza" post="outbreaks. Sustained investment and ample financial allocation are needed"/>
   <result pre="and Zika virus.1 A total of 2926 confirmed cases of" exact="dengue fever" post="were documented in 2016 in Saudi Arabia alone,2 and"/>
   <result pre="vector (Aedes mosquito species). Saudi Arabia recorded 6000 cases of" exact="dengue fever" post="in 2015, and six infected patients died.2Aedes aegypti and"/>
   <result pre="other mosquito-borne flaviviruses within the Flaviviridae family such as Zika," exact="yellow fever," post="West Nile, and Japanese encephalitis.1,3-5 In 2006, a total"/>
   <result pre="indica green-synthesized silver nanoparticles: A sustainable control tool against the" exact="malaria" post="vector Anopheles stephensi?Res Vet Sci2015 Oct;102(102):127-135. 10.1016/j.rvsc.2015.08.00126412532 9AzizATAl-ShamiSAMahyoubJAHatabbiMAhmadAHMd RawiCSPromoting"/>
   <result pre="community opinion survey.PLoS Curr2016 May;8:8. 10.1371/currents.outbreaks.1c39ec05a743d41ee39391ed0f2ed8d327366585 15MainsJWBrelsfoardCLRoseRIDobsonSLFemale adult Aedes albopictus" exact="suppression" post="by wolbachia-infected male mosquitoes.Sci Rep2016 Sep;6:33846. 10.1038/srep3384627659038 16MuruganKPriyankaVDineshDMadhiyazhaganPPanneerselvamCSubramaniamJet al.Predation"/>
   <result pre="using Hugonia mystax: larvicidal potential against Zika virus, dengue, and" exact="malaria" post="vector mosquitoes.Artif Cells Nanomed Biotechnol2017 Nov;45(7):1317-1325. 10.1080/21691401.2016.122866427611658 19TamboEChenJHZhouXNKhaterEIOutwitting dengue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6746389\results\search\disease\results.xml">
   <result pre="(CHIKV) is a mosquito-borne virus that infects humans and causes" exact="chikungunya" post="fever—characterized by fever, rash and chronic arthralgia. Treatment of"/>
   <result pre="virus that infects humans and causes chikungunya fever—characterized by fever," exact="rash" post="and chronic arthralgia. Treatment of chikungunya fever is limited"/>
   <result pre="chikungunya fever—characterized by fever, rash and chronic arthralgia. Treatment of" exact="chikungunya" post="fever is limited to the alleviation of the symptoms"/>
   <result pre="tissues including muscle, joints and the liver [3]. CHIKV causes" exact="chikungunya" post="fever which is characterized by high fever, maculopapular rash,"/>
   <result pre="In some cases more severe symptoms occur—including encephalitis, encephalopathy, myocarditis," exact="hepatitis" post="and Guillain Barré syndrome [5, 6], however chikungunya fever-associated"/>
   <result pre="encephalopathy, myocarditis, hepatitis and Guillain Barré syndrome [5, 6], however" exact="chikungunya" post="fever-associated death is rare [7]. Due to the chronic"/>
   <result pre="Cl- intracellular channels (CLICs), 2) voltage-gated Cl- channels (CLCs), 3)" exact="cystic fibrosis" post="transmembrane conductance regulator (CFTR), 4) calcium-activated Cl- channels (CaCCs),"/>
   <result pre="and NPPB and involvement in other virus infections such as" exact="hepatitis" post="C virus and Merkel cell polyomavirus [21, 32]. Initially,"/>
   <result pre="screens, the involvement of several Cl- channel/transporter proteins in the" exact="hepatitis" post="C virus lifecycle has previously been reported [21], with"/>
   <result pre="Hygiene. 1955;49(1):28–32. 10.1016/0035-9203(55)90080-814373834 2WahidB, AliA, RafiqueS, IdreesM. Global expansion of" exact="chikungunya" post="virus: mapping the 64-year history. International Journal of Infectious"/>
   <result pre="Infectious Diseases. 2017;58:69–76. 10.1016/j.ijid.2017.03.00628288924 3SchwartzO, AlbertML. Biology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol. 2010;8(7):491–500. Epub 2010/06/17. 10.1038/nrmicro236820551973 4MinerJJ,"/>
   <result pre="10.1038/nrmicro236820551973 4MinerJJ, YeangA, XianH, FoxJM, TaffnerS, MalkovaON, et al.Brief report:" exact="chikungunya" post="viral arthritis in the United States: a mimic of"/>
   <result pre="YeangA, XianH, FoxJM, TaffnerS, MalkovaON, et al.Brief report: chikungunya viral" exact="arthritis" post="in the United States: a mimic of seronegative rheumatoid"/>
   <result pre="viral arthritis in the United States: a mimic of seronegative" exact="rheumatoid arthritis." post="Arthritis &amp;amp; Rheumatology. 2015;67(5):1214–20.25605621 5LemantJ, BoissonV, WinerA, ThibaultL, AndréH,"/>
   <result pre="2015;67(5):1214–20.25605621 5LemantJ, BoissonV, WinerA, ThibaultL, AndréH, TixierF, et al.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
   <result pre="SimonF. Morbidity and impaired quality of life 30 months after" exact="chikungunya" post="infection: comparative cohort of infected and uninfected French military"/>
   <result pre="LippiatJD, HarrisM, MankouriJ. Requirement for chloride channel function during the" exact="hepatitis" post="C virus life cycle. Journal of virology. 2015;89(7):4023–9. 10.1128/JVI.02946-1425609806"/>
   <result pre="BraunP, MeyerM, et al.A human genome-wide loss-of-function screen identifies effective" exact="chikungunya" post="antiviral drugs. Nature communications. 2016;7. 23PohjalaL, UttA, VarjakM, LullaA,"/>
   <result pre="ShankarEM, RahmanNA, et al.A combination of doxycycline and ribavirin alleviated" exact="chikungunya" post="infection. PloS one. 2015;10(5):e012636010.1371/journal.pone.012636025970853 28BriolantS, GarinD, ScaramozzinoN, JouanA, CranceJ."/>
   <result pre="De MirandaJ, SchechterMC, CarneiroFA, SalgadoLT, MachadoGF, et al.Inactivation of vesicular" exact="stomatitis" post="virus through inhibition of membrane fusion by chemical modification"/>
   <result pre="ScholteFEM, SnijderEJ, van HemertMJ. An in vitro assay to study" exact="chikungunya" post="virus RNA synthesis and the mode of action of"/>
   <result pre="ZaidA, TengT-S, HerreroLJ, WolfS, et al.Specific inhibition of NLRP3 in" exact="chikungunya" post="disease reveals a role for inflammasomes in alphavirus-induced inflammation."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6749704\results\search\disease\results.xml">
   <result pre="doi: 10.1186/s12916-019-1411-9 : Research Article The case for a universal" exact="hepatitis" post="C vaccine to achieve hepatitis C elimination ScottNicknick.scott@burnet.edu.au12WilsonDavid P.david.wilson@burnet.edu.au12ThompsonAlexander"/>
   <result pre="The case for a universal hepatitis C vaccine to achieve" exact="hepatitis" post="C elimination ScottNicknick.scott@burnet.edu.au12WilsonDavid P.david.wilson@burnet.edu.au12ThompsonAlexander J.alexander.thompson@svhm.org.au34BarnesEleanorellie.barnes@ndm.ox.ac.uk56El-SayedManalmanalhelsayed@yahoo.co.uk7BenzakenAdele Schwartzadelebenz@gmail.com8DrummerHeidi E.heidi.drummer@burnet.edu.au1910HellardMargaret E.margaret.hellard@burnet.edu.au121011[1], 0000"/>
   <result pre="The introduction of highly effective direct-acting antiviral (DAA) therapy for" exact="hepatitis" post="C has led to calls to eliminate it as"/>
   <result pre="suggest it is possible to develop a vaccine to prevent" exact="hepatitis" post="C. Using a mathematical model, we examined the potential"/>
   <result pre="a mathematical model, we examined the potential impact of a" exact="hepatitis" post="C vaccine on the feasibility and cost of achieving"/>
   <result pre="countries (47%). Conclusions These findings strongly support the case for" exact="hepatitis" post="C vaccine development as an urgent public health need,"/>
   <result pre="vaccine development as an urgent public health need, to ensure" exact="hepatitis" post="C elimination is achievable and at substantially reduced costs"/>
   <result pre="There are vast differences in the epidemiology and burden of" exact="hepatitis" post="C across the globe that have significant implications for"/>
   <result pre="significant implications for meeting the World Health Organization (WHO) 2030" exact="hepatitis" post="C elimination targets. A consequence is that responses to"/>
   <result pre="hepatitis C elimination targets. A consequence is that responses to" exact="hepatitis" post="C must be tailored to particular settings; major considerations"/>
   <result pre="and human resources). The majority of high-income countries have concentrated" exact="hepatitis" post="C epidemics with transmission predominantly occurring among PWID [1–3]."/>
   <result pre="occurring among PWID [1–3]. In settings where the prevalence of" exact="hepatitis" post="C among PWID is less than approximately 50%, mathematical"/>
   <result pre="number of European countries [5–8]. However, if the prevalence of" exact="hepatitis" post="C among PWID is extremely high (greater than approximately"/>
   <result pre="therefore likely to need significant additional prevention measures to achieve" exact="hepatitis" post="C elimination. Many low- and middle-income countries have generalised"/>
   <result pre="in addition to transmission among PWID. The prospects of reducing" exact="hepatitis" post="C incidence through treatment-as-prevention in these countries is low"/>
   <result pre="sources of transmission, and minimal existing prevention interventions. Vaccines for" exact="hepatitis" post="C have been in pre-clinical development since the discovery"/>
   <result pre="C have been in pre-clinical development since the discovery of" exact="hepatitis" post="C virus almost 30 years ago. Two candidates have reached"/>
   <result pre="the possibility of developing a vaccine for the prevention of" exact="hepatitis" post="C within the next 5–10 years. However, vigorous research and"/>
   <result pre="within the next 5–10 years. However, vigorous research and development of" exact="hepatitis" post="C vaccine candidates and the immunological requirements for natural"/>
   <result pre="of direct acting antiviral therapies (DAAs), highly effective treatments for" exact="hepatitis" post="C. The global spotlight is currently focussed on the"/>
   <result pre="imagine a vaccine not playing a central role in long-term" exact="hepatitis" post="C control strategies for the majority of the world."/>
   <result pre="In this study, we used a mathematical model to project" exact="hepatitis" post="C incidence reduction following the implementation of a variety"/>
   <result pre="achieve the WHO elimination target of an 80% reduction in" exact="hepatitis" post="C incidence by 2030 in the most cost-effective way"/>
   <result pre="The analysis was performed with and without a theoretical prophylactic" exact="hepatitis" post="C vaccine, to determine if additional impact and/or cost"/>
   <result pre="and relative importance that a future vaccine has in achieving" exact="hepatitis" post="C elimination. Methods Model description We used a dynamic"/>
   <result pre="Methods Model description We used a dynamic compartmental model of" exact="hepatitis" post="C transmission (Fig. 1). The model included two population"/>
   <result pre="15–64-year-old population, as a proxy for non-PWID at risk of" exact="hepatitis" post="C infection in settings with generalised or mixed epidemics)."/>
   <result pre="rather than antibody testing due to known past exposure to" exact="hepatitis" post="C. Susceptible individuals could become infected according to the"/>
   <result pre="C. Susceptible individuals could become infected according to the current" exact="hepatitis" post="C prevalence within their population group, whether or not"/>
   <result pre="constant that allows the model to be adapted to the" exact="hepatitis" post="C prevalence in the given setting. For concentrated epidemic"/>
   <result pre="prevalence of injecting drug use [9] and the prevalence of" exact="hepatitis" post="C among PWID [9] and the general population [14,"/>
   <result pre="and the general community. Limited global datasets were available with" exact="hepatitis" post="C prevalence estimates, meaning that the models were calibrated"/>
   <result pre="be considered to be the theoretical maximum attainable impact of" exact="hepatitis" post="C elimination programmes. By assuming high coverage of testing"/>
   <result pre="theoretical settings that had concentrated epidemics (25%, 50% or 75%" exact="hepatitis" post="C prevalence among PWID), generalised epidemics (1%, 2%, 3%,"/>
   <result pre="epidemics (1%, 2%, 3%, 5%, 10%, 15%, 25% or 30%" exact="hepatitis" post="C prevalence among the general community) and mixed epidemics"/>
   <result pre="among the general community) and mixed epidemics (all combinations of" exact="hepatitis" post="C prevalence among PWID and the general community). Results"/>
   <result pre="period (2018–2030) This was implemented as 1/12th of people with" exact="hepatitis" post="C in the general population being diagnosed every year"/>
   <result pre="income classification AND the total number of people living with" exact="hepatitis" post="C was &amp;gt; 5 times the total number of estimated"/>
   <result pre="hepatitis C was &amp;gt; 5 times the total number of estimated" exact="hepatitis" post="C-infected PWID. This classification was used as without modelling"/>
   <result pre="unable to produce the correct number of people living with" exact="hepatitis" post="C based on injecting drug use-related transmission alone. Countries"/>
   <result pre="the national level), since their PWID populations had significantly higher" exact="hepatitis" post="C prevalence than the general community, and so the"/>
   <result pre="was taken for costs (Table 2). The commodity cost of" exact="hepatitis" post="C antibody tests, RNA tests, and treatment were based"/>
   <result pre="file 1: Appendix E—Table S7). The median relative reduction in" exact="hepatitis" post="C incidence in the optimal strategies without a vaccine"/>
   <result pre="impact of a vaccine on the feasibility and cost of" exact="hepatitis" post="C elimination. Total cases averted 2018–2030 using the optimal"/>
   <result pre="among PWID. Common to these countries is a very high" exact="hepatitis" post="C prevalence among PWID (&amp;gt; 80%). The extremely high prevalence"/>
   <result pre="meant that there were not many uninfected PWID, and so" exact="hepatitis" post="C incidence was low. Scaling up treatment led to"/>
   <result pre="vaccines can play an important role in the elimination of" exact="hepatitis" post="C. We found that for the majority of settings,"/>
   <result pre="of settings, the WHO target of an 80% reduction in" exact="hepatitis" post="C incidence by 2030 is unlikely to be achieved"/>
   <result pre="be achieved without additional prevention measures. Integrating a vaccine within" exact="hepatitis" post="C testing and treatment programmes could greatly improve the"/>
   <result pre="fewer than 29% of countries analysed were able to reduce" exact="hepatitis" post="C incidence by 80% by 2030 in the model"/>
   <result pre="treatment programmes have the potential to produce major gains towards" exact="hepatitis" post="C elimination, they have limitations that will require additional"/>
   <result pre="they have limitations that will require additional intervention, and a" exact="hepatitis" post="C vaccine is worth pursuing to fill this gap."/>
   <result pre="developed countries, a vaccine could significantly reduce the costs of" exact="hepatitis" post="C elimination. When a vaccine was modelled at US$200"/>
   <result pre="concentrated and mixed epidemic settings, respectively. Therefore, a vaccine for" exact="hepatitis" post="C must be cheap and simple to manufacture so"/>
   <result pre="for Disease Control in the USA prices adult vaccines for" exact="hepatitis" post="B at US$30.81; human papillomavirus at US$144.18; measles, mumps,"/>
   <result pre="B at US$30.81; human papillomavirus at US$144.18; measles, mumps, and" exact="rubella" post="at US$45.65; and varicella at US$77.57 [27]. However, in"/>
   <result pre="at US$77.57 [27]. However, in low- and middle-income countries, the" exact="hepatitis" post="B vaccine can cost as little as US$0.16 per"/>
   <result pre="additional prevention measures, the optimal global incidence reduction strategy for" exact="hepatitis" post="C is to implement targeted test and treat programmes"/>
   <result pre="test and treat programmes among those at high risk of" exact="hepatitis" post="C infection and to implement hepatitis C vaccination through"/>
   <result pre="at high risk of hepatitis C infection and to implement" exact="hepatitis" post="C vaccination through these programmes. It is estimated that"/>
   <result pre="programmes. It is estimated that only 20% of people with" exact="hepatitis" post="C were diagnosed globally in 2015 [22], meaning that"/>
   <result pre="It is therefore worth examining the potential to combine a" exact="hepatitis" post="C vaccine with other vaccines targeting this age group"/>
   <result pre="vaccines targeting this age group such as human papillomavirus or" exact="hepatitis" post="B. Harm reduction for PWID has an important role"/>
   <result pre="for PWID has an important role to play in the" exact="hepatitis" post="C elimination agenda. In sensitivity analyses, we tested the"/>
   <result pre="and opioid substitution therapy should be considered essential components of" exact="viral hepatitis" post="strategies as recommended by the WHO [29]. The total"/>
   <result pre="opioid substitution therapy should be considered essential components of viral" exact="hepatitis" post="strategies as recommended by the WHO [29]. The total"/>
   <result pre="the WHO [29]. The total cost of reaching the WHO" exact="hepatitis" post="C elimination targets has been estimated at US$51 billion"/>
   <result pre="globally [30]. For many countries, the direct costs associated with" exact="hepatitis" post="C are currently low, because there are no or"/>
   <result pre="because there are no or limited services available to manage" exact="hepatitis" post="C-related liver disease. As a result, the required outlay"/>
   <result pre="are no or limited services available to manage hepatitis C-related" exact="liver disease." post="As a result, the required outlay on hepatitis C"/>
   <result pre="C-related liver disease. As a result, the required outlay on" exact="hepatitis" post="C testing and treatment programmes represents new costs with"/>
   <result pre="direct economic benefits. However, when the indirect economic benefits of" exact="hepatitis" post="C elimination are considered, such as a larger and"/>
   <result pre="other programmes as a way to improve prevention and reduce" exact="hepatitis" post="C transmission—only one component of hepatitis C elimination—and the"/>
   <result pre="improve prevention and reduce hepatitis C transmission—only one component of" exact="hepatitis" post="C elimination—and the vaccine was modelled to be delivered"/>
   <result pre="treatment programmes because they will also be required to reduce" exact="hepatitis" post="C morbidity and mortality. Our estimate that a US$200"/>
   <result pre="in the estimated total cost, should financing be obtained for" exact="hepatitis" post="C elimination. The total cost of developing a vaccine"/>
   <result pre="of the first phase II efficacy trial of a prophylactic" exact="hepatitis" post="C vaccine designed to generate cellular immunity, released in"/>
   <result pre="this study, it is a reminder that a vaccine for" exact="hepatitis" post="C will still require significant research and development investment."/>
   <result pre="with 28 past and current phase II trials [32]. For" exact="hepatitis" post="C, the market size of a vaccine will be"/>
   <result pre="DAAs to underpin global elimination efforts is blocking interest in" exact="hepatitis" post="C vaccine development. Like almost all vaccines, a public-private"/>
   <result pre="this study relate to the hypothetical vaccine. Prophylactic vaccines for" exact="hepatitis" post="C are currently undergoing clinical trials, and their final"/>
   <result pre="restored after attaining DAA-mediated viral clearance and is responsive to" exact="hepatitis" post="C vaccination. However, our sensitivity analysis suggests that vaccine"/>
   <result pre="costs could be avoided by inclusion with human papillomavirus or" exact="hepatitis" post="B vaccine schedules. When a vaccine is available, it"/>
   <result pre="this study was to generate evidence that a vaccine for" exact="hepatitis" post="C has the potential to unlock health and economic"/>
   <result pre="stabilised treatment. Conclusion These findings strongly support the case for" exact="hepatitis" post="C vaccine development as an urgent public health need,"/>
   <result pre="vaccine development as an urgent public health need, to ensure" exact="hepatitis" post="C elimination is achievable and at substantially reduced costs"/>
   <result pre="Appendix A. country specific data inputs (population sizes, prevalence of" exact="hepatitis" post="C among PWID and the general community, and staff"/>
   <result pre="settings (results from concentrated, generalised and mixed epidemic settings, with" exact="hepatitis" post="C prevalence of 25/50/75% among PWID +/− 1/2/3/5/10/15/20/25/30% among the"/>
   <result pre="funding to her institution from GSK to deliver studies in" exact="hepatitis" post="C vaccines that encode class II invariant chain. MH"/>
   <result pre="Gilead Sciences, AbbVie, and BMS. References References 1.ShepardCWFinelliLAlterMJGlobal epidemiology of" exact="hepatitis" post="C virus infectionLancet Infect Dis20055955856710.1016/S1473-3099(05)70216-416122679 2.HajarizadehBGrebelyJDoreGJEpidemiology and natural history"/>
   <result pre="of HCV infectionNat Rev Gastroenterol Hepatol201310955356210.1038/nrgastro.2013.10723817321 3.NelsonPKMathersBMCowieBHaganHDes JarlaisDHoryniakDDegenhardtLGlobal epidemiology of" exact="hepatitis" post="B and hepatitis C in people who inject drugs:"/>
   <result pre="Rev Gastroenterol Hepatol201310955356210.1038/nrgastro.2013.10723817321 3.NelsonPKMathersBMCowieBHaganHDes JarlaisDHoryniakDDegenhardtLGlobal epidemiology of hepatitis B and" exact="hepatitis" post="C in people who inject drugs: results of systematic"/>
   <result pre="in people who inject drugs: results of systematic reviewsLancet2011378979157158310.1016/S0140-6736(11)61097-021802134 4.ScottNSacks-DavisRPedranaADoyleJThompsonAHellardMEliminating" exact="hepatitis" post="C: the importance of frequent testing of people who"/>
   <result pre="HCV incidence and mortality elimination targets: a cost-effectiveness modelGut20176681507151510.1136/gutjnl-2016-31150427196586 6.ScottNDoyleJWilsonDPWadeAHowellJPedranaAThompsonAHellardMReaching" exact="hepatitis" post="C virus elimination targets requires health system interventions to"/>
   <result pre="who inject drugs in EuropeJ Hepatol20186840241110.1016/j.jhep.2017.10.01029080808 8.ScottNÓlafssonSGottfreðssonMTyrfingssonTRúnarsdóttirVHansdottirIHernandezUBSigmundsdóttirGHellardMModelling the elimination of" exact="hepatitis" post="C as a public health threat in Iceland: a"/>
   <result pre="2019. Accessed 13 June 2019 12.MicallefJMKaldorJMDoreGJSpontaneous viral clearance following acute" exact="hepatitis" post="C infection: a systematic review of longitudinal studiesJ Viral"/>
   <result pre="Accessed 1 May 2018 14.BlachSZeuzemSMannsMAltraifIDubergA-SMuljonoDHWakedIAlavianSMLeeM-HNegroFGlobal prevalence and genotype distribution of" exact="hepatitis" post="C virus infection in 2015: a modelling studyLancet Gastroenterol"/>
   <result pre="studyLancet Gastroenterol Hepatol20172316117610.1016/S2468-1253(16)30181-928404132 15.GowerEEstesCBlachSRazavi-ShearerKRazaviHGlobal epidemiology and genotype distribution of the" exact="hepatitis" post="C virus infectionJ Hepatol2014611 SupplS45S5710.1016/j.jhep.2014.07.02725086286 16.collab: World Health OrganizationDisability"/>
   <result pre="syringe provision and opiate substitution therapy on the incidence of" exact="hepatitis" post="C virus in injecting drug users: pooling of UK"/>
   <result pre="ribavirin in treatment-naive and previously treated patients with genotype 1" exact="hepatitis" post="C virus infection (LONESTAR): an open-label, randomised, phase 2"/>
   <result pre="eraPLoS One2018138e020210910.1371/journal.pone.020210930114207 29.collab: World Health OrganizationGlobal health sector strategy on" exact="viral hepatitis" post="2016–20212016 30.Pedrana A, Howell J, Schröder S, Scott N,"/>
   <result pre="One2018138e020210910.1371/journal.pone.020210930114207 29.collab: World Health OrganizationGlobal health sector strategy on viral" exact="hepatitis" post="2016–20212016 30.Pedrana A, Howell J, Schröder S, Scott N,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6749736\results\search\disease\results.xml">
   <result pre="transmission spreading page-count: Introduction African swine fever (ASF) is an" exact="infectious disease" post="causing high mortality of pigs, and is notifiable to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6750865\results\search\disease\results.xml">
   <result pre="of neuronal and glial cells development and microcephaly. Keywords ZIKV" exact="microcephaly" post="neuroinflammatory response cell death fig-count: ref-count: page-count: Perspectives Zika"/>
   <result pre="to the outbreak and exponential growth of reported cases of" exact="microcephaly" post="and other congenital defects.1,2 ZIKV exhibits extreme versatility and"/>
   <result pre="infection. These studies suggest that there is a link between" exact="microcephaly" post="and cell death resulting from the neuroinflammatory response, whereby"/>
   <result pre="and ZIKV-induced microcephaly. Apoptosis, Necrosis, And Necroptosis The development of" exact="microcephaly" post="presents a great challenge owing to the lack of"/>
   <result pre="various mechanisms to maintain homeostasis, without causing major damage; in" exact="microcephaly" post="cases, apoptosis induces the uncontrolled death of neurons and"/>
   <result pre="extremely harmful to neurons and glial cells, i.e., pyroptosis in" exact="microcephaly" post="cases ZIKV-induced.17–20 Interestingly, pyroptosis differs from apoptosis and necrosis"/>
   <result pre="the viral pathogenesis. Conclusion And Future Direction Many questions about" exact="microcephaly" post="induced by ZIKV remain. However, investigations of several mechanisms"/>
   <result pre="of ZIKV infection suggest that there is a link between" exact="microcephaly" post="and cell death in which the neuroinflammatory response in"/>
   <result pre="Possible integrated mechanism of cell injury and its relationship with" exact="microcephaly" post="ZIKV-induced and cell death. Cell injury is determined by"/>
   <result pre="paraptosis, and autophagy can directly impact on the development of" exact="microcephaly" post="during ZIKV congenital infection or in the death of"/>
   <result pre="neurons and glial cells by necrosis induced by ZIKV in" exact="microcephaly" post="cases. Another type of cell death associated with microcephaly,"/>
   <result pre="of cell damage in central nervous system of fatal cases" exact="microcephaly" post="by Zika virus. Sci Rep. 2018;1:1. doi:10.1038/s41598-017-17765-5 8.SolomonIH, MilnerDA,"/>
   <result pre="apoptosis and in situ immune response in fatal cases of" exact="microcephaly" post="caused by Zika virus. Am J Pathol. 2018;9440:30153–30156. 13.Ghosh"/>
   <result pre="damage to the central nervous system in fatal Zika virus" exact="microcephaly" post="cases. Cytokine. 2018;111:255–264. doi:10.1016/j.cyto.2018.08.00830199767 21.ZhengY, LiuQ, WuY, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6751066\results\search\disease\results.xml">
   <result pre="of the Creative Commons Attribution 4.0 International license.mBio.02180-19.pdf Current seasonal" exact="influenza" post="vaccines are suboptimal and low in immunogenicity and do"/>
   <result pre="and do not provide long-lasting immunity and cross protection against" exact="influenza" post="virus strains that have antigenically drifted. More-effective influenza vaccines"/>
   <result pre="protection against influenza virus strains that have antigenically drifted. More-effective" exact="influenza" post="vaccines which can induce both humoral immunity and T"/>
   <result pre="and T cell immunity are needed. The NS1 protein of" exact="influenza" post="virus is a virulence element and the critical factor"/>
   <result pre="vaccines in humans. We have generated a panel of both" exact="influenza" post="A and influenza B DelNS1 LAIVs which are able"/>
   <result pre="We have generated a panel of both influenza A and" exact="influenza" post="B DelNS1 LAIVs which are able to grow in"/>
   <result pre="and emerging influenza. Abstract ABSTRACT Nonstructural protein 1 (NS1) of" exact="influenza" post="virus is a key virulence element with multifunctional roles"/>
   <result pre="would create a safer and more extensively immunogenic live attenuated" exact="influenza" post="virus (LAIV) vaccine. However, DelNS1 viruses are very difficult"/>
   <result pre="developed two master backbones of deleted-NS1 (DelNS1) viral genomes from" exact="influenza" post="A or B viruses which contain novel adaptive mutations"/>
   <result pre="nonpathogenic in mice but replicate well in vaccine-producing cells. Both" exact="influenza" post="A and influenza B DelNS1 LAIVs grow better at"/>
   <result pre="but replicate well in vaccine-producing cells. Both influenza A and" exact="influenza" post="B DelNS1 LAIVs grow better at 33°C than at"/>
   <result pre="strong long-lasting cross protection against heterosubtypic or antigenically distantly related" exact="influenza" post="viruses in mice. Mechanistic investigations revealed that DelNS1-LAIVs induce"/>
   <result pre="against seasonal and emerging influenza. KEYWORDS live attenuated vaccine NS1" exact="influenza" post="vaccines Funding Research Grant Council of Hong Kong SAR"/>
   <result pre="to alleviate the disease burden and mortality associated with seasonal" exact="influenza" post="and is also the method of choice to curb"/>
   <result pre="circulating strains makes it difficult to predict the evolution of" exact="influenza" post="viruses (IVs). An inability to induce long-lasting immunity and"/>
   <result pre="inability to induce long-lasting immunity and the effects of historical" exact="influenza" post="virus infections on vaccine-induced immune responses further complicate the"/>
   <result pre="responses further complicate the current vaccine strategy. Mismatch of seasonal" exact="influenza" post="vaccines and circulating strains occurs regularly, resulting in severe"/>
   <result pre="influenza vaccines and circulating strains occurs regularly, resulting in severe" exact="influenza" post="seasons (1). It is also recognized that HA-based influenza"/>
   <result pre="severe influenza seasons (1). It is also recognized that HA-based" exact="influenza" post="vaccine technology cannot respond swiftly to emerging pandemic viruses,"/>
   <result pre="the 2009 H1N1 pandemic. Therefore, it is imperative to develop" exact="influenza" post="vaccines with the ability to induce enduring broadly protective"/>
   <result pre="induce enduring broadly protective immunity against matched and mismatched seasonal" exact="influenza" post="virus strains and that can be produced rapidly in"/>
   <result pre="In recent years, new strategies for the development of novel" exact="influenza" post="vaccines conferring superior length and breadth of protection have"/>
   <result pre="antibodies targeting the more highly conserved stem region of the" exact="influenza" post="virus HA protein (7, 8). Attention has also recently"/>
   <result pre="Attention has also recently been focused on immunity elicited by" exact="influenza" post="virus neuraminidase (NA), which is less variable than HA,"/>
   <result pre="based on the conserved ectodomain of matrix protein 2 of" exact="influenza" post="virus have been evaluated previously in multiple reports (11,"/>
   <result pre="evaluated previously in multiple reports (11, 12). Another strategy in" exact="influenza" post="vaccine research focuses on using live attenuated influenza viruses"/>
   <result pre="strategy in influenza vaccine research focuses on using live attenuated" exact="influenza" post="viruses (LAIVs) to mimic natural infection and induce both"/>
   <result pre="natural infection and induce both humoral and cellular immunity to" exact="influenza" post="virus. A cold-adapted LAIV (Influenza Mist) has been licensed"/>
   <result pre="aim to induce HA-specific neutralizing or stem-targeting antibodies to block" exact="influenza" post="virus, LAIVs elicit multifaceted immune responses through limited virus"/>
   <result pre="able to induce broader cross protective immunity than current inactivated" exact="influenza" post="vaccines. It has long been questioned why natural infections"/>
   <result pre="vaccines. It has long been questioned why natural infections with" exact="influenza" post="virus fail to induce broad and long-lasting immunity against"/>
   <result pre="immunity and interference with the induction of adaptive immunity during" exact="influenza" post="virus infection (19, 20). A role for NS1 in"/>
   <result pre="considered a desirable strategy for making safer and more immunogenic" exact="influenza" post="vaccines (22). An NS1-truncated vaccine induces strong immune responses"/>
   <result pre="of H3N2 or H1N1 viruses also cross protect against swine" exact="influenza" post="viruses in pigs (25–27), further highlighting the potential of"/>
   <result pre="preventing influenza. Furthermore, two clinical trials using deleted-NS1-trivalent LAIVs containing" exact="influenza" post="virus H1N1, H3N2, and B strains demonstrated induction of"/>
   <result pre="strain-specific and cross-neutralizing antibodies in vaccinated humans (28, 29). However," exact="influenza" post="viruses with truncated or deleted NS1 grow at relatively"/>
   <result pre="has hampered the commercial development of deleted-NS1 (DelNS1) live attenuated" exact="influenza" post="virus vaccine strains. Previous studies published by ourselves and"/>
   <result pre="acquisition of adaptive mutations that restore NS1-regulated M splicing during" exact="influenza" post="virus infection would increase virus replication ability in interferon-deficient"/>
   <result pre="sufficient quantities of DelNS1 viruses for use as live attenuated" exact="influenza" post="vaccines. It will also be important to evaluate if"/>
   <result pre="(31), we have established a panel of DelNS1 versions of" exact="influenza" post="A (2009 H1N1, H3N2, and H7N9) and B virus"/>
   <result pre="master donor strains derived from the 2009 H1N1 and HK2011" exact="influenza" post="B virus strains, respectively. We found that different strains"/>
   <result pre="B virus strains, respectively. We found that different strains of" exact="influenza" post="viruses utilize different adaptive strategies to support replication of"/>
   <result pre="of whether they originated from seasonal, pandemic, or highly pathogenic" exact="avian influenza" post="viruses, and are naturally cold-adapted. Importantly, immunization of mice"/>
   <result pre="whether they originated from seasonal, pandemic, or highly pathogenic avian" exact="influenza" post="viruses, and are naturally cold-adapted. Importantly, immunization of mice"/>
   <result pre="H5N1 or H7N9 viruses. Broad protection against antigenically distantly related" exact="influenza" post="viruses was also observed for DelNS1-H3N2 and DelNS1 B"/>
   <result pre="and for expressing additional antigens to enhance specific immunity against" exact="influenza" post="viruses. DelNS1 LAIVs with adaptive mutations enabling growth in"/>
   <result pre="more-effective and broadly protective vaccines for seasonal and emerging pandemic" exact="influenza" post="viruses. RESULTS Generation of 2009 H1N1 DelNS1 virus with"/>
   <result pre="humans and has become one of the two prevalent seasonal" exact="influenza" post="A viruses. We consider this to be an ideal"/>
   <result pre="an ideal virus from which to make a backbone for" exact="influenza" post="A DelNS1 LAIV. Using technology similar to that previously"/>
   <result pre="spontaneous and is a desirable feature in a live attenuated" exact="influenza" post="virus vaccine. To further verify the contribution of the"/>
   <result pre="attenuates the pathogenic properties of both seasonal and highly pathogenic" exact="avian influenza" post="viruses. FIG 2 Avirulence of CA4-DelNS1 virus. (A) A549"/>
   <result pre="the pathogenic properties of both seasonal and highly pathogenic avian" exact="influenza" post="viruses. FIG 2 Avirulence of CA4-DelNS1 virus. (A) A549"/>
   <result pre="challenge. To assess the protective ability of DelNS1 virus in" exact="influenza" post="virus infection, we immunized mice once with CA4-DelNS1 virus,"/>
   <result pre="vaccinated mice at day 3 postchallenge (Fig. 3B). Highly pathogenic" exact="avian influenza" post="H5N1 virus infection is fatal in approximately 60% of"/>
   <result pre="mice at day 3 postchallenge (Fig. 3B). Highly pathogenic avian" exact="influenza" post="H5N1 virus infection is fatal in approximately 60% of"/>
   <result pre="(Fig. S3A to C). Cross protective immunity against antigenically distinct" exact="influenza" post="A strains was also induced by CA4-DelNS1 (H1N1) and"/>
   <result pre="H1N1 strain, no significant DI genomes were detected from either" exact="influenza" post="A or influenza B DelNS1 LAIV (Fig. S2E). These"/>
   <result pre="significant DI genomes were detected from either influenza A or" exact="influenza" post="B DelNS1 LAIV (Fig. S2E). These results show that"/>
   <result pre="LAIV (Fig. S2E). These results show that DelNS1 live attenuated" exact="influenza" post="virus induces sustained and highly protective immunity against lethal"/>
   <result pre="that deletion of NS1 from CA4 created a live attenuated" exact="influenza" post="vaccine that seems to be more cross protective than"/>
   <result pre="LAIVs can elicit immunity that is sufficiently broad to overcome" exact="influenza" post="vaccine mismatches caused by antigenic drift of seasonal influenza"/>
   <result pre="overcome influenza vaccine mismatches caused by antigenic drift of seasonal" exact="influenza" post="viruses. 10.1128/mBio.02180-19.4FIG S4Viral titers in lungs of mice infected"/>
   <result pre="terms of the Creative Commons Attribution 4.0 International license. DelNS1" exact="influenza" post="B virus cross protects against different genetic lineages. To"/>
   <result pre="further evaluate the potential of DelNS1 LAIVs for use in" exact="influenza" post="vaccine applications, we generated a DelNS1 influenza B virus"/>
   <result pre="for use in influenza vaccine applications, we generated a DelNS1" exact="influenza" post="B virus using a master donor backbone from a"/>
   <result pre="virus using a master donor backbone from a Victoria lineage" exact="influenza" post="B virus, B/Hong Kong/8038/2011. The NS1 coding region was"/>
   <result pre="NS segment of B/Hong Kong/8038/2011, and a NS1-deleted version of" exact="influenza" post="B virus was rescued using a reverse genetics protocol"/>
   <result pre="5A) as described above. A NS1-deleted version of B/Hong Kong/8038/2011" exact="influenza" post="B virus adapted to replicate in MDCK cells and"/>
   <result pre="assay (Fig. S5A). Analysis of growth properties found that DelNS1-B8038" exact="influenza" post="B virus replicates at 33°C in MDCK cells but"/>
   <result pre="reduced replication efficiency at 37°C (Fig. 5C), similarly to CA4-DelNS1" exact="influenza" post="A viruses. DelNS1-B8038 LAIV cannot replicate in interferon-competent A549"/>
   <result pre="cells (Fig. 5C). There are two genetically distinct lineages of" exact="influenza" post="B viruses, namely, Victoria and Yamagata, cocirculating in humans."/>
   <result pre="cocirculating in humans. To assess if DelNS1-B8038, a Victoria lineage" exact="influenza" post="B virus, provides protection from infection with both lineages"/>
   <result pre="B virus, provides protection from infection with both lineages of" exact="influenza" post="B virus, mice were immunized once through the nasal"/>
   <result pre="route and were then (after 3 weeks) challenged with mouse-adapted" exact="influenza" post="B virus of either the Yamagata (B/Florida/4/2006) or Victoria"/>
   <result pre="is able to induce cross protective activity against antigenically distinct" exact="influenza" post="B virus strains. FIG 5 Generation and characterization of"/>
   <result pre="and characterization of DelNS1 B LAIV. (A) Generation of DelNS1-B8038" exact="influenza" post="B virus by reverse genetics. pHW2000 plasmids containing an"/>
   <result pre="the virus titer stabilized. (B) Adaptive mutations in growth-adapted DelNS1-B8038" exact="influenza" post="B virus. Mutations in PA (T210C), NA (T1429C), NP"/>
   <result pre="M (G88C plus A280G) were identified. (C) Growth of DelNS1-B8038" exact="influenza" post="B virus in cell culture. MDCK or A549 cells"/>
   <result pre="mice were challenged with mouse-adapted B/Brisbane/60/2008 (Victoria) or B/Florida/4/2006 (Yamagata)" exact="influenza" post="B virus at 10 MLD50. Body weight and survival"/>
   <result pre="10.1128/mBio.02180-19.5FIG S5Viral titers in lungs of mice infected with mouse-adapted" exact="influenza" post="B viruses. Download FIG S5, PDF file, 0.1 MB."/>
   <result pre="ca-LAIV-immunized mice. CD4+ and CD8+ T cells specific for conserved" exact="influenza" post="virus (NP) epitopes were analyzed using intracellular cytokine staining"/>
   <result pre="of the two for mediating cross protective cell immunity against" exact="influenza" post="virus infection. However, when CA4-DelNS1 LAIV-immunized mice were depleted"/>
   <result pre="immunities and that cross protective immunity was mainly mediated by" exact="influenza" post="virus-specific T cells. FIG 6 DelNS1 LAIV induces cross"/>
   <result pre="6 DelNS1 LAIV induces cross protective T cell responses against" exact="influenza" post="viruses. (A) Induction of antigen-specific CD8+ and CD4+ T"/>
   <result pre="protective immunity against challenge with H7N9, H5N1, and HK68 (H3N2)" exact="influenza" post="A viruses (Fig. 3; see also Fig. S2 and"/>
   <result pre="S3), no protection was observed when mice were challenged with" exact="influenza" post="B virus (Fig. 7B). This indicates that the cross"/>
   <result pre="the cross protective immunity induced by CA4-DelNS1 (H1N1) LAIV is" exact="influenza" post="A specific and does not extend to other types"/>
   <result pre="A specific and does not extend to other types of" exact="influenza" post="virus or to other viruses. Since NS1 is deleted"/>
   <result pre="in its place. We tested this possibility by expressing the" exact="influenza" post="B HA1 domain in the NS1 site of the"/>
   <result pre="BHA1 from the CA4-DelNS1 (H1N1) backbone (Fig. 7A). Expression of" exact="influenza" post="B virus HA1 was confirmed by Western blot analysis,"/>
   <result pre="7 mice in the group immunized with vaccine expressing the" exact="influenza" post="B HA1 antigen survived, while all mice immunized with"/>
   <result pre="These data highlight a novel strategy to improve the current" exact="influenza" post="vaccine regime by using DelNS1 LAIV to express additional"/>
   <result pre="viral antigens and thereby broaden and enhance specific immunity to" exact="influenza" post="viruses. FIG 7 DelNS1 LAIV expression of B-HA1 antigen"/>
   <result pre="expression of B-HA1 antigen protected against lethal challenge with both" exact="influenza" post="A and B viruses in mice. (A) Illustration of"/>
   <result pre="CA4-DelNS1 and then challenged 3 weeks later with mouse-adapted H1N1" exact="influenza" post="A virus (A/California/04/2009, 10 MLD50) or influenza B virus"/>
   <result pre="with mouse-adapted H1N1 influenza A virus (A/California/04/2009, 10 MLD50) or" exact="influenza" post="B virus (B/Brisbane/60/2008, 10 MLD50) and monitored for 14 days."/>
   <result pre="CA4-DelNS1 virus or CA4-DelNS1-BHA1, which contains the HA1 gene of" exact="influenza" post="B virus (B/Brisbane/60/2008) at the site in the NS"/>
   <result pre="7 (D) mice. 10.1128/mBio.02180-19.7FIG S7Construction of CA4-DelNS1 (H1N1) LAIV expressing" exact="influenza" post="B virus HA1. Download FIG S7, PDF file, 0.2"/>
   <result pre="Creative Commons Attribution 4.0 International license. DISCUSSION Currently available inactivated" exact="influenza" post="vaccines are suboptimal, particularly in the groups that are"/>
   <result pre="development of more highly effective and cross protective and long-lasting" exact="influenza" post="vaccines must be pursued. Influenza viruses in which the"/>
   <result pre="more immunogenic, due to the absence of the immune response" exact="suppression" post="usually mediated by the NS1 protein. With this assumption,"/>
   <result pre="this assumption, we established a panel of DelNS1 live attenuated" exact="influenza" post="viruses (LAIVs) bearing adaptive mutations that support their replication"/>
   <result pre="virus assistance. Master donor backbone viruses were established for both" exact="influenza" post="A virus and influenza B virus and were verified"/>
   <result pre="backbone viruses were established for both influenza A virus and" exact="influenza" post="B virus and were verified in in vitro and"/>
   <result pre="the lower temperature of 33°C. Given the rapid evolution of" exact="influenza" post="viruses and the uncertainty regarding the emergence of novel"/>
   <result pre="and the uncertainty regarding the emergence of novel strains, future" exact="influenza" post="vaccines should ideally provide cross protection against antigenically drifted"/>
   <result pre="against antigenically drifted viral strains and novel subtypes of zoonotic" exact="influenza" post="viruses. Our data strongly support the use of a"/>
   <result pre="more-effective and broader immunity for protection against seasonal and pandemic" exact="influenza" post="virus strains. We have shown DelNS1 H1N1, H3N2, and"/>
   <result pre="the capacity to express extra viral antigens will make better" exact="influenza" post="vaccines, addressing some critical pitfalls of existing products. One"/>
   <result pre="the advantages of LAIV vaccines over inactivated split or subunit" exact="influenza" post="virus vaccines is the ability to induce both humoral"/>
   <result pre="is one of the key criteria for seasonal and pandemic" exact="influenza" post="vaccines. The superior ability of LAIVs to induce potent"/>
   <result pre="are seronegative or who have not experienced previous infection with" exact="influenza" post="viruses, being shed at a comparatively high titer for"/>
   <result pre="below 2 years old, who are commonly naive with respect to" exact="influenza" post="virus infection. On the other hand, preexisting immunity from"/>
   <result pre="use of premature termination codons to attenuate or completely block" exact="influenza" post="virus replication in normal cells (6, 14–16). Those studies"/>
   <result pre="if such strategies can be applied in other subtypes of" exact="influenza" post="A or influenza B viruses, given that strain-specific adaptive"/>
   <result pre="can be applied in other subtypes of influenza A or" exact="influenza" post="B viruses, given that strain-specific adaptive mechanisms are relatively"/>
   <result pre="viruses, given that strain-specific adaptive mechanisms are relatively common in" exact="influenza" post="viruses. There is also concern regarding the stability of"/>
   <result pre="strains being regained during infection with LAIV vaccines. Live attenuated" exact="influenza" post="vaccines with modified NS1 or lacking the entire NS1"/>
   <result pre="or of individuals who had not previously been infected with" exact="influenza" post="virus. The safety features inherent with the removal of"/>
   <result pre="the LAIV vaccine for use against both seasonal and pandemic" exact="influenza" post="virus strains. Influenza virus is unique in its ability"/>
   <result pre="to induce high-level protective humoral and T cell responses to" exact="influenza" post="viruses. Our data show that cross protective immunity elicited"/>
   <result pre="rapidly, with more H3N2 epidemics being recorded than H1N1 or" exact="influenza" post="B virus epidemics in the years since H3N2 emerged"/>
   <result pre="challenge with HK68-MA virus. One strategy to improve the current" exact="influenza" post="vaccine regime is to induce immunities to multiple viral"/>
   <result pre="strain; we have demonstrated that expressing the HA1 domain of" exact="influenza" post="B virus in the CA4-DelNS1 system protects immunized mice"/>
   <result pre="vectors to express extra antigens to enhance specific immunity against" exact="influenza" post="or to serve as vaccines for other respiratory viruses."/>
   <result pre="and H3N2 LAIVs together with LAIVs representing either of the" exact="influenza" post="B virus lineages to optimize cross protection against wild-type"/>
   <result pre="H1N1 virus A/California/04/2009, H5N1 virus A/Vietnam/1194/2004, H7N9 virus A/Zhejiang/DTID-ZJU01/2013, and" exact="influenza" post="B virus B/HK/8038/2011 were rescued by reverse genetics (49,"/>
   <result pre="viruses were as described previously (35–37, 51). Cold-adapted live attenuated" exact="influenza" post="vaccine (ca-LAIV-H1N1) was purified from the Influenza Mist LAIV"/>
   <result pre="from the Influenza Mist LAIV vaccine available in the 2012" exact="influenza" post="season. Construction of plasmids. NS1 deletion plasmid pHW2000-DelNS1 was"/>
   <result pre="inverse PCR were 5′-GACATACTTATGAGGATGTC-3′ (CA4-DelNS1-F) and 5′-CTGAAAGCTTGACATGGTGTTG-3′ (CA4-DelNS1-R). Primers for" exact="influenza" post="B DelNS1 inverse PCR were 5′-CTCAATTTGTGTTGTGGTCATGTTGTCCGCC-3′ (Influenza b-DelNS1-F) and"/>
   <result pre="pHW2000 plasmids containing the DelNS1 segment and the other 7" exact="influenza" post="virus genomic segments, together with an NS1 expression plasmid,"/>
   <result pre="or A/Hong Kong/1/1968 virus were used for virus rescue. For" exact="influenza" post="B DelNS1 virus DelNS1-B8038, rescued virus was passaged 10"/>
   <result pre="(34). For comparisons, passaged CA4-DelNS1, commercial coadapted Flumist live attenuated" exact="influenza" post="vaccine (2014–2015 season), plaque-purified cold-adapted H1N1 CA7 from Flumist,"/>
   <result pre="100 PFU; for H7N9, 10 MLD50, 2 × 105 PFU; for mouse-adapted" exact="influenza" post="B/Florida/4/2006 virus, 10 MLD50, 5 × 105 PFU; for mouse-adapted influenza"/>
   <result pre="mouse-adapted influenza B/Florida/4/2006 virus, 10 MLD50, 5 × 105 PFU; for mouse-adapted" exact="influenza" post="B/Brisbane/60/2008 virus, 10 MLD50, 5 × 106 PFU; for mouse-adapted H3N2"/>
   <result pre="Xia N, Yuen K-Y, Chen H. 2019. Generation of DelNS1" exact="influenza" post="viruses: a strategy for optimizing live attenuated influenza vaccines."/>
   <result pre="of DelNS1 influenza viruses: a strategy for optimizing live attenuated" exact="influenza" post="vaccines. mBio 10:e02180-19. https://doi.org/10.1128/mBio.02180-19. ACKNOWLEDGMENTS We thank Robert Webster"/>
   <result pre="Ortega-SanchezIR, MessonnierML, ThompsonWW, WortleyPM, WeintraubE, BridgesCB2007The annual impact of seasonal" exact="influenza" post="in the US: measuring disease burden and costs. Vaccine25:5086–5096."/>
   <result pre="Immunol53:102–110. doi:10.1016/j.coi.2018.04.015.29734023 3.NachbagauerR, PaleseP2018Development of next generation hemagglutinin-based broadly protective" exact="influenza" post="virus vaccines. Curr Opin Immunol53:51–57. doi:10.1016/j.coi.2018.04.001.29680576 4.PetschB, SchneeM, VogelAB,"/>
   <result pre="KrampsT2012Protective efficacy of in vitro synthesized, specific mRNA vaccines against" exact="influenza" post="A virus infection. Nat Biotechnol30:1210–1216. doi:10.1038/nbt.2436.23159882 5.LiebowitzD, LindbloomJD, BrandlJR,"/>
   <result pre="doi:10.1038/nbt.2436.23159882 5.LiebowitzD, LindbloomJD, BrandlJR, GargSJ, TuckerSN2015High titre neutralising antibodies to" exact="influenza" post="after oral tablet immunisation: a phase 1, randomised, placebo-controlled"/>
   <result pre="Infect Dis15:1041–1048. doi:10.1016/S1473-3099(15)00266-2.26333337 6.BazM, BoonnakK, PaskelM, SantosC, PowellT, TownsendA, SubbaraoK2015Nonreplicating" exact="influenza" post="A virus vaccines confer broad protection against lethal challenge."/>
   <result pre="MeertenS, YuW, KoudstaalW, GoudsmitJ, WardAB, MeijbergW, WilsonIA, RadoševićK2015A stable trimeric" exact="influenza" post="hemagglutinin stem as a broadly protective immunogen. Science349:1301–1306. doi:10.1126/science.aac7263.26303961"/>
   <result pre="tenOeverBR, TanGS, SubramaniamS, PaleseP, KrammerF2017Broadly protective murine monoclonal antibodies against" exact="influenza" post="B virus target highly conserved neuraminidase epitopes. Nat Microbiol2:1415–1424."/>
   <result pre="SaelensX2011Universal vaccine based on ectodomain of matrix protein 2 of" exact="influenza" post="A: Fc receptors and alveolar macrophages mediate protection. J"/>
   <result pre="macrophages mediate protection. J Immunol186:1022–1031. doi:10.4049/jimmunol.0902147.21169548 12.KolpeA, SchepensB, FiersW, SaelensX2017M2-based" exact="influenza" post="vaccines: recent advances and clinical potential. Expert Rev Vaccines16:123–136."/>
   <result pre="BaiH, WuTT, WangJ, ShuY, SunR2018Genome-wide identification of interferon-sensitive mutations enables" exact="influenza" post="vaccine design. Science359:290–296. doi:10.1126/science.aan8806.29348231 15.SiL, XuH, ZhouX, ZhangZ, TianZ,"/>
   <result pre="WuY, ZhangB, NiuZ, ZhangC, FuG, XiaoS, XiaQ, ZhangL, ZhouD2016Generation of" exact="influenza" post="A viruses as live but replication-incompetent virus vaccines. Science354:1170–1173."/>
   <result pre="BloomBR, LiQ, DengJC, ZhouP, QinFX, ChengG2017Generation of a live attenuated" exact="influenza" post="vaccine that elicits broad protection in mice and ferrets."/>
   <result pre="mice and ferrets. Cell Host Microbe21:334–343. doi:10.1016/j.chom.2017.02.007.28279345 17.KrugRM2015Functions of the" exact="influenza" post="A virus NS1 protein in antiviral defense. Curr Opin"/>
   <result pre="WangX, BaslerCF, TaubenbergerJK, BumgarnerRE, PaleseP, KatzeMG, Garcia-SastreA2002Cellular transcriptional profiling in" exact="influenza" post="A virus-infected lung epithelial cells: the role of the"/>
   <result pre="KraussS, WebbyRJ, WebsterRG2017Molecular basis of mammalian transmissibility of avian H1N1" exact="influenza" post="viruses and their pandemic potential. Proc Natl Acad Sci"/>
   <result pre="Proc Natl Acad Sci U S A114:11217–11222. doi:10.1073/pnas.1713974114.28874549 22.RichtJA, Garcia-SastreA2009Attenuated" exact="influenza" post="virus vaccines with modified NS1 proteins. Curr Top Microbiol"/>
   <result pre="Immunol333:177–195. doi:10.1007/978-3-540-92165-3_9.19768406 23.MuellerSN, LangleyWA, CarneroE, Garcia-SastreA, AhmedR2010Immunization with live attenuated" exact="influenza" post="viruses that express altered NS1 proteins results in potent"/>
   <result pre="JankeBH, WuWH, YoonKJ, WebbyRJ, SolorzanoA, Garcia-SastreA2006Vaccination of pigs against swine" exact="influenza" post="viruses by using an NS1-truncated modified live-virus vaccine. J"/>
   <result pre="HenningsonJN, LorussoA, VincentAL, LovingCL, RothJA, KehrliMEJr.2012Vaccination with NS1-truncated H3N2 swine" exact="influenza" post="virus primes T cells and confers cross-protection against an"/>
   <result pre="MaW, LagerKM, RichtJA, JankeBH, SandbulteMR, GaugerPC, LovingCL, WebbyRJ, Garcia-SastreA2012Live attenuated" exact="influenza" post="vaccine provides superior protection from heterologous infection in pigs"/>
   <result pre="infection in pigs with maternal antibodies without inducing vaccine-associated enhanced" exact="respiratory disease." post="J Virol86:10597–10605. doi:10.1128/JVI.01439-12.22811541 28.MosslerC, GroissF, WolztM, WolschekM, SeipeltJ, MusterT2013Phase"/>
   <result pre="WolztM, WolschekM, SeipeltJ, MusterT2013Phase I/II trial of a replication-deficient trivalent" exact="influenza" post="virus vaccine lacking NS1. Vaccine31:6194–6200. doi:10.1016/j.vaccine.2013.10.061.24183981 29.WacheckV, EgorovA, GroissF,"/>
   <result pre="RoethlE, MorokuttiA, WolschekM, FerkoB, SeipeltJ, Dick-GudenusR, MusterT2010A novel type of" exact="influenza" post="vaccine: safety and immunogenicity of replication-deficient influenza virus created"/>
   <result pre="novel type of influenza vaccine: safety and immunogenicity of replication-deficient" exact="influenza" post="virus created by deletion of the interferon antagonist NS1."/>
   <result pre="30.EgorovA, BrandtS, SereinigS, RomanovaJ, FerkoB, KatingerD, GrassauerA, AlexandrovaG, KatingerH, MusterT1998Transfectant" exact="influenza" post="A viruses with long deletions in the NS1 protein"/>
   <result pre="of the M segment of viral RNA supports replication of" exact="influenza" post="virus with an NS1 deletion by modulating alternative splicing"/>
   <result pre="ReiterM, NakowitschS, HumerJ, MorokuttiA, MusterT, EgorovA, KittelC2009Development of a live-attenuated" exact="influenza" post="B DeltaNS1 intranasal vaccine candidate. Vaccine27:2851–2857. doi:10.1016/j.vaccine.2009.02.087.19366569 33.van WielinkR,"/>
   <result pre="M-gene segment can substantially increase replication efficiency of NS1 deletion" exact="influenza" post="A virus in MDCK cells. J Virol86:12341–12350. doi:10.1128/JVI.01725-12.22951840 34.GouldPS,"/>
   <result pre="in MDCK cells. J Virol86:12341–12350. doi:10.1128/JVI.01725-12.22951840 34.GouldPS, EastonAJ, DimmockNJ2017Live attenuated" exact="influenza" post="vaccine contains substantial and unexpected amounts of defective viral"/>
   <result pre="LiuH, KitLC, BairdS, NesrallahM2001Pattern of mutation in the genome of" exact="influenza" post="A virus on adaptation to increased virulence in the"/>
   <result pre="NichollsJM, GuanY, WaldmannTA, PeirisJS, PereraLP, PoonLL2014IL-15 adjuvanted multivalent vaccinia-based universal" exact="influenza" post="vaccine requires CD4+ T cells for heterosubtypic protection. Proc"/>
   <result pre="multimechanistic antibody targeting the receptor binding site potently cross-protects against" exact="influenza" post="B viruses. Sci Transl Med doi:10.1126/scitranslmed.aam5752. 38.BelongiaEA, SimpsonMD, KingJP,"/>
   <result pre="Transl Med doi:10.1126/scitranslmed.aam5752. 38.BelongiaEA, SimpsonMD, KingJP, SundaramME, KelleyNS, OsterholmMT, McLeanHQ2016Variable" exact="influenza" post="vaccine effectiveness by subtype: a systematic review and meta-analysis"/>
   <result pre="challenges and solutions. Cell Host Microbe17:295–300. doi:10.1016/j.chom.2015.02.012.25766291 40.JinH, SubbaraoK2015Live attenuated" exact="influenza" post="vaccine. Curr Top Microbiol Immunol386:181–204. doi:10.1007/82_2014_410.25059893 41.MurphyBR, CoelinghK2002Principles underlying"/>
   <result pre="CoelinghK2002Principles underlying the development and use of live attenuated cold-adapted" exact="influenza" post="A and B virus vaccines. Viral Immunol15:295–323. doi:10.1089/08828240260066242.12081014 42.CoelinghKL,"/>
   <result pre="Viral Immunol15:295–323. doi:10.1089/08828240260066242.12081014 42.CoelinghKL, LukeCJ, JinH, TalaatKR2014Development of live attenuated" exact="influenza" post="vaccines against pandemic influenza strains. Expert Rev Vaccines13:855–871. doi:10.1586/14760584.2014.922417.24867587"/>
   <result pre="LukeCJ, JinH, TalaatKR2014Development of live attenuated influenza vaccines against pandemic" exact="influenza" post="strains. Expert Rev Vaccines13:855–871. doi:10.1586/14760584.2014.922417.24867587 43.HeatonNS, SachsD, ChenCJ, HaiR,"/>
   <result pre="Rev Vaccines13:855–871. doi:10.1586/14760584.2014.922417.24867587 43.HeatonNS, SachsD, ChenCJ, HaiR, PaleseP2013Genome-wide mutagenesis of" exact="influenza" post="virus reveals unique plasticity of the hemagglutinin and NS1"/>
   <result pre="U S A110:20248–20253. doi:10.1073/pnas.1320524110.24277853 44.CarrilloB, ChoiJM, BornholdtZA, SankaranB, RiceAP, PrasadBV2014The" exact="influenza" post="A virus protein NS1 displays structural polymorphism. J Virol88:4113–4122."/>
   <result pre="LiuH, ChenY, SongW, YuenKY, ChenH2017An NS-segment exonic splicing enhancer regulates" exact="influenza" post="A virus replication in mammalian cells. Nat Commun8:14751. doi:10.1038/ncomms14751.28323816"/>
   <result pre="NguyenTH, WertheimHFL, HurtAC, OsterhausA, BarrIG, FouchierRAM, HorbyPW, SmithDJ2014Antibody landscapes after" exact="influenza" post="virus infection or vaccination. Science346:996–1000. doi:10.1126/science.1256427.25414313 47.SmithDJ, LapedesAS, de"/>
   <result pre="BestebroerTM, RimmelzwaanGF, OsterhausAD, FouchierRA2004Mapping the antigenic and genetic evolution of" exact="influenza" post="virus. Science305:371–376. doi:10.1126/science.1097211.15218094 48.BedfordT, RileyS, BarrIG, BroorS, ChadhaM, CoxNJ,"/>
   <result pre="SuchardMA, TashiroM, WangD, XuX, LemeyP, RussellCA2015Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic drift. Nature523:217–220. doi:10.1038/nature14460.26053121 49.HoffmannE, NeumannG,"/>
   <result pre="NeumannG, KawaokaY, HobomG, WebsterRG2000A DNA transfection system for generation of" exact="influenza" post="A virus from eight plasmids. Proc Natl Acad Sci"/>
   <result pre="in viral protein PB2 enhances the effects of E627K on" exact="influenza" post="virus replication. Nat Commun5:5509. doi:10.1038/ncomms6509.25409547 51.ZhengB, ChanKH, ZhangAJ, ZhouJ,"/>
   <result pre="WooPC, ChanJF, ToKK, ChenH, YuenKY2010D225G mutation in hemagglutinin of pandemic" exact="influenza" post="H1N1 (2009) virus enhances virulence in mice. Exp Biol"/>
   <result pre="LambertK, TakimotoT, TophamDJ2011T cell-mediated protection against lethal 2009 pandemic H1N1" exact="influenza" post="virus infection in a mouse model. J Virol85:448–455. doi:10.1128/JVI.01812-10.20980523"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6751421\results\search\disease\results.xml">
   <result pre="America. In the eastern part of India epidemics of acute" exact="hepatitis" post="E are well reported. Hepatitis E commonly presents as"/>
   <result pre="are well reported. Hepatitis E commonly presents as self-limiting acute" exact="viral hepatitis" post="among young adults, except for some critical clinical complications"/>
   <result pre="well reported. Hepatitis E commonly presents as self-limiting acute viral" exact="hepatitis" post="among young adults, except for some critical clinical complications"/>
   <result pre="critical clinical complications during pregnancy. In epidemiological research, subclinical acute" exact="hepatitis" post="E infection is also reported from different parts of"/>
   <result pre="literature there are reports of rare extrahepatic manifestation of acute" exact="hepatitis" post="E. Here we present an elderly lady with acute"/>
   <result pre="hepatitis E. Here we present an elderly lady with acute" exact="hepatitis" post="E who primarily presented with acute myocarditis. Keywords Hepatitis"/>
   <result pre="elderly lady with acute hepatitis E who primarily presented with" exact="acute myocarditis." post="Keywords Hepatitis E Myocarditis Dilated cardiomyopathy Elderly woman fig-count:"/>
   <result pre="primarily presented with acute myocarditis. Keywords Hepatitis E Myocarditis Dilated" exact="cardiomyopathy" post="Elderly woman fig-count: table-count: ref-count: page-count: Introduction India is"/>
   <result pre="table-count: ref-count: page-count: Introduction India is an endemic zone of" exact="hepatitis" post="E virus (HEV), which is associated with both sporadic"/>
   <result pre="IgG antibody was found in 41.8% of patients with acute" exact="viral hepatitis" post="and in 23% of healthy individuals, indicating a high"/>
   <result pre="antibody was found in 41.8% of patients with acute viral" exact="hepatitis" post="and in 23% of healthy individuals, indicating a high"/>
   <result pre="Hepatitis E is a self-limiting disease and most people with" exact="hepatitis" post="E recover completely, except for antenatal HEV infection which"/>
   <result pre="third trimester (15–25% of cases) [2]. Apart from hepatic manifestation," exact="hepatitis" post="E causes florid extrahepatic manifestations including acute pancreatitis, Guillain-Barré"/>
   <result pre="from hepatic manifestation, hepatitis E causes florid extrahepatic manifestations including" exact="acute pancreatitis," post="Guillain-Barré syndrome, neuralgic amyotrophy, haemolytic anaemia, thrombocytopenia, glomerulonephritis, and"/>
   <result pre="and mixed cryoglobulinaemia. Viral infection is an important cause of" exact="acute myocarditis," post="and the spectrum of viruses known to cause myocarditis"/>
   <result pre="acute myocarditis, and the spectrum of viruses known to cause" exact="myocarditis" post="has changed in the past two decades. Myocarditis occurs"/>
   <result pre="response between host-pathogen interaction that affects mainly younger adults. Acute" exact="myocarditis" post="is uncommon in hepatitis E infection and has been"/>
   <result pre="that affects mainly younger adults. Acute myocarditis is uncommon in" exact="hepatitis" post="E infection and has been reported in young adults"/>
   <result pre="up to date, there is no reported case of HEV-induced" exact="myocarditis" post="especially in the elderly. To the best of our"/>
   <result pre="best of our knowledge, this is the first case of" exact="hepatitis" post="E-induced acute myocarditis, observed in an elderly woman from"/>
   <result pre="our knowledge, this is the first case of hepatitis E-induced" exact="acute myocarditis," post="observed in an elderly woman from West Bengal, India."/>
   <result pre="housewife presented to our hospital with exertional dyspnoea, gradually increasing" exact="shortness" post="of breath, chest pain, palpitation, and decreased urine output"/>
   <result pre="days. She denied any history of diabetes, hypertension, any pre-existing" exact="liver disease," post="abdominal discomfort, or passage of blood or mucus in"/>
   <result pre="or mucus in stool. She was known to have intermittent" exact="shortness" post="of breath especially in the winter season, but she"/>
   <result pre="physician. She had never required hospital admission for exacerbation of" exact="chronic obstructive pulmonary disease." post="This time there was no history of fever, cough"/>
   <result pre="lost her usual appetite. She did not have any skin" exact="rash" post="or arthralgia. Clinical observation at the emergency room revealed"/>
   <result pre="with a very high titre. Other viral screens such as" exact="hepatitis" post="A, hepatitis B, hepatitis C, HIV, and dengue all"/>
   <result pre="very high titre. Other viral screens such as hepatitis A," exact="hepatitis" post="B, hepatitis C, HIV, and dengue all came negative,"/>
   <result pre="titre. Other viral screens such as hepatitis A, hepatitis B," exact="hepatitis" post="C, HIV, and dengue all came negative, and IgM"/>
   <result pre="for Leptospira was also negative. Her peripheral blood smear for" exact="malaria" post="parasite and rapid malarial antigen tests were negative. Her"/>
   <result pre="and dyspnoeic. Repeat arterial blood gas analysis revealed type 1" exact="respiratory failure" post="with hypoxemia, and ECG showed sinus tachycardia, elevation of"/>
   <result pre="enlarged, and the ejection fraction was 25%, suggestive of dilated" exact="cardiomyopathy" post="(Fig. 1, 2, 3). NT pro-BNP was markedly high"/>
   <result pre="(239.1 mg/dL, 17.42% of total CK). This was suggestive of" exact="myocarditis" post="with acutely decompensated heart failure, and a low-dose cardioselective"/>
   <result pre="exposure such as alcohol, heavy metal poisoning, nutrient deficiency). Acute" exact="myocarditis" post="often presents with acute life-threatening decompensated heart failure and"/>
   <result pre="myocarditis, including parvoviruses, adenovirus, H1N1 flu infection, Epstein-Barr virus infection," exact="rubella" post="(German measles), varicella (chickenpox), mumps, measles, yellow fever, dengue,"/>
   <result pre="Epstein-Barr virus infection, rubella (German measles), varicella (chickenpox), mumps, measles," exact="yellow fever," post="dengue, polio, rabies, hepatitis A and C, HIV, and"/>
   <result pre="measles), varicella (chickenpox), mumps, measles, yellow fever, dengue, polio, rabies," exact="hepatitis" post="A and C, HIV, and Zika infection, and parvovirus"/>
   <result pre="infection, and parvovirus B19 [3, 4, 5, 6, 7]. Viral" exact="myocarditis" post="usually progresses on two stages although the exact pathophysiology"/>
   <result pre="10]. Myocarditis is one of the rarest extrahepatic complications of" exact="hepatitis" post="E infection. Up to date, hepatitis E-mediated intense myocarditis"/>
   <result pre="rarest extrahepatic complications of hepatitis E infection. Up to date," exact="hepatitis" post="E-mediated intense myocarditis has been accounted for in three"/>
   <result pre="of hepatitis E infection. Up to date, hepatitis E-mediated intense" exact="myocarditis" post="has been accounted for in three peer-reviewed journals, of"/>
   <result pre="were young adults aged &amp;lt;40 years. The pathophysiology of postinfective" exact="myocarditis" post="being immunogenic and depending on the host immune response,"/>
   <result pre="mostly young adults are affected. However, the non-infective aetiology of" exact="myocarditis" post="has no age bar. Postinfective myocarditis in the elderly"/>
   <result pre="the non-infective aetiology of myocarditis has no age bar. Postinfective" exact="myocarditis" post="in the elderly is rare. Viral myocarditis presents with"/>
   <result pre="age bar. Postinfective myocarditis in the elderly is rare. Viral" exact="myocarditis" post="presents with various symptoms, ranging from negligibly symptomatic cases"/>
   <result pre="to fatal arrhythmia and cardiogenic shock, and may create chronic" exact="myocarditis" post="and enlarged cardiomyopathy in a few patients [11, 12]."/>
   <result pre="and cardiogenic shock, and may create chronic myocarditis and enlarged" exact="cardiomyopathy" post="in a few patients [11, 12]. A combination of"/>
   <result pre="endomyocardial biopsy findings remain the standard of care for diagnosing" exact="myocarditis" post="[14]. Cardiac MRI might be helpful for diagnosing myocarditis"/>
   <result pre="diagnosing myocarditis [14]. Cardiac MRI might be helpful for diagnosing" exact="myocarditis" post="by documenting muscle oedema, hyperaemia, or fibrosis [15]. The"/>
   <result pre="muscle oedema, hyperaemia, or fibrosis [15]. The clinical diagnosis of" exact="myocarditis" post="was established based on the clinical setting and finding"/>
   <result pre="the inherent risk of the procedure at this age. HEV-induced" exact="acute myocarditis" post="was the only apparent cause for this acutely decompensated"/>
   <result pre="inherent risk of the procedure at this age. HEV-induced acute" exact="myocarditis" post="was the only apparent cause for this acutely decompensated"/>
   <result pre="dyspnoea, and she required no oxygen. Conclusion The concomitant acute" exact="viral hepatitis" post="E and acute myocarditis in this case and the"/>
   <result pre="and she required no oxygen. Conclusion The concomitant acute viral" exact="hepatitis" post="E and acute myocarditis in this case and the"/>
   <result pre="no oxygen. Conclusion The concomitant acute viral hepatitis E and" exact="acute myocarditis" post="in this case and the subsequent resolution of cardiac"/>
   <result pre="oxygen. Conclusion The concomitant acute viral hepatitis E and acute" exact="myocarditis" post="in this case and the subsequent resolution of cardiac"/>
   <result pre="subsequent resolution of cardiac symptoms with a resolution of acute" exact="hepatitis" post="indicated an aetiological link between hepatitis and myocarditis. We"/>
   <result pre="a resolution of acute hepatitis indicated an aetiological link between" exact="hepatitis" post="and myocarditis. We feel that it is pertinent to"/>
   <result pre="that it is pertinent to report that benign self-limiting acute" exact="hepatitis" post="E can sometimes be complicated by life-threatening acute myocarditis"/>
   <result pre="self-limiting acute hepatitis E can sometimes be complicated by life-threatening" exact="acute myocarditis" post="leading to decompensated heart failure. In spite of the"/>
   <result pre="acute hepatitis E can sometimes be complicated by life-threatening acute" exact="myocarditis" post="leading to decompensated heart failure. In spite of the"/>
   <result pre="spite of the fact that there were repeated outbreaks of" exact="viral hepatitis" post="E in West Bengal, there had to date been"/>
   <result pre="of the fact that there were repeated outbreaks of viral" exact="hepatitis" post="E in West Bengal, there had to date been"/>
   <result pre="there had to date been no reported case of HEV-induced" exact="acute myocarditis." post="To our knowledge, this is so far the first"/>
   <result pre="ever reported case from West Bengal, and we feel that" exact="hepatitis" post="E should also be kept in mind as a"/>
   <result pre="be kept in mind as a possible viral aetiology of" exact="acute myocarditis," post="irrespective of age. Statement of Ethics This article does"/>
   <result pre="conflict of interest exists. References References 1BazerbachiFHaffarSGargSKLakeJRExtra-hepatic manifestations associated with" exact="hepatitis" post="E virus infection: a comprehensive review of the literatureGastroenterology2015Reportspp."/>
   <result pre="Physician2015761(7)607826175368 3FairweatherDStaffordKASungYKUpdate on coxsackievirus B3 myocarditisCurr Opin Rheumatol2012724(4)401722488075 4SpartalisMTzatzakiESpartalisEDamaskosCMavrogeniSVoudrisVParvovirus B19" exact="myocarditis" post="of fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÂGasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant myocarditis associated with"/>
   <result pre="Rheumatol2012724(4)401722488075 4SpartalisMTzatzakiESpartalisEDamaskosCMavrogeniSVoudrisVParvovirus B19 myocarditis of fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÂGasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant" exact="myocarditis" post="associated with the H1N1 influenza virus: case report and"/>
   <result pre="fulminant evolutionCardiol Res201788(4)172528868104 5LoboMLTaguchiÂGasparHAFerrantiJFde CarvalhoWBDelgadoAFFulminant myocarditis associated with the H1N1" exact="influenza" post="virus: case report and literature reviewRev Bras Ter Intensiva2014Jul-Sep26(3)321625295829"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6754462\results\search\disease\results.xml">
   <result pre="help to implement efficient strategies to curb the burden of" exact="dengue fever." post="We conducted this systematic review and meta-analysis to determine"/>
   <result pre="terms Dengue virus Viral infection Epidemiology Introduction The incidence of" exact="dengue fever" post="has grown in the last decade worldwide. According to"/>
   <result pre="be presented as a flu-like illness including headache, myalgia, and" exact="rash" post="like other endemic fever diseases in Africa (example: malaria"/>
   <result pre="and rash like other endemic fever diseases in Africa (example:" exact="malaria" post="and chikungunya fever)2,4. Currently, there is no treatment for"/>
   <result pre="like other endemic fever diseases in Africa (example: malaria and" exact="chikungunya" post="fever)2,4. Currently, there is no treatment for dengue infection."/>
   <result pre="the most seriously affected regions7. In Africa, the first reported" exact="dengue fever" post="outbreaks occurred in Zanzibar in 1823 and 1870. Several"/>
   <result pre="Burkina-Faso, Egypt, South Africa and Senegal, reported unconfirmed outbreaks of" exact="dengue fever" post="in early 1900s. Although many outbreaks aren’t ever officially"/>
   <result pre="continent and build effective interventions to curb the burden of" exact="dengue fever" post="in the continent. Methods Design The Preferred Reporting Items"/>
   <result pre="methodology as in already published meta-analysis of prevalence studies for" exact="chikungunya" post="fever10. Criteria for considering studies for the review We"/>
   <result pre="to curb the burden DENV infection in Africa since severe" exact="dengue fever" post="can rapidly lead to serious illness and death, especially"/>
   <result pre="vaccine and antiretroviral treatment to rapidly curb the burden of" exact="dengue fever" post="in Africa. Another approach for curbing the burden of"/>
   <result pre="fever in Africa. Another approach for curbing the burden of" exact="dengue fever" post="is vector control. For curbing the burden of vector-borne"/>
   <result pre="DENV infection is high in the African continent although this" exact="infectious disease" post="is considered as neglected tropical disease. It is therefore"/>
   <result pre="considered as neglected tropical disease. It is therefore necessary that" exact="dengue fever" post="deserves more attention from healthcare workers, researchers, and health"/>
   <result pre="In the absence to date of effective antiviral treatment for" exact="dengue fever," post="strategies to curb its burden should therefore focus on"/>
   <result pre="future distributions of the sylvatic cycles of dengue virus and" exact="yellow fever" post="virusInfection, Genetics and Evolution20131929231110.1016/j.meegid.2013.03.00823523817 36.WeetmanDavidKamgangBasileBadoloAthanaseMoyesCatherineShearerFreyaCoulibalyMamadouPintoJoãoLambrechtsLouisMcCallPhilipAedes Mosquitoes and Aedes-Borne Arboviruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6757286\results\search\disease\results.xml">
   <result pre="to humans and animals, with the potential to cause severe" exact="pneumonia" post="and death. Annual vaccination strategies are a mainstay to"/>
   <result pre="related to influenza. However, protection from the emerging subtypes of" exact="influenza" post="A viruses (IAV) even in vaccinated individuals is challenging."/>
   <result pre="runny nose) in any age group [5]. Still others like" exact="influenza" post="A virus (IAV) can cause severe infections in patients"/>
   <result pre="for public health concern. Although generally milder than pandemics, seasonal" exact="influenza" post="epidemics can cause around 650,000 deaths globally each year"/>
   <result pre="year [7]. Despite mainstay vaccination strategies to minimize IAV infections," exact="influenza" post="pandemics have occurred once every 10-30 years, primarily due"/>
   <result pre="subtypes of IAV (H1N1 and H3N2) and two lineages of" exact="influenza" post="B viruses (Victoria and Yamagata) cause annual epidemics in"/>
   <result pre="IAVs dominate, inducing more severe morbidity and mortality compared to" exact="influenza" post="B viruses, therefore, will be the focus of this"/>
   <result pre="and cause severe, lethal disease. In fact, H5N1 highly pathogenic" exact="avian influenza" post="(HPAI) and the H7N9 low pathogenic avian influenza viruses"/>
   <result pre="cause severe, lethal disease. In fact, H5N1 highly pathogenic avian" exact="influenza" post="(HPAI) and the H7N9 low pathogenic avian influenza viruses"/>
   <result pre="highly pathogenic avian influenza (HPAI) and the H7N9 low pathogenic" exact="avian influenza" post="viruses pose a serious public health concern due to"/>
   <result pre="pathogenic avian influenza (HPAI) and the H7N9 low pathogenic avian" exact="influenza" post="viruses pose a serious public health concern due to"/>
   <result pre="rates of 52.79% and 39.42% [17]. The most severe H1N1" exact="influenza" post="pandemic occurred in 1918 claiming over 50 million lives"/>
   <result pre="during HPAI H5N1 virus infection [32–34] often leading to severe" exact="pneumonia" post="and death. Secondly, phagocytosis of infected cells by antigen-presenting"/>
   <result pre="first to respond to any noxious stimuli, their role during" exact="influenza" post="is complex and accumulation in the lungs is impacted"/>
   <result pre="the pulmonary endothelia and epithelia [56, 57] leading to severe" exact="pneumonia" post="suggesting that uncontrolled NET production may contribute to disease"/>
   <result pre="CD8+ T cell activation and recruitment into the lungs during" exact="influenza" post="emphasizing the reliance of adaptive immune cells on those"/>
   <result pre="by impaired clearance of surfactant proteins, cellular debris, dead cells," exact="pulmonary edema," post="and inflammation [102, 103]. Moreover, transgenic mice selectively depleted"/>
   <result pre="103]. Moreover, transgenic mice selectively depleted of AMs exhibit severe" exact="influenza" post="[104, 105] suggesting a critical role for AMs in"/>
   <result pre="CXCL10, is greater for highly pathogenic H5N1 virus than seasonal" exact="influenza" post="viruses [116, 117] suggesting that these inflammatory mediators may"/>
   <result pre="observations suggest that pulmonary dysfunction observed in fatal cases of" exact="influenza" post="depends on how macrophages respond to the invading virus."/>
   <result pre="mediators [131], a possible role in recruiting other leukocytes during" exact="influenza" post="needs to be more fully explored. Compared to other"/>
   <result pre="likely to suffer from IAV-induced morbidity and mortality [151–153]. Pediatric" exact="influenza" post="patients who developed acute pneumonia demonstrated a rise in"/>
   <result pre="morbidity and mortality [151–153]. Pediatric influenza patients who developed acute" exact="pneumonia" post="demonstrated a rise in the serum IL-5 levels and"/>
   <result pre="demonstrated a rise in the serum IL-5 levels and peripheral" exact="eosinophilia" post="[154], suggesting that eosinophil recruitment may be necessary for"/>
   <result pre="recruitment may be necessary for late-stage anti-influenza host defense. Pulmonary" exact="eosinophilia" post="has also been documented in IAV-infected mice [155–158] suggesting"/>
   <result pre="Based on known functions of eosinophils during parasite infections and" exact="allergy" post="[159], it may be likely that their influx into"/>
   <result pre="virus in situ (Figure 3). Additionally, mice suffering from acute" exact="allergy" post="are protected from IAV-induced airway damage [157] suggesting that"/>
   <result pre="CD8+ T cells [160] forecast multifaceted functions for eosinophils during" exact="influenza" post="pathogenesis [163]. 7. Natural Killer Cells: On-Site Killing As"/>
   <result pre="cell receptor, termed NKT cells, have gained more attention from" exact="influenza" post="virologists in recent years. These cells provide immunoprotection during"/>
   <result pre="potent producers of IL-5, ILC2s may regulate eosinophil infiltration during" exact="influenza" post="[155, 188]. Within the lungs, ILC2s increase expression of"/>
   <result pre="cytolysis of IAV-infected cells [179–182]. However, IFNγ can also enhance" exact="influenza" post="disease severity possibly through suppression of ILC2 function [189]."/>
   <result pre="However, IFNγ can also enhance influenza disease severity possibly through" exact="suppression" post="of ILC2 function [189]. 9. γδ T Cells: Holding"/>
   <result pre="AECs to produce IL-33 (Figure 4), protecting neonates from severe" exact="influenza" post="[199]. Since γδ T cell-mediated IL-33 production serves as"/>
   <result pre="York Academy of Sciences20141323111513910.1111/nyas.1246224891213 10TongS.ZhuX.LiY.et al.New world bats harbor diverse" exact="influenza" post="A virusesPLoS Pathogens2013910, article e100365710.1371/journal.ppat.1003657 11CainiS.KronemanM.WiegersT.el Guerche-SéblainC.PagetJ.Clinical characteristics and"/>
   <result pre="virusesPLoS Pathogens2013910, article e100365710.1371/journal.ppat.1003657 11CainiS.KronemanM.WiegersT.el Guerche-SéblainC.PagetJ.Clinical characteristics and severity of" exact="influenza" post="infections by virus type, subtype, and lineage: a systematic"/>
   <result pre="and mortality in Hong Kong, 1998-2013Scientific Reports201771p. 92910.1038/s41598-017-01021-x28428558 13DaleyA.NallusamyR.IsaacsD.Comparison of" exact="influenza" post="A and influenza B virus infection in hospitalized childrenJournal"/>
   <result pre="Hong Kong, 1998-2013Scientific Reports201771p. 92910.1038/s41598-017-01021-x28428558 13DaleyA.NallusamyR.IsaacsD.Comparison of influenza A and" exact="influenza" post="B virus infection in hospitalized childrenJournal of Paediatrics and"/>
   <result pre="of influenza: past and presentAnnual Review of Medicine200051140742110.1146/annurev.med.51.1.407 15KalthoffD.GlobigA.BeerM.(Highly pathogenic)" exact="avian influenza" post="as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian influenza"/>
   <result pre="influenza: past and presentAnnual Review of Medicine200051140742110.1146/annurev.med.51.1.407 15KalthoffD.GlobigA.BeerM.(Highly pathogenic) avian" exact="influenza" post="as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian influenza"/>
   <result pre="avian influenza as a zoonotic agentVeterinary Microbiology20101403-423724510.1016/j.vetmic.2009.08.02219782482 16WongS. S. Y.YuenK.Avian" exact="influenza" post="virus infections in humansChest2006129115616810.1378/chest.129.1.15616424427 17collab: World Health OrganizationInfluenza at"/>
   <result pre="pandemicsEmerging Infectious Diseases2006121152210.3201/eid1209.05-097916494711 19SimonsenL.SpreeuwenbergP.LustigR.et al.Global mortality estimates for the 2009" exact="influenza" post="pandemic from the GLaMOR project: a modeling studyPLoS Medicine20131011,"/>
   <result pre="e100155810.1371/journal.pmed.100155824302890 20KreijtzJ. H. C. M.FouchierR. A. M.RimmelzwaanG. F.Immune responses to" exact="influenza" post="virus infectionVirus Research20111621-2193010.1016/j.virusres.2011.09.02221963677 21LeMessurierK. S.LinY.McCullersJ. A.SamarasingheA. E.Antimicrobial peptides alter"/>
   <result pre="21LeMessurierK. S.LinY.McCullersJ. A.SamarasingheA. E.Antimicrobial peptides alter early immune response to" exact="influenza" post="A virus infection in C57BL/6 miceAntiviral Research201613320821710.1016/j.antiviral.2016.08.01327531368 22PanW.DongZ.LiF.et al.Visualizing"/>
   <result pre="influenza A virus infection in C57BL/6 miceAntiviral Research201613320821710.1016/j.antiviral.2016.08.01327531368 22PanW.DongZ.LiF.et al.Visualizing" exact="influenza" post="virus infection in living miceNature Communications201341, article 236910.1038/ncomms3369 23ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis"/>
   <result pre="miceNature Communications201341, article 236910.1038/ncomms3369 23ManicassamyB.ManicassamyS.Belicha-VillanuevaA.PisanelliG.PulendranB.Garcia-SastreA.Analysis of in vivo dynamics of" exact="influenza" post="virus infection in mice using a GFP reporter virusProceedings"/>
   <result pre="W.WenX.et al.Clinical and virological factors associated with viremia in pandemic" exact="influenza" post="A/H1N1/2009 virus infectionPLoS One201169, article e2253410.1371/journal.pone.0022534 25TaubenbergerJ. K.MorensD. M.The"/>
   <result pre="virus infectionPLoS One201169, article e2253410.1371/journal.pone.0022534 25TaubenbergerJ. K.MorensD. M.The pathology of" exact="influenza" post="virus infectionsAnnual Review of Pathology20083149952210.1146/annurev.pathmechdis.3.121806.15431618039138 26HaleB. G.RandallR. E.OrtinJ.JacksonD.The multifunctional"/>
   <result pre="Review of Pathology20083149952210.1146/annurev.pathmechdis.3.121806.15431618039138 26HaleB. G.RandallR. E.OrtinJ.JacksonD.The multifunctional NS1 protein of" exact="influenza" post="A virusesThe Journal of General Virology200889102359237610.1099/vir.0.2008/004606-018796704 27KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions"/>
   <result pre="virusesThe Journal of General Virology200889102359237610.1099/vir.0.2008/004606-018796704 27KochsG.Garcia-SastreA.Martinez-SobridoL.Multiple anti-interferon actions of the" exact="influenza" post="A virus NS1 proteinJournal of Virology200781137011702110.1128/JVI.02581-0617442719 28ChenX.LiuS.GorayaM. U.MaaroufM.HuangS.ChenJ. L.Host"/>
   <result pre="NS1 proteinJournal of Virology200781137011702110.1128/JVI.02581-0617442719 28ChenX.LiuS.GorayaM. U.MaaroufM.HuangS.ChenJ. L.Host immune response to" exact="influenza" post="A virus infectionFrontiers in Immunology20189p. 32010.3389/fimmu.2018.00320 29HallerO.KochsG.Human MxA protein:"/>
   <result pre="30MatsukuraS.KokubuF.KuboH.et al.Expression of RANTES by normal airway epithelial cells after" exact="influenza" post="virus A infectionAmerican Journal of Respiratory Cell and Molecular"/>
   <result pre="e2944310.1371/journal.pone.002944322238612 32de JongM. D.SimmonsC. P.ThanhT. T.et al.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
   <result pre="Medicine200612101203120710.1038/nm1477 33PeirisJ. S. M.YuW. C.LeungC. W.et al.Re-emergence of fatal human" exact="influenza" post="A subtype H5N1 diseaseThe Lancet2004363940961761910.1016/S0140-6736(04)15595-5 34ToK. F.ChanP. K. S.ChanK."/>
   <result pre="K. S.ChanK. F.et al.Pathology of fatal human infection associated with" exact="avian influenza" post="A H5N1 virusJournal of Medical Virology200163324224610.1002/1096-9071(200103)63:3&amp;lt;242::AID-JMV1007&amp;gt;3.0.CO;2-N11170064 35TateM. D.IoannidisL. J.CrokerB.BrownL."/>
   <result pre="S.ChanK. F.et al.Pathology of fatal human infection associated with avian" exact="influenza" post="A H5N1 virusJournal of Medical Virology200163324224610.1002/1096-9071(200103)63:3&amp;lt;242::AID-JMV1007&amp;gt;3.0.CO;2-N11170064 35TateM. D.IoannidisL. J.CrokerB.BrownL."/>
   <result pre="E.BrooksA. G.ReadingP. C.The role of neutrophils during mild and severe" exact="influenza" post="virus infections of micePLoS One201163, article e1761810.1371/journal.pone.001761821423798 36TateM. D.BrooksA."/>
   <result pre="of neutrophils in the upper and lower respiratory tract during" exact="influenza" post="virus infection of miceRespiratory Research200891p. 5710.1186/1465-9921-9-57 37BradleyL. M.DouglassM. F.ChatterjeeD.AkiraS.BaatenB."/>
   <result pre="9 mediates neutrophil migration into the airways in response to" exact="influenza" post="virus-induced toll-like receptor signalingPLoS Pathogens201284, article e100264110.1371/journal.ppat.1002641 38HaydenF. G.FritzR.LoboM."/>
   <result pre="G.FritzR.LoboM. C.AlvordW.StroberW.StrausS. E.Local and systemic cytokine responses during experimental human" exact="influenza" post="A virus infection. Relation to symptom formation and host"/>
   <result pre="R.CXCR2 is required for neutrophil recruitment to the lung during" exact="influenza" post="virus infection, but is not essential for viral clearanceViral"/>
   <result pre="in both protection against and recovery from pulmonary infection with" exact="influenza" post="virus in miceJournal of Virology20088262772278310.1128/JVI.01210-0718184718 41BarlowP. G.SvobodaP.MackellarA.et al.Antiviral activity"/>
   <result pre="Virology20088262772278310.1128/JVI.01210-0718184718 41BarlowP. G.SvobodaP.MackellarA.et al.Antiviral activity and increased host defense against" exact="influenza" post="infection elicited by the human cathelicidin LL-37PLoS One2011610, article"/>
   <result pre="ameliorate lung injury and the development of severe disease during" exact="influenza" post="infectionJournal of Immunology2009183117441745010.4049/jimmunol.090249719917678 44PerroneL. A.PlowdenJ. K.García-SastreA.KatzJ. M.TumpeyT. M.H5N1 and"/>
   <result pre="of Immunology2009183117441745010.4049/jimmunol.090249719917678 44PerroneL. A.PlowdenJ. K.García-SastreA.KatzJ. M.TumpeyT. M.H5N1 and 1918 pandemic" exact="influenza" post="virus infection results in early and excessive infiltration of"/>
   <result pre="e100011510.1371/journal.ppat.1000115 45MalachowaN.FreedmanB.SturdevantD. E.et al.Differential ability of pandemic and seasonal H1N1" exact="influenza" post="A viruses to alter the function of human neutrophilsmSphere20183110.1128/mSphereDirect.00567-1729299535"/>
   <result pre="neutrophilsmSphere20183110.1128/mSphereDirect.00567-1729299535 46IvanF. X.TanK. S.PhoonM. C.et al.Neutrophils infected with highly virulent" exact="influenza" post="H3N2 virus exhibit augmented early cell death and rapid"/>
   <result pre="influenzaClinical Infectious Diseases200847121575157810.1086/59319618990065 48ZhangZ.HuangT.YuF.et al.Infectious progeny of 2009 A (H1N1)" exact="influenza" post="virus replicated in and released from human neutrophilsScientific Reports201551,"/>
   <result pre="S.AbramsonJ. S.Synthesis of viral proteins in polymorphonuclear leukocytes infected with" exact="influenza" post="A virusJournal of Clinical Microbiology1988267126712703045149 50YippB. G.KubesP.NETosis: how vital"/>
   <result pre="neutrophil extracellular trap formation is not required for immunity against" exact="influenza" post="infectionPLoS One201167, article e2204310.1371/journal.pone.002204321779371 54TripathiS.VermaA.KimE. J.WhiteM. R.HartshornK. L.LL-37 modulates"/>
   <result pre="e2204310.1371/journal.pone.002204321779371 54TripathiS.VermaA.KimE. J.WhiteM. R.HartshornK. L.LL-37 modulates human neutrophil responses to" exact="influenza" post="A virusJournal of Leukocyte Biology201496593193810.1189/jlb.4A1113-604RR25082153 55HoeksemaM.TripathiS.WhiteM.et al.Arginine-rich histones have"/>
   <result pre="Leukocyte Biology201496593193810.1189/jlb.4A1113-604RR25082153 55HoeksemaM.TripathiS.WhiteM.et al.Arginine-rich histones have strong antiviral activity for" exact="influenza" post="A virusesInnate Immunity201521773674510.1177/175342591559379426138524 56ZhuL.LiuL.ZhangY.et al.High level of neutrophil extracellular"/>
   <result pre="of neutrophil extracellular traps correlates with poor prognosis of severe" exact="influenza" post="A infectionThe Journal of Infectious Diseases2018217342843710.1093/infdis/jix47529325098 57NarasarajuT.YangE.SamyR. P.et al.Excessive"/>
   <result pre="and neutrophil extracellular traps contribute to acute lung injury of" exact="influenza" post="pneumonitisThe American Journal of Pathology2011179119921010.1016/j.ajpath.2011.03.01321703402 58HuffordM. M.RichardsonG.ZhouH.et al.Influenza-infected neutrophils"/>
   <result pre="in the airwaysScience20153496252, article aaa435210.1126/science.aaa4352 60TumpeyT. M.Garcia-SastreA.TaubenbergerJ. K.et al.Pathogenicity of" exact="influenza" post="viruses with genes from the 1918 pandemic virus: functional"/>
   <result pre="in miceJournal of Virology20057923149331494410.1128/JVI.79.23.14933-14944.200516282492 61YatmazS.SeowH. J.GualanoR. C.et al.Glutathione peroxidase-1 reduces" exact="influenza" post="A virus-induced lung inflammationAmerican Journal of Respiratory Cell and"/>
   <result pre="Biology2013481172610.1165/rcmb.2011-0345OC23002098 62VlahosR.StambasJ.BozinovskiS.BroughtonB. R. S.DrummondG. R.SelemidisS.Inhibition of Nox2 oxidase activity ameliorates" exact="influenza" post="A virus-induced lung inflammationPLoS Pathogens201172, article e100127110.1371/journal.ppat.100127121304882 63ThomasG. D.HamersA."/>
   <result pre="69HeroldS.von WulffenW.SteinmuellerM.et al.Alveolar epithelial cells direct monocyte transepithelial migration upon" exact="influenza" post="virus infection: impact of chemokines and adhesion moleculesJournal of"/>
   <result pre="leukocyte attracting chemokine production after stimulation with active and inactivated" exact="influenza" post="A virusCellular Immunology199818611710.1006/cimm.1998.12959637759 71SprengerH.MeyerR. G.KaufmannA.BussfeldD.RischkowskyE.GemsaD.Selective induction of monocyte and"/>
   <result pre="71SprengerH.MeyerR. G.KaufmannA.BussfeldD.RischkowskyE.GemsaD.Selective induction of monocyte and not neutrophil-attracting chemokines after" exact="influenza" post="A virus infectionJournal of Experimental Medicine199618431191119610.1084/jem.184.3.11919064338 72ZenK.ParkosC. A.Leukocyte-epithelial interactionsCurrent"/>
   <result pre="tropismVirus201829454855210.1007/s13337-018-0499-430539061 80LamichhaneP. P.BoonnakK.ChangsomD.et al.H5N1 NS genomic segment distinctly governs the" exact="influenza" post="virus infectivity and cytokine induction in monocytic cellsAsian Pacific"/>
   <result pre="of Allergy and Immunology2018361586828802028 81LeeA. C. Y.ToK. K. W.ZhuH.et al.Avian" exact="influenza" post="virus A H7N9 infects multiple mononuclear cell types in"/>
   <result pre="activated U937 cells with recombinant vaccinia viruses inserted 2004 H5N1" exact="influenza" post="HA genes and NS genesAsian Pacific Journal of Allergy"/>
   <result pre="D.LeMessurierK. S.SchofieldA. K.WoolardS. N.SamarasingheA. E.Macrophage CD14 impacts immune defenses against" exact="influenza" post="virus in allergic hostsMicrobial Pathogenesis201912721221910.1016/j.micpath.2018.12.00830529429 85ClineT. D.BeckD.BianchiniE.Influenza virus replication"/>
   <result pre="of General Virology201798102401241210.1099/jgv.0.00092228884667 86NicolM. Q.DutiaB. M.The role of macrophages in" exact="influenza" post="A virus infectionFuture Virology20149984786210.2217/fvl.14.65 87LinS. J.LoM.KuoR. L.et al.The pathological"/>
   <result pre="amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic" exact="influenza" post="infectionJournal of Biomedical Science2014211p. 9910.1186/s12929-014-0099-6 88LinK. L.SuzukiY.NakanoH.RamsburgE.GunnM. D.CCR2+ monocyte-derived"/>
   <result pre="CCR5 and CCR2 deficiency in the pulmonary inflammatory response to" exact="influenza" post="A virusThe American Journal of Pathology200015661951195910.1016/S0002-9440(10)65068-710854218 90ZaynagetdinovR.SherrillT. P.KendallP. L.et"/>
   <result pre="for CD200 in lung immune homeostasis and the severity of" exact="influenza" post="infectionNature Immunology2008991074108310.1038/ni.163718660812 102KimH. M.LeeY. W.LeeK. J.et al.Alveolar macrophages are"/>
   <result pre="102KimH. M.LeeY. W.LeeK. J.et al.Alveolar macrophages are indispensable for controlling" exact="influenza" post="viruses in lungs of pigsJournal of Virology20088294265427410.1128/JVI.02602-0718287245 103TateM. D.PickettD."/>
   <result pre="C.Critical role of airway macrophages in modulating disease severity during" exact="influenza" post="virus infection of miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar"/>
   <result pre="of miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar macrophages prevent lethal" exact="influenza" post="pneumonia by inhibiting infection of type-1 alveolar epithelial cellsPLoS"/>
   <result pre="miceJournal of Virology201084157569758010.1128/JVI.00291-1020504924 104CardaniA.BoultonA.KimT. S.BracialeT. J.Alveolar macrophages prevent lethal influenza" exact="pneumonia" post="by inhibiting infection of type-1 alveolar epithelial cellsPLoS Pathogens2017131,"/>
   <result pre="105SchneiderC.NobsS. P.HeerA. K.et al.Alveolar macrophages are essential for protection from" exact="respiratory failure" post="and associated morbidity following influenza virus infectionPLoS Pathogens2014104, article"/>
   <result pre="essential for protection from respiratory failure and associated morbidity following" exact="influenza" post="virus infectionPLoS Pathogens2014104, article e100405310.1371/journal.ppat.100405324699679 106WangJ.NikradM. P.TravantyE. A.et al.Innate"/>
   <result pre="P.TravantyE. A.et al.Innate immune response of human alveolar macrophages during" exact="influenza" post="A infectionPLoS One201273, article e2987910.1371/journal.pone.002987922396727 107YuW. C. L.ChanR. W."/>
   <result pre="primary human alveolar epithelial cells and alveolar macrophages infected with" exact="influenza" post="H5N1 and H1N1 virusesJournal of Virology201185146844685510.1128/JVI.02200-1021543489 108EttensohnD. B.FramptonM. W.NicholsJ."/>
   <result pre="may not be susceptible to direct infection by a human" exact="influenza" post="virusThe Journal of Infectious Diseases2016214111658166510.1093/infdis/jiw41327601618 109LondriganS. L.ShortK. R.MaJ.et al.Infection"/>
   <result pre="Diseases2016214111658166510.1093/infdis/jiw41327601618 109LondriganS. L.ShortK. R.MaJ.et al.Infection of mouse macrophages by seasonal" exact="influenza" post="viruses can be restricted at the level of virus"/>
   <result pre="proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal" exact="influenza" post="virus challenge in miceInfluenza and Other Respiratory Viruses20104530731110.1111/j.1750-2659.2010.00155.x20716159 115HuangS.ZhuB.CheonI."/>
   <result pre="receptors in adult and neonatal macrophages infected with human or" exact="avian influenza" post="virusesThe Journal of Infectious Diseases20061941617010.1086/50469016741883 117CheungC. Y.PoonL. L. M.LauA."/>
   <result pre="in adult and neonatal macrophages infected with human or avian" exact="influenza" post="virusesThe Journal of Infectious Diseases20061941617010.1086/50469016741883 117CheungC. Y.PoonL. L. M.LauA."/>
   <result pre="M.LauA. S.et al.Induction of proinflammatory cytokines in human macrophages by" exact="influenza" post="A (H5N1) viruses: a mechanism for the unusual severity"/>
   <result pre="for the unusual severity of human disease?The Lancet200236093481831183710.1016/S0140-6736(02)11772-7 118FriesenhagenJ.BoergelingY.HrinciusE.LudwigS.RothJ.ViemannD.Highly pathogenic" exact="avian influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJournal"/>
   <result pre="the unusual severity of human disease?The Lancet200236093481831183710.1016/S0140-6736(02)11772-7 118FriesenhagenJ.BoergelingY.HrinciusE.LudwigS.RothJ.ViemannD.Highly pathogenic avian" exact="influenza" post="viruses inhibit effective immune responses of human blood-derived macrophagesJournal"/>
   <result pre="human blood-derived macrophagesJournal of Leukocyte Biology2012921112010.1189/jlb.091147922442495 119WaithmanJ.MinternJ. D.Dendritic cells and" exact="influenza" post="A virus infectionVirulence20123760360810.4161/viru.2186423076333 120HeathW. R.CarboneF. R.Dendritic cell subsets in"/>
   <result pre="miceImmunological Reviews20102341557510.1111/j.0105-2896.2009.00885.x20193012 127GeurtsvanKesselC. H.WillartM. A. M.van RijtL. S.et al.Clearance of" exact="influenza" post="virus from the lung depends on migratory langerin+CD11b− but"/>
   <result pre="cells and monocytes to respiratory mucosal sites in children with" exact="influenza" post="virus or respiratory syncytial virus infectionThe Journal of Infectious"/>
   <result pre="131HoA. W. S.PrabhuN.BettsR. J.et al.Lung CD103+ dendritic cells efficiently transport" exact="influenza" post="virus to the lymph node and load viral antigen"/>
   <result pre="of Immunology2011187116011602110.4049/jimmunol.110098722043017 132HelftJ.ManicassamyB.GuermonprezP.et al.Cross-presenting CD103+ dendritic cells are protected from" exact="influenza" post="virus infectionJournal of Clinical Investigation2012122114037404710.1172/JCI6065923041628 133del RioM.-L.Rodriguez-BarbosaJ. I.KremmerE.FörsterR.CD103− and"/>
   <result pre="determine the functional fate of migratory lung dendritic cells during" exact="influenza" post="virus infectionPLoS Pathogens2011711, article e100234510.1371/journal.ppat.100234522072965 135KimT. S.BracialeT. J.Respiratory dendritic"/>
   <result pre="al.Two distinct activation states of plasmacytoid dendritic cells induced by" exact="influenza" post="virus and CpG 1826 oligonucleotideJournal of Leukocyte Biology200883361062010.1189/jlb.080751118029397 138WolfA."/>
   <result pre="138WolfA. I.BuehlerD.HensleyS. E.et al.Plasmacytoid dendritic cells are dispensable during primary" exact="influenza" post="virus infectionJournal of Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human"/>
   <result pre="of Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human dendritic cells to" exact="avian influenza" post="H5N1 virus infection and protection by IFN-α and TLR"/>
   <result pre="Immunology2009182287187910.4049/jimmunol.182.2.87119124730 139ThitithanyanontA.EngeringA.EkchariyawatP.et al.High susceptibility of human dendritic cells to avian" exact="influenza" post="H5N1 virus infection and protection by IFN-α and TLR"/>
   <result pre="expression profiles but exhibit differential type I IFN responses to" exact="influenza" post="A virus infectionJournal of Immunology201920272069208110.4049/jimmunol.180119130760619 141LuiG.ManchesO.AngelJ.MolensJ. P.ChaperotL.PlumasJ.Plasmacytoid dendritic cells"/>
   <result pre="interleukin 6Immunity200319222523410.1016/S1074-7613(03)00208-512932356 143DoorleyL. A.LeMessurierK. S.IversonA. R.PalipaneM.SamarasingheA. E.Humoral immune responses during" exact="asthma" post="and influenza co-morbidity in miceImmunobiology2017222121064107310.1016/j.imbio.2017.08.00228889999 144SandbulteM. R.BoonA. C. M.WebbyR."/>
   <result pre="143DoorleyL. A.LeMessurierK. S.IversonA. R.PalipaneM.SamarasingheA. E.Humoral immune responses during asthma and" exact="influenza" post="co-morbidity in miceImmunobiology2017222121064107310.1016/j.imbio.2017.08.00228889999 144SandbulteM. R.BoonA. C. M.WebbyR. J.RiberdyJ. M.Analysis"/>
   <result pre="from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity" exact="influenza" post="virusesVirology20083811222810.1016/j.virol.2008.08.01818801551 145FonteneauJ.-F.GillietM.LarssonM.et al.Activation of influenza virus-specific CD4+ and CD8+"/>
   <result pre="infected with H5N1 or low-pathogenicity influenza virusesVirology20083811222810.1016/j.virol.2008.08.01818801551 145FonteneauJ.-F.GillietM.LarssonM.et al.Activation of" exact="influenza" post="virus-specific CD4+ and CD8+ T cells: a new role"/>
   <result pre="adaptive immunityBlood200310193520352610.1182/blood-2002-10-306312511409 146DavidsonS.CrottaS.McCabeT. M.WackA.Pathogenic potential of interferon αβ in acute" exact="influenza" post="infectionNature Communications20145110.1038/ncomms4864 147BoonnakK.VogelL.FeldmannF.FeldmannH.LeggeK. L.SubbaraoK.Lymphopenia associated with highly virulent H5N1"/>
   <result pre="Immunology2014192125906591210.4049/jimmunol.130299224829418 148LangloisR. A.LeggeK. L.Plasmacytoid dendritic cells enhance mortality during lethal" exact="influenza" post="infections by eliminating virus-specific CD8 T cellsJournal of Immunology201018484440444610.4049/jimmunol.090298420220091"/>
   <result pre="enhanced mononuclear phagocyte response in lungs of mice with lethal" exact="influenza" post="virus infectionComparative Immunology, Microbiology and Infectious Diseases201235430931710.1016/j.cimid.2012.01.01222421538 151BramleyA. M.DasguptaS.SkarbinskiJ.et"/>
   <result pre="Diseases201235430931710.1016/j.cimid.2012.01.01222421538 151BramleyA. M.DasguptaS.SkarbinskiJ.et al.Intensive care unit patients with 2009 pandemic" exact="influenza" post="A (H1N1pdm09) virus infection - United States, 2009Influenza and"/>
   <result pre="al.Factors associated with death or hospitalization due to pandemic 2009" exact="influenza" post="A (H1N1) infection in CaliforniaJAMA2009302171896190210.1001/jama.2009.158319887665 153VaillantL.la RucheG.TarantolaA.BarbozaP.epidemic intelligence teamEpidemiology"/>
   <result pre="RucheG.TarantolaA.BarbozaP.epidemic intelligence teamEpidemiology of fatal cases associated with pandemic H1N1" exact="influenza" post="2009Euro Surveillance2009143310.2807/ese.14.33.19309-en 154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral"/>
   <result pre="influenza 2009Euro Surveillance2009143310.2807/ese.14.33.19309-en 154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral" exact="eosinophilia" post="in acute pneumonia in Japanese children infected by pandemic"/>
   <result pre="154TeraiM.HondaT.YamamotoS.et al.Early induction of interleukin-5 and peripheral eosinophilia in acute" exact="pneumonia" post="in Japanese children infected by pandemic 2009 influenza A"/>
   <result pre="in acute pneumonia in Japanese children infected by pandemic 2009" exact="influenza" post="A in the Tokyo areaMicrobiology and Immunology201155534134610.1111/j.1348-0421.2011.00320.x21323726 155GorskiS. A.HahnY."/>
   <result pre="cell production of IL-5 is regulated by NKT cells during" exact="influenza" post="virus infectionPLoS Pathogens201399, article e100361510.1371/journal.ppat.100361524068930 156DiPiazzaA.NogalesA.PoultonN.WilsonP. C.Martínez-SobridoL.SantA. J.Pandemic 2009"/>
   <result pre="virus infectionPLoS Pathogens201399, article e100361510.1371/journal.ppat.100361524068930 156DiPiazzaA.NogalesA.PoultonN.WilsonP. C.Martínez-SobridoL.SantA. J.Pandemic 2009 H1N1" exact="influenza" post="Venus reporter virus reveals broad diversity of MHC class"/>
   <result pre="N.BoydK. L.HoseltonS. A.SchuhJ. M.McCullersJ. A.The immune profile associated with acute" exact="allergic asthma" post="accelerates clearance of influenza virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR."/>
   <result pre="L.HoseltonS. A.SchuhJ. M.McCullersJ. A.The immune profile associated with acute allergic" exact="asthma" post="accelerates clearance of influenza virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR."/>
   <result pre="immune profile associated with acute allergic asthma accelerates clearance of" exact="influenza" post="virusImmunology and Cell Biology201492544945910.1038/icb.2013.11324469764 158FurzeR. C.HussellT.SelkirkM. E.Amelioration of influenza-induced"/>
   <result pre="C. N.DuanS.et al.Eosinophils promote antiviral immunity in mice infected with" exact="influenza" post="A virusThe Journal of Immunology201719883214322610.4049/jimmunol.160078728283567 161SpencerL. A.SzelaC. T.PerezS. A."/>
   <result pre="distinct population of NK cells and mediates their migration during" exact="influenza" post="virus infection in micePLoS One2012712, article e5202710.1371/journal.pone.005202723272202 165KumarP.ThakarM. S.OuyangW.MalarkannanS.IL-22"/>
   <result pre="conventional NK cells is epithelial regenerative and inflammation protective during" exact="influenza" post="infectionMucosal Immunology201361698210.1038/mi.2012.4922739232 166GazitR.GrudaR.ElboimM.et al.Lethal influenza infection in the absence"/>
   <result pre="regenerative and inflammation protective during influenza infectionMucosal Immunology201361698210.1038/mi.2012.4922739232 166GazitR.GrudaR.ElboimM.et al.Lethal" exact="influenza" post="infection in the absence of the natural killer cell"/>
   <result pre="R.HeuselJ. W.LeggeK. L.Natural killer cell recruitment to the lung during" exact="influenza" post="A virus infection is dependent on CXCR3, CCR5, and"/>
   <result pre="killer cells in pigs experimentally infected with 2009 pandemic H1N1" exact="influenza" post="A virusPLoS One201496, article e10061910.1371/journal.pone.0100619 169GrégoireC.ChassonL.LuciC.et al.The trafficking of"/>
   <result pre="human NK cellsNature200140968231055106010.1038/3505911011234016 174DuN.ZhouJ.LinX.et al.Differential activation of NK cells by" exact="influenza" post="A pseudotype H5N1 and 1918 and 2009 pandemic H1N1"/>
   <result pre="inflammatory monocytes in the lungs and decrease immune-pathology during severe" exact="influenza" post="A virus infectionJournal of Leukocyte Biology201291335736810.1189/jlb.041118422003207 177De SantoC.SalioM.MasriS. H.et"/>
   <result pre="SantoC.SalioM.MasriS. H.et al.Invariant NKT cells reduce the immunosuppressive activity of" exact="influenza" post="A virus-induced myeloid-derived suppressor cells in mice and humansThe"/>
   <result pre="al.Interleukin-22 is produced by invariant natural killer T lymphocytes during" exact="influenza" post="A virus infection: potential role in protection against lung"/>
   <result pre="innate lymphoid cellsTrends in Immunology201233838939610.1016/j.it.2012.04.00522609147 186Le GofficR.ArshadM. I.RauchM.et al.Infection with" exact="influenza" post="virus induces IL-33 in murine lungsAmerican Journal of Respiratory"/>
   <result pre="C.et al.Innate lymphoid cells promote lung-tissue homeostasis after infection with" exact="influenza" post="virusNature Immunology201112111045105410.1038/ni.213121946417 189CalifanoD.FuruyaY.RobertsS.AvramD.McKenzieA. N. J.MetzgerD. W.IFN-γ increases susceptibility to"/>
   <result pre="influenza virusNature Immunology201112111045105410.1038/ni.213121946417 189CalifanoD.FuruyaY.RobertsS.AvramD.McKenzieA. N. J.MetzgerD. W.IFN-γ increases susceptibility to" exact="influenza" post="A infection through suppression of group II innate lymphoid"/>
   <result pre="N. J.MetzgerD. W.IFN-γ increases susceptibility to influenza A infection through" exact="suppression" post="of group II innate lymphoid cellsMucosal Immunology201811120921910.1038/mi.2017.4128513592 190ChienY. H.MeyerC.BonnevilleM.γδ"/>
   <result pre="and beyondAnnual Review of Immunology201432112115510.1146/annurev-immunol-032713-120216 191TuW.ZhengJ.LiuY.et al.The aminobisphosphonate pamidronate controls" exact="influenza" post="pathogenesis by expanding a γδ T cell population in"/>
   <result pre="192QinG.LiuY.ZhengJ.et al.Type 1 responses of human Vγ9Vδ2 T cells to" exact="influenza" post="A virusesJournal of Virology20118519101091011610.1128/JVI.05341-1121752902 193GlatzelA.WeschD.SchiemannF.BrandtE.JanssenO.KabelitzD.Patterns of chemokine receptor expression"/>
   <result pre="cellsThe Journal of Immunology2002168104920492910.4049/jimmunol.168.10.492011994442 194LiH.XiangZ.FengT.et al.Human Vγ9Vδ2-T cells efficiently kill" exact="influenza" post="virus-infected lung alveolar epithelial cellsCellular &amp;amp; Molecular Immunology201310215916410.1038/cmi.2012.7023353835 195QinG.MaoH.ZhengJ.et"/>
   <result pre="display potent cytotoxicity against monocyte-derived macrophages infected with human and" exact="avian influenza" post="virusesThe Journal of Infectious Diseases2009200685886510.1086/60541319656068 196JamesonJ. M.CruzJ.CostanzoA.TerajimaM.EnnisF. A.A role"/>
   <result pre="potent cytotoxicity against monocyte-derived macrophages infected with human and avian" exact="influenza" post="virusesThe Journal of Infectious Diseases2009200685886510.1086/60541319656068 196JamesonJ. M.CruzJ.CostanzoA.TerajimaM.EnnisF. A.A role"/>
   <result pre="mevalonate pathway in the induction of subtype cross-reactive immunity to" exact="influenza" post="A virus by human γδ T lymphocytesCellular Immunology20102641717710.1016/j.cellimm.2010.04.01320483407 197DongP.JuX.YanY.et"/>
   <result pre="T cells provide protective function in highly pathogenic avian H5N1" exact="influenza" post="A virus infectionFrontiers in Immunology20189p. 281210.3389/fimmu.2018.02812 198LuY.LiZ.MaC.et al.The interaction"/>
   <result pre="A virus infectionFrontiers in Immunology20189p. 281210.3389/fimmu.2018.02812 198LuY.LiZ.MaC.et al.The interaction of" exact="influenza" post="H5N1 viral hemagglutinin with sialic acid receptors leads to"/>
   <result pre="C.et al.Lung γδ T cells mediate protective responses during neonatal" exact="influenza" post="infection that are associated with type 2 immunityImmunity2018493531544.e610.1016/j.immuni.2018.07.01130170813 Figure"/>
   <result pre="Figure 1 Schematic representation of neutrophil-mediated host defense mechanisms during" exact="influenza" post="virus infection. Influenza A virus- (IAV)-infected airway epithelium releases"/>
   <result pre="macrophage-, and dendritic cell- (DC-) controlled immunoprotection and immunopathology during" exact="influenza" post="virus infection. Influenza A virus- (IAV-) infected airway epithelium"/>
   <result pre="IFNγ released by NK cell destroy IAV-infected cells while IL-22" exact="aids" post="in the regeneration of damaged epithelium. Figure 4 Innate"/>
   <result pre="and γδ T cells are important during early stages of" exact="influenza" post="virus infection. Schematic representation of immunoprotection and immunopathology mediated"/>
   <result pre="5 Yin and Yang of innate immune cell functions during" exact="influenza" post="virus infection. At steady state, innate immune cells corporate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6759257\results\search\disease\results.xml">
   <result pre="of the Togaviridae family. Other viruses in this genus include" exact="chikungunya" post="virus (CHIKV), Barmah Forest virus (BFV), Sindbis virus, and"/>
   <result pre="Forest virus (BFV), Sindbis virus, and Eastern and Western equine" exact="encephalitis" post="viruses. The prototype strain of RRV (T48) was isolated"/>
   <result pre="EPA occur after infection with BFV, CHIKV, Epstein-Barr virus (22)," exact="rubella" post="virus (23), and parvovirus B19 (24). BFV co-circulates with"/>
   <result pre="75%), stiff neck (38% and 71%), fever (33% and 47%)," exact="rash" post="(9.5% and 65%), headache (28% and 41%), and sore"/>
   <result pre="potential of the virus. The recent experience with Zika and" exact="chikungunya" post="viruses underscores the serious threat posed to global health"/>
   <result pre="Med Hyg. 1984;33:1228–31. 10.4269/ajtmh.1984.33.12286095694 9. ScrimgeourEM. Suspected Ross River virus" exact="encephalitis" post="in Papua New Guinea.Aust N Z J Med. 1999;29:559."/>
   <result pre="Med. 1999;29:559. 10.1111/j.1445-5994.1999.tb00759.x10868536 10. ScrimgeourEM, AaskovJG, MatzLR. Ross River virus" exact="arthritis" post="in Papua New Guinea.Trans R Soc Trop Med Hyg."/>
   <result pre="The ecology and epidemiology of Ross River and Murray Valley" exact="encephalitis" post="viruses in Western Australia: examples of One Health in"/>
   <result pre="PykeAT, McMahonJ, WarrilowD. Complete coding sequence of a case of" exact="chikungunya" post="virus imported into Australia.Genome Announc. 2017;5:e00310–7. 10.1128/genomeA.00310-1728495775 26. JansenCC,"/>
   <result pre="usual suspects: comparison of the relative roles of potential urban" exact="chikungunya" post="virus vectors in Australia.PLoS One. 2015;10:e0134975. 10.1371/journal.pone.013497526247366 27. HuestonL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6759472\results\search\disease\results.xml">
   <result pre="Strazza et al., 2011; McRae, 2016; Bertrand et al., 2019a)," exact="hepatitis" post="C virus (HCV) (Liu et al., 2009; Crema et"/>
   <result pre="WNV, together with several other major human pathogens, including Japanese" exact="encephalitis" post="virus, dengue virus, and Zika virus (ZIKV), are members"/>
   <result pre="Compared to other flavivirus, ZIKV is less neuroinvasive, rarely causing" exact="meningitis" post="and encephalitis (Carteaux et al., 2016). ZIKV can infect"/>
   <result pre="other flavivirus, ZIKV is less neuroinvasive, rarely causing meningitis and" exact="encephalitis" post="(Carteaux et al., 2016). ZIKV can infect a variety"/>
   <result pre="infect a variety of cells, including neural progenitor cells, causing" exact="microcephaly" post="and neurodevelopmental injuries (Tang et al., 2016). Human and"/>
   <result pre="2014; Cao-Lormeau et al., 2016; Watrin et al., 2016) and" exact="microcephaly" post="in infants (Brasil et al., 2016a, b; Schuler-Faccini et"/>
   <result pre="infect CNS cells, a condition that has been linked to" exact="microcephaly" post="in infants and Guillain-Barré syndrome in adults. Here we"/>
   <result pre="Asian strains of ZIKV, previously associated with Guillain-Barré syndrome and" exact="microcephaly" post="(Lessler et al., 2016). In Asia, on the other"/>
   <result pre="2017). Infections of BMECs with other neurotropic flaviviruses, such as" exact="tick-borne encephalitis" post="virus (Palus et al., 2017) and West Nile virus"/>
   <result pre="Infections of BMECs with other neurotropic flaviviruses, such as tick-borne" exact="encephalitis" post="virus (Palus et al., 2017) and West Nile virus"/>
   <result pre="integrity, as demonstrated for other neurotropic flaviviruses, such as Japanese" exact="encephalitis" post="virus (Kim et al., 2016) and dengue virus (Velandia-Romero"/>
   <result pre="influence the development of neuronal division and growth, leading to" exact="microcephaly" post="in offspring. While the gene expression changes observed in"/>
   <result pre="BertrandL.MerothF.TournebizeM.LedaA. R.SunE.ToborekM. (2019b). Targeting the HIV-infected brain to improve ischemic" exact="stroke" post="outcome.Nat. Commun.10:2009. 10.1038/s41467-019-10046-x31043599 BramleyJ. C.DrummondC. G.LennemannN. J.GoodC. A.KimK. S.CoyneC."/>
   <result pre="B.UyangaaE.et al. (2016). Ablation of CD11c(hi) dendritic cells exacerbates Japanese" exact="encephalitis" post="by regulating blood-brain barrier permeability and altering tight junction/adhesion"/>
   <result pre="R.CoyneC. B.WangT. (2009). Tight junction proteins claudin-1 and occludin control" exact="hepatitis" post="C virus entry and are downregulated during infection to"/>
   <result pre="al. (2016). Zika virus causes testis damage and leads to" exact="male infertility" post="in mice.Cell167:e10. 10.1016/j.cell.2016.11.01627884405 McRaeM. (2016). HIV and viral protein"/>
   <result pre="(2016). Zika virus causes testis damage and leads to male" exact="infertility" post="in mice.Cell167:e10. 10.1016/j.cell.2016.11.01627884405 McRaeM. (2016). HIV and viral protein"/>
   <result pre="report, french polynesia, december 2013.Euro. Surveill.19:20720. 24626205 PalusM.VancovaM.SirmarovaJ.ElsterovaJ.PernerJ.RuzekD. (2017). Tick-borne" exact="encephalitis" post="virus infects human brain microvascular endothelial cells without compromising"/>
   <result pre="P.PessoaA.et al. (2016). Possible association between zika virus infection and" exact="microcephaly" post="- Brazil, 2015.MMWR Morb. Mortal. Wkly. Rep.6559–62. 10.15585/mmwr.mm6503e226820244 SchulzkeJ."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6760898\results\search\disease\results.xml">
   <result pre="Analysis Methods : Molecular Biology Techniques: Genotyping Molecular characterization of" exact="measles" post="virus strains circulating in Cameroon during the 2013-2016 epidemics"/>
   <result pre="circulating in Cameroon during the 2013-2016 epidemics Molecular characterization of" exact="measles" post="virus strains circulating in Cameroon Obam MekandaFranck-MartinData curationFormal analysisInvestigationWriting"/>
   <result pre="and source are credited.pone.0222428.pdf Abstract The first genotyping data on" exact="measles" post="virus (MeV) strains in Cameroon dates from 1994, while"/>
   <result pre="genotypes circulating in Cameroon. Ninety throat swabs collected during recent" exact="measles" post="outbreaks were analyzed by MeV genotyping RT-PCR using the"/>
   <result pre="viral infection of the child and young adult caused by" exact="measles" post="virus (MeV): a 15.9 kb enveloped, non-segmented, negative-stranded RNA"/>
   <result pre="[2]. Clinically a person is declared a suspect case of" exact="measles" post="when he has a generalized maculopapular rash and fever,"/>
   <result pre="suspect case of measles when he has a generalized maculopapular" exact="rash" post="and fever, with cough and/or coryza, and/or conjunctivitis [3]."/>
   <result pre="generalized maculopapular rash and fever, with cough and/or coryza, and/or" exact="conjunctivitis" post="[3]. Once the disease progresses, the immunosuppression caused by"/>
   <result pre="conjunctivitis [3]. Once the disease progresses, the immunosuppression caused by" exact="measles" post="virus (MeV) exposes the patient to bacterial super infections"/>
   <result pre="virus (MeV) exposes the patient to bacterial super infections causing" exact="otitis media," post="pneumonia, or gastrointestinal infections. The main cause of measles-related"/>
   <result pre="malnutrition and vitamin A deficiency [4]. Before the introduction of" exact="measles" post="immunization in the 1960s, almost everyone contracted measles usually"/>
   <result pre="introduction of measles immunization in the 1960s, almost everyone contracted" exact="measles" post="usually during childhood with an estimated annual incidence of"/>
   <result pre="year. Since the introduction of the vaccine, the incidence of" exact="measles" post="as well as the associated early mortality rate decreased."/>
   <result pre="in Africa and Asia [5]. To date, some countries where" exact="measles" post="has been declared eliminated have confirmed new cases in"/>
   <result pre="The WHO European Region which was already close to eliminating" exact="measles" post="confirmed a total of 21,315 cases between 2016 and"/>
   <result pre="B3.2, and B3.3) [9]. As part of strategic plan for" exact="measles" post="control and elimination, the World Health Organization (WHO) has"/>
   <result pre="of strains is a key tool in the study of" exact="measles" post="transmission pathways, evaluation of endemic measles eradication and indirect"/>
   <result pre="in the study of measles transmission pathways, evaluation of endemic" exact="measles" post="eradication and indirect evaluation of the vaccination system in"/>
   <result pre="defined geographic area for ≥12 months of period of time," exact="measles" post="can be decleared eliminated in this area or region"/>
   <result pre="Ethics statement This study was carried out as part of" exact="measles" post="surveillance in Cameroon at Centre Pasteur of Cameroon (CPC),"/>
   <result pre="Pasteur of Cameroon (CPC), the National Reference Laboratory (NRL) for" exact="measles" post="since 2011. There was thus no need for an"/>
   <result pre="throat swabs collected during the 2013, 2014, 2015 and 2016" exact="measles" post="outbreaks were collected by the surveillance team of the"/>
   <result pre="nucleotides of the N gene according to WHO recommendations for" exact="measles" post="virus strains genotyping [17]. All consensus sequences obtained from"/>
   <result pre="shown next to the main tree branches. Discussion Cameroon integrated" exact="measles" post="surveillance in 1974 through sentinel sites in the city"/>
   <result pre="with extremes of 7 months and 20 years, suggesting that," exact="measles" post="remains a disease of children and young adults regardless"/>
   <result pre="the patient in whom the MeV strains were detected presented" exact="rash" post="at varying periods between 1 month and 12 years"/>
   <result pre="better follow-up of the recommendations for control and elimination of" exact="measles" post="as proposed by WHO. The study provided recent data"/>
   <result pre="proposed by WHO. The study provided recent data on circulating" exact="measles" post="viral strains throughout the country as the incidence of"/>
   <result pre="measles viral strains throughout the country as the incidence of" exact="measles" post="has increased worldwide. The limits of this work were"/>
   <result pre="1551–1585. https://jhu.pure.elsevier.com/en/publications/measles-virus 2AllaA, Waku-KouomouD, BenjouadA, ElaouadR, WildTF. Rapid diversification of" exact="measles" post="virus genotypes circulating in Morocco during 2004–2005 epidemics. J"/>
   <result pre="4MahamudA, BurtonA, HassanM, AhmedJA, WagachaJB, SpiegelP, et al.Risk factors for" exact="measles" post="mortality among hospitalized Somali refugees displaced by famine, Kenya,"/>
   <result pre="1148–1153. 6EomH, ParkY, KimJ, YangJ-S, KangH, KimK, et al.Occurrence of" exact="measles" post="in a country with elimination status: Amplifying measles infection"/>
   <result pre="al.Occurrence of measles in a country with elimination status: Amplifying" exact="measles" post="infection in hospitalized children due to imported virus. PLoS"/>
   <result pre="Media C, et al. Europe observes a 4-fold increase in" exact="measles" post="cases in 2017 compared to previous year. 2018; 2017–2019."/>
   <result pre="Ben YahiaA, AbudherA, SlimA, et al.Genetic characterization of clade B" exact="measles" post="viruses isolated in Tunisia and Libya 2002–2009 and a"/>
   <result pre="Update on the global distribution of genotypes of wild type" exact="measles" post="viruses. J Infect Dis. 2003;187Suppl: S270-610.1086/36804212721925 13PatelMK, Gacic-doboM, StrebelPM,"/>
   <result pre="16DemanouM, RatsitoharanaR, YongaM, DossehA, AnyaB, KobelaM, et al.Molecular characterization of" exact="measles" post="viruses that circulated in Cameroon between 2010 and 2011."/>
   <result pre="IkusikaO, AduF, OyefoluAO, et al.Molecular epidemiology of Nigerian and Ghanaian" exact="measles" post="virus isolates reveals a genotype circulating widely in western"/>
   <result pre="MubarakHSVan De BildtMWG, MustafaOAVosHW, MukhtarMMIbrahimSA, et al.Genetic characterization of wild-type" exact="measles" post="viruses circulating in suburban Khartoum, 1997–2000. J Gen Virol."/>
   <result pre="R, Acho A, Ebua J, et al. Molecular characterisation of" exact="measles" post="virus strains among refugees from Central African Republic in"/>
   <result pre="in Cameroon in 2014. 2018; 24GateffC. Evaluation of a mass" exact="measles" post="immunization campaign in yaoundé, cameroun. Trans R Soc Trop"/>
   <result pre="[Internet]. [cited 9 May 2019]. https://www.cdc.gov/vaccines/vpd/mmr/public/index.html 26Secondary failure rates of" exact="measles" post="vaccines: a metaanalysis … : The Pediatric Infectious Disease Journal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6763598\results\search\disease\results.xml">
   <result pre="were sequentially imported to Brazil and South America. Cases of" exact="yellow fever," post="caused by YFV, were first reported in Brazil in"/>
   <result pre="YFV, were first reported in Brazil in 1685. Thousands of" exact="yellow fever" post="cases were noticed until the beginning of the twentieth"/>
   <result pre="disease. Vector eradication together with vaccination contributed to elimination of" exact="yellow fever" post="from Brazilian urban areas (2). In 1981, the first"/>
   <result pre="with mild infections in Africa and Asia, was associated to" exact="microcephaly" post="and Guillain-Barré syndrome in the Americas (6). The first"/>
   <result pre="virus was very quickly spreaded and 141 suspected cases of" exact="microcephaly" post="were reported in Northeastern states, in addition to many"/>
   <result pre="many cases of spontaneous abortions and stillbirths (6–9). In 2016" exact="yellow fever" post="cases were reported again in Brazil, with a total"/>
   <result pre="are highly pathogenic. Examples are West Nile virus (WNV), Japanese" exact="encephalitis" post="virus (JEV), Saint Louis encephalitis virus (SLEV) and Rocio"/>
   <result pre="West Nile virus (WNV), Japanese encephalitis virus (JEV), Saint Louis" exact="encephalitis" post="virus (SLEV) and Rocio virus (ROCV) (11). Such pathogens"/>
   <result pre="(ZIKV), Yellow fever virus (YFV), West Nile virus (WNV), Japanese" exact="encephalitis" post="virus (JEV), Saint Louis encephalitis virus (SLEV), Rocio virus"/>
   <result pre="West Nile virus (WNV), Japanese encephalitis virus (JEV), Saint Louis" exact="encephalitis" post="virus (SLEV), Rocio virus (ROCV), Cacipocore virus (CPCV), Ilhéus"/>
   <result pre="virus, Zika virus, Yellow Fever virus, West Nile virus, Japanese" exact="encephalitis" post="virus, Saint Louis encephalitis virus, Rocio virus, Cacipocore virus,"/>
   <result pre="Fever virus, West Nile virus, Japanese encephalitis virus, Saint Louis" exact="encephalitis" post="virus, Rocio virus, Cacipocore virus, Ilheus virus, and Iguape"/>
   <result pre="field; any MHC restriction at the MHC restriction field and" exact="infectious disease" post="at the disease field. Conservancy Analysis of Selected Epitopes"/>
   <result pre="protective immune response against dengue virus elicited in a mouse" exact="encephalitis" post="model. Virology. (2016) 487:41–9. 10.1016/j.virol.2015.10.00626496698 31.RivinoLKumaranEAPJovanovicVNaduaKTeoEWPangSWet al.. Differential targeting"/>
   <result pre="187:4268–79. 10.4049/jimmunol.1101970 40.de MeloABNascimentoEJMBraga-NetoUDhaliaRSilvaAMOelkeMet al.. T-cell memory responses elicited by" exact="yellow fever" post="vaccine are targeted to overlapping epitopes containing multiple HLA-I"/>
   <result pre="196:5–12. 10.1016/j.virusres.2014.10.02225449574 43.TurtleLBaliTBuxtonGChibSChanSSoniMet al.. Human T cell responses to Japanese" exact="encephalitis" post="virus in health and disease. J Exp Med. (2016)"/>
   <result pre="Bull World Health Organ. (2011) 89:766–74. 10.2471/BLT.10.085233 48.KonishiEKitaiYTabeiYNishimuraKHaradaS. Natural Japanese" exact="encephalitis" post="virus infection among humans in west and east Japan"/>
   <result pre="program. Vaccine. (2010) 28:2664–70. 10.1016/j.vaccine.2010.01.00820080072 49.JentesESPoumerolGGershmanMDHillDRLemarchandJLewisRFet al.. The revised global" exact="yellow fever" post="risk map and recommendations for vaccination, 2010: consensus of"/>
   <result pre="Dis. (2011) 11:622–32. 10.1016/S1473-3099(11)70147-521798462 50.AmarillaAAFumagalliMJFigueiredoMLLima-JuniorDSSantos-JuniorNNAlfonsoHLet al.. Ilheus and Saint Louis" exact="encephalitis" post="viruses elicit cross-protection against a lethal Rocio virus challenge"/>
   <result pre="Med. (2014) 372:141103114505002. 10.1056/NEJMoa141103725365753 54.LiJGaoNFanDChenHShengZFuSet al.. Cross-protection induced by Japanese" exact="encephalitis" post="vaccines against different genotypes of Dengue viruses in mice."/>
   <result pre="mice immunized with recombinant E protein domain III of Japanese" exact="encephalitis" post="virus. Immunol Lett. (2011) 138:156–60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against"/>
   <result pre="Immunol Lett. (2011) 138:156–60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against circulating Japanese" exact="encephalitis" post="virus and West Nile Virus by live attenuated Japanese"/>
   <result pre="encephalitis virus and West Nile Virus by live attenuated Japanese" exact="encephalitis" post="vaccine SA 14-14-2. Int J Infect Dis. (2016) 45:43410.1016/j.ijid.2016.02.922"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6766991\results\search\disease\results.xml">
   <result pre="on 9 December 2018)10.1186/s13567-016-0405-227912792 23.CastrucciM.R.DonatelliI.Genetic reassortment between avian and human" exact="influenza" post="A viruses in Italian pigsVirology1993193503506Available online: https://www.ncbi.nlm.nih.gov/pubmed/8438586(accessed on 9"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6769590\results\search\disease\results.xml">
   <result pre="the formal identification of viral selenoproteins in the genome of" exact="molluscum contagiosum" post="and fowlpox viruses demonstrated the importance of selenoproteins in"/>
   <result pre="in viral cycle. reactive oxygen species glutathione peroxidases thioredoxin reductases" exact="influenza" post="virus hepatitis C virus coxsackie virus human immunodeficiency virus"/>
   <result pre="cycle. reactive oxygen species glutathione peroxidases thioredoxin reductases influenza virus" exact="hepatitis" post="C virus coxsackie virus human immunodeficiency virus molluscum contagiosum"/>
   <result pre="influenza virus hepatitis C virus coxsackie virus human immunodeficiency virus" exact="molluscum contagiosum" post="virus viral selenoproteins immunity 1. Introduction Selenium is an"/>
   <result pre="viruses associated with ROS production are human immunodeficiency virus (HIV)," exact="hepatitis" post="B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus"/>
   <result pre="production are human immunodeficiency virus (HIV), hepatitis B virus (HBV)," exact="hepatitis" post="C virus (HCV), Epstein-Barr virus (EBV), herpes simplex virus"/>
   <result pre="B virus (HBV), hepatitis C virus (HCV), Epstein-Barr virus (EBV)," exact="herpes simplex" post="virus type 1 (HSV-1), vesicular stomatitis virus (VSV), respiratory"/>
   <result pre="Epstein-Barr virus (EBV), herpes simplex virus type 1 (HSV-1), vesicular" exact="stomatitis" post="virus (VSV), respiratory syncytial virus (RSV), human T cell"/>
   <result pre="(RSV), human T cell leukaemia virus type 1 (HTLV-1) and" exact="influenza" post="viruses [34]. The mechanisms of ROS generation by the"/>
   <result pre="has been implicated in many pathological conditions including carcinogenesis [36]," exact="neurodegeneration" post="[37,38], atherosclerosis, diabetes [39], and aging [40]. The production"/>
   <result pre="the antioxidant enzyme manganese superoxide dismutase MnSOD [64]. In chronic" exact="hepatitis" post="C, direct interaction of core protein with mitochondria is"/>
   <result pre="stress. This phenomenon has been reported in animal models for" exact="influenza" post="and coxsackie viruses [95,98,99], but the molecular mechanism remains"/>
   <result pre="pancreas, and liver [100]. In the early 1930s an endemic" exact="cardiomyopathy" post="termed Keshan disease was first described in Heilongjiang province,"/>
   <result pre="in childbearing age [66]. It is characterized by cardiac enlargement," exact="congestive heart failure," post="pulmonary edema and death. Keshan disease spread in another"/>
   <result pre="[66]. It is characterized by cardiac enlargement, congestive heart failure," exact="pulmonary edema" post="and death. Keshan disease spread in another 12 provinces"/>
   <result pre="this family: A, B, C and Thogotovirus, but only three" exact="influenza" post="viruses are infectious for humans (A, B and C)"/>
   <result pre="genome consists of eight segmented single-stranded RNA segments (seven for" exact="influenza" post="C virus) encoding between 9 to 12 proteins, including"/>
   <result pre="M1 and M2 [113]. Various subtypes of the most common" exact="influenza" post="A viruses are classified based on the diversity in"/>
   <result pre="NA combinations. Influenza A and B viruses cause epidemics, whereas" exact="influenza" post="C virus tends to cause infections with less severe"/>
   <result pre="revaccinate people at risk every year. The patients infected with" exact="influenza" post="virus display a marked increase in DNA, lipid and"/>
   <result pre="urine [41,114,115,116]. Models of mice and cell lines infected with" exact="influenza" post="viruses also show an enhanced production of ROS together"/>
   <result pre="to study the changes in redox homeostasis induced by the" exact="influenza" post="virus. The work from Beck’s laboratory extended this novel"/>
   <result pre="virus in selenium deficient host has been also reported for" exact="influenza" post="virus similarly to what was found for coxsackie virus."/>
   <result pre="either deficient or adequate in selenium for 4 weeks. Then," exact="influenza" post="A/Bangkok/1/79 (H3N2), a strain that induces mild pneumonitis in"/>
   <result pre="for coxsackie and influenza. 4.4. Hepatitis C Virus (HCV) The" exact="hepatitis" post="C virus (HCV) is an enveloped, linear, positive-sense single-stranded"/>
   <result pre="in immune cells. In 80% of the patients with acute" exact="hepatitis" post="C, the disease evolves to chronic hepatitis, with 2%"/>
   <result pre="the disease evolves to chronic hepatitis, with 2% developing liver" exact="cirrhosis" post="and 1–5% developing liver cancer [143,144]. Many characteristics of"/>
   <result pre="chronic hepatitis, with 2% developing liver cirrhosis and 1–5% developing" exact="liver cancer" post="[143,144]. Many characteristics of oxidative stress have been reported"/>
   <result pre="hepatitis, with 2% developing liver cirrhosis and 1–5% developing liver" exact="cancer" post="[143,144]. Many characteristics of oxidative stress have been reported"/>
   <result pre="Many characteristics of oxidative stress have been reported during chronic" exact="hepatitis" post="C, including a decrease in GSH, increase in MDA,"/>
   <result pre="mechanisms, SELENOM, has been reported to be upregulated in human" exact="hepatocellular carcinoma" post="(HCC) cell lines and liver biopsies of patients with"/>
   <result pre="(HCC) cell lines and liver biopsies of patients with HCV-related" exact="cirrhosis" post="[155]. Whether this is true for other endoplasmic reticulum"/>
   <result pre="HBV includes several viruses that infect liver cells and cause" exact="hepatitis" post="in humans and animals. In the viral genome, the"/>
   <result pre="develop a chronic infection which can further lead to a" exact="cirrhosis" post="(in 20% of the cases) [156,157]. Several studies showed"/>
   <result pre="linked to hepatocellular damage. In intervention studies, selenium supplementation decreased" exact="cancer" post="incidence in HBV infected patients [162], but when the"/>
   <result pre="affects the skin and is caused by the dermatotropic poxvirus" exact="molluscum contagiosum" post="virus (MCV) [237,238]. Unlike smallpox and human monkeypox diseases,"/>
   <result pre="by the dermatotropic poxvirus molluscum contagiosum virus (MCV) [237,238]. Unlike" exact="smallpox" post="and human monkeypox diseases, MCV is nonlethal, mostly common"/>
   <result pre="poxvirus molluscum contagiosum virus (MCV) [237,238]. Unlike smallpox and human" exact="monkeypox" post="diseases, MCV is nonlethal, mostly common in children and"/>
   <result pre="from eukaryotic genomes in the viral genomes of fowlpox and" exact="molluscum contagiosum" post="viruses lead to the careful investigation for further examples"/>
   <result pre="the genomes of HIV-1, HIV-2, HCV, coxsackie virus B3 and" exact="measles" post="viruses [183]. Despite these in silico data that GPX-related"/>
   <result pre="the -1 reading frame of the NS4 region of Japanese" exact="encephalitis" post="virus (JEV). JEV belongs to the Flaviviridae family, which"/>
   <result pre="(JEV). JEV belongs to the Flaviviridae family, which also includes" exact="dengue fever" post="virus (DENV), yellow fever virus (YFV) and West Nile"/>
   <result pre="the Flaviviridae family, which also includes dengue fever virus (DENV)," exact="yellow fever" post="virus (YFV) and West Nile virus (WNV). The gene"/>
   <result pre="(ROS) homeostasis and redox regulation in cellular signalingCell. Signal.20122498199010.1016/j.cellsig.2012.01.00822286106 36.TrachoothamD.AlexandreJ.HuangP.Targeting" exact="cancer" post="cells by ROS-mediated mechanisms: A radical therapeutic approach?Nat. Rev."/>
   <result pre="FrancescoP.FavalliC.RotilioG.GaraciE.Evidence for antiviral activity of glutathione: In vitro inhibition of" exact="herpes simplex" post="virus type 1 replicationAntivir. Res.19952723725310.1016/0166-3542(95)00008-A8540746 64.FloresS.C.MareckiJ.C.HarperK.P.BoseS.K.NelsonS.K.McCordJ.M.Tat protein of human"/>
   <result pre="translational recoding of UGA as selenocysteineNucleic Acids Res.2009375868588010.1093/nar/gkp63519651878 73.LinH.C.HoS.C.ChenY.Y.KhooK.H.HsuP.H.YenH.C.SELENOPROTEINS. CRL2" exact="aids" post="elimination of truncated selenoproteins produced by failed UGA/Sec decodingScience2015349919510.1126/science.aab051526138980"/>
   <result pre="in transgenic miceJ. Nutr.19981281070107610.1093/jn/128.7.10709649587 90.MullerM.F.FlorianS.PommerS.OsterhoffM.EsworthyR.S.ChuF.F.Brigelius-FloheR.KippA.P.Deletion of glutathione peroxidase-2 inhibits azoxymethane-induced" exact="colon cancer" post="developmentPLoS ONE20138e7205510.1371/journal.pone.007205523977205 91.RheeS.G.Overview on PeroxiredoxinMol. Cells2016391510.14348/molcells.2016.236826831451 92.LuJ.HolmgrenA.The thioredoxin antioxidant"/>
   <result pre="transgenic miceJ. Nutr.19981281070107610.1093/jn/128.7.10709649587 90.MullerM.F.FlorianS.PommerS.OsterhoffM.EsworthyR.S.ChuF.F.Brigelius-FloheR.KippA.P.Deletion of glutathione peroxidase-2 inhibits azoxymethane-induced colon" exact="cancer" post="developmentPLoS ONE20138e7205510.1371/journal.pone.007205523977205 91.RheeS.G.Overview on PeroxiredoxinMol. Cells2016391510.14348/molcells.2016.236826831451 92.LuJ.HolmgrenA.The thioredoxin antioxidant"/>
   <result pre="Biol. Med.2003341263127010.1016/S0891-5849(03)00101-112726914 95.BeckM.A.NelsonH.K.ShiQ.Van DaelP.SchiffrinE.J.BlumS.BarclayD.LevanderO.A.Selenium deficiency increases the pathology of an" exact="influenza" post="virus infectionFASEB J.2001151481148310.1096/fj.00-0721fje11387264 96.BeckM.A.MatthewsC.C.Micronutrients and host resistance to viral"/>
   <result pre="of enteroviral genomic sequences in myocardium from cases of endemic" exact="cardiomyopathy" post="(Keshan disease) in ChinaHeart20008369670110.1136/heart.83.6.69610814633 106.LiuY.ChibaM.InabaY.KondoM.Keshan disease—A review from the"/>
   <result pre="in the pathogenesis of viral cardiomyopathyCongest Heart Fail20071319319910.1111/j.1527-5299.2007.06410.x17673870 113.PleschkaS.Overview of" exact="influenza" post="virusesCurr. Top. Microbiol. Immunol.201337012010.1007/82_2012_27223124938 114.LimJ.Y.OhE.KimY.JungW.W.KimH.S.LeeJ.SulD.Enhanced oxidative damage to DNA,"/>
   <result pre="enzymes, cytokines, and heat shock proteins in patients infected with" exact="influenza" post="H1N1 virusActa Virol.20145825326010.4149/av_2014_03_25325283860 115.NgM.P.LeeJ.C.LokeW.M.YeoL.L.QuekA.M.LimE.C.HalliwellB.SeetR.C.Does influenza A infection increase oxidative"/>
   <result pre="proteins in patients infected with influenza H1N1 virusActa Virol.20145825326010.4149/av_2014_03_25325283860 115.NgM.P.LeeJ.C.LokeW.M.YeoL.L.QuekA.M.LimE.C.HalliwellB.SeetR.C.Does" exact="influenza" post="A infection increase oxidative damage?Antioxid. Redox Signal.2014211025103110.1089/ars.2014.590724673169 116.ErkekogluP.AsciA.CeyhanM.KizilgunM.SchweizerU.AtasC.KaraA.Kocer GirayB.Selenium"/>
   <result pre="J. Pediatr.20135527128224217073 117.BuffintonG.D.ChristenS.PeterhansE.StockerR.Oxidative stress in lungs of mice infected with" exact="influenza" post="A virusFree Radic. Res. Commun.1992169911010.3109/107157692090491631321077 118.HennetT.PeterhansE.StockerR.Alterations in antioxidant defences"/>
   <result pre="antioxidant defences in lung and liver of mice infected with" exact="influenza" post="A virusJ. Gen. Virol.199273 Pt 1394610.1099/0022-1317-73-1-391530963 119.AmatoreD.SgarbantiR.AquilanoK.BaldelliS.LimongiD.CivitelliL.NencioniL.GaraciE.CirioloM.R.PalamaraA.T.Influenza virus replication"/>
   <result pre="120.YeS.LowtherS.StambasJ.Inhibition of reactive oxygen species production ameliorates inflammation induced by" exact="influenza" post="A viruses via upregulation of SOCS1 and SOCS3J. Virol.2015892672268310.1128/JVI.03529-1425520513"/>
   <result pre="121.NelsonH.K.ShiQ.Van DaelP.SchiffrinE.J.BlumS.BarclayD.LevanderO.A.BeckM.A.Host nutritional selenium status as a driving force for" exact="influenza" post="virus mutationsFASEB J.2001151846184810.1096/fj.01-0115fje11481250 122.JaspersI.ZhangW.BrightonL.E.CarsonJ.L.StybloM.BeckM.A.Selenium deficiency alters epithelial cell morphology"/>
   <result pre="Biol. Med.2007421826183710.1016/j.freeradbiomed.2007.03.01717512462 123.SheridanP.A.ZhongN.CarlsonB.A.PerellaC.M.HatfieldD.L.BeckM.A.Decreased selenoprotein expression alters the immune response during" exact="influenza" post="virus infection in miceJ. Nutr.20071371466147110.1093/jn/137.6.146617513408 124.StýbloM.WaltonF.S.HarmonA.W.SheridanP.A.BeckM.A.Activation of superoxide dismutase"/>
   <result pre="Nutr.20071371466147110.1093/jn/137.6.146617513408 124.StýbloM.WaltonF.S.HarmonA.W.SheridanP.A.BeckM.A.Activation of superoxide dismutase in selenium-deficient mice infected with" exact="influenza" post="virusJ. Trace Elem. Med. Biol.200721526210.1016/j.jtemb.2006.11.00117317526 125.LiW.BeckM.A.Selenium deficiency induced an"/>
   <result pre="deficiency induced an altered immune response and increased survival following" exact="influenza" post="A/Puerto Rico/8/34 infectionExp. Biol. Med.2007232412419 126.FergusonM.R.RojoD.R.von LindernJ.J.O’BrienW.A.HIV-1 replication cycleClin."/>
   <result pre="139.KamwesigaJ.MutabaziV.KayumbaJ.TayariJ.C.UwimbabaziJ.C.BatanageG.UweraG.BaziruwihaM.NtizimiraC.MurebwayireA.et al.Effect of selenium supplementation on CD4+ T-cell recovery, viral" exact="suppression" post="and morbidity of HIV-infected patients in Rwanda: A randomized"/>
   <result pre="selenium compounds increaseProc. Natl. Acad. Sci. USA19999683583910.1073/pnas.96.3.8359927654 143.DavisG.L.Treatment of chronic" exact="hepatitis" post="CBMJ20013231141114210.1136/bmj.323.7322.114111711386 144.IvanovA.V.BartoschB.SmirnovaO.A.IsaguliantsM.G.KochetkovS.N.HCV and oxidative stress in the liverViruses2013543946910.3390/v502043923358390 145.BoyaP.de"/>
   <result pre="metabolism in peripheral blood mononuclear cells from patients with chronic" exact="hepatitis" post="CJ. Hepatol.19993180881410.1016/S0168-8278(99)80281-510580577 146.De MariaN.ColantoniA.FagiuoliS.LiuG.J.RogersB.K.FarinatiF.Van ThielD.H.FloydR.A.Association between reactive oxygen species"/>
   <result pre="ThielD.H.FloydR.A.Association between reactive oxygen species and disease activity in chronic" exact="hepatitis" post="CFree Radic. Biol. Med.19962129129510.1016/0891-5849(96)00044-58855439 147.BianchiG.MarchesiniG.BriziM.RossiB.ForlaniG.BoniP.MelchiondaN.ThomasethK.PaciniG.Nutritional effects of oral zinc"/>
   <result pre="DNA repair enzyme NEIL1J. Gastroenterol. Hepatol.20102562763410.1111/j.1440-1746.2009.06128.x20074151 150.BureauC.BernadJ.ChaoucheN.OrfilaC.BeraudM.GonindardC.AlricL.VinelJ.P.PipyB.Nonstructural 3 protein of" exact="hepatitis" post="C virus triggers an oxidative burst in human monocytes"/>
   <result pre="via activation of NADPH oxidaseJ. Biol. Chem.2001276230772308310.1074/jbc.M10069820011304537 151.Garcia-MediavillaM.V.Sanchez-CamposS.Gonzalez-PerezP.Gomez-GonzaloM.MajanoP.L.Lopez-CabreraM.ClementeG.Garcia-MonzonC.Gonzalez-GallegoJ.Differential contribution of" exact="hepatitis" post="C virus NS5A and core proteins to the induction"/>
   <result pre="micronutrient, oxidative stress, and viral load in patients with chronic" exact="hepatitis" post="CWorld J. Gastroenterol.2005114697470210.3748/wjg.v11.i30.469716094713 153.LookM.P.RockstrohJ.K.RaoG.S.KreuzerK.A.BartonS.LemochH.SudhopT.HochJ.StockingerK.SpenglerU.et al.Serum selenium, plasma glutathione (GSH)"/>
   <result pre="Rep.201662248710.1038/srep2248726927933 155.GuerrieroE.AccardoM.CaponeF.ColonnaG.CastelloG.CostantiniS.Assessment of the Selenoprotein M (SELM) over-expression on human" exact="hepatocellular carcinoma" post="tissues by immunohistochemistryEur. J. Histochem.201458243310.4081/ejh.2014.243325578973 156.TsaiK.N.KuoC.F.OuJ.J.Mechanisms of Hepatitis B"/>
   <result pre="have an implication on interferon treatment of children with chronic" exact="hepatitis" post="B infectionBiol. Trace Elem. Res.201013515316110.1007/s12011-009-8507-619727570 159.AbediankenariS.GhasemiM.NasehiM.M.AbediS.HosseiniV.Determination of trace elements"/>
   <result pre="Elem. Res.201013515316110.1007/s12011-009-8507-619727570 159.AbediankenariS.GhasemiM.NasehiM.M.AbediS.HosseiniV.Determination of trace elements in patients with chronic" exact="hepatitis" post="BActa Med. Iran.20114966766922071642 160.KhanM.S.DilawarS.AliI.RaufN.The possible role of selenium concentration"/>
   <result pre="BActa Med. Iran.20114966766922071642 160.KhanM.S.DilawarS.AliI.RaufN.The possible role of selenium concentration in" exact="hepatitis" post="B and C patientsSaudi J. Gastroenterol. Off. J. Saudi"/>
   <result pre="J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc.20121810611010.4103/1319-3767.9381122421715 161.ChengZ.ZhiX.SunG.GuoW.HuangY.SunW.TianX.ZhaoF.HuK.Sodium selenite suppresses" exact="hepatitis" post="B virus transcription and replication in human hepatoma cell"/>
   <result pre="hepatoma cell linesJ. Med. Virol.20168865366310.1002/jmv.2436626331371 162.YuS.Y.ZhuY.J.LiW.G.Protective role of selenium against" exact="hepatitis" post="B virus and primary liver cancer in QidongBiol. Trace"/>
   <result pre="162.YuS.Y.ZhuY.J.LiW.G.Protective role of selenium against hepatitis B virus and primary" exact="liver cancer" post="in QidongBiol. Trace Elem. Res.19975611712410.1007/BF027789879152515 163.FinsterbuschT.MankertzA.Porcine circoviruses—Small but powerfulVirus"/>
   <result pre="role of selenium against hepatitis B virus and primary liver" exact="cancer" post="in QidongBiol. Trace Elem. Res.19975611712410.1007/BF027789879152515 163.FinsterbuschT.MankertzA.Porcine circoviruses—Small but powerfulVirus"/>
   <result pre="activating the AKT/mTOR signaling pathwayVet. Res.2018491510.1186/s13567-018-0508-z29439710 169.SumbaP.O.KabiruE.W.NamuyengaE.FioreN.OtienoR.O.MoormannA.M.OragoA.S.RosenbaumP.F.RochfordR.Microgeographic variations in Burkitt’s" exact="lymphoma" post="incidence correlate with differences in malnutrition, malaria and Epstein-Barr"/>
   <result pre="variations in Burkitt’s lymphoma incidence correlate with differences in malnutrition," exact="malaria" post="and Epstein-Barr virusBr. J. Cancer20101031736174110.1038/sj.bjc.660594721102592 170.JianS.-W.MeiC.-E.LiangY.-N.LiD.ChenQ.-L.LuoH.-L.LiY.-Q.CaiT.-Y.Influence of selenium-rich rice"/>
   <result pre="experimental viral myocarditisBiol. Trace Elem. Res.200180233110.1385/BTER:80:1:2311393307 180.SepúlvedaR.T.ZhangJ.WatsonR.R.Selenium supplementation decreases coxsackievirus" exact="heart disease" post="during murine AIDSCardiovasc. Toxicol.20022536110.1385/CT:2:1:5312189280 181.MolinY.FriskP.IlbäckN.-G.Viral RNA kinetics is associated"/>
   <result pre="virus B3 infectionMicrobes Infect.20091149349910.1016/j.micinf.2009.02.00219233309 182.JunE.J.YeJ.S.HwangI.S.KimY.K.LeeH.Selenium deficiency contributes to the chronic" exact="myocarditis" post="in coxsackievirus-infected miceActa Virol.201155232910.4149/av_2011_01_2321434702 183.ZhangW.RamanathanC.S.NadimpalliR.G.BhatA.A.CoxA.G.TaylorE.W.Selenium-dependent glutathione peroxidase modules encoded"/>
   <result pre="Aires, ArgentinaPublic Health Nutr.20121553854510.1017/S136898001100136421740621 188.GroenbaekK.FriisH.HansenM.Ring-LarsenH.KrarupH.B.The effect of antioxidant supplementation on" exact="hepatitis" post="C viral load, transaminases and oxidative status: A randomized"/>
   <result pre="load, transaminases and oxidative status: A randomized trial among chronic" exact="hepatitis" post="C virus-infected patientsEur. J. Gastroenterol. Hepatol.20061898598910.1097/01.meg.0000231746.76136.4a16894312 189.ZhangW.CoxA.G.TaylorE.W.Hepatitis C virus"/>
   <result pre="191.ZhongH.TaylorE.W.Structure and dynamics of a predicted ferredoxin-like selenoprotein in Japanese" exact="encephalitis" post="virusJ. Mol. Graph. Model.20042322323110.1016/j.jmgm.2004.07.00215530818 192.FangL.-Q.GoeijenbierM.ZuoS.-Q.WangL.-P.LiangS.KleinS.L.LiX.-L.LiuK.LiangL.GongP.et al.The association between hantavirus"/>
   <result pre="of AH1N1 patients in Mexico CitySci. Rep.20133128410.1038/srep0128423422930 197.YuL.SunL.NanY.ZhuL.-Y.Protection from H1N1" exact="influenza" post="virus infections in mice by supplementation with selenium: A"/>
   <result pre="supplementation enhances antiviral immunity in chickens challenged with low pathogenic" exact="avian influenza" post="virus subtype H9N2Vet. Immunol. Immunopathol.2019207626810.1016/j.vetimm.2018.12.00230593352 199.DeryabinP.G.LvovD.K.BotikovA.G.IvanovV.KalinovskyT.NiedzwieckiA.RathM.Effects of a nutrient"/>
   <result pre="enhances antiviral immunity in chickens challenged with low pathogenic avian" exact="influenza" post="virus subtype H9N2Vet. Immunol. Immunopathol.2019207626810.1016/j.vetimm.2018.12.00230593352 199.DeryabinP.G.LvovD.K.BotikovA.G.IvanovV.KalinovskyT.NiedzwieckiA.RathM.Effects of a nutrient"/>
   <result pre="mixture on infectious properties of the highly pathogenic strain of" exact="avian influenza" post="virus A/H5N1BioFactors (Oxford)200833859710.1002/biof.5520330201 200.ReffettJ.K.SpearsJ.W.BrownT.T.Effect of dietary selenium and vitamin"/>
   <result pre="on infectious properties of the highly pathogenic strain of avian" exact="influenza" post="virus A/H5N1BioFactors (Oxford)200833859710.1002/biof.5520330201 200.ReffettJ.K.SpearsJ.W.BrownT.T.Effect of dietary selenium and vitamin"/>
   <result pre="viruses for which an oxidative stress has been reported are" exact="herpes simplex" post="virus type 1 (HSV-1), influenza viruses, vesicular stomatitis virus"/>
   <result pre="has been reported are herpes simplex virus type 1 (HSV-1)," exact="influenza" post="viruses, vesicular stomatitis virus (VSV), Epstein-Barr virus (EBV), human"/>
   <result pre="are herpes simplex virus type 1 (HSV-1), influenza viruses, vesicular" exact="stomatitis" post="virus (VSV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV),"/>
   <result pre="virus (HIV), human T cell leukaemia virus type 1 (HTLV-1)," exact="hepatitis" post="B virus (HBV), respiratory syncytial virus (RSV) and hepatitis"/>
   <result pre="(HTLV-1), hepatitis B virus (HBV), respiratory syncytial virus (RSV) and" exact="hepatitis" post="C virus (HCV) [34]. Figure 2 Enzymatic activities of"/>
   <result pre="as CVB3/0, and shown in blue) does not lead to" exact="myocarditis" post="in this animal model, although replicating in the mice"/>
   <result pre="the cardio-virulence of the virus, which can now induce severe" exact="myocarditis" post="even in selenium adequate mice. To investigate whether the"/>
   <result pre="[108]. These mice, infected with the benign strain CVB3/0, developed" exact="myocarditis" post="and nucleotide mutations of the viral genome isolated from"/>
   <result pre="selenium deficient mice. Figure 4 Evolution of the pathogenicity of" exact="influenza" post="virus as a function of dietary selenium intake in"/>
   <result pre="number of immune cells, the nucleotide mutations of the isolated" exact="influenza" post="viruses, the oxidation status of glutathione (reduced/oxidized), the GPX"/>
   <result pre="the observations made with coxsackie virus, the mutations of the" exact="influenza" post="viral genome increased the pathogenicity of the virus, which"/>
   <result pre="sequences of the selenoproteins present in the viral genomes of" exact="molluscum contagiosum" post="virus subtype 1 (MCV1) (A,B) and of fowlpox virus"/>
   <result pre="selenomethionineSelenite ↓ viral replication via thiol interaction [184] Live attenuated" exact="poliomyelitis" post="vaccine SS = Sodium selenite↑ GPX activity after infection"/>
   <result pre="effects but has no impacts on viral production [190] Japanese" exact="encephalitis" post="virus (JEV) [191] Bunyaviridae Hantaan virus (HTNV) or Seoul"/>
   <result pre="of TNFalpha and IFNgammaNo change in viral load [197] Avian" exact="influenza" post="(H9N2) SS sodium enriched yeast or sodium selenite↓ viral"/>
   <result pre="2011 #4334} SS = selenized table salt or selenized yeastLower" exact="cancer" post="induced by HBV incidence [162] CT = HepG2 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6770471\results\search\disease\results.xml">
   <result pre="mainly affects children. However, PV infections can lead to paralytic" exact="poliomyelitis" post="which can result in death. Following the WHO 1988"/>
   <result pre="Following the WHO 1988 polio eradication program, the number of" exact="poliomyelitis" post="has been reduced by 99% worldwide but a small"/>
   <result pre="[25] and is one of the main etiological agents of" exact="hand, foot and mouth disease" post="(HFMD) [26]. Some cases of EV-A71 infections have been"/>
   <result pre="one of the main etiological agents of hand, foot and" exact="mouth disease" post="(HFMD) [26]. Some cases of EV-A71 infections have been"/>
   <result pre="EV-A71 infections have been associated with neurological complications such as" exact="aseptic meningitis," post="brainstem encephalitis and acute flaccid paralysis [27]. In China,"/>
   <result pre="been associated with neurological complications such as aseptic meningitis, brainstem" exact="encephalitis" post="and acute flaccid paralysis [27]. In China, enteroviruses such"/>
   <result pre="headache, pain in various parts of the body, prostration, rash," exact="lymphadenopathy" post="and leukopenia that affects young children and adults [36]."/>
   <result pre="in various parts of the body, prostration, rash, lymphadenopathy and" exact="leukopenia" post="that affects young children and adults [36]. However, dengue"/>
   <result pre="and adults [36]. However, dengue infection can progress to severe" exact="dengue hemorrhagic fever" post="(DHF) and dengue shock syndrome (DSS). Severe dengue affects"/>
   <result pre="illness with high fever, severe joint pain, polyarthralgia, myalgia, maculopapular" exact="rash" post="and edema. While the fever and rash are self-limiting"/>
   <result pre="polyarthralgia, myalgia, maculopapular rash and edema. While the fever and" exact="rash" post="are self-limiting and are able to resolve within a"/>
   <result pre="the first time in 2012 in Saudi Arabia. The viral" exact="respiratory disease" post="was caused by a novel coronavirus. The causative coronaviruses"/>
   <result pre="are similar to the common flu but in some patients," exact="pneumonia" post="and gastrointestinal symptoms including diarrhea and organ failure were"/>
   <result pre="flu but in some patients, pneumonia and gastrointestinal symptoms including" exact="diarrhea" post="and organ failure were reported [100]. Since September 2012"/>
   <result pre="divided amongst 14 genera [109]. Diseases associated with Paramyxoviridae included" exact="measles" post="(MeV), mumps and Newcastle disease (NDV). Paramyxoviridae virions are"/>
   <result pre="14 genera [109]. Diseases associated with Paramyxoviridae included measles (MeV)," exact="mumps" post="and Newcastle disease (NDV). Paramyxoviridae virions are enveloped and"/>
   <result pre="in the lymphoid tissue, liver, lungs, conjunctiva and skin. The" exact="measles" post="virus (MeV) may persist in the brain, causing fatal"/>
   <result pre="neurodegenerative diseases. This virus can only infect humans and causes" exact="subacute sclerosing panencephalitis" post="and encephalitis [112,113,114]. Measles often lead to fatality in"/>
   <result pre="can only infect humans and causes subacute sclerosing panencephalitis and" exact="encephalitis" post="[112,113,114]. Measles often lead to fatality in young children"/>
   <result pre="respiratory tract infections like pneumonia, brain swelling or encephalitis, dehydration," exact="diarrhea" post="and ear infections [115]. The MeV is a negative"/>
   <result pre="muscle aches, weakness, fatigue and loss of appetite. Complications of" exact="mumps" post="are rare but they can be potentially serious involving"/>
   <result pre="hearing loss, heart problems and miscarriage. In the United States," exact="mumps" post="was one of common disease prior to vaccination became"/>
   <result pre="dramatic decrease was observed in the number of infections. However," exact="mumps" post="outbreaks still occur in the United States and there"/>
   <result pre="at high risk. There is currently no specific treatment for" exact="mumps" post="[122]. The strain Urabe AM9 is one of the"/>
   <result pre="mumps [122]. The strain Urabe AM9 is one of the" exact="mumps" post="virus strains that was widely used in vaccines but"/>
   <result pre="widely used in vaccines but this strain was associated with" exact="meningitis" post="and was withdrawn from the market. Sauder et al."/>
   <result pre="identify the attenuation markers [123]. Passaging of the Urabe AM9" exact="mumps" post="virus in Vero or chicken embryo fibroblast (CEF) cell"/>
   <result pre="avian pathogen that can be transmitted to humans and cause" exact="conjunctivitis" post="and an influenza like disease [124]. Clinical diseases affecting"/>
   <result pre="can be transmitted to humans and cause conjunctivitis and an" exact="influenza" post="like disease [124]. Clinical diseases affecting the neurological, gastrointestinal,"/>
   <result pre="bovine respiratory syncytial virus (BRSV) is a common source of" exact="pneumonia" post="in calves. Clinical infections stem from yearly outbreaks of"/>
   <result pre="that can damage the bronchioles, leading to severe onset of" exact="bronchiolitis" post="in caws [135]. Palivizumab (PZ) is the sole humanized"/>
   <result pre="Palivizumab (PZ) is the sole humanized monoclonal antibody against an" exact="infectious disease" post="that recognizes the fusion protein of respiratory syncytial virus"/>
   <result pre="can be filamentous, 80–120 nm in diameter (Figure 9A). The" exact="influenza" post="virus genome is 12–15 kb and contains 8 segments"/>
   <result pre="(Figure 9B). Influenza viruses are pathogenic and they can cause" exact="influenza" post="in vertebrates, including birds, humans and other mammals [139]."/>
   <result pre="and the poly(A) tail is added by the viral polymerase" exact="stuttering" post="on the poly U sequence. Alternative splicing of the"/>
   <result pre="protein (M1 or M) [140]. Influenza Virus (IV) The annual" exact="influenza" post="epidemics caused about 3 to 5 million cases of"/>
   <result pre="severe illness with 290,000 to 680,000 deaths worldwide [141]. Current" exact="influenza" post="vaccines have sub-optimal efficacy, as there was a lack"/>
   <result pre="antigenic proximity between the vaccine candidate and the circulating seasonal" exact="influenza" post="virus strains. During the 2016–2017 influenza epidemic, the influenza"/>
   <result pre="and the circulating seasonal influenza virus strains. During the 2016–2017" exact="influenza" post="epidemic, the influenza A (H3N2) viruses from the clade"/>
   <result pre="seasonal influenza virus strains. During the 2016–2017 influenza epidemic, the" exact="influenza" post="A (H3N2) viruses from the clade 3c.2a were dominant"/>
   <result pre="reassortment in order to understand the molecular evolution of the" exact="influenza" post="A (H3N2) isolated directly from clinical samples. Of the"/>
   <result pre="different clade 3c.3a. Many distinct substitutions spanning across the whole" exact="influenza" post="proteome, HA, NA and non-structural protein 1 were found"/>
   <result pre="The epidemiology and molecular characterization of low and highly pathogenic" exact="avian influenza" post="virus strains (LPAIV &amp;amp; HPAIV, respectively) isolated from Germany"/>
   <result pre="epidemiology and molecular characterization of low and highly pathogenic avian" exact="influenza" post="virus strains (LPAIV &amp;amp; HPAIV, respectively) isolated from Germany"/>
   <result pre="[144]. However, studies focusing on the diversity of quasispecies of" exact="avian influenza" post="in the human host are few. Watanabe et al."/>
   <result pre="However, studies focusing on the diversity of quasispecies of avian" exact="influenza" post="in the human host are few. Watanabe et al."/>
   <result pre="against mutants with lower thermostability [145]. The quasispecies population of" exact="influenza" post="A virus was also reported to be in a"/>
   <result pre="into 8 genotypes. More than one billion people have contracted" exact="hepatitis" post="B virus (HBV) and more than 200 million patients"/>
   <result pre="and more than 200 million patients are chronically infected with" exact="hepatitis" post="B (CHB) [153]. CHB infections result in the development"/>
   <result pre="B (CHB) [153]. CHB infections result in the development of" exact="hepatocellular carcinoma" post="and chronic liver failure [151] and every year CHB"/>
   <result pre="Implications for pathogenesisProc. Natl. Acad. Sci. USA1998953152315610.1073/pnas.95.6.31529501231 18.DonohueR.C.PfallerC.K.CattaneoR.Cyclical adaptation of" exact="measles" post="virus quasispecies to epithelial and lymphocytic cells: To V"/>
   <result pre="disease of the central nervous systemJ. Infect. Dis.197412930430910.1093/infdis/129.3.3044361245 26.IshimaruY.NakanoS.YamaokaK.TakamiS.Outbreaks of" exact="hand, foot and mouth disease" post="by enterovirus 71. High incidence of complication disorders of"/>
   <result pre="central nervous systemJ. Infect. Dis.197412930430910.1093/infdis/129.3.3044361245 26.IshimaruY.NakanoS.YamaokaK.TakamiS.Outbreaks of hand, foot and" exact="mouth disease" post="by enterovirus 71. High incidence of complication disorders of"/>
   <result pre="and neurologic disease—United States, 1977–1991J. Infect. Dis.199416990590810.1093/infdis/169.4.9058133108 28.XingW.LiaoQ.ViboudC.ZhangJ.SunJ.WuJ.T.ChangZ.LiuF.FangV.J.ZhengY.Hand, foot and" exact="mouth disease" post="in China, 2008–12: An epidemiological studyLancet Infect. Dis.20141430831810.1016/S1473-3099(13)70342-624485991 29.MandaryM.PohC.Changes"/>
   <result pre="58.ThiboutotM.M.KannanS.KawalekarO.U.ShedlockD.J.KhanA.S.SaranganG.SrikanthP.WeinerD.B.MuthumaniK.Chikungunya: A potentially emerging epidemic?PLoS Negl. Trop. Dis.20104e62310.1371/journal.pntd.000062320436958 59.LemantJ.BoissonV.WinerA.ThibaultL.AndréH.TixierF.LemercierM.AntokE.CrestaM.P.GrivardP.Serious acute" exact="chikungunya" post="virus infection requiring intensive care during the Reunion Island"/>
   <result pre="112.BiesbroeckL.SidburyR.Viral exanthems: an updateDermatol. Ther.20132643343810.1111/dth.1210724552405 113.LudlowM.McQuaidS.MilnerD.de SwartR.L.DuprexW.P.Pathological consequences of systemic" exact="measles" post="virus infectionJ. Pathol.201523525326510.1002/path.445725294240 114.WatanabeS.ShiroganeY.SatoY.HashiguchiT.YanagiY.New Insights into Measles Virus Brain"/>
   <result pre="into Measles Virus Brain InfectionsTrends Microbiol.20192716417510.1016/j.tim.2018.08.01030220445 115.HuimingY.ChaominW.MengM.Vitamin A for treating" exact="measles" post="in childrenCochrane Database Syst. Rev.20054CD001479 116.PfallerC.K.CattaneoR.SchnellM.J.Reverse genetics of Mononegavirales:"/>
   <result pre="genetics of Mononegavirales: How they work, new vaccines and new" exact="cancer" post="therapeuticsVirology2015479–48033134410.1016/j.virol.2015.01.029 117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and suppression of cytokine signal"/>
   <result pre="new vaccines and new cancer therapeuticsVirology2015479–48033134410.1016/j.virol.2015.01.029 117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and" exact="suppression" post="of cytokine signal transduction by measles virus V proteinJ."/>
   <result pre="117.PalosaariH.ParisienJ.-P.RodriguezJ.J.UlaneC.M.HorvathC.M.STAT protein interference and suppression of cytokine signal transduction by" exact="measles" post="virus V proteinJ. Virol.2003777635764410.1128/JVI.77.13.7635-7644.200312805463 118.DevauxP.HodgeG.McChesneyM.B.CattaneoR.Attenuation of V- or C-defective"/>
   <result pre="measles virus V proteinJ. Virol.2003777635764410.1128/JVI.77.13.7635-7644.200312805463 118.DevauxP.HodgeG.McChesneyM.B.CattaneoR.Attenuation of V- or C-defective" exact="measles" post="viruses: Infection control by the inflammatory and interferon responses"/>
   <result pre="and V proteinsJ. Virol.2008828296830610.1128/JVI.00108-0818562542 120.RamachandranA.ParisienJ.-P.HorvathC.M.STAT2 is a primary target for" exact="measles" post="virus V protein-mediated alpha/beta interferon signaling inhibitionJ. Virol.2008828330833810.1128/JVI.00831-0818579593 121.CattaneoR.SchmidA.EschleD.BaczkoK.ter"/>
   <result pre="Virol.2008828330833810.1128/JVI.00831-0818579593 121.CattaneoR.SchmidA.EschleD.BaczkoK.ter MeulenV.BilleterM.A.Biased hypermutation and other genetic changes in defective" exact="measles" post="viruses in human brain infectionsCell19885525526510.1016/0092-8674(88)90048-73167982 122.PaddockM.What to Know About"/>
   <result pre="MumpsUniversity of Illinois-Chicago, School of MedicineChicago, IL, USA2017 123.SauderC.J.VandenburghK.M.IskowR.C.MalikT.CarboneK.M.RubinS.A.Changes in" exact="mumps" post="virus neurovirulence phenotype associated with quasispecies heterogeneityVirology2006350485710.1016/j.virol.2006.01.03516494912 124.GanarK.DasM.SinhaS.KumarS.Newcastle disease"/>
   <result pre="airway cellsJ. Virol.201892e02004-1710.1128/JVI.02004-1729563293 146.BarbezangeC.JonesL.BlancH.IsakovO.CelnikerG.EnoufV.ShomronN.VignuzziM.van der WerfS.Seasonal genetic drift of human" exact="influenza" post="A virus quasispecies revealed by deep sequencingFront. Microbiol.20189259610.3389/fmicb.2018.0259630429836 147.ManchandaH.SeidelN.BlaessM.F.ClausR.A.LindeJ.SlevogtH.SauerbreiA.GuthkeR.SchmidtkeM.Differential"/>
   <result pre="modulate host responses. Figure 9 (A) The schematic illustration of" exact="influenza" post="A virion with the two major glycoproteins displayed on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6771106\results\search\disease\results.xml">
   <result pre="further understanding of intraocular viral persistence and the pathogenesis of" exact="uveitis" post="in EVD survivors. Keywords Ebola Filovirus microRNA Retina Retinal"/>
   <result pre="indicate involvement of the retinal pigment epithelium are associated with" exact="uveitis" post="[3]. Zaire ebolavirus may persist at immune-privileged sites, such"/>
   <result pre="number of interactions for each molecule Discussion Zaire ebolavirus causes" exact="uveitis" post="in EVD survivors [26, 27]. We have identified miRNAs"/>
   <result pre="One other interacting miRNA—miR-101—prevents cell death in the context of" exact="herpes simplex" post="virus type 1 infection [30], pointing to a common"/>
   <result pre="cell populations, through the action of viral proteins—VP24 and VP35—and" exact="suppression" post="of RIG-I signaling [32]. Our prior work has demonstrated"/>
   <result pre="infected with cytomegalovirus [33]. MicroRNA-29b is also activated in Japanese" exact="encephalitis" post="virus infection, particularly in persons with neurological sequelae, and"/>
   <result pre="in the ocular fluid of EBOV survivors, particularly those with" exact="uveitis" post="and present biomarkers for ocular involvement. Other investigators have"/>
   <result pre="[45]. Molecular mimicry of miR-155 is also seen in Kaposi" exact="sarcoma" post="herpesvirus infection of B-cells, enabling the virus to drive"/>
   <result pre="their involvement in the intraocular persistence of EBOV and EBOV-associated" exact="uveitis" post="in EVD survivors. Limitations We studied EBOV infection in"/>
   <result pre="tissues and fluids (EVICT) study: reverse transcription-polymerase chain reaction and" exact="cataract" post="surgery outcomes of Ebola survivors in Sierra LeoneEBioMedicine20183021722410.1016/j.ebiom.2018.03.02029622497 27.ForresterJVEbola"/>
   <result pre="Immunol200116741900190810.4049/jimmunol.167.4.190011489969 34.BaluniMGhildiyalSSinghDReddyDHKumarRDholeTNIncreased serum microRNA-29b expression and bad recovery in Japanese" exact="encephalitis" post="virus infected patients; a new component to improve the"/>
   <result pre="Eye Res20092828711610.1016/j.preteyeres.2008.11.00319071227 49.McArdleAJTurkovaACunningtonAJWhen do co-infections matter?Curr Opin Infect Dis201831320921510.1097/QCO.000000000000044729698255 50.GuptaASwaminathanGMartin-GarciaJNavas-MartinSMicroRNAs," exact="hepatitis" post="C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6771534\results\search\disease\results.xml">
   <result pre="Inc.Hoboken pmcid: 6771534 doi: 10.1002/rmv.2054RMV2054RMV-2019-004.R2 : Review: Reviews Characteristics of" exact="herpes simplex" post="virus infection and pathogenesis suggest a strategy for vaccine"/>
   <result pre="(HSV) can cause oral or genital ulcerative lesions and even" exact="encephalitis" post="in various age groups with high infection rates. More"/>
   <result pre="Medicine2016�?I2M�?1�?019 fig-count: table-count: page-count: word-count: XuX, ZhangY, LiQ. Characteristics of" exact="herpes simplex" post="virus infection and pathogenesis suggest a strategy for vaccine"/>
   <result pre="2 HCF�?1 host cell factor 1 HS heparin sulfate HSV" exact="herpes simplex" post="virus HVEM herpes virus entry mediator ICAM�?1 intercellular adhesion"/>
   <result pre="ocular herpes can lead to blindness, and neonatal herpes or" exact="encephalitis" post="can result in higher death rates.2, 3, 4 In"/>
   <result pre="infection are reported annually.8 It is not surprising that a" exact="viral disease" post="with such severe clinical outcomes and such a strong"/>
   <result pre="for HSV vaccine development. Table 1 Development and status of" exact="herpes simplex" post="virus (HSV) vaccine candidates Candidate Type Name Description Preclinical"/>
   <result pre="for the stimulation of adaptive immunity. Figure 1 Interactions of" exact="herpes simplex" post="virus (HSV) surface glycoproteins and tegument proteins with cellular"/>
   <result pre="could be generated with molecular techniques. Figure 3 Tactics for" exact="herpes simplex" post="virus (HSV) vaccine development. The design of HSV vaccine"/>
   <result pre="Med. 2016;375(7):666�?674.27532832 5McQuillanG, Kruszon�?MoranD, ElaineW, FlaggEW, Ryne Paulose�?RamR. Prevalence of" exact="herpes simplex" post="virus type 1 and type 2 in persons aged"/>
   <result pre="NCHS Data Brief. 2018;304:1�?8. 6BradleyH, MarkowitzLE, GibsonT, McQuillanGM. Seroprevalence of" exact="herpes simplex" post="virus types 1 and 2—United States, 1999�?2010. J Infect"/>
   <result pre="et al. Global and regional estimates of prevalent and incident" exact="herpes simplex" post="virus type 1 infections in 2012. PLoS ONE. 2015;10(10):e0140765.26510007"/>
   <result pre="WaldA. Status of vaccine research and development of vaccines for" exact="herpes simplex" post="virus. Vaccine. 2016;34(26):2948�?2952.26973067 10AwasthiS, FriedmanHM. Status of prophylactic and"/>
   <result pre="BernsteinDI, et al. Efficacy results of a trial of a" exact="herpes simplex" post="vaccine. N Engl J Med. 2012;366(1):34�?43.22216840 13SicurellaM, NicoliF, GalleraniE,"/>
   <result pre="J Med. 2012;366(1):34�?43.22216840 13SicurellaM, NicoliF, GalleraniE, et al. An attenuated" exact="herpes simplex" post="virus type 1 (HSV1) encoding the HIV�?1 Tat protein"/>
   <result pre="JackmanWT, et al. Evaluation of AD472, a live attenuated recombinant" exact="herpes simplex" post="virus type 2 vaccine in guinea pigs. Vaccine. 2005;23(46�?47):5424�?5431.15950327"/>
   <result pre="19SrivastavaR, KhanAA, SpencerD, et al. HLA�?A02:01�?restricted epitopes identified from the" exact="herpes simplex" post="virus tegument protein VP11/12 preferentially recall polyfunctional effector memory"/>
   <result pre="PLoS ONE. 2015;10(4):e0121518.25837802 21BrehmM, SamaniegoLA, BonneauRH, DeLucaNA, TevethiaSS. Immunogenicity of" exact="herpes simplex" post="virus type 1 mutants containing deletions in one or"/>
   <result pre="activity improves the immunogenicity and protective capacity of a replication�?incompetent" exact="herpes simplex" post="virus type 1 vaccine strain. J Virol. 2000;74:11137�?11144.11070010 23HuK,"/>
   <result pre="containing DNA vaccine pRSC�?gD�?IL�?21 confers protection against mucosal challenge with" exact="herpes simplex" post="virus type 1 in mice. Vaccine. 2011;29(7):1455�?1462.21185849 24DuttonJL, LiB,"/>
   <result pre="A novel DNA vaccine technology conveying protection against a lethal" exact="herpes simplex" post="viral challenge in mice. PLoS ONE. 2013;8(10):e76407.24098493 25VeselenakRL, ShlapoberskyM,"/>
   <result pre="by HSV�?1, an update. Virol J. 2016;13(1):38.26952111 29WeirJP. Regulation of" exact="herpes simplex" post="virus gene expression. Gene. 2011;271:117�?130. 30MillerCSDR, JacobRJ. Molecular aspects"/>
   <result pre="virus gene expression. Gene. 2011;271:117�?130. 30MillerCSDR, JacobRJ. Molecular aspects of" exact="herpes simplex" post="virus I latency, reactivation, and recurrence. Crit Rev Oral"/>
   <result pre="Oral Biol Med. 1998;9(4):541�?562.9825226 31Al�?DujailiLJ, ClerkinPP, ClementC, et al. Ocular" exact="herpes simplex" post="virus: how are latency, reactivation, recurrent disease and therapy"/>
   <result pre="36MelchjorsenJ, SirenJ, JulkunenI, PaludanSR, MatikainenS. Induction of cytokine expression by" exact="herpes simplex" post="virus in human monocyte�?derived macrophages and dendritic cells is"/>
   <result pre="2006;87(5):1099�?1108.16603509 37ChewT, TaylorKE, MossmanKL. Innate and adaptive immune responses to" exact="herpes simplex" post="virus. Viruses. 2009;1(3):979�?1002.21994578 38LucindaN, FigueiredoMM, PessoaNL, et al. Dendritic"/>
   <result pre="2009;5(5):e1000392.19478997 41DolanA, JamiesonFE, CunninghamC, BarnettBC, McGeochDJ. The genome sequence of" exact="herpes simplex" post="virus type 2. J Virol. 1998;72:2010�?2021.9499055 42WellerSK, CoenDM. Herpes"/>
   <result pre="J Virol. 2015;89(16):8206�?8218.26018161 44LoretS, GuayG, LippeR. Comprehensive characterization of extracellular" exact="herpes simplex" post="virus type 1 virions. J Virol. 2008;82(17):8605�?8618.18596102 45AkhtarJ, ShuklaD."/>
   <result pre="45AkhtarJ, ShuklaD. Viral entry mechanisms: cellular and viral mediators of" exact="herpes simplex" post="virus entry. FEBS J. 2009;276(24):7228�?7236.19878306 46ChiangHS, LiuHM. The molecular"/>
   <result pre="Front Immunol. 2019;9:3086.30671058 47Kurt�?JonesEA, OrzalliMH, KnipeDM. Innate immune mechanisms and" exact="herpes simplex" post="virus infection and disease. Adv Anat Embryol Cell Biol."/>
   <result pre="Microbiol. 2004;6(5):401�?410.15056211 51SatohT, AriiJ, SuenagaT, et al. PILRalpha is a" exact="herpes simplex" post="virus�?1 entry coreceptor that associates with glycoprotein B. Cell."/>
   <result pre="ArgnaniR, AndersonDB, ZucchiniS, ManservigiR, GloriosoJC. Heparan sulfate proteoglycan binding by" exact="herpes simplex" post="virus type 1 glycoproteins B and C, which differ"/>
   <result pre="(gC), H (gH) and L (gL) are associated with enhanced" exact="herpes simplex" post="virus type�?1 (McKrae) entry via the paired immunoglobulin�?like type�?2"/>
   <result pre="et al. Soluble V domain of nectin�?1/HveC enables entry of" exact="herpes simplex" post="virus type 1 (HSV�?1) into HSV�?resistant cells by binding"/>
   <result pre="et al. A novel role for 3�?O�?sulfated heparan sulfate in" exact="herpes simplex" post="virus 1 entry. Cell. 1999;99(1):13�?22.10520990 56HeldweinEE. gH/gL supercomplexes at"/>
   <result pre="tuned fusion machine. Viruses. 2015;7(12):6552�?6569.26690469 58RogalinHB, HeldweinEE. Interplay between the" exact="herpes simplex" post="virus 1 gB cytodomain and the gH cytotail during"/>
   <result pre="Virol. 2015;89(24):12262�?12272.26401042 59AltgärdeN, ErikssonC, PeerboomN, et al. Mucin�?like region of" exact="herpes simplex" post="virus type 1 attachment protein glycoprotein C (gC) modulates"/>
   <result pre="Sci U S A. 2015;112(29):E3901�?E3910.26157134 61KalamvokiM, DeschampsT. Extracellular vesicles during" exact="herpes simplex" post="virus type 1 infection: an inquire. Virol J. 2016;13(1):63.27048572"/>
   <result pre="HVEM expressions in circulating CD4(+) and CD8(+) T cells in" exact="hepatocellular carcinoma" post="patients. J Immunol Res. 2018;2018: 4561571. 10.1155/2018/4561571 65DesaiP, AbboudG,"/>
   <result pre="mucosal immunity. J Immunol. 2017;199(8):2968�?2975.28864473 66DaiX, ZhouZH. Structure of the" exact="herpes simplex" post="virus 1 capsid with associated tegument protein complexes. Science."/>
   <result pre="of herpesviruses. Virus Res. 2015;210:308�?317.26365681 68SpearPG, RoizmanB. Proteins specified by" exact="herpes simplex" post="virus. V. Purification and structural proteins of the herpes"/>
   <result pre="J Virol. 1972;9(1):143�?159.4110104 69HeineJW, HonessRW, CassaiE, RoizmanB. Proteins specified by" exact="herpes simplex" post="virus. XII. The virion polypeptides of type 1 strains."/>
   <result pre="of the capsid vertex�?specific component at the capsid�?tegument interface of" exact="herpes simplex" post="virus 1. J Virol. 2015;89(3):1502�?1511.25410861 75CardoneG, NewcombWW, ChengN, et"/>
   <result pre="75CardoneG, NewcombWW, ChengN, et al. The UL36 tegument protein of" exact="herpes simplex" post="virus 1 has a composite binding site at the"/>
   <result pre="Virol. 2012;86(8):4058�?4064.22345483 76WangS, MottKR, WawrowskyK, KousoulasKG, LuscherB, GhiasiH. Binding of" exact="herpes simplex" post="virus 1 UL20 to GODZ (DHHC3) affects its palmitoylation"/>
   <result pre="DouglasMW, CunninghamAL, DiefenbachRJ. Determination of interactions between tegument proteins of" exact="herpes simplex" post="virus type 1. J Virol. 2005;79(15):9566�?9571.16014918 79MbongEF, WoodleyL, DunkerleyE,"/>
   <result pre="2005;79(15):9566�?9571.16014918 79MbongEF, WoodleyL, DunkerleyE, SchrimpfJE, MorrisonLA, DuffyC. Deletion of the" exact="herpes simplex" post="virus 1 UL49 gene results in mRNA and protein"/>
   <result pre="J Virol. 2012;86(22):12351�?12361.22951838 80MossmanK, SherburneR, LaveryC, DuncanJ, SmileyJR. Evidence that" exact="herpes simplex" post="virus VP16 is required for viral egress downstream of"/>
   <result pre="81SvobodovaS, BellS, CrumpCM. Analysis of the interaction between the essential" exact="herpes simplex" post="virus 1 tegument proteins VP16 and VP1/2. J Virol."/>
   <result pre="Cell Biol. 1997;17(12):7108�?71018.9372942 85DauberB, PoonD, dos SantosT, et al. The" exact="herpes simplex" post="virus virion host shutoff protein enhances translation of viral"/>
   <result pre="its mRNA. Virol J. 2015;12(1):203.26625984 87RollerRJ, HaugoAC, YangK, BainesJD. The" exact="herpes simplex" post="virus 1 UL51 gene product has cell type�?specific functions"/>
   <result pre="al. Dual function of the pUL7�?pUL51 tegument protein complex in" exact="herpes simplex" post="virus 1 infection. J Virol. 2017;91(2):e02196�?e02116.27852850 89RollerRJ, FettersR. The"/>
   <result pre="simplex virus 1 infection. J Virol. 2017;91(2):e02196�?e02116.27852850 89RollerRJ, FettersR. The" exact="herpes simplex" post="virus 1 UL51 protein interacts with the UL7 protein"/>
   <result pre="al. The mutated tegument protein UL7 attenuates the virulence of" exact="herpes simplex" post="virus 1 by reducing the modulation of alpha�?4 gene"/>
   <result pre="GuoY, FanS, et al. Attenuated phenotypes and analysis of a" exact="herpes simplex" post="virus 1 strain with partial deletion of the UL7,"/>
   <result pre="genes. Virol Sin. 2017;32(5):404�?414.28971351 92StrunkU, SaffranHA, WuFW, SmileyJR. Role of" exact="herpes simplex" post="virus VP11/12 tyrosine�?based motifs in binding and activation of"/>
   <result pre="2013;87(20):11276�?11286.23946459 93ChadhaP, SarfoA, ZhangD, et al. Domain interaction studies of" exact="herpes simplex" post="virus 1 tegument protein UL16 reveal its interaction with"/>
   <result pre="IbanezFJ, Retamal�?DiazAR, et al. Evasion of early antiviral responses by" exact="herpes simplex" post="viruses. Mediators Inflamm. 2015;2015:593757.25918478 98KoyanagiN, ImaiT, ShindoK, et al."/>
   <result pre="2017;127(10):3784�?3795.28891812 99YangY, WuS, WangY, et al. The Us3 protein of" exact="herpes simplex" post="virus 1 inhibits T cell signaling by confining linker"/>
   <result pre="interferon (IFN�?α β) signaling in astrocytes mediates protection against viral" exact="encephalomyelitis" post="and regulates IFN�?γ�?dependent responses. J Virol. 2018;92:e01901�?e01917.29491163 101ChengL, YuH,"/>
   <result pre="102RasmussenSB, SorensenLN, MalmgaardL, et al. Type I interferon production during" exact="herpes simplex" post="virus infection is controlled by cell�?type�?specific viral recognition through"/>
   <result pre="RIG�?I and MDA�?5. J Virol. 2012;86(7):3528�?3540.22301138 105MaY, HeB. Recognition of" exact="herpes simplex" post="viruses: toll�?like receptors and beyond. J Mol Biol. 2014;426(6):1133�?1147.24262390"/>
   <result pre="the antiviral effector tetherin. Mucosal Immunol. 2016;9(4):1065�?1075.26627457 107FatahzadehM, SchwartzRA. Human" exact="herpes simplex" post="virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J"/>
   <result pre="The immediate�?early protein, ICP0, is essential for the resistance of" exact="herpes simplex" post="virus to interferon�?alpha/beta. Virology. 2002;293(2):295�?304.11886249 109ZhangJ, WangK, WangS, ZhengC."/>
   <result pre="CBP. J Virol. 2013;87(17):9788�?9801.23824799 116ManivanhR, MehrbachJ, KnipeDM, LeibDA. Role of" exact="herpes simplex" post="virus 1 γ34.5 in the regulation of IRF3 signaling."/>
   <result pre="beta play a critical role in the resistance against lethal" exact="herpes simplex" post="virus encephalitis. J Infect Dis. 2007;196(6):853�?860.17703415 120SchmitzJ, OwyangA, OldhamE,"/>
   <result pre="the rules of programmed cell death to improve therapy of" exact="cancer" post="and other diseases. EMBO J. 2011;30(18):3667�?3683.21863020 124MartineA, JenniferO, JohnAB."/>
   <result pre="Induction and prevention of apoptosis in human HEp�?2 cells by" exact="herpes simplex" post="virus type 1. J Virol. 1999;73(12):10359�?10370.10559354 125JiangX, WangX. Cytochrome"/>
   <result pre="Harb Perspect Biol. 2013;5:a008722.23378584 129YuX, HeS. The interplay between human" exact="herpes simplex" post="virus infection and the apoptosis and necroptosis cell death"/>
   <result pre="Virol J. 2016;13(1):77.27154074 130MediciMA, SciortinoMT, PerriD, et al. Protection by" exact="herpes simplex" post="virus glycoprotein D against Fas�?mediated apoptosis. J Biol Chem."/>
   <result pre="XIAP and Bax involved in apoptosis in cells infected with" exact="herpes simplex" post="virus 1 and effect of pavine alkaloid (�?)�?thalimonine on"/>
   <result pre="virus 1 and effect of pavine alkaloid (�?)�?thalimonine on virus�?induced" exact="suppression" post="of apoptosis. Acta Virol. 2004;48:193�?196.15595215 133MoriI, GoshimaF, WatanabeD, et"/>
   <result pre="136MoriaI, GoshimaF, KoshizukaT, et al. The US3 protein kinase of" exact="herpes simplex" post="virus attenuates the activation of the c�?Jun N�?terminal protein"/>
   <result pre="apoptosis in HeLa cells. J Virol. 2009;83(4):1767�?1777.19073744 140AubertM, BlahoJA. The" exact="herpes simplex" post="virus type 1 regulatory protein ICP27 is required for"/>
   <result pre="TurzaNM, KobeltDJ, et al. Infection of mature dendritic cells with" exact="herpes simplex" post="virus type 1 dramatically reduces lymphoid chemokine�?mediated migration. J"/>
   <result pre="BosnjakL, CunninghamAL. Immature monocyte�?derived dendritic cells are productively infected with" exact="herpes simplex" post="virus type 1. J Virol. 2001;75(13):5958�?5964.11390597 145WuB, GengS, BiY,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="1-part\PMC6773679\results\search\disease\results.xml">
   <result pre="syncytial virus infection, ranging from mild respiratory illnesses to severe" exact="bronchiolitis" post="and pneumonia4,7. Children under five years, aged adults, and"/>
   <result pre="cough (69, 90.8%), sore throat (38, 50.0%), expectoration (16, 90.8%)," exact="shortness" post="of breath (10, 13.2%) and nasal discharge (6, 7.9%)."/>
   <result pre="epidemic control and potential vaccine design. Viruses like H3N2 seasonal" exact="influenza" post="virus are highly transmissible, and a new adaptive variant"/>
   <result pre="transportation data to predict the global transmission dynamics of human" exact="influenza" post="H3N2PLoS Pathog.201410e100393210.1371/journal.ppat.100393224586153 36.RegevLet al.Characterization of Human Metapneumovirus Infections in"/>
   <result pre="Influenza A (H3N2) VirusesScience200832034034610.1126/science.115413718420927 39.BedfordTet al.Global circulation patterns of seasonal" exact="influenza" post="viruses vary with antigenic driftNature201552321722010.1038/nature1446026053121 40.RambautAet al.The genomic and"/>
   <result pre="antigenic driftNature201552321722010.1038/nature1446026053121 40.RambautAet al.The genomic and epidemiological dynamics of human" exact="influenza" post="A virusNature200845361561910.1038/nature0694518418375 41.ThaoNTTet al.Evolution and Spatiotemporal Dynamics of Enterovirus"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
